ID   MEOX2_HUMAN             Reviewed;         304 AA.
AC   P50222; A4D127; B2R8I7; O75263; Q9UPL6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 2.
DT   25-OCT-2017, entry version 159.
DE   RecName: Full=Homeobox protein MOX-2;
DE   AltName: Full=Growth arrest-specific homeobox;
DE   AltName: Full=Mesenchyme homeobox 2;
GN   Name=MEOX2; Synonyms=GAX, MOX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-80 DEL.
RC   TISSUE=Embryo;
RX   PubMed=7607679; DOI=10.1016/0888-7543(95)80174-K;
RA   Grigoriou M., Kastrinaki M.-C., Modi W., Theodorakis K., Mankoo B.,
RA   Pachnis V., Karagogeos D.;
RT   "Isolation of the human MOX2 homeobox gene and localization to
RT   chromosome 7p22.1-p21.3.";
RL   Genomics 26:550-555(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT 79-HIS-HIS-80 DEL.
RC   TISSUE=Heart;
RX   PubMed=7713505; DOI=10.1006/geno.1994.1663;
RA   Lepage D.F., Walsh K.;
RT   "Molecular cloning and localization of the human GAX gene to 7p21.";
RL   Genomics 24:535-540(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-80 DEL.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT HIS-80 DEL.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-80 DEL.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH RNF10.
RX   PubMed=16335786; DOI=10.1007/s11010-005-0823-3;
RA   Lin J., Friesen M.T., Bocangel P., Cheung D., Rawszer K., Wigle J.T.;
RT   "Characterization of Mesenchyme Homeobox 2 (MEOX2) transcription
RT   factor binding to RING finger protein 10.";
RL   Mol. Cell. Biochem. 275:75-84(2005).
RN   [8]
RP   POLY-HIS POLYMORPHISM.
RX   PubMed=19760604; DOI=10.1002/gcc.20705;
RA   Ohshima J., Haruta M., Arai Y., Kasai F., Fujiwara Y., Ariga T.,
RA   Okita H., Fukuzawa M., Hata J., Horie H., Kaneko Y.;
RT   "Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified
RT   in a 7p21 homozygous deletion region in a Wilms tumor.";
RL   Genes Chromosomes Cancer 48:1037-1050(2009).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19266028; DOI=10.1371/journal.pgen.1000397;
RA   Salichs E., Ledda A., Mularoni L., Alba M.M., de la Luna S.;
RT   "Genome-wide analysis of histidine repeats reveals their role in the
RT   localization of human proteins to the nuclear speckles compartment.";
RL   PLoS Genet. 5:E1000397-E1000397(2009).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLN-236.
RX   PubMed=22206000; DOI=10.1371/journal.pone.0029099;
RA   Douville J.M., Cheung D.Y., Herbert K.L., Moffatt T., Wigle J.T.;
RT   "Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent
RT   kinase inhibitors p21 and p16 in vascular endothelial cells.";
RL   PLoS ONE 6:E29099-E29099(2011).
CC   -!- FUNCTION: Mesodermal transcription factor that plays a key role in
CC       somitogenesis and is required for sclerotome development (By
CC       similarity). Activates expression of CDKN1A and CDKN2A in
CC       endothelial cells, acting as a regulator of vascular cell
CC       proliferation. While it activates CDKN1A in a DNA-dependent
CC       manner, it activates CDKN2A in a DNA-independent manner
CC       (PubMed:22206000). May have a regulatory role when quiescent
CC       vascular smooth muscle cells reenter the cell cycle.
CC       {ECO:0000250|UniProtKB:P32443, ECO:0000269|PubMed:22206000}.
CC   -!- SUBUNIT: Interacts with RNF10. {ECO:0000269|PubMed:16335786}.
CC   -!- INTERACTION:
CC       Q6ZVW3:-; NbExp=3; IntAct=EBI-748397, EBI-10255586;
CC       Q7Z783:-; NbExp=3; IntAct=EBI-748397, EBI-9088990;
CC       Q9NWJ2:-; NbExp=3; IntAct=EBI-748397, EBI-10315029;
CC       O43707:ACTN4; NbExp=3; IntAct=EBI-748397, EBI-351526;
CC       P58397:ADAMTS12; NbExp=3; IntAct=EBI-748397, EBI-9028051;
CC       Q99943:AGPAT1; NbExp=3; IntAct=EBI-748397, EBI-3893468;
CC       O43865:AHCYL1; NbExp=3; IntAct=EBI-748397, EBI-2371423;
CC       Q719I0:AHSA2; NbExp=3; IntAct=EBI-748397, EBI-9361704;
CC       Q92688:ANP32B; NbExp=3; IntAct=EBI-748397, EBI-762428;
CC       Q6P4J0:ARD1A; NbExp=3; IntAct=EBI-748397, EBI-10252815;
CC       Q14155:ARHGEF7; NbExp=3; IntAct=EBI-748397, EBI-717515;
CC       Q9NXU5:ARL15; NbExp=4; IntAct=EBI-748397, EBI-711759;
CC       Q8WYA1-3:ARNTL2; NbExp=4; IntAct=EBI-748397, EBI-12268276;
CC       A9UGY9:ATG5; NbExp=3; IntAct=EBI-748397, EBI-10175276;
CC       O60909-2:B4GALT2; NbExp=4; IntAct=EBI-748397, EBI-12261054;
CC       Q5TBC7:BCL2L15; NbExp=3; IntAct=EBI-748397, EBI-10247136;
CC       Q06187:BTK; NbExp=3; IntAct=EBI-748397, EBI-624835;
CC       Q9NX04:C1orf109; NbExp=5; IntAct=EBI-748397, EBI-8643161;
CC       Q9H257:CARD9; NbExp=3; IntAct=EBI-748397, EBI-751319;
CC       P31944:CASP14; NbExp=3; IntAct=EBI-748397, EBI-2510738;
CC       Q8IW40:CCDC103; NbExp=5; IntAct=EBI-748397, EBI-10261970;
CC       Q8IYE1:CCDC13; NbExp=4; IntAct=EBI-748397, EBI-10961312;
CC       P24863:CCNC; NbExp=5; IntAct=EBI-748397, EBI-395261;
CC       Q8IYX8-2:CEP57L1; NbExp=3; IntAct=EBI-748397, EBI-10181988;
CC       Q9UKJ5:CHIC2; NbExp=5; IntAct=EBI-748397, EBI-741528;
CC       Q9H2X0:CHRD; NbExp=5; IntAct=EBI-748397, EBI-947551;
CC       P07510-2:CHRNG; NbExp=3; IntAct=EBI-748397, EBI-11979451;
CC       Q6FI81:CIAPIN1; NbExp=3; IntAct=EBI-748397, EBI-750511;
CC       Q96Q77:CIB3; NbExp=7; IntAct=EBI-748397, EBI-10292696;
CC       Q9UHC6:CNTNAP2; NbExp=3; IntAct=EBI-748397, EBI-310892;
CC       Q14055:COL9A2; NbExp=4; IntAct=EBI-748397, EBI-714971;
CC       O95741:CPNE6; NbExp=3; IntAct=EBI-748397, EBI-719005;
CC       Q9UBL6-2:CPNE7; NbExp=4; IntAct=EBI-748397, EBI-12012272;
CC       O95639:CPSF4; NbExp=3; IntAct=EBI-748397, EBI-725860;
CC       Q9UGL9:CRCT1; NbExp=3; IntAct=EBI-748397, EBI-713677;
CC       Q9Y534:CSDC2; NbExp=3; IntAct=EBI-748397, EBI-1763657;
CC       P04141:CSF2; NbExp=6; IntAct=EBI-748397, EBI-1809826;
CC       P68400:CSNK2A1; NbExp=4; IntAct=EBI-748397, EBI-347804;
CC       Q8WYA6:CTNNBL1; NbExp=3; IntAct=EBI-748397, EBI-748128;
CC       Q9P0U4:CXXC1; NbExp=3; IntAct=EBI-748397, EBI-949911;
CC       Q8WYQ5:DGCR8; NbExp=3; IntAct=EBI-748397, EBI-528411;
CC       Q9NVM6:DNAJC17; NbExp=4; IntAct=EBI-748397, EBI-12260682;
CC       Q8NF50:DOCK8; NbExp=3; IntAct=EBI-748397, EBI-2548605;
CC       Q96FJ2:DYNLL2; NbExp=3; IntAct=EBI-748397, EBI-742371;
CC       O60869:EDF1; NbExp=3; IntAct=EBI-748397, EBI-781301;
CC       Q12805:EFEMP1; NbExp=5; IntAct=EBI-748397, EBI-536772;
CC       O95967:EFEMP2; NbExp=3; IntAct=EBI-748397, EBI-743414;
CC       P52797:EFNA3; NbExp=3; IntAct=EBI-748397, EBI-722730;
CC       Q8N9N8:EIF1AD; NbExp=3; IntAct=EBI-748397, EBI-750700;
CC       P63241:EIF5A; NbExp=5; IntAct=EBI-748397, EBI-373150;
CC       Q9NPA0:EMC7; NbExp=4; IntAct=EBI-748397, EBI-6309137;
CC       P50402:EMD; NbExp=5; IntAct=EBI-748397, EBI-489887;
CC       Q7L775:EPM2AIP1; NbExp=7; IntAct=EBI-748397, EBI-6255981;
CC       P62508:ESRRG; NbExp=3; IntAct=EBI-748397, EBI-2834260;
CC       Q8NE31:FAM13C; NbExp=3; IntAct=EBI-748397, EBI-751248;
CC       Q9BU27:FAM3A; NbExp=3; IntAct=EBI-748397, EBI-10298603;
CC       Q5TZK3:FAM74A6; NbExp=5; IntAct=EBI-748397, EBI-10247271;
CC       Q8TES7-6:FBF1; NbExp=3; IntAct=EBI-748397, EBI-10244131;
CC       Q9UBX5:FBLN5; NbExp=3; IntAct=EBI-748397, EBI-947897;
CC       O75344:FKBP6; NbExp=5; IntAct=EBI-748397, EBI-744771;
CC       Q6PIV2:FOXR1; NbExp=3; IntAct=EBI-748397, EBI-10253815;
CC       Q9BTY2:FUCA2; NbExp=3; IntAct=EBI-748397, EBI-9050116;
CC       Q495W5:FUT11; NbExp=3; IntAct=EBI-748397, EBI-2907712;
CC       Q13065:GAGE1; NbExp=3; IntAct=EBI-748397, EBI-10227730;
CC       P36383:GJC1; NbExp=4; IntAct=EBI-748397, EBI-11979659;
CC       Q8NEA9:GMCL1P1; NbExp=5; IntAct=EBI-748397, EBI-745707;
CC       Q6PKC0:GMPR2; NbExp=3; IntAct=EBI-748397, EBI-10254128;
CC       Q53Y01:GNG11; NbExp=3; IntAct=EBI-748397, EBI-10243023;
CC       Q0D2H9:GOLGA8DP; NbExp=5; IntAct=EBI-748397, EBI-10181276;
CC       Q08AF8:GOLGA8G; NbExp=3; IntAct=EBI-748397, EBI-10181260;
CC       Q9NWQ4:GPATCH2L; NbExp=3; IntAct=EBI-748397, EBI-5666657;
CC       Q9Y4H4:GPSM3; NbExp=3; IntAct=EBI-748397, EBI-347538;
CC       O14929:HAT1; NbExp=5; IntAct=EBI-748397, EBI-2339359;
CC       O14929-2:HAT1; NbExp=3; IntAct=EBI-748397, EBI-10181798;
CC       Q9H0R4:HDHD2; NbExp=3; IntAct=EBI-748397, EBI-10304657;
CC       Q96MH2:HEXIM2; NbExp=5; IntAct=EBI-748397, EBI-5460660;
CC       P14210:HGF; NbExp=3; IntAct=EBI-748397, EBI-1039104;
CC       P04440:HLA-DPB1; NbExp=4; IntAct=EBI-748397, EBI-2802503;
CC       Q86VS8:HOOK3; NbExp=4; IntAct=EBI-748397, EBI-1777078;
CC       Q5SSJ5:HP1BP3; NbExp=3; IntAct=EBI-748397, EBI-2880687;
CC       P28566:HTR1E; NbExp=3; IntAct=EBI-748397, EBI-1043151;
CC       Q86VF2:IGFN1; NbExp=3; IntAct=EBI-748397, EBI-10259767;
CC       P01583:IL1A; NbExp=3; IntAct=EBI-748397, EBI-1749782;
CC       Q9UHH9:IP6K2; NbExp=3; IntAct=EBI-748397, EBI-747509;
CC       O43736:ITM2A; NbExp=3; IntAct=EBI-748397, EBI-2431769;
CC       Q9BX67:JAM3; NbExp=4; IntAct=EBI-748397, EBI-4314733;
CC       Q92993:KAT5; NbExp=3; IntAct=EBI-748397, EBI-399080;
CC       Q2M2Z5:KIZ; NbExp=3; IntAct=EBI-748397, EBI-2554344;
CC       Q9NSK0:KLC4; NbExp=3; IntAct=EBI-748397, EBI-949319;
CC       Q2WGJ6:KLHL38; NbExp=3; IntAct=EBI-748397, EBI-6426443;
CC       Q6KB66:KRT80; NbExp=3; IntAct=EBI-748397, EBI-3046635;
CC       O43790:KRT86; NbExp=3; IntAct=EBI-748397, EBI-9996498;
CC       P60412:KRTAP10-11; NbExp=5; IntAct=EBI-748397, EBI-10217483;
CC       P60370:KRTAP10-5; NbExp=5; IntAct=EBI-748397, EBI-10172150;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-748397, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=6; IntAct=EBI-748397, EBI-10172052;
CC       P59990:KRTAP12-1; NbExp=5; IntAct=EBI-748397, EBI-10210845;
CC       P60329:KRTAP12-4; NbExp=5; IntAct=EBI-748397, EBI-10176396;
CC       Q9BYQ6:KRTAP4-11; NbExp=5; IntAct=EBI-748397, EBI-10302392;
CC       Q9BQ66:KRTAP4-12; NbExp=3; IntAct=EBI-748397, EBI-739863;
CC       Q9BYR5:KRTAP4-2; NbExp=5; IntAct=EBI-748397, EBI-10172511;
CC       Q9BYR0:KRTAP4-7; NbExp=3; IntAct=EBI-748397, EBI-10302547;
CC       Q6L8G9:KRTAP5-6; NbExp=5; IntAct=EBI-748397, EBI-10250562;
CC       P26371:KRTAP5-9; NbExp=5; IntAct=EBI-748397, EBI-3958099;
CC       Q9BYQ4:KRTAP9-2; NbExp=5; IntAct=EBI-748397, EBI-1044640;
CC       Q86UP2:KTN1; NbExp=3; IntAct=EBI-748397, EBI-359761;
CC       A0A0C4DGV4:LAMTOR5; NbExp=3; IntAct=EBI-748397, EBI-10173304;
CC       O43561-2:LAT; NbExp=4; IntAct=EBI-748397, EBI-8070286;
CC       Q5T7P3:LCE1B; NbExp=3; IntAct=EBI-748397, EBI-10245913;
CC       Q5TA79:LCE2A; NbExp=5; IntAct=EBI-748397, EBI-10246607;
CC       Q5TA78:LCE4A; NbExp=3; IntAct=EBI-748397, EBI-10246358;
CC       Q9Y333:LSM2; NbExp=3; IntAct=EBI-748397, EBI-347416;
CC       Q9Y5V3:MAGED1; NbExp=3; IntAct=EBI-748397, EBI-716006;
CC       O60336:MAPKBP1; NbExp=5; IntAct=EBI-748397, EBI-947402;
CC       P53582:METAP1; NbExp=4; IntAct=EBI-748397, EBI-1051435;
CC       Q6NSB6:MKRN3; NbExp=3; IntAct=EBI-748397, EBI-10195599;
CC       Q6P2C6:MLLT6; NbExp=3; IntAct=EBI-748397, EBI-5773143;
CC       P08254:MMP3; NbExp=3; IntAct=EBI-748397, EBI-6957351;
CC       Q6PF18:MORN3; NbExp=3; IntAct=EBI-748397, EBI-9675802;
CC       Q96HT8:MRFAP1L1; NbExp=3; IntAct=EBI-748397, EBI-748896;
CC       Q96DH6:MSI2; NbExp=3; IntAct=EBI-748397, EBI-2462339;
CC       A1L3X4:MT1DP; NbExp=5; IntAct=EBI-748397, EBI-10172129;
CC       Q9H6H2:MUM1; NbExp=3; IntAct=EBI-748397, EBI-10307610;
CC       P41227:NAA10; NbExp=5; IntAct=EBI-748397, EBI-747693;
CC       Q8IZF0:NALCN; NbExp=3; IntAct=EBI-748397, EBI-7085333;
CC       P61601:NCALD; NbExp=3; IntAct=EBI-748397, EBI-749635;
CC       O43639:NCK2; NbExp=3; IntAct=EBI-748397, EBI-713635;
CC       P20783:NTF3; NbExp=3; IntAct=EBI-748397, EBI-1025994;
CC       Q14990:ODF1; NbExp=4; IntAct=EBI-748397, EBI-10234557;
CC       Q8WWZ8:OIT3; NbExp=5; IntAct=EBI-748397, EBI-10277776;
CC       Q99784-3:OLFM1; NbExp=4; IntAct=EBI-748397, EBI-12304423;
CC       Q9UJX0:OSGIN1; NbExp=3; IntAct=EBI-748397, EBI-9057006;
CC       Q7Z4N8:P4HA3; NbExp=3; IntAct=EBI-748397, EBI-10181968;
CC       Q9UNF0:PACSIN2; NbExp=5; IntAct=EBI-748397, EBI-742503;
CC       Q7Z2X7:PAGE2; NbExp=3; IntAct=EBI-748397, EBI-10256818;
CC       Q9NWT1:PAK1IP1; NbExp=4; IntAct=EBI-748397, EBI-7641942;
CC       Q9HBI0:PARVG; NbExp=5; IntAct=EBI-748397, EBI-3921217;
CC       Q92824:PCSK5; NbExp=3; IntAct=EBI-748397, EBI-751290;
CC       Q96JS3:PGBD1; NbExp=6; IntAct=EBI-748397, EBI-10290053;
CC       Q13526:PIN1; NbExp=5; IntAct=EBI-748397, EBI-714158;
CC       Q549H9:PKIG; NbExp=3; IntAct=EBI-748397, EBI-10243311;
CC       O15305:PMM2; NbExp=4; IntAct=EBI-748397, EBI-10182608;
CC       Q96T60:PNKP; NbExp=4; IntAct=EBI-748397, EBI-1045072;
CC       A1L4L9:POM121C; NbExp=3; IntAct=EBI-748397, EBI-10172978;
CC       P62140:PPP1CB; NbExp=4; IntAct=EBI-748397, EBI-352350;
CC       O43741:PRKAB2; NbExp=3; IntAct=EBI-748397, EBI-1053424;
CC       A6NJB7:PRR19; NbExp=3; IntAct=EBI-748397, EBI-10174045;
CC       P40306:PSMB10; NbExp=3; IntAct=EBI-748397, EBI-603329;
CC       P62191:PSMC1; NbExp=3; IntAct=EBI-748397, EBI-357598;
CC       Q53XL8:PSMC1; NbExp=3; IntAct=EBI-748397, EBI-10242995;
CC       O00487:PSMD14; NbExp=3; IntAct=EBI-748397, EBI-722193;
CC       O00233:PSMD9; NbExp=4; IntAct=EBI-748397, EBI-750973;
CC       P43115-12:PTGER3; NbExp=3; IntAct=EBI-748397, EBI-10234038;
CC       P10826-2:RARB; NbExp=3; IntAct=EBI-748397, EBI-8583223;
CC       Q96PM5:RCHY1; NbExp=3; IntAct=EBI-748397, EBI-947779;
CC       Q6P9E2:RECK; NbExp=5; IntAct=EBI-748397, EBI-10253121;
CC       Q52LD8:RFTN2; NbExp=4; IntAct=EBI-748397, EBI-12278276;
CC       Q9H4E5:RHOJ; NbExp=3; IntAct=EBI-748397, EBI-6285694;
CC       Q9H871:RMND5A; NbExp=3; IntAct=EBI-748397, EBI-2797992;
CC       P61313:RPL15; NbExp=5; IntAct=EBI-748397, EBI-443462;
CC       P62829:RPL23; NbExp=4; IntAct=EBI-748397, EBI-353303;
CC       Q06455-4:RUNX1T1; NbExp=3; IntAct=EBI-748397, EBI-10224192;
CC       Q9NUL5:RYDEN; NbExp=3; IntAct=EBI-748397, EBI-10313866;
CC       Q9BWG6:SCNM1; NbExp=3; IntAct=EBI-748397, EBI-748391;
CC       O00560:SDCBP; NbExp=4; IntAct=EBI-748397, EBI-727004;
CC       Q01105:SET; NbExp=3; IntAct=EBI-748397, EBI-1053182;
CC       Q9H788:SH2D4A; NbExp=4; IntAct=EBI-748397, EBI-747035;
CC       O00241-2:SIRPB1; NbExp=3; IntAct=EBI-748397, EBI-10179231;
CC       Q6P1K1:SLC48A1; NbExp=3; IntAct=EBI-748397, EBI-1222191;
CC       P84022:SMAD3; NbExp=6; IntAct=EBI-748397, EBI-347161;
CC       Q969G3:SMARCE1; NbExp=7; IntAct=EBI-748397, EBI-455078;
CC       Q8NB12:SMYD1; NbExp=4; IntAct=EBI-748397, EBI-8463848;
CC       P10451:SPP1; NbExp=3; IntAct=EBI-748397, EBI-723648;
CC       O43609:SPRY1; NbExp=5; IntAct=EBI-748397, EBI-3866665;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-748397, EBI-742487;
CC       Q99909:SSX3; NbExp=3; IntAct=EBI-748397, EBI-10295431;
CC       O75716:STK16; NbExp=3; IntAct=EBI-748397, EBI-749295;
CC       O75558:STX11; NbExp=3; IntAct=EBI-748397, EBI-714135;
CC       O14662:STX16; NbExp=3; IntAct=EBI-748397, EBI-2853548;
CC       P61764:STXBP1; NbExp=3; IntAct=EBI-748397, EBI-960169;
CC       Q9BSW7:SYT17; NbExp=7; IntAct=EBI-748397, EBI-745392;
CC       Q53T94:TAF1B; NbExp=4; IntAct=EBI-748397, EBI-1560239;
CC       Q5QJ74:TBCEL; NbExp=3; IntAct=EBI-748397, EBI-10244795;
CC       Q15560:TCEA2; NbExp=5; IntAct=EBI-748397, EBI-710310;
CC       A0A024R6G0:TCL6; NbExp=3; IntAct=EBI-748397, EBI-10173366;
CC       Q8N7M0:TCTEX1D1; NbExp=3; IntAct=EBI-748397, EBI-10267606;
CC       P01137:TGFB1; NbExp=3; IntAct=EBI-748397, EBI-779636;
CC       Q86XR7:TICAM2; NbExp=3; IntAct=EBI-748397, EBI-525927;
CC       Q9NV29:TMEM100; NbExp=3; IntAct=EBI-748397, EBI-8644968;
CC       Q12888:TP53BP1; NbExp=3; IntAct=EBI-748397, EBI-396540;
CC       Q9Y4K3:TRAF6; NbExp=3; IntAct=EBI-748397, EBI-359276;
CC       Q8WV44:TRIM41; NbExp=7; IntAct=EBI-748397, EBI-725997;
CC       Q8IWZ5:TRIM42; NbExp=5; IntAct=EBI-748397, EBI-5235829;
CC       Q96NG3:TTC25; NbExp=3; IntAct=EBI-748397, EBI-1046387;
CC       Q5VTQ0-4:TTC39B; NbExp=3; IntAct=EBI-748397, EBI-10247626;
CC       Q8N5M4:TTC9C; NbExp=5; IntAct=EBI-748397, EBI-2851213;
CC       P40222:TXLNA; NbExp=3; IntAct=EBI-748397, EBI-359793;
CC       P11441:UBL4A; NbExp=3; IntAct=EBI-748397, EBI-356983;
CC       Q8N7F7:UBL4B; NbExp=3; IntAct=EBI-748397, EBI-10267507;
CC       Q9H3U1:UNC45A; NbExp=5; IntAct=EBI-748397, EBI-1048763;
CC       Q9NZ43:USE1; NbExp=3; IntAct=EBI-748397, EBI-742842;
CC       P11473:VDR; NbExp=3; IntAct=EBI-748397, EBI-286357;
CC       Q8NEX5:WFDC9; NbExp=3; IntAct=EBI-748397, EBI-10270812;
CC       O43543:XRCC2; NbExp=3; IntAct=EBI-748397, EBI-3918457;
CC       O75132:ZBED4; NbExp=3; IntAct=EBI-748397, EBI-2860059;
CC       Q96NC0:ZMAT2; NbExp=3; IntAct=EBI-748397, EBI-2682299;
CC       Q15973:ZNF124; NbExp=5; IntAct=EBI-748397, EBI-2555767;
CC       Q86UD4:ZNF329; NbExp=3; IntAct=EBI-748397, EBI-7233259;
CC       Q494X3:ZNF404; NbExp=3; IntAct=EBI-748397, EBI-10241626;
CC       Q8TAU3:ZNF417; NbExp=5; IntAct=EBI-748397, EBI-740727;
CC       Q6P088:ZNF483; NbExp=3; IntAct=EBI-748397, EBI-10196963;
CC       Q8TBZ8:ZNF564; NbExp=3; IntAct=EBI-748397, EBI-10273713;
CC       Q7Z3I7:ZNF572; NbExp=3; IntAct=EBI-748397, EBI-10172590;
CC       Q96SQ5:ZNF587; NbExp=5; IntAct=EBI-748397, EBI-6427977;
CC       Q8IW36:ZNF695; NbExp=3; IntAct=EBI-748397, EBI-10261951;
CC       Q6ZMS7:ZNF783; NbExp=4; IntAct=EBI-748397, EBI-10254978;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19266028,
CC       ECO:0000269|PubMed:22206000}. Nucleus speckle
CC       {ECO:0000255|PROSITE-ProRule:PRU00108,
CC       ECO:0000269|PubMed:19266028}.
CC   -!- TISSUE SPECIFICITY: Embryo and placenta.
CC   -!- DOMAIN: The polyhistidine repeat may act as a targeting signal to
CC       nuclear speckles. {ECO:0000269|PubMed:19266028}.
CC   -!- POLYMORPHISM: The poly-His region of MEOX2 is polymorphic and the
CC       number of His varies in the population.
CC       {ECO:0000269|PubMed:19760604}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X82629; CAA57949.1; -; mRNA.
DR   EMBL; L36328; AAA58497.1; -; mRNA.
DR   EMBL; AK313386; BAG36184.1; -; mRNA.
DR   EMBL; AC005550; AAC33152.1; -; Genomic_DNA.
DR   EMBL; AC004452; AAC06184.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24289.1; -; Genomic_DNA.
DR   EMBL; BC017021; AAH17021.1; -; mRNA.
DR   CCDS; CCDS34605.1; -.
DR   PIR; A55641; A55641.
DR   PIR; A56837; A56837.
DR   RefSeq; NP_005915.2; NM_005924.4.
DR   UniGene; Hs.170355; -.
DR   ProteinModelPortal; P50222; -.
DR   SMR; P50222; -.
DR   BioGrid; 110386; 212.
DR   IntAct; P50222; 655.
DR   MINT; MINT-202865; -.
DR   STRING; 9606.ENSP00000262041; -.
DR   iPTMnet; P50222; -.
DR   PhosphoSitePlus; P50222; -.
DR   BioMuta; MEOX2; -.
DR   DMDM; 93141286; -.
DR   PaxDb; P50222; -.
DR   PeptideAtlas; P50222; -.
DR   PRIDE; P50222; -.
DR   DNASU; 4223; -.
DR   Ensembl; ENST00000262041; ENSP00000262041; ENSG00000106511.
DR   GeneID; 4223; -.
DR   KEGG; hsa:4223; -.
DR   UCSC; uc003stc.4; human.
DR   CTD; 4223; -.
DR   DisGeNET; 4223; -.
DR   EuPathDB; HostDB:ENSG00000106511.5; -.
DR   GeneCards; MEOX2; -.
DR   H-InvDB; HIX0006493; -.
DR   HGNC; HGNC:7014; MEOX2.
DR   HPA; HPA053793; -.
DR   MIM; 600535; gene.
DR   neXtProt; NX_P50222; -.
DR   OpenTargets; ENSG00000106511; -.
DR   PharmGKB; PA30748; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000230987; -.
DR   HOVERGEN; HBG052456; -.
DR   InParanoid; P50222; -.
DR   KO; K09322; -.
DR   OMA; SWHIPQM; -.
DR   OrthoDB; EOG091G0PFO; -.
DR   PhylomeDB; P50222; -.
DR   TreeFam; TF351603; -.
DR   SIGNOR; P50222; -.
DR   ChiTaRS; MEOX2; human.
DR   GeneWiki; MEOX2; -.
DR   GenomeRNAi; 4223; -.
DR   PRO; PR:P50222; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106511; -.
DR   CleanEx; HS_MEOX2; -.
DR   Genevisible; P50222; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0060173; P:limb development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IGI:BHF-UCL.
DR   GO; GO:0070997; P:neuron death; IMP:UniProtKB.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0061053; P:somite development; IBA:GO_Central.
DR   GO; GO:0001757; P:somite specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Developmental protein; DNA-binding;
KW   Homeobox; Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    304       Homeobox protein MOX-2.
FT                                /FTId=PRO_0000049197.
FT   DNA_BIND    187    246       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     42     47       Poly-Ser.
FT   COMPBIAS     68     80       Poly-His.
FT   COMPBIAS     81     86       Poly-Gln.
FT   VARIANT      79     80       Missing. {ECO:0000269|PubMed:7713505}.
FT                                /FTId=VAR_026040.
FT   VARIANT      80     80       Missing. {ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7607679}.
FT                                /FTId=VAR_026041.
FT   VARIANT     287    287       I -> L (in dbSNP:rs2237493).
FT                                /FTId=VAR_049585.
FT   MUTAGEN     236    236       Q->E: Abolishes DNA-binding. Does not
FT                                affect ability to activate expression of
FT                                CDKN2A. {ECO:0000269|PubMed:22206000}.
FT   CONFLICT     58     58       G -> D (in Ref. 2; AAA58497).
FT                                {ECO:0000305}.
SQ   SEQUENCE   304 AA;  33594 MW;  0C008479D6995389 CRC64;
     MEHPLFGCLR SPHATAQGLH PFSQSSLALH GRSDHMSYPE LSTSSSSCII AGYPNEEGMF
     ASQHHRGHHH HHHHHHHHHH QQQQHQALQT NWHLPQMSSP PSAARHSLCL QPDSGGPPEL
     GSSPPVLCSN SSSLGSSTPT GAACAPGDYG RQALSPAEAE KRSGGKRKSD SSDSQEGNYK
     SEVNSKPRKE RTAFTKEQIR ELEAEFAHHN YLTRLRRYEI AVNLDLTERQ VKVWFQNRRM
     KWKRVKGGQQ GAAAREKELV NVKKGTLLPS ELSGIGAATL QQTGDSIANE DSHDSDHSSE
     HAHL
//
ID   NKX25_HUMAN             Reviewed;         324 AA.
AC   P52952; A8K3K0; B4DNB6; E9PBU6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   25-OCT-2017, entry version 185.
DE   RecName: Full=Homeobox protein Nkx-2.5;
DE   AltName: Full=Cardiac-specific homeobox;
DE   AltName: Full=Homeobox protein CSX;
DE   AltName: Full=Homeobox protein NK-2 homolog E;
GN   Name=NKX2-5; Synonyms=CSX, NKX2.5, NKX2E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=8900537;
RA   Turbay D., Wechsler S.B., Blanchard K.M., Izumo S.;
RT   "Molecular cloning, chromosomal mapping, and characterization of the
RT   human cardiac-specific homeobox gene hCsx.";
RL   Mol. Med. 2:86-96(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal lung;
RA   Tate G., Mitsuya T.;
RT   "Human Nkx-2.5 gene.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT ASP-74.
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, VARIANT HIS-236, AND CHARACTERIZATION OF VARIANT HIS-236.
RX   PubMed=22560297; DOI=10.1016/j.devcel.2012.02.009;
RA   Koss M., Bolze A., Brendolan A., Saggese M., Capellini T.D.,
RA   Bojilova E., Boisson B., Prall O.W., Elliott D.A., Solloway M.,
RA   Lenti E., Hidaka C., Chang C.P., Mahlaoui N., Harvey R.P.,
RA   Casanova J.L., Selleri L.;
RT   "Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-
RT   5/p15 module.";
RL   Dev. Cell 22:913-926(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 138-194 OF MUTANT SER-193 OF
RP   HOMODIMER IN COMPLEX WITH DNA, SUBUNIT, AND DNA-BINDING.
RX   PubMed=22849347; DOI=10.1021/bi300849c;
RA   Pradhan L., Genis C., Scone P., Weinberg E.O., Kasahara H., Nam H.J.;
RT   "Crystal structure of the human NKX2.5 homeodomain in complex with DNA
RT   target.";
RL   Biochemistry 51:6312-6319(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF 142-194 IN COMPLEX WITH TBX5
RP   AND DNA, INTERACTION WITH TBX5, AND DNA-BINDING.
RX   PubMed=26926761; DOI=10.1021/acs.biochem.6b00171;
RA   Pradhan L., Gopal S., Li S., Ashur S., Suryanarayanan S., Kasahara H.,
RA   Nam H.J.;
RT   "Intermolecular interactions of cardiac transcription factors NKX2.5
RT   and TBX5.";
RL   Biochemistry 55:1702-1710(2016).
RN   [10]
RP   VARIANT ASD7 MET-178.
RX   PubMed=9651244; DOI=10.1126/science.281.5373.108;
RA   Schott J.-J., Benson D.W., Basson C.T., Pease W., Silberbach G.M.,
RA   Moak J.P., Maron B.J., Seidman C.E., Seidman J.G.;
RT   "Congenital heart disease caused by mutations in the transcription
RT   factor NKX2-5.";
RL   Science 281:108-111(1998).
RN   [11]
RP   VARIANT TOF CYS-25, AND VARIANTS ASD7 LYS-188; GLY-189 AND CYS-191.
RX   PubMed=10587520; DOI=10.1172/JCI8154;
RA   Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C.,
RA   Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S.,
RA   Seidman J.G., Seidman C.E., Plowden J., Kugler J.D.;
RT   "Mutations in the cardiac transcription factor NKX2.5 affect diverse
RT   cardiac developmental pathways.";
RL   J. Clin. Invest. 104:1567-1573(1999).
RN   [12]
RP   VARIANTS TOF GLN-21; CYS-25; CYS-216 AND VAL-219.
RX   PubMed=11714651; DOI=10.1161/hc4601.098427;
RA   Goldmuntz E., Geiger E., Benson D.W.;
RT   "NKX2.5 mutations in patients with tetralogy of fallot.";
RL   Circulation 104:2565-2568(2001).
RN   [13]
RP   VARIANTS ASD7 ILE-15; VAL-63; GLU-127 AND THR-275, VARIANTS TOF
RP   GLN-21; PRO-22; CYS-25; CYS-216; VAL-219 AND THR-323, VARIANT CTMH
RP   ASN-291 DEL, VARIANT HLHS2 CYS-25, AND INVOLVEMENT IN CONGENITAL HEART
RP   MALFORMATIONS.
RX   PubMed=14607454; DOI=10.1016/j.jacc.2003.05.004;
RA   McElhinney D.B., Geiger E., Blinder J., Benson D.W., Goldmuntz E.;
RT   "NKX2.5 mutations in patients with congenital heart disease.";
RL   J. Am. Coll. Cardiol. 42:1650-1655(2003).
RN   [14]
RP   VARIANTS ASD7 PRO-7; SER-19; CYS-25; PRO-45; LEU-51; PRO-69; LEU-77;
RP   SER-114; ARG-114; ARG-118; ARG-124; VAL-126; SER-133; THR-135;
RP   PRO-144; MET-178; GLU-183; THR-192; ARG-192; ARG-194; GLU-205;
RP   VAL-219; ASN-226; HIS-248; PRO-279; PHE-279; VAL-281; VAL-286;
RP   HIS-294; GLY-299; GLY-305; SER-320 AND GLN-322.
RX   PubMed=15342699; DOI=10.1136/jmg.2003.017483;
RA   Reamon-Buettner S.M., Borlak J.;
RT   "Somatic NKX2-5 mutations as a novel mechanism of disease in complex
RT   congenital heart disease.";
RL   J. Med. Genet. 41:684-690(2004).
RN   [15]
RP   VARIANTS ASD7 ILE-15; GLN-21; PRO-22; CYS-25; VAL-63; GLU-127;
RP   CYS-142; MET-178; HIS-187; LYS-188; GLY-189; CYS-190; CYS-191;
RP   CYS-216; VAL-219; THR-275 AND THR-323, AND VARIANT HLHS2 CYS-25.
RX   PubMed=15810002; DOI=10.1002/ajmg.a.30684;
RA   Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y.,
RA   Tomita H., Furutani M., Imamura S., Takao A., Nakazawa M.,
RA   Matsuoka R.;
RT   "Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal
RT   defect.";
RL   Am. J. Med. Genet. A 135:47-52(2005).
RN   [16]
RP   VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161, AND CHARACTERIZATION OF
RP   VARIANTS CHNG5 CYS-25; SER-119 AND PRO-161.
RX   PubMed=16418214; DOI=10.1210/jc.2005-1350;
RA   Dentice M., Cordeddu V., Rosica A., Ferrara A.M., Santarpia L.,
RA   Salvatore D., Chiovato L., Perri A., Moschini L., Fazzini C.,
RA   Olivieri A., Costa P., Stoppioni V., Baserga M., De Felice M.,
RA   Sorcini M., Fenzi G., Di Lauro R., Tartaglia M., Macchia P.E.;
RT   "Missense mutation in the transcription factor NKX2-5: a novel
RT   molecular event in the pathogenesis of thyroid dysgenesis.";
RL   J. Clin. Endocrinol. Metab. 91:1428-1433(2006).
RN   [17]
RP   VARIANT CTHM CYS-25.
RX   PubMed=17891434; DOI=10.1007/s00246-007-9058-2;
RA   Akcaboy M.I., Cengiz F.B., Inceoglu B., Ucar T., Atalay S., Tutar E.,
RA   Tekin M.;
RT   "The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart
RT   anomalies: mutation or polymorphism?";
RL   Pediatr. Cardiol. 29:126-129(2008).
RN   [18]
RP   VARIANT VSD3 GLN-283.
RX   PubMed=21110066; DOI=10.1007/s10709-010-9522-4;
RA   Peng T., Wang L., Zhou S.F., Li X.;
RT   "Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients
RT   with non-familial congenital heart disease.";
RL   Genetica 138:1231-1240(2010).
RN   [19]
RP   VARIANT VSD3 ALA-59, AND CHARACTERIZATION OF VARIANT VSD3 ALA-59.
RX   PubMed=21165553; DOI=10.3892/ijmm.2010.585;
RA   Wang J., Xin Y.F., Liu X.Y., Liu Z.M., Wang X.Z., Yang Y.Q.;
RT   "A novel NKX2-5 mutation in familial ventricular septal defect.";
RL   Int. J. Mol. Med. 27:369-375(2011).
CC   -!- FUNCTION: Implicated in commitment to and/or differentiation of
CC       the myocardial lineage. Acts as a transcriptional activator of ANF
CC       in cooperation with GATA4 (By similarity). Binds to the core DNA
CC       motif of NPPA promoter (PubMed:22849347, PubMed:26926761). It is
CC       transcriptionally controlled by PBX1 and acts as a transcriptional
CC       repressor of CDKN2B (By similarity). It is required for spleen
CC       development. {ECO:0000250|UniProtKB:P42582,
CC       ECO:0000269|PubMed:22560297, ECO:0000269|PubMed:22849347,
CC       ECO:0000269|PubMed:26926761}.
CC   -!- SUBUNIT: Homodimer (via the homeobox); binds DNA as homodimer
CC       (PubMed:22849347). Interacts (via the homeobox) with TBX5 (via the
CC       T-box); this complex binds DNA (PubMed:26926761). Interacts with
CC       HIPK1 and HIPK2, but not HIPK3. Interacts with the C-terminal zinc
CC       finger of GATA4 through its homeobox domain. Also interacts with
CC       JARID2 which represses its ability to activate transcription of
CC       ANF. Interacts with FBLIM1. Interacts with TBX18 (By similarity).
CC       {ECO:0000250|UniProtKB:P42582, ECO:0000269|PubMed:22849347,
CC       ECO:0000269|PubMed:26926761}.
CC   -!- INTERACTION:
CC       Q99593-1:TBX5; NbExp=6; IntAct=EBI-936601, EBI-304423;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P52952-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P52952-2; Sequence=VSP_043492, VSP_043493;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P52952-3; Sequence=VSP_045481, VSP_045482;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed only in the heart.
CC   -!- DOMAIN: The homeobox domain binds to double-stranded DNA
CC       (PubMed:22849347). {ECO:0000269|PubMed:22849347}.
CC   -!- DISEASE: Atrial septal defect 7, with or without atrioventricular
CC       conduction defects (ASD7) [MIM:108900]: A congenital heart
CC       malformation characterized by incomplete closure of the wall
CC       between the atria resulting in blood flow from the left to the
CC       right atria, and atrioventricular conduction defects in some
CC       cases. {ECO:0000269|PubMed:10587520, ECO:0000269|PubMed:14607454,
CC       ECO:0000269|PubMed:15342699, ECO:0000269|PubMed:15810002,
CC       ECO:0000269|PubMed:9651244}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital
CC       heart anomaly which consists of pulmonary stenosis, ventricular
CC       septal defect, dextroposition of the aorta (aorta is on the right
CC       side instead of the left) and hypertrophy of the right ventricle.
CC       In this condition, blood from both ventricles (oxygen-rich and
CC       oxygen-poor) is pumped into the body often causing cyanosis.
CC       {ECO:0000269|PubMed:10587520, ECO:0000269|PubMed:11714651,
CC       ECO:0000269|PubMed:14607454}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A
CC       group of congenital heart defects involving the outflow tracts.
CC       Examples include truncus arteriosus communis, double-outlet right
CC       ventricle and transposition of great arteries. Truncus arteriosus
CC       communis is characterized by a single outflow tract instead of a
CC       separate aorta and pulmonary artery. In transposition of the great
CC       arteries, the aorta arises from the right ventricle and the
CC       pulmonary artery from the left ventricle. In double outlet of the
CC       right ventricle, both the pulmonary artery and aorta arise from
CC       the right ventricle. {ECO:0000269|PubMed:14607454,
CC       ECO:0000269|PubMed:17891434}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Hypothyroidism, congenital, non-goitrous, 5 (CHNG5)
CC       [MIM:225250]: A non-autoimmune condition characterized by
CC       resistance to thyroid-stimulating hormone (TSH) leading to
CC       increased levels of plasma TSH and low levels of thyroid hormone.
CC       CHNG5 presents variable severity depending on the completeness of
CC       the defect. Most patients are euthyroid and asymptomatic, with a
CC       normal sized thyroid gland. Only a subset of patients develop
CC       hypothyroidism and present a hypoplastic thyroid gland.
CC       {ECO:0000269|PubMed:16418214}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ventricular septal defect 3 (VSD3) [MIM:614432]: A common
CC       form of congenital cardiovascular anomaly that may occur alone or
CC       in combination with other cardiac malformations. It can affect any
CC       portion of the ventricular septum, resulting in abnormal
CC       communications between the two lower chambers of the heart.
CC       Classification is based on location of the communication, such as
CC       perimembranous, inlet, outlet (infundibular), central muscular,
CC       marginal muscular, or apical muscular defect. Large defects that
CC       go unrepaired may give rise to cardiac enlargement, congestive
CC       heart failure, pulmonary hypertension, Eisenmenger's syndrome,
CC       delayed fetal brain development, arrhythmias, and even sudden
CC       cardiac death. {ECO:0000269|PubMed:21110066,
CC       ECO:0000269|PubMed:21165553}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Hypoplastic left heart syndrome 2 (HLHS2) [MIM:614435]: A
CC       syndrome due to defective development of the aorta proximal to the
CC       entrance of the ductus arteriosus, and hypoplasia of the left
CC       ventricle and mitral valve. As a result of the abnormal
CC       circulation, the ductus arteriosus and foramen ovale are patent
CC       and the right atrium, right ventricle, and pulmonary artery are
CC       enlarged. {ECO:0000269|PubMed:14607454,
CC       ECO:0000269|PubMed:15810002}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NKX25ID42958ch5q35.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U34962; AAC50470.1; -; mRNA.
DR   EMBL; AB021133; BAA35181.1; -; mRNA.
DR   EMBL; AK297844; BAG60178.1; -; mRNA.
DR   EMBL; AK290615; BAF83304.1; -; mRNA.
DR   EMBL; AK309495; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC008412; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61404.1; -; Genomic_DNA.
DR   EMBL; BC025711; AAH25711.1; -; mRNA.
DR   CCDS; CCDS4387.1; -. [P52952-1]
DR   CCDS; CCDS54949.1; -. [P52952-2]
DR   CCDS; CCDS54950.1; -. [P52952-3]
DR   RefSeq; NP_001159647.1; NM_001166175.1. [P52952-3]
DR   RefSeq; NP_001159648.1; NM_001166176.1. [P52952-2]
DR   RefSeq; NP_004378.1; NM_004387.3. [P52952-1]
DR   UniGene; Hs.54473; -.
DR   PDB; 3RKQ; X-ray; 1.70 A; A/B=138-192.
DR   PDB; 4S0H; X-ray; 2.82 A; B/F=142-192.
DR   PDBsum; 3RKQ; -.
DR   PDBsum; 4S0H; -.
DR   ProteinModelPortal; P52952; -.
DR   SMR; P52952; -.
DR   BioGrid; 107864; 20.
DR   IntAct; P52952; 11.
DR   STRING; 9606.ENSP00000327758; -.
DR   iPTMnet; P52952; -.
DR   PhosphoSitePlus; P52952; -.
DR   BioMuta; NKX2-5; -.
DR   DMDM; 1708211; -.
DR   PaxDb; P52952; -.
DR   PeptideAtlas; P52952; -.
DR   PRIDE; P52952; -.
DR   DNASU; 1482; -.
DR   Ensembl; ENST00000329198; ENSP00000327758; ENSG00000183072. [P52952-1]
DR   Ensembl; ENST00000424406; ENSP00000395378; ENSG00000183072. [P52952-3]
DR   Ensembl; ENST00000521848; ENSP00000427906; ENSG00000183072. [P52952-2]
DR   GeneID; 1482; -.
DR   KEGG; hsa:1482; -.
DR   UCSC; uc003mcm.3; human. [P52952-1]
DR   CTD; 1482; -.
DR   DisGeNET; 1482; -.
DR   EuPathDB; HostDB:ENSG00000183072.9; -.
DR   GeneCards; NKX2-5; -.
DR   HGNC; HGNC:2488; NKX2-5.
DR   HPA; HPA065034; -.
DR   MalaCards; NKX2-5; -.
DR   MIM; 108900; phenotype.
DR   MIM; 187500; phenotype.
DR   MIM; 217095; phenotype.
DR   MIM; 225250; phenotype.
DR   MIM; 600584; gene.
DR   MIM; 614432; phenotype.
DR   MIM; 614435; phenotype.
DR   neXtProt; NX_P52952; -.
DR   OpenTargets; ENSG00000183072; -.
DR   Orphanet; 95713; Athyreosis.
DR   Orphanet; 1479; Atrial septal defect - atrioventricular conduction defects.
DR   Orphanet; 99103; Atrial septal defect, ostium secundum type.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 101351; Familial isolated congenital asplenia.
DR   Orphanet; 871; Familial progressive cardiac conduction defect.
DR   Orphanet; 2248; Hypoplastic left heart syndrome.
DR   Orphanet; 99097; Single ventricular septal defect.
DR   Orphanet; 3303; Tetralogy of Fallot.
DR   Orphanet; 95720; Thyroid hypoplasia.
DR   PharmGKB; PA24202; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; P52952; -.
DR   KO; K09345; -.
DR   OMA; DKKELCA; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; P52952; -.
DR   TreeFam; TF351204; -.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-HSA-5578768; Physiological factors.
DR   SignaLink; P52952; -.
DR   SIGNOR; P52952; -.
DR   GeneWiki; NKX2-5; -.
DR   GenomeRNAi; 1482; -.
DR   PRO; PR:P52952; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000183072; -.
DR   CleanEx; HS_NKX2-5; -.
DR   ExpressionAtlas; P52952; baseline and differential.
DR   Genevisible; P52952; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0032991; C:macromolecular complex; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0005667; C:transcription factor complex; IC:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0010736; F:serum response element binding; ISS:BHF-UCL.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IMP:NTNU_SB.
DR   GO; GO:0001190; F:transcriptional activator activity, RNA polymerase II transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:BHF-UCL.
DR   GO; GO:0007512; P:adult heart development; IMP:BHF-UCL.
DR   GO; GO:0003278; P:apoptotic process involved in heart morphogenesis; IEA:Ensembl.
DR   GO; GO:0055014; P:atrial cardiac muscle cell development; ISS:BHF-UCL.
DR   GO; GO:0060413; P:atrial septum morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0060928; P:atrioventricular node cell development; IEA:Ensembl.
DR   GO; GO:0060929; P:atrioventricular node cell fate commitment; IEA:Ensembl.
DR   GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0003166; P:bundle of His development; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0003161; P:cardiac conduction system development; IMP:BHF-UCL.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0060048; P:cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003211; P:cardiac ventricle formation; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0035050; P:embryonic heart tube development; ISS:BHF-UCL.
DR   GO; GO:0060971; P:embryonic heart tube left/right pattern formation; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; ISS:BHF-UCL.
DR   GO; GO:0003007; P:heart morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060347; P:heart trabecula formation; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; ISS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0060037; P:pharyngeal system development; ISS:BHF-UCL.
DR   GO; GO:0051891; P:positive regulation of cardioblast differentiation; ISS:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL.
DR   GO; GO:0045823; P:positive regulation of heart contraction; ISS:BHF-UCL.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IMP:BHF-UCL.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0010735; P:positive regulation of transcription via serum response element binding; ISS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0003342; P:proepicardium development; IEA:Ensembl.
DR   GO; GO:0003350; P:pulmonary myocardium development; IEA:Ensembl.
DR   GO; GO:0003168; P:Purkinje myocyte differentiation; IEA:Ensembl.
DR   GO; GO:1903779; P:regulation of cardiac conduction; ISS:BHF-UCL.
DR   GO; GO:0060043; P:regulation of cardiac muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; ISS:BHF-UCL.
DR   GO; GO:0003221; P:right ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0045214; P:sarcomere organization; IEA:Ensembl.
DR   GO; GO:0003285; P:septum secundum development; IMP:BHF-UCL.
DR   GO; GO:0048536; P:spleen development; IMP:UniProtKB.
DR   GO; GO:0030878; P:thyroid gland development; IMP:BHF-UCL.
DR   GO; GO:0001570; P:vasculogenesis; ISS:BHF-UCL.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; ISS:BHF-UCL.
DR   GO; GO:0055005; P:ventricular cardiac myofibril assembly; IEA:Ensembl.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR033629; NKX-2.5.
DR   PANTHER; PTHR24340:SF28; PTHR24340:SF28; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Atrial septal defect;
KW   Complete proteome; Congenital hypothyroidism; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    324       Homeobox protein Nkx-2.5.
FT                                /FTId=PRO_0000048937.
FT   DNA_BIND    138    197       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108,
FT                                ECO:0000269|PubMed:22849347,
FT                                ECO:0000269|PubMed:26926761}.
FT   COMPBIAS     42    108       Ala/Pro-rich.
FT   COMPBIAS    208    282       Ala/Pro-rich.
FT   VAR_SEQ     112    151       ELCALQKAVELEKTEADNAERPRARRRRKPRVLFSQAQVY
FT                                -> GCELPRGQRPPVLFSSALSQPDFLQMLSETCRWLPVHL
FT                                AE (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043492.
FT   VAR_SEQ     112    112       E -> A (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045481.
FT   VAR_SEQ     113    324       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045482.
FT   VAR_SEQ     152    324       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043493.
FT   VARIANT       7      7       L -> P (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038212.
FT   VARIANT      15     15       K -> I (in ASD7; dbSNP:rs387906773).
FT                                {ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038213.
FT   VARIANT      16     16       D -> A (in dbSNP:rs17052019).
FT                                /FTId=VAR_049581.
FT   VARIANT      19     19       N -> S (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038214.
FT   VARIANT      21     21       E -> Q (in TOF and ASD7;
FT                                dbSNP:rs104893904).
FT                                {ECO:0000269|PubMed:11714651,
FT                                ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038215.
FT   VARIANT      22     22       Q -> P (in ASD7 and TOF).
FT                                {ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038216.
FT   VARIANT      25     25       R -> C (in ASD7, TOF, CHNG5, HLHS2 and
FT                                CTHM; unknown pathological significance;
FT                                exhibits significant functional
FT                                impairment with reduction of
FT                                transactivation properties and dominant-
FT                                negative effect; the mutant protein
FT                                activity on the DIO2, TG and TPO
FT                                promoters is significantly impaired;
FT                                dbSNP:rs28936670).
FT                                {ECO:0000269|PubMed:10587520,
FT                                ECO:0000269|PubMed:11714651,
FT                                ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15342699,
FT                                ECO:0000269|PubMed:15810002,
FT                                ECO:0000269|PubMed:16418214,
FT                                ECO:0000269|PubMed:17891434}.
FT                                /FTId=VAR_010116.
FT   VARIANT      45     45       S -> P (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038217.
FT   VARIANT      51     51       F -> L (in ASD7; somatic mutation;
FT                                dbSNP:rs753937287).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038218.
FT   VARIANT      59     59       P -> A (in VSD3; significantly reduced
FT                                activation of NPPA gene compared to wild-
FT                                type; dbSNP:rs387906775).
FT                                {ECO:0000269|PubMed:21165553}.
FT                                /FTId=VAR_067586.
FT   VARIANT      63     63       A -> V (in ASD7; dbSNP:rs530270916).
FT                                {ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038219.
FT   VARIANT      69     69       L -> P (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038220.
FT   VARIANT      74     74       G -> D (in dbSNP:rs201362118).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_069058.
FT   VARIANT      77     77       P -> L (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038221.
FT   VARIANT     114    114       C -> R (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038222.
FT   VARIANT     114    114       C -> S (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038223.
FT   VARIANT     118    118       K -> R (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038224.
FT   VARIANT     119    119       A -> S (in CHNG5; exhibits a significant
FT                                functional impairment with reduction of
FT                                transactivation properties and dominant-
FT                                negative effect which was associated with
FT                                reduced DNA binding; dbSNP:rs137852684).
FT                                {ECO:0000269|PubMed:16418214}.
FT                                /FTId=VAR_047869.
FT   VARIANT     124    124       K -> R (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038225.
FT   VARIANT     126    126       E -> V (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038226.
FT   VARIANT     127    127       A -> E (in ASD7; dbSNP:rs387906774).
FT                                {ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038227.
FT   VARIANT     133    133       P -> S (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038228.
FT   VARIANT     135    135       A -> T (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038229.
FT   VARIANT     142    142       R -> C (in ASD7).
FT                                {ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038230.
FT   VARIANT     144    144       L -> P (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038231.
FT   VARIANT     161    161       R -> P (in CHNG5; exhibits a significant
FT                                functional impairment with reduction of
FT                                transactivation properties and dominant-
FT                                negative effect which was associated with
FT                                reduced DNA binding; dbSNP:rs137852685).
FT                                {ECO:0000269|PubMed:16418214}.
FT                                /FTId=VAR_047870.
FT   VARIANT     178    178       T -> M (in ASD7; dbSNP:rs104893900).
FT                                {ECO:0000269|PubMed:15342699,
FT                                ECO:0000269|PubMed:15810002,
FT                                ECO:0000269|PubMed:9651244}.
FT                                /FTId=VAR_003752.
FT   VARIANT     183    183       K -> E (in ASD7; somatic mutation;
FT                                dbSNP:rs137852686).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038232.
FT   VARIANT     187    187       Q -> H (in ASD7).
FT                                {ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038233.
FT   VARIANT     188    188       N -> K (in ASD7).
FT                                {ECO:0000269|PubMed:10587520,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_010117.
FT   VARIANT     189    189       R -> G (in ASD7).
FT                                {ECO:0000269|PubMed:10587520,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_010118.
FT   VARIANT     190    190       R -> C (in ASD7; dbSNP:rs104893906).
FT                                {ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038234.
FT   VARIANT     191    191       Y -> C (in ASD7).
FT                                {ECO:0000269|PubMed:10587520,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_010119.
FT   VARIANT     192    192       K -> R (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038235.
FT   VARIANT     192    192       K -> T (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038236.
FT   VARIANT     194    194       K -> R (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038237.
FT   VARIANT     205    205       V -> E (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038238.
FT   VARIANT     216    216       R -> C (in TOF and ASD7;
FT                                dbSNP:rs104893905).
FT                                {ECO:0000269|PubMed:11714651,
FT                                ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038239.
FT   VARIANT     219    219       A -> V (in ASD7 and TOF; somatic
FT                                mutation; dbSNP:rs104893902).
FT                                {ECO:0000269|PubMed:11714651,
FT                                ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15342699,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038240.
FT   VARIANT     226    226       D -> N (in ASD7; somatic mutation;
FT                                dbSNP:rs760528062).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038241.
FT   VARIANT     236    236       P -> H (found in patients with isolated
FT                                congenital asplenia; unknown pathological
FT                                significance; does not affect DNA
FT                                binding; impairs transactivation
FT                                activity; dbSNP:rs397515399).
FT                                {ECO:0000269|PubMed:22560297}.
FT                                /FTId=VAR_069590.
FT   VARIANT     248    248       Y -> H (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038242.
FT   VARIANT     275    275       P -> T (in ASD7; dbSNP:rs368366482).
FT                                {ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038243.
FT   VARIANT     279    279       S -> F (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038244.
FT   VARIANT     279    279       S -> P (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038245.
FT   VARIANT     281    281       A -> V (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038246.
FT   VARIANT     283    283       P -> Q (in VSD3; dbSNP:rs375086983).
FT                                {ECO:0000269|PubMed:21110066}.
FT                                /FTId=VAR_067587.
FT   VARIANT     286    286       A -> V (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038247.
FT   VARIANT     291    291       Missing (in CTMH).
FT                                {ECO:0000269|PubMed:14607454}.
FT                                /FTId=VAR_067588.
FT   VARIANT     294    294       N -> H (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038248.
FT   VARIANT     299    299       D -> G (in ASD7; somatic mutation;
FT                                dbSNP:rs137852683).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038249.
FT   VARIANT     305    305       S -> G (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038250.
FT   VARIANT     320    320       G -> S (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038251.
FT   VARIANT     322    322       R -> Q (in ASD7; somatic mutation).
FT                                {ECO:0000269|PubMed:15342699}.
FT                                /FTId=VAR_038252.
FT   VARIANT     323    323       A -> T (in ASD7 and TOF).
FT                                {ECO:0000269|PubMed:14607454,
FT                                ECO:0000269|PubMed:15810002}.
FT                                /FTId=VAR_038253.
FT   HELIX       147    157       {ECO:0000244|PDB:3RKQ}.
FT   HELIX       165    175       {ECO:0000244|PDB:3RKQ}.
FT   HELIX       179    192       {ECO:0000244|PDB:3RKQ}.
SQ   SEQUENCE   324 AA;  34918 MW;  ACCC9C2F9C292586 CRC64;
     MFPSPALTPT PFSVKDILNL EQQQRSLAAA GELSARLEAT LAPSSCMLAA FKPEAYAGPE
     AAAPGLPELR AELGRAPSPA KCASAFPAAP AFYPRAYSDP DPAKDPRAEK KELCALQKAV
     ELEKTEADNA ERPRARRRRK PRVLFSQAQV YELERRFKQQ RYLSAPERDQ LASVLKLTST
     QVKIWFQNRR YKCKRQRQDQ TLELVGLPPP PPPPARRIAV PVLVRDGKPC LGDSAPYAPA
     YGVGLNPYGY NAYPAYPGYG GAACSPGYSC TAAYPAGPSP AQPATAAANN NFVNFGVGDL
     NAVQSPGIPQ SNSGVSTLHG IRAW
//
ID   PAX6_HUMAN              Reviewed;         422 AA.
AC   P26367; Q6N006; Q99413;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   25-OCT-2017, entry version 209.
DE   RecName: Full=Paired box protein Pax-6;
DE   AltName: Full=Aniridia type II protein;
DE   AltName: Full=Oculorhombin;
GN   Name=PAX6; Synonyms=AN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal eye;
RX   PubMed=1684738; DOI=10.1016/0092-8674(91)90284-6;
RA   Ton C.C.T., Hirvonen H., Miwa H., Weil M.M., Monaghan P., Jordan T.,
RA   van Heyningen V., Hastie N.D., Meijers-Heijboer H., Drechsler M.,
RA   Royer-Pokora B., Collins F.S., Swaroop A., Strong L.C., Saunders G.F.;
RT   "Positional cloning and characterization of a paired box- and
RT   homeobox-containing gene from the aniridia region.";
RL   Cell 67:1059-1074(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1345175; DOI=10.1038/ng1192-232;
RA   Glaser T., Walton D.S., Maas R.L.;
RT   "Genomic structure, evolutionary conservation and aniridia mutations
RT   in the human PAX6 gene.";
RL   Nat. Genet. 2:232-239(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Liu J., Zhang B., Zhou Y., Peng X., Yuan J., Qiang B.;
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5A).
RC   TISSUE=Cerebellum;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ALTERNATIVE SPLICING, AND DNA-BINDING.
RX   PubMed=7958875; DOI=10.1101/gad.8.17.2022;
RA   Epstein J.A., Glaser T., Cai J., Jepeal L., Walton D.S., Maas R.L.;
RT   "Two independent and interactive DNA-binding subdomains of the Pax6
RT   paired domain are regulated by alternative splicing.";
RL   Genes Dev. 8:2022-2034(1994).
RN   [8]
RP   INVOLVEMENT IN KERH.
RX   PubMed=7668281;
RA   Mirzayans F., Pearce W.G., MacDonald I.M., Walter M.A.;
RT   "Mutation of the PAX6 gene in patients with autosomal dominant
RT   keratitis.";
RL   Am. J. Hum. Genet. 57:539-548(1995).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=19414065; DOI=10.1016/j.ijdevneu.2009.04.004;
RA   Larsen K.B., Lutterodt M., Rath M.F., Moeller M.;
RT   "Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early
RT   human fetal retina.";
RL   Int. J. Dev. Neurosci. 27:485-492(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   INVOLVEMENT IN AN2.
RX   PubMed=24290376; DOI=10.1016/j.ajhg.2013.10.028;
RA   Bhatia S., Bengani H., Fish M., Brown A., Divizia M.T., de Marco R.,
RA   Damante G., Grainger R., van Heyningen V., Kleinjan D.A.;
RT   "Disruption of autoregulatory feedback by a mutation in a remote,
RT   ultraconserved PAX6 enhancer causes aniridia.";
RL   Am. J. Hum. Genet. 93:1126-1134(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 4-136.
RX   PubMed=10346815; DOI=10.1101/gad.13.10.1263;
RA   Xu H.E., Rould M.A., Xu W., Epstein J.A., Maas R.L., Pabo C.O.;
RT   "Crystal structure of the human Pax-6 paired domain-DNA complex
RT   reveals specific roles for the linker region and carboxyl-terminal
RT   subdomain in DNA binding.";
RL   Genes Dev. 13:1263-1275(1999).
RN   [14]
RP   REVIEW ON VARIANTS.
RX   PubMed=9482572;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M;
RA   Prosser J., van Heyningen V.;
RT   "PAX6 mutations reviewed.";
RL   Hum. Mutat. 11:93-108(1998).
RN   [15]
RP   STRUCTURE BY NMR OF 211-277.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of the human paired box
RT   protein PAX-6.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [16]
RP   VARIANT AN1 TRP-208.
RX   PubMed=8364574; DOI=10.1093/hmg/2.7.915;
RA   Hanson I.M., Seawright A., Hardman K., Hodgson S., Zaletayev D.,
RA   Fekete G., van Heyningen V.;
RT   "PAX6 mutations in aniridia.";
RL   Hum. Mol. Genet. 2:915-920(1993).
RN   [17]
RP   VARIANT ASGD5 GLY-26.
RX   PubMed=8162071; DOI=10.1038/ng0294-168;
RA   Hanson I.M., Fletcher J.M., Jordan T., Brown A., Taylor D.,
RA   Adams R.J., Punnet H.H., van Heyningen V.;
RT   "Mutations at the PAX6 locus are found in heterogeneous anterior
RT   segment malformations including Peters' anomaly.";
RL   Nat. Genet. 6:168-173(1994).
RN   [18]
RP   VARIANTS FVH1 CYS-125 AND CYS-128.
RX   PubMed=8640214; DOI=10.1038/ng0696-141;
RA   Azuma N., Nishina S., Yanagisawa H., Okuyama T., Yamada M.;
RT   "PAX6 missense mutation in isolated foveal hypoplasia.";
RL   Nat. Genet. 13:141-142(1996).
RN   [19]
RP   VARIANT AN1 ARG-87, AND VARIANT GLY-26.
RX   PubMed=9147640; DOI=10.1093/hmg/6.3.381;
RA   Tang H.K., Chao L.-Y., Saunders G.F.;
RT   "Functional analysis of paired box missense mutations in the PAX6
RT   gene.";
RL   Hum. Mol. Genet. 6:381-386(1997).
RN   [20]
RP   VARIANT AN1 22-PRO--ARG-26 DEL.
RX   PubMed=9281415; DOI=10.1006/mcpr.1997.0117;
RA   Axton R., Hanson I.M., Love J., Seawright A., Prosser J.,
RA   van Heyningen V.;
RT   "Combined SSCP/heteroduplex analysis in the screening for PAX6
RT   mutations.";
RL   Mol. Cell. Probes 11:287-292(1997).
RN   [21]
RP   VARIANT AN1 TRP-18.
RX   PubMed=9792406;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:5<304::AID-HUMU3>3.3.CO;2-Y;
RA   Wolf M.T.F., Lorenz B., Winterpacht A., Drechsler M., Schumacher V.,
RA   Royer-Pokora B., Blankenagel A., Zabel B., Wildhardt G.;
RT   "Ten novel mutations found in Aniridia.";
RL   Hum. Mutat. 12:304-313(1998).
RN   [22]
RP   VARIANT EYE MALFORMATIONS ARG-422.
RX   PubMed=9538891;
RA   Azuma N., Yamada M.;
RT   "Missense mutation at the C-terminus of the PAX6 gene in ocular
RT   anterior segment anomalies.";
RL   Invest. Ophthalmol. Vis. Sci. 39:828-830(1998).
RN   [23]
RP   VARIANTS AN1 SER-17; VAL-29; GLN-44 AND HIS-178.
RX   PubMed=9856761;
RA   Azuma N., Hotta Y., Tanaka H., Yamada M.;
RT   "Missense mutations in the PAX6 gene in aniridia.";
RL   Invest. Ophthalmol. Vis. Sci. 39:2524-2528(1998).
RN   [24]
RP   VARIANT ASGD5 ASP-53.
RX   PubMed=10441571; DOI=10.1086/302529;
RA   Azuma N., Yamaguchi Y., Handa H., Hayakawa M., Kanai A., Yamada M.;
RT   "Missense mutation in the alternative splice region of the PAX6 gene
RT   in eye anomalies.";
RL   Am. J. Hum. Genet. 65:656-663(1999).
RN   [25]
RP   ALTERNATIVE SPLICING, AND VARIANTS AN1 SER-42; LEU-53; PRO-63; GLU-79
RP   AND GLN-208.
RX   PubMed=10234503; DOI=10.1038/sj.ejhg.5200308;
RA   Groenskov K., Rosenberg T., Sand A., Broendum-Nielsen K.;
RT   "Mutational analysis of PAX6: 16 novel mutations including 5 missense
RT   mutations with a mild aniridia phenotype.";
RL   Eur. J. Hum. Genet. 7:274-286(1999).
RN   [26]
RP   VARIANTS AN1 PRO-33; PRO-43 AND ASP-126, AND VARIANT FVH1 VAL-64.
RX   PubMed=9931324; DOI=10.1093/hmg/8.2.165;
RA   Hanson I.M., Churchill A., Love J., Axton R., Moore T., Clarke M.,
RA   Meire F., van Heyningen V.;
RT   "Missense mutations in the most ancient residues of the PAX6 paired
RT   domain underlie a spectrum of human congenital eye malformations.";
RL   Hum. Mol. Genet. 8:165-172(1999).
RN   [27]
RP   VARIANTS AN1 SER-29; ARG-119 AND ALA-353.
RA   Wildhardt G.;
RL   Unpublished observations (APR-1999).
RN   [28]
RP   VARIANT AN1 37-ALA--PRO-39 DEL.
RA   Saunders G.F.;
RL   Unpublished observations (AUG-1999).
RN   [29]
RP   VARIANT NYSTAGMUS ARG-118.
RX   PubMed=10955655; DOI=10.1007/s004170000124;
RA   Sonoda S., Isashiki Y., Tabata Y., Kimura K., Kakiuchi T., Ohba N.;
RT   "A novel PAX6 gene mutation (P118R) in a family with congenital
RT   nystagmus associated with a variant form of aniridia.";
RL   Graefes Arch. Clin. Exp. Ophthalmol. 238:552-558(2000).
RN   [30]
RP   VARIANT AN1 37-ARG--PRO-39 DEL, AND VARIANT ASP-387.
RX   PubMed=10737978;
RX   DOI=10.1002/(SICI)1098-1004(200004)15:4<332::AID-HUMU5>3.0.CO;2-1;
RA   Chao L.-Y., Huff V., Strong L.C., Saunders G.F.;
RT   "Mutation in the PAX6 gene in twenty patients with aniridia.";
RL   Hum. Mutat. 15:332-339(2000).
RN   [31]
RP   VARIANT AN1 ARG-119.
RX   PubMed=11553050; DOI=10.1034/j.1399-0004.2001.600210.x;
RA   Malandrini A., Mari F., Palmeri S., Gambelli S., Berti G.,
RA   Bruttini M., Bardelli A.M., Williamson K., van Heyningen V.,
RA   Renieri A.;
RT   "PAX6 mutation in a family with aniridia, congenital ptosis, and
RT   mental retardation.";
RL   Clin. Genet. 60:151-154(2001).
RN   [32]
RP   VARIANTS AN1 GLN-375 AND ARG-422.
RX   PubMed=11309364; DOI=10.1093/hmg/10.9.911;
RA   Singh S., Chao L.-Y., Mishra R., Davies J., Saunders G.F.;
RT   "Missense mutation at the C-terminus of PAX6 negatively modulates
RT   homeodomain function.";
RL   Hum. Mol. Genet. 10:911-918(2001).
RN   [33]
RP   VARIANT AN1 THR-242.
RX   PubMed=11826019; DOI=10.1136/jmg.39.1.16;
RA   Morrison D., FitzPatrick D., Hanson I., Williamson K.,
RA   van Heyningen V., Fleck B., Jones I., Chalmers J., Campbell H.;
RT   "National study of microphthalmia, anophthalmia, and coloboma (MAC) in
RT   Scotland: investigation of genetic aetiology.";
RL   J. Med. Genet. 39:16-22(2002).
RN   [34]
RP   INVOLVEMENT IN OPTIC-NERVE MALFORMATIONS, VARIANT MORNING GLORY DISK
RP   ANOMALY SER-68, VARIANT COLON SER-258, VARIANT COAD SER-258, VARIANT
RP   ASGD5 PRO-363, AND VARIANTS BONH ILE-292; ARG-378; VAL-381 AND
RP   ALA-391.
RX   PubMed=12721955; DOI=10.1086/375555;
RA   Azuma N., Yamaguchi Y., Handa H., Tadokoro K., Asaka A., Kawase E.,
RA   Yamada M.;
RT   "Mutations of the PAX6 gene detected in patients with a variety of
RT   optic-nerve malformations.";
RL   Am. J. Hum. Genet. 72:1565-1570(2003).
RN   [35]
RP   VARIANTS AN1 PRO-19 AND 22-PRO--ARG-26 DEL.
RX   PubMed=12634864; DOI=10.1038/sj.ejhg.5200940;
RA   Vincent M.-C., Pujo A.-L., Olivier D., Calvas P.;
RT   "Screening for PAX6 gene mutations is consistent with
RT   haploinsufficiency as the main mechanism leading to various ocular
RT   defects.";
RL   Eur. J. Hum. Genet. 11:163-169(2003).
RN   [36]
RP   VARIANTS AN1 ARG-46; ARG-52; THR-56; ASP-73 AND LYS-87, VARIANT
RP   THR-321, CHARACTERIZATION OF VARIANTS AN1 ARG-46; ARG-52; LEU-53;
RP   THR-56 AND ASP-73, AND CHARACTERIZATION OF VARIANT THR-321.
RX   PubMed=12552561; DOI=10.1002/humu.10163;
RA   Chao L.-Y., Mishra R., Strong L.C., Saunders G.F.;
RT   "Missense mutations in the DNA-binding region and termination codon in
RT   PAX6.";
RL   Hum. Mutat. 21:138-145(2003).
RN   [37]
RP   CHARACTERIZATION OF VARIANT AN1 THR-242.
RX   PubMed=16493447; DOI=10.1038/sj.ejhg.5201579;
RA   D'Elia A.V., Puppin C., Pellizzari L., Pianta A., Bregant E.,
RA   Lonigro R., Tell G., Fogolari F., van Heyningen V., Damante G.;
RT   "Molecular analysis of a human PAX6 homeobox mutant.";
RL   Eur. J. Hum. Genet. 14:744-751(2006).
RN   [38]
RP   INVOLVEMENT IN AN1.
RX   PubMed=17595013; DOI=10.1002/ajmg.a.31808;
RA   Graziano C., D'Elia A.V., Mazzanti L., Moscano F., Guidelli Guidi S.,
RA   Scarano E., Turchetti D., Franzoni E., Romeo G., Damante G., Seri M.;
RT   "A de novo nonsense mutation of PAX6 gene in a patient with aniridia,
RT   ataxia, and mental retardation.";
RL   Am. J. Med. Genet. A 143:1802-1805(2007).
RN   [39]
RP   VARIANT AN1 ARG-395.
RX   PubMed=21850189;
RA   Zhang X., Wang P., Li S., Xiao X., Guo X., Zhang Q.;
RT   "Mutation spectrum of PAX6 in Chinese patients with aniridia.";
RL   Mol. Vis. 17:2139-2147(2011).
RN   [40]
RP   VARIANT AN1 PRO-19.
RX   PubMed=24033328; DOI=10.1111/cge.12275;
RA   Chassaing N., Causse A., Vigouroux A., Delahaye A., Alessandri J.L.,
RA   Boespflug-Tanguy O., Boute-Benejean O., Dollfus H., Duban-Bedu B.,
RA   Gilbert-Dussardier B., Giuliano F., Gonzales M., Holder-Espinasse M.,
RA   Isidor B., Jacquemont M.L., Lacombe D., Martin-Coignard D.,
RA   Mathieu-Dramard M., Odent S., Picone O., Pinson L., Quelin C.,
RA   Sigaudy S., Toutain A., Thauvin-Robinet C., Kaplan J., Calvas P.;
RT   "Molecular findings and clinical data in a cohort of 150 patients with
RT   anophthalmia/microphthalmia.";
RL   Clin. Genet. 86:326-334(2014).
CC   -!- FUNCTION: Transcription factor with important functions in the
CC       development of the eye, nose, central nervous system and pancreas.
CC       Required for the differentiation of pancreatic islet alpha cells
CC       (By similarity). Competes with PAX4 in binding to a common element
CC       in the glucagon, insulin and somatostatin promoters. Regulates
CC       specification of the ventral neuron subtypes by establishing the
CC       correct progenitor domains (By similarity). Isoform 5a appears to
CC       function as a molecular switch that specifies target genes.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MAF and MAFB. Interacts with TRIM11; this
CC       interaction leads to ubiquitination and proteasomal degradation,
CC       as well as inhibition of transactivation, possibly in part by
CC       preventing PAX6 binding to consensus DNA sequences. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P63168:Dynll1 (xeno); NbExp=3; IntAct=EBI-747278, EBI-349121;
CC       Q9Y247:FAM50B; NbExp=4; IntAct=EBI-747278, EBI-742802;
CC       O95872:GPANK1; NbExp=4; IntAct=EBI-747278, EBI-751540;
CC       O15347:HMGB3; NbExp=4; IntAct=EBI-747278, EBI-2214136;
CC       Q9NSC5:HOMER3; NbExp=5; IntAct=EBI-747278, EBI-748420;
CC       P31273:HOXC8; NbExp=4; IntAct=EBI-747278, EBI-1752118;
CC       Q08493-2:PDE4C; NbExp=4; IntAct=EBI-747278, EBI-12169289;
CC       Q9UIG4:PSORS1C2; NbExp=4; IntAct=EBI-747278, EBI-11974061;
CC       P63166:Sumo1 (xeno); NbExp=2; IntAct=EBI-15892945, EBI-80152;
CC       Q3SXR9:VCX2; NbExp=4; IntAct=EBI-747278, EBI-11983741;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P26367-1; Sequence=Displayed;
CC       Name=5a; Synonyms=Pax6-5a;
CC         IsoId=P26367-2; Sequence=VSP_002366;
CC       Name=3; Synonyms=Pax6-5A,6*;
CC         IsoId=P26367-3; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Fetal eye, brain, spinal cord and olfactory
CC       epithelium. Isoform 5a is less abundant than the PAX6 shorter
CC       form.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the developing eye and brain.
CC       Expression in the retina peaks at fetal days 51-60. At 6-week old,
CC       in the retina, is predominantly detected in the neural layer (at
CC       protein level). At 8- and 10-week old, in the retina, the
CC       expression is strongest in the inner and middle layer of the
CC       neural part (at protein level). {ECO:0000269|PubMed:19414065}.
CC   -!- PTM: Ubiquitinated by TRIM11, leading to ubiquitination and
CC       proteasomal degradation. {ECO:0000250}.
CC   -!- DISEASE: Aniridia 1 (AN1) [MIM:106210]: A congenital, bilateral,
CC       panocular disorder characterized by complete absence of the iris
CC       or extreme iris hypoplasia. Aniridia is not just an isolated
CC       defect in iris development but it is associated with macular and
CC       optic nerve hypoplasia, cataract, corneal changes, nystagmus.
CC       Visual acuity is generally low but is unrelated to the degree of
CC       iris hypoplasia. Glaucoma is a secondary problem causing
CC       additional visual loss over time. {ECO:0000269|PubMed:10234503,
CC       ECO:0000269|PubMed:10737978, ECO:0000269|PubMed:11309364,
CC       ECO:0000269|PubMed:11553050, ECO:0000269|PubMed:11826019,
CC       ECO:0000269|PubMed:12552561, ECO:0000269|PubMed:12634864,
CC       ECO:0000269|PubMed:16493447, ECO:0000269|PubMed:17595013,
CC       ECO:0000269|PubMed:21850189, ECO:0000269|PubMed:24033328,
CC       ECO:0000269|PubMed:8364574, ECO:0000269|PubMed:9147640,
CC       ECO:0000269|PubMed:9281415, ECO:0000269|PubMed:9792406,
CC       ECO:0000269|PubMed:9856761, ECO:0000269|PubMed:9931324,
CC       ECO:0000269|Ref.27, ECO:0000269|Ref.28}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Anterior segment dysgenesis 5 (ASGD5) [MIM:604229]: A
CC       form of anterior segment dysgenesis, a group of defects affecting
CC       anterior structures of the eye including cornea, iris, lens,
CC       trabecular meshwork, and Schlemm canal. Anterior segment
CC       dysgeneses result from abnormal migration or differentiation of
CC       the neural crest derived mesenchymal cells that give rise to
CC       components of the anterior chamber during eye development.
CC       Different anterior segment anomalies may exist alone or in
CC       combination, including iris hypoplasia, enlarged or reduced
CC       corneal diameter, corneal vascularization and opacity, posterior
CC       embryotoxon, corectopia, polycoria, abnormal iridocorneal angle,
CC       ectopia lentis, and anterior synechiae between the iris and
CC       posterior corneal surface. Clinical conditions falling within the
CC       phenotypic spectrum of anterior segment dysgeneses include
CC       aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters
CC       anomaly, and iridogoniodysgenesis. {ECO:0000269|PubMed:10441571,
CC       ECO:0000269|PubMed:12721955, ECO:0000269|PubMed:8162071}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Foveal hypoplasia 1 (FVH1) [MIM:136520]: An isolated form
CC       of foveal hypoplasia, a developmental defect of the eye defined as
CC       the lack of foveal depression with continuity of all neurosensory
CC       retinal layers in the presumed foveal area. Clinical features
CC       include absence of foveal pit on optical coherence tomography,
CC       absence of foveal hyperpigmentation, absence of foveal
CC       avascularity, absence of foveal and macular reflexes, decreased
CC       visual acuity, and nystagmus. Anterior segment anomalies and
CC       cataract are observed in some FVH1 patients.
CC       {ECO:0000269|PubMed:8640214, ECO:0000269|PubMed:9931324}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Keratitis hereditary (KERH) [MIM:148190]: An ocular
CC       disorder characterized by corneal opacification, recurrent stromal
CC       keratitis and vascularization. {ECO:0000269|PubMed:7668281}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Coloboma, ocular, autosomal dominant (COAD) [MIM:120200]:
CC       A set of malformations resulting from abnormal morphogenesis of
CC       the optic cup and stalk, and the fusion of the fetal fissure
CC       (optic fissure). The clinical presentation is variable. Some
CC       individuals may present with minimal defects in the anterior iris
CC       leaf without other ocular defects. More complex malformations
CC       create a combination of iris, uveoretinal and/or optic nerve
CC       defects without or with microphthalmia or even anophthalmia.
CC       {ECO:0000269|PubMed:12721955}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Coloboma of optic nerve (COLON) [MIM:120430]: An ocular
CC       defect that is due to malclosure of the fetal intraocular fissure
CC       affecting the optic nerve head. In some affected individuals, it
CC       appears as enlargement of the physiologic cup with severely
CC       affected eyes showing huge cavities at the site of the disk.
CC       {ECO:0000269|PubMed:12721955}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Bilateral optic nerve hypoplasia (BONH) [MIM:165550]: A
CC       congenital anomaly in which the optic disk appears abnormally
CC       small. It may be an isolated finding or part of a spectrum of
CC       anatomic and functional abnormalities that includes partial or
CC       complete agenesis of the septum pellucidum, other midline brain
CC       defects, cerebral anomalies, pituitary dysfunction, and structural
CC       abnormalities of the pituitary. {ECO:0000269|PubMed:12721955}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Aniridia 2 (AN2) [MIM:617141]: A form of aniridia, a
CC       congenital, bilateral, panocular disorder characterized by
CC       complete absence of the iris or extreme iris hypoplasia. Aniridia
CC       is not just an isolated defect in iris development but it is
CC       associated with macular and optic nerve hypoplasia, cataract,
CC       corneal changes, nystagmus. Visual acuity is generally low but is
CC       unrelated to the degree of iris hypoplasia. Glaucoma is a
CC       secondary problem causing additional visual loss over time.
CC       {ECO:0000269|PubMed:24290376}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis. A mutation in a PAX6
CC       long-range cis-regulatory element, known as SIMO, affects PAX6
CC       expression in the developing eye and has pathological
CC       consequences. The mutation is located in ELP4 intron 9, 150 kb
CC       downstream of PAX6. {ECO:0000269|PubMed:24290376}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Human PAX6 allelic variant database web site;
CC       URL="http://pax6.hgu.mrc.ac.uk/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PAX6ID211ch11p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M77844; AAA59962.1; -; mRNA.
DR   EMBL; M93650; AAA36416.1; -; mRNA.
DR   EMBL; AY047583; AAK95849.1; -; mRNA.
DR   EMBL; BX640762; CAE45868.1; -; mRNA.
DR   EMBL; Z95332; CAG38363.1; -; Genomic_DNA.
DR   EMBL; Z83307; CAG38363.1; JOINED; Genomic_DNA.
DR   EMBL; Z83307; CAG38087.1; -; Genomic_DNA.
DR   EMBL; Z95332; CAG38087.1; JOINED; Genomic_DNA.
DR   EMBL; BC011953; AAH11953.1; -; mRNA.
DR   CCDS; CCDS31451.1; -. [P26367-1]
DR   CCDS; CCDS31452.1; -. [P26367-2]
DR   PIR; A56674; A56674.
DR   RefSeq; NP_000271.1; NM_000280.4. [P26367-1]
DR   RefSeq; NP_001121084.1; NM_001127612.1. [P26367-1]
DR   RefSeq; NP_001245393.1; NM_001258464.1. [P26367-1]
DR   RefSeq; NP_001245394.1; NM_001258465.1. [P26367-1]
DR   RefSeq; NP_001297088.1; NM_001310159.1.
DR   RefSeq; NP_001297090.1; NM_001310161.1.
DR   RefSeq; NP_001595.2; NM_001604.5. [P26367-2]
DR   UniGene; Hs.270303; -.
DR   UniGene; Hs.611376; -.
DR   PDB; 2CUE; NMR; -; A=211-277.
DR   PDB; 6PAX; X-ray; 2.50 A; A=4-136.
DR   PDBsum; 2CUE; -.
DR   PDBsum; 6PAX; -.
DR   ProteinModelPortal; P26367; -.
DR   SMR; P26367; -.
DR   BioGrid; 111114; 48.
DR   CORUM; P26367; -.
DR   DIP; DIP-37436N; -.
DR   IntAct; P26367; 114.
DR   MINT; MINT-1465118; -.
DR   STRING; 9606.ENSP00000368401; -.
DR   iPTMnet; P26367; -.
DR   PhosphoSitePlus; P26367; -.
DR   BioMuta; PAX6; -.
DR   DMDM; 6174889; -.
DR   PaxDb; P26367; -.
DR   PeptideAtlas; P26367; -.
DR   PRIDE; P26367; -.
DR   DNASU; 5080; -.
DR   Ensembl; ENST00000241001; ENSP00000241001; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000379107; ENSP00000368401; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000379109; ENSP00000368403; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000379129; ENSP00000368424; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000379132; ENSP00000368427; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000419022; ENSP00000404100; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000606377; ENSP00000480026; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000638903; ENSP00000492296; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000638914; ENSP00000492315; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000639409; ENSP00000492476; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000639916; ENSP00000490963; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000640287; ENSP00000492822; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000640368; ENSP00000492024; ENSG00000007372. [P26367-2]
DR   Ensembl; ENST00000640610; ENSP00000491295; ENSG00000007372. [P26367-1]
DR   Ensembl; ENST00000640975; ENSP00000491872; ENSG00000007372. [P26367-2]
DR   GeneID; 5080; -.
DR   KEGG; hsa:5080; -.
DR   UCSC; uc001mtg.6; human. [P26367-1]
DR   CTD; 5080; -.
DR   DisGeNET; 5080; -.
DR   EuPathDB; HostDB:ENSG00000007372.20; -.
DR   GeneCards; PAX6; -.
DR   GeneReviews; PAX6; -.
DR   HGNC; HGNC:8620; PAX6.
DR   HPA; CAB034143; -.
DR   HPA; HPA030775; -.
DR   MalaCards; PAX6; -.
DR   MIM; 106210; phenotype.
DR   MIM; 120200; phenotype.
DR   MIM; 120430; phenotype.
DR   MIM; 136520; phenotype.
DR   MIM; 148190; phenotype.
DR   MIM; 165550; phenotype.
DR   MIM; 604229; phenotype.
DR   MIM; 607108; gene.
DR   MIM; 617141; phenotype.
DR   neXtProt; NX_P26367; -.
DR   OpenTargets; ENSG00000007372; -.
DR   Orphanet; 1065; Aniridia - cerebellar ataxia - intellectual disability.
DR   Orphanet; 2334; Autosomal dominant keratitis.
DR   Orphanet; 2253; Foveal hypoplasia - presenile cataract.
DR   Orphanet; 250923; Isolated aniridia.
DR   Orphanet; 137902; Isolated optic nerve hypoplasia.
DR   Orphanet; 35737; Morning glory syndrome.
DR   Orphanet; 194; Ocular coloboma.
DR   Orphanet; 708; Peters anomaly.
DR   Orphanet; 893; WAGR syndrome.
DR   PharmGKB; PA32960; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00680000099553; -.
DR   HOVERGEN; HBG009115; -.
DR   InParanoid; P26367; -.
DR   KO; K08031; -.
DR   OMA; QTGTWGT; -.
DR   PhylomeDB; P26367; -.
DR   TreeFam; TF320146; -.
DR   Reactome; R-HSA-210745; Regulation of gene expression in beta cells.
DR   Reactome; R-HSA-381771; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1).
DR   Reactome; R-HSA-400511; Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP).
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SignaLink; P26367; -.
DR   SIGNOR; P26367; -.
DR   ChiTaRS; PAX6; human.
DR   EvolutionaryTrace; P26367; -.
DR   GeneWiki; PAX6; -.
DR   GenomeRNAi; 5080; -.
DR   PRO; PR:P26367; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000007372; -.
DR   CleanEx; HS_PAX6; -.
DR   ExpressionAtlas; P26367; baseline and differential.
DR   Genevisible; P26367; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0070410; F:co-SMAD binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0035035; F:histone acetyltransferase binding; ISS:BHF-UCL.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; ISS:BHF-UCL.
DR   GO; GO:0070412; F:R-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0048708; P:astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0001568; P:blood vessel development; IMP:DFLAT.
DR   GO; GO:0001709; P:cell fate determination; IEA:Ensembl.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl.
DR   GO; GO:0021902; P:commitment of neuronal cell to specific neuron type in forebrain; IEA:Ensembl.
DR   GO; GO:0061303; P:cornea development in camera-type eye; IMP:DFLAT.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl.
DR   GO; GO:0001654; P:eye development; TAS:ProtInc.
DR   GO; GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl.
DR   GO; GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0021905; P:forebrain-midbrain boundary formation; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:DFLAT.
DR   GO; GO:0021986; P:habenula development; IEA:Ensembl.
DR   GO; GO:0061072; P:iris morphogenesis; IMP:DFLAT.
DR   GO; GO:0030216; P:keratinocyte differentiation; IEA:Ensembl.
DR   GO; GO:0032808; P:lacrimal gland development; IEA:Ensembl.
DR   GO; GO:0002088; P:lens development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0048663; P:neuron fate commitment; NAS:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0021778; P:oligodendrocyte cell fate specification; IEA:Ensembl.
DR   GO; GO:0003322; P:pancreatic A cell development; IMP:BHF-UCL.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL.
DR   GO; GO:0033365; P:protein localization to organelle; IEA:Ensembl.
DR   GO; GO:0009786; P:regulation of asymmetric cell division; IEA:Ensembl.
DR   GO; GO:0030334; P:regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0048505; P:regulation of timing of cell differentiation; IEA:Ensembl.
DR   GO; GO:0021918; P:regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0021912; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification; IEA:Ensembl.
DR   GO; GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEP:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0003309; P:type B pancreatic cell differentiation; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00292; PAX; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Developmental protein; Differentiation; Disease mutation; DNA-binding;
KW   Homeobox; Nucleus; Paired box; Peters anomaly; Reference proteome;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    422       Paired box protein Pax-6.
FT                                /FTId=PRO_0000050185.
FT   DOMAIN        4    130       Paired. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00381}.
FT   DNA_BIND    210    269       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    131    209       Gln/Gly-rich.
FT   COMPBIAS    279    422       Pro/Ser/Thr-rich.
FT   VAR_SEQ      47     47       Q -> QTHADAKVQVLDNQN (in isoform 5a).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_002366.
FT   VARIANT      17     17       N -> S (in AN1).
FT                                {ECO:0000269|PubMed:9856761}.
FT                                /FTId=VAR_003808.
FT   VARIANT      18     18       G -> W (in AN1).
FT                                {ECO:0000269|PubMed:9792406}.
FT                                /FTId=VAR_003809.
FT   VARIANT      19     19       R -> P (in AN1).
FT                                {ECO:0000269|PubMed:12634864,
FT                                ECO:0000269|PubMed:24033328}.
FT                                /FTId=VAR_047860.
FT   VARIANT      22     26       Missing (in AN1).
FT                                {ECO:0000269|PubMed:12634864,
FT                                ECO:0000269|PubMed:9281415}.
FT                                /FTId=VAR_008693.
FT   VARIANT      26     26       R -> G (in ASGD5; dbSNP:rs121907913).
FT                                {ECO:0000269|PubMed:8162071,
FT                                ECO:0000269|PubMed:9147640}.
FT                                /FTId=VAR_003810.
FT   VARIANT      29     29       I -> S (in AN1). {ECO:0000269|Ref.27}.
FT                                /FTId=VAR_008694.
FT   VARIANT      29     29       I -> V (in AN1).
FT                                {ECO:0000269|PubMed:9856761}.
FT                                /FTId=VAR_003811.
FT   VARIANT      33     33       A -> P (in AN1).
FT                                {ECO:0000269|PubMed:9931324}.
FT                                /FTId=VAR_008695.
FT   VARIANT      37     39       Missing (in AN1). {ECO:0000269|Ref.28}.
FT                                /FTId=VAR_008696.
FT   VARIANT      42     42       I -> S (in AN1; mild).
FT                                {ECO:0000269|PubMed:10234503}.
FT                                /FTId=VAR_008697.
FT   VARIANT      43     43       S -> P (in AN1).
FT                                {ECO:0000269|PubMed:9931324}.
FT                                /FTId=VAR_008698.
FT   VARIANT      44     44       R -> Q (in AN1).
FT                                {ECO:0000269|PubMed:9856761}.
FT                                /FTId=VAR_003812.
FT   VARIANT      46     46       L -> R (in AN1; shows almost no binding
FT                                efficiency; transcriptional activation
FT                                ability is about 50% lower than that of
FT                                the wild-type protein).
FT                                {ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_047861.
FT   VARIANT      52     52       C -> R (in AN1; shows almost no binding
FT                                efficiency; transcriptional activation
FT                                ability is about 50% lower than that of
FT                                the wild-type protein).
FT                                {ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_047862.
FT   VARIANT      53     53       V -> D (in ASGD5; also found in patients
FT                                with congenital cataract and foveal
FT                                hypoplasia).
FT                                {ECO:0000269|PubMed:10441571}.
FT                                /FTId=VAR_008700.
FT   VARIANT      53     53       V -> L (in AN1; mild; shows 50% lower
FT                                DNA-binding and transactivation ability
FT                                than the wild-type protein).
FT                                {ECO:0000269|PubMed:10234503,
FT                                ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_008699.
FT   VARIANT      56     56       I -> T (in AN1; shows only one-quarter to
FT                                one-third the binding ability of the
FT                                normal wild-type protein; exhibits normal
FT                                transactivation).
FT                                {ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_047863.
FT   VARIANT      63     63       T -> P (in AN1; mild).
FT                                {ECO:0000269|PubMed:10234503}.
FT                                /FTId=VAR_008701.
FT   VARIANT      64     64       G -> V (in foveal hypoplasia; associated
FT                                with presenile cataract syndrome;
FT                                dbSNP:rs121907920).
FT                                {ECO:0000269|PubMed:9931324}.
FT                                /FTId=VAR_008702.
FT   VARIANT      68     68       P -> S (in morning glory disk anomaly;
FT                                significant impairment of transcriptional
FT                                activation ability; dbSNP:rs121907923).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017540.
FT   VARIANT      73     73       G -> D (in AN1; shows almost no binding
FT                                efficiency; transcriptional activation
FT                                ability is about 80% of that of the wild-
FT                                type protein).
FT                                {ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_047864.
FT   VARIANT      79     79       A -> E (in AN1; mild).
FT                                {ECO:0000269|PubMed:10234503}.
FT                                /FTId=VAR_008703.
FT   VARIANT      87     87       I -> K (in AN1).
FT                                {ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_047865.
FT   VARIANT      87     87       I -> R (in AN1; loss of activity).
FT                                {ECO:0000269|PubMed:9147640}.
FT                                /FTId=VAR_003813.
FT   VARIANT     118    118       P -> R (in a family with nystagmus
FT                                associated with a variant form of
FT                                aniridia). {ECO:0000269|PubMed:10955655}.
FT                                /FTId=VAR_015065.
FT   VARIANT     119    119       S -> R (in AN1; dbSNP:rs121907928).
FT                                {ECO:0000269|PubMed:11553050,
FT                                ECO:0000269|Ref.27}.
FT                                /FTId=VAR_008704.
FT   VARIANT     125    125       R -> C (in FVH1; isolated).
FT                                {ECO:0000269|PubMed:8640214}.
FT                                /FTId=VAR_017541.
FT   VARIANT     126    126       V -> D (in AN1; atypical form;
FT                                dbSNP:rs121907919).
FT                                {ECO:0000269|PubMed:9931324}.
FT                                /FTId=VAR_008705.
FT   VARIANT     128    128       R -> C (in FVH1; isolated;
FT                                dbSNP:rs121907918).
FT                                {ECO:0000269|PubMed:8640214}.
FT                                /FTId=VAR_003814.
FT   VARIANT     178    178       Q -> H (in AN1).
FT                                {ECO:0000269|PubMed:9856761}.
FT                                /FTId=VAR_003815.
FT   VARIANT     208    208       R -> Q (in AN1; mild; dbSNP:rs749244084).
FT                                {ECO:0000269|PubMed:10234503}.
FT                                /FTId=VAR_008706.
FT   VARIANT     208    208       R -> W (in AN1; dbSNP:rs757259413).
FT                                {ECO:0000269|PubMed:8364574}.
FT                                /FTId=VAR_003816.
FT   VARIANT     242    242       R -> T (in AN1; the mutant homeodomain
FT                                binds DNA as well as the wild-type
FT                                homeodomain; the mutant does not modify
FT                                the DNA-binding properties of the paired
FT                                domain; the steady-state levels of the
FT                                full-length mutant protein are higher
FT                                than those of the wild-type one; a
FT                                responsive promoter is activated to a
FT                                higher extent by the mutant protein than
FT                                by the wild-type protein; the presence of
FT                                the mutation reduces sensitivity to
FT                                trypsin digestion; dbSNP:rs121907927).
FT                                {ECO:0000269|PubMed:11826019,
FT                                ECO:0000269|PubMed:16493447}.
FT                                /FTId=VAR_047866.
FT   VARIANT     258    258       F -> S (in COAD and COLON; significant
FT                                impairment of transcriptional activation
FT                                ability; dbSNP:rs121907925).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017542.
FT   VARIANT     292    292       S -> I (in BONH; significant impairment
FT                                of ability to activate transcription).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017543.
FT   VARIANT     321    321       A -> T (shows about two-fold higher
FT                                binding efficiency than the normal wild-
FT                                type protein; transcriptional activation
FT                                ability is about 89% of that of the wild-
FT                                type protein).
FT                                {ECO:0000269|PubMed:12552561}.
FT                                /FTId=VAR_047867.
FT   VARIANT     353    353       S -> A (in AN1; dbSNP:rs373661718).
FT                                {ECO:0000269|Ref.27}.
FT                                /FTId=VAR_008707.
FT   VARIANT     363    363       S -> P (in ASGD5).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017544.
FT   VARIANT     375    375       P -> Q (in AN1; reduced DNA binding
FT                                ability; dbSNP:rs200015827).
FT                                {ECO:0000269|PubMed:11309364}.
FT                                /FTId=VAR_015066.
FT   VARIANT     378    378       Q -> R (in optic nerve aplasia).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017545.
FT   VARIANT     381    381       M -> V (in BONH).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017546.
FT   VARIANT     387    387       G -> D. {ECO:0000269|PubMed:10737978}.
FT                                /FTId=VAR_047868.
FT   VARIANT     391    391       T -> A (in BONH; dbSNP:rs121907926).
FT                                {ECO:0000269|PubMed:12721955}.
FT                                /FTId=VAR_017547.
FT   VARIANT     395    395       G -> R (in AN1).
FT                                {ECO:0000269|PubMed:21850189}.
FT                                /FTId=VAR_067698.
FT   VARIANT     422    422       Q -> R (in AN1 and ocular anterior
FT                                segment anomalies; loss of DNA binding
FT                                ability; dbSNP:rs780356070).
FT                                {ECO:0000269|PubMed:11309364,
FT                                ECO:0000269|PubMed:9538891}.
FT                                /FTId=VAR_008708.
FT   CONFLICT    317    317       R -> L (in Ref. 1; AAA59962).
FT                                {ECO:0000305}.
FT   CONFLICT    369    369       Y -> C (in Ref. 4; CAE45868).
FT                                {ECO:0000305}.
FT   STRAND        6      8       {ECO:0000244|PDB:6PAX}.
FT   STRAND       14     16       {ECO:0000244|PDB:6PAX}.
FT   HELIX        23     34       {ECO:0000244|PDB:6PAX}.
FT   HELIX        39     46       {ECO:0000244|PDB:6PAX}.
FT   HELIX        50     63       {ECO:0000244|PDB:6PAX}.
FT   STRAND       77     79       {ECO:0000244|PDB:6PAX}.
FT   HELIX        81     93       {ECO:0000244|PDB:6PAX}.
FT   HELIX        99    108       {ECO:0000244|PDB:6PAX}.
FT   TURN        114    116       {ECO:0000244|PDB:6PAX}.
FT   HELIX       120    133       {ECO:0000244|PDB:6PAX}.
FT   HELIX       219    229       {ECO:0000244|PDB:2CUE}.
FT   HELIX       237    246       {ECO:0000244|PDB:2CUE}.
FT   HELIX       251    275       {ECO:0000244|PDB:2CUE}.
SQ   SEQUENCE   422 AA;  46683 MW;  C33CDD2C1B13C397 CRC64;
     MQNSHSGVNQ LGGVFVNGRP LPDSTRQKIV ELAHSGARPC DISRILQVSN GCVSKILGRY
     YETGSIRPRA IGGSKPRVAT PEVVSKIAQY KRECPSIFAW EIRDRLLSEG VCTNDNIPSV
     SSINRVLRNL ASEKQQMGAD GMYDKLRMLN GQTGSWGTRP GWYPGTSVPG QPTQDGCQQQ
     EGGGENTNSI SSNGEDSDEA QMRLQLKRKL QRNRTSFTQE QIEALEKEFE RTHYPDVFAR
     ERLAAKIDLP EARIQVWFSN RRAKWRREEK LRNQRRQASN TPSHIPISSS FSTSVYQPIP
     QPTTPVSSFT SGSMLGRTDT ALTNTYSALP PMPSFTMANN LPMQPPVPSQ TSSYSCMLPT
     SPSVNGRSYD TYTPPHMQTH MNSQPMGTSG TTSTGLISPG VSVPVQVPGS EPDMSQYWPR
     LQ
//
ID   HXA1_HUMAN              Reviewed;         335 AA.
AC   P49639; A4D184; B2R8U7; O43363;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   27-SEP-2017, entry version 179.
DE   RecName: Full=Homeobox protein Hox-A1;
DE   AltName: Full=Homeobox protein Hox-1F;
GN   Name=HOXA1; Synonyms=HOX1F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Ovary;
RX   PubMed=7622051; DOI=10.1016/0378-1119(95)92712-G;
RA   Hong Y.S., Kim S.Y., Bhattacharya A., Pratt D.R., Hong W.K.,
RA   Tainsky M.A.;
RT   "Structure and function of the HOX A1 human homeobox gene cDNA.";
RL   Gene 159:209-214(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ARG-73.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-335 (ISOFORMS 1; 2 AND 3).
RX   PubMed=7488013; DOI=10.1006/bbrc.1995.2522;
RA   Chariot A., Moreau L., Senterre G., Sobel M., Castronovo V.;
RT   "Retinoic acid induces three newly cloned HOXA1 transcripts in MCF7
RT   breast cancer cells.";
RL   Biochem. Biophys. Res. Commun. 215:713-720(1995).
RN   [8]
RP   VARIANT ARG-73.
RX   PubMed=11091361;
RX   DOI=10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M;
RA   Ingram J.L., Stodgell C.J., Hyman S.L., Figlewicz D.A., Weitkamp L.R.,
RA   Rodier P.M.;
RT   "Discovery of allelic variants of HOXA1 and HOXB1: genetic
RT   susceptibility to autism spectrum disorders.";
RL   Teratology 62:393-405(2000).
RN   [9]
RP   INVOLVEMENT IN ABDS AND BSAS.
RX   PubMed=16155570; DOI=10.1038/ng1636;
RA   Tischfield M.A., Bosley T.M., Salih M.A.M., Alorainy I.A., Sener E.C.,
RA   Nester M.J., Oystreck D.T., Chan W.-M., Andrews C., Erickson R.P.,
RA   Engle E.C.;
RT   "Homozygous HOXA1 mutations disrupt human brainstem, inner ear,
RT   cardiovascular and cognitive development.";
RL   Nat. Genet. 37:1035-1037(2005).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Acts on the anterior body structures. Seems to act in the
CC       maintenance and/or generation of hindbrain segments.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-740785, EBI-740785;
CC       Q6UY14-3:ADAMTSL4; NbExp=7; IntAct=EBI-740785, EBI-10173507;
CC       Q9NP73-4:ALG13; NbExp=3; IntAct=EBI-740785, EBI-10186621;
CC       P05187:ALPP; NbExp=4; IntAct=EBI-740785, EBI-1211484;
CC       Q9Y4X0-3:AMMECR1; NbExp=4; IntAct=EBI-740785, EBI-12823597;
CC       Q9H2G9:BLZF1; NbExp=5; IntAct=EBI-740785, EBI-2548012;
CC       J3KQ12:BSCL2; NbExp=4; IntAct=EBI-740785, EBI-11532900;
CC       Q5T4B2:CERCAM; NbExp=4; IntAct=EBI-740785, EBI-12261896;
CC       Q9UKJ5:CHIC2; NbExp=3; IntAct=EBI-740785, EBI-741528;
CC       Q9H2X0:CHRD; NbExp=3; IntAct=EBI-740785, EBI-947551;
CC       Q9BYD5:CNFN; NbExp=4; IntAct=EBI-740785, EBI-12819063;
CC       P27658:COL8A1; NbExp=4; IntAct=EBI-740785, EBI-747133;
CC       A8MQ03:CYSRT1; NbExp=4; IntAct=EBI-740785, EBI-3867333;
CC       Q86UW9:DTX2; NbExp=4; IntAct=EBI-740785, EBI-740376;
CC       A4D161:FAM221A; NbExp=6; IntAct=EBI-740785, EBI-11960181;
CC       O15353:FOXN1; NbExp=4; IntAct=EBI-740785, EBI-11319000;
CC       P15976:GATA1; NbExp=3; IntAct=EBI-740785, EBI-3909284;
CC       P14770:GP9; NbExp=5; IntAct=EBI-740785, EBI-1754109;
CC       P28799:GRN; NbExp=9; IntAct=EBI-740785, EBI-747754;
CC       Q15486:GUSBP1; NbExp=6; IntAct=EBI-740785, EBI-712457;
CC       P09022:Hoxa1 (xeno); NbExp=4; IntAct=EBI-740785, EBI-3957603;
CC       Q0VD86:INCA1; NbExp=4; IntAct=EBI-740785, EBI-6509505;
CC       Q5T749:KPRP; NbExp=4; IntAct=EBI-740785, EBI-10981970;
CC       Q15323:KRT31; NbExp=5; IntAct=EBI-740785, EBI-948001;
CC       O76014:KRT37; NbExp=4; IntAct=EBI-740785, EBI-1045716;
CC       O76015:KRT38; NbExp=5; IntAct=EBI-740785, EBI-1047263;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-740785, EBI-10171697;
CC       P78385:KRT83; NbExp=4; IntAct=EBI-740785, EBI-10221390;
CC       Q07627:KRTAP1-1; NbExp=4; IntAct=EBI-740785, EBI-11959885;
CC       Q9BYS1:KRTAP1-5; NbExp=4; IntAct=EBI-740785, EBI-11741292;
CC       P60412:KRTAP10-11; NbExp=9; IntAct=EBI-740785, EBI-10217483;
CC       P60370:KRTAP10-5; NbExp=5; IntAct=EBI-740785, EBI-10172150;
CC       P60410:KRTAP10-8; NbExp=7; IntAct=EBI-740785, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=9; IntAct=EBI-740785, EBI-10172052;
CC       P59990:KRTAP12-1; NbExp=9; IntAct=EBI-740785, EBI-10210845;
CC       P59991:KRTAP12-2; NbExp=3; IntAct=EBI-740785, EBI-10176379;
CC       P60328:KRTAP12-3; NbExp=4; IntAct=EBI-740785, EBI-11953334;
CC       P60329:KRTAP12-4; NbExp=7; IntAct=EBI-740785, EBI-10176396;
CC       Q9BYR9:KRTAP2-4; NbExp=4; IntAct=EBI-740785, EBI-14065470;
CC       Q6PEX3:KRTAP26-1; NbExp=5; IntAct=EBI-740785, EBI-3957672;
CC       Q9BYR7:KRTAP3-2; NbExp=5; IntAct=EBI-740785, EBI-751260;
CC       Q9BYQ6:KRTAP4-11; NbExp=5; IntAct=EBI-740785, EBI-10302392;
CC       Q9BQ66:KRTAP4-12; NbExp=6; IntAct=EBI-740785, EBI-739863;
CC       Q9BYR5:KRTAP4-2; NbExp=7; IntAct=EBI-740785, EBI-10172511;
CC       Q9BYR0:KRTAP4-7; NbExp=3; IntAct=EBI-740785, EBI-10302547;
CC       Q6L8G9:KRTAP5-6; NbExp=9; IntAct=EBI-740785, EBI-10250562;
CC       P26371:KRTAP5-9; NbExp=9; IntAct=EBI-740785, EBI-3958099;
CC       Q3LI66:KRTAP6-2; NbExp=4; IntAct=EBI-740785, EBI-11962084;
CC       Q9BYQ4:KRTAP9-2; NbExp=9; IntAct=EBI-740785, EBI-1044640;
CC       Q9BYQ3:KRTAP9-3; NbExp=4; IntAct=EBI-740785, EBI-1043191;
CC       Q9BYQ2:KRTAP9-4; NbExp=3; IntAct=EBI-740785, EBI-10185730;
CC       Q9BYQ0:KRTAP9-8; NbExp=4; IntAct=EBI-740785, EBI-11958364;
CC       Q5T7P2:LCE1A; NbExp=4; IntAct=EBI-740785, EBI-11962058;
CC       Q5T7P3:LCE1B; NbExp=7; IntAct=EBI-740785, EBI-10245913;
CC       Q5T754:LCE1F; NbExp=4; IntAct=EBI-740785, EBI-11958008;
CC       Q5TA81:LCE2C; NbExp=4; IntAct=EBI-740785, EBI-11973993;
CC       Q5TA82:LCE2D; NbExp=4; IntAct=EBI-740785, EBI-10246750;
CC       Q5T5B0:LCE3E; NbExp=3; IntAct=EBI-740785, EBI-10245456;
CC       Q5TA78:LCE4A; NbExp=7; IntAct=EBI-740785, EBI-10246358;
CC       Q5TCM9:LCE5A; NbExp=4; IntAct=EBI-740785, EBI-11955689;
CC       Q9UHV8:LGALS13; NbExp=5; IntAct=EBI-740785, EBI-3957707;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-740785, EBI-724076;
CC       Q92802:N4BP2L2; NbExp=3; IntAct=EBI-740785, EBI-2514973;
CC       Q7Z3S9:NOTCH2NL; NbExp=5; IntAct=EBI-740785, EBI-945833;
CC       Q6NSM0:NR1D2; NbExp=4; IntAct=EBI-740785, EBI-10250949;
CC       P40425:PBX2; NbExp=3; IntAct=EBI-740785, EBI-348489;
CC       Q13526:PIN1; NbExp=4; IntAct=EBI-740785, EBI-714158;
CC       P04156:PRNP; NbExp=4; IntAct=EBI-740785, EBI-977302;
CC       O75360:PROP1; NbExp=4; IntAct=EBI-740785, EBI-9027467;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-740785, EBI-740322;
CC       Q9UGC6:RGS17; NbExp=7; IntAct=EBI-740785, EBI-3918154;
CC       O76081:RGS20; NbExp=3; IntAct=EBI-740785, EBI-1052678;
CC       O76081-6:RGS20; NbExp=3; IntAct=EBI-740785, EBI-10178530;
CC       O00560:SDCBP; NbExp=5; IntAct=EBI-740785, EBI-727004;
CC       O43609:SPRY1; NbExp=7; IntAct=EBI-740785, EBI-3866665;
CC       O43463:SUV39H1; NbExp=2; IntAct=EBI-740785, EBI-349968;
CC       Q8IV04:TBC1D10C; NbExp=5; IntAct=EBI-740785, EBI-10261452;
CC       Q8N5G2:TMEM57; NbExp=4; IntAct=EBI-740785, EBI-2683507;
CC       Q13077:TRAF1; NbExp=3; IntAct=EBI-740785, EBI-359224;
CC       Q8IWZ5:TRIM42; NbExp=10; IntAct=EBI-740785, EBI-5235829;
CC       O14817:TSPAN4; NbExp=4; IntAct=EBI-740785, EBI-8652667;
CC       Q2TAL6:VWC2; NbExp=4; IntAct=EBI-740785, EBI-11957238;
CC       B2RUY7:VWC2L; NbExp=4; IntAct=EBI-740785, EBI-11747707;
CC       Q9NZC7-5:WWOX; NbExp=4; IntAct=EBI-740785, EBI-12040603;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3; Synonyms=36 kDa;
CC         IsoId=P49639-1; Sequence=Displayed;
CC       Name=1; Synonyms=14 kDa;
CC         IsoId=P49639-2; Sequence=VSP_002376, VSP_002377;
CC         Note=Lacks the homeobox domain.;
CC       Name=2; Synonyms=24 kDa;
CC         IsoId=P49639-3; Sequence=VSP_002378, VSP_002379;
CC         Note=Lacks the homeobox domain.;
CC   -!- DISEASE: Athabaskan brainstem dysgenesis syndrome (ABDS)
CC       [MIM:601536]: Characterized by horizontal gaze palsy,
CC       sensorineural deafness, central hypoventilation, and developmental
CC       delay. Some patients had swallowing dysfunction, vocal cord
CC       paralysis, facial paresis, seizures, and cardiac outflow tract
CC       anomalies. {ECO:0000269|PubMed:16155570}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Bosley-Salih-Alorainy syndrome (BSAS) [MIM:601536]: A
CC       disease characterized by horizontal gaze abnormalities, deafness,
CC       facial weakness, vascular malformations of the internal carotid
CC       arteries and cardiac outflow trac. Some patients manifest mental
CC       retardation and autism spectrum disorder. Affected individuals do
CC       not suffer from central hypoventilation. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Labial subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10421; AAA86954.1; -; mRNA.
DR   EMBL; AK313514; BAG36294.1; -; mRNA.
DR   EMBL; AC004079; AAS00374.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24228.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93861.1; -; Genomic_DNA.
DR   EMBL; BC032547; AAH32547.1; -; mRNA.
DR   EMBL; U37431; AAC50248.1; -; mRNA.
DR   EMBL; U37431; AAC50249.1; -; mRNA.
DR   EMBL; U37431; AAC50250.1; -; mRNA.
DR   EMBL; S79869; AAB35424.2; -; mRNA.
DR   EMBL; S79871; AAB35425.1; -; mRNA.
DR   EMBL; S79910; AAB35423.2; -; mRNA.
DR   CCDS; CCDS5401.1; -. [P49639-1]
DR   CCDS; CCDS5402.2; -. [P49639-2]
DR   PIR; G01448; G01448.
DR   RefSeq; NP_005513.1; NM_005522.4. [P49639-1]
DR   RefSeq; NP_705873.2; NM_153620.2. [P49639-2]
DR   UniGene; Hs.67397; -.
DR   ProteinModelPortal; P49639; -.
DR   SMR; P49639; -.
DR   BioGrid; 109438; 67.
DR   ELM; P49639; -.
DR   IntAct; P49639; 243.
DR   MINT; MINT-1437157; -.
DR   STRING; 9606.ENSP00000343246; -.
DR   iPTMnet; P49639; -.
DR   PhosphoSitePlus; P49639; -.
DR   BioMuta; HOXA1; -.
DR   DMDM; 6166216; -.
DR   PaxDb; P49639; -.
DR   PeptideAtlas; P49639; -.
DR   PRIDE; P49639; -.
DR   DNASU; 3198; -.
DR   Ensembl; ENST00000343060; ENSP00000343246; ENSG00000105991.
DR   GeneID; 3198; -.
DR   KEGG; hsa:3198; -.
DR   UCSC; uc003sye.4; human. [P49639-1]
DR   CTD; 3198; -.
DR   DisGeNET; 3198; -.
DR   EuPathDB; HostDB:ENSG00000105991.7; -.
DR   GeneCards; HOXA1; -.
DR   HGNC; HGNC:5099; HOXA1.
DR   MalaCards; HOXA1; -.
DR   MIM; 142955; gene.
DR   MIM; 601536; phenotype.
DR   neXtProt; NX_P49639; -.
DR   Orphanet; 69739; Athabaskan brainstem dysgenesis syndrome.
DR   Orphanet; 69737; Bosley-Salih-Alorainy syndrome.
DR   PharmGKB; PA29376; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   HOGENOM; HOG000247020; -.
DR   HOVERGEN; HBG006089; -.
DR   InParanoid; P49639; -.
DR   KO; K09301; -.
DR   OrthoDB; EOG091G0LR2; -.
DR   PhylomeDB; P49639; -.
DR   TreeFam; TF317730; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SIGNOR; P49639; -.
DR   GeneWiki; Homeobox_A1; -.
DR   GenomeRNAi; 3198; -.
DR   PRO; PR:P49639; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105991; -.
DR   CleanEx; HS_HOXA1; -.
DR   ExpressionAtlas; P49639; baseline and differential.
DR   Genevisible; P49639; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0021599; P:abducens nerve formation; IMP:DFLAT.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IMP:DFLAT.
DR   GO; GO:0060840; P:artery development; IMP:DFLAT.
DR   GO; GO:0048844; P:artery morphogenesis; IMP:DFLAT.
DR   GO; GO:0090102; P:cochlea development; IMP:DFLAT.
DR   GO; GO:0090103; P:cochlea morphogenesis; IMP:DFLAT.
DR   GO; GO:0050890; P:cognition; IDA:DFLAT.
DR   GO; GO:0048702; P:embryonic neurocranium morphogenesis; IMP:DFLAT.
DR   GO; GO:0048839; P:inner ear development; IMP:DFLAT.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0050905; P:neuromuscular process; IDA:DFLAT.
DR   GO; GO:0007634; P:optokinetic behavior; IDA:DFLAT.
DR   GO; GO:0042473; P:outer ear morphogenesis; IDA:DFLAT.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0050795; P:regulation of behavior; IDA:DFLAT.
DR   GO; GO:0060876; P:semicircular canal formation; IMP:DFLAT.
DR   GO; GO:0007605; P:sensory perception of sound; IDA:DFLAT.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autism spectrum disorder; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    335       Homeobox protein Hox-A1.
FT                                /FTId=PRO_0000200030.
FT   DNA_BIND    229    288       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       204    209       Antp-type hexapeptide.
FT   COMPBIAS     65     74       Poly-His.
FT   COMPBIAS    142    146       Poly-His.
FT   COMPBIAS    314    317       Poly-Ser.
FT   VAR_SEQ     119    137       VSGGYPQCAPAVYSGNLSS -> PPRSLSLPRIGDIFSSAD
FT                                F (in isoform 1).
FT                                {ECO:0000303|PubMed:7488013}.
FT                                /FTId=VSP_002376.
FT   VAR_SEQ     138    335       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:7488013}.
FT                                /FTId=VSP_002377.
FT   VAR_SEQ     219    227       KVGEYGYLG -> QSCWLVDAP (in isoform 2).
FT                                {ECO:0000303|PubMed:7488013}.
FT                                /FTId=VSP_002378.
FT   VAR_SEQ     228    335       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7488013}.
FT                                /FTId=VSP_002379.
FT   VARIANT      73     73       H -> R (frequent polymorphism in
FT                                individuals of European or African
FT                                origin; dbSNP:rs10951154).
FT                                {ECO:0000269|PubMed:11091361,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_010305.
FT   VARIANT     189    189       E -> A (in dbSNP:rs17500494).
FT                                /FTId=VAR_030576.
SQ   SEQUENCE   335 AA;  36641 MW;  3C3A2D0A59A4181C CRC64;
     MDNARMNSFL EYPILSSGDS GTCSARAYPS DHRITTFQSC AVSANSCGGD DRFLVGRGVQ
     IGSPHHHHHH HHHHPQPATY QTSGNLGVSY SHSSCGPSYG SQNFSAPYSP YALNQEADVS
     GGYPQCAPAV YSGNLSSPMV QHHHHHQGYA GGAVGSPQYI HHSYGQEHQS LALATYNNSL
     SPLHASHQEA CRSPASETSS PAQTFDWMKV KRNPPKTGKV GEYGYLGQPN AVRTNFTTKQ
     LTELEKEFHF NKYLTRARRV EIAASLQLNE TQVKIWFQNR RMKQKKREKE GLLPISPATP
     PGNDEKAEES SEKSSSSPCV PSPGSSTSDT LTTSH
//
ID   PITX2_HUMAN             Reviewed;         317 AA.
AC   Q99697; A8K6C6; B2RA02; B3KXS0; O60578; O60579; O60580; Q3KQX9;
AC   Q9BY17;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   25-OCT-2017, entry version 187.
DE   RecName: Full=Pituitary homeobox 2;
DE   AltName: Full=ALL1-responsive protein ARP1;
DE   AltName: Full=Homeobox protein PITX2;
DE   AltName: Full=Paired-like homeodomain transcription factor 2;
DE   AltName: Full=RIEG bicoid-related homeobox transcription factor;
DE   AltName: Full=Solurshin;
GN   Name=PITX2; Synonyms=ARP1, RGS, RIEG, RIEG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PTX2B), AND VARIANTS RIEG1
RP   GLN-100; PRO-114 AND PRO-137.
RC   TISSUE=Craniofacial, and Fetal brain;
RX   PubMed=8944018; DOI=10.1038/ng1296-392;
RA   Semina E.V., Reiter R., Leysens N.J., Alward W.L.M., Small K.W.,
RA   Datson N.A., Siegle-Bartelt J., Bierke-Nelson D., Bitoun P.,
RA   Zabel B.U., Carey J.C., Murray J.C.;
RT   "Cloning and characterization of a novel bicoid-related homeobox
RT   transcription factor gene, RIEG, involved in Rieger syndrome.";
RL   Nat. Genet. 14:392-399(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PTX2A; PTX2B AND PTX2C), AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=9539779; DOI=10.1073/pnas.95.8.4573;
RA   Arakawa H., Nakamura T., Zhadanov A.B., Fidanza Y., Yano T.,
RA   Bullrich F., Shimizu M., Blechman J., Mazo A., Canaani E., Croce C.M.;
RT   "Identification and characterization of the ARP1 gene, a target for
RT   the human acute leukemia ALL1 gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4573-4578(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM PTX2A).
RA   Semina E.V., Funkhauser C., Bitoun P., Daack-Hirsch S., Alward W.L.M.,
RA   Amendt B., Murray J.C.;
RT   "Spectrum and frequency of PITX2 mutations in patients with Rieger
RT   syndrome and related ocular anomalies.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PTX2A; PTX2B AND
RP   PTX2C).
RC   TISSUE=Placenta, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PTX2C AND PTX2A).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   STRUCTURE BY NMR OF 85-144 OF WILD-TYPE AND MUTANT HIS-108 IN COMPLEX
RP   WITH DNA, AND VARIANT RDC HIS-108.
RX   PubMed=22224469; DOI=10.1021/bi201639x;
RA   Doerdelmann T., Kojetin D.J., Baird-Titus J.M., Solt L.A.,
RA   Burris T.P., Rance M.;
RT   "Structural and biophysical insights into the ligand-free Pitx2
RT   homeodomain and a ring dermoid of the cornea inducing homeodomain
RT   mutant.";
RL   Biochemistry 51:665-676(2012).
RN   [8]
RP   VARIANT ASGD4 TRP-130.
RX   PubMed=9437321; DOI=10.1016/S0002-9394(99)80242-6;
RA   Alward W.L.M., Semina E.V., Kalenak J.W., Heon E., Sheth B.P.,
RA   Stone E.M., Murray J.C.;
RT   "Autosomal dominant iris hypoplasia is caused by a mutation in the
RT   Rieger syndrome (RIEG/PITX2) gene.";
RL   Am. J. Ophthalmol. 125:98-100(1998).
RN   [9]
RP   VARIANT ASGD4 HIS-115.
RX   PubMed=9618168; DOI=10.1093/hmg/7.7.1113;
RA   Kulak S.C., Kozlowski K., Semina E.V., Pearce W.G., Walter M.A.;
RT   "Mutation in the RIEG1 gene in patients with iridogoniodysgenesis
RT   syndrome.";
RL   Hum. Mol. Genet. 7:1113-1117(1998).
RN   [10]
RP   INVOLVEMENT IN ASGD4.
RX   PubMed=10051017;
RA   Doward W., Perveen R., Lloyd I.C., Ridgway A.E.A., Wilson L.,
RA   Black G.C.M.;
RT   "A mutation in the RIEG1 gene associated with Peters' anomaly.";
RL   J. Med. Genet. 36:152-155(1999).
RN   [11]
RP   VARIANTS RIEG1 GLU-134 AND CYS-136.
RX   PubMed=10937553;
RA   Perveen R., Lloyd I.C., Clayton-Smith J., Churchill A.,
RA   van Heyningen V., Hanson I., Taylor D., McKeown C., Super M., Kerr B.,
RA   Winter R., Black G.C.M.;
RT   "Phenotypic variability and asymmetry of Rieger syndrome associated
RT   with PITX2 mutations.";
RL   Invest. Ophthalmol. Vis. Sci. 41:2456-2460(2000).
RN   [12]
RP   VARIANTS RIEG1 ARG-128--134-LYS DEL AND LEU-129, AND CHARACTERIZATION
RP   OF VARIANTS RIEG1 ARG-128--134-LYS DEL AND LEU-129.
RX   PubMed=11487566; DOI=10.1093/hmg/10.16.1631;
RA   Priston M., Kozlowski K., Gill D., Letwin K., Buys Y., Levin A.V.,
RA   Walter M.A., Heon E.;
RT   "Functional analyses of two newly identified PITX2 mutants reveal a
RT   novel molecular mechanism for Axenfeld-Rieger syndrome.";
RL   Hum. Mol. Genet. 10:1631-1638(2001).
RN   [13]
RP   VARIANTS RIEG1 LEU-110; CYS-136; VAL-151 AND THR-154.
RX   PubMed=12381896; DOI=10.1159/000065602;
RA   Phillips J.C.;
RT   "Four novel mutations in the PITX2 gene in patients with Axenfeld-
RT   Rieger syndrome.";
RL   Ophthalmic Res. 34:324-326(2002).
RN   [14]
RP   VARIANT RDC HIS-108.
RX   PubMed=15591271; DOI=10.1136/jmg.2004.022434;
RA   Xia K., Wu L., Liu X., Xi X., Liang D., Zheng D., Cai F., Pan Q.,
RA   Long Z., Dai H., Hu Z., Tang B., Zhang Z., Xia J.;
RT   "Mutation in PITX2 is associated with ring dermoid of the cornea.";
RL   J. Med. Genet. 41:E129-E129(2004).
RN   [15]
RP   VARIANTS RIEG1 LEU-110 AND ARG-110.
RX   PubMed=16936096; DOI=10.1167/iovs.06-0343;
RA   Weisschuh N., Dressler P., Schuettauf F., Wolf C., Wissinger B.,
RA   Gramer E.;
RT   "Novel mutations of FOXC1 and PITX2 in patients with Axenfeld-Rieger
RT   malformations.";
RL   Invest. Ophthalmol. Vis. Sci. 47:3846-3852(2006).
RN   [16]
RP   ERRATUM.
RA   Weisschuh N., Dressler P., Schuettauf F., Wolf C., Wissinger B.,
RA   Gramer E.;
RL   Invest. Ophthalmol. Vis. Sci. 47:5162-5162(2006).
RN   [17]
RP   VARIANT ASGD4 LEU-58 (ISOFORM PTX2A).
RX   PubMed=20881294; DOI=10.1167/iovs.10-5309;
RA   D'haene B., Meire F., Claerhout I., Kroes H.Y., Plomp A., Arens Y.H.,
RA   de Ravel T., Casteels I., De Jaegere S., Hooghe S., Wuyts W.,
RA   van den Ende J., Roulez F., Veenstra-Knol H.E., Oldenburg R.A.,
RA   Giltay J., Verheij J.B., de Faber J.T., Menten B., De Paepe A.,
RA   Kestelyn P., Leroy B.P., De Baere E.;
RT   "Expanding the spectrum of FOXC1 and PITX2 mutations and copy number
RT   changes in patients with anterior segment malformations.";
RL   Invest. Ophthalmol. Vis. Sci. 52:324-333(2011).
CC   -!- FUNCTION: Controls cell proliferation in a tissue-specific manner
CC       and is involved in morphogenesis. During embryonic development,
CC       exerts a role in the expansion of muscle progenitors. May play a
CC       role in the proper localization of asymmetric organs such as the
CC       heart and stomach. Isoform PTX2C is involved in left-right
CC       asymmetry the developing embryo (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P35222:CTNNB1; NbExp=2; IntAct=EBI-1175211, EBI-491549;
CC       Q12948:FOXC1; NbExp=6; IntAct=EBI-1175243, EBI-1175253;
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-1175211, EBI-3957603;
CC       Q02078:MEF2A; NbExp=2; IntAct=EBI-1175243, EBI-2656305;
CC       P10037:Pou1f1 (xeno); NbExp=2; IntAct=EBI-1175243, EBI-9825525;
CC       P67809:YBX1; NbExp=3; IntAct=EBI-1175211, EBI-354065;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=PTX2B; Synonyms=ARP1B;
CC         IsoId=Q99697-1; Sequence=Displayed;
CC       Name=PTX2C; Synonyms=ARP1C;
CC         IsoId=Q99697-2; Sequence=VSP_002260;
CC       Name=PTX2A; Synonyms=ARP1A;
CC         IsoId=Q99697-3; Sequence=VSP_002261;
CC         Note=Variant in position: 58:F->L (in ASGD4).
CC         {ECO:0000269|PubMed:20881294};
CC   -!- PTM: Phosphorylation at Thr-90 impairs its association with the
CC       CCND1 mRNA-stabilizing complex thus shortening the half-life of
CC       CCND1. {ECO:0000250}.
CC   -!- DISEASE: Axenfeld-Rieger syndrome 1 (RIEG1) [MIM:180500]: An
CC       autosomal dominant disorder of morphogenesis that results in
CC       abnormal development of the anterior segment of the eye, and
CC       results in blindness from glaucoma in approximately 50% of
CC       affected individuals. Additional features include aniridia,
CC       maxillary hypoplasia, hypodontia, anal stenosis, redundant
CC       periumbilical skin. {ECO:0000269|PubMed:10937553,
CC       ECO:0000269|PubMed:11487566, ECO:0000269|PubMed:12381896,
CC       ECO:0000269|PubMed:16936096, ECO:0000269|PubMed:8944018}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Anterior segment dysgenesis 4 (ASGD4) [MIM:137600]: A
CC       form of anterior segment dysgenesis, a group of defects affecting
CC       anterior structures of the eye including cornea, iris, lens,
CC       trabecular meshwork, and Schlemm canal. Anterior segment
CC       dysgeneses result from abnormal migration or differentiation of
CC       the neural crest derived mesenchymal cells that give rise to
CC       components of the anterior chamber during eye development.
CC       Different anterior segment anomalies may exist alone or in
CC       combination, including iris hypoplasia, enlarged or reduced
CC       corneal diameter, corneal vascularization and opacity, posterior
CC       embryotoxon, corectopia, polycoria, abnormal iridocorneal angle,
CC       ectopia lentis, and anterior synechiae between the iris and
CC       posterior corneal surface. Clinical conditions falling within the
CC       phenotypic spectrum of anterior segment dysgeneses include
CC       aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters
CC       anomaly, and iridogoniodysgenesis. ASGD4 is an autosomal dominant
CC       disease. {ECO:0000269|PubMed:10051017,
CC       ECO:0000269|PubMed:20881294, ECO:0000269|PubMed:9437321,
CC       ECO:0000269|PubMed:9618168}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ring dermoid of cornea (RDC) [MIM:180550]: An ocular
CC       disorder characterized by bilateral annular limbal dermoids
CC       (growths with a skin-like structure) with corneal and conjunctival
CC       extension. {ECO:0000269|PubMed:15591271,
CC       ECO:0000269|PubMed:22224469}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U69961; AAC16257.1; -; mRNA.
DR   EMBL; AF048720; AAC39716.1; -; mRNA.
DR   EMBL; AF048721; AAC39717.1; -; mRNA.
DR   EMBL; AF048722; AAC39718.1; -; mRNA.
DR   EMBL; AF238048; AAK15048.1; -; Genomic_DNA.
DR   EMBL; AK127829; BAG54582.1; -; mRNA.
DR   EMBL; AK291591; BAF84280.1; -; mRNA.
DR   EMBL; AK313987; BAG36699.1; -; mRNA.
DR   EMBL; CH471057; EAX06262.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06263.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06264.1; -; Genomic_DNA.
DR   EMBL; BC013998; AAH13998.1; -; mRNA.
DR   EMBL; BC106010; AAI06011.1; -; mRNA.
DR   CCDS; CCDS3692.1; -. [Q99697-1]
DR   CCDS; CCDS3693.1; -. [Q99697-3]
DR   CCDS; CCDS3694.1; -. [Q99697-2]
DR   RefSeq; NP_000316.2; NM_000325.5. [Q99697-2]
DR   RefSeq; NP_001191326.1; NM_001204397.1. [Q99697-1]
DR   RefSeq; NP_001191327.1; NM_001204398.1. [Q99697-1]
DR   RefSeq; NP_001191328.1; NM_001204399.1. [Q99697-3]
DR   RefSeq; NP_700475.1; NM_153426.2. [Q99697-1]
DR   RefSeq; NP_700476.1; NM_153427.2. [Q99697-3]
DR   RefSeq; XP_011530329.1; XM_011532027.2. [Q99697-3]
DR   UniGene; Hs.643588; -.
DR   UniGene; Hs.738484; -.
DR   PDB; 2L7F; NMR; -; P=85-144.
DR   PDB; 2L7M; NMR; -; P=85-144.
DR   PDB; 2LKX; NMR; -; A=85-144.
DR   PDBsum; 2L7F; -.
DR   PDBsum; 2L7M; -.
DR   PDBsum; 2LKX; -.
DR   ProteinModelPortal; Q99697; -.
DR   SMR; Q99697; -.
DR   BioGrid; 111325; 18.
DR   CORUM; Q99697; -.
DR   IntAct; Q99697; 42.
DR   STRING; 9606.ENSP00000304169; -.
DR   iPTMnet; Q99697; -.
DR   PhosphoSitePlus; Q99697; -.
DR   BioMuta; PITX2; -.
DR   DMDM; 6174907; -.
DR   EPD; Q99697; -.
DR   MaxQB; Q99697; -.
DR   PaxDb; Q99697; -.
DR   PeptideAtlas; Q99697; -.
DR   PRIDE; Q99697; -.
DR   DNASU; 5308; -.
DR   Ensembl; ENST00000306732; ENSP00000304169; ENSG00000164093. [Q99697-2]
DR   Ensembl; ENST00000354925; ENSP00000347004; ENSG00000164093. [Q99697-1]
DR   Ensembl; ENST00000355080; ENSP00000347192; ENSG00000164093. [Q99697-3]
DR   Ensembl; ENST00000394598; ENSP00000378097; ENSG00000164093. [Q99697-1]
DR   Ensembl; ENST00000613094; ENSP00000484763; ENSG00000164093. [Q99697-1]
DR   Ensembl; ENST00000614423; ENSP00000481951; ENSG00000164093. [Q99697-1]
DR   Ensembl; ENST00000616641; ENSP00000484909; ENSG00000164093. [Q99697-3]
DR   GeneID; 5308; -.
DR   KEGG; hsa:5308; -.
DR   UCSC; uc003iac.4; human. [Q99697-1]
DR   CTD; 5308; -.
DR   DisGeNET; 5308; -.
DR   EuPathDB; HostDB:ENSG00000164093.15; -.
DR   GeneCards; PITX2; -.
DR   GeneReviews; PITX2; -.
DR   HGNC; HGNC:9005; PITX2.
DR   HPA; HPA050074; -.
DR   HPA; HPA062728; -.
DR   MalaCards; PITX2; -.
DR   MIM; 137600; phenotype.
DR   MIM; 180500; phenotype.
DR   MIM; 180550; phenotype.
DR   MIM; 601542; gene.
DR   neXtProt; NX_Q99697; -.
DR   OpenTargets; ENSG00000164093; -.
DR   Orphanet; 98978; Axenfeld anomaly.
DR   Orphanet; 782; Axenfeld-Rieger syndrome.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 708; Peters anomaly.
DR   Orphanet; 91483; Rieger anomaly.
DR   Orphanet; 91481; Ring dermoid of cornea.
DR   PharmGKB; PA33339; -.
DR   eggNOG; KOG0486; Eukaryota.
DR   eggNOG; ENOG410ZZ6J; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000273886; -.
DR   HOVERGEN; HBG068770; -.
DR   InParanoid; Q99697; -.
DR   KO; K04686; -.
DR   OMA; PLNIDHH; -.
DR   OrthoDB; EOG091G0H7U; -.
DR   PhylomeDB; Q99697; -.
DR   TreeFam; TF351940; -.
DR   Reactome; R-HSA-8866906; TFAP2 (AP-2) family regulates transcription of other transcription factors.
DR   SignaLink; Q99697; -.
DR   SIGNOR; Q99697; -.
DR   ChiTaRS; PITX2; human.
DR   EvolutionaryTrace; Q99697; -.
DR   GeneWiki; PITX2; -.
DR   GenomeRNAi; 5308; -.
DR   PRO; PR:Q99697; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164093; -.
DR   CleanEx; HS_PITX2; -.
DR   ExpressionAtlas; Q99697; baseline and differential.
DR   Genevisible; Q99697; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005667; C:transcription factor complex; IDA:MGI.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IC:BHF-UCL.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:BHF-UCL.
DR   GO; GO:0001191; F:transcriptional repressor activity, RNA polymerase II transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0055009; P:atrial cardiac muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0003171; P:atrioventricular valve development; IEA:Ensembl.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0043010; P:camera-type eye development; IMP:BHF-UCL.
DR   GO; GO:0003253; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0061325; P:cell proliferation involved in outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0035993; P:deltoid tuberosity development; IMP:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL.
DR   GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0061031; P:endodermal digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0002074; P:extraocular skeletal muscle development; IEA:Ensembl.
DR   GO; GO:0008585; P:female gonad development; IEA:Ensembl.
DR   GO; GO:0035315; P:hair cell differentiation; IC:BHF-UCL.
DR   GO; GO:0021855; P:hypothalamus cell migration; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0061072; P:iris morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0060460; P:left lung morphogenesis; IEA:Ensembl.
DR   GO; GO:0070986; P:left/right axis specification; ISS:BHF-UCL.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007520; P:myoblast fusion; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0042476; P:odontogenesis; IMP:BHF-UCL.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0060127; P:prolactin secreting cell differentiation; TAS:BHF-UCL.
DR   GO; GO:0003350; P:pulmonary myocardium development; IEA:Ensembl.
DR   GO; GO:0060577; P:pulmonary vein morphogenesis; IEA:Ensembl.
DR   GO; GO:0030334; P:regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0060126; P:somatotropin secreting cell differentiation; TAS:BHF-UCL.
DR   GO; GO:0048536; P:spleen development; ISS:BHF-UCL.
DR   GO; GO:0021763; P:subthalamic nucleus development; IEA:Ensembl.
DR   GO; GO:0060578; P:superior vena cava morphogenesis; IEA:Ensembl.
DR   GO; GO:0035886; P:vascular smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016233; Homeobox_Pitx/unc30.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   PIRSF; PIRSF000563; Homeobox_protein_Pitx/Unc30; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Peters anomaly; Phosphoprotein; Reference proteome.
FT   CHAIN         1    317       Pituitary homeobox 2.
FT                                /FTId=PRO_0000049223.
FT   DNA_BIND     85    144       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       279    292       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOTIF       285    289       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOD_RES      90     90       Phosphothreonine; by PKB/AKT2.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     61       METNCRKLVSACVQLGVQPAAVECLFSKDSEIKKVEFTDSP
FT                                ESRKEAASSKFFPRQHPGAN -> MNCMKGPLHLEHRAAGT
FT                                KLSAVSSSSCHHPQPLAMASVLAPGQPRSLDSSKHRLEVHT
FT                                ISDTSSPEAA (in isoform PTX2C).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9539779}.
FT                                /FTId=VSP_002260.
FT   VAR_SEQ      16     61       Missing (in isoform PTX2A).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9539779}.
FT                                /FTId=VSP_002261.
FT   VARIANT     100    100       L -> Q (in RIEG1; dbSNP:rs104893857).
FT                                {ECO:0000269|PubMed:8944018}.
FT                                /FTId=VAR_003763.
FT   VARIANT     108    108       R -> H (in RDC; results in 25% loss of
FT                                transactivation activity;
FT                                dbSNP:rs104893862).
FT                                {ECO:0000269|PubMed:15591271,
FT                                ECO:0000269|PubMed:22224469}.
FT                                /FTId=VAR_035027.
FT   VARIANT     110    110       P -> L (in RIEG1).
FT                                {ECO:0000269|PubMed:12381896,
FT                                ECO:0000269|PubMed:16936096}.
FT                                /FTId=VAR_058735.
FT   VARIANT     110    110       P -> R (in RIEG1).
FT                                {ECO:0000269|PubMed:16936096}.
FT                                /FTId=VAR_058736.
FT   VARIANT     114    114       T -> P (in RIEG1; dbSNP:rs104893858).
FT                                {ECO:0000269|PubMed:8944018}.
FT                                /FTId=VAR_003764.
FT   VARIANT     115    115       R -> H (in ASGD4; dbSNP:rs104893861).
FT                                {ECO:0000269|PubMed:9618168}.
FT                                /FTId=VAR_003765.
FT   VARIANT     128    134       Missing (in RIEG1; more than 100-fold
FT                                reduction in DNA binding activity as well
FT                                as no detectable transactivation
FT                                activity).
FT                                /FTId=VAR_035028.
FT   VARIANT     129    129       V -> L (in RIEG1; more than 200% increase
FT                                in transactivation activity;
FT                                dbSNP:rs121909249).
FT                                {ECO:0000269|PubMed:11487566}.
FT                                /FTId=VAR_035029.
FT   VARIANT     130    130       R -> W (in ASGD4; dbSNP:rs121909248).
FT                                {ECO:0000269|PubMed:9437321}.
FT                                /FTId=VAR_003762.
FT   VARIANT     134    134       K -> E (in RIEG1; dbSNP:rs387906810).
FT                                {ECO:0000269|PubMed:10937553}.
FT                                /FTId=VAR_058737.
FT   VARIANT     136    136       R -> C (in RIEG1).
FT                                {ECO:0000269|PubMed:10937553,
FT                                ECO:0000269|PubMed:12381896}.
FT                                /FTId=VAR_058738.
FT   VARIANT     137    137       R -> P (in RIEG1; dbSNP:rs104893859).
FT                                {ECO:0000269|PubMed:8944018}.
FT                                /FTId=VAR_003766.
FT   VARIANT     151    151       L -> V (in RIEG1).
FT                                {ECO:0000269|PubMed:12381896}.
FT                                /FTId=VAR_058739.
FT   VARIANT     154    154       N -> T (in RIEG1).
FT                                {ECO:0000269|PubMed:12381896}.
FT                                /FTId=VAR_058740.
FT   CONFLICT     13     13       V -> L (in Ref. 1 and 3). {ECO:0000305}.
FT   CONFLICT     99     99       E -> Q (in Ref. 1; AAC16257).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       A -> T (in Ref. 4; BAF84280).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       N -> K (in Ref. 1 and 3). {ECO:0000305}.
FT   STRAND       86     88       {ECO:0000244|PDB:2L7M}.
FT   STRAND       90     92       {ECO:0000244|PDB:2L7M}.
FT   HELIX        94    106       {ECO:0000244|PDB:2L7F}.
FT   HELIX       112    122       {ECO:0000244|PDB:2L7F}.
FT   HELIX       126    141       {ECO:0000244|PDB:2L7F}.
SQ   SEQUENCE   317 AA;  35370 MW;  00853AFDBA4433CB CRC64;
     METNCRKLVS ACVQLGVQPA AVECLFSKDS EIKKVEFTDS PESRKEAASS KFFPRQHPGA
     NEKDKSQQGK NEDVGAEDPS KKKRQRRQRT HFTSQQLQEL EATFQRNRYP DMSTREEIAV
     WTNLTEARVR VWFKNRRAKW RKRERNQQAE LCKNGFGPQF NGLMQPYDDM YPGYSYNNWA
     AKGLTSASLS TKSFPFFNSM NVNPLSSQSM FSPPNSISSM SMSSSMVPSA VTGVPGSSLN
     SLNNLNNLSS PSLNSAVPTP ACPYAPPTPP YVYRDTCNSS LASLRLKAKQ HSSFGYASVQ
     NPASNLSACQ YAVDRPV
//
ID   NKX31_HUMAN             Reviewed;         234 AA.
AC   Q99801; O15465; Q9H2P4; Q9H2P5; Q9H2P6; Q9H2P7; Q9HBG0;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2001, sequence version 2.
DT   25-OCT-2017, entry version 162.
DE   RecName: Full=Homeobox protein Nkx-3.1;
DE   AltName: Full=Homeobox protein NK-3 homolog A;
GN   Name=NKX3-1; Synonyms=NKX3.1, NKX3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INDUCTION BY ANDROGENS.
RC   TISSUE=Prostate;
RX   PubMed=9226374; DOI=10.1006/geno.1997.4715;
RA   He W.-W., Sciavolino P.J., Wing J., Augustus M., Hudson P.,
RA   Meissner P.S., Curtis R.T., Shell B.K., Bostwick D.G., Tindall D.J.,
RA   Gelmann E.P., Abate-Shen C., Carter K.C.;
RT   "A novel human prostate-specific, androgen-regulated homeobox gene
RT   (NKX3.1) that maps to 8p21, a region frequently deleted in prostate
RT   cancer.";
RL   Genomics 43:69-77(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INDUCTION BY ANDROGENS.
RX   PubMed=9537602;
RX   DOI=10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H;
RA   Prescott J.L., Blok L., Tindall D.J.;
RT   "Isolation and androgen regulation of the human homeobox cDNA,
RT   NKX3.1.";
RL   Prostate 35:71-80(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5), SUBCELLULAR
RP   LOCATION, AND INDUCTION BY ESTROGENS.
RC   TISSUE=Prostate;
RX   PubMed=11137288; DOI=10.1016/S0378-1119(00)00453-4;
RA   Korkmaz K.S., Korkmaz C.G., Ragnhildstveit E., Kizildag S.,
RA   Pretlow T.G., Saatcioglu F.;
RT   "Full-length cDNA sequence and genomic organization of human NKX3A
RT   -- alternative mRNA forms and regulation by both androgens and
RT   estrogens.";
RL   Gene 260:25-36(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH SPDEF.
RX   PubMed=11809674;
RA   Chen H., Nandi A.K., Li X., Bieberich C.J.;
RT   "NKX-3.1 interacts with prostate-derived Ets factor and regulates the
RT   activity of the PSA promoter.";
RL   Cancer Res. 62:338-340(2002).
RN   [6]
RP   INTERACTION WITH WDR77.
RX   PubMed=12972618; DOI=10.1128/MCB.23.19.7019-7029.2003;
RA   Hosohata K., Li P., Hosohata Y., Qin J., Roeder R.G., Wang Z.;
RT   "Purification and identification of a novel complex which is involved
RT   in androgen receptor-dependent transcription.";
RL   Mol. Cell. Biol. 23:7019-7029(2003).
RN   [7]
RP   INTERACTION WITH TOPORS, AND UBIQUITINATION BY TOPORS.
RX   PubMed=18077445; DOI=10.1074/jbc.M708630200;
RA   Guan B., Pungaliya P., Li X., Uquillas C., Mutton L.N., Rubin E.H.,
RA   Bieberich C.J.;
RT   "Ubiquitination by TOPORS regulates the prostate tumor suppressor
RT   NKX3.1.";
RL   J. Biol. Chem. 283:4834-4840(2008).
RN   [8]
RP   FUNCTION AS TUMOR SUPPRESSOR.
RX   PubMed=19462257; DOI=10.1007/s11033-009-9549-8;
RA   Zhang P., Liu W., Zhang J., Guan H., Chen W., Cui X., Liu Q.,
RA   Jiang A.;
RT   "Gene expression profiles in the PC-3 human prostate cancer cells
RT   induced by NKX3.1.";
RL   Mol. Biol. Rep. 37:1505-1512(2010).
RN   [9]
RP   STRUCTURE BY NMR OF 132-189.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution NMR structure of homeobox domain of homeobox protein NKX-3.1
RT   from Homo sapiens, Northeast structural genomics consortium target
RT   HR6470A.";
RL   Submitted (APR-2011) to the PDB data bank.
RN   [10]
RP   VARIANT CYS-52.
RX   PubMed=9377551;
RA   Voeller H.J., Augustus M., Madike V., Bova G.S., Carter K.C.,
RA   Gelmann E.P.;
RT   "Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21,
RT   is not mutated in human prostate cancers.";
RL   Cancer Res. 57:4455-4459(1997).
RN   [11]
RP   ERRATUM.
RA   Voeller H.J., Augustus M., Madike V., Bova G.S., Carter K.C.,
RA   Gelmann E.P.;
RL   Cancer Res. 57:5613-5613(1997).
CC   -!- FUNCTION: Transcription factor, which binds preferentially the
CC       consensus sequence 5'-TAAGT[AG]-3' and can behave as a
CC       transcriptional repressor. Plays an important role in normal
CC       prostate development, regulating proliferation of glandular
CC       epithelium and in the formation of ducts in prostate. Acts as a
CC       tumor suppressor controlling prostate carcinogenesis, as shown by
CC       the ability to inhibit proliferation and invasion activities of
CC       PC-3 prostate cancer cells. {ECO:0000269|PubMed:19462257}.
CC   -!- SUBUNIT: Interacts with serum response factor (SRF) (By
CC       similarity). Interacts with SPDEF. Interacts with WDR77. Interacts
CC       with TOPORS which polyubiquitinates NKX3-1 and induces its
CC       proteasomal degradation. {ECO:0000250,
CC       ECO:0000269|PubMed:11809674, ECO:0000269|PubMed:12972618,
CC       ECO:0000269|PubMed:18077445}.
CC   -!- INTERACTION:
CC       Q96KQ7:EHMT2; NbExp=3; IntAct=EBI-16208773, EBI-744366;
CC       Q96BI1:SLC22A18; NbExp=4; IntAct=EBI-1385894, EBI-11721845;
CC       P11387:TOP1; NbExp=6; IntAct=EBI-1385894, EBI-876302;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:11137288}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q99801-1; Sequence=Displayed;
CC       Name=2; Synonyms=V2;
CC         IsoId=Q99801-2; Sequence=VSP_002230;
CC       Name=3; Synonyms=V4;
CC         IsoId=Q99801-3; Sequence=VSP_002231;
CC       Name=4; Synonyms=V3;
CC         IsoId=Q99801-4; Sequence=VSP_002232;
CC       Name=5; Synonyms=V1;
CC         IsoId=Q99801-5; Sequence=VSP_002233;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the prostate and, at a
CC       lower level, in the testis. {ECO:0000269|PubMed:9226374,
CC       ECO:0000269|PubMed:9537602}.
CC   -!- INDUCTION: By androgens and, in the LNCaP cell line, by estrogens.
CC       Androgenic control may be lost in prostate cancer cells during
CC       tumor progression from an androgen-dependent to an androgen-
CC       independent phase. {ECO:0000269|PubMed:11137288,
CC       ECO:0000269|PubMed:9226374, ECO:0000269|PubMed:9537602}.
CC   -!- PTM: Ubiquitinated by TOPORS; monoubiquitinated at several
CC       residues and also polyubiquitinated on single residues.
CC       {ECO:0000269|PubMed:18077445}.
CC   -!- SIMILARITY: Belongs to the NK-3 homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NKX31ID41541ch8p21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U91540; AAB68662.1; -; mRNA.
DR   EMBL; U80669; AAB38747.1; -; mRNA.
DR   EMBL; AF247704; AAG09781.1; -; mRNA.
DR   EMBL; AF249669; AAG39735.1; -; mRNA.
DR   EMBL; AF249670; AAG39736.1; -; mRNA.
DR   EMBL; AF249671; AAG39737.1; -; mRNA.
DR   EMBL; AF249672; AAG39738.1; -; mRNA.
DR   EMBL; BC074863; AAH74863.1; -; mRNA.
DR   EMBL; BC074864; AAH74864.1; -; mRNA.
DR   CCDS; CCDS59095.1; -. [Q99801-3]
DR   CCDS; CCDS6042.1; -. [Q99801-1]
DR   RefSeq; NP_001243268.1; NM_001256339.1. [Q99801-3]
DR   RefSeq; NP_006158.2; NM_006167.3. [Q99801-1]
DR   UniGene; Hs.55999; -.
DR   PDB; 2L9R; NMR; -; A=132-189.
DR   PDBsum; 2L9R; -.
DR   DisProt; DP00683; -.
DR   ProteinModelPortal; Q99801; -.
DR   SMR; Q99801; -.
DR   BioGrid; 110888; 35.
DR   CORUM; Q99801; -.
DR   DIP; DIP-39687N; -.
DR   IntAct; Q99801; 12.
DR   STRING; 9606.ENSP00000370253; -.
DR   iPTMnet; Q99801; -.
DR   PhosphoSitePlus; Q99801; -.
DR   BioMuta; NKX3-1; -.
DR   DMDM; 17377578; -.
DR   MaxQB; Q99801; -.
DR   PaxDb; Q99801; -.
DR   PeptideAtlas; Q99801; -.
DR   PRIDE; Q99801; -.
DR   DNASU; 4824; -.
DR   Ensembl; ENST00000380871; ENSP00000370253; ENSG00000167034. [Q99801-1]
DR   Ensembl; ENST00000523261; ENSP00000429729; ENSG00000167034. [Q99801-3]
DR   GeneID; 4824; -.
DR   KEGG; hsa:4824; -.
DR   UCSC; uc011kzx.3; human. [Q99801-1]
DR   CTD; 4824; -.
DR   DisGeNET; 4824; -.
DR   EuPathDB; HostDB:ENSG00000167034.9; -.
DR   GeneCards; NKX3-1; -.
DR   HGNC; HGNC:7838; NKX3-1.
DR   MIM; 602041; gene.
DR   neXtProt; NX_Q99801; -.
DR   OpenTargets; ENSG00000167034; -.
DR   PharmGKB; PA31645; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; Q99801; -.
DR   KO; K09348; -.
DR   OMA; QTAKQPQ; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; Q99801; -.
DR   TreeFam; TF315720; -.
DR   SignaLink; Q99801; -.
DR   SIGNOR; Q99801; -.
DR   ChiTaRS; NKX3-1; human.
DR   GeneWiki; NKX3-1; -.
DR   GenomeRNAi; 4824; -.
DR   PRO; PR:Q99801; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000167034; -.
DR   CleanEx; HS_NKX3-1; -.
DR   Genevisible; Q99801; HS.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004882; F:androgen receptor activity; IDA:UniProtKB.
DR   GO; GO:0001047; F:core promoter binding; IDA:UniProtKB.
DR   GO; GO:0030284; F:estrogen receptor activity; IDA:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0097162; F:MADS box domain binding; IEA:Ensembl.
DR   GO; GO:0030295; F:protein kinase activator activity; IDA:UniProtKB.
DR   GO; GO:0043621; F:protein self-association; IDA:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000983; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060442; P:branching involved in prostate gland morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; ISS:UniProtKB.
DR   GO; GO:0035690; P:cellular response to drug; IEP:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IDA:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB.
DR   GO; GO:0035907; P:dorsal aorta development; IEA:Ensembl.
DR   GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0071850; P:mitotic cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; ISS:UniProtKB.
DR   GO; GO:0071899; P:negative regulation of estrogen receptor binding; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0060037; P:pharyngeal system development; IEA:Ensembl.
DR   GO; GO:2000836; P:positive regulation of androgen secretion; IDA:UniProtKB.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2001022; P:positive regulation of response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0043491; P:protein kinase B signaling; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0033574; P:response to testosterone; ISS:UniProtKB.
DR   GO; GO:0007431; P:salivary gland development; ISS:UniProtKB.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; Nucleus; Polymorphism; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Tumor suppressor;
KW   Ubl conjugation.
FT   CHAIN         1    234       Homeobox protein Nkx-3.1.
FT                                /FTId=PRO_0000048945.
FT   DNA_BIND    124    183       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       8     56       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11137288}.
FT                                /FTId=VSP_002230.
FT   VAR_SEQ      13     87       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11137288}.
FT                                /FTId=VSP_002231.
FT   VAR_SEQ      15     83       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11137288}.
FT                                /FTId=VSP_002232.
FT   VAR_SEQ      40     83       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11137288}.
FT                                /FTId=VSP_002233.
FT   VARIANT      52     52       R -> C (in dbSNP:rs2228013).
FT                                {ECO:0000269|PubMed:9377551}.
FT                                /FTId=VAR_011612.
FT   CONFLICT      8      8       R -> W (in Ref. 3; AAG39737).
FT                                {ECO:0000305}.
FT   CONFLICT     85     85       E -> D (in Ref. 2; AAB38747).
FT                                {ECO:0000305}.
FT   CONFLICT    135    135       Q -> R (in Ref. 3; AAG39738).
FT                                {ECO:0000305}.
FT   CONFLICT    196    196       S -> F (in Ref. 2; AAB38747).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       Y -> H (in Ref. 2; AAB38747).
FT                                {ECO:0000305}.
FT   CONFLICT    234    234       W -> G (in Ref. 1; AAB68662).
FT                                {ECO:0000305}.
FT   HELIX       133    145       {ECO:0000244|PDB:2L9R}.
FT   HELIX       151    160       {ECO:0000244|PDB:2L9R}.
FT   HELIX       165    178       {ECO:0000244|PDB:2L9R}.
FT   STRAND      182    185       {ECO:0000244|PDB:2L9R}.
SQ   SEQUENCE   234 AA;  26350 MW;  C99A0943E15B2A55 CRC64;
     MLRVPEPRPG EAKAEGAAPP TPSKPLTSFL IQDILRDGAQ RQGGRTSSQR QRDPEPEPEP
     EPEGGRSRAG AQNDQLSTGP RAAPEEAETL AETEPERHLG SYLLDSENTS GALPRLPQTP
     KQPQKRSRAA FSHTQVIELE RKFSHQKYLS APERAHLAKN LKLTETQVKI WFQNRRYKTK
     RKQLSSELGD LEKHSSLPAL KEEAFSRASL VSVYNSYPYY PYLYCVGSWS PAFW
//
ID   PO5F1_HUMAN             Reviewed;         360 AA.
AC   Q01860; A6NCS1; A6NLL8; D2IYK4; P31359; Q15167; Q15168; Q16422;
AC   Q5STF3; Q5STF4;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   25-OCT-2017, entry version 188.
DE   RecName: Full=POU domain, class 5, transcription factor 1;
DE   AltName: Full=Octamer-binding protein 3;
DE            Short=Oct-3;
DE   AltName: Full=Octamer-binding protein 4;
DE            Short=Oct-4;
DE   AltName: Full=Octamer-binding transcription factor 3;
DE            Short=OTF-3;
GN   Name=POU5F1; Synonyms=OCT3, OCT4, OTF3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), VARIANTS ALA-322 AND
RP   LEU-357, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=1408763; DOI=10.1093/nar/20.17.4613;
RA   Takeda J., Seino S., Bell G.I.;
RT   "Human Oct3 gene family: cDNA sequences, alternative splicing, gene
RT   organization, chromosomal location, and expression at low levels in
RT   adult tissues.";
RL   Nucleic Acids Res. 20:4613-4620(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=20604894; DOI=10.1111/j.1399-0039.2010.01526.x;
RA   Stuart P.E., Nair R.P., Hiremagalore R., Kullavanijaya P.,
RA   Kullavanijaya P., Tejasvi T., Lim H.W., Voorhees J.J., Elder J.T.;
RT   "Comparison of MHC class I risk haplotypes in Thai and Caucasian
RT   psoriatics shows locus heterogeneity at PSORS1.";
RL   Tissue Antigens 76:387-397(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood leukocyte;
RX   PubMed=16702430; DOI=10.1534/genetics.106.057034;
RA   Shiina T., Ota M., Shimizu S., Katsuyama Y., Hashimoto N., Takasu M.,
RA   Anzai T., Kulski J.K., Kikkawa E., Naruse T., Kimura N., Yanagiya K.,
RA   Watanabe A., Hosomichi K., Kohara S., Iwamoto C., Umehara Y.,
RA   Meyer A., Wanner V., Sano K., Macquin C., Ikeo K., Tokunaga K.,
RA   Gojobori T., Inoko H., Bahram S.;
RT   "Rapid evolution of major histocompatibility complex class I genes in
RT   primates generates new disease alleles in humans via hitchhiking
RT   diversity.";
RL   Genetics 173:1555-1570(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 188-274, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart, and Skeletal muscle;
RX   PubMed=7908264; DOI=10.1111/j.1432-1033.1994.tb18676.x;
RA   Wey E., Lyons G.E., Schaefer B.W.;
RT   "A human POU domain gene, mPOU, is expressed in developing brain and
RT   specific adult tissues.";
RL   Eur. J. Biochem. 220:753-762(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 212-283.
RX   PubMed=8567814; DOI=10.1093/oxfordjournals.humrep.a135792;
RA   Abdel-Rahman B., Fiddler M., Rappolee D., Pergament E.;
RT   "Expression of transcription regulating genes in human preimplantation
RT   embryos.";
RL   Hum. Reprod. 10:2787-2792(1995).
RN   [10]
RP   IDENTIFICATION.
RX   PubMed=16229821; DOI=10.1016/j.bbrc.2005.09.157;
RA   Suo G., Han J., Wang X., Zhang J., Zhao Y., Zhao Y., Dai J.;
RT   "Oct4 pseudogenes are transcribed in cancers.";
RL   Biochem. Biophys. Res. Commun. 337:1047-1051(2005).
RN   [11]
RP   BIOTECHNOLOGY, AND FUNCTION.
RX   PubMed=18035408; DOI=10.1016/j.cell.2007.11.019;
RA   Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K.,
RA   Yamanaka S.;
RT   "Induction of pluripotent stem cells from adult human fibroblasts by
RT   defined factors.";
RL   Cell 131:861-872(2007).
RN   [12]
RP   INTERACTION WITH PKM, SUBCELLULAR LOCATION, DOMAIN, AND INDUCTION.
RX   PubMed=18191611; DOI=10.1016/j.biocel.2007.11.009;
RA   Lee J., Kim H.K., Han Y.-M., Kim J.;
RT   "Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with
RT   Oct-4 in regulating transcription.";
RL   Int. J. Biochem. Cell Biol. 40:1043-1054(2008).
RN   [13]
RP   UBIQUITINATION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND
RP   INTERACTION WITH WWP2.
RX   PubMed=19274063; DOI=10.1038/cr.2009.31;
RA   Xu H., Wang W., Li C., Yu H., Yang A., Wang B., Jin Y.;
RT   "WWP2 promotes degradation of transcription factor OCT4 in human
RT   embryonic stem cells.";
RL   Cell Res. 19:561-573(2009).
RN   [14]
RP   PHOSPHORYLATION AT SER-111, AND SUBCELLULAR LOCATION.
RX   PubMed=23024368; DOI=10.1074/jbc.M112.386755;
RA   Spelat R., Ferro F., Curcio F.;
RT   "Serine 111 phosphorylation regulates OCT4A protein subcellular
RT   distribution and degradation.";
RL   J. Biol. Chem. 287:38279-38288(2012).
RN   [15]
RP   PHOSPHORYLATION AT SER-111; THR-235; SER-236; SER-289; SER-290 AND
RP   SER-355.
RX   PubMed=22474382; DOI=10.1073/pnas.1203874109;
RA   Brumbaugh J., Hou Z., Russell J.D., Howden S.E., Yu P., Ledvina A.R.,
RA   Coon J.J., Thomson J.A.;
RT   "Phosphorylation regulates human OCT4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:7162-7168(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH PCGF1.
RX   PubMed=26687479; DOI=10.1038/srep18388;
RA   Oliviero G., Munawar N., Watson A., Streubel G., Manning G.,
RA   Bardwell V., Bracken A.P., Cagney G.;
RT   "The variant Polycomb Repressor Complex 1 component PCGF1 interacts
RT   with a pluripotency sub-network that includes DPPA4, a regulator of
RT   embryogenesis.";
RL   Sci. Rep. 5:18388-18388(2015).
CC   -!- FUNCTION: Transcription factor that binds to the octamer motif
CC       (5'-ATTTGCAT-3'). Forms a trimeric complex with SOX2 on DNA and
CC       controls the expression of a number of genes involved in embryonic
CC       development such as YES1, FGF4, UTF1 and ZFP206. Critical for
CC       early embryogenesis and for embryonic stem cell pluripotency.
CC       {ECO:0000269|PubMed:18035408}.
CC   -!- SUBUNIT: Interacts with UBE2I and ZSCAN10 (By similarity).
CC       Interacts with PKM. Interacts with WWP2. Interacts with PCGF1
CC       (PubMed:26687479). Interacts with ESRRB; recruits ESRRB near the
CC       POU5F1-SOX2 element in the NANOG proximal promoter; the
CC       intercaction is DNA independent (By similarity).
CC       {ECO:0000250|UniProtKB:P20263, ECO:0000269|PubMed:18191611,
CC       ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:26687479}.
CC   -!- INTERACTION:
CC       P03259:- (xeno); NbExp=2; IntAct=EBI-475687, EBI-6947456;
CC       P49711:CTCF; NbExp=2; IntAct=EBI-475687, EBI-932887;
CC       Q8JSK4:E1A (xeno); NbExp=2; IntAct=EBI-475687, EBI-7453955;
CC       Q9UJU5:FOXD3; NbExp=2; IntAct=EBI-475687, EBI-475674;
CC       P63158:Hmgb1 (xeno); NbExp=3; IntAct=EBI-475687, EBI-6665811;
CC       O95983:MBD3; NbExp=3; IntAct=EBI-475687, EBI-1783068;
CC       O00308:WWP2; NbExp=4; IntAct=EBI-475687, EBI-743923;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Expressed in a
CC       diffuse and slightly punctuate pattern.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A; Synonyms=Oct-3A, Oct3A;
CC         IsoId=Q01860-1; Sequence=Displayed;
CC       Name=B; Synonyms=Oct-3B, Oct3B;
CC         IsoId=Q01860-2; Sequence=VSP_002333;
CC   -!- TISSUE SPECIFICITY: Expressed in developing brain. Highest levels
CC       found in specific cell layers of the cortex, the olfactory bulb,
CC       the hippocampus and the cerebellum. Low levels of expression in
CC       adult tissues. {ECO:0000269|PubMed:1408763,
CC       ECO:0000269|PubMed:7908264}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in undifferentiated
CC       embryonic stem cells and expression decreases gradually after
CC       embryoid body (EB) formation. {ECO:0000269|PubMed:19274063}.
CC   -!- INDUCTION: Transcriptional activity is positively regulated by
CC       PKM. {ECO:0000269|PubMed:18191611}.
CC   -!- DOMAIN: The POU-specific domain mediates interaction with PKM.
CC       {ECO:0000269|PubMed:18191611}.
CC   -!- PTM: Sumoylation enhances the protein stability, DNA binding and
CC       transactivation activity. Sumoylation is required for enhanced
CC       YES1 expression (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated; undergoes 'Lys-63'-linked polyubiquitination
CC       by WWP2 leading to proteasomal degradation. {ECO:0000250}.
CC   -!- PTM: ERK1/2-mediated phosphorylation at Ser-111 promotes nuclear
CC       exclusion and proteasomal degradation. Phosphorylation at Thr-235
CC       and Ser-236 decrease DNA-binding and alters ability to activate
CC       transcription. {ECO:0000269|PubMed:22474382,
CC       ECO:0000269|PubMed:23024368}.
CC   -!- BIOTECHNOLOGY: POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 are the four
CC       Yamanaka factors. When combined, these factors are sufficient to
CC       reprogram differentiated cells to an embryonic-like state
CC       designated iPS (induced pluripotent stem) cells. iPS cells exhibit
CC       the morphology and growth properties of ES cells and express ES
CC       cell marker genes. {ECO:0000269|PubMed:18035408}.
CC   -!- MISCELLANEOUS: Several pseudogenes of POU5F1 have been described
CC       on chromosomes 1, 3, 8, 10 and 12. 2 of them, localized in
CC       chromosomes 8 and 10, are transcribed in cancer tissues but not in
CC       normal ones and may be involved in the regulation of POU5F1 gene
CC       activity in carcinogenesis.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       5 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Oct-4 entry;
CC       URL="https://en.wikipedia.org/wiki/Oct-4";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11898; CAA77951.1; -; mRNA.
DR   EMBL; Z11899; CAA77952.1; -; mRNA.
DR   EMBL; GQ472773; ACZ95700.1; -; Genomic_DNA.
DR   EMBL; AB088113; BAC54946.1; -; Genomic_DNA.
DR   EMBL; AB202105; BAE78630.1; -; Genomic_DNA.
DR   EMBL; AB103619; BAF31281.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63311.1; -; Genomic_DNA.
DR   EMBL; AL662833; CAI17407.1; -; Genomic_DNA.
DR   EMBL; AL662833; CAI17408.1; -; Genomic_DNA.
DR   EMBL; AL662844; CAI18331.1; -; Genomic_DNA.
DR   EMBL; AL773544; CAI18485.1; -; Genomic_DNA.
DR   EMBL; AL773544; CAI18486.1; -; Genomic_DNA.
DR   EMBL; BX088580; CAI18708.1; -; Genomic_DNA.
DR   EMBL; BX088580; CAI18709.1; -; Genomic_DNA.
DR   EMBL; CR759815; CAQ07092.1; -; Genomic_DNA.
DR   EMBL; CR759815; CAQ07093.1; -; Genomic_DNA.
DR   EMBL; CR388229; CAQ09226.1; -; Genomic_DNA.
DR   EMBL; CR388229; CAQ09227.1; -; Genomic_DNA.
DR   EMBL; CR847794; CAQ10780.1; -; Genomic_DNA.
DR   EMBL; CR847794; CAQ10781.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03367.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03368.1; -; Genomic_DNA.
DR   EMBL; BC117435; AAI17436.1; -; mRNA.
DR   EMBL; BC117437; AAI17438.1; -; mRNA.
DR   EMBL; Z21963; CAA79974.1; -; mRNA.
DR   EMBL; Z21964; CAA79975.1; -; mRNA.
DR   EMBL; S81255; AAB35990.1; -; mRNA.
DR   CCDS; CCDS34391.1; -. [Q01860-1]
DR   PIR; S25561; S25561.
DR   PIR; S32652; S32652.
DR   RefSeq; NP_001272916.1; NM_001285987.1. [Q01860-2]
DR   RefSeq; NP_002692.2; NM_002701.5. [Q01860-1]
DR   UniGene; Hs.249184; -.
DR   UniGene; Hs.632482; -.
DR   UniGene; Hs.646545; -.
DR   ProteinModelPortal; Q01860; -.
DR   SMR; Q01860; -.
DR   BioGrid; 111456; 317.
DR   CORUM; Q01860; -.
DR   DIP; DIP-33440N; -.
DR   ELM; Q01860; -.
DR   IntAct; Q01860; 15.
DR   MINT; MINT-87567; -.
DR   STRING; 9606.ENSP00000259915; -.
DR   ChEMBL; CHEMBL3580526; -.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00368; Norepinephrine.
DR   iPTMnet; Q01860; -.
DR   PhosphoSitePlus; Q01860; -.
DR   DMDM; 400659; -.
DR   EPD; Q01860; -.
DR   MaxQB; Q01860; -.
DR   PaxDb; Q01860; -.
DR   PeptideAtlas; Q01860; -.
DR   PRIDE; Q01860; -.
DR   DNASU; 5460; -.
DR   Ensembl; ENST00000259915; ENSP00000259915; ENSG00000204531. [Q01860-1]
DR   Ensembl; ENST00000376243; ENSP00000365419; ENSG00000206454. [Q01860-2]
DR   Ensembl; ENST00000383524; ENSP00000373016; ENSG00000206454. [Q01860-1]
DR   Ensembl; ENST00000412166; ENSP00000387646; ENSG00000229094. [Q01860-2]
DR   Ensembl; ENST00000419095; ENSP00000413622; ENSG00000235068. [Q01860-2]
DR   Ensembl; ENST00000429314; ENSP00000387619; ENSG00000237582. [Q01860-2]
DR   Ensembl; ENST00000429603; ENSP00000392877; ENSG00000233911. [Q01860-1]
DR   Ensembl; ENST00000433063; ENSP00000405041; ENSG00000235068. [Q01860-1]
DR   Ensembl; ENST00000433348; ENSP00000412665; ENSG00000230336. [Q01860-2]
DR   Ensembl; ENST00000434616; ENSP00000388842; ENSG00000229094. [Q01860-1]
DR   Ensembl; ENST00000437747; ENSP00000391681; ENSG00000237582. [Q01860-1]
DR   Ensembl; ENST00000451077; ENSP00000391507; ENSG00000233911. [Q01860-2]
DR   Ensembl; ENST00000454714; ENSP00000400047; ENSG00000230336. [Q01860-1]
DR   GeneID; 5460; -.
DR   KEGG; hsa:5460; -.
DR   UCSC; uc003nsv.4; human. [Q01860-1]
DR   CTD; 5460; -.
DR   DisGeNET; 5460; -.
DR   EuPathDB; HostDB:ENSG00000204531.15; -.
DR   GeneCards; POU5F1; -.
DR   H-InvDB; HIX0159939; -.
DR   H-InvDB; HIX0164984; -.
DR   H-InvDB; HIX0166817; -.
DR   H-InvDB; HIX0167068; -.
DR   H-InvDB; HIX0167306; -.
DR   H-InvDB; HIX0167552; -.
DR   H-InvDB; HIX0168865; -.
DR   H-InvDB; HIX0201948; -.
DR   HGNC; HGNC:9221; POU5F1.
DR   HPA; CAB025600; -.
DR   HPA; CAB026380; -.
DR   HPA; HPA058267; -.
DR   MIM; 164177; gene.
DR   neXtProt; NX_Q01860; -.
DR   OpenTargets; ENSG00000204531; -.
DR   PharmGKB; PA33545; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOVERGEN; HBG057998; -.
DR   InParanoid; Q01860; -.
DR   KO; K09367; -.
DR   OMA; LENMFLQ; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; Q01860; -.
DR   TreeFam; TF316413; -.
DR   Reactome; R-HSA-2892245; POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation.
DR   Reactome; R-HSA-2892247; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation.
DR   Reactome; R-HSA-452723; Transcriptional regulation of pluripotent stem cells.
DR   SignaLink; Q01860; -.
DR   SIGNOR; Q01860; -.
DR   GenomeRNAi; 5460; -.
DR   PRO; PR:Q01860; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204531; -.
DR   ExpressionAtlas; Q01860; baseline and differential.
DR   Genevisible; Q01860; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IDA:HGNC.
DR   GO; GO:0035198; F:miRNA binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:HGNC.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0001824; P:blastocyst development; ISS:BHF-UCL.
DR   GO; GO:0003130; P:BMP signaling pathway involved in heart induction; IMP:BHF-UCL.
DR   GO; GO:0060913; P:cardiac cell fate determination; IDA:BHF-UCL.
DR   GO; GO:0060795; P:cell fate commitment involved in formation of primary germ layer; IMP:BHF-UCL.
DR   GO; GO:0001714; P:endodermal cell fate specification; IDA:MGI.
DR   GO; GO:0042789; P:mRNA transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0035413; P:positive regulation of catenin import into nucleus; IDA:BHF-UCL.
DR   GO; GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0009786; P:regulation of asymmetric cell division; ISS:BHF-UCL.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0090081; P:regulation of heart induction by regulation of canonical Wnt signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0090308; P:regulation of methylation-dependent chromatin silencing; IDA:BHF-UCL.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC.
DR   GO; GO:0009611; P:response to wounding; IEP:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IDA:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR015585; POU_dom_5.
DR   PANTHER; PTHR11636:SF86; PTHR11636:SF86; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Developmental protein; DNA-binding; Homeobox; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    360       POU domain, class 5, transcription factor
FT                                1.
FT                                /FTId=PRO_0000100747.
FT   DOMAIN      138    212       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    230    289       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     111    111       Phosphoserine; by MAPK.
FT                                {ECO:0000269|PubMed:22474382,
FT                                ECO:0000269|PubMed:23024368}.
FT   MOD_RES     235    235       Phosphothreonine.
FT                                {ECO:0000269|PubMed:22474382}.
FT   MOD_RES     236    236       Phosphoserine.
FT                                {ECO:0000269|PubMed:22474382}.
FT   MOD_RES     289    289       Phosphoserine.
FT                                {ECO:0000269|PubMed:22474382}.
FT   MOD_RES     290    290       Phosphoserine.
FT                                {ECO:0000269|PubMed:22474382}.
FT   MOD_RES     355    355       Phosphoserine.
FT                                {ECO:0000269|PubMed:22474382}.
FT   CROSSLNK    123    123       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   VAR_SEQ       1    135       MAGHLASDFAFSPPPGGGGDGPGGPEPGWVDPRTWLSFQGP
FT                                PGGPGIGPGVGPGSEVWGIPPCPPPYEFCGGMAYCGPQVGV
FT                                GLVPQGGLETSQPEGEAGVGVESNSDGASPEPCTVTPGAVK
FT                                LEKEKLEQNPEE -> MHFYRLFLGATRRFLNPEWKGEIDN
FT                                WCVYVLTSLLPFKIQ (in isoform B).
FT                                {ECO:0000303|PubMed:1408763}.
FT                                /FTId=VSP_002333.
FT   VARIANT     226    226       L -> F (in dbSNP:rs1150767).
FT                                /FTId=VAR_046203.
FT   VARIANT     322    322       T -> A. {ECO:0000269|PubMed:1408763}.
FT                                /FTId=VAR_003774.
FT   VARIANT     351    351       T -> I (in dbSNP:rs1061120).
FT                                /FTId=VAR_046204.
FT   VARIANT     357    357       M -> L. {ECO:0000269|PubMed:1408763}.
FT                                /FTId=VAR_003775.
FT   CONFLICT    189    189       A -> G (in Ref. 8; CAA79974).
FT                                {ECO:0000305}.
FT   CONFLICT    220    220       I -> T (in Ref. 8; CAA79974).
FT                                {ECO:0000305}.
FT   CONFLICT    227    227       V -> L (in Ref. 8; CAA79974).
FT                                {ECO:0000305}.
FT   CONFLICT    230    230       R -> G (in Ref. 8; CAA79975).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       R -> Q (in Ref. 8; CAA79975).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       Q -> R (in Ref. 8; CAA79975).
FT                                {ECO:0000305}.
FT   CONFLICT    272    272       D -> DVVR (in Ref. 9; AAB35990).
FT                                {ECO:0000305}.
SQ   SEQUENCE   360 AA;  38571 MW;  934C58DAEA0C535B CRC64;
     MAGHLASDFA FSPPPGGGGD GPGGPEPGWV DPRTWLSFQG PPGGPGIGPG VGPGSEVWGI
     PPCPPPYEFC GGMAYCGPQV GVGLVPQGGL ETSQPEGEAG VGVESNSDGA SPEPCTVTPG
     AVKLEKEKLE QNPEESQDIK ALQKELEQFA KLLKQKRITL GYTQADVGLT LGVLFGKVFS
     QTTICRFEAL QLSFKNMCKL RPLLQKWVEE ADNNENLQEI CKAETLVQAR KRKRTSIENR
     VRGNLENLFL QCPKPTLQQI SHIAQQLGLE KDVVRVWFCN RRQKGKRSSS DYAQREDFEA
     AGSPFSGGPV SFPLAPGPHF GTPGYGSPHF TALYSSVPFP EGEAFPPVSV TTLGSPMHSN
//
ID   SIX1_HUMAN              Reviewed;         284 AA.
AC   Q15475; Q53Y16; Q96H64;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Homeobox protein SIX1;
DE   AltName: Full=Sine oculis homeobox homolog 1;
GN   Name=SIX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Muscle;
RX   PubMed=8617500; DOI=10.1006/geno.1996.0172;
RA   Boucher C.A., Carey N., Edwards Y.H., Siciliano M.J., Johnson K.J.;
RT   "Cloning of the human SIX1 gene and its assignment to chromosome 14.";
RL   Genomics 33:140-142(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Gallardo M.E., Rodriguez de Cordoba S.;
RT   "Partial genomic sequence of human SIX1.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT CYS-99.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT CYS-99.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=10801845; DOI=10.1074/jbc.M002446200;
RA   Ford H.L., Landesman-Bollag E., Dacwag C.S., Stukenberg P.T.,
RA   Pardee A.B., Seldin D.C.;
RT   "Cell cycle-regulated phosphorylation of the human SIX1 homeodomain
RT   protein.";
RL   J. Biol. Chem. 275:22245-22254(2000).
RN   [6]
RP   FUNCTION.
RX   PubMed=15123840; DOI=10.1073/pnas.0401139101;
RA   Coletta R.D., Christensen K., Reichenberger K.J., Lamb J.,
RA   Micomonaco D., Huang L., Wolf D.M., Muller-Tidow C., Golub T.R.,
RA   Kawakami K., Ford H.L.;
RT   "The Six1 homeoprotein stimulates tumorigenesis by reactivation of
RT   cyclin A1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:6478-6483(2004).
RN   [7]
RP   UBIQUITINATION, INTERACTION WITH CDC20, AND SUBCELLULAR LOCATION.
RX   PubMed=17130831; DOI=10.1038/sj.onc.1210122;
RA   Christensen K.L., Brennan J.D., Aldridge C.S., Ford H.L.;
RT   "Cell cycle regulation of the human Six1 homeoprotein is mediated by
RT   APC(Cdh1).";
RL   Oncogene 26:3406-3414(2007).
RN   [8]
RP   INTERACTION WITH TBX18.
RX   PubMed=26235987; DOI=10.1016/j.ajhg.2015.07.001;
RA   Vivante A., Kleppa M.J., Schulz J., Kohl S., Sharma A., Chen J.,
RA   Shril S., Hwang D.Y., Weiss A.C., Kaminski M.M., Shukrun R.,
RA   Kemper M.J., Lehnhardt A., Beetz R., Sanna-Cherchi S., Verbitsky M.,
RA   Gharavi A.G., Stuart H.M., Feather S.A., Goodship J.A., Goodship T.H.,
RA   Woolf A.S., Westra S.J., Doody D.P., Bauer S.B., Lee R.S., Adam R.M.,
RA   Lu W., Reutter H.M., Kehinde E.O., Mancini E.J., Lifton R.P.,
RA   Tasic V., Lienkamp S.S., Jueppner H., Kispert A., Hildebrandt F.;
RT   "Mutations in TBX18 cause dominant urinary tract malformations via
RT   transcriptional dysregulation of ureter development.";
RL   Am. J. Hum. Genet. 97:291-301(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) OF 1-189 IN COMPLEX WITH EYA2,
RP   FUNCTION, SUBUNIT, DNA-BINDING, CHARACTERIZATION OF VARIANT BOS3
RP   GLU-17, AND CHARACTERIZATION OF VARIANT DFNA23 GLU-133 DEL.
RX   PubMed=23435380; DOI=10.1038/nsmb.2505;
RA   Patrick A.N., Cabrera J.H., Smith A.L., Chen X.S., Ford H.L., Zhao R.;
RT   "Structure-function analyses of the human SIX1-EYA2 complex reveal
RT   insights into metastasis and BOR syndrome.";
RL   Nat. Struct. Mol. Biol. 20:447-453(2013).
RN   [10]
RP   VARIANTS BOS3 TRP-110 AND CYS-129, VARIANT DFNA23 GLU-133 DEL,
RP   CHARACTERIZATION OF VARIANTS BOS3 TRP-110 AND CYS-129,
RP   CHARACTERIZATION OF VARIANT DFNA23 GLU-133 DEL, FUNCTION, INTERACTION
RP   WITH EYA1, AND POSSIBLE INVOLVEMENT IN BOR.
RX   PubMed=15141091; DOI=10.1073/pnas.0308475101;
RA   Ruf R.G., Xu P.-X., Silvius D., Otto E.A., Beekmann F., Muerb U.T.,
RA   Kumar S., Neuhaus T.J., Kemper M.J., Raymond R.M. Jr., Brophy P.D.,
RA   Berkman J., Gattas M., Hyland V., Ruf E.-M., Schwartz C., Chang E.H.,
RA   Smith R.J.H., Stratakis C.A., Weil D., Petit C., Hildebrandt F.;
RT   "SIX1 mutations cause branchio-oto-renal syndrome by disruption of
RT   EYA1-SIX1-DNA complexes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8090-8095(2004).
RN   [11]
RP   VARIANT BOS3 ARG-122.
RX   PubMed=17637804; DOI=10.1038/sj.ejhg.5201900;
RA   Sanggaard K.M., Rendtorff N.D., Kjaer K.W., Eiberg H., Johnsen T.,
RA   Gimsing S., Dyrmose J., Nielsen K.O., Lage K., Tranebjaerg L.;
RT   "Branchio-oto-renal syndrome: detection of EYA1 and SIX1 mutations in
RT   five out of six Danish families by combining linkage, MLPA and
RT   sequencing analyses.";
RL   Eur. J. Hum. Genet. 15:1121-1131(2007).
RN   [12]
RP   VARIANTS BOS3 GLU-17; PRO-73; GLY-106; GLN-110; TRP-110; CYS-112 AND
RP   CYS-129.
RX   PubMed=18330911; DOI=10.1002/humu.20714;
RA   Kochhar A., Orten D.J., Sorensen J.L., Fischer S.M., Cremers C.W.,
RA   Kimberling W.J., Smith R.J.;
RT   "SIX1 mutation screening in 247 branchio-oto-renal syndrome families:
RT   a recurrent missense mutation associated with BOR.";
RL   Hum. Mutat. 29:565-565(2008).
RN   [13]
RP   CHARACTERIZATION OF VARIANTS BOS3 GLU-17; GLY-106; TRP-110 AND
RP   CYS-112, CHARACTERIZATION OF VARIANT DFNA23 GLU-133 DEL, FUNCTION,
RP   DNA-BINDING, SUBCELLULAR LOCATION, INTERACTION WITH EYA1 AND EYA2, AND
RP   POSSIBLE INVOLVEMENT IN BOR.
RX   PubMed=19497856; DOI=10.1074/jbc.M109.016832;
RA   Patrick A.N., Schiemann B.J., Yang K., Zhao R., Ford H.L.;
RT   "Biochemical and functional characterization of six SIX1 Branchio-oto-
RT   renal syndrome mutations.";
RL   J. Biol. Chem. 284:20781-20790(2009).
RN   [14]
RP   VARIANT BOS3 CYS-129, AND VARIANT BOR LEU-249.
RX   PubMed=21280147; DOI=10.1002/humu.21402;
RA   Krug P., Moriniere V., Marlin S., Koubi V., Gabriel H.D., Colin E.,
RA   Bonneau D., Salomon R., Antignac C., Heidet L.;
RT   "Mutation screening of the EYA1, SIX1, and SIX5 genes in a large
RT   cohort of patients harboring branchio-oto-renal syndrome calls into
RT   question the pathogenic role of SIX5 mutations.";
RL   Hum. Mutat. 32:183-190(2011).
CC   -!- FUNCTION: Transcription factor that is involved in the regulation
CC       of cell proliferation, apoptosis and embryonic development. Plays
CC       an important role in the development of several organs, including
CC       kidney, muscle and inner ear. Depending on context, functions as
CC       transcriptional repressor or activator. Lacks an activation
CC       domain, and requires interaction with EYA family members for
CC       transcription activation. Mediates nuclear translocation of EYA1
CC       and EYA2. Binds the 5'-TCA[AG][AG]TTNC-3' motif present in the
CC       MEF3 element in the MYOG promoter. Regulates the expression of
CC       numerous genes, including MYC, CCND1 and EZR. Acts as activator of
CC       the IGFBP5 promoter, probably coactivated by EYA2. Repression of
CC       precursor cell proliferation in myoblasts is switched to
CC       activation through recruitment of EYA3 to the SIX1-DACH1 complex.
CC       During myogenesis, seems to act together with EYA2 and DACH2 (By
CC       similarity). Regulates the expression of CCNA1. {ECO:0000250,
CC       ECO:0000269|PubMed:15123840, ECO:0000269|PubMed:15141091,
CC       ECO:0000269|PubMed:19497856, ECO:0000269|PubMed:23435380}.
CC   -!- SUBUNIT: Interacts with DACH1 and EYA3 (By similarity). Interacts
CC       with EYA1 and EYA2. Interacts with CDC20. Interacts with TBX18
CC       (PubMed:26235987). {ECO:0000250, ECO:0000269|PubMed:15141091,
CC       ECO:0000269|PubMed:17130831, ECO:0000269|PubMed:19497856,
CC       ECO:0000269|PubMed:23435380, ECO:0000269|PubMed:26235987}.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=3; IntAct=EBI-743675, EBI-717810;
CC       Q08117-2:AES; NbExp=5; IntAct=EBI-743675, EBI-11741437;
CC       Q99502:EYA1; NbExp=4; IntAct=EBI-743675, EBI-12244764;
CC       O00167:EYA2; NbExp=2; IntAct=EBI-743675, EBI-750211;
CC       O00167-1:EYA2; NbExp=3; IntAct=EBI-743675, EBI-16038245;
CC       Q99750:MDFI; NbExp=2; IntAct=EBI-743675, EBI-724076;
CC       Q58EX7:PLEKHG4; NbExp=4; IntAct=EBI-743675, EBI-949255;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10801845,
CC       ECO:0000269|PubMed:17130831, ECO:0000269|PubMed:19497856}.
CC       Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in skeletal muscle.
CC   -!- PTM: Phosphorylated during interphase; becomes hyperphosphorylated
CC       during mitosis. Hyperphosphorylation impairs binding to promoter
CC       elements. {ECO:0000269|PubMed:10801845}.
CC   -!- PTM: Ubiquitinated by the anaphase promoting complex (APC),
CC       leading to its proteasomal degradation.
CC       {ECO:0000269|PubMed:17130831}.
CC   -!- DISEASE: Deafness, autosomal dominant, 23 (DFNA23) [MIM:605192]: A
CC       form of non-syndromic deafness characterized by prelingual,
CC       bilateral, symmetric hearing loss with a conductive component
CC       present in some but not all patients.
CC       {ECO:0000269|PubMed:15141091, ECO:0000269|PubMed:19497856,
CC       ECO:0000269|PubMed:23435380}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Branchiootic syndrome 3 (BOS3) [MIM:608389]: A syndrome
CC       characterized by usually bilateral branchial cleft fistulas or
CC       cysts, sensorineural and/or conductive hearing loss, pre-auricular
CC       pits, and structural defects of the outer, middle or inner ear.
CC       Otic defects include malformed and hypoplastic pinnae, a narrowed
CC       external ear canal, bulbous internal auditory canal, stapes
CC       fixation, malformed and hypoplastic cochlea. Branchial and otic
CC       anomalies overlap with those seen in individuals with the
CC       branchiootorenal syndrome. However renal anomalies are absent in
CC       branchiootic syndrome patients. {ECO:0000269|PubMed:15141091,
CC       ECO:0000269|PubMed:17637804, ECO:0000269|PubMed:18330911,
CC       ECO:0000269|PubMed:19497856, ECO:0000269|PubMed:21280147,
CC       ECO:0000269|PubMed:23435380}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in SIX1 could be a cause of branchiootorenal
CC       syndrome (BOR). BOR is an autosomal dominant disorder manifested
CC       by various combinations of preauricular pits, branchial fistulae
CC       or cysts, lacrimal duct stenosis, hearing loss, structural defects
CC       of the outer, middle, or inner ear, and renal dysplasia.
CC       Associated defects include asthenic habitus, long narrow facies,
CC       constricted palate, deep overbite, and myopia. Hearing loss may be
CC       due to mondini type cochlear defect and stapes fixation.
CC       Penetrance of BOR syndrome is high, although expressivity can be
CC       extremely variable. {ECO:0000305|PubMed:15141091,
CC       ECO:0000305|PubMed:19497856}.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SIX1ID42302ch14q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X91868; CAA62974.1; -; mRNA.
DR   EMBL; AF323497; AAK06772.1; -; Genomic_DNA.
DR   EMBL; BT007083; AAP35746.1; -; mRNA.
DR   EMBL; BC008874; AAH08874.1; -; mRNA.
DR   CCDS; CCDS9748.1; -.
DR   RefSeq; NP_005973.1; NM_005982.3.
DR   UniGene; Hs.633506; -.
DR   PDB; 4EGC; X-ray; 1.99 A; A=1-189.
DR   PDBsum; 4EGC; -.
DR   ProteinModelPortal; Q15475; -.
DR   SMR; Q15475; -.
DR   BioGrid; 112386; 16.
DR   DIP; DIP-34448N; -.
DR   IntAct; Q15475; 13.
DR   MINT; MINT-140054; -.
DR   STRING; 9606.ENSP00000247182; -.
DR   iPTMnet; Q15475; -.
DR   PhosphoSitePlus; Q15475; -.
DR   BioMuta; SIX1; -.
DR   DMDM; 2495290; -.
DR   MaxQB; Q15475; -.
DR   PaxDb; Q15475; -.
DR   PeptideAtlas; Q15475; -.
DR   PRIDE; Q15475; -.
DR   DNASU; 6495; -.
DR   Ensembl; ENST00000247182; ENSP00000247182; ENSG00000126778.
DR   GeneID; 6495; -.
DR   KEGG; hsa:6495; -.
DR   UCSC; uc001xfb.5; human.
DR   CTD; 6495; -.
DR   DisGeNET; 6495; -.
DR   EuPathDB; HostDB:ENSG00000126778.8; -.
DR   GeneCards; SIX1; -.
DR   GeneReviews; SIX1; -.
DR   HGNC; HGNC:10887; SIX1.
DR   HPA; CAB058690; -.
DR   HPA; HPA001893; -.
DR   MalaCards; SIX1; -.
DR   MIM; 601205; gene.
DR   MIM; 605192; phenotype.
DR   MIM; 608389; phenotype.
DR   neXtProt; NX_Q15475; -.
DR   OpenTargets; ENSG00000126778; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   Orphanet; 107; BOR syndrome.
DR   Orphanet; 52429; Branchio-otic syndrome.
DR   PharmGKB; PA35787; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000261680; -.
DR   HOVERGEN; HBG003609; -.
DR   InParanoid; Q15475; -.
DR   KO; K15614; -.
DR   OMA; AGGNKQN; -.
DR   OrthoDB; EOG091G083I; -.
DR   PhylomeDB; Q15475; -.
DR   TreeFam; TF315545; -.
DR   SignaLink; Q15475; -.
DR   SIGNOR; Q15475; -.
DR   ChiTaRS; SIX1; human.
DR   GeneWiki; SIX1; -.
DR   GenomeRNAi; 6495; -.
DR   PRO; PR:Q15475; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000126778; -.
DR   CleanEx; HS_SIX1; -.
DR   ExpressionAtlas; Q15475; baseline and differential.
DR   Genevisible; Q15475; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001223; F:transcription coactivator binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0035909; P:aorta morphogenesis; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IEA:InterPro.
DR   GO; GO:1905243; P:cellular response to 3,3',5-triiodo-L-thyronine; IEA:Ensembl.
DR   GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0021610; P:facial nerve morphogenesis; IEA:Ensembl.
DR   GO; GO:0061197; P:fungiform papilla morphogenesis; IEA:Ensembl.
DR   GO; GO:0048699; P:generation of neurons; ISS:UniProtKB.
DR   GO; GO:0048839; P:inner ear development; ISS:UniProtKB.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0072172; P:mesonephric tubule formation; ISS:UniProtKB.
DR   GO; GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0051451; P:myoblast migration; ISS:UniProtKB.
DR   GO; GO:0061055; P:myotome development; IEA:Ensembl.
DR   GO; GO:0090191; P:negative regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0048665; P:neuron fate specification; IEA:Ensembl.
DR   GO; GO:0030910; P:olfactory placode formation; IEA:Ensembl.
DR   GO; GO:0001759; P:organ induction; ISS:UniProtKB.
DR   GO; GO:0071599; P:otic vesicle development; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; ISS:UniProtKB.
DR   GO; GO:0060037; P:pharyngeal system development; IEA:Ensembl.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:2000729; P:positive regulation of mesenchymal cell proliferation involved in ureter development; IEA:Ensembl.
DR   GO; GO:0072513; P:positive regulation of secondary heart field cardioblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0072107; P:positive regulation of ureteric bud formation; ISS:UniProtKB.
DR   GO; GO:0034504; P:protein localization to nucleus; IDA:UniProtKB.
DR   GO; GO:0072095; P:regulation of branch elongation involved in ureteric bud branching; ISS:UniProtKB.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045664; P:regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IEA:Ensembl.
DR   GO; GO:2001014; P:regulation of skeletal muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0014842; P:regulation of skeletal muscle satellite cell proliferation; IEA:Ensembl.
DR   GO; GO:0008582; P:regulation of synaptic growth at neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISS:UniProtKB.
DR   GO; GO:0048538; P:thymus development; ISS:UniProtKB.
DR   GO; GO:0030878; P:thyroid gland development; ISS:UniProtKB.
DR   GO; GO:0061551; P:trigeminal ganglion development; IEA:Ensembl.
DR   GO; GO:0072193; P:ureter smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0001657; P:ureteric bud development; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031278; SIX1.
DR   InterPro; IPR031701; SIX1_SD.
DR   PANTHER; PTHR10390:SF13; PTHR10390:SF13; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Apoptosis; Complete proteome; Cytoplasm;
KW   Deafness; Developmental protein; Disease mutation; DNA-binding;
KW   Homeobox; Non-syndromic deafness; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    284       Homeobox protein SIX1.
FT                                /FTId=PRO_0000049295.
FT   DNA_BIND    124    183       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      17     17       V -> E (in BOS3; crucial for interaction
FT                                with EYA1 and EYA2 and transcription
FT                                factor activity; dbSNP:rs397515562).
FT                                {ECO:0000269|PubMed:18330911,
FT                                ECO:0000269|PubMed:19497856,
FT                                ECO:0000269|PubMed:23435380}.
FT                                /FTId=VAR_064948.
FT   VARIANT      73     73       H -> P (in BOS3).
FT                                {ECO:0000269|PubMed:18330911}.
FT                                /FTId=VAR_064949.
FT   VARIANT      99     99       R -> C (in dbSNP:rs17850414).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_067446.
FT   VARIANT     106    106       V -> G (in BOS3; crucial for protein
FT                                stability, DNA binding and transcription
FT                                factor activity; dbSNP:rs397515560).
FT                                {ECO:0000269|PubMed:18330911,
FT                                ECO:0000269|PubMed:19497856}.
FT                                /FTId=VAR_064950.
FT   VARIANT     110    110       R -> Q (in BOS3).
FT                                {ECO:0000269|PubMed:18330911}.
FT                                /FTId=VAR_064951.
FT   VARIANT     110    110       R -> W (in BOS3; crucial for interaction
FT                                with EYA1, DNA binding and transcription
FT                                factor activity; dbSNP:rs80356459).
FT                                {ECO:0000269|PubMed:15141091,
FT                                ECO:0000269|PubMed:18330911,
FT                                ECO:0000269|PubMed:19497856}.
FT                                /FTId=VAR_031024.
FT   VARIANT     112    112       R -> C (in BOS3; crucial for DNA binding
FT                                and transcription factor activity;
FT                                dbSNP:rs397515561).
FT                                {ECO:0000269|PubMed:18330911,
FT                                ECO:0000269|PubMed:19497856}.
FT                                /FTId=VAR_064952.
FT   VARIANT     122    122       W -> R (in BOS3; dbSNP:rs121909770).
FT                                {ECO:0000269|PubMed:17637804}.
FT                                /FTId=VAR_064953.
FT   VARIANT     129    129       Y -> C (in BOS3; crucial for interaction
FT                                with EYA1, DNA binding and transcription
FT                                factor activity; dbSNP:rs104894478).
FT                                {ECO:0000269|PubMed:15141091,
FT                                ECO:0000269|PubMed:18330911,
FT                                ECO:0000269|PubMed:21280147}.
FT                                /FTId=VAR_031025.
FT   VARIANT     133    133       Missing (in DFNA23; in addition to
FT                                deafness the patient had renal anomalies
FT                                suggesting a branchiootorenal syndrome;
FT                                crucial for interaction with EYA1, DNA
FT                                binding and transcription factor
FT                                activity). {ECO:0000269|PubMed:15141091,
FT                                ECO:0000269|PubMed:19497856,
FT                                ECO:0000269|PubMed:23435380}.
FT                                /FTId=VAR_031026.
FT   VARIANT     249    249       P -> L (in BOR; uncertain pathological
FT                                significance; dbSNP:rs368974927).
FT                                {ECO:0000269|PubMed:21280147}.
FT                                /FTId=VAR_064954.
FT   HELIX        11     23       {ECO:0000244|PDB:4EGC}.
FT   HELIX        27     36       {ECO:0000244|PDB:4EGC}.
FT   HELIX        47     60       {ECO:0000244|PDB:4EGC}.
FT   HELIX        63     72       {ECO:0000244|PDB:4EGC}.
FT   HELIX        77     79       {ECO:0000244|PDB:4EGC}.
FT   HELIX        80     99       {ECO:0000244|PDB:4EGC}.
FT   HELIX       105    114       {ECO:0000244|PDB:4EGC}.
FT   HELIX       135    145       {ECO:0000244|PDB:4EGC}.
FT   HELIX       151    161       {ECO:0000244|PDB:4EGC}.
FT   HELIX       165    184       {ECO:0000244|PDB:4EGC}.
SQ   SEQUENCE   284 AA;  32210 MW;  A4195376CFB9E3EA CRC64;
     MSMLPSFGFT QEQVACVCEV LQQGGNLERL GRFLWSLPAC DHLHKNESVL KAKAVVAFHR
     GNFRELYKIL ESHQFSPHNH PKLQQLWLKA HYVEAEKLRG RPLGAVGKYR VRRKFPLPRT
     IWDGEETSYC FKEKSRGVLR EWYAHNPYPS PREKRELAEA TGLTTTQVSN WFKNRRQRDR
     AAEAKERENT ENNNSSSNKQ NQLSPLEGGK PLMSSSEEEF SPPQSPDQNS VLLLQGNMGH
     ARSSNYSLPG LTASQPSHGL QTHQHQLQDS LLGPLTSSLV DLGS
//
ID   SATB1_HUMAN             Reviewed;         763 AA.
AC   Q01826; B3KXF1; C9JTR6; Q59EQ0;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   25-OCT-2017, entry version 175.
DE   RecName: Full=DNA-binding protein SATB1;
DE   AltName: Full=Special AT-rich sequence-binding protein 1;
GN   Name=SATB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=1505028; DOI=10.1016/0092-8674(92)90432-C;
RA   Dickinson L.A., Joh T., Kohwi Y., Kohwi-Shigematsu T.;
RT   "A tissue-specific MAR/SAR DNA-binding protein with unusual binding
RT   site recognition.";
RL   Cell 70:631-645(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno F.R.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF ARG-646; ARG-648 AND 693-PHE--ASN-695.
RX   PubMed=9111059; DOI=10.1074/jbc.272.17.11463;
RA   Dickinson L.A., Dickinson C.D., Kohwi-Shigematsu T.;
RT   "An atypical homeodomain in SATB1 promotes specific recognition of the
RT   key structural element in a matrix attachment region.";
RL   J. Biol. Chem. 272:11463-11470(1997).
RN   [8]
RP   FUNCTION.
RX   PubMed=9548713; DOI=10.1083/jcb.141.2.335;
RA   de Belle I., Cai S., Kohwi-Shigematsu T.;
RT   "The genomic sequences bound to special AT-rich sequence-binding
RT   protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated
RT   with the nuclear matrix at the bases of the chromatin loops.";
RL   J. Cell Biol. 141:335-348(1998).
RN   [9]
RP   FUNCTION, IDENTIFICATION IN THE GAMMA-GLOBIN PROMOTER COMPLEX, AND
RP   IDENTIFICATION IN THE ENHANCER BINDING FACTOR COMPLEX.
RX   PubMed=10595394; DOI=10.1089/104454999314809;
RA   Case S.S., Huber P., Lloyd J.A.;
RT   "The gammaPE complex contains both SATB1 and HOXB2 and has positive
RT   and negative roles in human gamma-globin gene regulation.";
RL   DNA Cell Biol. 18:805-817(1999).
RN   [10]
RP   CLEAVAGE BY CASPASES, AND SUBCELLULAR LOCATION.
RX   PubMed=10800076; DOI=10.1038/sj.cdd.4400668;
RA   Gotzmann J., Meissner M., Gerner C.;
RT   "The fate of the nuclear matrix-associated-region-binding protein
RT   SATB1 during apoptosis.";
RL   Cell Death Differ. 7:425-438(2000).
RN   [11]
RP   FUNCTION, MUTAGENESIS OF ASP-254, SUBUNIT, AND CLEAVAGE BY CASPASE-6.
RX   PubMed=11463840; DOI=10.1128/MCB.21.16.5591-5604.2001;
RA   Galande S., Dickinson L.A., Mian I.S., Sikorska M.,
RA   Kohwi-Shigematsu T.;
RT   "SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated
RT   dimerization, causing detachment from chromatin early in T-cell
RT   apoptosis.";
RL   Mol. Cell. Biol. 21:5591-5604(2001).
RN   [12]
RP   INTERACTION WITH POLR2J2.
RX   PubMed=12036295; DOI=10.1006/geno.2002.6772;
RA   Durrin L.K., Krontiris T.G.;
RT   "The thymocyte-specific MAR binding protein, SATB1, interacts in vitro
RT   with a novel variant of DNA-directed RNA polymerase II, subunit 11.";
RL   Genomics 79:809-817(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=12374985; DOI=10.1038/nature01084;
RA   Yasui D., Miyano M., Cai S., Varga-Weisz P., Kohwi-Shigematsu T.;
RT   "SATB1 targets chromatin remodelling to regulate genes over long
RT   distances.";
RL   Nature 419:641-645(2002).
RN   [14]
RP   INTERACTION WITH EP300.
RX   PubMed=14605447; DOI=10.1111/j.1348-0421.2003.tb03438.x;
RA   Fujii Y., Kumatori A., Nakamura M.;
RT   "SATB1 makes a complex with p300 and represses gp91(phox) promoter
RT   activity.";
RL   Microbiol. Immunol. 47:803-811(2003).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12692553; DOI=10.1038/ng1146;
RA   Cai S., Han H.-J., Kohwi-Shigematsu T.;
RT   "Tissue-specific nuclear architecture and gene expression regulated by
RT   SATB1.";
RL   Nat. Genet. 34:42-51(2003).
RN   [16]
RP   FUNCTION.
RX   PubMed=15618465; DOI=10.1182/blood-2004-08-2988;
RA   Wen J., Huang S., Rogers H., Dickinson L.A., Kohwi-Shigematsu T.,
RA   Noguchi C.T.;
RT   "SATB1 family protein expressed during early erythroid differentiation
RT   modifies globin gene expression.";
RL   Blood 105:3330-3339(2005).
RN   [17]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-29; ARG-32; GLU-34 AND
RP   ASN-36, AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=15970696;
RA   Nakayama Y., Mian I.S., Kohwi-Shigematsu T., Ogawa T.;
RT   "A nuclear targeting determinant for SATB1, a genome organizer in the
RT   T cell lineage.";
RL   Cell Cycle 4:1099-1106(2005).
RN   [18]
RP   SUMOYLATION.
RX   PubMed=15561718; DOI=10.1074/jbc.M411718200;
RA   Gocke C.B., Yu H., Kang J.;
RT   "Systematic identification and analysis of mammalian small ubiquitin-
RT   like modifier substrates.";
RL   J. Biol. Chem. 280:5004-5012(2005).
RN   [19]
RP   SUBCELLULAR LOCATION, AND NUCLEAR MATRIX TARGETING SEQUENCE.
RX   PubMed=15851481; DOI=10.1074/jbc.M414076200;
RA   Seo J., Lozano M.M., Dudley J.P.;
RT   "Nuclear matrix binding regulates SATB1-mediated transcriptional
RT   repression.";
RL   J. Biol. Chem. 280:24600-24609(2005).
RN   [20]
RP   INTERACTION WITH DYNLT3, AND SUBCELLULAR LOCATION.
RX   PubMed=16079286; DOI=10.1242/jcs.02472;
RA   Yeh T.-Y., Chuang J.-Z., Sung C.-H.;
RT   "Dynein light chain rp3 acts as a nuclear matrix-associated
RT   transcriptional modulator in a dynein-independent pathway.";
RL   J. Cell Sci. 118:3431-3443(2005).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH HIV-1 TAT AND HDAC1.
RX   PubMed=15713622; DOI=10.1128/MCB.25.5.1620-1633.2005;
RA   Kumar P.P., Purbey P.K., Ravi D.S., Mitra D., Galande S.;
RT   "Displacement of SATB1-bound histone deacetylase 1 corepressor by the
RT   human immunodeficiency virus type 1 transactivator induces expression
RT   of interleukin-2 and its receptor in T cells.";
RL   Mol. Cell. Biol. 25:1620-1633(2005).
RN   [22]
RP   FUNCTION, AND CLEAVAGE BY CASPASE-3.
RX   PubMed=16377216; DOI=10.1016/j.cellbi.2005.10.025;
RA   Sun Y., Wang T., Su Y., Yin Y., Xu S., Ma C., Han X.;
RT   "The behavior of SATB1, a MAR-binding protein, in response to
RT   apoptosis stimulation.";
RL   Cell Biol. Int. 30:244-247(2006).
RN   [23]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH HDAC1
RP   AND PCAF, MUTAGENESIS OF LYS-136 AND SER-185, ACETYLATION AT LYS-136,
RP   AND PHOSPHORYLATION AT SER-185.
RX   PubMed=16630892; DOI=10.1016/j.molcel.2006.03.010;
RA   Kumar P.P., Purbey P.K., Sinha C.K., Notani D., Limaye A.,
RA   Jayani R.S., Galande S.;
RT   "Phosphorylation of SATB1, a global gene regulator, acts as a
RT   molecular switch regulating its transcriptional activity in vivo.";
RL   Mol. Cell 22:231-243(2006).
RN   [24]
RP   FUNCTION.
RX   PubMed=17376900; DOI=10.1128/JVI.01405-06;
RA   Kumar P.P., Mehta S., Purbey P.K., Notani D., Jayani R.S.,
RA   Purohit H.J., Raje D.V., Ravi D.S., Bhonde R.R., Mitra D., Galande S.;
RT   "SATB1-binding sequences and Alu-like motifs define a unique chromatin
RT   context in the vicinity of human immunodeficiency virus type 1
RT   integration sites.";
RL   J. Virol. 81:5617-5627(2007).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH PML.
RX   PubMed=17173041; DOI=10.1038/ncb1516;
RA   Kumar P.P., Bischof O., Purbey P.K., Notani D., Urlaub H., Dejean A.,
RA   Galande S.;
RT   "Functional interaction between PML and SATB1 regulates chromatin-loop
RT   architecture and transcription of the MHC class I locus.";
RL   Nat. Cell Biol. 9:45-56(2007).
RN   [26]
RP   INTERACTION WITH CYTOMEGALOVIRUS UNIQUE REGION.
RX   PubMed=17512569; DOI=10.1016/j.virol.2007.04.024;
RA   Lee J., Klase Z., Gao X., Caldwell J.S., Stinski M.F., Kashanchi F.,
RA   Chao S.-H.;
RT   "Cellular homeoproteins, SATB1 and CDP, bind to the unique region
RT   between the human cytomegalovirus UL127 and major immediate-early
RT   genes.";
RL   Virology 366:117-125(2007).
RN   [27]
RP   SUMOYLATION AT LYS-744, MUTAGENESIS OF LYS-411; LYS-486; LYS-720 AND
RP   LYS-744, SUBCELLULAR LOCATION, AND CLEAVAGE BY CASPASE-6.
RX   PubMed=18408014; DOI=10.1074/jbc.M800512200;
RA   Tan J.-A.T., Sun Y., Song J., Chen Y., Krontiris T.G., Durrin L.K.;
RT   "SUMO conjugation to the matrix attachment region-binding protein,
RT   special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to
RT   promyelocytic nuclear bodies where it undergoes caspase cleavage.";
RL   J. Biol. Chem. 283:18124-18134(2008).
RN   [28]
RP   FUNCTION, AND ROLE IN BREAST TUMOR GROWTH AND METASTASIS.
RX   PubMed=18337816; DOI=10.1038/nature06781;
RA   Han H.-J., Russo J., Kohwi Y., Kohwi-Shigematsu T.;
RT   "SATB1 reprogrammes gene expression to promote breast tumour growth
RT   and metastasis.";
RL   Nature 452:187-193(2008).
RN   [29]
RP   SUBUNIT, AND INTERACTION WITH DNA AND NUCLEAR MATRIX.
RX   PubMed=18187506; DOI=10.1093/nar/gkm1151;
RA   Purbey P.K., Singh S., Kumar P.P., Mehta S., Ganesh K.N., Mitra D.,
RA   Galande S.;
RT   "PDZ domain-mediated dimerization and homeodomain-directed specificity
RT   are required for high-affinity DNA binding by SATB1.";
RL   Nucleic Acids Res. 36:2107-2122(2008).
RN   [30]
RP   FUNCTION.
RX   PubMed=19332023; DOI=10.1016/j.bbrc.2009.03.122;
RA   Gong H., Wang Z., Zhao G.-W., Lv X., Wei G.-H., Wang L., Liu D.-P.,
RA   Liang C.-C.;
RT   "SATB1 regulates beta-like globin genes through matrix related nuclear
RT   relocation of the cluster.";
RL   Biochem. Biophys. Res. Commun. 383:11-15(2009).
RN   [31]
RP   FUNCTION.
RX   PubMed=19430959; DOI=10.1007/s11033-009-9538-y;
RA   Cai R., Xu W., Dai B., Cai X., Xu R., Lu J.;
RT   "SATB1 binds an intronic MAR sequence in human PI3kgamma in vitro.";
RL   Mol. Biol. Rep. 37:1461-1465(2010).
RN   [32]
RP   FUNCTION, MUTAGENESIS OF LYS-136, AND INTERACTION WITH CTBP1.
RX   PubMed=19103759; DOI=10.1128/MCB.00822-08;
RA   Purbey P.K., Singh S., Notani D., Kumar P.P., Limaye A.S., Galande S.;
RT   "Acetylation-dependent interaction of SATB1 and CtBP1 mediates
RT   transcriptional repression by SATB1.";
RL   Mol. Cell. Biol. 29:1321-1337(2009).
RN   [33]
RP   FUNCTION.
RX   PubMed=19247486; DOI=10.1371/journal.pone.0004629;
RA   Wang L., Di L.-J., Lv X., Zheng W., Xue Z., Guo Z.-C., Liu D.-P.,
RA   Liang C.-C.;
RT   "Inter-MAR association contributes to transcriptionally active looping
RT   events in human beta-globin gene cluster.";
RL   PLoS ONE 4:E4629-E4629(2009).
RN   [34]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-51, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [35]
RP   STRUCTURE BY NMR OF 353-490 IN COMPLEX WITH MAR DNA, AND MUTAGENESIS
RP   OF SER-373; ARG-380; LYS-384; ARG-395; SER-406; ARG-410; LYS-416;
RP   ARG-427; ARG-442; SER-451 AND LYS-475.
RX   PubMed=16371359; DOI=10.1074/jbc.M510933200;
RA   Yamaguchi H., Tateno M., Yamasaki K.;
RT   "Solution structure and DNA-binding mode of the matrix attachment
RT   region-binding domain of the transcription factor SATB1 that regulates
RT   the T-cell maturation.";
RL   J. Biol. Chem. 281:5319-5327(2006).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 368-452 IN COMPLEX WITH MAR
RP   DNA, AND MUTAGENESIS OF GLN-402 AND GLY-403.
RX   PubMed=17652321; DOI=10.1093/nar/gkm504;
RA   Yamasaki K., Akiba T., Yamasaki T., Harata K.;
RT   "Structural basis for recognition of the matrix attachment region of
RT   DNA by transcription factor SATB1.";
RL   Nucleic Acids Res. 35:5073-5084(2007).
CC   -!- FUNCTION: Crucial silencing factor contributing to the initiation
CC       of X inactivation mediated by Xist RNA that occurs during
CC       embryogenesis and in lymphoma (By similarity). Binds to DNA at
CC       special AT-rich sequences, the consensus SATB1-binding sequence
CC       (CSBS), at nuclear matrix- or scaffold-associated regions. Thought
CC       to recognize the sugar-phosphate structure of double-stranded DNA.
CC       Transcriptional repressor controlling nuclear and viral gene
CC       expression in a phosphorylated and acetylated status-dependent
CC       manner, by binding to matrix attachment regions (MARs) of DNA and
CC       inducing a local chromatin-loop remodeling. Acts as a docking site
CC       for several chromatin remodeling enzymes (e.g. PML at the MHC-I
CC       locus) and also by recruiting corepressors (HDACs) or coactivators
CC       (HATs) directly to promoters and enhancers. Modulates genes that
CC       are essential in the maturation of the immune T-cell CD8SP from
CC       thymocytes. Required for the switching of fetal globin species,
CC       and beta- and gamma-globin genes regulation during erythroid
CC       differentiation. Plays a role in chromatin organization and
CC       nuclear architecture during apoptosis. Interacts with the unique
CC       region (UR) of cytomegalovirus (CMV). Alu-like motifs and SATB1-
CC       binding sites provide a unique chromatin context which seems
CC       preferentially targeted by the HIV-1 integration machinery.
CC       Moreover, HIV-1 Tat may overcome SATB1-mediated repression of IL2
CC       and IL2RA (interleukin) in T-cells by binding to the same domain
CC       than HDAC1. Delineates specific epigenetic modifications at target
CC       gene loci, directly up-regulating metastasis-associated genes
CC       while down-regulating tumor-suppressor genes. Reprograms chromatin
CC       organization and the transcription profiles of breast tumors to
CC       promote growth and metastasis. {ECO:0000250,
CC       ECO:0000269|PubMed:10595394, ECO:0000269|PubMed:11463840,
CC       ECO:0000269|PubMed:12374985, ECO:0000269|PubMed:12692553,
CC       ECO:0000269|PubMed:1505028, ECO:0000269|PubMed:15618465,
CC       ECO:0000269|PubMed:15713622, ECO:0000269|PubMed:16377216,
CC       ECO:0000269|PubMed:16630892, ECO:0000269|PubMed:17173041,
CC       ECO:0000269|PubMed:17376900, ECO:0000269|PubMed:18337816,
CC       ECO:0000269|PubMed:19103759, ECO:0000269|PubMed:19247486,
CC       ECO:0000269|PubMed:19332023, ECO:0000269|PubMed:19430959,
CC       ECO:0000269|PubMed:9111059, ECO:0000269|PubMed:9548713}.
CC   -!- SUBUNIT: Interacts with CUX1 (via DNA-binding domains); the
CC       interaction inhibits the attachment of both proteins to DNA (By
CC       similarity). Homodimer. Part of the nuclear protein complex gamma-
CC       globin promoter and enhancer binding factor (gamma-PE) composed at
CC       least of SATB1 and HOXB2. Interaction with CtBP1 when not
CC       acetylated stabalizes attachment to DNA and promotes transcription
CC       repression. Interacts with PCAF. Interacts with sumoylated PML,
CC       HDAC1 and HIV-1 Tat via the PDZ-like dimerization domain.
CC       Interacts also with DYNLT3 and POLR2J2. Binds to EP300.
CC       {ECO:0000250, ECO:0000269|PubMed:10595394,
CC       ECO:0000269|PubMed:11463840, ECO:0000269|PubMed:12036295,
CC       ECO:0000269|PubMed:14605447, ECO:0000269|PubMed:15713622,
CC       ECO:0000269|PubMed:16079286, ECO:0000269|PubMed:16371359,
CC       ECO:0000269|PubMed:16630892, ECO:0000269|PubMed:17173041,
CC       ECO:0000269|PubMed:17512569, ECO:0000269|PubMed:17652321,
CC       ECO:0000269|PubMed:18187506, ECO:0000269|PubMed:19103759}.
CC   -!- INTERACTION:
CC       G2XKQ0:-; NbExp=3; IntAct=EBI-743747, EBI-10175576;
CC       P55212:CASP6; NbExp=2; IntAct=EBI-743747, EBI-718729;
CC       P35222:CTNNB1; NbExp=9; IntAct=EBI-743747, EBI-491549;
CC       P63165:SUMO1; NbExp=2; IntAct=EBI-743747, EBI-80140;
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix. Nucleus, PML body.
CC       Note=Organized into a cage-like network anchoring loops of
CC       heterochromatin and tethering specialized DNA sequences. When
CC       sumoylated, localized in promyelocytic leukemia nuclear bodies
CC       (PML NBs).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q01826-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q01826-2; Sequence=VSP_038296;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in thymus.
CC       {ECO:0000269|PubMed:1505028}.
CC   -!- PTM: Sumoylated. Sumoylation promotes cleavage by caspases.
CC       {ECO:0000269|PubMed:15561718, ECO:0000269|PubMed:18408014}.
CC   -!- PTM: Phosphorylated by PKC. Acetylated by PCAF. Phosphorylated
CC       form interacts with HDAC1, but unphosphorylated form interacts
CC       with PCAF. DNA binding properties are activated by phosphorylation
CC       and inactivated by acetylation. In opposition, gene expression is
CC       down-regulated by phosphorylation but up-regulated by acetylation.
CC       {ECO:0000269|PubMed:16630892}.
CC   -!- PTM: Cleaved at Asp-254 by caspase-3 and caspase-6 during T-cell
CC       apoptosis in thymus and during B-cell stimulation. The cleaved
CC       forms cannot dimerize and lose transcription regulation function
CC       because of impaired DNA and chromatin association.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92998.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SATB1ID44225ch3p24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97287; AAA60304.1; -; mRNA.
DR   EMBL; AK127242; BAG54463.1; -; mRNA.
DR   EMBL; AB209761; BAD92998.1; ALT_INIT; mRNA.
DR   EMBL; AC139618; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC144521; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64291.1; -; Genomic_DNA.
DR   EMBL; BC001744; AAH01744.1; -; mRNA.
DR   CCDS; CCDS2631.1; -. [Q01826-1]
DR   CCDS; CCDS56242.1; -. [Q01826-2]
DR   PIR; A43314; A43314.
DR   RefSeq; NP_001124482.1; NM_001131010.3. [Q01826-1]
DR   RefSeq; NP_001182399.1; NM_001195470.2. [Q01826-2]
DR   RefSeq; NP_001309800.1; NM_001322871.1. [Q01826-2]
DR   RefSeq; NP_001309801.1; NM_001322872.1. [Q01826-1]
DR   RefSeq; NP_001309802.1; NM_001322873.1. [Q01826-1]
DR   RefSeq; NP_001309803.1; NM_001322874.1. [Q01826-1]
DR   RefSeq; NP_001309804.1; NM_001322875.1. [Q01826-1]
DR   RefSeq; NP_002962.1; NM_002971.5. [Q01826-1]
DR   RefSeq; XP_011532290.1; XM_011533988.2. [Q01826-2]
DR   RefSeq; XP_011532291.1; XM_011533989.2. [Q01826-2]
DR   UniGene; Hs.517717; -.
DR   UniGene; Hs.593276; -.
DR   PDB; 1YSE; NMR; -; A=353-490.
DR   PDB; 2L1P; NMR; -; A=179-250.
DR   PDB; 2MW8; NMR; -; A=641-707.
DR   PDB; 2O49; X-ray; 2.00 A; A=368-452.
DR   PDB; 2O4A; X-ray; 1.75 A; A=368-452.
DR   PDB; 3NZL; X-ray; 1.20 A; A=179-250.
DR   PDB; 3TUO; X-ray; 1.70 A; A/B/C/D=71-171.
DR   PDBsum; 1YSE; -.
DR   PDBsum; 2L1P; -.
DR   PDBsum; 2MW8; -.
DR   PDBsum; 2O49; -.
DR   PDBsum; 2O4A; -.
DR   PDBsum; 3NZL; -.
DR   PDBsum; 3TUO; -.
DR   ProteinModelPortal; Q01826; -.
DR   SMR; Q01826; -.
DR   BioGrid; 112211; 58.
DR   DIP; DIP-48757N; -.
DR   IntAct; Q01826; 32.
DR   MINT; MINT-1478608; -.
DR   iPTMnet; Q01826; -.
DR   PhosphoSitePlus; Q01826; -.
DR   BioMuta; SATB1; -.
DR   DMDM; 417747; -.
DR   EPD; Q01826; -.
DR   MaxQB; Q01826; -.
DR   PeptideAtlas; Q01826; -.
DR   PRIDE; Q01826; -.
DR   DNASU; 6304; -.
DR   Ensembl; ENST00000338745; ENSP00000341024; ENSG00000182568. [Q01826-1]
DR   Ensembl; ENST00000417717; ENSP00000399518; ENSG00000182568. [Q01826-2]
DR   Ensembl; ENST00000454909; ENSP00000399708; ENSG00000182568. [Q01826-1]
DR   GeneID; 6304; -.
DR   KEGG; hsa:6304; -.
DR   UCSC; uc003cbh.4; human. [Q01826-1]
DR   CTD; 6304; -.
DR   DisGeNET; 6304; -.
DR   EuPathDB; HostDB:ENSG00000182568.16; -.
DR   GeneCards; SATB1; -.
DR   HGNC; HGNC:10541; SATB1.
DR   HPA; CAB056144; -.
DR   HPA; HPA051769; -.
DR   MIM; 602075; gene.
DR   neXtProt; NX_Q01826; -.
DR   OpenTargets; ENSG00000182568; -.
DR   PharmGKB; PA34951; -.
DR   GeneTree; ENSGT00390000008096; -.
DR   HOGENOM; HOG000004805; -.
DR   HOVERGEN; HBG054240; -.
DR   InParanoid; Q01826; -.
DR   OMA; SMDHLNE; -.
DR   OrthoDB; EOG091G02HV; -.
DR   PhylomeDB; Q01826; -.
DR   TreeFam; TF332714; -.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   SIGNOR; Q01826; -.
DR   ChiTaRS; SATB1; human.
DR   EvolutionaryTrace; Q01826; -.
DR   GeneWiki; SATB1; -.
DR   GenomeRNAi; 6304; -.
DR   PMAP-CutDB; Q01826; -.
DR   PRO; PR:Q01826; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000182568; -.
DR   CleanEx; HS_SATB1; -.
DR   ExpressionAtlas; Q01826; baseline and differential.
DR   Genevisible; Q01826; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005720; C:nuclear heterochromatin; IEA:Ensembl.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003690; F:double-stranded DNA binding; TAS:ProtInc.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0050798; P:activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0043367; P:CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl.
DR   GO; GO:0043374; P:CD8-positive, alpha-beta T cell differentiation; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; TAS:ProtInc.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0008544; P:epidermis development; IEA:Ensembl.
DR   GO; GO:0097194; P:execution phase of apoptosis; TAS:Reactome.
DR   GO; GO:0016571; P:histone methylation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:MGI.
DR   GO; GO:0060004; P:reflex; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR032355; CUTL.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR032392; ULD.
DR   Pfam; PF02376; CUT; 2.
DR   Pfam; PF16557; CUTL; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16534; ULD; 1.
DR   SMART; SM01109; CUT; 2.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 2.
DR   PROSITE; PS51042; CUT; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Chromosomal rearrangement; Complete proteome; DNA-binding; Homeobox;
KW   Host-virus interaction; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    763       DNA-binding protein SATB1.
FT                                /FTId=PRO_0000202398.
FT   DNA_BIND    361    448       CUT 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    484    571       CUT 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    645    704       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       90    204       PDZ-like dimerization domain.
FT   REGION      224    278       Nuclear matrix targeting sequence (NMTS).
FT   REGION      400    410       Matrix attachment region (MAR) DNA-
FT                                binding.
FT   MOTIF        20     40       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:15970696}.
FT   MOTIF       139    143       Protein interaction.
FT   COMPBIAS    591    607       Poly-Gln.
FT   COMPBIAS    609    614       Poly-Pro.
FT   BINDING     390    390       Matrix attachment region (MAR) DNA.
FT   BINDING     425    425       Matrix attachment region (MAR) DNA.
FT   SITE        254    255       Cleavage; by caspases.
FT   MOD_RES     136    136       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:16630892}.
FT   MOD_RES     185    185       Phosphoserine.
FT                                {ECO:0000269|PubMed:16630892}.
FT   MOD_RES     637    637       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60611}.
FT   CROSSLNK     51     51       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    744    744       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:18408014}.
FT   VAR_SEQ     592    592       I -> IQSPSPTTLGKGESRGVFLPGLPTPAPWLGAAP
FT                                (in isoform 2). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_038296.
FT   MUTAGEN      29     29       K->A: Loss of nuclear localization,
FT                                cytoplasmic.
FT                                {ECO:0000269|PubMed:15970696}.
FT   MUTAGEN      32     32       R->A: Loss of nuclear localization,
FT                                cytoplasmic.
FT                                {ECO:0000269|PubMed:15970696}.
FT   MUTAGEN      34     34       E->A: Normal nuclear localization.
FT                                {ECO:0000269|PubMed:15970696}.
FT   MUTAGEN      36     36       N->A: Normal nuclear localization.
FT                                {ECO:0000269|PubMed:15970696}.
FT   MUTAGEN     136    136       K->A,Q,R: No acetylation.
FT                                {ECO:0000269|PubMed:16630892,
FT                                ECO:0000269|PubMed:19103759}.
FT   MUTAGEN     185    185       S->A: No phosphorylation.
FT                                {ECO:0000269|PubMed:16630892}.
FT   MUTAGEN     254    254       D->A: CASP6-resistant.
FT                                {ECO:0000269|PubMed:11463840}.
FT   MUTAGEN     373    373       S->A: Slightly reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     380    380       R->N: Reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     384    384       K->N: Impaired MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     395    395       R->N: Reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     402    402       Q->A: Impaired MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:17652321}.
FT   MUTAGEN     403    403       G->A: Impaired MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:17652321}.
FT   MUTAGEN     406    406       S->A: Impaired MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     410    410       R->N: Impaired MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     411    411       K->R: Normal sumoylation.
FT                                {ECO:0000269|PubMed:18408014}.
FT   MUTAGEN     416    416       K->N: Impaired MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     427    427       R->N: Reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     442    442       R->N: Reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     451    451       S->A: Slightly reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     475    475       K->N: Reduced MAR-DNA-binding.
FT                                {ECO:0000269|PubMed:16371359}.
FT   MUTAGEN     486    486       K->R: Normal sumoylation.
FT                                {ECO:0000269|PubMed:18408014}.
FT   MUTAGEN     646    646       R->A: Reduced interaction with matrix
FT                                attachment region (MAR) DNA; when
FT                                associated with A-648.
FT                                {ECO:0000269|PubMed:9111059}.
FT   MUTAGEN     648    648       R->A: Reduced interaction with matrix
FT                                attachment region (MAR) DNA; when
FT                                associated with A-646.
FT                                {ECO:0000269|PubMed:9111059}.
FT   MUTAGEN     693    695       FQN->AAA: Reduced interaction with matrix
FT                                attachment region (MAR) DNA.
FT                                {ECO:0000269|PubMed:9111059}.
FT   MUTAGEN     720    720       K->R: Normal sumoylation.
FT                                {ECO:0000269|PubMed:18408014}.
FT   MUTAGEN     744    744       K->R: Loss of sumoylation.
FT                                {ECO:0000269|PubMed:18408014}.
FT   STRAND       72     83       {ECO:0000244|PDB:3TUO}.
FT   STRAND       92    102       {ECO:0000244|PDB:3TUO}.
FT   HELIX       107    109       {ECO:0000244|PDB:3TUO}.
FT   HELIX       110    117       {ECO:0000244|PDB:3TUO}.
FT   HELIX       122    127       {ECO:0000244|PDB:3TUO}.
FT   STRAND      129    134       {ECO:0000244|PDB:3TUO}.
FT   HELIX       142    144       {ECO:0000244|PDB:3TUO}.
FT   HELIX       153    157       {ECO:0000244|PDB:3TUO}.
FT   TURN        158    163       {ECO:0000244|PDB:3TUO}.
FT   STRAND      164    169       {ECO:0000244|PDB:3TUO}.
FT   HELIX       181    183       {ECO:0000244|PDB:3NZL}.
FT   HELIX       186    196       {ECO:0000244|PDB:3NZL}.
FT   TURN        197    199       {ECO:0000244|PDB:3NZL}.
FT   HELIX       202    208       {ECO:0000244|PDB:3NZL}.
FT   STRAND      209    211       {ECO:0000244|PDB:3NZL}.
FT   HELIX       213    221       {ECO:0000244|PDB:3NZL}.
FT   HELIX       230    245       {ECO:0000244|PDB:3NZL}.
FT   HELIX       375    386       {ECO:0000244|PDB:2O4A}.
FT   HELIX       390    398       {ECO:0000244|PDB:2O4A}.
FT   HELIX       402    411       {ECO:0000244|PDB:2O4A}.
FT   HELIX       415    417       {ECO:0000244|PDB:2O49}.
FT   HELIX       420    433       {ECO:0000244|PDB:2O4A}.
FT   HELIX       437    452       {ECO:0000244|PDB:2O4A}.
FT   HELIX       653    665       {ECO:0000244|PDB:2MW8}.
FT   HELIX       672    681       {ECO:0000244|PDB:2MW8}.
FT   HELIX       687    702       {ECO:0000244|PDB:2MW8}.
SQ   SEQUENCE   763 AA;  85957 MW;  D4FE09B09FB7683B CRC64;
     MDHLNEATQG KEHSEMSNNV SDPKGPPAKI ARLEQNGSPL GRGRLGSTGA KMQGVPLKHS
     GHLMKTNLRK GTMLPVFCVV EHYENAIEYD CKEEHAEFVL VRKDMLFNQL IEMALLSLGY
     SHSSAAQAKG LIQVGKWNPV PLSYVTDAPD ATVADMLQDV YHVVTLKIQL HSCPKLEDLP
     PEQWSHTTVR NALKDLLKDM NQSSLAKECP LSQSMISSIV NSTYYANVSA AKCQEFGRWY
     KHFKKTKDMM VEMDSLSELS QQGANHVNFG QQPVPGNTAE QPPSPAQLSH GSQPSVRTPL
     PNLHPGLVST PISPQLVNQQ LVMAQLLNQQ YAVNRLLAQQ SLNQQYLNHP PPVSRSMNKP
     LEQQVSTNTE VSSEIYQWVR DELKRAGISQ AVFARVAFNR TQGLLSEILR KEEDPKTASQ
     SLLVNLRAMQ NFLQLPEAER DRIYQDERER SLNAASAMGP APLISTPPSR PPQVKTATIA
     TERNGKPENN TMNINASIYD EIQQEMKRAK VSQALFAKVA ATKSQGWLCE LLRWKEDPSP
     ENRTLWENLS MIRRFLSLPQ PERDAIYEQE SNAVHHHGDR PPHIIHVPAE QIQQQQQQQQ
     QQQQQQQAPP PPQPQQQPQT GPRLPPRQPT VASPAESDEE NRQKTRPRTK ISVEALGILQ
     SFIQDVGLYP DEEAIQTLSA QLDLPKYTII KFFQNQRYYL KHHGKLKDNS GLEVDVAEYK
     EEELLKDLEE SVQDKNTNTL FSVKLEEELS VEGNTDINTD LKD
//
ID   NKX21_HUMAN             Reviewed;         371 AA.
AC   P43699; D3DSA3; O14954; O14955; Q7KZF6; Q9BRJ8;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Homeobox protein Nkx-2.1;
DE   AltName: Full=Homeobox protein NK-2 homolog A;
DE   AltName: Full=Thyroid nuclear factor 1;
DE   AltName: Full=Thyroid transcription factor 1;
DE            Short=TTF-1;
DE   AltName: Full=Thyroid-specific enhancer-binding protein;
DE            Short=T/EBP;
GN   Name=NKX2-1 {ECO:0000312|HGNC:HGNC:11825};
GN   Synonyms=NKX2A, TITF1, TTF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=7711079; DOI=10.1016/0167-4781(95)00033-D;
RA   Oguchi H., Pan Y.-T., Kimura S.;
RT   "The complete nucleotide sequence of the mouse thyroid-specific
RT   enhancer-binding protein (T/EBP) gene: extensive identity of the
RT   deduced amino acid sequence with the human protein.";
RL   Biochim. Biophys. Acta 1261:304-306(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid;
RX   PubMed=7711080; DOI=10.1016/0167-4781(95)00034-E;
RA   Saiardi A., Tassi V., de Filippis V., Civitareale D.;
RT   "Cloning and sequence analysis of human thyroid transcription factor
RT   1.";
RL   Biochim. Biophys. Acta 1261:307-310(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=7713914; DOI=10.1074/jbc.270.14.8108;
RA   Ikeda K., Clark J.C., Shaw-White J.R., Stahlman M.T., Boutell C.J.,
RA   Whitsett J.A.;
RT   "Gene structure and expression of human thyroid transcription factor-1
RT   in respiratory epithelial cells.";
RL   J. Biol. Chem. 270:8108-8114(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung;
RX   PubMed=9545595; DOI=10.1016/S0167-4781(97)00210-8;
RA   Hamdan H., Liu H., Li C., Jones C., Lee M., deLemos R., Minoo P.;
RT   "Structure of the human Nkx2.1 gene.";
RL   Biochim. Biophys. Acta 1396:336-348(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid;
RA   Endo T., Ohno M., Nakazato M.;
RT   "Cloning of the human TTF-1 gene.";
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH WWTR1.
RX   PubMed=19010321; DOI=10.1016/j.yexcr.2008.10.016;
RA   Di Palma T., D'Andrea B., Liguori G.L., Liguoro A., de Cristofaro T.,
RA   Del Prete D., Pappalardo A., Mascia A., Zannini M.;
RT   "TAZ is a coactivator for Pax8 and TTF-1, two transcription factors
RT   involved in thyroid differentiation.";
RL   Exp. Cell Res. 315:162-175(2009).
RN   [11]
RP   INVOLVEMENT IN NMTC1, VARIANT NMTC1 VAL-339, AND CHARACTERIZATION OF
RP   VARIANT NMTC1 VAL-339.
RX   PubMed=19176457; DOI=10.1093/jnci/djn471;
RA   Ngan E.S., Lang B.H., Liu T., Shum C.K., So M.T., Lau D.K., Leon T.Y.,
RA   Cherny S.S., Tsai S.Y., Lo C.Y., Khoo U.S., Tam P.K.,
RA   Garcia-Barcelo M.M.;
RT   "A germline mutation (A339V) in thyroid transcription factor-1 (TITF-
RT   1/NKX2.1) in patients with multinodular goiter and papillary thyroid
RT   carcinoma.";
RL   J. Natl. Cancer Inst. 101:162-175(2009).
RN   [12]
RP   VARIANTS BHC LEU-208 AND SER-213, AND INVOLVEMENT IN BHC.
RX   PubMed=11971878; DOI=10.1093/hmg/11.8.971;
RA   Breedveld G.J., van Dongen J.W.F., Danesino C., Guala A., Percy A.K.,
RA   Dure L.S., Harper P., Lazarou L.P., van der Linde H., Joosse M.,
RA   Grueters A., MacDonald M.E., de Vries B.B.A., Arts W.F.M.,
RA   Oostra B.A., Krude H., Heutink P.;
RT   "Mutations in TITF-1 are associated with benign hereditary chorea.";
RL   Hum. Mol. Genet. 11:971-979(2002).
RN   [13]
RP   INVOLVEMENT IN CAHTP.
RX   PubMed=11854318; DOI=10.1172/JCI0214192;
RA   Pohlenz J., Dumitrescu A., Zundel D., Martine U., Schoenberger W.,
RA   Koo E., Weiss R.E., Cohen R.N., Kimura S., Refetoff S.;
RT   "Partial deficiency of thyroid transcription factor 1 produces
RT   predominantly neurological defects in humans and mice.";
RL   J. Clin. Invest. 109:469-473(2002).
RN   [14]
RP   VARIANT CAHTP PHE-205.
RX   PubMed=11854319; DOI=10.1172/JCI0214341;
RA   Krude H., Schuetz B., Biebermann H., von Moers A., Schnabel D.,
RA   Neitzel H., Toennies H., Weise D., Lafferty A., Schwarz S.,
RA   DeFelice M., von Deimling A., van Landeghem F., DiLauro R.,
RA   Grueters A.;
RT   "Choreoathetosis, hypothyroidism, and pulmonary alterations due to
RT   human NKX2-1 haploinsufficiency.";
RL   J. Clin. Invest. 109:475-480(2002).
RN   [15]
RP   INVOLVEMENT IN CAHTP.
RX   PubMed=15289765; DOI=10.1016/j.jpeds.2004.04.011;
RA   Doyle D.A., Gonzalez I., Thomas B., Scavina M.;
RT   "Autosomal dominant transmission of congenital hypothyroidism,
RT   neonatal respiratory distress, and ataxia caused by a mutation of
RT   NKX2-1.";
RL   J. Pediatr. 145:190-193(2004).
RN   [16]
RP   INVOLVEMENT IN CAHTP AND IN BHC.
RX   PubMed=15955952; DOI=10.1212/01.WNL.0000164000.75046.CC;
RA   Asmus F., Horber V., Pohlenz J., Schwabe D., Zimprich A., Munz M.,
RA   Schoening M., Gasser T.;
RT   "A novel TITF-1 mutation causes benign hereditary chorea with response
RT   to levodopa.";
RL   Neurology 64:1952-1954(2005).
RN   [17]
RP   VARIANT BHC PRO-179.
RX   PubMed=24453141; DOI=10.1177/0883073813518243;
RA   Williamson S., Kirkpatrick M., Greene S., Goudie D.;
RT   "A novel mutation of NKX2-1 affecting 2 generations with
RT   hypothyroidism and choreoathetosis: part of the spectrum of brain-
RT   thyroid-lung syndrome.";
RL   J. Child Neurol. 29:666-669(2014).
RN   [18]
RP   VARIANTS CAHTP ARG-203 AND PHE-205.
RX   PubMed=24714694; DOI=10.1136/jmedgenet-2013-102248;
RA   Thorwarth A., Schnittert-Huebener S., Schrumpf P., Mueller I.,
RA   Jyrch S., Dame C., Biebermann H., Kleinau G., Katchanov J.,
RA   Schuelke M., Ebert G., Steininger A., Boennemann C., Brockmann K.,
RA   Christen H.J., Crock P., deZegher F., Griese M., Hewitt J.,
RA   Ivarsson S., Huebner C., Kapelari K., Plecko B., Rating D., Stoeva I.,
RA   Ropers H.H., Grueters A., Ullmann R., Krude H.;
RT   "Comprehensive genotyping and clinical characterisation reveal 27
RT   novel NKX2-1 mutations and expand the phenotypic spectrum.";
RL   J. Med. Genet. 51:375-387(2014).
RN   [19]
RP   VARIANTS BHC HIS-172 AND SER-208, AND CHARACTERIZATION OF VARIANTS BHC
RP   HIS-172 AND SER-208.
RX   PubMed=26723978; DOI=10.1016/j.jns.2015.11.050;
RA   Provenzano C., Zamboni M., Veneziano L., Mantuano E., Garavaglia B.,
RA   Zorzi G., Pagonabarraga J., Giunti P., Civitareale D.;
RT   "Functional characterization of two novel mutations in TTF-1/NKX2.1
RT   homeodomain in patients with benign hereditary chorea.";
RL   J. Neurol. Sci. 360:78-83(2016).
CC   -!- FUNCTION: Transcription factor that binds and activates the
CC       promoter of thyroid specific genes such as thyroglobulin,
CC       thyroperoxidase, and thyrotropin receptor. Crucial in the
CC       maintenance of the thyroid differentiation phenotype. May play a
CC       role in lung development and surfactant homeostasis. Forms a
CC       regulatory loop with GRHL2 that coordinates lung epithelial cell
CC       morphogenesis and differentiation. Activates the transcription of
CC       GNRHR and plays a role in enhancing the circadian oscillation of
CC       its gene expression. Represses the transcription of the circadian
CC       transcriptional repressor NR1D1 (By similarity).
CC       {ECO:0000250|UniProtKB:P23441, ECO:0000250|UniProtKB:P50220}.
CC   -!- SUBUNIT: Interacts with WWTR1. {ECO:0000269|PubMed:19010321}.
CC   -!- INTERACTION:
CC       Q9P031:CCDC59; NbExp=4; IntAct=EBI-1391923, EBI-1047110;
CC       P16333:NCK1; NbExp=2; IntAct=EBI-1391923, EBI-389883;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P50220}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P43699-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=P43699-3; Sequence=VSP_037890;
CC   -!- TISSUE SPECIFICITY: Thyroid and lung.
CC   -!- PTM: Phosphorylated on serine residues by STK3/MST2.
CC       {ECO:0000250}.
CC   -!- DISEASE: Chorea, hereditary benign (BHC) [MIM:118700]: A rare
CC       autosomal dominant movement disorder, defined by early onset in
CC       childhood, a stable or non-progressive course of chorea, and no
CC       mental deterioration. Chorea is characterized by involuntary,
CC       forcible, rapid, jerky movements that may be subtle or become
CC       confluent, markedly altering normal patterns of movement.
CC       {ECO:0000269|PubMed:11971878, ECO:0000269|PubMed:15955952,
CC       ECO:0000269|PubMed:24453141, ECO:0000269|PubMed:26723978}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Choreoathetosis and congenital hypothyroidism with or
CC       without pulmonary dysfunction (CAHTP) [MIM:610978]: An autosomal
CC       dominant disorder that manifests in infancy with neurological
CC       disturbances, hypothyroidism, and respiratory problems. It is
CC       characterized by movement abnormalities beginning with muscular
CC       hypotonia followed by the development of chorea, athetosis,
CC       dystonia, ataxia, and dysarthria. {ECO:0000269|PubMed:11854318,
CC       ECO:0000269|PubMed:11854319, ECO:0000269|PubMed:15289765,
CC       ECO:0000269|PubMed:15955952, ECO:0000269|PubMed:24714694}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Thyroid cancer, non-medullary, 1 (NMTC1) [MIM:188550]: A
CC       form of non-medullary thyroid cancer (NMTC), a cancer
CC       characterized by tumors originating from the thyroid follicular
CC       cells. NMTCs represent approximately 95% of all cases of thyroid
CC       cancer and are classified into papillary, follicular, Hurthle
CC       cell, and anaplastic neoplasms. {ECO:0000269|PubMed:19176457}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH06221.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA23527.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NKX2-1ID44015ch14q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U19756; AAA86099.1; -; mRNA.
DR   EMBL; X82850; CAA58053.1; -; mRNA.
DR   EMBL; U19816; AAC50125.1; -; Genomic_DNA.
DR   EMBL; U33749; AAB52381.1; -; mRNA.
DR   EMBL; U43203; AAA89066.1; -; mRNA.
DR   EMBL; D50739; BAA23527.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; D50740; BAA23529.1; -; mRNA.
DR   EMBL; BT009773; AAP88775.1; -; mRNA.
DR   EMBL; AL132857; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW65858.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65856.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65859.1; -; Genomic_DNA.
DR   EMBL; BC006221; AAH06221.2; ALT_INIT; mRNA.
DR   CCDS; CCDS41945.1; -. [P43699-3]
DR   CCDS; CCDS9659.1; -. [P43699-1]
DR   PIR; G02321; G02321.
DR   RefSeq; NP_001073136.1; NM_001079668.2. [P43699-3]
DR   RefSeq; NP_003308.1; NM_003317.3. [P43699-1]
DR   UniGene; Hs.94367; -.
DR   ProteinModelPortal; P43699; -.
DR   SMR; P43699; -.
DR   BioGrid; 112936; 10.
DR   IntAct; P43699; 8.
DR   MINT; MINT-192847; -.
DR   STRING; 9606.ENSP00000346879; -.
DR   iPTMnet; P43699; -.
DR   PhosphoSitePlus; P43699; -.
DR   BioMuta; NKX2-1; -.
DR   DMDM; 1174819; -.
DR   MaxQB; P43699; -.
DR   PaxDb; P43699; -.
DR   PeptideAtlas; P43699; -.
DR   PRIDE; P43699; -.
DR   DNASU; 7080; -.
DR   Ensembl; ENST00000354822; ENSP00000346879; ENSG00000136352. [P43699-3]
DR   Ensembl; ENST00000498187; ENSP00000429607; ENSG00000136352. [P43699-1]
DR   Ensembl; ENST00000518149; ENSP00000428341; ENSG00000136352. [P43699-1]
DR   Ensembl; ENST00000522719; ENSP00000429519; ENSG00000136352. [P43699-1]
DR   GeneID; 7080; -.
DR   KEGG; hsa:7080; -.
DR   UCSC; uc001wtt.4; human. [P43699-1]
DR   CTD; 7080; -.
DR   DisGeNET; 7080; -.
DR   EuPathDB; HostDB:ENSG00000136352.17; -.
DR   GeneCards; NKX2-1; -.
DR   HGNC; HGNC:11825; NKX2-1.
DR   HPA; CAB000078; -.
DR   HPA; CAB053633; -.
DR   HPA; HPA074316; -.
DR   MalaCards; NKX2-1; -.
DR   MIM; 118700; phenotype.
DR   MIM; 188550; phenotype.
DR   MIM; 600635; gene.
DR   MIM; 610978; phenotype.
DR   neXtProt; NX_P43699; -.
DR   OpenTargets; ENSG00000136352; -.
DR   Orphanet; 95713; Athyreosis.
DR   Orphanet; 1429; Benign familial chorea.
DR   Orphanet; 209905; Brain-lung-thyroid syndrome.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   Orphanet; 95720; Thyroid hypoplasia.
DR   PharmGKB; PA36531; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; P43699; -.
DR   KO; K09342; -.
DR   OMA; MGHNGTV; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; P43699; -.
DR   TreeFam; TF351204; -.
DR   SIGNOR; P43699; -.
DR   GeneWiki; NK2_homeobox_1; -.
DR   GenomeRNAi; 7080; -.
DR   PRO; PR:P43699; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000136352; -.
DR   CleanEx; HS_NKX2-1; -.
DR   CleanEx; HS_TTF1; -.
DR   ExpressionAtlas; P43699; baseline and differential.
DR   Genevisible; P43699; HS.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0001047; F:core promoter binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IMP:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0044213; F:intronic transcription regulatory region DNA binding; IDA:MGI.
DR   GO; GO:0001161; F:intronic transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001012; F:RNA polymerase II regulatory region DNA binding; IDA:MGI.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl.
DR   GO; GO:0021892; P:cerebral cortex GABAergic interneuron differentiation; IEA:Ensembl.
DR   GO; GO:0060486; P:Clara cell differentiation; IEA:Ensembl.
DR   GO; GO:0031128; P:developmental induction; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; IEA:Ensembl.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEP:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEP:UniProtKB.
DR   GO; GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0021877; P:forebrain neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0021759; P:globus pallidus development; IMP:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0033327; P:Leydig cell differentiation; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEP:UniProtKB.
DR   GO; GO:0060430; P:lung saccule development; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:Ensembl.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0009725; P:response to hormone; IEP:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0030878; P:thyroid gland development; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Biological rhythms;
KW   Complete proteome; Congenital hypothyroidism; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    371       Homeobox protein Nkx-2.1.
FT                                /FTId=PRO_0000049343.
FT   DNA_BIND    161    220       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    234    243       Poly-Gly.
FT   COMPBIAS    246    253       Poly-Gln.
FT   COMPBIAS    294    303       Poly-Ala.
FT   MOD_RES     254    254       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P23441}.
FT   VAR_SEQ       1      1       M -> MWSGGSGKARGWEAAAGGRSSPGRLSRRRIM (in
FT                                isoform 3). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9545595,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_037890.
FT   VARIANT     172    172       Q -> H (in BHC; decrease in DNA-binding;
FT                                no effect on transcription activation
FT                                from thyroglobulin/TG, nor from pulmonary
FT                                surfactant-associated protein C/SFTPC
FT                                gene promoters).
FT                                {ECO:0000269|PubMed:26723978}.
FT                                /FTId=VAR_075209.
FT   VARIANT     179    179       R -> P (in BHC; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24453141}.
FT                                /FTId=VAR_077542.
FT   VARIANT     203    203       T -> R (in CAHTP).
FT                                {ECO:0000269|PubMed:24714694}.
FT                                /FTId=VAR_073040.
FT   VARIANT     205    205       V -> F (in CAHTP; dbSNP:rs137852692).
FT                                {ECO:0000269|PubMed:11854319,
FT                                ECO:0000269|PubMed:24714694}.
FT                                /FTId=VAR_034906.
FT   VARIANT     208    208       W -> L (in BHC; dbSNP:rs28936672).
FT                                {ECO:0000269|PubMed:11971878}.
FT                                /FTId=VAR_015188.
FT   VARIANT     208    208       W -> S (in BHC; loss of transcription
FT                                activation).
FT                                {ECO:0000269|PubMed:26723978}.
FT                                /FTId=VAR_075210.
FT   VARIANT     213    213       R -> S (in BHC; dbSNP:rs28936671).
FT                                {ECO:0000269|PubMed:11971878}.
FT                                /FTId=VAR_015189.
FT   VARIANT     339    339       A -> V (in NMTC1; loss of transcription
FT                                regulatory region DNA binding; decreased
FT                                transcription factor activity, sequence-
FT                                specific DNA binding; tested for the
FT                                thyroglobulin gene; associated with
FT                                dominant impairment of thyroid-specific
FT                                genes transcription and increased thyroid
FT                                cells proliferation; dbSNP:rs537209983).
FT                                {ECO:0000269|PubMed:19176457}.
FT                                /FTId=VAR_075769.
FT   CONFLICT     49     49       P -> H (in Ref. 5; BAA23527/BAA23529).
FT                                {ECO:0000305}.
FT   CONFLICT     61     61       H -> P (in Ref. 5; BAA23527/BAA23529).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       S -> T (in Ref. 5; BAA23527/BAA23529).
FT                                {ECO:0000305}.
FT   CONFLICT    161    161       R -> G (in Ref. 5; BAA23527/BAA23529).
FT                                {ECO:0000305}.
SQ   SEQUENCE   371 AA;  38596 MW;  5F1E3B40A1BBD862 CRC64;
     MSMSPKHTTP FSVSDILSPL EESYKKVGME GGGLGAPLAA YRQGQAAPPT AAMQQHAVGH
     HGAVTAAYHM TAAGVPQLSH SAVGGYCNGN LGNMSELPPY QDTMRNSASG PGWYGANPDP
     RFPAISRFMG PASGMNMSGM GGLGSLGDVS KNMAPLPSAP RRKRRVLFSQ AQVYELERRF
     KQQKYLSAPE REHLASMIHL TPTQVKIWFQ NHRYKMKRQA KDKAAQQQLQ QDSGGGGGGG
     GTGCPQQQQA QQQSPRRVAV PVLVKDGKPC QAGAPAPGAA SLQGHAQQQA QHQAQAAQAA
     AAAISVGSGG AGLGAHPGHQ PGSAGQSPDL AHHAASPAAL QGQVSSLSHL NSSGSDYGTM
     SCSTLLYGRT W
//
ID   CRX_HUMAN               Reviewed;         299 AA.
AC   O43186; Q0QD45;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 171.
DE   RecName: Full=Cone-rod homeobox protein;
GN   Name=CRX; Synonyms=CORD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT CORD2 ALA-80.
RX   PubMed=9390563; DOI=10.1016/S0092-8674(00)80440-7;
RA   Freund C.L., Gregory-Evans C.Y., Furukawa T., Papaioannou M.,
RA   Looser J., Ploder L., Bellingham J., Ng D., Herbrick J.-A.S.,
RA   Duncan A., Scherer S.W., Tsui L.-C., Loutradis-Anagnostou A.,
RA   Jacobson S.G., Cepko C.L., Bhattacharya S.S., McInnes R.R.;
RT   "Cone-rod dystrophy due to mutations in a novel photoreceptor-specific
RT   homeobox gene (CRX) essential for maintenance of the photoreceptor.";
RL   Cell 91:543-553(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-54.
RC   TISSUE=Retina;
RX   PubMed=17286855; DOI=10.1186/1471-2164-8-42;
RA   Roni V., Carpio R., Wissinger B.;
RT   "Mapping of transcription start sites of human retina expressed
RT   genes.";
RL   BMC Genomics 8:42-42(2007).
RN   [6]
RP   FUNCTION.
RX   PubMed=10625658; DOI=10.1074/jbc.275.2.1152;
RA   Kimura A., Singh D., Wawrousek E.F., Kikuchi M., Nakamura M.,
RA   Shinohara T.;
RT   "Both PCE-1/RX and OTX/CRX interactions are necessary for
RT   photoreceptor-specific gene expression.";
RL   J. Biol. Chem. 275:1152-1160(2000).
RN   [7]
RP   INTERACTION WITH NRL, CHARACTERIZATION OF VARIANT CORD2 TRP-41, AND
RP   CHARACTERIZATION OF VARIANT LCA7 TRP-90.
RX   PubMed=10887186; DOI=10.1074/jbc.M003658200;
RA   Mitton K.P., Swain P.K., Chen S., Xu S., Zack D.J., Swaroop A.;
RT   "The leucine zipper of NRL interacts with the CRX homeodomain. A
RT   possible mechanism of transcriptional synergy in rhodopsin
RT   regulation.";
RL   J. Biol. Chem. 275:29794-29799(2000).
RN   [8]
RP   INTERACTION WITH RAX2.
RX   PubMed=15028672; DOI=10.1093/hmg/ddh117;
RA   Wang Q.-L., Chen S., Esumi N., Swain P.K., Haines H.S., Peng G.,
RA   Melia B.M., McIntosh I., Heckenlively J.R., Jacobson S.G., Stone E.M.,
RA   Swaroop A., Zack D.J.;
RT   "QRX, a novel homeobox gene, modulates photoreceptor gene
RT   expression.";
RL   Hum. Mol. Genet. 13:1025-1040(2004).
RN   [9]
RP   VARIANTS CORD2 TRP-41 AND MET-242, VARIANT RP GLN-41, AND VARIANT
RP   THR-158.
RX   PubMed=9427255; DOI=10.1016/S0896-6273(00)80423-7;
RA   Swain P.K., Chen S., Wang Q.-L., Affatigato L.M., Coats C.L.,
RA   Brady K.D., Fishman G.A., Jacobson S.G., Swaroop A., Stone E.,
RA   Sieving P.A., Zack D.J.;
RT   "Mutations in the cone-rod homeobox gene are associated with the cone-
RT   rod dystrophy photoreceptor degeneration.";
RL   Neuron 19:1329-1336(1997).
RN   [10]
RP   VARIANT RP GLN-41, VARIANT CORD2 ALA-80, AND VARIANT LCA7
RP   146-LEU--PRO-149 DEL.
RX   PubMed=9792858; DOI=10.1086/302101;
RA   Sohocki M.M., Sullivan L.S., Mintz-Hittner H.A., Birch D.,
RA   Heckenlively J.R., Freund C.L., McInnes R.R., Daiger S.P.;
RT   "A range of clinical phenotypes associated with mutations in CRX, a
RT   photoreceptor transcription-factor gene.";
RL   Am. J. Hum. Genet. 63:1307-1315(1998).
RN   [11]
RP   VARIANT LCA7 TRP-90.
RX   PubMed=9931337; DOI=10.1093/hmg/8.2.299;
RA   Swaroop A., Wang Q.-L., Wu W., Cook J., Coats C., Xu S., Chen S.,
RA   Zack D.J., Sieving P.A.;
RT   "Leber congenital amaurosis caused by a homozygous mutation (R90W) in
RT   the homeodomain of the retinal transcription factor CRX: direct
RT   evidence for the involvement of CRX in the development of
RT   photoreceptor function.";
RL   Hum. Mol. Genet. 8:299-305(1999).
RN   [12]
RP   VARIANTS ASP-10; ILE-66; ASP-122 AND THR-158, AND VARIANTS RP GLN-41
RP   AND GLN-115.
RX   PubMed=11139241;
RX   DOI=10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K;
RA   Sohocki M.M., Daiger S.P., Bowne S.J., Rodriquez J.A., Northrup H.,
RA   Heckenlively J.R., Birch D.G., Mintz-Hittner H., Ruiz R.S.,
RA   Lewis R.A., Saperstein D.A., Sullivan L.S.;
RT   "Prevalence of mutations causing retinitis pigmentosa and other
RT   inherited retinopathies.";
RL   Hum. Mutat. 17:42-51(2001).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-141.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [14]
RP   VARIANT ALA-154.
RX   PubMed=18682808;
RA   Seong M.W., Kim S.Y., Yu Y.S., Hwang J.M., Kim J.Y., Park S.S.;
RT   "Molecular characterization of Leber congenital amaurosis in
RT   Koreans.";
RL   Mol. Vis. 14:1429-1436(2008).
RN   [15]
RP   VARIANT LCA7 ASN-88, AND CHARACTERIZATION OF VARIANT LCA7 ASN-88.
RX   PubMed=20513135; DOI=10.1002/humu.21268;
RA   Nichols L.L. II, Alur R.P., Boobalan E., Sergeev Y.V., Caruso R.C.,
RA   Stone E.M., Swaroop A., Johnson M.A., Brooks B.P.;
RT   "Two novel CRX mutant proteins causing autosomal dominant Leber
RT   congenital amaurosis interact differently with NRL.";
RL   Hum. Mutat. 31:E1472-E1483(2010).
RN   [16]
RP   VARIANT LCA7 LYS-42.
RX   PubMed=21602930; DOI=10.1371/journal.pone.0019458;
RA   Li L., Xiao X., Li S., Jia X., Wang P., Guo X., Jiao X., Zhang Q.,
RA   Hejtmancik J.F.;
RT   "Detection of variants in 15 genes in 87 unrelated Chinese patients
RT   with Leber congenital amaurosis.";
RL   PLoS ONE 6:E19458-E19458(2011).
RN   [17]
RP   VARIANT ASP-122.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E.,
RA   Fennell T., O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B.,
RA   Tukiainen T., Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K.,
RA   Zhao F., Zou J., Pierce-Hoffman E., Berghout J., Cooper D.N.,
RA   Deflaux N., DePristo M., Do R., Flannick J., Fromer M., Gauthier L.,
RA   Goldstein J., Gupta N., Howrigan D., Kiezun A., Kurki M.I.,
RA   Moonshine A.L., Natarajan P., Orozco L., Peloso G.M., Poplin R.,
RA   Rivas M.A., Ruano-Rubio V., Rose S.A., Ruderfer D.M., Shakir K.,
RA   Stenson P.D., Stevens C., Thomas B.P., Tiao G., Tusie-Luna M.T.,
RA   Weisburd B., Won H.H., Yu D., Altshuler D.M., Ardissino D.,
RA   Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S.,
RA   Laakso M., McCarroll S., McCarthy M.I., McGovern D., McPherson R.,
RA   Neale B.M., Palotie A., Purcell S.M., Saleheen D., Scharf J.M.,
RA   Sklar P., Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C.,
RA   Wilson J.G., Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Transcription factor that binds and transactivates the
CC       sequence 5'-TAATC[CA]-3' which is found upstream of several
CC       photoreceptor-specific genes, including the opsin genes. Acts
CC       synergistically with other transcription factors, such as NRL,
CC       RORB and RAX, to regulate photoreceptor cell-specific gene
CC       transcription. Essential for the maintenance of mammalian
CC       photoreceptors. {ECO:0000269|PubMed:10625658}.
CC   -!- SUBUNIT: Interacts (via the homeobox) with NRL (via the leucine-
CC       zipper domain). Interacts with PDC, RAX2, RORB and SCA7.
CC       {ECO:0000269|PubMed:10887186, ECO:0000269|PubMed:15028672}.
CC   -!- INTERACTION:
CC       Q9NYB9:ABI2; NbExp=3; IntAct=EBI-748171, EBI-743598;
CC       Q08117:AES; NbExp=3; IntAct=EBI-748171, EBI-717810;
CC       O94817:ATG12; NbExp=3; IntAct=EBI-748171, EBI-746742;
CC       Q9NX04:C1orf109; NbExp=3; IntAct=EBI-748171, EBI-8643161;
CC       Q96LT7:C9orf72; NbExp=3; IntAct=EBI-748171, EBI-2961725;
CC       P35219:CA8; NbExp=6; IntAct=EBI-748171, EBI-718700;
CC       P24863:CCNC; NbExp=3; IntAct=EBI-748171, EBI-395261;
CC       P63241:EIF5A; NbExp=3; IntAct=EBI-748171, EBI-373150;
CC       O75603:GCM2; NbExp=8; IntAct=EBI-748171, EBI-10188645;
CC       Q96NT3:GUCD1; NbExp=3; IntAct=EBI-748171, EBI-8293751;
CC       Q63ZY3:KANK2; NbExp=4; IntAct=EBI-748171, EBI-2556193;
CC       Q14154:KIAA0141; NbExp=3; IntAct=EBI-748171, EBI-2805660;
CC       Q5THT1:KLHL32; NbExp=3; IntAct=EBI-748171, EBI-10247181;
CC       Q71RC2-6:LARP4; NbExp=3; IntAct=EBI-748171, EBI-10255841;
CC       Q17RB8:LONRF1; NbExp=4; IntAct=EBI-748171, EBI-2341787;
CC       Q8TC57:M1AP; NbExp=3; IntAct=EBI-748171, EBI-748182;
CC       Q6P2C6:MLLT6; NbExp=3; IntAct=EBI-748171, EBI-5773143;
CC       Q9Y221:NIP7; NbExp=3; IntAct=EBI-748171, EBI-749003;
CC       Q9UJX0:OSGIN1; NbExp=3; IntAct=EBI-748171, EBI-9057006;
CC       Q7Z2X4:PID1; NbExp=3; IntAct=EBI-748171, EBI-10256685;
CC       Q96T49:PPP1R16B; NbExp=3; IntAct=EBI-748171, EBI-10293968;
CC       O43741:PRKAB2; NbExp=5; IntAct=EBI-748171, EBI-1053424;
CC       P0CG20:PRR35; NbExp=4; IntAct=EBI-748171, EBI-11986293;
CC       P40306:PSMB10; NbExp=3; IntAct=EBI-748171, EBI-603329;
CC       Q2TAL8:QRICH1; NbExp=5; IntAct=EBI-748171, EBI-2798044;
CC       A1L4F5:ROR2; NbExp=3; IntAct=EBI-748171, EBI-10172778;
CC       Q01974:ROR2; NbExp=4; IntAct=EBI-748171, EBI-6422642;
CC       O00560:SDCBP; NbExp=4; IntAct=EBI-748171, EBI-727004;
CC       P84022:SMAD3; NbExp=3; IntAct=EBI-748171, EBI-347161;
CC       P35711:SOX5; NbExp=3; IntAct=EBI-748171, EBI-3505701;
CC       O75716:STK16; NbExp=3; IntAct=EBI-748171, EBI-749295;
CC       Q5T011-5:SZT2; NbExp=3; IntAct=EBI-748171, EBI-10245139;
CC       P03410:tax (xeno); NbExp=3; IntAct=EBI-748171, EBI-9676218;
CC       O95947:TBX6; NbExp=4; IntAct=EBI-748171, EBI-2824328;
CC       Q14CS0:UBXN2B; NbExp=3; IntAct=EBI-748171, EBI-1993619;
CC       O94888:UBXN7; NbExp=4; IntAct=EBI-748171, EBI-1993627;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Retina.
CC   -!- DISEASE: Leber congenital amaurosis 7 (LCA7) [MIM:613829]: A
CC       severe dystrophy of the retina, typically becoming evident in the
CC       first years of life. Visual function is usually poor and often
CC       accompanied by nystagmus, sluggish or near-absent pupillary
CC       responses, photophobia, high hyperopia and keratoconus.
CC       {ECO:0000269|PubMed:10887186, ECO:0000269|PubMed:20513135,
CC       ECO:0000269|PubMed:21602930, ECO:0000269|PubMed:9792858,
CC       ECO:0000269|PubMed:9931337}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cone-rod dystrophy 2 (CORD2) [MIM:120970]: An inherited
CC       retinal dystrophy characterized by retinal pigment deposits
CC       visible on fundus examination, predominantly in the macular
CC       region, and initial loss of cone photoreceptors followed by rod
CC       degeneration. This leads to decreased visual acuity and
CC       sensitivity in the central visual field, followed by loss of
CC       peripheral vision. Severe loss of vision occurs earlier than in
CC       retinitis pigmentosa, due to cone photoreceptors degenerating at a
CC       higher rate than rod photoreceptors. {ECO:0000269|PubMed:10887186,
CC       ECO:0000269|PubMed:9390563, ECO:0000269|PubMed:9427255,
CC       ECO:0000269|PubMed:9792858}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Retinitis pigmentosa (RP) [MIM:268000]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:11139241,
CC       ECO:0000269|PubMed:9427255, ECO:0000269|PubMed:9792858}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the CRX gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/crxmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF024711; AAB88418.1; -; Genomic_DNA.
DR   EMBL; BT007364; AAP36028.1; -; mRNA.
DR   EMBL; AC008745; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016664; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC053672; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; DQ426868; ABD90533.1; -; mRNA.
DR   CCDS; CCDS12706.1; -.
DR   RefSeq; NP_000545.1; NM_000554.5.
DR   UniGene; Hs.617342; -.
DR   UniGene; Hs.633434; -.
DR   UniGene; Hs.639114; -.
DR   ProteinModelPortal; O43186; -.
DR   SMR; O43186; -.
DR   BioGrid; 107796; 43.
DR   IntAct; O43186; 100.
DR   MINT; MINT-1442706; -.
DR   STRING; 9606.ENSP00000221996; -.
DR   iPTMnet; O43186; -.
DR   PhosphoSitePlus; O43186; -.
DR   BioMuta; CRX; -.
DR   PaxDb; O43186; -.
DR   PeptideAtlas; O43186; -.
DR   PRIDE; O43186; -.
DR   DNASU; 1406; -.
DR   Ensembl; ENST00000221996; ENSP00000221996; ENSG00000105392.
DR   Ensembl; ENST00000539067; ENSP00000445565; ENSG00000105392.
DR   GeneID; 1406; -.
DR   KEGG; hsa:1406; -.
DR   UCSC; uc002phq.5; human.
DR   CTD; 1406; -.
DR   DisGeNET; 1406; -.
DR   EuPathDB; HostDB:ENSG00000105392.15; -.
DR   GeneCards; CRX; -.
DR   GeneReviews; CRX; -.
DR   HGNC; HGNC:2383; CRX.
DR   HPA; HPA036762; -.
DR   HPA; HPA036763; -.
DR   MalaCards; CRX; -.
DR   MIM; 120970; phenotype.
DR   MIM; 268000; phenotype.
DR   MIM; 602225; gene.
DR   MIM; 613829; phenotype.
DR   neXtProt; NX_O43186; -.
DR   OpenTargets; ENSG00000105392; -.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   Orphanet; 65; Leber congenital amaurosis.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA26903; -.
DR   eggNOG; KOG2251; Eukaryota.
DR   eggNOG; ENOG4111XIJ; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000082677; -.
DR   HOVERGEN; HBG004028; -.
DR   InParanoid; O43186; -.
DR   KO; K09337; -.
DR   OMA; SDVCPDP; -.
DR   OrthoDB; EOG091G0K9K; -.
DR   PhylomeDB; O43186; -.
DR   TreeFam; TF351179; -.
DR   SIGNOR; O43186; -.
DR   ChiTaRS; CRX; human.
DR   GeneWiki; CRX_(gene); -.
DR   GenomeRNAi; 1406; -.
DR   PRO; PR:O43186; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105392; -.
DR   CleanEx; HS_CRX; -.
DR   ExpressionAtlas; O43186; baseline and differential.
DR   Genevisible; O43186; HS.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0046534; P:positive regulation of photoreceptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR032966; CRX.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR013851; Otx_TF_C.
DR   PANTHER; PTHR24329:SF331; PTHR24329:SF331; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03529; TF_Otx; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Cone-rod dystrophy;
KW   Developmental protein; Differentiation; Disease mutation; DNA-binding;
KW   Homeobox; Leber congenital amaurosis; Neurogenesis; Nucleus;
KW   Polymorphism; Reference proteome; Retinitis pigmentosa;
KW   Sensory transduction; Transcription; Transcription regulation; Vision.
FT   CHAIN         1    299       Cone-rod homeobox protein.
FT                                /FTId=PRO_0000048862.
FT   DNA_BIND     39     98       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      10     10       H -> D (in dbSNP:rs139340178).
FT                                {ECO:0000269|PubMed:11139241}.
FT                                /FTId=VAR_076956.
FT   VARIANT      41     41       R -> Q (in RP; dbSNP:rs61748436).
FT                                {ECO:0000269|PubMed:11139241,
FT                                ECO:0000269|PubMed:9427255,
FT                                ECO:0000269|PubMed:9792858}.
FT                                /FTId=VAR_007946.
FT   VARIANT      41     41       R -> W (in CORD2; exhibits reduced DNA
FT                                binding, transcriptional synergy and
FT                                interaction with NRL; dbSNP:rs104894672).
FT                                {ECO:0000269|PubMed:10887186,
FT                                ECO:0000269|PubMed:9427255}.
FT                                /FTId=VAR_003750.
FT   VARIANT      42     42       E -> K (in LCA7; unknown pathological
FT                                significance; dbSNP:rs863224863).
FT                                {ECO:0000269|PubMed:21602930}.
FT                                /FTId=VAR_067189.
FT   VARIANT      66     66       V -> I (in dbSNP:rs61748438).
FT                                {ECO:0000269|PubMed:11139241}.
FT                                /FTId=VAR_076957.
FT   VARIANT      80     80       E -> A (in CORD2; dbSNP:rs28939682).
FT                                {ECO:0000269|PubMed:9390563,
FT                                ECO:0000269|PubMed:9792858}.
FT                                /FTId=VAR_003751.
FT   VARIANT      88     88       K -> N (in LCA7; reduces NRL
FT                                transactivation and reduces steady state
FT                                levels of CRX and NRL; altered
FT                                localization to the cytoplasm).
FT                                {ECO:0000269|PubMed:20513135}.
FT                                /FTId=VAR_063919.
FT   VARIANT      90     90       R -> W (in LCA7; reduced DNA-binding
FT                                ability, transcriptional synergy and
FT                                interaction with NRL; dbSNP:rs104894673).
FT                                {ECO:0000269|PubMed:10887186,
FT                                ECO:0000269|PubMed:9931337}.
FT                                /FTId=VAR_008714.
FT   VARIANT     115    115       R -> Q (in RP; unknown pathological
FT                                significance; dbSNP:rs750727986).
FT                                {ECO:0000269|PubMed:11139241}.
FT                                /FTId=VAR_076958.
FT   VARIANT     122    122       G -> D (in dbSNP:rs61748441).
FT                                {ECO:0000269|PubMed:11139241,
FT                                ECO:0000269|PubMed:27535533}.
FT                                /FTId=VAR_008282.
FT   VARIANT     141    141       S -> F (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036438.
FT   VARIANT     146    149       Missing (in LCA7).
FT                                {ECO:0000269|PubMed:9792858}.
FT                                /FTId=VAR_007947.
FT   VARIANT     154    154       T -> A (in dbSNP:rs763651232).
FT                                {ECO:0000269|PubMed:18682808}.
FT                                /FTId=VAR_067190.
FT   VARIANT     158    158       A -> T (in dbSNP:rs61748445).
FT                                {ECO:0000269|PubMed:11139241,
FT                                ECO:0000269|PubMed:9427255}.
FT                                /FTId=VAR_007948.
FT   VARIANT     242    242       V -> M (in CORD2; dbSNP:rs61748459).
FT                                {ECO:0000269|PubMed:9427255}.
FT                                /FTId=VAR_007949.
SQ   SEQUENCE   299 AA;  32261 MW;  46747C09277A0864 CRC64;
     MMAYMNPGPH YSVNALALSG PSVDLMHQAV PYPSAPRKQR RERTTFTRSQ LEELEALFAK
     TQYPDVYARE EVALKINLPE SRVQVWFKNR RAKCRQQRQQ QKQQQQPPGG QAKARPAKRK
     AGTSPRPSTD VCPDPLGISD SYSPPLPGPS GSPTTAVATV SIWSPASESP LPEAQRAGLV
     ASGPSLTSAP YAMTYAPASA FCSSPSAYGS PSSYFSGLDP YLSPMVPQLG GPALSPLSGP
     SVGPSLAQSP TSLSGQSYGA YSPVDSLEFK DPTGTWKFTY NPMDPLDYKD QSAWKFQIL
//
ID   ZFHX3_HUMAN             Reviewed;        3703 AA.
AC   Q15911; D3DWS8; O15101; Q13719;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 2.
DT   25-OCT-2017, entry version 175.
DE   RecName: Full=Zinc finger homeobox protein 3;
DE   AltName: Full=AT motif-binding factor 1;
DE   AltName: Full=AT-binding transcription factor 1;
DE   AltName: Full=Alpha-fetoprotein enhancer-binding protein;
DE   AltName: Full=Zinc finger homeodomain protein 3;
DE            Short=ZFH-3;
GN   Name=ZFHX3; Synonyms=ATBF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND VARIANTS ALA-72 AND
RP   ALA-777.
RC   TISSUE=Lung;
RX   PubMed=7592926; DOI=10.1074/jbc.270.45.26840;
RA   Miura Y., Tam T., Ido A., Morinaga T., Miki T., Hashimoto T.,
RA   Tamaoki T.;
RT   "Cloning and characterization of an ATBF1 isoform that expresses in a
RT   neuronal differentiation-dependent manner.";
RL   J. Biol. Chem. 270:26840-26848(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   TISSUE=Hepatoma;
RX   PubMed=1719379; DOI=10.1128/MCB.11.12.6041;
RA   Morinaga T., Yasuda H., Higashio K., Tamaoki T.;
RT   "A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains
RT   four homeodomains and seventeen zinc fingers.";
RL   Mol. Cell. Biol. 11:6041-6049(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 1-1190 (ISOFORM A),
RP   AND VARIANT SER-997.
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [6]
RP   FUNCTION AS REGULATOR OF MYOBLASTS DIFFERENTIATION.
RX   PubMed=11312261; DOI=10.1074/jbc.M010378200;
RA   Berry F.B., Miura Y., Mihara K., Kaspar P., Sakata N.,
RA   Hashimoto-Tamaoki T., Tamaoki T.;
RT   "Positive and negative regulation of myogenic differentiation of C2C12
RT   cells by isoforms of the multiple homeodomain zinc finger
RT   transcription factor ATBF1.";
RL   J. Biol. Chem. 276:25057-25065(2001).
RN   [7]
RP   INTERACTION WITH PIAS3.
RX   PubMed=14715251; DOI=10.1016/j.bbrc.2003.12.054;
RA   Nojiri S., Joh T., Miura Y., Sakata N., Nomura T., Nakao H., Sobue S.,
RA   Ohara H., Asai K., Ito M.;
RT   "ATBF1 enhances the suppression of STAT3 signaling by interaction with
RT   PIAS3.";
RL   Biochem. Biophys. Res. Commun. 314:97-103(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-571, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION IN GASTRIC CANCER, AND TISSUE SPECIFICITY.
RX   PubMed=17330845; DOI=10.1002/ijc.22654;
RA   Mori Y., Kataoka H., Miura Y., Kawaguchi M., Kubota E., Ogasawara N.,
RA   Oshima T., Tanida S., Sasaki M., Ohara H., Mizoshita T., Tatematsu M.,
RA   Asai K., Joh T.;
RT   "Subcellular localization of ATBF1 regulates MUC5AC transcription in
RT   gastric cancer.";
RL   Int. J. Cancer 121:241-247(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1197, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ASSOCIATION WITH ATRIAL FIBRILLATION AND ISCHEMIC STROKE.
RX   PubMed=19597491; DOI=10.1038/ng.417;
RA   Gudbjartsson D.F., Holm H., Gretarsdottir S., Thorleifsson G.,
RA   Walters G.B., Thorgeirsson G., Gulcher J., Mathiesen E.B.,
RA   Njolstad I., Nyrnes A., Wilsgaard T., Hald E.M., Hveem K.,
RA   Stoltenberg C., Kucera G., Stubblefield T., Carter S., Roden D.,
RA   Ng M.C.Y., Baum L., So W.Y., Wong K.S., Chan J.C.N., Gieger C.,
RA   Wichmann H.-E., Gschwendtner A., Dichgans M., Kuhlenbaeumer G.,
RA   Berger K., Ringelstein E.B., Bevan S., Markus H.S., Kostulas K.,
RA   Hillert J., Sveinbjoernsdottir S., Valdimarsson E.M., Lochen M.-L.,
RA   Ma R.C.W., Darbar D., Kong A., Arnar D.O., Thorsteinsdottir U.,
RA   Stefansson K.;
RT   "A sequence variant in ZFHX3 on 16q22 associates with atrial
RT   fibrillation and ischemic stroke.";
RL   Nat. Genet. 41:876-878(2009).
RN   [14]
RP   ASSOCIATION WITH ATRIAL FIBRILLATION.
RX   PubMed=19597492; DOI=10.1038/ng.416;
RA   Benjamin E.J., Rice K.M., Arking D.E., Pfeufer A., van Noord C.,
RA   Smith A.V., Schnabel R.B., Bis J.C., Boerwinkle E., Sinner M.F.,
RA   Dehghan A., Lubitz S.A., D'Agostino R.B. Sr., Lumley T., Ehret G.B.,
RA   Heeringa J., Aspelund T., Newton-Cheh C., Larson M.G., Marciante K.D.,
RA   Soliman E.Z., Rivadeneira F., Wang T.J., Eiriksdottir G., Levy D.,
RA   Psaty B.M., Li M., Chamberlain A.M., Hofman A., Vasan R.S.,
RA   Harris T.B., Rotter J.I., Kao W.H., Agarwal S.K., Stricker B.H.C.,
RA   Wang K., Launer L.J., Smith N.L., Chakravarti A., Uitterlinden A.G.,
RA   Wolf P.A., Sotoodehnia N., Koettgen A., van Duijn C.M., Meitinger T.,
RA   Mueller M., Perz S., Steinbeck G., Wichmann H.-E., Lunetta K.L.,
RA   Heckbert S.R., Gudnason V., Alonso A., Kaab S., Ellinor P.T.,
RA   Witteman J.C.M.;
RT   "Variants in ZFHX3 are associated with atrial fibrillation in
RT   individuals of European ancestry.";
RL   Nat. Genet. 41:879-881(2009).
RN   [15]
RP   FUNCTION, INTERACTION WITH RUNX3, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20599712; DOI=10.1016/j.bbrc.2010.06.090;
RA   Mabuchi M., Kataoka H., Miura Y., Kim T.S., Kawaguchi M., Ebi M.,
RA   Tanaka M., Mori Y., Kubota E., Mizushima T., Shimura T., Mizoshita T.,
RA   Tanida S., Kamiya T., Asai K., Joh T.;
RT   "Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to
RT   the nucleus with runt domain transcription factor 3 (RUNX3) in
RT   response to TGF-beta signal transduction.";
RL   Biochem. Biophys. Res. Commun. 398:321-325(2010).
RN   [16]
RP   FUNCTION, INTERACTION WITH ESR1, AND TISSUE SPECIFICITY.
RX   PubMed=20720010; DOI=10.1074/jbc.M110.128330;
RA   Dong X.Y., Sun X., Guo P., Li Q., Sasahara M., Ishii Y., Dong J.T.;
RT   "ATBF1 inhibits estrogen receptor (ER) function by selectively
RT   competing with AIB1 for binding to the ER in ER-positive breast cancer
RT   cells.";
RL   J. Biol. Chem. 285:32801-32809(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-533 AND SER-571, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   UBIQUITINATION, PROTEASOMAL DEGRADATION, AND INTERACTION WITH TRIM25.
RX   PubMed=22452784; DOI=10.1042/BJ20111890;
RA   Dong X.Y., Fu X., Fan S., Guo P., Su D., Dong J.T.;
RT   "Oestrogen causes ATBF1 protein degradation through the oestrogen-
RT   responsive E3 ubiquitin ligase EFP.";
RL   Biochem. J. 444:581-590(2012).
RN   [19]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M.,
RA   Meza-Zepeda L.A., Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-426; SER-571; SER-1204;
RP   SER-2795; SER-2896 AND SER-3432, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH SMAD2 AND SMAD3.
RX   PubMed=25105025; DOI=10.1155/2014/970346;
RA   Sakata N., Kaneko S., Ikeno S., Miura Y., Nakabayashi H., Dong X.Y.,
RA   Dong J.T., Tamaoki T., Nakano N., Itoh S.;
RT   "TGF-beta signaling cooperates with AT motif-binding factor-1 for
RT   repression of the alpha -fetoprotein promoter.";
RL   J. Signal Transduct. 2014:970346-970346(2014).
RN   [23]
RP   SUMOYLATION AT LYS-2349; LYS-2806 AND LYS-3258, SUBCELLULAR LOCATION,
RP   NUCLEAR LOCALIZATION SIGNAL, AND MUTAGENESIS OF 2615-LYS--LYS-2617;
RP   LYS-2349; LYS-2806 AND LYS-3258.
RX   PubMed=24651376; DOI=10.1371/journal.pone.0092746;
RA   Sun X., Li J., Dong F.N., Dong J.T.;
RT   "Characterization of nuclear localization and SUMOylation of the ATBF1
RT   transcription factor in epithelial cells.";
RL   PLoS ONE 9:E92746-E92746(2014).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2806, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   STRUCTURE BY NMR OF 2241-2305 AND 2629-2698.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second and third homeobox domain of AT-
RT   binding transcription factor 1 (ATBF1).";
RL   Submitted (JUN-2006) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional regulator which can act as an activator
CC       or a repressor. Inhibits the enhancer element of the AFP gene by
CC       binding to its AT-rich core sequence. In concert with SMAD-
CC       dependent TGF-beta signaling can repress the transcription of AFP
CC       via its interaction with SMAD2/3 (PubMed:25105025). Regulates the
CC       circadian locomotor rhythms via transcriptional activation of
CC       neuropeptidergic genes which are essential for intercellular
CC       synchrony and rhythm amplitude in the suprachiasmatic nucleus
CC       (SCN) of the brain (By similarity). Regulator of myoblasts
CC       differentiation through the binding to the AT-rich sequence of
CC       MYF6 promoter and promoter repression (PubMed:11312261). Down-
CC       regulates the MUC5AC promoter in gastric cancer (PubMed:17330845).
CC       In association with RUNX3, upregulates CDKN1A promoter activity
CC       following TGF-beta stimulation (PubMed:20599712). Inhibits
CC       estrogen receptor (ESR1) function by selectively competing with
CC       coactivator NCOA3 for binding to ESR1 in ESR1-positive breast
CC       cancer cells (PubMed:20720010). {ECO:0000250|UniProtKB:Q61329,
CC       ECO:0000269|PubMed:11312261, ECO:0000269|PubMed:17330845,
CC       ECO:0000269|PubMed:20599712, ECO:0000269|PubMed:20720010,
CC       ECO:0000269|PubMed:25105025}.
CC   -!- SUBUNIT: Interacts with FNBP3 (By similarity). Interacts with
CC       ALKBH4 and PIAS3. Interacts with ESR1. Interacts with RUNX3.
CC       Interacts with TRIM25. Interacts with SMAD2 and SMAD3.
CC       {ECO:0000250|UniProtKB:Q61329, ECO:0000269|PubMed:14715251,
CC       ECO:0000269|PubMed:20599712, ECO:0000269|PubMed:20720010,
CC       ECO:0000269|PubMed:22452784, ECO:0000269|PubMed:23145062,
CC       ECO:0000269|PubMed:25105025}.
CC   -!- INTERACTION:
CC       Q08117-2:AES; NbExp=4; IntAct=EBI-10237226, EBI-11741437;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-10237226, EBI-10171697;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20599712,
CC       ECO:0000269|PubMed:24651376}. Cytoplasm
CC       {ECO:0000269|PubMed:20599712}. Note=Translocates from the
CC       cytoplasm to the nucleus following TGF-beta stimulation. Expressed
CC       in nuclear body (NB)-like dots in the nucleus some of which
CC       overlap or closely associate with PML body.
CC       {ECO:0000269|PubMed:20599712, ECO:0000269|PubMed:24651376}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=Q15911-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q15911-2; Sequence=VSP_006825;
CC   -!- TISSUE SPECIFICITY: Not found in normal gastric mucosa but found
CC       in gastric carcinoma cells (at protein level). Expression is
CC       higher in ER-positive breast tumors than ER-negative breast tumors
CC       (at protein level). {ECO:0000269|PubMed:17330845,
CC       ECO:0000269|PubMed:20599712, ECO:0000269|PubMed:20720010,
CC       ECO:0000269|PubMed:22452784}.
CC   -!- PTM: Phosphorylation decreases its sensitivity to calpain-mediated
CC       proteolysis. {ECO:0000250|UniProtKB:Q61329}.
CC   -!- PTM: Adult brain-derived ZFHX3 is sensitive, but embryonic brain-
CC       derived ZFHX3 is resistant to calpain 1-mediated proteolysis.
CC       {ECO:0000250|UniProtKB:Q61329}.
CC   -!- PTM: Ubiquitinated, leading to its proteasomal degradation.
CC       {ECO:0000269|PubMed:22452784}.
CC   -!- PTM: Nuclear localization is essential for its sumoylation.
CC       {ECO:0000269|PubMed:24651376}.
CC   -!- POLYMORPHISM: Genetic variations in ZFHX3 are associated with
CC       atrial fibrillation and ischemic stroke in individuals of European
CC       ancestry. {ECO:0000269|PubMed:19597491,
CC       ECO:0000269|PubMed:19597492}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ATBF1ID357.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L32832; AAC14462.1; -; mRNA.
DR   EMBL; D10250; BAA01095.1; -; mRNA.
DR   EMBL; AC004943; AAC79153.1; -; Genomic_DNA.
DR   EMBL; AC132068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471166; EAW59168.1; -; Genomic_DNA.
DR   EMBL; CH471166; EAW59170.1; -; Genomic_DNA.
DR   EMBL; AC002044; AAC31674.1; -; Genomic_DNA.
DR   CCDS; CCDS10908.1; -. [Q15911-1]
DR   CCDS; CCDS54035.1; -. [Q15911-2]
DR   PIR; A41948; A41948.
DR   RefSeq; NP_001158238.1; NM_001164766.1. [Q15911-2]
DR   RefSeq; NP_008816.3; NM_006885.3. [Q15911-1]
DR   UniGene; Hs.598297; -.
DR   PDB; 2DA1; NMR; -; A=2146-2202.
DR   PDB; 2DA2; NMR; -; A=2243-2299.
DR   PDB; 2DA3; NMR; -; A=2632-2698.
DR   PDBsum; 2DA1; -.
DR   PDBsum; 2DA2; -.
DR   PDBsum; 2DA3; -.
DR   ProteinModelPortal; Q15911; -.
DR   SMR; Q15911; -.
DR   BioGrid; 106954; 10.
DR   IntAct; Q15911; 26.
DR   MINT; MINT-1462085; -.
DR   STRING; 9606.ENSP00000268489; -.
DR   iPTMnet; Q15911; -.
DR   PhosphoSitePlus; Q15911; -.
DR   BioMuta; ZFHX3; -.
DR   DMDM; 108935822; -.
DR   EPD; Q15911; -.
DR   MaxQB; Q15911; -.
DR   PaxDb; Q15911; -.
DR   PeptideAtlas; Q15911; -.
DR   PRIDE; Q15911; -.
DR   Ensembl; ENST00000268489; ENSP00000268489; ENSG00000140836. [Q15911-1]
DR   Ensembl; ENST00000397992; ENSP00000438926; ENSG00000140836. [Q15911-2]
DR   GeneID; 463; -.
DR   KEGG; hsa:463; -.
DR   UCSC; uc002fck.4; human. [Q15911-1]
DR   CTD; 463; -.
DR   DisGeNET; 463; -.
DR   EuPathDB; HostDB:ENSG00000140836.14; -.
DR   GeneCards; ZFHX3; -.
DR   H-InvDB; HIX0038876; -.
DR   HGNC; HGNC:777; ZFHX3.
DR   HPA; HPA059353; -.
DR   MalaCards; ZFHX3; -.
DR   MIM; 104155; gene.
DR   neXtProt; NX_Q15911; -.
DR   OpenTargets; ENSG00000140836; -.
DR   PharmGKB; PA162409676; -.
DR   eggNOG; KOG1146; Eukaryota.
DR   eggNOG; ENOG410XYHC; LUCA.
DR   GeneTree; ENSGT00530000063717; -.
DR   HOGENOM; HOG000155777; -.
DR   HOVERGEN; HBG050606; -.
DR   InParanoid; Q15911; -.
DR   KO; K09378; -.
DR   OMA; QYNENKQ; -.
DR   OrthoDB; EOG091G0611; -.
DR   PhylomeDB; Q15911; -.
DR   TreeFam; TF323288; -.
DR   Reactome; R-HSA-8941855; RUNX3 regulates CDKN1A transcription.
DR   SIGNOR; Q15911; -.
DR   ChiTaRS; ZFHX3; human.
DR   EvolutionaryTrace; Q15911; -.
DR   GeneWiki; ATBF1; -.
DR   GenomeRNAi; 463; -.
DR   PRO; PR:Q15911; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000140836; -.
DR   CleanEx; HS_ZFHX3; -.
DR   Genevisible; Q15911; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IDA:MGI.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; TAS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:1904059; P:regulation of locomotor rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0071559; P:response to transforming growth factor beta; IDA:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 4.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 4.10.1050.10; -; 2.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR026939; At2g23090-like.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00046; Homeobox; 4.
DR   SMART; SM00389; HOX; 4.
DR   SMART; SM00355; ZnF_C2H2; 23.
DR   SMART; SM00451; ZnF_U1; 7.
DR   SUPFAM; SSF46689; SSF46689; 4.
DR   SUPFAM; SSF57667; SSF57667; 8.
DR   PROSITE; PS00027; HOMEOBOX_1; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 14.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Cytoplasm; DNA-binding; Homeobox; Isopeptide bond; Metal-binding;
KW   Myogenesis; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   3703       Zinc finger homeobox protein 3.
FT                                /FTId=PRO_0000046930.
FT   ZN_FING      79    101       C2H2-type 1; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     282    305       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     640    663       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     671    694       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     726    750       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     804    828       C2H2-type 6; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     945    968       C2H2-type 7; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     984   1008       C2H2-type 8; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    1040   1064       C2H2-type 9; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    1088   1112       C2H2-type 10; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    1223   1246       C2H2-type 11; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    1252   1275       C2H2-type 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1360   1385       C2H2-type 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1401   1423       C2H2-type 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1429   1452       C2H2-type 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1545   1569       C2H2-type 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1596   1620       C2H2-type 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1983   2006       C2H2-type 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   2145   2204       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND   2242   2301       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    2328   2351       C2H2-type 19; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    2530   2552       C2H2-type 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   2641   2700       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    2711   2734       C2H2-type 21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   2944   3003       Homeobox 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    3024   3048       C2H2-type 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    3529   3553       C2H2-type 23. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   MOTIF      2615   2617       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:24651376}.
FT   COMPBIAS    104    107       Poly-Pro.
FT   COMPBIAS    460    489       Poly-Glu.
FT   COMPBIAS    770    784       Poly-Ala.
FT   COMPBIAS   1723   1743       Poly-Gln.
FT   COMPBIAS   1789   1794       Poly-Gln.
FT   COMPBIAS   1852   1857       Poly-Gln.
FT   COMPBIAS   2037   2052       Poly-Pro.
FT   COMPBIAS   3197   3209       Poly-Gln.
FT   COMPBIAS   3210   3214       Poly-Pro.
FT   COMPBIAS   3227   3231       Poly-Gln.
FT   COMPBIAS   3376   3389       Poly-Gln.
FT   COMPBIAS   3392   3395       Poly-Gln.
FT   COMPBIAS   3507   3527       Poly-Gly.
FT   COMPBIAS   3597   3600       Poly-Pro.
FT   COMPBIAS   3636   3639       Poly-Ser.
FT   MOD_RES     426    426       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     428    428       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     533    533       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1197   1197       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1204   1204       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1590   1590       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    2625   2625       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    2786   2786       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    2795   2795       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2892   2892       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    2896   2896       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3409   3409       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    3418   3418       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    3432   3432       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3593   3593       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   MOD_RES    3677   3677       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61329}.
FT   CROSSLNK   2349   2349       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000269|PubMed:24651376}.
FT   CROSSLNK   2806   2806       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000269|PubMed:24651376}.
FT   CROSSLNK   2806   2806       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   3258   3258       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000269|PubMed:24651376}.
FT   VAR_SEQ       1    914       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:1719379}.
FT                                /FTId=VSP_006825.
FT   VARIANT      72     72       S -> A (in dbSNP:rs7193297).
FT                                {ECO:0000269|PubMed:7592926}.
FT                                /FTId=VAR_026663.
FT   VARIANT     146    146       S -> G (in dbSNP:rs58480263).
FT                                /FTId=VAR_061927.
FT   VARIANT     428    428       T -> P (in dbSNP:rs16971436).
FT                                /FTId=VAR_026664.
FT   VARIANT     460    460       E -> Q (in dbSNP:rs2073852).
FT                                /FTId=VAR_019968.
FT   VARIANT     777    777       V -> A (in dbSNP:rs4788682).
FT                                {ECO:0000269|PubMed:7592926}.
FT                                /FTId=VAR_026665.
FT   VARIANT     997    997       A -> S (in dbSNP:rs2213978).
FT                                {ECO:0000269|PubMed:10493829}.
FT                                /FTId=VAR_052733.
FT   VARIANT    3374   3374       A -> V.
FT                                /FTId=VAR_011694.
FT   VARIANT    3377   3384       Missing.
FT                                /FTId=VAR_011695.
FT   VARIANT    3421   3421       P -> A (in dbSNP:rs8044440).
FT                                /FTId=VAR_026666.
FT   VARIANT    3527   3527       G -> GGG.
FT                                /FTId=VAR_011696.
FT   MUTAGEN    2349   2349       K->A: Loss of sumoylation.
FT                                {ECO:0000269|PubMed:24651376}.
FT   MUTAGEN    2615   2617       KRK->AAA: Loss of nuclear localization.
FT                                {ECO:0000269|PubMed:24651376}.
FT   MUTAGEN    2806   2806       K->A: Loss of sumoylation.
FT                                {ECO:0000269|PubMed:24651376}.
FT   MUTAGEN    3258   3258       K->A: Loss of sumoylation.
FT                                {ECO:0000269|PubMed:24651376}.
FT   CONFLICT    422    422       P -> A (in Ref. 1; AAC14462).
FT                                {ECO:0000305}.
FT   CONFLICT    579    579       A -> T (in Ref. 1; AAC14462).
FT                                {ECO:0000305}.
FT   CONFLICT    767    767       S -> I (in Ref. 1; AAC14462).
FT                                {ECO:0000305}.
FT   CONFLICT    846    849       RHLG -> HHRV (in Ref. 1; AAC14462).
FT                                {ECO:0000305}.
FT   CONFLICT   1150   1190       EEAIEDVEGPSETAADPEELAKDQEGGASSSQAEKELTDSP
FT                                -> GEWSHRHGRPRLGLGVHLLETSRGLLFEGDVTDPAGPH
FT                                VPY (in Ref. 5; AAC31674). {ECO:0000305}.
FT   HELIX      2154   2166       {ECO:0000244|PDB:2DA1}.
FT   HELIX      2174   2182       {ECO:0000244|PDB:2DA1}.
FT   HELIX      2186   2201       {ECO:0000244|PDB:2DA1}.
FT   HELIX      2251   2263       {ECO:0000244|PDB:2DA2}.
FT   HELIX      2269   2278       {ECO:0000244|PDB:2DA2}.
FT   HELIX      2283   2297       {ECO:0000244|PDB:2DA2}.
FT   TURN       2650   2652       {ECO:0000244|PDB:2DA3}.
FT   HELIX      2653   2662       {ECO:0000244|PDB:2DA3}.
FT   HELIX      2668   2678       {ECO:0000244|PDB:2DA3}.
FT   HELIX      2682   2697       {ECO:0000244|PDB:2DA3}.
SQ   SEQUENCE   3703 AA;  404419 MW;  395F5D14A08112CB CRC64;
     MEGCDSPVVS GKDNGCGIPQ HQQWTELNST HLPDKPSSME QSTGESHGPL DSLRAPFNER
     LAESTASAGP PSEPASKEVT CNECSASFAS LQTYMEHHCP SARPPPPLRE ESASDTGEEG
     DEESDVENLA GEIVYQPDGS AYIVESLSQL TQGGGACGSG SGSGPLPSLF LNSLPGAGGK
     QGDPSCAAPV YPQIINTFHI ASSFGKWFEG PDQAFPNTSA LAGLSPVLHS FRVFDVRHKS
     NKDYLNSDGS AKSSCVSKDV PNNVDLSKFD GFVLYGKRKP ILMCFLCKLS FGYVRSFVTH
     AVHDHRMTLS EDERKILSNK NISAIIQGIG KDKEPLVSFL EPKNKNFQHP LVSTANLIGP
     GHSFYGKFSG IRMEGEEALP AGSAAGPEQP QAGLLTPSTL LNLGGLTSSV LKTPITSVPL
     GPLASSPTKS SEGKDSGAAE GEKQEVGDGD CFSEKVEPAE EEAEEEEEEE EAEEEEEEEE
     EEEEEEEDEG CKGLFPSELD EELEDRPHEE PGAAAGSSSK KDLALSNQSI SNSPLMPNVL
     QTLSRGTAST SSNSASSFVV FDGANRRNRL SFNSEGVRAN VAEGGRRLDF ADESANKDNA
     TAPEPNESTE GDDGGFVPHH QHAGSLCELG VGECPSGSGV ECPKCDTVLG SSRSLGGHMT
     MMHSRNSCKT LKCPKCNWHY KYQQTLEAHM KEKHPEPGGS CVYCKSGQPH PRLARGESYT
     CGYKPFRCEV CNYSTTTKGN LSIHMQSDKH LNNMQNLQNG GGEQVFSHTA GAAAAAVAAA
     AAAANISSSC GAPSPTKPKT KPTWRCEVCD YETNVARNLR IHMTSEKHMH NMMLLQQNMT
     QIQHNRHLGL GSLPSPAEAE LYQYYLAQNM NLPNLKMDSA ASDAQFMMSG FQLDPAGPMA
     AMTPALVGGE IPLDMRLGGG QLVSEELMNL GESFIQTNDP SLKLFQCAVC NKFTTDNLDM
     LGLHMNVERS LSEDEWKAVM GDSYQCKLCR YNTQLKANFQ LHCKTDKHVQ KYQLVAHIKE
     GGKANEWRLK CVAIGNPVHL KCNACDYYTN SLEKLRLHTV NSRHEASLKL YKHLQQHESG
     VEGESCYYHC VLCNYSTKAK LNLIQHVRSM KHQRSESLRK LQRLQKGLPE EDEDLGQIFT
     IRRCPSTDPE EAIEDVEGPS ETAADPEELA KDQEGGASSS QAEKELTDSP ATSKRISFPG
     SSESPLSSKR PKTAEEIKPE QMYQCPYCKY SNADVNRLRV HAMTQHSVQP MLRCPLCQDM
     LNNKIHLQLH LTHLHSVAPD CVEKLIMTVT TPEMVMPSSM FLPAAVPDRD GNSNLEEAGK
     QPETSEDLGK NILPSASTEQ SGDLKPSPAD PGSVREDSGF ICWKKGCNQV FKTSAALQTH
     FNEVHAKRPQ LPVSDRHVYK YRCNQCSLAF KTIEKLQLHS QYHVIRAATM CCLCQRSFRT
     FQALKKHLET SHLELSEADI QQLYGGLLAN GDLLAMGDPT LAEDHTIIVE EDKEEESDLE
     DKQSPTGSDS GSVQEDSGSE PKRALPFRKG PNFTMEKFLD PSRPYKCTVC KESFTQKNIL
     LVHYNSVSHL HKLKRALQES ATGQPEPTSS PDNKPFKCNT CNVAYSQSST LEIHMRSVLH
     QTKARAAKLE AASGSSNGTG NSSSISLSSS TPSPVSTSGS NTFTTSNPSS AGIAPSSNLL
     SQVPTESVGM PPLGNPIGAN IASPSEPKEA NRKKLADMIA SRQQQQQQQQ QQQQQQQQQQ
     QAQTLAQAQA QVQAHLQQEL QQQAALIQSQ LFNPTLLPHF PMTTETLLQL QQQQHLLFPF
     YIPSAEFQLN PEVSLPVTSG ALTLTGTGPG LLEDLKAQVQ VPQQSHQQIL PQQQQNQLSI
     AQSHSALLQP SQHPEKKNKL VIKEKEKESQ RERDSAEGGE GNTGPKETLP DALKAKEKKE
     LAPGGGSEPS MLPPRIASDA RGNATKALLE NFGFELVIQY NENKQKVQKK NGKTDQGENL
     EKLECDSCGK LFSNILILKS HQEHVHQNYF PFKQLERFAK QYRDHYDKLY PLRPQTPEPP
     PPPPPPPPPP LPAAPPQPAS TPAIPASAPP ITSPTIAPAQ PSVPLTQLSM PMELPIFSPL
     MMQTMPLQTL PAQLPPQLGP VEPLPADLAQ LYQHQLNPTL LQQQNKRPRT RITDDQLRVL
     RQYFDINNSP SEEQIKEMAD KSGLPQKVIK HWFRNTLFKE RQRNKDSPYN FSNPPITSLE
     ELKIDSRPPS PEPPKQEYWG SKRSSRTRFT DYQLRVLQDF FDANAYPKDD EFEQLSNLLN
     LPTRVIVVWF QNARQKARKN YENQGEGKDG ERRELTNDRY IRTSNLNYQC KKCSLVFQRI
     FDLIKHQKKL CYKDEDEEGQ DDSQNEDSMD AMEILTPTSS SCSTPMPSQA YSAPAPSANN
     TASSAFLQLT AEAEELATFN SKTEAGDEKP KLAEAPSAQP NQTQEKQGQP KPELQQQEQP
     EQKTNTPQQK LPQLVSLPSL PQPPPQAPPP QCPLPQSSPS PSQLSHLPLK PLHTSTPQQL
     ANLPPQLIPY QCDQCKLAFP SFEHWQEHQQ LHFLSAQNQF IHPQFLDRSL DMPFMLFDPS
     NPLLASQLLS GAIPQIPASS ATSPSTPTST MNTLKRKLEE KASASPGEND SGTGGEEPQR
     DKRLRTTITP EQLEILYQKY LLDSNPTRKM LDHIAHEVGL KKRVVQVWFQ NTRARERKGQ
     FRAVGPAQAH RRCPFCRALF KAKTALEAHI RSRHWHEAKR AGYNLTLSAM LLDCDGGLQM
     KGDIFDGTSF SHLPPSSSDG QGVPLSPVSK TMELSPRTLL SPSSIKVEGI EDFESPSMSS
     VNLNFDQTKL DNDDCSSVNT AITDTTTGDE GNADNDSATG IATETKSSSA PNEGLTKAAM
     MAMSEYEDRL SSGLVSPAPS FYSKEYDNEG TVDYSETSSL ADPCSPSPGA SGSAGKSGDS
     GDRPGQKRFR TQMTNLQLKV LKSCFNDYRT PTMLECEVLG NDIGLPKRVV QVWFQNARAK
     EKKSKLSMAK HFGINQTSYE GPKTECTLCG IKYSARLSVR DHIFSQQHIS KVKDTIGSQL
     DKEKEYFDPA TVRQLMAQQE LDRIKKANEV LGLAAQQQGM FDNTPLQALN LPTAYPALQG
     IPPVLLPGLN SPSLPGFTPS NTALTSPKPN LMGLPSTTVP SPGLPTSGLP NKPSSASLSS
     PTPAQATMAM GPQQPPQQQQ QQQQPQVQQP PPPPAAQPPP TPQLPLQQQQ QRKDKDSEKV
     KEKEKAHKGK GEPLPVPKKE KGEAPTATAA TISAPLPTME YAVDPAQLQA LQAALTSDPT
     ALLTSQFLPY FVPGFSPYYA PQIPGALQSG YLQPMYGMEG LFPYSPALSQ ALMGLSPGSL
     LQQYQQYQQS LQEAIQQQQQ RQLQQQQQQK VQQQQPKASQ TPVPPGAPSP DKDPAKESPK
     PEEQKNTPRE VSPLLPKLPE EPEAESKSAD SLYDPFIVPK VQYKLVCRKC QAGFSDEEAA
     RSHLKSLCFF GQSVVNLQEM VLHVPTGGGG GGSGGGGGGG GGGGGGGSYH CLACESALCG
     EEALSQHLES ALHKHRTITR AARNAKEHPS LLPHSACFPD PSTASTSQSA AHSNDSPPPP
     SAAAPSSASP HASRKSWPQV VSRASAAKPP SFPPLSSSST VTSSSCSTSG VQPSMPTDDY
     SEESDTDLSQ KSDGPASPVE GPKDPSCPKD SGLTSVGTDT FRL
//
ID   PAX3_HUMAN              Reviewed;         479 AA.
AC   P23760; G5E9C1; Q16448; Q494Z3; Q494Z4; Q53T90; Q6GSJ9; Q86UQ2;
AC   Q86UQ3;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   25-OCT-2017, entry version 196.
DE   RecName: Full=Paired box protein Pax-3;
DE   AltName: Full=HuP2;
GN   Name=PAX3; Synonyms=HUP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PAX3G AND PAX3H), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=14639621; DOI=10.1002/ijc.11527;
RA   Parker C.J., Shawcross S.G., Li H., Wang Q.-Y., Herrington C.S.,
RA   Kumar S., MacKie R.M., Prime W., Renne I.G., Sisley K., Kumar P.;
RT   "Expression of PAX 3 alternatively spliced transcripts and
RT   identification of two new isoforms in human tumors of neural crest
RT   origin.";
RL   Int. J. Cancer 108:314-320(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PAX3B; 6 AND 7).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29 AND 197-479.
RX   PubMed=7782066; DOI=10.1016/0888-7543(95)80076-X;
RA   Macina R.A., Barr F.G., Galili N., Riethman H.C.;
RT   "Genomic organization of the human PAX3 gene: DNA sequence analysis of
RT   the region disrupted in alveolar rhabdomyosarcoma.";
RL   Genomics 26:1-8(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 30-195.
RX   PubMed=2501086;
RA   Burri M., Tromvoukis Y., Bopp D., Frigerio G., Noll M.;
RT   "Conservation of the paired domain in metazoans and its structure in
RT   three isolated human genes.";
RL   EMBO J. 8:1183-1190(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 196-392, AND VARIANTS WS1 LEU-45
RP   AND ASP-99.
RX   PubMed=7981674; DOI=10.1093/hmg/3.7.1069;
RA   Tassabehji M., Newton V.E., Leverton K., Turnbull K., Seemanova E.,
RA   Kunze J., Sperling K., Strachan T., Read A.P.;
RT   "PAX3 gene structure and mutations: close analogies between
RT   Waardenburg syndrome and the Splotch mouse.";
RL   Hum. Mol. Genet. 3:1069-1074(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PAX3A AND PAX3B).
RX   PubMed=7545913; DOI=10.1007/BF00212021;
RA   Tsukamoto K., Nakamura Y., Niikawa N.;
RT   "Isolation of two isoforms of the PAX3 gene transcripts and their
RT   tissue-specific alternative expression in human adult tissues.";
RL   Hum. Genet. 93:270-274(1994).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 1-319 (ISOFORM 6/7), AND CHROMOSOMAL
RP   TRANSLOCATION WITH NCOA1.
RX   PubMed=15313887; DOI=10.1158/0008-5472.CAN-04-0844;
RA   Wachtel M., Dettling M., Koscielniak E., Stegmaier S., Treuner J.,
RA   Simon-Klingenstein K., Buehlmann P., Niggli F.K., Schaefer B.W.;
RT   "Gene expression signatures identify rhabdomyosarcoma subtypes and
RT   detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.";
RL   Cancer Res. 64:5539-5545(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-74, AND VARIANT WS1
RP   63-ALA--ILE-67 DEL.
RX   PubMed=1347148; DOI=10.1038/355635a0;
RA   Tassabehji M., Read A.P., Newton V.E., Harris R., Balling R.,
RA   Gruss P., Strachan T.;
RT   "Waardenburg's syndrome patients have mutations in the human homologue
RT   of the Pax-3 paired box gene.";
RL   Nature 355:635-636(1992).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 265-319.
RA   Lalwani A.K., Ploplis B., Fex J., Grundfast K.M., San Agustin T.B.,
RA   Wilcox E.R.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   INVOLVEMENT IN RMS2, AND CHROMOSOMAL TRANSLOCATION WITH FOXO1.
RX   PubMed=8275086; DOI=10.1038/ng1193-230;
RA   Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S.,
RA   Rauscher F.J. III, Emanuel B.S., Rovera G., Barr F.G.;
RT   "Fusion of a fork head domain gene to PAX3 in the solid tumour
RT   alveolar rhabdomyosarcoma.";
RL   Nat. Genet. 5:230-235(1993).
RN   [14]
RP   INTERACTION WITH DAXX.
RX   PubMed=10393185; DOI=10.1093/emboj/18.13.3702;
RA   Hollenbach A.D., Sublett J.E., McPherson C.J., Grosveld G.;
RT   "The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated
RT   repressor hDaxx.";
RL   EMBO J. 18:3702-3711(1999).
RN   [15]
RP   INVOLVEMENT IN WS1.
RX   PubMed=1303193; DOI=10.1093/hmg/1.4.243;
RA   Morell R., Friedman T.B., Moeljopawiro S., Hartono S., Asher J.H. Jr.;
RT   "A frameshift mutation in the HuP2 paired domain of the probable human
RT   homolog of murine Pax-3 is responsible for Waardenburg syndrome type 1
RT   in an Indonesian family.";
RL   Hum. Mol. Genet. 1:243-247(1992).
RN   [16]
RP   ALTERNATIVE SPLICING, AND FUNCTION.
RX   PubMed=16951170; DOI=10.1158/0008-5472.CAN-06-0947;
RA   Wang Q., Kumar S., Slevin M., Kumar P.;
RT   "Functional analysis of alternative isoforms of the transcription
RT   factor PAX3 in melanocytes in vitro.";
RL   Cancer Res. 66:8574-8580(2006).
RN   [17]
RP   PHOSPHORYLATION AT SER-201; SER-205 AND SER-209.
RX   PubMed=21440083; DOI=10.1016/j.biocel.2011.03.010;
RA   Dietz K.N., Miller P.J., Iyengar A.S., Loupe J.M., Hollenbach A.D.;
RT   "Identification of serines 201 and 209 as sites of Pax3
RT   phosphorylation and the altered phosphorylation status of Pax3-FOXO1
RT   during early myogenic differentiation.";
RL   Int. J. Biochem. Cell Biol. 43:936-945(2011).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 219-278 IN COMPLEX WITH DNA,
RP   AND SUBUNIT.
RX   PubMed=19199574; DOI=10.1021/bi802052y;
RA   Birrane G., Soni A., Ladias J.A.;
RT   "Structural basis for DNA recognition by the human PAX3 homeodomain.";
RL   Biochemistry 48:1148-1155(2009).
RN   [19]
RP   VARIANT WS1 LEU-50.
RX   PubMed=1347149; DOI=10.1038/355637a0;
RA   Baldwin C.T., Hoth C.F., Amos J.A., Da-Silva E.O., Milunsky A.;
RT   "An exonic mutation in the HuP2 paired domain gene causes
RT   Waardenburg's syndrome.";
RL   Nature 355:637-638(1992).
RN   [20]
RP   VARIANT WS1 ALA-81.
RX   PubMed=8490648; DOI=10.1038/ng0193-26;
RA   Tassabehji M., Read A.P., Newton V.E., Patton M., Gruss P., Harris R.,
RA   Strachan T.;
RT   "Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and
RT   type 2.";
RL   Nat. Genet. 3:26-30(1993).
RN   [21]
RP   VARIANTS WS3 HIS-47 AND WS1 LEU-56.
RX   PubMed=8447316;
RA   Hoth C.F., Milunsky A., Lipsky N., Sheffer R., Clarren S.K.,
RA   Baldwin C.T.;
RT   "Mutations in the paired domain of the human PAX3 gene cause Klein-
RT   Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I
RT   (WS-I).";
RL   Am. J. Hum. Genet. 52:455-462(1993).
RN   [22]
RP   VARIANT WS1 VAL-62.
RX   PubMed=7833953; DOI=10.1002/humu.1380040310;
RA   Pierpont J.W., Doolan L.D., Amann K., Snead G.R., Erickson R.P.;
RT   "A single base pair substitution within the paired box of PAX3 in an
RT   individual with Waardenburg syndrome type 1 (WS1).";
RL   Hum. Mutat. 4:227-228(1994).
RN   [23]
RP   VARIANTS WS1 PHE-265 AND GLY-271.
RX   PubMed=7825605;
RA   Lalwani A.K., Brister J.R., Fex J., Grundfast K.M., Ploplis B.,
RA   San Agustin T.B., Wilcox E.R.;
RT   "Further elucidation of the genomic structure of PAX3, and
RT   identification of two different point mutations within the PAX3
RT   homeobox that cause Waardenburg syndrome type 1 in two families.";
RL   Am. J. Hum. Genet. 56:75-83(1995).
RN   [24]
RP   VARIANT WS3 PHE-84.
RX   PubMed=7726174;
RA   Zlotogora J., Lerer I., Bar-David S., Ergaz Z., Abeliovich D.;
RT   "Homozygosity for Waardenburg syndrome.";
RL   Am. J. Hum. Genet. 56:1173-1178(1995).
RN   [25]
RP   VARIANTS WS1 MET-60; GLU-85 AND SER-238.
RX   PubMed=8533800; DOI=10.1002/ajmg.1320580205;
RA   Baldwin C.T., Hoth C.F., Macina R.A., Milunsky A.;
RT   "Mutations in PAX3 that cause Waardenburg syndrome type I: ten new
RT   mutations and review of the literature.";
RL   Am. J. Med. Genet. 58:115-122(1995).
RN   [26]
RP   VARIANTS WS1 MET-78; ALA-81; ASP-99; CYS-266; CYS-270; CYS-271 AND
RP   HIS-271, AND VARIANT LYS-315.
RX   PubMed=8589691; DOI=10.1093/hmg/4.11.2131;
RA   Tassabehji M., Newton V.E., Liu X.-Z., Brady A., Donnai D.,
RA   Krajewska-Walasek M., Murday V., Norman A., Obersztyn E., Reardon W.,
RA   Rice J.C., Trembath R., Wieacker P., Whiteford M., Winter R.,
RA   Read A.P.;
RT   "The mutational spectrum in Waardenburg syndrome.";
RL   Hum. Mol. Genet. 4:2131-2137(1995).
RN   [27]
RP   VARIANTS WS1 ARG-48; CYS-270 AND HIS-271, AND VARIANTS LYS-273 AND
RP   LYS-315.
RX   PubMed=8845842; DOI=10.1093/hmg/5.4.497;
RA   Pandya A., Xia X.-J., Landa B.L., Arnos K.S., Israel J., Lloyd J.,
RA   James A.L., Diehl S.R., Blanton S.H., Nance W.E.;
RT   "Phenotypic variation in Waardenburg syndrome: mutational
RT   heterogeneity, modifier genes or polygenic background?";
RL   Hum. Mol. Genet. 5:497-502(1996).
RN   [28]
RP   VARIANT CDHS LYS-47.
RX   PubMed=8664898;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H;
RA   Asher J.H. Jr., Sommer A., Morell R., Friedman T.B.;
RT   "Missense mutation in the paired domain of PAX3 causes craniofacial-
RT   deafness-hand syndrome.";
RL   Hum. Mutat. 7:30-35(1996).
RN   [29]
RP   VARIANT LYS-315.
RX   PubMed=8863157; DOI=10.1136/jmg.33.8.655;
RA   Hol F.A., Geurds M.P.A., Chatkupt S., Shugart Y.Y., Balling R.,
RA   Schrander-Stumpel C.T.R.M., Johnson W.G., Hamel B.C.J.,
RA   Mariman E.C.M.;
RT   "PAX genes and human neural tube defects: an amino acid substitution
RT   in PAX1 in a patient with spina bifida.";
RL   J. Med. Genet. 33:655-660(1996).
RN   [30]
RP   VARIANT WS1 PHE-59.
RX   PubMed=9067759;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:2<177::AID-HUMU11>3.0.CO;2-#;
RA   Soejima H., Fujimoto M., Tsukamoto K., Matsumoto N., Yoshiura K.,
RA   Fukushima Y., Jinno Y., Niikawa N.;
RT   "Three novel PAX3 mutations observed in patients with Waardenburg
RT   syndrome type 1.";
RL   Hum. Mutat. 9:177-180(1997).
RN   [31]
RP   VARIANT WS1 VAL-62.
RX   PubMed=9452070;
RA   Hol F.A., Geurds M.P.A., Cremers C.W.R.J., Hamel B.C.J.,
RA   Mariman E.C.M.;
RT   "Identification of two PAX3 mutations causing Waardenburg syndrome,
RT   one within the paired domain (M62V) and the other downstream of the
RT   homeodomain (Q282X).";
RL   Hum. Mutat. Suppl. 1:S145-S147(1998).
RN   [32]
RP   VARIANT WS1 HIS-391.
RX   PubMed=9541113; DOI=10.1136/jmg.35.3.248;
RA   Carey M.L., Friedman T.B., Asher J.H. Jr., Innis J.W.;
RT   "Septo-optic dysplasia and WS1 in the proband of a WS1 family
RT   segregating for a novel mutation in PAX3 exon 7.";
RL   J. Med. Genet. 35:248-250(1998).
RN   [33]
RP   VARIANT LYS-315.
RX   PubMed=9584079; DOI=10.1006/mcpr.1997.0149;
RA   Wang C., Kim E., Attaie A., Smith T.N., Wilcox E.R., Lalwani A.K.;
RT   "A PAX3 polymorphism (T315K) in a family exhibiting Waardenburg
RT   syndrome type 2.";
RL   Mol. Cell. Probes 12:55-57(1998).
RN   [34]
RP   VARIANT WS1 ASN-59.
RA   Markova T.G., Shevtsov S.P., Moskolenko L.N., Lantsov A.A.,
RA   Schwartz E.I.;
RT   "A novel missense mutation Ile59Asn in the PAX3 gene in a family with
RT   Waardenburg syndrome type I.";
RL   Hum. Mutat. 13:85-85(1999).
RN   [35]
RP   VARIANT WS3 CYS-270.
RA   Bottani A., Antonarakis S.E., Blouin J.-L.;
RL   Submitted (MAY-1999) to UniProtKB.
RN   [36]
RP   VARIANT WS1 LEU-73.
RX   PubMed=10779847; DOI=10.1076/1381-6810(200003)2111-IFT025;
RA   Sotirova V.N., Rezaie T.M., Khoshsorour M.M., Sarfarazi M.;
RT   "Identification of a novel mutation in the paired domain of PAX3 in an
RT   Iranian family with Waardenburg syndrome type I.";
RL   Ophthalmic Genet. 21:25-28(2000).
RN   [37]
RP   VARIANT WS1 MET-60, AND VARIANT WS3 HIS-90.
RX   PubMed=12949970; DOI=10.1002/ajmg.a.20260;
RA   Wollnik B., Tukel T., Uyguner O., Ghanbari A., Kayserili H.,
RA   Emiroglu M., Yuksel-Apak M.;
RT   "Homozygous and heterozygous inheritance of PAX3 mutations causes
RT   different types of Waardenburg syndrome.";
RL   Am. J. Med. Genet. A 122:42-45(2003).
CC   -!- FUNCTION: Transcription factor that may regulate cell
CC       proliferation, migration and apoptosis. Involved in neural
CC       development and myogenesis. {ECO:0000269|PubMed:16951170}.
CC   -!- SUBUNIT: Can bind to DNA as a homodimer or a heterodimer with
CC       PAX7. Interacts with PAXBP1; the interaction links PAX3 to a WDR5-
CC       containing histone methyltransferase complex. Interacts with DAXX.
CC       Interacts with TBX18. {ECO:0000250|UniProtKB:P24610,
CC       ECO:0000269|PubMed:10393185, ECO:0000269|PubMed:19199574}.
CC   -!- INTERACTION:
CC       P20265:POU3F2; NbExp=2; IntAct=EBI-1167564, EBI-1167176;
CC       P56693:SOX10; NbExp=2; IntAct=EBI-1167564, EBI-1167533;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=Pax3; Synonyms=Pax3C;
CC         IsoId=P23760-1; Sequence=Displayed;
CC       Name=Pax3A;
CC         IsoId=P23760-2; Sequence=VSP_002355, VSP_002356;
CC       Name=Pax3B;
CC         IsoId=P23760-3; Sequence=VSP_002357, VSP_002358;
CC       Name=Pax3G;
CC         IsoId=P23760-4; Sequence=VSP_042004;
CC       Name=Pax3H;
CC         IsoId=P23760-5; Sequence=VSP_042005;
CC       Name=6;
CC         IsoId=P23760-6; Sequence=VSP_043634, VSP_043635;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=P23760-7; Sequence=VSP_043635;
CC       Name=Pax3E;
CC         IsoId=P23760-8; Sequence=VSP_044915;
CC   -!- DISEASE: Waardenburg syndrome 1 (WS1) [MIM:193500]: WS1 is an
CC       autosomal dominant disorder characterized by non-progressive
CC       sensorineural deafness, pigmentary disturbances such as frontal
CC       white blaze of hair, heterochromia of irides, white eyelashes,
CC       leukoderma, and wide bridge of nose owing to lateral displacement
CC       of the inner canthus of each eye (dystopia canthorum). WS1 shows
CC       variable clinical expression and some affected individuals do not
CC       manifest hearing impairment or iris pigmentation disturbances.
CC       Dystopia canthorum is the most consistent sign and is found in 98%
CC       of the patients. {ECO:0000269|PubMed:10779847,
CC       ECO:0000269|PubMed:12949970, ECO:0000269|PubMed:1303193,
CC       ECO:0000269|PubMed:1347148, ECO:0000269|PubMed:1347149,
CC       ECO:0000269|PubMed:7825605, ECO:0000269|PubMed:7833953,
CC       ECO:0000269|PubMed:7981674, ECO:0000269|PubMed:8447316,
CC       ECO:0000269|PubMed:8490648, ECO:0000269|PubMed:8533800,
CC       ECO:0000269|PubMed:8589691, ECO:0000269|PubMed:8845842,
CC       ECO:0000269|PubMed:9067759, ECO:0000269|PubMed:9452070,
CC       ECO:0000269|PubMed:9541113, ECO:0000269|Ref.34}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Waardenburg syndrome 3 (WS3) [MIM:148820]: WS3 is an
CC       autosomal dominant disorder characterized by sensorineural
CC       deafness, pigmentary disturbances, dystopia canthorum and limb
CC       anomalies such as hypoplasia of the musculoskeletal system,
CC       flexion contractures, fusion of the carpal bones, syndactylies.
CC       {ECO:0000269|PubMed:12949970, ECO:0000269|PubMed:7726174,
CC       ECO:0000269|PubMed:8447316, ECO:0000269|Ref.35}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Craniofacial-deafness-hand syndrome (CDHS) [MIM:122880]:
CC       Thought to be an autosomal dominant disease which comprises
CC       absence or hypoplasia of the nasal bones, hypoplastic maxilla,
CC       small and short nose with thin nares, limited movement of the
CC       wrist, short palpebral fissures, ulnar deviation of the fingers,
CC       hypertelorism and profound sensory-neural deafness.
CC       {ECO:0000269|PubMed:8664898}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of
CC       rhabdomyosarcoma, a highly malignant tumor of striated muscle
CC       derived from primitive mesenchymal cells and exhibiting
CC       differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is
CC       one of the most frequently occurring soft tissue sarcomas and the
CC       most common in children. It occurs in four forms: alveolar,
CC       pleomorphic, embryonal and botryoidal rhabdomyosarcomas.
CC       {ECO:0000269|PubMed:8275086}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis. A chromosomal
CC       aberration involving PAX3 is found in rhabdomyosarcoma.
CC       Translocation (2;13)(q35;q14) with FOXO1. The resulting protein is
CC       a transcriptional activator. {ECO:0000269|PubMed:8275086}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PAX3 is a cause
CC       of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with NCOA1
CC       generates the NCOA1-PAX3 oncogene consisting of the N-terminus
CC       part of PAX3 and the C-terminus part of NCOA1. The fusion protein
CC       acts as a transcriptional activator. Rhabdomyosarcoma is the most
CC       common soft tissue carcinoma in childhood, representing 5-8% of
CC       all malignancies in children. {ECO:0000269|PubMed:15313887}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PAX3ID70ch2q35.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY251279; AAP13872.1; -; mRNA.
DR   EMBL; AY251280; AAP13873.1; -; mRNA.
DR   EMBL; AK291278; BAF83967.1; -; mRNA.
DR   EMBL; AC010980; AAY14900.1; -; Genomic_DNA.
DR   EMBL; AC012591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70789.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70791.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70794.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70796.1; -; Genomic_DNA.
DR   EMBL; BC063547; AAH63547.1; -; mRNA.
DR   EMBL; BC101299; AAI01300.1; -; mRNA.
DR   EMBL; BC101300; AAI01301.1; -; mRNA.
DR   EMBL; BC101301; AAI01302.1; -; mRNA.
DR   EMBL; BC101302; AAI01303.1; -; mRNA.
DR   EMBL; BC114363; AAI14364.1; -; mRNA.
DR   EMBL; U12263; AAA80573.1; -; Genomic_DNA.
DR   EMBL; U12259; AAA80574.1; -; Genomic_DNA.
DR   EMBL; U12258; AAA80574.1; JOINED; Genomic_DNA.
DR   EMBL; U12260; AAA80574.1; JOINED; Genomic_DNA.
DR   EMBL; U12262; AAA80574.1; JOINED; Genomic_DNA.
DR   EMBL; X15043; CAA33145.1; -; Genomic_DNA.
DR   EMBL; X15252; CAA33145.1; JOINED; Genomic_DNA.
DR   EMBL; X15253; CAA33145.1; JOINED; Genomic_DNA.
DR   EMBL; Z29972; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z29973; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z29974; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; S69369; AAB30167.1; -; mRNA.
DR   EMBL; S69370; AAB30168.1; -; mRNA.
DR   EMBL; AY633656; AAT47737.1; -; mRNA.
DR   EMBL; S83614; AAB21476.1; -; Genomic_DNA.
DR   EMBL; L10614; AAA91849.1; -; Genomic_DNA.
DR   CCDS; CCDS2448.1; -. [P23760-8]
DR   CCDS; CCDS2449.1; -. [P23760-5]
DR   CCDS; CCDS2450.1; -. [P23760-4]
DR   CCDS; CCDS2451.1; -. [P23760-3]
DR   CCDS; CCDS42825.1; -. [P23760-7]
DR   CCDS; CCDS42826.1; -. [P23760-1]
DR   CCDS; CCDS46522.1; -. [P23760-6]
DR   CCDS; CCDS46523.1; -. [P23760-2]
DR   PIR; I54276; I54276.
DR   PIR; I68547; I68547.
DR   PIR; S06960; S06960.
DR   RefSeq; NP_000429.2; NM_000438.5. [P23760-2]
DR   RefSeq; NP_001120838.1; NM_001127366.2. [P23760-6]
DR   RefSeq; NP_039230.1; NM_013942.4. [P23760-3]
DR   RefSeq; NP_852122.1; NM_181457.3. [P23760-1]
DR   RefSeq; NP_852123.1; NM_181458.3. [P23760-7]
DR   RefSeq; NP_852124.1; NM_181459.3. [P23760-8]
DR   RefSeq; NP_852125.1; NM_181460.3. [P23760-5]
DR   RefSeq; NP_852126.1; NM_181461.3. [P23760-4]
DR   UniGene; Hs.42146; -.
DR   PDB; 3CMY; X-ray; 1.95 A; A=219-278.
DR   PDBsum; 3CMY; -.
DR   ProteinModelPortal; P23760; -.
DR   SMR; P23760; -.
DR   BioGrid; 111111; 21.
DR   CORUM; P23760; -.
DR   IntAct; P23760; 11.
DR   MINT; MINT-202884; -.
DR   STRING; 9606.ENSP00000375921; -.
DR   iPTMnet; P23760; -.
DR   PhosphoSitePlus; P23760; -.
DR   BioMuta; PAX3; -.
DR   DMDM; 1172022; -.
DR   EPD; P23760; -.
DR   MaxQB; P23760; -.
DR   PaxDb; P23760; -.
DR   PeptideAtlas; P23760; -.
DR   PRIDE; P23760; -.
DR   DNASU; 5077; -.
DR   Ensembl; ENST00000258387; ENSP00000258387; ENSG00000135903. [P23760-3]
DR   Ensembl; ENST00000336840; ENSP00000338767; ENSG00000135903. [P23760-5]
DR   Ensembl; ENST00000344493; ENSP00000342092; ENSG00000135903. [P23760-4]
DR   Ensembl; ENST00000350526; ENSP00000343052; ENSG00000135903. [P23760-1]
DR   Ensembl; ENST00000392069; ENSP00000375921; ENSG00000135903. [P23760-8]
DR   Ensembl; ENST00000392070; ENSP00000375922; ENSG00000135903. [P23760-7]
DR   Ensembl; ENST00000409551; ENSP00000386750; ENSG00000135903. [P23760-6]
DR   Ensembl; ENST00000409828; ENSP00000386817; ENSG00000135903. [P23760-2]
DR   GeneID; 5077; -.
DR   KEGG; hsa:5077; -.
DR   UCSC; uc002vmt.3; human. [P23760-1]
DR   CTD; 5077; -.
DR   DisGeNET; 5077; -.
DR   EuPathDB; HostDB:ENSG00000135903.18; -.
DR   GeneCards; PAX3; -.
DR   GeneReviews; PAX3; -.
DR   HGNC; HGNC:8617; PAX3.
DR   HPA; HPA063659; -.
DR   HPA; HPA069000; -.
DR   MalaCards; PAX3; -.
DR   MIM; 122880; phenotype.
DR   MIM; 148820; phenotype.
DR   MIM; 193500; phenotype.
DR   MIM; 268220; phenotype.
DR   MIM; 606597; gene.
DR   neXtProt; NX_P23760; -.
DR   OpenTargets; ENSG00000135903; -.
DR   Orphanet; 99756; Alveolar rhabdomyosarcoma.
DR   Orphanet; 1529; Craniofacial-deafness-hand syndrome.
DR   Orphanet; 894; Waardenburg syndrome type 1.
DR   Orphanet; 896; Waardenburg syndrome type 3.
DR   PharmGKB; PA32957; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00680000099553; -.
DR   HOGENOM; HOG000230939; -.
DR   HOVERGEN; HBG009115; -.
DR   InParanoid; P23760; -.
DR   KO; K09381; -.
DR   OMA; VHQSTLP; -.
DR   OrthoDB; EOG091G0S4E; -.
DR   PhylomeDB; P23760; -.
DR   TreeFam; TF351610; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SignaLink; P23760; -.
DR   SIGNOR; P23760; -.
DR   ChiTaRS; PAX3; human.
DR   EvolutionaryTrace; P23760; -.
DR   GeneWiki; PAX3; -.
DR   GenomeRNAi; 5077; -.
DR   PRO; PR:P23760; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000135903; -.
DR   CleanEx; HS_PAX3; -.
DR   ExpressionAtlas; P23760; baseline and differential.
DR   Genevisible; P23760; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022106; Pax7_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12360; Pax7; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; Deafness; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Myogenesis; Neurogenesis; Nucleus; Paired box;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome;
KW   Transcription; Transcription regulation; Waardenburg syndrome.
FT   CHAIN         1    479       Paired box protein Pax-3.
FT                                /FTId=PRO_0000050178.
FT   DOMAIN       34    161       Paired. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00381}.
FT   DNA_BIND    219    278       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   SITE        319    320       Breakpoint for translocation to form
FT                                PAX3-NCOA1 oncogene.
FT   MOD_RES     201    201       Phosphoserine.
FT                                {ECO:0000269|PubMed:21440083}.
FT   MOD_RES     205    205       Phosphoserine.
FT                                {ECO:0000269|PubMed:21440083}.
FT   MOD_RES     209    209       Phosphoserine.
FT                                {ECO:0000269|PubMed:21440083}.
FT   VAR_SEQ     108    108       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043634.
FT   VAR_SEQ     196    215       ASAPQSDEGSDIDSEPDLPL -> GKRWRLGRRTCWVTWRA
FT                                SAS (in isoform Pax3A).
FT                                {ECO:0000303|PubMed:7545913}.
FT                                /FTId=VSP_002355.
FT   VAR_SEQ     196    206       ASAPQSDEGSD -> GKALVSGVSSH (in isoform
FT                                Pax3B). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7545913}.
FT                                /FTId=VSP_002357.
FT   VAR_SEQ     207    479       Missing (in isoform Pax3B).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7545913}.
FT                                /FTId=VSP_002358.
FT   VAR_SEQ     216    479       Missing (in isoform Pax3A).
FT                                {ECO:0000303|PubMed:7545913}.
FT                                /FTId=VSP_002356.
FT   VAR_SEQ     393    479       MGLLTNHGGVPHQPQTDYALSPLTGGLEPTTTVSASCSQRL
FT                                DHMKSLDSLPTSQSYCPPTYSTTGYSMDPVTGYQYGQYGQS
FT                                KPWTF -> PFIISSQISRK (in isoform Pax3G).
FT                                {ECO:0000303|PubMed:14639621}.
FT                                /FTId=VSP_042004.
FT   VAR_SEQ     393    479       MGLLTNHGGVPHQPQTDYALSPLTGGLEPTTTVSASCSQRL
FT                                DHMKSLDSLPTSQSYCPPTYSTTGYSMDPVTGYQYGQYGQS
FT                                KPWTF -> PFIISSQISLGFKSF (in isoform
FT                                Pax3H). {ECO:0000303|PubMed:14639621}.
FT                                /FTId=VSP_042005.
FT   VAR_SEQ     475    479       KPWTF -> AFHYLKPDIA (in isoform 6 and
FT                                isoform 7). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043635.
FT   VAR_SEQ     475    479       KPWTF -> AFHYLKPDIAWFQILLNTFDKSSGEEEDLEQ
FT                                (in isoform Pax3E). {ECO:0000305}.
FT                                /FTId=VSP_044915.
FT   VARIANT      45     45       F -> L (in WS1).
FT                                {ECO:0000269|PubMed:7981674}.
FT                                /FTId=VAR_003790.
FT   VARIANT      47     47       N -> H (in WS3; dbSNP:rs104893653).
FT                                {ECO:0000269|PubMed:8447316}.
FT                                /FTId=VAR_003791.
FT   VARIANT      47     47       N -> K (in CDHS; dbSNP:rs104893652).
FT                                {ECO:0000269|PubMed:8664898}.
FT                                /FTId=VAR_003792.
FT   VARIANT      48     48       G -> R (in WS1).
FT                                {ECO:0000269|PubMed:8845842}.
FT                                /FTId=VAR_017533.
FT   VARIANT      50     50       P -> L (in WS1; important hearing loss;
FT                                dbSNP:rs104893650).
FT                                {ECO:0000269|PubMed:1347149}.
FT                                /FTId=VAR_003793.
FT   VARIANT      56     56       R -> L (in WS1; associated with
FT                                meningomyelocele; dbSNP:rs267606931).
FT                                {ECO:0000269|PubMed:8447316}.
FT                                /FTId=VAR_003794.
FT   VARIANT      59     59       I -> F (in WS1).
FT                                {ECO:0000269|PubMed:9067759}.
FT                                /FTId=VAR_003795.
FT   VARIANT      59     59       I -> N (in WS1). {ECO:0000269|Ref.34}.
FT                                /FTId=VAR_003796.
FT   VARIANT      60     60       V -> M (in WS1).
FT                                {ECO:0000269|PubMed:12949970,
FT                                ECO:0000269|PubMed:8533800}.
FT                                /FTId=VAR_003797.
FT   VARIANT      62     62       M -> V (in WS1).
FT                                {ECO:0000269|PubMed:7833953,
FT                                ECO:0000269|PubMed:9452070}.
FT                                /FTId=VAR_003798.
FT   VARIANT      63     67       Missing (in WS1).
FT                                {ECO:0000269|PubMed:1347148}.
FT                                /FTId=VAR_003799.
FT   VARIANT      73     73       S -> L (in WS1).
FT                                {ECO:0000269|PubMed:10779847}.
FT                                /FTId=VAR_013640.
FT   VARIANT      78     78       V -> M (in WS1).
FT                                {ECO:0000269|PubMed:8589691}.
FT                                /FTId=VAR_017534.
FT   VARIANT      81     81       G -> A (in WS1; originally classified as
FT                                Waardenburg syndrome type 2;
FT                                dbSNP:rs587776586).
FT                                {ECO:0000269|PubMed:8490648,
FT                                ECO:0000269|PubMed:8589691}.
FT                                /FTId=VAR_003800.
FT   VARIANT      84     84       S -> F (in WS3; dbSNP:rs104893651).
FT                                {ECO:0000269|PubMed:7726174}.
FT                                /FTId=VAR_003801.
FT   VARIANT      85     85       K -> E (in WS1).
FT                                {ECO:0000269|PubMed:8533800}.
FT                                /FTId=VAR_003802.
FT   VARIANT      90     90       Y -> H (in WS3; dbSNP:rs28939096).
FT                                {ECO:0000269|PubMed:12949970}.
FT                                /FTId=VAR_017535.
FT   VARIANT      99     99       G -> D (in WS1).
FT                                {ECO:0000269|PubMed:7981674,
FT                                ECO:0000269|PubMed:8589691}.
FT                                /FTId=VAR_003803.
FT   VARIANT     238    238       F -> S (in WS1).
FT                                {ECO:0000269|PubMed:8533800}.
FT                                /FTId=VAR_003804.
FT   VARIANT     265    265       V -> F (in WS1).
FT                                {ECO:0000269|PubMed:7825605}.
FT                                /FTId=VAR_003805.
FT   VARIANT     266    266       W -> C (in WS1).
FT                                {ECO:0000269|PubMed:8589691}.
FT                                /FTId=VAR_017536.
FT   VARIANT     270    270       R -> C (in WS1 and WS3).
FT                                {ECO:0000269|PubMed:8589691,
FT                                ECO:0000269|PubMed:8845842,
FT                                ECO:0000269|Ref.35}.
FT                                /FTId=VAR_013619.
FT   VARIANT     271    271       R -> C (in WS1).
FT                                {ECO:0000269|PubMed:8589691}.
FT                                /FTId=VAR_017537.
FT   VARIANT     271    271       R -> G (in WS1).
FT                                {ECO:0000269|PubMed:7825605}.
FT                                /FTId=VAR_003806.
FT   VARIANT     271    271       R -> H (in WS1; associated with Lys-273
FT                                in one family; dbSNP:rs774528745).
FT                                {ECO:0000269|PubMed:8589691,
FT                                ECO:0000269|PubMed:8845842}.
FT                                /FTId=VAR_017538.
FT   VARIANT     273    273       R -> K (associated with His-271 in one
FT                                Waardenburg syndrome type I family).
FT                                {ECO:0000269|PubMed:8845842}.
FT                                /FTId=VAR_017539.
FT   VARIANT     315    315       T -> K (in dbSNP:rs2234675).
FT                                {ECO:0000269|PubMed:8589691,
FT                                ECO:0000269|PubMed:8845842,
FT                                ECO:0000269|PubMed:8863157,
FT                                ECO:0000269|PubMed:9584079}.
FT                                /FTId=VAR_003807.
FT   VARIANT     391    391       Q -> H (in WS1).
FT                                {ECO:0000269|PubMed:9541113}.
FT                                /FTId=VAR_013641.
FT   CONFLICT    358    358       S -> R (in Ref. 1; AAP13872/AAP13873).
FT                                {ECO:0000305}.
FT   HELIX       228    240       {ECO:0000244|PDB:3CMY}.
FT   HELIX       246    256       {ECO:0000244|PDB:3CMY}.
FT   HELIX       260    276       {ECO:0000244|PDB:3CMY}.
SQ   SEQUENCE   479 AA;  52968 MW;  8AFCA674E3ACB4FE CRC64;
     MTTLAGAVPR MMRPGPGQNY PRSGFPLEVS TPLGQGRVNQ LGGVFINGRP LPNHIRHKIV
     EMAHHGIRPC VISRQLRVSH GCVSKILCRY QETGSIRPGA IGGSKPKQVT TPDVEKKIEE
     YKRENPGMFS WEIRDKLLKD AVCDRNTVPS VSSISRILRS KFGKGEEEEA DLERKEAEES
     EKKAKHSIDG ILSERASAPQ SDEGSDIDSE PDLPLKRKQR RSRTTFTAEQ LEELERAFER
     THYPDIYTRE ELAQRAKLTE ARVQVWFSNR RARWRKQAGA NQLMAFNHLI PGGFPPTAMP
     TLPTYQLSET SYQPTSIPQA VSDPSSTVHR PQPLPPSTVH QSTIPSNPDS SSAYCLPSTR
     HGFSSYTDSF VPPSGPSNPM NPTIGNGLSP QVMGLLTNHG GVPHQPQTDY ALSPLTGGLE
     PTTTVSASCS QRLDHMKSLD SLPTSQSYCP PTYSTTGYSM DPVTGYQYGQ YGQSKPWTF
//
ID   HHEX_HUMAN              Reviewed;         270 AA.
AC   Q03014; B1AQ17; Q96CE9;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   27-SEP-2017, entry version 172.
DE   RecName: Full=Hematopoietically-expressed homeobox protein HHEX;
DE            Short=Homeobox protein HEX;
DE   AltName: Full=Homeobox protein PRH;
GN   Name=HHEX; Synonyms=HEX, PRH, PRHX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=1360645; DOI=10.1093/nar/20.21.5661;
RA   Crompton M.R., Bartlett T.J., Macgregor A.D., Manfioletti G.,
RA   Buratti E., Giancotti V., Goodwin G.H.;
RT   "Identification of a novel vertebrate homeobox gene expressed in
RT   haematopoietic cells.";
RL   Nucleic Acids Res. 20:5661-5667(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Myeloid leukemia cell;
RX   PubMed=8103988; DOI=10.1006/bbrc.1993.2140;
RA   Hromas R.A., Collins S.J., Radich J.;
RT   "PCR cloning of an orphan homeobox gene (PRH) preferentially expressed
RT   in myeloid and liver cells.";
RL   Biochem. Biophys. Res. Commun. 195:976-983(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 122-270, AND TISSUE SPECIFICITY.
RC   TISSUE=Leukemia, and Peripheral blood monocyte;
RX   PubMed=8096636; DOI=10.1093/nar/21.5.1245;
RA   Bedford F.K., Ashworth A., Enver T., Wiedemann L.M.;
RT   "HEX: a novel homeobox gene expressed during haematopoiesis and
RT   conserved between mouse and human.";
RL   Nucleic Acids Res. 21:1245-1249(1993).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-53, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   3D-STRUCTURE MODELING OF 136-196.
RX   PubMed=7911091; DOI=10.1016/0014-5793(94)00446-3;
RA   Neidle S., Goodwin G.H.;
RT   "A homology-based molecular model of the proline-rich homeodomain
RT   protein Prh, from haematopoietic cells.";
RL   FEBS Lett. 345:93-98(1994).
RN   [10]
RP   STRUCTURE BY NMR OF 138-194.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RSGI RUH-028, a homeobox domain from human.";
RL   Submitted (NOV-2006) to the PDB data bank.
CC   -!- FUNCTION: Recognizes the DNA sequence 5'-ATTAA-3'. Transcriptional
CC       repressor. May play a role in hematopoietic differentiation.
CC       Establishes anterior identity at two levels; acts early to enhance
CC       canonical WNT-signaling by repressing expression of TLE4, and acts
CC       later to inhibit NODAL-signaling by directly targeting NODAL (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q5VWX1:KHDRBS2; NbExp=4; IntAct=EBI-747421, EBI-742808;
CC       P60370:KRTAP10-5; NbExp=3; IntAct=EBI-747421, EBI-10172150;
CC       P60371:KRTAP10-6; NbExp=4; IntAct=EBI-747421, EBI-12012928;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-747421, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-747421, EBI-10171774;
CC       O75690:KRTAP5-8; NbExp=4; IntAct=EBI-747421, EBI-12134621;
CC       Q7Z3S9:NOTCH2NL; NbExp=4; IntAct=EBI-747421, EBI-945833;
CC       Q05BL1:TP53BP2; NbExp=4; IntAct=EBI-747421, EBI-11952721;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Liver and promyelocytic leukemia cell line HL-
CC       60. {ECO:0000269|PubMed:1360645, ECO:0000269|PubMed:8096636,
CC       ECO:0000269|PubMed:8103988}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during hematopoiesis.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X67235; CAA47661.1; -; mRNA.
DR   EMBL; L16499; AAA02988.1; -; mRNA.
DR   EMBL; AK314891; BAG37405.1; -; mRNA.
DR   EMBL; AL590080; CAH74086.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50087.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50088.1; -; Genomic_DNA.
DR   EMBL; BC014336; AAH14336.1; -; mRNA.
DR   EMBL; BC015110; AAH15110.1; -; mRNA.
DR   EMBL; BC050638; AAH50638.1; -; mRNA.
DR   EMBL; Z21533; CAA79730.1; -; mRNA.
DR   CCDS; CCDS7423.1; -.
DR   PIR; JN0767; JN0767.
DR   RefSeq; NP_002720.1; NM_002729.4.
DR   UniGene; Hs.118651; -.
DR   PDB; 2E1O; NMR; -; A=138-194.
DR   PDBsum; 2E1O; -.
DR   ProteinModelPortal; Q03014; -.
DR   SMR; Q03014; -.
DR   BioGrid; 109335; 10.
DR   IntAct; Q03014; 25.
DR   MINT; MINT-1439118; -.
DR   STRING; 9606.ENSP00000282728; -.
DR   iPTMnet; Q03014; -.
DR   PhosphoSitePlus; Q03014; -.
DR   BioMuta; HHEX; -.
DR   DMDM; 547658; -.
DR   EPD; Q03014; -.
DR   MaxQB; Q03014; -.
DR   PaxDb; Q03014; -.
DR   PeptideAtlas; Q03014; -.
DR   PRIDE; Q03014; -.
DR   DNASU; 3087; -.
DR   Ensembl; ENST00000282728; ENSP00000282728; ENSG00000152804.
DR   GeneID; 3087; -.
DR   KEGG; hsa:3087; -.
DR   UCSC; uc001kid.4; human.
DR   CTD; 3087; -.
DR   DisGeNET; 3087; -.
DR   EuPathDB; HostDB:ENSG00000152804.10; -.
DR   GeneCards; HHEX; -.
DR   HGNC; HGNC:4901; HHEX.
DR   HPA; HPA051894; -.
DR   HPA; HPA055460; -.
DR   MIM; 604420; gene.
DR   neXtProt; NX_Q03014; -.
DR   OpenTargets; ENSG00000152804; -.
DR   PharmGKB; PA29274; -.
DR   eggNOG; KOG0483; Eukaryota.
DR   eggNOG; ENOG410Z2UE; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000049110; -.
DR   HOVERGEN; HBG055460; -.
DR   InParanoid; Q03014; -.
DR   KO; K08024; -.
DR   OMA; DNSCDQR; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; Q03014; -.
DR   TreeFam; TF325047; -.
DR   EvolutionaryTrace; Q03014; -.
DR   GeneWiki; HHEX; -.
DR   GenomeRNAi; 3087; -.
DR   PRO; PR:Q03014; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000152804; -.
DR   CleanEx; HS_HHEX; -.
DR   ExpressionAtlas; Q03014; baseline and differential.
DR   Genevisible; Q03014; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0008301; F:DNA binding, bending; IDA:BHF-UCL.
DR   GO; GO:0008190; F:eukaryotic initiation factor 4E binding; IDA:BHF-UCL.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0070491; F:repressing transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0017025; F:TBP-class protein binding; TAS:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008283; P:cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0071103; P:DNA conformation change; IDA:BHF-UCL.
DR   GO; GO:0035050; P:embryonic heart tube development; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; IEA:Ensembl.
DR   GO; GO:0048853; P:forebrain morphogenesis; IEA:Ensembl.
DR   GO; GO:0061010; P:gall bladder development; IEA:Ensembl.
DR   GO; GO:0061011; P:hepatic duct development; IEA:Ensembl.
DR   GO; GO:0061017; P:hepatoblast differentiation; IEA:Ensembl.
DR   GO; GO:0070365; P:hepatocyte differentiation; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0022027; P:interkinetic nuclear migration; IEA:Ensembl.
DR   GO; GO:0006406; P:mRNA export from nucleus; IDA:BHF-UCL.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0002573; P:myeloid leukocyte differentiation; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISS:BHF-UCL.
DR   GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL.
DR   GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; TAS:BHF-UCL.
DR   GO; GO:0010621; P:negative regulation of transcription by transcription factor localization; IC:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR   GO; GO:0016973; P:poly(A)+ mRNA export from nucleus; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060431; P:primary lung bud formation; IEA:Ensembl.
DR   GO; GO:0090009; P:primitive streak formation; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IDA:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Differentiation; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Wnt signaling pathway.
FT   CHAIN         1    270       Hematopoietically-expressed homeobox
FT                                protein HHEX.
FT                                /FTId=PRO_0000049074.
FT   DNA_BIND    137    196       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      1    133       Pro-rich.
FT   MOD_RES      53     53       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT    115    115       L -> V (in Ref. 2; AAA02988).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       A -> T (in Ref. 6; AAH14336).
FT                                {ECO:0000305}.
FT   HELIX       146    158       {ECO:0000244|PDB:2E1O}.
FT   HELIX       164    173       {ECO:0000244|PDB:2E1O}.
FT   HELIX       178    194       {ECO:0000244|PDB:2E1O}.
SQ   SEQUENCE   270 AA;  30022 MW;  9C16BB6D494475FC CRC64;
     MQYPHPGPAA GAVGVPLYAP TPLLQPAHPT PFYIEDILGR GPAAPTPAPT LPSPNSSFTS
     LVSPYRTPVY EPTPIHPAFS HHSAAALAAA YGPGGFGGPL YPFPRTVNDY THALLRHDPL
     GKPLLWSPFL QRPLHKRKGG QVRFSNDQTI ELEKKFETQK YLSPPERKRL AKMLQLSERQ
     VKTWFQNRRA KWRRLKQENP QSNKKEELES LDSSCDQRQD LPSEQNKGAS LDSSQCSPSP
     ASQEDLESEI SEDSDQEVDI EGDKSYFNAG
//
ID   PDX1_HUMAN              Reviewed;         283 AA.
AC   P52945; O60594; Q5VYW2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Pancreas/duodenum homeobox protein 1;
DE            Short=PDX-1;
DE   AltName: Full=Glucose-sensitive factor;
DE            Short=GSF;
DE   AltName: Full=Insulin promoter factor 1;
DE            Short=IPF-1;
DE   AltName: Full=Insulin upstream factor 1;
DE            Short=IUF-1;
DE   AltName: Full=Islet/duodenum homeobox-1;
DE            Short=IDX-1;
DE   AltName: Full=Somatostatin-transactivating factor 1;
DE            Short=STF-1;
GN   Name=PDX1; Synonyms=IPF1, STF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7590740; DOI=10.1006/geno.1995.1120;
RA   Stoffel M., Stein R., Wright C.V., Espinosa R. III, le Beau M.M.,
RA   Bell G.I.;
RT   "Localization of human homeodomain transcription factor insulin
RT   promoter factor 1 (IPF1) to chromosome band 13q12.1.";
RL   Genomics 28:125-126(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Pancreatic islet;
RX   PubMed=8635654; DOI=10.2337/diab.45.6.789;
RA   Inoue H., Riggs A.C., Tanizawa Y., Ueda K., Kuwano A., Liu L.,
RA   Donis-Keller H., Permutt M.A.;
RT   "Isolation, characterization, and chromosomal mapping of the human
RT   insulin promoter factor 1 (IPF-1) gene.";
RL   Diabetes 45:789-794(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pancreatic islet;
RA   Hiroshi I.;
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pancreatic islet;
RA   Marshak S., Totary H., Cerasi E., Melloul D.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hara M., Lindner T.H., Paz V.P., Wang X., Iwasaki N., Bell G.I.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pancreatic islet;
RX   PubMed=9252422; DOI=10.1074/jbc.272.33.20936;
RA   Macfarlane W.M., Smith S.B., James R.F., Clifton A.D., Doza Y.N.,
RA   Cohen P., Docherty K.;
RT   "The p38/reactivating kinase mitogen-activated protein kinase cascade
RT   mediates the activation of the transcription factor insulin upstream
RT   factor 1 and insulin gene transcription by high glucose in pancreatic
RT   beta-cells.";
RL   J. Biol. Chem. 272:20936-20944(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   INVOLVEMENT IN PAGEN1.
RX   PubMed=8988180; DOI=10.1038/ng0197-106;
RA   Stoffers D.A., Zinkin N.T., Stanojevic V., Clarke W.L., Habener J.F.;
RT   "Pancreatic agenesis attributable to a single nucleotide deletion in
RT   the human IPF1 gene coding sequence.";
RL   Nat. Genet. 15:106-110(1997).
RN   [10]
RP   INTERACTION WITH SETD7.
RX   PubMed=16141209; DOI=10.1074/jbc.M505741200;
RA   Francis J., Chakrabarti S.K., Garmey J.C., Mirmira R.G.;
RT   "Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II
RT   elongation during activation of insulin transcription.";
RL   J. Biol. Chem. 280:36244-36253(2005).
RN   [11]
RP   PHOSPHORYLATION AT SER-268 BY HIPK2.
RX   PubMed=20637728; DOI=10.1016/j.bbrc.2010.07.035;
RA   An R., da Silva Xavier G., Semplici F., Vakhshouri S., Hao H.X.,
RA   Rutter J., Pagano M.A., Meggio F., Pinna L.A., Rutter G.A.;
RT   "Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-
RT   269 is HIPK2-dependent and affects PDX1 subnuclear localization.";
RL   Biochem. Biophys. Res. Commun. 399:155-161(2010).
RN   [12]
RP   VARIANTS MODY4 ARG-18; ASN-76 AND HIS-197.
RX   PubMed=10545530; DOI=10.1172/JCI7449;
RA   Macfarlane W.M., Frayling T.M., Ellard S., Evans J.C., Allen L.I.,
RA   Bulman M.P., Ayres S., Shepherd M., Clark P., Millward A., Demaine A.,
RA   Wilkin T., Docherty K., Hattersley A.T.;
RT   "Missense mutations in the insulin promoter factor-1 gene predispose
RT   to type 2 diabetes.";
RL   J. Clin. Invest. 104:R33-R39(1999).
RN   [13]
RP   VARIANTS MODY4 LEU-59; ASN-76 AND PRO-243 INS.
RX   PubMed=10545531; DOI=10.1172/JCI7469;
RA   Hani E.H., Stoffers D.A., Chevre J.-C., Durand E., Stanojevic V.,
RA   Dina C., Habener J.F., Froguel P.;
RT   "Defective mutations in the insulin promoter factor-1 (IPF-1) gene in
RT   late-onset type 2 diabetes mellitus.";
RL   J. Clin. Invest. 104:R41-R48(1999).
CC   -!- FUNCTION: Activates insulin, somatostatin, glucokinase, islet
CC       amyloid polypeptide and glucose transporter type 2 gene
CC       transcription. Particularly involved in glucose-dependent
CC       regulation of insulin gene transcription. As part of a
CC       PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved
CC       in the transcriptional activation of the ELA1 enhancer; the
CC       complex binds to the enhancer B element and cooperates with the
CC       transcription factor 1 complex (PTF1) bound to the enhancer A
CC       element. Binds preferentially the DNA motif 5'-[CT]TAAT[TG]-3'.
CC       During development, specifies the early pancreatic epithelium,
CC       permitting its proliferation, branching and subsequent
CC       differentiation. At adult stage, required for maintaining the
CC       hormone-producing phenotype of the beta-cell.
CC   -!- SUBUNIT: Interacts with the basic helix-loop-helix domains of
CC       TCF3(E47) and NEUROD1 and with HMG-I(Y). Interacts with SPOP (By
CC       similarity). Interacts with the methyltransferase SETD7. Part of a
CC       PDX1:PBX1b:MEIS2b complex. {ECO:0000250,
CC       ECO:0000269|PubMed:16141209}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytosol {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Duodenum and pancreas (Langerhans islet beta
CC       cells and small subsets of endocrine non-beta-cells, at low levels
CC       in acinar cells).
CC   -!- DOMAIN: The Antp-type hexapeptide mediates heterodimerization with
CC       PBX on a regulatory element of the somatostatin promoter.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The homeodomain, which contains the nuclear localization
CC       signal, not only mediates DNA-binding, but also acts as a protein-
CC       protein interaction domain for TCF3(E47), NEUROD1 and HMG-I(Y).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated by the SAPK2 pathway at high intracellular
CC       glucose concentration. Phosphorylated by HIPK2 on Ser-268 upon
CC       glucose accumulation. This phosphorylation mediates subnuclear
CC       localization shifting. Phosphorylation by PASK may lead to
CC       translocation into the cytosol (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Pancreatic agenesis 1 (PAGEN1) [MIM:260370]: A disease
CC       characterized by isolated hypoplasia or agenesis of the pancreas,
CC       pancreatic beta-cell failure resulting in neonatal insulin-
CC       dependent diabetes mellitus, and exocrine pancreatic
CC       insufficiency. {ECO:0000269|PubMed:8988180}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Maturity-onset diabetes of the young 4 (MODY4)
CC       [MIM:606392]: A form of diabetes that is characterized by an
CC       autosomal dominant mode of inheritance, onset in childhood or
CC       early adulthood (usually before 25 years of age), a primary defect
CC       in insulin secretion and frequent insulin-independence at the
CC       beginning of the disease. {ECO:0000269|PubMed:10545530,
CC       ECO:0000269|PubMed:10545531}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: According to PubMed:16141209, it may be methylated
CC       by SETD7 in vitro. However, the relevance of methylation is unsure
CC       in vivo.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. IPF1/XlHbox-8
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PDX1ID43921ch13q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U35632; AAA88820.1; -; mRNA.
DR   EMBL; S82178; AAB47101.1; -; Genomic_DNA.
DR   EMBL; S82168; AAB47101.1; JOINED; Genomic_DNA.
DR   EMBL; U30329; AAA74012.1; -; mRNA.
DR   EMBL; X99894; CAA68169.1; -; mRNA.
DR   EMBL; AF035260; AAB88463.1; -; Genomic_DNA.
DR   EMBL; AF035259; AAB88463.1; JOINED; Genomic_DNA.
DR   EMBL; AF049893; AAC05157.1; -; mRNA.
DR   EMBL; AL353195; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08420.1; -; Genomic_DNA.
DR   CCDS; CCDS9327.1; -.
DR   PIR; G01926; G01926.
DR   RefSeq; NP_000200.1; NM_000209.3.
DR   UniGene; Hs.32938; -.
DR   ProteinModelPortal; P52945; -.
DR   SMR; P52945; -.
DR   BioGrid; 109860; 9.
DR   ELM; P52945; -.
DR   IntAct; P52945; 2.
DR   MINT; MINT-1894661; -.
DR   STRING; 9606.ENSP00000370421; -.
DR   iPTMnet; P52945; -.
DR   PhosphoSitePlus; P52945; -.
DR   BioMuta; PDX1; -.
DR   DMDM; 1708540; -.
DR   PaxDb; P52945; -.
DR   PeptideAtlas; P52945; -.
DR   PRIDE; P52945; -.
DR   DNASU; 3651; -.
DR   Ensembl; ENST00000381033; ENSP00000370421; ENSG00000139515.
DR   GeneID; 3651; -.
DR   KEGG; hsa:3651; -.
DR   UCSC; uc001urt.3; human.
DR   CTD; 3651; -.
DR   DisGeNET; 3651; -.
DR   EuPathDB; HostDB:ENSG00000139515.5; -.
DR   GeneCards; PDX1; -.
DR   GeneReviews; PDX1; -.
DR   HGNC; HGNC:6107; PDX1.
DR   HPA; CAB025873; -.
DR   HPA; HPA059146; -.
DR   MalaCards; PDX1; -.
DR   MIM; 125853; phenotype.
DR   MIM; 260370; phenotype.
DR   MIM; 600733; gene.
DR   MIM; 606392; phenotype.
DR   neXtProt; NX_P52945; -.
DR   OpenTargets; ENSG00000139515; -.
DR   Orphanet; 552; MODY.
DR   Orphanet; 2805; Partial pancreatic agenesis.
DR   Orphanet; 99885; Permanent neonatal diabetes mellitus.
DR   PharmGKB; PA162399173; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000115484; -.
DR   HOVERGEN; HBG004525; -.
DR   InParanoid; P52945; -.
DR   KO; K07594; -.
DR   OMA; PPPCLYM; -.
DR   OrthoDB; EOG091G0GVH; -.
DR   PhylomeDB; P52945; -.
DR   TreeFam; TF326223; -.
DR   Reactome; R-HSA-210745; Regulation of gene expression in beta cells.
DR   Reactome; R-HSA-210747; Regulation of gene expression in early pancreatic precursor cells.
DR   SignaLink; P52945; -.
DR   SIGNOR; P52945; -.
DR   GeneWiki; PDX1; -.
DR   GenomeRNAi; 3651; -.
DR   PRO; PR:P52945; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000139515; -.
DR   CleanEx; HS_PDX1; -.
DR   Genevisible; P52945; HS.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0010260; P:animal organ senescence; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0051594; P:detection of glucose; ISS:BHF-UCL.
DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.
DR   GO; GO:0031017; P:exocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0030073; P:insulin secretion; IDA:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL.
DR   GO; GO:0010942; P:positive regulation of cell death; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0043279; P:response to alkaloid; IEA:Ensembl.
DR   GO; GO:0010157; P:response to chlorate; IEA:Ensembl.
DR   GO; GO:0034097; P:response to cytokine; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0070542; P:response to fatty acid; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0010040; P:response to iron(II) ion; IEA:Ensembl.
DR   GO; GO:0043201; P:response to leucine; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0033273; P:response to vitamin; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0060290; P:transdifferentiation; IEA:Ensembl.
DR   GO; GO:0003309; P:type B pancreatic cell differentiation; IDA:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Cytoplasm; Developmental protein;
KW   Diabetes mellitus; Disease mutation; DNA-binding; Homeobox; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    283       Pancreas/duodenum homeobox protein 1.
FT                                /FTId=PRO_0000049147.
FT   DNA_BIND    146    205       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       13     73       Transactivation domain. {ECO:0000250}.
FT   MOTIF       118    123       Antp-type hexapeptide.
FT   MOTIF       197    203       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   COMPBIAS     42     51       Poly-Pro.
FT   COMPBIAS    216    219       Poly-Gly.
FT   COMPBIAS    239    244       Poly-Pro.
FT   MOD_RES     151    151       Phosphothreonine; by PASK.
FT                                {ECO:0000250|UniProtKB:P52946}.
FT   MOD_RES     268    268       Phosphoserine; by HIPK2.
FT                                {ECO:0000269|PubMed:20637728}.
FT   VARIANT      18     18       C -> R (in MODY4; dbSNP:rs137852785).
FT                                {ECO:0000269|PubMed:10545530}.
FT                                /FTId=VAR_009309.
FT   VARIANT      59     59       Q -> L (in MODY4; dbSNP:rs137852784).
FT                                {ECO:0000269|PubMed:10545531}.
FT                                /FTId=VAR_009310.
FT   VARIANT      76     76       D -> N (in MODY4; unknown pathological
FT                                significance; dbSNP:rs137852783).
FT                                {ECO:0000269|PubMed:10545530,
FT                                ECO:0000269|PubMed:10545531}.
FT                                /FTId=VAR_009311.
FT   VARIANT     197    197       R -> H (in MODY4; dbSNP:rs137852786).
FT                                {ECO:0000269|PubMed:10545530}.
FT                                /FTId=VAR_009312.
FT   VARIANT     243    243       P -> PP (in MODY4).
FT                                {ECO:0000269|PubMed:10545531}.
FT                                /FTId=VAR_009313.
FT   CONFLICT     56     56       A -> S (in Ref. 6; AAC05157).
FT                                {ECO:0000305}.
FT   CONFLICT    116    116       Q -> H (in Ref. 6; AAC05157).
FT                                {ECO:0000305}.
FT   CONFLICT    210    211       GG -> SS (in Ref. 6; AAC05157).
FT                                {ECO:0000305}.
SQ   SEQUENCE   283 AA;  30771 MW;  5D48EC8D3289F72B CRC64;
     MNGEEQYYAA TQLYKDPCAF QRGPAPEFSA SPPACLYMGR QPPPPPPHPF PGALGALEQG
     SPPDISPYEV PPLADDPAVA HLHHHLPAQL ALPHPPAGPF PEGAEPGVLE EPNRVQLPFP
     WMKSTKAHAW KGQWAGGAYA AEPEENKRTR TAYTRAQLLE LEKEFLFNKY ISRPRRVELA
     VMLNLTERHI KIWFQNRRMK WKKEEDKKRG GGTAVGGGGV AEPEQDCAVT SGEELLALPP
     PPPPGGAVPP AAPVAAREGR LPPGLSASPQ PSSVAPRRPQ EPR
//
ID   SIX3_HUMAN              Reviewed;         332 AA.
AC   O95343; D6W5A5; Q53T42;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   25-OCT-2017, entry version 149.
DE   RecName: Full=Homeobox protein SIX3;
DE   AltName: Full=Sine oculis homeobox homolog 3;
GN   Name=SIX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9889003; DOI=10.1006/geno.1998.5611;
RA   Granadino B., Gallardo M.E., Lopez-Rios J., Sanz R., Ramos C.,
RA   Ayuso C., Bovolenta P., Rodriguez de Cordoba S.;
RT   "Genomic cloning, structure, expression pattern, and chromosomal
RT   location of the human SIX3 gene.";
RL   Genomics 55:100-105(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10415461; DOI=10.1076/opge.20.1.7.2298;
RA   Leppert G.S., Yang J.-M., Sundin O.H.;
RT   "Sequence and location of SIX3, a homeobox gene expressed in the human
RT   eye.";
RL   Ophthalmic Genet. 20:7-21(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RA   Clark B.J., Hanson I.M., Brown A.G., Ferrier R.K., Prosser J.,
RA   van Heyningen V.;
RT   "SIX3, a member of the Sine oculis/Six family of transcription
RT   factors, is expressed in the developing and adult human eye.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH NR4A3.
RX   PubMed=12543801;
RA   Laflamme C., Filion C., Bridge J.A., Ladanyi M., Goldring M.B.,
RA   Labelle Y.;
RT   "The homeotic protein Six3 is a coactivator of the nuclear receptor
RT   NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human
RT   extraskeletal myxoid chondrosarcomas.";
RL   Cancer Res. 63:449-454(2003).
RN   [8]
RP   INTERACTION WITH TLE1 AND AES, AND MUTAGENESIS OF PHE-87; VAL-95 AND
RP   LEU-99.
RX   PubMed=12441302; DOI=10.1242/dev.00185;
RA   Lopez-Rios J., Tessmar K., Loosli F., Wittbrodt J., Bovolenta P.;
RT   "Six3 and Six6 activity is modulated by members of the groucho
RT   family.";
RL   Development 130:185-195(2003).
RN   [9]
RP   CHARACTERIZATION OF VARIANTS HPE2 ALA-250 AND PRO-257.
RX   PubMed=15523651; DOI=10.1002/humu.20102;
RA   Laflamme C., Filion C., Labelle Y.;
RT   "Functional characterization of SIX3 homeodomain mutations in
RT   holoprosencephaly: interaction with the nuclear receptor NR4A3/NOR1.";
RL   Hum. Mutat. 24:502-508(2004).
RN   [10]
RP   INTERACTION WITH GMNN.
RX   PubMed=14973488; DOI=10.1038/nature02292;
RA   Del Bene F., Tessmar-Raible K., Wittbrodt J.;
RT   "Direct interaction of geminin and Six3 in eye development.";
RL   Nature 427:745-749(2004).
RN   [11]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=18775421; DOI=10.1016/j.ydbio.2008.08.008;
RA   Gaston-Massuet C., Andoniadou C.L., Signore M., Sajedi E., Bird S.,
RA   Turner J.M., Martinez-Barbera J.P.;
RT   "Genetic interaction between the homeobox transcription factors HESX1
RT   and SIX3 is required for normal pituitary development.";
RL   Dev. Biol. 324:322-333(2008).
RN   [12]
RP   FUNCTION IN EYE DEVELOPMENT AND FOREBRAIN DORSAL/VENTRAL PATTERN
RP   FORMATION, INVOLVEMENT IN HPE2, AND VARIANTS HPE2 CYS-37; ASP-93;
RP   CYS-113; LEU-114; ASP-138; ILE-157; VAL-172; HIS-174; VAL-213;
RP   TRP-218; PRO-218; PRO-227; CYS-244; LEU-254; LEU-258; HIS-262; SER-269
RP   AND LEU-297.
RX   PubMed=18791198; DOI=10.1093/hmg/ddn294;
RA   Domene S., Roessler E., El-Jaick K.B., Snir M., Brown J.L.,
RA   Velez J.I., Bale S., Lacbawan F., Muenke M., Feldman B.;
RT   "Mutations in the human SIX3 gene in holoprosencephaly are loss of
RT   function.";
RL   Hum. Mol. Genet. 17:3919-3928(2008).
RN   [13]
RP   VARIANTS HPE2 VAL-226; ALA-250 AND PRO-257.
RX   PubMed=10369266; DOI=10.1038/9718;
RA   Wallis D.E., Roessler E., Hehr U., Nanni L., Wiltshire T.,
RA   Richieri-Costa A., Gillessen-Kaesbach G., Zackai E.H., Rommens J.,
RA   Muenke M.;
RT   "Mutations in the homeodomain of the human SIX3 gene cause
RT   holoprosencephaly.";
RL   Nat. Genet. 22:196-198(1999).
RN   [14]
RP   VARIANTS HPE2 GLY-92; VAL-105; PRO-173; ILE-202; ARG-231 AND TRP-257.
RX   PubMed=15221788; DOI=10.1002/humu.20056;
RA   Dubourg C., Lazaro L., Pasquier L., Bendavid C., Blayau M.,
RA   Le Duff F., Durou M.-R., Odent S., David V.;
RT   "Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients
RT   with features of holoprosencephaly spectrum: mutation review and
RT   genotype-phenotype correlations.";
RL   Hum. Mutat. 24:43-51(2004).
RN   [15]
RP   VARIANT HPE2 ASP-69.
RX   PubMed=17001667; DOI=10.1002/ajmg.a.31377;
RA   Ribeiro L.A., El-Jaick K.B., Muenke M., Richieri-Costa A.;
RT   "SIX3 mutations with holoprosencephaly.";
RL   Am. J. Med. Genet. A 140:2577-2583(2006).
RN   [16]
RP   VARIANTS HPE2 VAL-79; HIS-155 DEL; GLY-257; MET-269 AND THR-269.
RX   PubMed=20531442; DOI=10.1038/ejhg.2010.70;
RA   Paulussen A.D., Schrander-Stumpel C.T., Tserpelis D.C., Spee M.K.,
RA   Stegmann A.P., Mancini G.M., Brooks A.S., Collee M., Maat-Kievit A.,
RA   Simon M.E., van Bever Y., Stolte-Dijkstra I.,
RA   Kerstjens-Frederikse W.S., Herkert J.C., van Essen A.J.,
RA   Lichtenbelt K.D., van Haeringen A., Kwee M.L., Lachmeijer A.M.,
RA   Tan-Sindhunata G.M., van Maarle M.C., Arens Y.H., Smeets E.E.,
RA   de Die-Smulders C.E., Engelen J.J., Smeets H.J., Herbergs J.;
RT   "The unfolding clinical spectrum of holoprosencephaly due to mutations
RT   in SHH, ZIC2, SIX3 and TGIF genes.";
RL   Eur. J. Hum. Genet. 18:999-1005(2010).
RN   [17]
RP   INVOLVEMENT IN SCHZC, AND VARIANTS SCHZC CYS-37 AND SER-167.
RX   PubMed=20157829; DOI=10.1007/s00439-010-0797-4;
RA   Hehr U., Pineda-Alvarez D.E., Uyanik G., Hu P., Zhou N., Hehr A.,
RA   Schell-Apacik C., Altus C., Daumer-Haas C., Meiner A., Steuernagel P.,
RA   Roessler E., Winkler J., Muenke M.;
RT   "Heterozygous mutations in SIX3 and SHH are associated with
RT   schizencephaly and further expand the clinical spectrum of
RT   holoprosencephaly.";
RL   Hum. Genet. 127:555-561(2010).
CC   -!- FUNCTION: Transcriptional regulator which can act as both a
CC       transcriptional repressor and activator by binding a ATTA
CC       homeodomain core recognition sequence on these target genes.
CC       During forebrain development represses WNT1 expression allowing
CC       zona limitans intrathalamica formation and thereby ensuring proper
CC       anterio-posterior patterning of the diencephalon and formation of
CC       the rostral diencephalon. Acts as a direct upstream activator of
CC       SHH expression in the rostral diencephalon ventral midline and
CC       that in turn SHH maintains its expression. In addition, Six3
CC       activity is required for the formation of the telencephalon.
CC       During postnatal stages of brain development is necessary for
CC       ependymal cell maturation by promoting the maturation of radial
CC       glia into ependymal cells through regulation of neuroblast
CC       proliferation and migration. Acts on the proliferation and
CC       differentiation of neural progenitor cells through activating
CC       transcription of CCND1 AND CCND2. During early lens formation
CC       plays a role in lens induction and specification by activating
CC       directly PAX6 in the presumptive lens ectoderm. In turn PAX6
CC       activates SIX3 resulting in activation of PDGFRA and CCND1
CC       promoting cell proliferation. Also is required for the neuroretina
CC       development by directly suppressing WNT8B expression in the
CC       anterior neural plate territory. Its action during retina
CC       development and lens morphogenesis is AES and TLE4-dependent
CC       manner. Furthermore, during eye development regulates several
CC       genes expression. Before and during early lens development
CC       represses the CRYGF promoter by binding a SIX repressor element.
CC       Directly activates RHO transcription, or cooperates with CRX or
CC       NRL. Six3 functions also in the formation of the proximodistal
CC       axis of the optic cup, and promotes the formation of optic
CC       vesicles-like structures. During pituitary development, acts in
CC       parallel or alternatively with HESX1 to control cell proliferation
CC       through Wnt/beta-catenin pathway (By similarity). Plays a role in
CC       eye development by suppressing WNT1 expression and in dorsal-
CC       ventral patterning by repressing BMP signaling pathway.
CC       {ECO:0000250|UniProtKB:Q62233, ECO:0000269|PubMed:18791198}.
CC   -!- SUBUNIT: Interacts with EYA4; translocates EYA4 from the cytoplasm
CC       to the nucleus and promotes activation of their target genes (By
CC       similarity). Interacts with MTA1 and HDAC2; represses its own
CC       transcription (By similarity). Interacts with MTA1; facilitates
CC       the binding of SIX3 to the core DNA motif of SIX3 promoter (By
CC       similarity). Interacts with EYA1; promotes EYA1 translocation to
CC       the nucleus (By similarity). Interacts with TLE1 and AES (via Q
CC       domain); can act in combination with either TLE1 and/or AES
CC       leading to transcriptional repression or activation, respectively.
CC       Interacts (via homeobox) with NR4A3; differentially regulates the
CC       transcriptional activities NR4A3. Interacts with GMNN. Interacts
CC       with TLE4. {ECO:0000250|UniProtKB:Q62233,
CC       ECO:0000269|PubMed:12441302, ECO:0000269|PubMed:12543801,
CC       ECO:0000269|PubMed:14973488}.
CC   -!- INTERACTION:
CC       Q92570:NR4A3; NbExp=3; IntAct=EBI-13644574, EBI-13644623;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q62233,
CC       ECO:0000255|PROSITE-ProRule:PRU00108}.
CC   -!- DEVELOPMENTAL STAGE: Expression is detected in Rathke's pouch and
CC       overlying ventral diencephalon at carnegie stage 17 and in the
CC       anterior and posterior lobes of the pituitary at carnegie stage
CC       20. At fetal stage, expression is observed in the anterior
CC       pituitary, and the ventricular zones of the hypothalamus and
CC       telencephalic vesicles. {ECO:0000269|PubMed:18775421}.
CC   -!- DISEASE: Holoprosencephaly 2 (HPE2) [MIM:157170]: A structural
CC       anomaly of the brain, in which the developing forebrain fails to
CC       correctly separate into right and left hemispheres.
CC       Holoprosencephaly is genetically heterogeneous and associated with
CC       several distinct facies and phenotypic variability.
CC       {ECO:0000269|PubMed:10369266, ECO:0000269|PubMed:15221788,
CC       ECO:0000269|PubMed:15523651, ECO:0000269|PubMed:17001667,
CC       ECO:0000269|PubMed:18791198, ECO:0000269|PubMed:20531442}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Schizencephaly (SCHZC) [MIM:269160]: Extremely rare human
CC       congenital disorder characterized by a full-thickness cleft within
CC       the cerebral hemispheres. These clefts are lined with gray matter
CC       and most commonly involve the parasylvian regions. Large portions
CC       of the cerebral hemispheres may be absent and replaced by cerebro-
CC       spinal fluid. {ECO:0000269|PubMed:20157829}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF092047; AAD11939.1; -; Genomic_DNA.
DR   EMBL; AF049339; AAD15753.1; -; Genomic_DNA.
DR   EMBL; AF083891; AAD51091.1; -; Genomic_DNA.
DR   EMBL; AJ012611; CAB42539.1; -; mRNA.
DR   EMBL; AC012354; AAX93283.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00267.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00268.1; -; Genomic_DNA.
DR   CCDS; CCDS1821.1; -.
DR   RefSeq; NP_005404.1; NM_005413.3.
DR   UniGene; Hs.567336; -.
DR   ProteinModelPortal; O95343; -.
DR   SMR; O95343; -.
DR   BioGrid; 112387; 5.
DR   IntAct; O95343; 1.
DR   STRING; 9606.ENSP00000260653; -.
DR   iPTMnet; O95343; -.
DR   PhosphoSitePlus; O95343; -.
DR   BioMuta; SIX3; -.
DR   EPD; O95343; -.
DR   MaxQB; O95343; -.
DR   PaxDb; O95343; -.
DR   PeptideAtlas; O95343; -.
DR   PRIDE; O95343; -.
DR   DNASU; 6496; -.
DR   Ensembl; ENST00000260653; ENSP00000260653; ENSG00000138083.
DR   GeneID; 6496; -.
DR   KEGG; hsa:6496; -.
DR   UCSC; uc002run.2; human.
DR   CTD; 6496; -.
DR   DisGeNET; 6496; -.
DR   EuPathDB; HostDB:ENSG00000138083.4; -.
DR   GeneCards; SIX3; -.
DR   GeneReviews; SIX3; -.
DR   H-InvDB; HIX0161628; -.
DR   HGNC; HGNC:10889; SIX3.
DR   HPA; HPA067988; -.
DR   MalaCards; SIX3; -.
DR   MIM; 157170; phenotype.
DR   MIM; 269160; phenotype.
DR   MIM; 603714; gene.
DR   neXtProt; NX_O95343; -.
DR   OpenTargets; ENSG00000138083; -.
DR   Orphanet; 93925; Alobar holoprosencephaly.
DR   Orphanet; 93924; Lobar holoprosencephaly.
DR   Orphanet; 280200; Microform holoprosencephaly.
DR   Orphanet; 93926; Midline interhemispheric variant of holoprosencephaly.
DR   Orphanet; 799; Schizencephaly.
DR   Orphanet; 220386; Semilobar holoprosencephaly.
DR   Orphanet; 280195; Septopreoptic holoprosencephaly.
DR   PharmGKB; PA35789; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000261680; -.
DR   HOVERGEN; HBG003609; -.
DR   InParanoid; O95343; -.
DR   KO; K19473; -.
DR   OMA; ELSMFQL; -.
DR   OrthoDB; EOG091G083I; -.
DR   PhylomeDB; O95343; -.
DR   TreeFam; TF315545; -.
DR   SIGNOR; O95343; -.
DR   ChiTaRS; SIX3; human.
DR   GeneWiki; SIX3; -.
DR   GenomeRNAi; 6496; -.
DR   PRO; PR:O95343; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138083; -.
DR   CleanEx; HS_SIX3; -.
DR   Genevisible; O95343; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0042826; F:histone deacetylase binding; IEA:Ensembl.
DR   GO; GO:0005102; F:receptor binding; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0001222; F:transcription corepressor binding; IPI:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:1902742; P:apoptotic process involved in development; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; TAS:ProtInc.
DR   GO; GO:0021846; P:cell proliferation in forebrain; ISS:UniProtKB.
DR   GO; GO:0048512; P:circadian behavior; IEA:Ensembl.
DR   GO; GO:0002070; P:epithelial cell maturation; ISS:UniProtKB.
DR   GO; GO:0001654; P:eye development; IDA:UniProtKB.
DR   GO; GO:0021797; P:forebrain anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0021798; P:forebrain dorsal/ventral pattern formation; IDA:UniProtKB.
DR   GO; GO:0002088; P:lens development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:1990086; P:lens fiber cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0070306; P:lens fiber cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0014016; P:neuroblast differentiation; ISS:UniProtKB.
DR   GO; GO:0097402; P:neuroblast migration; ISS:UniProtKB.
DR   GO; GO:0003404; P:optic vesicle morphogenesis; ISS:UniProtKB.
DR   GO; GO:0021983; P:pituitary gland development; ISS:UniProtKB.
DR   GO; GO:0000060; P:protein import into nucleus, translocation; ISS:UniProtKB.
DR   GO; GO:0009946; P:proximal/distal axis specification; ISS:UniProtKB.
DR   GO; GO:1901987; P:regulation of cell cycle phase transition; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:2000177; P:regulation of neural precursor cell proliferation; ISS:UniProtKB.
DR   GO; GO:0061074; P:regulation of neural retina development; ISS:UniProtKB.
DR   GO; GO:1902692; P:regulation of neuroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0021537; P:telencephalon development; ISS:UniProtKB.
DR   GO; GO:0021978; P:telencephalon regionalization; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   InterPro; IPR032949; SIX3.
DR   PANTHER; PTHR10390:SF31; PTHR10390:SF31; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Holoprosencephaly; Homeobox; Nucleus; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    332       Homeobox protein SIX3.
FT                                /FTId=PRO_0000049299.
FT   DNA_BIND    206    265       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       72    119       Interaction with AES.
FT                                {ECO:0000250|UniProtKB:Q62233}.
FT   REGION      232    234       Bind to RHO promoter.
FT                                {ECO:0000250|UniProtKB:Q62233}.
FT   COMPBIAS     33     69       Gly-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00008}.
FT   VARIANT      37     37       G -> C (in SCHZC AND HPE2;
FT                                dbSNP:rs199823175).
FT                                {ECO:0000269|PubMed:18791198,
FT                                ECO:0000269|PubMed:20157829}.
FT                                /FTId=VAR_071335.
FT   VARIANT      69     69       G -> D (in HPE2; dbSNP:rs121917881).
FT                                {ECO:0000269|PubMed:17001667}.
FT                                /FTId=VAR_038418.
FT   VARIANT      79     79       M -> V (in HPE2).
FT                                {ECO:0000269|PubMed:20531442}.
FT                                /FTId=VAR_071336.
FT   VARIANT      92     92       V -> G (in HPE2).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023797.
FT   VARIANT      93     93       A -> D (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071337.
FT   VARIANT     105    105       I -> V (in HPE2).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023798.
FT   VARIANT     113    113       W -> C (in HPE2; dbSNP:rs137853021).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071338.
FT   VARIANT     114    114       S -> L (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071339.
FT   VARIANT     138    138       V -> D (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071340.
FT   VARIANT     155    155       Missing (in HPE2).
FT                                {ECO:0000269|PubMed:20531442}.
FT                                /FTId=VAR_071341.
FT   VARIANT     157    157       F -> I (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071342.
FT   VARIANT     167    167       A -> S (in SCHZC; dbSNP:rs387906868).
FT                                {ECO:0000269|PubMed:20157829}.
FT                                /FTId=VAR_071343.
FT   VARIANT     172    172       A -> V (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071344.
FT   VARIANT     173    173       H -> P (in HPE2).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023799.
FT   VARIANT     174    174       Y -> H (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071345.
FT   VARIANT     202    202       T -> I (in HPE2).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023800.
FT   VARIANT     213    213       F -> V (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071346.
FT   VARIANT     218    218       R -> P (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071347.
FT   VARIANT     218    218       R -> W (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071348.
FT   VARIANT     226    226       L -> V (in HPE2; dbSNP:rs121917878).
FT                                {ECO:0000269|PubMed:10369266}.
FT                                /FTId=VAR_003771.
FT   VARIANT     227    227       Q -> P (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071349.
FT   VARIANT     231    231       P -> R (in HPE2).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023801.
FT   VARIANT     244    244       G -> C (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071350.
FT   VARIANT     250    250       V -> A (in HPE2; Significantly decreased
FT                                its ability to activate NR4A3;
FT                                dbSNP:rs121917880).
FT                                {ECO:0000269|PubMed:10369266,
FT                                ECO:0000269|PubMed:15523651}.
FT                                /FTId=VAR_003772.
FT   VARIANT     254    254       F -> L (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071351.
FT   VARIANT     257    257       R -> G (in HPE2).
FT                                {ECO:0000269|PubMed:20531442}.
FT                                /FTId=VAR_071352.
FT   VARIANT     257    257       R -> P (in HPE2; Significantly decreased
FT                                interaction with NR4A3; Significantly
FT                                decreased its ability to activate NR4A3;
FT                                dbSNP:rs121917879).
FT                                {ECO:0000269|PubMed:10369266,
FT                                ECO:0000269|PubMed:15523651}.
FT                                /FTId=VAR_003773.
FT   VARIANT     257    257       R -> W (in HPE2).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023802.
FT   VARIANT     258    258       R -> L (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071353.
FT   VARIANT     262    262       R -> H (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071354.
FT   VARIANT     269    269       R -> M (in HPE2).
FT                                {ECO:0000269|PubMed:20531442}.
FT                                /FTId=VAR_071355.
FT   VARIANT     269    269       R -> S (in HPE2).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071356.
FT   VARIANT     269    269       R -> T (in HPE2).
FT                                {ECO:0000269|PubMed:20531442}.
FT                                /FTId=VAR_071357.
FT   VARIANT     297    297       P -> L (in HPE2; dbSNP:rs780942050).
FT                                {ECO:0000269|PubMed:18791198}.
FT                                /FTId=VAR_071358.
FT   MUTAGEN      87     87       F->E: Decreased interaction with AES and
FT                                loss ineteraction with TLE1.
FT                                {ECO:0000269|PubMed:12441302}.
FT   MUTAGEN      95     95       V->P: Loss of interaction with TLE1 and
FT                                AES; when associated with P-99.
FT                                {ECO:0000269|PubMed:12441302}.
FT   MUTAGEN      99     99       L->P: Loss of interaction with TLE1 and
FT                                AES; when associated with P-95.
FT                                {ECO:0000269|PubMed:12441302}.
SQ   SEQUENCE   332 AA;  35487 MW;  21EA07F6A2DD978F CRC64;
     MVFRSPLDLY SSHFLLPNFA DSHHRSILLA SSGGGNGAGG GGGAGGGSGG GNGAGGGGAG
     GAGGGGGGGS RAPPEELSMF QLPTLNFSPE QVASVCETLE ETGDIERLGR FLWSLPVAPG
     ACEAINKHES ILRARAVVAF HTGNFRDLYH ILENHKFTKE SHGKLQAMWL EAHYQEAEKL
     RGRPLGPVDK YRVRKKFPLP RTIWDGEQKT HCFKERTRSL LREWYLQDPY PNPSKKRELA
     QATGLTPTQV GNWFKNRRQR DRAAAAKNRL QHQAIGPSGM RSLAEPGCPT HGSAESPSTA
     ASPTTSVSSL TERADTGTSI LSVTSSDSEC DV
//
ID   OTX1_HUMAN              Reviewed;         354 AA.
AC   P32242; A6NHA2; B3KTJ4; Q53TG6;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Homeobox protein OTX1;
DE   AltName: Full=Orthodenticle homolog 1;
GN   Name=OTX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8101484;
RA   Simeone A., Acampora D., Mallamaci A., Stornaiuolo A., D'Apice M.R.,
RA   Nigro V., Boncinelli E.;
RT   "A vertebrate gene related to orthodenticle contains a homeodomain of
RT   the bicoid class and demarcates anterior neuroectoderm in the
RT   gastrulating mouse embryo.";
RL   EMBO J. 12:2735-2747(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=19414065; DOI=10.1016/j.ijdevneu.2009.04.004;
RA   Larsen K.B., Lutterodt M., Rath M.F., Moeller M.;
RT   "Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early
RT   human fetal retina.";
RL   Int. J. Dev. Neurosci. 27:485-492(2009).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-344, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-344, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Probably plays a role in the development of the brain
CC       and the sense organs. Can bind to the BCD target sequence (BTS):
CC       5'-TCTAATCCC-3'.
CC   -!- INTERACTION:
CC       Q6UY14-3:ADAMTSL4; NbExp=4; IntAct=EBI-740446, EBI-10173507;
CC       Q8NHP1-2:AKR7L; NbExp=4; IntAct=EBI-740446, EBI-12816993;
CC       P05187:ALPP; NbExp=4; IntAct=EBI-740446, EBI-1211484;
CC       Q9UKJ5:CHIC2; NbExp=3; IntAct=EBI-740446, EBI-741528;
CC       Q9H2X0:CHRD; NbExp=3; IntAct=EBI-740446, EBI-947551;
CC       P27658:COL8A1; NbExp=4; IntAct=EBI-740446, EBI-747133;
CC       P49747:COMP; NbExp=5; IntAct=EBI-740446, EBI-2531022;
CC       A8MQ03:CYSRT1; NbExp=4; IntAct=EBI-740446, EBI-3867333;
CC       Q9UBX5:FBLN5; NbExp=3; IntAct=EBI-740446, EBI-947897;
CC       P28799:GRN; NbExp=10; IntAct=EBI-740446, EBI-747754;
CC       Q5TA45:INTS11; NbExp=4; IntAct=EBI-740446, EBI-748258;
CC       Q96T55:KCNK16; NbExp=3; IntAct=EBI-740446, EBI-10294109;
CC       Q5T749:KPRP; NbExp=4; IntAct=EBI-740446, EBI-10981970;
CC       Q14533:KRT81; NbExp=9; IntAct=EBI-740446, EBI-739648;
CC       P78386:KRT85; NbExp=4; IntAct=EBI-740446, EBI-1049371;
CC       P60412:KRTAP10-11; NbExp=5; IntAct=EBI-740446, EBI-10217483;
CC       P60370:KRTAP10-5; NbExp=5; IntAct=EBI-740446, EBI-10172150;
CC       P60409-2:KRTAP10-7; NbExp=4; IntAct=EBI-740446, EBI-10695388;
CC       P60410:KRTAP10-8; NbExp=9; IntAct=EBI-740446, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=8; IntAct=EBI-740446, EBI-10172052;
CC       P59991:KRTAP12-2; NbExp=5; IntAct=EBI-740446, EBI-10176379;
CC       P60328:KRTAP12-3; NbExp=6; IntAct=EBI-740446, EBI-11953334;
CC       P60329:KRTAP12-4; NbExp=7; IntAct=EBI-740446, EBI-10176396;
CC       Q6PEX3:KRTAP26-1; NbExp=3; IntAct=EBI-740446, EBI-3957672;
CC       Q9BYR7:KRTAP3-2; NbExp=5; IntAct=EBI-740446, EBI-751260;
CC       Q9BYR6:KRTAP3-3; NbExp=5; IntAct=EBI-740446, EBI-3957694;
CC       Q9BYQ6:KRTAP4-11; NbExp=5; IntAct=EBI-740446, EBI-10302392;
CC       Q9BQ66:KRTAP4-12; NbExp=6; IntAct=EBI-740446, EBI-739863;
CC       Q9BYR5:KRTAP4-2; NbExp=3; IntAct=EBI-740446, EBI-10172511;
CC       Q9BYR0:KRTAP4-7; NbExp=3; IntAct=EBI-740446, EBI-10302547;
CC       Q6L8G9:KRTAP5-6; NbExp=5; IntAct=EBI-740446, EBI-10250562;
CC       P26371:KRTAP5-9; NbExp=9; IntAct=EBI-740446, EBI-3958099;
CC       Q9BYQ4:KRTAP9-2; NbExp=7; IntAct=EBI-740446, EBI-1044640;
CC       Q9BYQ3:KRTAP9-3; NbExp=6; IntAct=EBI-740446, EBI-1043191;
CC       Q9BYQ2:KRTAP9-4; NbExp=5; IntAct=EBI-740446, EBI-10185730;
CC       Q9BYQ0:KRTAP9-8; NbExp=4; IntAct=EBI-740446, EBI-11958364;
CC       Q5T7P3:LCE1B; NbExp=3; IntAct=EBI-740446, EBI-10245913;
CC       Q5TA79:LCE2A; NbExp=3; IntAct=EBI-740446, EBI-10246607;
CC       Q5TA81:LCE2C; NbExp=4; IntAct=EBI-740446, EBI-11973993;
CC       Q5TA82:LCE2D; NbExp=3; IntAct=EBI-740446, EBI-10246750;
CC       Q5TA78:LCE4A; NbExp=3; IntAct=EBI-740446, EBI-10246358;
CC       Q6ZP95:LOC642947; NbExp=4; IntAct=EBI-740446, EBI-12813431;
CC       Q99750:MDFI; NbExp=7; IntAct=EBI-740446, EBI-724076;
CC       Q7Z3S9:NOTCH2NL; NbExp=4; IntAct=EBI-740446, EBI-945833;
CC       Q16633:POU2AF1; NbExp=4; IntAct=EBI-740446, EBI-943588;
CC       Q93062:RBPMS; NbExp=4; IntAct=EBI-740446, EBI-740322;
CC       Q9UGC6:RGS17; NbExp=5; IntAct=EBI-740446, EBI-3918154;
CC       O76081:RGS20; NbExp=4; IntAct=EBI-740446, EBI-1052678;
CC       Q16348:SLC15A2; NbExp=4; IntAct=EBI-740446, EBI-12806032;
CC       Q92922:SMARCC1; NbExp=3; IntAct=EBI-740446, EBI-355653;
CC       O43609:SPRY1; NbExp=3; IntAct=EBI-740446, EBI-3866665;
CC       O43597:SPRY2; NbExp=4; IntAct=EBI-740446, EBI-742487;
CC       Q63HR2:TNS2; NbExp=6; IntAct=EBI-740446, EBI-949753;
CC       Q9UF72:TP73-AS1; NbExp=4; IntAct=EBI-740446, EBI-11976343;
CC       B2RUY7:VWC2L; NbExp=4; IntAct=EBI-740446, EBI-11747707;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain. Detected in the anterior
CC       part of the neural fetal retina (at protein level).
CC       {ECO:0000269|PubMed:19414065}.
CC   -!- DEVELOPMENTAL STAGE: Embryo.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK095680; BAG53106.1; -; mRNA.
DR   EMBL; AC009501; AAY24357.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99967.1; -; Genomic_DNA.
DR   EMBL; BC007621; AAH07621.1; -; mRNA.
DR   CCDS; CCDS1873.1; -.
DR   PIR; S39406; S39406.
DR   RefSeq; NP_001186699.1; NM_001199770.1.
DR   RefSeq; NP_055377.1; NM_014562.3.
DR   UniGene; Hs.734360; -.
DR   ProteinModelPortal; P32242; -.
DR   SMR; P32242; -.
DR   BioGrid; 111053; 41.
DR   IntAct; P32242; 122.
DR   MINT; MINT-1437362; -.
DR   STRING; 9606.ENSP00000282549; -.
DR   iPTMnet; P32242; -.
DR   PhosphoSitePlus; P32242; -.
DR   BioMuta; OTX1; -.
DR   DMDM; 417425; -.
DR   EPD; P32242; -.
DR   MaxQB; P32242; -.
DR   PaxDb; P32242; -.
DR   PeptideAtlas; P32242; -.
DR   PRIDE; P32242; -.
DR   DNASU; 5013; -.
DR   Ensembl; ENST00000282549; ENSP00000282549; ENSG00000115507.
DR   Ensembl; ENST00000366671; ENSP00000355631; ENSG00000115507.
DR   GeneID; 5013; -.
DR   KEGG; hsa:5013; -.
DR   UCSC; uc002scd.4; human.
DR   CTD; 5013; -.
DR   DisGeNET; 5013; -.
DR   EuPathDB; HostDB:ENSG00000115507.9; -.
DR   GeneCards; OTX1; -.
DR   HGNC; HGNC:8521; OTX1.
DR   HPA; CAB012341; -.
DR   HPA; HPA052122; -.
DR   MIM; 600036; gene.
DR   neXtProt; NX_P32242; -.
DR   OpenTargets; ENSG00000115507; -.
DR   PharmGKB; PA32848; -.
DR   eggNOG; KOG2251; Eukaryota.
DR   eggNOG; ENOG4111XIJ; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOVERGEN; HBG004028; -.
DR   InParanoid; P32242; -.
DR   KO; K09326; -.
DR   OMA; PPYGVNG; -.
DR   OrthoDB; EOG091G0K9K; -.
DR   PhylomeDB; P32242; -.
DR   TreeFam; TF351179; -.
DR   ChiTaRS; OTX1; human.
DR   GeneWiki; OTX1; -.
DR   GenomeRNAi; 5013; -.
DR   PRO; PR:P32242; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115507; -.
DR   CleanEx; HS_OTX1; -.
DR   ExpressionAtlas; P32242; baseline and differential.
DR   Genevisible; P32242; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048852; P:diencephalon morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0022037; P:metencephalon development; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003026; Otx1_TF.
DR   InterPro; IPR003025; Otx_TF.
DR   InterPro; IPR013851; Otx_TF_C.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03529; TF_Otx; 1.
DR   PRINTS; PR01256; OTX1HOMEOBOX.
DR   PRINTS; PR01255; OTXHOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Isopeptide bond; Nucleus; Reference proteome; Ubl conjugation.
FT   CHAIN         1    354       Homeobox protein OTX1.
FT                                /FTId=PRO_0000049207.
FT   DNA_BIND     38     97       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    275    301       His-rich.
FT   CROSSLNK    344    344       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
SQ   SEQUENCE   354 AA;  37327 MW;  E32C1E47464BDDAA CRC64;
     MMSYLKQPPY GMNGLGLAGP AMDLLHPSVG YPATPRKQRR ERTTFTRSQL DVLEALFAKT
     RYPDIFMREE VALKINLPES RVQVWFKNRR AKCRQQQQSG SGTKSRPAKK KSSPVRESSG
     SESSGQFTPP AVSSSASSSS SASSSSANPA AAAAAGLGGN PVAAASSLST PAASSIWSPA
     SISPGSAPAS VSVPEPLAAP SNTSCMQRSV AAGAATAAAS YPMSYGQGGS YGQGYPTPSS
     SYFGGVDCSS YLAPMHSHHH PHQLSPMAPS SMAGHHHHHP HAHHPLSQSS GHHHHHHHHH
     HQGYGGSGLA FNSADCLDYK EPGAAAASSA WKLNFNSPDC LDYKDQASWR FQVL
//
ID   ZEB1_HUMAN              Reviewed;        1124 AA.
AC   P37275; B4DJV0; B4DUW9; E9PCM7; F5H4I8; Q12924; Q13800; Q2KJ05;
AC   Q5T968; Q5VZ84; Q8NB68;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   25-OCT-2017, entry version 182.
DE   RecName: Full=Zinc finger E-box-binding homeobox 1;
DE   AltName: Full=NIL-2-A zinc finger protein;
DE   AltName: Full=Negative regulator of IL2;
DE   AltName: Full=Transcription factor 8;
DE            Short=TCF-8;
GN   Name=ZEB1; Synonyms=AREB6, TCF8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8138542;
RA   Watanabe Y., Kawakami K., Hirayama Y., Nagano K.;
RT   "Transcription factors positively and negatively regulating the Na,K-
RT   ATPase alpha 1 subunit gene.";
RL   J. Biochem. 114:849-855(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Bachman N.J., Scarpulla R.C.;
RT   "A human zinc finger homeodomain protein homologous to the chicken
RT   delta-crystallin enhancer binding protein, delta EF1.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-798 (ISOFORM 5).
RC   TISSUE=Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 390-1124.
RX   PubMed=1840704; DOI=10.1126/science.1840704;
RA   Williams T.M., Moolten D., Burlein J., Romano J., Bhaerman R.,
RA   Godillot A., Mellon M., Rauscher F.J. III, Kant J.A.;
RT   "Identification of a zinc finger protein that inhibits IL-2 gene
RT   expression.";
RL   Science 254:1791-1794(1991).
RN   [8]
RP   INVOLVEMENT IN PPCD3.
RX   PubMed=16252232; DOI=10.1086/497348;
RA   Krafchak C.M., Pawar H., Moroi S.E., Sugar A., Lichter P.R.,
RA   Mackey D.A., Mian S., Nairus T., Elner V., Schteingart M.T.,
RA   Downs C.A., Kijek T.G., Johnson J.M., Trager E.H., Rozsa F.W.,
RA   Mandal M.N.A., Epstein M.P., Vollrath D., Ayyagari R., Boehnke M.,
RA   Richards J.E.;
RT   "Mutations in TCF8 cause posterior polymorphous corneal dystrophy and
RT   ectopic expression of COL4A3 by corneal endothelial cells.";
RL   Am. J. Hum. Genet. 77:694-708(2005).
RN   [9]
RP   SUMOYLATION AT LYS-347 AND LYS-774.
RX   PubMed=16061479; DOI=10.1074/jbc.M504477200;
RA   Long J., Zuo D., Park M.;
RT   "Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates
RT   transcriptional repression of E-cadherin.";
RL   J. Biol. Chem. 280:35477-35489(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-322, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=19935649; DOI=10.1038/ncb1998;
RA   Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F.,
RA   Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A.,
RA   Brunton V.G., Morton J., Sansom O., Schuler J., Stemmler M.P.,
RA   Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T.;
RT   "The EMT-activator ZEB1 promotes tumorigenicity by repressing
RT   stemness-inhibiting microRNAs.";
RL   Nat. Cell Biol. 11:1487-1495(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642; SER-679 AND
RP   THR-702, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=20175752; DOI=10.1042/BJ20091578;
RA   Papadopoulou V., Postigo A., Sanchez-Tillo E., Porter A.C.,
RA   Wagner S.D.;
RT   "ZEB1 and CtBP form a repressive complex at a distal promoter element
RT   of the BCL6 locus.";
RL   Biochem. J. 427:541-550(2010).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SMARCA4, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20418909; DOI=10.1038/onc.2010.102;
RA   Sanchez-Tillo E., Lazaro A., Torrent R., Cuatrecasas M., Vaquero E.C.,
RA   Castells A., Engel P., Postigo A.;
RT   "ZEB1 represses E-cadherin and induces an EMT by recruiting the
RT   SWI/SNF chromatin-remodeling protein BRG1.";
RL   Oncogene 29:3490-3500(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679 AND THR-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-186; LYS-195; LYS-307;
RP   LYS-331; LYS-335; LYS-347; LYS-439; LYS-493; LYS-504; LYS-515;
RP   LYS-548; LYS-553 AND LYS-774, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   STRUCTURE BY NMR OF 583-642.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain from human NIL-2-A zinc
RT   finger protein, transcription factor 8.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [26]
RP   VARIANTS FECD6 THR-78; ALA-649; PRO-810; PRO-840 AND THR-905.
RX   PubMed=20036349; DOI=10.1016/j.ajhg.2009.12.001;
RA   Riazuddin S.A., Zaghloul N.A., Al-Saif A., Davey L., Diplas B.H.,
RA   Meadows D.N., Eghrari A.O., Minear M.A., Li Y.J., Klintworth G.K.,
RA   Afshari N., Gregory S.G., Gottsch J.D., Katsanis N.;
RT   "Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy
RT   and interact with FCD4 on chromosome 9p.";
RL   Am. J. Hum. Genet. 86:45-53(2010).
RN   [27]
RP   INVOLVEMENT IN FECD6 AND PPCD3, VARIANT FECD6 HIS-640,
RP   CHARACTERIZATION OF VARIANTS FECD6 THR-78 AND HIS-640, AND VARIANT
RP   GLU-525.
RX   PubMed=23599324; DOI=10.1167/iovs.13-11781;
RA   Lechner J., Dash D.P., Muszynska D., Hosseini M., Segev F., George S.,
RA   Frazer D.G., Moore J.E., Kaye S.B., Young T., Simpson D.A.,
RA   Churchill A.J., Heon E., Willoughby C.E.;
RT   "Mutational spectrum of the ZEB1 gene in corneal dystrophies supports
RT   a genotype-phenotype correlation.";
RL   Invest. Ophthalmol. Vis. Sci. 54:3215-3223(2013).
RN   [28]
RP   VARIANTS FECD6 THR-78; ALA-649; SER-696; PRO-810; PRO-840 AND GLY-905,
RP   CHARACTERIZATION OF VARIANTS FECD6 THR-78; ALA-649; SER-696; PRO-810;
RP   PRO-840 AND GLY-905, AND SUBCELLULAR LOCATION.
RX   PubMed=25190660; DOI=10.1167/iovs.14-15247;
RA   Chung D.W., Frausto R.F., Ann L.B., Jang M.S., Aldave A.J.;
RT   "Functional impact of ZEB1 mutations associated with posterior
RT   polymorphous and Fuchs' endothelial corneal dystrophies.";
RL   Invest. Ophthalmol. Vis. Sci. 55:6159-6166(2014).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Inhibits
CC       interleukin-2 (IL-2) gene expression. Enhances or represses the
CC       promoter activity of the ATP1A1 gene depending on the quantity of
CC       cDNA and on the cell type. Represses E-cadherin promoter and
CC       induces an epithelial-mesenchymal transition (EMT) by recruiting
CC       SMARCA4/BRG1. Represses BCL6 transcription in the presence of the
CC       corepressor CTBP1. Positively regulates neuronal differentiation.
CC       Represses RCOR1 transcription activation during neurogenesis.
CC       Represses transcription by binding to the E box (5'-CANNTG-3').
CC       Promotes tumorigenicity by repressing stemness-inhibiting
CC       microRNAs. {ECO:0000269|PubMed:19935649,
CC       ECO:0000269|PubMed:20175752, ECO:0000269|PubMed:20418909}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with SMARCA4/BRG1.
CC       {ECO:0000269|PubMed:20418909}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20418909,
CC       ECO:0000269|PubMed:25190660}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P37275-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37275-2; Sequence=VSP_045184;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P37275-3; Sequence=VSP_047280;
CC       Name=4;
CC         IsoId=P37275-4; Sequence=VSP_047281;
CC       Name=5;
CC         IsoId=P37275-5; Sequence=VSP_047279, VSP_045184;
CC   -!- TISSUE SPECIFICITY: Colocalizes with SMARCA4/BRG1 in E-cadherin-
CC       negative cells from established lines, and stroma of normal colon
CC       as well as in de-differentiated epithelial cells at the invasion
CC       front of colorectal carcinomas (at protein level). Expressed in
CC       heart and skeletal muscle, but not in liver, spleen, or pancreas.
CC       {ECO:0000269|PubMed:20418909}.
CC   -!- DISEASE: Corneal dystrophy, posterior polymorphous, 3 (PPCD3)
CC       [MIM:609141]: A subtype of posterior corneal dystrophy, a disease
CC       characterized by alterations of Descemet membrane presenting as
CC       vesicles, opacities or band-like lesions on slit-lamp examination
CC       and specular microscopy. Affected patient typically are
CC       asymptomatic. {ECO:0000269|PubMed:16252232,
CC       ECO:0000269|PubMed:23599324}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Corneal dystrophy, Fuchs endothelial, 6 (FECD6)
CC       [MIM:613270]: A corneal disease caused by loss of endothelium of
CC       the central cornea. It is characterized by focal wart-like guttata
CC       that arise from Descemet membrane and develop in the central
CC       cornea, epithelial blisters, reduced vision and pain. Descemet
CC       membrane is thickened by abnormal collagenous deposition.
CC       {ECO:0000269|PubMed:20036349, ECO:0000269|PubMed:23599324,
CC       ECO:0000269|PubMed:25190660}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the delta-EF1/ZFH-1 C2H2-type zinc-finger
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG62481.1; Type=Frameshift; Positions=177; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D15050; BAA03646.1; -; mRNA.
DR   EMBL; U12170; AAA20602.1; -; mRNA.
DR   EMBL; AK091478; BAC03673.1; -; mRNA.
DR   EMBL; AK296244; BAG58962.1; -; mRNA.
DR   EMBL; AK300830; BAG62481.1; ALT_FRAME; mRNA.
DR   EMBL; AL158080; CAI17320.1; -; Genomic_DNA.
DR   EMBL; AL117340; CAI17320.1; JOINED; Genomic_DNA.
DR   EMBL; AL161935; CAI17320.1; JOINED; Genomic_DNA.
DR   EMBL; AL355148; CAI17320.1; JOINED; Genomic_DNA.
DR   EMBL; AL161935; CAH74132.1; -; Genomic_DNA.
DR   EMBL; AL117340; CAH74132.1; JOINED; Genomic_DNA.
DR   EMBL; AL158080; CAH74132.1; JOINED; Genomic_DNA.
DR   EMBL; AL355148; CAH74132.1; JOINED; Genomic_DNA.
DR   EMBL; AL117340; CAI12550.1; -; Genomic_DNA.
DR   EMBL; AL158080; CAI12550.1; JOINED; Genomic_DNA.
DR   EMBL; AL161935; CAI12550.1; JOINED; Genomic_DNA.
DR   EMBL; AL355148; CAI12550.1; JOINED; Genomic_DNA.
DR   EMBL; AL355148; CAI15108.1; -; Genomic_DNA.
DR   EMBL; AL117340; CAI15108.1; JOINED; Genomic_DNA.
DR   EMBL; AL158080; CAI15108.1; JOINED; Genomic_DNA.
DR   EMBL; AL161935; CAI15108.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW85989.1; -; Genomic_DNA.
DR   EMBL; BC112392; AAI12393.1; -; mRNA.
DR   EMBL; M81699; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS44370.1; -. [P37275-5]
DR   CCDS; CCDS53505.1; -. [P37275-2]
DR   CCDS; CCDS53506.1; -. [P37275-4]
DR   CCDS; CCDS53507.1; -. [P37275-3]
DR   CCDS; CCDS7169.1; -. [P37275-1]
DR   PIR; JX0293; JX0293.
DR   RefSeq; NP_001121600.1; NM_001128128.2. [P37275-5]
DR   RefSeq; NP_001167564.1; NM_001174093.1. [P37275-4]
DR   RefSeq; NP_001167565.1; NM_001174094.1.
DR   RefSeq; NP_001167566.1; NM_001174095.1. [P37275-3]
DR   RefSeq; NP_001167567.1; NM_001174096.1. [P37275-2]
DR   RefSeq; NP_110378.3; NM_030751.5. [P37275-1]
DR   UniGene; Hs.124503; -.
DR   PDB; 2E19; NMR; -; A=586-642.
DR   PDBsum; 2E19; -.
DR   ProteinModelPortal; P37275; -.
DR   SMR; P37275; -.
DR   BioGrid; 112796; 26.
DR   CORUM; P37275; -.
DR   ELM; P37275; -.
DR   IntAct; P37275; 3.
DR   MINT; MINT-94525; -.
DR   STRING; 9606.ENSP00000354487; -.
DR   iPTMnet; P37275; -.
DR   PhosphoSitePlus; P37275; -.
DR   BioMuta; ZEB1; -.
DR   DMDM; 6166575; -.
DR   EPD; P37275; -.
DR   MaxQB; P37275; -.
DR   PaxDb; P37275; -.
DR   PeptideAtlas; P37275; -.
DR   PRIDE; P37275; -.
DR   Ensembl; ENST00000320985; ENSP00000319248; ENSG00000148516. [P37275-1]
DR   Ensembl; ENST00000361642; ENSP00000354487; ENSG00000148516. [P37275-2]
DR   Ensembl; ENST00000446923; ENSP00000391612; ENSG00000148516. [P37275-5]
DR   Ensembl; ENST00000542815; ENSP00000444891; ENSG00000148516. [P37275-3]
DR   Ensembl; ENST00000560721; ENSP00000452787; ENSG00000148516. [P37275-4]
DR   GeneID; 6935; -.
DR   KEGG; hsa:6935; -.
DR   UCSC; uc001ivs.5; human. [P37275-1]
DR   CTD; 6935; -.
DR   DisGeNET; 6935; -.
DR   EuPathDB; HostDB:ENSG00000148516.21; -.
DR   GeneCards; ZEB1; -.
DR   HGNC; HGNC:11642; ZEB1.
DR   HPA; CAB058686; -.
DR   HPA; HPA027524; -.
DR   MalaCards; ZEB1; -.
DR   MIM; 189909; gene.
DR   MIM; 609141; phenotype.
DR   MIM; 613270; phenotype.
DR   neXtProt; NX_P37275; -.
DR   OpenTargets; ENSG00000148516; -.
DR   Orphanet; 98974; Fuchs endothelial corneal dystrophy.
DR   Orphanet; 98973; Posterior polymorphous corneal dystrophy.
DR   PharmGKB; PA162409589; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   GeneTree; ENSGT00630000089829; -.
DR   HOGENOM; HOG000264256; -.
DR   HOVERGEN; HBG004697; -.
DR   InParanoid; P37275; -.
DR   KO; K09299; -.
DR   OMA; ECEKPQG; -.
DR   OrthoDB; EOG091G0F7Y; -.
DR   PhylomeDB; P37275; -.
DR   TreeFam; TF331759; -.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   SignaLink; P37275; -.
DR   SIGNOR; P37275; -.
DR   ChiTaRS; ZEB1; human.
DR   EvolutionaryTrace; P37275; -.
DR   GeneWiki; ZEB1; -.
DR   GenomeRNAi; 6935; -.
DR   PRO; PR:P37275; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148516; -.
DR   CleanEx; HS_ZEB1; -.
DR   ExpressionAtlas; P37275; baseline and differential.
DR   Genevisible; P37275; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0010464; P:regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0051150; P:regulation of smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0033081; P:regulation of T cell differentiation in thymus; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   Gene3D; 4.10.1050.10; -; 1.
DR   InterPro; IPR026939; At2g23090-like.
DR   InterPro; IPR008598; Di19_Zn_binding_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Corneal dystrophy; Differentiation; Disease mutation; DNA-binding;
KW   Homeobox; Isopeptide bond; Metal-binding; Neurogenesis; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1124       Zinc finger E-box-binding homeobox 1.
FT                                /FTId=PRO_0000047231.
FT   ZN_FING     170    193       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     200    222       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     240    262       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     268    292       C2H2-type 4; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   DNA_BIND    581    640       Homeobox; atypical.
FT   ZN_FING     904    926       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     932    954       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     960    981       C2H2-type 7; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   COMPBIAS    989   1124       Glu-rich (acidic).
FT   MOD_RES      31     31       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62947}.
FT   MOD_RES      33     33       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62947}.
FT   MOD_RES     313    313       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     642    642       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     679    679       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     693    693       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     700    700       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     702    702       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     704    704       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   CROSSLNK    186    186       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    195    195       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    307    307       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    331    331       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    335    335       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    347    347       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    347    347       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    439    439       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    493    493       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    504    504       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    515    515       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    548    548       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    553    553       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     19       MADGPRCKRRKQANPRRNN -> MK (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047279.
FT   VAR_SEQ      20     87       VTNYNTVVETNSDSDDEDKLHIVEEESVTDAADCEGVPEDD
FT                                LPTDQTVLPGRSSEREGNAKNCWEDDR -> G (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047280.
FT   VAR_SEQ      87    107       RKEGQEILGPEAQADEAGCTV -> I (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047281.
FT   VAR_SEQ      87     87       R -> TG (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045184.
FT   VARIANT      78     78       N -> T (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs80194531).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:23599324,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063759.
FT   VARIANT      90     90       G -> R (in dbSNP:rs12217419).
FT                                /FTId=VAR_052731.
FT   VARIANT     525    525       G -> E (found in a patient with FECD6).
FT                                {ECO:0000269|PubMed:23599324}.
FT                                /FTId=VAR_072897.
FT   VARIANT     553    553       K -> R (in dbSNP:rs35753967).
FT                                /FTId=VAR_031824.
FT   VARIANT     640    640       Q -> H (in FECD6; down-regulation of
FT                                several collagen genes expression;
FT                                dbSNP:rs779148597).
FT                                {ECO:0000269|PubMed:23599324}.
FT                                /FTId=VAR_072898.
FT   VARIANT     649    649       P -> A (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs781750314).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063760.
FT   VARIANT     696    696       N -> S (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs567252241).
FT                                {ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_072899.
FT   VARIANT     810    810       Q -> P (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs199944415).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063761.
FT   VARIANT     840    840       Q -> P (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs118020901).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063762.
FT   VARIANT     905    905       A -> G (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs78449005).
FT                                {ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_072900.
FT   VARIANT     905    905       A -> T (in FECD6).
FT                                {ECO:0000269|PubMed:20036349}.
FT                                /FTId=VAR_063763.
FT   CONFLICT     12     12       Q -> R (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT     81     81       N -> S (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       E -> K (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT    220    220       T -> A (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       M -> T (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    420    420       V -> I (in Ref. 2; AAA20602).
FT                                {ECO:0000305}.
FT   CONFLICT    472    472       K -> R (in Ref. 3; BAG58962).
FT                                {ECO:0000305}.
FT   CONFLICT    609    609       E -> Q (in Ref. 7; M81699).
FT                                {ECO:0000305}.
FT   CONFLICT    654    654       I -> T (in Ref. 2; AAA20602).
FT                                {ECO:0000305}.
FT   CONFLICT    672    672       D -> H (in Ref. 7; M81699).
FT                                {ECO:0000305}.
FT   CONFLICT    681    681       L -> S (in Ref. 7; M81699).
FT                                {ECO:0000305}.
FT   CONFLICT    775    775       K -> T (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    793    794       IP -> KY (in Ref. 3; BAG58962).
FT                                {ECO:0000305}.
FT   CONFLICT    797    797       A -> N (in Ref. 3; BAG58962).
FT                                {ECO:0000305}.
FT   CONFLICT    818    818       A -> V (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    838    838       I -> T (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT   1066   1066       E -> G (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   HELIX       590    600       {ECO:0000244|PDB:2E19}.
FT   HELIX       608    618       {ECO:0000244|PDB:2E19}.
FT   HELIX       622    634       {ECO:0000244|PDB:2E19}.
SQ   SEQUENCE   1124 AA;  124074 MW;  0A2714CC37C848D1 CRC64;
     MADGPRCKRR KQANPRRNNV TNYNTVVETN SDSDDEDKLH IVEEESVTDA ADCEGVPEDD
     LPTDQTVLPG RSSEREGNAK NCWEDDRKEG QEILGPEAQA DEAGCTVKDD ECESDAENEQ
     NHDPNVEEFL QQQDTAVIFP EAPEEDQRQG TPEASGHDEN GTPDAFSQLL TCPYCDRGYK
     RFTSLKEHIK YRHEKNEDNF SCSLCSYTFA YRTQLERHMT SHKSGRDQRH VTQSGCNRKF
     KCTECGKAFK YKHHLKEHLR IHSGEKPYEC PNCKKRFSHS GSYSSHISSK KCISLIPVNG
     RPRTGLKTSQ CSSPSLSASP GSPTRPQIRQ KIENKPLQEQ LSVNQIKTEP VDYEFKPIVV
     ASGINCSTPL QNGVFTGGGP LQATSSPQGM VQAVVLPTVG LVSPISINLS DIQNVLKVAV
     DGNVIRQVLE NNQANLASKE QETINASPIQ QGGHSVISAI SLPLVDQDGT TKIIINYSLE
     QPSQLQVVPQ NLKKENPVAT NSCKSEKLPE DLTVKSEKDK SFEGGVNDST CLLCDDCPGD
     INALPELKHY DLKQPTQPPP LPAAEAEKPE SSVSSATGDG NLSPSQPPLK NLLSLLKAYY
     ALNAQPSAEE LSKIADSVNL PLDVVKKWFE KMQAGQISVQ SSEPSSPEPG KVNIPAKNND
     QPQSANANEP QDSTVNLQSP LKMTNSPVLP VGSTTNGSRS STPSPSPLNL SSSRNTQGYL
     YTAEGAQEEP QVEPLDLSLP KQQGELLERS TITSVYQNSV YSVQEEPLNL SCAKKEPQKD
     SCVTDSEPVV NVIPPSANPI NIAIPTVTAQ LPTIVAIADQ NSVPCLRALA ANKQTILIPQ
     VAYTYSTTVS PAVQEPPLKV IQPNGNQDER QDTSSEGVSN VEDQNDSDST PPKKKMRKTE
     NGMYACDLCD KIFQKSSSLL RHKYEHTGKR PHECGICKKA FKHKHHLIEH MRLHSGEKPY
     QCDKCGKRFS HSGSYSQHMN HRYSYCKREA EERDSTEQEE AGPEILSNEH VGARASPSQG
     DSDERESLTR EEDEDSEKEE EEEDKEMEEL QEEKECEKPQ GDEEEEEEEE EVEEEEVEEA
     ENEGEEAKTE GLMKDDRAES QASSLGQKVG ESSEQVSEEK TNEA
//
ID   MSX1_HUMAN              Reviewed;         303 AA.
AC   P28360; A0SZU5; A8K3M1; Q96NY4;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2013, sequence version 3.
DT   25-OCT-2017, entry version 191.
DE   RecName: Full=Homeobox protein MSX-1;
DE   AltName: Full=Homeobox protein Hox-7;
DE   AltName: Full=Msh homeobox 1-like protein;
GN   Name=MSX1; Synonyms=HOX7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lymphocyte;
RX   PubMed=1685479; DOI=10.1016/0888-7543(91)90074-O;
RA   Hewitt J.E., Clarke L.E., Iven A., Williamson R.;
RT   "Structure and sequence of the human homeobox gene HOX7.";
RL   Genomics 11:670-678(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Ectomesenchyme;
RX   PubMed=1284527; DOI=10.1093/hmg/1.6.407;
RA   Padanilam B.J., Stadler S.H., Mills K.A., McLeod L.B., Solursh M.,
RA   Lee B.M., Ramirez F., Buetow K.H., Murray J.C.;
RT   "Characterization of the human HOX 7 cDNA and identification of
RT   polymorphic markers.";
RL   Hum. Mol. Genet. 1:407-410(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND VARIANTS OFC5 VAL-84;
RP   ASP-97; GLY-120; GLU-122 AND SER-157.
RX   PubMed=12807959; DOI=10.1136/jmg.40.6.399;
RA   Jezewski P.A., Vieira A.R., Nishimura C., Ludwig B., Johnson M.,
RA   O'Brien S.E., Daack-Hirsch S., Schultz R.E., Weber A., Nepomucena B.,
RA   Romitti P.A., Christensen K., Orioli I.M., Castilla E.E., Machida J.,
RA   Natsume N., Murray J.C.;
RT   "Complete sequencing shows a role for MSX1 in non-syndromic cleft lip
RT   and palate.";
RL   J. Med. Genet. 40:399-407(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-157.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Neuroblastoma, and Pancreatic carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-156.
RA   Prasad S., Shama Rao K., Mukhyopadhyay A.;
RT   "Single nucleotide polymorphism analysis of the MSX1 gene within
RT   Indian population for cleft lip and palate.";
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 191-251, AND INVOLVEMENT IN
RP   WOLF-HIRSCHHORN SYNDROME.
RX   PubMed=1969845; DOI=10.1007/BF00195823;
RA   Ivens A., Flavin N., Williamson R., Dixon M., Bates G., Buckingham M.,
RA   Robert B.;
RT   "The human homeobox gene HOX7 maps to chromosome 4p16.1 and may be
RT   implicated in Wolf-Hirschhorn syndrome.";
RL   Hum. Genet. 84:473-476(1990).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN ECTD3.
RX   PubMed=11369996; DOI=10.1086/321271;
RA   Jumlongras D., Bei M., Stimson J.M., Wang W.-F., DePalma S.R.,
RA   Seidman C.E., Felbor U., Maas R., Seidman J.G., Olsen B.R.;
RT   "A nonsense mutation in MSX1 causes Witkop syndrome.";
RL   Am. J. Hum. Genet. 69:67-74(2001).
RN   [10]
RP   VARIANT STHAG1 PRO-202.
RX   PubMed=8696335; DOI=10.1038/ng0896-417;
RA   Vastardis H., Karimbux N., Guthua S.W., Seidman J.G., Seidman C.E.;
RT   "A human MSX1 homeodomain missense mutation causes selective tooth
RT   agenesis.";
RL   Nat. Genet. 13:417-421(1996).
RN   [11]
RP   VARIANT STHAG1 LYS-67.
RX   PubMed=12097313; DOI=10.1177/154405910208100410;
RA   Lidral A.C., Reising B.C.;
RT   "The role of MSX1 in human tooth agenesis.";
RL   J. Dent. Res. 81:274-278(2002).
CC   -!- FUNCTION: Acts as a transcriptional repressor. May play a role in
CC       limb-pattern formation. Acts in cranofacial development and
CC       specifically in odontogenesis. Expression in the developing nail
CC       bed mesenchyme is important for nail plate thickness and
CC       integrity. {ECO:0000269|PubMed:11369996,
CC       ECO:0000269|PubMed:12807959}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in the developing nail bed
CC       mesenchyme. {ECO:0000269|PubMed:11369996}.
CC   -!- PTM: Sumoylated by PIAS1, desumoylated by SENP1. {ECO:0000250}.
CC   -!- DISEASE: Tooth agenesis, selective, 1 (STHAG1) [MIM:106600]: A
CC       form of selective tooth agenesis, a common anomaly characterized
CC       by the congenital absence of one or more teeth. Selective tooth
CC       agenesis without associated systemic disorders has sometimes been
CC       divided into 2 types: oligodontia, defined as agenesis of 6 or
CC       more permanent teeth, and hypodontia, defined as agenesis of less
CC       than 6 teeth. The number in both cases does not include absence of
CC       third molars (wisdom teeth). STHAG1 can be associated with
CC       orofacial cleft in some patients. {ECO:0000269|PubMed:12097313,
CC       ECO:0000269|PubMed:8696335}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=MSX1 is deleted in some patients with Wolf-
CC       Hirschhorn syndrome (WHS). WHS results from sub-telomeric
CC       deletions in the short arm of chromosome 4.
CC       {ECO:0000305|PubMed:1969845}.
CC   -!- DISEASE: Ectodermal dysplasia 3, Witkop type (ECTD3) [MIM:189500]:
CC       A form of ectodermal dysplasia, a heterogeneous group of disorders
CC       due to abnormal development of two or more ectodermal structures
CC       such as hair, teeth, nails and sweat glands, with or without any
CC       additional clinical sign. Each combination of clinical features
CC       represents a different type of ectodermal dysplasia. ECTD3 is
CC       characterized by abnormalities largely limited largely to teeth
CC       (some of which are missing) and nails (which are poorly formed
CC       early in life, especially toenails). This condition is
CC       distinguished from anhidrotic ectodermal dysplasia by autosomal
CC       dominant inheritance and little involvement of hair and sweat
CC       glands. The teeth are not as severely affected.
CC       {ECO:0000269|PubMed:11369996}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]: A
CC       birth defect consisting of cleft lips with or without cleft
CC       palate. Cleft lips are associated with cleft palate in two-third
CC       of cases. A cleft lip can occur on one or both sides and range in
CC       severity from a simple notch in the upper lip to a complete
CC       opening in the lip extending into the floor of the nostril and
CC       involving the upper gum. {ECO:0000269|PubMed:12807959}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the Msh homeobox family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-7 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52683.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA58665.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH67353.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAL17870.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=ABK81117.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAF83325.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M76732; AAA58665.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M76731; AAA58665.1; JOINED; Genomic_DNA.
DR   EMBL; M97676; AAA52683.1; ALT_INIT; mRNA.
DR   EMBL; AF426432; AAL17870.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AK290636; BAF83325.1; ALT_INIT; mRNA.
DR   EMBL; AC092437; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021285; AAH21285.4; -; mRNA.
DR   EMBL; BC067353; AAH67353.1; ALT_INIT; mRNA.
DR   EMBL; EF065625; ABK81117.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS3378.2; -.
DR   PIR; A40560; A40560.
DR   PIR; I54320; I54320.
DR   RefSeq; NP_002439.2; NM_002448.3.
DR   UniGene; Hs.424414; -.
DR   ProteinModelPortal; P28360; -.
DR   SMR; P28360; -.
DR   BioGrid; 110593; 14.
DR   CORUM; P28360; -.
DR   IntAct; P28360; 4.
DR   MINT; MINT-6611751; -.
DR   STRING; 9606.ENSP00000372170; -.
DR   iPTMnet; P28360; -.
DR   PhosphoSitePlus; P28360; -.
DR   BioMuta; MSX1; -.
DR   DMDM; 557952603; -.
DR   MaxQB; P28360; -.
DR   PaxDb; P28360; -.
DR   PeptideAtlas; P28360; -.
DR   PRIDE; P28360; -.
DR   Ensembl; ENST00000382723; ENSP00000372170; ENSG00000163132.
DR   GeneID; 4487; -.
DR   KEGG; hsa:4487; -.
DR   UCSC; uc003gif.4; human.
DR   CTD; 4487; -.
DR   DisGeNET; 4487; -.
DR   EuPathDB; HostDB:ENSG00000163132.6; -.
DR   GeneCards; MSX1; -.
DR   HGNC; HGNC:7391; MSX1.
DR   HPA; CAB026198; -.
DR   HPA; HPA063895; -.
DR   HPA; HPA073604; -.
DR   MalaCards; MSX1; -.
DR   MIM; 106600; phenotype.
DR   MIM; 142983; gene.
DR   MIM; 189500; phenotype.
DR   MIM; 608874; phenotype.
DR   neXtProt; NX_P28360; -.
DR   OpenTargets; ENSG00000163132; -.
DR   Orphanet; 199306; Cleft lip/palate.
DR   Orphanet; 2227; Hypodontia.
DR   Orphanet; 2228; Hypodontia - dysplasia of nails.
DR   Orphanet; 99798; Oligodontia.
DR   PharmGKB; PA31196; -.
DR   eggNOG; KOG0492; Eukaryota.
DR   eggNOG; ENOG410YT2J; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231922; -.
DR   HOVERGEN; HBG005205; -.
DR   InParanoid; P28360; -.
DR   KO; K09341; -.
DR   OMA; CMAPSIA; -.
DR   OrthoDB; EOG091G0P1V; -.
DR   PhylomeDB; P28360; -.
DR   TreeFam; TF350699; -.
DR   SignaLink; P28360; -.
DR   SIGNOR; P28360; -.
DR   ChiTaRS; MSX1; human.
DR   GeneWiki; MSX1; -.
DR   GenomeRNAi; 4487; -.
DR   PRO; PR:P28360; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000163132; -.
DR   CleanEx; HS_MSX1; -.
DR   Genevisible; P28360; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0035326; F:enhancer binding; IEA:Ensembl.
DR   GO; GO:0002039; F:p53 binding; IPI:BHF-UCL.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000982; F:transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0090427; P:activation of meiosis; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0061312; P:BMP signaling pathway involved in heart development; IEA:Ensembl.
DR   GO; GO:0060349; P:bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0060536; P:cartilage morphogenesis; IEA:Ensembl.
DR   GO; GO:0000902; P:cell morphogenesis; IDA:BHF-UCL.
DR   GO; GO:0071316; P:cellular response to nicotine; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035880; P:embryonic nail plate morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IEA:Ensembl.
DR   GO; GO:0060325; P:face morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0061180; P:mammary gland epithelium development; IEA:Ensembl.
DR   GO; GO:0010463; P:mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0007517; P:muscle organ development; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0051154; P:negative regulation of striated muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:BHF-UCL.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IC:BHF-UCL.
DR   GO; GO:1902255; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; IDA:BHF-UCL.
DR   GO; GO:2001055; P:positive regulation of mesenchymal cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IDA:BHF-UCL.
DR   GO; GO:0050821; P:protein stabilization; IDA:BHF-UCL.
DR   GO; GO:0042481; P:regulation of odontogenesis; IEA:Ensembl.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Ectodermal dysplasia; Homeobox; Isopeptide bond; Nucleus;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    303       Homeobox protein MSX-1.
FT                                /FTId=PRO_0000049086.
FT   DNA_BIND    172    231       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     35     42       Poly-Ala.
FT   COMPBIAS    261    269       Poly-Ala.
FT   CROSSLNK     15     15       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   CROSSLNK    133    133       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   VARIANT      67     67       M -> K (in STHAG1; dbSNP:rs121913130).
FT                                {ECO:0000269|PubMed:12097313}.
FT                                /FTId=VAR_015712.
FT   VARIANT      84     84       E -> V (in OFC5; cleft palate only;
FT                                dbSNP:rs28928890).
FT                                {ECO:0000269|PubMed:12807959}.
FT                                /FTId=VAR_018391.
FT   VARIANT      97     97       G -> D (in OFC5; cleft palate only).
FT                                {ECO:0000269|PubMed:12807959}.
FT                                /FTId=VAR_018392.
FT   VARIANT     120    120       V -> G (in OFC5; cleft palate only;
FT                                dbSNP:rs759548721).
FT                                {ECO:0000269|PubMed:12807959}.
FT                                /FTId=VAR_018393.
FT   VARIANT     122    122       G -> E (in OFC5; bilateral cleft palate;
FT                                dbSNP:rs28933081).
FT                                {ECO:0000269|PubMed:12807959}.
FT                                /FTId=VAR_018394.
FT   VARIANT     157    157       R -> S (in OFC5; unilateral cleft palate;
FT                                dbSNP:rs150284621).
FT                                {ECO:0000269|PubMed:12807959,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_018395.
FT   VARIANT     202    202       R -> P (in STHAG1; dbSNP:rs121913129).
FT                                {ECO:0000269|PubMed:8696335}.
FT                                /FTId=VAR_003754.
FT   CONFLICT     28     28       G -> D (in Ref. 4; BAF83325).
FT                                {ECO:0000305}.
FT   CONFLICT     45     45       A -> T (in Ref. 2; AAA58665).
FT                                {ECO:0000305}.
FT   CONFLICT     97     99       GVP -> ASR (in Ref. 2; AAA58665).
FT                                {ECO:0000305}.
FT   CONFLICT    146    146       M -> T (in Ref. 4; BAF83325).
FT                                {ECO:0000305}.
FT   CONFLICT    222    222       N -> S (in Ref. 4; BAF83325).
FT                                {ECO:0000305}.
SQ   SEQUENCE   303 AA;  31496 MW;  1B5F01B35920E64F CRC64;
     MAPAADMTSL PLGVKVEDSA FGKPAGGGAG QAPSAAAATA AAMGADEEGA KPKVSPSLLP
     FSVEALMADH RKPGAKESAL APSEGVQAAG GSAQPLGVPP GSLGAPDAPS SPRPLGHFSV
     GGLLKLPEDA LVKAESPEKP ERTPWMQSPR FSPPPARRLS PPACTLRKHK TNRKPRTPFT
     TAQLLALERK FRQKQYLSIA ERAEFSSSLS LTETQVKIWF QNRRAKAKRL QEAELEKLKM
     AAKPMLPPAA FGLSFPLGGP AAVAAAAGAS LYGASGPFQR AALPVAPVGL YTAHVGYSMY
     HLT
//
ID   MEIS2_HUMAN             Reviewed;         477 AA.
AC   O14770; A6NJI5; A8MWD5; B3KP98; B3KPQ6; Q96DI2; Q96KI4; Q96KI5;
AC   Q9NRS1; Q9NRS2; Q9NRS3;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   27-SEP-2017, entry version 159.
DE   RecName: Full=Homeobox protein Meis2;
DE   AltName: Full=Meis1-related protein 1;
GN   Name=MEIS2; Synonyms=MRG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10764806; DOI=10.1074/jbc.M908382199;
RA   Yang Y., Hwang C.K., D'Souza U.M., Lee S.-H., Junn E., Mouradian M.M.;
RT   "Three-amino acid extension loop homeodomain proteins Meis2 and TGIF
RT   differentially regulate transcription.";
RL   J. Biol. Chem. 275:20734-20741(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6 AND 8).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 7).
RC   TISSUE=Muscle, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 271-477 (ISOFORM 3).
RX   PubMed=9383298; DOI=10.1007/s003359900621;
RA   Smith J.E. Jr., Afonja O., Yee H.T., Inghirami G., Takeshita K.;
RT   "Chromosomal mapping to 15q14 and expression analysis of the human
RT   MEIS2 homeobox gene.";
RL   Mamm. Genome 8:951-952(1997).
RN   [7]
RP   FUNCTION.
RX   PubMed=11279116; DOI=10.1074/jbc.M100678200;
RA   Liu Y., MacDonald R.J., Swift G.H.;
RT   "DNA binding and transcriptional activation by a PDX1.PBX1b.MEIS2b
RT   trimer and cooperation with a pancreas-specific basic helix-loop-helix
RT   complex.";
RL   J. Biol. Chem. 276:17985-17993(2001).
RN   [8]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20523026; DOI=10.1159/000297602;
RA   Larsen K.B., Lutterodt M.C., Laursen H., Graem N., Pakkenberg B.,
RA   Mollgard K., Moller M.;
RT   "Spatiotemporal distribution of PAX6 and MEIS2 expression and total
RT   cell numbers in the ganglionic eminence in the early developing human
RT   forebrain.";
RL   Dev. Neurosci. 32:149-162(2010).
RN   [9]
RP   DOMAIN, INTERACTION WITH PBX1, AND MUTAGENESIS OF LEU-85; LEU-88;
RP   94-GLU--GLU-97; ILE-151; LEU-154; 158-LEU-LEU-159; LEU-161 AND
RP   ARG-332.
RX   PubMed=20553494; DOI=10.1111/j.1742-4658.2010.07668.x;
RA   Hyman-Walsh C., Bjerke G.A., Wotton D.;
RT   "An autoinhibitory effect of the homothorax domain of Meis2.";
RL   FEBS J. 277:2584-2597(2010).
RN   [10]
RP   INTERACTION WITH TLX1.
RX   PubMed=19559479; DOI=10.1016/j.leukres.2009.06.003;
RA   Milech N., Gottardo N.G., Ford J., D'Souza D., Greene W.K., Kees U.R.,
RA   Watt P.M.;
RT   "MEIS proteins as partners of the TLX1/HOX11 oncoprotein.";
RL   Leuk. Res. 34:358-363(2010).
RN   [11]
RP   FUNCTION, INTERACTION WITH SP1; SP3 AND KLF4, AND MUTAGENESIS OF
RP   ARG-332.
RX   PubMed=21746878; DOI=10.1128/MCB.01456-10;
RA   Bjerke G.A., Hyman-Walsh C., Wotton D.;
RT   "Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.";
RL   Mol. Cell. Biol. 31:3723-3733(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   INVOLVEMENT IN CPCMR.
RX   PubMed=24678003; DOI=10.1002/ajmg.a.36498;
RA   Johansson S., Berland S., Gradek G.A., Bongers E., de Leeuw N.,
RA   Pfundt R., Fannemel M., Roedningen O., Brendehaug A., Haukanes B.I.,
RA   Hovland R., Helland G., Houge G.;
RT   "Haploinsufficiency of MEIS2 is associated with orofacial clefting and
RT   learning disability.";
RL   Am. J. Med. Genet. A 164A:1622-1626(2014).
RN   [14]
RP   INVOLVEMENT IN CPCMR, AND VARIANT CPCMR ARG-333 DEL.
RX   PubMed=25712757; DOI=10.1002/ajmg.a.36989;
RA   Louw J.J., Corveleyn A., Jia Y., Hens G., Gewillig M., Devriendt K.;
RT   "MEIS2 involvement in cardiac development, cleft palate, and
RT   intellectual disability.";
RL   Am. J. Med. Genet. A 167A:1142-1146(2015).
RN   [15]
RP   INVOLVEMENT IN CPCMR, AND VARIANT CPCMR 204-SER--GLN-477 DEL.
RX   PubMed=27225850; DOI=10.1038/jhg.2016.54;
RA   Fujita A., Isidor B., Piloquet H., Corre P., Okamoto N., Nakashima M.,
RA   Tsurusaki Y., Saitsu H., Miyake N., Matsumoto N.;
RT   "De novo MEIS2 mutation causes syndromic developmental delay with
RT   persistent gastro-esophageal reflux.";
RL   J. Hum. Genet. 61:835-838(2016).
CC   -!- FUNCTION: Involved in transcriptional regulation. Binds to HOX or
CC       PBX proteins to form dimers, or to a DNA-bound dimer of PBX and
CC       HOX proteins and thought to have a role in stabilization of the
CC       homeoprotein-DNA complex. Isoform 3 is required for the activity
CC       of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells involved
CC       in the transcriptional activation of the ELA1 enhancer; the
CC       complex binds to the enhancer B element and cooperates with the
CC       transcription factor 1 complex (PTF1) bound to the enhancer A
CC       element; MEIS2 is not involved in complex DNA-binding. Probably in
CC       complex with PBX1, is involved in transcriptional regulation by
CC       KLF4. Isoform 3 and isoform 4 can bind to a EPHA8 promoter
CC       sequence containing the DNA motif 5'-CGGTCA-3'; in cooperation
CC       with a PBX protein (such as PBX2) is proposed to be involved in
CC       the transcriptional activation of EPHA8 in the developing
CC       midbrain. May be involved in regulation of myeloid
CC       differentiation. Can bind to the DNA sequence 5'-TGACAG-3'in the
CC       activator ACT sequence of the D(1A) dopamine receptor (DRD1)
CC       promoter and activate DRD1 transcription; isoform 5 cannot
CC       activate DRD1 transcription. {ECO:0000269|PubMed:10764806,
CC       ECO:0000269|PubMed:11279116, ECO:0000269|PubMed:21746878}.
CC   -!- SUBUNIT: Isoform 2 interacts with TLX1. Isoform 3 interacts with
CC       HOXA13 and PBX1 isoform PBX1b. Isoform 4 interacts with SP1, SP3
CC       and KLF4. Isoform 4 and isoform 5 interact with PBX1 isoform
CC       PBX1a; the interaction partially relieves MEIS2 autoinhibition.
CC       Isoform 3 also known as MEIS2b is part of a PDX1:PBX1b:Meis2B
CC       complex; Meis2B is recruited by PBX1b and can be replaced by
CC       isoform 4 in a small fraction of complexes. Can form trimeric
CC       complexes including HOXB8 and PBX2 or PBX3.
CC       {ECO:0000269|PubMed:19559479, ECO:0000269|PubMed:20553494,
CC       ECO:0000269|PubMed:21746878}.
CC   -!- INTERACTION:
CC       Q5TZZ9:ANXA1; NbExp=3; IntAct=EBI-2804934, EBI-10181435;
CC       Q6P1W5:C1orf94; NbExp=3; IntAct=EBI-2804934, EBI-946029;
CC       P03363:gag-pro-pol (xeno); NbExp=3; IntAct=EBI-2804934, EBI-9676133;
CC       A0A1B0GWI1:LINC00238; NbExp=4; IntAct=EBI-8025850, EBI-10181422;
CC       Q9BVL2:NUP58; NbExp=4; IntAct=EBI-8025850, EBI-2811583;
CC       O43482:OIP5; NbExp=4; IntAct=EBI-8025850, EBI-536879;
CC       Q9UJX0:OSGIN1; NbExp=3; IntAct=EBI-2804934, EBI-9057006;
CC       P40424:PBX1; NbExp=8; IntAct=EBI-8025850, EBI-301611;
CC       Q9BYU1:PBX4; NbExp=6; IntAct=EBI-8025850, EBI-10302990;
CC       P31314:TLX1; NbExp=4; IntAct=EBI-6390216, EBI-2820655;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P97367}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1; Synonyms=Meis2C;
CC         IsoId=O14770-1; Sequence=Displayed;
CC       Name=2; Synonyms=Meis2A;
CC         IsoId=O14770-2; Sequence=VSP_002245, VSP_002246;
CC       Name=3; Synonyms=Meis2B;
CC         IsoId=O14770-3; Sequence=VSP_002242, VSP_002245, VSP_002246;
CC       Name=4; Synonyms=Meis2D;
CC         IsoId=O14770-4; Sequence=VSP_002242;
CC       Name=5; Synonyms=Meis2E;
CC         IsoId=O14770-5; Sequence=VSP_002243, VSP_002244;
CC       Name=6;
CC         IsoId=O14770-6; Sequence=VSP_043219, VSP_002242, VSP_002245,
CC                                  VSP_002246;
CC       Name=7;
CC         IsoId=O14770-7; Sequence=VSP_043494, VSP_002242, VSP_002245,
CC                                  VSP_002246;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=O14770-8; Sequence=VSP_043494, VSP_002245, VSP_002246;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in various tissues. Expressed at
CC       high level in the lymphoid organs of hematopoietic tissues. Also
CC       expressed in some regions of the brain, such as the putamen.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the proliferative zones of the
CC       fetal neocortex. Expressed at a very high level in the developing
CC       ganglionic eminence and at a more moderate level in the cortical
CC       plate. {ECO:0000269|PubMed:20523026}.
CC   -!- DISEASE: Cleft palate, cardiac defects, and mental retardation
CC       (CPCMR) [MIM:600987]: An autosomal dominant disease characterized
CC       by multiple congenital malformations, mild-to-severe intellectual
CC       disability with poor speech, and delayed psychomotor development.
CC       Congenital malformations include heart defects, cleft lip/palate,
CC       distally-placed thumbs and toes, and cutaneous syndactyly between
CC       the second and third toes. {ECO:0000269|PubMed:24678003,
CC       ECO:0000269|PubMed:25712757, ECO:0000269|PubMed:27225850}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF178948; AAF81638.1; -; mRNA.
DR   EMBL; AF179896; AAF81639.1; -; mRNA.
DR   EMBL; AF179897; AAF81640.1; -; mRNA.
DR   EMBL; AF179898; AAF81641.1; -; mRNA.
DR   EMBL; AF179899; AAF81642.1; -; mRNA.
DR   EMBL; AK056038; BAG51610.1; -; mRNA.
DR   EMBL; AK056620; BAG51768.1; -; mRNA.
DR   EMBL; AC018563; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069483; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471125; EAW92353.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92354.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92356.1; -; Genomic_DNA.
DR   EMBL; BC001516; AAH01516.1; -; mRNA.
DR   EMBL; BC001844; AAH01844.3; -; mRNA.
DR   EMBL; BC007202; AAH07202.1; -; mRNA.
DR   EMBL; BC050431; AAH50431.1; -; mRNA.
DR   EMBL; AF017418; AAB70270.1; -; mRNA.
DR   CCDS; CCDS10044.1; -. [O14770-1]
DR   CCDS; CCDS10045.1; -. [O14770-4]
DR   CCDS; CCDS42014.1; -. [O14770-7]
DR   CCDS; CCDS45217.1; -. [O14770-2]
DR   CCDS; CCDS45218.1; -. [O14770-3]
DR   CCDS; CCDS45219.1; -. [O14770-8]
DR   CCDS; CCDS45220.1; -. [O14770-6]
DR   RefSeq; NP_001207411.1; NM_001220482.1. [O14770-4]
DR   RefSeq; NP_002390.1; NM_002399.3. [O14770-7]
DR   RefSeq; NP_733774.1; NM_170674.4. [O14770-3]
DR   RefSeq; NP_733775.1; NM_170675.4. [O14770-1]
DR   RefSeq; NP_733776.1; NM_170676.4. [O14770-4]
DR   RefSeq; NP_733777.1; NM_170677.4. [O14770-2]
DR   RefSeq; NP_758526.1; NM_172315.2. [O14770-8]
DR   RefSeq; NP_758527.1; NM_172316.2. [O14770-6]
DR   RefSeq; XP_016877694.1; XM_017022205.1. [O14770-6]
DR   UniGene; Hs.510989; -.
DR   PDB; 3K2A; X-ray; 1.95 A; A/B=281-345.
DR   PDB; 4XRM; X-ray; 1.60 A; A/B=281-342.
DR   PDB; 5BNG; X-ray; 3.50 A; A/B=283-342.
DR   PDB; 5EG0; X-ray; 3.10 A; A=284-338.
DR   PDBsum; 3K2A; -.
DR   PDBsum; 4XRM; -.
DR   PDBsum; 5BNG; -.
DR   PDBsum; 5EG0; -.
DR   ProteinModelPortal; O14770; -.
DR   SMR; O14770; -.
DR   BioGrid; 110376; 32.
DR   DIP; DIP-61027N; -.
DR   IntAct; O14770; 31.
DR   STRING; 9606.ENSP00000453793; -.
DR   iPTMnet; O14770; -.
DR   PhosphoSitePlus; O14770; -.
DR   BioMuta; MEIS2; -.
DR   MaxQB; O14770; -.
DR   PaxDb; O14770; -.
DR   PeptideAtlas; O14770; -.
DR   PRIDE; O14770; -.
DR   DNASU; 4212; -.
DR   Ensembl; ENST00000314177; ENSP00000326296; ENSG00000134138. [O14770-5]
DR   Ensembl; ENST00000338564; ENSP00000341400; ENSG00000134138. [O14770-4]
DR   Ensembl; ENST00000340545; ENSP00000339549; ENSG00000134138. [O14770-7]
DR   Ensembl; ENST00000397620; ENSP00000380745; ENSG00000134138. [O14770-6]
DR   Ensembl; ENST00000397624; ENSP00000380749; ENSG00000134138. [O14770-6]
DR   Ensembl; ENST00000424352; ENSP00000404185; ENSG00000134138. [O14770-2]
DR   Ensembl; ENST00000557796; ENSP00000452693; ENSG00000134138. [O14770-7]
DR   Ensembl; ENST00000559085; ENSP00000453390; ENSG00000134138. [O14770-8]
DR   Ensembl; ENST00000559561; ENSP00000453497; ENSG00000134138. [O14770-3]
DR   Ensembl; ENST00000561208; ENSP00000453793; ENSG00000134138. [O14770-1]
DR   GeneID; 4212; -.
DR   KEGG; hsa:4212; -.
DR   UCSC; uc001zjl.4; human. [O14770-1]
DR   CTD; 4212; -.
DR   DisGeNET; 4212; -.
DR   EuPathDB; HostDB:ENSG00000134138.19; -.
DR   GeneCards; MEIS2; -.
DR   HGNC; HGNC:7001; MEIS2.
DR   HPA; CAB004999; -.
DR   HPA; HPA003256; -.
DR   MalaCards; MEIS2; -.
DR   MIM; 600987; phenotype.
DR   MIM; 601740; gene.
DR   neXtProt; NX_O14770; -.
DR   OpenTargets; ENSG00000134138; -.
DR   Orphanet; 261190; 15q14 microdeletion syndrome.
DR   PharmGKB; PA30741; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000253923; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; O14770; -.
DR   KO; K16670; -.
DR   OMA; LHASQHY; -.
DR   OrthoDB; EOG091G0KDP; -.
DR   PhylomeDB; O14770; -.
DR   TreeFam; TF318093; -.
DR   ChiTaRS; MEIS2; human.
DR   EvolutionaryTrace; O14770; -.
DR   GeneWiki; MEIS2; -.
DR   GenomeRNAi; 4212; -.
DR   PRO; PR:O14770; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000134138; -.
DR   CleanEx; HS_MEIS2; -.
DR   ExpressionAtlas; O14770; baseline and differential.
DR   Genevisible; O14770; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003712; F:transcription cofactor activity; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0001654; P:eye development; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR   GO; GO:0110024; P:positive regulation of cardiac muscle myoblast proliferation; IDA:BHF-UCL.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0070848; P:response to growth factor; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Cytoplasm; Developmental protein; Disease mutation; DNA-binding;
KW   Homeobox; Mental retardation; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    477       Homeobox protein Meis2.
FT                                /FTId=PRO_0000049108.
FT   DNA_BIND    276    338       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   REGION       71    191       Required for interaction with PBX1.
FT                                {ECO:0000250}.
FT   REGION      340    477       Transcriptional activation domain.
FT   COMPBIAS    195    244       Ser/Thr-rich.
FT   COMPBIAS    246    273       Asp/Glu-rich (acidic).
FT   COMPBIAS    266    273       Poly-Asp.
FT   VAR_SEQ       1     89       MAQRYDELPHYGGMDGVGVPASMYGDPHAPRPIPPVHHLNH
FT                                GPPLHATQHYGAHAPHPNVMPASMGSAVNDALKRDKDAIYG
FT                                HPLFPLL -> M (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043219.
FT   VAR_SEQ       1     13       Missing (in isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043494.
FT   VAR_SEQ     301    302       HP -> VY (in isoform 5).
FT                                {ECO:0000303|PubMed:10764806}.
FT                                /FTId=VSP_002243.
FT   VAR_SEQ     303    477       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:10764806}.
FT                                /FTId=VSP_002244.
FT   VAR_SEQ     346    352       Missing (in isoform 3, isoform 4, isoform
FT                                6 and isoform 7).
FT                                {ECO:0000303|PubMed:10764806,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9383298}.
FT                                /FTId=VSP_002242.
FT   VAR_SEQ     384    401       LQSMPGDYVSQGGPMGMS -> PMSGMGMNMGMDGQWHYM
FT                                (in isoform 2, isoform 3, isoform 6,
FT                                isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:10764806,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9383298}.
FT                                /FTId=VSP_002245.
FT   VAR_SEQ     402    477       Missing (in isoform 2, isoform 3, isoform
FT                                6, isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:10764806,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9383298}.
FT                                /FTId=VSP_002246.
FT   VARIANT     204    477       Missing (in CPCMR).
FT                                {ECO:0000269|PubMed:27225850}.
FT                                /FTId=VAR_078978.
FT   VARIANT     333    333       Missing (in CPCMR).
FT                                {ECO:0000269|PubMed:25712757}.
FT                                /FTId=VAR_078979.
FT   MUTAGEN      85     85       L->A: Impairs interaction with PBX1; when
FT                                associated with A-88.
FT                                {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN      88     88       L->A: Impairs interaction with PBX1; when
FT                                associated with A-85. HELIX 285 297.
FT                                {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN      94     97       EKCE->NNGT: Impairs interaction with
FT                                PBX1. {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN     151    151       I->A: Impairs interaction with PBX1; when
FT                                associated with A-154.
FT                                {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN     154    154       L->A: Impairs interaction with PBX1; when
FT                                associated with A-151.
FT                                {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN     158    159       LL->AA: Impairs interaction with PBX1;
FT                                when associated with A-161.
FT                                {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN     161    161       L->A: Impairs interaction with PBX1; when
FT                                associated with 158-A-A-159.
FT                                {ECO:0000269|PubMed:20553494}.
FT   MUTAGEN     332    332       R->M: Impairs DNA binding and PBX1-
FT                                dependent transcriptional activation. No
FT                                effect on interaction with PBX1.
FT                                {ECO:0000269|PubMed:20553494,
FT                                ECO:0000269|PubMed:21746878}.
FT   HELIX       287    296       {ECO:0000244|PDB:4XRM}.
FT   TURN        298    300       {ECO:0000244|PDB:3K2A}.
FT   HELIX       306    316       {ECO:0000244|PDB:4XRM}.
FT   HELIX       320    333       {ECO:0000244|PDB:4XRM}.
FT   HELIX       335    339       {ECO:0000244|PDB:4XRM}.
SQ   SEQUENCE   477 AA;  51790 MW;  94EBD0801A312B24 CRC64;
     MAQRYDELPH YGGMDGVGVP ASMYGDPHAP RPIPPVHHLN HGPPLHATQH YGAHAPHPNV
     MPASMGSAVN DALKRDKDAI YGHPLFPLLA LVFEKCELAT CTPREPGVAG GDVCSSDSFN
     EDIAVFAKQV RAEKPLFSSN PELDNLMIQA IQVLRFHLLE LEKVHELCDN FCHRYISCLK
     GKMPIDLVID ERDGSSKSDH EELSGSSTNL ADHNPSSWRD HDDATSTHSA GTPGPSSGGH
     ASQSGDNSSE QGDGLDNSVA SPGTGDDDDP DKDKKRQKKR GIFPKVATNI MRAWLFQHLT
     HPYPSEEQKK QLAQDTGLTI LQVNNWFINA RRRIVQPMID QSNRAGFLLD PSVSQGAAYS
     PEGQPMGSFV LDGQQHMGIR PAGLQSMPGD YVSQGGPMGM SMAQPSYTPP QMTPHPTQLR
     HGPPMHSYLP SHPHHPAMMM HGGPPTHPGM TMSAQSPTML NSVDPNVGGQ VMDIHAQ
//
ID   HXD13_HUMAN             Reviewed;         343 AA.
AC   P35453;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 3.
DT   25-OCT-2017, entry version 163.
DE   RecName: Full=Homeobox protein Hox-D13;
DE   AltName: Full=Homeobox protein Hox-4I;
GN   Name=HOXD13; Synonyms=HOX4I;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8614804; DOI=10.1126/science.272.5261.548;
RA   Muragaki Y., Mundlos S., Upton J., Olsen B.R.;
RT   "Altered growth and branching patterns in synpolydactyly caused by
RT   mutations in HOXD13.";
RL   Science 272:548-551(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Arai Y., Arai K., Kita K., Miwa H., Kamada N., Ohki M.;
RT   "The t(2:11)(q31:p15) translocation in acute myeloid leukemia fuses
RT   NUP98 nucleoporin gene to HOXD13 homeobox gene.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 276-341.
RX   PubMed=1675198; DOI=10.1016/0888-7543(91)90482-T;
RA   D'Esposito M., Morelli F., Acampora D., Migliaccio E., Simeone A.,
RA   Boncinelli E.;
RT   "EVX2, a human homeobox gene homologous to the even-skipped
RT   segmentation gene, is localized at the 5' end of HOX4 locus on
RT   chromosome 2.";
RL   Genomics 10:43-50(1991).
RN   [5]
RP   INVOLVEMENT IN VACTERL.
RX   PubMed=19006232; DOI=10.1002/ajmg.a.32426;
RA   Garcia-Barcelo M.-M., Wong K.K., Lui V.C., Yuan Z.W., So M.T.,
RA   Ngan E.S., Miao X.P., Chung P.H., Khong P.L., Tam P.K.;
RT   "Identification of a HOXD13 mutation in a VACTERL patient.";
RL   Am. J. Med. Genet. A 146:3181-3185(2008).
RN   [6]
RP   INVOLVEMENT IN BDSDO, AND VARIANT BDSDO LYS-325.
RX   PubMed=23995701; DOI=10.1101/gr.157610.113;
RA   Ibrahim D.M., Hansen P., Roedelsperger C., Stiege A.C., Doelken S.C.,
RA   Horn D., Jaeger M., Janetzki C., Krawitz P., Leschik G., Wagner F.,
RA   Scheuer T., Schmidt-von Kegler M., Seemann P., Timmermann B.,
RA   Robinson P.N., Mundlos S., Hecht J.;
RT   "Distinct global shifts in genomic binding profiles of limb
RT   malformation-associated HOXD13 mutations.";
RL   Genome Res. 23:2091-2102(2013).
RN   [7]
RP   VARIANT SPD1 ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-57 INS.
RX   PubMed=8817328; DOI=10.1093/hmg/5.7.945;
RA   Akarsu A.N., Stoilov I., Yilmaz E., Sayli B.S., Sarfarazi M.;
RT   "Genomic structure of HOXD13 gene: a nine polyalanine duplication
RT   causes synpolydactyly in two unrelated families.";
RL   Hum. Mol. Genet. 5:945-952(1996).
RN   [8]
RP   VARIANT SPD1 TRP-306.
RX   PubMed=12414828; DOI=10.1136/jmg.39.11.852;
RA   Debeer P., Bacchelli C., Scambler P.J., De Smet L., Fryns J.-P.,
RA   Goodman F.R.;
RT   "Severe digital abnormalities in a patient heterozygous for both a
RT   novel missense mutation in HOXD13 and a polyalanine tract expansion in
RT   HOXA13.";
RL   J. Med. Genet. 39:852-856(2002).
RN   [9]
RP   VARIANTS BDE1 CYS-316 AND LEU-322, AND VARIANT BDD CYS-316.
RX   PubMed=12649808; DOI=10.1086/374721;
RA   Johnson D., Kan S.H., Oldridge M., Trembath R.C., Roche P.,
RA   Esnouf R.M., Giele H., Wilkie A.O.;
RT   "Missense mutations in the homeodomain of HOXD13 are associated with
RT   brachydactyly types D and E.";
RL   Am. J. Hum. Genet. 72:984-997(2003).
RN   [10]
RP   VARIANT SPD1 ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-57 INS, AND VARIANT
RP   57-ALA-ALA-58 DEL.
RX   PubMed=16222680; DOI=10.1002/ajmg.a.30971;
RA   Kjaer K.W., Hansen L., Eiberg H., Utkus A., Skovgaard L.T., Leicht P.,
RA   Opitz J.M., Tommerup N.;
RT   "A 72-year-old Danish puzzle resolved -- comparative analysis of
RT   phenotypes in families with different-sized HOXD13 polyalanine
RT   expansions.";
RL   Am. J. Med. Genet. A 138:328-339(2005).
RN   [11]
RP   VARIANT BDSD 57-ALA--ALA-62 DEL, VARIANT SDTY5 ARG-325,
RP   CHARACTERIZATION OF VARIANT BDSD 57-ALA--ALA-62 DEL, AND
RP   CHARACTERIZATION OF VARIANT SDTY5 ARG-325.
RX   PubMed=17236141; DOI=10.1086/511387;
RA   Zhao X., Sun M., Zhao J., Leyva J.A., Zhu H., Yang W., Zeng X., Ao Y.,
RA   Liu Q., Liu G., Lo W.H.Y., Jabs E.W., Amzel L.M., Shan X., Zhang X.;
RT   "Mutations in HOXD13 underlie syndactyly type V and a novel
RT   brachydactyly-syndactyly syndrome.";
RL   Am. J. Hum. Genet. 80:361-371(2007).
RN   [12]
RP   VARIANTS SPD1 GLN-306 AND GLY-306, CHARACTERIZATION OF VARIANTS SPD1
RP   GLN-306 AND GLY-306, CHARACTERIZATION OF VARIANT BDE1 LEU-322,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24789103; DOI=10.1371/journal.pone.0096192;
RA   Dai L., Liu D., Song M., Xu X., Xiong G., Yang K., Zhang K., Meng H.,
RA   Guo H., Bai Y.;
RT   "Mutations in the homeodomain of HOXD13 cause syndactyly type 1-c in
RT   two Chinese families.";
RL   PLoS ONE 9:E96192-E96192(2014).
RN   [13]
RP   VARIANT SPD1 ARG-313, AND CHARACTERIZATION OF VARIANT SPD1 ARG-313.
RX   PubMed=26581570; DOI=10.1002/ajmg.a.37464;
RA   Ibrahim D.M., Tayebi N., Knaus A., Stiege A.C., Sahebzamani A.,
RA   Hecht J., Mundlos S., Spielmann M.;
RT   "A homozygous HOXD13 missense mutation causes a severe form of
RT   synpolydactyly with metacarpal to carpal transformation.";
RL   Am. J. Med. Genet. A 170:615-621(2016).
CC   -!- FUNCTION: Sequence-specific transcription factor that binds gene
CC       promoters and activates their transcription (PubMed:24789103).
CC       Part of a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis (By
CC       similarity). {ECO:0000250|UniProtKB:P24344,
CC       ECO:0000269|PubMed:24789103}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:24789103}.
CC   -!- POLYMORPHISM: The poly-Ala region is polymorphic (11 to 15
CC       residues) in the normal population and is expanded to about 22-29
CC       residues in SPD1 and syndactyly type 5 patients.
CC   -!- DISEASE: Synpolydactyly 1 (SPD1) [MIM:186000]: Limb malformation
CC       that shows a characteristic manifestation in both hands and feet.
CC       This condition is inherited as an autosomal dominant trait with
CC       reduced penetrance. {ECO:0000269|PubMed:12414828,
CC       ECO:0000269|PubMed:16222680, ECO:0000269|PubMed:24789103,
CC       ECO:0000269|PubMed:26581570, ECO:0000269|PubMed:8817328}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Brachydactyly D (BDD) [MIM:113200]: A form of
CC       brachydactyly. Brachydactyly defines a group of inherited
CC       malformations characterized by shortening of the digits due to
CC       abnormal development of the phalanges and/or the metacarpals.
CC       Brachydactyly type D is characterized by short and broad terminal
CC       phalanges of the thumbs and big toes.
CC       {ECO:0000269|PubMed:12649808}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Syndactyly 5 (SDTY5) [MIM:186300]: A form of syndactyly,
CC       a congenital anomaly of the hand or foot marked by persistence of
CC       the webbing between adjacent digits that are more or less
CC       completely attached. The characteristic finding in SDTY5 is the
CC       presence of an associated metacarpal and metatarsal fusion. The
CC       metacarpals and metatarsals most commonly fused are the 4th and
CC       5th or the 3rd and 4th. Soft tissue syndactyly usually affects the
CC       3rd and 4th fingers and the 2nd and 3rd toes.
CC       {ECO:0000269|PubMed:17236141}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Brachydactyly-syndactyly syndrome (BDSD) [MIM:610713]: A
CC       disease characterized by generalized shortening of the hands and
CC       feet, broad and short distal phalanges of the thumbs, and
CC       cutaneous syndactyly of toes 2 and 3. The limb phenotypes observed
CC       in this syndrome overlap those of brachydactyly types A4, D, E and
CC       syndactyly type 1. {ECO:0000269|PubMed:17236141}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Brachydactyly E1 (BDE1) [MIM:113300]: A form of
CC       brachydactyly. Brachydactyly defines a group of inherited
CC       malformations characterized by shortening of the digits due to
CC       abnormal development of the phalanges and/or the metacarpals.
CC       Brachydactyly type E is characterized by shortening of the fingers
CC       mainly in the metacarpals and metatarsals. Wide variability in the
CC       number of digits affected occurs from person to person, even in
CC       the same family. Some individuals are moderately short of stature.
CC       Brachydactyly type E1 is characterized by shortening limited to
CC       fourth metacarpals and/or metatarsals.
CC       {ECO:0000269|PubMed:12649808, ECO:0000269|PubMed:24789103}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: VACTERL association (VACTERL) [MIM:192350]: VACTERL is an
CC       acronym for vertebral anomalies, anal atresia, congenital cardiac
CC       disease, tracheoesophageal fistula, renal anomalies, radial
CC       dysplasia, and other limb defects. {ECO:0000269|PubMed:19006232}.
CC       Note=The gene represented in this entry may be involved in disease
CC       pathogenesis.
CC   -!- DISEASE: Brachydactyly-syndactyly-oligodactyly syndrome (BDSDO)
CC       [MIM:610713]: A syndrome characterized by a complex brachydactyly-
CC       syndactyly-oligodactyly phenotype. Limb anomalies include reduced
CC       number of digits that are severely shortened, camptodactyly,
CC       syndactyly, absence of terminal phalanges of the thumbs, and
CC       absence of nails of the thumbs and toes.
CC       {ECO:0000269|PubMed:23995701}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-9 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51635.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA95352.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA95352.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF005220; AAC51635.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF005219; AAC51635.1; JOINED; Genomic_DNA.
DR   EMBL; AB032481; BAA95352.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS2264.2; -.
DR   PIR; B39065; B39065.
DR   RefSeq; NP_000514.2; NM_000523.3.
DR   UniGene; Hs.152414; -.
DR   ProteinModelPortal; P35453; -.
DR   SMR; P35453; -.
DR   BioGrid; 109479; 48.
DR   IntAct; P35453; 17.
DR   STRING; 9606.ENSP00000376322; -.
DR   iPTMnet; P35453; -.
DR   PhosphoSitePlus; P35453; -.
DR   BioMuta; HOXD13; -.
DR   DMDM; 223590221; -.
DR   EPD; P35453; -.
DR   MaxQB; P35453; -.
DR   PaxDb; P35453; -.
DR   PeptideAtlas; P35453; -.
DR   PRIDE; P35453; -.
DR   DNASU; 3239; -.
DR   Ensembl; ENST00000392539; ENSP00000376322; ENSG00000128714.
DR   GeneID; 3239; -.
DR   KEGG; hsa:3239; -.
DR   UCSC; uc002ukf.2; human.
DR   CTD; 3239; -.
DR   DisGeNET; 3239; -.
DR   EuPathDB; HostDB:ENSG00000128714.5; -.
DR   GeneCards; HOXD13; -.
DR   HGNC; HGNC:5136; HOXD13.
DR   HPA; HPA064064; -.
DR   MalaCards; HOXD13; -.
DR   MIM; 113200; phenotype.
DR   MIM; 113300; phenotype.
DR   MIM; 142989; gene.
DR   MIM; 186000; phenotype.
DR   MIM; 186300; phenotype.
DR   MIM; 192350; phenotype.
DR   MIM; 610713; phenotype.
DR   neXtProt; NX_P35453; -.
DR   OpenTargets; ENSG00000128714; -.
DR   Orphanet; 93385; Brachydactyly type D.
DR   Orphanet; 93387; Brachydactyly type E.
DR   Orphanet; 93409; Brachydactyly-syndactyly, Zhao type.
DR   Orphanet; 93406; Syndactyly type 5.
DR   Orphanet; 295195; Synpolydactyly type 1.
DR   Orphanet; 887; VACTERL/VATER association.
DR   Orphanet; 295191; Zygodactyly type 3.
DR   PharmGKB; PA29410; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140879; -.
DR   HOGENOM; HOG000231176; -.
DR   HOVERGEN; HBG106958; -.
DR   InParanoid; P35453; -.
DR   KO; K09298; -.
DR   OMA; YSCRMSH; -.
DR   OrthoDB; EOG091G0E5Q; -.
DR   PhylomeDB; P35453; -.
DR   TreeFam; TF330813; -.
DR   SIGNOR; P35453; -.
DR   ChiTaRS; HOXD13; human.
DR   GeneWiki; HOXD13; -.
DR   GenomeRNAi; 3239; -.
DR   PRO; PR:P35453; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128714; -.
DR   CleanEx; HS_HOXD13; -.
DR   Genevisible; P35453; HS.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IMP:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0060602; P:branch elongation of an epithelium; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0048619; P:embryonic hindgut morphogenesis; IEA:Ensembl.
DR   GO; GO:0030539; P:male genitalia development; IEA:Ensembl.
DR   GO; GO:0060571; P:morphogenesis of an epithelial fold; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl.
DR   GO; GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR022067; HoxA13_N.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF12284; HoxA13_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation; Triplet repeat expansion.
FT   CHAIN         1    343       Homeobox protein Hox-D13.
FT                                /FTId=PRO_0000200244.
FT   DNA_BIND    276    335       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     25     30       Poly-Ser.
FT   COMPBIAS     32     36       Poly-Ala.
FT   COMPBIAS     57     71       Poly-Ala.
FT   COMPBIAS     85     92       Poly-Ser.
FT   COMPBIAS    113    118       Poly-Ala.
FT   VARIANT      57     63       Missing (in BDSD; does not affect
FT                                capacity to transactivate EPHA7
FT                                promoter).
FT                                /FTId=VAR_031649.
FT   VARIANT      57     58       Missing. {ECO:0000269|PubMed:16222680}.
FT                                /FTId=VAR_031648.
FT   VARIANT      57     57       A -> AAAAAAAAAA (in SPD1).
FT                                {ECO:0000269|PubMed:16222680,
FT                                ECO:0000269|PubMed:8817328}.
FT                                /FTId=VAR_003818.
FT   VARIANT     252    252       S -> A (in dbSNP:rs35290213).
FT                                /FTId=VAR_031650.
FT   VARIANT     306    306       R -> G (in SPD1; decreases the
FT                                transcriptional activator activity).
FT                                {ECO:0000269|PubMed:24789103}.
FT                                /FTId=VAR_076833.
FT   VARIANT     306    306       R -> Q (in SPD1; decreases the
FT                                transcriptional activator activity;
FT                                dbSNP:rs879255265).
FT                                {ECO:0000269|PubMed:24789103}.
FT                                /FTId=VAR_076834.
FT   VARIANT     306    306       R -> W (in SPD1; dbSNP:rs28933082).
FT                                {ECO:0000269|PubMed:12414828}.
FT                                /FTId=VAR_031651.
FT   VARIANT     313    313       T -> R (in SPD1; disrupts interaction
FT                                with DNA). {ECO:0000269|PubMed:26581570}.
FT                                /FTId=VAR_075400.
FT   VARIANT     316    316       S -> C (in BDE1 and BDD;
FT                                dbSNP:rs28928892).
FT                                {ECO:0000269|PubMed:12649808}.
FT                                /FTId=VAR_015952.
FT   VARIANT     322    322       I -> L (in BDE1; decreases the
FT                                transcriptional activator activity;
FT                                dbSNP:rs28928891).
FT                                {ECO:0000269|PubMed:12649808,
FT                                ECO:0000269|PubMed:24789103}.
FT                                /FTId=VAR_015953.
FT   VARIANT     325    325       Q -> K (in BDSDO; dbSNP:rs875989842).
FT                                {ECO:0000269|PubMed:23995701}.
FT                                /FTId=VAR_076835.
FT   VARIANT     325    325       Q -> R (in SDTY5; impairs capacity to
FT                                transactivate EPHA7 promoter;
FT                                dbSNP:rs104893635).
FT                                {ECO:0000269|PubMed:17236141,
FT                                ECO:0000269|PubMed:23995701}.
FT                                /FTId=VAR_031652.
SQ   SEQUENCE   343 AA;  36101 MW;  CF34D0319021430A CRC64;
     MSRAGSWDMD GLRADGGGAG GAPASSSSSS VAAAAASGQC RGFLSAPVFA GTHSGRAAAA
     AAAAAAAAAA ASGFAYPGTS ERTGSSSSSS SSAVVAARPE APPAKECPAP TPAAAAAAPP
     SAPALGYGYH FGNGYYSCRM SHGVGLQQNA LKSSPHASLG GFPVEKYMDV SGLASSSVPA
     NEVPARAKEV SFYQGYTSPY QHVPGYIDMV STFGSGEPRH EAYISMEGYQ SWTLANGWNS
     QVYCTKDQPQ GSHFWKSSFP GDVALNQPDM CVYRRGRKKR VPYTKLQLKE LENEYAINKF
     INKDKRRRIS AATNLSERQV TIWFQNRRVK DKKIVSKLKD TVS
//
ID   ZEB2_HUMAN              Reviewed;        1214 AA.
AC   O60315; A0JP09; B7Z2P2; F5H814; Q9UED1;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   25-OCT-2017, entry version 187.
DE   RecName: Full=Zinc finger E-box-binding homeobox 2;
DE   AltName: Full=Smad-interacting protein 1;
DE            Short=SMADIP1;
DE   AltName: Full=Zinc finger homeobox protein 1b;
GN   Name=ZEB2; Synonyms=KIAA0569, SIP1, ZFHX1B, ZFX1B;
GN   ORFNames=HRIHFB2411;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INVOLVEMENT IN MOWS.
RX   PubMed=11448942; DOI=10.1093/hmg/10.14.1503;
RA   Cacheux V., Dastot-Le Moal F., Kaeaeriaeinen H., Bondurand N.,
RA   Rintala R., Boissier B., Wilson M., Mowat D., Goossens M.;
RT   "Loss-of-function mutations in SIP1 Smad interacting protein 1 result
RT   in a syndromic Hirschsprung disease.";
RL   Hum. Mol. Genet. 10:1503-1510(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11279515; DOI=10.1038/86860;
RA   Wakamatsu N., Yamada Y., Yamada K., Ono T., Nomura N., Taniguchi H.,
RA   Kitoh H., Mutoh N., Yamanaka T., Mushiake K., Kato K., Sonta S.,
RA   Nagaya M.;
RT   "Mutations in SIP1, encoding Smad interacting protein 1, cause a form
RT   of Hirschsprung disease.";
RL   Nat. Genet. 27:369-370(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1161-1214 (ISOFORM 1), AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9853615; DOI=10.1038/4315;
RA   Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A.;
RT   "Selection system for genes encoding nuclear-targeted proteins.";
RL   Nat. Biotechnol. 16:1338-1342(1998).
RN   [8]
RP   FUNCTION, SUMOYLATION AT LYS-391 AND LYS-866, INTERACTION WITH CBX4
RP   AND CTBP1, AND SUBCELLULAR LOCATION.
RX   PubMed=16061479; DOI=10.1074/jbc.M504477200;
RA   Long J., Zuo D., Park M.;
RT   "Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates
RT   transcriptional repression of E-cadherin.";
RL   J. Biol. Chem. 280:35477-35489(2005).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-377, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142; SER-360; SER-647;
RP   THR-782; SER-784 AND SER-1122, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-391 AND LYS-866, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-391, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-391; LYS-479; LYS-555;
RP   LYS-611; LYS-632; LYS-713 AND LYS-866, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [15]
RP   STRUCTURE BY NMR OF 647-705.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of zinc finger homeobox
RT   protein 1B (SMAD interacting protein 1).";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [16]
RP   VARIANT MOWS ASN-99 DEL.
RX   PubMed=12451214; DOI=10.1212/01.WNL.0000034842.78350.4E;
RA   Yoneda M., Fujita T., Yamada Y., Yamada K., Fujii A., Inagaki T.,
RA   Nakagawa H., Shimada A., Kishikawa M., Nagaya M., Azuma T.,
RA   Kuriyama M., Wakamatsu N.;
RT   "Late infantile Hirschsprung disease-mental retardation syndrome with
RT   a 3-bp deletion in ZFHX1B.";
RL   Neurology 59:1637-1640(2002).
RN   [17]
RP   VARIANT MOWS GLY-953.
RX   PubMed=15384097; DOI=10.1002/ajmg.a.30312;
RA   Gregory-Evans C.Y., Vieira H., Dalton R., Adams G.G.W., Salt A.,
RA   Gregory-Evans K.;
RT   "Ocular coloboma and high myopia with Hirschsprung disease associated
RT   with a novel ZFHX1B missense mutation and trisomy 21.";
RL   Am. J. Med. Genet. A 131:86-90(2004).
RN   [18]
RP   VARIANT MOWS ARG-1119.
RX   PubMed=16688751; DOI=10.1002/ajmg.a.31267;
RA   Heinritz W., Zweier C., Froster U.G., Strenge S., Kujat A., Syrbe S.,
RA   Rauch A., Schuster V.;
RT   "A missense mutation in the ZFHX1B gene associated with an atypical
RT   Mowat-Wilson syndrome phenotype.";
RL   Am. J. Med. Genet. A 140:1223-1227(2006).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-983.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Transcriptional inhibitor that binds to DNA sequence 5'-
CC       CACCT-3' in different promoters. Represses transcription of E-
CC       cadherin. {ECO:0000269|PubMed:16061479}.
CC   -!- SUBUNIT: Binds activated SMAD1, activated SMAD2 and activated
CC       SMAD3; binding with SMAD4 is not detected (By similarity).
CC       Interacts with CBX4 and CTBP1. {ECO:0000250,
CC       ECO:0000269|PubMed:16061479}.
CC   -!- INTERACTION:
CC       Q96KQ7:EHMT2; NbExp=6; IntAct=EBI-717614, EBI-744366;
CC       Q13330:MTA1; NbExp=12; IntAct=EBI-717614, EBI-714236;
CC       O94776:MTA2; NbExp=4; IntAct=EBI-717614, EBI-1783035;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16061479,
CC       ECO:0000269|PubMed:9853615}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60315-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60315-2; Sequence=VSP_044797;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Sumoylation on Lys-391 and Lys-866 is promoted by the E3
CC       SUMO-protein ligase CBX4, and impairs interaction with CTBP1 and
CC       transcription repression activity. {ECO:0000269|PubMed:16061479}.
CC   -!- DISEASE: Mowat-Wilson syndrome (MOWS) [MIM:235730]: A complex
CC       developmental disorder characterized by mental retardation,
CC       delayed motor development, epilepsy, microcephaly and a wide
CC       spectrum of clinically heterogeneous features suggestive of
CC       neurocristopathies at the cephalic, cardiac, and vagal levels.
CC       Affected patients show an easily recognizable facial appearance
CC       with deep set eyes and hypertelorism, medially divergent, broad
CC       eyebrows, prominent columella, pointed chin and uplifted, notched
CC       ear lobes. Some patients manifest Hirschsprung disease.
CC       {ECO:0000269|PubMed:11448942, ECO:0000269|PubMed:12451214,
CC       ECO:0000269|PubMed:15384097, ECO:0000269|PubMed:16688751}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the delta-EF1/ZFH-1 C2H2-type zinc-finger
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25495.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY029472; AAK52081.1; -; Genomic_DNA.
DR   EMBL; AB056507; BAB40819.1; -; mRNA.
DR   EMBL; AB011141; BAA25495.2; ALT_INIT; mRNA.
DR   EMBL; AK294928; BAH11928.1; -; mRNA.
DR   EMBL; AC009951; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC127102; AAI27103.1; -; mRNA.
DR   EMBL; AB015341; BAA34798.1; -; mRNA.
DR   CCDS; CCDS2186.1; -. [O60315-1]
DR   CCDS; CCDS54403.1; -. [O60315-2]
DR   RefSeq; NP_001165124.1; NM_001171653.1. [O60315-2]
DR   RefSeq; NP_055610.1; NM_014795.3. [O60315-1]
DR   RefSeq; XP_006712944.1; XM_006712881.3. [O60315-1]
DR   RefSeq; XP_006712945.1; XM_006712882.3. [O60315-1]
DR   UniGene; Hs.34871; -.
DR   PDB; 2DA7; NMR; -; A=647-704.
DR   PDBsum; 2DA7; -.
DR   ProteinModelPortal; O60315; -.
DR   SMR; O60315; -.
DR   BioGrid; 115175; 22.
DR   CORUM; O60315; -.
DR   ELM; O60315; -.
DR   IntAct; O60315; 23.
DR   MINT; MINT-1181379; -.
DR   STRING; 9606.ENSP00000302501; -.
DR   iPTMnet; O60315; -.
DR   PhosphoSitePlus; O60315; -.
DR   BioMuta; ZEB2; -.
DR   EPD; O60315; -.
DR   MaxQB; O60315; -.
DR   PaxDb; O60315; -.
DR   PeptideAtlas; O60315; -.
DR   PRIDE; O60315; -.
DR   Ensembl; ENST00000409487; ENSP00000386854; ENSG00000169554. [O60315-1]
DR   Ensembl; ENST00000539609; ENSP00000443792; ENSG00000169554. [O60315-2]
DR   Ensembl; ENST00000558170; ENSP00000454157; ENSG00000169554. [O60315-1]
DR   Ensembl; ENST00000627532; ENSP00000487174; ENSG00000169554. [O60315-1]
DR   GeneID; 9839; -.
DR   KEGG; hsa:9839; -.
DR   UCSC; uc002tvu.4; human. [O60315-1]
DR   CTD; 9839; -.
DR   DisGeNET; 9839; -.
DR   EuPathDB; HostDB:ENSG00000169554.16; -.
DR   GeneCards; ZEB2; -.
DR   GeneReviews; ZEB2; -.
DR   HGNC; HGNC:14881; ZEB2.
DR   HPA; HPA003456; -.
DR   MalaCards; ZEB2; -.
DR   MIM; 235730; phenotype.
DR   MIM; 605802; gene.
DR   neXtProt; NX_O60315; -.
DR   OpenTargets; ENSG00000169554; -.
DR   Orphanet; 261552; Mowat-Wilson syndrome due to a ZEB2 point mutation.
DR   Orphanet; 261537; Mowat-Wilson syndrome due to monosomy 2q22.
DR   PharmGKB; PA162409612; -.
DR   eggNOG; ENOG410IMF7; Eukaryota.
DR   eggNOG; ENOG410ZQ40; LUCA.
DR   GeneTree; ENSGT00630000089829; -.
DR   HOGENOM; HOG000264256; -.
DR   HOVERGEN; HBG004697; -.
DR   InParanoid; O60315; -.
DR   KO; K09299; -.
DR   OrthoDB; EOG091G0F7Y; -.
DR   PhylomeDB; O60315; -.
DR   TreeFam; TF331759; -.
DR   SignaLink; O60315; -.
DR   SIGNOR; O60315; -.
DR   ChiTaRS; ZEB2; human.
DR   EvolutionaryTrace; O60315; -.
DR   GeneWiki; ZEB2; -.
DR   GenomeRNAi; 9839; -.
DR   PRO; PR:O60315; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000169554; -.
DR   CleanEx; HS_SIP1; -.
DR   CleanEx; HS_ZEB2; -.
DR   ExpressionAtlas; O60315; baseline and differential.
DR   Genevisible; O60315; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019208; F:phosphatase regulator activity; NAS:UniProtKB.
DR   GO; GO:0070412; F:R-SMAD binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:BHF-UCL.
DR   GO; GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl.
DR   GO; GO:0048668; P:collateral sprouting; IEA:Ensembl.
DR   GO; GO:0021540; P:corpus callosum morphogenesis; IEA:Ensembl.
DR   GO; GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0048066; P:developmental pigmentation; ISS:BHF-UCL.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0061373; P:mammillary axonal complex development; IEA:Ensembl.
DR   GO; GO:0097324; P:melanocyte migration; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0001755; P:neural crest cell migration; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl.
DR   GO; GO:1902748; P:positive regulation of lens fiber cell differentiation; IEA:Ensembl.
DR   GO; GO:0048023; P:positive regulation of melanin biosynthetic process; IC:BHF-UCL.
DR   GO; GO:0045636; P:positive regulation of melanocyte differentiation; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:1903056; P:regulation of melanosome organization; ISS:BHF-UCL.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   Gene3D; 4.10.1050.10; -; 1.
DR   InterPro; IPR026939; At2g23090-like.
DR   InterPro; IPR008598; Di19_Zn_binding_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; DNA-binding; Epilepsy; Hirschsprung disease;
KW   Homeobox; Isopeptide bond; Mental retardation; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1214       Zinc finger E-box-binding homeobox 2.
FT                                /FTId=PRO_0000047236.
FT   ZN_FING     211    234       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     241    263       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     282    304       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     310    334       C2H2-type 4; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     581    605       C2H2-type 5; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   DNA_BIND    644    703       Homeobox; atypical.
FT   ZN_FING     999   1021       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1027   1049       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1055   1076       C2H2-type 8; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   REGION      437    487       SMAD-MH2 binding domain. {ECO:0000250}.
FT   COMPBIAS   1084   1214       Glu-rich (acidic).
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0G7}.
FT   MOD_RES     360    360       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     364    364       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0G7}.
FT   MOD_RES     377    377       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     647    647       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     731    731       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0G7}.
FT   MOD_RES     780    780       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0G7}.
FT   MOD_RES     782    782       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     784    784       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1122   1122       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1124   1124       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0G7}.
FT   MOD_RES    1203   1203       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0G7}.
FT   CROSSLNK    391    391       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    391    391       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    479    479       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    555    555       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    611    611       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    632    632       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    713    713       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    866    866       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    866    866       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     111    134       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044797.
FT   VARIANT      99     99       Missing (in MOWS).
FT                                {ECO:0000269|PubMed:12451214}.
FT                                /FTId=VAR_027016.
FT   VARIANT     953    953       R -> G (in MOWS).
FT                                {ECO:0000269|PubMed:15384097}.
FT                                /FTId=VAR_027017.
FT   VARIANT     983    983       D -> N (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035563.
FT   VARIANT    1119   1119       Q -> R (in MOWS; dbSNP:rs137852983).
FT                                {ECO:0000269|PubMed:16688751}.
FT                                /FTId=VAR_027018.
FT   CONFLICT   1155   1155       D -> G (in Ref. 4; BAH11928).
FT                                {ECO:0000305}.
FT   HELIX       654    665       {ECO:0000244|PDB:2DA7}.
FT   HELIX       671    681       {ECO:0000244|PDB:2DA7}.
FT   HELIX       685    700       {ECO:0000244|PDB:2DA7}.
SQ   SEQUENCE   1214 AA;  136447 MW;  B578FD91339C3FDD CRC64;
     MKQPIMADGP RCKRRKQANP RRKNVVNYDN VVDTGSETDE EDKLHIAEDD GIANPLDQET
     SPASVPNHES SPHVSQALLP REEEEDEIRE GGVEHPWHNN EILQASVDGP EEMKEDYDTM
     GPEATIQTAI NNGTVKNANC TSDFEEYFAK RKLEERDGHA VSIEEYLQRS DTAIIYPEAP
     EELSRLGTPE ANGQEENDLP PGTPDAFAQL LTCPYCDRGY KRLTSLKEHI KYRHEKNEEN
     FSCPLCSYTF AYRTQLERHM VTHKPGTDQH QMLTQGAGNR KFKCTECGKA FKYKHHLKEH
     LRIHSGEKPY ECPNCKKRFS HSGSYSSHIS SKKCIGLISV NGRMRNNIKT GSSPNSVSSS
     PTNSAITQLR NKLENGKPLS MSEQTGLLKI KTEPLDFNDY KVLMATHGFS GTSPFMNGGL
     GATSPLGVHP SAQSPMQHLG VGMEAPLLGF PTMNSNLSEV QKVLQIVDNT VSRQKMDCKA
     EEISKLKGYH MKDPCSQPEE QGVTSPNIPP VGLPVVSHNG ATKSIIDYTL EKVNEAKACL
     QSLTTDSRRQ ISNIKKEKLR TLIDLVTDDK MIENHNISTP FSCQFCKESF PGPIPLHQHE
     RYLCKMNEEI KAVLQPHENI VPNKAGVFVD NKALLLSSVL SEKGMTSPIN PYKDHMSVLK
     AYYAMNMEPN SDELLKISIA VGLPQEFVKE WFEQRKVYQY SNSRSPSLER SSKPLAPNSN
     PPTKDSLLPR SPVKPMDSIT SPSIAELHNS VTNCDPPLRL TKPSHFTNIK PVEKLDHSRS
     NTPSPLNLSS TSSKNSHSSS YTPNSFSSEE LQAEPLDLSL PKQMKEPKSI IATKNKTKAS
     SISLDHNSVS SSSENSDEPL NLTFIKKEFS NSNNLDNKST NPVFSMNPFS AKPLYTALPP
     QSAFPPATFM PPVQTSIPGL RPYPGLDQMS FLPHMAYTYP TGAATFADMQ QRRKYQRKQG
     FQGELLDGAQ DYMSGLDDMT DSDSCLSRKK IKKTESGMYA CDLCDKTFQK SSSLLRHKYE
     HTGKRPHQCQ ICKKAFKHKH HLIEHSRLHS GEKPYQCDKC GKRFSHSGSY SQHMNHRYSY
     CKREAEEREA AEREAREKGH LEPTELLMNR AYLQSITPQG YSDSEERESM PRDGESEKEH
     EKEGEDGYGK LGRQDGDEEF EEEEEESENK SMDTDPETIR DEEETGDHSM DDSSEDGKME
     TKSDHEEDNM EDGM
//
ID   PIT1_HUMAN              Reviewed;         291 AA.
AC   P28069; O75757; Q15132; Q15133; Q9UD34; Q9UEL3;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   25-OCT-2017, entry version 181.
DE   RecName: Full=Pituitary-specific positive transcription factor 1;
DE            Short=PIT-1;
DE   AltName: Full=Growth hormone factor 1;
DE            Short=GHF-1;
GN   Name=POU1F1; Synonyms=GHF1, PIT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   TISSUE=Pituitary anterior lobe;
RX   PubMed=1956794; DOI=10.1093/nar/19.22.6329;
RA   Lew A.M., Elsholtz H.P.;
RT   "Cloning of the human cDNA for transcription factor Pit-1.";
RL   Nucleic Acids Res. 19:6329-6329(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM B).
RX   PubMed=1370379; DOI=10.1016/0167-4781(92)90494-K;
RA   Tatsumi K.I., Notomi T., Amino N., Miyai K.;
RT   "Nucleotide sequence of the complementary DNA for human Pit-1/GHF-1.";
RL   Biochim. Biophys. Acta 1129:231-234(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A).
RA   Tatsumi K., Notomi T., Irie Y., Endo Y., Onogi S., Amino N., Miyai K.;
RT   "The structure and the chromosomal location of the human PIT1 gene.";
RL   Submitted (AUG-1992) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71, AND ALTERNATIVE SPLICING
RP   (ISOFORM A).
RC   TISSUE=Placenta;
RX   PubMed=7721104; DOI=10.1016/0378-1119(94)00757-J;
RA   Delhase M., Vila V., Hooghe-Peters E.L., Castrillo J.-L.;
RT   "A novel pituitary transcription factor is produced by alternative
RT   splicing of the human GHF-1/PIT-1 gene.";
RL   Gene 155:273-275(1995).
RN   [5]
RP   SEQUENCE REVISION.
RA   Delhase M.;
RL   Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-47.
RX   PubMed=1487156; DOI=10.1016/0378-1119(92)90234-G;
RA   Ohta K., Nobukuni Y., Mitsubuchi H., Ohta T., Tohma T., Jinno Y.,
RA   Endo F., Matsuda I.;
RT   "Characterization of the gene encoding human pituitary-specific
RT   transcription factor, Pit-1.";
RL   Gene 122:387-388(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 214-273, VARIANT CPHD1 TRP-271,
RP   AND INVOLVEMENT IN CPHD1.
RX   PubMed=7852536; DOI=10.1210/jcem.80.2.7852536;
RA   Cohen L.E., Wondisford F.E., Salvatoni A., Maghnie M.,
RA   Brucker-Davis F., Weintraub B.D., Radovick S.;
RT   "A 'hot spot' in the Pit-1 gene responsible for combined pituitary
RT   hormone deficiency: clinical and molecular correlates.";
RL   J. Clin. Endocrinol. Metab. 80:679-684(1995).
RN   [8]
RP   VARIANTS CPHD1 LEU-24; GLN-143 AND TRP-271.
RX   PubMed=1472057; DOI=10.1016/0006-291X(92)92281-2;
RA   Ohta K., Nobukuni Y., Mitsubuchi H., Fujimoto S., Matsuo N.,
RA   Inagaki H., Endo F., Matsuda I.;
RT   "Mutations in the Pit-1 gene in children with combined pituitary
RT   hormone deficiency.";
RL   Biochem. Biophys. Res. Commun. 189:851-855(1992).
RN   [9]
RP   VARIANT CPHD1 TRP-271.
RX   PubMed=1509262; DOI=10.1126/science.257.5073.1115;
RA   Radovick S., Nations M., Du Y., Berg L.A., Weintraub B.D.,
RA   Wondisford F.E.;
RT   "A mutation in the POU-homeodomain of Pit-1 responsible for combined
RT   pituitary hormone deficiency.";
RL   Science 257:1115-1118(1992).
RN   [10]
RP   VARIANT CPHD1 PRO-158.
RX   PubMed=1509263; DOI=10.1126/science.257.5073.1118;
RA   Pfaeffle R.W., DiMattia G.E., Parks J.S., Brown M.R., Wit J.M.,
RA   Jansen M., van der Nat H., van den Brande J.L., Rosenfeld M.G.,
RA   Ingraham H.A.;
RT   "Mutation of the POU-specific domain of Pit-1 and hypopituitarism
RT   without pituitary hypoplasia.";
RL   Science 257:1118-1121(1992).
RN   [11]
RP   VARIANTS ARG-4 AND TYR-227.
RC   TISSUE=Pituitary;
RX   PubMed=8346040; DOI=10.1093/nar/21.15.3584;
RA   Pernasetti F.M., Wera S., Belayew A., Martial J.A.;
RT   "Cloning of a human GHF-1/Pit-1 cDNA variant.";
RL   Nucleic Acids Res. 21:3584-3584(1993).
RN   [12]
RP   VARIANT CPHD1 CYS-135.
RX   PubMed=8768831; DOI=10.1210/jcem.81.8.8768831;
RA   Pellegrini-Bouiller I., Belicar P., Barlier A., Gunz G., Charvet J.P.,
RA   Jaquet P., Brue T., Vialettes B., Enjalbert A.;
RT   "A new mutation of the gene encoding the transcription factor Pit-1 is
RT   responsible for combined pituitary hormone deficiency.";
RL   J. Clin. Endocrinol. Metab. 81:2790-2796(1996).
RN   [13]
RP   VARIANT CPHD1 GLY-174.
RX   PubMed=9485179; DOI=10.1159/000023134;
RA   Brown M.R., Parks J.S., Adess M.E., Rich B.H., Rosenthal I.M.,
RA   Voss T.C., VanderHeyden T.C., Hurley D.L.;
RT   "Central hypothyroidism reveals compound heterozygous mutations in the
RT   Pit-1 gene.";
RL   Horm. Res. 49:98-102(1998).
RN   [14]
RP   VARIANT CPHD1 SER-239.
RX   PubMed=9626142; DOI=10.1210/jcem.83.6.4901;
RA   Pernasetti F.M., Milner R.D.G., Al-Ashwal A.A.Z., de Zegher F.,
RA   Chavez V.M., Muller M., Martial J.A.;
RT   "Pro239Ser: a novel recessive mutation of the Pit-1 gene in seven
RT   Middle Eastern children with growth hormone, prolactin, and
RT   thyrotropin deficiency.";
RL   J. Clin. Endocrinol. Metab. 83:2079-2083(1998).
RN   [15]
RP   VARIANT CPHD1 ARG-193.
RX   PubMed=11297581; DOI=10.1210/jcem.86.4.7371;
RA   Hendriks-Stegeman B.I., Augustijn K.D., Bakker B., Holthuizen P.,
RA   van der Vliet P.C., Jansen M.;
RT   "Combined pituitary hormone deficiency caused by compound
RT   heterozygosity for two novel mutations in the POU domain of the
RT   PIT1/POU1F1 gene.";
RL   J. Clin. Endocrinol. Metab. 86:1545-1550(2001).
RN   [16]
RP   VARIANTS CPHD1 GLN-172; LYS-230 AND TRP-271, AND CHARACTERIZATION OF
RP   VARIANTS CPHD1 GLN-172 AND LYS-230.
RX   PubMed=15928241; DOI=10.1210/jc.2005-0570;
RA   Turton J.P.G., Reynaud R., Mehta A., Torpiano J., Saveanu A.,
RA   Woods K.S., Tiulpakov A., Zdravkovic V., Hamilton J.,
RA   Attard-Montalto S., Parascandalo R., Vella C., Clayton P.E.,
RA   Shalet S., Barton J., Brue T., Dattani M.T.;
RT   "Novel mutations within the POU1F1 gene associated with variable
RT   combined pituitary hormone deficiency.";
RL   J. Clin. Endocrinol. Metab. 90:4762-4770(2005).
RN   [17]
RP   VARIANT CPHD1 ARG-179, AND CHARACTERIZATION OF VARIANT CPHD1 ARG-179.
RX   PubMed=16968807; DOI=10.1210/jc.2005-2289;
RA   Miyata I., Vallette-Kasic S., Saveanu A., Takeuchi M., Yoshikawa H.,
RA   Tajima A., Tojo K., Reynaud R., Gueydan M., Enjalbert A., Tajima N.,
RA   Eto Y., Brue T.;
RT   "Identification and functional analysis of the novel S179R POU1F1
RT   mutation associated with combined pituitary hormone deficiency.";
RL   J. Clin. Endocrinol. Metab. 91:4981-4987(2006).
RN   [18]
RP   VARIANT CPHD1 TRP-265, CHARACTERIZATION OF VARIANT CPHD1 TRP-265, AND
RP   FUNCTION.
RX   PubMed=22010633; DOI=10.1111/j.1365-2265.2011.04236.x;
RA   Turton J.P., Strom M., Langham S., Dattani M.T., Le Tissier P.;
RT   "Two novel mutations in the POU1F1 gene generate null alleles through
RT   different mechanisms leading to c ombined pituitary hormone
RT   deficiency.";
RL   Clin. Endocrinol. (Oxf.) 76:387-393(2012).
RN   [19]
RP   VARIANT CPHD1 LEU-76, CHARACTERIZATION OF VARIANT CPHD1 LEU-76,
RP   FUNCTION, INTERACTION WITH ELK1; LHX3 AND PITX1, DNA-BINDING,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-74; THR-75; PRO-76;
RP   CYS-77 AND LEU-78.
RX   PubMed=26612202; DOI=10.1093/hmg/ddv486;
RA   Sobrier M.L., Tsai Y.C., Perez C., Leheup B., Bouceba T.,
RA   Duquesnoy P., Copin B., Sizova D., Penzo A., Stanger B.Z., Cooke N.E.,
RA   Liebhaber S.A., Amselem S.;
RT   "Functional characterization of a human POU1F1 mutation associated
RT   with isolated growth hormone deficiency: a novel etiology for IGHD.";
RL   Hum. Mol. Genet. 25:472-483(2016).
CC   -!- FUNCTION: Transcription factor involved in the specification of
CC       the lactotrope, somatotrope, and thyrotrope phenotypes in the
CC       developing anterior pituitary. Specifically binds to the consensus
CC       sequence 5'-TAAAT-3'. Activates growth hormone and prolactin genes
CC       (PubMed:22010633, PubMed:26612202). {ECO:0000269|PubMed:22010633,
CC       ECO:0000269|PubMed:26612202}.
CC   -!- SUBUNIT: Interacts with PITX1 (PubMed:26612202). Interacts with
CC       LHX3 (PubMed:26612202). Interacts with ELK1 (PubMed:26612202).
CC       {ECO:0000269|PubMed:26612202}.
CC   -!- INTERACTION:
CC       Q14847-2:LASP1; NbExp=4; IntAct=EBI-8673859, EBI-9088686;
CC       Q969G2:LHX4; NbExp=4; IntAct=EBI-8673859, EBI-2865388;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26612202}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B; Synonyms=Pit-1B, GHF-1;
CC         IsoId=P28069-1; Sequence=Displayed;
CC       Name=A; Synonyms=Pit-1A, GHF-2;
CC         IsoId=P28069-2; Sequence=VSP_002314;
CC         Note=Altered in its ability to trans-activate compared to
CC         isoform B.;
CC   -!- DISEASE: Pituitary hormone deficiency, combined, 1 (CPHD1)
CC       [MIM:613038]: Combined pituitary hormone deficiency is defined as
CC       the impaired production of growth hormone and one or more of the
CC       other five anterior pituitary hormones. CPHD1 is characterized by
CC       pleiotropic deficiencies of growth hormone, prolactin and thyroid-
CC       stimulating hormone, while the production of adrenocorticotropic
CC       hormone, luteinizing hormone, and follicle-stimulating hormone are
CC       preserved. In infancy severe growth deficiency from birth as well
CC       as distinctive facial features with prominent forehead, marked
CC       midfacial hypoplasia with depressed nasal bridge, deep-set eyes,
CC       and a short nose with anteverted nostrils and hypoplastic
CC       pituitary gland by MRI examination can be seen. Some cases present
CC       with severe mental retardation along with short stature.
CC       {ECO:0000269|PubMed:11297581, ECO:0000269|PubMed:1472057,
CC       ECO:0000269|PubMed:1509262, ECO:0000269|PubMed:1509263,
CC       ECO:0000269|PubMed:15928241, ECO:0000269|PubMed:16968807,
CC       ECO:0000269|PubMed:22010633, ECO:0000269|PubMed:26612202,
CC       ECO:0000269|PubMed:7852536, ECO:0000269|PubMed:8768831,
CC       ECO:0000269|PubMed:9485179, ECO:0000269|PubMed:9626142}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA54440.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18781; AAA60093.1; -; mRNA.
DR   EMBL; X62429; CAA44295.1; -; mRNA.
DR   EMBL; D10216; BAA01068.1; -; mRNA.
DR   EMBL; X72215; CAA51017.1; -; mRNA.
DR   EMBL; D12892; BAA02291.1; -; Genomic_DNA.
DR   EMBL; X77223; CAA54440.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; X77224; CAA54440.2; JOINED; Genomic_DNA.
DR   EMBL; X77223; CAA54441.1; -; Genomic_DNA.
DR   EMBL; X77224; CAA54441.1; JOINED; Genomic_DNA.
DR   EMBL; D11333; BAA34536.1; -; Genomic_DNA.
DR   CCDS; CCDS2919.1; -. [P28069-1]
DR   CCDS; CCDS46873.1; -. [P28069-2]
DR   PIR; S18718; S18718.
DR   RefSeq; NP_000297.1; NM_000306.3. [P28069-1]
DR   RefSeq; NP_001116229.1; NM_001122757.2. [P28069-2]
DR   UniGene; Hs.591654; -.
DR   ProteinModelPortal; P28069; -.
DR   SMR; P28069; -.
DR   BioGrid; 111445; 15.
DR   IntAct; P28069; 8.
DR   MINT; MINT-1521664; -.
DR   iPTMnet; P28069; -.
DR   PhosphoSitePlus; P28069; -.
DR   BioMuta; POU1F1; -.
DR   DMDM; 123408; -.
DR   PRIDE; P28069; -.
DR   DNASU; 5449; -.
DR   Ensembl; ENST00000344265; ENSP00000342931; ENSG00000064835. [P28069-2]
DR   Ensembl; ENST00000350375; ENSP00000263781; ENSG00000064835. [P28069-1]
DR   GeneID; 5449; -.
DR   KEGG; hsa:5449; -.
DR   UCSC; uc003dqq.2; human. [P28069-1]
DR   CTD; 5449; -.
DR   DisGeNET; 5449; -.
DR   EuPathDB; HostDB:ENSG00000064835.10; -.
DR   GeneCards; POU1F1; -.
DR   HGNC; HGNC:9210; POU1F1.
DR   HPA; HPA041646; -.
DR   HPA; HPA050624; -.
DR   MalaCards; POU1F1; -.
DR   MIM; 173110; gene.
DR   MIM; 613038; phenotype.
DR   neXtProt; NX_P28069; -.
DR   OpenTargets; ENSG00000064835; -.
DR   Orphanet; 95494; Combined pituitary hormone deficiencies, genetic forms.
DR   Orphanet; 226307; Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
DR   PharmGKB; PA33534; -.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116302; -.
DR   HOVERGEN; HBG053120; -.
DR   InParanoid; P28069; -.
DR   KO; K09363; -.
DR   OMA; MSCQPFT; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; P28069; -.
DR   TreeFam; TF316413; -.
DR   SIGNOR; P28069; -.
DR   GeneWiki; Pituitary-specific_positive_transcription_factor_1; -.
DR   GenomeRNAi; 5449; -.
DR   PRO; PR:P28069; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000064835; -.
DR   CleanEx; HS_POU1F1; -.
DR   ExpressionAtlas; P28069; baseline and differential.
DR   Genevisible; P28069; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0008340; P:determination of adult lifespan; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0051169; P:nuclear transport; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0043567; P:regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0060133; P:somatotropin secreting cell development; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR015586; Pit_1.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   PANTHER; PTHR11636:SF84; PTHR11636:SF84; 2.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome; Disease mutation;
KW   DNA-binding; Dwarfism; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    291       Pituitary-specific positive transcription
FT                                factor 1.
FT                                /FTId=PRO_0000100697.
FT   DOMAIN      124    198       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    214    273       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ      47     47       T -> TVPSILSLIQTPKCLCTHFSVTTLGNT (in
FT                                isoform A). {ECO:0000305}.
FT                                /FTId=VSP_002314.
FT   VARIANT       4      4       Q -> R (in dbSNP:rs1051612).
FT                                {ECO:0000269|PubMed:8346040}.
FT                                /FTId=VAR_003776.
FT   VARIANT      19     19       A -> V (in dbSNP:rs35182189).
FT                                /FTId=VAR_049361.
FT   VARIANT      24     24       P -> L (in CPHD1; dbSNP:rs104893757).
FT                                {ECO:0000269|PubMed:1472057}.
FT                                /FTId=VAR_003777.
FT   VARIANT      76     76       P -> L (in CPHD1; reduces transactivation
FT                                capacity on the GH1 gene; increases the
FT                                functional binding on the GH1 promoter;
FT                                increases the interaction with ELK1, LHX3
FT                                and PITX1).
FT                                {ECO:0000269|PubMed:26612202}.
FT                                /FTId=VAR_075530.
FT   VARIANT     135    135       F -> C (in CPHD1; dbSNP:rs104893761).
FT                                {ECO:0000269|PubMed:8768831}.
FT                                /FTId=VAR_010574.
FT   VARIANT     143    143       R -> Q (in CPHD1; dbSNP:rs104893759).
FT                                {ECO:0000269|PubMed:1472057}.
FT                                /FTId=VAR_003778.
FT   VARIANT     158    158       A -> P (in CPHD1; dbSNP:rs104893756).
FT                                {ECO:0000269|PubMed:1509263}.
FT                                /FTId=VAR_003779.
FT   VARIANT     172    172       R -> Q (in CPHD1; associated with severe
FT                                impairment of transactivation; has a
FT                                greatly reduced DNA-binding affinity as
FT                                the wild-type protein;
FT                                dbSNP:rs104893765).
FT                                {ECO:0000269|PubMed:15928241}.
FT                                /FTId=VAR_063425.
FT   VARIANT     174    174       E -> G (in CPHD1).
FT                                {ECO:0000269|PubMed:9485179}.
FT                                /FTId=VAR_010575.
FT   VARIANT     179    179       S -> R (in CPHD1; transactivation
FT                                capacity of this mutant is markedly
FT                                decreased on the GH1; PRL, TSHB and
FT                                POU1F1 genes; abolishes the functional
FT                                interaction of POU1F1 on the PRL promoter
FT                                with the coactivator CREBBP but not with
FT                                the transcription factor LHX3; displays
FT                                normal nuclear accumulation but a
FT                                markedly decreased binding to a DNA
FT                                response element; dbSNP:rs104893766).
FT                                {ECO:0000269|PubMed:16968807}.
FT                                /FTId=VAR_063426.
FT   VARIANT     193    193       W -> R (in CPHD1; dbSNP:rs104893758).
FT                                {ECO:0000269|PubMed:11297581}.
FT                                /FTId=VAR_015260.
FT   VARIANT     227    227       D -> Y (in dbSNP:rs1131815).
FT                                {ECO:0000269|PubMed:8346040}.
FT                                /FTId=VAR_003780.
FT   VARIANT     230    230       E -> K (in CPHD1; associated with less
FT                                severe impairment of transactivation; has
FT                                a similar DNA-binding affinity as the
FT                                wild-type protein; dbSNP:rs104893764).
FT                                {ECO:0000269|PubMed:15928241}.
FT                                /FTId=VAR_063427.
FT   VARIANT     239    239       P -> S (in CPHD1; loss of function;
FT                                dbSNP:rs104893762).
FT                                {ECO:0000269|PubMed:9626142}.
FT                                /FTId=VAR_010576.
FT   VARIANT     265    265       R -> W (in CPHD1; found in a compound
FT                                heterozygote also carrying an intragenic
FT                                frameshift deletion; reduces
FT                                transactivation capacity on the PRL gene;
FT                                increases instability of the protein;
FT                                dbSNP:rs780359925).
FT                                {ECO:0000269|PubMed:22010633}.
FT                                /FTId=VAR_075531.
FT   VARIANT     271    271       R -> W (in CPHD1; dbSNP:rs104893755).
FT                                {ECO:0000269|PubMed:1472057,
FT                                ECO:0000269|PubMed:1509262,
FT                                ECO:0000269|PubMed:15928241,
FT                                ECO:0000269|PubMed:7852536}.
FT                                /FTId=VAR_003781.
FT   MUTAGEN      74     74       L->A: No effect on the interaction with
FT                                ELK1, LHX3 and PITX1.
FT                                {ECO:0000269|PubMed:26612202}.
FT   MUTAGEN      75     75       T->A: Increases the interaction with
FT                                LHX3. No effect on the interaction with
FT                                ELK1. {ECO:0000269|PubMed:26612202}.
FT   MUTAGEN      76     76       P->A: Increases the interaction with LHX3
FT                                and PITX1. No effect on the interaction
FT                                with ELK1. {ECO:0000269|PubMed:26612202}.
FT   MUTAGEN      77     77       C->A: Increases the interaction with LHX3
FT                                and PITX1. No effect on the interaction
FT                                with ELK1. {ECO:0000269|PubMed:26612202}.
FT   MUTAGEN      78     78       L->A: Increases the interaction with LHX3
FT                                and PITX1. No effect on the interaction
FT                                with ELK1. {ECO:0000269|PubMed:26612202}.
SQ   SEQUENCE   291 AA;  32912 MW;  0866777E3E425873 CRC64;
     MSCQAFTSAD TFIPLNSDAS ATLPLIMHHS AAECLPVSNH ATNVMSTATG LHYSVPSCHY
     GNQPSTYGVM AGSLTPCLYK FPDHTLSHGF PPIHQPLLAE DPTAADFKQE LRRKSKLVEE
     PIDMDSPEIR ELEKFANEFK VRRIKLGYTQ TNVGEALAAV HGSEFSQTTI CRFENLQLSF
     KNACKLKAIL SKWLEEAEQV GALYNEKVGA NERKRKRRTT ISIAAKDALE RHFGEQNKPS
     SQEIMRMAEE LNLEKEVVRV WFCNRRQREK RVKTSLNQSL FSISKEHLEC R
//
ID   ISL1_HUMAN              Reviewed;         349 AA.
AC   P61371; P20663; P47894;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 1.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Insulin gene enhancer protein ISL-1;
DE            Short=Islet-1;
GN   Name=ISL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=7907017; DOI=10.1210/endo.134.3.7907017;
RA   Wang M., Drucker D.J.;
RT   "The LIM domain homeobox gene isl-1: conservation of human, hamster,
RT   and rat complementary deoxyribonucleic acid sequences and expression
RT   in cell types of nonneuroendocrine lineage.";
RL   Endocrinology 134:1416-1422(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-349.
RC   TISSUE=Pancreatic islet;
RX   PubMed=7912209; DOI=10.2337/diab.43.7.935;
RA   Tanizawa Y., Riggs A.C., Dagogo-Jack S., Vaxillaire M., Froguel P.,
RA   Liu L., Donis-Keller H., Permutt M.A.;
RT   "Isolation of the human LIM/homeodomain gene islet-1 and
RT   identification of a simple sequence repeat polymorphism.";
RL   Diabetes 43:935-941(1994).
RN   [3]
RP   ERRATUM.
RA   Tanizawa Y., Riggs A.C., Dagogo-Jack S., Vaxillaire M., Froguel P.,
RA   Liu L., Donis-Keller H., Permutt M.A.;
RL   Diabetes 43:1171-1171(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
CC   -!- FUNCTION: DNA-binding transcriptional activator. Recognizes and
CC       binds to the consensus octamer binding site 5'-ATAATTAA-3' in
CC       promoter of target genes. Plays a fundamental role in the gene
CC       regulatory network essential for retinal ganglion cell (RGC)
CC       differentiation. Cooperates with the transcription factor POU4F2
CC       to achieve maximal levels of expression of RGC target genes and
CC       RGC fate specification in the developing retina. Involved in the
CC       specification of motor neurons in cooperation with LHX3 and LDB1.
CC       Binds to insulin gene enhancer sequences. Essential for heart
CC       development. Marker of one progenitor cell population that give
CC       rise to the outflow tract, right ventricle, a subset of left
CC       ventricular cells, and a large number of atrial cells as well, its
CC       function is required for these progenitors to contribute to the
CC       heart. Controls the expression of FGF and BMP growth factors in
CC       this cell population and is required for proliferation and
CC       survival of cells within pharyngeal foregut endoderm and adjacent
CC       splanchnic mesoderm as well as for migration of cardiac
CC       progenitors into the heart (By similarity).
CC       {ECO:0000250|UniProtKB:P61372, ECO:0000250|UniProtKB:P61374}.
CC   -!- SUBUNIT: At neuronal promoters, displaces LDB1 from LHX3 LIM
CC       domain to form a ternary complex in which ISL1 contacts both LHX3
CC       and LDB1. Interacts (via C-terminus) with POU4F2 (via C-terminus).
CC       Interacts with POU3F2. Interacts with POU4F3. Interacts (via N-
CC       terminal domain) with MLIP; the interaction represses ISL1
CC       transactivator activity (By similarity).
CC       {ECO:0000250|UniProtKB:P61372}.
CC   -!- INTERACTION:
CC       Q8NB15:ZNF511; NbExp=3; IntAct=EBI-3906896, EBI-10269136;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P61372}.
CC   -!- TISSUE SPECIFICITY: Expressed in subsets of neurons of the adrenal
CC       medulla and dorsal root ganglion, inner nuclear and ganglion cell
CC       layers in the retina, the pineal and some regions of the brain.
CC       {ECO:0000269|PubMed:7907017}.
CC   -!- PTM: Phosphorylated. {ECO:0000250|UniProtKB:P61372}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S70721; AAD14064.1; -; mRNA.
DR   EMBL; U07559; AAA81946.1; -; mRNA.
DR   EMBL; BC031213; AAH31213.1; -; mRNA.
DR   CCDS; CCDS43314.1; -.
DR   PIR; I53277; I53277.
DR   RefSeq; NP_002193.2; NM_002202.2.
DR   UniGene; Hs.505; -.
DR   ProteinModelPortal; P61371; -.
DR   SMR; P61371; -.
DR   BioGrid; 109877; 27.
DR   IntAct; P61371; 10.
DR   MINT; MINT-3022667; -.
DR   STRING; 9606.ENSP00000230658; -.
DR   iPTMnet; P61371; -.
DR   PhosphoSitePlus; P61371; -.
DR   BioMuta; ISL1; -.
DR   DMDM; 47606423; -.
DR   EPD; P61371; -.
DR   MaxQB; P61371; -.
DR   PaxDb; P61371; -.
DR   PeptideAtlas; P61371; -.
DR   PRIDE; P61371; -.
DR   DNASU; 3670; -.
DR   Ensembl; ENST00000230658; ENSP00000230658; ENSG00000016082.
DR   GeneID; 3670; -.
DR   KEGG; hsa:3670; -.
DR   UCSC; uc003jor.4; human.
DR   CTD; 3670; -.
DR   DisGeNET; 3670; -.
DR   EuPathDB; HostDB:ENSG00000016082.14; -.
DR   GeneCards; ISL1; -.
DR   HGNC; HGNC:6132; ISL1.
DR   HPA; HPA057416; -.
DR   MalaCards; ISL1; -.
DR   MIM; 600366; gene.
DR   neXtProt; NX_P61371; -.
DR   OpenTargets; ENSG00000016082; -.
DR   PharmGKB; PA29932; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000236304; -.
DR   HOVERGEN; HBG004671; -.
DR   InParanoid; P61371; -.
DR   KO; K09370; -.
DR   OMA; RIHDQWI; -.
DR   OrthoDB; EOG091G09L9; -.
DR   PhylomeDB; P61371; -.
DR   TreeFam; TF315442; -.
DR   Reactome; R-HSA-400511; Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP).
DR   SIGNOR; P61371; -.
DR   ChiTaRS; ISL1; human.
DR   GeneWiki; ISL1; -.
DR   GenomeRNAi; 3670; -.
DR   PRO; PR:P61371; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000016082; -.
DR   CleanEx; HS_ISL1; -.
DR   ExpressionAtlas; P61371; baseline and differential.
DR   Genevisible; P61371; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:BHF-UCL.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0001158; F:enhancer sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0030331; F:estrogen receptor binding; ISS:BHF-UCL.
DR   GO; GO:0016922; F:ligand-dependent nuclear receptor binding; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0060413; P:atrial septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0031103; P:axon regeneration; IEA:Ensembl.
DR   GO; GO:0060913; P:cardiac cell fate determination; IDA:BHF-UCL.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; IEA:Ensembl.
DR   GO; GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; ISS:BHF-UCL.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0060384; P:innervation; ISS:BHF-UCL.
DR   GO; GO:0048762; P:mesenchymal cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0090074; P:negative regulation of protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0001755; P:neural crest cell migration; IEA:Ensembl.
DR   GO; GO:0048665; P:neuron fate specification; ISS:BHF-UCL.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0031016; P:pancreas development; ISS:BHF-UCL.
DR   GO; GO:0048936; P:peripheral nervous system neuron axonogenesis; ISS:BHF-UCL.
DR   GO; GO:0060037; P:pharyngeal system development; ISS:BHF-UCL.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IEA:Ensembl.
DR   GO; GO:0071657; P:positive regulation of granulocyte colony-stimulating factor production; ISS:BHF-UCL.
DR   GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISS:BHF-UCL.
DR   GO; GO:0035066; P:positive regulation of histone acetylation; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IC:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; ISS:BHF-UCL.
DR   GO; GO:0032730; P:positive regulation of interleukin-1 alpha production; ISS:BHF-UCL.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISS:BHF-UCL.
DR   GO; GO:1901258; P:positive regulation of macrophage colony-stimulating factor production; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IEA:Ensembl.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISS:BHF-UCL.
DR   GO; GO:0003266; P:regulation of secondary heart field cardioblast proliferation; IEA:Ensembl.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   GO; GO:0003139; P:secondary heart field specification; IMP:BHF-UCL.
DR   GO; GO:0048880; P:sensory system development; ISS:BHF-UCL.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; ISS:BHF-UCL.
DR   GO; GO:0021559; P:trigeminal nerve development; ISS:BHF-UCL.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0021524; P:visceral motor neuron differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; LIM domain; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    349       Insulin gene enhancer protein ISL-1.
FT                                /FTId=PRO_0000075746.
FT   DOMAIN       17     70       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       79    133       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    181    240       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      262    291       LIM-binding domain (LID). {ECO:0000250}.
FT   COMPBIAS    241    349       Gln-rich.
SQ   SEQUENCE   349 AA;  39036 MW;  4DB82FD09154F404 CRC64;
     MGDMGDPPKK KRLISLCVGC GNQIHDQYIL RVSPDLEWHA ACLKCAECNQ YLDESCTCFV
     RDGKTYCKRD YIRLYGIKCA KCSIGFSKND FVMRARSKVY HIECFRCVAC SRQLIPGDEF
     ALREDGLFCR ADHDVVERAS LGAGDPLSPL HPARPLQMAA EPISARQPAL RPHVHKQPEK
     TTRVRTVLNE KQLHTLRTCY AANPRPDALM KEQLVEMTGL SPRVIRVWFQ NKRCKDKKRS
     IMMKQLQQQQ PNDKTNIQGM TGTPMVAASP ERHDGGLQAN PVEVQSYQPP WKVLSDFALQ
     SDIDQPAFQQ LVNFSEGGPG SNSTGSEVAS MSSQLPDTPN SMVASPIEA
//
ID   PO4F2_HUMAN             Reviewed;         409 AA.
AC   Q12837; B1PJR6; B2RC84; Q13883; Q14987;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   02-MAR-2010, sequence version 2.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=POU domain, class 4, transcription factor 2 {ECO:0000312|HGNC:HGNC:9219};
DE   AltName: Full=Brain-specific homeobox/POU domain protein 3B;
DE            Short=Brain-3B;
DE            Short=Brn-3B;
GN   Name=POU4F2 {ECO:0000312|HGNC:HGNC:9219}; Synonyms=BRN3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=7691107; DOI=10.1016/0896-6273(93)90079-7;
RA   Xiang M., Zhou L.-J., Peng Y., Eddy R.L., Shows T.B., Nathans J.;
RT   "Brn-3b: a POU domain gene expressed in a subset of retinal ganglion
RT   cells.";
RL   Neuron 11:689-701(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=8332509; DOI=10.1093/nar/21.12.2946;
RA   Ring C.J.A., Latchman D.S.;
RT   "The human Brn-3b POU transcription factor shows only limited homology
RT   to the Brn-3a/RDC-1 factor outside the conserved POU domain.";
RL   Nucleic Acids Res. 21:2946-2946(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-409 (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, DOMAIN, AND MUTAGENESIS OF 171-HIS--HIS-185.
RC   TISSUE=Testis;
RX   PubMed=19266028; DOI=10.1371/journal.pgen.1000397;
RA   Salichs E., Ledda A., Mularoni L., Alba M.M., de la Luna S.;
RT   "Genome-wide analysis of histidine repeats reveals their role in the
RT   localization of human proteins to the nuclear speckles compartment.";
RL   PLoS Genet. 5:E1000397-E1000397(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 274-391 (ISOFORM 1/2).
RX   PubMed=8234287; DOI=10.1073/pnas.90.21.10260;
RA   Bhargava A.K., Li Z., Weissman S.M.;
RT   "Differential expression of four members of the POU family of proteins
RT   in activated and phorbol 12-myristate 13-acetate-treated Jurkat T
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10260-10264(1993).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=11526481; DOI=10.1038/sj.onc.1204491;
RA   Dennis J.H., Budhram-Mahadeo V., Latchman D.S.;
RT   "The Brn-3b POU family transcription factor regulates the cellular
RT   growth, proliferation, and anchorage dependence of MCF7 human breast
RT   cancer cells.";
RL   Oncogene 20:4961-4971(2001).
RN   [9]
RP   FUNCTION (ISOFORMS 1 AND 2), AND DNA (ISOFORMS 1 AND 2).
RX   PubMed=23805044;
RA   Zhang L., Wahlin K., Li Y., Masuda T., Yang Z., Zack D.J., Esumi N.;
RT   "RIT2, a neuron-specific small guanosine triphosphatase, is expressed
RT   in retinal neuronal cells and its promoter is modulated by the POU4
RT   transcription factors.";
RL   Mol. Vis. 19:1371-1386(2013).
CC   -!- FUNCTION: DNA-binding transcriptional regulator and coregulator
CC       that recognizes and binds to the consensus octamer binding site
CC       5'-AT[A/T]A[T/A]T[A/T]A-3' in promoter of target genes
CC       (PubMed:19266028, PubMed:23805044). Plays a fundamental role in
CC       the gene regulatory network essential for retinal ganglion cell
CC       (RGC) differentiation. Cooperates with the transcription factor
CC       ISL1 to achieve RGC fate specification in the developing retina.
CC       Plays also a role in RGC axon formation and guidance by regulating
CC       gene expression of specific target genes. Plays a role in TNFSF11-
CC       mediated terminal osteoclast differentiation. Binds chromatin at
CC       promoter region of target genes (By similarity).
CC       {ECO:0000250|UniProtKB:Q63934, ECO:0000269|PubMed:19266028,
CC       ECO:0000269|PubMed:23805044}.
CC   -!- FUNCTION: Isoform 1: Acts either as a transcriptional activator or
CC       repressor (PubMed:19266028, PubMed:23805044). Negatively regulates
CC       transcriptional activity of homeobox domain transcriptional
CC       factors DLX1 and DLX2, and hence prevents DLX1- and DLX2-mediated
CC       ability to promote amacrine cells specification. Involved in the
CC       positive regulation of the transcriptional factor PAX6 expression
CC       through its binding to the neuroretina-specific enhancer in
CC       neuroretina cells. Mediates positive transcriptional regulation of
CC       heat shock protein HSPB1 expression in cardiac myocytes.
CC       Positively regulates POU4F1 expression by interacting directly
CC       with a highly conserved autoregulatory domain surrounding the
CC       transcription initiation site of the POU4F1 gene promoter. Plays a
CC       role in the regulation of breast cancer cell growth by promoting
CC       transcription activation as well as repression of specific target
CC       genes. Involved in tumor breast progression and invasion (By
CC       similarity). Stimulates the promoter activity of the GTP-binding
CC       protein RIT2 gene containing the octamer binding site in retinal
CC       ganglion cells (PubMed:23805044). Plays also a role either as a
CC       transcriptional coactivator or corepressor. Transcriptional
CC       coactivator cooperating with transcription factors ISL1 and ISL2
CC       to potentiate transcriptional activation of retinal ganglion cell
CC       (RGC) target genes. Antagonizes the transcriptional stimulatory
CC       activity of POU4F1 by preventing its binding to the octamer motif.
CC       Binds to the octamer binding site to form a ternary complex with
CC       ISL1 in promoter of target genes (By similarity).
CC       {ECO:0000250|UniProtKB:Q63934, ECO:0000269|PubMed:23805044}.
CC   -!- FUNCTION: Isoform 2: Acts either as a transcriptional activator or
CC       repressor (PubMed:23805044). Stimulates the promoter activity of
CC       the neuronal nicotinic acetylcholine receptor alpha CHRNA2.
CC       Negatively regulates the apoptosis regulator BAX promoter
CC       activity. Inhibits promoter activity of the neuronal intermediate
CC       filament protein alpha-internexin INA gene. Plays a role in the
CC       regulation of breast cancer cell growth by promoting transcription
CC       activation as well as repression of specific target genes.
CC       Involved in tumor breast progression and invasion (By similarity).
CC       Inhibits the promoter activity of the GTP-binding protein RIT2
CC       gene containing the octamer binding site in retinal ganglion cells
CC       (PubMed:23805044). Plays also a role either as transcriptional
CC       coactivator or corepressor. Transcriptional coactivator
CC       cooperating with transcription factors TP53 to potentiate
CC       transcriptional activation of BAX promoter activity, and hence
CC       increases neuronal cell apoptosis. Antagonizes the transcriptional
CC       stimulatory activity of POU4F1 by preventing its binding to the
CC       octamer motif. Acts also as a transcriptional coactivator via its
CC       interaction with the transcription factor ESR1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q63934, ECO:0000269|PubMed:23805044}.
CC   -!- SUBUNIT: Isoform 1: Interacts with DLX1 (via homeobox DNA-binding
CC       domain); this interaction suppresses DLX1-mediated transcriptional
CC       activity in postnatal retina and enhances retinal ganglion cell
CC       (RGC) differentiation. Isoform 1: Interacts with DLX2 (via
CC       homeobox DNA-binding domain); this interaction enhances RGC
CC       differentiation. Isoform 1: Interacts (via C-terminus) with ISL1
CC       (via C-terminus). Isoform 1: Interacts with ISL2. Isoform 1
CC       interacts with LHX2. Isoform 2: Interacts (via C-terminus) with
CC       TP53 (via C-terminus). Isoform 2: Interacts with POU4F1 isoform 1;
CC       this interaction inhibits both POU4F1 DNA-binding and
CC       transcriptional activities. Isoform 2: Interacts (C-terminus) with
CC       ESR1 (via DNA-binding domain); this interaction increases the
CC       estrogen receptor ESR1 transcriptional activity in a DNA- and
CC       ligand 17-beta-estradiol-independent manner.
CC       {ECO:0000250|UniProtKB:Q63934}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7691107}.
CC       Nucleus speckle {ECO:0000269|PubMed:19266028}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q63934}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q63934}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Brn-3b long {ECO:0000303|PubMed:23805044},
CC       Brn-3b-l {ECO:0000303|PubMed:23805044};
CC         IsoId=Q12837-1; Sequence=Displayed;
CC       Name=2; Synonyms=Brn-3b short {ECO:0000303|PubMed:23805044},
CC       Brn-3b-s {ECO:0000303|PubMed:23805044};
CC         IsoId=Q12837-2; Sequence=VSP_058837;
CC   -!- TISSUE SPECIFICITY: Expressed in the ganglion cell layer of the
CC       retina (PubMed:7691107). Expressed in breast cancer cell lines (at
CC       protein level) (PubMed:11526481). Expressed in the brain
CC       (PubMed:7691107). Expressed in breast cancer cell lines
CC       (PubMed:11526481). {ECO:0000269|PubMed:11526481,
CC       ECO:0000269|PubMed:7691107}.
CC   -!- DOMAIN: The transcriptional activation domain within the N-
CC       terminal region is sufficient to induce transcriptional activity.
CC       The transcriptional repression domain containing the POU-specific
CC       domain and POU homeodomain is necessary for DNA-binding activity
CC       and also sufficient to induce transcriptional repression in a DNA-
CC       binding independent manner (By similarity). The polyhistidine
CC       repeat acts as a targeting signal to nuclear speckles
CC       (PubMed:19266028). {ECO:0000250|UniProtKB:Q12837,
CC       ECO:0000250|UniProtKB:Q63934, ECO:0000269|PubMed:19266028}.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       4 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U06233; AAA16509.1; -; mRNA.
DR   EMBL; AK314982; BAG37481.1; -; mRNA.
DR   EMBL; AC093887; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC136344; AAI36345.1; -; mRNA.
DR   EMBL; BC136345; AAI36346.1; -; mRNA.
DR   EMBL; EU439706; ACA49233.1; -; mRNA.
DR   EMBL; X71488; CAA50589.1; -; mRNA.
DR   EMBL; L20434; AAA36393.1; -; mRNA.
DR   CCDS; CCDS34074.1; -. [Q12837-1]
DR   PIR; I38502; I38502.
DR   RefSeq; NP_004566.2; NM_004575.2. [Q12837-1]
DR   UniGene; Hs.266; -.
DR   ProteinModelPortal; Q12837; -.
DR   SMR; Q12837; -.
DR   BioGrid; 111454; 1.
DR   STRING; 9606.ENSP00000281321; -.
DR   iPTMnet; Q12837; -.
DR   PhosphoSitePlus; Q12837; -.
DR   BioMuta; POU4F2; -.
DR   DMDM; 290457652; -.
DR   PaxDb; Q12837; -.
DR   PeptideAtlas; Q12837; -.
DR   PRIDE; Q12837; -.
DR   Ensembl; ENST00000281321; ENSP00000281321; ENSG00000151615. [Q12837-1]
DR   GeneID; 5458; -.
DR   KEGG; hsa:5458; -.
DR   UCSC; uc003ikv.4; human. [Q12837-1]
DR   CTD; 5458; -.
DR   DisGeNET; 5458; -.
DR   EuPathDB; HostDB:ENSG00000151615.3; -.
DR   GeneCards; POU4F2; -.
DR   H-InvDB; HIX0031516; -.
DR   HGNC; HGNC:9219; POU4F2.
DR   MIM; 113725; gene.
DR   neXtProt; NX_Q12837; -.
DR   OpenTargets; ENSG00000151615; -.
DR   PharmGKB; PA33543; -.
DR   eggNOG; KOG1168; Eukaryota.
DR   eggNOG; ENOG410XPNX; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116305; -.
DR   HOVERGEN; HBG031829; -.
DR   InParanoid; Q12837; -.
DR   KO; K09366; -.
DR   OMA; QYHAAMN; -.
DR   OrthoDB; EOG091G0WBK; -.
DR   PhylomeDB; Q12837; -.
DR   TreeFam; TF316413; -.
DR   Reactome; R-HSA-6804759; Regulation of TP53 Activity through Association with Co-factors.
DR   SignaLink; Q12837; -.
DR   SIGNOR; Q12837; -.
DR   GeneWiki; POU4F2; -.
DR   GenomeRNAi; 5458; -.
DR   PRO; PR:Q12837; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000151615; -.
DR   CleanEx; HS_POU4F2; -.
DR   Genevisible; Q12837; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:UniProtKB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; ISS:UniProtKB.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB.
DR   GO; GO:1990791; P:dorsal root ganglion development; ISS:UniProtKB.
DR   GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; IDA:UniProtKB.
DR   GO; GO:1902870; P:negative regulation of amacrine cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; ISS:UniProtKB.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISS:UniProtKB.
DR   GO; GO:0090259; P:regulation of retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00093; HTH_XRE; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Apoptosis; Cell membrane;
KW   Complete proteome; Cytoplasm; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Membrane; Nucleus; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    409       POU domain, class 4, transcription factor
FT                                2.
FT                                /FTId=PRO_0000100740.
FT   DOMAIN      250    327       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    345    404       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       91    237       Transcriptional activation domain.
FT                                {ECO:0000250|UniProtKB:Q63934}.
FT   REGION      238    409       Transcriptional repression domain.
FT                                {ECO:0000250|UniProtKB:Q63934}.
FT   MOTIF       110    119       POU-IV box.
FT   MOTIF       171    185       Nuclear speckle targeting signal.
FT                                {ECO:0000269|PubMed:19266028}.
FT   COMPBIAS      1      4       Poly-Met.
FT   COMPBIAS     43     51       Poly-Ser.
FT   COMPBIAS     54     68       Poly-Gly.
FT   COMPBIAS     70     79       Poly-Ser.
FT   COMPBIAS     80     83       Poly-Gly.
FT   COMPBIAS    126    129       Poly-His.
FT   COMPBIAS    155    158       Poly-Ser.
FT   COMPBIAS    171    182       Poly-His.
FT   VAR_SEQ       1    144       Missing (in isoform 2).
FT                                /FTId=VSP_058837.
FT   VARIANT      40     40       I -> T (in dbSNP:rs13152799).
FT                                /FTId=VAR_059321.
FT   MUTAGEN     171    185       Missing: Absent from nuclear speckle; no
FT                                change in transcriptional activity.
FT                                {ECO:0000269|PubMed:19266028}.
FT   CONFLICT     54     54       G -> GG (in Ref. 1; AAA16509 and 3;
FT                                BAG37481/AAI36345/AAI36346).
FT                                {ECO:0000305}.
FT   CONFLICT    165    165       S -> C (in Ref. 1; AAA16509).
FT                                {ECO:0000305}.
FT   CONFLICT    182    182       Missing (in Ref. 2; CAA50589).
FT                                {ECO:0000305}.
SQ   SEQUENCE   409 AA;  43087 MW;  42E2C174674E8DFC CRC64;
     MMMMSLNSKQ AFSMPHGGSL HVEPKYSALH STSPGSSAPI APSASSPSSS SNAGGGGGGG
     GGGGGGGGRS SSSSSSGSSG GGGSEAMRRA CLPTPPSNIF GGLDESLLAR AEALAAVDIV
     SQSKSHHHHP PHHSPFKPDA TYHTMNTIPC TSAASSSSVP ISHPSALAGT HHHHHHHHHH
     HHQPHQALEG ELLEHLSPGL ALGAMAGPDG AVVSTPAHAP HMATMNPMHQ AALSMAHAHG
     LPSHMGCMSD VDADPRDLEA FAERFKQRRI KLGVTQADVG SALANLKIPG VGSLSQSTIC
     RFESLTLSHN NMIALKPILQ AWLEEAEKSH REKLTKPELF NGAEKKRKRT SIAAPEKRSL
     EAYFAIQPRP SSEKIAAIAE KLDLKKNVVR VWFCNQRQKQ KRMKYSAGI
//
ID   LHX1_HUMAN              Reviewed;         406 AA.
AC   P48742; Q3MIW0;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 2.
DT   27-SEP-2017, entry version 156.
DE   RecName: Full=LIM/homeobox protein Lhx1;
DE            Short=LIM homeobox protein 1;
DE   AltName: Full=Homeobox protein Lim-1;
DE            Short=hLim-1;
GN   Name=LHX1; Synonyms=LIM-1, LIM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9212161;
RA   Dong W.F., Heng H.H.Q., Lowsky R., Xu Y., Decoteau J.F., Shi X.-M.,
RA   Tsui L.-C., Minden M.D.;
RT   "Cloning, expression, and chromosomal localization to 11p12-13 of a
RT   human LIM/homeobox gene, hLim-1.";
RL   DNA Cell Biol. 16:671-678(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potential transcription factor. May play a role in early
CC       mesoderm formation and later in lateral mesoderm differentiation
CC       and neurogenesis. {ECO:0000269|PubMed:9212161}.
CC   -!- SUBUNIT: Interacts with LDB1 via the tandem LIM domains.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q53TS8:C2CD6; NbExp=4; IntAct=EBI-11990598, EBI-739879;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, thymus, and tonsils.
CC       Expressed in samples from patients with chronic myeloid leukemia
CC       (CML) and in 58% of acute myeloid leukemia (AML) cell lines.
CC       {ECO:0000269|PubMed:9212161}.
CC   -!- DOMAIN: The LIM domains exert a negative regulatory function and
CC       disruption of the LIM domains produces an activated form. In
CC       addition, two activation domains and a negative regulatory domain
CC       exist C-terminally to the homeobox (By similarity). {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U14755; AAA21644.1; -; mRNA.
DR   EMBL; AC023315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025882; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC111936; AAI11937.1; -; mRNA.
DR   EMBL; BC101674; AAI01675.1; -; mRNA.
DR   CCDS; CCDS11316.1; -.
DR   PIR; G01507; G01507.
DR   RefSeq; NP_005559.2; NM_005568.4.
DR   UniGene; Hs.443727; -.
DR   ProteinModelPortal; P48742; -.
DR   SMR; P48742; -.
DR   BioGrid; 110163; 5.
DR   IntAct; P48742; 3.
DR   STRING; 9606.ENSP00000254457; -.
DR   iPTMnet; P48742; -.
DR   PhosphoSitePlus; P48742; -.
DR   BioMuta; LHX1; -.
DR   DMDM; 60416412; -.
DR   EPD; P48742; -.
DR   PaxDb; P48742; -.
DR   PeptideAtlas; P48742; -.
DR   PRIDE; P48742; -.
DR   DNASU; 3975; -.
DR   Ensembl; ENST00000614239; ENSP00000477829; ENSG00000273706.
DR   Ensembl; ENST00000620305; ENSP00000484449; ENSG00000274577.
DR   GeneID; 3975; -.
DR   KEGG; hsa:3975; -.
DR   UCSC; uc032feb.2; human.
DR   CTD; 3975; -.
DR   DisGeNET; 3975; -.
DR   EuPathDB; HostDB:ENSG00000273706.4; -.
DR   GeneCards; LHX1; -.
DR   HGNC; HGNC:6593; LHX1.
DR   HPA; CAB002770; -.
DR   MalaCards; LHX1; -.
DR   MIM; 601999; gene.
DR   neXtProt; NX_P48742; -.
DR   OpenTargets; ENSG00000273706; -.
DR   Orphanet; 261265; 17q12 microdeletion syndrome.
DR   Orphanet; 247775; Classic Mayer-Rokitansky-Kuster-Hauser syndrome.
DR   Orphanet; 2578; MURCS association.
DR   PharmGKB; PA30364; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000231630; -.
DR   HOVERGEN; HBG006263; -.
DR   InParanoid; P48742; -.
DR   KO; K09372; -.
DR   OMA; DDQNLGG; -.
DR   OrthoDB; EOG091G0BSD; -.
DR   PhylomeDB; P48742; -.
DR   TreeFam; TF315442; -.
DR   SIGNOR; P48742; -.
DR   GeneWiki; LHX1; -.
DR   GenomeRNAi; 3975; -.
DR   PRO; PR:P48742; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000273706; -.
DR   CleanEx; HS_LHX1; -.
DR   ExpressionAtlas; P48742; baseline and differential.
DR   Genevisible; P48742; HS.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0043234; C:protein complex; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; ISS:UniProtKB.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; ISS:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISS:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; ISS:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0021702; P:cerebellar Purkinje cell differentiation; ISS:UniProtKB.
DR   GO; GO:0021937; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; ISS:UniProtKB.
DR   GO; GO:0021549; P:cerebellum development; ISS:UniProtKB.
DR   GO; GO:0060067; P:cervix development; ISS:UniProtKB.
DR   GO; GO:0072049; P:comma-shaped body morphogenesis; ISS:UniProtKB.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB.
DR   GO; GO:0001705; P:ectoderm formation; ISS:UniProtKB.
DR   GO; GO:0009880; P:embryonic pattern specification; ISS:UniProtKB.
DR   GO; GO:0060059; P:embryonic retina morphogenesis in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0048703; P:embryonic viscerocranium morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001706; P:endoderm formation; ISS:UniProtKB.
DR   GO; GO:0060429; P:epithelium development; ISS:UniProtKB.
DR   GO; GO:0021871; P:forebrain regionalization; ISS:UniProtKB.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; ISS:UniProtKB.
DR   GO; GO:0060322; P:head development; ISS:UniProtKB.
DR   GO; GO:0035852; P:horizontal cell localization; IEA:Ensembl.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0097477; P:lateral motor column neuron migration; ISS:UniProtKB.
DR   GO; GO:0072177; P:mesonephric duct development; IEA:Ensembl.
DR   GO; GO:0072278; P:metanephric comma-shaped body morphogenesis; IEA:Ensembl.
DR   GO; GO:0072224; P:metanephric glomerulus development; IEA:Ensembl.
DR   GO; GO:0035502; P:metanephric part of ureteric bud development; IEA:Ensembl.
DR   GO; GO:0072283; P:metanephric renal vesicle morphogenesis; IEA:Ensembl.
DR   GO; GO:0072284; P:metanephric S-shaped body morphogenesis; IEA:Ensembl.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0035849; P:nephric duct elongation; IEA:Ensembl.
DR   GO; GO:0072178; P:nephric duct morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0060066; P:oviduct development; ISS:UniProtKB.
DR   GO; GO:0035846; P:oviduct epithelium development; ISS:UniProtKB.
DR   GO; GO:0061205; P:paramesonephric duct development; ISS:UniProtKB.
DR   GO; GO:0007389; P:pattern specification process; ISS:UniProtKB.
DR   GO; GO:2000744; P:positive regulation of anterior head development; ISS:UniProtKB.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB.
DR   GO; GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB.
DR   GO; GO:2000768; P:positive regulation of nephron tubule epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0009791; P:post-embryonic development; ISS:UniProtKB.
DR   GO; GO:0090009; P:primitive streak formation; ISS:UniProtKB.
DR   GO; GO:0048793; P:pronephros development; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0072077; P:renal vesicle morphogenesis; ISS:UniProtKB.
DR   GO; GO:0010842; P:retina layer formation; ISS:UniProtKB.
DR   GO; GO:0072050; P:S-shaped body morphogenesis; ISS:UniProtKB.
DR   GO; GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0021537; P:telencephalon development; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0001657; P:ureteric bud development; ISS:UniProtKB.
DR   GO; GO:0001655; P:urogenital system development; ISS:UniProtKB.
DR   GO; GO:0035847; P:uterine epithelium development; ISS:UniProtKB.
DR   GO; GO:0060065; P:uterus development; ISS:UniProtKB.
DR   GO; GO:0060068; P:vagina development; ISS:UniProtKB.
DR   GO; GO:0021517; P:ventral spinal cord development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; LIM domain; Metal-binding; Neurogenesis;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    406       LIM/homeobox protein Lhx1.
FT                                /FTId=PRO_0000075769.
FT   DOMAIN        4     54       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       63    117       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    180    239       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63007}.
FT   CONFLICT     67     67       A -> R (in Ref. 1; AAA21644).
FT                                {ECO:0000305}.
FT   CONFLICT    184    184       R -> G (in Ref. 1; AAA21644).
FT                                {ECO:0000305}.
FT   CONFLICT    245    248       GARR -> AG (in Ref. 1; AAA21644).
FT                                {ECO:0000305}.
SQ   SEQUENCE   406 AA;  44808 MW;  06C5A417A943C15D CRC64;
     MVHCAGCKRP ILDRFLLNVL DRAWHVKCVQ CCECKCNLTE KCFSREGKLY CKNDFFRCFG
     TKCAGCAQGI SPSDLVRRAR SKVFHLNCFT CMMCNKQLST GEELYIIDEN KFVCKEDYLS
     NSSVAKENSL HSATTGSDPS LSPDSQDPSQ DDAKDSESAN VSDKEAGSNE NDDQNLGAKR
     RGPRTTIKAK QLETLKAAFA ATPKPTRHIR EQLAQETGLN MRVIQVWFQN RRSKERRMKQ
     LSALGARRHA FFRSPRRMRP LVDRLEPGEL IPNGPFSFYG DYQSEYYGPG GNYDFFPQGP
     PSSQAQTPVD LPFVPSSGPS GTPLGGLEHP LPGHHPSSEA QRFTDILAHP PGDSPSPEPS
     LPGPLHSMSA EVFGPSPPFS SLSVNGGASY GNHLSHPPEM NEAAVW
//
ID   ALX1_HUMAN              Reviewed;         326 AA.
AC   Q15699; Q546C8; Q96FH4;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   25-OCT-2017, entry version 156.
DE   RecName: Full=ALX homeobox protein 1 {ECO:0000305};
DE   AltName: Full=Cartilage homeoprotein 1 {ECO:0000250|UniProtKB:Q63087};
DE            Short=CART-1 {ECO:0000250|UniProtKB:Q63087};
GN   Name=ALX1 {ECO:0000312|HGNC:HGNC:1494};
GN   Synonyms=CART1 {ECO:0000303|PubMed:9753625};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8756334; DOI=10.1089/dna.1996.15.531;
RA   Gordon D.F., Wagner J., Atkinson B.L., Chiono M., Berry R., Sikela J.,
RA   Gutierrez-Hartmann A.;
RT   "Human Cart-1: structural organization, chromosomal localization, and
RT   functional analysis of a cartilage-specific homeodomain cDNA.";
RL   DNA Cell Biol. 15:531-541(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Felder B., Stegmann K., Ermert A., Koch M.C.;
RT   "SNPs of transcription factor CART1 in cases with neural tube
RT   defects.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=9753625; DOI=10.1006/bbrc.1998.9257;
RA   Cai R.L.;
RT   "Human CART1, a paired-class homeodomain protein, activates
RT   transcription through palindromic binding sites.";
RL   Biochem. Biophys. Res. Commun. 250:305-311(1998).
RN   [5]
RP   INVOLVEMENT IN FND3, AND FUNCTION.
RX   PubMed=20451171; DOI=10.1016/j.ajhg.2010.04.002;
RA   Uz E., Alanay Y., Aktas D., Vargel I., Gucer S., Tuncbilek G.,
RA   von Eggeling F., Yilmaz E., Deren O., Posorski N., Ozdag H., Liehr T.,
RA   Balci S., Alikasifoglu M., Wollnik B., Akarsu N.A.;
RT   "Disruption of ALX1 causes extreme microphthalmia and severe facial
RT   clefting: expanding the spectrum of autosomal-recessive ALX-related
RT   frontonasal dysplasia.";
RL   Am. J. Hum. Genet. 86:789-796(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=23288509; DOI=10.1158/0008-5472.CAN-12-2377;
RA   Yuan H., Kajiyama H., Ito S., Yoshikawa N., Hyodo T., Asano E.,
RA   Hasegawa H., Maeda M., Shibata K., Hamaguchi M., Kikkawa F., Senga T.;
RT   "ALX1 induces snail expression to promote epithelial-to-mesenchymal
RT   transition and invasion of ovarian cancer cells.";
RL   Cancer Res. 73:1581-1590(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-69 AND SER-306,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Sequence-specific DNA-binding transcription factor that
CC       binds palindromic sequences within promoters and may activate or
CC       repress the transcription of a subset of genes (PubMed:9753625,
CC       PubMed:8756334). Most probably regulates the expression of genes
CC       involved in the development of mesenchyme-derived craniofacial
CC       structures. Early on in development, it plays a role in forebrain
CC       mesenchyme survival (PubMed:20451171). May also induce epithelial
CC       to mesenchymal transition (EMT) through the expression of SNAI1
CC       (PubMed:23288509). {ECO:0000269|PubMed:20451171,
CC       ECO:0000269|PubMed:23288509, ECO:0000269|PubMed:8756334,
CC       ECO:0000269|PubMed:9753625}.
CC   -!- SUBUNIT: Binds DNA as a homodimer; required for transcriptional
CC       activation (PubMed:9753625). Interacts (via homeobox domain) with
CC       EP300; acetylates ALX1 and stimulates its transcriptional
CC       activity. {ECO:0000250|UniProtKB:Q63087,
CC       ECO:0000269|PubMed:9753625}.
CC   -!- INTERACTION:
CC       O94829:IPO13; NbExp=2; IntAct=EBI-750671, EBI-747310;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8756334,
CC       ECO:0000269|PubMed:9753625}.
CC   -!- TISSUE SPECIFICITY: Cartilage and cervix tissue.
CC       {ECO:0000269|PubMed:8756334}.
CC   -!- DOMAIN: The OAR motif may negatively regulate DNA-binding and
CC       therefore transcriptional activity. It is found in the C-terminal
CC       transactivation domain that stimulates transcription.
CC       {ECO:0000250|UniProtKB:Q63087}.
CC   -!- PTM: Acetylated at Lys-131 by EP300; increases interaction with
CC       EP300 and stimulates ALX1 transcriptional activity.
CC       {ECO:0000250|UniProtKB:Q8C8B0}.
CC   -!- DISEASE: Frontonasal dysplasia 3 (FND3) [MIM:613456]: The term
CC       frontonasal dysplasia describes an array of abnormalities
CC       affecting the eyes, forehead and nose and linked to midfacial
CC       dysraphia. The clinical picture is highly variable. Major findings
CC       include true ocular hypertelorism; broadening of the nasal root;
CC       median facial cleft affecting the nose and/or upper lip and
CC       palate; unilateral or bilateral clefting of the alae nasi; lack of
CC       formation of the nasal tip; anterior cranium bifidum occultum; a
CC       V-shaped or widow's peak frontal hairline.
CC       {ECO:0000269|PubMed:20451171}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The makings of a face
CC       - Issue 173 of November 2015;
CC       URL="http://web.expasy.org/spotlight/back_issues/173/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U31986; AAB08960.1; -; mRNA.
DR   EMBL; AJ558236; CAD90155.1; -; Genomic_DNA.
DR   EMBL; AJ558237; CAD90155.1; JOINED; Genomic_DNA.
DR   EMBL; BC010923; AAH10923.1; -; mRNA.
DR   CCDS; CCDS9028.1; -.
DR   RefSeq; NP_008913.2; NM_006982.2.
DR   UniGene; Hs.41683; -.
DR   ProteinModelPortal; Q15699; -.
DR   SMR; Q15699; -.
DR   BioGrid; 113764; 2.
DR   IntAct; Q15699; 13.
DR   MINT; MINT-1465062; -.
DR   STRING; 9606.ENSP00000315417; -.
DR   iPTMnet; Q15699; -.
DR   PhosphoSitePlus; Q15699; -.
DR   BioMuta; ALX1; -.
DR   DMDM; 90111820; -.
DR   PaxDb; Q15699; -.
DR   PeptideAtlas; Q15699; -.
DR   PRIDE; Q15699; -.
DR   DNASU; 8092; -.
DR   Ensembl; ENST00000316824; ENSP00000315417; ENSG00000180318.
DR   GeneID; 8092; -.
DR   KEGG; hsa:8092; -.
DR   CTD; 8092; -.
DR   DisGeNET; 8092; -.
DR   EuPathDB; HostDB:ENSG00000180318.3; -.
DR   GeneCards; ALX1; -.
DR   H-InvDB; HIX0018568; -.
DR   HGNC; HGNC:1494; ALX1.
DR   HPA; HPA001598; -.
DR   HPA; HPA018905; -.
DR   MalaCards; ALX1; -.
DR   MIM; 601527; gene.
DR   MIM; 613456; phenotype.
DR   neXtProt; NX_Q15699; -.
DR   OpenTargets; ENSG00000180318; -.
DR   Orphanet; 306542; Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome.
DR   PharmGKB; PA162376294; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG050798; -.
DR   InParanoid; Q15699; -.
DR   KO; K09334; -.
DR   OMA; HVSLNNF; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; Q15699; -.
DR   TreeFam; TF350743; -.
DR   GeneWiki; ALX1; -.
DR   GenomeRNAi; 8092; -.
DR   PRO; PR:Q15699; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000180318; -.
DR   CleanEx; HS_ALX1; -.
DR   ExpressionAtlas; Q15699; baseline and differential.
DR   Genevisible; Q15699; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0001502; P:cartilage condensation; TAS:ProtInc.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0001755; P:neural crest cell migration; IEA:InterPro.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR033209; ALX1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   PANTHER; PTHR24329:SF359; PTHR24329:SF359; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    326       ALX homeobox protein 1.
FT                                /FTId=PRO_0000048855.
FT   DNA_BIND    132    191       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      192    326       Transactivation domain.
FT                                {ECO:0000250|UniProtKB:Q63087}.
FT   MOTIF       306    319       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      69     69       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     131    131       N6-acetyllysine; by EP300.
FT                                {ECO:0000250|UniProtKB:Q8C8B0}.
FT   MOD_RES     306    306       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT    125    125       S -> T (in Ref. 1; AAB08960).
FT                                {ECO:0000305}.
SQ   SEQUENCE   326 AA;  36961 MW;  9EB7374DE42E041B CRC64;
     MEFLSEKFAL KSPPSKNSDF YMGAGGPLEH VMETLDNESF YSKASAGKCV QAFGPLPRAE
     HHVRLERTSP CQDSSVNYGI TKVEGQPLHT ELNRAMDNCN SLRMSPVKGM QEKGELDELG
     DKCDSNVSSS KKRRHRTTFT SLQLEELEKV FQKTHYPDVY VREQLALRTE LTEARVQVWF
     QNRRAKWRKR ERYGQIQQAK SHFAATYDIS VLPRTDSYPQ IQNNLWAGNA SGGSVVTSCM
     LPRDTSSCMT PYSHSPRTDS SYTGFSNHQN QFSHVPLNNF FTDSLLTGAT NGHAFETKPE
     FERRSSSIAV LRMKAKEHTA NISWAM
//
ID   ADNP2_HUMAN             Reviewed;        1131 AA.
AC   Q6IQ32; A8K951; O94943; Q9H9P3;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   27-SEP-2017, entry version 137.
DE   RecName: Full=Activity-dependent neuroprotector homeobox protein 2;
DE            Short=ADNP homeobox protein 2;
DE   AltName: Full=Zinc finger protein 508;
GN   Name=ADNP2; Synonyms=KIAA0863, ZNF508;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   SEQUENCE REVISION.
RA   Ohara O., Suyama M., Kikuno R., Nagase T., Ishikawa K.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1024, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1032, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-118; LYS-146; LYS-979;
RP   LYS-1018 AND LYS-1032, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       P83916:CBX1; NbExp=3; IntAct=EBI-2838654, EBI-78129;
CC       Q13185:CBX3; NbExp=4; IntAct=EBI-2838654, EBI-78176;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74886.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB14180.1; Type=Frameshift; Positions=466; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB020670; BAA74886.2; ALT_INIT; mRNA.
DR   EMBL; AK022688; BAB14180.1; ALT_FRAME; mRNA.
DR   EMBL; AK292566; BAF85255.1; -; mRNA.
DR   EMBL; CH471117; EAW66646.1; -; Genomic_DNA.
DR   EMBL; BC071589; AAH71589.1; -; mRNA.
DR   CCDS; CCDS32853.1; -.
DR   RefSeq; NP_055728.1; NM_014913.3.
DR   RefSeq; XP_005266713.1; XM_005266656.4.
DR   UniGene; Hs.131915; -.
DR   ProteinModelPortal; Q6IQ32; -.
DR   SMR; Q6IQ32; -.
DR   BioGrid; 116522; 15.
DR   IntAct; Q6IQ32; 12.
DR   STRING; 9606.ENSP00000262198; -.
DR   iPTMnet; Q6IQ32; -.
DR   PhosphoSitePlus; Q6IQ32; -.
DR   BioMuta; ADNP2; -.
DR   DMDM; 74757998; -.
DR   EPD; Q6IQ32; -.
DR   MaxQB; Q6IQ32; -.
DR   PaxDb; Q6IQ32; -.
DR   PeptideAtlas; Q6IQ32; -.
DR   PRIDE; Q6IQ32; -.
DR   DNASU; 22850; -.
DR   Ensembl; ENST00000262198; ENSP00000262198; ENSG00000101544.
DR   GeneID; 22850; -.
DR   KEGG; hsa:22850; -.
DR   UCSC; uc032hie.2; human.
DR   CTD; 22850; -.
DR   DisGeNET; 22850; -.
DR   EuPathDB; HostDB:ENSG00000101544.8; -.
DR   GeneCards; ADNP2; -.
DR   HGNC; HGNC:23803; ADNP2.
DR   HPA; HPA007126; -.
DR   MIM; 617422; gene.
DR   neXtProt; NX_Q6IQ32; -.
DR   OpenTargets; ENSG00000101544; -.
DR   PharmGKB; PA162375700; -.
DR   eggNOG; ENOG410IHQQ; Eukaryota.
DR   eggNOG; ENOG410ZPT3; LUCA.
DR   GeneTree; ENSGT00530000063631; -.
DR   HOGENOM; HOG000247070; -.
DR   HOVERGEN; HBG059494; -.
DR   InParanoid; Q6IQ32; -.
DR   OMA; DVASFFG; -.
DR   OrthoDB; EOG091G03Q0; -.
DR   PhylomeDB; Q6IQ32; -.
DR   TreeFam; TF328818; -.
DR   ChiTaRS; ADNP2; human.
DR   GenomeRNAi; 22850; -.
DR   PRO; PR:Q6IQ32; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101544; -.
DR   CleanEx; HS_ADNP2; -.
DR   ExpressionAtlas; Q6IQ32; baseline and differential.
DR   Genevisible; Q6IQ32; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1131       Activity-dependent neuroprotector
FT                                homeobox protein 2.
FT                                /FTId=PRO_0000280416.
FT   ZN_FING      73     96       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     106    128       C2H2-type 2; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     155    178       C2H2-type 3; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     215    240       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     694    716       C2H2-type 5; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     747    768       C2H2-type 6; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     770    793       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     875    898       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     913    937       C2H2-type 9; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   DNA_BIND   1043   1102       Homeobox.
FT   COMPBIAS    268    427       Pro-rich.
FT   MOD_RES    1024   1024       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   CROSSLNK    118    118       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    146    146       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    979    979       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1018   1018       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1032   1032       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   1032   1032       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CONFLICT    757    757       S -> P (in Ref. 3; BAB14180).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1131 AA;  122833 MW;  73BCB3F755E6906D CRC64;
     MFQIPVENLD NIRKVRKKVK GILVDIGLDS CKELLKDLKG FDPGEKYFHN TSWGDVSLWE
     PSGKKVRYRT KPYCCGLCKY STKVLTSFKN HLHRYHEDEI DQELVIPCPN CVFASQPKVV
     GRHFRMFHAP VRKVQNYTVN ILGETKSSRS DVISFTCLKC NFSNTLYYSM KKHVLVAHFH
     YLINSYFGLR TEEMGEQPKT NDTVSIEKIP PPDKYYCKKC NANASSQDAL MYHILTSDIH
     RDLENKLRSV ISEHIKRTGL LKQTHIAPKP AAHLAAPANG SAPSAPAQPP CFHLALPQNS
     PSPAAGQPVT VAQGAPGSLT HSPPAAGQSH MTLVSSPLPV GQNSLTLQPP APQPVFLSHG
     VPLHQSVNPP VLPLSQPVGP VNKSVGTSVL PINQTVRPGV LPLTQPVGPI NRPVGPGVLP
     VSPSVTPGVL QAVSPGVLSV SRAVPSGVLP AGQMTPAGQM TPAGVIPGQT ATSGVLPTGQ
     MVQSGVLPVG QTAPSRVLPP GQTAPLRVIS AGQVVPSGLL SPNQTVSSSA VVPVNQGVNS
     GVLQLSQPVV SGVLPVGQPV RPGVLQLNQT VGTNILPVNQ PVRPGASQNT TFLTSGSILR
     QLIPTGKQVN GIPTYTLAPV SVTLPVPPGG LATVAPPQMP IQLLPSGAAA PMAGSMPGMP
     SPPVLVNAAQ SVFVQASSSA ADTNQVLKQA KQWKTCPVCN ELFPSNVYQV HMEVAHKHSE
     SKSGEKLEPE KLAACAPFLK WMREKTVRCL SCKCLVSEEE LIHHLLMHGL GCLFCPCTFH
     DIKGLSEHSR NRHLGKKKLP MDYSNRGFQL DVDANGNLLF PHLDFITILP KEKLGEREVY
     LAILAGIHSK SLVPVYVKVR PQAEGTPGST GKRVSTCPFC FGPFVTTEAY ELHLKERHHI
     MPTVHTVLKS PAFKCIHCCG VYTGNMTLAA IAVHLVRCRS APKDSSSDLQ AQPGFIHNSE
     LLLVSGEVMH DSSFSVKRKL PDGHLGAEDQ RHGEEQPPIL NADAAPGPEK VTSVVPFKRQ
     RNESRTEGPI VKDEALQILA LDPKKYEGRS YEEKKQFLKD YFHKKPYPSK KEIELLSSLF
     WVWKIDVASF FGKRRYICMK AIKNHKPSVL LGFDMSELKN VKHRLNFEYE P
//
ID   ADNP_HUMAN              Reviewed;        1102 AA.
AC   Q9H2P0; E1P5Y2; O94881; Q5BKU2; Q9UG34;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-SEP-2017, entry version 155.
DE   RecName: Full=Activity-dependent neuroprotector homeobox protein;
DE   AltName: Full=Activity-dependent neuroprotective protein;
GN   Name=ADNP; Synonyms=ADNP1, KIAA0784;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=11013255; DOI=10.1074/jbc.M007416200;
RA   Zamostiano R., Pinhasov A., Gelber E., Steingart R.A., Seroussi E.,
RA   Giladi E., Bassan M., Wollman Y., Eyre H.J., Mulley J.C.,
RA   Brenneman D.E., Gozes I.;
RT   "Cloning and characterization of the human activity-dependent
RT   neuroprotective protein.";
RL   J. Biol. Chem. 276:708-714(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 30-1102.
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 98-1102.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-953 AND SER-955,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   CHARACTERIZATION OF NAP PEPTIDE.
RX   PubMed=19091000; DOI=10.1186/1471-2202-9-S3-S3;
RA   Gozes I., Divinski I., Piltzer I.;
RT   "NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-
RT   42).";
RL   BMC Neurosci. 9:S3-S3(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409; SER-709; SER-736;
RP   SER-876 AND SER-878, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-736 AND SER-953, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1035 AND LYS-1042, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-709; SER-805;
RP   SER-953 AND SER-955, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-409; SER-921 AND
RP   SER-953, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-409; SER-608;
RP   SER-709; SER-736; SER-921; SER-953 AND SER-955, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-953, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   INVOLVEMENT IN HVDAS.
RX   PubMed=24531329; DOI=10.1038/ng.2899;
RA   Helsmoortel C., Vulto-van Silfhout A.T., Coe B.P., Vandeweyer G.,
RA   Rooms L., van den Ende J., Schuurs-Hoeijmakers J.H., Marcelis C.L.,
RA   Willemsen M.H., Vissers L.E., Yntema H.G., Bakshi M., Wilson M.,
RA   Witherspoon K.T., Malmgren H., Nordgren A., Anneren G., Fichera M.,
RA   Bosco P., Romano C., de Vries B.B., Kleefstra T., Kooy R.F.,
RA   Eichler E.E., Van der Aa N.;
RT   "A SWI/SNF-related autism syndrome caused by de novo mutations in
RT   ADNP.";
RL   Nat. Genet. 46:380-384(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-144; LYS-279; LYS-408;
RP   LYS-716; LYS-731; LYS-930 AND LYS-1035, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-144; LYS-266; LYS-367;
RP   LYS-408; LYS-427; LYS-621; LYS-716; LYS-731 AND LYS-1035, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-144; LYS-600; LYS-606;
RP   LYS-930 AND LYS-1035, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-39; LYS-72; LYS-144;
RP   LYS-155; LYS-203; LYS-231; LYS-266; LYS-274; LYS-278; LYS-311;
RP   LYS-335; LYS-367; LYS-408; LYS-427; LYS-600; LYS-606; LYS-616;
RP   LYS-621; LYS-632; LYS-658; LYS-699; LYS-716; LYS-728; LYS-731;
RP   LYS-745; LYS-807; LYS-829; LYS-835; LYS-914; LYS-930; LYS-935;
RP   LYS-1016; LYS-1035 AND LYS-1042, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [24]
RP   VARIANT VAL-1094.
RX   PubMed=26637798; DOI=10.1016/j.neuron.2015.11.009;
RA   D'Gama A.M., Pochareddy S., Li M., Jamuar S.S., Reiff R.E., Lam A.T.,
RA   Sestan N., Walsh C.A.;
RT   "Targeted DNA Sequencing from Autism Spectrum Disorder Brains
RT   Implicates Multiple Genetic Mechanisms.";
RL   Neuron 88:910-917(2015).
CC   -!- FUNCTION: Potential transcription factor. May mediate some of the
CC       neuroprotective peptide VIP-associated effects involving normal
CC       growth and cancer proliferation.
CC   -!- INTERACTION:
CC       P83916:CBX1; NbExp=3; IntAct=EBI-1764854, EBI-78129;
CC       Q13185:CBX3; NbExp=3; IntAct=EBI-1764854, EBI-78176;
CC       P45973:CBX5; NbExp=3; IntAct=EBI-1764854, EBI-78219;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Strong expression in heart,
CC       skeletal muscle, kidney and placenta. In brain, expression is
CC       stronger in the cerebellum and cortex regions. No expression
CC       detected in the colon. Strong increase of expression in colon and
CC       breast cancer tissues.
CC   -!- DISEASE: Helsmoortel-van der Aa syndrome (HVDAS) [MIM:615873]: A
CC       disorder characterized by intellectual disability, autism spectrum
CC       disorder, and dysmorphic facial features including prominent
CC       forehead, high hairline, downslanting palpebral fissures, notched
CC       eyelids, broad nasal bridge, thin upper lip, and smooth philtrum.
CC       {ECO:0000269|PubMed:24531329}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: When isolated from the sequence, neuroprotective
CC       peptide (NAP) provides neuroprotection against the amyloid-beta
CC       peptide.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF250860; AAG47651.1; -; mRNA.
DR   EMBL; AL034553; CAB53748.2; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75611.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75612.1; -; Genomic_DNA.
DR   EMBL; BC090933; AAH90933.1; -; mRNA.
DR   EMBL; AB018327; BAA34504.1; -; mRNA.
DR   EMBL; AL080163; CAB45752.1; -; mRNA.
DR   CCDS; CCDS13433.1; -.
DR   PIR; T12546; T12546.
DR   RefSeq; NP_001269460.1; NM_001282531.2.
DR   RefSeq; NP_001269461.1; NM_001282532.1.
DR   RefSeq; NP_001334440.1; NM_001347511.1.
DR   RefSeq; NP_056154.1; NM_015339.4.
DR   RefSeq; NP_852107.1; NM_181442.3.
DR   RefSeq; XP_011527049.1; XM_011528747.2.
DR   RefSeq; XP_016883247.1; XM_017027758.1.
DR   RefSeq; XP_016883248.1; XM_017027759.1.
DR   UniGene; Hs.293736; -.
DR   UniGene; Hs.570355; -.
DR   ProteinModelPortal; Q9H2P0; -.
DR   BioGrid; 116967; 60.
DR   DIP; DIP-47288N; -.
DR   IntAct; Q9H2P0; 36.
DR   MINT; MINT-1626775; -.
DR   STRING; 9606.ENSP00000342905; -.
DR   iPTMnet; Q9H2P0; -.
DR   PhosphoSitePlus; Q9H2P0; -.
DR   DMDM; 24636245; -.
DR   EPD; Q9H2P0; -.
DR   MaxQB; Q9H2P0; -.
DR   PaxDb; Q9H2P0; -.
DR   PeptideAtlas; Q9H2P0; -.
DR   PRIDE; Q9H2P0; -.
DR   Ensembl; ENST00000349014; ENSP00000342905; ENSG00000101126.
DR   Ensembl; ENST00000371602; ENSP00000360662; ENSG00000101126.
DR   Ensembl; ENST00000396029; ENSP00000379346; ENSG00000101126.
DR   Ensembl; ENST00000396032; ENSP00000379349; ENSG00000101126.
DR   Ensembl; ENST00000621696; ENSP00000483881; ENSG00000101126.
DR   GeneID; 23394; -.
DR   KEGG; hsa:23394; -.
DR   UCSC; uc002xvt.3; human.
DR   CTD; 23394; -.
DR   DisGeNET; 23394; -.
DR   EuPathDB; HostDB:ENSG00000101126.15; -.
DR   GeneCards; ADNP; -.
DR   HGNC; HGNC:15766; ADNP.
DR   HPA; HPA006371; -.
DR   MalaCards; ADNP; -.
DR   MIM; 611386; gene.
DR   MIM; 615873; phenotype.
DR   neXtProt; NX_Q9H2P0; -.
DR   OpenTargets; ENSG00000101126; -.
DR   Orphanet; 404448; ADNP-related multiple congenital anomalies-intellectual disability-autism spectrum disorder.
DR   PharmGKB; PA24582; -.
DR   eggNOG; ENOG410IIIX; Eukaryota.
DR   eggNOG; ENOG410XYDF; LUCA.
DR   GeneTree; ENSGT00530000063631; -.
DR   HOGENOM; HOG000232088; -.
DR   HOVERGEN; HBG024319; -.
DR   InParanoid; Q9H2P0; -.
DR   OMA; CRSTFND; -.
DR   OrthoDB; EOG091G00XX; -.
DR   PhylomeDB; Q9H2P0; -.
DR   TreeFam; TF328818; -.
DR   ChiTaRS; ADNP; human.
DR   GenomeRNAi; 23394; -.
DR   PRO; PR:Q9H2P0; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101126; -.
DR   CleanEx; HS_ADNP; -.
DR   ExpressionAtlas; Q9H2P0; baseline and differential.
DR   Genevisible; Q9H2P0; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048487; F:beta-tubulin binding; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0005507; F:copper ion binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
DR   GO; GO:0032147; P:activation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0032091; P:negative regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IEA:Ensembl.
DR   GO; GO:0033484; P:nitric oxide homeostasis; IEA:Ensembl.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0010835; P:regulation of protein ADP-ribosylation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0009743; P:response to carbohydrate; IEA:Ensembl.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0007614; P:short-term memory; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Autism spectrum disorder; Complete proteome; DNA-binding;
KW   Homeobox; Isopeptide bond; Mental retardation; Metal-binding;
KW   Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   1102       Activity-dependent neuroprotector
FT                                homeobox protein.
FT                                /FTId=PRO_0000048807.
FT   ZN_FING      74     97       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     107    129       C2H2-type 2; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     165    188       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     221    244       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     447    469       C2H2-type 5; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     489    510       C2H2-type 6; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     512    535       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     622    647       C2H2-type 8; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     662    686       C2H2-type 9; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   DNA_BIND    754    814       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      354    361       Neuroprotective peptide (NAP).
FT                                {ECO:0000269|PubMed:19091000}.
FT   MOD_RES      98     98       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     348    348       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q9Z103}.
FT   MOD_RES     409    409       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     608    608       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     709    709       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     736    736       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     738    738       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z103}.
FT   MOD_RES     805    805       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     876    876       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     878    878       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     886    886       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKL8}.
FT   MOD_RES     889    889       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z103}.
FT   MOD_RES     921    921       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     953    953       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     955    955       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1035   1035       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1042   1042       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1071   1071       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z103}.
FT   CROSSLNK     39     39       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     72     72       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    144    144       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    155    155       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    203    203       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    231    231       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    266    266       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    274    274       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    278    278       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    279    279       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    311    311       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    335    335       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    367    367       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    408    408       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    427    427       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    600    600       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    606    606       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    616    616       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    621    621       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    632    632       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    658    658       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    699    699       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    716    716       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    728    728       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    731    731       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    745    745       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    807    807       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    829    829       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    835    835       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    914    914       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    930    930       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    935    935       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1016   1016       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1035   1035       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1042   1042       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VARIANT    1094   1094       G -> V (found in a patient with autism;
FT                                unknown pathological significance;
FT                                dbSNP:rs780706686).
FT                                {ECO:0000269|PubMed:26637798}.
FT                                /FTId=VAR_078696.
SQ   SEQUENCE   1102 AA;  123563 MW;  4132E3EF814AF43B CRC64;
     MFQLPVNNLG SLRKARKTVK KILSDIGLEY CKEHIEDFKQ FEPNDFYLKN TTWEDVGLWD
     PSLTKNQDYR TKPFCCSACP FSSKFFSAYK SHFRNVHSED FENRILLNCP YCTFNADKKT
     LETHIKIFHA PNASAPSSSL STFKDKNKND GLKPKQADSV EQAVYYCKKC TYRDPLYEIV
     RKHIYREHFQ HVAAPYIAKA GEKSLNGAVP LGSNAREESS IHCKRCLFMP KSYEALVQHV
     IEDHERIGYQ VTAMIGHTNV VVPRSKPLML IAPKPQDKKS MGLPPRIGSL ASGNVRSLPS
     QQMVNRLSIP KPNLNSTGVN MMSSVHLQQN NYGVKSVGQG YSVGQSMRLG LGGNAPVSIP
     QQSQSVKQLL PSGNGRSYGL GSEQRSQAPA RYSLQSANAS SLSSGQLKSP SLSQSQASRV
     LGQSSSKPAA AATGPPPGNT SSTQKWKICT ICNELFPENV YSVHFEKEHK AEKVPAVANY
     IMKIHNFTSK CLYCNRYLPT DTLLNHMLIH GLSCPYCRST FNDVEKMAAH MRMVHIDEEM
     GPKTDSTLSF DLTLQQGSHT NIHLLVTTYN LRDAPAESVA YHAQNNPPVP PKPQPKVQEK
     ADIPVKSSPQ AAVPYKKDVG KTLCPLCFSI LKGPISDALA HHLRERHQVI QTVHPVEKKL
     TYKCIHCLGV YTSNMTASTI TLHLVHCRGV GKTQNGQDKT NAPSRLNQSP SLAPVKRTYE
     QMEFPLLKKR KLDDDSDSPS FFEEKPEEPV VLALDPKGHE DDSYEARKSF LTKYFNKQPY
     PTRREIEKLA ASLWLWKSDI ASHFSNKRKK CVRDCEKYKP GVLLGFNMKE LNKVKHEMDF
     DAEWLFENHD EKDSRVNASK TADKKLNLGK EDDSSSDSFE NLEEESNESG SPFDPVFEVE
     PKISNDNPEE HVLKVIPEDA SESEEKLDQK EDGSKYETIH LTEEPTKLMH NASDSEVDQD
     DVVEWKDGAS PSESGPGSQQ VSDFEDNTCE MKPGTWSDES SQSEDARSSK PAAKKKATMQ
     GDREQLKWKN SSYGKVEGFW SKDQSQWKNA SENDERLSNP QIEWQNSTID SEDGEQFDNM
     TDGVAEPMHG SLAGVKLSSQ QA
//
ID   ALX4_HUMAN              Reviewed;         411 AA.
AC   Q9H161; Q96JN7; Q9H198; Q9HAY9;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   25-OCT-2017, entry version 157.
DE   RecName: Full=Homeobox protein aristaless-like 4;
GN   Name=ALX4; Synonyms=KIAA1788;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND POSSIBLE INVOLVEMENT IN POSHS.
RX   PubMed=11017806; DOI=10.1086/321218;
RA   Wu Y.-Q., Badano J.L., McCaskill C., Vogel H., Potocki L.,
RA   Shaffer L.G.;
RT   "Haploinsufficiency of ALX4 as a potential cause of parietal foramina
RT   in the 11p11.2 contiguous gene-deletion syndrome.";
RL   Am. J. Hum. Genet. 67:1327-1332(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-35, AND VARIANT PFM2
RP   PRO-272.
RX   PubMed=11106354; DOI=10.1136/jmg.37.12.916;
RA   Wuyts W., Cleiren E., Homfray T., Rasore-Quartino A., Vanhoenacker F.,
RA   Van Hul W.;
RT   "The ALX4 homeobox gene is mutated in patients with ossification
RT   defects of the skull (foramina parietalia permagna, OMIM 168500).";
RL   J. Med. Genet. 37:916-920(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANTS THR-35 AND SER-102,
RP   AND VARIANT PFM2 GLN-218.
RX   PubMed=11137991; DOI=10.1038/83703;
RA   Mavrogiannis L.A., Antonopoulou I., Baxova A., Kutilek S., Kim C.A.,
RA   Sugayama S.M., Salamanca A., Wall S.A., Morriss-Kay G.M.,
RA   Wilkie A.O.M.;
RT   "Haploinsufficiency of the human homeobox gene ALX4 causes skull
RT   ossification defects.";
RL   Nat. Genet. 27:17-18(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [5]
RP   POSSIBLE INVOLVEMENT IN POSHS.
RX   PubMed=11903336; DOI=10.1034/j.1399-0004.2001.600506.x;
RA   Hall C.R., Wu Y., Shaffer L.G., Hecht J.T.;
RT   "Familial case of Potocki-Shaffer syndrome associated with
RT   microdeletion of EXT2 and ALX4.";
RL   Clin. Genet. 60:356-359(2001).
RN   [6]
RP   INVOLVEMENT IN FND2, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19692347; DOI=10.1093/hmg/ddp391;
RA   Kayserili H., Uz E., Niessen C., Vargel I., Alanay Y., Tuncbilek G.,
RA   Yigit G., Uyguner O., Candan S., Okur H., Kaygin S., Balci S.,
RA   Mavili E., Alikasifoglu M., Haase I., Wollnik B., Akarsu N.A.;
RT   "ALX4 dysfunction disrupts craniofacial and epidermal development.";
RL   Hum. Mol. Genet. 18:4357-4366(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANTS CRS5 PHE-7 AND GLU-211, VARIANT LEU-306, CHARACTERIZATION OF
RP   VARIANTS CRS5 PHE-7 AND GLU-211, AND CHARACTERIZATION OF VARIANT
RP   LEU-306.
RX   PubMed=22829454; DOI=10.1002/humu.22166;
RA   Yagnik G., Ghuman A., Kim S., Stevens C.G., Kimonis V., Stoler J.,
RA   Sanchez-Lara P.A., Bernstein J.A., Naydenov C., Drissi H.,
RA   Cunningham M.L., Kim J., Boyadjiev S.A.;
RT   "ALX4 gain-of-function mutations in nonsyndromic craniosynostosis.";
RL   Hum. Mutat. 33:1626-1629(2012).
CC   -!- FUNCTION: Transcription factor involved in skull and limb
CC       development. Plays an essential role in craniofacial development,
CC       skin and hair follicle development. {ECO:0000269|PubMed:19692347}.
CC   -!- SUBUNIT: Binds DNA. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138,
CC       ECO:0000269|PubMed:19692347}.
CC   -!- TISSUE SPECIFICITY: Expression is likely to be restricted to bone.
CC       Found in parietal bone.
CC   -!- DISEASE: Parietal foramina 2 (PFM2) [MIM:609597]: Autosomal
CC       dominant disease characterized by oval defects of the parietal
CC       bones caused by deficient ossification around the parietal notch,
CC       which is normally obliterated during the fifth fetal month. PFM2
CC       is also a clinical feature of Potocki-Shaffer syndrome.
CC       {ECO:0000269|PubMed:11106354, ECO:0000269|PubMed:11137991}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Frontonasal dysplasia 2 (FND2) [MIM:613451]: The term
CC       frontonasal dysplasia describes an array of abnormalities
CC       affecting the eyes, forehead and nose and linked to midfacial
CC       dysraphia. The clinical picture is highly variable. Major findings
CC       include true ocular hypertelorism; broadening of the nasal root;
CC       median facial cleft affecting the nose and/or upper lip and
CC       palate; unilateral or bilateral clefting of the alae nasi; lack of
CC       formation of the nasal tip; anterior cranium bifidum occultum; a
CC       V-shaped or widow's peak frontal hairline.
CC       {ECO:0000269|PubMed:19692347}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Potocki-Shaffer syndrome (POSHS) [MIM:601224]: A syndrome
CC       characterized by foramina parietalia permagna, multiple exostoses,
CC       and craniofacial dysostosis and mental retardation in some cases.
CC       {ECO:0000305|PubMed:11017806, ECO:0000305|PubMed:11903336}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Craniosynostosis 5 (CRS5) [MIM:615529]: A primary
CC       abnormality of skull growth involving premature fusion of one or
CC       more cranial sutures. The growth velocity of the skull often
CC       cannot match that of the developing brain resulting in an abnormal
CC       head shape and, in some cases, increased intracranial pressure,
CC       which must be treated promptly to avoid permanent
CC       neurodevelopmental disability. {ECO:0000269|PubMed:22829454}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG23961.1; Type=Frameshift; Positions=314, 323, 340; Evidence={ECO:0000305};
CC       Sequence=BAB47417.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF294629; AAG23961.1; ALT_FRAME; mRNA.
DR   EMBL; AF308822; AAK38835.1; -; Genomic_DNA.
DR   EMBL; AF308823; AAK38835.1; JOINED; Genomic_DNA.
DR   EMBL; AF308824; AAK38835.1; JOINED; Genomic_DNA.
DR   EMBL; AF308825; AAK38835.1; JOINED; Genomic_DNA.
DR   EMBL; AJ404888; CAC15060.1; -; mRNA.
DR   EMBL; AJ279074; CAC15120.1; -; Genomic_DNA.
DR   EMBL; AJ279075; CAC15120.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279076; CAC15120.1; JOINED; Genomic_DNA.
DR   EMBL; AJ279077; CAC15120.1; JOINED; Genomic_DNA.
DR   EMBL; AB058691; BAB47417.1; ALT_INIT; mRNA.
DR   CCDS; CCDS31468.1; -.
DR   RefSeq; NP_068745.2; NM_021926.3.
DR   UniGene; Hs.436055; -.
DR   PDB; 2M0C; NMR; -; A=209-280.
DR   PDBsum; 2M0C; -.
DR   ProteinModelPortal; Q9H161; -.
DR   SMR; Q9H161; -.
DR   BioGrid; 121938; 13.
DR   IntAct; Q9H161; 5.
DR   STRING; 9606.ENSP00000332744; -.
DR   iPTMnet; Q9H161; -.
DR   PhosphoSitePlus; Q9H161; -.
DR   BioMuta; ALX4; -.
DR   DMDM; 254763249; -.
DR   MaxQB; Q9H161; -.
DR   PaxDb; Q9H161; -.
DR   PeptideAtlas; Q9H161; -.
DR   PRIDE; Q9H161; -.
DR   DNASU; 60529; -.
DR   Ensembl; ENST00000329255; ENSP00000332744; ENSG00000052850.
DR   GeneID; 60529; -.
DR   KEGG; hsa:60529; -.
DR   UCSC; uc001myb.4; human.
DR   CTD; 60529; -.
DR   DisGeNET; 60529; -.
DR   EuPathDB; HostDB:ENSG00000052850.5; -.
DR   GeneCards; ALX4; -.
DR   GeneReviews; ALX4; -.
DR   HGNC; HGNC:450; ALX4.
DR   HPA; HPA001903; -.
DR   MalaCards; ALX4; -.
DR   MIM; 601224; phenotype.
DR   MIM; 605420; gene.
DR   MIM; 609597; phenotype.
DR   MIM; 613451; phenotype.
DR   MIM; 615529; phenotype.
DR   neXtProt; NX_Q9H161; -.
DR   OpenTargets; ENSG00000052850; -.
DR   Orphanet; 228390; Frontonasal dysplasia with alopecia and genital anomaly.
DR   Orphanet; 35093; Isolated scaphocephaly.
DR   Orphanet; 60015; Parietal foramina.
DR   Orphanet; 52022; Potocki-Shaffer syndrome.
DR   PharmGKB; PA24755; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG004214; -.
DR   InParanoid; Q9H161; -.
DR   KO; K09451; -.
DR   OMA; HMGQTHM; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; Q9H161; -.
DR   TreeFam; TF350743; -.
DR   GeneWiki; ALX4; -.
DR   GenomeRNAi; 60529; -.
DR   PRO; PR:Q9H161; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000052850; -.
DR   CleanEx; HS_ALX4; -.
DR   Genevisible; Q9H161; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; NAS:UniProtKB.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0001942; P:hair follicle development; IMP:UniProtKB.
DR   GO; GO:0007517; P:muscle organ development; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; NAS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR033203; ALX4.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   PANTHER; PTHR24329:SF322; PTHR24329:SF322; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Complete proteome; Craniosynostosis;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    411       Homeobox protein aristaless-like 4.
FT                                /FTId=PRO_0000048814.
FT   DNA_BIND    214    273       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       391    404       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS    104    115       Poly-Gln.
FT   MOD_RES     200    200       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT       7      7       V -> F (in CRS5; low-penetrance mutation
FT                                associated with disease susceptibility;
FT                                results in gain-of-function;
FT                                dbSNP:rs281865153).
FT                                {ECO:0000269|PubMed:22829454}.
FT                                /FTId=VAR_069279.
FT   VARIANT      35     35       R -> T (in dbSNP:rs3824915).
FT                                {ECO:0000269|PubMed:11106354,
FT                                ECO:0000269|PubMed:11137991}.
FT                                /FTId=VAR_010783.
FT   VARIANT     102    102       P -> S (in dbSNP:rs12421995).
FT                                {ECO:0000269|PubMed:11137991}.
FT                                /FTId=VAR_010784.
FT   VARIANT     211    211       K -> E (in CRS5; low-penetrance mutation
FT                                associated with disease susceptibility;
FT                                results in gain-of-function;
FT                                dbSNP:rs281865154).
FT                                {ECO:0000269|PubMed:22829454}.
FT                                /FTId=VAR_069280.
FT   VARIANT     218    218       R -> Q (in PFM2; dbSNP:rs104894193).
FT                                {ECO:0000269|PubMed:11137991}.
FT                                /FTId=VAR_010785.
FT   VARIANT     257    257       R -> T (in dbSNP:rs3824915).
FT                                /FTId=VAR_058413.
FT   VARIANT     272    272       R -> P (in PFM2; dbSNP:rs104894196).
FT                                {ECO:0000269|PubMed:11106354}.
FT                                /FTId=VAR_010897.
FT   VARIANT     306    306       P -> L (in dbSNP:rs149897209).
FT                                {ECO:0000269|PubMed:22829454}.
FT                                /FTId=VAR_069281.
FT   CONFLICT    134    134       D -> N (in Ref. 1; AAG23961).
FT                                {ECO:0000305}.
FT   HELIX       223    235       {ECO:0000244|PDB:2M0C}.
FT   HELIX       241    251       {ECO:0000244|PDB:2M0C}.
FT   HELIX       255    269       {ECO:0000244|PDB:2M0C}.
SQ   SEQUENCE   411 AA;  44241 MW;  D41780B230C7E55C CRC64;
     MNAETCVSYC ESPAAAMDAY YSPVSQSREG SSPFRAFPGG DKFGTTFLSA AAKAQGFGDA
     KSRARYGAGQ QDLATPLESG AGARGSFNKF QPQPSTPQPQ PPPQPQPQQQ QPQPQPPAQP
     HLYLQRGACK TPPDGSLKLQ EGSSGHSAAL QVPCYAKESS LGEPELPPDS DTVGMDSSYL
     SVKEAGVKGP QDRASSDLPS PLEKADSESN KGKKRRNRTT FTSYQLEELE KVFQKTHYPD
     VYAREQLAMR TDLTEARVQV WFQNRRAKWR KRERFGQMQQ VRTHFSTAYE LPLLTRAENY
     AQIQNPSWLG NNGAASPVPA CVVPCDPVPA CMSPHAHPPG SGASSVTDFL SVSGAGSHVG
     QTHMGSLFGA ASLSPGLNGY ELNGEPDRKT SSIAALRMKA KEHSAAISWA T
//
ID   ALX3_HUMAN              Reviewed;         343 AA.
AC   O95076; O95075; Q5T8M4;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   25-OCT-2017, entry version 144.
DE   RecName: Full=Homeobox protein aristaless-like 3;
DE   AltName: Full=Proline-rich transcription factor ALX3;
GN   Name=ALX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF
RP   1-92.
RC   TISSUE=Neuroblastoma;
RX   PubMed=11807986; DOI=10.1002/gcc.10030;
RA   Wimmer K., Zhu X.-X., Rouillard J.-M., Ambros P.F., Lamb B.J.,
RA   Kuick R., Eckart M., Weinhausl A., Fonatsch C., Hanash S.M.;
RT   "Combined restriction landmark genomic scanning and virtual genome
RT   scans identify a novel human homeobox gene, ALX3, that is
RT   hypermethylated in neuroblastoma.";
RL   Genes Chromosomes Cancer 33:285-294(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS FND1 VAL-168; TRP-183; TRP-196 AND SER-203.
RX   PubMed=19409524; DOI=10.1016/j.ajhg.2009.04.009;
RA   Twigg S.R.F., Versnel S.L., Nuernberg G., Lees M.M., Bhat M.,
RA   Hammond P., Hennekam R.C.M., Hoogeboom A.J., Hurst J.A., Johnson D.,
RA   Robinson A.A., Scambler P.J., Gerrelli D., Nuernberg P.,
RA   Mathijssen I.M.J., Wilkie A.O.M.;
RT   "Frontorhiny, a distinctive presentation of frontonasal dysplasia
RT   caused by recessive mutations in the ALX3 homeobox gene.";
RL   Am. J. Hum. Genet. 84:698-705(2009).
CC   -!- FUNCTION: Transcriptional regulator with a possible role in
CC       patterning of mesoderm during development. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- DISEASE: Frontonasal dysplasia 1 (FND1) [MIM:136760]: The term
CC       frontonasal dysplasia describes an array of abnormalities
CC       affecting the eyes, forehead and nose and linked to midfacial
CC       dysraphia. The clinical picture is highly variable. Major findings
CC       include true ocular hypertelorism; broadening of the nasal root;
CC       median facial cleft affecting the nose and/or upper lip and
CC       palate; unilateral or bilateral clefting of the alae nasi; lack of
CC       formation of the nasal tip; anterior cranium bifidum occultum; a
CC       V-shaped or widow's peak frontal hairline.
CC       {ECO:0000269|PubMed:19409524}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF008202; AAD01417.2; -; Genomic_DNA.
DR   EMBL; AF008203; AAD01418.1; -; mRNA.
DR   EMBL; AL160006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56430.1; -; Genomic_DNA.
DR   EMBL; BC112007; AAI12008.1; -; mRNA.
DR   EMBL; BC113428; AAI13429.1; -; mRNA.
DR   CCDS; CCDS819.1; -.
DR   RefSeq; NP_006483.2; NM_006492.2.
DR   UniGene; Hs.669953; -.
DR   ProteinModelPortal; O95076; -.
DR   SMR; O95076; -.
DR   BioGrid; 106755; 19.
DR   STRING; 9606.ENSP00000358807; -.
DR   iPTMnet; O95076; -.
DR   PhosphoSitePlus; O95076; -.
DR   BioMuta; ALX3; -.
DR   PaxDb; O95076; -.
DR   PeptideAtlas; O95076; -.
DR   PRIDE; O95076; -.
DR   Ensembl; ENST00000369792; ENSP00000358807; ENSG00000156150.
DR   GeneID; 257; -.
DR   KEGG; hsa:257; -.
DR   UCSC; uc001dzb.4; human.
DR   CTD; 257; -.
DR   DisGeNET; 257; -.
DR   EuPathDB; HostDB:ENSG00000156150.6; -.
DR   GeneCards; ALX3; -.
DR   H-InvDB; HIX0023725; -.
DR   H-InvDB; HIX0159682; -.
DR   HGNC; HGNC:449; ALX3.
DR   MalaCards; ALX3; -.
DR   MIM; 136760; phenotype.
DR   MIM; 606014; gene.
DR   neXtProt; NX_O95076; -.
DR   OpenTargets; ENSG00000156150; -.
DR   Orphanet; 391474; Frontorhiny.
DR   PharmGKB; PA24754; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG004213; -.
DR   InParanoid; O95076; -.
DR   KO; K09323; -.
DR   OMA; SIHGFPP; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; O95076; -.
DR   TreeFam; TF350743; -.
DR   GenomeRNAi; 257; -.
DR   PRO; PR:O95076; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000156150; -.
DR   CleanEx; HS_ALX3; -.
DR   Genevisible; O95076; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:InterPro.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR033211; ALX3.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   PANTHER; PTHR24329:SF340; PTHR24329:SF340; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    343       Homeobox protein aristaless-like 3.
FT                                /FTId=PRO_0000048812.
FT   DNA_BIND    153    212       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     168    168       L -> V (in FND1; dbSNP:rs121908167).
FT                                {ECO:0000269|PubMed:19409524}.
FT                                /FTId=VAR_063226.
FT   VARIANT     183    183       R -> W (in FND1; dbSNP:rs121908168).
FT                                {ECO:0000269|PubMed:19409524}.
FT                                /FTId=VAR_063227.
FT   VARIANT     196    196       R -> W (in FND1; dbSNP:rs121908170).
FT                                {ECO:0000269|PubMed:19409524}.
FT                                /FTId=VAR_063228.
FT   VARIANT     203    203       N -> S (in FND1; dbSNP:rs121908166).
FT                                {ECO:0000269|PubMed:19409524}.
FT                                /FTId=VAR_063229.
FT   VARIANT     234    234       P -> A (in dbSNP:rs12749726).
FT                                /FTId=VAR_047475.
FT   CONFLICT     72     72       L -> M (in Ref. 1; AAD01417).
FT                                {ECO:0000305}.
FT   CONFLICT     86     86       F -> L (in Ref. 1; AAD01417).
FT                                {ECO:0000305}.
FT   CONFLICT    249    249       S -> G (in Ref. 1; AAD01418).
FT                                {ECO:0000305}.
SQ   SEQUENCE   343 AA;  36935 MW;  0BB20630D5CB817B CRC64;
     MDPEHCAPFR VGPAPGPYVA SGDEPPGPQG TPAAAPHLHP APPRGPRLTR FPACGPLEPY
     LPEPAKPPAK YLQDLGPGPA LNGGHFYEGP AEAEEKTSKA ASFPQLPLDC RGGPRDGPSN
     LQGSPGPCLA SLHLPLSPGL PDSMELAKNK SKKRRNRTTF STFQLEELEK VFQKTHYPDV
     YAREQLALRT DLTEARVQVW FQNRRAKWRK RERYGKIQEG RNPFTAAYDI SVLPRTDSHP
     QLQNSLWASP GSGSPGGPCL VSPEGIPSPC MSPYSHPHGS VAGFMGVPAP SAAHPGIYSI
     HGFPPTLGGH SFEPSSDGDY KSPSLVSLRV KPKEPPGLLN WTT
//
ID   ANHX_HUMAN              Reviewed;         379 AA.
AC   E9PGG2; Q96MC1;
DT   11-JUL-2012, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   27-SEP-2017, entry version 48.
DE   RecName: Full=Anomalous homeobox protein;
GN   Name=ANHX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK057223; BAB71386.1; -; mRNA.
DR   EMBL; AC226150; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS53855.1; -.
DR   RefSeq; NP_001177983.1; NM_001191054.1.
DR   UniGene; Hs.703008; -.
DR   ProteinModelPortal; E9PGG2; -.
DR   SMR; E9PGG2; -.
DR   STRING; 9606.ENSP00000409950; -.
DR   iPTMnet; E9PGG2; -.
DR   PhosphoSitePlus; E9PGG2; -.
DR   BioMuta; ANHX; -.
DR   PaxDb; E9PGG2; -.
DR   PRIDE; E9PGG2; -.
DR   Ensembl; ENST00000419717; ENSP00000409950; ENSG00000227059.
DR   Ensembl; ENST00000545940; ENSP00000439513; ENSG00000227059.
DR   GeneID; 647589; -.
DR   KEGG; hsa:647589; -.
DR   UCSC; uc010tci.2; human.
DR   CTD; 647589; -.
DR   EuPathDB; HostDB:ENSG00000227059.6; -.
DR   GeneCards; ANHX; -.
DR   HGNC; HGNC:40024; ANHX.
DR   neXtProt; NX_E9PGG2; -.
DR   OpenTargets; ENSG00000227059; -.
DR   eggNOG; ENOG410IVR3; Eukaryota.
DR   eggNOG; ENOG410YN05; LUCA.
DR   GeneTree; ENSGT00390000013263; -.
DR   HOGENOM; HOG000168385; -.
DR   InParanoid; E9PGG2; -.
DR   OMA; FPREVRQ; -.
DR   OrthoDB; EOG091G07SI; -.
DR   PhylomeDB; E9PGG2; -.
DR   GenomeRNAi; 647589; -.
DR   PRO; PR:E9PGG2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000227059; -.
DR   Genevisible; E9PGG2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    379       Anomalous homeobox protein.
FT                                /FTId=PRO_0000418211.
FT   DNA_BIND    135    196       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CONFLICT     23     23       T -> A (in Ref. 1; BAB71386).
FT                                {ECO:0000305}.
FT   CONFLICT    272    272       T -> S (in Ref. 1; BAB71386).
FT                                {ECO:0000305}.
FT   CONFLICT    346    346       A -> V (in Ref. 1; BAB71386).
FT                                {ECO:0000305}.
SQ   SEQUENCE   379 AA;  41695 MW;  61A359395E76AAF8 CRC64;
     MQSFLTLLKE HEDTCAPPAE LVTLAGRLCR DFQDDLAQLQ PLVTAILDSQ LRLHLLDNAD
     VALACARVLD QQEQQQAACR LLEGCQVPGG SQELVQLWND IHYRLVMRRL GVAALTPVQK
     FRCRKRNPPP PSLCPEGLKS RNFPREVREK LHNFAVGVNT NPSKAERENL ALETSLTPEQ
     VYNWFANYRR RQRALPQHMK PAQQATAEDP GARERGPDLL QPSGNPRVDS GFVDRPQWSE
     EREEKGPPQS PQTTQGPWEP LALAPDFPAD ETVSKPLDVS GHPQSVQLEE GLGTSSGRTE
     LRVGSFLVTQ PPLQAPEFIL TQSPPELAPA PSAFPGPVSA MELSQALPSS QVQCSDSQAS
     GDAFWGARML LEFSGSSLG
//
ID   ARGFX_HUMAN             Reviewed;         315 AA.
AC   A6NJG6;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   27-SEP-2017, entry version 81.
DE   RecName: Full=Arginine-fifty homeobox;
GN   Name=ARGFX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=17005330; DOI=10.1016/j.gene.2006.07.034;
RA   Booth H.A., Holland P.W.H.;
RT   "Annotation, nomenclature and evolution of four novel homeobox genes
RT   expressed in the human germ line.";
RL   Gene 387:7-14(2007).
CC   -!- FUNCTION: Putative transcription factor. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Expressed at low level in testis and
CC       undifferentiated embryonic stem cells.
CC       {ECO:0000269|PubMed:17005330}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC069239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS33834.1; -.
DR   RefSeq; NP_001012677.1; NM_001012659.1.
DR   UniGene; Hs.224976; -.
DR   ProteinModelPortal; A6NJG6; -.
DR   SMR; A6NJG6; -.
DR   STRING; 9606.ENSP00000335578; -.
DR   iPTMnet; A6NJG6; -.
DR   PhosphoSitePlus; A6NJG6; -.
DR   BioMuta; ARGFX; -.
DR   EPD; A6NJG6; -.
DR   PaxDb; A6NJG6; -.
DR   PRIDE; A6NJG6; -.
DR   TopDownProteomics; A6NJG6; -.
DR   Ensembl; ENST00000334384; ENSP00000335578; ENSG00000186103.
DR   GeneID; 503582; -.
DR   KEGG; hsa:503582; -.
DR   UCSC; uc062myc.1; human.
DR   CTD; 503582; -.
DR   EuPathDB; HostDB:ENSG00000186103.3; -.
DR   GeneCards; ARGFX; -.
DR   HGNC; HGNC:30146; ARGFX.
DR   HPA; HPA043049; -.
DR   MIM; 611164; gene.
DR   neXtProt; NX_A6NJG6; -.
DR   OpenTargets; ENSG00000186103; -.
DR   PharmGKB; PA142672588; -.
DR   eggNOG; KOG2251; Eukaryota.
DR   eggNOG; ENOG4111XIJ; LUCA.
DR   GeneTree; ENSGT00730000111572; -.
DR   HOGENOM; HOG000034042; -.
DR   InParanoid; A6NJG6; -.
DR   OMA; MQDTQWE; -.
DR   OrthoDB; EOG091G0DAL; -.
DR   PhylomeDB; A6NJG6; -.
DR   TreeFam; TF351179; -.
DR   GenomeRNAi; 503582; -.
DR   PRO; PR:A6NJG6; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000186103; -.
DR   CleanEx; HS_ARGFX; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    315       Arginine-fifty homeobox.
FT                                /FTId=PRO_0000311325.
FT   DNA_BIND     78    137       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     145    145       R -> Q (in dbSNP:rs9813391).
FT                                /FTId=VAR_037226.
SQ   SEQUENCE   315 AA;  35617 MW;  D3EDBA45BAB43352 CRC64;
     MRNRMAPENP QPDPFINRNY SNMKVIPPQD PASPSFTLLS KLECSGTVSA YCSLNLPGST
     DPPTSASRVA ATTAIRRRHK ERTSFTHQQY EELEALFSQT MFPDRNLQEK LALRLDLPES
     TVKVWFRNRR FKLKKQQQQQ SAKQRNQILP SKKNVPTSPR TSPSPYAFSP VISDFYSSLP
     SQPLDPSNWA WNSTFTESST SDFQMQDTQW ERLVASVPAL YSDAYDIFQI IELYNLPDEN
     EISSSSFHCL YQYLSPTKYQ VGGQGSSLSI FAGPAVGLSP AQTWPNMTSQ AFEAYSLTDS
     LEFQKTSNMV DLGFL
//
ID   ARX_HUMAN               Reviewed;         562 AA.
AC   Q96QS3;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=Homeobox protein ARX;
DE   AltName: Full=Aristaless-related homeobox;
GN   Name=ARX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=12359145; DOI=10.1016/S1096-7192(02)00126-9;
RA   Ohira R.H., Zhang Y.H., Guo W., Dipple K., Shih S., Doerr J.,
RA   Huang B.-L., Fu L., Abu-Khalil A., Geschwind D., McCabe E.;
RT   "Human ARX gene: genomic characterization and expression.";
RL   Mol. Genet. Metab. 77:179-188(2002).
RN   [2]
RP   VARIANT EIEE1 ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-155 INS.
RX   PubMed=12376946; DOI=10.1002/ajmg.10714;
RA   Turner G., Partington M., Kerr B., Mangelsdorf M., Gecz J.;
RT   "Variable expression of mental retardation, autism, seizures, and
RT   dystonic hand movements in two families with an identical ARX gene
RT   mutation.";
RL   Am. J. Med. Genet. 112:405-411(2002).
RN   [3]
RP   VARIANTS MRXARX PRO-33 AND SER-286, AND TISSUE SPECIFICITY.
RX   PubMed=11971879; DOI=10.1093/hmg/11.8.981;
RA   Bienvenu T., Poirier K., Friocourt G., Bahi N., Beaumont D.,
RA   Fauchereau F., Ben-Jeema L., Zemni R., Vinet M.-C., Francis F.,
RA   Couvert P., Gomot M., Moraine C., van Bokhoven H., Kalscheuer V.,
RA   Frints S., Gecz J., Ohzaki K., Chaabouni H., Fryns J.-P.,
RA   Desportes V., Beldjord C., Chelly J.;
RT   "ARX, a novel Prd-class-homeobox gene highly expressed in the
RT   telencephalon, is mutated in X-linked mental retardation.";
RL   Hum. Mol. Genet. 11:981-991(2002).
RN   [4]
RP   VARIANTS EIEE1 ALA-ALA-ALA-ALA-ALA-ALA-ALA-115 INS;
RP   ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-155 INS AND LEU-353, VARIANT PRTS
RP   ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-155 INS, AND TISSUE SPECIFICITY.
RX   PubMed=11889467; DOI=10.1038/ng862;
RA   Stroemme P., Mangelsdorf M.E., Shaw M.A., Lower K.M., Lewis S.M.E.,
RA   Bruyere H., Luetcherath V., Gedeon A.K., Wallace R.H., Scheffer I.E.,
RA   Turner G., Partington M., Frints S.G.M., Fryns J.-P., Sutherland G.R.,
RA   Mulley J.C., Gecz J.;
RT   "Mutations in the human ortholog of aristaless cause X-linked mental
RT   retardation and epilepsy.";
RL   Nat. Genet. 30:441-445(2002).
RN   [5]
RP   VARIANTS LISX2 HIS-332 AND GLN-343.
RX   PubMed=12379852; DOI=10.1038/ng1009;
RA   Kitamura K., Yanazawa M., Sugiyama N., Miura H., Iizuka-Kogo A.,
RA   Kusaka M., Omichi K., Suzuki R., Kato-Fukui Y., Kamiirisa K.,
RA   Matsuo M., Kamijo S., Kasahara M., Yoshioka H., Ogata T., Fukuda T.,
RA   Kondo I., Kato M., Dobyns W.B., Yokoyama M., Morohashi K.;
RT   "Mutation of ARX causes abnormal development of forebrain and testes
RT   in mice and X-linked lissencephaly with abnormal genitalia in
RT   humans.";
RL   Nat. Genet. 32:359-369(2002).
RN   [6]
RP   VARIANTS LISX2 PRO-332; HIS-332; GLN-343; ARG-353 AND THR-521, AND
RP   VARIANT ACCAG ASN-333.
RX   PubMed=14722918; DOI=10.1002/humu.10310;
RA   Kato M., Das S., Petras K., Kitamura K., Morohashi K., Abuelo D.N.,
RA   Barr M., Bonneau D., Brady A.F., Carpenter N.J., Cipero K.L.,
RA   Frisone F., Fukuda T., Guerrini R., Iida E., Itoh M., Lewanda A.F.,
RA   Nanba Y., Oka A., Proud V.K., Saugier-Veber P., Schelley S.L.,
RA   Selicorni A., Shaner R., Silengo M., Stewart F., Sugiyama N.,
RA   Toyama J., Toutain A., Vargas A.L., Yanazawa M., Zackai E.H.,
RA   Dobyns W.B.;
RT   "Mutations of ARX are associated with striking pleiotropy and
RT   consistent genotype-phenotype correlation.";
RL   Hum. Mutat. 23:147-159(2004).
RN   [7]
RP   VARIANT EIEE1 LEU-353.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Transcription factor required for normal brain
CC       development. May be important for maintenance of specific neuronal
CC       subtypes in the cerebral cortex and axonal guidance in the floor
CC       plate.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in fetal and adult
CC       brain and skeletal muscle. Expression is specific to the
CC       telencephalon and ventral thalamus. There is an absence of
CC       expression in the cerebellum throughout development and also in
CC       adult. {ECO:0000269|PubMed:11889467, ECO:0000269|PubMed:11971879,
CC       ECO:0000269|PubMed:12359145}.
CC   -!- DISEASE: Lissencephaly, X-linked 2 (LISX2) [MIM:300215]: A classic
CC       type lissencephaly associated with abnormal genitalia. Patients
CC       have severe congenital or postnatal microcephaly, lissencephaly,
CC       agenesis of the corpus callosum, neonatal-onset intractable
CC       epilepsy, poor temperature regulation, chronic diarrhea, and
CC       ambiguous or underdeveloped genitalia.
CC       {ECO:0000269|PubMed:12379852, ECO:0000269|PubMed:14722918}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 1 (EIEE1)
CC       [MIM:308350]: A severe form of epilepsy characterized by frequent
CC       tonic seizures or spasms beginning in infancy with a specific EEG
CC       finding of suppression-burst patterns, characterized by high-
CC       voltage bursts alternating with almost flat suppression phases.
CC       Patients may progress to West syndrome, which is characterized by
CC       tonic spasms with clustering, arrest of psychomotor development,
CC       and hypsarrhythmia on EEG. {ECO:0000269|PubMed:11889467,
CC       ECO:0000269|PubMed:12376946, ECO:0000269|PubMed:27864847}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Partington syndrome (PRTS) [MIM:309510]: Characterized by
CC       mental retardation, episodic dystonic hand movements, and
CC       dysarthria. {ECO:0000269|PubMed:11889467}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mental retardation, X-linked, ARX-related (MRXARX)
CC       [MIM:300419]: A disorder characterized by significantly below
CC       average general intellectual functioning associated with
CC       impairments in adaptive behavior and manifested during the
CC       developmental period. Intellectual deficiency is the only primary
CC       symptom of non-syndromic X-linked mental retardation, while
CC       syndromic mental retardation presents with associated physical,
CC       neurological and/or psychiatric manifestations.
CC       {ECO:0000269|PubMed:11971879}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Agenesis of the corpus callosum, with abnormal genitalia
CC       (ACCAG) [MIM:300004]: A X-linked syndrome with variable expression
CC       in females. It is characterized by agenesis of corpus callosum,
CC       mental retardation and seizures. Manifestations in surviving males
CC       include severe acquired micrencephaly, mental retardation, limb
CC       contractures, scoliosis, tapered fingers with hyperconvex nails, a
CC       characteristic face with large eyes, prominent supraorbital
CC       ridges, synophrys, optic atrophy, broad alveolar ridges, and
CC       seizures. Urologic anomalies include renal dysplasia,
CC       cryptorchidism, and hypospadias. {ECO:0000269|PubMed:14722918}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY038071; AAK93901.1; -; mRNA.
DR   CCDS; CCDS14215.1; -.
DR   RefSeq; NP_620689.1; NM_139058.2.
DR   UniGene; Hs.300304; -.
DR   ProteinModelPortal; Q96QS3; -.
DR   SMR; Q96QS3; -.
DR   BioGrid; 127998; 17.
DR   IntAct; Q96QS3; 18.
DR   STRING; 9606.ENSP00000368332; -.
DR   iPTMnet; Q96QS3; -.
DR   PhosphoSitePlus; Q96QS3; -.
DR   BioMuta; ARX; -.
DR   DMDM; 27923733; -.
DR   PaxDb; Q96QS3; -.
DR   PeptideAtlas; Q96QS3; -.
DR   PRIDE; Q96QS3; -.
DR   Ensembl; ENST00000379044; ENSP00000368332; ENSG00000004848.
DR   GeneID; 170302; -.
DR   KEGG; hsa:170302; -.
DR   UCSC; uc004dbp.5; human.
DR   CTD; 170302; -.
DR   DisGeNET; 170302; -.
DR   EuPathDB; HostDB:ENSG00000004848.6; -.
DR   GeneCards; ARX; -.
DR   HGNC; HGNC:18060; ARX.
DR   MalaCards; ARX; -.
DR   MIM; 300004; phenotype.
DR   MIM; 300215; phenotype.
DR   MIM; 300382; gene.
DR   MIM; 300419; phenotype.
DR   MIM; 308350; phenotype.
DR   MIM; 309510; phenotype.
DR   neXtProt; NX_Q96QS3; -.
DR   OpenTargets; ENSG00000004848; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   Orphanet; 364063; Infantile epileptic-dyskinetic encephalopathy.
DR   Orphanet; 2508; Micrencephaly - corpus callosum agenesis - abnormal genitalia.
DR   Orphanet; 94083; Partington syndrome.
DR   Orphanet; 3175; Spasticity - intellectual disability - X-linked epilepsy.
DR   Orphanet; 3451; West syndrome.
DR   Orphanet; 452; X-linked lissencephaly with abnormal genitalia.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA25024; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000012381; -.
DR   HOVERGEN; HBG004285; -.
DR   InParanoid; Q96QS3; -.
DR   KO; K09452; -.
DR   OMA; IGPTFGR; -.
DR   OrthoDB; EOG091G0S4E; -.
DR   PhylomeDB; Q96QS3; -.
DR   TreeFam; TF350743; -.
DR   SIGNOR; Q96QS3; -.
DR   GeneWiki; Aristaless_related_homeobox; -.
DR   GenomeRNAi; 170302; -.
DR   PRO; PR:Q96QS3; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000004848; -.
DR   CleanEx; HS_ARX; -.
DR   ExpressionAtlas; Q96QS3; baseline and differential.
DR   Genevisible; Q96QS3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0001206; F:transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl.
DR   GO; GO:0021853; P:cerebral cortex GABAergic interneuron migration; IEA:Ensembl.
DR   GO; GO:0021800; P:cerebral cortex tangential migration; IEA:Ensembl.
DR   GO; GO:0021831; P:embryonic olfactory bulb interneuron precursor migration; IEA:Ensembl.
DR   GO; GO:0072148; P:epithelial cell fate commitment; IEA:Ensembl.
DR   GO; GO:0021759; P:globus pallidus development; IEA:Ensembl.
DR   GO; GO:0044241; P:lipid digestion; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0046622; P:positive regulation of organ growth; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   Disease mutation; DNA-binding; Epilepsy; Homeobox; Lissencephaly;
KW   Mental retardation; Neurogenesis; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation; Triplet repeat expansion.
FT   CHAIN         1    562       Homeobox protein ARX.
FT                                /FTId=PRO_0000048819.
FT   DNA_BIND    328    387       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       530    543       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS    100    155       Ala-rich.
FT   COMPBIAS    224    253       Glu-rich.
FT   COMPBIAS    395    459       Pro-rich.
FT   COMPBIAS    425    544       Ala-rich.
FT   VARIANT      33     33       L -> P (in MRXARX; dbSNP:rs28936077).
FT                                {ECO:0000269|PubMed:11971879}.
FT                                /FTId=VAR_015669.
FT   VARIANT     115    115       A -> AAAAAAAA (in EIEE1).
FT                                /FTId=VAR_015177.
FT   VARIANT     155    155       A -> AAAAAAAAA (in EIEE1 and PRTS; also
FT                                found in non-specific mental retardation
FT                                families; frequent mutation).
FT                                {ECO:0000269|PubMed:11889467,
FT                                ECO:0000269|PubMed:12376946}.
FT                                /FTId=VAR_015670.
FT   VARIANT     286    286       G -> S (in MRXARX; dbSNP:rs28935479).
FT                                {ECO:0000269|PubMed:11971879}.
FT                                /FTId=VAR_015671.
FT   VARIANT     332    332       R -> H (in LISX2; dbSNP:rs111033612).
FT                                {ECO:0000269|PubMed:12379852,
FT                                ECO:0000269|PubMed:14722918}.
FT                                /FTId=VAR_015178.
FT   VARIANT     332    332       R -> P (in LISX2).
FT                                {ECO:0000269|PubMed:14722918}.
FT                                /FTId=VAR_033260.
FT   VARIANT     333    333       T -> N (in ACCAG; dbSNP:rs104894745).
FT                                {ECO:0000269|PubMed:14722918}.
FT                                /FTId=VAR_033261.
FT   VARIANT     343    343       L -> Q (in LISX2; dbSNP:rs104894741).
FT                                {ECO:0000269|PubMed:12379852,
FT                                ECO:0000269|PubMed:14722918}.
FT                                /FTId=VAR_015179.
FT   VARIANT     353    353       P -> L (in EIEE1; corpus callosum
FT                                hypoplasia and simplified gyral pattern
FT                                observed in one patient;
FT                                dbSNP:rs104894743).
FT                                {ECO:0000269|PubMed:11889467,
FT                                ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_015180.
FT   VARIANT     353    353       P -> R (in LISX2).
FT                                {ECO:0000269|PubMed:14722918}.
FT                                /FTId=VAR_033262.
FT   VARIANT     521    521       A -> T (in LISX2; severe phenotype;
FT                                dbSNP:rs746120093).
FT                                {ECO:0000269|PubMed:14722918}.
FT                                /FTId=VAR_033263.
SQ   SEQUENCE   562 AA;  58160 MW;  FBDF41E387C65532 CRC64;
     MSNQYQEEGC SERPECKSKS PTLLSSYCID SILGRRSPCK MRLLGAAQSL PAPLTSRADP
     EKAVQGSPKS SSAPFEAELH LPPKLRRLYG PGGGRLLQGA AAAAAAAAAA AAAAATATAG
     PRGEAPPPPP PTARPGERPD GAGAAAAAAA AAAAAWDTLK ISQAPQVSIS RSKSYRENGA
     PFVPPPPALD ELGGPGGVTH PEERLGVAGG PGSAPAAGGG TGTEDDEEEL LEDEEDEDEE
     EELLEDDEEE LLEDDARALL KEPRRCPVAA TGAVAAAAAA AVATEGGELS PKEELLLHPE
     DAEGKDGEDS VCLSAGSDSE EGLLKRKQRR YRTTFTSYQL EELERAFQKT HYPDVFTREE
     LAMRLDLTEA RVQVWFQNRR AKWRKREKAG AQTHPPGLPF PGPLSATHPL SPYLDASPFP
     PHHPALDSAW TAAAAAAAAA FPSLPPPPGS ASLPPSGAPL GLSTFLGAAV FRHPAFISPA
     FGRLFSTMAP LTSASTAAAL LRQPTPAVEG AVASGALADP ATAAADRRAS SIAALRLKAK
     EHAAQLTQLN ILPGTSTGKE VC
//
ID   BARH2_HUMAN             Reviewed;         387 AA.
AC   Q9NY43; A0AVP2; Q7Z4N7;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   25-OCT-2017, entry version 132.
DE   RecName: Full=BarH-like 2 homeobox protein;
GN   Name=BARHL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Shan Y.X., Yu L., Huang C.Q., Guo Z.K.;
RT   "Cloning and characterization of human novel homeodomain box gene
RT   BARHL2.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 297-364.
RX   PubMed=10814725; DOI=10.1093/hmg/9.9.1443;
RA   Bulfone A., Menguzzato E., Broccoli V., Marchitiello A., Gattuso C.,
RA   Mariani M., Consalez G.G., Martinez S., Ballabio A., Banfi S.;
RT   "Barhl1, a gene belonging to a new subfamily of mammalian homeobox
RT   genes, is expressed in migrating neurons of the CNS.";
RL   Hum. Mol. Genet. 9:1443-1452(2000).
CC   -!- FUNCTION: Potential regulator of neural basic helix-loop-helix
CC       genes. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q04864:REL; NbExp=3; IntAct=EBI-10316571, EBI-307352;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the BAR homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY338397; AAQ01189.1; -; mRNA.
DR   EMBL; BC126439; AAI26440.1; -; mRNA.
DR   EMBL; BC126441; AAI26442.1; -; mRNA.
DR   EMBL; AJ251753; CAB92440.1; -; Genomic_DNA.
DR   CCDS; CCDS730.1; -.
DR   RefSeq; NP_064447.1; NM_020063.1.
DR   UniGene; Hs.451956; -.
DR   ProteinModelPortal; Q9NY43; -.
DR   SMR; Q9NY43; -.
DR   BioGrid; 131253; 1.
DR   IntAct; Q9NY43; 1.
DR   STRING; 9606.ENSP00000359474; -.
DR   iPTMnet; Q9NY43; -.
DR   PhosphoSitePlus; Q9NY43; -.
DR   BioMuta; BARHL2; -.
DR   DMDM; 47117915; -.
DR   EPD; Q9NY43; -.
DR   PaxDb; Q9NY43; -.
DR   PeptideAtlas; Q9NY43; -.
DR   PRIDE; Q9NY43; -.
DR   Ensembl; ENST00000370445; ENSP00000359474; ENSG00000143032.
DR   GeneID; 343472; -.
DR   KEGG; hsa:343472; -.
DR   UCSC; uc001dns.4; human.
DR   CTD; 343472; -.
DR   EuPathDB; HostDB:ENSG00000143032.7; -.
DR   GeneCards; BARHL2; -.
DR   HGNC; HGNC:954; BARHL2.
DR   HPA; HPA028176; -.
DR   HPA; HPA031326; -.
DR   MIM; 605212; gene.
DR   neXtProt; NX_Q9NY43; -.
DR   OpenTargets; ENSG00000143032; -.
DR   PharmGKB; PA25258; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000231533; -.
DR   HOVERGEN; HBG050663; -.
DR   InParanoid; Q9NY43; -.
DR   KO; K09360; -.
DR   OMA; MEPPEPH; -.
DR   OrthoDB; EOG091G13SM; -.
DR   PhylomeDB; Q9NY43; -.
DR   TreeFam; TF316128; -.
DR   GenomeRNAi; 343472; -.
DR   PRO; PR:Q9NY43; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143032; -.
DR   CleanEx; HS_BARHL2; -.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IBA:GO_Central.
DR   GO; GO:0001709; P:cell fate determination; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; IEA:Ensembl.
DR   GO; GO:0030516; P:regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    387       BarH-like 2 homeobox protein.
FT                                /FTId=PRO_0000048829.
FT   DNA_BIND    232    291       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     92    127       Gln/Pro-rich.
SQ   SEQUENCE   387 AA;  41981 MW;  F563EA63489D936D CRC64;
     MTMEGASGSS FGIDTILSSA SSGSPGMMNG DFRPLGEART ADFRSQATPS PCSEIDTVGT
     APSSPISVTM EPPEPHLVAD ATQHHHHLHH SQQPPPPAAA PTQSLQPLPQ QQQPLPPQQP
     PPPPPQQLGS AASAPRTSTS SFLIKDILGD SKPLAACAPY STSVSSPHHT PKQESNAVHE
     SFRPKLEQED SKTKLDKRED SQSDIKCHGT KEEGDREITS SRESPPVRAK KPRKARTAFS
     DHQLNQLERS FERQKYLSVQ DRMDLAAALN LTDTQVKTWY QNRRTKWKRQ TAVGLELLAE
     AGNYSALQRM FPSPYFYHPS LLGSMDSTTA AAAAAAMYSS MYRTPPAPHP QLQRPLVPRV
     LIHGLGPGGQ PALNPLSSPI PGTPHPR
//
ID   BARX2_HUMAN             Reviewed;         279 AA.
AC   Q9UMQ3; O43518; Q6NT51;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 3.
DT   27-SEP-2017, entry version 153.
DE   RecName: Full=Homeobox protein BarH-like 2;
GN   Name=BARX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10854790; DOI=10.1016/S0378-1119(00)00169-4;
RA   Krasner A., Wallace L., Thiagalingam A., Jones C., Lengauer C.,
RA   Minahan L., Ma Y., Kalikin L., Feinberg A.P., Jabs E.W.,
RA   Tunnacliffe A., Baylin S.B., Ball D.W., Nelkin B.D.;
RT   "Cloning and chromosomal localization of the human BARX2 homeobox
RT   protein gene.";
RL   Gene 250:171-180(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10644443; DOI=10.1006/geno.1999.6037;
RA   Hjalt T.A., Murray J.C.;
RT   "The human BARX2 gene: genomic structure, chromosomal localization,
RT   and single nucleotide polymorphisms.";
RL   Genomics 62:456-459(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Colon;
RA   Lindon C., Goodbourn S.;
RT   "Expression cloning of the human version of Barx2 as a cAMP response
RT   element binding protein- (CREB)- interacting factor.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor. Binds optimally to the DNA
CC       consensus sequence 5'-YYTAATGRTTTTY-3'. May control the expression
CC       of neural adhesion molecules such as L1 or Ng-CAM during embryonic
CC       development of both the central and peripherical nervous system.
CC       May be involved in controlling adhesive processes in keratinizing
CC       epithelia (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q13643:FHL3; NbExp=4; IntAct=EBI-12053927, EBI-741101;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult salivary gland and
CC       at much lower levels in mammary gland, kidney and placenta.
CC   -!- SIMILARITY: Belongs to the BAR homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC04705.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC04705.1; Type=Frameshift; Positions=11; Evidence={ECO:0000305};
CC       Sequence=AAF09453.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAF09453.1; Type=Frameshift; Positions=11; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF031924; AAC04705.1; ALT_SEQ; mRNA.
DR   EMBL; AF171222; AAF09453.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF171219; AAF09453.1; JOINED; Genomic_DNA.
DR   EMBL; AF171220; AAF09453.1; JOINED; Genomic_DNA.
DR   EMBL; AF171221; AAF09453.1; JOINED; Genomic_DNA.
DR   EMBL; AJ243512; CAB50736.1; -; mRNA.
DR   EMBL; AP003775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67743.1; -; Genomic_DNA.
DR   EMBL; BC069378; AAH69378.1; -; mRNA.
DR   EMBL; BC111432; AAI11433.1; -; mRNA.
DR   EMBL; BC111572; AAI11573.1; -; mRNA.
DR   CCDS; CCDS8481.1; -.
DR   RefSeq; NP_003649.2; NM_003658.4.
DR   UniGene; Hs.591944; -.
DR   ProteinModelPortal; Q9UMQ3; -.
DR   SMR; Q9UMQ3; -.
DR   BioGrid; 114108; 1.
DR   IntAct; Q9UMQ3; 2.
DR   STRING; 9606.ENSP00000281437; -.
DR   iPTMnet; Q9UMQ3; -.
DR   PhosphoSitePlus; Q9UMQ3; -.
DR   BioMuta; BARX2; -.
DR   DMDM; 254763427; -.
DR   EPD; Q9UMQ3; -.
DR   PaxDb; Q9UMQ3; -.
DR   PeptideAtlas; Q9UMQ3; -.
DR   PRIDE; Q9UMQ3; -.
DR   Ensembl; ENST00000281437; ENSP00000281437; ENSG00000043039.
DR   GeneID; 8538; -.
DR   KEGG; hsa:8538; -.
DR   UCSC; uc001qfc.5; human.
DR   CTD; 8538; -.
DR   DisGeNET; 8538; -.
DR   EuPathDB; HostDB:ENSG00000043039.6; -.
DR   GeneCards; BARX2; -.
DR   H-InvDB; HIX0171307; -.
DR   HGNC; HGNC:956; BARX2.
DR   HPA; CAB033311; -.
DR   HPA; HPA068414; -.
DR   MIM; 604823; gene.
DR   neXtProt; NX_Q9UMQ3; -.
DR   OpenTargets; ENSG00000043039; -.
DR   PharmGKB; PA25260; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000231924; -.
DR   HOVERGEN; HBG050665; -.
DR   InParanoid; Q9UMQ3; -.
DR   KO; K09361; -.
DR   OMA; GQPQELP; -.
DR   OrthoDB; EOG091G10IN; -.
DR   PhylomeDB; Q9UMQ3; -.
DR   TreeFam; TF350735; -.
DR   GenomeRNAi; 8538; -.
DR   PRO; PR:Q9UMQ3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000043039; -.
DR   CleanEx; HS_BARX2; -.
DR   Genevisible; Q9UMQ3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IMP:NTNU_SB.
DR   GO; GO:0001502; P:cartilage condensation; IBA:GO_Central.
DR   GO; GO:0014902; P:myotube differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    279       Homeobox protein BarH-like 2.
FT                                /FTId=PRO_0000048838.
FT   DNA_BIND    133    192       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   279 AA;  31188 MW;  8C2537E524528467 CRC64;
     MHCHAELRLS SPGQLKAARR RYKTFMIDEI LSKETCDYFE KLSLYSVCPS LVVRPKPLHS
     CTGSPSLRAY PLLSVITRQP TVISHLVPAT PGIAQALSCH QVTEAVSAEA PGGEALASSE
     SETEQPTPRQ KKPRRSRTIF TELQLMGLEK KFQKQKYLST PDRLDLAQSL GLTQLQVKTW
     YQNRRMKWKK MVLKGGQEAP TKPKGRPKKN SIPTSEEIEA EEKMNSQAQG QEQLEPSQGQ
     EELCEAQEPK ARDVPLEMAE PPDPPQELPI PSSEPPPLS
//
ID   BARH1_HUMAN             Reviewed;         327 AA.
AC   Q9BZE3; Q5T6V2; Q9NY88;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   25-OCT-2017, entry version 143.
DE   RecName: Full=BarH-like 1 homeobox protein;
GN   Name=BARHL1; ORFNames=FKSG31;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wang Y.-G., Gong L.;
RT   "Cloning and characterization of FKSG31, a novel gene encoding human
RT   BarH-like 1 protein.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15487006; DOI=10.1002/ajmg.a.30227;
RA   Gould D.B., Walter M.A.;
RT   "Mutational analysis of BARHL1 and BARX1 in three new patients with
RT   Joubert syndrome.";
RL   Am. J. Med. Genet. A 131:205-208(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 157-327.
RX   PubMed=10814725; DOI=10.1093/hmg/9.9.1443;
RA   Bulfone A., Menguzzato E., Broccoli V., Marchitiello A., Gattuso C.,
RA   Mariani M., Consalez G.G., Martinez S., Ballabio A., Banfi S.;
RT   "Barhl1, a gene belonging to a new subfamily of mammalian homeobox
RT   genes, is expressed in migrating neurons of the CNS.";
RL   Hum. Mol. Genet. 9:1443-1452(2000).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the BAR homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF325688; AAG50279.1; -; mRNA.
DR   EMBL; AF321618; AAK52674.1; -; mRNA.
DR   EMBL; AK054797; BAB70807.1; -; mRNA.
DR   EMBL; AL354735; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW88005.1; -; Genomic_DNA.
DR   EMBL; BC136956; AAI36957.1; -; mRNA.
DR   EMBL; BC136969; AAI36970.1; -; mRNA.
DR   EMBL; AJ237816; CAB92439.1; -; Genomic_DNA.
DR   CCDS; CCDS6950.1; -.
DR   RefSeq; NP_064448.1; NM_020064.3.
DR   UniGene; Hs.283809; -.
DR   ProteinModelPortal; Q9BZE3; -.
DR   SMR; Q9BZE3; -.
DR   BioGrid; 121195; 3.
DR   STRING; 9606.ENSP00000263610; -.
DR   iPTMnet; Q9BZE3; -.
DR   PhosphoSitePlus; Q9BZE3; -.
DR   BioMuta; BARHL1; -.
DR   DMDM; 29336920; -.
DR   PaxDb; Q9BZE3; -.
DR   PRIDE; Q9BZE3; -.
DR   Ensembl; ENST00000263610; ENSP00000263610; ENSG00000125492.
DR   Ensembl; ENST00000542090; ENSP00000444704; ENSG00000125492.
DR   GeneID; 56751; -.
DR   KEGG; hsa:56751; -.
DR   UCSC; uc004cbp.2; human.
DR   CTD; 56751; -.
DR   EuPathDB; HostDB:ENSG00000125492.9; -.
DR   GeneCards; BARHL1; -.
DR   HGNC; HGNC:953; BARHL1.
DR   HPA; HPA004809; -.
DR   MIM; 605211; gene.
DR   neXtProt; NX_Q9BZE3; -.
DR   OpenTargets; ENSG00000125492; -.
DR   PharmGKB; PA25257; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000231533; -.
DR   HOVERGEN; HBG050663; -.
DR   InParanoid; Q9BZE3; -.
DR   KO; K09360; -.
DR   OMA; SDSEYKG; -.
DR   OrthoDB; EOG091G13SM; -.
DR   PhylomeDB; Q9BZE3; -.
DR   TreeFam; TF316128; -.
DR   GenomeRNAi; 56751; -.
DR   PRO; PR:Q9BZE3; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000125492; -.
DR   CleanEx; HS_BARHL1; -.
DR   Genevisible; Q9BZE3; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IBA:GO_Central.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    327       BarH-like 1 homeobox protein.
FT                                /FTId=PRO_0000048826.
FT   DNA_BIND    178    237       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   327 AA;  35074 MW;  5BFCE201BC6359D6 CRC64;
     MEGSNGFGID SILSHRAGSP ALPKGDPLLG DCRSPLELSP RSESSSDCSS PASPGRDCLE
     TGTPRPGGAS GPGLDSHLQP GQLSAPAQSR TVTSSFLIRD ILADCKPLAA CAPYSSSGQP
     AAPEPGGRLA AKAAEDFRDK LDKSGSNASS DSEYKVKEEG DREISSSRDS PPVRLKKPRK
     ARTAFTDHQL AQLERSFERQ KYLSVQDRME LAASLNLTDT QVKTWYQNRR TKWKRQTAVG
     LELLAEAGNY SALQRMFPSP YFYPQSLVSN LDPGAALYLY RGPSAPPPAL QRPLVPRILI
     HGLQGASEPP PPLPPLAGVL PRAAQPR
//
ID   BSH_HUMAN               Reviewed;         233 AA.
AC   Q3C1V8;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 2.
DT   27-SEP-2017, entry version 99.
DE   RecName: Full=Brain-specific homeobox protein homolog;
GN   Name=BSX; Synonyms=BSX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-93.
RA   Totoki Y., Yada T., Sakaki Y., Takeda T.;
RT   "Identification of novel human genes predicted by combining multiple
RT   gene finders.";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: DNA binding protein that function as transcriptional
CC       activator. Is essentiel for normal postnatal growth and nursing.
CC       Is an essential factor for neuronal neuropeptide Y and agouti-
CC       related peptide function and locomotory behavior in the control of
CC       energy balance (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q810B3}.
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Of fidgets and food
CC       - Issue 85 of August 2007;
CC       URL="http://web.expasy.org/spotlight/back_issues/085";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP003040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB231738; BAE46889.1; -; mRNA.
DR   CCDS; CCDS41728.1; -.
DR   RefSeq; NP_001091639.1; NM_001098169.1.
DR   UniGene; Hs.449687; -.
DR   ProteinModelPortal; Q3C1V8; -.
DR   SMR; Q3C1V8; -.
DR   STRING; 9606.ENSP00000344285; -.
DR   iPTMnet; Q3C1V8; -.
DR   PhosphoSitePlus; Q3C1V8; -.
DR   BioMuta; BSX; -.
DR   DMDM; 156630463; -.
DR   EPD; Q3C1V8; -.
DR   PaxDb; Q3C1V8; -.
DR   PRIDE; Q3C1V8; -.
DR   Ensembl; ENST00000343035; ENSP00000344285; ENSG00000188909.
DR   GeneID; 390259; -.
DR   KEGG; hsa:390259; -.
DR   UCSC; uc010rzs.3; human.
DR   CTD; 390259; -.
DR   DisGeNET; 390259; -.
DR   EuPathDB; HostDB:ENSG00000188909.4; -.
DR   GeneCards; BSX; -.
DR   HGNC; HGNC:20450; BSX.
DR   HPA; HPA015654; -.
DR   MIM; 611074; gene.
DR   neXtProt; NX_Q3C1V8; -.
DR   OpenTargets; ENSG00000188909; -.
DR   PharmGKB; PA162377618; -.
DR   eggNOG; KOG0491; Eukaryota.
DR   eggNOG; ENOG4111UAT; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000231924; -.
DR   HOVERGEN; HBG050738; -.
DR   InParanoid; Q3C1V8; -.
DR   OMA; LHKPEHH; -.
DR   OrthoDB; EOG091G0QT3; -.
DR   PhylomeDB; Q3C1V8; -.
DR   TreeFam; TF350735; -.
DR   GenomeRNAi; 390259; -.
DR   PRO; PR:Q3C1V8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000188909; -.
DR   CleanEx; HS_BSX; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0042755; P:eating behavior; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0060056; P:mammary gland involution; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    233       Brain-specific homeobox protein homolog.
FT                                /FTId=PRO_0000299170.
FT   DNA_BIND    110    169       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     68     80       His-rich.
FT   CONFLICT     55     55       G -> S (in Ref. 2; BAE46889).
FT                                {ECO:0000305}.
SQ   SEQUENCE   233 AA;  25933 MW;  D11ECA435986FA1C CRC64;
     MNLNFTSPLH PASSQRPTSF FIEDILLHKP KPLREVAPDH FASSLASRVP LLDYGYPLMP
     TPTLLAPHAH HPLHKGDHHH PYFLTTSGMP VPALFPHPQH AELPGKHCRR RKARTVFSDS
     QLSGLEKRFE IQRYLSTPER VELATALSLS ETQVKTWFQN RRMKHKKQLR KSQDEPKAPD
     GPESPEGSPR GSEAATAAEA RLSLPAGPFV LTEPEDEVDI GDEGELGSGP HVL
//
ID   BARX1_HUMAN             Reviewed;         254 AA.
AC   Q9HBU1; Q6P2R4; Q96GH8;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   27-SEP-2017, entry version 146.
DE   RecName: Full=Homeobox protein BarH-like 1;
GN   Name=BARX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-48.
RC   TISSUE=Craniofacial;
RX   PubMed=10995576; DOI=10.1006/geno.2000.6307;
RA   Gould D.B., Walter M.A.;
RT   "Cloning, characterization, localization, and mutational screening of
RT   the human BARX1 gene.";
RL   Genomics 68:336-342(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=9804553; DOI=10.1126/science.282.5391.1136;
RA   Tucker A.S., Matthews K.L., Sharpe P.T.;
RT   "Transformation of tooth type induced by inhibition of BMP
RT   signaling.";
RL   Science 282:1136-1138(1998).
RN   [6]
RP   STRUCTURE BY NMR OF 132-199.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of homeobox protein BarH-
RT   like 1.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: Transcription factor, which is involved in craniofacial
CC       development, in odontogenesis and in stomach organogenesis. May
CC       have a role in the differentiation of molars from incisors. Plays
CC       a role in suppressing endodermal Wnt activity (By similarity).
CC       Binds to a regulatory module of the NCAM promoter. {ECO:0000250,
CC       ECO:0000269|PubMed:9804553}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HBU1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HBU1-2; Sequence=VSP_034700;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at higher levels
CC       in testis and heart. Detected in craniofacial tissue and adult
CC       iris, but not in lymphocytes, fibroblasts, choroid retina, retinal
CC       pigment epithelium, kidney, or fetal liver.
CC   -!- POLYMORPHISM: The polymorphism is not associated with Axenfeld-
CC       Reiger syndrome (ARS), iridogoniodysgenesis syndrome (IGDS) or
CC       related ocular malformations. {ECO:0000305|PubMed:10995576}.
CC   -!- SIMILARITY: Belongs to the BAR homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG23738.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF213356; AAG23738.1; ALT_FRAME; mRNA.
DR   EMBL; AL357073; CAQ06883.1; -; Genomic_DNA.
DR   EMBL; AL357073; CAQ06884.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62873.1; -; Genomic_DNA.
DR   EMBL; BC009458; AAH09458.1; -; mRNA.
DR   EMBL; BC064363; AAH64363.1; -; mRNA.
DR   CCDS; CCDS35070.2; -. [Q9HBU1-1]
DR   RefSeq; NP_067545.3; NM_021570.3. [Q9HBU1-1]
DR   UniGene; Hs.164960; -.
DR   PDB; 2DMT; NMR; -; A=133-199.
DR   PDBsum; 2DMT; -.
DR   ProteinModelPortal; Q9HBU1; -.
DR   SMR; Q9HBU1; -.
DR   BioGrid; 121031; 7.
DR   IntAct; Q9HBU1; 6.
DR   MINT; MINT-6782029; -.
DR   STRING; 9606.ENSP00000253968; -.
DR   iPTMnet; Q9HBU1; -.
DR   PhosphoSitePlus; Q9HBU1; -.
DR   BioMuta; BARX1; -.
DR   DMDM; 205830909; -.
DR   EPD; Q9HBU1; -.
DR   MaxQB; Q9HBU1; -.
DR   PaxDb; Q9HBU1; -.
DR   PeptideAtlas; Q9HBU1; -.
DR   PRIDE; Q9HBU1; -.
DR   DNASU; 56033; -.
DR   Ensembl; ENST00000253968; ENSP00000253968; ENSG00000131668. [Q9HBU1-1]
DR   Ensembl; ENST00000401724; ENSP00000385613; ENSG00000131668. [Q9HBU1-2]
DR   GeneID; 56033; -.
DR   KEGG; hsa:56033; -.
DR   UCSC; uc004aud.3; human. [Q9HBU1-1]
DR   CTD; 56033; -.
DR   DisGeNET; 56033; -.
DR   EuPathDB; HostDB:ENSG00000131668.13; -.
DR   GeneCards; BARX1; -.
DR   HGNC; HGNC:955; BARX1.
DR   HPA; HPA055858; -.
DR   MIM; 603260; gene.
DR   neXtProt; NX_Q9HBU1; -.
DR   OpenTargets; ENSG00000131668; -.
DR   PharmGKB; PA25259; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000231924; -.
DR   HOVERGEN; HBG050665; -.
DR   InParanoid; Q9HBU1; -.
DR   KO; K09361; -.
DR   OMA; FHSHLAV; -.
DR   OrthoDB; EOG091G10IN; -.
DR   PhylomeDB; Q9HBU1; -.
DR   TreeFam; TF350735; -.
DR   EvolutionaryTrace; Q9HBU1; -.
DR   GenomeRNAi; 56033; -.
DR   PRO; PR:Q9HBU1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000131668; -.
DR   CleanEx; HS_BARX1; -.
DR   Genevisible; Q9HBU1; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IBA:GO_Central.
DR   GO; GO:0048513; P:animal organ development; IBA:GO_Central.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; IEA:Ensembl.
DR   GO; GO:0055123; P:digestive system development; IBA:GO_Central.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0009888; P:tissue development; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    254       Homeobox protein BarH-like 1.
FT                                /FTId=PRO_0000048834.
FT   DNA_BIND    142    201       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     44     53       Poly-Ala.
FT   VAR_SEQ       1    154       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034700.
FT   VARIANT      48     48       A -> T (in dbSNP:rs191789925).
FT                                {ECO:0000269|PubMed:10995576}.
FT                                /FTId=VAR_010927.
FT   CONFLICT      8      8       G -> A (in Ref. 1; AAG23738).
FT                                {ECO:0000305}.
FT   CONFLICT     14     14       P -> A (in Ref. 1; AAG23738).
FT                                {ECO:0000305}.
FT   CONFLICT     24     24       H -> Q (in Ref. 1; AAG23738).
FT                                {ECO:0000305}.
FT   CONFLICT    122    123       QL -> HV (in Ref. 1; AAG23738).
FT                                {ECO:0000305}.
FT   HELIX       151    163       {ECO:0000244|PDB:2DMT}.
FT   HELIX       169    179       {ECO:0000244|PDB:2DMT}.
FT   HELIX       183    197       {ECO:0000244|PDB:2DMT}.
SQ   SEQUENCE   254 AA;  27298 MW;  772C7C12F765C684 CRC64;
     MQRPGEPGAA RFGPPEGCAD HRPHRYRSFM IEEILTEPPG PKGAAPAAAA AAAGELLKFG
     VQALLAARPF HSHLAVLKAE QAAVFKFPLA PLGCSGLSSA LLAAGPGLPG AAGAPHLPLE
     LQLRGKLEAA GPGEPGTKAK KGRRSRTVFT ELQLMGLEKR FEKQKYLSTP DRIDLAESLG
     LSQLQVKTWY QNRRMKWKKI VLQGGGLESP TKPKGRPKKN SIPTSEQLTE QERAKDAEKP
     AEVPGEPSDR SRED
//
ID   CDX2_HUMAN              Reviewed;         313 AA.
AC   Q99626; O00503; Q5VTU7; Q969L8; Q9UD92;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   25-OCT-2017, entry version 165.
DE   RecName: Full=Homeobox protein CDX-2;
DE   AltName: Full=CDX-3;
DE   AltName: Full=Caudal-type homeobox protein 2;
GN   Name=CDX2; Synonyms=CDX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-293.
RX   PubMed=9459001; DOI=10.1017/S0003480097006465;
RA   Drummond F.J., Putt W., Fox M., Edwards Y.H.;
RT   "Cloning and chromosome assignment of the human CDX2 gene.";
RL   Ann. Hum. Genet. 61:393-400(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-293.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9036867;
RX   DOI=10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1;
RA   Mallo G.V., Rechreche H., Frigerio J.-M., Rocha D., Zweibaum A.,
RA   Lacasa M., Jordan B.R., Dusetti N.J., Dagorn J.-C., Iovanna J.L.;
RT   "Molecular cloning, sequencing and expression of the mRNA encoding
RT   human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA
RT   expression during colorectal carcinogenesis.";
RL   Int. J. Cancer 74:35-44(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-293.
RX   PubMed=11161380; DOI=10.1054/bjoc.2000.1544;
RA   Sivagnanasundaram S., Islam I., Talbot I., Drummond F., Walters J.R.,
RA   Edwards Y.H.;
RT   "The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.";
RL   Br. J. Cancer 84:218-225(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-293.
RA   Tanizawa Y., Ueda K., Inoue H., Ayame H., Aoki M., Kuwano A.,
RA   German M.S., Liu L., Donis-Keller H., Permutt M.A., Oka Y.;
RT   "Isolation, characterization, and linkage mapping of the human caudal-
RT   type homeobox gene, CDX2/3.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-293.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 205-232.
RC   TISSUE=T-cell;
RX   PubMed=8105782; DOI=10.1006/bbrc.1993.2235;
RA   Inamori K., Takeshita K., Chiba S., Yazaki Y., Hirai H.;
RT   "Identification of homeobox genes expressed in human T-lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 196:203-208(1993).
CC   -!- FUNCTION: Involved in the transcriptional regulation of multiple
CC       genes expressed in the intestinal epithelium. Important in broad
CC       range of functions from early differentiation to maintenance of
CC       the intestinal epithelial lining of both the small and large
CC       intestine.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Phosphorylation of Ser-60 mediates the transactivation
CC       capacity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the Caudal homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDX2ID326.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13709; CAA74038.1; -; mRNA.
DR   EMBL; U51096; AAB40603.1; -; mRNA.
DR   EMBL; AJ278431; CAB94779.1; -; Genomic_DNA.
DR   EMBL; AJ278432; CAB94779.1; JOINED; Genomic_DNA.
DR   EMBL; AJ278434; CAB94779.1; JOINED; Genomic_DNA.
DR   EMBL; AF007886; AAD05200.1; -; Genomic_DNA.
DR   EMBL; AF007884; AAD05200.1; JOINED; Genomic_DNA.
DR   EMBL; AF007885; AAD05200.1; JOINED; Genomic_DNA.
DR   EMBL; AL591024; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014461; AAH14461.1; -; mRNA.
DR   CCDS; CCDS9328.1; -.
DR   PIR; PN0625; PN0625.
DR   RefSeq; NP_001256.3; NM_001265.4.
DR   UniGene; Hs.127383; -.
DR   UniGene; Hs.174249; -.
DR   UniGene; Hs.740844; -.
DR   PDB; 5LTY; X-ray; 2.66 A; K/M=185-255.
DR   PDBsum; 5LTY; -.
DR   ProteinModelPortal; Q99626; -.
DR   SMR; Q99626; -.
DR   BioGrid; 107475; 15.
DR   IntAct; Q99626; 3.
DR   STRING; 9606.ENSP00000370408; -.
DR   iPTMnet; Q99626; -.
DR   PhosphoSitePlus; Q99626; -.
DR   BioMuta; Cdx2; -.
DR   DMDM; 311033469; -.
DR   EPD; Q99626; -.
DR   MaxQB; Q99626; -.
DR   PaxDb; Q99626; -.
DR   PeptideAtlas; Q99626; -.
DR   PRIDE; Q99626; -.
DR   DNASU; 1045; -.
DR   Ensembl; ENST00000381020; ENSP00000370408; ENSG00000165556.
DR   GeneID; 1045; -.
DR   KEGG; hsa:1045; -.
DR   UCSC; uc001urv.5; human.
DR   CTD; 1045; -.
DR   DisGeNET; 1045; -.
DR   EuPathDB; HostDB:ENSG00000165556.9; -.
DR   GeneCards; CDX2; -.
DR   HGNC; HGNC:1806; CDX2.
DR   HPA; CAB002221; -.
DR   HPA; HPA045669; -.
DR   HPA; HPA049580; -.
DR   MIM; 600297; gene.
DR   neXtProt; NX_Q99626; -.
DR   OpenTargets; ENSG00000165556; -.
DR   PharmGKB; PA26352; -.
DR   eggNOG; KOG0848; Eukaryota.
DR   eggNOG; ENOG4111W2J; LUCA.
DR   GeneTree; ENSGT00530000063388; -.
DR   HOGENOM; HOG000115975; -.
DR   HOVERGEN; HBG005302; -.
DR   InParanoid; Q99626; -.
DR   KO; K09312; -.
DR   OMA; GPSWPSP; -.
DR   OrthoDB; EOG091G0LXJ; -.
DR   PhylomeDB; Q99626; -.
DR   TreeFam; TF351605; -.
DR   Reactome; R-HSA-381771; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1).
DR   SIGNOR; Q99626; -.
DR   GeneWiki; CDX2; -.
DR   GenomeRNAi; 1045; -.
DR   PRO; PR:Q99626; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000165556; -.
DR   CleanEx; HS_CDX2; -.
DR   Genevisible; Q99626; HS.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008333; P:endosome to lysosome transport; IEA:Ensembl.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0060575; P:intestinal epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060711; P:labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0014807; P:regulation of somitogenesis; ISS:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR006820; Caudal_activation_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF04731; Caudal_act; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    313       Homeobox protein CDX-2.
FT                                /FTId=PRO_0000048849.
FT   DNA_BIND    186    245       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     46     53       Poly-Ala.
FT   COMPBIAS     85     92       Poly-Ala.
FT   COMPBIAS    250    256       Poly-Gln.
FT   COMPBIAS    257    270       Poly-Pro.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P43241}.
FT   VARIANT     293    293       P -> S (in dbSNP:rs1805107).
FT                                {ECO:0000269|PubMed:11161380,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9036867,
FT                                ECO:0000269|PubMed:9459001,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014530.
FT   CONFLICT     52     53       AA -> Q (in Ref. 2; AAB40603).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       Missing (in Ref. 2; AAB40603).
FT                                {ECO:0000305}.
FT   CONFLICT     95     95       G -> A (in Ref. 2; AAB40603).
FT                                {ECO:0000305}.
FT   HELIX       195    207       {ECO:0000244|PDB:5LTY}.
FT   HELIX       213    223       {ECO:0000244|PDB:5LTY}.
FT   HELIX       227    254       {ECO:0000244|PDB:5LTY}.
SQ   SEQUENCE   313 AA;  33520 MW;  B5724F1F7CA569AF CRC64;
     MYVSYLLDKD VSMYPSSVRH SGGLNLAPQN FVSPPQYPDY GGYHVAAAAA AAANLDSAQS
     PGPSWPAAYG APLREDWNGY APGGAAAAAN AVAHGLNGGS PAAAMGYSSP ADYHPHHHPH
     HHPHHPAAAP SCASGLLQTL NPGPPGPAAT AAAEQLSPGG QRRNLCEWMR KPAQQSLGSQ
     VKTRTKDKYR VVYTDHQRLE LEKEFHYSRY ITIRRKAELA ATLGLSERQV KIWFQNRRAK
     ERKINKKKLQ QQQQQQPPQP PPPPPQPPQP QPGPLRSVPE PLSPVSSLQA SVPGSVPGVL
     GPTGGVLNPT VTQ
//
ID   CERS3_HUMAN             Reviewed;         383 AA.
AC   Q8IU89; Q8NE64; Q8NEN6;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   25-OCT-2017, entry version 133.
DE   RecName: Full=Ceramide synthase 3;
DE            Short=CerS3;
DE            EC=2.3.1.24;
DE   AltName: Full=Dihydroceramide synthase 3;
DE   AltName: Full=LAG1 longevity assurance homolog 3;
GN   Name=CERS3; Synonyms=LASS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-370.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN ARCI9.
RX   PubMed=23754960; DOI=10.1371/journal.pgen.1003536;
RA   Radner F.P., Marrakchi S., Kirchmeier P., Kim G.J., Ribierre F.,
RA   Kamoun B., Abid L., Leipoldt M., Turki H., Schempp W., Heilig R.,
RA   Lathrop M., Fischer J.;
RT   "Mutations in CERS3 cause autosomal recessive congenital ichthyosis in
RT   humans.";
RL   PLoS Genet. 9:E1003536-E1003536(2013).
CC   -!- FUNCTION: Has (dihydro)ceramide synthesis activity with relatively
CC       broad substrate specificity, but a preference for C18:0 and other
CC       middle- to long-chain fatty acyl-CoAs (By similarity). It is
CC       crucial for the synthesis of very long-chain ceramides in the
CC       epidermis, to maintain epidermal lipid homeostasis and terminal
CC       differentiation. {ECO:0000250, ECO:0000269|PubMed:23754960}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + sphingosine = CoA + N-
CC       acylsphingosine.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + dihydrosphingosine = CoA + N-
CC       acyldihydrosphingosine.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the epidermis, where it localizes
CC       at the interface between the stratum granulosum and the stratum
CC       corneum (at protein level). {ECO:0000269|PubMed:23754960}.
CC   -!- DISEASE: Ichthyosis, congenital, autosomal recessive 9 (ARCI9)
CC       [MIM:615023]: A form of autosomal recessive congenital ichthyosis,
CC       a disorder of keratinization with abnormal differentiation and
CC       desquamation of the epidermis, resulting in abnormal skin scaling
CC       over the whole body. The main skin phenotypes are lamellar
CC       ichthyosis (LI) and non-bullous congenital ichthyosiform
CC       erythroderma (NCIE), although phenotypic overlap within the same
CC       patient or among patients from the same family can occur. Lamellar
CC       ichthyosis is a condition often associated with an embedment in a
CC       collodion-like membrane at birth; skin scales later develop,
CC       covering the entire body surface. Non-bullous congenital
CC       ichthyosiform erythroderma characterized by fine whitish scaling
CC       on an erythrodermal background; larger brownish scales are present
CC       on the buttocks, neck and legs. {ECO:0000269|PubMed:23754960}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC015723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027020; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC028703; AAH28703.1; -; mRNA.
DR   EMBL; BC034500; AAH34500.1; -; mRNA.
DR   EMBL; BC034970; AAH34970.1; -; mRNA.
DR   CCDS; CCDS10384.1; -.
DR   RefSeq; NP_001277270.1; NM_001290341.2.
DR   RefSeq; NP_001277271.1; NM_001290342.2.
DR   RefSeq; NP_001277272.1; NM_001290343.1.
DR   RefSeq; NP_849164.2; NM_178842.4.
DR   RefSeq; XP_016877492.1; XM_017022003.1.
DR   RefSeq; XP_016877493.1; XM_017022004.1.
DR   UniGene; Hs.662371; -.
DR   ProteinModelPortal; Q8IU89; -.
DR   SMR; Q8IU89; -.
DR   BioGrid; 128485; 1.
DR   STRING; 9606.ENSP00000284382; -.
DR   SwissLipids; SLP:000000259; -.
DR   iPTMnet; Q8IU89; -.
DR   PhosphoSitePlus; Q8IU89; -.
DR   BioMuta; CERS3; -.
DR   DMDM; 322510043; -.
DR   PaxDb; Q8IU89; -.
DR   PeptideAtlas; Q8IU89; -.
DR   PRIDE; Q8IU89; -.
DR   DNASU; 204219; -.
DR   Ensembl; ENST00000284382; ENSP00000284382; ENSG00000154227.
DR   Ensembl; ENST00000394113; ENSP00000377672; ENSG00000154227.
DR   Ensembl; ENST00000538112; ENSP00000437640; ENSG00000154227.
DR   GeneID; 204219; -.
DR   KEGG; hsa:204219; -.
DR   UCSC; uc002bvz.4; human.
DR   CTD; 204219; -.
DR   DisGeNET; 204219; -.
DR   EuPathDB; HostDB:ENSG00000154227.13; -.
DR   GeneCards; CERS3; -.
DR   HGNC; HGNC:23752; CERS3.
DR   HPA; HPA006092; -.
DR   HPA; HPA024356; -.
DR   MalaCards; CERS3; -.
DR   MIM; 615023; phenotype.
DR   MIM; 615276; gene.
DR   neXtProt; NX_Q8IU89; -.
DR   OpenTargets; ENSG00000154227; -.
DR   Orphanet; 79394; Congenital non-bullous ichthyosiform erythroderma.
DR   Orphanet; 363992; Ichthyosis-short stature-brachydactyly-microspherophakia syndrome.
DR   PharmGKB; PA134873153; -.
DR   eggNOG; KOG1607; Eukaryota.
DR   eggNOG; COG5058; LUCA.
DR   GeneTree; ENSGT00550000074401; -.
DR   HOVERGEN; HBG052310; -.
DR   InParanoid; Q8IU89; -.
DR   KO; K04710; -.
DR   OMA; FQEACWR; -.
DR   OrthoDB; EOG091G0BWM; -.
DR   PhylomeDB; Q8IU89; -.
DR   TreeFam; TF314319; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   GenomeRNAi; 204219; -.
DR   PRO; PR:Q8IU89; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000154227; -.
DR   CleanEx; HS_LASS3; -.
DR   ExpressionAtlas; Q8IU89; baseline and differential.
DR   Genevisible; Q8IU89; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Ichthyosis;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    383       Ceramide synthase 3.
FT                                /FTId=PRO_0000185511.
FT   TRANSMEM     32     52       Helical. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical. {ECO:0000255}.
FT   TRANSMEM    174    194       Helical. {ECO:0000255}.
FT   TRANSMEM    205    225       Helical. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TRANSMEM    298    318       Helical. {ECO:0000255}.
FT   DOMAIN      130    331       TLC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00205}.
FT   DNA_BIND     66    127       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    346    355       Poly-Glu.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q1A3B0}.
FT   VARIANT      45     45       Y -> C (in dbSNP:rs60405735).
FT                                /FTId=VAR_061847.
FT   VARIANT     342    342       D -> G (in dbSNP:rs1023783).
FT                                /FTId=VAR_057276.
FT   VARIANT     370    370       R -> G (in dbSNP:rs2439928).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_019328.
FT   CONFLICT    144    144       Missing (in Ref. 2; AAH34500).
FT                                {ECO:0000305}.
FT   CONFLICT    316    316       L -> R (in Ref. 2; AAH28703).
FT                                {ECO:0000305}.
SQ   SEQUENCE   383 AA;  46316 MW;  6711189C189C8469 CRC64;
     MFWTFKEWFW LERFWLPPTI KWSDLEDHDG LVFVKPSHLY VTIPYAFLLL IIRRVFEKFV
     ASPLAKSFGI KETVRKVTPN TVLENFFKHS TRQPLQTDIY GLAKKCNLTE RQVERWFRSR
     RNQERPSRLK KFQEACWRFA FYLMITVAGI AFLYDKPWLY DLWEVWNGYP KQPLLPSQYW
     YYILEMSFYW SLLFRLGFDV KRKDFLAHII HHLAAISLMS FSWCANYIRS GTLVMIVHDV
     ADIWLESAKM FSYAGWTQTC NTLFFIFSTI FFISRLIVFP FWILYCTLIL PMYHLEPFFS
     YIFLNLQLMI LQVLHLYWGY YILKMLNRCI FMKSIQDVRS DDEDYEEEEE EEEEEATKGK
     EMDCLKNGLR AERHLIPNGQ HGH
//
ID   CERS4_HUMAN             Reviewed;         394 AA.
AC   Q9HA82; D6W665;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   25-OCT-2017, entry version 144.
DE   RecName: Full=Ceramide synthase 4;
DE            Short=CerS4;
DE   AltName: Full=LAG1 longevity assurance homolog 4;
GN   Name=CERS4; Synonyms=LASS4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-353 AND
RP   GLN-379.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-366.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-353 AND
RP   GLN-379.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May be either a bona fide (dihydro)ceramide synthase or
CC       a modulator of its activity. When overexpressed in cells is
CC       involved in the production of sphingolipids containing different
CC       fatty acid donors (N-linked stearoyl- (C18) or arachidoyl- (C20)
CC       ceramides) in a fumonisin B1-independent manner (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}; Multi-pass membrane protein {ECO:0000305}.
CC       Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK022151; BAB13972.1; -; mRNA.
DR   EMBL; AC022146; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW68940.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68941.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68942.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68945.1; -; Genomic_DNA.
DR   EMBL; BC009828; AAH09828.1; -; mRNA.
DR   CCDS; CCDS12197.1; -.
DR   RefSeq; NP_078828.2; NM_024552.2.
DR   RefSeq; XP_011526592.1; XM_011528290.2.
DR   RefSeq; XP_011526593.1; XM_011528291.2.
DR   RefSeq; XP_011526594.1; XM_011528292.2.
DR   RefSeq; XP_011526595.1; XM_011528293.2.
DR   RefSeq; XP_011526596.1; XM_011528294.2.
DR   RefSeq; XP_011526597.1; XM_011528295.2.
DR   RefSeq; XP_016882792.1; XM_017027303.1.
DR   RefSeq; XP_016882793.1; XM_017027304.1.
DR   RefSeq; XP_016882794.1; XM_017027305.1.
DR   UniGene; Hs.515111; -.
DR   ProteinModelPortal; Q9HA82; -.
DR   SMR; Q9HA82; -.
DR   BioGrid; 122740; 2.
DR   IntAct; Q9HA82; 1.
DR   MINT; MINT-4650665; -.
DR   STRING; 9606.ENSP00000251363; -.
DR   SwissLipids; SLP:000000699; -.
DR   iPTMnet; Q9HA82; -.
DR   PhosphoSitePlus; Q9HA82; -.
DR   BioMuta; CERS4; -.
DR   DMDM; 296434561; -.
DR   EPD; Q9HA82; -.
DR   MaxQB; Q9HA82; -.
DR   PaxDb; Q9HA82; -.
DR   PeptideAtlas; Q9HA82; -.
DR   PRIDE; Q9HA82; -.
DR   DNASU; 79603; -.
DR   Ensembl; ENST00000251363; ENSP00000251363; ENSG00000090661.
DR   Ensembl; ENST00000559450; ENSP00000453509; ENSG00000090661.
DR   GeneID; 79603; -.
DR   KEGG; hsa:79603; -.
DR   UCSC; uc002mjg.4; human.
DR   CTD; 79603; -.
DR   DisGeNET; 79603; -.
DR   EuPathDB; HostDB:ENSG00000090661.11; -.
DR   GeneCards; CERS4; -.
DR   HGNC; HGNC:23747; CERS4.
DR   HPA; CAB033734; -.
DR   HPA; HPA054729; -.
DR   MIM; 615334; gene.
DR   neXtProt; NX_Q9HA82; -.
DR   OpenTargets; ENSG00000090661; -.
DR   PharmGKB; PA134915173; -.
DR   eggNOG; KOG1607; Eukaryota.
DR   eggNOG; COG5058; LUCA.
DR   GeneTree; ENSGT00550000074401; -.
DR   HOGENOM; HOG000231977; -.
DR   HOVERGEN; HBG052310; -.
DR   InParanoid; Q9HA82; -.
DR   KO; K04710; -.
DR   OMA; LYHESWL; -.
DR   OrthoDB; EOG091G0BWM; -.
DR   PhylomeDB; Q9HA82; -.
DR   TreeFam; TF314319; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   GenomeRNAi; 79603; -.
DR   PRO; PR:Q9HA82; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000090661; -.
DR   CleanEx; HS_LASS4; -.
DR   ExpressionAtlas; Q9HA82; baseline and differential.
DR   Genevisible; Q9HA82; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Endoplasmic reticulum; Homeobox;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    394       Ceramide synthase 4.
FT                                /FTId=PRO_0000185512.
FT   TRANSMEM     32     52       Helical. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TRANSMEM    260    280       Helical. {ECO:0000255}.
FT   TRANSMEM    304    324       Helical. {ECO:0000255}.
FT   DOMAIN      131    332       TLC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00205}.
FT   DNA_BIND     67    128       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     342    342       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D6J1}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D6J1}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D6J1}.
FT   VARIANT     119    119       R -> Q (in dbSNP:rs17159388).
FT                                /FTId=VAR_034065.
FT   VARIANT     301    301       G -> S (in dbSNP:rs2288413).
FT                                /FTId=VAR_019556.
FT   VARIANT     353    353       A -> V (in dbSNP:rs17160348).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_060263.
FT   VARIANT     366    366       A -> T (in dbSNP:rs36259).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_019557.
FT   VARIANT     379    379       R -> Q (in dbSNP:rs17160349).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_060264.
SQ   SEQUENCE   394 AA;  46399 MW;  DAA12AA386ED2802 CRC64;
     MLSSFNEWFW QDRFWLPPNV TWTELEDRDG RVYPHPQDLL AALPLALVLL AMRLAFERFI
     GLPLSRWLGV RDQTRRQVKP NATLEKHFLT EGHRPKEPQL SLLAAQCGLT LQQTQRWFRR
     RRNQDRPQLT KKFCEASWRF LFYLSSFVGG LSVLYHESWL WAPVMCWDRY PNQTLKPSLY
     WWYLLELGFY LSLLIRLPFD VKRKDFKEQV IHHFVAVILM TFSYSANLLR IGSLVLLLHD
     SSDYLLEACK MVNYMQYQQV CDALFLIFSF VFFYTRLVLF PTQILYTTYY ESISNRGPFF
     GYYFFNGLLM LLQLLHVFWS CLILRMLYSF MKKGQMEKDI RSDVEESDSS EEAAAAQEPL
     QLKNGAAGGP RPAPTDGPRS RVAGRLTNRH TTAT
//
ID   CERS2_HUMAN             Reviewed;         380 AA.
AC   Q96G23; D3DV06; Q5SZE5; Q9HD96; Q9NW79;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Ceramide synthase 2;
DE            Short=CerS2;
DE   AltName: Full=LAG1 longevity assurance homolog 2;
DE   AltName: Full=SP260;
DE   AltName: Full=Tumor metastasis-suppressor gene 1 protein;
GN   Name=CERS2; Synonyms=LASS2, TMSG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INTERACTION WITH
RP   ATP6V0C; ASGR1; ASGR2 AND SLC22A1/OCT1.
RC   TISSUE=Liver;
RX   PubMed=11543633; DOI=10.1006/geno.2001.6614;
RA   Pan H., Qin W.-X., Huo K.-K., Wan D.-F., Yu Y., Xu Z.-G., Hu Q.-D.,
RA   Gu K.T., Zhou X.-M., Jiang H.-Q., Zhang P.-P., Huang Y., Li Y.-Y.,
RA   Gu J.-R.;
RT   "Cloning, mapping, and characterization of a human homologue of the
RT   yeast longevity assurance gene LAG1.";
RL   Genomics 77:58-64(2001).
RN   [2]
RP   SEQUENCE REVISION.
RA   Qin W.-X., Gu J.-R., Wan D.-F., Zhou X.-M., Jiang H.-Q., Zhang P.-P.,
RA   Huang Y., Qiu X.-K., Qian L.F., He L.P., Li H.N., Yu Y., Yu J.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Xingfeng C., Yi G.;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 59-380.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 151-380.
RC   TISSUE=Prostatic carcinoma;
RA   Liu Y., Zheng J., Wu B., Fang W.;
RT   "Cancer metastasis-related gene.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-19.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-19.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   INTERACTION WITH ELOV1; HSD17B12 AND TECR.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Suppresses the growth of cancer cells. May be involved
CC       in sphingolipid synthesis.
CC   -!- SUBUNIT: Interacts with ATP6V0C, ASGR1, ASGR2 and SLC22A1/OCT1.
CC       Interacts with ELOV1, HSD17B12 and TECR.
CC       {ECO:0000269|PubMed:11543633, ECO:0000269|PubMed:20937905}.
CC   -!- INTERACTION:
CC       P07306:ASGR1; NbExp=3; IntAct=EBI-1057080, EBI-1172335;
CC       P07307:ASGR2; NbExp=3; IntAct=EBI-1057080, EBI-1172636;
CC       P27449:ATP6V0C; NbExp=3; IntAct=EBI-1057080, EBI-721179;
CC       P07900:HSP90AA1; NbExp=2; IntAct=EBI-1057080, EBI-296047;
CC       O15245:SLC22A1; NbExp=3; IntAct=EBI-1057080, EBI-1172714;
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}; Multi-pass membrane protein {ECO:0000305}.
CC       Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, liver, brain, heart,
CC       placenta and lung. {ECO:0000269|PubMed:11543633}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91505.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF177338; AAG17982.2; -; mRNA.
DR   EMBL; AY091458; AAM12028.1; -; mRNA.
DR   EMBL; AL590133; CAI13330.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53497.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53498.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53499.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53502.1; -; Genomic_DNA.
DR   EMBL; BC001357; AAH01357.2; -; mRNA.
DR   EMBL; BC010032; AAH10032.1; -; mRNA.
DR   EMBL; AK001105; BAA91505.1; ALT_INIT; mRNA.
DR   EMBL; AF189062; AAF01058.4; -; mRNA.
DR   CCDS; CCDS973.1; -.
DR   RefSeq; NP_071358.1; NM_022075.4.
DR   RefSeq; NP_859530.1; NM_181746.3.
DR   RefSeq; XP_011507754.1; XM_011509452.2.
DR   UniGene; Hs.744017; -.
DR   ProteinModelPortal; Q96G23; -.
DR   SMR; Q96G23; -.
DR   BioGrid; 118992; 45.
DR   IntAct; Q96G23; 26.
DR   STRING; 9606.ENSP00000271688; -.
DR   SwissLipids; SLP:000000256; -.
DR   iPTMnet; Q96G23; -.
DR   PhosphoSitePlus; Q96G23; -.
DR   SwissPalm; Q96G23; -.
DR   BioMuta; CERS2; -.
DR   DMDM; 51316514; -.
DR   EPD; Q96G23; -.
DR   MaxQB; Q96G23; -.
DR   PaxDb; Q96G23; -.
DR   PeptideAtlas; Q96G23; -.
DR   PRIDE; Q96G23; -.
DR   DNASU; 29956; -.
DR   Ensembl; ENST00000271688; ENSP00000271688; ENSG00000143418.
DR   Ensembl; ENST00000368954; ENSP00000357950; ENSG00000143418.
DR   GeneID; 29956; -.
DR   KEGG; hsa:29956; -.
DR   UCSC; uc001evy.3; human.
DR   CTD; 29956; -.
DR   DisGeNET; 29956; -.
DR   EuPathDB; HostDB:ENSG00000143418.19; -.
DR   GeneCards; CERS2; -.
DR   HGNC; HGNC:14076; CERS2.
DR   HPA; HPA027262; -.
DR   MIM; 606920; gene.
DR   neXtProt; NX_Q96G23; -.
DR   OpenTargets; ENSG00000143418; -.
DR   PharmGKB; PA30300; -.
DR   eggNOG; KOG1607; Eukaryota.
DR   eggNOG; COG5058; LUCA.
DR   GeneTree; ENSGT00550000074401; -.
DR   HOVERGEN; HBG052310; -.
DR   InParanoid; Q96G23; -.
DR   KO; K04710; -.
DR   OMA; GKQPKQA; -.
DR   OrthoDB; EOG091G0BWM; -.
DR   PhylomeDB; Q96G23; -.
DR   TreeFam; TF314319; -.
DR   BRENDA; 2.3.1.24; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; CERS2; human.
DR   GeneWiki; LASS2; -.
DR   GenomeRNAi; 29956; -.
DR   PRO; PR:Q96G23; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143418; -.
DR   CleanEx; HS_LASS2; -.
DR   ExpressionAtlas; Q96G23; baseline and differential.
DR   Genevisible; Q96G23; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISS:BHF-UCL.
DR   GO; GO:1900148; P:negative regulation of Schwann cell migration; ISS:BHF-UCL.
DR   GO; GO:1905045; P:negative regulation of Schwann cell proliferation involved in axon regeneration; ISS:BHF-UCL.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Endoplasmic reticulum; Glycoprotein;
KW   Homeobox; Lipid biosynthesis; Lipid metabolism; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    380       Ceramide synthase 2.
FT                                /FTId=PRO_0000185509.
FT   TOPO_DOM      1     40       Lumenal. {ECO:0000255}.
FT   TRANSMEM     41     61       Helical. {ECO:0000255}.
FT   TOPO_DOM     62    139       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical. {ECO:0000255}.
FT   TOPO_DOM    161    180       Lumenal. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    208       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TOPO_DOM    230    263       Lumenal. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    303       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    304    324       Helical. {ECO:0000255}.
FT   TOPO_DOM    325    380       Lumenal. {ECO:0000255}.
FT   DOMAIN      131    332       TLC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00205}.
FT   DNA_BIND     67    128       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     341    341       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     346    346       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     19     19       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:19159218}.
FT   VARIANT     115    115       E -> A (in dbSNP:rs267738).
FT                                /FTId=VAR_052325.
FT   CONFLICT    154    154       I -> T (in Ref. 8; AAF01058).
FT                                {ECO:0000305}.
FT   CONFLICT    345    345       E -> V (in Ref. 8; AAF01058).
FT                                {ECO:0000305}.
FT   CONFLICT    353    353       E -> K (in Ref. 8; AAF01058).
FT                                {ECO:0000305}.
SQ   SEQUENCE   380 AA;  44876 MW;  C8CEAF6AAD0B4577 CRC64;
     MLQTLYDYFW WERLWLPVNL TWADLEDRDG RVYAKASDLY ITLPLALLFL IVRYFFELYV
     ATPLAALLNI KEKTRLRAPP NATLEHFYLT SGKQPKQVEV ELLSRQSGLS GRQVERWFRR
     RRNQDRPSLL KKFREASWRF TFYLIAFIAG MAVIVDKPWF YDMKKVWEGY PIQSTIPSQY
     WYYMIELSFY WSLLFSIASD VKRKDFKEQI IHHVATIILI SFSWFANYIR AGTLIMALHD
     SSDYLLESAK MFNYAGWKNT CNNIFIVFAI VFIITRLVIL PFWILHCTLV YPLELYPAFF
     GYYFFNSMMG VLQLLHIFWA YLILRMAHKF ITGKLVEDER SDREETESSE GEEAAAGGGA
     KSRPLANGHP ILNNNHRKND
//
ID   CERS5_HUMAN             Reviewed;         392 AA.
AC   Q8N5B7; B4DV54;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   25-OCT-2017, entry version 141.
DE   RecName: Full=Ceramide synthase 5;
DE            Short=CerS5;
DE            EC=2.3.1.24;
DE   AltName: Full=LAG1 longevity assurance homolog 5;
GN   Name=CERS5; Synonyms=LASS5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Dihydroceramide synthase. Catalyzes the acylation of
CC       sphingosine to form dihydroceramide, with high selectivity toward
CC       palmitoyl-CoA as acyl donor compared to stearoyl-CoA. Inhibited by
CC       fumonisin B1 (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + sphingosine = CoA + N-
CC       acylsphingosine.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}; Multi-pass membrane protein {ECO:0000305}.
CC       Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N5B7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N5B7-2; Sequence=VSP_054572;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300937; BAG62566.1; -; mRNA.
DR   EMBL; AC074032; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139016; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58133.1; -; Genomic_DNA.
DR   EMBL; BC032565; AAH32565.1; -; mRNA.
DR   CCDS; CCDS61120.1; -. [Q8N5B7-2]
DR   CCDS; CCDS8801.1; -. [Q8N5B7-1]
DR   RefSeq; NP_001268660.1; NM_001281731.1. [Q8N5B7-2]
DR   RefSeq; NP_671723.1; NM_147190.3. [Q8N5B7-1]
DR   UniGene; Hs.270525; -.
DR   ProteinModelPortal; Q8N5B7; -.
DR   SMR; Q8N5B7; -.
DR   BioGrid; 124788; 12.
DR   STRING; 9606.ENSP00000325485; -.
DR   SwissLipids; SLP:000000261; -.
DR   iPTMnet; Q8N5B7; -.
DR   PhosphoSitePlus; Q8N5B7; -.
DR   SwissPalm; Q8N5B7; -.
DR   BioMuta; CERS5; -.
DR   DMDM; 51316484; -.
DR   EPD; Q8N5B7; -.
DR   MaxQB; Q8N5B7; -.
DR   PaxDb; Q8N5B7; -.
DR   PeptideAtlas; Q8N5B7; -.
DR   PRIDE; Q8N5B7; -.
DR   Ensembl; ENST00000317551; ENSP00000325485; ENSG00000139624. [Q8N5B7-1]
DR   Ensembl; ENST00000422340; ENSP00000389050; ENSG00000139624. [Q8N5B7-2]
DR   GeneID; 91012; -.
DR   KEGG; hsa:91012; -.
DR   UCSC; uc001rwd.6; human. [Q8N5B7-1]
DR   CTD; 91012; -.
DR   DisGeNET; 91012; -.
DR   EuPathDB; HostDB:ENSG00000139624.12; -.
DR   GeneCards; CERS5; -.
DR   HGNC; HGNC:23749; CERS5.
DR   HPA; HPA026589; -.
DR   MIM; 615335; gene.
DR   neXtProt; NX_Q8N5B7; -.
DR   OpenTargets; ENSG00000139624; -.
DR   PharmGKB; PA134882694; -.
DR   eggNOG; KOG1607; Eukaryota.
DR   eggNOG; COG5058; LUCA.
DR   GeneTree; ENSGT00550000074401; -.
DR   HOGENOM; HOG000231977; -.
DR   HOVERGEN; HBG052310; -.
DR   InParanoid; Q8N5B7; -.
DR   KO; K04710; -.
DR   OMA; SKQTDMS; -.
DR   OrthoDB; EOG091G0BWM; -.
DR   PhylomeDB; Q8N5B7; -.
DR   TreeFam; TF314319; -.
DR   BRENDA; 2.3.1.24; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00222; -.
DR   ChiTaRS; CERS5; human.
DR   GenomeRNAi; 91012; -.
DR   PRO; PR:Q8N5B7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139624; -.
DR   CleanEx; HS_LASS5; -.
DR   ExpressionAtlas; Q8N5B7; baseline and differential.
DR   Genevisible; Q8N5B7; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IDA:HGNC.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:HGNC.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding;
KW   Endoplasmic reticulum; Glycoprotein; Homeobox; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Nucleus; Polymorphism; Reference proteome;
KW   Sphingolipid metabolism; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    392       Ceramide synthase 5.
FT                                /FTId=PRO_0000185514.
FT   TOPO_DOM      1     46       Lumenal. {ECO:0000255}.
FT   TRANSMEM     47     67       Helical. {ECO:0000255}.
FT   TOPO_DOM     68    147       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical. {ECO:0000255}.
FT   TOPO_DOM    169    182       Lumenal. {ECO:0000255}.
FT   TRANSMEM    183    203       Helical. {ECO:0000255}.
FT   TOPO_DOM    204    213       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical. {ECO:0000255}.
FT   TOPO_DOM    235    271       Lumenal. {ECO:0000255}.
FT   TRANSMEM    272    292       Helical. {ECO:0000255}.
FT   TOPO_DOM    293    310       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    311    331       Helical. {ECO:0000255}.
FT   TOPO_DOM    332    392       Lumenal. {ECO:0000255}.
FT   DOMAIN      139    340       TLC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00205}.
FT   DNA_BIND     75    136       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     65       MATAAQGPLSLLWGWLWSERFWLPENVSWADLEGPADGYGY
FT                                PRGRHILSVFPLAAGIFFVRLLFE -> MMKPRPK (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054572.
FT   VARIANT      75     75       C -> R (in dbSNP:rs7302981).
FT                                /FTId=VAR_019558.
SQ   SEQUENCE   392 AA;  45752 MW;  E95658B20CE114B5 CRC64;
     MATAAQGPLS LLWGWLWSER FWLPENVSWA DLEGPADGYG YPRGRHILSV FPLAAGIFFV
     RLLFERFIAK PCALCIGIED SGPYQAQPNA ILEKVFISIT KYPDKKRLEG LSKQLDWNVR
     KIQCWFRHRR NQDKPPTLTK FCESMWRFTF YLCIFCYGIR FLWSSPWFWD IRQCWHNYPF
     QPLSSGLYHY YIMELAFYWS LMFSQFTDIK RKDFLIMFVH HLVTIGLISF SYINNMVRVG
     TLIMCLHDVS DFLLEAAKLA NYAKYQRLCD TLFVIFSAVF MVTRLGIYPF WILNTTLFES
     WEIIGPYASW WLLNGLLLTL QLLHVIWSYL IARIALKALI RGKVSKDDRS DVESSSEEED
     VTTCTKSPCD SSSSNGANRV NGHMGGSYWA EE
//
ID   CERS6_HUMAN             Reviewed;         384 AA.
AC   Q6ZMG9; Q32M63; Q8N617;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Ceramide synthase 6;
DE            Short=CerS6;
DE   AltName: Full=LAG1 longevity assurance homolog 6;
GN   Name=CERS6; Synonyms=LASS6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 191-384 (ISOFORM 1).
RC   TISSUE=Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-18.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- FUNCTION: May be involved in sphingolipid synthesis or its
CC       regulation. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}; Multi-pass membrane protein {ECO:0000305}.
CC       Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6ZMG9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZMG9-2; Sequence=VSP_045162;
CC   -!- PTM: Glycosylation on Asn-18 is not necessary for function.
CC       {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH30800.2; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK172775; BAD18757.1; -; mRNA.
DR   EMBL; AC009475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC019086; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC097453; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC109284; AAI09285.1; -; mRNA.
DR   EMBL; BC109285; AAI09286.1; -; mRNA.
DR   EMBL; BC030800; AAH30800.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS2228.1; -. [Q6ZMG9-1]
DR   CCDS; CCDS58734.1; -. [Q6ZMG9-2]
DR   RefSeq; NP_001243055.1; NM_001256126.1. [Q6ZMG9-2]
DR   RefSeq; NP_982288.1; NM_203463.2. [Q6ZMG9-1]
DR   UniGene; Hs.506829; -.
DR   UniGene; Hs.743222; -.
DR   ProteinModelPortal; Q6ZMG9; -.
DR   SMR; Q6ZMG9; -.
DR   BioGrid; 128987; 41.
DR   STRING; 9606.ENSP00000306579; -.
DR   SwissLipids; SLP:000000700; -.
DR   iPTMnet; Q6ZMG9; -.
DR   PhosphoSitePlus; Q6ZMG9; -.
DR   SwissPalm; Q6ZMG9; -.
DR   BioMuta; CERS6; -.
DR   DMDM; 51316251; -.
DR   EPD; Q6ZMG9; -.
DR   MaxQB; Q6ZMG9; -.
DR   PaxDb; Q6ZMG9; -.
DR   PeptideAtlas; Q6ZMG9; -.
DR   PRIDE; Q6ZMG9; -.
DR   Ensembl; ENST00000305747; ENSP00000306579; ENSG00000172292. [Q6ZMG9-1]
DR   Ensembl; ENST00000392687; ENSP00000376453; ENSG00000172292. [Q6ZMG9-2]
DR   GeneID; 253782; -.
DR   KEGG; hsa:253782; -.
DR   UCSC; uc002ueb.3; human. [Q6ZMG9-1]
DR   CTD; 253782; -.
DR   DisGeNET; 253782; -.
DR   EuPathDB; HostDB:ENSG00000172292.14; -.
DR   GeneCards; CERS6; -.
DR   HGNC; HGNC:23826; CERS6.
DR   HPA; HPA044683; -.
DR   HPA; HPA063527; -.
DR   MIM; 615336; gene.
DR   neXtProt; NX_Q6ZMG9; -.
DR   OpenTargets; ENSG00000172292; -.
DR   PharmGKB; PA134925480; -.
DR   eggNOG; KOG1607; Eukaryota.
DR   eggNOG; COG5058; LUCA.
DR   GeneTree; ENSGT00550000074401; -.
DR   HOGENOM; HOG000231977; -.
DR   HOVERGEN; HBG052310; -.
DR   InParanoid; Q6ZMG9; -.
DR   KO; K04710; -.
DR   OMA; CKAISKG; -.
DR   OrthoDB; EOG091G0BWM; -.
DR   PhylomeDB; Q6ZMG9; -.
DR   TreeFam; TF314319; -.
DR   BRENDA; 2.3.1.24; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; CERS6; human.
DR   GenomeRNAi; 253782; -.
DR   PRO; PR:Q6ZMG9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000172292; -.
DR   CleanEx; HS_LASS6; -.
DR   Genevisible; Q6ZMG9; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding;
KW   Endoplasmic reticulum; Glycoprotein; Homeobox; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Nucleus; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    384       Ceramide synthase 6.
FT                                /FTId=PRO_0000185516.
FT   TOPO_DOM      1     34       Lumenal. {ECO:0000255}.
FT   TRANSMEM     35     55       Helical. {ECO:0000255}.
FT   TOPO_DOM     56    177       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical. {ECO:0000255}.
FT   TOPO_DOM    199    204       Lumenal. {ECO:0000255}.
FT   TRANSMEM    205    225       Helical. {ECO:0000255}.
FT   TOPO_DOM    226    262       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    302       Lumenal. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    384       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      130    331       TLC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00205}.
FT   DNA_BIND     66    127       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CARBOHYD     18     18       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ     334    334       K -> KAGKWNPLH (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045162.
SQ   SEQUENCE   384 AA;  44890 MW;  B3C400D6317D9E5E CRC64;
     MAGILAWFWN ERFWLPHNVT WADLKNTEEA TFPQAEDLYL AFPLAFCIFM VRLIFERFVA
     KPCAIALNIQ ANGPQIAPPN AILEKVFTAI TKHPDEKRLE GLSKQLDWDV RSIQRWFRQR
     RNQEKPSTLT RFCESMWRFS FYLYVFTYGV RFLKKTPWLW NTRHCWYNYP YQPLTTDLHY
     YYILELSFYW SLMFSQFTDI KRKDFGIMFL HHLVSIFLIT FSYVNNMARV GTLVLCLHDS
     ADALLEAAKM ANYAKFQKMC DLLFVMFAVV FITTRLGIFP LWVLNTTLFE SWEIVGPYPS
     WWVFNLLLLL VQGLNCFWSY LIVKIACKAV SRGKVSKDDR SDIESSSDEE DSEPPGKNPH
     TATTTNGTSG TNGYLLTGSC SMDD
//
ID   CDX1_HUMAN              Reviewed;         265 AA.
AC   P47902; Q4VAU4; Q9NYK8;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   27-SEP-2017, entry version 159.
DE   RecName: Full=Homeobox protein CDX-1;
DE   AltName: Full=Caudal-type homeobox protein 1;
GN   Name=CDX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Small intestine;
RX   PubMed=8530027; DOI=10.1006/geno.1995.1132;
RA   Bonner C.A., Lofus S.K., Wasmuth J.J.;
RT   "Isolation, characterization, and precise physical localization of
RT   human CDX1, a caudal-type homeobox gene.";
RL   Genomics 28:206-211(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9036867;
RX   DOI=10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1;
RA   Mallo G.V., Rechreche H., Frigerio J.-M., Rocha D., Zweibaum A.,
RA   Lacasa M., Jordan B.R., Dusetti N.J., Dagorn J.-C., Iovanna J.L.;
RT   "Molecular cloning, sequencing and expression of the mRNA encoding
RT   human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA
RT   expression during colorectal carcinogenesis.";
RL   Int. J. Cancer 74:35-44(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Malakooti J.;
RT   "Molecular cloning and sequencing of the human CDX1 homeobox gene.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=24623306; DOI=10.7554/eLife.02313;
RA   Serra R.W., Fang M., Park S.M., Hutchinson L., Green M.R.;
RT   "A KRAS-directed transcriptional silencing pathway that mediates the
RT   CpG island methylator phenotype.";
RL   Elife 3:E02313-E02313(2014).
CC   -!- FUNCTION: Plays a role in transcriptional regulation
CC       (PubMed:24623306). Involved in activated KRAS-mediated
CC       transcriptional activation of PRKD1 in colorectal cancer (CRC)
CC       cells (PubMed:24623306). Binds to the PRKD1 promoter in colorectal
CC       cancer (CRC) cells (PubMed:24623306). Could play a role in the
CC       terminal differentiation of the intestine.
CC       {ECO:0000269|PubMed:24623306}.
CC   -!- INTERACTION:
CC       P49715:CEBPA; NbExp=3; IntAct=EBI-8514176, EBI-1172054;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P47902-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P47902-2; Sequence=VSP_021030;
CC   -!- TISSUE SPECIFICITY: Intestinal epithelium.
CC   -!- SIMILARITY: Belongs to the Caudal homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U16360; AAA80284.1; -; Genomic_DNA.
DR   EMBL; U15212; AAC50237.1; -; mRNA.
DR   EMBL; U51095; AAB40602.1; -; mRNA.
DR   EMBL; AF239666; AAF61234.1; -; mRNA.
DR   EMBL; BC096251; AAH96251.1; -; mRNA.
DR   CCDS; CCDS4304.1; -. [P47902-1]
DR   PIR; I38868; I38868.
DR   PIR; I38881; I38881.
DR   RefSeq; NP_001795.2; NM_001804.2. [P47902-1]
DR   UniGene; Hs.1545; -.
DR   PDB; 5LUX; X-ray; 3.23 A; K/L=153-215.
DR   PDBsum; 5LUX; -.
DR   ProteinModelPortal; P47902; -.
DR   SMR; P47902; -.
DR   BioGrid; 107474; 77.
DR   ELM; P47902; -.
DR   IntAct; P47902; 1.
DR   MINT; MINT-6800278; -.
DR   STRING; 9606.ENSP00000231656; -.
DR   iPTMnet; P47902; -.
DR   PhosphoSitePlus; P47902; -.
DR   BioMuta; CDX1; -.
DR   DMDM; 116241291; -.
DR   MaxQB; P47902; -.
DR   PaxDb; P47902; -.
DR   PeptideAtlas; P47902; -.
DR   PRIDE; P47902; -.
DR   Ensembl; ENST00000231656; ENSP00000231656; ENSG00000113722. [P47902-1]
DR   GeneID; 1044; -.
DR   KEGG; hsa:1044; -.
DR   UCSC; uc003lrq.4; human. [P47902-1]
DR   CTD; 1044; -.
DR   DisGeNET; 1044; -.
DR   EuPathDB; HostDB:ENSG00000113722.16; -.
DR   GeneCards; CDX1; -.
DR   HGNC; HGNC:1805; CDX1.
DR   HPA; HPA055196; -.
DR   MIM; 600746; gene.
DR   neXtProt; NX_P47902; -.
DR   OpenTargets; ENSG00000113722; -.
DR   PharmGKB; PA26351; -.
DR   eggNOG; KOG0848; Eukaryota.
DR   eggNOG; ENOG4111W2J; LUCA.
DR   GeneTree; ENSGT00530000063388; -.
DR   HOGENOM; HOG000115975; -.
DR   HOVERGEN; HBG005302; -.
DR   InParanoid; P47902; -.
DR   KO; K09312; -.
DR   OMA; EDWHSYG; -.
DR   OrthoDB; EOG091G0LXJ; -.
DR   PhylomeDB; P47902; -.
DR   TreeFam; TF351605; -.
DR   SignaLink; P47902; -.
DR   SIGNOR; P47902; -.
DR   GeneWiki; CDX1; -.
DR   GenomeRNAi; 1044; -.
DR   PRO; PR:P47902; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113722; -.
DR   CleanEx; HS_CDX1; -.
DR   ExpressionAtlas; P47902; baseline and differential.
DR   Genevisible; P47902; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; IBA:GO_Central.
DR   GO; GO:0060349; P:bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0014807; P:regulation of somitogenesis; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR006820; Caudal_activation_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF04731; Caudal_act; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    265       Homeobox protein CDX-1.
FT                                /FTId=PRO_0000048846.
FT   DNA_BIND    154    213       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    143    149       Poly-Gly.
FT   COMPBIAS    217    221       Poly-Gln.
FT   VAR_SEQ       1    135       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_021030.
FT   VARIANT     130    130       P -> R (in dbSNP:rs2302275).
FT                                /FTId=VAR_020149.
FT   CONFLICT     28     29       QA -> AN (in Ref. 1; AAA80284/AAC50237
FT                                and 2; AAB40602). {ECO:0000305}.
FT   HELIX       163    175       {ECO:0000244|PDB:5LUX}.
FT   HELIX       181    191       {ECO:0000244|PDB:5LUX}.
FT   HELIX       195    214       {ECO:0000244|PDB:5LUX}.
SQ   SEQUENCE   265 AA;  28138 MW;  484CB284E3357BC6 CRC64;
     MYVGYVLDKD SPVYPGPARP ASLGLGPQAY GPPAPPPAPP QYPDFSSYSH VEPAPAPPTA
     WGAPFPAPKD DWAAAYGPGP AAPAASPASL AFGPPPDFSP VPAPPGPGPG LLAQPLGGPG
     TPSSPGAQRP TPYEWMRRSV AAGGGGGSGK TRTKDKYRVV YTDHQRLELE KEFHYSRYIT
     IRRKSELAAN LGLTERQVKI WFQNRRAKER KVNKKKQQQQ QPPQPPMAHD ITATPAGPSL
     GGLCPSNTSL LATSSPMPVK EEFLP
//
ID   CDX4_HUMAN              Reviewed;         284 AA.
AC   O14627; A1A513; Q5JS20;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   27-SEP-2017, entry version 134.
DE   RecName: Full=Homeobox protein CDX-4;
DE   AltName: Full=Caudal-type homeobox protein 4;
GN   Name=CDX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Chen E.Y., States D.J., Mazzarella R.;
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Chiaroni P., Colleaux L., Briault S., Lossi A.M., Moraine C.,
RA   Fontes M.;
RT   "Genomic structure of the human CDX4 gene: a potential candidate for
RT   the FG syndrome.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       P61024:CKS1B; NbExp=3; IntAct=EBI-10181162, EBI-456371;
CC       P25800:LMO1; NbExp=3; IntAct=EBI-10181162, EBI-8639312;
CC       P25791:LMO2; NbExp=3; IntAct=EBI-10181162, EBI-739696;
CC       Q13131:PRKAA1; NbExp=3; IntAct=EBI-10181162, EBI-1181405;
CC       O43741:PRKAB2; NbExp=3; IntAct=EBI-10181162, EBI-1053424;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the Caudal homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF003530; AAB66319.1; -; Genomic_DNA.
DR   EMBL; AF029879; AAD01894.1; -; Genomic_DNA.
DR   EMBL; AF029877; AAD01894.1; JOINED; Genomic_DNA.
DR   EMBL; AF029878; AAD01894.1; JOINED; Genomic_DNA.
DR   EMBL; AL450108; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471104; EAW98667.1; -; Genomic_DNA.
DR   EMBL; BC128233; AAI28234.1; -; mRNA.
DR   CCDS; CCDS14424.1; -.
DR   RefSeq; NP_005184.1; NM_005193.1.
DR   UniGene; Hs.553488; -.
DR   ProteinModelPortal; O14627; -.
DR   SMR; O14627; -.
DR   BioGrid; 107476; 6.
DR   IntAct; O14627; 6.
DR   STRING; 9606.ENSP00000362613; -.
DR   PhosphoSitePlus; O14627; -.
DR   BioMuta; CDX4; -.
DR   EPD; O14627; -.
DR   MaxQB; O14627; -.
DR   PaxDb; O14627; -.
DR   PeptideAtlas; O14627; -.
DR   PRIDE; O14627; -.
DR   Ensembl; ENST00000373514; ENSP00000362613; ENSG00000131264.
DR   GeneID; 1046; -.
DR   KEGG; hsa:1046; -.
DR   UCSC; uc011mqk.3; human.
DR   CTD; 1046; -.
DR   DisGeNET; 1046; -.
DR   EuPathDB; HostDB:ENSG00000131264.3; -.
DR   GeneCards; CDX4; -.
DR   HGNC; HGNC:1808; CDX4.
DR   HPA; HPA056528; -.
DR   MIM; 300025; gene.
DR   neXtProt; NX_O14627; -.
DR   OpenTargets; ENSG00000131264; -.
DR   PharmGKB; PA26353; -.
DR   eggNOG; KOG0848; Eukaryota.
DR   eggNOG; ENOG4111W2J; LUCA.
DR   GeneTree; ENSGT00530000063388; -.
DR   HOGENOM; HOG000115975; -.
DR   HOVERGEN; HBG005302; -.
DR   InParanoid; O14627; -.
DR   KO; K09312; -.
DR   OMA; HCNRYIT; -.
DR   OrthoDB; EOG091G0LXJ; -.
DR   PhylomeDB; O14627; -.
DR   TreeFam; TF351605; -.
DR   GenomeRNAi; 1046; -.
DR   PRO; PR:O14627; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000131264; -.
DR   CleanEx; HS_CDX4; -.
DR   Genevisible; O14627; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR   GO; GO:0009948; P:anterior/posterior axis specification; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0060711; P:labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR006820; Caudal_activation_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF04731; Caudal_act; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    284       Homeobox protein CDX-4.
FT                                /FTId=PRO_0000048852.
FT   DNA_BIND    173    232       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   284 AA;  30480 MW;  96D365D9F5F6D6D7 CRC64;
     MYGSCLLEKE AGMYPGTLMS PGGDGTAGTG GTGGGGSPMP ASNFAAAPAF SHYMGYPHMP
     SMDPHWPSLG VWGSPYSPPR EDWSVYPGPS STMGTVPVND VTSSPAAFCS TDYSNLGPVG
     GGTSGSSLPG QAGGSLVPTD AGAAKASSPS RSRHSPYAWM RKTVQVTGKT RTKEKYRVVY
     TDHQRLELEK EFHCNRYITI QRKSELAVNL GLSERQVKIW FQNRRAKERK MIKKKISQFE
     NSGGSVQSDS DSISPGELPN TFFTTPSAVR GFQPIEIQQV IVSE
//
ID   DBX1_HUMAN              Reviewed;         343 AA.
AC   A6NMT0;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   27-SEP-2017, entry version 78.
DE   RecName: Full=Homeobox protein DBX1;
DE   AltName: Full=Developing brain homeobox protein 1;
GN   Name=DBX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
CC   -!- FUNCTION: Could have a role in patterning the central nervous
CC       system during embryogenesis. Has a key role in regulating the
CC       distinct phenotypic features that distinguish two major classes of
CC       ventral interneurons, V0 and V1 neurons. Regulates the
CC       transcription factor profile, neurotransmitter phenotype,
CC       intraspinal migratory path and axonal trajectory of V0 neurons,
CC       features that differentiate them from an adjacent set of V1
CC       neurons (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the H2.0 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC068860; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001025036.2; NM_001029865.2.
DR   UniGene; Hs.558604; -.
DR   ProteinModelPortal; A6NMT0; -.
DR   SMR; A6NMT0; -.
DR   iPTMnet; A6NMT0; -.
DR   PhosphoSitePlus; A6NMT0; -.
DR   BioMuta; DBX1; -.
DR   PRIDE; A6NMT0; -.
DR   DNASU; 120237; -.
DR   Ensembl; ENST00000524983; ENSP00000436881; ENSG00000109851.
DR   GeneID; 120237; -.
DR   KEGG; hsa:120237; -.
DR   UCSC; uc021qey.2; human.
DR   CTD; 120237; -.
DR   DisGeNET; 120237; -.
DR   EuPathDB; HostDB:ENSG00000109851.6; -.
DR   GeneCards; DBX1; -.
DR   HGNC; HGNC:33185; DBX1.
DR   HPA; HPA039802; -.
DR   neXtProt; NX_A6NMT0; -.
DR   OpenTargets; ENSG00000109851; -.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOVERGEN; HBG005454; -.
DR   InParanoid; A6NMT0; -.
DR   OMA; MMFPSLI; -.
DR   OrthoDB; EOG091G0MGV; -.
DR   PhylomeDB; A6NMT0; -.
DR   GeneWiki; DBX1; -.
DR   GenomeRNAi; 120237; -.
DR   PRO; PR:A6NMT0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000109851; -.
DR   CleanEx; HS_DBX1; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0021521; P:ventral spinal cord interneuron specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    343       Homeobox protein DBX1.
FT                                /FTId=PRO_0000302843.
FT   DNA_BIND    181    240       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    276    280       Poly-Glu.
FT   COMPBIAS    329    339       Poly-Glu.
SQ   SEQUENCE   343 AA;  37283 MW;  E5C4EB73331E7B69 CRC64;
     MMFPGLLAPP AGYPSLLRPT PTLTLPQSLQ SAFSGHSSFL VEDLIRISRP PAYLPRSVPT
     ASMSPPRQGA PTALTDTGAS DLGSPGPGSR RGGSPPTAFS PASETTFLKF GVNAILSSGP
     RTETSPALLQ SVPPKTFAFP YFEGSFQPFI RSSYFPASSS VVPIPGTFSW PLAARGKPRR
     GMLRRAVFSD VQRKALEKMF QKQKYISKPD RKKLAAKLGL KDSQVKIWFQ NRRMKWRNSK
     ERELLSSGGC REQTLPTKLN PHPDLSDVGQ KGPGNEEEEE GPGSPSHRLA YHASSDPQHL
     RDPRLPGPLP PSPAHSSSPG KPSDFSDSEE EEEGEEQEEI TVS
//
ID   CUX1_HUMAN              Reviewed;        1505 AA.
AC   P39880; B3KV79; J3KQV9; Q6NYH4; Q75LE5; Q75MT2; Q75MT3; Q86UJ7;
AC   Q9UEV5;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   25-OCT-2017, entry version 170.
DE   RecName: Full=Homeobox protein cut-like 1;
DE   AltName: Full=CCAAT displacement protein;
DE            Short=CDP;
DE   AltName: Full=Homeobox protein cux-1;
GN   Name=CUX1; Synonyms=CUTL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Umbilical vein;
RX   PubMed=1301999; DOI=10.1038/ng0492-50;
RA   Neufeld E.J., Skalnik D.G., Lievens P.M.-J., Orkin S.H.;
RT   "Human CCAAT displacement protein is homologous to the Drosophila
RT   homeoprotein, cut.";
RL   Nat. Genet. 1:50-55(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 11).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 48-224 (ISOFORMS 1/2/3).
RX   PubMed=9799793;
RA   Gloeckner G., Scherer S., Schattevoy R., Boright A.P., Weber J.,
RA   Tsui L.-C., Rosenthal A.;
RT   "Large-scale sequencing of two regions in human chromosome 7q22:
RT   analysis of 650 kb of genomic sequence around the EPO and CUTL1 loci
RT   reveals 17 genes.";
RL   Genome Res. 8:1060-1073(1998).
RN   [6]
RP   ALTERNATIVE SPLICING (ISOFORMS 5; 6 AND 7).
RX   PubMed=10607901; DOI=10.1016/S0378-1119(99)00465-5;
RA   Rong Zeng W., Soucie E., Sung Moon N., Martin-Soudant N., Berube G.,
RA   Leduy L., Nepveu A.;
RT   "Exon/intron structure and alternative transcripts of the CUTL1
RT   gene.";
RL   Gene 241:75-85(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1059; SER-1270; SER-1455
RP   AND SER-1486, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540
RP   (ISOFORM 11), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-811, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-785, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-785; LYS-811; LYS-842 AND
RP   LYS-1284, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Probably has a broad role in mammalian development as a
CC       repressor of developmentally regulated gene expression. May act by
CC       preventing binding of positively-activing CCAAT factors to
CC       promoters. Component of nf-munr repressor; binds to the matrix
CC       attachment regions (MARs) (5' and 3') of the immunoglobulin heavy
CC       chain enhancer. Represses T-cell receptor (TCR) beta enhancer
CC       function by binding to MARbeta, an ATC-rich DNA sequence located
CC       upstream of the TCR beta enhancer. Binds to the TH enhancer; may
CC       require the basic helix-loop-helix protein TCF4 as a coactivator
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with BANP. Interacts with SATB1 (via DNA-
CC       binding domains); the interaction inhibits the attachment of both
CC       proteins to DNA (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P39880-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P39880-2; Sequence=VSP_002310;
CC       Name=3;
CC         IsoId=P39880-3; Sequence=VSP_015747;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P39880-4; Sequence=VSP_017358;
CC       Name=6;
CC         IsoId=P39880-5; Sequence=VSP_017359;
CC       Name=7;
CC         IsoId=P39880-6; Sequence=VSP_017358, VSP_017359;
CC       Name=11;
CC         IsoId=P39880-9; Sequence=VSP_015747, VSP_045924, VSP_045925,
CC                                  VSP_045926;
CC         Note=No experimental confirmation available. Contains a
CC         phosphoserine at position 540. {ECO:0000244|PubMed:23186163};
CC       Name=4; Synonyms=CASP;
CC         IsoId=Q13948-1; Sequence=External;
CC       Name=8;
CC         IsoId=Q13948-2; Sequence=External;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=Q13948-9; Sequence=External;
CC         Note=No experimental confirmation available.;
CC       Name=10;
CC         IsoId=Q13948-10; Sequence=External;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: Asn-1290 may participate in regulating DNA-binding
CC       activity by promoting homo- and heterodimerization.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M74099; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK122726; BAG53691.1; -; mRNA.
DR   EMBL; AC005072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005086; AAP22331.1; -; Genomic_DNA.
DR   EMBL; AC005088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005096; AAS07410.1; -; Genomic_DNA.
DR   EMBL; AC005103; AAS07388.1; -; Genomic_DNA.
DR   EMBL; AC092788; AAS07523.1; -; Genomic_DNA.
DR   EMBL; BC066592; AAH66592.1; -; mRNA.
DR   EMBL; AF047825; AAC78778.1; -; Genomic_DNA.
DR   CCDS; CCDS56498.1; -. [P39880-3]
DR   CCDS; CCDS56499.1; -. [P39880-9]
DR   CCDS; CCDS5721.1; -. [P39880-1]
DR   RefSeq; NP_001189472.1; NM_001202543.1. [P39880-3]
DR   RefSeq; NP_001189473.1; NM_001202544.2.
DR   RefSeq; NP_001189474.1; NM_001202545.2. [P39880-9]
DR   RefSeq; NP_852477.1; NM_181500.3.
DR   RefSeq; NP_853530.2; NM_181552.3. [P39880-1]
DR   UniGene; Hs.191482; -.
DR   ProteinModelPortal; P39880; -.
DR   SMR; P39880; -.
DR   BioGrid; 107903; 56.
DR   ELM; P39880; -.
DR   IntAct; P39880; 26.
DR   MINT; MINT-271237; -.
DR   STRING; 9606.ENSP00000353401; -.
DR   iPTMnet; P39880; -.
DR   PhosphoSitePlus; P39880; -.
DR   BioMuta; UGT3A1; -.
DR   EPD; P39880; -.
DR   PaxDb; P39880; -.
DR   PeptideAtlas; P39880; -.
DR   PRIDE; P39880; -.
DR   DNASU; 1523; -.
DR   Ensembl; ENST00000292535; ENSP00000292535; ENSG00000257923. [P39880-1]
DR   Ensembl; ENST00000360264; ENSP00000353401; ENSG00000257923. [P39880-3]
DR   Ensembl; ENST00000425244; ENSP00000409745; ENSG00000257923. [P39880-9]
DR   Ensembl; ENST00000546411; ENSP00000450125; ENSG00000257923. [P39880-4]
DR   Ensembl; ENST00000549414; ENSP00000446630; ENSG00000257923. [P39880-2]
DR   Ensembl; ENST00000550008; ENSP00000447373; ENSG00000257923. [P39880-5]
DR   Ensembl; ENST00000556210; ENSP00000451558; ENSG00000257923. [P39880-6]
DR   GeneID; 1523; -.
DR   UCSC; uc003uys.5; human. [P39880-1]
DR   CTD; 1523; -.
DR   DisGeNET; 1523; -.
DR   EuPathDB; HostDB:ENSG00000257923.9; -.
DR   GeneCards; CUX1; -.
DR   HGNC; HGNC:2557; CUX1.
DR   HPA; HPA003277; -.
DR   HPA; HPA003317; -.
DR   MIM; 116896; gene.
DR   neXtProt; NX_P39880; -.
DR   OpenTargets; ENSG00000257923; -.
DR   PharmGKB; PA162382924; -.
DR   eggNOG; KOG0963; Eukaryota.
DR   eggNOG; KOG2252; Eukaryota.
DR   eggNOG; ENOG410XPKP; LUCA.
DR   GeneTree; ENSGT00530000063019; -.
DR   HOVERGEN; HBG051268; -.
DR   InParanoid; P39880; -.
DR   OMA; VANWRRT; -.
DR   OrthoDB; EOG091G011E; -.
DR   PhylomeDB; P39880; -.
DR   TreeFam; TF318206; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   SIGNOR; P39880; -.
DR   ChiTaRS; CUX1; human.
DR   GeneWiki; CUTL1; -.
DR   GenomeRNAi; 1523; -.
DR   PMAP-CutDB; P39880; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000257923; -.
DR   CleanEx; HS_CUX1; -.
DR   ExpressionAtlas; P39880; baseline and differential.
DR   Genevisible; P39880; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030674; F:protein binding, bridging; IEA:Ensembl.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0048193; P:Golgi vesicle transport; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0000301; P:retrograde transport, vesicle recycling within Golgi; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   Pfam; PF02376; CUT; 3.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM01109; CUT; 3.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 3.
DR   PROSITE; PS51042; CUT; 3.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1   1505       Homeobox protein cut-like 1.
FT                                /FTId=PRO_0000202393.
FT   DNA_BIND    542    629       CUT 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    934   1021       CUT 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND   1117   1204       CUT 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND   1244   1303       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COILED       56    407       {ECO:0000255}.
FT   COMPBIAS   1406   1438       Ala-rich.
FT   MOD_RES     763    763       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     909    909       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P53565}.
FT   MOD_RES    1059   1059       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1069   1069       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P53565}.
FT   MOD_RES    1270   1270       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1337   1337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P53564}.
FT   MOD_RES    1455   1455       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1486   1486       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1496   1496       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P53564}.
FT   CROSSLNK    785    785       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    811    811       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    842    842       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1284   1284       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     10       MLCVAGARLK -> MAANVGSMFQYWKRFDLQQLQ (in
FT                                isoform 3 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015747.
FT   VAR_SEQ      90    135       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045924.
FT   VAR_SEQ     408    509       Missing (in isoform 5 and isoform 7).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_017358.
FT   VAR_SEQ     409    667       SARRKGKDQPESRRPGSLPAPPPSQLPRNPGEQASNTNGTH
FT                                QFSPAGLSQDFFSSSLASPSLPLASTGKFALNSLLQRQLMQ
FT                                SFYSKAMQEAGSTSMIFSTGPYSTNSISSQSPLQQSPDVNG
FT                                MAPSPSQSESAGSVSEGEEMDTAEIARQVKEQLIKHNIGQR
FT                                IFGHYVLGLSQGSVSEILARPKPWNKLTVRGKEPFHKMKQF
FT                                LSDEQNILALRSIQGRQRENPGQSLNRLFQEVPKRRNGSEG
FT                                NITTRIRASETGS -> RCAELQVRITEAVATATEQRELIA
FT                                RLEQDLSIIQSIQRPDAEGAAEHRLEKIPEPIKEATALFYG
FT                                PAAPASGALPEGQVDSLLSIISSQRERFRARNQELEAENRL
FT                                AQHTLQALQSELDSLRADNIKLFEKIKFLQSYPGRGSGSDD
FT                                TELRYSSQYEERLDPFSSFSKRERQRKYLSLSPWDKATLSM
FT                                GRLVLSNKMARTIGFFYTLFLHCLVFLVLYKLAWSESMERD
FT                                CATFCAKKFADHLHKFHENDNGAAAGDLWQ (in
FT                                isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045925.
FT   VAR_SEQ     632    687       Missing (in isoform 6 and isoform 7).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_017359.
FT   VAR_SEQ     632    653       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1301999}.
FT                                /FTId=VSP_002310.
FT   VAR_SEQ     668   1505       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045926.
FT   CONFLICT      5      5       A -> R (in Ref. 1; M74099).
FT                                {ECO:0000305}.
FT   CONFLICT    145    145       K -> I (in Ref. 2; BAG53691).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       A -> V (in Ref. 2; BAG53691).
FT                                {ECO:0000305}.
FT   CONFLICT    704    705       DA -> EP (in Ref. 1; M74099).
FT                                {ECO:0000305}.
FT   CONFLICT    844    844       E -> R (in Ref. 1; M74099).
FT                                {ECO:0000305}.
FT   CONFLICT   1436   1436       S -> T (in Ref. 1; M74099).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1505 AA;  164187 MW;  0F9027E5B8F08D95 CRC64;
     MLCVAGARLK RELDATATVL ANRQDESEQS RKRLIEQSRE FKKNTPEDLR KQVAPLLKSF
     QGEIDALSKR SKEAEAAFLN VYKRLIDVPD PVPALDLGQQ LQLKVQRLHD IETENQKLRE
     TLEEYNKEFA EVKNQEVTIK ALKEKIREYE QTLKNQAETI ALEKEQKLQN DFAEKERKLQ
     ETQMSTTSKL EEAEHKVQSL QTALEKTRTE LFDLKTKYDE ETTAKADEIE MIMTDLERAN
     QRAEVAQREA ETLREQLSSA NHSLQLASQI QKAPDVEQAI EVLTRSSLEV ELAAKEREIA
     QLVEDVQRLQ ASLTKLRENS ASQISQLEQQ LSAKNSTLKQ LEEKLKGQAD YEEVKKELNI
     LKSMEFAPSE GAGTQDAAKP LEVLLLEKNR SLQSENAALR ISNSDLSGSA RRKGKDQPES
     RRPGSLPAPP PSQLPRNPGE QASNTNGTHQ FSPAGLSQDF FSSSLASPSL PLASTGKFAL
     NSLLQRQLMQ SFYSKAMQEA GSTSMIFSTG PYSTNSISSQ SPLQQSPDVN GMAPSPSQSE
     SAGSVSEGEE MDTAEIARQV KEQLIKHNIG QRIFGHYVLG LSQGSVSEIL ARPKPWNKLT
     VRGKEPFHKM KQFLSDEQNI LALRSIQGRQ RENPGQSLNR LFQEVPKRRN GSEGNITTRI
     RASETGSDEA IKSILEQAKR ELQVQKTAEP AQPSSASGSG NSDDAIRSIL QQARREMEAQ
     QAALDPALKQ APLSQSDITI LTPKLLSTSP MPTVSSYPPL AISLKKPSAA PEAGASALPN
     PPALKKEAQD APGLDPQGAA DCAQGVLRQV KNEVGRSGAW KDHWWSAVQP ERRNAASSEE
     AKAEETGGGK EKGSGGSGGG SQPRAERSQL QGPSSSEYWK EWPSAESPYS QSSELSLTGA
     SRSETPQNSP LPSSPIVPMS KPTKPSVPPL TPEQYEVYMY QEVDTIELTR QVKEKLAKNG
     ICQRIFGEKV LGLSQGSVSD MLSRPKPWSK LTQKGREPFI RMQLWLNGEL GQGVLPVQGQ
     QQGPVLHSVT SLQDPLQQGC VSSESTPKTS ASCSPAPESP MSSSESVKSL TELVQQPCPP
     IEASKDSKPP EPSDPPASDS QPTTPLPLSG HSALSIQELV AMSPELDTYG ITKRVKEVLT
     DNNLGQRLFG ETILGLTQGS VSDLLARPKP WHKLSLKGRE PFVRMQLWLN DPNNVEKLMD
     MKRMEKKAYM KRRHSSVSDS QPCEPPSVGT EYSQGASPQP QHQLKKPRVV LAPEEKEALK
     RAYQQKPYPS PKTIEDLATQ LNLKTSTVIN WFHNYRSRIR RELFIEEIQA GSQGQAGASD
     SPSARSGRAA PSSEGDSCDG VEATEGPGSA DTEEPKSQGE AEREEVPRPA EQTEPPPSGT
     PGPDDARDDD HEGGPVEGPG PLPSPASATA TAAPAAPEDA ATSAAAAPGE GPAAPSSAPP
     PSNSSSSSAP RRPSSLQSLF GLPEAAGARD SRDNPLRKKK AANLNSIIHR LEKAASREEP
     IEWEF
//
ID   CUX2_HUMAN              Reviewed;        1486 AA.
AC   O14529; A7E2Y4;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 4.
DT   27-SEP-2017, entry version 161.
DE   RecName: Full=Homeobox protein cut-like 2;
DE   AltName: Full=Homeobox protein cux-2;
GN   Name=CUX2; Synonyms=CUTL2, KIAA0293;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-1472.
RC   TISSUE=Brain;
RX   PubMed=9179496; DOI=10.1093/dnares/4.1.53;
RA   Ohara O., Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N.,
RA   Nomura N.;
RT   "Construction and characterization of human brain cDNA libraries
RT   suitable for analysis of cDNA clones encoding relatively large
RT   proteins.";
RL   DNA Res. 4:53-59(1997).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-1472.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   STRUCTURE BY NMR OF 544-631 AND 887-1125.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the first, second and third CUT domains of
RT   human homeobox protein CUX-2 (CUT-like 2).";
RL   Submitted (OCT-2005) to the PDB data bank.
CC   -!- FUNCTION: May be a transcription factor involved in neural
CC       specification. Binds to DNA in a sequence-specific manner (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00374}.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA22962.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB006631; BAA22962.2; ALT_INIT; mRNA.
DR   EMBL; AC005805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002352; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002978; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC151245; AAI51246.1; -; mRNA.
DR   CCDS; CCDS41837.1; -.
DR   RefSeq; NP_056082.2; NM_015267.3.
DR   UniGene; Hs.124953; -.
DR   PDB; 1WH6; NMR; -; A=887-974.
DR   PDB; 1WH8; NMR; -; A=1028-1125.
DR   PDB; 1X2L; NMR; -; A=544-631.
DR   PDBsum; 1WH6; -.
DR   PDBsum; 1WH8; -.
DR   PDBsum; 1X2L; -.
DR   ProteinModelPortal; O14529; -.
DR   SMR; O14529; -.
DR   STRING; 9606.ENSP00000261726; -.
DR   iPTMnet; O14529; -.
DR   PhosphoSitePlus; O14529; -.
DR   BioMuta; CUX2; -.
DR   EPD; O14529; -.
DR   MaxQB; O14529; -.
DR   PaxDb; O14529; -.
DR   PeptideAtlas; O14529; -.
DR   PRIDE; O14529; -.
DR   DNASU; 23316; -.
DR   Ensembl; ENST00000261726; ENSP00000261726; ENSG00000111249.
DR   GeneID; 23316; -.
DR   KEGG; hsa:23316; -.
DR   UCSC; uc001tsa.4; human.
DR   CTD; 23316; -.
DR   DisGeNET; 23316; -.
DR   EuPathDB; HostDB:ENSG00000111249.13; -.
DR   GeneCards; CUX2; -.
DR   HGNC; HGNC:19347; CUX2.
DR   HPA; HPA044772; -.
DR   MIM; 610648; gene.
DR   neXtProt; NX_O14529; -.
DR   OpenTargets; ENSG00000111249; -.
DR   PharmGKB; PA162382977; -.
DR   eggNOG; KOG0963; Eukaryota.
DR   eggNOG; KOG2252; Eukaryota.
DR   eggNOG; ENOG410XPKP; LUCA.
DR   GeneTree; ENSGT00530000063019; -.
DR   HOGENOM; HOG000143386; -.
DR   HOVERGEN; HBG051268; -.
DR   InParanoid; O14529; -.
DR   KO; K09313; -.
DR   OMA; ACCSPQG; -.
DR   OrthoDB; EOG091G011E; -.
DR   PhylomeDB; O14529; -.
DR   TreeFam; TF318206; -.
DR   ChiTaRS; CUX2; human.
DR   EvolutionaryTrace; O14529; -.
DR   GenomeRNAi; 23316; -.
DR   PRO; PR:O14529; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111249; -.
DR   CleanEx; HS_CUX2; -.
DR   ExpressionAtlas; O14529; baseline and differential.
DR   Genevisible; O14529; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0071310; P:cellular response to organic substance; IEA:Ensembl.
DR   GO; GO:0050890; P:cognition; IMP:UniProtKB.
DR   GO; GO:0048193; P:Golgi vesicle transport; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB.
DR   GO; GO:0007614; P:short-term memory; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   Pfam; PF02376; CUT; 3.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM01109; CUT; 3.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 3.
DR   PROSITE; PS51042; CUT; 3.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation.
FT   CHAIN         1   1486       Homeobox protein cut-like 2.
FT                                /FTId=PRO_0000202396.
FT   DNA_BIND    544    631       CUT 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    887    974       CUT 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND   1038   1125       CUT 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND   1168   1227       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COILED      195    374       {ECO:0000255}.
FT   COILED      690    717       {ECO:0000255}.
FT   COMPBIAS    440    535       Pro-rich.
FT   COMPBIAS    802    813       Poly-Ser.
FT   COMPBIAS   1327   1437       Pro-rich.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VARIANT    1472   1472       V -> L (in dbSNP:rs6490073).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9179496}.
FT                                /FTId=VAR_065096.
FT   HELIX       555    568       {ECO:0000244|PDB:1X2L}.
FT   HELIX       573    579       {ECO:0000244|PDB:1X2L}.
FT   HELIX       585    593       {ECO:0000244|PDB:1X2L}.
FT   HELIX       598    600       {ECO:0000244|PDB:1X2L}.
FT   HELIX       603    616       {ECO:0000244|PDB:1X2L}.
FT   HELIX       620    630       {ECO:0000244|PDB:1X2L}.
FT   HELIX       889    893       {ECO:0000244|PDB:1WH6}.
FT   HELIX       898    910       {ECO:0000244|PDB:1WH6}.
FT   TURN        911    913       {ECO:0000244|PDB:1WH6}.
FT   HELIX       916    922       {ECO:0000244|PDB:1WH6}.
FT   HELIX       928    936       {ECO:0000244|PDB:1WH6}.
FT   TURN        941    943       {ECO:0000244|PDB:1WH6}.
FT   HELIX       946    961       {ECO:0000244|PDB:1WH6}.
FT   HELIX      1037   1043       {ECO:0000244|PDB:1WH8}.
FT   HELIX      1049   1062       {ECO:0000244|PDB:1WH8}.
FT   HELIX      1067   1073       {ECO:0000244|PDB:1WH8}.
FT   HELIX      1079   1087       {ECO:0000244|PDB:1WH8}.
FT   TURN       1092   1094       {ECO:0000244|PDB:1WH8}.
FT   HELIX      1097   1111       {ECO:0000244|PDB:1WH8}.
FT   HELIX      1115   1123       {ECO:0000244|PDB:1WH8}.
SQ   SEQUENCE   1486 AA;  161677 MW;  71782EF5214D0262 CRC64;
     MAANVGSMFQ YWKRFDLRRL QKELNSVASE LSARQEESEH SHKHLIELRR EFKKNVPEEI
     REMVAPVLKS FQAEVVALSK RSQEAEAAFL SVYKQLIEAP DPVPVFEAAR SLDDRLQPPS
     FDPSGQPRRD LHTSWKRNPE LLSPKEQREG TSPAGPTLTE GSRLPGIPGK ALLTETLLQR
     NEAEKQKGLQ EVQITLAARL GEAEEKIKVL HSALKATQAE LLELRRKYDE EAASKADEVG
     LIMTNLEKAN QRAEAAQREV ESLREQLASV NSSIRLACCS PQGPSGDKVN FTLCSGPRLE
     AALASKDREI LRLLKDVQHL QSSLQELEEA SANQIADLER QLTAKSEAIE KLEEKLQAQS
     DYEEIKTELS ILKAMKLASS TCSLPQGMAK PEDSLLIAKE AFFPTQKFLL EKPSLLASPE
     EDPSEDDSIK DSLGTEQSYP SPQQLPPPPG PEDPLSPSPG QPLLGPSLGP DGTRTFSLSP
     FPSLASGERL MMPPAAFKGE AGGLLVFPPA FYGAKPPTAP ATPAPGPEPL GGPEPADGGG
     GGAAGPGAEE EQLDTAEIAF QVKEQLLKHN IGQRVFGHYV LGLSQGSVSE ILARPKPWRK
     LTVKGKEPFI KMKQFLSDEQ NVLALRTIQV RQRGSITPRI RTPETGSDDA IKSILEQAKK
     EIESQKGGEP KTSVAPLSIA NGTTPASTSE DAIKSILEQA RREMQAQQQA LLEMEVAPRG
     RSVPPSPPER PSLATASQNG APALVKQEEG SGGPAQAPLP VLSPAAFVQS IIRKVKSEIG
     DAGYFDHHWA SDRGLLSRPY ASVSPSLSSS SSSGYSGQPN GRAWPRGDEA PVPPEDEAAA
     GAEDEPPRTG ELKAEGATAE AGARLPYYPA YVPRTLKPTV PPLTPEQYEL YMYREVDTLE
     LTRQVKEKLA KNGICQRIFG EKVLGLSQGS VSDMLSRPKP WSKLTQKGRE PFIRMQLWLS
     DQLGQAVGQQ PGASQASPTE PRSSPSPPPS PTEPEKSSQE PLSLSLESSK ENQQPEGRSS
     SSLSGKMYSG SQAPGGIQEI VAMSPELDTY SITKRVKEVL TDNNLGQRLF GESILGLTQG
     SVSDLLSRPK PWHKLSLKGR EPFVRMQLWL NDPHNVEKLR DMKKLEKKAY LKRRYGLIST
     GSDSESPATR SECPSPCLQP QDLSLLQIKK PRVVLAPEEK EALRKAYQLE PYPSQQTIEL
     LSFQLNLKTN TVINWFHNYR SRMRREMLVE GTQDEPDLDP SGGPGILPPG HSHPDPTPQS
     PDSETEDQKP TVKELELQEG PEENSTPLTT QDKAQVRIKQ EQMEEDAEEE AGSQPQDSGE
     LDKGQGPPKE EHPDPPGNDG LPKVAPGPLL PGGSTPDCPS LHPQQESEAG ERLHPDPLSF
     KSASESSRCS LEVSLNSPSA ASSPGLMMSV SPVPSSSAPI SPSPPGAPPA KVPSASPTAD
     MAGALHPSAK VNPNLQRRHE KMANLNNIIY RVERAANREE ALEWEF
//
ID   DBX2_HUMAN              Reviewed;         339 AA.
AC   Q6ZNG2;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   27-SEP-2017, entry version 107.
DE   RecName: Full=Homeobox protein DBX2;
DE   AltName: Full=Developing brain homeobox protein 2;
GN   Name=DBX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-171.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the H2.0 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK131230; BAD18413.1; -; mRNA.
DR   EMBL; AC008127; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079033; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC089986; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS31781.1; -.
DR   RefSeq; NP_001004329.2; NM_001004329.2.
DR   UniGene; Hs.302764; -.
DR   ProteinModelPortal; Q6ZNG2; -.
DR   SMR; Q6ZNG2; -.
DR   STRING; 9606.ENSP00000331470; -.
DR   iPTMnet; Q6ZNG2; -.
DR   PhosphoSitePlus; Q6ZNG2; -.
DR   BioMuta; DBX2; -.
DR   DMDM; 296434473; -.
DR   PaxDb; Q6ZNG2; -.
DR   PeptideAtlas; Q6ZNG2; -.
DR   PRIDE; Q6ZNG2; -.
DR   DNASU; 440097; -.
DR   Ensembl; ENST00000332700; ENSP00000331470; ENSG00000185610.
DR   GeneID; 440097; -.
DR   KEGG; hsa:440097; -.
DR   UCSC; uc001rok.2; human.
DR   CTD; 440097; -.
DR   DisGeNET; 440097; -.
DR   EuPathDB; HostDB:ENSG00000185610.6; -.
DR   GeneCards; DBX2; -.
DR   HGNC; HGNC:33186; DBX2.
DR   HPA; HPA066053; -.
DR   neXtProt; NX_Q6ZNG2; -.
DR   OpenTargets; ENSG00000185610; -.
DR   PharmGKB; PA162383249; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000112172; -.
DR   HOVERGEN; HBG104467; -.
DR   InParanoid; Q6ZNG2; -.
DR   OMA; TRWAFQV; -.
DR   OrthoDB; EOG091G0MGV; -.
DR   PhylomeDB; Q6ZNG2; -.
DR   TreeFam; TF350735; -.
DR   GeneWiki; DBX2; -.
DR   GenomeRNAi; 440097; -.
DR   PRO; PR:Q6ZNG2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000185610; -.
DR   CleanEx; HS_DBX2; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    339       Homeobox protein DBX2.
FT                                /FTId=PRO_0000302849.
FT   DNA_BIND    186    245       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     171    171       M -> V (in dbSNP:rs2731038).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_034969.
SQ   SEQUENCE   339 AA;  36555 MW;  7E9CAD61C3DAEBEB CRC64;
     MLPSAVAAHA GAYWDVVASS ALLNLPAAPG FGNLGKSFLI ENLLRVGGAP TPRLQPPAPH
     DPATALATAG AQLRPLPASP VPLKLCPAAE QVSPAGAPYG TRWAFQVLSP SADSARLPGR
     APGDRDCTFQ PSAPAPSKPF LLSTPPFYSA CCGGSCRRPA SSTAFPREES MLPLLTQDSN
     SKARRGILRR AVFSEDQRKA LEKMFQKQKY ISKTDRKKLA INLGLKESQV KIWFQNRRMK
     WRNSKEKEVL SNRCIQEVGL QEDPLSRSAL GFPSPCPSIW DVPQQHSSPR WRENSPEPSE
     RLIQESSGAP PPEANSLQGA LYLCSEEEAG SKGVLTGAV
//
ID   DMBX1_HUMAN             Reviewed;         382 AA.
AC   Q8NFW5; A6NNN2; Q8NFW6; Q8NHD9;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   25-OCT-2017, entry version 128.
DE   RecName: Full=Diencephalon/mesencephalon homeobox protein 1;
DE   AltName: Full=Orthodenticle homolog 3;
DE   AltName: Full=Paired-like homeobox protein DMBX1;
GN   Name=DMBX1 {ECO:0000312|HGNC:HGNC:19026};
GN   Synonyms=MBX {ECO:0000303|PubMed:12142024}, OTX3,
GN   PAXB {ECO:0000312|EMBL:BAC00920.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAM90590.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Fetus {ECO:0000269|PubMed:12142024};
RX   PubMed=12142024; DOI=10.1006/dbio.2002.0709;
RA   Kawahara A., Chien C.-B., Dawid I.B.;
RT   "The homeobox gene mbx is involved in eye and tectum development.";
RL   Dev. Biol. 248:107-117(2002).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAC00920.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain {ECO:0000269|PubMed:12055180};
RX   PubMed=12055180; DOI=10.1074/jbc.C100767200;
RA   Zhang Y., Miki T., Iwanaga T., Koseki Y., Okuno M., Sunaga Y.,
RA   Ozaki N., Yano H., Koseki H., Seino S.;
RT   "Identification, tissue expression, and functional characterization of
RT   Otx3, a novel member of the Otx family.";
RL   J. Biol. Chem. 277:28065-28069(2002).
RN   [3] {ECO:0000312|EMBL:CAI19185.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
CC   -!- FUNCTION: Functions as a transcriptional repressor. May repress
CC       OTX2-mediated transactivation by forming a heterodimer with OTX2
CC       on the P3C (5'-TAATCCGATTA-3') sequence. Required for brain
CC       development (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer or heterodimer. Forms heterodimers with OTX2
CC       (By similarity). {ECO:0000250|UniProtKB:Q91ZK4}.
CC   -!- INTERACTION:
CC       Q8N1N4:KRT78; NbExp=4; IntAct=EBI-12823415, EBI-1056564;
CC       O15160:POLR1C; NbExp=4; IntAct=EBI-12823415, EBI-1055079;
CC       Q7Z5A4:PRSS42; NbExp=4; IntAct=EBI-12823415, EBI-13040866;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O35137,
CC       ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-
CC       ProRule:PRU00138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:12142024}; Synonyms=MBX-L
CC       {ECO:0000312|EMBL:AAM90590.1};
CC         IsoId=Q8NFW5-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:12055180, ECO:0000269|PubMed:12142024};
CC       Synonyms=MBX-S {ECO:0000312|EMBL:AAM90589.1};
CC         IsoId=Q8NFW5-2; Sequence=VSP_052251;
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC00920.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF398527; AAM90589.1; -; mRNA.
DR   EMBL; AF398528; AAM90590.1; -; mRNA.
DR   EMBL; AB037699; BAC00920.1; ALT_INIT; mRNA.
DR   EMBL; AL137797; CAI19184.1; -; Genomic_DNA.
DR   EMBL; AL137797; CAI19185.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06907.1; -; Genomic_DNA.
DR   CCDS; CCDS536.1; -. [Q8NFW5-2]
DR   RefSeq; NP_671725.1; NM_147192.2. [Q8NFW5-1]
DR   RefSeq; NP_757379.1; NM_172225.1. [Q8NFW5-2]
DR   RefSeq; XP_011538970.1; XM_011540668.2. [Q8NFW5-2]
DR   RefSeq; XP_016855778.1; XM_017000289.1. [Q8NFW5-2]
DR   UniGene; Hs.375623; -.
DR   ProteinModelPortal; Q8NFW5; -.
DR   SMR; Q8NFW5; -.
DR   BioGrid; 126053; 1.
DR   IntAct; Q8NFW5; 91.
DR   STRING; 9606.ENSP00000353132; -.
DR   iPTMnet; Q8NFW5; -.
DR   PhosphoSitePlus; Q8NFW5; -.
DR   BioMuta; DMBX1; -.
DR   DMDM; 74762571; -.
DR   PaxDb; Q8NFW5; -.
DR   PeptideAtlas; Q8NFW5; -.
DR   PRIDE; Q8NFW5; -.
DR   Ensembl; ENST00000360032; ENSP00000353132; ENSG00000197587. [Q8NFW5-2]
DR   Ensembl; ENST00000371956; ENSP00000361024; ENSG00000197587. [Q8NFW5-1]
DR   GeneID; 127343; -.
DR   KEGG; hsa:127343; -.
DR   UCSC; uc001cpw.4; human. [Q8NFW5-1]
DR   CTD; 127343; -.
DR   DisGeNET; 127343; -.
DR   EuPathDB; HostDB:ENSG00000197587.10; -.
DR   GeneCards; DMBX1; -.
DR   HGNC; HGNC:19026; DMBX1.
DR   HPA; HPA026811; -.
DR   MIM; 607410; gene.
DR   neXtProt; NX_Q8NFW5; -.
DR   OpenTargets; ENSG00000197587; -.
DR   PharmGKB; PA38780; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000261650; -.
DR   HOVERGEN; HBG061416; -.
DR   InParanoid; Q8NFW5; -.
DR   OMA; QAQQVWN; -.
DR   OrthoDB; EOG091G0EWK; -.
DR   PhylomeDB; Q8NFW5; -.
DR   TreeFam; TF351609; -.
DR   GenomeRNAi; 127343; -.
DR   PRO; PR:Q8NFW5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000197587; -.
DR   CleanEx; HS_DMBX1; -.
DR   Genevisible; Q8NFW5; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0008343; P:adult feeding behavior; IEA:Ensembl.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR   GO; GO:0048589; P:developmental growth; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    382       Diencephalon/mesencephalon homeobox
FT                                protein 1.
FT                                /FTId=PRO_0000262954.
FT   DNA_BIND     71    130       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION        1    156       Interaction with OTX2 and is required for
FT                                repressor activity.
FT                                {ECO:0000250|UniProtKB:Q91ZK4}.
FT   MOTIF       359    372       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   VAR_SEQ      52     56       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12055180,
FT                                ECO:0000303|PubMed:12142024}.
FT                                /FTId=VSP_052251.
FT   VARIANT     205    205       A -> P (in dbSNP:rs34614765).
FT                                /FTId=VAR_049578.
FT   CONFLICT    227    227       R -> K (in Ref. 2; BAC00920).
FT                                {ECO:0000305}.
SQ   SEQUENCE   382 AA;  41198 MW;  8119E5351E026BFE CRC64;
     MQHYGVNGYS LHAMNSLSAM YNLHQQAAQQ AQHAPDYRPS VHALTLAERL AGCTFQDIIL
     EARYGSQHRK QRRSRTAFTA QQLEALEKTF QKTHYPDVVM RERLAMCTNL PEARVQVWFK
     NRRAKFRKKQ RSLQKEQLQK QKEAEGSHGE GKAEAPTPDT QLDTEQPPRL PGSDPPAELH
     LSLSEQSASE SAPEDQPDRE EDPRAGAEDP KAEKSPGADS KGLGCKRGSP KADSPGSLTI
     TPVAPGGGLL GPSHSYSSSP LSLFRLQEQF RQHMAATNNL VHYSSFEVGG PAPAAAAAAA
     AVPYLGVNMA PLGSLHCQSY YQSLSAAAAA HQGVWGSPLL PAPPAGLAPA SATLNSKTTS
     IENLRLRAKQ HAASLGLDTL PN
//
ID   DU4L3_HUMAN             Reviewed;         424 AA.
AC   P0CJ86;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 1.
DT   27-SEP-2017, entry version 49.
DE   RecName: Full=Double homeobox protein 4-like protein 3;
GN   Name=DUX4L3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC126281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; P0CJ86; -.
DR   SMR; P0CJ86; -.
DR   iPTMnet; P0CJ86; -.
DR   PhosphoSitePlus; P0CJ86; -.
DR   DMDM; 325530033; -.
DR   PaxDb; P0CJ86; -.
DR   PRIDE; P0CJ86; -.
DR   GeneCards; DUX4L3; -.
DR   HGNC; HGNC:38688; DUX4L3.
DR   HPA; HPA058451; -.
DR   neXtProt; NX_P0CJ86; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   InParanoid; P0CJ86; -.
DR   PhylomeDB; P0CJ86; -.
DR   PRO; PR:P0CJ86; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    424       Double homeobox protein 4-like protein 3.
FT                                /FTId=PRO_0000405251.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    338       Pro-rich.
SQ   SEQUENCE   424 AA;  44926 MW;  F26D864B7DFC4A11 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGVS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SASARQGQMQ GIPAPSQALQ
     EPAPWSALPC GLLLDELLAS PEFLQQAQPL LETEAPGELE ASEEAASLEA PLSEEEYRAL
     LEEL
//
ID   DU4L7_HUMAN             Reviewed;         424 AA.
AC   P0CJ90;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 1.
DT   27-SEP-2017, entry version 48.
DE   RecName: Full=Double homeobox protein 4-like protein 7;
GN   Name=DUX4L7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC126281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; P0CJ90; -.
DR   SMR; P0CJ90; -.
DR   iPTMnet; P0CJ90; -.
DR   PhosphoSitePlus; P0CJ90; -.
DR   DMDM; 325530037; -.
DR   PaxDb; P0CJ90; -.
DR   PRIDE; P0CJ90; -.
DR   GeneCards; DUX4L7; -.
DR   HGNC; HGNC:37266; DUX4L7.
DR   HPA; HPA058451; -.
DR   neXtProt; NX_P0CJ90; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   InParanoid; P0CJ90; -.
DR   PhylomeDB; P0CJ90; -.
DR   PRO; PR:P0CJ90; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    424       Double homeobox protein 4-like protein 7.
FT                                /FTId=PRO_0000405255.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    338       Pro-rich.
SQ   SEQUENCE   424 AA;  44926 MW;  F26D864B7DFC4A11 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGVS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SASARQGQMQ GIPAPSQALQ
     EPAPWSALPC GLLLDELLAS PEFLQQAQPL LETEAPGELE ASEEAASLEA PLSEEEYRAL
     LEEL
//
ID   DU4L2_HUMAN             Reviewed;         424 AA.
AC   P0CJ85;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 1.
DT   27-SEP-2017, entry version 48.
DE   RecName: Full=Double homeobox protein 4-like protein 2;
GN   Name=DUX4L2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC126281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; P0CJ85; -.
DR   SMR; P0CJ85; -.
DR   STRING; 9606.ENSP00000451995; -.
DR   iPTMnet; P0CJ85; -.
DR   PhosphoSitePlus; P0CJ85; -.
DR   DMDM; 325530032; -.
DR   PaxDb; P0CJ85; -.
DR   PRIDE; P0CJ85; -.
DR   DisGeNET; 728410; -.
DR   GeneCards; DUX4L2; -.
DR   HGNC; HGNC:37267; DUX4L2.
DR   HPA; HPA058451; -.
DR   neXtProt; NX_P0CJ85; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   InParanoid; P0CJ85; -.
DR   PhylomeDB; P0CJ85; -.
DR   PRO; PR:P0CJ85; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    424       Double homeobox protein 4-like protein 2.
FT                                /FTId=PRO_0000405250.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    338       Pro-rich.
SQ   SEQUENCE   424 AA;  44926 MW;  F26D864B7DFC4A11 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGVS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SASARQGQMQ GIPAPSQALQ
     EPAPWSALPC GLLLDELLAS PEFLQQAQPL LETEAPGELE ASEEAASLEA PLSEEEYRAL
     LEEL
//
ID   DLX3_HUMAN              Reviewed;         287 AA.
AC   O60479; B3KQL6;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Homeobox protein DLX-3;
GN   Name=DLX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INVOLVEMENT IN TDO.
RX   PubMed=9467018; DOI=10.1093/hmg/7.3.563;
RA   Price J.A., Bowden D.W., Wright J.T., Pettenati M.J., Hart T.C.;
RT   "Identification of a mutation in DLX3 associated with tricho-dento-
RT   osseous (TDO) syndrome.";
RL   Hum. Mol. Genet. 7:563-569(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Foreskin;
RX   PubMed=11792834; DOI=10.1073/pnas.012584999;
RA   Sumiyama K., Irvine S.Q., Stock D.W., Weiss K.M., Kawasaki K.,
RA   Shimizu N., Shashikant C.S., Miller W., Ruddle F.H.;
RT   "Genomic structure and functional control of the Dlx3-7 bigene
RT   cluster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:780-785(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN AI4.
RX   PubMed=15666299; DOI=10.1002/ajmg.a.30521;
RA   Dong J., Amor D., Aldred M.J., Gu T., Escamilla M., MacDougall M.;
RT   "DLX3 mutation associated with autosomal dominant amelogenesis
RT   imperfecta with taurodontism.";
RL   Am. J. Med. Genet. A 133:138-141(2005).
CC   -!- FUNCTION: Likely to play a regulatory role in the development of
CC       the ventral forebrain. May play a role in craniofacial patterning
CC       and morphogenesis.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- DISEASE: Trichodentoosseous syndrome (TDO) [MIM:190320]: An
CC       autosomal dominant disease characterized by curly kinky hair at
CC       birth, enamel hypoplasia, taurodontism, thickening of cortical
CC       bones and variable expression of craniofacial morphology.
CC       {ECO:0000269|PubMed:9467018}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Amelogenesis imperfecta 4 (AI4) [MIM:104510]: An
CC       autosomal dominant defect of enamel formation associated with
CC       enlarged pulp chambers. Enamel is thin, teeth are small and widely
CC       spaced. {ECO:0000269|PubMed:15666299}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF028233; AAC14397.1; -; Genomic_DNA.
DR   EMBL; AF452638; AAL99504.1; -; Genomic_DNA.
DR   EMBL; AK075167; BAG52078.1; -; mRNA.
DR   EMBL; CH471109; EAW94650.1; -; Genomic_DNA.
DR   EMBL; BC012361; AAH12361.1; -; mRNA.
DR   EMBL; BC028970; AAH28970.1; -; mRNA.
DR   CCDS; CCDS11556.1; -.
DR   RefSeq; NP_005211.1; NM_005220.2.
DR   UniGene; Hs.134194; -.
DR   PDB; 4XRS; X-ray; 3.50 A; G/I=131-186.
DR   PDBsum; 4XRS; -.
DR   ProteinModelPortal; O60479; -.
DR   SMR; O60479; -.
DR   BioGrid; 108091; 2.
DR   IntAct; O60479; 2.
DR   STRING; 9606.ENSP00000389870; -.
DR   iPTMnet; O60479; -.
DR   PhosphoSitePlus; O60479; -.
DR   BioMuta; DLX3; -.
DR   MaxQB; O60479; -.
DR   PaxDb; O60479; -.
DR   PeptideAtlas; O60479; -.
DR   PRIDE; O60479; -.
DR   DNASU; 1747; -.
DR   Ensembl; ENST00000434704; ENSP00000389870; ENSG00000064195.
DR   GeneID; 1747; -.
DR   KEGG; hsa:1747; -.
DR   UCSC; uc002ipy.3; human.
DR   CTD; 1747; -.
DR   DisGeNET; 1747; -.
DR   EuPathDB; HostDB:ENSG00000064195.7; -.
DR   GeneCards; DLX3; -.
DR   HGNC; HGNC:2916; DLX3.
DR   MalaCards; DLX3; -.
DR   MIM; 104510; phenotype.
DR   MIM; 190320; phenotype.
DR   MIM; 600525; gene.
DR   neXtProt; NX_O60479; -.
DR   OpenTargets; ENSG00000064195; -.
DR   Orphanet; 100034; Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism.
DR   Orphanet; 3352; Tricho-dento-osseous syndrome.
DR   PharmGKB; PA27371; -.
DR   eggNOG; KOG0850; Eukaryota.
DR   eggNOG; ENOG410ZHZR; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231940; -.
DR   HOVERGEN; HBG005493; -.
DR   InParanoid; O60479; -.
DR   KO; K09315; -.
DR   OMA; SWYHTQN; -.
DR   OrthoDB; EOG091G0P17; -.
DR   PhylomeDB; O60479; -.
DR   TreeFam; TF350606; -.
DR   SIGNOR; O60479; -.
DR   GeneWiki; DLX3; -.
DR   GeneWiki; DLX3_(gene); -.
DR   GenomeRNAi; 1747; -.
DR   PRO; PR:O60479; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000064195; -.
DR   CleanEx; HS_DLX3; -.
DR   ExpressionAtlas; O60479; baseline and differential.
DR   Genevisible; O60479; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0071895; P:odontoblast differentiation; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR022135; Distal-less_N.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF12413; DLL_N; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amelogenesis imperfecta; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome.
FT   CHAIN         1    287       Homeobox protein DLX-3.
FT                                /FTId=PRO_0000049026.
FT   DNA_BIND    129    188       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   STRAND      138    141       {ECO:0000244|PDB:4XRS}.
FT   TURN        142    144       {ECO:0000244|PDB:4XRS}.
FT   HELIX       145    150       {ECO:0000244|PDB:4XRS}.
FT   HELIX       159    163       {ECO:0000244|PDB:4XRS}.
FT   TURN        164    166       {ECO:0000244|PDB:4XRS}.
FT   HELIX       171    178       {ECO:0000244|PDB:4XRS}.
SQ   SEQUENCE   287 AA;  31738 MW;  DCA9716E51D78DD1 CRC64;
     MSGSFDRKLS SILTDISSSL SCHAGSKDSP TLPESSVTDL GYYSAPQHDY YSGQPYGQTV
     NPYTYHHQFN LNGLAGTGAY SPKSEYTYGA SYRQYGAYRE QPLPAQDPVS VKEEPEAEVR
     MVNGKPKKVR KPRTIYSSYQ LAALQRRFQK AQYLALPERA ELAAQLGLTQ TQVKIWFQNR
     RSKFKKLYKN GEVPLEHSPN NSDSMACNSP PSPALWDTSS HSTPAPARSQ LPPPLPYSAS
     PSYLDDPTNS WYHAQNLSGP HLQQQPPQPA TLHHASPGPP PNPGAVY
//
ID   DLX2_HUMAN              Reviewed;         328 AA.
AC   Q07687; B4DMK4; B7ZA14;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   25-OCT-2017, entry version 150.
DE   RecName: Full=Homeobox protein DLX-2;
GN   Name=DLX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8812481; DOI=10.1006/geno.1996.0387;
RA   McGuinness T., Porteus M.H., Smiga S., Bulfone A., Kingsley C.,
RA   Qiu M., Liu J.K., Long J.E., Xu D., Rubenstein J.L.R.;
RT   "Sequence, organization, and transcription of the Dlx-1 and Dlx-2
RT   locus.";
RL   Genomics 35:473-485(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 85-328 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7901126; DOI=10.1016/0378-1119(93)90212-L;
RA   Selski D.J., Thomas N.E., Coleman P.D., Rogers K.E.;
RT   "The human brain homeogene, DLX-2: cDNA sequence and alignment with
RT   the murine homologue.";
RL   Gene 132:301-303(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 152-217.
RC   TISSUE=Embryo;
RX   PubMed=7907794; DOI=10.1073/pnas.91.6.2250;
RA   Simeone A., Acampora D., Pannese M., D'Esposito M., Stornaiuolo A.,
RA   Gulisano M., Mallamaci A., Kastury K., Druck T., Huebner K.,
RA   Boncinelli E.;
RT   "Cloning and characterization of two members of the vertebrate Dlx
RT   gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2250-2254(1994).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
CC   -!- FUNCTION: Acts as a transcriptional activator. Plays a role in
CC       terminal differentiation of interneurons, such as amacrine and
CC       bipolar cells in the developing retina. Likely to play a
CC       regulatory role in the development of the ventral forebrain. May
CC       play a role in craniofacial patterning and morphogenesis.
CC       {ECO:0000250|UniProtKB:P40764}.
CC   -!- SUBUNIT: Interacts (via homeobox DNA-binding domain) with POU4F2;
CC       this interaction enhances retinal ganglion cell (RGC)
CC       differentiation. {ECO:0000250|UniProtKB:P40764}.
CC   -!- INTERACTION:
CC       P28799:GRN; NbExp=3; IntAct=EBI-3908234, EBI-747754;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q07687-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q07687-2; Sequence=VSP_054287, VSP_054288;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U51003; AAB40902.1; -; Genomic_DNA.
DR   EMBL; AK297503; BAG59916.1; -; mRNA.
DR   EMBL; AK316129; BAH14500.1; -; mRNA.
DR   EMBL; AC104801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032558; AAH32558.1; -; mRNA.
DR   EMBL; L07919; AAA19663.1; -; mRNA.
DR   CCDS; CCDS2248.1; -. [Q07687-1]
DR   PIR; B53495; B53495.
DR   PIR; G02469; G02469.
DR   RefSeq; NP_004396.1; NM_004405.3. [Q07687-1]
DR   UniGene; Hs.419; -.
DR   ProteinModelPortal; Q07687; -.
DR   SMR; Q07687; -.
DR   BioGrid; 108090; 13.
DR   IntAct; Q07687; 3.
DR   STRING; 9606.ENSP00000234198; -.
DR   iPTMnet; Q07687; -.
DR   PhosphoSitePlus; Q07687; -.
DR   BioMuta; DLX2; -.
DR   DMDM; 2506529; -.
DR   PaxDb; Q07687; -.
DR   PeptideAtlas; Q07687; -.
DR   PRIDE; Q07687; -.
DR   DNASU; 1746; -.
DR   Ensembl; ENST00000234198; ENSP00000234198; ENSG00000115844. [Q07687-1]
DR   Ensembl; ENST00000466293; ENSP00000446904; ENSG00000115844. [Q07687-2]
DR   GeneID; 1746; -.
DR   KEGG; hsa:1746; -.
DR   UCSC; uc010zdx.2; human. [Q07687-1]
DR   CTD; 1746; -.
DR   DisGeNET; 1746; -.
DR   EuPathDB; HostDB:ENSG00000115844.10; -.
DR   GeneCards; DLX2; -.
DR   HGNC; HGNC:2915; DLX2.
DR   HPA; HPA056965; -.
DR   MIM; 126255; gene.
DR   neXtProt; NX_Q07687; -.
DR   OpenTargets; ENSG00000115844; -.
DR   PharmGKB; PA27370; -.
DR   eggNOG; KOG0850; Eukaryota.
DR   eggNOG; ENOG410ZHZR; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231940; -.
DR   HOVERGEN; HBG005493; -.
DR   InParanoid; Q07687; -.
DR   KO; K18488; -.
DR   OMA; FLGNYPW; -.
DR   OrthoDB; EOG091G0P17; -.
DR   PhylomeDB; Q07687; -.
DR   TreeFam; TF350606; -.
DR   SIGNOR; Q07687; -.
DR   GeneWiki; DLX2; -.
DR   GenomeRNAi; 1746; -.
DR   PRO; PR:Q07687; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115844; -.
DR   CleanEx; HS_DLX2; -.
DR   ExpressionAtlas; Q07687; baseline and differential.
DR   Genevisible; Q07687; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; TAS:ProtInc.
DR   GO; GO:0048755; P:branching morphogenesis of a nerve; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0021893; P:cerebral cortex GABAergic interneuron fate commitment; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0046533; P:negative regulation of photoreceptor cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:1902871; P:positive regulation of amacrine cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0021882; P:regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0021544; P:subpallium development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR022135; Distal-less_N.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF12413; DLL_N; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; Differentiation; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    328       Homeobox protein DLX-2.
FT                                /FTId=PRO_0000049023.
FT   DNA_BIND    152    211       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     41     46       Poly-Ser.
FT   COMPBIAS     75     81       Poly-Gly.
FT   COMPBIAS    251    259       Poly-Gly.
FT   COMPBIAS    309    315       Poly-His.
FT   COMPBIAS    316    319       Poly-Gly.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336}.
FT   VAR_SEQ     197    217       KIWFQNRRSKFKKMWKSGEIP -> GLAPCRGEESAGLRWL
FT                                GSRRV (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054287.
FT   VAR_SEQ     218    328       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054288.
FT   CONFLICT    178    178       A -> V (in Ref. 2; BAG59916).
FT                                {ECO:0000305}.
SQ   SEQUENCE   328 AA;  34243 MW;  BB6A077256F58022 CRC64;
     MTGVFDSLVA DMHSTQIAAS STYHQHQQPP SGGGAGPGGN SSSSSSLHKP QESPTLPVST
     ATDSSYYTNQ QHPAGGGGGG GSPYAHMGSY QYQASGLNNV PYSAKSSYDL GYTAAYTSYA
     PYGTSSSPAN NEPEKEDLEP EIRIVNGKPK KVRKPRTIYS SFQLAALQRR FQKTQYLALP
     ERAELAASLG LTQTQVKIWF QNRRSKFKKM WKSGEIPSEQ HPGASASPPC ASPPVSAPAS
     WDFGVPQRMA GGGGPGSGGS GAGSSGSSPS SAASAFLGNY PWYHQTSGSA SHLQATAPLL
     HPTQTPQPHH HHHHHGGGGA PVSAGTIF
//
ID   DLX1_HUMAN              Reviewed;         255 AA.
AC   P56177; D3DPD7; Q53ZU4; Q7Z724; Q8IYB2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   25-OCT-2017, entry version 153.
DE   RecName: Full=Homeobox protein DLX-1;
GN   Name=DLX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   SMAD4, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=14671321; DOI=10.1073/pnas.2536757100;
RA   Chiba S., Takeshita K., Imai Y., Kumano K., Kurokawa M., Masuda S.,
RA   Shimizu K., Nakamura S., Ruddle F.H., Hirai H.;
RT   "Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling
RT   pathway from activin A in hematopoietic cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15577-15582(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   CYS-136.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 128-193 (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=7907794; DOI=10.1073/pnas.91.6.2250;
RA   Simeone A., Acampora D., Pannese M., D'Esposito M., Stornaiuolo A.,
RA   Gulisano M., Mallamaci A., Kastury K., Druck T., Huebner K.,
RA   Boncinelli E.;
RT   "Cloning and characterization of two members of the vertebrate Dlx
RT   gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2250-2254(1994).
CC   -!- FUNCTION: Plays a role as a transcriptional activator or repressor
CC       (PubMed:14671321). Inhibits several cytokine signaling pathways,
CC       such as TGFB1, activin-A/INHBA and BMP4 by interfering with the
CC       transcriptional stimulatory activity of transcription factors,
CC       such as MSX2, FAST2, SMAD2 and SMAD3 during hematopoietic cell
CC       differentiation (PubMed:14671321). Plays a role in terminal
CC       differentiation of interneurons, such as amacrine and bipolar
CC       cells in the developing retina (By similarity). Likely to play a
CC       regulatory role in the development of the ventral forebrain (By
CC       similarity). May play a role in craniofacial patterning and
CC       morphogenesis and may be involved in the early development of
CC       diencephalic subdivisions (By similarity).
CC       {ECO:0000250|UniProtKB:Q64317, ECO:0000269|PubMed:14671321}.
CC   -!- SUBUNIT: Interacts with SMAD4 (via homeobox DNA-binding domain)
CC       (PubMed:14671321). Interacts (via homeobox DNA-binding domain)
CC       with POU4F2; this interaction suppresses DLX1-mediated
CC       transcriptional activity in postnatal retina and enhances retinal
CC       ganglion cell (RGC) differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:Q64317, ECO:0000269|PubMed:14671321}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14671321}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P56177-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56177-2; Sequence=VSP_043589;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in hematopoietic cell lines.
CC       {ECO:0000269|PubMed:14671321}.
CC   -!- DOMAIN: The homeobox DNA-binding domain is necessary for its
CC       nuclear localization, transcriptional and erythroid
CC       differentiation activities (PubMed:14671321).
CC       {ECO:0000269|PubMed:14671321}.
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY257976; AAO91939.1; -; mRNA.
DR   EMBL; AC015976; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11185.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11187.1; -; Genomic_DNA.
DR   EMBL; BC036189; AAH36189.2; -; mRNA.
DR   EMBL; BC053351; AAH53351.1; -; mRNA.
DR   CCDS; CCDS2247.2; -. [P56177-1]
DR   CCDS; CCDS33328.1; -. [P56177-2]
DR   PIR; A53495; A53495.
DR   RefSeq; NP_001033582.1; NM_001038493.1. [P56177-2]
DR   RefSeq; NP_835221.2; NM_178120.4. [P56177-1]
DR   UniGene; Hs.407015; -.
DR   ProteinModelPortal; P56177; -.
DR   SMR; P56177; -.
DR   BioGrid; 108089; 2.
DR   IntAct; P56177; 1.
DR   STRING; 9606.ENSP00000354478; -.
DR   iPTMnet; P56177; -.
DR   PhosphoSitePlus; P56177; -.
DR   BioMuta; DLX1; -.
DR   DMDM; 116241335; -.
DR   EPD; P56177; -.
DR   PaxDb; P56177; -.
DR   PeptideAtlas; P56177; -.
DR   PRIDE; P56177; -.
DR   DNASU; 1745; -.
DR   Ensembl; ENST00000341900; ENSP00000341786; ENSG00000144355. [P56177-2]
DR   Ensembl; ENST00000361725; ENSP00000354478; ENSG00000144355. [P56177-1]
DR   GeneID; 1745; -.
DR   KEGG; hsa:1745; -.
DR   UCSC; uc002uhm.4; human. [P56177-1]
DR   CTD; 1745; -.
DR   DisGeNET; 1745; -.
DR   EuPathDB; HostDB:ENSG00000144355.14; -.
DR   GeneCards; DLX1; -.
DR   HGNC; HGNC:2914; DLX1.
DR   HPA; HPA035666; -.
DR   HPA; HPA045884; -.
DR   MIM; 600029; gene.
DR   neXtProt; NX_P56177; -.
DR   OpenTargets; ENSG00000144355; -.
DR   PharmGKB; PA27369; -.
DR   eggNOG; KOG0850; Eukaryota.
DR   eggNOG; ENOG410ZHZR; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231941; -.
DR   HOVERGEN; HBG005493; -.
DR   InParanoid; P56177; -.
DR   KO; K09314; -.
DR   OMA; EMTMTTI; -.
DR   OrthoDB; EOG091G0P17; -.
DR   PhylomeDB; P56177; -.
DR   TreeFam; TF315720; -.
DR   GeneWiki; DLX1; -.
DR   GenomeRNAi; 1745; -.
DR   PRO; PR:P56177; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000144355; -.
DR   CleanEx; HS_DLX1; -.
DR   ExpressionAtlas; P56177; baseline and differential.
DR   Genevisible; P56177; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IMP:UniProtKB.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IMP:UniProtKB.
DR   GO; GO:0021893; P:cerebral cortex GABAergic interneuron fate commitment; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IMP:UniProtKB.
DR   GO; GO:1903845; P:negative regulation of cellular response to transforming growth factor beta stimulus; IMP:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0046533; P:negative regulation of photoreceptor cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:1902871; P:positive regulation of amacrine cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0021882; P:regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0021544; P:subpallium development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; Differentiation; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    255       Homeobox protein DLX-1.
FT                                /FTId=PRO_0000049020.
FT   DNA_BIND    128    187       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ     106    255       ADSEKSTVVEGGEVRFNGKGKKIRKPRTIYSSLQLQALNRR
FT                                FQQTQYLALPERAELAASLGLTQTQVKIWFQNKRSKFKKLM
FT                                KQGGAALEGSALANGRALSAGSPPVPPGWNPNSSSGKGSGG
FT                                NAGSYIPSYTSWYPSAHQEAMQQPQLM -> QDLVPKQAIQ
FT                                VQEADEAGWGGSGG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043589.
FT   VARIANT     136    136       S -> C (in dbSNP:rs17853565).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028443.
SQ   SEQUENCE   255 AA;  27320 MW;  99B468315FBFE7BD CRC64;
     MTMTTMPESL NSPVSGKAVF MEFGPPNQQM SPSPMSHGHY SMHCLHSAGH SQPDGAYSSA
     SSFSRPLGYP YVNSVSSHAS SPYISSVQSY PGSASLAQSR LEDPGADSEK STVVEGGEVR
     FNGKGKKIRK PRTIYSSLQL QALNRRFQQT QYLALPERAE LAASLGLTQT QVKIWFQNKR
     SKFKKLMKQG GAALEGSALA NGRALSAGSP PVPPGWNPNS SSGKGSGGNA GSYIPSYTSW
     YPSAHQEAMQ QPQLM
//
ID   DLX5_HUMAN              Reviewed;         289 AA.
AC   P56178; B7Z4P3; Q9UPL1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   25-OCT-2017, entry version 161.
DE   RecName: Full=Homeobox protein DLX-5;
GN   Name=DLX5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 137-202 (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=7907794; DOI=10.1073/pnas.91.6.2250;
RA   Simeone A., Acampora D., Pannese M., D'Esposito M., Stornaiuolo A.,
RA   Gulisano M., Mallamaci A., Kastury K., Druck T., Huebner K.,
RA   Boncinelli E.;
RT   "Cloning and characterization of two members of the vertebrate Dlx
RT   gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2250-2254(1994).
RN   [5]
RP   INTERACTION WITH XRCC6.
RC   TISSUE=Osteoblast;
RX   PubMed=12145306; DOI=10.1074/jbc.M206482200;
RA   Willis D.M., Loewy A.P., Charlton-Kachigian N., Shao J.-S.,
RA   Ornitz D.M., Towler D.A.;
RT   "Regulation of osteocalcin gene expression by a novel Ku antigen
RT   transcription factor complex.";
RL   J. Biol. Chem. 277:37280-37291(2002).
RN   [6]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=19497851; DOI=10.1074/jbc.M109.021477;
RA   Xu J., Testa J.R.;
RT   "DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by
RT   transcriptionally regulating MYC.";
RL   J. Biol. Chem. 284:20593-20601(2009).
RN   [7]
RP   STRUCTURE BY NMR OF 138-194.
RG   RIKEN structural genomics initiative (RSGI);
RT   "The solution structure of the homeobox domain of human homeobox
RT   protein DLX-5.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [8]
RP   VARIANT SHFM1D PRO-178.
RX   PubMed=22121204; DOI=10.1136/jmedgenet-2011-100556;
RA   Shamseldin H.E., Faden M.A., Alashram W., Alkuraya F.S.;
RT   "Identification of a novel DLX5 mutation in a family with autosomal
RT   recessive split hand and foot malformation.";
RL   J. Med. Genet. 49:16-20(2012).
CC   -!- FUNCTION: Transcriptional factor involved in bone development.
CC       Acts as an immediate early BMP-responsive transcriptional
CC       activator essential for osteoblast differentiation. Stimulates
CC       ALPL promoter activity in a RUNX2-independent manner during
CC       osteoblast differentiation. Stimulates SP7 promoter activity
CC       during osteoblast differentiation. Promotes cell proliferation by
CC       up-regulating MYC promoter activity. Involved as a positive
CC       regulator of both chondrogenesis and chondrocyte hypertrophy in
CC       the endochondral skeleton. Binds to the homeodomain-response
CC       element of the ALPL and SP7 promoter. Binds to the MYC promoter.
CC       Requires the 5'-TAATTA-3' consensus sequence for DNA-binding.
CC       {ECO:0000269|PubMed:19497851}.
CC   -!- SUBUNIT: Interacts with XRCC6 (Ku70).
CC       {ECO:0000269|PubMed:12145306}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P56178-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56178-2; Sequence=VSP_056884;
CC         Note=No experimental confirmation available.;
CC   -!- DEVELOPMENTAL STAGE: First expressed in embryos at 8.5-9 days in
CC       facial and branchial arch mesenchyme, otic vesicles and
CC       frontonasal ectoderm around olfactory placodes, a day later
CC       expression is seen in the developing forebrain in primordia of the
CC       ganglionic eminence and ventral diencephalic regions. In day 12.5
CC       embryos, expressed in the brain and bones, and also in all
CC       skeletal structures of midgestation embryos after the first
CC       cartilage formation. Expression remains unaltered in both brain
CC       and skeleton in day 15 embryos and slowly decreases in day 17
CC       embryos.
CC   -!- PTM: Phosphorylated. Phosphorylation of Ser-34 and Ser-217 by
CC       MAPK14 enhances its transcriptional activity. Phosphorylation by
CC       CaMK2 increases its protein stability (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Split-hand/foot malformation 1 with sensorineural hearing
CC       loss, autosomal recessive (SHFM1D) [MIM:220600]: A disease
CC       characterized by the association of split-hand/foot malformation
CC       with deafness. Split-hand/foot malformation is a limb malformation
CC       involving the central rays of the autopod and presenting with
CC       syndactyly, median clefts of the hands and feet, and aplasia
CC       and/or hypoplasia of the phalanges, metacarpals, and metatarsals.
CC       Some patients have been found to have mental retardation,
CC       ectodermal and craniofacial findings, and orofacial clefting.
CC       {ECO:0000269|PubMed:22121204}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DLX5ID44295ch7q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK023493; BAB14587.1; -; mRNA.
DR   EMBL; AK297614; BAH12629.1; -; mRNA.
DR   EMBL; AC004774; AAC17833.1; -; Genomic_DNA.
DR   EMBL; BC006226; AAH06226.1; -; mRNA.
DR   CCDS; CCDS5647.1; -. [P56178-1]
DR   PIR; C53495; C53495.
DR   RefSeq; NP_005212.1; NM_005221.5. [P56178-1]
DR   UniGene; Hs.99348; -.
DR   PDB; 2DJN; NMR; -; A=138-194.
DR   PDB; 4RDU; X-ray; 1.85 A; A/D=135-198.
DR   PDBsum; 2DJN; -.
DR   PDBsum; 4RDU; -.
DR   ProteinModelPortal; P56178; -.
DR   SMR; P56178; -.
DR   BioGrid; 108093; 14.
DR   IntAct; P56178; 9.
DR   MINT; MINT-4720915; -.
DR   STRING; 9606.ENSP00000222598; -.
DR   iPTMnet; P56178; -.
DR   PhosphoSitePlus; P56178; -.
DR   BioMuta; DLX5; -.
DR   DMDM; 12644329; -.
DR   PaxDb; P56178; -.
DR   PeptideAtlas; P56178; -.
DR   PRIDE; P56178; -.
DR   DNASU; 1749; -.
DR   Ensembl; ENST00000222598; ENSP00000222598; ENSG00000105880. [P56178-1]
DR   Ensembl; ENST00000486603; ENSP00000475008; ENSG00000105880. [P56178-2]
DR   GeneID; 1749; -.
DR   KEGG; hsa:1749; -.
DR   UCSC; uc011kim.2; human. [P56178-1]
DR   CTD; 1749; -.
DR   DisGeNET; 1749; -.
DR   EuPathDB; HostDB:ENSG00000105880.4; -.
DR   GeneCards; DLX5; -.
DR   HGNC; HGNC:2918; DLX5.
DR   HPA; HPA005670; -.
DR   MalaCards; DLX5; -.
DR   MIM; 220600; phenotype.
DR   MIM; 600028; gene.
DR   neXtProt; NX_P56178; -.
DR   OpenTargets; ENSG00000105880; -.
DR   Orphanet; 71271; Split hand - split foot - deafness.
DR   Orphanet; 2440; Split hand-split foot malformation.
DR   PharmGKB; PA27373; -.
DR   eggNOG; KOG0850; Eukaryota.
DR   eggNOG; ENOG410ZHZR; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231940; -.
DR   HOVERGEN; HBG005493; -.
DR   InParanoid; P56178; -.
DR   KO; K18489; -.
DR   OMA; NSASWYP; -.
DR   OrthoDB; EOG091G0P17; -.
DR   PhylomeDB; P56178; -.
DR   TreeFam; TF350606; -.
DR   SIGNOR; P56178; -.
DR   EvolutionaryTrace; P56178; -.
DR   GeneWiki; DLX5; -.
DR   GenomeRNAi; 1749; -.
DR   PRO; PR:P56178; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105880; -.
DR   CleanEx; HS_DLX5; -.
DR   ExpressionAtlas; P56178; baseline and differential.
DR   Genevisible; P56178; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; ISS:BHF-UCL.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; ISS:BHF-UCL.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0030509; P:BMP signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0001958; P:endochondral ossification; ISS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0097376; P:interneuron axon guidance; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0021889; P:olfactory bulb interneuron differentiation; IEA:Ensembl.
DR   GO; GO:0060166; P:olfactory pit development; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; ISS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR022135; Distal-less_N.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF12413; DLL_N; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Deafness; Developmental protein; Disease mutation; DNA-binding;
KW   Homeobox; Nucleus; Osteogenesis; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    289       Homeobox protein DLX-5.
FT                                /FTId=PRO_0000049031.
FT   DNA_BIND    137    196       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES      34     34       Phosphoserine; by MAPK14; in vitro.
FT                                {ECO:0000250|UniProtKB:P70396}.
FT   MOD_RES     217    217       Phosphoserine; by MAPK14; in vitro.
FT                                {ECO:0000250|UniProtKB:P70396}.
FT   VAR_SEQ     182    289       KIWFQNKRSKIKKIMKNGEMPPEHSPSSSDPMACNSPQSPA
FT                                VWEPQGSSRSLSHHPHAHPPTSNQSPASSYLENSASWYTSA
FT                                ASSINSHLPPPGSLQHPLALASGTLY -> NTALPCTRPA
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056884.
FT   VARIANT     178    178       Q -> P (in SHFM1D; dbSNP:rs387906737).
FT                                {ECO:0000269|PubMed:22121204}.
FT                                /FTId=VAR_067413.
FT   VARIANT     234    234       S -> R (in dbSNP:rs35273378).
FT                                /FTId=VAR_033874.
FT   HELIX       146    158       {ECO:0000244|PDB:4RDU}.
FT   HELIX       164    173       {ECO:0000244|PDB:4RDU}.
FT   HELIX       178    196       {ECO:0000244|PDB:4RDU}.
SQ   SEQUENCE   289 AA;  31540 MW;  5BC9970B12E30554 CRC64;
     MTGVFDRRVP SIRSGDFQAP FQTSAAMHHP SQESPTLPES SATDSDYYSP TGGAPHGYCS
     PTSASYGKAL NPYQYQYHGV NGSAGSYPAK AYADYSYASS YHQYGGAYNR VPSATNQPEK
     EVTEPEVRMV NGKPKKVRKP RTIYSSFQLA ALQRRFQKTQ YLALPERAEL AASLGLTQTQ
     VKIWFQNKRS KIKKIMKNGE MPPEHSPSSS DPMACNSPQS PAVWEPQGSS RSLSHHPHAH
     PPTSNQSPAS SYLENSASWY TSAASSINSH LPPPGSLQHP LALASGTLY
//
ID   DLX6_HUMAN              Reviewed;         175 AA.
AC   P56179; A4D1I2; B3KSQ0; J3KR92; Q3ZAR6; Q9UPL2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   25-OCT-2017, entry version 153.
DE   RecName: Full=Homeobox protein DLX-6;
GN   Name=DLX6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 49-114.
RC   TISSUE=Embryo;
RX   PubMed=7907794; DOI=10.1073/pnas.91.6.2250;
RA   Simeone A., Acampora D., Pannese M., D'Esposito M., Stornaiuolo A.,
RA   Gulisano M., Mallamaci A., Kastury K., Druck T., Huebner K.,
RA   Boncinelli E.;
RT   "Cloning and characterization of two members of the vertebrate Dlx
RT   gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2250-2254(1994).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P56179-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56179-2; Sequence=VSP_040732;
CC       Name=3;
CC         IsoId=P56179-3; Sequence=VSP_047248;
CC   -!- DEVELOPMENTAL STAGE: First expressed in embryos at 8.5-9 days in
CC       facial and branchial arch mesenchyme, otic vesicles and
CC       frontonasal ectoderm around olfactory placodes, a day later
CC       expression is seen in the developing forebrain in primordia of the
CC       ganglionic eminence and ventral diencephalic regions. In day 12.5
CC       embryos, expressed in the brain and bones, and also in all
CC       skeletal structures of midgestation embryos after the first
CC       cartilage formation, and expression progressively declines in both
CC       brain and skeleton in day 15 embryos.
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004774; AAC17832.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24122.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76744.1; -; Genomic_DNA.
DR   EMBL; BC069363; AAH69363.1; -; mRNA.
DR   EMBL; BC103688; AAI03689.1; -; mRNA.
DR   EMBL; BC103689; AAI03690.1; -; mRNA.
DR   EMBL; BC103690; AAI03691.1; -; mRNA.
DR   EMBL; BC109381; AAI09382.1; -; mRNA.
DR   EMBL; AK094086; BAG52812.1; -; mRNA.
DR   CCDS; CCDS47647.2; -. [P56179-3]
DR   PIR; D53495; D53495.
DR   RefSeq; NP_005213.3; NM_005222.3. [P56179-3]
DR   UniGene; Hs.249196; -.
DR   ProteinModelPortal; P56179; -.
DR   SMR; P56179; -.
DR   BioGrid; 108094; 20.
DR   IntAct; P56179; 1.
DR   STRING; 9606.ENSP00000428480; -.
DR   iPTMnet; P56179; -.
DR   PhosphoSitePlus; P56179; -.
DR   DMDM; 12644330; -.
DR   PaxDb; P56179; -.
DR   PeptideAtlas; P56179; -.
DR   PRIDE; P56179; -.
DR   Ensembl; ENST00000518156; ENSP00000428480; ENSG00000006377. [P56179-3]
DR   GeneID; 1750; -.
DR   KEGG; hsa:1750; -.
DR   UCSC; uc022ahu.2; human. [P56179-1]
DR   CTD; 1750; -.
DR   DisGeNET; 1750; -.
DR   EuPathDB; HostDB:ENSG00000006377.10; -.
DR   GeneCards; DLX6; -.
DR   H-InvDB; HIX0006871; -.
DR   HGNC; HGNC:2919; DLX6.
DR   HPA; HPA030608; -.
DR   HPA; HPA061460; -.
DR   MIM; 600030; gene.
DR   neXtProt; NX_P56179; -.
DR   OpenTargets; ENSG00000006377; -.
DR   PharmGKB; PA27374; -.
DR   eggNOG; KOG0850; Eukaryota.
DR   eggNOG; ENOG410ZHZR; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231941; -.
DR   HOVERGEN; HBG005493; -.
DR   InParanoid; P56179; -.
DR   KO; K09314; -.
DR   OMA; HQDSMQR; -.
DR   OrthoDB; EOG091G0P17; -.
DR   PhylomeDB; P56179; -.
DR   TreeFam; TF315720; -.
DR   GeneWiki; DLX6; -.
DR   GenomeRNAi; 1750; -.
DR   PRO; PR:P56179; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000006377; -.
DR   CleanEx; HS_DLX6; -.
DR   ExpressionAtlas; P56179; baseline and differential.
DR   Genevisible; P56179; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0060322; P:head development; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    175       Homeobox protein DLX-6.
FT                                /FTId=PRO_0000049034.
FT   DNA_BIND     49    108       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1      1       M -> MMTMTTMADGLEGQDSSKSAFMEFGQQQQQQHSPAM
FT                                AGAHYPLHCLHSAAAAAAAGSHHHHHHQHHHHGSPYASGGG
FT                                NSYNHRSLAAYPYM (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_040732.
FT   VAR_SEQ       1      1       M -> MMTMTTMADGLEGQDSSKSAFMEFGQQQQQQQQQQQ
FT                                QQQQQQQQPPPPPPPPPQPHSQQSSPAMAGAHYPLHCLHSA
FT                                AAAAAAGSHHHHHHQHHHHGSPYASGGGNSYNHRSLAAYPY
FT                                M (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047248.
SQ   SEQUENCE   175 AA;  19708 MW;  F5552738D7E0CB84 CRC64;
     MSHSQHSPYL QSYHNSSAAA QTRGDDTDQQ KTTVIENGEI RFNGKGKKIR KPRTIYSSLQ
     LQALNHRFQQ TQYLALPERA ELAASLGLTQ TQVKIWFQNK RSKFKKLLKQ GSNPHESDPL
     QGSAALSPRS PALPPVWDVS ASAKGVSMPP NSYMPGYSHW YSSPHQDTMQ RPQMM
//
ID   DLX4_HUMAN              Reviewed;         240 AA.
AC   Q92988; D3DTX2; D3DTX3; O60480; Q13265; Q6PJK0; Q9HBE0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 4.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Homeobox protein DLX-4;
DE   AltName: Full=Beta protein 1;
DE   AltName: Full=Homeobox protein DLX-7;
DE   AltName: Full=Homeobox protein DLX-8;
GN   Name=DLX4; Synonyms=BP1, DLX7, DLX8, DLX9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Leukemia;
RX   PubMed=8975708; DOI=10.1006/geno.1996.0634;
RA   Nakamura S., Stock D.W., Wydner K.L., Bollekens J.A., Takeshita K.,
RA   Nagai B.M., Chiba S., Kitamura T., Freeland T.M., Zhao Z.,
RA   Minowada J., Lawrence J.B., Weiss K.M., Ruddle F.H.;
RT   "Genomic analysis of a new mammalian distal-less gene: Dlx7.";
RL   Genomics 38:314-324(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9467018; DOI=10.1093/hmg/7.3.563;
RA   Price J.A., Bowden D.W., Wright J.T., Pettenati M.J., Hart T.C.;
RT   "Identification of a mutation in DLX3 associated with tricho-dento-
RT   osseous (TDO) syndrome.";
RL   Hum. Mol. Genet. 7:563-569(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11069021; DOI=10.1038/sj.leu.2401912;
RA   Haga S.B., Fu S., Karp J.E., Ross D.D., Williams D.M., Hankins W.D.,
RA   Behm F., Ruscetti F.W., Chang M., Smith B.D., Becton D.,
RA   Raimondi S.C., Berg P.E.;
RT   "BP1, a new homeobox gene, is frequently expressed in acute
RT   leukemias.";
RL   Leukemia 14:1867-1875(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RX   PubMed=11909945; DOI=10.1128/MCB.22.8.2505-2514.2002;
RA   Chase M.B., Fu S., Haga S.B., Davenport G., Stevenson H., Do K.,
RA   Morgan D., Mah A.L., Berg P.E.;
RT   "BP1, a homeodomain-containing isoform of DLX4, represses the beta-
RT   globin gene.";
RL   Mol. Cell. Biol. 22:2505-2514(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Foreskin;
RX   PubMed=11792834; DOI=10.1073/pnas.012584999;
RA   Sumiyama K., Irvine S.Q., Stock D.W., Weiss K.M., Kawasaki K.,
RA   Shimizu N., Shashikant C.S., Miller W., Ruddle F.H.;
RT   "Genomic structure and functional control of the Dlx3-7 bigene
RT   cluster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:780-785(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-177.
RC   TISSUE=Placenta;
RX   PubMed=9073066; DOI=10.1016/S0378-1119(96)00706-8;
RA   Quinn L.M., Johnson B.V., Nicholl J., Sutherland G.R., Kalionis B.;
RT   "Isolation and identification of homeobox genes from the human
RT   placenta including a novel member of the Distal-less family, DLX4.";
RL   Gene 187:55-61(1997).
RN   [10]
RP   INVOLVEMENT IN OFC15, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25954033; DOI=10.1093/hmg/ddv167;
RA   Wu D., Mandal S., Choi A., Anderson A., Prochazkova M., Perry H.,
RA   Gil-Da-Silva-Lopes V.L., Lao R., Wan E., Tang P.L., Kwok P.Y.,
RA   Klein O., Zhuan B., Slavotinek A.M.;
RT   "DLX4 is associated with orofacial clefting and abnormal jaw
RT   development.";
RL   Hum. Mol. Genet. 24:4340-4352(2015).
CC   -!- FUNCTION: May play a role in determining the production of
CC       hemoglobin S. May act as a repressor. During embryonic
CC       development, plays a role in palatogenesis.
CC       {ECO:0000269|PubMed:11909945, ECO:0000269|PubMed:25954033}.
CC   -!- INTERACTION:
CC       P16333:NCK1; NbExp=3; IntAct=EBI-1752755, EBI-389883;
CC       Q13485:SMAD4; NbExp=5; IntAct=EBI-1752755, EBI-347263;
CC       P08047:SP1; NbExp=4; IntAct=EBI-1752755, EBI-298336;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:25954033}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist. PubMed:9073066
CC         (AAC51171) sequence may be an additional isoform.;
CC       Name=1;
CC         IsoId=Q92988-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92988-2; Sequence=VSP_002236;
CC         Note=Ref.1 (AAC50942) sequence is in conflict in position:
CC         8:P->H. Ref.1 (AAC50942) sequence is in conflict in position:
CC         15:Y->N. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q92988-3; Sequence=VSP_002236, VSP_017043;
CC   -!- TISSUE SPECIFICITY: Expressed in leukemia cells and placenta. Also
CC       expressed in kidney and fetal liver. {ECO:0000269|PubMed:11069021,
CC       ECO:0000269|PubMed:11909945}.
CC   -!- DISEASE: Non-syndromic orofacial cleft 15 (OFC15) [MIM:616788]: A
CC       birth defect consisting of cleft lips with or without cleft
CC       palate. Cleft lips are associated with cleft palate in two-third
CC       of cases. A cleft lip can occur on one or both sides and range in
CC       severity from a simple notch in the upper lip to a complete
CC       opening in the lip extending into the floor of the nostril and
CC       involving the upper gum. OFC15 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:25954033}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the distal-less homeobox family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DLX4ID49827ch17q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U73328; AAC50942.1; -; mRNA.
DR   EMBL; AF028235; AAC14398.1; -; Genomic_DNA.
DR   EMBL; AF254115; AAG31975.1; -; mRNA.
DR   EMBL; AF452638; AAL99503.1; -; Genomic_DNA.
DR   EMBL; BT006978; AAP35624.1; -; mRNA.
DR   EMBL; CH471109; EAW94651.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94653.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94654.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94655.1; -; Genomic_DNA.
DR   EMBL; BC005812; AAH05812.1; -; mRNA.
DR   EMBL; BC014419; AAH14419.1; -; mRNA.
DR   EMBL; BC016145; AAH16145.1; -; mRNA.
DR   EMBL; U31762; AAC51171.1; -; mRNA.
DR   CCDS; CCDS11555.1; -. [Q92988-1]
DR   CCDS; CCDS45728.1; -. [Q92988-2]
DR   PIR; G01958; G01958.
DR   RefSeq; NP_001925.2; NM_001934.3. [Q92988-2]
DR   RefSeq; NP_612138.1; NM_138281.2. [Q92988-1]
DR   RefSeq; XP_016879780.1; XM_017024291.1. [Q92988-2]
DR   UniGene; Hs.591167; -.
DR   ProteinModelPortal; Q92988; -.
DR   SMR; Q92988; -.
DR   BioGrid; 108092; 4.
DR   IntAct; Q92988; 14.
DR   MINT; MINT-6489135; -.
DR   STRING; 9606.ENSP00000240306; -.
DR   iPTMnet; Q92988; -.
DR   PhosphoSitePlus; Q92988; -.
DR   BioMuta; DLX4; -.
DR   DMDM; 85700416; -.
DR   PaxDb; Q92988; -.
DR   PeptideAtlas; Q92988; -.
DR   PRIDE; Q92988; -.
DR   DNASU; 1748; -.
DR   Ensembl; ENST00000240306; ENSP00000240306; ENSG00000108813. [Q92988-1]
DR   Ensembl; ENST00000411890; ENSP00000410622; ENSG00000108813. [Q92988-2]
DR   Ensembl; ENST00000611342; ENSP00000480366; ENSG00000108813. [Q92988-3]
DR   GeneID; 1748; -.
DR   KEGG; hsa:1748; -.
DR   UCSC; uc002ipv.4; human. [Q92988-1]
DR   CTD; 1748; -.
DR   DisGeNET; 1748; -.
DR   EuPathDB; HostDB:ENSG00000108813.10; -.
DR   GeneCards; DLX4; -.
DR   HGNC; HGNC:2917; DLX4.
DR   HPA; HPA059933; -.
DR   MalaCards; DLX4; -.
DR   MIM; 601911; gene.
DR   MIM; 616788; phenotype.
DR   neXtProt; NX_Q92988; -.
DR   OpenTargets; ENSG00000108813; -.
DR   PharmGKB; PA27372; -.
DR   eggNOG; KOG0850; Eukaryota.
DR   eggNOG; ENOG410ZHZR; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOVERGEN; HBG005493; -.
DR   InParanoid; Q92988; -.
DR   KO; K09314; -.
DR   OMA; YSGPYGH; -.
DR   OrthoDB; EOG091G0L8C; -.
DR   PhylomeDB; Q92988; -.
DR   TreeFam; TF315720; -.
DR   GeneWiki; DLX4; -.
DR   GenomeRNAi; 1748; -.
DR   PRO; PR:Q92988; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108813; -.
DR   CleanEx; HS_DLX4; -.
DR   Genevisible; Q92988; HS.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    240       Homeobox protein DLX-4.
FT                                /FTId=PRO_0000049028.
FT   DNA_BIND    117    176       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1     94       MTSLPCPLPGRDASKAVFPDLAPVPSVAAAYPLGLSPTTAA
FT                                SPNLSYSRPYGHLLSYPYTEPANPGDSYLSCQQPAALSQPL
FT                                CGPAEHPQELEA -> MKLSVLPPRSLLAPYTVLCCPP
FT                                (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8975708}.
FT                                /FTId=VSP_002236.
FT   VAR_SEQ     162    240       KIWFQNKRSKYKKLLKQNSGGQEGDFPGRTFSVSPCSPPLP
FT                                SLWDLPKAGTLPTSGYGNSFGAWYQHHSSDVLASPQMM ->
FT                                GPVSSFPISHLPWFSGNSSPSPSCE (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017043.
FT   CONFLICT      1     94       MTSLPCPLPGRDASKAVFPDLAPVPSVAAAYPLGLSPTTAA
FT                                SPNLSYSRPYGHLLSYPYTEPANPGDSYLSCQQPAALSQPL
FT                                CGPAEHPQELEA -> GGSLSLPPEPLCARCPTKEGAAPRR
FT                                PGFWGSLETQAATVWRGRHGHFSCRVRLSRGAARYSRRGQG
FT                                KPGVTISAARLVFKVLSAGPLTHPAGRSRRLPRGHRLKPLS
FT                                IALSLCLQCPSSVISRPRLSPGPSLSAPPYPKLAPPPVAEL
FT                                RPPTAGAAVPWLWPSARFLPRVTGPIRVGAPLGAELRLVSP
FT                                GAVNVGVETLHAE (in Ref. 9). {ECO:0000305}.
FT   CONFLICT    113    113       P -> A (in Ref. 1; AAC50942).
FT                                {ECO:0000305}.
FT   CONFLICT    203    203       S -> Y (in Ref. 1; AAC50942).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       A -> P (in Ref. 1; AAC50942).
FT                                {ECO:0000305}.
FT   CONFLICT    235    235       Missing (in Ref. 1; AAC50942).
FT                                {ECO:0000305}.
SQ   SEQUENCE   240 AA;  26263 MW;  18EE52CF20C126EB CRC64;
     MTSLPCPLPG RDASKAVFPD LAPVPSVAAA YPLGLSPTTA ASPNLSYSRP YGHLLSYPYT
     EPANPGDSYL SCQQPAALSQ PLCGPAEHPQ ELEADSEKPR LSPEPSERRP QAPAKKLRKP
     RTIYSSLQLQ HLNQRFQHTQ YLALPERAQL AAQLGLTQTQ VKIWFQNKRS KYKKLLKQNS
     GGQEGDFPGR TFSVSPCSPP LPSLWDLPKA GTLPTSGYGN SFGAWYQHHS SDVLASPQMM
//
ID   DU4L5_HUMAN             Reviewed;         424 AA.
AC   P0CJ88;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 1.
DT   27-SEP-2017, entry version 47.
DE   RecName: Full=Double homeobox protein 4-like protein 5;
GN   Name=DUX4L5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC126281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; P0CJ88; -.
DR   SMR; P0CJ88; -.
DR   iPTMnet; P0CJ88; -.
DR   PhosphoSitePlus; P0CJ88; -.
DR   PaxDb; P0CJ88; -.
DR   PRIDE; P0CJ88; -.
DR   DisGeNET; 653545; -.
DR   GeneCards; DUX4L5; -.
DR   HGNC; HGNC:38689; DUX4L5.
DR   HPA; HPA058451; -.
DR   neXtProt; NX_P0CJ88; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   InParanoid; P0CJ88; -.
DR   PhylomeDB; P0CJ88; -.
DR   PRO; PR:P0CJ88; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    424       Double homeobox protein 4-like protein 5.
FT                                /FTId=PRO_0000405253.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    338       Pro-rich.
SQ   SEQUENCE   424 AA;  44926 MW;  F26D864B7DFC4A11 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGVS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SASARQGQMQ GIPAPSQALQ
     EPAPWSALPC GLLLDELLAS PEFLQQAQPL LETEAPGELE ASEEAASLEA PLSEEEYRAL
     LEEL
//
ID   DUX1_HUMAN              Reviewed;         170 AA.
AC   O43812;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   27-SEP-2017, entry version 110.
DE   RecName: Full=Double homeobox protein 1;
GN   Name=DUX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Rhabdomyosarcoma;
RX   PubMed=9736770; DOI=10.1093/hmg/7.11.1681;
RA   Ding H., Beckers M.-C., Plaisance S., Marynen P., Collen D.,
RA   Belayew A.;
RT   "Characterization of a double homeodomain protein (DUX1) encoded by a
RT   cDNA homologous to 3.3-kb dispersed repeated elements.";
RL   Hum. Mol. Genet. 7:1681-1694(1998).
RN   [2]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15709750; DOI=10.1021/bi047992w;
RA   Oestlund C., Garcia-Carrasquillo R.M., Belayew A., Worman H.J.;
RT   "Intracellular trafficking and dynamics of double homeodomain
RT   proteins.";
RL   Biochemistry 44:2378-2384(2005).
CC   -!- FUNCTION: Probable transcription activator. Binds the P5 DNA
CC       element sequence 5'-GATCTGAGTCTAATTGAGAATTACTGTAC-3'.
CC       {ECO:0000269|PubMed:9736770}.
CC   -!- INTERACTION:
CC       P17661:DES; NbExp=4; IntAct=EBI-11599346, EBI-1055572;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:15709750,
CC       ECO:0000269|PubMed:9736770}. Note=Actively transported through the
CC       nuclear pore complex (NPC).
CC   -!- TISSUE SPECIFICITY: Expressed in rhabdomyosarcoma TE671 cells as
CC       well as in several other normal and cancer cells.
CC       {ECO:0000269|PubMed:9736770}.
CC   -!- DOMAIN: Homeobox domain 2 confers nuclear targeting.
CC   -!- MISCELLANEOUS: DUX genes are present in 3.3-kilobase elements, a
CC       tandem repeat family scattered in the genome found on the short
CC       arms of all acrocentric chromosomes as well as on several other
CC       chromosomes.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ001481; CAA04776.1; -; mRNA.
DR   RefSeq; NP_036278.1; NM_012146.1.
DR   UniGene; Hs.274469; -.
DR   ProteinModelPortal; O43812; -.
DR   SMR; O43812; -.
DR   IntAct; O43812; 7.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   PeptideAtlas; O43812; -.
DR   PRIDE; O43812; -.
DR   DNASU; 26584; -.
DR   GeneID; 26584; -.
DR   KEGG; hsa:26584; -.
DR   CTD; 26584; -.
DR   DisGeNET; 26584; -.
DR   GeneCards; DUX1; -.
DR   HGNC; HGNC:3079; DUX1.
DR   HPA; HPA058451; -.
DR   MIM; 611441; gene.
DR   neXtProt; NX_O43812; -.
DR   PharmGKB; PA27535; -.
DR   HOVERGEN; HBG081466; -.
DR   InParanoid; O43812; -.
DR   PhylomeDB; O43812; -.
DR   GenomeRNAi; 26584; -.
DR   PRO; PR:O43812; -.
DR   Proteomes; UP000005640; Unplaced.
DR   CleanEx; HS_DUX1; -.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    170       Double homeobox protein 1.
FT                                /FTId=PRO_0000252410.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   170 AA;  19347 MW;  7E3B34169B081F08 CRC64;
     MALLTALDDT LPEEAQGPGR RMILLSTPSQ SDALRACFER NLYPGIATKE ELAQGIDIPE
     PRVQIWFQNE RSCQLRQHRR QSRPWPGRRD PQKGRRKRTA ITGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHR GQSGRAPTQA SIRCNAAPIG
//
ID   DUX5_HUMAN              Reviewed;         197 AA.
AC   Q96PT3;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   27-SEP-2017, entry version 88.
DE   RecName: Full=Double homeobox protein 5;
GN   Name=DUX5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11245978; DOI=10.1016/S0378-1119(00)00602-8;
RA   Beckers M.-C., Gabrieels J., van der Maarel S., De Vriese A.,
RA   Frants R.R., Collen D., Belayew A.;
RT   "Active genes in junk DNA? Characterization of DUX genes embedded
RT   within 3.3 kb repeated elements.";
RL   Gene 264:51-57(2001).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96PT3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96PT3-2; Sequence=VSP_020959;
CC   -!- TISSUE SPECIFICITY: Expressed in hepatoma Hep3B cells.
CC       {ECO:0000269|PubMed:11245978}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal tissue.
CC       {ECO:0000269|PubMed:11245978}.
CC   -!- MISCELLANEOUS: DUX genes are present in 3.3-kilobase elements, a
CC       tandem repeat family scattered in the genome found on the short
CC       arms of all acrocentric chromosomes as well as on several other
CC       chromosomes. May be functional despite lack of introns and a
CC       poly(A) addition signal.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF133131; AAD33598.1; -; Genomic_DNA.
DR   EMBL; AF133131; AAL02243.1; -; Genomic_DNA.
DR   RefSeq; NP_036278.1; NM_012146.1. [Q96PT3-2]
DR   RefSeq; NP_036281.2; NM_012149.2. [Q96PT3-1]
DR   UniGene; Hs.274469; -.
DR   ProteinModelPortal; Q96PT3; -.
DR   SMR; Q96PT3; -.
DR   IntAct; Q96PT3; 2.
DR   DMDM; 74717113; -.
DR   EPD; Q96PT3; -.
DR   PeptideAtlas; Q96PT3; -.
DR   PRIDE; Q96PT3; -.
DR   DNASU; 26581; -.
DR   DNASU; 26584; -.
DR   GeneID; 26581; -.
DR   GeneID; 26584; -.
DR   KEGG; hsa:26581; -.
DR   KEGG; hsa:26584; -.
DR   CTD; 26581; -.
DR   CTD; 26584; -.
DR   DisGeNET; 26584; -.
DR   GeneCards; DUX5; -.
DR   HGNC; HGNC:3083; DUX5.
DR   HPA; HPA058451; -.
DR   MIM; 611444; gene.
DR   neXtProt; NX_Q96PT3; -.
DR   PharmGKB; PA27535; -.
DR   PharmGKB; PA27539; -.
DR   HOVERGEN; HBG081466; -.
DR   InParanoid; Q96PT3; -.
DR   PhylomeDB; Q96PT3; -.
DR   PRO; PR:Q96PT3; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1    197       Double homeobox protein 5.
FT                                /FTId=PRO_0000252414.
FT   DNA_BIND     46    105       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    121    180       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1     27       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_020959.
FT   VARIANT      60     60       A -> V (in dbSNP:rs10865697).
FT                                /FTId=VAR_059347.
FT   VARIANT     118    118       P -> L (in dbSNP:rs9755233).
FT                                /FTId=VAR_059348.
FT   VARIANT     119    119       Q -> P (in dbSNP:rs12374009).
FT                                /FTId=VAR_059349.
FT   VARIANT     180    180       S -> A (in dbSNP:rs12632317).
FT                                /FTId=VAR_059350.
FT   VARIANT     180    180       S -> T (in dbSNP:rs12632317).
FT                                /FTId=VAR_059351.
SQ   SEQUENCE   197 AA;  22164 MW;  9F20E036413853F4 CRC64;
     MPAEVHGSPP ASLCPCQSVK FRPGLPEMAL LTALDDTLPE EAQGPGRRMI LLSTPSQSDA
     LRACFERNLY PGIATKEELA QGIDIPEPRV QIWFQNERSC QLRQHRRQSR PWPGRRDPQK
     GRRKRTAITG SQTALLLRAF EKDRFPGIAA REELARETGL PESRIQIWFQ NRRARHRGQS
     GRAPTQASIR CNAAPIG
//
ID   DUX4_HUMAN              Reviewed;         424 AA.
AC   Q9UBX2;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   25-OCT-2017, entry version 129.
DE   RecName: Full=Double homeobox protein 4 {ECO:0000312|HGNC:HGNC:50800};
DE   AltName: Full=Double homeobox protein 10 {ECO:0000312|EMBL:AAK91509.1};
GN   Name=DUX4 {ECO:0000312|HGNC:HGNC:50800}; Synonyms=DUX10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   INVOLVEMENT IN FSHD1.
RX   PubMed=10433963; DOI=10.1016/S0378-1119(99)00267-X;
RA   Gabrieels J., Beckers M.-C., Ding H., De Vriese A., Plaisance S.,
RA   van der Maarel S.M., Padberg G.W., Frants R.R., Hewitt J.E.,
RA   Collen D., Belayew A.;
RT   "Nucleotide sequence of the partially deleted D4Z4 locus in a patient
RT   with FSHD identifies a putative gene within each 3.3 kb element.";
RL   Gene 236:25-32(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Leclercq I., Matteotti C., Deneubourg G., Leo O., Van der Maarel S.M.,
RA   Frants R.R., Padberg G.W., Coppee F., Belayew A.;
RT   "A subtelomeric exchange between chromosomes 4q35 and 10q26 observed
RT   in a patient with FSHD maintains a double homeobox (DUX) gene within
RT   the 3.3 kb repeats of the D4Z4 locus.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15709750; DOI=10.1021/bi047992w;
RA   Oestlund C., Garcia-Carrasquillo R.M., Belayew A., Worman H.J.;
RT   "Intracellular trafficking and dynamics of double homeodomain
RT   proteins.";
RL   Biochemistry 44:2378-2384(2005).
RN   [5]
RP   INVOLVEMENT IN FSHD1.
RX   PubMed=19320656; DOI=10.1111/j.1399-0004.2009.01158.x;
RA   Mostacciuolo M.L., Pastorello E., Vazza G., Miorin M., Angelini C.,
RA   Tomelleri G., Galluzzi G., Trevisan C.P.;
RT   "Facioscapulohumeral muscular dystrophy: epidemiological and molecular
RT   study in a north-east Italian population sample.";
RL   Clin. Genet. 75:550-555(2009).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21060811; DOI=10.1371/journal.pgen.1001181;
RA   Snider L., Geng L.N., Lemmers R.J., Kyba M., Ware C.B., Nelson A.M.,
RA   Tawil R., Filippova G.N., van der Maarel S.M., Tapscott S.J.,
RA   Miller D.G.;
RT   "Facioscapulohumeral dystrophy: incomplete suppression of a
RT   retrotransposed gene.";
RL   PLoS Genet. 6:E1001181-E1001181(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=24145033; DOI=10.1074/jbc.M113.504522;
RA   Dmitriev P., Stankevicins L., Ansseau E., Petrov A., Barat A.,
RA   Dessen P., Robert T., Turki A., Lazar V., Labourer E., Belayew A.,
RA   Carnac G., Laoudj-Chenivesse D., Lipinski M., Vassetzky Y.S.;
RT   "Defective regulation of microRNA target genes in myoblasts from
RT   facioscapulohumeral dystrophy patients.";
RL   J. Biol. Chem. 288:34989-35002(2013).
CC   -!- FUNCTION: Involved in transcriptional regulation. May regulate
CC       microRNA (miRNA) expression. {ECO:0000269|PubMed:10433963,
CC       ECO:0000269|PubMed:24145033}.
CC   -!- SUBUNIT: May exist as a monomer or a dimer.
CC   -!- INTERACTION:
CC       P17661:DES; NbExp=3; IntAct=EBI-11600078, EBI-1055572;
CC       P31001:Des (xeno); NbExp=2; IntAct=EBI-11600078, EBI-298565;
CC       O94829:IPO13; NbExp=2; IntAct=EBI-11600078, EBI-747310;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:15709750,
CC       ECO:0000269|PubMed:21060811}. Note=Actively transported through
CC       the nuclear pore complex (NPC).
CC   -!- TISSUE SPECIFICITY: Does not seem to be expressed in normal
CC       muscle, but is detected in muscle of individuals with FSHD, and
CC       also in testis (at protein level) (PubMed:21060811). Does not seem
CC       to be expressed in normal muscle, but in muscle of individuals
CC       with FSHD, where it may be toxic to cells.
CC       {ECO:0000269|PubMed:10433963, ECO:0000269|PubMed:21060811}.
CC   -!- DOMAIN: Both homeobox domains confer nuclear targeting.
CC   -!- DISEASE: Facioscapulohumeral muscular dystrophy 1 (FSHD1)
CC       [MIM:158900]: A degenerative muscle disease characterized by
CC       slowly progressive weakness of the muscles of the face, upper-arm,
CC       and shoulder girdle. The onset of symptoms usually occurs in the
CC       first or second decade of life. Affected individuals usually
CC       present with impairment of upper extremity elevation. This tends
CC       to be followed by facial weakness, primarily involving the
CC       orbicularis oris and orbicularis oculi muscles.
CC       {ECO:0000269|PubMed:10433963, ECO:0000269|PubMed:19320656}.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis. The disease is caused by deletion of an integral
CC       number of units of a 3.3-kb tandem repeats, termed D4Z4
CC       macrosatellite, located on chromosome 4q35. In unaffected
CC       subjects, the D4Z4 array consists of 11-150 repeats, while in
CC       FSHD1 patients, the array is reduced to 1-10 repeats
CC       (PubMed:19320656). DUX4 is located in D4Z4 macrosatellite which is
CC       epigenetically repressed in somatic tissues. D4Z4 chromatin
CC       relaxation in FSHD1 results in inefficient epigenetic repression
CC       of DUX4 and a variegated pattern of DUX4 protein expression in a
CC       subset of skeletal muscle nuclei. Ectopic expression of DUX4 in
CC       skeletal muscle activates the expression of stem cell and germline
CC       genes, and, when overexpressed in somatic cells, DUX4 can
CC       ultimately lead to cell death. {ECO:0000269|PubMed:19320656}.
CC   -!- MISCELLANEOUS: DUX genes are present in 3.3-kilobase elements, a
CC       tandem repeat family scattered in the genome found on the short
CC       arms of all acrocentric chromosomes as well as on several other
CC       chromosomes.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF117653; AAD54067.2; -; Genomic_DNA.
DR   EMBL; AF117653; AAD54068.2; -; Genomic_DNA.
DR   EMBL; AY044051; AAK91509.1; -; Genomic_DNA.
DR   EMBL; AC215524; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS77990.1; -.
DR   RefSeq; NP_001280727.1; NM_001293798.2.
DR   RefSeq; NP_001292997.1; NM_001306068.2.
DR   RefSeq; XP_016885822.1; XM_017030333.1.
DR   RefSeq; XP_016885823.1; XM_017030334.1.
DR   RefSeq; XP_016885824.1; XM_017030335.1.
DR   RefSeq; XP_016885825.1; XM_017030336.1.
DR   RefSeq; XP_016885826.1; XM_017030337.1.
DR   RefSeq; XP_016885827.1; XM_017030338.1.
DR   RefSeq; XP_016885828.1; XM_017030339.1.
DR   RefSeq; XP_016885829.1; XM_017030340.1.
DR   UniGene; Hs.728749; -.
DR   ProteinModelPortal; Q9UBX2; -.
DR   SMR; Q9UBX2; -.
DR   IntAct; Q9UBX2; 284.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; Q9UBX2; -.
DR   PhosphoSitePlus; Q9UBX2; -.
DR   DMDM; 74720085; -.
DR   PaxDb; Q9UBX2; -.
DR   PRIDE; Q9UBX2; -.
DR   Ensembl; ENST00000565211; ENSP00000458065; ENSG00000260596.
DR   Ensembl; ENST00000569241; ENSP00000456539; ENSG00000260596.
DR   Ensembl; ENST00000616166; ENSP00000483555; ENSG00000260596.
DR   Ensembl; ENST00000637517; ENSP00000489958; ENSG00000283949.
DR   GeneID; 100288687; -.
DR   GeneID; 107987484; -.
DR   GeneID; 107987485; -.
DR   GeneID; 107987486; -.
DR   GeneID; 107987487; -.
DR   GeneID; 107987488; -.
DR   GeneID; 107987489; -.
DR   GeneID; 107987490; -.
DR   GeneID; 107987491; -.
DR   KEGG; hsa:100288687; -.
DR   KEGG; hsa:107987484; -.
DR   KEGG; hsa:107987485; -.
DR   KEGG; hsa:107987486; -.
DR   KEGG; hsa:107987487; -.
DR   KEGG; hsa:107987488; -.
DR   KEGG; hsa:107987489; -.
DR   KEGG; hsa:107987490; -.
DR   KEGG; hsa:107987491; -.
DR   UCSC; uc031tgs.2; human.
DR   CTD; 100288687; -.
DR   DisGeNET; 100288687; -.
DR   DisGeNET; 107987484; -.
DR   DisGeNET; 107987485; -.
DR   DisGeNET; 107987486; -.
DR   DisGeNET; 107987487; -.
DR   DisGeNET; 107987488; -.
DR   DisGeNET; 107987489; -.
DR   DisGeNET; 107987490; -.
DR   DisGeNET; 107987491; -.
DR   EuPathDB; HostDB:ENSG00000260596.5; -.
DR   GeneCards; DUX4; -.
DR   GeneReviews; DUX4; -.
DR   HGNC; HGNC:50800; DUX4.
DR   HPA; HPA058451; -.
DR   MalaCards; DUX4; -.
DR   MIM; 158900; phenotype.
DR   MIM; 606009; gene.
DR   neXtProt; NX_Q9UBX2; -.
DR   OpenTargets; ENSG00000260596; -.
DR   Orphanet; 269; Facioscapulohumeral dystrophy.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00610000085975; -.
DR   HOVERGEN; HBG063255; -.
DR   InParanoid; Q9UBX2; -.
DR   OMA; AAWEPQA; -.
DR   OrthoDB; EOG091G0ISS; -.
DR   PhylomeDB; Q9UBX2; -.
DR   SIGNOR; Q9UBX2; -.
DR   GenomeRNAi; 100288687; -.
DR   PRO; PR:Q9UBX2; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000260596; -.
DR   CleanEx; HS_DUX4; -.
DR   ExpressionAtlas; Q9UBX2; baseline and differential.
DR   Genevisible; Q9UBX2; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0070317; P:negative regulation of G0 to G1 transition; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    424       Double homeobox protein 4.
FT                                /FTId=PRO_0000252413.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     16     98       Arg-rich.
FT   COMPBIAS    156    245       Ala-rich.
SQ   SEQUENCE   424 AA;  44940 MW;  C51E9EE25C6661B8 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGIS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SASARQGQMQ GIPAPSQALQ
     EPAPWSALPC GLLLDELLAS PEFLQQAQPL LETEAPGELE ASEEAASLEA PLSEEEYRAL
     LEEL
//
ID   DU4L6_HUMAN             Reviewed;         424 AA.
AC   P0CJ89;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 1.
DT   27-SEP-2017, entry version 47.
DE   RecName: Full=Double homeobox protein 4-like protein 6;
GN   Name=DUX4L6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC126281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; P0CJ89; -.
DR   SMR; P0CJ89; -.
DR   iPTMnet; P0CJ89; -.
DR   PhosphoSitePlus; P0CJ89; -.
DR   DMDM; 325530036; -.
DR   PaxDb; P0CJ89; -.
DR   PRIDE; P0CJ89; -.
DR   GeneCards; DUX4L6; -.
DR   HGNC; HGNC:37265; DUX4L6.
DR   HPA; HPA058451; -.
DR   neXtProt; NX_P0CJ89; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   InParanoid; P0CJ89; -.
DR   PhylomeDB; P0CJ89; -.
DR   PRO; PR:P0CJ89; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    424       Double homeobox protein 4-like protein 6.
FT                                /FTId=PRO_0000405254.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    338       Pro-rich.
SQ   SEQUENCE   424 AA;  44926 MW;  F26D864B7DFC4A11 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGVS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SASARQGQMQ GIPAPSQALQ
     EPAPWSALPC GLLLDELLAS PEFLQQAQPL LETEAPGELE ASEEAASLEA PLSEEEYRAL
     LEEL
//
ID   DU4L4_HUMAN             Reviewed;         422 AA.
AC   P0CJ87;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 1.
DT   27-SEP-2017, entry version 51.
DE   RecName: Full=Double homeobox protein 4-like protein 4;
GN   Name=DUX4L4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC126281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; P0CJ87; -.
DR   SMR; P0CJ87; -.
DR   STRING; 9606.ENSP00000438513; -.
DR   iPTMnet; P0CJ87; -.
DR   PhosphoSitePlus; P0CJ87; -.
DR   DMDM; 325530034; -.
DR   PaxDb; P0CJ87; -.
DR   PRIDE; P0CJ87; -.
DR   GeneCards; DUX4L4; -.
DR   HGNC; HGNC:38686; DUX4L4.
DR   HPA; HPA058451; -.
DR   neXtProt; NX_P0CJ87; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   InParanoid; P0CJ87; -.
DR   PhylomeDB; P0CJ87; -.
DR   PRO; PR:P0CJ87; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    422       Double homeobox protein 4-like protein 4.
FT                                /FTId=PRO_0000405252.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    367       Pro-rich.
SQ   SEQUENCE   422 AA;  44826 MW;  01E2DFA529FC6FB7 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGVS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGEA PPPQPAPPDA SARQGQMQGI PAPSQALQEP
     APWSALPCGL LLDELLASPE FLQQAQPLLE TEAPGELEAS EEAASLEAPL SEEEYRALLE
     EL
//
ID   DUXA_HUMAN              Reviewed;         204 AA.
AC   A6NLW8;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   27-SEP-2017, entry version 83.
DE   RecName: Full=Double homeobox protein A;
GN   Name=DUXA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=17005330; DOI=10.1016/j.gene.2006.07.034;
RA   Booth H.A., Holland P.W.H.;
RT   "Annotation, nomenclature and evolution of four novel homeobox genes
RT   expressed in the human germ line.";
RL   Gene 387:7-14(2007).
CC   -!- FUNCTION: Putative transcription factor. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC025588; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS33126.1; -.
DR   RefSeq; NP_001012747.1; NM_001012729.1.
DR   UniGene; Hs.585857; -.
DR   ProteinModelPortal; A6NLW8; -.
DR   SMR; A6NLW8; -.
DR   STRING; 9606.ENSP00000452398; -.
DR   iPTMnet; A6NLW8; -.
DR   PhosphoSitePlus; A6NLW8; -.
DR   BioMuta; DUXA; -.
DR   PaxDb; A6NLW8; -.
DR   PRIDE; A6NLW8; -.
DR   Ensembl; ENST00000554048; ENSP00000452398; ENSG00000258873.
DR   GeneID; 503835; -.
DR   KEGG; hsa:503835; -.
DR   UCSC; uc002qoa.2; human.
DR   CTD; 503835; -.
DR   EuPathDB; HostDB:ENSG00000258873.2; -.
DR   GeneCards; DUXA; -.
DR   H-InvDB; HIX0016200; -.
DR   HGNC; HGNC:32179; DUXA.
DR   HPA; HPA059358; -.
DR   MIM; 611168; gene.
DR   neXtProt; NX_A6NLW8; -.
DR   OpenTargets; ENSG00000258873; -.
DR   PharmGKB; PA142671924; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00610000085975; -.
DR   HOGENOM; HOG000112297; -.
DR   InParanoid; A6NLW8; -.
DR   OMA; RCRTTYS; -.
DR   OrthoDB; EOG091G0K3P; -.
DR   PhylomeDB; A6NLW8; -.
DR   TreeFam; TF340750; -.
DR   GenomeRNAi; 503835; -.
DR   PRO; PR:A6NLW8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000258873; -.
DR   CleanEx; HS_DUXA; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    204       Double homeobox protein A.
FT                                /FTId=PRO_0000311327.
FT   DNA_BIND     15     74       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    101    160       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   204 AA;  23817 MW;  56A0906E62A3BB56 CRC64;
     MAEDTYSHKM VKTNHRRCRT KFTEEQLKIL INTFNQKPYP GYATKQKLAL EINTEESRIQ
     IWFQNRRARH GFQKRPEAET LESSQSQGQD QPGVEFQSRE ARRCRTTYSA SQLHTLIKAF
     MKNPYPGIDS REELAKEIGV PESRVQIWFQ NRRSRLLLQR KREPVASLEQ EEQGKIPEGL
     QGAEDTQNGT NFTSDSHFSG ARTW
//
ID   DPRX_HUMAN              Reviewed;         191 AA.
AC   A6NFQ7;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   27-SEP-2017, entry version 80.
DE   RecName: Full=Divergent paired-related homeobox;
GN   Name=DPRX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=17005330; DOI=10.1016/j.gene.2006.07.034;
RA   Booth H.A., Holland P.W.H.;
RT   "Annotation, nomenclature and evolution of four novel homeobox genes
RT   expressed in the human germ line.";
RL   Gene 387:7-14(2007).
CC   -!- FUNCTION: Putative transcription factor. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011487; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS33103.1; -.
DR   RefSeq; NP_001012746.1; NM_001012728.1.
DR   RefSeq; XP_011525313.1; XM_011527011.2.
DR   RefSeq; XP_011525314.1; XM_011527012.2.
DR   UniGene; Hs.579941; -.
DR   ProteinModelPortal; A6NFQ7; -.
DR   SMR; A6NFQ7; -.
DR   STRING; 9606.ENSP00000365838; -.
DR   iPTMnet; A6NFQ7; -.
DR   PhosphoSitePlus; A6NFQ7; -.
DR   BioMuta; DPRX; -.
DR   EPD; A6NFQ7; -.
DR   PaxDb; A6NFQ7; -.
DR   PRIDE; A6NFQ7; -.
DR   Ensembl; ENST00000376650; ENSP00000365838; ENSG00000204595.
DR   GeneID; 503834; -.
DR   KEGG; hsa:503834; -.
DR   UCSC; uc002qcf.1; human.
DR   CTD; 503834; -.
DR   EuPathDB; HostDB:ENSG00000204595.1; -.
DR   GeneCards; DPRX; -.
DR   HGNC; HGNC:32166; DPRX.
DR   HPA; HPA043682; -.
DR   MIM; 611165; gene.
DR   neXtProt; NX_A6NFQ7; -.
DR   PharmGKB; PA142671957; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00640000091698; -.
DR   HOGENOM; HOG000112264; -.
DR   InParanoid; A6NFQ7; -.
DR   OMA; HRKRTMF; -.
DR   OrthoDB; EOG091G0KB4; -.
DR   PhylomeDB; A6NFQ7; -.
DR   GenomeRNAi; 503834; -.
DR   PRO; PR:A6NFQ7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000204595; -.
DR   CleanEx; HS_DPRX; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    191       Divergent paired-related homeobox.
FT                                /FTId=PRO_0000311326.
FT   DNA_BIND     16     75       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   191 AA;  21648 MW;  D804219AD5A69066 CRC64;
     MPGSEDLRKG KDQMHSHRKR TMFTKKQLED LNILFNENPY PNPSLQKEMA SKIDIHPTVL
     QVWFKNHRAK LKKAKCKHIH QKQETPQPPI PEGGVSTSVG LRNADTLPRL PNAAHPIGLV
     YTGHRVPSFQ LILYPNLKVP ANDFIGHRIV HFGCCRDPNI YCLYPILESQ VCAPSFHSGS
     PACSSNQSRE R
//
ID   DRGX_HUMAN              Reviewed;         263 AA.
AC   A6NNA5;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 80.
DE   RecName: Full=Dorsal root ganglia homeobox protein;
DE   AltName: Full=Paired-related homeobox protein-like 1;
GN   Name=DRGX; Synonyms=PRRXL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Transcription factor required for the formation of
CC       correct projections from nociceptive sensory neurons to the dorsal
CC       horn of the spinal cord and normal perception of pain.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with RGMB. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC027674; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471187; EAW93100.1; -; Genomic_DNA.
DR   CCDS; CCDS44388.2; -.
DR   RefSeq; NP_001263380.1; NM_001276451.1.
DR   UniGene; Hs.534530; -.
DR   ProteinModelPortal; A6NNA5; -.
DR   SMR; A6NNA5; -.
DR   STRING; 9606.ENSP00000401653; -.
DR   iPTMnet; A6NNA5; -.
DR   PhosphoSitePlus; A6NNA5; -.
DR   PaxDb; A6NNA5; -.
DR   PRIDE; A6NNA5; -.
DR   Ensembl; ENST00000374139; ENSP00000363254; ENSG00000165606.
DR   Ensembl; ENST00000434016; ENSP00000401653; ENSG00000165606.
DR   GeneID; 644168; -.
DR   KEGG; hsa:644168; -.
DR   UCSC; uc021pqd.2; human.
DR   CTD; 644168; -.
DR   EuPathDB; HostDB:ENSG00000165606.8; -.
DR   GeneCards; DRGX; -.
DR   HGNC; HGNC:21536; DRGX.
DR   HPA; HPA043978; -.
DR   MIM; 606701; gene.
DR   neXtProt; NX_A6NNA5; -.
DR   OpenTargets; ENSG00000165606; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG106743; -.
DR   InParanoid; A6NNA5; -.
DR   OMA; KGSPLCS; -.
DR   OrthoDB; EOG091G0YX9; -.
DR   PhylomeDB; A6NNA5; -.
DR   GenomeRNAi; 644168; -.
DR   PRO; PR:A6NNA5; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000165606; -.
DR   CleanEx; HS_DRGX; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0009593; P:detection of chemical stimulus; IEA:Ensembl.
DR   GO; GO:0016048; P:detection of temperature stimulus; IEA:Ensembl.
DR   GO; GO:0021516; P:dorsal spinal cord development; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0050954; P:sensory perception of mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0021559; P:trigeminal nerve development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    263       Dorsal root ganglia homeobox protein.
FT                                /FTId=PRO_0000300814.
FT   DNA_BIND     33     92       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       204    217       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
SQ   SEQUENCE   263 AA;  28672 MW;  7FF77B9C4763EDE6 CRC64;
     MFYFHCPPQL EGTATFGNHS SGDFDDGFLR RKQRRNRTTF TLQQLEALEA VFAQTHYPDV
     FTREELAMKI NLTEARVQVW FQNRRAKWRK TERGASDQEP GAKEPMAEVT PPPVRNINSP
     PPGDQARSKK EALEAQQSLG RTVGPAGPFF PSCLPGTLLN TATYAQALSH VASLKGGPLC
     SCCVPDPMGL SFLPTYGCQS NRTASVATLR MKAREHSEAV LQSANLLPST SSSPGPVAKP
     APPDGSQEKT SPTKEQSEAE KSV
//
ID   DUX3_HUMAN              Reviewed;         197 AA.
AC   Q96PT4; Q9UND2;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   27-SEP-2017, entry version 86.
DE   RecName: Full=Putative double homeobox protein 3;
GN   Name=DUX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), TISSUE
RP   SPECIFICITY, ALTERNATIVE SPLICING, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Blood;
RX   PubMed=11245978; DOI=10.1016/S0378-1119(00)00602-8;
RA   Beckers M.-C., Gabrieels J., van der Maarel S., De Vriese A.,
RA   Frants R.R., Collen D., Belayew A.;
RT   "Active genes in junk DNA? Characterization of DUX genes embedded
RT   within 3.3 kb repeated elements.";
RL   Gene 264:51-57(2001).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96PT4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96PT4-2; Sequence=VSP_020958;
CC   -!- TISSUE SPECIFICITY: Expressed in hepatoma Hep3B cells.
CC       {ECO:0000269|PubMed:11245978}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal tissue.
CC       {ECO:0000269|PubMed:11245978}.
CC   -!- MISCELLANEOUS: DUX genes are present in 3.3-kilobase elements, a
CC       tandem repeat family scattered in the genome found on the short
CC       arms of all acrocentric chromosomes as well as on several other
CC       chromosomes. May be functional despite lack of introns and of a
CC       poly(A) addition signal.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF133130; AAL02242.1; -; Genomic_DNA.
DR   EMBL; AF133130; AAD33597.1; -; Genomic_DNA.
DR   ProteinModelPortal; Q96PT4; -.
DR   SMR; Q96PT4; -.
DR   IntAct; Q96PT4; 5.
DR   MINT; MINT-7970020; -.
DR   DMDM; 74717114; -.
DR   PeptideAtlas; Q96PT4; -.
DR   PRIDE; Q96PT4; -.
DR   DNASU; 26582; -.
DR   GeneCards; DUX3; -.
DR   HGNC; HGNC:3081; DUX3.
DR   HPA; HPA058451; -.
DR   MIM; 611443; gene.
DR   neXtProt; NX_Q96PT4; -.
DR   PharmGKB; PA27537; -.
DR   HOVERGEN; HBG081466; -.
DR   InParanoid; Q96PT4; -.
DR   PhylomeDB; Q96PT4; -.
DR   GenomeRNAi; 26582; -.
DR   PRO; PR:Q96PT4; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Repeat.
FT   CHAIN         1    197       Putative double homeobox protein 3.
FT                                /FTId=PRO_0000252412.
FT   DNA_BIND     46    105       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    121    180       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1     27       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_020958.
SQ   SEQUENCE   197 AA;  22130 MW;  4545E2738BFCE954 CRC64;
     MPAEVHGSPP ASLCPCPSVK FRPGLPAMAL LTALDDTLPE EAQGPGRRMI LLSTPSQSDA
     LRACFERNLY PGIATKEQLA QGIDIPEPRV QIWFQNERSC QLRQHRRQSR PWPGRRDPQK
     GRRKRTAITG SQTALLLRAF EKDRFPGIPA REELARETGL PESRIQLWFQ NRRARHWGQS
     GRAPTQASIR CNAAPIG
//
ID   DUX4C_HUMAN             Reviewed;         374 AA.
AC   Q6RFH8;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   27-SEP-2017, entry version 83.
DE   RecName: Full=Double homeobox protein 4C;
DE   AltName: Full=Double homeobox protein 4, centromeric;
DE            Short=DUX4c;
DE   AltName: Full=Double homeobox protein 4-like protein 9;
GN   Name=DUX4L9; Synonyms=DUX4C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, INTERACTION WITH MYF5,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=19829708; DOI=10.1371/journal.pone.0007482;
RA   Ansseau E., Laoudj-Chenivesse D., Marcowycz A., Tassin A.,
RA   Vanderplanck C., Sauvage S., Barro M., Mahieu I., Leroy A.,
RA   Leclercq I., Mainfroid V., Figlewicz D., Mouly V., Butler-Browne G.,
RA   Belayew A., Coppee F.;
RT   "DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human
RT   myoblast proliferation.";
RL   PLoS ONE 4:E7482-E7482(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=18723017; DOI=10.1016/j.expneurol.2008.07.022;
RA   Bosnakovski D., Lamb S., Simsek T., Xu Z., Belayew A., Perlingeiro R.,
RA   Kyba M.;
RT   "DUX4c, an FSHD candidate gene, interferes with myogenic regulators
RT   and abolishes myoblast differentiation.";
RL   Exp. Neurol. 214:87-96(2008).
RN   [4]
RP   FUNCTION.
RX   PubMed=24145033; DOI=10.1074/jbc.M113.504522;
RA   Dmitriev P., Stankevicins L., Ansseau E., Petrov A., Barat A.,
RA   Dessen P., Robert T., Turki A., Lazar V., Labourer E., Belayew A.,
RA   Carnac G., Laoudj-Chenivesse D., Lipinski M., Vassetzky Y.S.;
RT   "Defective regulation of microRNA target genes in myoblasts from
RT   facioscapulohumeral dystrophy patients.";
RL   J. Biol. Chem. 288:34989-35002(2013).
CC   -!- FUNCTION: May be involved in transcriptional regulation (By
CC       similarity). Down-regulates MYOD1 expression and may up-regulate
CC       MYF5 expression. May regulate microRNA (miRNA) transcription,
CC       upregulating the expression of some myogenic miRNAs, including
CC       MIR1-1, MIR133A2, MIR133B and MIR206. Impairs the differentiation
CC       of myoblasts and may be involved in muscle regeneration.
CC       {ECO:0000250, ECO:0000269|PubMed:18723017,
CC       ECO:0000269|PubMed:19829708, ECO:0000269|PubMed:24145033}.
CC   -!- SUBUNIT: May interact with MYF5; regulates MYF5 expression.
CC   -!- INTERACTION:
CC       P17661:DES; NbExp=4; IntAct=EBI-11599882, EBI-1055572;
CC       O94829:IPO13; NbExp=2; IntAct=EBI-11599882, EBI-747310;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:19829708}.
CC   -!- TISSUE SPECIFICITY: Expressed in muscles, as well as in primary
CC       myoblasts and myotubes (at protein level).
CC       {ECO:0000269|PubMed:19829708}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated during myoblasts differentiation
CC       (at protein level). {ECO:0000269|PubMed:19829708}.
CC   -!- DISEASE: Note=Up-regulated in myoblasts of facioscapulohumeral
CC       muscular dystrophy (FSHD) patients (at protein level).
CC       {ECO:0000269|PubMed:19829708}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY500824; AAS15569.1; -; Genomic_DNA.
DR   EMBL; AF146191; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; Q6RFH8; -.
DR   SMR; Q6RFH8; -.
DR   IntAct; Q6RFH8; 51.
DR   iPTMnet; Q6RFH8; -.
DR   PhosphoSitePlus; Q6RFH8; -.
DR   DMDM; 74710112; -.
DR   PRIDE; Q6RFH8; -.
DR   DisGeNET; 100288711; -.
DR   GeneCards; DUX4L9; -.
DR   H-InvDB; HIX0020902; -.
DR   HGNC; HGNC:33855; DUX4L9.
DR   HPA; HPA058451; -.
DR   MIM; 615581; gene.
DR   neXtProt; NX_Q6RFH8; -.
DR   HOVERGEN; HBG063255; -.
DR   InParanoid; Q6RFH8; -.
DR   PhylomeDB; Q6RFH8; -.
DR   PRO; PR:Q6RFH8; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 2.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    374       Double homeobox protein 4C.
FT                                /FTId=PRO_0000405256.
FT   DNA_BIND     19     78       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND     94    153       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    156    245       Ala-rich.
FT   COMPBIAS    191    338       Pro-rich.
SQ   SEQUENCE   374 AA;  39442 MW;  B7F4ED12BED46821 CRC64;
     MALPTPSDST LPAEARGRGR RRRLVWTPSQ SEALRACFER NPYPGIATRE RLAQAIGIPE
     PRVQIWFQNE RSRQLRQHRR ESRPWPGRRG PPEGRRKRTA VTGSQTALLL RAFEKDRFPG
     IAAREELARE TGLPESRIQI WFQNRRARHP GQGGRAPAQA GGLCSAAPGG GHPAPSWVAF
     AHTGAWGTGL PAPHVPCAPG ALPQGAFVSQ AARAAPALQP SQAAPAEGIS QPAPARGDFA
     YAAPAPPDGA LSHPQAPRWP PHPGKSREDR DPQRDGLPGP CAVAQPGPAQ AGPQGQGVLA
     PPTSQGSPWW GWGRGPQVAG AAWEPQAGAA PPPQPAPPDA SAASTDASHP GASQPLQEPG
     RSSTVTSSLL YELL
//
ID   EMX2_HUMAN              Reviewed;         252 AA.
AC   Q04743; G3V305; Q96NN8; Q9BQF4;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   25-OCT-2017, entry version 165.
DE   RecName: Full=Homeobox protein EMX2;
DE   AltName: Full=Empty spiracles homolog 2;
DE   AltName: Full=Empty spiracles-like protein 2;
GN   Name=EMX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11549315; DOI=10.1006/geno.2001.6590;
RA   Noonan F.C., Mutch D.G., Mallon M., Goodfellow P.J.;
RT   "Characterization of the homeodomain gene EMX2: sequence conservation,
RT   expression analysis and a search for mutations in endometrial
RT   cancers.";
RL   Genomics 76:37-44(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 95-252 (ISOFORM 1).
RX   PubMed=1352754;
RA   Simeone A., Gulisano M., Acampora D., Stornaiuolo A., Rambaldi M.,
RA   Boncinelli E.;
RT   "Two vertebrate homeobox genes related to the Drosophila empty
RT   spiracles gene are expressed in the embryonic cerebral cortex.";
RL   EMBO J. 11:2541-2550(1992).
RN   [6]
RP   INVOLVEMENT IN SCHZC.
RX   PubMed=8528262; DOI=10.1038/ng0196-94;
RA   Brunelli S., Faiella A., Capra V., Nigro V., Simeone A., Cama A.,
RA   Boncinelli E.;
RT   "Germline mutations in the homeobox gene EMX2 in patients with severe
RT   schizencephaly.";
RL   Nat. Genet. 12:94-96(1996).
CC   -!- FUNCTION: Transcription factor, which in cooperation with EMX2,
CC       acts to generate the boundary between the roof and archipallium in
CC       the developing brain. May function in combinations with OTX1/2 to
CC       specify cell fates in the developing central nervous system.
CC   -!- INTERACTION:
CC       P06730:EIF4E; NbExp=4; IntAct=EBI-399831, EBI-73440;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q04743-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q04743-2; Sequence=VSP_045823;
CC   -!- TISSUE SPECIFICITY: Cerebral cortex.
CC   -!- DISEASE: Schizencephaly (SCHZC) [MIM:269160]: Extremely rare human
CC       congenital disorder characterized by a full-thickness cleft within
CC       the cerebral hemispheres. These clefts are lined with gray matter
CC       and most commonly involve the parasylvian regions. Large portions
CC       of the cerebral hemispheres may be absent and replaced by cerebro-
CC       spinal fluid. {ECO:0000269|PubMed:8528262}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the EMX homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF301598; AAK95496.1; -; mRNA.
DR   EMBL; AL161811; CAB82104.1; -; mRNA.
DR   EMBL; AK055041; BAB70842.1; -; mRNA.
DR   EMBL; AC005871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X68880; CAA48751.1; -; mRNA.
DR   CCDS; CCDS53583.1; -. [Q04743-2]
DR   CCDS; CCDS7601.1; -. [Q04743-1]
DR   PIR; S22722; S22722.
DR   RefSeq; NP_001159396.1; NM_001165924.1. [Q04743-2]
DR   RefSeq; NP_004089.1; NM_004098.3. [Q04743-1]
DR   UniGene; Hs.202095; -.
DR   ProteinModelPortal; Q04743; -.
DR   SMR; Q04743; -.
DR   BioGrid; 108333; 3.
DR   IntAct; Q04743; 2.
DR   STRING; 9606.ENSP00000358202; -.
DR   iPTMnet; Q04743; -.
DR   PhosphoSitePlus; Q04743; -.
DR   BioMuta; EMX2; -.
DR   DMDM; 19862512; -.
DR   PaxDb; Q04743; -.
DR   PeptideAtlas; Q04743; -.
DR   PRIDE; Q04743; -.
DR   DNASU; 2018; -.
DR   Ensembl; ENST00000442245; ENSP00000474874; ENSG00000170370. [Q04743-2]
DR   Ensembl; ENST00000553456; ENSP00000450962; ENSG00000170370. [Q04743-1]
DR   GeneID; 2018; -.
DR   KEGG; hsa:2018; -.
DR   UCSC; uc001ldh.5; human. [Q04743-1]
DR   CTD; 2018; -.
DR   DisGeNET; 2018; -.
DR   EuPathDB; HostDB:ENSG00000170370.11; -.
DR   GeneCards; EMX2; -.
DR   HGNC; HGNC:3341; EMX2.
DR   HPA; HPA003497; -.
DR   HPA; HPA065294; -.
DR   MalaCards; EMX2; -.
DR   MIM; 269160; phenotype.
DR   MIM; 600035; gene.
DR   neXtProt; NX_Q04743; -.
DR   OpenTargets; ENSG00000170370; -.
DR   Orphanet; 799; Schizencephaly.
DR   PharmGKB; PA27778; -.
DR   eggNOG; KOG0843; Eukaryota.
DR   eggNOG; ENOG4111SRW; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000247032; -.
DR   HOVERGEN; HBG005024; -.
DR   InParanoid; Q04743; -.
DR   KO; K09317; -.
DR   OMA; FQPTPKR; -.
DR   OrthoDB; EOG091G0P41; -.
DR   PhylomeDB; Q04743; -.
DR   TreeFam; TF317015; -.
DR   SIGNOR; Q04743; -.
DR   GeneWiki; EMX2; -.
DR   GenomeRNAi; 2018; -.
DR   PRO; PR:Q04743; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000170370; -.
DR   CleanEx; HS_EMX2; -.
DR   ExpressionAtlas; Q04743; baseline and differential.
DR   Genevisible; Q04743; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl.
DR   GO; GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl.
DR   GO; GO:0021542; P:dentate gyrus development; IEA:Ensembl.
DR   GO; GO:0021885; P:forebrain cell migration; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0072001; P:renal system development; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    252       Homeobox protein EMX2.
FT                                /FTId=PRO_0000048868.
FT   DNA_BIND    154    213       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     54     59       Poly-Ala.
FT   VAR_SEQ     137    252       NDTSPESFLLHNALARKPKRIRTAFSPSQLLRLEHAFEKNH
FT                                YVVGAERKQLAHSLSLTETQVKVWFQNRRTKFKRQKLEEEG
FT                                SDSQQKKKGTHHINRWRIATKQASPEEIDVTSDD -> KSM
FT                                VSEPKNKVQKAEAGGRRLRFATKEKRDAPY (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_045823.
FT   CONFLICT    104    104       S -> P (in Ref. 3; BAB70842).
FT                                {ECO:0000305}.
SQ   SEQUENCE   252 AA;  28303 MW;  90DAEFFC893A971C CRC64;
     MFQPAPKRCF TIESLVAKDS PLPASRSEDP IRPAALSYAN SSPINPFLNG FHSAAAAAAG
     RGVYSNPDLV FAEAVSHPPN PAVPVHPVPP PHALAAHPLP SSHSPHPLFA SQQRDPSTFY
     PWLIHRYRYL GHRFQGNDTS PESFLLHNAL ARKPKRIRTA FSPSQLLRLE HAFEKNHYVV
     GAERKQLAHS LSLTETQVKV WFQNRRTKFK RQKLEEEGSD SQQKKKGTHH INRWRIATKQ
     ASPEEIDVTS DD
//
ID   EVX2_HUMAN              Reviewed;         476 AA.
AC   Q03828;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   27-SEP-2017, entry version 131.
DE   RecName: Full=Homeobox even-skipped homolog protein 2;
DE   AltName: Full=EVX-2;
GN   Name=EVX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 144-300.
RX   PubMed=1675198; DOI=10.1016/0888-7543(91)90482-T;
RA   D'Esposito M., Morelli F., Acampora D., Migliaccio E., Simeone A.,
RA   Boncinelli E.;
RT   "EVX2, a human homeobox gene homologous to the even-skipped
RT   segmentation gene, is localized at the 5' end of HOX4 locus on
RT   chromosome 2.";
RL   Genomics 10:43-50(1991).
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed during early embryogenesis and
CC       neurogenesis in a biphasic manner.
CC   -!- SIMILARITY: Belongs to the even-skipped homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M59983; AAA52414.1; -; Genomic_DNA.
DR   EMBL; M59982; AAA52414.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS33333.1; -.
DR   PIR; A39065; A39065.
DR   RefSeq; NP_001073927.1; NM_001080458.1.
DR   UniGene; Hs.452341; -.
DR   ProteinModelPortal; Q03828; -.
DR   SMR; Q03828; -.
DR   STRING; 9606.ENSP00000312385; -.
DR   BioMuta; EVX2; -.
DR   DMDM; 12231013; -.
DR   PaxDb; Q03828; -.
DR   PRIDE; Q03828; -.
DR   Ensembl; ENST00000308618; ENSP00000312385; ENSG00000174279.
DR   GeneID; 344191; -.
DR   KEGG; hsa:344191; -.
DR   UCSC; uc010zeu.3; human.
DR   CTD; 344191; -.
DR   DisGeNET; 344191; -.
DR   EuPathDB; HostDB:ENSG00000174279.4; -.
DR   GeneCards; EVX2; -.
DR   HGNC; HGNC:3507; EVX2.
DR   HPA; HPA041576; -.
DR   MIM; 142991; gene.
DR   neXtProt; NX_Q03828; -.
DR   OpenTargets; ENSG00000174279; -.
DR   PharmGKB; PA27920; -.
DR   eggNOG; KOG0844; Eukaryota.
DR   eggNOG; ENOG4111RMB; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000231897; -.
DR   HOVERGEN; HBG005620; -.
DR   InParanoid; Q03828; -.
DR   KO; K09320; -.
DR   OMA; YPFHSHV; -.
DR   OrthoDB; EOG091G0JVN; -.
DR   PhylomeDB; Q03828; -.
DR   TreeFam; TF315938; -.
DR   GenomeRNAi; 344191; -.
DR   PRO; PR:Q03828; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000174279; -.
DR   CleanEx; HS_EVX2; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0035108; P:limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    476       Homeobox even-skipped homolog protein 2.
FT                                /FTId=PRO_0000048872.
FT   DNA_BIND    188    247       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    294    301       Poly-Ala.
FT   COMPBIAS    304    308       Poly-Ala.
FT   COMPBIAS    346    351       Poly-Ala.
FT   COMPBIAS    356    370       Poly-Ala.
FT   COMPBIAS    373    378       Poly-Ala.
FT   COMPBIAS    398    408       Poly-Ala.
FT   COMPBIAS    413    434       Poly-Gly.
SQ   SEQUENCE   476 AA;  47800 MW;  6AA99041BA151C3F CRC64;
     MMERIRKEMI LMERGLHSPT AGKRFSNLSN SAGNAVLEAL ENSQHPARLS PRLPSAPLHS
     ALGELPAKGK FEIDTLFNLQ HTGSESTVSS EISSAAESRK KPGHYSEAAA EADMSSDVEV
     GCSALRSPGG LGAAQLKENN GKGYAESGSA AGTTTSASGS GLGSLHGGSG GSGGSAALGG
     SGSGADQVRR YRTAFTREQI ARLEKEFYRE NYVSRPRRCE LAAALNLPET TIKVWFQNRR
     MKDKRQRLAM SWPHPADPSF YTYMMTHAAA TGSLPYPFHS HVPLHYYPHV GVTAAAAAAA
     ASGAAAAASS PFATSIRPLD TFRALSHPYS RPELLCSFRH PGLYQAPAAA AGLNSAASAA
     AAAAAAAAAA SSAAAAGAPP SGGSAPCSCL SCHSSQSAAA AAAAAAAALG SRGGGGGGGG
     GGGGGGGGAG AGGGSDFGCS AAAPRSESGF LPYSAAVLSK TAVSPPDQRD EAPLTR
//
ID   EMX1_HUMAN              Reviewed;         257 AA.
AC   Q04741; Q0D2P0; Q53T30; Q86XB0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 2.
DT   27-SEP-2017, entry version 143.
DE   RecName: Full=Homeobox protein EMX1;
DE   AltName: Full=Empty spiracles homolog 1;
DE   AltName: Full=Empty spiracles-like protein 1;
GN   Name=EMX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 105-257.
RX   PubMed=1352754;
RA   Simeone A., Gulisano M., Acampora D., Stornaiuolo A., Rambaldi M.,
RA   Boncinelli E.;
RT   "Two vertebrate homeobox genes related to the Drosophila empty
RT   spiracles gene are expressed in the embryonic cerebral cortex.";
RL   EMBO J. 11:2541-2550(1992).
RN   [4]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH WRD11.
RX   PubMed=20887964; DOI=10.1016/j.ajhg.2010.08.018;
RA   Kim H.G., Ahn J.W., Kurth I., Ullmann R., Kim H.T., Kulharya A.,
RA   Ha K.S., Itokawa Y., Meliciani I., Wenzel W., Lee D., Rosenberger G.,
RA   Ozata M., Bick D.P., Sherins R.J., Nagase T., Tekin M., Kim S.H.,
RA   Kim C.H., Ropers H.H., Gusella J.F., Kalscheuer V., Choi C.Y.,
RA   Layman L.C.;
RT   "WDR11, a WD protein that interacts with transcription factor EMX1, is
RT   mutated in idiopathic hypogonadotropic hypogonadism and Kallmann
RT   syndrome.";
RL   Am. J. Hum. Genet. 87:465-479(2010).
CC   -!- FUNCTION: Transcription factor, which in cooperation with EMX2,
CC       acts to generate the boundary between the roof and archipallium in
CC       the developing brain. May function in combinations with OTX1/2 to
CC       specify cell fates in the developing central nervous system.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:20887964}. Cytoplasm
CC       {ECO:0000269|PubMed:20887964}. Note=Might be shuttling between the
CC       nucleus and the cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q04741-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q04741-2; Sequence=VSP_022145, VSP_022146;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Cerebral cortex.
CC   -!- SIMILARITY: Belongs to the EMX homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH45762.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC012366; AAY14744.1; -; Genomic_DNA.
DR   EMBL; BC037242; AAH37242.1; -; mRNA.
DR   EMBL; BC045762; AAH45762.2; ALT_INIT; mRNA.
DR   EMBL; X68879; CAA48750.1; -; mRNA.
DR   PIR; S22721; S22721.
DR   RefSeq; NP_004088.2; NM_004097.2.
DR   RefSeq; XP_011530999.1; XM_011532697.2. [Q04741-2]
DR   UniGene; Hs.516090; -.
DR   ProteinModelPortal; Q04741; -.
DR   SMR; Q04741; -.
DR   BioGrid; 108331; 7.
DR   STRING; 9606.ENSP00000258106; -.
DR   EPD; Q04741; -.
DR   PaxDb; Q04741; -.
DR   PeptideAtlas; Q04741; -.
DR   PRIDE; Q04741; -.
DR   Ensembl; ENST00000258106; ENSP00000258106; ENSG00000135638.
DR   GeneID; 2016; -.
DR   KEGG; hsa:2016; -.
DR   UCSC; uc002sin.1; human. [Q04741-1]
DR   CTD; 2016; -.
DR   DisGeNET; 2016; -.
DR   EuPathDB; HostDB:ENSG00000135638.13; -.
DR   GeneCards; EMX1; -.
DR   HGNC; HGNC:3340; EMX1.
DR   HPA; HPA006230; -.
DR   HPA; HPA006421; -.
DR   MIM; 600034; gene.
DR   neXtProt; NX_Q04741; -.
DR   PharmGKB; PA27777; -.
DR   eggNOG; KOG0843; Eukaryota.
DR   eggNOG; ENOG4111SRW; LUCA.
DR   HOGENOM; HOG000247032; -.
DR   HOVERGEN; HBG005024; -.
DR   InParanoid; Q04741; -.
DR   KO; K09317; -.
DR   OrthoDB; EOG091G0P41; -.
DR   PhylomeDB; Q04741; -.
DR   TreeFam; TF317015; -.
DR   ChiTaRS; EMX1; human.
DR   GeneWiki; EMX1; -.
DR   GenomeRNAi; 2016; -.
DR   PRO; PR:Q04741; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000135638; -.
DR   CleanEx; HS_EMX1; -.
DR   ExpressionAtlas; Q04741; baseline and differential.
DR   Genevisible; Q04741; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0048854; P:brain morphogenesis; IEA:Ensembl.
DR   GO; GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0060563; P:neuroepithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:1990138; P:neuron projection extension; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0060019; P:radial glial cell differentiation; IEA:Ensembl.
DR   GO; GO:0070445; P:regulation of oligodendrocyte progenitor proliferation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome.
FT   CHAIN         1    257       Homeobox protein EMX1.
FT                                /FTId=PRO_0000048866.
FT   DNA_BIND    159    218       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1    138       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022145.
FT   VAR_SEQ     139    140       FQ -> MV (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022146.
SQ   SEQUENCE   257 AA;  28039 MW;  127B0BE676F14B46 CRC64;
     MFQPAAKRGF TIESLVAKDG GTGGGTGGGG AGSHLLAAAA SEEPLRPTAL NYPHPSAAEA
     AFVSGFPAAA AAGAGRSLYG GPELVFPEAM NHPALTVHPA HQLGASPLQP PHSFFGAQHR
     DPLHFYPWVL RNRFFGHRFQ ASDVPQDGLL LHGPFARKPK RIRTAFSPSQ LLRLERAFEK
     NHYVVGAERK QLAGSLSLSE TQVKVWFQNR RTKYKRQKLE EEGPESEQKK KGSHHINRWR
     IATKQANGED IDVTSND
//
ID   ESX1_HUMAN              Reviewed;         406 AA.
AC   Q8N693; B0QYU3; Q7Z6K7;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   27-SEP-2017, entry version 127.
DE   RecName: Full=Homeobox protein ESX1;
DE   AltName: Full=Extraembryonic, spermatogenesis, homeobox 1;
DE   Contains:
DE     RecName: Full=Homeobox protein ESX1-N;
DE   Contains:
DE     RecName: Full=Homeobox protein ESX1-C;
GN   Name=ESX1; Synonyms=ESX1L, ESX1R;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Germ cell;
RX   PubMed=11374906; DOI=10.1006/geno.2001.6532;
RA   Fohn L.E., Behringer R.R.;
RT   "ESX1L, a novel X chromosome-linked human homeobox gene expressed in
RT   the placenta and testis.";
RL   Genomics 74:105-108(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, PROTEOLYTIC PROCESSING,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15235584; DOI=10.1038/sj.onc.1207884;
RA   Ozawa H., Ashizawa S., Naito M., Yanagihara M., Ohnishi N., Maeda T.,
RA   Matsuda Y., Jo Y., Higashi H., Kakita A., Hatakeyama M.;
RT   "Paired-like homeodomain protein ESXR1 possesses a cleavable C-
RT   terminal region that inhibits cyclin degradation.";
RL   Oncogene 23:6590-6602(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=15897875; DOI=10.1038/sj.onc.1208736;
RA   Yanagihara M., Ishikawa S., Naito M., Nakajima J., Aburatani H.,
RA   Hatakeyama M.;
RT   "Paired-like homeoprotein ESXR1 acts as a sequence-specific
RT   transcriptional repressor of the human K-ras gene.";
RL   Oncogene 24:5878-5887(2005).
CC   -!- FUNCTION: May coordinately regulate cell cycle progression and
CC       transcription during spermatogenesis. Inhibits degradation of
CC       polyubiquitinated cyclin A and cyclin B1 and thereby arrests the
CC       cell cycle at early M phase. ESXR1-N acts as a transcriptional
CC       repressor. Binds to the sequence 5'-TAATGTTATTA-3' which is
CC       present within the first intron of the KRAS gene and inhibits its
CC       expression. ESXR1-C has the ability to inhibit cyclin turnover.
CC       {ECO:0000269|PubMed:15235584, ECO:0000269|PubMed:15897875}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15235584}.
CC       Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108,
CC       ECO:0000269|PubMed:15235584}. Note=ESXR1-N localizes specifically
CC       to the nucleus while ESXR1-C localizes specifically to the
CC       cytoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed in placenta and testis. Expressed in
CC       testicular germ cell tumors. {ECO:0000269|PubMed:11374906,
CC       ECO:0000269|PubMed:15235584}.
CC   -!- PTM: Undergoes proteolytic cleavage; produces a 45 kDa N-terminal
CC       homeodomain-containing fragment (ESXR1-N) and a 20 kDa C-terminal
CC       fragment (ESXR1-C). {ECO:0000269|PubMed:15235584}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY114148; AAM62141.1; -; mRNA.
DR   EMBL; AL049631; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471120; EAX02755.1; -; Genomic_DNA.
DR   EMBL; BC042633; AAH42633.1; -; mRNA.
DR   EMBL; BC053599; AAH53599.1; -; mRNA.
DR   CCDS; CCDS14516.1; -.
DR   RefSeq; NP_703149.1; NM_153448.3.
DR   UniGene; Hs.223782; -.
DR   ProteinModelPortal; Q8N693; -.
DR   SMR; Q8N693; -.
DR   BioGrid; 123270; 2.
DR   IntAct; Q8N693; 3.
DR   MINT; MINT-7970367; -.
DR   STRING; 9606.ENSP00000361669; -.
DR   iPTMnet; Q8N693; -.
DR   PhosphoSitePlus; Q8N693; -.
DR   BioMuta; ESX1; -.
DR   DMDM; 116241356; -.
DR   PaxDb; Q8N693; -.
DR   PeptideAtlas; Q8N693; -.
DR   PRIDE; Q8N693; -.
DR   Ensembl; ENST00000372588; ENSP00000361669; ENSG00000123576.
DR   GeneID; 80712; -.
DR   KEGG; hsa:80712; -.
DR   UCSC; uc004ely.4; human.
DR   CTD; 80712; -.
DR   DisGeNET; 80712; -.
DR   EuPathDB; HostDB:ENSG00000123576.5; -.
DR   GeneCards; ESX1; -.
DR   HGNC; HGNC:14865; ESX1.
DR   HPA; HPA051992; -.
DR   MIM; 300154; gene.
DR   neXtProt; NX_Q8N693; -.
DR   OpenTargets; ENSG00000123576; -.
DR   PharmGKB; PA27892; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00820000127081; -.
DR   HOGENOM; HOG000198273; -.
DR   HOVERGEN; HBG084082; -.
DR   InParanoid; Q8N693; -.
DR   KO; K18491; -.
DR   OMA; MAPVPPW; -.
DR   OrthoDB; EOG091G0L2D; -.
DR   PhylomeDB; Q8N693; -.
DR   TreeFam; TF315976; -.
DR   GeneWiki; ESX1; -.
DR   GenomeRNAi; 80712; -.
DR   PRO; PR:Q8N693; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000123576; -.
DR   CleanEx; HS_ESX1; -.
DR   Genevisible; Q8N693; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR013847; POU.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    406       Homeobox protein ESX1.
FT                                /FTId=PRO_0000048876.
FT   CHAIN         1      ?       Homeobox protein ESX1-N.
FT                                /FTId=PRO_0000386625.
FT   CHAIN         ?    406       Homeobox protein ESX1-C.
FT                                /FTId=PRO_0000386626.
FT   REPEAT      244    252       1.
FT   REPEAT      253    261       2.
FT   REPEAT      262    270       3.
FT   REPEAT      271    279       4.
FT   REPEAT      280    288       5.
FT   REPEAT      289    297       6.
FT   REPEAT      298    306       7.
FT   REPEAT      307    315       8.
FT   REPEAT      316    324       9.
FT   REPEAT      325    333       10.
FT   REPEAT      334    342       11.
FT   REPEAT      343    351       12.
FT   REPEAT      352    360       13.
FT   REPEAT      361    369       14.
FT   REPEAT      370    378       15.
FT   DNA_BIND    139    198       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      244    378       15 X 9 AA tandem repeats of P-P-x-x-P-x-
FT                                P-P-x.
FT   MOTIF       138    143       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   VARIANT     314    314       T -> P (in dbSNP:rs9697856).
FT                                /FTId=VAR_059352.
FT   CONFLICT    320    320       P -> R (in Ref. 5; AAH42633/AAH53599).
FT                                {ECO:0000305}.
FT   CONFLICT    338    339       RV -> PL (in Ref. 5; AAH42633/AAH53599).
FT                                {ECO:0000305}.
SQ   SEQUENCE   406 AA;  44297 MW;  7013E3986F1148FA CRC64;
     MESLRGYTHS DIGYRSLAVG EDIEEVNDEK LTVTSLMARG GEDEENTRSK PEYGTEAENN
     VGTEGSVPSD DQDREGGGGH EPEQQQEEPP LTKPEQQQEE PPLLELKQEQ EEPPQTTVEG
     PQPAEGPQTA EGPQPPERKR RRRTAFTQFQ LQELENFFDE SQYPDVVARE RLAARLNLTE
     DRVQVWFQNR RAKWKRNQRV LMLRNTATAD LAHPLDMFLG GAYYAAPALD PALCVHLVPQ
     LPRPPVLPVP PMPPRPPMVP MPPRPPIAPM PPMAPVPPGS RMAPVPPGPR MAPVPPWPPM
     APVPPWPPMA PVPTGPPMAP VPPGPPMARV PPGPPMARVP PGPPMAPLPP GPPMAPLPPG
     PPMAPLPPGP PMAPLPPRSH VPHTGLAPVH ITWAPVINSY YACPFF
//
ID   EVX1_HUMAN              Reviewed;         407 AA.
AC   P49640; A4D199; B4DQJ0;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   25-OCT-2017, entry version 133.
DE   RecName: Full=Homeobox even-skipped homolog protein 1;
DE   AltName: Full=EVX-1;
GN   Name=EVX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=1684419; DOI=10.1093/nar/19.23.6541;
RA   Faiella A., D'Esposito M., Rambaldi M., Acampora D., Balsofiore S.,
RA   Stornaiuolo A., Mallamaci M., Migliaccio E., Gulisano M.;
RT   "Isolation and mapping of EVX1, a human homeobox gene homologous to
RT   even-skipped, localized at the 5' end of HOX1 locus on chromosome 7.";
RL   Nucleic Acids Res. 19:6541-6545(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7499236; DOI=10.1074/jbc.270.46.27695;
RA   Briata P., van de Werken R., Airoldi I., Ilengo C., di Blas E.,
RA   Boncinelli E., Corte G.;
RT   "Transcriptional repression by the human homeobox protein EVX1 in
RT   transfected mammalian cells.";
RL   J. Biol. Chem. 270:27695-27701(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
CC   -!- FUNCTION: May play a role in the specification of neuronal cell
CC       types.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49640-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49640-2; Sequence=VSP_056502;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the even-skipped homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60655; CAA43062.1; -; mRNA.
DR   EMBL; U68782; AAB07598.1; -; Genomic_DNA.
DR   EMBL; U68781; AAB07598.1; JOINED; Genomic_DNA.
DR   EMBL; AK298822; BAG60952.1; -; mRNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93892.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24216.1; -; Genomic_DNA.
DR   CCDS; CCDS5413.1; -. [P49640-1]
DR   PIR; S22586; S22586.
DR   RefSeq; NP_001291448.1; NM_001304519.1. [P49640-2]
DR   RefSeq; NP_001291449.1; NM_001304520.1. [P49640-2]
DR   RefSeq; NP_001980.1; NM_001989.4. [P49640-1]
DR   UniGene; Hs.369879; -.
DR   ProteinModelPortal; P49640; -.
DR   SMR; P49640; -.
DR   BioGrid; 108429; 1.
DR   STRING; 9606.ENSP00000419266; -.
DR   BioMuta; EVX1; -.
DR   DMDM; 1352398; -.
DR   EPD; P49640; -.
DR   PaxDb; P49640; -.
DR   PRIDE; P49640; -.
DR   DNASU; 2128; -.
DR   Ensembl; ENST00000496902; ENSP00000419266; ENSG00000106038. [P49640-1]
DR   GeneID; 2128; -.
DR   KEGG; hsa:2128; -.
DR   UCSC; uc003szd.2; human. [P49640-1]
DR   CTD; 2128; -.
DR   DisGeNET; 2128; -.
DR   EuPathDB; HostDB:ENSG00000106038.12; -.
DR   GeneCards; EVX1; -.
DR   HGNC; HGNC:3506; EVX1.
DR   HPA; HPA055132; -.
DR   MIM; 142996; gene.
DR   neXtProt; NX_P49640; -.
DR   OpenTargets; ENSG00000106038; -.
DR   PharmGKB; PA27919; -.
DR   eggNOG; KOG0844; Eukaryota.
DR   eggNOG; ENOG4111RMB; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000231897; -.
DR   HOVERGEN; HBG005620; -.
DR   InParanoid; P49640; -.
DR   KO; K09320; -.
DR   OMA; CHSGPAN; -.
DR   OrthoDB; EOG091G0JVN; -.
DR   PhylomeDB; P49640; -.
DR   TreeFam; TF315938; -.
DR   SIGNOR; P49640; -.
DR   GenomeRNAi; 2128; -.
DR   PRO; PR:P49640; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106038; -.
DR   CleanEx; HS_EVX1; -.
DR   ExpressionAtlas; P49640; baseline and differential.
DR   Genevisible; P49640; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    407       Homeobox even-skipped homolog protein 1.
FT                                /FTId=PRO_0000048870.
FT   DNA_BIND    183    242       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    114    124       Asp/Glu-rich (acidic).
FT   COMPBIAS    289    297       Ala-rich.
FT   COMPBIAS    361    368       Ala-rich.
FT   VAR_SEQ       1    182       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056502.
SQ   SEQUENCE   407 AA;  42440 MW;  75D696ECA1431D5A CRC64;
     MESRKDMVVF LDGGQLGTLV GKRVSNLSEA VGSPLPEPPE KMVPRGCLSP RAVPPATRER
     GGGGPEEEPV DGLAGSAAGP GAEPQVAGAA MLGPGPPAPS VDSLSGQGQP SSSDTESDFY
     EEIEVSCTPD CATGNAEYQH SKGSGSEALV GSPNGGSETP KSNGGSGGGG SQGTLACSAS
     DQMRRYRTAF TREQIARLEK EFYRENYVSR PRRCELAAAL NLPETTIKVW FQNRRMKDKR
     QRLAMTWPHP ADPAFYTYMM SHAAAAGGLP YPFPSHLPLP YYSPVGLGAA SAASAAASPF
     SGSLRPLDTF RVLSQPYPRP ELLCAFRHPP LYPGPAHGLG ASAGGPCSCL ACHSGPANGL
     APRAAAASDF TCASTSRSDS FLTFAPSVLS KASSVALDQR EEVPLTR
//
ID   GBX1_HUMAN              Reviewed;         363 AA.
AC   Q14549;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 2.
DT   25-OCT-2017, entry version 142.
DE   RecName: Full=Homeobox protein GBX-1;
DE   AltName: Full=Gastrulation and brain-specific homeobox protein 1;
GN   Name=GBX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 225-363.
RX   PubMed=8097731; DOI=10.1016/0014-5793(93)81564-G;
RA   Matsui T., Hirai M., Wakita M., Hirano M., Kurosawa Y.;
RT   "Expression of a novel human homeobox-containing gene that maps to
RT   chromosome 7q36.1 in hematopoietic cells.";
RL   FEBS Lett. 322:181-185(1993).
RN   [3]
RP   STRUCTURE BY NMR OF 256-325.
RG   Joint center for structural genomics (JCSG);
RT   "NMR structure of the homeodomain transcription factor GBX1 from Homo
RT   sapiens.";
RL   Submitted (JAN-2013) to the PDB data bank.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010973; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L11239; AAA36002.1; -; Genomic_DNA.
DR   CCDS; CCDS43682.1; -.
DR   PIR; S32510; S32510.
DR   RefSeq; NP_001092304.1; NM_001098834.2.
DR   PDB; 2M34; NMR; -; A=256-325.
DR   PDB; 2ME0; NMR; -; A=256-325.
DR   PDB; 2ME6; NMR; -; A=256-325.
DR   PDB; 2N8G; NMR; -; A=256-325.
DR   PDBsum; 2M34; -.
DR   PDBsum; 2ME0; -.
DR   PDBsum; 2ME6; -.
DR   PDBsum; 2N8G; -.
DR   ProteinModelPortal; Q14549; -.
DR   SMR; Q14549; -.
DR   BioGrid; 108906; 1.
DR   STRING; 9606.ENSP00000297537; -.
DR   iPTMnet; Q14549; -.
DR   PhosphoSitePlus; Q14549; -.
DR   DMDM; 115502392; -.
DR   EPD; Q14549; -.
DR   MaxQB; Q14549; -.
DR   PaxDb; Q14549; -.
DR   PeptideAtlas; Q14549; -.
DR   PRIDE; Q14549; -.
DR   DNASU; 2636; -.
DR   Ensembl; ENST00000297537; ENSP00000297537; ENSG00000164900.
DR   GeneID; 2636; -.
DR   KEGG; hsa:2636; -.
DR   UCSC; uc011kvg.3; human.
DR   CTD; 2636; -.
DR   DisGeNET; 2636; -.
DR   EuPathDB; HostDB:ENSG00000164900.4; -.
DR   GeneCards; GBX1; -.
DR   HGNC; HGNC:4185; GBX1.
DR   HPA; HPA055783; -.
DR   MIM; 603354; gene.
DR   neXtProt; NX_Q14549; -.
DR   OpenTargets; ENSG00000164900; -.
DR   PharmGKB; PA28599; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000060099; -.
DR   HOVERGEN; HBG003967; -.
DR   InParanoid; Q14549; -.
DR   KO; K09321; -.
DR   OMA; RARSEPC; -.
DR   OrthoDB; EOG091G0SCQ; -.
DR   PhylomeDB; Q14549; -.
DR   TreeFam; TF351530; -.
DR   ChiTaRS; GBX1; human.
DR   GenomeRNAi; 2636; -.
DR   PRO; PR:Q14549; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164900; -.
DR   CleanEx; HS_GBX1; -.
DR   Genevisible; Q14549; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0019230; P:proprioception; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0097374; P:sensory neuron axon guidance; IEA:Ensembl.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR031251; GBX-1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   PANTHER; PTHR24334:SF2; PTHR24334:SF2; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    363       Homeobox protein GBX-1.
FT                                /FTId=PRO_0000048878.
FT   DNA_BIND    261    320       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      5     22       Gly-rich.
FT   COMPBIAS     33    179       Pro-rich.
FT   COMPBIAS     60    133       Ala-rich.
FT   VARIANT     194    194       A -> T (in dbSNP:rs11975799).
FT                                /FTId=VAR_049579.
FT   STRAND      264    268       {ECO:0000244|PDB:2M34}.
FT   HELIX       270    282       {ECO:0000244|PDB:2M34}.
FT   HELIX       288    297       {ECO:0000244|PDB:2M34}.
FT   HELIX       302    320       {ECO:0000244|PDB:2M34}.
SQ   SEQUENCE   363 AA;  37629 MW;  738A37958DBD2E43 CRC64;
     MQRAGGGSAP GGNGGGGGGG PGTAFSIDSL IGPPPPRSGH LLYTGYPMFM PYRPLVLPQA
     LAPAPLPAGL PPLAPLASFA GRLTNTFCAG LGQAVPSMVA LTTALPSFAE PPDAFYGPQE
     LAAAAAAAAA TAARNNPEPG GRRPEGGLEA DELLPAREKV AEPPPPPPPH FSETFPSLPA
     EGKVYSSDEE KLEASAGDPA GSEQEEEGSG GDSEDDGFLD SSAGGPGALL GPKPKLKGSL
     GTGAEEGAPV TAGVTAPGGK SRRRRTAFTS EQLLELEKEF HCKKYLSLTE RSQIAHALKL
     SEVQVKIWFQ NRRAKWKRIK AGNVSSRSGE PVRNPKIVVP IPVHVNRFAV RSQHQQMEQG
     ARP
//
ID   GBX2_HUMAN              Reviewed;         348 AA.
AC   P52951; B2RPH7; O43833; Q53RX5; Q9Y5Y1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 3.
DT   25-OCT-2017, entry version 142.
DE   RecName: Full=Homeobox protein GBX-2;
DE   AltName: Full=Gastrulation and brain-specific homeobox protein 2;
GN   Name=GBX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=8838315; DOI=10.1006/geno.1996.0056;
RA   Lin X., Swaroop A., Vaccarino F.M., Murtha M.T., Haas M., Ji X.,
RA   Ruddle F.H., Leckman J.F.;
RT   "Characterization and sequence analysis of the human homeobox-
RT   containing gene GBX2.";
RL   Genomics 31:335-342(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Gao A.C., Lou W., Isaacs J.T.;
RT   "Enhanced GBX2 expression induces the growth of human prostate cancer
RT   cells via transcriptional stimulation of the interleukin-6 gene.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 216-348.
RX   PubMed=7903253; DOI=10.1016/0014-5793(93)81620-F;
RA   Matsui T., Hirai M., Hirano M., Kurosawa Y.;
RT   "The HOX complex neighbored by the EVX gene, as well as two other
RT   homeobox-containing genes, the GBX-class and the EN-class, are located
RT   on the same chromosomes 2 and 7 in humans.";
RL   FEBS Lett. 336:107-110(1993).
CC   -!- FUNCTION: May act as a transcription factor for cell pluripotency
CC       and differentiation in the embryo.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U31468; AAC03241.1; -; Genomic_DNA.
DR   EMBL; AF118452; AAD39907.1; -; mRNA.
DR   EMBL; AC079135; AAX93240.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW71084.1; -; Genomic_DNA.
DR   EMBL; BC137448; AAI37449.1; -; mRNA.
DR   EMBL; BC137449; AAI37450.1; -; mRNA.
DR   EMBL; U02080; AAA17406.1; -; Genomic_DNA.
DR   CCDS; CCDS2515.1; -.
DR   PIR; S39540; S39540.
DR   RefSeq; NP_001476.2; NM_001485.3.
DR   UniGene; Hs.184945; -.
DR   UniGene; Hs.735751; -.
DR   ProteinModelPortal; P52951; -.
DR   SMR; P52951; -.
DR   BioGrid; 108907; 3.
DR   STRING; 9606.ENSP00000302251; -.
DR   iPTMnet; P52951; -.
DR   PhosphoSitePlus; P52951; -.
DR   BioMuta; GBX2; -.
DR   DMDM; 12644308; -.
DR   EPD; P52951; -.
DR   MaxQB; P52951; -.
DR   PaxDb; P52951; -.
DR   PeptideAtlas; P52951; -.
DR   PRIDE; P52951; -.
DR   Ensembl; ENST00000306318; ENSP00000302251; ENSG00000168505.
DR   GeneID; 2637; -.
DR   KEGG; hsa:2637; -.
DR   UCSC; uc002vvw.2; human.
DR   CTD; 2637; -.
DR   DisGeNET; 2637; -.
DR   EuPathDB; HostDB:ENSG00000168505.6; -.
DR   GeneCards; GBX2; -.
DR   HGNC; HGNC:4186; GBX2.
DR   HPA; HPA067809; -.
DR   MIM; 601135; gene.
DR   neXtProt; NX_P52951; -.
DR   OpenTargets; ENSG00000168505; -.
DR   PharmGKB; PA28600; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000060099; -.
DR   HOVERGEN; HBG003967; -.
DR   InParanoid; P52951; -.
DR   KO; K09321; -.
DR   OMA; FMPYRSV; -.
DR   OrthoDB; EOG091G0SCQ; -.
DR   PhylomeDB; P52951; -.
DR   TreeFam; TF351530; -.
DR   GeneWiki; GBX2; -.
DR   GenomeRNAi; 2637; -.
DR   PRO; PR:P52951; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000168505; -.
DR   CleanEx; HS_GBX2; -.
DR   ExpressionAtlas; P52951; baseline and differential.
DR   Genevisible; P52951; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001190; F:transcriptional activator activity, RNA polymerase II transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0048483; P:autonomic nervous system development; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0021930; P:cerebellar granule cell precursor proliferation; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021884; P:forebrain neuron development; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0021555; P:midbrain-hindbrain boundary morphogenesis; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0001755; P:neural crest cell migration; IEA:Ensembl.
DR   GO; GO:0021568; P:rhombomere 2 development; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR031250; GBX-2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   PANTHER; PTHR24334:SF3; PTHR24334:SF3; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    348       Homeobox protein GBX-2.
FT                                /FTId=PRO_0000048880.
FT   DNA_BIND    247    306       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     56     63       Poly-Pro.
FT   COMPBIAS    121    124       Poly-Ala.
FT   COMPBIAS    248    251       Poly-Arg.
FT   CONFLICT     74    194       LPPAHPHHQIPSLPTGFCSSLAQGMALTSTLMATLPGGFSA
FT                                SPQHQEAAAARKFAPQPLPGGGNFDKAEALQADAEDGKGFL
FT                                AKEGSLLAFSAAETVQASLVGAVRGQGKDESKVEDDPKG
FT                                -> CRPHTLTTRSPACPQASAPAWRRAWRSPLRSWPRSPAA
FT                                SPRRPSTRRRQRPASSRRSRCPAAVTSTRRRRCRLTRRTAK
FT                                ASWPKRARCSPSPRPRRCRLRSSGLSEGKGKTSQRWKTTRS
FT                                (in Ref. 1; AAC03241). {ECO:0000305}.
FT   CONFLICT    216    237       QAAHKEEDPGHALEETPPSSGA -> PGSSQGGRPGPRGGG
FT                                DPAEQRR (in Ref. 6). {ECO:0000305}.
SQ   SEQUENCE   348 AA;  37348 MW;  5D31EA57B0CB07C0 CRC64;
     MSAAFPPSLM MMQRPLGSST AFSIDSLIGS PPQPSPGHFV YTGYPMFMPY RPVVLPPPPP
     PPPALPQAAL QPALPPAHPH HQIPSLPTGF CSSLAQGMAL TSTLMATLPG GFSASPQHQE
     AAAARKFAPQ PLPGGGNFDK AEALQADAED GKGFLAKEGS LLAFSAAETV QASLVGAVRG
     QGKDESKVED DPKGKEESFS LESDVDYSSD DNLTGQAAHK EEDPGHALEE TPPSSGAAGS
     TTSTGKNRRR RTAFTSEQLL ELEKEFHCKK YLSLTERSQI AHALKLSEVQ VKIWFQNRRA
     KWKRVKAGNA NSKTGEPSRN PKIVVPIPVH VSRFAIRSQH QQLEQARP
//
ID   GSX1_HUMAN              Reviewed;         264 AA.
AC   Q9H4S2; Q9UD62;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-SEP-2017, entry version 127.
DE   RecName: Full=GS homeobox 1;
DE   AltName: Full=Homeobox protein GSH-1;
GN   Name=GSX1; Synonyms=GSH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=11731616; DOI=10.1210/mend.15.12.0747;
RA   Mutsuga N., Iwasaki Y., Morishita M., Nomura A., Yamamori E.,
RA   Yoshida M., Asai M., Ozaki N., Kambe F., Seo H., Oiso Y., Saito H.;
RT   "Homeobox protein Gsh-1-dependent regulation of the rat GHRH gene
RT   promoter.";
RL   Mol. Endocrinol. 15:2149-2156(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 155-193.
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
CC   -!- FUNCTION: Probable transcription factor that binds to the DNA
CC       sequence 5'-GC[TA][AC]ATTA[GA]-3'. Activates the transcription of
CC       the GHRH gene. Plays an important role in pituitary development.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB044157; BAB78692.1; -; mRNA.
DR   EMBL; AB044158; BAB78693.1; -; Genomic_DNA.
DR   EMBL; AL390738; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS9326.1; -.
DR   RefSeq; NP_663632.1; NM_145657.2.
DR   UniGene; Hs.351785; -.
DR   ProteinModelPortal; Q9H4S2; -.
DR   SMR; Q9H4S2; -.
DR   STRING; 9606.ENSP00000304331; -.
DR   iPTMnet; Q9H4S2; -.
DR   PhosphoSitePlus; Q9H4S2; -.
DR   BioMuta; GSX1; -.
DR   DMDM; 27923786; -.
DR   PaxDb; Q9H4S2; -.
DR   PeptideAtlas; Q9H4S2; -.
DR   PRIDE; Q9H4S2; -.
DR   DNASU; 219409; -.
DR   Ensembl; ENST00000302945; ENSP00000304331; ENSG00000169840.
DR   GeneID; 219409; -.
DR   KEGG; hsa:219409; -.
DR   UCSC; uc001urr.2; human.
DR   CTD; 219409; -.
DR   EuPathDB; HostDB:ENSG00000169840.4; -.
DR   GeneCards; GSX1; -.
DR   HGNC; HGNC:20374; GSX1.
DR   HPA; HPA047096; -.
DR   MIM; 616542; gene.
DR   neXtProt; NX_Q9H4S2; -.
DR   OpenTargets; ENSG00000169840; -.
DR   PharmGKB; PA162390373; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000010106; -.
DR   HOVERGEN; HBG003555; -.
DR   InParanoid; Q9H4S2; -.
DR   KO; K09310; -.
DR   OMA; CHSRKAG; -.
DR   OrthoDB; EOG091G0HAO; -.
DR   PhylomeDB; Q9H4S2; -.
DR   TreeFam; TF315938; -.
DR   GenomeRNAi; 219409; -.
DR   PRO; PR:Q9H4S2; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000169840; -.
DR   CleanEx; HS_GSX1; -.
DR   Genevisible; Q9H4S2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0021984; P:adenohypophysis development; IEA:Ensembl.
DR   GO; GO:0021854; P:hypothalamus development; IEA:Ensembl.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Complete proteome; Developmental protein; DNA-binding;
KW   Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    264       GS homeobox 1.
FT                                /FTId=PRO_0000048894.
FT   DNA_BIND    147    206       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION        1     20       SNAG domain. {ECO:0000250}.
FT   COMPBIAS    111    118       Poly-Ala.
FT   COMPBIAS    213    223       Poly-Gly.
SQ   SEQUENCE   264 AA;  27883 MW;  25F4C4336E270C00 CRC64;
     MPRSFLVDSL VLREAGEKKA PEGSPPPLFP YAVPPPHALH GLSPGACHAR KAGLLCVCPL
     CVTASQLHGP PGPPALPLLK ASFPPFGSQY CHAPLGRQHS AVSPGVAHGP AAAAAAAALY
     QTSYPLPDPR QFHCISVDSS SNQLPSSKRM RTAFTSTQLL ELEREFASNM YLSRLRRIEI
     ATYLNLSEKQ VKIWFQNRRV KHKKEGKGSN HRGGGGGGAG GGGSAPQGCK CASLSSAKCS
     EDDDELPMSP SSSGKDDRDL TVTP
//
ID   GSX2_HUMAN              Reviewed;         304 AA.
AC   Q9BZM3;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   27-SEP-2017, entry version 123.
DE   RecName: Full=GS homeobox 2;
DE   AltName: Full=Genetic-screened homeobox 2;
DE   AltName: Full=Homeobox protein GSH-2;
GN   Name=GSX2; Synonyms=GSH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-107.
RA   Sakai T., Sakamoto S., Nakamura K., Muraki T.;
RT   "Human homeobox protein GSH-2.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-107.
RA   Cools J., Marynen P.;
RT   "The sequence of the human GSH2 gene.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-107.
RA   Dauwerse H.G., Peters D.J.M., Breuning M.H.;
RT   "The genomic sequence of the human GSH-2 gene.";
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-107.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: During telencephalic development, causes ventralization
CC       of pallial progenitors and, depending on the developmental stage,
CC       specifies different neuronal fates. At early stages, necessary and
CC       sufficient to correctly specify the ventral lateral ganglionic
CC       eminence (LGE) and its major derivatives, the striatal projection
CC       neurons. At later stages, may specify LGE progenitors toward
CC       dorsal LGE fates, including olfactory bulb interneurons (By
CC       similarity). Transcription factor that binds 5'-CNAATTAG-3' DNA
CC       sequence. {ECO:0000250|UniProtKB:P31316}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028838; BAB84822.1; -; mRNA.
DR   EMBL; AF306344; AAK00880.1; -; Genomic_DNA.
DR   EMBL; AF306343; AAK00880.1; JOINED; Genomic_DNA.
DR   EMBL; AF439445; AAM08285.1; -; Genomic_DNA.
DR   EMBL; AC110298; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC075089; AAH75089.1; -; mRNA.
DR   EMBL; BC075090; AAH75090.1; -; mRNA.
DR   CCDS; CCDS3494.1; -.
DR   RefSeq; NP_573574.1; NM_133267.2.
DR   UniGene; Hs.371899; -.
DR   ProteinModelPortal; Q9BZM3; -.
DR   SMR; Q9BZM3; -.
DR   IntAct; Q9BZM3; 1.
DR   STRING; 9606.ENSP00000319118; -.
DR   BioMuta; GSX2; -.
DR   DMDM; 296434530; -.
DR   PaxDb; Q9BZM3; -.
DR   PRIDE; Q9BZM3; -.
DR   DNASU; 170825; -.
DR   Ensembl; ENST00000326902; ENSP00000319118; ENSG00000180613.
DR   Ensembl; ENST00000611459; ENSP00000483522; ENSG00000180613.
DR   GeneID; 170825; -.
DR   KEGG; hsa:170825; -.
DR   UCSC; uc010igp.2; human.
DR   CTD; 170825; -.
DR   DisGeNET; 170825; -.
DR   EuPathDB; HostDB:ENSG00000180613.10; -.
DR   GeneCards; GSX2; -.
DR   HGNC; HGNC:24959; GSX2.
DR   MIM; 616253; gene.
DR   neXtProt; NX_Q9BZM3; -.
DR   OpenTargets; ENSG00000180613; -.
DR   PharmGKB; PA162390374; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000010106; -.
DR   HOVERGEN; HBG003555; -.
DR   InParanoid; Q9BZM3; -.
DR   KO; K09310; -.
DR   OMA; FCVCPLC; -.
DR   OrthoDB; EOG091G0HAO; -.
DR   PhylomeDB; Q9BZM3; -.
DR   TreeFam; TF315938; -.
DR   GenomeRNAi; 170825; -.
DR   PRO; PR:Q9BZM3; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000180613; -.
DR   CleanEx; HS_GSX2; -.
DR   ExpressionAtlas; Q9BZM3; baseline and differential.
DR   Genevisible; Q9BZM3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0048853; P:forebrain morphogenesis; IEA:Ensembl.
DR   GO; GO:0021575; P:hindbrain morphogenesis; IEA:Ensembl.
DR   GO; GO:0048665; P:neuron fate specification; IEA:Ensembl.
DR   GO; GO:0021889; P:olfactory bulb interneuron differentiation; IEA:Ensembl.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030334; P:regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   GO; GO:0060163; P:subpallium neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0021978; P:telencephalon regionalization; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    304       GS homeobox 2.
FT                                /FTId=PRO_0000048896.
FT   DNA_BIND    202    261       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    124    130       Poly-His.
FT   COMPBIAS    134    139       Poly-His.
FT   COMPBIAS    147    162       Poly-Ala.
FT   VARIANT     107    107       G -> S (in dbSNP:rs13144341).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.2,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_049580.
SQ   SEQUENCE   304 AA;  32031 MW;  2C879AC635C07F0D CRC64;
     MSRSFYVDSL IIKDTSRPAP SLPEPHPGPD FFIPLGMPPP LVMSVSGPGC PSRKSGAFCV
     CPLCVTSHLH SSRGSVGAGS GGAGAGVTGA GGSGVAGAAG ALPLLKGQFS SAPGDAQFCP
     RVNHAHHHHH PPQHHHHHHQ PQQPGSAAAA AAAAAAAAAA AALGHPQHHA PVCTATTYNV
     ADPRRFHCLT MGGSDASQVP NGKRMRTAFT STQLLELERE FSSNMYLSRL RRIEIATYLN
     LSEKQVKIWF QNRRVKHKKE GKGTQRNSHA GCKCVGSQVH YARSEDEDSL SPASANDDKE
     ISPL
//
ID   GSC2_HUMAN              Reviewed;         205 AA.
AC   O15499;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Homeobox protein goosecoid-2;
DE            Short=GSC-2;
DE   AltName: Full=Homeobox protein goosecoid-like;
DE            Short=GSC-L;
GN   Name=GSC2; Synonyms=GSCL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT CYS-47.
RX   PubMed=9441739; DOI=10.1006/geno.1997.5046;
RA   Funke B., St Jore B., Puech A., Sirotkin H., Edelmann L., Carlson C.,
RA   Raft S., Pandita R.K., Kucherlapati R., Skoultchi A., Morrow B.E.;
RT   "Characterization and mutation analysis of goosecoid-like (GSCL), a
RT   homeodomain-containing gene that maps to the critical region for
RT   VCFS/DGS on 22q11.";
RL   Genomics 46:364-372(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9150167;
RA   Gottlieb S., Emanuel B.S., Driscoll D.A., Sellinger B., Wang Z.,
RA   Roe B., Budarf M.L.;
RT   "The DiGeorge syndrome minimal critical region contains a goosecoid-
RT   like (GSCL) homeobox gene that is expressed early in human
RT   development.";
RL   Am. J. Hum. Genet. 60:1194-1201(1997).
CC   -!- FUNCTION: May have a role in development. May regulate its own
CC       transcription. May bind the bicoid consensus sequence TAATCC.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Detected in adult testis and pituitary, and in
CC       9-10 week fetal tissue (thorax). Probably expressed in other
CC       tissues at low levels.
CC   -!- DEVELOPMENTAL STAGE: Expressed in early human development as well
CC       as in a limited number of adult tissues.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U96402; AAC39544.1; -; Genomic_DNA.
DR   CCDS; CCDS13757.1; -.
DR   RefSeq; NP_005306.1; NM_005315.1.
DR   UniGene; Hs.534318; -.
DR   ProteinModelPortal; O15499; -.
DR   SMR; O15499; -.
DR   STRING; 9606.ENSP00000086933; -.
DR   iPTMnet; O15499; -.
DR   PhosphoSitePlus; O15499; -.
DR   BioMuta; GSC2; -.
DR   PaxDb; O15499; -.
DR   PRIDE; O15499; -.
DR   DNASU; 2928; -.
DR   Ensembl; ENST00000086933; ENSP00000086933; ENSG00000063515.
DR   GeneID; 2928; -.
DR   KEGG; hsa:2928; -.
DR   UCSC; uc011ags.3; human.
DR   CTD; 2928; -.
DR   DisGeNET; 2928; -.
DR   EuPathDB; HostDB:ENSG00000063515.2; -.
DR   GeneCards; GSC2; -.
DR   HGNC; HGNC:4613; GSC2.
DR   HPA; HPA043011; -.
DR   MIM; 601845; gene.
DR   neXtProt; NX_O15499; -.
DR   OpenTargets; ENSG00000063515; -.
DR   PharmGKB; PA162390265; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000112823; -.
DR   HOVERGEN; HBG005922; -.
DR   InParanoid; O15499; -.
DR   KO; K09325; -.
DR   OMA; CPFSIEH; -.
DR   OrthoDB; EOG091G0OQ6; -.
DR   PhylomeDB; O15499; -.
DR   TreeFam; TF351613; -.
DR   GenomeRNAi; 2928; -.
DR   PRO; PR:O15499; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000063515; -.
DR   CleanEx; HS_GSC2; -.
DR   Genevisible; O15499; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IC:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    205       Homeobox protein goosecoid-2.
FT                                /FTId=PRO_0000048891.
FT   DNA_BIND    126    185       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      2      5       Poly-Ala.
FT   COMPBIAS     64     70       Poly-Cys.
FT   VARIANT      47     47       R -> C (in dbSNP:rs34341950).
FT                                {ECO:0000269|PubMed:9441739}.
FT                                /FTId=VAR_008549.
SQ   SEQUENCE   205 AA;  21545 MW;  665C33D9C454E7A7 CRC64;
     MAAAAGGAAS RRGAGRPCPF SIEHILSSLP ERSLPARAAC PPQPAGRQSP AKPEEPGAPE
     AAPCACCCCC GPRAAPCGPP EAAAGLGARL AWPLRLGPAV PLSLGAPAGG SGALPGAVGP
     GSQRRTRRHR TIFSEEQLQA LEALFVQNQY PDVSTRERLA GRIRLREERV EVWFKNRRAK
     WRHQKRASAS ARLLPGVKKS PKGSC
//
ID   GSC_HUMAN               Reviewed;         257 AA.
AC   P56915; Q86YR1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 2.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Homeobox protein goosecoid;
GN   Name=GSC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Leukocyte;
RX   PubMed=7916327; DOI=10.1006/geno.1994.1281;
RA   Blum M., De Robertis E.M., Kojis T., Heinzmann C., Klisak I.,
RA   Geissert D., Sparkes R.S.;
RT   "Molecular cloning of the human homeobox gene goosecoid (GSC) and
RT   mapping of the gene to human chromosome 14q32.1.";
RL   Genomics 21:388-393(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RA   Guo J.H., Chen S., Chen L., Yu L.;
RT   "Cloning and expression pattern, DNA binding study of two novel human
RT   Hox genes.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND INVOLVEMENT IN SAMS.
RX   PubMed=24290375; DOI=10.1016/j.ajhg.2013.10.027;
RA   Parry D.A., Logan C.V., Stegmann A.P., Abdelhamed Z.A., Calder A.,
RA   Khan S., Bonthron D.T., Clowes V., Sheridan E., Ghali N.,
RA   Chudley A.E., Dobbie A., Stumpel C.T., Johnson C.A.;
RT   "SAMS, a syndrome of short stature, auditory-canal atresia, mandibular
RT   hypoplasia, and skeletal abnormalities is a unique neurocristopathy
RT   caused by mutations in Goosecoid.";
RL   Am. J. Hum. Genet. 93:1135-1142(2013).
RN   [5]
RP   STRUCTURE BY NMR OF 161-217.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of homeobox protein
RT   goosecoid.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: Regulates chordin (CHRD). May play a role in spatial
CC       programing within discrete embryonic fields or lineage
CC       compartments during organogenesis. In concert with NKX3-2, plays a
CC       role in defining the structural components of the middle ear;
CC       required for the development of the entire tympanic ring (By
CC       similarity). Probably involved in the regulatory networks that
CC       define neural crest cell fate specification and determine mesoderm
CC       cell lineages in mammals. {ECO:0000250,
CC       ECO:0000269|PubMed:24290375}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Short stature, auditory canal atresia, mandibular
CC       hypoplasia, skeletal abnormalities (SAMS) [MIM:602471]: An
CC       autosomal recessive developmental disorder with features of a
CC       first and second branchial arch syndrome, and with unique
CC       rhizomelic skeletal anomalies. Craniofacial abnormalities can lead
CC       to conductive hearing loss, respiratory insufficiency, and feeding
CC       difficulties. Skeletal features include bilateral humeral
CC       hypoplasia, humeroscapular synostosis, pelvic abnormalities, and
CC       proximal defects of the femora. Affected individuals may also have
CC       some features of a neurocristopathy or abnormal mesoderm
CC       development, such as urogenital anomalies, that are distinct from
CC       other branchial arch syndromes. {ECO:0000269|PubMed:24290375}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY177407; AAO18645.1; -; mRNA.
DR   EMBL; BC063580; AAH63580.1; -; mRNA.
DR   CCDS; CCDS9930.1; -.
DR   PIR; A54677; A54677.
DR   RefSeq; NP_776248.1; NM_173849.2.
DR   UniGene; Hs.440438; -.
DR   PDB; 2DMU; NMR; -; A=161-217.
DR   PDBsum; 2DMU; -.
DR   ProteinModelPortal; P56915; -.
DR   SMR; P56915; -.
DR   BioGrid; 126899; 4.
DR   ELM; P56915; -.
DR   STRING; 9606.ENSP00000238558; -.
DR   iPTMnet; P56915; -.
DR   PhosphoSitePlus; P56915; -.
DR   BioMuta; GSC; -.
DR   DMDM; 61252078; -.
DR   PaxDb; P56915; -.
DR   PRIDE; P56915; -.
DR   Ensembl; ENST00000238558; ENSP00000238558; ENSG00000133937.
DR   GeneID; 145258; -.
DR   KEGG; hsa:145258; -.
DR   UCSC; uc001ydu.4; human.
DR   CTD; 145258; -.
DR   DisGeNET; 145258; -.
DR   EuPathDB; HostDB:ENSG00000133937.4; -.
DR   GeneCards; GSC; -.
DR   HGNC; HGNC:4612; GSC.
DR   HPA; HPA075650; -.
DR   MalaCards; GSC; -.
DR   MIM; 138890; gene.
DR   MIM; 602471; phenotype.
DR   neXtProt; NX_P56915; -.
DR   OpenTargets; ENSG00000133937; -.
DR   Orphanet; 397623; Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome.
DR   PharmGKB; PA29004; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000112823; -.
DR   HOVERGEN; HBG005921; -.
DR   InParanoid; P56915; -.
DR   KO; K09324; -.
DR   OMA; PVGPSCC; -.
DR   OrthoDB; EOG091G0OQ6; -.
DR   PhylomeDB; P56915; -.
DR   TreeFam; TF351613; -.
DR   SIGNOR; P56915; -.
DR   EvolutionaryTrace; P56915; -.
DR   GeneWiki; GSC_(gene); -.
DR   GenomeRNAi; 145258; -.
DR   PRO; PR:P56915; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000133937; -.
DR   CleanEx; HS_GSC; -.
DR   Genevisible; P56915; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001103; F:RNA polymerase II repressing transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; NAS:UniProtKB.
DR   GO; GO:0042474; P:middle ear morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0014036; P:neural crest cell fate specification; IMP:UniProtKB.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein; DNA-binding;
KW   Dwarfism; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    257       Homeobox protein goosecoid.
FT                                /FTId=PRO_0000048885.
FT   DNA_BIND    160    219       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CONFLICT     26     28       AHS -> RT (in Ref. 1). {ECO:0000305}.
FT   CONFLICT     45     47       Missing (in Ref. 1). {ECO:0000305}.
FT   CONFLICT     65     65       Missing (in Ref. 1). {ECO:0000305}.
FT   CONFLICT     74     74       S -> T (in Ref. 1). {ECO:0000305}.
FT   HELIX       169    181       {ECO:0000244|PDB:2DMU}.
FT   HELIX       187    196       {ECO:0000244|PDB:2DMU}.
FT   HELIX       201    217       {ECO:0000244|PDB:2DMU}.
SQ   SEQUENCE   257 AA;  28150 MW;  BA2A56144F921407 CRC64;
     MPASMFSIDN ILAARPRCKD SVLPVAHSAA APVVFPALHG DSLYGASGGA SSDYGAFYPR
     PVAPGGAGLP AAVSGSRLGY NNYFYGQLHV QAAPVGPACC GAVPPLGAQQ CSCVPTPPGY
     EGPGSVLVSP VPHQMLPYMN VGTLSRTELQ LLNQLHCRRK RRHRTIFTDE QLEALENLFQ
     ETKYPDVGTR EQLARKVHLR EEKVEVWFKN RRAKWRRQKR SSSEESENAE KWNKTSSSKA
     SPEKREEEGK SDLDSDS
//
ID   HDX_HUMAN               Reviewed;         690 AA.
AC   Q7Z353; A8K1Y5; B7ZL18; Q5JZB4; Q96NK7;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   25-OCT-2017, entry version 131.
DE   RecName: Full=Highly divergent homeobox;
GN   Name=HDX; Synonyms=CXorf43;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   SER-397.
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-397.
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 164-194; 257-263; 326-347; 614-623 AND 629-634,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-135; LYS-140; LYS-144;
RP   LYS-163; LYS-172; LYS-194; LYS-212; LYS-221; LYS-232 AND LYS-613, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [8]
RP   STRUCTURE BY NMR OF 435-501.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of the hypothetical
RT   protein, DKFZp686K21156.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- INTERACTION:
CC       Q9Y3E2:BOLA1; NbExp=4; IntAct=EBI-1052734, EBI-1049556;
CC       Q9UI47-2:CTNNA3; NbExp=4; IntAct=EBI-1052734, EBI-11962928;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7Z353-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z353-2; Sequence=VSP_027708;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI42095.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK055240; BAB70886.1; -; mRNA.
DR   EMBL; BX538112; CAD98024.1; -; mRNA.
DR   EMBL; AK290050; BAF82739.1; -; mRNA.
DR   EMBL; AL035552; CAI42056.1; -; Genomic_DNA.
DR   EMBL; AL022160; CAI42056.1; JOINED; Genomic_DNA.
DR   EMBL; AL022160; CAI42095.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL022160; CAI42096.1; -; Genomic_DNA.
DR   EMBL; AL035552; CAI42096.1; JOINED; Genomic_DNA.
DR   EMBL; CH471104; EAW98572.1; -; Genomic_DNA.
DR   EMBL; CH471104; EAW98573.1; -; Genomic_DNA.
DR   EMBL; BC101720; AAI01721.1; -; mRNA.
DR   EMBL; BC101722; AAI01723.1; -; mRNA.
DR   EMBL; BC143522; AAI43523.1; -; mRNA.
DR   CCDS; CCDS35342.1; -. [Q7Z353-1]
DR   CCDS; CCDS55456.1; -. [Q7Z353-2]
DR   RefSeq; NP_001170949.1; NM_001177478.1. [Q7Z353-2]
DR   RefSeq; NP_001170950.1; NM_001177479.1. [Q7Z353-1]
DR   RefSeq; NP_653258.2; NM_144657.4. [Q7Z353-1]
DR   RefSeq; XP_006724682.1; XM_006724619.1. [Q7Z353-2]
DR   RefSeq; XP_011529165.1; XM_011530863.2. [Q7Z353-1]
DR   RefSeq; XP_011529166.1; XM_011530864.1. [Q7Z353-1]
DR   RefSeq; XP_016884763.1; XM_017029274.1. [Q7Z353-1]
DR   UniGene; Hs.559546; -.
DR   PDB; 2DA4; NMR; -; A=435-501.
DR   PDBsum; 2DA4; -.
DR   ProteinModelPortal; Q7Z353; -.
DR   SMR; Q7Z353; -.
DR   BioGrid; 126559; 4.
DR   IntAct; Q7Z353; 14.
DR   STRING; 9606.ENSP00000297977; -.
DR   iPTMnet; Q7Z353; -.
DR   PhosphoSitePlus; Q7Z353; -.
DR   BioMuta; HDX; -.
DR   DMDM; 74762426; -.
DR   EPD; Q7Z353; -.
DR   PaxDb; Q7Z353; -.
DR   PeptideAtlas; Q7Z353; -.
DR   PRIDE; Q7Z353; -.
DR   Ensembl; ENST00000297977; ENSP00000297977; ENSG00000165259. [Q7Z353-1]
DR   Ensembl; ENST00000373177; ENSP00000362272; ENSG00000165259. [Q7Z353-1]
DR   Ensembl; ENST00000506585; ENSP00000423670; ENSG00000165259. [Q7Z353-2]
DR   GeneID; 139324; -.
DR   KEGG; hsa:139324; -.
DR   UCSC; uc004eek.3; human. [Q7Z353-1]
DR   CTD; 139324; -.
DR   EuPathDB; HostDB:ENSG00000165259.13; -.
DR   GeneCards; HDX; -.
DR   HGNC; HGNC:26411; HDX.
DR   HPA; HPA047189; -.
DR   MIM; 300994; gene.
DR   neXtProt; NX_Q7Z353; -.
DR   OpenTargets; ENSG00000165259; -.
DR   PharmGKB; PA162390630; -.
DR   eggNOG; ENOG410IE54; Eukaryota.
DR   eggNOG; ENOG4110JHR; LUCA.
DR   GeneTree; ENSGT00390000008591; -.
DR   HOGENOM; HOG000112876; -.
DR   HOVERGEN; HBG095615; -.
DR   InParanoid; Q7Z353; -.
DR   OMA; QRSYKPE; -.
DR   OrthoDB; EOG091G031B; -.
DR   PhylomeDB; Q7Z353; -.
DR   TreeFam; TF330998; -.
DR   EvolutionaryTrace; Q7Z353; -.
DR   GenomeRNAi; 139324; -.
DR   PRO; PR:Q7Z353; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000165259; -.
DR   CleanEx; HS_HDX; -.
DR   ExpressionAtlas; Q7Z353; baseline and differential.
DR   Genevisible; Q7Z353; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Homeobox; Isopeptide bond;
KW   Nucleus; Polymorphism; Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1    690       Highly divergent homeobox.
FT                                /FTId=PRO_0000299487.
FT   DNA_BIND      3     63       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    435    498       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CROSSLNK    135    135       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    140    140       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    144    144       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    163    163       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    172    172       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    194    194       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    212    212       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    221    221       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    232    232       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    613    613       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     58       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_027708.
FT   VARIANT     193    193       A -> T (in dbSNP:rs35653454).
FT                                /FTId=VAR_034827.
FT   VARIANT     397    397       F -> S (in dbSNP:rs35161124).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_034828.
FT   HELIX       444    454       {ECO:0000244|PDB:2DA4}.
FT   TURN        455    459       {ECO:0000244|PDB:2DA4}.
FT   HELIX       463    476       {ECO:0000244|PDB:2DA4}.
FT   HELIX       480    497       {ECO:0000244|PDB:2DA4}.
SQ   SEQUENCE   690 AA;  77206 MW;  572AA4D182400736 CRC64;
     MNLRSVFTVE QQRILQRYYE NGMTNQSKNC FQLILQCAQE TKLDFSVVRT WVGNKRRKMS
     SKNSESGTAT TGTSLSAPDI TVRNVVNIAR PSSQQSSWTS ANNDVIVTGI YSPASSSSRQ
     GTNKHTDTQI TEAHKIPIQK TATKNDTEFQ LHIPVQRQVA HCKNASLLLG EKTIILSRQT
     SVLNAGNSVF NHAKKNYGNS SVQASEMTVP QKPSVCHRPC KIEPVGIQRS YKPEHTGPAL
     HNLCGQKPTI RDPYCRTQNL EIREVFSLAV SDYPQRILGG NAPQKPSSAE GNCLSIAMET
     GDAEDEYARE EELASMRAQI PSYSRFYESG SSLRAENQST TLPGPGRNMP NSQMVNIRDM
     SDNVLYQNRN YHLTPRTSLH TASSTMYSNT NPLRSNFSPH FASSNQLRLS QNQNNYQISG
     NLTVPWITGC SRKRALQDRT QFSDRDLATL KKYWDNGMTS LGSVCREKIE AVATELNVDC
     EIVRTWIGNR RRKYRLMGIE VPPPRGGPAD FSEQPESGSL SALTPGEEAG PEVGEDNDRN
     DEVSICLSEG SSQEEPNEVV PNDARAHKEE DHHAVTTDNV KIEIIDDEES DMISNSEVEQ
     VNSFLDYKNE EVKFIENELE IQKQKYFKLQ TFVRSLILAM KADDKEQQQA LLSDLPPELE
     EMDFNHASLE PDDTSFSVSS LSEKNVSESL
//
ID   HME1_HUMAN              Reviewed;         392 AA.
AC   Q05925; Q4ZG44;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   25-OCT-2017, entry version 153.
DE   RecName: Full=Homeobox protein engrailed-1;
DE            Short=Homeobox protein en-1;
DE            Short=Hu-En-1;
GN   Name=EN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1363401; DOI=10.1002/dvg.1020130505;
RA   Logan C., Hanks M.C., Noble-Topham S., Nallainathan D., Provart N.J.,
RA   Joyner A.L.;
RT   "Cloning and sequence comparison of the mouse, human, and chicken
RT   engrailed genes reveal potential functional domains and regulatory
RT   regions.";
RL   Dev. Genet. 13:345-358(1992).
RN   [2]
RP   SEQUENCE REVISION TO 288.
RA   Logan C., Hanks M.C., Noble-Topham S., Nallainathan D., Provart N.J.,
RA   Joyner A.L.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the engrailed homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12699; AAA53502.2; -; Genomic_DNA.
DR   EMBL; L12698; AAA53502.2; JOINED; Genomic_DNA.
DR   EMBL; AC012665; AAX88967.1; -; Genomic_DNA.
DR   EMBL; CH471103; EAW95206.1; -; Genomic_DNA.
DR   CCDS; CCDS2123.1; -.
DR   PIR; B48423; B48423.
DR   RefSeq; NP_001417.3; NM_001426.3.
DR   UniGene; Hs.271977; -.
DR   ProteinModelPortal; Q05925; -.
DR   SMR; Q05925; -.
DR   BioGrid; 108334; 2.
DR   STRING; 9606.ENSP00000295206; -.
DR   iPTMnet; Q05925; -.
DR   PhosphoSitePlus; Q05925; -.
DR   BioMuta; EN1; -.
DR   DMDM; 215274149; -.
DR   MaxQB; Q05925; -.
DR   PaxDb; Q05925; -.
DR   PeptideAtlas; Q05925; -.
DR   PRIDE; Q05925; -.
DR   DNASU; 2019; -.
DR   Ensembl; ENST00000295206; ENSP00000295206; ENSG00000163064.
DR   GeneID; 2019; -.
DR   KEGG; hsa:2019; -.
DR   UCSC; uc002tlm.4; human.
DR   CTD; 2019; -.
DR   DisGeNET; 2019; -.
DR   EuPathDB; HostDB:ENSG00000163064.6; -.
DR   GeneCards; EN1; -.
DR   HGNC; HGNC:3342; EN1.
DR   HPA; CAB014884; -.
DR   HPA; HPA073141; -.
DR   MIM; 131290; gene.
DR   neXtProt; NX_Q05925; -.
DR   OpenTargets; ENSG00000163064; -.
DR   PharmGKB; PA27779; -.
DR   eggNOG; KOG0493; Eukaryota.
DR   eggNOG; ENOG4111P06; LUCA.
DR   GeneTree; ENSGT00900000140915; -.
DR   HOGENOM; HOG000247054; -.
DR   HOVERGEN; HBG005975; -.
DR   InParanoid; Q05925; -.
DR   KO; K09319; -.
DR   OMA; NCGPPDG; -.
DR   OrthoDB; EOG091G0XBB; -.
DR   PhylomeDB; Q05925; -.
DR   TreeFam; TF106461; -.
DR   SignaLink; Q05925; -.
DR   GeneWiki; EN1_(gene); -.
DR   GenomeRNAi; 2019; -.
DR   PRO; PR:Q05925; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163064; -.
DR   CleanEx; HS_EN1; -.
DR   Genevisible; Q05925; HS.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0042756; P:drinking behavior; IEA:Ensembl.
DR   GO; GO:1990403; P:embryonic brain development; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0030917; P:midbrain-hindbrain boundary development; IEA:Ensembl.
DR   GO; GO:0061743; P:motor learning; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0043473; P:pigmentation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0035176; P:social behavior; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR019549; Homeobox-engrailed_C-terminal.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000747; Homeobox_engrailed.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR019737; Homoebox-engrailed_CS.
DR   Pfam; PF10525; Engrail_1_C_sig; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00026; ENGRAILED.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00033; ENGRAILED; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    392       Homeobox protein engrailed-1.
FT                                /FTId=PRO_0000196062.
FT   DNA_BIND    303    362       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    199    218       Poly-Ala.
FT   COMPBIAS    224    231       Poly-Gly.
FT   CONFLICT     18     18       A -> G (in Ref. 1; AAA53502).
FT                                {ECO:0000305}.
SQ   SEQUENCE   392 AA;  40115 MW;  BDFE6279E9C27BFD CRC64;
     MEEQQPEPKS QRDSALGAAA AATPGGLSLS LSPGASGSSG SGSDGDSVPV SPQPAPPSPP
     AAPCLPPLAH HPHLPPHPPP PPPQHLAAPA HQPQPAAQLH RTTNFFIDNI LRPDFGCKKE
     QPPPQLLVAA AARGGAGGGG RVERDRGQTA AGRDPVHPLG TRAPGAASLL CAPDANCGPP
     DGSQPAAAGA GASKAGNPAA AAAAAAAAVA AAAAAAAAKP SDTGGGGSGG GAGSPGAQGT
     KYPEHGNPAI LLMGSANGGP VVKTDSQQPL VWPAWVYCTR YSDRPSSGPR TRKLKKKKNE
     KEDKRPRTAF TAEQLQRLKA EFQANRYITE QRRQTLAQEL SLNESQIKIW FQNKRAKIKK
     ATGIKNGLAL HLMAQGLYNH STTTVQDKDE SE
//
ID   HMX2_HUMAN              Reviewed;         273 AA.
AC   A2RU54; B2RNV5;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   25-OCT-2017, entry version 94.
DE   RecName: Full=Homeobox protein HMX2;
DE   AltName: Full=Homeobox protein H6 family member 2;
GN   Name=HMX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor involved in specification of
CC       neuronal cell types and which is required for inner ear and
CC       hypothalamus development. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the HMX homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471066; EAW49288.1; -; Genomic_DNA.
DR   EMBL; BC132758; AAI32759.1; -; mRNA.
DR   EMBL; BC137139; AAI37140.1; -; mRNA.
DR   CCDS; CCDS31305.1; -.
DR   RefSeq; NP_005510.1; NM_005519.1.
DR   RefSeq; XP_005269800.1; XM_005269743.3.
DR   UniGene; Hs.444756; -.
DR   ProteinModelPortal; A2RU54; -.
DR   SMR; A2RU54; -.
DR   IntAct; A2RU54; 2.
DR   STRING; 9606.ENSP00000341108; -.
DR   iPTMnet; A2RU54; -.
DR   PhosphoSitePlus; A2RU54; -.
DR   BioMuta; HMX2; -.
DR   EPD; A2RU54; -.
DR   PaxDb; A2RU54; -.
DR   PRIDE; A2RU54; -.
DR   TopDownProteomics; A2RU54; -.
DR   Ensembl; ENST00000339992; ENSP00000341108; ENSG00000188816.
DR   GeneID; 3167; -.
DR   KEGG; hsa:3167; -.
DR   UCSC; uc001lhc.1; human.
DR   CTD; 3167; -.
DR   EuPathDB; HostDB:ENSG00000188816.3; -.
DR   GeneCards; HMX2; -.
DR   HGNC; HGNC:5018; HMX2.
DR   HPA; HPA043379; -.
DR   MIM; 600647; gene.
DR   neXtProt; NX_A2RU54; -.
DR   OpenTargets; ENSG00000188816; -.
DR   PharmGKB; PA29345; -.
DR   eggNOG; KOG0485; Eukaryota.
DR   eggNOG; ENOG4111R8D; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG045543; -.
DR   InParanoid; A2RU54; -.
DR   KO; K09349; -.
DR   OMA; PFPCLGT; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; A2RU54; -.
DR   TreeFam; TF320562; -.
DR   GenomeRNAi; 3167; -.
DR   PRO; PR:A2RU54; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000188816; -.
DR   CleanEx; HS_HMX2; -.
DR   Genevisible; A2RU54; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Neurogenesis; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    273       Homeobox protein HMX2.
FT                                /FTId=PRO_0000294366.
FT   DNA_BIND    149    208       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   273 AA;  29598 MW;  1100C836F8D131F1 CRC64;
     MGSKEDAGKG CPAAGGVSSF TIQSILGGGP SEAPREPVGW PARKRSLSVS SEEEEPDDGW
     KAPACFCPDQ HGPKEQGPKH HPPIPFPCLG TPKGSGGSGP GGLERTPFLS PSHSDFKEEK
     ERLLPAGSPS PGSERPRDGG AERQAGAAKK KTRTVFSRSQ VYQLESTFDM KRYLSSSERA
     CLASSLQLTE TQVKTWFQNR RNKWKRQLSA ELEAANMAHA SAQTLVSMPL VFRDSSLLRV
     PVPRSLAFPA PLYYPGSNLS ALPLYNLYNK LDY
//
ID   HMX1_HUMAN              Reviewed;         348 AA.
AC   Q9NP08;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   25-OCT-2017, entry version 119.
DE   RecName: Full=Homeobox protein HMX1;
DE   AltName: Full=Homeobox protein H6;
GN   Name=HMX1; Synonyms=H6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Craniofacial;
RX   PubMed=1360670; DOI=10.1073/pnas.89.23.11579;
RA   Stadler H.S., Padanilam B.J., Buetow K., Murray J.C., Solursh M.;
RT   "Identification and genetic mapping of a homeobox gene to the 4p16.1
RT   region of human chromosome 4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:11579-11583(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=10206974; DOI=10.1074/jbc.274.17.11635;
RA   Amendt B.A., Sutherland L.B., Russo A.F.;
RT   "Transcriptional antagonism between Hmx1 and Nkx2.5 for a shared DNA-
RT   binding site.";
RL   J. Biol. Chem. 274:11635-11642(1999).
RN   [4]
RP   INVOLVEMENT IN OCACS.
RX   PubMed=18423520; DOI=10.1016/j.ajhg.2008.03.007;
RA   Schorderet D.F., Nichini O., Boisset G., Polok B., Tiab L., Mayeur H.,
RA   Raji B., de la Houssaye G., Abitbol M.M., Munier F.L.;
RT   "Mutation in the human homeobox gene NKX5-3 causes an oculo-auricular
RT   syndrome.";
RL   Am. J. Hum. Genet. 82:1178-1184(2008).
CC   -!- FUNCTION: DNA-binding protein that binds to the 5'-CAAG-3' core
CC       sequence. May function as a transcriptional repressor. Seems to
CC       act as a transcriptional antagonist of NKX2-5. May play an
CC       important role in the development of craniofacial structures such
CC       as the eye and ear. {ECO:0000269|PubMed:10206974}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DISEASE: Oculoauricular syndrome (OCACS) [MIM:612109]: A syndrome
CC       characterized by microphthalmia, microcornea, anterior segment
CC       dysgenesis, cataract, ocular coloboma, retinal pigment epithelium
CC       abnormalities, rod-cone dystrophy, and anomalies of the external
CC       ear. {ECO:0000269|PubMed:18423520}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the HMX homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF70205.1; Type=Frameshift; Positions=35, 60, 84, 89, 157, 179, 277; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M99587; AAF70205.1; ALT_FRAME; mRNA.
DR   EMBL; AC116612; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS47018.1; -.
DR   PIR; A47234; A47234.
DR   RefSeq; NP_001293071.1; NM_001306142.1.
DR   RefSeq; NP_061815.2; NM_018942.2.
DR   UniGene; Hs.104134; -.
DR   ProteinModelPortal; Q9NP08; -.
DR   SMR; Q9NP08; -.
DR   STRING; 9606.ENSP00000383516; -.
DR   iPTMnet; Q9NP08; -.
DR   PhosphoSitePlus; Q9NP08; -.
DR   BioMuta; HMX1; -.
DR   DMDM; 259016250; -.
DR   PaxDb; Q9NP08; -.
DR   PeptideAtlas; Q9NP08; -.
DR   PRIDE; Q9NP08; -.
DR   DNASU; 3166; -.
DR   Ensembl; ENST00000400677; ENSP00000383516; ENSG00000215612.
DR   GeneID; 3166; -.
DR   KEGG; hsa:3166; -.
DR   UCSC; uc003izz.2; human.
DR   CTD; 3166; -.
DR   DisGeNET; 3166; -.
DR   EuPathDB; HostDB:ENSG00000215612.6; -.
DR   GeneCards; HMX1; -.
DR   H-InvDB; HIX0031931; -.
DR   HGNC; HGNC:5017; HMX1.
DR   MalaCards; HMX1; -.
DR   MIM; 142992; gene.
DR   MIM; 612109; phenotype.
DR   neXtProt; NX_Q9NP08; -.
DR   OpenTargets; ENSG00000215612; -.
DR   Orphanet; 157962; Oculoauricular syndrome, Schorderet type.
DR   PharmGKB; PA29344; -.
DR   eggNOG; KOG0485; Eukaryota.
DR   eggNOG; ENOG4111R8D; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000171379; -.
DR   HOVERGEN; HBG031610; -.
DR   InParanoid; Q9NP08; -.
DR   KO; K09349; -.
DR   OMA; VLYHESP; -.
DR   PhylomeDB; Q9NP08; -.
DR   TreeFam; TF320562; -.
DR   SignaLink; Q9NP08; -.
DR   GenomeRNAi; 3166; -.
DR   PRO; PR:Q9NP08; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000215612; -.
DR   CleanEx; HS_HMX1; -.
DR   ExpressionAtlas; Q9NP08; baseline and differential.
DR   Genevisible; Q9NP08; HS.
DR   GO; GO:0005634; C:nucleus; IC:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IMP:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Cataract; Complete proteome; Developmental protein; DNA-binding;
KW   Homeobox; Microphthalmia; Nucleus; Reference proteome; Repressor;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    348       Homeobox protein HMX1.
FT                                /FTId=PRO_0000278453.
FT   DNA_BIND    203    262       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       263    273       HMX family specific domain 1.
FT   MOTIF       276    289       HMX family specific domain 2.
FT   COMPBIAS     48     51       Poly-Asp.
FT   COMPBIAS     61     64       Poly-Arg.
FT   COMPBIAS    273    316       Pro-rich.
FT   CONFLICT    277    277       Q -> A (in Ref. 1; AAF70205).
FT                                {ECO:0000305}.
FT   CONFLICT    308    310       PAA -> RR (in Ref. 1; AAF70205).
FT                                {ECO:0000305}.
SQ   SEQUENCE   348 AA;  36155 MW;  7B2AE7662699B15A CRC64;
     MPDELTEPGR ATPARASSFL IENLLAAEAK GAGRATQGDG SREDEEEDDD DPEDEDAEQA
     RRRRLQRRRQ LLAGTGPGGE ARARALLGPG ALGLGPRPPP GPGPPFALGC GGAARWYPRA
     HGGYGGGLSP DTSDRDSPET GEEMGRAEGA WPRGPGPGAV QREAAELAAR GPAAGTEEAS
     ELAEVPAAAG ETRGGVGVGG GRKKKTRTVF SRSQVFQLES TFDLKRYLSS AERAGLAASL
     QLTETQVKIW FQNRRNKWKR QLAAELEAAS LSPPGAQRLV RVPVLYHESP PAAAAAGPPA
     TLPFPLAPAA PAPPPPLLGF SGALAYPLAA FPAAASVPFL RAQMPGLV
//
ID   HMX3_HUMAN              Reviewed;         357 AA.
AC   A6NHT5; A8MU06;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 95.
DE   RecName: Full=Homeobox protein HMX3;
DE   AltName: Full=Homeobox protein H6 family member 3;
DE   AltName: Full=Homeobox protein Nkx-5.1;
GN   Name=HMX3; Synonyms=NKX-5.1, NKX5-1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153 AND SER-180, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Transcription factor involved in specification of
CC       neuronal cell types and which is required for inner ear and
CC       hypothalamus development. Binds to the 5'-CAAGTG-3' core sequence.
CC       Controls semicircular canal formation in the inner ear. Also
CC       required for hypothalamic/pituitary axis of the CNS (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the HMX homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC012391; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49289.1; -; Genomic_DNA.
DR   CCDS; CCDS41575.1; -.
DR   RefSeq; NP_001099044.1; NM_001105574.1.
DR   UniGene; Hs.531194; -.
DR   ProteinModelPortal; A6NHT5; -.
DR   SMR; A6NHT5; -.
DR   BioGrid; 131098; 2.
DR   STRING; 9606.ENSP00000350549; -.
DR   iPTMnet; A6NHT5; -.
DR   PhosphoSitePlus; A6NHT5; -.
DR   BioMuta; HMX3; -.
DR   EPD; A6NHT5; -.
DR   MaxQB; A6NHT5; -.
DR   PaxDb; A6NHT5; -.
DR   PRIDE; A6NHT5; -.
DR   Ensembl; ENST00000357878; ENSP00000350549; ENSG00000188620.
DR   GeneID; 340784; -.
DR   KEGG; hsa:340784; -.
DR   UCSC; uc010quc.3; human.
DR   CTD; 340784; -.
DR   EuPathDB; HostDB:ENSG00000188620.9; -.
DR   GeneCards; HMX3; -.
DR   HGNC; HGNC:5019; HMX3.
DR   HPA; HPA069659; -.
DR   MIM; 613380; gene.
DR   neXtProt; NX_A6NHT5; -.
DR   OpenTargets; ENSG00000188620; -.
DR   PharmGKB; PA29346; -.
DR   eggNOG; KOG0485; Eukaryota.
DR   eggNOG; ENOG4111R8D; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG098273; -.
DR   InParanoid; A6NHT5; -.
DR   KO; K09349; -.
DR   OMA; HPIVTSV; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; A6NHT5; -.
DR   TreeFam; TF320562; -.
DR   GenomeRNAi; 340784; -.
DR   PRO; PR:A6NHT5; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000188620; -.
DR   CleanEx; HS_HMX3; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Neurogenesis; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    357       Homeobox protein HMX3.
FT                                /FTId=PRO_0000341382.
FT   DNA_BIND    227    286       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      2     52       Pro-rich.
FT   COMPBIAS     57     84       Ala-rich.
FT   COMPBIAS    319    326       Poly-Ala.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     180    180       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
SQ   SEQUENCE   357 AA;  37825 MW;  93C6A57D7924E0DA CRC64;
     MPEPGPDAAG TASAQPQPPP PPPPAPKESP FSIKNLLNGD HHRPPPKPQP PPRTLFAPAS
     AAAAAAAAAA AAAKGALEGA AGFALSQVGD LAFPRFEIPA QRFALPAHYL ERSPAWWYPY
     TLTPAGGHLP RPEASEKALL RDSSPASGTD RDSPEPLLKA DPDHKELDSK SPDEIILEES
     DSEESKKEGE AAPGAAGASV GAAAATPGAE DWKKGAESPE KKPACRKKKT RTVFSRSQVF
     QLESTFDMKR YLSSSERAGL AASLHLTETQ VKIWFQNRRN KWKRQLAAEL EAANLSHAAA
     QRIVRVPILY HENSAAEGAA AAAAGAPVPV SQPLLTFPHP VYYSHPVVSS VPLLRPV
//
ID   ME3L1_HUMAN             Reviewed;         274 AA.
AC   A6NDR6;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   27-SEP-2017, entry version 64.
DE   RecName: Full=Putative homeobox protein Meis3-like 1;
GN   Name=MEIS3P1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Could be the product of a pseudogene. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC015922; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   UniGene; Hs.356135; -.
DR   ProteinModelPortal; A6NDR6; -.
DR   SMR; A6NDR6; -.
DR   MaxQB; A6NDR6; -.
DR   PRIDE; A6NDR6; -.
DR   GeneCards; MEIS3P1; -.
DR   HGNC; HGNC:7002; MEIS3P1.
DR   neXtProt; NX_A6NDR6; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; A6NDR6; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   5: Uncertain;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    274       Putative homeobox protein Meis3-like 1.
FT                                /FTId=PRO_0000347055.
FT   DNA_BIND    161    223       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   274 AA;  30204 MW;  62E2805A71CBDF09 CRC64;
     MGPELGWGHP RGGDVCSSDS FNEDNTAFAK QVRSERPFFS SNPELDNLMI QAIQVLRFHL
     LELEKGKMPI DLVIEDRDGG CREDFEDYPA SCPSLPDQNN IWIRDHEDSG SVHLGTPGPS
     SGGLASQSGD NSSDQGVGLD TSVASPSSGG EDEDLDQEPR RNKKRGIFPK VATNIMRAWL
     FQHLSHPYPS EEQKKQLAQD TGLTILQVNN WFINARRRIV QPMIDQSNRT GQGAAFSPEG
     QPIGGYTETE PHVAFRAPAS VGMSLNSEGE WHYL
//
ID   LMX1A_HUMAN             Reviewed;         382 AA.
AC   Q8TE12; B3KXP6; Q0VDB5; Q5VWG4; Q8TE11;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   27-SEP-2017, entry version 137.
DE   RecName: Full=LIM homeobox transcription factor 1-alpha;
DE   AltName: Full=LIM/homeobox protein 1.1;
DE            Short=LMX-1.1;
DE   AltName: Full=LIM/homeobox protein LMX1A;
GN   Name=LMX1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12062816; DOI=10.1016/S0378-1119(02)00582-6;
RA   Thameem F., Wolford J.K., Wang J., German M.S., Bogardus C.,
RA   Prochazka M.;
RT   "Cloning, expression and genomic structure of human LMX1A, and variant
RT   screening in Pima Indians.";
RL   Gene 290:217-225(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LMX1A-4AB).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Acts as a transcriptional activator by binding to an
CC       A/T-rich sequence, the FLAT element, in the insulin gene promoter.
CC       Required for development of the roof plate and, in turn, for
CC       specification of dorsal cell fates in the CNS and developing
CC       vertebrae (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P62993:GRB2; NbExp=3; IntAct=EBI-10692065, EBI-401755;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TE12-1; Sequence=Displayed;
CC       Name=LMX1A-4AB;
CC         IsoId=Q8TE12-2; Sequence=VSP_003112;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in many tissues. Not
CC       found in heart, liver, spleen and testis. Relatively highly
CC       expressed in fetal brain. Isoform LMX1A-4AB is expressed in
CC       testis. {ECO:0000269|PubMed:12062816}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY078398; AAL82892.1; -; Genomic_DNA.
DR   EMBL; AY078391; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078392; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078393; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078394; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078395; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078396; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078397; AAL82892.1; JOINED; Genomic_DNA.
DR   EMBL; AY078398; AAL82893.1; -; Genomic_DNA.
DR   EMBL; AY078396; AAL82893.1; JOINED; Genomic_DNA.
DR   EMBL; AY078397; AAL82893.1; JOINED; Genomic_DNA.
DR   EMBL; AK127724; BAG54558.1; -; mRNA.
DR   EMBL; AL390730; CAH73258.1; -; Genomic_DNA.
DR   EMBL; AL160058; CAH73258.1; JOINED; Genomic_DNA.
DR   EMBL; AL160058; CAH71967.1; -; Genomic_DNA.
DR   EMBL; AL390730; CAH71967.1; JOINED; Genomic_DNA.
DR   EMBL; CH471067; EAW90744.1; -; Genomic_DNA.
DR   EMBL; BC119743; AAI19744.1; -; mRNA.
DR   EMBL; BC119744; AAI19745.1; -; mRNA.
DR   CCDS; CCDS1247.1; -. [Q8TE12-1]
DR   RefSeq; NP_001167540.1; NM_001174069.1. [Q8TE12-1]
DR   RefSeq; NP_796372.1; NM_177398.3. [Q8TE12-1]
DR   UniGene; Hs.667312; -.
DR   ProteinModelPortal; Q8TE12; -.
DR   SMR; Q8TE12; -.
DR   BioGrid; 110194; 5.
DR   IntAct; Q8TE12; 1.
DR   STRING; 9606.ENSP00000294816; -.
DR   iPTMnet; Q8TE12; -.
DR   PhosphoSitePlus; Q8TE12; -.
DR   BioMuta; LMX1A; -.
DR   DMDM; 27923801; -.
DR   PaxDb; Q8TE12; -.
DR   PeptideAtlas; Q8TE12; -.
DR   PRIDE; Q8TE12; -.
DR   DNASU; 4009; -.
DR   Ensembl; ENST00000294816; ENSP00000294816; ENSG00000162761. [Q8TE12-1]
DR   Ensembl; ENST00000342310; ENSP00000340226; ENSG00000162761. [Q8TE12-1]
DR   Ensembl; ENST00000367893; ENSP00000356868; ENSG00000162761. [Q8TE12-1]
DR   GeneID; 4009; -.
DR   KEGG; hsa:4009; -.
DR   UCSC; uc001gcz.3; human. [Q8TE12-1]
DR   CTD; 4009; -.
DR   DisGeNET; 4009; -.
DR   EuPathDB; HostDB:ENSG00000162761.14; -.
DR   GeneCards; LMX1A; -.
DR   HGNC; HGNC:6653; LMX1A.
DR   HPA; HPA028051; -.
DR   HPA; HPA030088; -.
DR   MIM; 600298; gene.
DR   neXtProt; NX_Q8TE12; -.
DR   OpenTargets; ENSG00000162761; -.
DR   PharmGKB; PA30416; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000231629; -.
DR   HOVERGEN; HBG052335; -.
DR   InParanoid; Q8TE12; -.
DR   KO; K09371; -.
DR   OMA; NDSLWHE; -.
DR   OrthoDB; EOG091G09Z3; -.
DR   PhylomeDB; Q8TE12; -.
DR   TreeFam; TF315442; -.
DR   SIGNOR; Q8TE12; -.
DR   GeneWiki; LMX1A; -.
DR   GenomeRNAi; 4009; -.
DR   PRO; PR:Q8TE12; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162761; -.
DR   CleanEx; HS_LMX1A; -.
DR   Genevisible; Q8TE12; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021542; P:dentate gyrus development; IEA:Ensembl.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:1904948; P:midbrain dopaminergic neuron differentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0042048; P:olfactory behavior; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001558; P:regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; LIM domain;
KW   Metal-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    382       LIM homeobox transcription factor 1-
FT                                alpha.
FT                                /FTId=PRO_0000075825.
FT   DOMAIN       33     92       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       92    154       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    195    254       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    240    274       Gln-rich.
FT   COMPBIAS    257    265       Poly-Gln.
FT   VAR_SEQ       1    249       Missing (in isoform LMX1A-4AB).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003112.
SQ   SEQUENCE   382 AA;  42747 MW;  55424762757FF5FD CRC64;
     MLDGLKMEEN FQSAIDTSAS FSSLLGRAVS PKSVCEGCQR VILDRFLLRL NDSFWHEQCV
     QCASCKEPLE TTCFYRDKKL YCKYDYEKLF AVKCGGCFEA IAPNEFVMRA QKSVYHLSCF
     CCCVCERQLQ KGDEFVLKEG QLLCKGDYEK ERELLSLVSP AASDSGKSDD EESLCKSAHG
     AGKGTAEEGK DHKRPKRPRT ILTTQQRRAF KASFEVSSKP CRKVRETLAA ETGLSVRVVQ
     VWFQNQRAKM KKLARRQQQQ QQDQQNTQRL SSAQTNGGGS AGMEGIMNPY TALPTPQQLL
     AIEQSVYSSD PFRQGLTPPQ MPGDHMHPYG AEPLFHDLDS DDTSLSNLGD CFLATSEAGP
     LQSRVGNPID HLYSMQNSYF TS
//
ID   PAX4_HUMAN              Reviewed;         350 AA.
AC   O43316; O95161; Q6B0H0;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=Paired box protein Pax-4;
GN   Name=PAX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9439631; DOI=10.1006/bbrc.1997.7935;
RA   Matsushita T., Yamaoka T., Otsuka S., Moritani M., Matsumoto T.,
RA   Itakura M.;
RT   "Molecular cloning of mouse paired-box-containing gene (Pax-4) from an
RT   islet beta cell line and deduced sequence of human Pax-4.";
RL   Biochem. Biophys. Res. Commun. 242:176-180(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=9753306; DOI=10.2337/diabetes.47.10.1650;
RA   Tao T., Wasson J., Bernal-Mizrachi E., Behn P.S., Chayen S.,
RA   Duprat L., Meyer J., Glaser B., Permutt M.A.;
RT   "Isolation and characterization of the human PAX4 gene.";
RL   Diabetes 47:1650-1653(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ALTERNATIVE SPLICING (ISOFORM 2).
RC   TISSUE=Insulinoma;
RX   PubMed=11263967; DOI=10.1006/bbrc.2001.4552;
RA   Miyamoto T., Kakizawa T., Ichikawa K., Nishio S., Kajikawa S.,
RA   Hashizume K.;
RT   "Expression of dominant negative form of PAX4 in human insulinoma.";
RL   Biochem. Biophys. Res. Commun. 282:34-40(2001).
RN   [6]
RP   VARIANT NIDDM TRP-129.
RX   PubMed=11723072; DOI=10.2337/diabetes.50.12.2864;
RA   Shimajiri Y., Sanke T., Furuta H., Hanabusa T., Nakagawa T.,
RA   Fujitani Y., Kajimoto Y., Takasu N., Nanjo K.;
RT   "A missense mutation of Pax4 gene (R121W) is associated with type 2
RT   diabetes in Japanese.";
RL   Diabetes 50:2864-2869(2001).
RN   [7]
RP   INVOLVEMENT IN KPD, AND VARIANTS KPD TRP-45 AND TRP-141.
RX   PubMed=15509590; DOI=10.1093/hmg/ddh341;
RA   Mauvais-Jarvis F., Smith S.B., Le May C., Leal S.M., Gautier J.-F.,
RA   Molokhia M., Riveline J.-P., Rajan A.S., Kevorkian J.-P., Zhang S.,
RA   Vexiau P., German M.S., Vaisse C.;
RT   "PAX4 gene variations predispose to ketosis-prone diabetes.";
RL   Hum. Mol. Genet. 13:3151-3159(2004).
RN   [8]
RP   VARIANT PRO-321 (ISOFORM 3), AND ASSOCIATION WITH SUSCEPTIBILITY TO
RP   IDDM.
RX   PubMed=15834548; DOI=10.1007/s00125-005-1723-5;
RA   Biason-Lauber A., Boehm B., Lang-Muritano M., Gauthier B.R., Brun T.,
RA   Wollheim C.B., Schoenle E.J.;
RT   "Association of childhood type 1 diabetes mellitus with a variant of
RT   PAX4: possible link to beta cell regenerative capacity.";
RL   Diabetologia 48:900-905(2005).
RN   [9]
RP   VARIANT MODY9 TRP-172, VARIANTS GLN-39; CYS-191; HIS-200 AND SER-200,
RP   VARIANT PRO-321 (ISOFORM 3), AND CHARACTERIZATION OF VARIANT MODY9
RP   TRP-172.
RX   PubMed=17426099; DOI=10.1210/jc.2006-1927;
RA   Plengvidhya N., Kooptiwut S., Songtawee N., Doi A., Furuta H.,
RA   Nishi M., Nanjo K., Tantibhedhyangkul W., Boonyasrisawat W.,
RA   Yenchitsomanus P.-T., Doria A., Banchuin N.;
RT   "PAX4 mutations in Thais with maturity onset diabetes of the young.";
RL   J. Clin. Endocrinol. Metab. 92:2821-2826(2007).
CC   -!- FUNCTION: Plays an important role in the differentiation and
CC       development of pancreatic islet beta cells. Transcriptional
CC       repressor that binds to a common element in the glucagon, insulin
CC       and somatostatin promoters. Competes with PAX6 for this same
CC       promoter binding site. Isoform 2 appears to be a dominant negative
CC       form antagonizing PAX4 transcriptional activity.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Pax4;
CC         IsoId=O43316-1; Sequence=Displayed;
CC       Name=2; Synonyms=Pax4V;
CC         IsoId=O43316-2; Sequence=VSP_002359, VSP_002360;
CC       Name=3;
CC         IsoId=O43316-4; Sequence=VSP_036448, VSP_036449;
CC         Note=Variant in position: 321:H->P (associated with
CC         susceptibility to IDDM, dbSNP:rs712701).;
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:11723072}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Diabetes mellitus, insulin-dependent (IDDM) [MIM:222100]:
CC       A multifactorial disorder of glucose homeostasis that is
CC       characterized by susceptibility to ketoacidosis in the absence of
CC       insulin therapy. Clinical features are polydipsia, polyphagia and
CC       polyuria which result from hyperglycemia-induced osmotic diuresis
CC       and secondary thirst. These derangements result in long-term
CC       complications that affect the eyes, kidneys, nerves, and blood
CC       vessels. {ECO:0000269|PubMed:15834548}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Diabetes mellitus, ketosis-prone (KPD) [MIM:612227]: An
CC       atypical form of diabetes mellitus characterized by an acute
CC       initial presentation with severe hyperglycemia and ketosis, as
CC       seen in classic type 1 diabetes, but after initiation of insulin
CC       therapy, prolonged remission is often possible with cessation of
CC       insulin therapy and maintenance of appropriate metabolic control.
CC       Metabolic studies show a markedly blunted insulin secretory
CC       response to glucose, partially reversible with the improvement of
CC       blood glucose control. Variable levels of insulin resistance are
CC       observed, especially in obese patients. Pancreatic beta-cell
CC       autoimmunity is a rare finding. {ECO:0000269|PubMed:15509590}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Maturity-onset diabetes of the young 9 (MODY9)
CC       [MIM:612225]: A form of diabetes that is characterized by an
CC       autosomal dominant mode of inheritance, onset in childhood or
CC       early adulthood (usually before 25 years of age), a primary defect
CC       in insulin secretion and frequent insulin-independence at the
CC       beginning of the disease. {ECO:0000269|PubMed:17426099}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AC073934; Type=Miscellaneous discrepancy; Note=According to the human genome assembly there is a stop codon in position 349.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB008913; BAA24506.1; -; mRNA.
DR   EMBL; AF043978; AAD02289.1; -; mRNA.
DR   EMBL; AC073934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074761; AAH74761.1; -; mRNA.
DR   CCDS; CCDS5797.1; -. [O43316-4]
DR   RefSeq; NP_006184.2; NM_006193.2. [O43316-4]
DR   UniGene; Hs.129706; -.
DR   ProteinModelPortal; O43316; -.
DR   SMR; O43316; -.
DR   BioGrid; 111112; 4.
DR   iPTMnet; O43316; -.
DR   PhosphoSitePlus; O43316; -.
DR   BioMuta; PAX4; -.
DR   PeptideAtlas; O43316; -.
DR   PRIDE; O43316; -.
DR   DNASU; 5078; -.
DR   Ensembl; ENST00000341640; ENSP00000339906; ENSG00000106331. [O43316-4]
DR   GeneID; 5078; -.
DR   KEGG; hsa:5078; -.
DR   UCSC; uc010lld.1; human. [O43316-1]
DR   CTD; 5078; -.
DR   DisGeNET; 5078; -.
DR   EuPathDB; HostDB:ENSG00000106331.14; -.
DR   GeneCards; PAX4; -.
DR   H-InvDB; HIX0033508; -.
DR   HGNC; HGNC:8618; PAX4.
DR   MalaCards; PAX4; -.
DR   MIM; 125853; phenotype.
DR   MIM; 167413; gene.
DR   MIM; 222100; phenotype.
DR   MIM; 612225; phenotype.
DR   MIM; 612227; phenotype.
DR   neXtProt; NX_O43316; -.
DR   OpenTargets; ENSG00000106331; -.
DR   Orphanet; 552; MODY.
DR   PharmGKB; PA32958; -.
DR   GeneTree; ENSGT00680000099553; -.
DR   HOGENOM; HOG000230939; -.
DR   HOVERGEN; HBG009115; -.
DR   InParanoid; O43316; -.
DR   KO; K08032; -.
DR   PhylomeDB; O43316; -.
DR   TreeFam; TF320146; -.
DR   Reactome; R-HSA-210746; Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells.
DR   SignaLink; O43316; -.
DR   GeneWiki; PAX4; -.
DR   GenomeRNAi; 5078; -.
DR   PRO; PR:O43316; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106331; -.
DR   CleanEx; HS_PAX4; -.
DR   ExpressionAtlas; O43316; baseline and differential.
DR   Genevisible; O43316; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001206; F:transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR033559; Pax-4.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   PANTHER; PTHR24329:SF14; PTHR24329:SF14; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00292; PAX; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Diabetes mellitus; Differentiation; Disease mutation; DNA-binding;
KW   Homeobox; Nucleus; Paired box; Polymorphism; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    350       Paired box protein Pax-4.
FT                                /FTId=PRO_0000050180.
FT   DOMAIN        5    131       Paired. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00381}.
FT   DNA_BIND    170    229       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      278    350       Transcription repression.
FT   VAR_SEQ       1      8       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9753306}.
FT                                /FTId=VSP_036448.
FT   VAR_SEQ     239    257       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002359.
FT   VAR_SEQ     258    350       QSPGSVPTAALPALEPLGPSCYQLCWATAPERCLSDTPPKA
FT                                CLKPCWDCGSFLLPVIAPSCVDVAWPCLDASLAHHLIGGAG
FT                                KATPTHFSHWP -> AVPWQCAHSSPACPGTTGSLLLSAVL
FT                                GNSTRKVSE (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002360.
FT   VAR_SEQ     305    350       DCGSFLLPVIAPSCVDVAWPCLDASLAHHLIGGAGKATPTH
FT                                FSHWP -> GHLPPQPNSLDSGLLCLPCPSSHCHLASLSGS
FT                                QALLWPGCPLLYGLE (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9753306}.
FT                                /FTId=VSP_036449.
FT   VARIANT      39     39       R -> Q (in dbSNP:rs115887120).
FT                                {ECO:0000269|PubMed:17426099}.
FT                                /FTId=VAR_054879.
FT   VARIANT      45     45       R -> W (in KPD; associated with disease
FT                                susceptibility).
FT                                {ECO:0000269|PubMed:15509590}.
FT                                /FTId=VAR_054880.
FT   VARIANT     129    129       R -> W (in NIDDM; associated with disease
FT                                susceptibility; dbSNP:rs114202595).
FT                                {ECO:0000269|PubMed:11723072}.
FT                                /FTId=VAR_054881.
FT   VARIANT     141    141       R -> W (in KPD; associated with disease
FT                                susceptibility; dbSNP:rs2233578).
FT                                {ECO:0000269|PubMed:15509590}.
FT                                /FTId=VAR_054882.
FT   VARIANT     172    172       R -> W (in MODY9; the mutant sequence
FT                                represses the activity of the insulin and
FT                                glucagon promoters by only 35% compared
FT                                to 50% and 57% respectively with wild-
FT                                type sequence).
FT                                {ECO:0000269|PubMed:17426099}.
FT                                /FTId=VAR_054883.
FT   VARIANT     191    191       R -> C (in dbSNP:rs114315130).
FT                                {ECO:0000269|PubMed:17426099}.
FT                                /FTId=VAR_054884.
FT   VARIANT     200    200       R -> H (in dbSNP:rs2233580).
FT                                {ECO:0000269|PubMed:17426099}.
FT                                /FTId=VAR_054885.
FT   VARIANT     200    200       R -> S (in dbSNP:rs3824004).
FT                                {ECO:0000269|PubMed:17426099}.
FT                                /FTId=VAR_054886.
SQ   SEQUENCE   350 AA;  37833 MW;  2C2343AF16AEAAAC CRC64;
     MHQDGISSMN QLGGLFVNGR PLPLDTRQQI VRLAVSGMRP CDISRILKVS NGCVSKILGR
     YYRTGVLEPK GIGGSKPRLA TPPVVARIAQ LKGECPALFA WEIQRQLCAE GLCTQDKTPS
     VSSINRVLRA LQEDQGLPCT RLRSPAVLAP AVLTPHSGSE TPRGTHPGTG HRNRTIFSPS
     QAEALEKEFQ RGQYPDSVAR GKLATATSLP EDTVRVWFSN RRAKWRRQEK LKWEMQLPGA
     SQGLTVPRVA PGIISAQQSP GSVPTAALPA LEPLGPSCYQ LCWATAPERC LSDTPPKACL
     KPCWDCGSFL LPVIAPSCVD VAWPCLDASL AHHLIGGAGK ATPTHFSHWP
//
ID   PAX7_HUMAN              Reviewed;         505 AA.
AC   P23759; E9PFV9; Q0VA99; Q2PJS5;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   24-JUN-2015, sequence version 4.
DT   25-OCT-2017, entry version 180.
DE   RecName: Full=Paired box protein Pax-7;
DE   AltName: Full=HuP1;
GN   Name=PAX7; Synonyms=HUP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=9339373; DOI=10.1006/geno.1997.4915;
RA   Vorobyov E., Mertsalov I., Dockhorn-Dworniczak B., Dworniczak B.,
RA   Horst J.;
RT   "The genomic organization and the full coding region of the human PAX7
RT   gene.";
RL   Genomics 45:168-174(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=16830101; DOI=10.1007/s00239-005-0163-7;
RA   Vorobyov E., Horst J.;
RT   "Getting the proto-Pax by the tail.";
RL   J. Mol. Evol. 63:153-164(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-467 (ISOFORMS 1/3).
RX   PubMed=7527137; DOI=10.1093/nar/22.22.4574;
RA   Schaefer B.W., Czerny T., Bernasconi M., Genini M., Busslinger M.;
RT   "Molecular cloning and characterization of a human PAX-7 cDNA
RT   expressed in normal and neoplastic myocytes.";
RL   Nucleic Acids Res. 22:4574-4582(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 30-195 (ISOFORM 2).
RX   PubMed=2501086;
RA   Burri M., Tromvoukis Y., Bopp D., Frigerio G., Noll M.;
RT   "Conservation of the paired domain in metazoans and its structure in
RT   three isolated human genes.";
RL   EMBO J. 8:1183-1190(1989).
RN   [8]
RP   INVOLVEMENT IN RMS2, AND CHROMOSOMAL TRANSLOCATION WITH FOXO1.
RX   PubMed=8187070;
RA   Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G.;
RT   "Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation
RT   in alveolar rhabdomyosarcoma.";
RL   Cancer Res. 54:2869-2872(1994).
RN   [9]
RP   INTERACTION WITH DAXX.
RX   PubMed=10393185; DOI=10.1093/emboj/18.13.3702;
RA   Hollenbach A.D., Sublett J.E., McPherson C.J., Grosveld G.;
RT   "The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated
RT   repressor hDaxx.";
RL   EMBO J. 18:3702-3711(1999).
CC   -!- FUNCTION: Transcription factor playing a role in myogenesis
CC       through regulation of muscle precursor cells proliferation.
CC       {ECO:0000250|UniProtKB:P47239}.
CC   -!- SUBUNIT: Can bind to DNA as a heterodimer with PAX3. Interacts
CC       with PAXBP1; the interaction links PAX7 to a WDR5-containing
CC       histone methyltransferase complex (By similarity). Interacts with
CC       DAXX (PubMed:10393185). {ECO:0000250|UniProtKB:P47239,
CC       ECO:0000269|PubMed:10393185}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P47239}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=P23759-3; Sequence=Displayed;
CC       Name=1; Synonyms=Long;
CC         IsoId=P23759-1; Sequence=VSP_057679;
CC       Name=2; Synonyms=Short;
CC         IsoId=P23759-2; Sequence=VSP_057678, VSP_057679;
CC   -!- DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of
CC       rhabdomyosarcoma, a highly malignant tumor of striated muscle
CC       derived from primitive mesenchymal cells and exhibiting
CC       differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is
CC       one of the most frequently occurring soft tissue sarcomas and the
CC       most common in children. It occurs in four forms: alveolar,
CC       pleomorphic, embryonal and botryoidal rhabdomyosarcomas.
CC       {ECO:0000269|PubMed:8187070}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis. A chromosomal
CC       aberration involving PAX7 is found in rhabdomyosarcoma.
CC       Translocation t(1;13)(p36;q14) with FOXO1. The resulting protein
CC       is a transcriptional activator. {ECO:0000269|PubMed:8187070}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X96743; CAA65520.1; -; mRNA.
DR   EMBL; X96744; CAA65521.1; -; Genomic_DNA.
DR   EMBL; X15042; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X15250; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X15251; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96745; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96746; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96747; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96748; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96744; CAA65522.1; -; Genomic_DNA.
DR   EMBL; X15042; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X15250; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X15251; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96745; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96746; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96747; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96748; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; DQ322591; ABC48797.1; -; mRNA.
DR   EMBL; AL021528; CAA16432.1; -; Genomic_DNA.
DR   EMBL; CH471134; EAW94853.1; -; Genomic_DNA.
DR   EMBL; BC121165; AAI21166.1; -; mRNA.
DR   EMBL; BC121166; AAI21167.1; -; mRNA.
DR   EMBL; Z35141; CAA84513.1; -; mRNA.
DR   CCDS; CCDS186.1; -. [P23759-1]
DR   CCDS; CCDS44074.1; -. [P23759-3]
DR   CCDS; CCDS44075.1; -. [P23759-2]
DR   PIR; S78502; S78502.
DR   RefSeq; NP_001128726.1; NM_001135254.1. [P23759-3]
DR   RefSeq; NP_002575.1; NM_002584.2. [P23759-1]
DR   RefSeq; NP_039236.1; NM_013945.2. [P23759-2]
DR   UniGene; Hs.113253; -.
DR   ProteinModelPortal; P23759; -.
DR   SMR; P23759; -.
DR   BioGrid; 111115; 6.
DR   IntAct; P23759; 12.
DR   MINT; MINT-7241806; -.
DR   STRING; 9606.ENSP00000364524; -.
DR   iPTMnet; P23759; -.
DR   PhosphoSitePlus; P23759; -.
DR   BioMuta; PAX7; -.
DR   DMDM; 8247951; -.
DR   PaxDb; P23759; -.
DR   PeptideAtlas; P23759; -.
DR   PRIDE; P23759; -.
DR   Ensembl; ENST00000375375; ENSP00000364524; ENSG00000009709. [P23759-1]
DR   Ensembl; ENST00000400661; ENSP00000383502; ENSG00000009709. [P23759-2]
DR   Ensembl; ENST00000420770; ENSP00000403389; ENSG00000009709. [P23759-3]
DR   GeneID; 5081; -.
DR   KEGG; hsa:5081; -.
DR   UCSC; uc001bay.3; human. [P23759-3]
DR   CTD; 5081; -.
DR   DisGeNET; 5081; -.
DR   EuPathDB; HostDB:ENSG00000009709.11; -.
DR   GeneCards; PAX7; -.
DR   HGNC; HGNC:8621; PAX7.
DR   MalaCards; PAX7; -.
DR   MIM; 167410; gene.
DR   MIM; 268220; phenotype.
DR   neXtProt; NX_P23759; -.
DR   OpenTargets; ENSG00000009709; -.
DR   Orphanet; 99756; Alveolar rhabdomyosarcoma.
DR   PharmGKB; PA32961; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00680000099553; -.
DR   HOGENOM; HOG000230939; -.
DR   HOVERGEN; HBG009115; -.
DR   InParanoid; P23759; -.
DR   KO; K09381; -.
DR   OMA; MKLGDHS; -.
DR   OrthoDB; EOG091G0S4E; -.
DR   TreeFam; TF351610; -.
DR   SIGNOR; P23759; -.
DR   ChiTaRS; PAX7; human.
DR   GeneWiki; PAX7; -.
DR   GenomeRNAi; 5081; -.
DR   PRO; PR:P23759; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000009709; -.
DR   CleanEx; HS_PAX7; -.
DR   Genevisible; P23759; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000983; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0010453; P:regulation of cell fate commitment; IEA:Ensembl.
DR   GO; GO:0043393; P:regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0014813; P:skeletal muscle satellite cell commitment; IEA:Ensembl.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022106; Pax7_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12360; Pax7; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Myogenesis; Nucleus;
KW   Paired box; Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    505       Paired box protein Pax-7.
FT                                /FTId=PRO_0000050194.
FT   DOMAIN       34    163       Paired. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00381}.
FT   DNA_BIND    217    276       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       27    210       Sufficient to mediate interaction with
FT                                PAXBP1. {ECO:0000250|UniProtKB:P47239}.
FT   MOTIF       479    491       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   VAR_SEQ     151    152       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_057678.
FT   VAR_SEQ     468    505       TAVDYLAKNVSLSTQRRMKLGEHSAVLGLLPVETGQAY ->
FT                                SECLVPWASPVPIPSPTPRASCLFMESYKVVSGWGMSISQM
FT                                EKLKSSQMEQFT (in isoform 1 and isoform
FT                                2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9339373}.
FT                                /FTId=VSP_057679.
FT   CONFLICT    468    468       T -> S (in Ref. 2; ABC48797).
FT                                {ECO:0000305}.
SQ   SEQUENCE   505 AA;  55119 MW;  E51CF8B3E8D4C3D9 CRC64;
     MAALPGTVPR MMRPAPGQNY PRTGFPLEVS TPLGQGRVNQ LGGVFINGRP LPNHIRHKIV
     EMAHHGIRPC VISRQLRVSH GCVSKILCRY QETGSIRPGA IGGSKPRQVA TPDVEKKIEE
     YKRENPGMFS WEIRDRLLKD GHCDRSTVPS GLVSSISRVL RIKFGKKEEE DEADKKEDDG
     EKKAKHSIDG ILGDKGNRLD EGSDVESEPD LPLKRKQRRS RTTFTAEQLE ELEKAFERTH
     YPDIYTREEL AQRTKLTEAR VQVWFSNRRA RWRKQAGANQ LAAFNHLLPG GFPPTGMPTL
     PPYQLPDSTY PTTTISQDGG STVHRPQPLP PSTMHQGGLA AAAAAADTSS AYGARHSFSS
     YSDSFMNPAA PSNHMNPVSN GLSPQVMSIL GNPSAVPPQP QADFSISPLH GGLDSATSIS
     ASCSQRADSI KPGDSLPTSQ AYCPPTYSTT GYSVDPVAGY QYGQYGQTAV DYLAKNVSLS
     TQRRMKLGEH SAVLGLLPVE TGQAY
//
ID   P5F1B_HUMAN             Reviewed;         359 AA.
AC   Q06416; D5K9S4; D5K9S9; D5K9T0; D5K9T1; D5K9T3; D5K9U3; D5K9U6;
AC   D5K9V4; D5K9V6; D5K9W0; D5K9W2; D5K9W7; D5K9X2; D5K9X3; D5K9X5;
AC   D5K9X8; D5K9X9; E9LRB1; E9LRB2; E9LRH5; E9LRH6; E9LRH7; E9LRK4;
AC   E9LRK5; E9LRK7; E9LRK8; E9LRM7; E9LRM9; E9LRN2; E9LRN4; E9LRN5;
AC   E9LRP8; E9LRQ0; E9LRQ2; E9LRQ3; E9LRQ4; E9LRQ5; E9LRS3; Q2VIK6;
AC   Q9BZV7; Q9BZV9;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 2.
DT   25-OCT-2017, entry version 143.
DE   RecName: Full=Putative POU domain, class 5, transcription factor 1B;
DE   AltName: Full=Oct4-pg1;
DE   AltName: Full=Octamer-binding protein 3-like;
DE   AltName: Full=Octamer-binding transcription factor 3-like;
GN   Name=POU5F1B;
GN   Synonyms=OCT4PG1, OTF3C, OTF3P1, POU5F1P1, POU5FLC20, POU5FLC8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=1408763; DOI=10.1093/nar/20.17.4613;
RA   Takeda J., Seino S., Bell G.I.;
RT   "Human Oct3 gene family: cDNA sequences, alternative splicing, gene
RT   organization, chromosomal location, and expression at low levels in
RT   adult tissues.";
RL   Nucleic Acids Res. 20:4613-4620(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=16201836; DOI=10.1371/journal.pbio.0030357;
RA   Marques A.C., Dupanloup I., Vinckenbosch N., Reymond A., Kaessmann H.;
RT   "Emergence of young human genes after a burst of retroposition in
RT   primates.";
RL   PLoS Biol. 3:E357-E357(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS THR-182 AND ASP-214.
RC   TISSUE=Kidney;
RA   van Roozendaal K.E.P., Gillis A.J.M., van Asseldonk M.,
RA   Oosterhuis J.W., Looijenga L.H.J., van Zoelen E.J.J.;
RT   "Identification and expression analysis of novel intron-less human
RT   POU5F1/OCT3 related POU domain genes.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary cancer;
RA   Zhao F.-Q., Buss K.;
RT   "Differential expression of Oct-4 gene and pseudogene in normal and
RT   breast cancer cells.";
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ARG-33; GLU-176; THR-182; ASP-214
RP   AND GLN-238, AND TISSUE SPECIFICITY.
RC   TISSUE=Glial tumor, and Mammary cancer;
RX   PubMed=21341266; DOI=10.1002/path.2827;
RA   Zhao S., Yuan Q., Hao H., Guo Y., Liu S., Zhang Y., Wang J., Liu H.,
RA   Wang F., Liu K., Ling E.A., Hao A.;
RT   "Expression of OCT4 pseudogenes in human tumours: lessons from glioma
RT   and breast carcinoma.";
RL   J. Pathol. 223:672-682(2011).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=16229821; DOI=10.1016/j.bbrc.2005.09.157;
RA   Suo G., Han J., Wang X., Zhang J., Zhao Y., Zhao Y., Dai J.;
RT   "Oct4 pseudogenes are transcribed in cancers.";
RL   Biochem. Biophys. Res. Commun. 337:1047-1051(2005).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18949397;
RA   Panagopoulos I., Moeller E., Collin A., Mertens F.;
RT   "The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1
RT   isoform 1.";
RL   Oncol. Rep. 20:1029-1033(2008).
CC   -!- FUNCTION: Shows weak transcriptional activator activity.
CC       {ECO:0000269|PubMed:18949397}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00530,
CC       ECO:0000269|PubMed:18949397}.
CC   -!- TISSUE SPECIFICITY: Detected at the mRNA level in several cancer
CC       tissues (breast, uterine cervix, lung, thyroid gland, esophagus,
CC       colon, urinary bladder, and glioma), but absent in normal tissues.
CC       {ECO:0000269|PubMed:16229821, ECO:0000269|PubMed:21341266}.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       5 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Could be the product of a pseudogene. Several pseudogenes
CC       of POU5F1 have been described on chromosomes 1, 3, 8, 10 and 12.
CC       Two of them, localized on chromosomes 8 and 10 have been shown to
CC       be preferentially transcribed in cancer tissues and may be
CC       involved in the regulation of POU5F1 gene activity in
CC       carcinogenesis. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11901; CAA77953.1; -; Genomic_DNA.
DR   EMBL; DQ120688; ABB92462.1; -; Genomic_DNA.
DR   EMBL; AF268615; AAG53083.1; -; mRNA.
DR   EMBL; AF268618; AAG53085.1; -; mRNA.
DR   EMBL; DQ486513; ABF29403.1; -; mRNA.
DR   EMBL; GU480835; ADE48561.1; -; mRNA.
DR   EMBL; GU480840; ADE48566.1; -; mRNA.
DR   EMBL; GU480841; ADE48567.1; -; mRNA.
DR   EMBL; GU480842; ADE48568.1; -; mRNA.
DR   EMBL; GU480845; ADE48570.1; -; mRNA.
DR   EMBL; GU480864; ADE48580.1; -; mRNA.
DR   EMBL; GU480868; ADE48583.1; -; mRNA.
DR   EMBL; GU480878; ADE48591.1; -; mRNA.
DR   EMBL; GU480880; ADE48593.1; -; mRNA.
DR   EMBL; GU480883; ADE48596.1; -; mRNA.
DR   EMBL; GU480886; ADE48597.1; -; mRNA.
DR   EMBL; GU480889; ADE48599.1; -; mRNA.
DR   EMBL; GU480896; ADE48604.1; -; mRNA.
DR   EMBL; GU480902; ADE48606.1; -; mRNA.
DR   EMBL; GU480905; ADE48609.1; -; mRNA.
DR   EMBL; GU480906; ADE48610.1; -; mRNA.
DR   EMBL; GU480908; ADE48612.1; -; mRNA.
DR   EMBL; GU480911; ADE48614.1; -; mRNA.
DR   EMBL; GU480912; ADE48615.1; -; mRNA.
DR   EMBL; GU480913; ADE48616.1; -; mRNA.
DR   EMBL; HQ122710; ADW77351.1; -; mRNA.
DR   EMBL; HQ122711; ADW77352.1; -; mRNA.
DR   EMBL; HQ122712; ADW77353.1; -; mRNA.
DR   EMBL; HQ122713; ADW77354.1; -; mRNA.
DR   EMBL; HQ122714; ADW77355.1; -; mRNA.
DR   EMBL; HQ122716; ADW77356.1; -; mRNA.
DR   EMBL; HQ122717; ADW77357.1; -; mRNA.
DR   EMBL; HQ122718; ADW77358.1; -; mRNA.
DR   EMBL; HQ122719; ADW77359.1; -; mRNA.
DR   EMBL; HQ122721; ADW77360.1; -; mRNA.
DR   EMBL; HQ122749; ADW77385.1; -; mRNA.
DR   EMBL; HQ122750; ADW77386.1; -; mRNA.
DR   EMBL; HQ122751; ADW77387.1; -; mRNA.
DR   EMBL; HQ122752; ADW77388.1; -; mRNA.
DR   EMBL; HQ122781; ADW77415.1; -; mRNA.
DR   EMBL; HQ122782; ADW77416.1; -; mRNA.
DR   EMBL; HQ122783; ADW77417.1; -; mRNA.
DR   EMBL; HQ122784; ADW77418.1; -; mRNA.
DR   EMBL; HQ122785; ADW77419.1; -; mRNA.
DR   EMBL; HQ122786; ADW77420.1; -; mRNA.
DR   EMBL; HQ122787; ADW77421.1; -; mRNA.
DR   EMBL; HQ122788; ADW77422.1; -; mRNA.
DR   EMBL; HQ122789; ADW77423.1; -; mRNA.
DR   EMBL; HQ122790; ADW77424.1; -; mRNA.
DR   EMBL; HQ122816; ADW77444.1; -; mRNA.
DR   EMBL; HQ122817; ADW77445.1; -; mRNA.
DR   EMBL; HQ122818; ADW77446.1; -; mRNA.
DR   EMBL; HQ122819; ADW77447.1; -; mRNA.
DR   EMBL; HQ122820; ADW77448.1; -; mRNA.
DR   EMBL; HQ122821; ADW77449.1; -; mRNA.
DR   EMBL; HQ122822; ADW77450.1; -; mRNA.
DR   EMBL; HQ122823; ADW77451.1; -; mRNA.
DR   EMBL; HQ122824; ADW77452.1; -; mRNA.
DR   EMBL; HQ122825; ADW77453.1; -; mRNA.
DR   EMBL; HQ122826; ADW77454.1; -; mRNA.
DR   EMBL; HQ122827; ADW77455.1; -; mRNA.
DR   EMBL; HQ122841; ADW77467.1; -; mRNA.
DR   EMBL; HQ122842; ADW77468.1; -; mRNA.
DR   EMBL; HQ122843; ADW77469.1; -; mRNA.
DR   EMBL; HQ122844; ADW77470.1; -; mRNA.
DR   EMBL; HQ122845; ADW77471.1; -; mRNA.
DR   EMBL; HQ122846; ADW77472.1; -; mRNA.
DR   EMBL; HQ122848; ADW77473.1; -; mRNA.
DR   EMBL; HQ122849; ADW77474.1; -; mRNA.
DR   EMBL; HQ122851; ADW77475.1; -; mRNA.
DR   EMBL; HQ122852; ADW77476.1; -; mRNA.
DR   EMBL; HQ122853; ADW77477.1; -; mRNA.
DR   EMBL; HQ122854; ADW77478.1; -; mRNA.
DR   EMBL; HQ122855; ADW77479.1; -; mRNA.
DR   EMBL; HQ122856; ADW77480.1; -; mRNA.
DR   EMBL; HQ122857; ADW77481.1; -; mRNA.
DR   EMBL; HQ122864; ADW77487.1; -; mRNA.
DR   EMBL; HQ122865; ADW77488.1; -; mRNA.
DR   EMBL; HQ122866; ADW77489.1; -; mRNA.
DR   EMBL; HQ122867; ADW77490.1; -; mRNA.
DR   EMBL; HQ122868; ADW77491.1; -; mRNA.
DR   EMBL; HQ122869; ADW77492.1; -; mRNA.
DR   EMBL; HQ122870; ADW77493.1; -; mRNA.
DR   EMBL; HQ122871; ADW77494.1; -; mRNA.
DR   EMBL; HQ122874; ADW77495.1; -; mRNA.
DR   EMBL; HQ122876; ADW77496.1; -; mRNA.
DR   EMBL; HQ122877; ADW77497.1; -; mRNA.
DR   EMBL; HQ122878; ADW77498.1; -; mRNA.
DR   EMBL; HQ122879; ADW77499.1; -; mRNA.
DR   EMBL; HQ122880; ADW77500.1; -; mRNA.
DR   EMBL; HQ122881; ADW77501.1; -; mRNA.
DR   EMBL; HQ122882; ADW77502.1; -; mRNA.
DR   EMBL; HQ122883; ADW77503.1; -; mRNA.
DR   EMBL; HQ122884; ADW77504.1; -; mRNA.
DR   EMBL; HQ122885; ADW77505.1; -; mRNA.
DR   EMBL; HQ122886; ADW77506.1; -; mRNA.
DR   EMBL; HQ122887; ADW77507.1; -; mRNA.
DR   EMBL; HQ122891; ADW77511.1; -; mRNA.
DR   EMBL; HQ122892; ADW77512.1; -; mRNA.
DR   EMBL; HQ122893; ADW77513.1; -; mRNA.
DR   EMBL; HQ122895; ADW77514.1; -; mRNA.
DR   EMBL; HQ122898; ADW77515.1; -; mRNA.
DR   EMBL; HQ122900; ADW77516.1; -; mRNA.
DR   EMBL; HQ122902; ADW77517.1; -; mRNA.
DR   EMBL; HQ122903; ADW77518.1; -; mRNA.
DR   EMBL; AC016883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS55274.1; -.
DR   RefSeq; NP_001153014.1; NM_001159542.1.
DR   UniGene; Hs.450254; -.
DR   ProteinModelPortal; Q06416; -.
DR   SMR; Q06416; -.
DR   STRING; 9606.ENSP00000375557; -.
DR   iPTMnet; Q06416; -.
DR   PhosphoSitePlus; Q06416; -.
DR   BioMuta; POU5F1B; -.
DR   DMDM; 357528826; -.
DR   EPD; Q06416; -.
DR   MaxQB; Q06416; -.
DR   PaxDb; Q06416; -.
DR   PeptideAtlas; Q06416; -.
DR   PRIDE; Q06416; -.
DR   Ensembl; ENST00000465342; ENSP00000419298; ENSG00000212993.
DR   GeneID; 5462; -.
DR   KEGG; hsa:5462; -.
DR   UCSC; uc003ysf.4; human.
DR   CTD; 5462; -.
DR   DisGeNET; 5462; -.
DR   EuPathDB; HostDB:ENSG00000212993.4; -.
DR   GeneCards; POU5F1B; -.
DR   HGNC; HGNC:9223; POU5F1B.
DR   HPA; HPA058267; -.
DR   MIM; 615739; gene.
DR   neXtProt; NX_Q06416; -.
DR   OpenTargets; ENSG00000212993; -.
DR   PharmGKB; PA33547; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000089941; -.
DR   InParanoid; Q06416; -.
DR   KO; K09367; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; Q06416; -.
DR   TreeFam; TF316413; -.
DR   GenomeRNAi; 5462; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000212993; -.
DR   Genevisible; Q06416; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR015585; POU_dom_5.
DR   PANTHER; PTHR11636:SF86; PTHR11636:SF86; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   5: Uncertain;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    359       Putative POU domain, class 5,
FT                                transcription factor 1B.
FT                                /FTId=PRO_0000100753.
FT   DOMAIN      138    212       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    229    288       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     111    111       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01860}.
FT   MOD_RES     235    235       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q01860}.
FT   MOD_RES     236    236       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01860}.
FT   MOD_RES     288    288       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01860}.
FT   MOD_RES     289    289       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01860}.
FT   MOD_RES     354    354       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01860}.
FT   VARIANT      33     33       L -> R (in dbSNP:rs1061394).
FT                                {ECO:0000269|PubMed:21341266}.
FT                                /FTId=VAR_067432.
FT   VARIANT      69     69       L -> F (in dbSNP:rs1061395).
FT                                /FTId=VAR_067433.
FT   VARIANT     176    176       G -> E (in dbSNP:rs6998061).
FT                                {ECO:0000269|PubMed:21341266}.
FT                                /FTId=VAR_067434.
FT   VARIANT     182    182       K -> T (in dbSNP:rs13273814).
FT                                {ECO:0000269|PubMed:21341266,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_067435.
FT   VARIANT     214    214       N -> D (in dbSNP:rs13274084).
FT                                {ECO:0000269|PubMed:21341266,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_067436.
FT   VARIANT     238    238       E -> Q (in dbSNP:rs7002225).
FT                                {ECO:0000269|PubMed:21341266}.
FT                                /FTId=VAR_067437.
FT   VARIANT     313    313       P -> L (in dbSNP:rs556361752).
FT                                /FTId=VAR_067438.
FT   CONFLICT     10     10       A -> T (in Ref. 5; ADE48599).
FT                                {ECO:0000305}.
FT   CONFLICT     13     13       P -> L (in Ref. 5; ADE48609/ADW77452).
FT                                {ECO:0000305}.
FT   CONFLICT     14     14       P -> T (in Ref. 5; ADW77351).
FT                                {ECO:0000305}.
FT   CONFLICT     23     25       WGA -> GGP (in Ref. 5; ADE48566/
FT                                ADE48597). {ECO:0000305}.
FT   CONFLICT     31     31       D -> G (in Ref. 5; ADE48567).
FT                                {ECO:0000305}.
FT   CONFLICT     31     31       D -> V (in Ref. 5; ADE48570).
FT                                {ECO:0000305}.
FT   CONFLICT     35     35       W -> R (in Ref. 5; ADW77415/ADW77416/
FT                                ADW77417/ADW77420/ADW77421).
FT                                {ECO:0000305}.
FT   CONFLICT     39     39       Q -> R (in Ref. 5; ADE48583).
FT                                {ECO:0000305}.
FT   CONFLICT     76     76       C -> R (in Ref. 5; ADW77445).
FT                                {ECO:0000305}.
FT   CONFLICT     79     79       Q -> H (in Ref. 5; ADW77469).
FT                                {ECO:0000305}.
FT   CONFLICT     91     91       E -> V (in Ref. 5; ADE48610/ADW77455).
FT                                {ECO:0000305}.
FT   CONFLICT    106    106       N -> S (in Ref. 5; ADE48612).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       S -> Y (in Ref. 5; ADW77513/ADW77518).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       L -> Q (in Ref. 5; ADE48580).
FT                                {ECO:0000305}.
FT   CONFLICT    130    130       E -> G (in Ref. 5; ADW77492).
FT                                {ECO:0000305}.
FT   CONFLICT    132    132       N -> D (in Ref. 5; ADW77447).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       D -> G (in Ref. 5; ADE48599).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       A -> T (in Ref. 5; ADE48616).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       L -> F (in Ref. 5; ADW77351).
FT                                {ECO:0000305}.
FT   CONFLICT    155    155       Q -> R (in Ref. 5; ADW77490/ADW77499/
FT                                ADW77502/ADW77503). {ECO:0000305}.
FT   CONFLICT    160    160       L -> P (in Ref. 5; ADW77417).
FT                                {ECO:0000305}.
FT   CONFLICT    163    163       T -> A (in Ref. 5; ADE48580).
FT                                {ECO:0000305}.
FT   CONFLICT    169    169       L -> F (in Ref. 5; ADW77415/ADW77420/
FT                                ADW77421). {ECO:0000305}.
FT   CONFLICT    169    169       L -> P (in Ref. 5; ADE48561).
FT                                {ECO:0000305}.
FT   CONFLICT    169    169       L -> R (in Ref. 5; ADE48583).
FT                                {ECO:0000305}.
FT   CONFLICT    196    196       N -> D (in Ref. 5; ADW77492).
FT                                {ECO:0000305}.
FT   CONFLICT    197    197       M -> I (in Ref. 1; CAA77953).
FT                                {ECO:0000305}.
FT   CONFLICT    201    201       R -> W (in Ref. 5; ADE48615).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       V -> E (in Ref. 5; ADW77493/ADW77501/
FT                                ADW77506). {ECO:0000305}.
FT   CONFLICT    211    211       A -> T (in Ref. 5; ADE48593/ADW77355/
FT                                ADW77358/ADW77387/ADW77418/ADW77423).
FT                                {ECO:0000305}.
FT   CONFLICT    235    235       T -> A (in Ref. 5; ADW77518/ADW77513).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       V -> M (in Ref. 5; ADW77488/ADW77496/
FT                                ADW77504/ADW77507). {ECO:0000305}.
FT   CONFLICT    246    246       E -> G (in Ref. 5; ADW77492).
FT                                {ECO:0000305}.
FT   CONFLICT    249    249       F -> L (in Ref. 5; ADW77474/ADW77481).
FT                                {ECO:0000305}.
FT   CONFLICT    250    250       L -> P (in Ref. 5; ADE48580).
FT                                {ECO:0000305}.
FT   CONFLICT    250    250       L -> Q (in Ref. 5; ADW77475).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       I -> T (in Ref. 5; ADW77488/ADW77496/
FT                                ADW77504/ADW77507). {ECO:0000305}.
FT   CONFLICT    264    264       Q -> H (in Ref. 5; ADE48609/ADW77452).
FT                                {ECO:0000305}.
FT   CONFLICT    264    264       Q -> L (in Ref. 5; ADW77477/ADW77476/
FT                                ADW77467). {ECO:0000305}.
FT   CONFLICT    272    272       V -> M (in Ref. 5; ADW77472/ADW77479).
FT                                {ECO:0000305}.
FT   CONFLICT    276    278       WFC -> CFG (in Ref. 5; ADW77495).
FT                                {ECO:0000305}.
FT   CONFLICT    282    282       Q -> R (in Ref. 5; ADW77494).
FT                                {ECO:0000305}.
FT   CONFLICT    284    284       G -> S (in Ref. 5; ADW77469).
FT                                {ECO:0000305}.
FT   CONFLICT    295    295       E -> V (in Ref. 5; ADE48583).
FT                                {ECO:0000305}.
FT   CONFLICT    318    318       H -> Q (in Ref. 5; ADW77444/ADW77445).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       T -> I (in Ref. 5; ADW77476/ADW77467/
FT                                ADW77477). {ECO:0000305}.
FT   CONFLICT    326    326       S -> G (in Ref. 5; ADW77444/ADW77445).
FT                                {ECO:0000305}.
FT   CONFLICT    331    331       A -> T (in Ref. 5; ADW77447/ADW77448/
FT                                ADW77451). {ECO:0000305}.
FT   CONFLICT    340    340       E -> V (in Ref. 5; ADE48570).
FT                                {ECO:0000305}.
SQ   SEQUENCE   359 AA;  38588 MW;  9AF853B116FCB75A CRC64;
     MAGHLASDFA FSPPPGGGGD GPWGAEPGWV DPLTWLSFQG PPGGPGIGPG VGPGSEVWGI
     PPCPPPYELC GGMAYCGPQV GVGLVPQGGL ETSQPESEAG VGVESNSNGA SPEPCTVPPG
     AVKLEKEKLE QNPEKSQDIK ALQKELEQFA KLLKQKRITL GYTQADVGLI LGVLFGKVFS
     QKTICRFEAL QLSFKNMCKL RPLLQKWVEE ADNNENLQEI CKAETLMQAR KRKRTSIENR
     VRGNLENLFL QCPKPTLQIS HIAQQLGLEK DVVRVWFCNR RQKGKRSSSD YAQREDFEAA
     GSPFSGGPVS FPPAPGPHFG TPGYGSPHFT ALYSSVPFPE GEVFPPVSVI TLGSPMHSN
//
ID   PBX3_HUMAN              Reviewed;         434 AA.
AC   P40426; E9PB27; Q5JSA0; Q5JSA1; Q5VXL3; Q96PF9; Q96PG0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   27-SEP-2017, entry version 162.
DE   RecName: Full=Pre-B-cell leukemia transcription factor 3;
DE   AltName: Full=Homeobox protein PBX3;
GN   Name=PBX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PBX3A AND PBX3B).
RX   PubMed=1682799; DOI=10.1128/MCB.11.12.6149;
RA   Monica K., Galili N., Nourse J., Saltman D., Cleary M.L.;
RT   "PBX2 and PBX3, new homeobox genes with extensive homology to the
RT   human proto-oncogene PBX1.";
RL   Mol. Cell. Biol. 11:6149-6157(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PBX3C AND PBX3D).
RX   PubMed=11579467; DOI=10.1002/gcc.1190;
RA   Milech N., Kees U.R., Watt P.M.;
RT   "Novel alternative PBX3 isoforms in leukemia cells with distinct
RT   interaction specificities.";
RL   Genes Chromosomes Cancer 32:275-280(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PBX3C AND 5).
RC   TISSUE=Adrenal gland, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PBX3A).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHARACTERIZATION.
RX   PubMed=7910944; DOI=10.1128/MCB.14.6.3938;
RA   Lu Q., Wright D.D., Kamps M.P.;
RT   "Fusion with E2A converts the Pbx1 homeodomain protein into a
RT   constitutive transcriptional activator in human leukemias carrying the
RT   t(1;19) translocation.";
RL   Mol. Cell. Biol. 14:3938-3948(1994).
RN   [7]
RP   INTERACTION WITH PBXIP1.
RX   PubMed=10825160; DOI=10.1074/jbc.M001323200;
RA   Abramovich C., Shen W.-F., Pineault N., Imren S., Montpetit B.,
RA   Largman C., Humphries R.K.;
RT   "Functional cloning and characterization of a novel nonhomeodomain
RT   protein that inhibits the binding of PBX1-HOX complexes to DNA.";
RL   J. Biol. Chem. 275:26172-26177(2000).
CC   -!- FUNCTION: Transcriptional activator that binds the sequence 5'-
CC       ATCAATCAA-3'.
CC   -!- SUBUNIT: Interacts with PBXIP1. {ECO:0000269|PubMed:10825160}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=PBX3a;
CC         IsoId=P40426-1; Sequence=Displayed;
CC       Name=PBX3b;
CC         IsoId=P40426-2; Sequence=VSP_002276, VSP_002277;
CC       Name=PBX3c;
CC         IsoId=P40426-3; Sequence=VSP_002275;
CC       Name=PBX3d;
CC         IsoId=P40426-4; Sequence=VSP_002275, VSP_002276, VSP_002277;
CC       Name=5;
CC         IsoId=P40426-5; Sequence=VSP_046311;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- SIMILARITY: Belongs to the TALE/PBX homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59841; CAA42502.1; -; mRNA.
DR   EMBL; AF355141; AAL09477.1; -; mRNA.
DR   EMBL; AF355142; AAL09478.1; -; mRNA.
DR   EMBL; AK289376; BAF82065.1; -; mRNA.
DR   EMBL; AK309713; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL358074; CAH73695.1; -; Genomic_DNA.
DR   EMBL; AL445186; CAH73695.1; JOINED; Genomic_DNA.
DR   EMBL; AL445186; CAI40243.1; -; Genomic_DNA.
DR   EMBL; AL358074; CAI40243.1; JOINED; Genomic_DNA.
DR   EMBL; AL445186; CAI40245.1; -; Genomic_DNA.
DR   EMBL; AL445186; CAI40244.1; -; Genomic_DNA.
DR   EMBL; AL627303; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC094883; AAH94883.1; -; mRNA.
DR   CCDS; CCDS48021.1; -. [P40426-5]
DR   CCDS; CCDS6865.1; -. [P40426-1]
DR   CCDS; CCDS83416.1; -. [P40426-2]
DR   PIR; S19010; S19010.
DR   RefSeq; NP_001128250.1; NM_001134778.1. [P40426-5]
DR   RefSeq; NP_001317711.1; NM_001330782.1. [P40426-2]
DR   RefSeq; NP_006186.1; NM_006195.5. [P40426-1]
DR   UniGene; Hs.428027; -.
DR   ProteinModelPortal; P40426; -.
DR   SMR; P40426; -.
DR   BioGrid; 111123; 27.
DR   IntAct; P40426; 3.
DR   STRING; 9606.ENSP00000362588; -.
DR   iPTMnet; P40426; -.
DR   PhosphoSitePlus; P40426; -.
DR   BioMuta; PBX3; -.
DR   DMDM; 730281; -.
DR   MaxQB; P40426; -.
DR   PaxDb; P40426; -.
DR   PeptideAtlas; P40426; -.
DR   PRIDE; P40426; -.
DR   Ensembl; ENST00000342287; ENSP00000341990; ENSG00000167081. [P40426-2]
DR   Ensembl; ENST00000373489; ENSP00000362588; ENSG00000167081. [P40426-1]
DR   Ensembl; ENST00000447726; ENSP00000387456; ENSG00000167081. [P40426-5]
DR   GeneID; 5090; -.
DR   KEGG; hsa:5090; -.
DR   UCSC; uc004bqb.4; human. [P40426-1]
DR   CTD; 5090; -.
DR   DisGeNET; 5090; -.
DR   EuPathDB; HostDB:ENSG00000167081.16; -.
DR   GeneCards; PBX3; -.
DR   HGNC; HGNC:8634; PBX3.
DR   HPA; HPA003881; -.
DR   MIM; 176312; gene.
DR   neXtProt; NX_P40426; -.
DR   OpenTargets; ENSG00000167081; -.
DR   PharmGKB; PA32972; -.
DR   eggNOG; KOG0774; Eukaryota.
DR   eggNOG; ENOG410XRVF; LUCA.
DR   GeneTree; ENSGT00390000016426; -.
DR   HOGENOM; HOG000266972; -.
DR   HOVERGEN; HBG000122; -.
DR   InParanoid; P40426; -.
DR   KO; K15610; -.
DR   PhylomeDB; P40426; -.
DR   TreeFam; TF314340; -.
DR   SIGNOR; P40426; -.
DR   ChiTaRS; PBX3; human.
DR   GeneWiki; PBX3; -.
DR   GenomeRNAi; 5090; -.
DR   PRO; PR:P40426; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000167081; -.
DR   CleanEx; HS_PBX3; -.
DR   ExpressionAtlas; P40426; baseline and differential.
DR   Genevisible; P40426; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007387; P:anterior compartment pattern formation; TAS:ProtInc.
DR   GO; GO:0021516; P:dorsal spinal cord development; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0007388; P:posterior compartment specification; TAS:ProtInc.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR005542; PBX.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03792; PBC; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    434       Pre-B-cell leukemia transcription factor
FT                                3.
FT                                /FTId=PRO_0000049239.
FT   DNA_BIND    235    297       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS    130    138       Poly-Ala.
FT   VAR_SEQ       1    181       Missing (in isoform PBX3c and isoform
FT                                PBX3d). {ECO:0000303|PubMed:11579467,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_002275.
FT   VAR_SEQ       1     75       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046311.
FT   VAR_SEQ     338    351       SSGSFNLPNSGDMF -> GYPPSCYQSDGRLQ (in
FT                                isoform PBX3b and isoform PBX3d).
FT                                {ECO:0000303|PubMed:11579467,
FT                                ECO:0000303|PubMed:1682799}.
FT                                /FTId=VSP_002276.
FT   VAR_SEQ     352    434       Missing (in isoform PBX3b and isoform
FT                                PBX3d). {ECO:0000303|PubMed:11579467,
FT                                ECO:0000303|PubMed:1682799}.
FT                                /FTId=VSP_002277.
FT   CONFLICT    323    323       V -> A (in Ref. 2; AAL09477).
FT                                {ECO:0000305}.
FT   CONFLICT    398    398       Y -> C (in Ref. 2; AAL09477).
FT                                {ECO:0000305}.
SQ   SEQUENCE   434 AA;  47190 MW;  81987E4C80C22069 CRC64;
     MDDQSRMLQT LAGVNLAGHS VQGGMALPPP PHGHEGADGD GRKQDIGDIL HQIMTITDQS
     LDEAQAKKHA LNCHRMKPAL FSVLCEIKEK TGLSIRGAQE EDPPDPQLMR LDNMLLAEGV
     SGPEKGGGSA AAAAAAAASG GSSDNSIEHS DYRAKLTQIR QIYHTELEKY EQACNEFTTH
     VMNLLREQSR TRPISPKEIE RMVGIIHRKF SSIQMQLKQS TCEAVMILRS RFLDARRKRR
     NFSKQATEIL NEYFYSHLSN PYPSEEAKEE LAKKCSITVS QVSNWFGNKR IRYKKNIGKF
     QEEANLYAAK TAVTAAHAVA AAVQNNQTNS PTTPNSGSSG SFNLPNSGDM FMNMQSLNGD
     SYQGSQVGAN VQSQVDTLRH VINQTGGYSD GLGGNSLYSP HNLNANGGWQ DATTPSSVTS
     PTEGPGSVHS DTSN
//
ID   PBX2_HUMAN              Reviewed;         430 AA.
AC   P40425; A2BFJ2;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   25-OCT-2017, entry version 166.
DE   RecName: Full=Pre-B-cell leukemia transcription factor 2;
DE   AltName: Full=Homeobox protein PBX2;
DE   AltName: Full=Protein G17;
GN   Name=PBX2; Synonyms=G17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1682799; DOI=10.1128/MCB.11.12.6149;
RA   Monica K., Galili N., Nourse J., Saltman D., Cleary M.L.;
RT   "PBX2 and PBX3, new homeobox genes with extensive homology to the
RT   human proto-oncogene PBX1.";
RL   Mol. Cell. Biol. 11:6149-6157(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7759099; DOI=10.1016/0888-7543(95)80007-9;
RA   Aguado B., Campbell R.D.;
RT   "The novel gene G17, located in the human major histocompatibility
RT   complex, encodes PBX2, a homeodomain-containing protein.";
RL   Genomics 25:650-659(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7835890; DOI=10.1006/geno.1994.1517;
RA   Sugaya K., Fukagawa T., Matsumoto K., Mita K., Takahashi E., Ando A.,
RA   Inoko H., Ikemura T.;
RT   "Three genes in the human MHC class III region near the junction with
RT   the class II: gene for receptor of advanced glycosylation end
RT   products, PBX2 homeobox gene and a notch homolog, human counterpart of
RT   mouse mammary tumor gene int-3.";
RL   Genomics 23:408-419(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=7910944; DOI=10.1128/MCB.14.6.3938;
RA   Lu Q., Wright D.D., Kamps M.P.;
RT   "Fusion with E2A converts the Pbx1 homeodomain protein into a
RT   constitutive transcriptional activator in human leukemias carrying the
RT   t(1;19) translocation.";
RL   Mol. Cell. Biol. 14:3938-3948(1994).
RN   [9]
RP   INTERACTION WITH PBXIP1.
RX   PubMed=10825160; DOI=10.1074/jbc.M001323200;
RA   Abramovich C., Shen W.-F., Pineault N., Imren S., Montpetit B.,
RA   Largman C., Humphries R.K.;
RT   "Functional cloning and characterization of a novel nonhomeodomain
RT   protein that inhibits the binding of PBX1-HOX complexes to DNA.";
RL   J. Biol. Chem. 275:26172-26177(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH MEIS1.
RX   PubMed=12609849; DOI=10.1182/blood-2002-02-0380;
RA   Okada Y., Nagai R., Sato T., Matsuura E., Minami T., Morita I.,
RA   Doi T.;
RT   "Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific
RT   transcription of the platelet factor 4 gene.";
RL   Blood 101:4748-4756(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136; SER-151 AND
RP   SER-330, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Transcriptional activator that binds the sequence 5'-
CC       ATCAATCAA-3'. Activates transcription of PF4 in complex with
CC       MEIS1. {ECO:0000269|PubMed:12609849}.
CC   -!- SUBUNIT: Forms heterodimers with MEIS1 and heterotrimers with
CC       MEIS1 and HOXA9. Interacts with PBXIP1.
CC       {ECO:0000269|PubMed:10825160, ECO:0000269|PubMed:12609849}.
CC   -!- INTERACTION:
CC       Q13515:BFSP2; NbExp=4; IntAct=EBI-348489, EBI-10229433;
CC       Q9H257:CARD9; NbExp=3; IntAct=EBI-348489, EBI-751319;
CC       P49639:HOXA1; NbExp=3; IntAct=EBI-348489, EBI-740785;
CC       P09067:HOXB5; NbExp=4; IntAct=EBI-348489, EBI-3893317;
CC       Q00444:HOXC5; NbExp=4; IntAct=EBI-348489, EBI-11955357;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- SIMILARITY: Belongs to the TALE/PBX homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59842; CAA42503.1; -; mRNA.
DR   EMBL; X80700; CAA56717.1; -; Genomic_DNA.
DR   EMBL; D28769; BAA05957.1; -; Genomic_DNA.
DR   EMBL; U89336; AAB47490.1; -; Genomic_DNA.
DR   EMBL; AL662884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662830; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL845464; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX284686; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR933878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR812478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03613.1; -; Genomic_DNA.
DR   EMBL; BC082261; AAH82261.1; -; mRNA.
DR   CCDS; CCDS4748.1; -.
DR   PIR; A56002; A56002.
DR   RefSeq; NP_002577.2; NM_002586.4.
DR   UniGene; Hs.509545; -.
DR   UniGene; Hs.718462; -.
DR   ProteinModelPortal; P40425; -.
DR   SMR; P40425; -.
DR   BioGrid; 111122; 36.
DR   CORUM; P40425; -.
DR   IntAct; P40425; 43.
DR   MINT; MINT-1032522; -.
DR   STRING; 9606.ENSP00000364190; -.
DR   iPTMnet; P40425; -.
DR   PhosphoSitePlus; P40425; -.
DR   BioMuta; PBX2; -.
DR   DMDM; 1352729; -.
DR   EPD; P40425; -.
DR   MaxQB; P40425; -.
DR   PaxDb; P40425; -.
DR   PeptideAtlas; P40425; -.
DR   PRIDE; P40425; -.
DR   DNASU; 5089; -.
DR   Ensembl; ENST00000375050; ENSP00000364190; ENSG00000204304.
DR   Ensembl; ENST00000383270; ENSP00000372757; ENSG00000206315.
DR   Ensembl; ENST00000420432; ENSP00000410710; ENSG00000236353.
DR   Ensembl; ENST00000431537; ENSP00000390009; ENSG00000232005.
DR   Ensembl; ENST00000433552; ENSP00000391745; ENSG00000224952.
DR   Ensembl; ENST00000453487; ENSP00000403948; ENSG00000225987.
DR   Ensembl; ENST00000453961; ENSP00000397177; ENSG00000237344.
DR   GeneID; 5089; -.
DR   KEGG; hsa:5089; -.
DR   UCSC; uc003oav.2; human.
DR   CTD; 5089; -.
DR   DisGeNET; 5089; -.
DR   EuPathDB; HostDB:ENSG00000204304.11; -.
DR   GeneCards; PBX2; -.
DR   HGNC; HGNC:8633; PBX2.
DR   HPA; HPA061478; -.
DR   MIM; 176311; gene.
DR   neXtProt; NX_P40425; -.
DR   OpenTargets; ENSG00000204304; -.
DR   PharmGKB; PA32971; -.
DR   eggNOG; KOG0774; Eukaryota.
DR   eggNOG; ENOG410XRVF; LUCA.
DR   GeneTree; ENSGT00390000016426; -.
DR   HOVERGEN; HBG000122; -.
DR   InParanoid; P40425; -.
DR   KO; K15609; -.
DR   OMA; IRANGGW; -.
DR   OrthoDB; EOG091G10TD; -.
DR   PhylomeDB; P40425; -.
DR   TreeFam; TF314340; -.
DR   SIGNOR; P40425; -.
DR   ChiTaRS; PBX2; human.
DR   GeneWiki; PBX2; -.
DR   GenomeRNAi; 5089; -.
DR   PRO; PR:P40425; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204304; -.
DR   CleanEx; HS_PBX2; -.
DR   ExpressionAtlas; P40425; baseline and differential.
DR   Genevisible; P40425; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR005542; PBX.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03792; PBC; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    430       Pre-B-cell leukemia transcription factor
FT                                2.
FT                                /FTId=PRO_0000049237.
FT   DNA_BIND    244    306       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS    137    145       Poly-Ala.
FT   MOD_RES     136    136       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     151    151       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35984}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35984}.
FT   CONFLICT    393    393       M -> I (in Ref. 1; CAA42503).
FT                                {ECO:0000305}.
SQ   SEQUENCE   430 AA;  45881 MW;  EF2FFA158C4DAF68 CRC64;
     MDERLLGPPP PGGGRGGLGL VSGEPGGPGE PPGGGDPGGG SGGVPGGRGK QDIGDILQQI
     MTITDQSLDE AQAKKHALNC HRMKPALFSV LCEIKEKTGL SIRSSQEEEP VDPQLMRLDN
     MLLAEGVAGP EKGGGSAAAA AAAAASGGGV SPDNSIEHSD YRSKLAQIRH IYHSELEKYE
     QACNEFTTHV MNLLREQSRT RPVAPKEMER MVSIIHRKFS AIQMQLKQST CEAVMILRSR
     FLDARRKRRN FSKQATEVLN EYFYSHLSNP YPSEEAKEEL AKKCGITVSQ VSNWFGNKRI
     RYKKNIGKFQ EEANIYAVKT AVSVTQGGHS RTSSPTPPSS AGSGGSFNLS GSGDMFLGMP
     GLNGDSYSAS QVESLRHSMG PGGYGDNLGG GQMYSPREMR ANGSWQEAVT PSSVTSPTEG
     PGSVHSDTSN
//
ID   HME2_HUMAN              Reviewed;         333 AA.
AC   P19622; A4D252; Q549U3; Q9UD58;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2002, sequence version 3.
DT   25-OCT-2017, entry version 156.
DE   RecName: Full=Homeobox protein engrailed-2;
DE            Short=Homeobox protein en-2;
DE            Short=Hu-En-2;
GN   Name=EN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1363401; DOI=10.1002/dvg.1020130505;
RA   Logan C., Hanks M.C., Noble-Topham S., Nallainathan D., Provart N.J.,
RA   Joyner A.L.;
RT   "Cloning and sequence comparison of the mouse, human, and chicken
RT   engrailed genes reveal potential functional domains and regulatory
RT   regions.";
RL   Dev. Genet. 13:345-358(1992).
RN   [2]
RP   SEQUENCE REVISION TO 229.
RA   Logan C., Hanks M.C., Noble-Topham S., Nallainathan D., Provart N.J.,
RA   Joyner A.L.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 230-333.
RX   PubMed=2565873; DOI=10.1016/0888-7543(89)90324-8;
RA   Poole S.J., Law M.L., Kao F.T., Lau Y.-F.C.;
RT   "Isolation and chromosomal localization of the human En-2 gene.";
RL   Genomics 4:225-231(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 252-290.
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
RN   [8]
RP   POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO AUTISM.
RX   PubMed=16252243; DOI=10.1086/497705;
RA   Benayed R., Gharani N., Rossman I., Mancuso V., Lazar G., Kamdar S.,
RA   Bruse S.E., Tischfield S., Smith B.J., Zimmerman R.A.,
RA   DiCicco-Bloom E., Brzustowicz L.M., Millonig J.H.;
RT   "Support for the homeobox transcription factor gene ENGRAILED 2 as an
RT   autism spectrum disorder susceptibility locus.";
RL   Am. J. Hum. Genet. 77:851-868(2005).
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Note=Genetic variations in EN2 may be associated with
CC       susceptibility to autism.
CC   -!- SIMILARITY: Belongs to the engrailed homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12701; AAA53504.2; -; Genomic_DNA.
DR   EMBL; L12700; AAA53504.2; JOINED; Genomic_DNA.
DR   EMBL; AC008060; AAQ96875.1; -; Genomic_DNA.
DR   EMBL; CH236954; EAL23909.1; -; Genomic_DNA.
DR   EMBL; BC104970; AAI04971.1; -; mRNA.
DR   EMBL; BC104972; AAI04973.1; -; mRNA.
DR   EMBL; J03066; AAF68670.1; -; Genomic_DNA.
DR   CCDS; CCDS5940.1; -.
DR   PIR; E48423; E48423.
DR   RefSeq; NP_001418.2; NM_001427.3.
DR   UniGene; Hs.134989; -.
DR   ProteinModelPortal; P19622; -.
DR   SMR; P19622; -.
DR   BioGrid; 108335; 4.
DR   STRING; 9606.ENSP00000297375; -.
DR   DrugBank; DB03309; N-Cyclohexyltaurine.
DR   iPTMnet; P19622; -.
DR   PhosphoSitePlus; P19622; -.
DR   BioMuta; EN2; -.
DR   DMDM; 21903415; -.
DR   PaxDb; P19622; -.
DR   PeptideAtlas; P19622; -.
DR   PRIDE; P19622; -.
DR   Ensembl; ENST00000297375; ENSP00000297375; ENSG00000164778.
DR   GeneID; 2020; -.
DR   KEGG; hsa:2020; -.
DR   UCSC; uc003wmb.3; human.
DR   CTD; 2020; -.
DR   DisGeNET; 2020; -.
DR   EuPathDB; HostDB:ENSG00000164778.4; -.
DR   GeneCards; EN2; -.
DR   HGNC; HGNC:3343; EN2.
DR   HPA; CAB025088; -.
DR   HPA; HPA045646; -.
DR   HPA; HPA069809; -.
DR   MIM; 131310; gene.
DR   neXtProt; NX_P19622; -.
DR   OpenTargets; ENSG00000164778; -.
DR   Orphanet; 106; Autism.
DR   PharmGKB; PA27780; -.
DR   eggNOG; KOG0493; Eukaryota.
DR   eggNOG; ENOG4111P06; LUCA.
DR   GeneTree; ENSGT00900000140915; -.
DR   HOGENOM; HOG000247054; -.
DR   HOVERGEN; HBG005975; -.
DR   InParanoid; P19622; -.
DR   KO; K09319; -.
DR   OMA; KDAGTCC; -.
DR   OrthoDB; EOG091G0XBB; -.
DR   PhylomeDB; P19622; -.
DR   TreeFam; TF106461; -.
DR   GeneWiki; EN2_(gene); -.
DR   GenomeRNAi; 2020; -.
DR   PRO; PR:P19622; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164778; -.
DR   CleanEx; HS_EN2; -.
DR   Genevisible; P19622; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:1990403; P:embryonic brain development; IEA:Ensembl.
DR   GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR019549; Homeobox-engrailed_C-terminal.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000747; Homeobox_engrailed.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR019737; Homoebox-engrailed_CS.
DR   Pfam; PF10525; Engrail_1_C_sig; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00026; ENGRAILED.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00033; ENGRAILED; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Autism; Autism spectrum disorder; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    333       Homeobox protein engrailed-2.
FT                                /FTId=PRO_0000196067.
FT   DNA_BIND    244    303       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     121    121       L -> F (in dbSNP:rs3735653).
FT                                /FTId=VAR_021985.
SQ   SEQUENCE   333 AA;  34211 MW;  ACF5399E383D6257 CRC64;
     MEENDPKPGE AAAAVEGQRQ PESSPGGGSG GGGGSSPGEA DTGRRRALML PAVLQAPGNH
     QHPHRITNFF IDNILRPEFG RRKDAGTCCA GAGGGRGGGA GGEGGASGAE GGGGAGGSEQ
     LLGSGSREPR QNPPCAPGAG GPLPAAGSDS PGDGEGGSKT LSLHGGAKKG GDPGGPLDGS
     LKARGLGGGD LSVSSDSDSS QAGANLGAQP MLWPAWVYCT RYSDRPSSGP RSRKPKKKNP
     NKEDKRPRTA FTAEQLQRLK AEFQTNRYLT EQRRQSLAQE LSLNESQIKI WFQNKRAKIK
     KATGNKNTLA VHLMAQGLYN HSTTAKEGKS DSE
//
ID   HOMEZ_HUMAN             Reviewed;         550 AA.
AC   Q8IX15; A1L445; B4DZ80; F8WCA3; Q6P049; Q86XB6; Q9P2A5;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   27-SEP-2017, entry version 145.
DE   RecName: Full=Homeobox and leucine zipper protein Homez;
DE   AltName: Full=Homeodomain leucine zipper-containing factor;
GN   Name=HOMEZ; Synonyms=KIAA1443;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION,
RP   ALTERNATIVE SPLICING, INTERACTION WITH HOXC8, AND TISSUE SPECIFICITY.
RX   PubMed=12925734; DOI=10.1073/pnas.1834010100;
RA   Bayarsaihan D., Enkhmandakh B., Makeyev A., Greally J.M.,
RA   Leckman J.F., Ruddle F.H.;
RT   "Homez, a homeobox leucine zipper gene specific to the vertebrate
RT   lineage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10358-10363(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 10-550 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-451, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351 AND THR-451, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-182; LYS-200 AND LYS-202,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   STRUCTURE BY NMR OF 361-423 AND 453-509.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domains of human homeodomain
RT   leucine zipper-encoding gene (HOMEZ).";
RL   Submitted (FEB-2007) to the PDB data bank.
CC   -!- FUNCTION: May function as a transcriptional regulator.
CC   -!- SUBUNIT: Homodimer or heterodimer (Potential). Interacts with
CC       HOXC8. {ECO:0000269|PubMed:12925734, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q8WTP8:AEN; NbExp=3; IntAct=EBI-10172004, EBI-8637627;
CC       Q08117:AES; NbExp=3; IntAct=EBI-10172004, EBI-717810;
CC       Q8N2Z9:CENPS; NbExp=3; IntAct=EBI-10172004, EBI-5529649;
CC       Q9H4E7:DEF6; NbExp=3; IntAct=EBI-10172004, EBI-745369;
CC       Q9H147:DNTTIP1; NbExp=3; IntAct=EBI-10172004, EBI-2795449;
CC       Q9UH73:EBF1; NbExp=3; IntAct=EBI-10172004, EBI-765426;
CC       O60573:EIF4E2; NbExp=3; IntAct=EBI-10172004, EBI-398610;
CC       Q14241:ELOA; NbExp=3; IntAct=EBI-10172004, EBI-742350;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-10172004, EBI-401755;
CC       P52292:KPNA2; NbExp=3; IntAct=EBI-10172004, EBI-349938;
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-10172004, EBI-739832;
CC       A1L1C6:LRRC7; NbExp=3; IntAct=EBI-10172004, EBI-10171988;
CC       Q15013:MAD2L1BP; NbExp=3; IntAct=EBI-10172004, EBI-712181;
CC       Q9BUE0:MED18; NbExp=3; IntAct=EBI-10172004, EBI-394640;
CC       Q9Y3B7:MRPL11; NbExp=3; IntAct=EBI-10172004, EBI-5453723;
CC       O43639:NCK2; NbExp=3; IntAct=EBI-10172004, EBI-713635;
CC       Q13526:PIN1; NbExp=3; IntAct=EBI-10172004, EBI-714158;
CC       Q13131:PRKAA1; NbExp=3; IntAct=EBI-10172004, EBI-1181405;
CC       P54646:PRKAA2; NbExp=3; IntAct=EBI-10172004, EBI-1383852;
CC       Q14498-3:RBM39; NbExp=3; IntAct=EBI-10172004, EBI-6654703;
CC       O76064:RNF8; NbExp=3; IntAct=EBI-10172004, EBI-373337;
CC       P32969:RPL9P9; NbExp=3; IntAct=EBI-10172004, EBI-358122;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-10172004, EBI-727004;
CC       Q08AM8:SH3RF2; NbExp=3; IntAct=EBI-10172004, EBI-10225873;
CC       Q8NB12:SMYD1; NbExp=3; IntAct=EBI-10172004, EBI-8463848;
CC       P08579:SNRPB2; NbExp=3; IntAct=EBI-10172004, EBI-1053651;
CC       P61956:SUMO2; NbExp=3; IntAct=EBI-10172004, EBI-473220;
CC       Q9BUZ4:TRAF4; NbExp=3; IntAct=EBI-10172004, EBI-3650647;
CC       O95365:ZBTB7A; NbExp=3; IntAct=EBI-10172004, EBI-2795384;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:12925734}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IX15-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IX15-3; Sequence=VSP_054303;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Strongly expressed in adult testis
CC       and kidney as well as fetal lung and kidney.
CC       {ECO:0000269|PubMed:12925734}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-25 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN76991.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA92681.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF463523; AAN76991.1; ALT_INIT; mRNA.
DR   EMBL; AB037864; BAA92681.1; ALT_INIT; mRNA.
DR   EMBL; AK302788; BAG63992.1; -; mRNA.
DR   EMBL; AL049829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC130392; AAI30393.1; -; mRNA.
DR   CCDS; CCDS45085.1; -. [Q8IX15-1]
DR   RefSeq; NP_065885.2; NM_020834.2. [Q8IX15-1]
DR   UniGene; Hs.632332; -.
DR   PDB; 2ECC; NMR; -; A=361-423.
DR   PDB; 2YS9; NMR; -; A=453-509.
DR   PDBsum; 2ECC; -.
DR   PDBsum; 2YS9; -.
DR   ProteinModelPortal; Q8IX15; -.
DR   SMR; Q8IX15; -.
DR   BioGrid; 121645; 34.
DR   IntAct; Q8IX15; 33.
DR   STRING; 9606.ENSP00000350049; -.
DR   iPTMnet; Q8IX15; -.
DR   PhosphoSitePlus; Q8IX15; -.
DR   BioMuta; HOMEZ; -.
DR   DMDM; 317373364; -.
DR   EPD; Q8IX15; -.
DR   MaxQB; Q8IX15; -.
DR   PaxDb; Q8IX15; -.
DR   PeptideAtlas; Q8IX15; -.
DR   PRIDE; Q8IX15; -.
DR   Ensembl; ENST00000357460; ENSP00000350049; ENSG00000215271. [Q8IX15-1]
DR   Ensembl; ENST00000561013; ENSP00000453979; ENSG00000215271. [Q8IX15-3]
DR   GeneID; 57594; -.
DR   KEGG; hsa:57594; -.
DR   UCSC; uc001wja.3; human. [Q8IX15-1]
DR   CTD; 57594; -.
DR   DisGeNET; 57594; -.
DR   EuPathDB; HostDB:ENSG00000215271.7; -.
DR   GeneCards; HOMEZ; -.
DR   H-InvDB; HIX0011535; -.
DR   HGNC; HGNC:20164; HOMEZ.
DR   HPA; HPA036316; -.
DR   HPA; HPA036317; -.
DR   MIM; 608119; gene.
DR   neXtProt; NX_Q8IX15; -.
DR   OpenTargets; ENSG00000215271; -.
DR   PharmGKB; PA162391555; -.
DR   eggNOG; ENOG410IFGX; Eukaryota.
DR   eggNOG; ENOG410YKZF; LUCA.
DR   GeneTree; ENSGT00530000063149; -.
DR   HOGENOM; HOG000136732; -.
DR   HOVERGEN; HBG051919; -.
DR   InParanoid; Q8IX15; -.
DR   OMA; LEPAWPQ; -.
DR   OrthoDB; EOG091G02WT; -.
DR   PhylomeDB; Q8IX15; -.
DR   TreeFam; TF333363; -.
DR   ChiTaRS; HOMEZ; human.
DR   EvolutionaryTrace; Q8IX15; -.
DR   GenomeRNAi; 57594; -.
DR   PRO; PR:Q8IX15; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000215271; -.
DR   CleanEx; HS_HOMEZ; -.
DR   ExpressionAtlas; Q8IX15; baseline and differential.
DR   Genevisible; Q8IX15; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 2.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR024578; Homez_homeobox_dom.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF11569; Homez; 1.
DR   SMART; SM00389; HOX; 2.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    550       Homeobox and leucine zipper protein
FT                                Homez.
FT                                /FTId=PRO_0000049135.
FT   DNA_BIND     55    114       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    355    415       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    451    510       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       358    363       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    160    195       Pro-rich.
FT   COMPBIAS    284    291       Poly-Ser.
FT   COMPBIAS    425    465       Pro-rich.
FT   COMPBIAS    515    536       Glu-rich.
FT   COMPBIAS    537    544       Poly-Asp.
FT   MOD_RES     351    351       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     451    451       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    182    182       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    200    200       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    202    202       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     13       MVRGWEPPPGLDC -> MLKSRISMRSRHPRR (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054303.
FT   VARIANT     278    278       A -> T (in dbSNP:rs10131813).
FT                                /FTId=VAR_055956.
FT   CONFLICT    302    302       A -> T (in Ref. 5; AAI30393).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       Missing (in Ref. 1; AAN76991, 2; BAA92681
FT                                and 5; AAI30393). {ECO:0000305}.
FT   CONFLICT    538    538       D -> E (in Ref. 5; AAI30393).
FT                                {ECO:0000305}.
FT   CONFLICT    538    538       Missing (in Ref. 3; BAG63992).
FT                                {ECO:0000305}.
FT   HELIX       365    377       {ECO:0000244|PDB:2ECC}.
FT   HELIX       383    392       {ECO:0000244|PDB:2ECC}.
FT   HELIX       397    413       {ECO:0000244|PDB:2ECC}.
FT   HELIX       464    472       {ECO:0000244|PDB:2YS9}.
FT   HELIX       480    487       {ECO:0000244|PDB:2YS9}.
FT   HELIX       492    502       {ECO:0000244|PDB:2YS9}.
SQ   SEQUENCE   550 AA;  61240 MW;  A7DDF6DD56D8BDF0 CRC64;
     MVRGWEPPPG LDCAISEGHK SEGTMPPNKE ASGLSSSPAG LICLPPISEE LQLVWTQAAQ
     TSELDSNEHL LKTFSYFPYP SLADIALLCL RYGLQMEKVK TWFMAQRLRC GISWSSEEIE
     ETRARVVYRR DQLHFKSLLS FTHHAGRPPE EVPPPPVPAP EQVGIGIGPP TLSKPTQTKG
     LKVEPEEPSQ MPPLPQSHQK LKESLMTPGS GAFPYQSDFW QHLQSSGLSK EQAGRGPNQS
     HGIGTASWNH STTVPQPQAR DKPPPIALIA SSCKEESASS VTPSSSSTSS SFQVLANGAT
     AASKPLQPLG CVPQSVSPSE QALPPHLEPA WPQGLRHNSV PGRVGPTEYL SPDMQRQRKT
     KRKTKEQLAI LKSFFLQCQW ARREDYQKLE QITGLPRPEI IQWFGDTRYA LKHGQLKWFR
     DNAVPGAPSF QDPAIPTPPP STRSLNERAE TPPLPIPPPP PDIQPLERYW AAHQQLRETD
     IPQLSQASRL STQQVLDWFD SRLPQPAEVV VCLDEEEEEE EEELPEDDEE EEEEEEEDDD
     DDDDDVIIQD
//
ID   HXA11_HUMAN             Reviewed;         313 AA.
AC   P31270; A4D190;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   25-OCT-2017, entry version 169.
DE   RecName: Full=Homeobox protein Hox-A11;
DE   AltName: Full=Homeobox protein Hox-1I;
GN   Name=HOXA11; Synonyms=HOX1I;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9745033; DOI=10.1007/s003359900870;
RA   Potter S.S., Branford W.W.;
RT   "Evolutionary conservation and tissue-specific processing of hoxa 11
RT   antisense transcripts.";
RL   Mamm. Genome 9:799-806(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Mi X., Winters J.L., Stevens D.B., Fleischman R.A.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 241-306.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [8]
RP   INVOLVEMENT IN RUSAT1.
RX   PubMed=11101832; DOI=10.1038/82511;
RA   Thompson A.A., Nguyen L.T.;
RT   "Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are
RT   associated with HOXA11 mutation.";
RL   Nat. Genet. 26:397-398(2000).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Radioulnar synostosis with amegakaryocytic
CC       thrombocytopenia 1 (RUSAT1) [MIM:605432]: The syndrome consists of
CC       an unusual association of bone marrow failure and skeletal
CC       defects. Patients have the same skeletal defects, the proximal
CC       fusion of the radius and ulna, resulting in extremely limited
CC       pronation and supination of the forearm. Some patients have also
CC       symptomatic thrombocytopenia, with bruising and bleeding problems
CC       since birth, necessitating correction by bone marrow or umbilical-
CC       cord stem-cell transplantation. {ECO:0000269|PubMed:11101832}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HOXA11ID40847ch7p15.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF071164; AAC80455.1; -; Genomic_DNA.
DR   EMBL; AF039307; AAB94761.1; -; Genomic_DNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236948; EAL24220.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93888.1; -; Genomic_DNA.
DR   EMBL; BC040948; AAH40948.1; -; mRNA.
DR   CCDS; CCDS5411.1; -.
DR   PIR; S14931; S14931.
DR   RefSeq; NP_005514.1; NM_005523.5.
DR   UniGene; Hs.249171; -.
DR   ProteinModelPortal; P31270; -.
DR   SMR; P31270; -.
DR   BioGrid; 109447; 5.
DR   IntAct; P31270; 1.
DR   STRING; 9606.ENSP00000006015; -.
DR   iPTMnet; P31270; -.
DR   PhosphoSitePlus; P31270; -.
DR   BioMuta; HOXA11; -.
DR   DMDM; 13124744; -.
DR   MaxQB; P31270; -.
DR   PaxDb; P31270; -.
DR   PeptideAtlas; P31270; -.
DR   PRIDE; P31270; -.
DR   DNASU; 3207; -.
DR   Ensembl; ENST00000006015; ENSP00000006015; ENSG00000005073.
DR   GeneID; 3207; -.
DR   KEGG; hsa:3207; -.
DR   UCSC; uc003syx.4; human.
DR   CTD; 3207; -.
DR   DisGeNET; 3207; -.
DR   EuPathDB; HostDB:ENSG00000005073.5; -.
DR   GeneCards; HOXA11; -.
DR   HGNC; HGNC:5101; HOXA11.
DR   HPA; HPA006770; -.
DR   HPA; HPA035623; -.
DR   MalaCards; HOXA11; -.
DR   MIM; 142958; gene.
DR   MIM; 605432; phenotype.
DR   neXtProt; NX_P31270; -.
DR   OpenTargets; ENSG00000005073; -.
DR   Orphanet; 71289; Radio-ulnar synostosis - amegakaryocytic thrombocytopenia.
DR   PharmGKB; PA29378; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231898; -.
DR   HOVERGEN; HBG052048; -.
DR   InParanoid; P31270; -.
DR   KO; K21951; -.
DR   OMA; FGKNTAN; -.
DR   OrthoDB; EOG091G0DZB; -.
DR   PhylomeDB; P31270; -.
DR   TreeFam; TF350668; -.
DR   SignaLink; P31270; -.
DR   SIGNOR; P31270; -.
DR   GeneWiki; HOXA11; -.
DR   GenomeRNAi; 3207; -.
DR   PRO; PR:P31270; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000005073; -.
DR   CleanEx; HS_HOXA11; -.
DR   ExpressionAtlas; P31270; baseline and differential.
DR   Genevisible; P31270; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; ISS:UniProtKB.
DR   GO; GO:0032993; C:protein-DNA complex; ISS:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048589; P:developmental growth; ISS:UniProtKB.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007501; P:mesodermal cell fate specification; ISS:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; ISS:UniProtKB.
DR   GO; GO:0001759; P:organ induction; IEA:Ensembl.
DR   GO; GO:0010720; P:positive regulation of cell development; ISS:UniProtKB.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0007338; P:single fertilization; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0060065; P:uterus development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR021918; DUF3528.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF12045; DUF3528; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    313       Homeobox protein Hox-A11.
FT                                /FTId=PRO_0000200095.
FT   DNA_BIND    241    300       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    177    183       Poly-Ala.
FT   COMPBIAS    195    199       Poly-Gly.
FT   COMPBIAS    204    207       Poly-Ala.
FT   COMPBIAS    212    215       Poly-Arg.
FT   COMPBIAS    218    221       Poly-Ser.
SQ   SEQUENCE   313 AA;  34486 MW;  B345B987816AB9FB CRC64;
     MDFDERGPCS SNMYLPSCTY YVSGPDFSSL PSFLPQTPSS RPMTYSYSSN LPQVQPVREV
     TFREYAIEPA TKWHPRGNLA HCYSAEELVH RDCLQAPSAA GVPGDVLAKS SANVYHHPTP
     AVSSNFYSTV GRNGVLPQAF DQFFETAYGT PENLASSDYP GDKSAEKGPP AATATSAAAA
     AAATGAPATS SSDSGGGGGC RETAAAAEEK ERRRRPESSS SPESSSGHTE DKAGGSSGQR
     TRKKRCPYTK YQIRELEREF FFSVYINKEK RLQLSRMLNL TDRQVKIWFQ NRRMKEKKIN
     RDRLQYYSAN PLL
//
ID   HXA6_HUMAN              Reviewed;         233 AA.
AC   P31267; A4D192; Q2M3G3; Q9UPM0;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Homeobox protein Hox-A6;
DE   AltName: Full=Homeobox protein Hox-1B;
GN   Name=HOXA6; Synonyms=HOX1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 155-220.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236948; EAL24222.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93875.1; -; Genomic_DNA.
DR   EMBL; BC069497; AAH69497.1; -; mRNA.
DR   EMBL; BC104915; AAI04916.1; -; mRNA.
DR   EMBL; BC104917; AAI04918.1; -; mRNA.
DR   CCDS; CCDS5407.1; -.
DR   PIR; S15538; S15538.
DR   RefSeq; NP_076919.1; NM_024014.3.
DR   UniGene; Hs.679517; -.
DR   ProteinModelPortal; P31267; -.
DR   SMR; P31267; -.
DR   BioGrid; 109443; 1.
DR   STRING; 9606.ENSP00000222728; -.
DR   iPTMnet; P31267; -.
DR   PhosphoSitePlus; P31267; -.
DR   BioMuta; HOXA6; -.
DR   DMDM; 17378385; -.
DR   MaxQB; P31267; -.
DR   PaxDb; P31267; -.
DR   PeptideAtlas; P31267; -.
DR   PRIDE; P31267; -.
DR   DNASU; 3203; -.
DR   Ensembl; ENST00000222728; ENSP00000222728; ENSG00000106006.
DR   GeneID; 3203; -.
DR   KEGG; hsa:3203; -.
DR   UCSC; uc003syo.3; human.
DR   CTD; 3203; -.
DR   DisGeNET; 3203; -.
DR   EuPathDB; HostDB:ENSG00000106006.6; -.
DR   GeneCards; HOXA6; -.
DR   HGNC; HGNC:5107; HOXA6.
DR   HPA; HPA004203; -.
DR   MIM; 142951; gene.
DR   neXtProt; NX_P31267; -.
DR   OpenTargets; ENSG00000106006; -.
DR   PharmGKB; PA29384; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P31267; -.
DR   KO; K09306; -.
DR   OMA; IACNRAS; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P31267; -.
DR   TreeFam; TF316310; -.
DR   GeneWiki; HOXA6; -.
DR   GenomeRNAi; 3203; -.
DR   PRO; PR:P31267; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106006; -.
DR   CleanEx; HS_HOXA6; -.
DR   Genevisible; P31267; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    233       Homeobox protein Hox-A6.
FT                                /FTId=PRO_0000200067.
FT   DNA_BIND    155    214       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       136    141       Antp-type hexapeptide.
SQ   SEQUENCE   233 AA;  26339 MW;  9D9DFD03FAF25967 CRC64;
     MSSYFVNPTF PGSLPSGQDS FLGQLPLYQA GYDALRPFPA SYGASSLPDK TYTSPCFYQQ
     SNSVLACNRA SYEYGASCFY SDKDLSGASP SGSGKQRGPG DYLHFSPEQQ YKPDSSSGQG
     KALHDEGADR KYTSPVYPWM QRMNSCAGAV YGSHGRRGRQ TYTRYQTLEL EKEFHFNRYL
     TRRRRIEIAN ALCLTERQIK IWFQNRRMKW KKENKLINST QPSGEDSEAK AGE
//
ID   HXB2_HUMAN              Reviewed;         356 AA.
AC   P14652; P10913; P17485;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   25-OCT-2017, entry version 166.
DE   RecName: Full=Homeobox protein Hox-B2;
DE   AltName: Full=Homeobox protein Hox-2.8;
DE   AltName: Full=Homeobox protein Hox-2H;
DE   AltName: Full=K8;
GN   Name=HOXB2; Synonyms=HOX2H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 132-208.
RC   TISSUE=Placenta;
RX   PubMed=2570724; DOI=10.1111/j.1432-0436.1989.tb00598.x;
RA   Giampaolo A., Acampora D., Zappavigna V., Pannese M., D'Esposito M.,
RA   Care A., Faiella A., Stornaiuolo A., Russo G., Simeone A.,
RA   Boncinelli E., Peschle C.;
RT   "Differential expression of human HOX-2 genes along the anterior-
RT   posterior axis in embryonic central nervous system.";
RL   Differentiation 40:191-197(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 143-208.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 143-202.
RX   PubMed=2901346;
RA   Kongsuwan K., Webb E., Housiaux P., Adams J.M.;
RT   "Expression of multiple homeobox genes within diverse mammalian
RT   haemopoietic lineages.";
RL   EMBO J. 7:2131-2138(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-42.
RX   PubMed=7876223; DOI=10.1074/jbc.270.9.4544;
RA   Vieille-Grosjean I., Huber P.;
RT   "Transcription factor GATA-1 regulates human HOXB2 gene expression in
RT   erythroid cells.";
RL   J. Biol. Chem. 270:4544-4550(1995).
RN   [7]
RP   FUNCTION, AND GAMMA-GLOBIN PROMOTER AND ENHANCER BINDING FACTOR
RP   COMPLEX.
RX   PubMed=10595394; DOI=10.1089/104454999314809;
RA   Case S.S., Huber P., Lloyd J.A.;
RT   "The gammaPE complex contains both SATB1 and HOXB2 and has positive
RT   and negative roles in human gamma-globin gene regulation.";
RL   DNA Cell Biol. 18:805-817(1999).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-274, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       {ECO:0000269|PubMed:10595394}.
CC   -!- SUBUNIT: Part of the nuclear protein complex gamma-globin promoter
CC       and enhancer binding factor (gamma-PE) composed at least by SATB1
CC       and HOXB2.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed in whole embryos and fetuses at 5-9
CC       weeks from conception.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Proboscipedia
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16665; CAA34655.1; -; mRNA.
DR   EMBL; BC074805; AAH74805.1; -; mRNA.
DR   EMBL; BC074806; AAH74806.1; -; mRNA.
DR   EMBL; X16176; CAA34298.1; -; Genomic_DNA.
DR   EMBL; X14571; CAA32709.1; -; mRNA.
DR   EMBL; X78978; CAA55581.1; -; Genomic_DNA.
DR   CCDS; CCDS11527.1; -.
DR   PIR; S07542; WJHU2H.
DR   RefSeq; NP_002136.1; NM_002145.3.
DR   UniGene; Hs.514289; -.
DR   ProteinModelPortal; P14652; -.
DR   SMR; P14652; -.
DR   BioGrid; 109452; 1.
DR   ELM; P14652; -.
DR   IntAct; P14652; 9.
DR   STRING; 9606.ENSP00000331741; -.
DR   iPTMnet; P14652; -.
DR   PhosphoSitePlus; P14652; -.
DR   BioMuta; HOXB2; -.
DR   DMDM; 123270; -.
DR   PaxDb; P14652; -.
DR   PeptideAtlas; P14652; -.
DR   PRIDE; P14652; -.
DR   DNASU; 3212; -.
DR   Ensembl; ENST00000330070; ENSP00000331741; ENSG00000173917.
DR   GeneID; 3212; -.
DR   KEGG; hsa:3212; -.
DR   UCSC; uc002inm.5; human.
DR   CTD; 3212; -.
DR   DisGeNET; 3212; -.
DR   EuPathDB; HostDB:ENSG00000173917.10; -.
DR   GeneCards; HOXB2; -.
DR   HGNC; HGNC:5113; HOXB2.
DR   HPA; HPA047857; -.
DR   MIM; 142967; gene.
DR   neXtProt; NX_P14652; -.
DR   OpenTargets; ENSG00000173917; -.
DR   PharmGKB; PA29389; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000063664; -.
DR   HOVERGEN; HBG006088; -.
DR   InParanoid; P14652; -.
DR   KO; K09302; -.
DR   OMA; HEFPWMK; -.
DR   OrthoDB; EOG091G0IJ4; -.
DR   PhylomeDB; P14652; -.
DR   TreeFam; TF317730; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   GeneWiki; HOXB2; -.
DR   GenomeRNAi; 3212; -.
DR   PRO; PR:P14652; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173917; -.
DR   CleanEx; HS_HOXB2; -.
DR   Genevisible; P14652; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0021612; P:facial nerve structural organization; IEA:Ensembl.
DR   GO; GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0048857; P:neural nucleus development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0021569; P:rhombomere 3 development; IEA:Ensembl.
DR   GO; GO:0021570; P:rhombomere 4 development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    356       Homeobox protein Hox-B2.
FT                                /FTId=PRO_0000200114.
FT   DNA_BIND    143    202       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF        94     99       Antp-type hexapeptide.
FT   MOD_RES     274    274       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT    136    138       PEA -> RRL (in Ref. 3; CAA34298).
FT                                {ECO:0000305}.
SQ   SEQUENCE   356 AA;  37914 MW;  D7ACA0E3D5BEBFB9 CRC64;
     MNFEFEREIG FINSQPSLAE CLTSFPAVLE TFQTSSIKES TLIPPPPPFE QTFPSLQPGA
     STLQRPRSQK RAEDGPALPP PPPPPLPAAP PAPEFPWMKE KKSAKKPSQS ATSPSPAASA
     VPASGVGSPA DGLGLPEAGG GGARRLRTAY TNTQLLELEK EFHFNKYLCR PRRVEIAALL
     DLTERQVKVW FQNRRMKHKR QTQHREPPDG EPACPGALED ICDPAEEPAA SPGGPSASRA
     AWEACCHPPE VVPGALSADP RPLAVRLEGA GASSPGCALR GAGGLEPGPL PEDVFSGRQD
     SPFLPDLNFF AADSCLQLSG GLSPSLQGSL DSPVPFSEEE LDFFTSTLCA IDLQFP
//
ID   HXB9_HUMAN              Reviewed;         250 AA.
AC   P17482; B2RDB7; Q9H1I1;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   25-OCT-2017, entry version 170.
DE   RecName: Full=Homeobox protein Hox-B9;
DE   AltName: Full=Homeobox protein Hox-2.5;
DE   AltName: Full=Homeobox protein Hox-2E;
GN   Name=HOXB9; Synonyms=HOX2E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 173-250.
RC   TISSUE=Placenta;
RX   PubMed=2570724; DOI=10.1111/j.1432-0436.1989.tb00598.x;
RA   Giampaolo A., Acampora D., Zappavigna V., Pannese M., D'Esposito M.,
RA   Care A., Faiella A., Stornaiuolo A., Russo G., Simeone A.,
RA   Boncinelli E., Peschle C.;
RT   "Differential expression of human HOX-2 genes along the anterior-
RT   posterior axis in embryonic central nervous system.";
RL   Differentiation 40:191-197(1989).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 185-250.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-133, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-745290, EBI-739580;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-745290, EBI-618309;
CC       Q07627:KRTAP1-1; NbExp=4; IntAct=EBI-745290, EBI-11959885;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-745290, EBI-10172052;
CC       P26371:KRTAP5-9; NbExp=3; IntAct=EBI-745290, EBI-3958099;
CC       Q3LI66:KRTAP6-2; NbExp=4; IntAct=EBI-745290, EBI-11962084;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-745290, EBI-741037;
CC       Q99750:MDFI; NbExp=5; IntAct=EBI-745290, EBI-724076;
CC       Q9UJV3-2:MID2; NbExp=5; IntAct=EBI-745290, EBI-10172526;
CC       Q8ND90:PNMA1; NbExp=5; IntAct=EBI-745290, EBI-302345;
CC       P21673:SAT1; NbExp=6; IntAct=EBI-745290, EBI-711613;
CC       Q15654:TRIP6; NbExp=3; IntAct=EBI-745290, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed in whole embryos and fetuses at 5-9
CC       weeks from conception.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY014296; AAG42144.1; -; Genomic_DNA.
DR   EMBL; AY014295; AAG42144.1; JOINED; Genomic_DNA.
DR   EMBL; AK315480; BAG37864.1; -; mRNA.
DR   EMBL; CH471109; EAW94721.1; -; Genomic_DNA.
DR   EMBL; BC015565; AAH15565.1; -; mRNA.
DR   EMBL; X16172; CAA34294.1; -; Genomic_DNA.
DR   CCDS; CCDS11534.1; -.
DR   PIR; A37042; A37042.
DR   RefSeq; NP_076922.1; NM_024017.4.
DR   UniGene; Hs.463350; -.
DR   ProteinModelPortal; P17482; -.
DR   SMR; P17482; -.
DR   BioGrid; 109459; 50.
DR   IntAct; P17482; 59.
DR   MINT; MINT-118223; -.
DR   STRING; 9606.ENSP00000309439; -.
DR   iPTMnet; P17482; -.
DR   PhosphoSitePlus; P17482; -.
DR   BioMuta; HOXB9; -.
DR   DMDM; 20141507; -.
DR   PaxDb; P17482; -.
DR   PeptideAtlas; P17482; -.
DR   PRIDE; P17482; -.
DR   Ensembl; ENST00000311177; ENSP00000309439; ENSG00000170689.
DR   GeneID; 3219; -.
DR   KEGG; hsa:3219; -.
DR   UCSC; uc002inx.4; human.
DR   CTD; 3219; -.
DR   DisGeNET; 3219; -.
DR   EuPathDB; HostDB:ENSG00000170689.9; -.
DR   GeneCards; HOXB9; -.
DR   HGNC; HGNC:5120; HOXB9.
DR   HPA; HPA031463; -.
DR   MIM; 142964; gene.
DR   neXtProt; NX_P17482; -.
DR   OpenTargets; ENSG00000170689; -.
DR   PharmGKB; PA29396; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231180; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P17482; -.
DR   KO; K09294; -.
DR   OMA; CSFQPKP; -.
DR   OrthoDB; EOG091G0H4X; -.
DR   PhylomeDB; P17482; -.
DR   TreeFam; TF317819; -.
DR   SIGNOR; P17482; -.
DR   ChiTaRS; HOXB9; human.
DR   GeneWiki; HOXB9; -.
DR   GenomeRNAi; 3219; -.
DR   PRO; PR:P17482; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000170689; -.
DR   CleanEx; HS_HOXB9; -.
DR   Genevisible; P17482; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR006711; Hox9_activation_N.
DR   InterPro; IPR017112; HXA9/HXB9/HXC9.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF04617; Hox9_act; 1.
DR   PIRSF; PIRSF037109; Homeobox_Hox9; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    250       Homeobox protein Hox-B9.
FT                                /FTId=PRO_0000200155.
FT   DNA_BIND    185    244       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     133    133       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CONFLICT    173    173       T -> A (in Ref. 5; CAA34294).
FT                                {ECO:0000305}.
SQ   SEQUENCE   250 AA;  28059 MW;  F06ECBC08FBBED2C CRC64;
     MSISGTLSSY YVDSIISHES EDAPPAKFPS GQYASSRQPG HAEHLEFPSC SFQPKAPVFG
     ASWAPLSPHA SGSLPSVYHP YIQPQGVPPA ESRYLRTWLE PAPRGEAAPG QGQAAVKAEP
     LLGAPGELLK QGTPEYSLET SAGREAVLSN QRPGYGDNKI CEGSEDKERP DQTNPSANWL
     HARSSRKKRC PYTKYQTLEL EKEFLFNMYL TRDRRHEVAR LLNLSERQVK IWFQNRRMKM
     KKMNKEQGKE
//
ID   HXC12_HUMAN             Reviewed;         282 AA.
AC   P31275; Q9BXJ6;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Homeobox protein Hox-C12;
DE   AltName: Full=Homeobox protein Hox-3F;
GN   Name=HOXC12; Synonyms=HOC3F, HOX3F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 214-279.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF328962; AAK16717.1; -; Genomic_DNA.
DR   EMBL; AF328963; AAK16717.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS8866.1; -.
DR   PIR; S14933; S14933.
DR   RefSeq; NP_776272.1; NM_173860.2.
DR   UniGene; Hs.381267; -.
DR   UniGene; Hs.587727; -.
DR   ProteinModelPortal; P31275; -.
DR   SMR; P31275; -.
DR   iPTMnet; P31275; -.
DR   PhosphoSitePlus; P31275; -.
DR   BioMuta; HOXC12; -.
DR   DMDM; 20141538; -.
DR   PaxDb; P31275; -.
DR   PeptideAtlas; P31275; -.
DR   PRIDE; P31275; -.
DR   DNASU; 3228; -.
DR   Ensembl; ENST00000243103; ENSP00000243103; ENSG00000123407.
DR   GeneID; 3228; -.
DR   KEGG; hsa:3228; -.
DR   UCSC; uc010soq.3; human.
DR   CTD; 3228; -.
DR   DisGeNET; 3228; -.
DR   EuPathDB; HostDB:ENSG00000123407.3; -.
DR   GeneCards; HOXC12; -.
DR   HGNC; HGNC:5124; HOXC12.
DR   HPA; HPA055632; -.
DR   MIM; 142975; gene.
DR   neXtProt; NX_P31275; -.
DR   OpenTargets; ENSG00000123407; -.
DR   PharmGKB; PA29399; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140879; -.
DR   HOGENOM; HOG000231177; -.
DR   HOVERGEN; HBG052050; -.
DR   InParanoid; P31275; -.
DR   KO; K09297; -.
DR   OMA; EPCNGYS; -.
DR   OrthoDB; EOG091G0HNN; -.
DR   PhylomeDB; P31275; -.
DR   TreeFam; TF351604; -.
DR   GeneWiki; HOXC12; -.
DR   GenomeRNAi; 3228; -.
DR   PRO; PR:P31275; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000123407; -.
DR   CleanEx; HS_HOXC12; -.
DR   Genevisible; P31275; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    282       Homeobox protein Hox-C12.
FT                                /FTId=PRO_0000200194.
FT   DNA_BIND    214    273       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   282 AA;  30171 MW;  493C53C511054A4D CRC64;
     MGEHNLLNPG FVGPLVNIHT GDTFYFPNFR ASGAQLPGLP SLSYPRRDNV CSLSWPSAEP
     CNGYPQPYLG SPVSLNPPFG RTCELARVED GKGYYREPCA EGGGGGLKRE ERGRDPGAGP
     GAALLPLEPS GPPALGFKYD YAAGGGGGDG GGGAGPPHDP PSCQSLESDS SSSLLNEGNK
     GAGAGDPGSL VSPLNPGGGL SASGAPWYPI NSRSRKKRKP YSKLQLAELE GEFLVNEFIT
     RQRRRELSDR LNLSDQQVKI WFQNRRMKKK RLLLREQALS FF
//
ID   HXC5_HUMAN              Reviewed;         222 AA.
AC   Q00444;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Homeobox protein Hox-C5;
DE   AltName: Full=Homeobox protein CP11;
DE   AltName: Full=Homeobox protein Hox-3D;
GN   Name=HOXC5; Synonyms=HOX3D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1346761;
RA   Arcioni L., Simeone A., Guazzi S., Zappavigna V., Boncinelli E.,
RA   Mavilio F.;
RT   "The upstream region of the human homeobox gene HOX3D is a target for
RT   regulation by retinoic acid and HOX homeoproteins.";
RL   EMBO J. 11:265-277(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 155-220.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       Q9UBR4-2:LHX3; NbExp=4; IntAct=EBI-11955357, EBI-12039345;
CC       P40425:PBX2; NbExp=4; IntAct=EBI-11955357, EBI-348489;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61755; CAA43894.1; -; Genomic_DNA.
DR   CCDS; CCDS8872.1; -.
DR   PIR; S20029; S20029.
DR   RefSeq; NP_061826.1; NM_018953.3.
DR   UniGene; Hs.549040; -.
DR   ProteinModelPortal; Q00444; -.
DR   SMR; Q00444; -.
DR   IntAct; Q00444; 8.
DR   STRING; 9606.ENSP00000309336; -.
DR   iPTMnet; Q00444; -.
DR   PhosphoSitePlus; Q00444; -.
DR   DMDM; 232262; -.
DR   MaxQB; Q00444; -.
DR   PaxDb; Q00444; -.
DR   PeptideAtlas; Q00444; -.
DR   PRIDE; Q00444; -.
DR   DNASU; 3222; -.
DR   Ensembl; ENST00000312492; ENSP00000309336; ENSG00000172789.
DR   GeneID; 3222; -.
DR   KEGG; hsa:3222; -.
DR   UCSC; uc001sew.4; human.
DR   CTD; 3222; -.
DR   DisGeNET; 3222; -.
DR   EuPathDB; HostDB:ENSG00000172789.3; -.
DR   GeneCards; HOXC5; -.
DR   HGNC; HGNC:5127; HOXC5.
DR   HPA; HPA026794; -.
DR   MIM; 142973; gene.
DR   neXtProt; NX_Q00444; -.
DR   OpenTargets; ENSG00000172789; -.
DR   PharmGKB; PA29402; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231178; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; Q00444; -.
DR   KO; K09305; -.
DR   OMA; CYSGLDL; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; Q00444; -.
DR   TreeFam; TF316310; -.
DR   BRENDA; 2.7.11.21; 2681.
DR   GeneWiki; HOXC5; -.
DR   GenomeRNAi; 3222; -.
DR   PRO; PR:Q00444; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000172789; -.
DR   Genevisible; Q00444; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    222       Homeobox protein Hox-C5.
FT                                /FTId=PRO_0000200169.
FT   DNA_BIND    155    214       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       140    145       Antp-type hexapeptide.
SQ   SEQUENCE   222 AA;  24976 MW;  9ABA38D35E4E61AB CRC64;
     MSSYVANSFY KQSPNIPAYN MQTCGNYGSA SEVQASRYCY GGLDLSITFP PPAPSNSLHG
     VDMAANPRAH PDRPACSAAA APGHAPGRDE AAPLNPGMYS QKAARPALEE RAKSSGEIKE
     EQAQTGQPAG LSQPPAPPQI YPWMTKLHMS HETDGKRSRT SYTRYQTLEL EKEFHFNRYL
     TRRRRIEIAN NLCLNERQIK IWFQNRRMKW KKDSKMKSKE AL
//
ID   HXA13_HUMAN             Reviewed;         388 AA.
AC   P31271; A4D188; O43371;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   25-OCT-2017, entry version 172.
DE   RecName: Full=Homeobox protein Hox-A13;
DE   AltName: Full=Homeobox protein Hox-1J;
GN   Name=HOXA13; Synonyms=HOX1J;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9020844; DOI=10.1038/ng0297-179;
RA   Mortlock D.P., Innis J.W.;
RT   "Mutation of HOXA13 in hand-foot-genital syndrome.";
RL   Nat. Genet. 15:179-180(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 322-387.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [6]
RP   STRUCTURE BY NMR OF 322-388 IN COMPLEX WITH DNA, AND SUBUNIT.
RX   PubMed=21829694; DOI=10.1371/journal.pone.0023069;
RA   Zhang Y., Larsen C.A., Stadler H.S., Ames J.B.;
RT   "Structural basis for sequence specific DNA binding and protein
RT   dimerization of HOXA13.";
RL   PLoS ONE 6:E23069-E23069(2011).
RN   [7]
RP   VARIANTS HFG HIS-372 AND ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-129 INS.
RX   PubMed=10839976; DOI=10.1086/302961;
RA   Goodman F.R., Bacchelli C., Brady A.F., Brueton L.A., Fryns J.-P.,
RA   Mortlock D.P., Innis J.W., Holmes L.B., Donnenfeld A.E., Feingold M.,
RA   Beemer F.A., Hennekam R.C.M., Scambler P.J.;
RT   "Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-
RT   genital syndrome.";
RL   Am. J. Hum. Genet. 67:197-202(2000).
RN   [8]
RP   VARIANT HFG ALA-ALA-ALA-ALA-ALA-ALA-125 INS.
RX   PubMed=12073020; DOI=10.1007/s00439-002-0712-8;
RA   Utsch B., Becker K., Brock D., Lentze M.J., Bidlingmaier F.,
RA   Ludwig M.;
RT   "A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene
RT   associated with hand-foot-genital syndrome: proper function of
RT   poly(A)-harbouring transcription factors depends on a critical repeat
RT   length?";
RL   Hum. Genet. 110:488-494(2002).
RN   [9]
RP   VARIANT GUTTS LEU-371.
RX   PubMed=11968094; DOI=10.1002/humu.9036;
RA   Innis J.W., Goodman F.R., Bacchelli C., Williams T.M., Mortlock D.P.,
RA   Sateesh P., Scambler P.J., McKinnon W., Guttmacher A.E.;
RT   "A HOXA13 allele with a missense mutation in the homeobox and a
RT   dinucleotide deletion in the promoter underlies Guttmacher syndrome.";
RL   Hum. Mutat. 19:573-574(2002).
RN   [10]
RP   VARIANT HFG PHE-368.
RX   PubMed=24934387; DOI=10.1002/ajmg.a.36648;
RA   Imagawa E., Kayserili H., Nishimura G., Nakashima M., Tsurusaki Y.,
RA   Saitsu H., Ikegawa S., Matsumoto N., Miyake N.;
RT   "Severe manifestations of hand-foot-genital syndrome associated with a
RT   novel HOXA13 mutation.";
RL   Am. J. Med. Genet. A 164A:2398-2402(2014).
RN   [11]
RP   VARIANT HFG PHE-375.
RX   PubMed=26590955; DOI=10.1002/ajmg.a.37478;
RA   Wallis M., Tsurusaki Y., Burgess T., Borzi P., Matsumoto N.,
RA   Miyake N., True D., Patel C.;
RT   "Dual genetic diagnoses: Atypical hand-foot-genital syndrome and
RT   developmental delay due to de novo mutations in HOXA13 and NRXN1.";
RL   Am. J. Med. Genet. A 170:717-724(2016).
CC   -!- FUNCTION: Sequence-specific, AT-rich binding transcription factor
CC       which is part of a developmental regulatory system that provides
CC       cells with specific positional identities on the anterior-
CC       posterior axis.
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Interacts with MEIS1, MEIS2 and
CC       MEIS3 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Hand-foot-genital syndrome (HFG) [MIM:140000]: A disorder
CC       characterized by limb and genitourinary anomalies. Clinical
CC       features include small feet with unusually short great toes and
CC       abnormal thumbs. Females with the disorder have duplication of the
CC       genital tract. {ECO:0000269|PubMed:10839976,
CC       ECO:0000269|PubMed:12073020, ECO:0000269|PubMed:24934387,
CC       ECO:0000269|PubMed:26590955}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Guttmacher syndrome (GUTTS) [MIM:176305]: Dominantly
CC       inherited combination of distal limb and genital tract
CC       abnormalities. It has several features in common with hand-foot-
CC       genital syndrome, including hypoplastic first digits and
CC       hypospadias. Typical features not seen in hand-foot-genital
CC       syndrome include postaxial polydactyly of the hands and
CC       uniphalangeal second toes with absent nails.
CC       {ECO:0000269|PubMed:11968094}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U82827; AAC50993.1; -; Genomic_DNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93890.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24218.1; -; Genomic_DNA.
DR   CCDS; CCDS5412.1; -.
DR   PIR; S14932; S14932.
DR   RefSeq; NP_000513.2; NM_000522.4.
DR   UniGene; Hs.592172; -.
DR   PDB; 2L7Z; NMR; -; A=322-388.
DR   PDBsum; 2L7Z; -.
DR   ProteinModelPortal; P31271; -.
DR   SMR; P31271; -.
DR   IntAct; P31271; 2.
DR   STRING; 9606.ENSP00000222753; -.
DR   iPTMnet; P31271; -.
DR   PhosphoSitePlus; P31271; -.
DR   BioMuta; HOXA13; -.
DR   DMDM; 116242513; -.
DR   EPD; P31271; -.
DR   MaxQB; P31271; -.
DR   PaxDb; P31271; -.
DR   PeptideAtlas; P31271; -.
DR   PRIDE; P31271; -.
DR   Ensembl; ENST00000222753; ENSP00000222753; ENSG00000106031.
DR   GeneID; 3209; -.
DR   KEGG; hsa:3209; -.
DR   UCSC; uc003szb.2; human.
DR   CTD; 3209; -.
DR   DisGeNET; 3209; -.
DR   EuPathDB; HostDB:ENSG00000106031.7; -.
DR   GeneCards; HOXA13; -.
DR   GeneReviews; HOXA13; -.
DR   H-InvDB; HIX0201189; -.
DR   HGNC; HGNC:5102; HOXA13.
DR   HPA; HPA046098; -.
DR   MalaCards; HOXA13; -.
DR   MIM; 140000; phenotype.
DR   MIM; 142959; gene.
DR   MIM; 176305; phenotype.
DR   neXtProt; NX_P31271; -.
DR   OpenTargets; ENSG00000106031; -.
DR   Orphanet; 2957; Guttmacher syndrome.
DR   Orphanet; 2438; Hand-foot-genital syndrome.
DR   PharmGKB; PA29379; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140879; -.
DR   HOGENOM; HOG000231176; -.
DR   HOVERGEN; HBG106958; -.
DR   InParanoid; P31271; -.
DR   KO; K09298; -.
DR   OMA; WIEPTVM; -.
DR   OrthoDB; EOG091G0E5Q; -.
DR   PhylomeDB; P31271; -.
DR   TreeFam; TF330813; -.
DR   SignaLink; P31271; -.
DR   SIGNOR; P31271; -.
DR   GeneWiki; HOXA13; -.
DR   GenomeRNAi; 3209; -.
DR   PRO; PR:P31271; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106031; -.
DR   CleanEx; HS_HOXA13; -.
DR   Genevisible; P31271; HS.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR022067; HoxA13_N.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF12284; HoxA13_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    388       Homeobox protein Hox-A13.
FT                                /FTId=PRO_0000200101.
FT   DNA_BIND    322    381       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     38     53       Poly-Ala.
FT   COMPBIAS     62     66       Poly-Ala.
FT   COMPBIAS     73     84       Poly-Ala.
FT   COMPBIAS    116    133       Poly-Ala.
FT   COMPBIAS    200    207       Poly-Ala.
FT   VARIANT     125    125       A -> AAAAAAA (in HFG).
FT                                {ECO:0000269|PubMed:12073020}.
FT                                /FTId=VAR_017773.
FT   VARIANT     129    129       A -> AAAAAAAAA (in HFG).
FT                                /FTId=VAR_017774.
FT   VARIANT     368    368       I -> F (in HFG; severe phenotype
FT                                overlapping with Guttmacher syndrome).
FT                                {ECO:0000269|PubMed:24934387}.
FT                                /FTId=VAR_075341.
FT   VARIANT     371    371       Q -> L (in GUTTS).
FT                                {ECO:0000269|PubMed:11968094}.
FT                                /FTId=VAR_017775.
FT   VARIANT     372    372       N -> H (in HFG; severe;
FT                                dbSNP:rs121912542).
FT                                {ECO:0000269|PubMed:10839976}.
FT                                /FTId=VAR_017776.
FT   VARIANT     375    375       V -> F (in HFG).
FT                                {ECO:0000269|PubMed:26590955}.
FT                                /FTId=VAR_075342.
FT   CONFLICT    146    146       G -> A (in Ref. 1; AAC50993).
FT                                {ECO:0000305}.
FT   CONFLICT    187    187       H -> P (in Ref. 1; AAC50993).
FT                                {ECO:0000305}.
FT   CONFLICT    195    195       A -> P (in Ref. 1; AAC50993).
FT                                {ECO:0000305}.
FT   CONFLICT    198    198       A -> P (in Ref. 1; AAC50993).
FT                                {ECO:0000305}.
FT   HELIX       331    343       {ECO:0000244|PDB:2L7Z}.
FT   HELIX       349    359       {ECO:0000244|PDB:2L7Z}.
FT   HELIX       364    377       {ECO:0000244|PDB:2L7Z}.
FT   STRAND      380    385       {ECO:0000244|PDB:2L7Z}.
SQ   SEQUENCE   388 AA;  39727 MW;  3512E7622FA931C4 CRC64;
     MTASVLLHPR WIEPTVMFLY DNGGGLVADE LNKNMEGAAA AAAAAAAAAA AGAGGGGFPH
     PAAAAAGGNF SVAAAAAAAA AAAANQCRNL MAHPAPLAPG AASAYSSAPG EAPPSAAAAA
     AAAAAAAAAA AAASSSGGPG PAGPAGAEAA KQCSPCSAAA QSSSGPAALP YGYFGSGYYP
     CARMGPHPNA IKSCAQPASA AAAAAFADKY MDTAGPAAEE FSSRAKEFAF YHQGYAAGPY
     HHHQPMPGYL DMPVVPGLGG PGESRHEPLG LPMESYQPWA LPNGWNGQMY CPKEQAQPPH
     LWKSTLPDVV SHPSDASSYR RGRKKRVPYT KVQLKELERE YATNKFITKD KRRRISATTN
     LSERQVTIWF QNRRVKEKKV INKLKTTS
//
ID   HXA7_HUMAN              Reviewed;         230 AA.
AC   P31268; A4D191; O43368; O43486; O95655; Q9NSC8; Q9UDM1;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Homeobox protein Hox-A7;
DE   AltName: Full=Homeobox protein Hox 1.1;
DE   AltName: Full=Homeobox protein Hox-1A;
GN   Name=HOXA7; Synonyms=HOX1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-18.
RX   PubMed=11435435; DOI=10.1074/jbc.M104598200;
RA   La Celle P.T., Polakowska R.R.;
RT   "Human homeobox HOXA7 regulates keratinocyte transglutaminase type 1
RT   and inhibits differentiation.";
RL   J. Biol. Chem. 276:32844-32853(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-18.
RX   PubMed=9804983; DOI=10.1016/S0167-4781(98)00170-5;
RA   McIlhatton M.A., Bremner P.S., McMullin M.F., Maxwell A.P.,
RA   Winter P.C., Lappin T.R.;
RT   "Sequence characterisation and expression of homeobox HOX A7 in the
RT   multi-potential erythroleukaemic cell line TF-1.";
RL   Biochim. Biophys. Acta 1442:329-333(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-18.
RX   PubMed=10911612; DOI=10.1385/MB:14:1:19;
RA   Kim M.H., Jin H., Seol E.Y., Yoo M., Park H.W.;
RT   "Sequence analysis and tissue specific expression of human HOXA7.";
RL   Mol. Biotechnol. 14:19-24(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-18.
RC   TISSUE=Placenta;
RA   Albrechtsen R., Wewer U.;
RL   Submitted (FEB-1995) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-91, AND VARIANT THR-18.
RA   Cho M., Kim M.H., Hwang C.Y., Min W.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 130-195.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       O00560:SDCBP; NbExp=4; IntAct=EBI-3910421, EBI-727004;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF026397; AAB94604.1; -; mRNA.
DR   EMBL; AJ005814; CAA06713.1; -; mRNA.
DR   EMBL; AF032095; AAD01939.2; -; Genomic_DNA.
DR   EMBL; X84803; CAA59270.1; -; Genomic_DNA.
DR   EMBL; X84804; CAA59270.1; JOINED; Genomic_DNA.
DR   EMBL; CH236948; EAL24221.1; -; Genomic_DNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93877.1; -; Genomic_DNA.
DR   EMBL; U92543; AAD00727.1; -; Genomic_DNA.
DR   CCDS; CCDS5408.1; -.
DR   PIR; S15536; S15536.
DR   RefSeq; NP_008827.2; NM_006896.3.
DR   UniGene; Hs.610216; -.
DR   UniGene; Hs.660918; -.
DR   ProteinModelPortal; P31268; -.
DR   SMR; P31268; -.
DR   BioGrid; 109444; 3.
DR   IntAct; P31268; 4.
DR   STRING; 9606.ENSP00000242159; -.
DR   iPTMnet; P31268; -.
DR   PhosphoSitePlus; P31268; -.
DR   BioMuta; HOXA7; -.
DR   DMDM; 311033439; -.
DR   MaxQB; P31268; -.
DR   PaxDb; P31268; -.
DR   PeptideAtlas; P31268; -.
DR   PRIDE; P31268; -.
DR   DNASU; 3204; -.
DR   Ensembl; ENST00000242159; ENSP00000242159; ENSG00000122592.
DR   GeneID; 3204; -.
DR   KEGG; hsa:3204; -.
DR   UCSC; uc003sys.4; human.
DR   CTD; 3204; -.
DR   DisGeNET; 3204; -.
DR   EuPathDB; HostDB:ENSG00000122592.7; -.
DR   GeneCards; HOXA7; -.
DR   HGNC; HGNC:5108; HOXA7.
DR   HPA; HPA074048; -.
DR   MIM; 142950; gene.
DR   neXtProt; NX_P31268; -.
DR   OpenTargets; ENSG00000122592; -.
DR   PharmGKB; PA29385; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P31268; -.
DR   KO; K09307; -.
DR   OMA; WKKEHKD; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P31268; -.
DR   TreeFam; TF316310; -.
DR   SIGNOR; P31268; -.
DR   GeneWiki; HOXA7; -.
DR   GenomeRNAi; 3204; -.
DR   PRO; PR:P31268; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000122592; -.
DR   CleanEx; HS_HOXA7; -.
DR   ExpressionAtlas; P31268; baseline and differential.
DR   Genevisible; P31268; HS.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IC:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0045617; P:negative regulation of keratinocyte differentiation; IDA:MGI.
DR   GO; GO:0002686; P:negative regulation of leukocyte migration; IDA:UniProtKB.
DR   GO; GO:0045656; P:negative regulation of monocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    230       Homeobox protein Hox-A7.
FT                                /FTId=PRO_0000200071.
FT   DNA_BIND    130    189       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       119    124       Antp-type hexapeptide.
FT   COMPBIAS    157    160       Poly-Arg.
FT   COMPBIAS    196    199       Poly-Ala.
FT   COMPBIAS    214    230       Asp/Glu-rich (highly acidic).
FT   COMPBIAS    223    230       Poly-Glu.
FT   VARIANT      18     18       A -> T (in dbSNP:rs2301721).
FT                                {ECO:0000269|PubMed:10911612,
FT                                ECO:0000269|PubMed:11435435,
FT                                ECO:0000269|PubMed:9804983,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_028001.
FT   CONFLICT     75     76       DA -> RR (in Ref. 8; AAD00727).
FT                                {ECO:0000305}.
FT   CONFLICT     78     78       Missing (in Ref. 4; CAA59270).
FT                                {ECO:0000305}.
FT   CONFLICT    174    174       I -> V (in Ref. 3; AAD01939).
FT                                {ECO:0000305}.
FT   CONFLICT    194    195       PT -> RL (in Ref. 4; CAA59270).
FT                                {ECO:0000305}.
FT   CONFLICT    195    195       T -> I (in Ref. 9; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    222    222       D -> Y (in Ref. 4; CAA59270).
FT                                {ECO:0000305}.
SQ   SEQUENCE   230 AA;  25355 MW;  8F77A6B0AFB516D5 CRC64;
     MSSSYYVNAL FSKYTAGASL FQNAEPTSCS FAPNSQRSGY GAGAGAFAST VPGLYNVNSP
     LYQSPFASGY GLGADAYGNL PCASYDQNIP GLCSDLAKGA CDKTDEGALH GAAEANFRIY
     PWMRSSGPDR KRGRQTYTRY QTLELEKEFH FNRYLTRRRR IEIAHALCLT ERQIKIWFQN
     RRMKWKKEHK DEGPTAAAAP EGAVPSAAAT AAADKADEED DDEEEEDEEE
//
ID   HXC13_HUMAN             Reviewed;         330 AA.
AC   P31276; Q5BL02; Q96J32; Q9NR24; Q9NYD5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 3.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=Homeobox protein Hox-C13;
DE   AltName: Full=Homeobox protein Hox-3G;
GN   Name=HOXC13; Synonyms=HOX3G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10835276; DOI=10.1006/jmbi.2000.3782;
RA   de Stanchina E., Gabellini D., Norio P., Giacca M., Peverali F.A.,
RA   Riva S., Falaschi A., Biamonti G.;
RT   "Selection of homeotic proteins for binding to a human DNA replication
RT   origin.";
RL   J. Mol. Biol. 299:667-680(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Li S., Zhang B., Li X.;
RT   "A homeobox protein interacting with promoter region of p21WAF1/CIP1
RT   gene is identical to HOX-C13 (HOX 3G).";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 185-330.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 260-325.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [7]
RP   INVOLVEMENT IN ECTD9.
RX   PubMed=23063621; DOI=10.1016/j.ajhg.2012.08.029;
RA   Lin Z., Chen Q., Shi L., Lee M., Giehl K.A., Tang Z., Wang H.,
RA   Zhang J., Yin J., Wu L., Xiao R., Liu X., Dai L., Zhu X., Li R.,
RA   Betz R.C., Zhang X., Yang Y.;
RT   "Loss-of-function mutations in HOXC13 cause pure hair and nail
RT   ectodermal dysplasia.";
RL   Am. J. Hum. Genet. 91:906-911(2012).
CC   -!- FUNCTION: Transcription factor which plays a role in hair follicle
CC       differentiation. Regulates FOXQ1 expression and that of other
CC       hair-specific genes (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P32519:ELF1; NbExp=3; IntAct=EBI-2293590, EBI-765526;
CC       O95644:NFATC1; NbExp=2; IntAct=EBI-2293590, EBI-6907210;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Ectodermal dysplasia 9, hair/nail type (ECTD9)
CC       [MIM:614931]: A form of ectodermal dysplasia, a heterogeneous
CC       group of disorders due to abnormal development of two or more
CC       ectodermal structures such as hair, teeth, nails and sweat glands,
CC       with or without any additional clinical sign. Each combination of
CC       clinical features represents a different type of ectodermal
CC       dysplasia. ECTD9 is characterized by hypotrichosis and nail
CC       dystrophy without non-ectodermal or other ectodermal
CC       manifestations. Hypotrichosis usually occurs after birth with
CC       varying degrees of severity, ranging from mild hair loss to
CC       complete atrichia, including the loss of scalp hair, beard,
CC       eyebrows, eyelashes, axillary hair, and pubic hair. Nail dystrophy
CC       affects all 20 digits by causing short fragile nails or spoon
CC       nails (koilonychia). {ECO:0000269|PubMed:23063621}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HOXC13ID473ch12q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF255676; AAF67760.1; -; mRNA.
DR   EMBL; AF263466; AAF73439.1; -; mRNA.
DR   EMBL; BT009908; AAP88910.1; -; mRNA.
DR   EMBL; BC090850; AAH90850.1; -; mRNA.
DR   EMBL; AK024027; BAB14786.1; -; mRNA.
DR   CCDS; CCDS8865.1; -.
DR   PIR; S14934; S14934.
DR   RefSeq; NP_059106.2; NM_017410.2.
DR   UniGene; Hs.118608; -.
DR   ProteinModelPortal; P31276; -.
DR   SMR; P31276; -.
DR   BioGrid; 109469; 16.
DR   IntAct; P31276; 19.
DR   STRING; 9606.ENSP00000243056; -.
DR   iPTMnet; P31276; -.
DR   PhosphoSitePlus; P31276; -.
DR   BioMuta; HOXC13; -.
DR   DMDM; 20141539; -.
DR   MaxQB; P31276; -.
DR   PaxDb; P31276; -.
DR   PeptideAtlas; P31276; -.
DR   PRIDE; P31276; -.
DR   DNASU; 3229; -.
DR   Ensembl; ENST00000243056; ENSP00000243056; ENSG00000123364.
DR   GeneID; 3229; -.
DR   KEGG; hsa:3229; -.
DR   UCSC; uc001sei.4; human.
DR   CTD; 3229; -.
DR   DisGeNET; 3229; -.
DR   EuPathDB; HostDB:ENSG00000123364.4; -.
DR   GeneCards; HOXC13; -.
DR   HGNC; HGNC:5125; HOXC13.
DR   HPA; HPA051634; -.
DR   MalaCards; HOXC13; -.
DR   MIM; 142976; gene.
DR   MIM; 614931; phenotype.
DR   neXtProt; NX_P31276; -.
DR   OpenTargets; ENSG00000123364; -.
DR   Orphanet; 69084; Pure hair and nail ectodermal dysplasia.
DR   PharmGKB; PA29400; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140879; -.
DR   HOGENOM; HOG000231176; -.
DR   HOVERGEN; HBG106958; -.
DR   InParanoid; P31276; -.
DR   KO; K09298; -.
DR   OMA; HSHNVNL; -.
DR   OrthoDB; EOG091G0E5Q; -.
DR   PhylomeDB; P31276; -.
DR   TreeFam; TF330813; -.
DR   SIGNOR; P31276; -.
DR   ChiTaRS; HOXC13; human.
DR   GeneWiki; HOXC13; -.
DR   GenomeRNAi; 3229; -.
DR   PRO; PR:P31276; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000123364; -.
DR   CleanEx; HS_HOXC13; -.
DR   Genevisible; P31276; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
DR   GO; GO:0035878; P:nail development; IEA:Ensembl.
DR   GO; GO:0043587; P:tongue morphogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR022067; HoxA13_N.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF12284; HoxA13_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding;
KW   Ectodermal dysplasia; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    330       Homeobox protein Hox-C13.
FT                                /FTId=PRO_0000200197.
FT   DNA_BIND    260    319       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     27     61       Gly-rich.
FT   VARIANT      50     50       S -> I (in dbSNP:rs1867298).
FT                                /FTId=VAR_012357.
FT   CONFLICT     95     95       D -> E (in Ref. 1; AAF67760).
FT                                {ECO:0000305}.
SQ   SEQUENCE   330 AA;  35379 MW;  7D67C5F1E5E4E915 CRC64;
     MTTSLLLHPR WPESLMYVYE DSAAESGIGG GGGGGGGGTG GAGGGCSGAS PGKAPSMDGL
     GSSCPASHCR DLLPHPVLGR PPAPLGAPQG AVYTDIPAPE AARQCAPPPA PPTSSSATLG
     YGYPFGGSYY GCRLSHNVNL QQKPCAYHPG DKYPEPSGAL PGDDLSSRAK EFAFYPSFAS
     SYQAMPGYLD VSVVPGISGH PEPRHDALIP VEGYQHWALS NGWDSQVYCS KEQSQSAHLW
     KSPFPDVVPL QPEVSSYRRG RKKRVPYTKV QLKELEKEYA ASKFITKEKR RRISATTNLS
     ERQVTIWFQN RRVKEKKVVS KSKAPHLHST
//
ID   HXC4_HUMAN              Reviewed;         264 AA.
AC   P09017;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 2.
DT   25-OCT-2017, entry version 171.
DE   RecName: Full=Homeobox protein Hox-C4;
DE   AltName: Full=Homeobox protein CP19;
DE   AltName: Full=Homeobox protein Hox-3E;
GN   Name=HOXC4; Synonyms=HOX3E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2898768; DOI=10.1093/nar/16.12.5379;
RA   Simeone A., Pannese M., Acampora D., D'Esposito M., Boncinelli E.;
RT   "At least three human homeoboxes on chromosome 12 belong to the same
RT   transcription unit.";
RL   Nucleic Acids Res. 16:5379-5390(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 156-221.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       P49761:CLK3; NbExp=4; IntAct=EBI-3923226, EBI-745579;
CC       O43639:NCK2; NbExp=4; IntAct=EBI-3923226, EBI-713635;
CC       Q9BZ95:NSD3; NbExp=2; IntAct=EBI-3923226, EBI-3390132;
CC       O43463:SUV39H1; NbExp=2; IntAct=EBI-3923226, EBI-349968;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Deformed
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07495; CAA30376.1; -; mRNA.
DR   EMBL; AY014298; AAG42145.1; -; Genomic_DNA.
DR   EMBL; AY014297; AAG42145.1; JOINED; Genomic_DNA.
DR   EMBL; AC023794; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS8873.1; -.
DR   PIR; S01030; WJHU3E.
DR   RefSeq; NP_055435.2; NM_014620.5.
DR   RefSeq; NP_705897.1; NM_153633.2.
DR   UniGene; Hs.549040; -.
DR   ProteinModelPortal; P09017; -.
DR   SMR; P09017; -.
DR   BioGrid; 109461; 23.
DR   IntAct; P09017; 13.
DR   MINT; MINT-194957; -.
DR   STRING; 9606.ENSP00000305973; -.
DR   iPTMnet; P09017; -.
DR   PhosphoSitePlus; P09017; -.
DR   BioMuta; HOXC4; -.
DR   DMDM; 281185468; -.
DR   EPD; P09017; -.
DR   MaxQB; P09017; -.
DR   PaxDb; P09017; -.
DR   PeptideAtlas; P09017; -.
DR   PRIDE; P09017; -.
DR   DNASU; 3221; -.
DR   Ensembl; ENST00000303406; ENSP00000305973; ENSG00000198353.
DR   Ensembl; ENST00000430889; ENSP00000399808; ENSG00000198353.
DR   GeneID; 3221; -.
DR   KEGG; hsa:3221; -.
DR   UCSC; uc001seu.5; human.
DR   CTD; 3221; -.
DR   DisGeNET; 3221; -.
DR   EuPathDB; HostDB:ENSG00000198353.7; -.
DR   GeneCards; HOXC4; -.
DR   H-InvDB; HIX0079410; -.
DR   H-InvDB; HIX0079484; -.
DR   H-InvDB; HIX0171647; -.
DR   HGNC; HGNC:5126; HOXC4.
DR   HPA; HPA053910; -.
DR   MIM; 142974; gene.
DR   neXtProt; NX_P09017; -.
DR   OpenTargets; ENSG00000198353; -.
DR   PharmGKB; PA29401; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231179; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P09017; -.
DR   KO; K09304; -.
DR   OMA; PPRASYQ; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P09017; -.
DR   TreeFam; TF352857; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   ChiTaRS; HOXC4; human.
DR   GeneWiki; HOXC4; -.
DR   GenomeRNAi; 3221; -.
DR   PRO; PR:P09017; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000198353; -.
DR   ExpressionAtlas; P09017; baseline and differential.
DR   Genevisible; P09017; HS.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0048562; P:embryonic organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    264       Homeobox protein Hox-C4.
FT                                /FTId=PRO_0000200164.
FT   DNA_BIND    156    215       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       135    140       Antp-type hexapeptide.
FT   COMPBIAS     54     60       Poly-Pro.
FT   COMPBIAS    183    186       Poly-Arg.
FT   VARIANT     158    158       R -> L (in dbSNP:rs11835301).
FT                                /FTId=VAR_055961.
FT   VARIANT     178    178       N -> S (in dbSNP:rs35406888).
FT                                /FTId=VAR_055962.
FT   CONFLICT    161    161       T -> A (in Ref. 1; CAA30376 and 2;
FT                                AAG42145). {ECO:0000305}.
SQ   SEQUENCE   264 AA;  29811 MW;  5CCD13995574226E CRC64;
     MIMSSYLMDS NYIDPKFPPC EEYSQNSYIP EHSPEYYGRT RESGFQHHHQ ELYPPPPPRP
     SYPERQYSCT SLQGPGNSRG HGPAQAGHHH PEKSQSLCEP APLSGASASP SPAPPACSQP
     APDHPSSAAS KQPIVYPWMK KIHVSTVNPN YNGGEPKRSR TAYTRQQVLE LEKEFHYNRY
     LTRRRRIEIA HSLCLSERQI KIWFQNRRMK WKKDHRLPNT KVRSAPPAGA APSTLSAATP
     GTSEDHSQSA TPPEQQRAED ITRL
//
ID   HXC6_HUMAN              Reviewed;         235 AA.
AC   P09630; B2RBV2; Q6DK09;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   25-OCT-2017, entry version 177.
DE   RecName: Full=Homeobox protein Hox-C6;
DE   AltName: Full=Homeobox protein CP25;
DE   AltName: Full=Homeobox protein HHO.C8;
DE   AltName: Full=Homeobox protein Hox-3C;
GN   Name=HOXC6; Synonyms=HOX3C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2885844; DOI=10.1073/pnas.84.14.4914;
RA   Simeone A., Mavilio F., Acampora D., Giampaolo A., Faiella A.,
RA   Zappavigna V., D'Esposito M., Pannese M., Russo G., Boncinelli E.,
RA   Peschle C.;
RT   "Two human homeobox genes, c1 and c8: structure analysis and
RT   expression in embryonic development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4914-4918(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2898768; DOI=10.1093/nar/16.12.5379;
RA   Simeone A., Pannese M., Acampora D., D'Esposito M., Boncinelli E.;
RT   "At least three human homeoboxes on chromosome 12 belong to the same
RT   transcription unit.";
RL   Nucleic Acids Res. 16:5379-5390(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=8870653; DOI=10.1042/bj3190091;
RA   Chariot A., Castronovo V., Le P., Gillet C., Sobel M.E., Gielen J.;
RT   "Cloning and expression of a new HOXC6 transcript encoding a
RT   repressing protein.";
RL   Biochem. J. 319:91-97(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 141-206.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P09630-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09630-2; Sequence=VSP_002392;
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S82986; AAB46892.1; -; mRNA.
DR   EMBL; M16938; AAA36007.1; -; mRNA.
DR   EMBL; AK314829; BAG37349.1; -; mRNA.
DR   EMBL; CH471054; EAW96746.1; -; Genomic_DNA.
DR   EMBL; BC074844; AAH74844.1; -; mRNA.
DR   EMBL; BC074845; AAH74845.1; -; mRNA.
DR   CCDS; CCDS41792.1; -. [P09630-2]
DR   CCDS; CCDS8871.1; -. [P09630-1]
DR   PIR; B28030; WJHU3C.
DR   RefSeq; NP_004494.1; NM_004503.3. [P09630-1]
DR   RefSeq; NP_710160.1; NM_153693.4. [P09630-2]
DR   UniGene; Hs.549040; -.
DR   ProteinModelPortal; P09630; -.
DR   SMR; P09630; -.
DR   BioGrid; 109463; 10.
DR   IntAct; P09630; 7.
DR   STRING; 9606.ENSP00000243108; -.
DR   iPTMnet; P09630; -.
DR   PhosphoSitePlus; P09630; -.
DR   BioMuta; HOXC6; -.
DR   DMDM; 115502398; -.
DR   PaxDb; P09630; -.
DR   PeptideAtlas; P09630; -.
DR   PRIDE; P09630; -.
DR   Ensembl; ENST00000243108; ENSP00000243108; ENSG00000197757. [P09630-1]
DR   Ensembl; ENST00000394331; ENSP00000377864; ENSG00000197757. [P09630-2]
DR   GeneID; 3223; -.
DR   KEGG; hsa:3223; -.
DR   UCSC; uc001ses.5; human. [P09630-1]
DR   CTD; 3223; -.
DR   DisGeNET; 3223; -.
DR   EuPathDB; HostDB:ENSG00000197757.7; -.
DR   GeneCards; HOXC6; -.
DR   HGNC; HGNC:5128; HOXC6.
DR   HPA; HPA054981; -.
DR   MIM; 142972; gene.
DR   neXtProt; NX_P09630; -.
DR   OpenTargets; ENSG00000197757; -.
DR   PharmGKB; PA29403; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P09630; -.
DR   KO; K09306; -.
DR   OMA; RMNSHSE; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P09630; -.
DR   TreeFam; TF316310; -.
DR   SIGNOR; P09630; -.
DR   ChiTaRS; HOXC6; human.
DR   GeneWiki; HOXC6; -.
DR   GenomeRNAi; 3223; -.
DR   PRO; PR:P09630; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000197757; -.
DR   CleanEx; HS_HOXC6; -.
DR   ExpressionAtlas; P09630; baseline and differential.
DR   Genevisible; P09630; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    235       Homeobox protein Hox-C6.
FT                                /FTId=PRO_0000200174.
FT   DNA_BIND    141    200       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       122    127       Antp-type hexapeptide.
FT   COMPBIAS    168    171       Poly-Arg.
FT   COMPBIAS    208    212       Poly-Gly.
FT   COMPBIAS    221    235       Glu/Lys-rich.
FT   VAR_SEQ       1     82       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:8870653}.
FT                                /FTId=VSP_002392.
FT   CONFLICT    218    218       L -> M (in Ref. 1 and 2). {ECO:0000305}.
SQ   SEQUENCE   235 AA;  26915 MW;  BD695C7347CB71C0 CRC64;
     MNSYFTNPSL SCHLAGGQDV LPNVALNSTA YDPVRHFSTY GAAVAQNRIY STPFYSPQEN
     VVFSSSRGPY DYGSNSFYQE KDMLSNCRQN TLGHNTQTSI AQDFSSEQGR TAPQDQKASI
     QIYPWMQRMN SHSGVGYGAD RRRGRQIYSR YQTLELEKEF HFNRYLTRRR RIEIANALCL
     TERQIKIWFQ NRRMKWKKES NLTSTLSGGG GGATADSLGG KEEKREETEE EKQKE
//
ID   HXD1_HUMAN              Reviewed;         328 AA.
AC   Q9GZZ0; B2RAB4;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   25-OCT-2017, entry version 129.
DE   RecName: Full=Homeobox protein Hox-D1;
DE   AltName: Full=Homeobox protein Hox-GG;
GN   Name=HOXD1; Synonyms=HOX4, HOX4G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11455954; DOI=10.1023/A:1011048931477;
RA   Appukuttan B., Sood R., Ott S., Makalowska I., Patel R.J., Wang X.,
RA   Robbins C.M., Brownstein M.J., Stout J.T.;
RT   "Isolation and characterization of the human homeobox gene HOX D1.";
RL   Mol. Biol. Rep. 27:195-201(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Oocyte;
RA   Adjaye J.;
RT   "Cloning and expression analysis of human HOXD1; a maternally-derived
RT   homeobox transcription factor abundant in unfertilized human
RT   oocytes.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Acts on the anterior body structures.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Labial subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF202118; AAG29939.1; -; Genomic_DNA.
DR   EMBL; AF241528; AAG44444.1; -; mRNA.
DR   EMBL; AK314120; BAG36811.1; -; mRNA.
DR   EMBL; CH471058; EAX11080.1; -; Genomic_DNA.
DR   CCDS; CCDS2271.1; -.
DR   RefSeq; NP_078777.1; NM_024501.2.
DR   UniGene; Hs.83465; -.
DR   ProteinModelPortal; Q9GZZ0; -.
DR   SMR; Q9GZZ0; -.
DR   BioGrid; 109471; 2.
DR   STRING; 9606.ENSP00000328598; -.
DR   iPTMnet; Q9GZZ0; -.
DR   PhosphoSitePlus; Q9GZZ0; -.
DR   DMDM; 17378648; -.
DR   PaxDb; Q9GZZ0; -.
DR   PeptideAtlas; Q9GZZ0; -.
DR   PRIDE; Q9GZZ0; -.
DR   DNASU; 3231; -.
DR   Ensembl; ENST00000331462; ENSP00000328598; ENSG00000128645.
DR   GeneID; 3231; -.
DR   KEGG; hsa:3231; -.
DR   UCSC; uc002ukv.5; human.
DR   CTD; 3231; -.
DR   DisGeNET; 3231; -.
DR   EuPathDB; HostDB:ENSG00000128645.12; -.
DR   GeneCards; HOXD1; -.
DR   HGNC; HGNC:5132; HOXD1.
DR   HPA; HPA040062; -.
DR   HPA; HPA056900; -.
DR   MIM; 142987; gene.
DR   neXtProt; NX_Q9GZZ0; -.
DR   OpenTargets; ENSG00000128645; -.
DR   PharmGKB; PA29406; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000247020; -.
DR   HOVERGEN; HBG006089; -.
DR   InParanoid; Q9GZZ0; -.
DR   KO; K09301; -.
DR   OMA; YLEYVSC; -.
DR   OrthoDB; EOG091G0LR2; -.
DR   PhylomeDB; Q9GZZ0; -.
DR   TreeFam; TF317730; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   ChiTaRS; HOXD1; human.
DR   GeneWiki; HOXD1; -.
DR   GenomeRNAi; 3231; -.
DR   PRO; PR:Q9GZZ0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128645; -.
DR   CleanEx; HS_HOXD1; -.
DR   Genevisible; Q9GZZ0; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0019233; P:sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    328       Homeobox protein Hox-D1.
FT                                /FTId=PRO_0000200201.
FT   DNA_BIND    229    288       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       204    209       Antp-type hexapeptide.
FT   VARIANT     296    296       A -> T (in dbSNP:rs6710142).
FT                                /FTId=VAR_034003.
SQ   SEQUENCE   328 AA;  34093 MW;  1B9EBBF4E2DA0301 CRC64;
     MSSYLEYVSC SSSGGVGGDV LSLAPKFCRS DARPVALQPA FPLGNGDGAF VSCLPLAAAR
     PSPSPPAAPA RPSVPPPAAP QYAQCTLEGA YEPGAAPAAA AGGADYGFLG SGPAYDFPGV
     LGRAADDGGS HVHYATSAVF SGGGSFLLSG QVDYAAFGEP GPFPACLKAS ADGHPGAFQT
     ASPAPGTYPK SVSPASGLPA AFSTFEWMKV KRNASKKGKL AEYGAASPSS AIRTNFSTKQ
     LTELEKEFHF NKYLTRARRI EIANCLHLND TQVKIWFQNR RMKQKKRERE GLLATAIPVA
     PLQLPLSGTT PTKFIKNPGS PSQSQEPS
//
ID   HXD4_HUMAN              Reviewed;         255 AA.
AC   P09016; B2R9R3; Q96AU0;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 3.
DT   25-OCT-2017, entry version 175.
DE   RecName: Full=Homeobox protein Hox-D4;
DE   AltName: Full=Homeobox protein HHO.C13;
DE   AltName: Full=Homeobox protein Hox-4B;
DE   AltName: Full=Homeobox protein Hox-5.1;
GN   Name=HOXD4; Synonyms=HOX4B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-123.
RX   PubMed=1975093; DOI=10.1093/nar/18.15.4361;
RA   Cianetti L., di Cristofaro A., Zappavigna V., Bottero L., Boccoli G.,
RA   Testa U., Russo G., Boncinelli E., Peschle C.;
RT   "Molecular mechanisms underlying the expression of the human HOX-5.1
RT   gene.";
RL   Nucleic Acids Res. 18:4361-4368(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2879245; DOI=10.1038/324664a0;
RA   Mavilio F., Simeone A., Giampaolo A., Faiella A., Zappavigna V.,
RA   Acampora D., Poiana G., Russo G., Peschle C., Boncinelli E.;
RT   "Differential and stage-related expression in embryonic tissues of a
RT   new human homoeobox gene.";
RL   Nature 324:664-668(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-123.
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 154-219.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Deformed
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17360; CAA35237.1; -; Genomic_DNA.
DR   EMBL; X04706; CAA28411.1; -; mRNA.
DR   EMBL; AK313885; BAG36610.1; -; mRNA.
DR   EMBL; BC016763; AAH16763.1; -; mRNA.
DR   EMBL; BC074797; AAH74797.1; -; mRNA.
DR   CCDS; CCDS2269.1; -.
DR   PIR; S10985; WJHU4B.
DR   RefSeq; NP_055436.2; NM_014621.2.
DR   UniGene; Hs.591609; -.
DR   ProteinModelPortal; P09016; -.
DR   SMR; P09016; -.
DR   BioGrid; 109473; 22.
DR   ELM; P09016; -.
DR   IntAct; P09016; 2.
DR   STRING; 9606.ENSP00000302548; -.
DR   iPTMnet; P09016; -.
DR   PhosphoSitePlus; P09016; -.
DR   BioMuta; HOXD4; -.
DR   DMDM; 20141491; -.
DR   MaxQB; P09016; -.
DR   PaxDb; P09016; -.
DR   PeptideAtlas; P09016; -.
DR   PRIDE; P09016; -.
DR   Ensembl; ENST00000306324; ENSP00000302548; ENSG00000170166.
DR   GeneID; 3233; -.
DR   KEGG; hsa:3233; -.
DR   UCSC; uc002uks.4; human.
DR   CTD; 3233; -.
DR   DisGeNET; 3233; -.
DR   EuPathDB; HostDB:ENSG00000170166.5; -.
DR   GeneCards; HOXD4; -.
DR   HGNC; HGNC:5138; HOXD4.
DR   HPA; HPA054383; -.
DR   HPA; HPA070349; -.
DR   MIM; 142981; gene+phenotype.
DR   neXtProt; NX_P09016; -.
DR   OpenTargets; ENSG00000170166; -.
DR   PharmGKB; PA29412; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231179; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P09016; -.
DR   KO; K09304; -.
DR   OMA; EQGADYY; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P09016; -.
DR   TreeFam; TF352857; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   GeneWiki; HOXD4; -.
DR   GenomeRNAi; 3233; -.
DR   PRO; PR:P09016; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170166; -.
DR   CleanEx; HS_HOXD4; -.
DR   Genevisible; P09016; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    255       Homeobox protein Hox-D4.
FT                                /FTId=PRO_0000200210.
FT   DNA_BIND    154    213       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       133    138       Antp-type hexapeptide.
FT   COMPBIAS    222    234       Poly-Ser.
FT   VARIANT     123    123       S -> P (in dbSNP:rs34727427).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:1975093}.
FT                                /FTId=VAR_067445.
FT   CONFLICT    142    142       V -> A (in Ref. 2; CAA28411).
FT                                {ECO:0000305}.
SQ   SEQUENCE   255 AA;  27885 MW;  39205343CDB0142F CRC64;
     MVMSSYMVNS KYVDPKFPPC EEYLQGGYLG EQGADYYGGG AQGADFQPPG LYPRPDFGEQ
     PFGGSGPGPG SALPARGHGQ EPGGPGGHYA APGEPCPAPP APPPAPLPGA RAYSQSDPKQ
     PPSGTALKQP AVVYPWMKKV HVNSVNPNYT GGEPKRSRTA YTRQQVLELE KEFHFNRYLT
     RRRRIEIAHT LCLSERQIKI WFQNRRMKWK KDHKLPNTKG RSSSSSSSSS CSSSVAPSQH
     LQPMAKDHHT DLTTL
//
ID   HXD8_HUMAN              Reviewed;         290 AA.
AC   P13378; F8WBG7; Q5BL00; Q8IXZ1;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   25-OCT-2017, entry version 165.
DE   RecName: Full=Homeobox protein Hox-D8;
DE   AltName: Full=Homeobox protein Hox-4E;
DE   AltName: Full=Homeobox protein Hox-5.4;
GN   Name=HOXD8; Synonyms=HOX4E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 193-287.
RX   PubMed=2568311; DOI=10.1101/gad.3.5.641;
RA   Oliver G., Sidell N., Fiske N., Heinzmann C., Mohandas T.,
RA   Sparkes R.S., De Robertis E.M.;
RT   "Complementary homeo protein gradients in developing limb buds.";
RL   Genes Dev. 3:641-650(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P13378-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13378-2; Sequence=VSP_042856;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P13378-3; Sequence=VSP_045862, VSP_045863;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY014304; AAG42152.1; -; Genomic_DNA.
DR   EMBL; AY014303; AAG42152.1; JOINED; Genomic_DNA.
DR   EMBL; AL520835; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC038709; AAH38709.1; -; mRNA.
DR   EMBL; BC090853; AAH90853.1; -; mRNA.
DR   EMBL; X15507; CAA33529.1; -; Genomic_DNA.
DR   CCDS; CCDS2268.1; -. [P13378-1]
DR   CCDS; CCDS56148.1; -. [P13378-2]
DR   PIR; B32830; B32830.
DR   RefSeq; NP_001186675.1; NM_001199746.1. [P13378-2]
DR   RefSeq; NP_062458.1; NM_019558.3. [P13378-1]
DR   UniGene; Hs.301963; -.
DR   UniGene; Hs.700870; -.
DR   ProteinModelPortal; P13378; -.
DR   SMR; P13378; -.
DR   BioGrid; 109474; 6.
DR   IntAct; P13378; 5.
DR   MINT; MINT-7032137; -.
DR   STRING; 9606.ENSP00000315949; -.
DR   iPTMnet; P13378; -.
DR   PhosphoSitePlus; P13378; -.
DR   BioMuta; HOXD8; -.
DR   DMDM; 13124737; -.
DR   MaxQB; P13378; -.
DR   PaxDb; P13378; -.
DR   PeptideAtlas; P13378; -.
DR   PRIDE; P13378; -.
DR   Ensembl; ENST00000313173; ENSP00000315949; ENSG00000175879. [P13378-1]
DR   Ensembl; ENST00000450510; ENSP00000409026; ENSG00000175879. [P13378-2]
DR   GeneID; 3234; -.
DR   KEGG; hsa:3234; -.
DR   UCSC; uc002uko.4; human. [P13378-1]
DR   CTD; 3234; -.
DR   DisGeNET; 3234; -.
DR   EuPathDB; HostDB:ENSG00000175879.8; -.
DR   GeneCards; HOXD8; -.
DR   HGNC; HGNC:5139; HOXD8.
DR   MIM; 142985; gene.
DR   neXtProt; NX_P13378; -.
DR   OpenTargets; ENSG00000175879; -.
DR   PharmGKB; PA29413; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P13378; -.
DR   KO; K09308; -.
DR   OMA; PCGGIAC; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P13378; -.
DR   TreeFam; TF316310; -.
DR   GeneWiki; HOXD8; -.
DR   GenomeRNAi; 3234; -.
DR   PRO; PR:P13378; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000175879; -.
DR   CleanEx; HS_HOXD8; -.
DR   ExpressionAtlas; P13378; baseline and differential.
DR   Genevisible; P13378; HS.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0008595; P:anterior/posterior axis specification, embryo; NAS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    290       Homeobox protein Hox-D8.
FT                                /FTId=PRO_0000200216.
FT   DNA_BIND    197    256       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     15     23       Poly-Ala.
FT   COMPBIAS     45     50       Poly-Ala.
FT   COMPBIAS    109    123       Poly-Pro.
FT   VAR_SEQ       1    184       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_045862.
FT   VAR_SEQ     193    193       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042856.
FT   VAR_SEQ     252    290       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_045863.
FT   CONFLICT     39     39       E -> G (in Ref. 4; AAH90853).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       G -> A (in Ref. 5; CAA33529).
FT                                {ECO:0000305}.
SQ   SEQUENCE   290 AA;  31911 MW;  75FF95A73E2AA85F CRC64;
     MSSYFVNPLY SKYKAAAAAA AAAGEAINPT YYDCHFAPEV GGRHAAAAAA LQLYGNSAAG
     FPHAPPQAHA HPHPSPPPSG TGCGGREGRG QEYFHPGGGS PAAAYQAAPP PPPHPPPPPP
     PPPCGGIACH GEPAKFYGYD NLQRQPIFTT QQEAELVQYP DCKSSSGNIG EDPDHLNQSS
     SPSQMFPWMR PQAAPGRRRG RQTYSRFQTL ELEKEFLFNP YLTRKRRIEV SHALALTERQ
     VKIWFQNRRM KWKKENNKDK FPVSRQEVKD GETKKEAQEL EEDRAEGLTN
//
ID   HESX1_HUMAN             Reviewed;         185 AA.
AC   Q9UBX0; Q52LC5; Q99667;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Homeobox expressed in ES cells 1;
DE   AltName: Full=Homeobox protein ANF;
DE            Short=hAnf;
GN   Name=HESX1; Synonyms=HANF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT SOD CYS-160, AND VARIANT
RP   SER-125.
RC   TISSUE=Fibrosarcoma;
RX   PubMed=9620767; DOI=10.1038/477;
RA   Dattani M.T., Martinez-Barbera J.-P., Thomas P.Q., Brickman J.M.,
RA   Gupta R., Maartensson I.-L., Toresson H., Fox M., Wales J.K.H.,
RA   Hindmarsh P.C., Krauss S., Beddington R.S.P., Robinson I.C.A.F.;
RT   "Mutations in the homeobox gene HESX1/Hesx1 associated with septo-
RT   optic dysplasia in human and mouse.";
RL   Nat. Genet. 19:125-133(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=9373136; DOI=10.1016/S0378-1119(97)00326-0;
RA   Kazanskaya O.V., Severtzova E.A., Barth K.A., Ermakova G.V.,
RA   Lukyanov S.A., Benyumov A.O., Pannese M., Boncinelli E., Wilson S.W.,
RA   Zaraisky A.G.;
RT   "Anf: a novel class of vertebrate homeobox genes expressed at the
RT   anterior end of the main embryonic axis.";
RL   Gene 200:25-34(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH TLE1.
RX   PubMed=11731482; DOI=10.1101/gad.932601;
RA   Dasen J.S., Martinez-Barbera J.-P., Herman T.S., O'Connell S.,
RA   Olson L., Ju B., Tollkuhn J., Baek S.H., Rose D.W., Rosenfeld M.G.;
RT   "Temporal regulation of a paired-like homeodomain repressor/TLE
RT   corepressor complex and a related activator is required for pituitary
RT   organogenesis.";
RL   Genes Dev. 15:3193-3207(2001).
RN   [5]
RP   STRUCTURE BY NMR OF 108-174, AND DNA-BINDING.
RX   PubMed=19561080; DOI=10.1074/jbc.M109.012054;
RA   Torrado M., Revuelta J., Gonzalez C., Corzana F., Bastida A.,
RA   Asensio J.L.;
RT   "Role of conserved salt bridges in homeodomain stability and DNA
RT   binding.";
RL   J. Biol. Chem. 284:23765-23779(2009).
RN   [6]
RP   VARIANT SOD LEU-170, VARIANT GHDPA ALA-181, AND VARIANT CPHD5 HIS-6.
RX   PubMed=11136712; DOI=10.1093/hmg/10.1.39;
RA   Thomas P.Q., Dattani M.T., Brickman J.M., McNay D., Warne G.,
RA   Zacharin M., Cameron F., Hurst J., Woods K., Dunger D., Stanhope R.,
RA   Forrest S., Robinson I.C., Beddington R.S.;
RT   "Heterozygous HESX1 mutations associated with isolated congenital
RT   pituitary hypoplasia and septo-optic dysplasia.";
RL   Hum. Mol. Genet. 10:39-45(2001).
RN   [7]
RP   VARIANT CPHD5 THR-26, AND CHARACTERIZATION OF VARIANT CPHD5 THR-26.
RX   PubMed=14561704; DOI=10.1172/JCI18589;
RA   Carvalho L.R., Woods K.S., Mendonca B.B., Marcal N., Zamparini A.L.,
RA   Stifani S., Brickman J.M., Arnhold I.J., Dattani M.T.;
RT   "A homozygous mutation in HESX1 is associated with evolving
RT   hypopituitarism due to impaired repressor-corepressor interaction.";
RL   J. Clin. Invest. 112:1192-1201(2003).
RN   [8]
RP   VARIANT GHDPA LYS-149, AND CHARACTERIZATION OF VARIANT GHDPA LYS-149.
RX   PubMed=17148560; DOI=10.1210/jc.2006-1609;
RA   McNay D.E.G., Turton J.P., Kelberman D., Woods K.S., Brauner R.,
RA   Papadimitriou A., Keller E., Keller A., Haufs N., Krude H.,
RA   Shalet S.M., Dattani M.T.;
RT   "HESX1 mutations are an uncommon cause of septooptic dysplasia and
RT   hypopituitarism.";
RL   J. Clin. Endocrinol. Metab. 92:691-697(2007).
RN   [9]
RP   VARIANT CPHD5 GLN-109, CHARACTERIZATION OF VARIANT CPHD5 GLN-109,
RP   FUNCTION, DNA-BINDING, AND SUBCELLULAR LOCATION.
RX   PubMed=26781211; DOI=10.1507/endocrj.EJ15-0409;
RA   Takagi M., Takahashi M., Ohtsu Y., Sato T., Narumi S., Arakawa H.,
RA   Hasegawa T.;
RT   "A novel mutation in HESX1 causes combined pituitary hormone
RT   deficiency without septo optic dysplasia phenotypes.";
RL   Endocr. J. 63:405-410(2016).
CC   -!- FUNCTION: Required for the normal development of the forebrain,
CC       eyes and other anterior structures such as the olfactory placodes
CC       and pituitary gland. Possible transcriptional repressor. Binds to
CC       the palindromic PIII sequence, 5'-AGCTTGAGTCTAATTGAATTAACTGTAC-3'.
CC       HESX1 and PROP1 bind as heterodimers on this palindromic site,
CC       and, in vitro, HESX1 can antagonize PROP1 activation.
CC       {ECO:0000250|UniProtKB:Q61658, ECO:0000269|PubMed:26781211}.
CC   -!- SUBUNIT: Can form heterodimers with PROP1 in binding to DNA (By
CC       similarity). Interacts with TLE1. {ECO:0000250,
CC       ECO:0000269|PubMed:11731482}.
CC   -!- INTERACTION:
CC       O60341:KDM1A; NbExp=2; IntAct=EBI-8470369, EBI-710124;
CC       Q96LA8:PRMT6; NbExp=2; IntAct=EBI-8470369, EBI-912440;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26781211}.
CC   -!- DEVELOPMENTAL STAGE: Strongly expressed in Rathke pouch in seven-
CC       week-old embryo.
CC   -!- DISEASE: Septooptic dysplasia (SOD) [MIM:182230]: A clinically
CC       heterogeneous disorder defined by any combination of optic nerve
CC       hypoplasia, pituitary gland hypoplasia with panhypopopituitarism,
CC       and midline abnormalities of the brain, including absence of the
CC       corpus callosum and septum pellucidum.
CC       {ECO:0000269|PubMed:11136712, ECO:0000269|PubMed:9620767}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Growth hormone deficiency with pituitary anomalies
CC       (GHDPA) [MIM:182230]: A disease characterized by low or absent
CC       growth hormone levels, in the presence of a hypoplastic anterior
CC       pituitary lobe and ectopic or absent posterior pituitary lobe.
CC       {ECO:0000269|PubMed:11136712, ECO:0000269|PubMed:17148560}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Pituitary hormone deficiency, combined, 5 (CPHD5)
CC       [MIM:182230]: Combined pituitary hormone deficiency is defined as
CC       the impaired production of growth hormone and one or more of the
CC       other five anterior pituitary hormones. CPHD5 is characterized by
CC       complete or partial deficiencies of growth hormone, thyroid-
CC       stimulating hormone, luteinizing hormone, follicle stimulating
CC       hormone and adrenocorticotropic hormone.
CC       {ECO:0000269|PubMed:11136712, ECO:0000269|PubMed:14561704,
CC       ECO:0000269|PubMed:26781211}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ANF homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF059734; AAC24523.1; -; Genomic_DNA.
DR   EMBL; U82811; AAB88275.1; -; mRNA.
DR   EMBL; U65437; AAB39561.1; -; Genomic_DNA.
DR   EMBL; BC069515; AAH69515.1; -; mRNA.
DR   EMBL; BC093979; AAH93979.1; -; mRNA.
DR   EMBL; BC112089; AAI12090.1; -; mRNA.
DR   CCDS; CCDS2881.1; -.
DR   RefSeq; NP_003856.1; NM_003865.2.
DR   RefSeq; XP_005265583.1; XM_005265526.4.
DR   RefSeq; XP_006713442.1; XM_006713379.3.
DR   RefSeq; XP_011532506.1; XM_011534204.2.
DR   RefSeq; XP_011532507.1; XM_011534205.2.
DR   RefSeq; XP_016862910.1; XM_017007421.1.
DR   UniGene; Hs.171980; -.
DR   PDB; 2K40; NMR; -; A=108-174.
DR   PDBsum; 2K40; -.
DR   ProteinModelPortal; Q9UBX0; -.
DR   SMR; Q9UBX0; -.
DR   BioGrid; 114347; 7.
DR   CORUM; Q9UBX0; -.
DR   IntAct; Q9UBX0; 8.
DR   MINT; MINT-8417673; -.
DR   STRING; 9606.ENSP00000295934; -.
DR   iPTMnet; Q9UBX0; -.
DR   PhosphoSitePlus; Q9UBX0; -.
DR   BioMuta; HESX1; -.
DR   DMDM; 12230168; -.
DR   EPD; Q9UBX0; -.
DR   PaxDb; Q9UBX0; -.
DR   PeptideAtlas; Q9UBX0; -.
DR   PRIDE; Q9UBX0; -.
DR   DNASU; 8820; -.
DR   Ensembl; ENST00000295934; ENSP00000295934; ENSG00000163666.
DR   GeneID; 8820; -.
DR   KEGG; hsa:8820; -.
DR   UCSC; uc003din.5; human.
DR   CTD; 8820; -.
DR   DisGeNET; 8820; -.
DR   EuPathDB; HostDB:ENSG00000163666.8; -.
DR   GeneCards; HESX1; -.
DR   HGNC; HGNC:4877; HESX1.
DR   HPA; HPA024187; -.
DR   MalaCards; HESX1; -.
DR   MIM; 182230; phenotype.
DR   MIM; 262600; phenotype.
DR   MIM; 601802; gene.
DR   neXtProt; NX_Q9UBX0; -.
DR   OpenTargets; ENSG00000163666; -.
DR   Orphanet; 95494; Combined pituitary hormone deficiencies, genetic forms.
DR   Orphanet; 226307; Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
DR   Orphanet; 478; Kallmann syndrome.
DR   Orphanet; 95496; Pituitary stalk interruption syndrome.
DR   Orphanet; 3157; Septo-optic dysplasia.
DR   PharmGKB; PA29255; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00860000133740; -.
DR   HOGENOM; HOG000112889; -.
DR   HOVERGEN; HBG004226; -.
DR   InParanoid; Q9UBX0; -.
DR   KO; K09354; -.
DR   OMA; KPSTCSF; -.
DR   OrthoDB; EOG091G112W; -.
DR   PhylomeDB; Q9UBX0; -.
DR   TreeFam; TF335506; -.
DR   ChiTaRS; HESX1; human.
DR   EvolutionaryTrace; Q9UBX0; -.
DR   GeneWiki; HESX1; -.
DR   GenomeRNAi; 8820; -.
DR   PRO; PR:Q9UBX0; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163666; -.
DR   CleanEx; HS_HESX1; -.
DR   ExpressionAtlas; Q9UBX0; baseline and differential.
DR   Genevisible; Q9UBX0; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0047485; F:protein N-terminus binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; TAS:ProtInc.
DR   GO; GO:0048853; P:forebrain morphogenesis; IEA:Ensembl.
DR   GO; GO:0043584; P:nose development; IEA:Ensembl.
DR   GO; GO:0030916; P:otic vesicle formation; IEA:Ensembl.
DR   GO; GO:0021983; P:pituitary gland development; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Dwarfism; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    185       Homeobox expressed in ES cells 1.
FT                                /FTId=PRO_0000048922.
FT   DNA_BIND    108    167       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT       6      6       Q -> H (in CPHD5; dbSNP:rs121909173).
FT                                {ECO:0000269|PubMed:11136712}.
FT                                /FTId=VAR_063230.
FT   VARIANT      26     26       I -> T (in CPHD5; the mutated protein is
FT                                associated with impaired transcriptional
FT                                repression but not DNA binding;
FT                                dbSNP:rs28936416).
FT                                {ECO:0000269|PubMed:14561704}.
FT                                /FTId=VAR_063231.
FT   VARIANT     109    109       R -> Q (in CPHD5; unknown pathological
FT                                significance; loss of DNA binding
FT                                ability; unable to repress PROP1-mediated
FT                                activation; no effect on nuclear
FT                                location; no effect on protein abundance;
FT                                dbSNP:rs768165720).
FT                                {ECO:0000269|PubMed:26781211}.
FT                                /FTId=VAR_078488.
FT   VARIANT     125    125       N -> S (in dbSNP:rs9878928).
FT                                {ECO:0000269|PubMed:9620767}.
FT                                /FTId=VAR_010400.
FT   VARIANT     149    149       E -> K (in GHDPA; unable to repress
FT                                PROP1-mediated activation;
FT                                dbSNP:rs104893742).
FT                                {ECO:0000269|PubMed:17148560}.
FT                                /FTId=VAR_063232.
FT   VARIANT     160    160       R -> C (in SOD; loss of DNA-binding;
FT                                dbSNP:rs28936702).
FT                                {ECO:0000269|PubMed:9620767}.
FT                                /FTId=VAR_010225.
FT   VARIANT     170    170       S -> L (in SOD; mild; dbSNP:rs28936703).
FT                                {ECO:0000269|PubMed:11136712}.
FT                                /FTId=VAR_063233.
FT   VARIANT     181    181       T -> A (in GHDPA; dbSNP:rs28936704).
FT                                {ECO:0000269|PubMed:11136712}.
FT                                /FTId=VAR_063234.
FT   HELIX       117    127       {ECO:0000244|PDB:2K40}.
FT   HELIX       135    145       {ECO:0000244|PDB:2K40}.
FT   HELIX       149    164       {ECO:0000244|PDB:2K40}.
SQ   SEQUENCE   185 AA;  21409 MW;  1F23D319EB4FDBF0 CRC64;
     MSPSLQEGAQ LGENKPSTCS FSIERILGLD QKKDCVPLMK PHRPWADTCS SSGKDGNLCL
     HVPNPPSGIS FPSVVDHPMP EERASKYENY FSASERLSLK RELSWYRGRR PRTAFTQNQI
     EVLENVFRVN CYPGIDIRED LAQKLNLEED RIQIWFQNRR AKLKRSHRES QFLMAKKNFN
     TNLLE
//
ID   HOP_HUMAN               Reviewed;          73 AA.
AC   Q9BPY8; A8K0Z2; E9PB55; G3V294; Q8N0V6; Q96CI1;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   25-OCT-2017, entry version 130.
DE   RecName: Full=Homeodomain-only protein;
DE   AltName: Full=Lung cancer-associated Y protein;
DE   AltName: Full=Not expressed in choriocarcinoma protein 1;
DE   AltName: Full=Odd homeobox protein 1;
GN   Name=HOPX; Synonyms=HOD, HOP, LAGY, NECC1, OB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Heart;
RX   PubMed=14516659; DOI=10.1016/S0925-4773(03)00090-X;
RA   Adu J., Leong F.T., Smith N.R., Leek J.P., Markham A.F.,
RA   Robinson P.A., Mighell A.J.;
RT   "Expression of mOb1, a novel atypical 73 amino acid K50-homeodomain
RT   protein, during mouse development.";
RL   Mech. Dev. 119:S43-S47(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   POSSIBLE INVOLVEMENT IN CHORIOCARCINOMA.
RX   PubMed=12573257; DOI=10.1016/S0888-7543(02)00011-3;
RA   Asanoma K., Matsuda T., Kondo H., Kato K., Kishino T., Niikawa N.,
RA   Wake N., Kato H.;
RT   "NECC1, a candidate choriocarcinoma suppressor gene that encodes a
RT   homeodomain consensus motif.";
RL   Genomics 81:15-25(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   POSSIBLE INVOLVEMENT IN LUNG CANCER.
RX   PubMed=12759545; DOI=10.1159/000070306;
RA   Chen Y., Petersen S., Pacyna-Gengelbach M., Pietas A., Petersen I.;
RT   "Identification of a novel homeobox-containing gene, LAGY, which is
RT   downregulated in lung cancer.";
RL   Oncology 64:450-458(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN HEAD AND NECK SQUAMOUS CELL CARCINOMA.
RX   PubMed=15213722; DOI=10.1038/sj.bjc.6601952;
RA   Lemaire F., Millon R., Muller D., Rabouel Y., Bracco L., Abecassis J.,
RA   Wasylyk B.;
RT   "Loss of HOP tumour suppressor expression in head and neck squamous
RT   cell carcinoma.";
RL   Br. J. Cancer 91:258-261(2004).
RN   [8]
RP   INVOLVEMENT IN ORAL SQUAMOUS CELL CARCINOMA.
RX   PubMed=15381369; DOI=10.1016/j.cancergencyto.2004.01.026;
RA   Toruner G.A., Ulger C., Alkan M., Galante A.T., Rinaggio J., Wilk R.,
RA   Tian B., Soteropoulos P., Hameed M.R., Schwalb M.N., Dermody J.J.;
RT   "Association between gene expression profile and tumor invasion in
RT   oral squamous cell carcinoma.";
RL   Cancer Genet. Cytogenet. 154:27-35(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH HSPA1A; HSPA1B AND HSPA8.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J.,
RA   Seok S.H., Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein
RT   refolding and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
CC   -!- FUNCTION: Atypical homeodomain protein which does not bind DNA and
CC       is required to modulate cardiac growth and development. Acts via
CC       its interaction with SRF, thereby modulating the expression of
CC       SRF-dependent cardiac-specific genes and cardiac development.
CC       Prevents SRF-dependent transcription either by inhibiting SRF
CC       binding to DNA or by recruiting histone deacetylase (HDAC)
CC       proteins that prevent transcription by SRF. Overexpression causes
CC       cardiac hypertrophy (By similarity). May act as a tumor
CC       suppressor. Acts as a co-chaperone for HSPA1A and HSPA1B chaperone
CC       proteins and assists in chaperone-mediated protein refolding
CC       (PubMed:27708256). {ECO:0000250|UniProtKB:Q8R1H0,
CC       ECO:0000269|PubMed:27708256}.
CC   -!- SUBUNIT: Interacts with serum response factor (SRF). Component of
CC       a large complex containing histone deacetylases such as HDAC2 (By
CC       similarity). Interacts with the acetylated forms of HSPA1A and
CC       HSPA1B. Interacts with HSPA8 (PubMed:27708256).
CC       {ECO:0000250|UniProtKB:Q8R1H0, ECO:0000269|PubMed:27708256}.
CC   -!- INTERACTION:
CC       Q99081:TCF12; NbExp=3; IntAct=EBI-10295883, EBI-722877;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8R1H0}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q8R1H0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=Q9BPY8-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9BPY8-2; Sequence=VSP_012659;
CC         Note=Ref.1 (AAM46830/AAM46831) sequences are in conflict in
CC         position: 76:P->L. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q9BPY8-3; Sequence=VSP_047290;
CC         Note=Gene prediction based on EST data.;
CC       Name=4;
CC         IsoId=Q9BPY8-4; Sequence=VSP_047290, VSP_012659;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in the heart,
CC       brain, placenta, lung, skeletal and smooth muscles, uterus,
CC       urinary bladder, kidney and spleen. Down-regulated in some types
CC       of cancer such as lung cancer, choriocarcinoma, head and neck
CC       squamous cell carcinoma and oral squamous cell carcinoma.
CC       {ECO:0000269|PubMed:12573257, ECO:0000269|PubMed:12759545}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF492675; AAM46827.1; -; mRNA.
DR   EMBL; AF492676; AAM46828.1; -; mRNA.
DR   EMBL; AF492677; AAM46829.1; -; mRNA.
DR   EMBL; AF492678; AAM46830.1; -; mRNA.
DR   EMBL; AF492679; AAM46831.1; -; mRNA.
DR   EMBL; AF492680; AAM46832.1; -; mRNA.
DR   EMBL; AF492681; AAM46833.1; -; mRNA.
DR   EMBL; AB059408; BAB40926.1; -; mRNA.
DR   EMBL; AB059409; BAB40927.1; -; mRNA.
DR   EMBL; AB059410; BAB40928.1; -; mRNA.
DR   EMBL; AF454763; AAL56613.1; -; mRNA.
DR   EMBL; AK289707; BAF82396.1; -; mRNA.
DR   EMBL; AC108215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014225; AAH14225.1; -; mRNA.
DR   CCDS; CCDS3507.1; -. [Q9BPY8-1]
DR   CCDS; CCDS47062.1; -. [Q9BPY8-3]
DR   CCDS; CCDS54767.1; -. [Q9BPY8-4]
DR   RefSeq; NP_001138931.1; NM_001145459.1. [Q9BPY8-1]
DR   RefSeq; NP_001138932.1; NM_001145460.1. [Q9BPY8-4]
DR   RefSeq; NP_115884.4; NM_032495.5. [Q9BPY8-3]
DR   RefSeq; NP_631957.1; NM_139211.4. [Q9BPY8-1]
DR   RefSeq; NP_631958.1; NM_139212.3. [Q9BPY8-1]
DR   RefSeq; XP_016864218.1; XM_017008729.1. [Q9BPY8-1]
DR   RefSeq; XP_016864219.1; XM_017008730.1. [Q9BPY8-1]
DR   RefSeq; XP_016864220.1; XM_017008731.1. [Q9BPY8-1]
DR   RefSeq; XP_016864221.1; XM_017008732.1. [Q9BPY8-1]
DR   RefSeq; XP_016864222.1; XM_017008733.1. [Q9BPY8-1]
DR   RefSeq; XP_016864223.1; XM_017008734.1. [Q9BPY8-1]
DR   UniGene; Hs.619396; -.
DR   ProteinModelPortal; Q9BPY8; -.
DR   SMR; Q9BPY8; -.
DR   BioGrid; 124117; 11.
DR   IntAct; Q9BPY8; 2.
DR   MINT; MINT-4534265; -.
DR   STRING; 9606.ENSP00000450527; -.
DR   iPTMnet; Q9BPY8; -.
DR   PhosphoSitePlus; Q9BPY8; -.
DR   BioMuta; HOPX; -.
DR   DMDM; 60392394; -.
DR   PaxDb; Q9BPY8; -.
DR   PeptideAtlas; Q9BPY8; -.
DR   PRIDE; Q9BPY8; -.
DR   DNASU; 84525; -.
DR   Ensembl; ENST00000317745; ENSP00000315198; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000337881; ENSP00000337330; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000381255; ENSP00000370654; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000381260; ENSP00000370659; ENSG00000171476. [Q9BPY8-2]
DR   Ensembl; ENST00000420433; ENSP00000396275; ENSG00000171476. [Q9BPY8-3]
DR   Ensembl; ENST00000503639; ENSP00000424101; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000508121; ENSP00000422175; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000553379; ENSP00000452340; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000554144; ENSP00000450527; ENSG00000171476. [Q9BPY8-4]
DR   Ensembl; ENST00000555760; ENSP00000452098; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000556376; ENSP00000451794; ENSG00000171476. [Q9BPY8-1]
DR   Ensembl; ENST00000556614; ENSP00000452003; ENSG00000171476. [Q9BPY8-1]
DR   GeneID; 84525; -.
DR   KEGG; hsa:84525; -.
DR   UCSC; uc003hbz.3; human. [Q9BPY8-1]
DR   CTD; 84525; -.
DR   DisGeNET; 84525; -.
DR   EuPathDB; HostDB:ENSG00000171476.21; -.
DR   GeneCards; HOPX; -.
DR   HGNC; HGNC:24961; HOPX.
DR   HPA; CAB018632; -.
DR   HPA; HPA030180; -.
DR   MIM; 607275; gene.
DR   neXtProt; NX_Q9BPY8; -.
DR   OpenTargets; ENSG00000171476; -.
DR   PharmGKB; PA162391564; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00390000017143; -.
DR   HOGENOM; HOG000112932; -.
DR   HOVERGEN; HBG051921; -.
DR   InParanoid; Q9BPY8; -.
DR   OMA; KVSKHPD; -.
DR   OrthoDB; EOG091G1BXE; -.
DR   PhylomeDB; Q9BPY8; -.
DR   SIGNOR; Q9BPY8; -.
DR   ChiTaRS; HOPX; human.
DR   GeneWiki; HOPX; -.
DR   GenomeRNAi; 84525; -.
DR   PRO; PR:Q9BPY8; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000171476; -.
DR   CleanEx; HS_HOPX; -.
DR   Genevisible; Q9BPY8; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:CAFA.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IDA:MGI.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001829; P:trophectodermal cell differentiation; IDA:MGI.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Developmental protein; Homeobox; Nucleus; Proto-oncogene;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1     73       Homeodomain-only protein.
FT                                /FTId=PRO_0000049129.
FT   DNA_BIND      3     62       Homeobox; atypical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1      1       M -> MLIFLGCYRRRLEERAGTM (in isoform 3
FT                                and isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_047290.
FT   VAR_SEQ      49     73       KWFKQRLAKWRRSEGLPSECRSVTD -> GSDLISRSKIWH
FT                                PESSPQREGYPHDSLPCLAFDYFSLLPPQCKEMV (in
FT                                isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:14516659}.
FT                                /FTId=VSP_012659.
FT   CONFLICT     72     72       T -> I (in Ref. 6; AAH14225).
FT                                {ECO:0000305}.
SQ   SEQUENCE   73 AA;  8260 MW;  CE65E4D2A8972022 CRC64;
     MSAETASGPT EDQVEILEYN FNKVDKHPDS TTLCLIAAEA GLSEEETQKW FKQRLAKWRR
     SEGLPSECRS VTD
//
ID   HLX_HUMAN               Reviewed;         488 AA.
AC   Q14774; B2R8A8; Q15988; Q59HE7; Q9NZ75;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 3.
DT   27-SEP-2017, entry version 160.
DE   RecName: Full=H2.0-like homeobox protein;
DE   AltName: Full=Homeobox protein HB24;
DE   AltName: Full=Homeobox protein HLX1;
GN   Name=HLX; Synonyms=HLX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=B-cell;
RX   PubMed=1676597;
RA   Deguchi Y., Moroney J.F., Wilson G.L., Fox C.H., Winter H.S.,
RA   Kehrl J.H.;
RT   "Cloning of a human homeobox gene that resembles a diverged Drosophila
RT   homeobox gene and is expressed in activated lymphocytes.";
RL   New Biol. 3:353-363(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hanrahan V., Kennedy M.A.;
RT   "Genomic sequence of human homeobox gene HLX1.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-356.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retina;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-326, AND VARIANT PRO-116.
RX   PubMed=7806220; DOI=10.1006/geno.1994.1394;
RA   Kennedy M.A., Rayner J.C., Morris C.M.;
RT   "Genomic structure, promoter sequence, and revised translation of
RT   human homeobox gene HLX1.";
RL   Genomics 22:348-355(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 350-369.
RX   PubMed=8095486; DOI=10.1006/geno.1993.1068;
RA   Nishimura D.Y., Purchio A.F., Murray J.C.;
RT   "Linkage localization of TGFB2 and the human homeobox gene HLX1 to
RT   chromosome 1q.";
RL   Genomics 15:357-364(1993).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Transcription factor required for TBX21/T-bet-dependent
CC       maturation of Th1 cells as well as maintenance of Th1-specific
CC       gene expression. Involved in embryogenesis and hematopoiesis (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q15022:SUZ12; NbExp=2; IntAct=EBI-6678255, EBI-1264675;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Low level in normal B and T-cells, high level
CC       in activated lymphocytes and monocytes. Also found in thymus,
CC       tonsil, bone marrow, developing vessels, and fetal brain.
CC   -!- SIMILARITY: Belongs to the H2.0 homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92049.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAD92049.1; Type=Frameshift; Positions=198, 259, 321; Evidence={ECO:0000305};
CC       Sequence=M60721; Type=Frameshift; Positions=69, 115, 152, 167; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60721; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF217621; AAF65541.1; -; Genomic_DNA.
DR   EMBL; AK313298; BAG36105.1; -; mRNA.
DR   EMBL; AB208812; BAD92049.1; ALT_SEQ; mRNA.
DR   EMBL; AL445423; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471100; EAW93289.1; -; Genomic_DNA.
DR   EMBL; BC007294; AAH07294.1; -; mRNA.
DR   EMBL; BC033808; AAH33808.1; -; mRNA.
DR   EMBL; U14328; AAC51346.1; -; Genomic_DNA.
DR   EMBL; U14325; AAC51346.1; JOINED; Genomic_DNA.
DR   EMBL; U14326; AAC51346.1; JOINED; Genomic_DNA.
DR   EMBL; U14327; AAC51346.1; JOINED; Genomic_DNA.
DR   EMBL; S56767; AAD13883.1; -; Genomic_DNA.
DR   CCDS; CCDS1527.1; -.
DR   PIR; A55180; A55180.
DR   RefSeq; NP_068777.1; NM_021958.3.
DR   UniGene; Hs.74870; -.
DR   ProteinModelPortal; Q14774; -.
DR   SMR; Q14774; -.
DR   BioGrid; 109387; 17.
DR   IntAct; Q14774; 5.
DR   STRING; 9606.ENSP00000355870; -.
DR   iPTMnet; Q14774; -.
DR   PhosphoSitePlus; Q14774; -.
DR   BioMuta; HLX; -.
DR   DMDM; 160291960; -.
DR   MaxQB; Q14774; -.
DR   PaxDb; Q14774; -.
DR   PeptideAtlas; Q14774; -.
DR   PRIDE; Q14774; -.
DR   DNASU; 3142; -.
DR   Ensembl; ENST00000366903; ENSP00000355870; ENSG00000136630.
DR   GeneID; 3142; -.
DR   KEGG; hsa:3142; -.
DR   UCSC; uc001hmv.5; human.
DR   CTD; 3142; -.
DR   DisGeNET; 3142; -.
DR   EuPathDB; HostDB:ENSG00000136630.12; -.
DR   GeneCards; HLX; -.
DR   H-InvDB; HIX0001609; -.
DR   HGNC; HGNC:4978; HLX.
DR   HPA; HPA005968; -.
DR   MIM; 142995; gene.
DR   neXtProt; NX_Q14774; -.
DR   OpenTargets; ENSG00000136630; -.
DR   PharmGKB; PA162391017; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000112911; -.
DR   HOVERGEN; HBG000457; -.
DR   InParanoid; Q14774; -.
DR   KO; K09339; -.
DR   OMA; GQHQFQD; -.
DR   OrthoDB; EOG091G0MD1; -.
DR   PhylomeDB; Q14774; -.
DR   TreeFam; TF350735; -.
DR   GeneWiki; HLX_(gene); -.
DR   GenomeRNAi; 3142; -.
DR   PRO; PR:Q14774; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000136630; -.
DR   CleanEx; HS_HLX; -.
DR   ExpressionAtlas; Q14774; baseline and differential.
DR   Genevisible; Q14774; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0048484; P:enteric nervous system development; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045629; P:negative regulation of T-helper 2 cell differentiation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0046622; P:positive regulation of organ growth; IEA:Ensembl.
DR   GO; GO:0045627; P:positive regulation of T-helper 1 cell differentiation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Differentiation; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    488       H2.0-like homeobox protein.
FT                                /FTId=PRO_0000048978.
FT   DNA_BIND    276    335       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     92    169       Pro-rich.
FT   COMPBIAS    125    137       Poly-Gln.
FT   COMPBIAS    366    454       Ser-rich.
FT   VARIANT     116    116       S -> P (in dbSNP:rs12141189).
FT                                {ECO:0000269|PubMed:7806220}.
FT                                /FTId=VAR_037162.
FT   VARIANT     356    356       P -> L (in dbSNP:rs2738755).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_037163.
FT   VARIANT     387    387       A -> G (in dbSNP:rs11578466).
FT                                /FTId=VAR_049582.
FT   CONFLICT     63     63       Missing (in Ref. 1; M60721).
FT                                {ECO:0000305}.
FT   CONFLICT    134    136       QQQ -> RRE (in Ref. 1; M60721).
FT                                {ECO:0000305}.
SQ   SEQUENCE   488 AA;  50789 MW;  FC2EA805DACAA0C1 CRC64;
     MFAAGLAPFY ASNFSLWSAA YCSSAGPGGC SFPLDPAAVK KPSFCIADIL HAGVGDLGAA
     PEGLAGASAA ALTAHLGSVH PHASFQAAAR SPLRPTPVVA PSEVPAGFPQ RLSPLSAAYH
     HHHPQQQQQQ QQPQQQQPPP PPRAGALQPP ASGTRVVPNP HHSGSAPAPS SKDLKFGIDR
     ILSAEFDPKV KEGNTLRDLT SLLTGGRPAG VHLSGLQPSA GQFFASLDPI NEASAILSPL
     NSNPRNSVQH QFQDTFPGPY AVLTKDTMPQ TYKRKRSWSR AVFSNLQRKG LEKRFEIQKY
     VTKPDRKQLA AMLGLTDAQV KVWFQNRRMK WRHSKEAQAQ KDKDKEAGEK PSGGAPAADG
     EQDERSPSRS EGEAESESSD SESLDMAPSD TERTEGSERS LHQTTVIKAP VTGALITASS
     AGSGGSSGGG GNSFSFSSAS SLSSSSTSAG CASSLGGGGA SELLPATQPT ASSAPKSPEP
     AQGALGCL
//
ID   HNF6_HUMAN              Reviewed;         465 AA.
AC   Q9UBC0; B2RTV4; Q99744; Q9UMR6;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   27-SEP-2017, entry version 151.
DE   RecName: Full=Hepatocyte nuclear factor 6;
DE            Short=HNF-6;
DE   AltName: Full=One cut domain family member 1;
DE   AltName: Full=One cut homeobox 1;
GN   Name=ONECUT1; Synonyms=HNF6, HNF6A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Furuta H., Horikawa Y., Wang Y.-Q., Bell G.I.;
RT   "Isolation and characterization of the human hepatocyte nuclear factor
RT   6 gene.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Furuta H., Wang Y.-Q., Bell G.I.;
RT   "The sequence of human mRNA for the hepatocyte nuclear factor-6
RT   alpha.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-368, AND VARIANT ALA-75.
RX   PubMed=10491763; DOI=10.1007/s001250051261;
RA   Moeller A.M., Ek J., Durviaux S.M., Urhammer S.A., Clausen J.O.,
RA   Eiberg H., Hansen T., Rousseau G.G., Lemaigre F.P., Pedersen O.;
RT   "Hepatocyte nuclear factor-6: associations between genetic variability
RT   and type II diabetes and between genetic variability and estimates of
RT   insulin secretion.";
RL   Diabetologia 42:1011-1016(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 174-465.
RA   Samadani U., Costa R.H.;
RT   "Yeast one-hybrid cloning of the partial human cDNA for hepatocyte
RT   nuclear factor 6.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Transcriptional activator. Binds the consensus sequence
CC       5'-DHWATTGAYTWWD-3' on a variety of gene promoters such as those
CC       of HNF3B and TTR. Important for liver genes transcription.
CC   -!- SUBUNIT: Binds DNA as a monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver; lower expression in
CC       testis and skin.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hepatocyte nuclear factors
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Hepatocyte_nuclear_factors";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF035581; AAD02033.1; -; Genomic_DNA.
DR   EMBL; AF035580; AAD02033.1; JOINED; Genomic_DNA.
DR   EMBL; U96173; AAD00826.1; -; mRNA.
DR   EMBL; CH471082; EAW77461.1; -; Genomic_DNA.
DR   EMBL; BC140830; AAI40831.1; -; mRNA.
DR   EMBL; Y17739; CAB50769.1; -; Genomic_DNA.
DR   EMBL; U77975; AAB61705.1; -; mRNA.
DR   CCDS; CCDS10150.1; -.
DR   RefSeq; NP_004489.1; NM_004498.2.
DR   UniGene; Hs.658573; -.
DR   ProteinModelPortal; Q9UBC0; -.
DR   SMR; Q9UBC0; -.
DR   BioGrid; 109417; 7.
DR   CORUM; Q9UBC0; -.
DR   STRING; 9606.ENSP00000302630; -.
DR   iPTMnet; Q9UBC0; -.
DR   PhosphoSitePlus; Q9UBC0; -.
DR   DMDM; 13627184; -.
DR   PaxDb; Q9UBC0; -.
DR   PeptideAtlas; Q9UBC0; -.
DR   PRIDE; Q9UBC0; -.
DR   Ensembl; ENST00000305901; ENSP00000302630; ENSG00000169856.
DR   GeneID; 3175; -.
DR   KEGG; hsa:3175; -.
DR   UCSC; uc002aci.3; human.
DR   CTD; 3175; -.
DR   DisGeNET; 3175; -.
DR   EuPathDB; HostDB:ENSG00000169856.8; -.
DR   GeneCards; ONECUT1; -.
DR   HGNC; HGNC:8138; ONECUT1.
DR   HPA; HPA003457; -.
DR   MIM; 604164; gene.
DR   neXtProt; NX_Q9UBC0; -.
DR   OpenTargets; ENSG00000169856; -.
DR   PharmGKB; PA31924; -.
DR   eggNOG; KOG2252; Eukaryota.
DR   eggNOG; ENOG410YWY4; LUCA.
DR   GeneTree; ENSGT00530000063019; -.
DR   HOGENOM; HOG000232114; -.
DR   HOVERGEN; HBG005981; -.
DR   InParanoid; Q9UBC0; -.
DR   KO; K08026; -.
DR   OMA; QMEEVNT; -.
DR   OrthoDB; EOG091G0E7H; -.
DR   PhylomeDB; Q9UBC0; -.
DR   TreeFam; TF318206; -.
DR   Reactome; R-HSA-210744; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells.
DR   Reactome; R-HSA-210747; Regulation of gene expression in early pancreatic precursor cells.
DR   SignaLink; Q9UBC0; -.
DR   ChiTaRS; ONECUT1; human.
DR   GenomeRNAi; 3175; -.
DR   PRO; PR:Q9UBC0; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000169856; -.
DR   CleanEx; HS_ONECUT1; -.
DR   ExpressionAtlas; Q9UBC0; baseline and differential.
DR   Genevisible; Q9UBC0; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; ISS:BHF-UCL.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IEA:Ensembl.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0060271; P:cilium assembly; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; IEA:Ensembl.
DR   GO; GO:0002064; P:epithelial cell development; IEA:Ensembl.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0048731; P:system development; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   Pfam; PF02376; CUT; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM01109; CUT; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS51042; CUT; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    465       Hepatocyte nuclear factor 6.
FT                                /FTId=PRO_0000202402.
FT   DNA_BIND    283    369       CUT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    385    444       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     69     72       Poly-His.
FT   COMPBIAS    124    138       Poly-His.
FT   COMPBIAS    455    460       Poly-Ser.
FT   VARIANT      75     75       P -> A (in dbSNP:rs74805019).
FT                                {ECO:0000269|PubMed:10491763}.
FT                                /FTId=VAR_010729.
FT   CONFLICT    220    220       A -> T (in Ref. 5 and 6). {ECO:0000305}.
FT   CONFLICT    284    284       S -> N (in Ref. 6; AAB61705).
FT                                {ECO:0000305}.
FT   CONFLICT    288    288       Q -> H (in Ref. 6; AAB61705).
FT                                {ECO:0000305}.
FT   CONFLICT    318    318       R -> K (in Ref. 6; AAB61705).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       K -> Q (in Ref. 6; AAB61705).
FT                                {ECO:0000305}.
SQ   SEQUENCE   465 AA;  51023 MW;  F47F78957A6ECFC2 CRC64;
     MNAQLTMEAI GELHGVSHEP VPAPADLLGG SPHARSSVAH RGSHLPPAHP RSMGMASLLD
     GGSGGGDYHH HHRAPEHSLA GPLHPTMTMA CETPPGMSMP TTYTTLTPLQ PLPPISTVSD
     KFPHHHHHHH HHHHPHHHQR LAGNVSGSFT LMRDERGLAS MNNLYTPYHK DVAGMGQSLS
     PLSSSGLGSI HNSQQGLPHY AHPGAAMPTD KMLTPNGFEA HHPAMLGRHG EQHLTPTSAG
     MVPINGLPPH HPHAHLNAQG HGQLLGTARE PNPSVTGAQV SNGSNSGQME EINTKEVAQR
     ITTELKRYSI PQAIFAQRVL CRSQGTLSDL LRNPKPWSKL KSGRETFRRM WKWLQEPEFQ
     RMSALRLAAC KRKEQEHGKD RGNTPKKPRL VFTDVQRRTL HAIFKENKRP SKELQITISQ
     QLGLELSTVS NFFMNARRRS LDKWQDEGSS NSGNSSSSSS TCTKA
//
ID   HXB7_HUMAN              Reviewed;         217 AA.
AC   P09629; A8K3N8; Q15957; Q53FN3; Q96BQ6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 4.
DT   25-OCT-2017, entry version 168.
DE   RecName: Full=Homeobox protein Hox-B7;
DE   AltName: Full=Homeobox protein HHO.C1;
DE   AltName: Full=Homeobox protein Hox-2C;
GN   Name=HOXB7; Synonyms=HOX2C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-9.
RX   PubMed=2885844; DOI=10.1073/pnas.84.14.4914;
RA   Simeone A., Mavilio F., Acampora D., Giampaolo A., Faiella A.,
RA   Zappavigna V., D'Esposito M., Pannese M., Russo G., Boncinelli E.,
RA   Peschle C.;
RT   "Two human homeobox genes, c1 and c8: structure analysis and
RT   expression in embryonic development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4914-4918(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-9.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-9.
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-9.
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-9.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 98-217.
RX   PubMed=1678287;
RA   Baier L.J., Hannibal M.C., Hanley E.W., Nabel G.J.;
RT   "Lymphoid expression and TATAA binding of a human protein containing
RT   an Antennapedia homeodomain.";
RL   Blood 78:1047-1055(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-217.
RX   PubMed=2573064; DOI=10.1073/pnas.86.21.8536;
RA   Shen W.-F., Largman C., Lowney P., Corral J.C., Detmer K.,
RA   Hauser C.A., Simonitch T.A., Hack F.M., Lawrence H.J.;
RT   "Lineage-restricted expression of homeobox-containing genes in human
RT   hematopoietic cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8536-8540(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 137-202.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       P49761:CLK3; NbExp=5; IntAct=EBI-1248457, EBI-745579;
CC       P78527:PRKDC; NbExp=2; IntAct=EBI-1248457, EBI-352053;
CC       P13010:XRCC5; NbExp=9; IntAct=EBI-1248457, EBI-357997;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16937; AAA36003.1; -; mRNA.
DR   EMBL; AK290653; BAF83342.1; -; mRNA.
DR   EMBL; AK223249; BAD96969.1; -; mRNA.
DR   EMBL; AC103702; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471109; EAW94725.1; -; Genomic_DNA.
DR   EMBL; BC015345; AAH15345.1; -; mRNA.
DR   EMBL; S49765; AAB19469.2; -; mRNA.
DR   EMBL; M30598; AAA36005.1; -; mRNA.
DR   CCDS; CCDS11532.1; -.
DR   PIR; A28030; WJHU2C.
DR   RefSeq; NP_004493.3; NM_004502.3.
DR   UniGene; Hs.436181; -.
DR   ProteinModelPortal; P09629; -.
DR   SMR; P09629; -.
DR   BioGrid; 109457; 13.
DR   ELM; P09629; -.
DR   IntAct; P09629; 5.
DR   STRING; 9606.ENSP00000239165; -.
DR   iPTMnet; P09629; -.
DR   PhosphoSitePlus; P09629; -.
DR   BioMuta; HOXB7; -.
DR   DMDM; 311033482; -.
DR   MaxQB; P09629; -.
DR   PaxDb; P09629; -.
DR   PeptideAtlas; P09629; -.
DR   PRIDE; P09629; -.
DR   DNASU; 3217; -.
DR   Ensembl; ENST00000239165; ENSP00000239165; ENSG00000260027.
DR   GeneID; 3217; -.
DR   KEGG; hsa:3217; -.
DR   UCSC; uc002inv.4; human.
DR   CTD; 3217; -.
DR   DisGeNET; 3217; -.
DR   EuPathDB; HostDB:ENSG00000260027.4; -.
DR   GeneCards; HOXB7; -.
DR   HGNC; HGNC:5118; HOXB7.
DR   HPA; HPA049940; -.
DR   MIM; 142962; gene.
DR   neXtProt; NX_P09629; -.
DR   OpenTargets; ENSG00000260027; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P09629; -.
DR   KO; K09307; -.
DR   OMA; CAPFEQN; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P09629; -.
DR   TreeFam; TF316310; -.
DR   SIGNOR; P09629; -.
DR   GeneWiki; HOXB7; -.
DR   GenomeRNAi; 3217; -.
DR   PRO; PR:P09629; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000260027; -.
DR   CleanEx; HS_HOXB7; -.
DR   Genevisible; P09629; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    217       Homeobox protein Hox-B7.
FT                                /FTId=PRO_0000200142.
FT   DNA_BIND    137    196       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       126    131       Antp-type hexapeptide.
FT   COMPBIAS    212    217       Glu-rich (acidic).
FT   VARIANT       9      9       T -> A (in dbSNP:rs7406910).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16625196,
FT                                ECO:0000269|PubMed:2885844,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_058204.
FT   CONFLICT     49     49       A -> V (in Ref. 2; BAF83342 and 3;
FT                                BAD96969). {ECO:0000305}.
FT   CONFLICT     53     53       A -> G (in Ref. 1; AAA36003).
FT                                {ECO:0000305}.
FT   CONFLICT     94     94       Q -> L (in Ref. 3; BAD96969).
FT                                {ECO:0000305}.
FT   CONFLICT    108    108       A -> G (in Ref. 7; AAB19469).
FT                                {ECO:0000305}.
FT   CONFLICT    118    118       L -> F (in Ref. 7; AAB19469).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       W -> S (in Ref. 1; AAA36003).
FT                                {ECO:0000305}.
FT   CONFLICT    153    153       E -> G (in Ref. 3; BAD96969).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       K -> N (in Ref. 7; AAB19469).
FT                                {ECO:0000305}.
FT   CONFLICT    173    173       T -> A (in Ref. 1; AAA36003 and 7;
FT                                AAB19469). {ECO:0000305}.
FT   CONFLICT    194    194       K -> N (in Ref. 7; AAB19469).
FT                                {ECO:0000305}.
FT   CONFLICT    200    202       GPG -> APA (in Ref. 7; AAB19469).
FT                                {ECO:0000305}.
SQ   SEQUENCE   217 AA;  24015 MW;  E92D63F437D34628 CRC64;
     MSSLYYANTL FSKYPASSSV FATGAFPEQT SCAFASNPQR PGYGAGSGAS FAASMQGLYP
     GGGGMAGQSA AGVYAAGYGL EPSSFNMHCA PFEQNLSGVC PGDSAKAAGA KEQRDSDLAA
     ESNFRIYPWM RSSGTDRKRG RQTYTRYQTL ELEKEFHYNR YLTRRRRIEI AHTLCLTERQ
     IKIWFQNRRM KWKKENKTAG PGTTGQDRAE AEEEEEE
//
ID   HXC11_HUMAN             Reviewed;         304 AA.
AC   O43248; A8K7D1; Q96DH2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 159.
DE   RecName: Full=Homeobox protein Hox-C11;
DE   AltName: Full=Homeobox protein Hox-3H;
GN   Name=HOXC11; Synonyms=HOX3H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9582375; DOI=10.1074/jbc.273.21.13297;
RA   Mitchelmore C.E., Troelsen J.T., Sjoestroem H., Noren O.;
RT   "The HOXC11 homeodomain protein interacts with the lactase-phlorizin
RT   hydrolase promoter and stimulates HNF1alpha-dependent transcription.";
RL   J. Biol. Chem. 273:13297-13306(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-178, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-178, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-82; LYS-116 AND LYS-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [8]
RP   VARIANT SER-130.
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Binds to a promoter element of the lactase-phlorizin hydrolase
CC       gene.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ000041; CAA03876.1; -; mRNA.
DR   EMBL; AK291946; BAF84635.1; -; mRNA.
DR   EMBL; CH471054; EAW96736.1; -; Genomic_DNA.
DR   EMBL; BC001543; AAH01543.1; -; mRNA.
DR   CCDS; CCDS8867.1; -.
DR   PIR; A60941; A60941.
DR   RefSeq; NP_055027.1; NM_014212.3.
DR   UniGene; Hs.127562; -.
DR   ProteinModelPortal; O43248; -.
DR   SMR; O43248; -.
DR   BioGrid; 109467; 14.
DR   IntAct; O43248; 4.
DR   STRING; 9606.ENSP00000446680; -.
DR   iPTMnet; O43248; -.
DR   PhosphoSitePlus; O43248; -.
DR   BioMuta; HOXC11; -.
DR   EPD; O43248; -.
DR   MaxQB; O43248; -.
DR   PaxDb; O43248; -.
DR   PeptideAtlas; O43248; -.
DR   PRIDE; O43248; -.
DR   DNASU; 3227; -.
DR   Ensembl; ENST00000546378; ENSP00000446680; ENSG00000123388.
DR   GeneID; 3227; -.
DR   KEGG; hsa:3227; -.
DR   UCSC; uc058oto.1; human.
DR   CTD; 3227; -.
DR   DisGeNET; 3227; -.
DR   EuPathDB; HostDB:ENSG00000123388.4; -.
DR   GeneCards; HOXC11; -.
DR   HGNC; HGNC:5123; HOXC11.
DR   HPA; HPA038291; -.
DR   MIM; 605559; gene.
DR   neXtProt; NX_O43248; -.
DR   OpenTargets; ENSG00000123388; -.
DR   PharmGKB; PA29398; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231898; -.
DR   HOVERGEN; HBG052048; -.
DR   InParanoid; O43248; -.
DR   KO; K09296; -.
DR   PhylomeDB; O43248; -.
DR   TreeFam; TF350668; -.
DR   SIGNOR; O43248; -.
DR   GeneWiki; HOXC11; -.
DR   GenomeRNAi; 3227; -.
DR   PRO; PR:O43248; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000123388; -.
DR   CleanEx; HS_HOXC11; -.
DR   ExpressionAtlas; O43248; baseline and differential.
DR   Genevisible; O43248; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; TAS:ProtInc.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0001759; P:organ induction; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR021918; DUF3528.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF12045; DUF3528; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Isopeptide bond; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    304       Homeobox protein Hox-C11.
FT                                /FTId=PRO_0000200192.
FT   DNA_BIND    232    291       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CROSSLNK     82     82       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    116    116       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    178    178       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   VARIANT     130    130       P -> S (in dbSNP:rs34652380).
FT                                {ECO:0000269|PubMed:11857506}.
FT                                /FTId=VAR_031850.
FT   VARIANT     222    222       A -> V (in dbSNP:rs12427129).
FT                                /FTId=VAR_034002.
FT   CONFLICT     48     48       S -> F (in Ref. 4; AAH01543).
FT                                {ECO:0000305}.
SQ   SEQUENCE   304 AA;  33748 MW;  EB357DEBB3DE165F CRC64;
     MFNSVNLGNF CSPSRKERGA DFGERGSCAS NLYLPSCTYY MPEFSTVSSF LPQAPSRQIS
     YPYSAQVPPV REVSYGLEPS GKWHHRNSYS SCYAAADELM HRECLPPSTV TEILMKNEGS
     YGGHHHPSAP HATPAGFYSS VNKNSVLPQA FDRFFDNAYC GGGDPPAEPP CSGKGEAKGE
     PEAPPASGLA SRAEAGAEAE AEEENTNPSS SGSAHSVAKE PAKGAAPNAP RTRKKRCPYS
     KFQIRELERE FFFNVYINKE KRLQLSRMLN LTDRQVKIWF QNRRMKEKKL SRDRLQYFSG
     NPLL
//
ID   HXC9_HUMAN              Reviewed;         260 AA.
AC   P31274; B2RCN7; Q9H1I0;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 3.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=Homeobox protein Hox-C9;
DE   AltName: Full=Homeobox protein Hox-3B;
GN   Name=HOXC9; Synonyms=HOX3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 192-257.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   STRUCTURE BY NMR OF 192-251 IN COMPLEX WITH GMNN, AND INTERACTION WITH
RP   GMNN.
RX   PubMed=22615398; DOI=10.1073/pnas.1200874109;
RA   Zhou B., Liu C., Xu Z., Zhu G.;
RT   "Structural basis for homeodomain recognition by the cell-cycle
RT   regulator Geminin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:8931-8936(2012).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-87.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBUNIT: Interacts with Geminin/GMNN, which inhibits
CC       transcriptional activity. {ECO:0000269|PubMed:22615398}.
CC   -!- INTERACTION:
CC       P03120:E2 (xeno); NbExp=3; IntAct=EBI-1779423, EBI-1779322;
CC       O60711:LPXN; NbExp=5; IntAct=EBI-1779423, EBI-744222;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY014302; AAG42151.1; -; Genomic_DNA.
DR   EMBL; AY014301; AAG42151.1; JOINED; Genomic_DNA.
DR   EMBL; AK000445; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK315194; BAG37634.1; -; mRNA.
DR   EMBL; CH471054; EAW96741.1; -; Genomic_DNA.
DR   EMBL; BC053894; AAH53894.1; -; mRNA.
DR   CCDS; CCDS8869.1; -.
DR   PIR; S15532; S15532.
DR   RefSeq; NP_008828.1; NM_006897.2.
DR   UniGene; Hs.658823; -.
DR   PDB; 2LP0; NMR; -; A=192-251.
DR   PDB; 2MSY; NMR; -; A=184-251.
DR   PDBsum; 2LP0; -.
DR   PDBsum; 2MSY; -.
DR   ProteinModelPortal; P31274; -.
DR   SMR; P31274; -.
DR   BioGrid; 109465; 24.
DR   IntAct; P31274; 21.
DR   MINT; MINT-2802481; -.
DR   STRING; 9606.ENSP00000302836; -.
DR   iPTMnet; P31274; -.
DR   PhosphoSitePlus; P31274; -.
DR   BioMuta; HOXC9; -.
DR   DMDM; 20141537; -.
DR   MaxQB; P31274; -.
DR   PaxDb; P31274; -.
DR   PeptideAtlas; P31274; -.
DR   PRIDE; P31274; -.
DR   DNASU; 3225; -.
DR   Ensembl; ENST00000303450; ENSP00000302836; ENSG00000180806.
DR   Ensembl; ENST00000508190; ENSP00000423861; ENSG00000180806.
DR   GeneID; 3225; -.
DR   KEGG; hsa:3225; -.
DR   UCSC; uc001seq.4; human.
DR   CTD; 3225; -.
DR   DisGeNET; 3225; -.
DR   EuPathDB; HostDB:ENSG00000180806.4; -.
DR   GeneCards; HOXC9; -.
DR   HGNC; HGNC:5130; HOXC9.
DR   HPA; HPA063965; -.
DR   HPA; HPA072160; -.
DR   MIM; 142971; gene.
DR   neXtProt; NX_P31274; -.
DR   OpenTargets; ENSG00000180806; -.
DR   PharmGKB; PA29405; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P31274; -.
DR   KO; K09294; -.
DR   OMA; SGPISNY; -.
DR   OrthoDB; EOG091G0ECO; -.
DR   PhylomeDB; P31274; -.
DR   TreeFam; TF317819; -.
DR   ChiTaRS; HOXC9; human.
DR   GeneWiki; HOXC9; -.
DR   GenomeRNAi; 3225; -.
DR   PRO; PR:P31274; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000180806; -.
DR   CleanEx; HS_HOXC9; -.
DR   ExpressionAtlas; P31274; baseline and differential.
DR   Genevisible; P31274; HS.
DR   GO; GO:0016235; C:aggresome; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR006711; Hox9_activation_N.
DR   InterPro; IPR017112; HXA9/HXB9/HXC9.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF04617; Hox9_act; 1.
DR   PIRSF; PIRSF037109; Homeobox_Hox9; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein; DNA-binding;
KW   Homeobox; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    260       Homeobox protein Hox-C9.
FT                                /FTId=PRO_0000200184.
FT   DNA_BIND    192    251       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      87     87       G -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036267.
FT   CONFLICT     47     47       C -> R (in Ref. 2; AK000445).
FT                                {ECO:0000305}.
FT   STRAND      186    188       {ECO:0000244|PDB:2MSY}.
FT   STRAND      194    196       {ECO:0000244|PDB:2LP0}.
FT   HELIX       201    213       {ECO:0000244|PDB:2LP0}.
FT   HELIX       219    228       {ECO:0000244|PDB:2LP0}.
FT   HELIX       233    248       {ECO:0000244|PDB:2LP0}.
SQ   SEQUENCE   260 AA;  29248 MW;  0B278FF94945BC1E CRC64;
     MSATGPISNY YVDSLISHDN EDLLASRFPA TGAHPAAARP SGLVPDCSDF PSCSFAPKPA
     VFSTSWAPVP SQSSVVYHPY GPQPHLGADT RYMRTWLEPL SGAVSFPSFP AGGRHYALKP
     DAYPGRRADC GPGEGRSYPD YMYGSPGELR DRAPQTLPSP EADALAGSKH KEEKADLDPS
     NPVANWIHAR STRKKRCPYT KYQTLELEKE FLFNMYLTRD RRYEVARVLN LTERQVKIWF
     QNRRMKMKKM NKEKTDKEQS
//
ID   HXD10_HUMAN             Reviewed;         340 AA.
AC   P28358; Q6NT10;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   25-OCT-2017, entry version 159.
DE   RecName: Full=Homeobox protein Hox-D10;
DE   AltName: Full=Homeobox protein Hox-4D;
DE   AltName: Full=Homeobox protein Hox-4E;
GN   Name=HOXD10; Synonyms=HOX4D, HOX4E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spinal cord;
RX   PubMed=1756725;
RA   Zappavigna V., Renucci A., Izpisua-Belmonte J.-C., Urier G.,
RA   Peschle C., Duboule D.;
RT   "HOX4 genes encode transcription factors with potential auto- and
RT   cross-regulatory capacities.";
RL   EMBO J. 10:4177-4187(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1351871; DOI=10.1016/0888-7543(92)90263-R;
RA   Redline R.W., Williams A.J., Patterson P., Collins T.;
RT   "Human HOX4E: a gene strongly expressed in the adult male and female
RT   urogenital tracts.";
RL   Genomics 13:425-430(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 266-331.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [5]
RP   VARIANT CVT LYS-319.
RX   PubMed=15146389; DOI=10.1086/422015;
RA   Shrimpton A.E., Levinsohn E.M., Yozawitz J.M., Packard D.S. Jr.,
RA   Cady R.B., Middleton F.A., Persico A.M., Hootnick D.R.;
RT   "A HOX gene mutation in a family with isolated congenital vertical
RT   talus and Charcot-Marie-Tooth disease.";
RL   Am. J. Hum. Genet. 75:92-96(2004).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       O14893:GEMIN2; NbExp=4; IntAct=EBI-12690664, EBI-443648;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in the adult male and
CC       female urogenital tracts.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the developing limb buds.
CC   -!- DISEASE: Vertical talus, congenital (CVT) [MIM:192950]: A rare
CC       malformation characterized by vertical orientation of the talus
CC       with a rigid dorsal dislocation of the navicular, equinus
CC       deformity of the calcaneus, abduction deformity of the forefoot,
CC       and contracture of the soft tissues of the hind- and mid-foot.
CC       This condition is usually associated with multiple other
CC       congenital deformities and only rarely is an isolated deformity
CC       with familial occurrence. {ECO:0000269|PubMed:15146389}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59373; CAA42017.1; -; mRNA.
DR   EMBL; BC069619; AAH69619.1; -; mRNA.
DR   EMBL; BC074760; AAH74760.1; -; mRNA.
DR   CCDS; CCDS2266.1; -.
DR   PIR; A42008; A42008.
DR   PIR; S18650; S18650.
DR   RefSeq; NP_002139.2; NM_002148.3.
DR   UniGene; Hs.123070; -.
DR   ProteinModelPortal; P28358; -.
DR   SMR; P28358; -.
DR   BioGrid; 109476; 5.
DR   IntAct; P28358; 1.
DR   STRING; 9606.ENSP00000249501; -.
DR   iPTMnet; P28358; -.
DR   PhosphoSitePlus; P28358; -.
DR   BioMuta; HOXD10; -.
DR   DMDM; 143811403; -.
DR   MaxQB; P28358; -.
DR   PaxDb; P28358; -.
DR   PeptideAtlas; P28358; -.
DR   PRIDE; P28358; -.
DR   DNASU; 3236; -.
DR   Ensembl; ENST00000249501; ENSP00000249501; ENSG00000128710.
DR   GeneID; 3236; -.
DR   KEGG; hsa:3236; -.
DR   UCSC; uc002ukj.4; human.
DR   CTD; 3236; -.
DR   DisGeNET; 3236; -.
DR   EuPathDB; HostDB:ENSG00000128710.5; -.
DR   GeneCards; HOXD10; -.
DR   HGNC; HGNC:5133; HOXD10.
DR   HPA; HPA065871; -.
DR   MalaCards; HOXD10; -.
DR   MIM; 142984; gene+phenotype.
DR   MIM; 192950; phenotype.
DR   neXtProt; NX_P28358; -.
DR   OpenTargets; ENSG00000128710; -.
DR   Orphanet; 295203; Congenital vertical talus, bilateral.
DR   Orphanet; 295201; Congenital vertical talus, unilateral.
DR   PharmGKB; PA29407; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231182; -.
DR   HOVERGEN; HBG052934; -.
DR   InParanoid; P28358; -.
DR   KO; K09295; -.
DR   OMA; NPRGSAK; -.
DR   OrthoDB; EOG091G0LON; -.
DR   PhylomeDB; P28358; -.
DR   TreeFam; TF317819; -.
DR   SIGNOR; P28358; -.
DR   GeneWiki; HOXD10; -.
DR   GenomeRNAi; 3236; -.
DR   PRO; PR:P28358; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128710; -.
DR   CleanEx; HS_HOXD10; -.
DR   Genevisible; P28358; HS.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0035136; P:forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0050905; P:neuromuscular process; IEA:Ensembl.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0007338; P:single fertilization; IEA:Ensembl.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    340       Homeobox protein Hox-D10.
FT                                /FTId=PRO_0000200226.
FT   DNA_BIND    266    325       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28359}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28359}.
FT   VARIANT     319    319       M -> K (in CVT; also in Charcot-Marie-
FT                                Tooth disease-like foot deformities;
FT                                dbSNP:rs104893634).
FT                                {ECO:0000269|PubMed:15146389}.
FT                                /FTId=VAR_022582.
FT   CONFLICT    150    150       G -> R (in Ref. 1; CAA42017).
FT                                {ECO:0000305}.
SQ   SEQUENCE   340 AA;  38411 MW;  FA6DB8C9DD97D7C9 CRC64;
     MSFPNSSPAA NTFLVDSLIS ACRSDSFYSS SASMYMPPPS ADMGTYGMQT CGLLPSLAKR
     EVNHQNMGMN VHPYIPQVDS WTDPNRSCRI EQPVTQQVPT CSFTTNIKEE SNCCMYSDKR
     NKLISAEVPS YQRLVPESCP VENPEVPVPG YFRLSQTYAT GKTQEYNNSP EGSSTVMLQL
     NPRGAAKPQL SAAQLQMEKK MNEPVSGQEP TKVSQVESPE AKGGLPEERS CLAEVSVSSP
     EVQEKESKEE IKSDTPTSNW LTAKSGRKKR CPYTKHQTLE LEKEFLFNMY LTRERRLEIS
     KSVNLTDRQV KIWFQNRRMK LKKMSRENRI RELTANLTFS
//
ID   HXD12_HUMAN             Reviewed;         270 AA.
AC   P35452; B5MCP0; Q0VAD7; Q0VAD8; Q9NS03;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   25-OCT-2017, entry version 152.
DE   RecName: Full=Homeobox protein Hox-D12;
DE   AltName: Full=Homeobox protein Hox-4H;
GN   Name=HOXD12; Synonyms=HOX4H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Miwa N., Yoshiura K., Kantaputra P.K., Soeda E., Niikawa N.;
RT   "The role of HOXD11 and HOXD12 for the mesomelic dysplasia Kantaptra
RT   type.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLN-186.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 202-267.
RX   PubMed=1675198; DOI=10.1016/0888-7543(91)90482-T;
RA   D'Esposito M., Morelli F., Acampora D., Migliaccio E., Simeone A.,
RA   Boncinelli E.;
RT   "EVX2, a human homeobox gene homologous to the even-skipped
RT   segmentation gene, is localized at the 5' end of HOX4 locus on
RT   chromosome 2.";
RL   Genomics 10:43-50(1991).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       Q13077:TRAF1; NbExp=3; IntAct=EBI-10206752, EBI-359224;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35452-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35452-2; Sequence=VSP_056816;
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF154915; AAF79044.1; -; Genomic_DNA.
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11094.1; -; Genomic_DNA.
DR   EMBL; BC121103; AAI21104.1; -; mRNA.
DR   EMBL; BC121104; AAI21105.1; -; mRNA.
DR   CCDS; CCDS46456.1; -. [P35452-1]
DR   PIR; C39065; C39065.
DR   RefSeq; NP_067016.3; NM_021193.3. [P35452-1]
DR   UniGene; Hs.450028; -.
DR   ProteinModelPortal; P35452; -.
DR   SMR; P35452; -.
DR   BioGrid; 109478; 7.
DR   IntAct; P35452; 1.
DR   STRING; 9606.ENSP00000385586; -.
DR   iPTMnet; P35452; -.
DR   PhosphoSitePlus; P35452; -.
DR   BioMuta; HOXD12; -.
DR   DMDM; 259016345; -.
DR   PaxDb; P35452; -.
DR   PeptideAtlas; P35452; -.
DR   PRIDE; P35452; -.
DR   Ensembl; ENST00000406506; ENSP00000385586; ENSG00000170178. [P35452-1]
DR   GeneID; 3238; -.
DR   KEGG; hsa:3238; -.
DR   UCSC; uc010zev.2; human. [P35452-1]
DR   CTD; 3238; -.
DR   DisGeNET; 3238; -.
DR   EuPathDB; HostDB:ENSG00000170178.6; -.
DR   GeneCards; HOXD12; -.
DR   H-InvDB; HIX0029976; -.
DR   HGNC; HGNC:5135; HOXD12.
DR   HPA; HPA059444; -.
DR   MIM; 142988; gene.
DR   neXtProt; NX_P35452; -.
DR   OpenTargets; ENSG00000170178; -.
DR   PharmGKB; PA29409; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140879; -.
DR   HOGENOM; HOG000231177; -.
DR   HOVERGEN; HBG052050; -.
DR   InParanoid; P35452; -.
DR   KO; K09297; -.
DR   OMA; KFYAPEA; -.
DR   OrthoDB; EOG091G0P35; -.
DR   PhylomeDB; P35452; -.
DR   TreeFam; TF351604; -.
DR   SIGNOR; P35452; -.
DR   GeneWiki; HOXD12; -.
DR   GenomeRNAi; 3238; -.
DR   PRO; PR:P35452; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170178; -.
DR   CleanEx; HS_HOXD12; -.
DR   ExpressionAtlas; P35452; baseline and differential.
DR   Genevisible; P35452; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    270       Homeobox protein Hox-D12.
FT                                /FTId=PRO_0000200238.
FT   DNA_BIND    202    261       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ     193    270       LPWGAAPGRARKKRKPYTKQQIAELENEFLVNEFINRQKRK
FT                                ELSNRLNLSDQQVKIWFQNRRMKKKRVVLREQALALY ->
FT                                KRCPCSPGRFGPGWEVGFKGECKGR (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056816.
FT   VARIANT     186    186       R -> Q (in dbSNP:rs35817516).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_071211.
FT   CONFLICT     33     47       GGQLAALPPISYPRG -> AASLAFPLSPTRA (in Ref.
FT                                1; AAF79044). {ECO:0000305}.
FT   CONFLICT     50     50       P -> S (in Ref. 4; AAI21105).
FT                                {ECO:0000305}.
FT   CONFLICT     62     64       QPA -> TC (in Ref. 1; AAF79044).
FT                                {ECO:0000305}.
FT   CONFLICT     81     84       GPLG -> ASR (in Ref. 1; AAF79044).
FT                                {ECO:0000305}.
FT   CONFLICT    193    201       LPWGAAPGR -> KRCPCSPGRPAVGGGPGE (in Ref.
FT                                1; AAF79044). {ECO:0000305}.
SQ   SEQUENCE   270 AA;  29031 MW;  224D53783405A162 CRC64;
     MCERSLYRAG YVGSLLNLQS PDSFYFSNLR PNGGQLAALP PISYPRGALP WAATPASCAP
     AQPAGATAFG GFSQPYLAGS GPLGLQPPTA KDGPEEQAKF YAPEAAAGPE ERGRTRPSFA
     PESSLAPAVA ALKAAKYDYA GVGRATPGST TLLQGAPCAP GFKDDTKGPL NLNMTVQAAG
     VASCLRPSLP DGLPWGAAPG RARKKRKPYT KQQIAELENE FLVNEFINRQ KRKELSNRLN
     LSDQQVKIWF QNRRMKKKRV VLREQALALY
//
ID   HXA3_HUMAN              Reviewed;         443 AA.
AC   O43365; A4D181;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 158.
DE   RecName: Full=Homeobox protein Hox-A3;
DE   AltName: Full=Homeobox protein Hox-1E;
GN   Name=HOXA3; Synonyms=HOX1E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-42 AND THR-131.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       O15145:ARPC3; NbExp=5; IntAct=EBI-8643838, EBI-351829;
CC       Q15437:SEC23B; NbExp=4; IntAct=EBI-8643838, EBI-742673;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004079; AAS00376.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24225.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93865.1; -; Genomic_DNA.
DR   EMBL; BC015180; AAH15180.1; -; mRNA.
DR   CCDS; CCDS5404.1; -.
DR   RefSeq; NP_109377.1; NM_030661.4.
DR   RefSeq; NP_705895.1; NM_153631.2.
DR   RefSeq; XP_005249787.1; XM_005249730.2.
DR   RefSeq; XP_005249788.1; XM_005249731.2.
DR   RefSeq; XP_005249789.1; XM_005249732.3.
DR   RefSeq; XP_006715778.1; XM_006715715.2.
DR   RefSeq; XP_011513645.1; XM_011515343.2.
DR   UniGene; Hs.659337; -.
DR   UniGene; Hs.732333; -.
DR   ProteinModelPortal; O43365; -.
DR   SMR; O43365; -.
DR   BioGrid; 109440; 9.
DR   IntAct; O43365; 6.
DR   STRING; 9606.ENSP00000324884; -.
DR   iPTMnet; O43365; -.
DR   PhosphoSitePlus; O43365; -.
DR   BioMuta; HOXA3; -.
DR   MaxQB; O43365; -.
DR   PaxDb; O43365; -.
DR   PeptideAtlas; O43365; -.
DR   PRIDE; O43365; -.
DR   DNASU; 3200; -.
DR   Ensembl; ENST00000317201; ENSP00000324884; ENSG00000105997.
DR   Ensembl; ENST00000396352; ENSP00000379640; ENSG00000105997.
DR   Ensembl; ENST00000612286; ENSP00000484411; ENSG00000105997.
DR   GeneID; 3200; -.
DR   KEGG; hsa:3200; -.
DR   UCSC; uc003syk.3; human.
DR   CTD; 3200; -.
DR   DisGeNET; 3200; -.
DR   EuPathDB; HostDB:ENSG00000105997.22; -.
DR   GeneCards; HOXA3; -.
DR   HGNC; HGNC:5104; HOXA3.
DR   HPA; HPA029157; -.
DR   MIM; 142954; gene.
DR   neXtProt; NX_O43365; -.
DR   OpenTargets; ENSG00000105997; -.
DR   PharmGKB; PA29381; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000252944; -.
DR   HOVERGEN; HBG107984; -.
DR   InParanoid; O43365; -.
DR   KO; K09303; -.
DR   OMA; VEPMSNS; -.
DR   OrthoDB; EOG091G0PFO; -.
DR   PhylomeDB; O43365; -.
DR   TreeFam; TF315938; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SignaLink; O43365; -.
DR   ChiTaRS; HOXA3; human.
DR   GeneWiki; HOXA3; -.
DR   GenomeRNAi; 3200; -.
DR   PRO; PR:O43365; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105997; -.
DR   CleanEx; HS_HOXA3; -.
DR   ExpressionAtlas; O43365; baseline and differential.
DR   Genevisible; O43365; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0048645; P:animal organ formation; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl.
DR   GO; GO:0060017; P:parathyroid gland development; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0010159; P:specification of animal organ position; IEA:Ensembl.
DR   GO; GO:0048538; P:thymus development; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR025281; DUF4074.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF13293; DUF4074; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    443       Homeobox protein Hox-A3.
FT                                /FTId=PRO_0000200043.
FT   DNA_BIND    191    250       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       155    160       Antp-type hexapeptide.
FT   COMPBIAS     78    137       Pro-rich.
FT   VARIANT      42     42       D -> N (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs764656757).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036264.
FT   VARIANT     131    131       A -> T (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036265.
SQ   SEQUENCE   443 AA;  46369 MW;  365C93E65CA8E8FE CRC64;
     MQKATYYDSS AIYGGYPYQA ANGFAYNANQ QPYPASAALG ADGEYHRPAC SLQSPSSAGG
     HPKAHELSEA CLRTLSAPPS QPPSLGEPPL HPPPPQAAPP APQPPQPAPQ PPAPTPAAPP
     PPSSASPPQN ASNNPTPANA AKSPLLNSPT VAKQIFPWMK ESRQNTKQKT SSSSSGESCA
     GDKSPPGQAS SKRARTAYTS AQLVELEKEF HFNRYLCRPR RVEMANLLNL TERQIKIWFQ
     NRRMKYKKDQ KGKGMLTSSG GQSPSRSPVP PGAGGYLNSM HSLVNSVPYE PQSPPPFSKP
     PQGTYGLPPA SYPASLPSCA PPPPPQKRYT AAGAGAGGTP DYDPHAHGLQ GNGSYGTPHI
     QGSPVFVGGS YVEPMSNSGP ALFGLTHLPH AASGAMDYGG AGPLGSGHHH GPGPGEPHPT
     YTDLTGHHPS QGRIQEAPKL THL
//
ID   HXB5_HUMAN              Reviewed;         269 AA.
AC   P09067; B2RC69; P09069; Q17RP4;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 3.
DT   25-OCT-2017, entry version 171.
DE   RecName: Full=Homeobox protein Hox-B5;
DE   AltName: Full=Homeobox protein HHO.C10;
DE   AltName: Full=Homeobox protein Hox-2A;
DE   AltName: Full=Homeobox protein Hu-1;
GN   Name=HOXB5; Synonyms=HOX2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1355360;
RA   Galang C.K., Hauser C.A.;
RT   "Cooperative DNA binding of the highly conserved human Hox 2.1
RT   homeodomain gene product.";
RL   New Biol. 4:558-568(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kidd K.K., Busygina V., DeMille M.M.C., Speed W.C., Ruggeri V.,
RA   Kidd J.R., Pakstis A.J.;
RT   "Overall linkage disequilibrium in 33 populations for highly
RT   informative multisite haplotypes spanning the HOXB gene cluster.";
RL   Am. J. Hum. Genet. 67:235-235(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 188-269.
RX   PubMed=4075393; DOI=10.1016/0092-8674(85)90008-X;
RA   Hauser C.A., Joyner A.L., Klein R.D., Learned T.K., Martin G.R.,
RA   Tjian R.;
RT   "Expression of homologous homeo-box-containing genes in differentiated
RT   human teratocarcinoma cells and mouse embryos.";
RL   Cell 43:19-28(1985).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 191-269.
RX   PubMed=6091895; DOI=10.1016/0092-8674(84)90261-7;
RA   Levine M., Rubin G.M., Tjian R.;
RT   "Human DNA sequences homologous to a protein coding region conserved
RT   between homeotic genes of Drosophila.";
RL   Cell 38:667-673(1984).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 200-269.
RX   PubMed=3453105; DOI=10.1038/320763a0;
RA   Simeone A., Mavilio F., Bottero L., Giampaolo A., Russo G.,
RA   Faiella A., Boncinelli E., Peschle C.;
RT   "A human homoeo box gene specifically expressed in spinal cord during
RT   embryonic development.";
RL   Nature 320:763-765(1986).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 199-269.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 217-269.
RC   TISSUE=Osteosarcoma;
RA   Waye M.M.Y.;
RT   "Cloning of a homeobox-containing cDNA (HHO.c10 or Hu-1) from a gt11
RT   cDNA library of human osteosarcoma cell MG-63.";
RL   Submitted (FEB-1993) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       P67870:CSNK2B; NbExp=4; IntAct=EBI-3893317, EBI-348169;
CC       Q13363-2:CTBP1; NbExp=3; IntAct=EBI-3893317, EBI-10171858;
CC       P56545-3:CTBP2; NbExp=5; IntAct=EBI-3893317, EBI-10171902;
CC       P43364-2:MAGEA11; NbExp=3; IntAct=EBI-3893317, EBI-10178634;
CC       Q9UJV3-2:MID2; NbExp=4; IntAct=EBI-3893317, EBI-10172526;
CC       P40425:PBX2; NbExp=4; IntAct=EBI-3893317, EBI-348489;
CC       Q9BUZ4:TRAF4; NbExp=4; IntAct=EBI-3893317, EBI-3650647;
CC       P36406:TRIM23; NbExp=5; IntAct=EBI-3893317, EBI-740098;
CC       P14373:TRIM27; NbExp=4; IntAct=EBI-3893317, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Spinal cord.
CC   -!- DEVELOPMENTAL STAGE: Embryo.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52681.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92299; AAA52682.1; -; mRNA.
DR   EMBL; AF287967; AAG31553.1; -; Genomic_DNA.
DR   EMBL; AK314964; BAG37466.1; -; mRNA.
DR   EMBL; BC117247; AAI17248.1; -; mRNA.
DR   EMBL; X03794; CAA27420.1; -; mRNA.
DR   EMBL; K02572; AAA52681.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M86726; AAB59430.1; -; mRNA.
DR   CCDS; CCDS11530.1; -.
DR   PIR; A24777; A24777.
DR   PIR; A45578; A45578.
DR   RefSeq; NP_002138.1; NM_002147.3.
DR   UniGene; Hs.654456; -.
DR   ProteinModelPortal; P09067; -.
DR   SMR; P09067; -.
DR   BioGrid; 109455; 52.
DR   ELM; P09067; -.
DR   IntAct; P09067; 50.
DR   STRING; 9606.ENSP00000239151; -.
DR   iPTMnet; P09067; -.
DR   PhosphoSitePlus; P09067; -.
DR   BioMuta; HOXB5; -.
DR   DMDM; 400000; -.
DR   MaxQB; P09067; -.
DR   PaxDb; P09067; -.
DR   PeptideAtlas; P09067; -.
DR   PRIDE; P09067; -.
DR   Ensembl; ENST00000239151; ENSP00000239151; ENSG00000120075.
DR   GeneID; 3215; -.
DR   KEGG; hsa:3215; -.
DR   UCSC; uc002inr.4; human.
DR   CTD; 3215; -.
DR   DisGeNET; 3215; -.
DR   EuPathDB; HostDB:ENSG00000120075.5; -.
DR   GeneCards; HOXB5; -.
DR   HGNC; HGNC:5116; HOXB5.
DR   HPA; HPA074454; -.
DR   MIM; 142960; gene.
DR   neXtProt; NX_P09067; -.
DR   OpenTargets; ENSG00000120075; -.
DR   PharmGKB; PA29392; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231178; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P09067; -.
DR   KO; K09305; -.
DR   OMA; CATASRE; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P09067; -.
DR   TreeFam; TF316310; -.
DR   GeneWiki; HOXB5; -.
DR   GenomeRNAi; 3215; -.
DR   PRO; PR:P09067; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000120075; -.
DR   CleanEx; HS_HOXB5; -.
DR   Genevisible; P09067; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    269       Homeobox protein Hox-B5.
FT                                /FTId=PRO_0000200128.
FT   DNA_BIND    194    253       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       176    181       Antp-type hexapeptide.
SQ   SEQUENCE   269 AA;  29434 MW;  58197F105DB0F8C4 CRC64;
     MSSYFVNSFS GRYPNGPDYQ LLNYGSGSSL SGSYRDPAAM HTGSYGYNYN GMDLSVNRSS
     ASSSHFGAVG ESSRAFPAPA QEPRFRQAAS SCSLSSPESL PCTNGDSHGA KPSASSPSDQ
     ATSASSSANF TEIDEASASS EPEEAASQLS SPSLARAQPE PMATSTAAPE GQTPQIFPWM
     RKLHISHDMT GPDGKRARTA YTRYQTLELE KEFHFNRYLT RRRRIEIAHA LCLSERQIKI
     WFQNRRMKWK KDNKLKSMSL ATAGSAFQP
//
ID   HXC10_HUMAN             Reviewed;         342 AA.
AC   Q9NYD6; O15219; O15220; Q9BVD5;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Homeobox protein Hox-C10;
DE   AltName: Full=Homeobox protein Hox-3I;
GN   Name=HOXC10; Synonyms=HOX3I;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10835276; DOI=10.1006/jmbi.2000.3782;
RA   de Stanchina E., Gabellini D., Norio P., Giacca M., Peverali F.A.,
RA   Riva S., Falaschi A., Biamonti G.;
RT   "Selection of homeotic proteins for binding to a human DNA replication
RT   origin.";
RL   J. Mol. Biol. 299:667-680(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 94-106 AND 258-297.
RX   PubMed=9357979; DOI=10.1016/S0014-5793(97)01118-6;
RA   Flagiello D., Gibaud A., Dutrillaux B., Poupon M.-F., Malfoy B.;
RT   "Distinct patterns of all-trans retinoic acid dependent expression of
RT   HOXB and HOXC homeogenes in human embryonal and small-cell lung
RT   carcinoma cell lines.";
RL   FEBS Lett. 415:263-267(1997).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8 AND SER-189, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-254, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-254, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-106; LYS-195 AND LYS-254,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF255675; AAF67759.1; -; mRNA.
DR   EMBL; BC001293; AAH01293.1; -; mRNA.
DR   EMBL; X99684; CAA67999.1; -; mRNA.
DR   EMBL; X99685; CAA68000.1; -; mRNA.
DR   CCDS; CCDS8868.1; -.
DR   PIR; B60941; B60941.
DR   RefSeq; NP_059105.2; NM_017409.3.
DR   UniGene; Hs.44276; -.
DR   ProteinModelPortal; Q9NYD6; -.
DR   SMR; Q9NYD6; -.
DR   BioGrid; 109466; 10.
DR   IntAct; Q9NYD6; 4.
DR   STRING; 9606.ENSP00000307321; -.
DR   iPTMnet; Q9NYD6; -.
DR   PhosphoSitePlus; Q9NYD6; -.
DR   BioMuta; HOXC10; -.
DR   MaxQB; Q9NYD6; -.
DR   PaxDb; Q9NYD6; -.
DR   PeptideAtlas; Q9NYD6; -.
DR   PRIDE; Q9NYD6; -.
DR   DNASU; 3226; -.
DR   Ensembl; ENST00000303460; ENSP00000307321; ENSG00000180818.
DR   GeneID; 3226; -.
DR   KEGG; hsa:3226; -.
DR   UCSC; uc001sen.4; human.
DR   CTD; 3226; -.
DR   DisGeNET; 3226; -.
DR   EuPathDB; HostDB:ENSG00000180818.4; -.
DR   GeneCards; HOXC10; -.
DR   HGNC; HGNC:5122; HOXC10.
DR   HPA; HPA053919; -.
DR   MIM; 605560; gene.
DR   neXtProt; NX_Q9NYD6; -.
DR   OpenTargets; ENSG00000180818; -.
DR   PharmGKB; PA29397; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231182; -.
DR   HOVERGEN; HBG052934; -.
DR   InParanoid; Q9NYD6; -.
DR   KO; K17444; -.
DR   OMA; CPRNVTP; -.
DR   OrthoDB; EOG091G0LON; -.
DR   PhylomeDB; Q9NYD6; -.
DR   TreeFam; TF317819; -.
DR   GeneWiki; HOXC10; -.
DR   GenomeRNAi; 3226; -.
DR   PRO; PR:Q9NYD6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000180818; -.
DR   CleanEx; HS_HOXC10; -.
DR   ExpressionAtlas; Q9NYD6; baseline and differential.
DR   Genevisible; Q9NYD6; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0050905; P:neuromuscular process; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    342       Homeobox protein Hox-C10.
FT                                /FTId=PRO_0000200190.
FT   DNA_BIND    268    327       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES       8      8       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     189    189       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    106    106       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    195    195       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CONFLICT    118    118       K -> N (in Ref. 1; AAF67759).
FT                                {ECO:0000305}.
FT   CONFLICT    265    265       A -> G (in Ref. 3; CAA68000).
FT                                {ECO:0000305}.
FT   CONFLICT    271    271       Missing (in Ref. 3; CAA68000).
FT                                {ECO:0000305}.
SQ   SEQUENCE   342 AA;  38073 MW;  BD8127FD43C2A37B CRC64;
     MTCPRNVTPN SYAEPLAAPG GGERYSRSAG MYMQSGSDFN CGVMRGCGLA PSLSKRDEGS
     SPSLALNTYP SYLSQLDSWG DPKAAYRLEQ PVGRPLSSCS YPPSVKEENV CCMYSAEKRA
     KSGPEAALYS HPLPESCLGE HEVPVPSYYR ASPSYSALDK TPHCSGANDF EAPFEQRASL
     NPRAEHLESP QLGGKVSFPE TPKSDSQTPS PNEIKTEQSL AGPKGSPSES EKERAKAADS
     SPDTSDNEAK EEIKAENTTG NWLTAKSGRK KRCPYTKHQT LELEKEFLFN MYLTRERRLE
     ISKTINLTDR QVKIWFQNRR MKLKKMNREN RIRELTSNFN FT
//
ID   HXC8_HUMAN              Reviewed;         242 AA.
AC   P31273; A8K4J4; O15221; O15362;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   25-OCT-2017, entry version 168.
DE   RecName: Full=Homeobox protein Hox-C8;
DE   AltName: Full=Homeobox protein Hox-3A;
GN   Name=HOXC8; Synonyms=HOX3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 64-114 AND 147-195.
RX   PubMed=9357979; DOI=10.1016/S0014-5793(97)01118-6;
RA   Flagiello D., Gibaud A., Dutrillaux B., Poupon M.-F., Malfoy B.;
RT   "Distinct patterns of all-trans retinoic acid dependent expression of
RT   HOXB and HOXC homeogenes in human embryonal and small-cell lung
RT   carcinoma cell lines.";
RL   FEBS Lett. 415:263-267(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 149-214.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [7]
RP   INTERACTION WITH HOMEZ.
RX   PubMed=12925734; DOI=10.1073/pnas.1834010100;
RA   Bayarsaihan D., Enkhmandakh B., Makeyev A., Greally J.M.,
RA   Leckman J.F., Ruddle F.H.;
RT   "Homez, a homeobox leucine zipper gene specific to the vertebrate
RT   lineage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10358-10363(2003).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBUNIT: Interacts with SMAD1 and HOMEZ.
CC       {ECO:0000269|PubMed:12925734}.
CC   -!- INTERACTION:
CC       Q9H2G9:BLZF1; NbExp=4; IntAct=EBI-1752118, EBI-2548012;
CC       Q6A162:KRT40; NbExp=4; IntAct=EBI-1752118, EBI-10171697;
CC       Q5SW96:LDLRAP1; NbExp=4; IntAct=EBI-1752118, EBI-747813;
CC       P26367:PAX6; NbExp=4; IntAct=EBI-1752118, EBI-747278;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY014300; AAG42146.1; -; Genomic_DNA.
DR   EMBL; AY014299; AAG42146.1; JOINED; Genomic_DNA.
DR   EMBL; AK290959; BAF83648.1; -; mRNA.
DR   EMBL; CH471054; EAW96743.1; -; Genomic_DNA.
DR   EMBL; BC053898; AAH53898.1; -; mRNA.
DR   EMBL; X99680; CAA67996.1; -; mRNA.
DR   EMBL; X99681; CAA67997.1; -; mRNA.
DR   CCDS; CCDS8870.1; -.
DR   PIR; S15534; S15534.
DR   RefSeq; NP_073149.1; NM_022658.3.
DR   UniGene; Hs.664500; -.
DR   ProteinModelPortal; P31273; -.
DR   SMR; P31273; -.
DR   BioGrid; 109464; 19.
DR   CORUM; P31273; -.
DR   DIP; DIP-52312N; -.
DR   ELM; P31273; -.
DR   IntAct; P31273; 89.
DR   MINT; MINT-2802457; -.
DR   STRING; 9606.ENSP00000040584; -.
DR   iPTMnet; P31273; -.
DR   PhosphoSitePlus; P31273; -.
DR   BioMuta; HOXC8; -.
DR   DMDM; 13124745; -.
DR   MaxQB; P31273; -.
DR   PaxDb; P31273; -.
DR   PeptideAtlas; P31273; -.
DR   PRIDE; P31273; -.
DR   DNASU; 3224; -.
DR   Ensembl; ENST00000040584; ENSP00000040584; ENSG00000037965.
DR   GeneID; 3224; -.
DR   KEGG; hsa:3224; -.
DR   UCSC; uc001ser.4; human.
DR   CTD; 3224; -.
DR   DisGeNET; 3224; -.
DR   EuPathDB; HostDB:ENSG00000037965.5; -.
DR   GeneCards; HOXC8; -.
DR   HGNC; HGNC:5129; HOXC8.
DR   HPA; CAB037020; -.
DR   HPA; HPA028911; -.
DR   MIM; 142970; gene.
DR   neXtProt; NX_P31273; -.
DR   OpenTargets; ENSG00000037965; -.
DR   PharmGKB; PA29404; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P31273; -.
DR   KO; K09308; -.
DR   OMA; FHHGTSS; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P31273; -.
DR   TreeFam; TF316310; -.
DR   SignaLink; P31273; -.
DR   SIGNOR; P31273; -.
DR   ChiTaRS; HOXC8; human.
DR   GeneWiki; HOXC8; -.
DR   GenomeRNAi; 3224; -.
DR   PRO; PR:P31273; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000037965; -.
DR   CleanEx; HS_HOXC8; -.
DR   Genevisible; P31273; HS.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    242       Homeobox protein Hox-C8.
FT                                /FTId=PRO_0000200180.
FT   DNA_BIND    149    208       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       138    143       Antp-type hexapeptide.
FT   CONFLICT    165    165       E -> Q (in Ref. 6; CAA67997).
FT                                {ECO:0000305}.
SQ   SEQUENCE   242 AA;  27755 MW;  30C1FD06228833FC CRC64;
     MSSYFVNPLF SKYKAGESLE PAYYDCRFPQ SVGRSHALVY GPGGSAPGFQ HASHHVQDFF
     HHGTSGISNS GYQQNPCSLS CHGDASKFYG YEALPRQSLY GAQQEASVVQ YPDCKSSANT
     NSSEGQGHLN QNSSPSLMFP WMRPHAPGRR SGRQTYSRYQ TLELEKEFLF NPYLTRKRRI
     EVSHALGLTE RQVKIWFQNR RMKWKKENNK DKLPGARDEE KVEEEGNEEE EKEEEEKEEN
     KD
//
ID   HXD3_HUMAN              Reviewed;         432 AA.
AC   P31249; Q99955; Q9BSC5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 3.
DT   25-OCT-2017, entry version 177.
DE   RecName: Full=Homeobox protein Hox-D3;
DE   AltName: Full=Homeobox protein Hox-4A;
GN   Name=HOXD3; Synonyms=HOX1D, HOX4A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1358204; DOI=10.1016/0167-4781(92)90173-W;
RA   Taniguchi Y., Fujii A., Moriuchi T.;
RT   "Cloning and sequencing of the human homeobox gene HOX4A.";
RL   Biochim. Biophys. Acta 1132:332-334(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Cianetti L.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 194-259.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-3957655, EBI-3957603;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-17 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA01891.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D11117; BAA01891.1; ALT_INIT; Genomic_DNA.
DR   EMBL; Y09980; CAA71102.1; -; Genomic_DNA.
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005124; AAH05124.1; -; mRNA.
DR   EMBL; BC008789; AAH08789.1; -; mRNA.
DR   CCDS; CCDS2270.1; -.
DR   PIR; S15548; S15548.
DR   PIR; S27198; S27198.
DR   RefSeq; NP_008829.3; NM_006898.4.
DR   RefSeq; XP_005246566.1; XM_005246509.3.
DR   RefSeq; XP_005246567.1; XM_005246510.4.
DR   RefSeq; XP_005246568.1; XM_005246511.3.
DR   RefSeq; XP_005246570.1; XM_005246513.4.
DR   RefSeq; XP_006712540.1; XM_006712477.2.
DR   RefSeq; XP_011509367.1; XM_011511065.2.
DR   RefSeq; XP_011509368.1; XM_011511066.2.
DR   UniGene; Hs.93574; -.
DR   ProteinModelPortal; P31249; -.
DR   SMR; P31249; -.
DR   BioGrid; 109472; 4.
DR   IntAct; P31249; 6.
DR   STRING; 9606.ENSP00000249440; -.
DR   iPTMnet; P31249; -.
DR   PhosphoSitePlus; P31249; -.
DR   BioMuta; HOXD3; -.
DR   DMDM; 224471887; -.
DR   PaxDb; P31249; -.
DR   PeptideAtlas; P31249; -.
DR   PRIDE; P31249; -.
DR   DNASU; 3232; -.
DR   Ensembl; ENST00000249440; ENSP00000249440; ENSG00000128652.
DR   Ensembl; ENST00000410016; ENSP00000386498; ENSG00000128652.
DR   GeneID; 3232; -.
DR   KEGG; hsa:3232; -.
DR   UCSC; uc002ukt.2; human.
DR   CTD; 3232; -.
DR   DisGeNET; 3232; -.
DR   EuPathDB; HostDB:ENSG00000128652.11; -.
DR   GeneCards; HOXD3; -.
DR   HGNC; HGNC:5137; HOXD3.
DR   HPA; HPA051831; -.
DR   HPA; HPA063671; -.
DR   MIM; 142980; gene.
DR   neXtProt; NX_P31249; -.
DR   OpenTargets; ENSG00000128652; -.
DR   PharmGKB; PA29411; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000252944; -.
DR   HOVERGEN; HBG107984; -.
DR   InParanoid; P31249; -.
DR   KO; K09303; -.
DR   OMA; YGYSTPH; -.
DR   OrthoDB; EOG091G0PFO; -.
DR   PhylomeDB; P31249; -.
DR   TreeFam; TF315938; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SIGNOR; P31249; -.
DR   GeneWiki; HOXD3; -.
DR   GenomeRNAi; 3232; -.
DR   PRO; PR:P31249; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128652; -.
DR   CleanEx; HS_HOXD3; -.
DR   ExpressionAtlas; P31249; baseline and differential.
DR   Genevisible; P31249; HS.
DR   GO; GO:0016235; C:aggresome; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IC:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; ISS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB.
DR   GO; GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0030878; P:thyroid gland development; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IMP:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR025281; DUF4074.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF13293; DUF4074; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    432       Homeobox protein Hox-D3.
FT                                /FTId=PRO_0000200204.
FT   DNA_BIND    194    253       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       160    165       Antp-type hexapeptide.
FT   COMPBIAS    100    104       Poly-Gly.
FT   COMPBIAS    116    124       Poly-Pro.
FT   COMPBIAS    150    153       Poly-Ser.
FT   VARIANT     129    129       S -> C (in dbSNP:rs1051932).
FT                                /FTId=VAR_011881.
FT   CONFLICT    257    257       G -> A (in Ref. 5). {ECO:0000305}.
SQ   SEQUENCE   432 AA;  45730 MW;  BC962D2AA076B87B CRC64;
     MLFEQGQQAL ELPECTMQKA AYYENPGLFG GYGYSKTTDT YGYSTPHQPY PPPAAASSLD
     TDYPGSACSI QSSAPLRAPA HKGAELNGSC MRPGTGNSQG GGGGSQPPGL NSEQQPPQPP
     PPPPTLPPSS PTNPGGGVPA KKPKGGPNAS SSSATISKQI FPWMKESRQN SKQKNSCATA
     GESCEDKSPP GPASKRVRTA YTSAQLVELE KEFHFNRYLC RPRRVEMANL LNLTERQIKI
     WFQNRRMKYK KDQKAKGILH SPASQSPERS PPLGGAAGHV AYSGQLPPVP GLAYDAPSPP
     AFAKSQPNMY GLAAYTAPLS SCLPQQKRYA APEFEPHPMA SNGGGFASAN LQGSPVYVGG
     NFVESMAPAS GPVFNLGHLS HPSSASVDYS CAAQIPGNHH HGPCDPHPTY TDLSAHHSSQ
     GRLPEAPKLT HL
//
ID   HXD9_HUMAN              Reviewed;         352 AA.
AC   P28356; Q86ST1;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 5.
DT   25-OCT-2017, entry version 154.
DE   RecName: Full=Homeobox protein Hox-D9;
DE   AltName: Full=Homeobox protein Hox-4C;
DE   AltName: Full=Homeobox protein Hox-5.2;
GN   Name=HOXD9; Synonyms=HOX4C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spinal cord;
RX   PubMed=1756725;
RA   Zappavigna V., Renucci A., Izpisua-Belmonte J.-C., Urier G.,
RA   Peschle C., Duboule D.;
RT   "HOX4 genes encode transcription factors with potential auto- and
RT   cross-regulatory capacities.";
RL   EMBO J. 10:4177-4187(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 274-352.
RX   PubMed=2568311; DOI=10.1101/gad.3.5.641;
RA   Oliver G., Sidell N., Fiske N., Heinzmann C., Mohandas T.,
RA   Sparkes R.S., De Robertis E.M.;
RT   "Complementary homeo protein gradients in developing limb buds.";
RL   Genes Dev. 3:641-650(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 285-350.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANT GLN-269 DEL.
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the developing limb buds.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-11 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH44855.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA42016.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59372; CAA42016.1; ALT_INIT; mRNA.
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC044855; AAH44855.2; ALT_INIT; mRNA.
DR   EMBL; X15506; CAA33528.1; -; Genomic_DNA.
DR   CCDS; CCDS2267.2; -.
DR   PIR; S18649; S18649.
DR   RefSeq; NP_055028.3; NM_014213.3.
DR   UniGene; Hs.236646; -.
DR   ProteinModelPortal; P28356; -.
DR   SMR; P28356; -.
DR   BioGrid; 109475; 9.
DR   IntAct; P28356; 3.
DR   STRING; 9606.ENSP00000249499; -.
DR   iPTMnet; P28356; -.
DR   PhosphoSitePlus; P28356; -.
DR   BioMuta; HOXD9; -.
DR   DMDM; 294862543; -.
DR   MaxQB; P28356; -.
DR   PaxDb; P28356; -.
DR   PeptideAtlas; P28356; -.
DR   PRIDE; P28356; -.
DR   Ensembl; ENST00000249499; ENSP00000249499; ENSG00000128709.
DR   GeneID; 3235; -.
DR   KEGG; hsa:3235; -.
DR   UCSC; uc010zex.3; human.
DR   CTD; 3235; -.
DR   DisGeNET; 3235; -.
DR   EuPathDB; HostDB:ENSG00000128709.11; -.
DR   GeneCards; HOXD9; -.
DR   HGNC; HGNC:5140; HOXD9.
DR   HPA; HPA068683; -.
DR   MIM; 142982; gene.
DR   neXtProt; NX_P28356; -.
DR   OpenTargets; ENSG00000128709; -.
DR   PharmGKB; PA29414; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231180; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P28356; -.
DR   KO; K09294; -.
DR   OMA; SGLYHPY; -.
DR   OrthoDB; EOG091G0LON; -.
DR   PhylomeDB; P28356; -.
DR   TreeFam; TF317819; -.
DR   SIGNOR; P28356; -.
DR   GeneWiki; HOXD9; -.
DR   GenomeRNAi; 3235; -.
DR   PRO; PR:P28356; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128709; -.
DR   CleanEx; HS_HOXD9; -.
DR   Genevisible; P28356; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0007338; P:single fertilization; IEA:Ensembl.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR006711; Hox9_activation_N.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF04617; Hox9_act; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    352       Homeobox protein Hox-D9.
FT                                /FTId=PRO_0000200220.
FT   DNA_BIND    285    344       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    125    159       Gly-rich.
FT   COMPBIAS    131    140       Poly-Gly.
FT   COMPBIAS    175    188       Ser/Thr-rich.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     269    269       Missing. {ECO:0000269|PubMed:11857506}.
FT                                /FTId=VAR_031851.
FT   CONFLICT    144    156       GPSPGPSGPANGR -> VPALAPAAQPTGC (in Ref.
FT                                3; AAH44855). {ECO:0000305}.
FT   CONFLICT    219    224       AATGGT -> GGDGGN (in Ref. 1; CAA42016).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       A -> E (in Ref. 1; CAA42016).
FT                                {ECO:0000305}.
SQ   SEQUENCE   352 AA;  36495 MW;  ECBFE68B48C0F532 CRC64;
     MLGGSAGRLK MSSSGTLSNY YVDSLIGHEG DEVFAARFGP PGPGAQGRPA GVADGPAATA
     AEFASCSFAP RSAVFSASWS AVPSQPPAAA AMSGLYHPYV PPPPLAASAS EPGRYVRSWM
     EPLPGFPGGA GGGGGGGGGG PGRGPSPGPS GPANGRHYGI KPETRAAPAP ATAASTTSSS
     STSLSSSSKR TECSVARESQ GSSGPEFSCN SFLQEKAAAA TGGTGPGAGI GAATGTGGSS
     EPSACSDHPI PGCSLKEEEK QHSQPQQQQL DPNNPAANWI HARSTRKKRC PYTKYQTLEL
     EKEFLFNMYL TRDRRYEVAR ILNLTERQVK IWFQNRRMKM KKMSKEKCPK GD
//
ID   HXA2_HUMAN              Reviewed;         376 AA.
AC   O43364; A1L4K3; B2RMW3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=Homeobox protein Hox-A2;
DE   AltName: Full=Homeobox protein Hox-1K;
GN   Name=HOXA2; Synonyms=HOX1K;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN MCRT.
RX   PubMed=23775976; DOI=10.1002/humu.22367;
RA   Brown K.K., Viana L.M., Helwig C.C., Artunduaga M.A.,
RA   Quintanilla-Dieck L., Jarrin P., Osorno G., McDonough B.,
RA   Depalma S.R., Eavey R.D., Seidman J.G., Seidman C.E.;
RT   "HOXA2 haploinsufficiency in dominant bilateral microtia and hearing
RT   loss.";
RL   Hum. Mutat. 34:1347-1351(2013).
RN   [6]
RP   VARIANT MHICP LYS-186.
RX   PubMed=18394579; DOI=10.1016/j.ajhg.2008.02.015;
RA   Alasti F., Sadeghi A., Sanati M.H., Farhadi M., Stollar E., Somers T.,
RA   Van Camp G.;
RT   "A mutation in HOXA2 is responsible for autosomal-recessive microtia
RT   in an Iranian family.";
RL   Am. J. Hum. Genet. 82:982-991(2008).
RN   [7]
RP   ERRATUM.
RA   Alasti F., Sadeghi A., Sanati M.H., Farhadi M., Stollar E., Somers T.,
RA   Van Camp G.;
RL   Am. J. Hum. Genet. 83:424-424(2008).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Microtia, hearing impairment, and cleft palate (MHICP)
CC       [MIM:612290]: A disease characterized by microtia, mixed symmetric
CC       severe to profound hearing impairment, and partial cleft palate.
CC       Microtia is a congenital deformity of the outer ear that is small
CC       and abnormally shaped. In classic microtia, the pinna is
CC       essentially absent, except for a vertical sausage-shaped skin
CC       remnant. The superior aspect of this sausage-shaped skin remnant
CC       consists of underlying unorganized cartilage, and the inferior
CC       aspect of this remnant consists of a relatively well-formed
CC       lobule. Syndromic forms of microtia occur in conjunction with
CC       other abnormalities including cleft palate, a congenital fissure
CC       of the soft and/or hard palate due to faulty fusion.
CC       {ECO:0000269|PubMed:18394579}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Microtia with or without hearing impairment (MCRT)
CC       [MIM:612290]: Microtia is a congenital deformity of the outer ear
CC       that is small and abnormally shaped. In classic microtia, the
CC       pinna is essentially absent, except for a vertical sausage-shaped
CC       skin remnant. The superior aspect of this sausage-shaped skin
CC       remnant consists of underlying unorganized cartilage, and the
CC       inferior aspect of this remnant consists of a relatively well-
CC       formed lobule. {ECO:0000269|PubMed:23775976}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Proboscipedia
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004079; AAS00375.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24227.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93864.1; -; Genomic_DNA.
DR   EMBL; BC130571; AAI30572.1; -; mRNA.
DR   EMBL; BC136500; AAI36501.1; -; mRNA.
DR   CCDS; CCDS5403.1; -.
DR   RefSeq; NP_006726.1; NM_006735.3.
DR   UniGene; Hs.445239; -.
DR   UniGene; Hs.592177; -.
DR   ProteinModelPortal; O43364; -.
DR   SMR; O43364; -.
DR   BioGrid; 109439; 5.
DR   STRING; 9606.ENSP00000222718; -.
DR   iPTMnet; O43364; -.
DR   PhosphoSitePlus; O43364; -.
DR   BioMuta; HOXA2; -.
DR   PaxDb; O43364; -.
DR   PeptideAtlas; O43364; -.
DR   PRIDE; O43364; -.
DR   Ensembl; ENST00000222718; ENSP00000222718; ENSG00000105996.
DR   GeneID; 3199; -.
DR   KEGG; hsa:3199; -.
DR   UCSC; uc003syh.4; human.
DR   CTD; 3199; -.
DR   DisGeNET; 3199; -.
DR   EuPathDB; HostDB:ENSG00000105996.6; -.
DR   GeneCards; HOXA2; -.
DR   HGNC; HGNC:5103; HOXA2.
DR   HPA; HPA078220; -.
DR   MalaCards; HOXA2; -.
DR   MIM; 604685; gene.
DR   MIM; 612290; phenotype.
DR   neXtProt; NX_O43364; -.
DR   OpenTargets; ENSG00000105996; -.
DR   Orphanet; 93976; Anotia.
DR   Orphanet; 140963; Bilateral microtia - deafness - cleft palate.
DR   Orphanet; 83463; Microtia.
DR   PharmGKB; PA29380; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000063664; -.
DR   HOVERGEN; HBG006088; -.
DR   InParanoid; O43364; -.
DR   KO; K09302; -.
DR   OMA; NCGSGLN; -.
DR   OrthoDB; EOG091G0IJ4; -.
DR   PhylomeDB; O43364; -.
DR   TreeFam; TF317730; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   GeneWiki; HOXA2; -.
DR   GenomeRNAi; 3199; -.
DR   PRO; PR:O43364; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105996; -.
DR   CleanEx; HS_HOXA2; -.
DR   Genevisible; O43364; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    376       Homeobox protein Hox-A2.
FT                                /FTId=PRO_0000200036.
FT   DNA_BIND    143    202       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF        94     99       Antp-type hexapeptide.
FT   VARIANT     186    186       Q -> K (in MHICP; dbSNP:rs119489104).
FT                                {ECO:0000269|PubMed:18394579}.
FT                                /FTId=VAR_048023.
SQ   SEQUENCE   376 AA;  41002 MW;  78EB388FE1EEAD72 CRC64;
     MNYEFEREIG FINSQPSLAE CLTSFPPVAD TFQSSSIKTS TLSHSTLIPP PFEQTIPSLN
     PGSHPRHGAG GRPKPSPAGS RGSPVPAGAL QPPEYPWMKE KKAAKKTALL PAAAAAATAA
     ATGPACLSHK ESLEIADGSG GGSRRLRTAY TNTQLLELEK EFHFNKYLCR PRRVEIAALL
     DLTERQVKVW FQNRRMKHKR QTQCKENQNS EGKCKSLEDS EKVEEDEEEK TLFEQALSVS
     GALLEREGYT FQQNALSQQQ APNGHNGDSQ SFPVSPLTSN EKNLKHFQHQ SPTVPNCLST
     MGQNCGAGLN NDSPEALEVP SLQDFSVFST DSCLQLSDAV SPSLPGSLDS PVDISADSLD
     FFTDTLTTID LQHLNY
//
ID   HXA4_HUMAN              Reviewed;         320 AA.
AC   Q00056; A4D180; O43366;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   25-OCT-2017, entry version 162.
DE   RecName: Full=Homeobox protein Hox-A4;
DE   AltName: Full=Homeobox protein Hox-1.4;
DE   AltName: Full=Homeobox protein Hox-1D;
GN   Name=HOXA4; Synonyms=HOX1D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PRO-70 AND PRO-140.
RX   PubMed=1675427; DOI=10.1128/MCB.11.7.3573;
RA   Buettner R., Yim S.O., Hong Y.S., Boncinelli E., Tainsky M.A.;
RT   "Alteration of homeobox gene expression by N-ras transformation of PA-
RT   1 human teratocarcinoma cells.";
RL   Mol. Cell. Biol. 11:3573-3583(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1981366; DOI=10.1111/j.1432-0436.1990.tb00458.x;
RA   Peverali F.A., D'Esposito M., Acampora D., Bunone G., Negri M.,
RA   Faiella A., Stornaiuolo A., Pannese M., Migliaccio E., Simeone A.,
RA   Valle G.D., Boncinelli E.;
RT   "Expression of HOX homeogenes in human neuroblastoma cell culture
RT   lines.";
RL   Differentiation 45:61-69(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 215-280.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 205-277.
RX   PubMed=2571574; DOI=10.1016/0888-7543(89)90054-2;
RA   Ferguson-Smith A.C., Fienberg A., Ruddle F.H.;
RT   "Isolation, chromosomal localization, and nucleotide sequence of the
RT   human HOX 1.4 homeobox.";
RL   Genomics 5:250-258(1989).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-37.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Binds to sites in the 5'-flanking sequence of its coding region
CC       with various affinities. The consensus sequences of the high and
CC       low affinity binding sites are 5'-TAATGA[CG]-3' and 5'-CTAATTTT-
CC       3'.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Embryonic nervous system.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Deformed
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M74297; AAA58664.1; -; mRNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93872.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24224.1; -; Genomic_DNA.
DR   EMBL; M28199; AAA53290.1; -; Genomic_DNA.
DR   CCDS; CCDS5405.1; -.
DR   PIR; A39724; A39724.
DR   RefSeq; NP_002132.3; NM_002141.4.
DR   UniGene; Hs.533357; -.
DR   UniGene; Hs.721126; -.
DR   ProteinModelPortal; Q00056; -.
DR   SMR; Q00056; -.
DR   BioGrid; 109441; 1.
DR   STRING; 9606.ENSP00000353151; -.
DR   iPTMnet; Q00056; -.
DR   PhosphoSitePlus; Q00056; -.
DR   BioMuta; HOXA4; -.
DR   DMDM; 116242514; -.
DR   MaxQB; Q00056; -.
DR   PaxDb; Q00056; -.
DR   PeptideAtlas; Q00056; -.
DR   PRIDE; Q00056; -.
DR   DNASU; 3201; -.
DR   Ensembl; ENST00000360046; ENSP00000353151; ENSG00000197576.
DR   Ensembl; ENST00000428284; ENSP00000408845; ENSG00000197576.
DR   Ensembl; ENST00000610970; ENSP00000479166; ENSG00000197576.
DR   GeneID; 3201; -.
DR   KEGG; hsa:3201; -.
DR   UCSC; uc003sym.4; human.
DR   CTD; 3201; -.
DR   DisGeNET; 3201; -.
DR   EuPathDB; HostDB:ENSG00000197576.13; -.
DR   GeneCards; HOXA4; -.
DR   HGNC; HGNC:5105; HOXA4.
DR   HPA; HPA060088; -.
DR   MIM; 142953; gene.
DR   neXtProt; NX_Q00056; -.
DR   OpenTargets; ENSG00000197576; -.
DR   PharmGKB; PA29382; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231179; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; Q00056; -.
DR   KO; K09304; -.
DR   OMA; YYAPRTA; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; Q00056; -.
DR   TreeFam; TF352857; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   GeneWiki; HOXA4; -.
DR   GenomeRNAi; 3201; -.
DR   PRO; PR:Q00056; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000197576; -.
DR   CleanEx; HS_HOXA4; -.
DR   ExpressionAtlas; Q00056; baseline and differential.
DR   Genevisible; Q00056; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    320       Homeobox protein Hox-A4.
FT                                /FTId=PRO_0000200048.
FT   DNA_BIND    215    274       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       194    199       Antp-type hexapeptide.
FT   COMPBIAS     15    192       Pro-rich (part of the transcriptional
FT                                activation domain).
FT   VARIANT      37     37       G -> D (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036266.
FT   VARIANT      70     70       T -> P (in dbSNP:rs6944345).
FT                                {ECO:0000269|PubMed:1675427}.
FT                                /FTId=VAR_028414.
FT   VARIANT     140    140       L -> P (in dbSNP:rs10251056).
FT                                {ECO:0000269|PubMed:1675427}.
FT                                /FTId=VAR_028415.
FT   VARIANT     178    178       L -> F (in dbSNP:rs13246088).
FT                                /FTId=VAR_028416.
FT   VARIANT     251    251       T -> P (in dbSNP:rs6976847).
FT                                /FTId=VAR_028417.
FT   VARIANT     317    317       P -> S (in dbSNP:rs17500757).
FT                                /FTId=VAR_028418.
FT   CONFLICT    108    108       A -> P (in Ref. 1; AAA58664).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       A -> S (in Ref. 7; AAA53290).
FT                                {ECO:0000305}.
FT   CONFLICT    275    276       KL -> NC (in Ref. 7; AAA53290).
FT                                {ECO:0000305}.
SQ   SEQUENCE   320 AA;  34499 MW;  D9B9C98901B06FE4 CRC64;
     MTMSSFLINS NYIEPKFPPF EEYAQHSGSG GADGGPGGGP GYQQPPAPPT QHLPLQQPQL
     PHAGGGREPT ASYYAPRTAR EPAYPAAALY PAHGAADTAY PYGYRGGASP GRPPQPEQPP
     AQAKGPAHGL HASHVLQPQL PPPLQPRAVP PAAPRRCEAA PATPGVPAGG SAPACPLLLA
     DKSPLGLKGK EPVVYPWMKK IHVSAVNPSY NGGEPKRSRT AYTRQQVLEL EKEFHFNRYL
     TRRRRIEIAH TLCLSERQVK IWFQNRRMKW KKDHKLPNTK MRSSNSASAS AGPPGKAQTQ
     SPHLHPHPHP STSTPVPSSI
//
ID   HXB6_HUMAN              Reviewed;         224 AA.
AC   P17509; A8K835; D3DTV5; P09068; Q9HB11; Q9UGH2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 4.
DT   25-OCT-2017, entry version 179.
DE   RecName: Full=Homeobox protein Hox-B6;
DE   AltName: Full=Homeobox protein Hox-2.2;
DE   AltName: Full=Homeobox protein Hox-2B;
DE   AltName: Full=Homeobox protein Hu-2;
GN   Name=HOXB6; Synonyms=HOX2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Placenta;
RX   PubMed=1672751; DOI=10.1093/nar/19.3.539;
RA   Shen W.-F., Detmer K., Simonitch-Eason T.A., Lawrence H.J.,
RA   Largman C.;
RT   "Alternative splicing of the HOX 2.2 homeobox gene in human
RT   hematopoietic cells and murine embryonic and adult tissues.";
RL   Nucleic Acids Res. 19:539-545(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Frezza D., D'Esposito M., Migliaccio E., Santini S.M., Fruscalzo A.;
RT   "Expression of HOX genes in T lymphocytes and hairy leukemia cell
RT   lines.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kidd K.K., Busygina V., DeMille M.M.C., Speed W.C., Ruggeri V.,
RA   Kidd J.R., Pakstis A.J.;
RT   "Overall linkage disequilibrium in 33 populations for highly
RT   informative multisite haplotypes spanning the HOXB gene cluster.";
RL   Am. J. Hum. Genet. 67:235-235(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 135-224.
RX   PubMed=2573064; DOI=10.1073/pnas.86.21.8536;
RA   Shen W.-F., Largman C., Lowney P., Corral J.C., Detmer K.,
RA   Hauser C.A., Simonitch T.A., Hack F.M., Lawrence H.J.;
RT   "Lineage-restricted expression of homeobox-containing genes in human
RT   hematopoietic cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8536-8540(1989).
RN   [8]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE OF 136-224.
RX   PubMed=6091895; DOI=10.1016/0092-8674(84)90261-7;
RA   Levine M., Rubin G.M., Tjian R.;
RT   "Human DNA sequences homologous to a protein coding region conserved
RT   between homeotic genes of Drosophila.";
RL   Cell 38:667-673(1984).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- INTERACTION:
CC       P49761:CLK3; NbExp=5; IntAct=EBI-741308, EBI-745579;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P17509-1; Sequence=Displayed;
CC       Name=2; Synonyms=Homeobox-less;
CC         IsoId=P17509-2; Sequence=VSP_002388, VSP_002389;
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58431; CAA41335.1; -; Genomic_DNA.
DR   EMBL; X58431; CAA41336.1; -; Genomic_DNA.
DR   EMBL; AJ270993; CAB65909.1; -; mRNA.
DR   EMBL; AF287967; AAG31552.1; -; Genomic_DNA.
DR   EMBL; AK292200; BAF84889.1; -; mRNA.
DR   EMBL; CH471109; EAW94728.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94729.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94730.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94731.1; -; Genomic_DNA.
DR   EMBL; BC014651; AAH14651.1; -; mRNA.
DR   EMBL; M30597; AAA36004.1; -; mRNA.
DR   EMBL; K02571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS11531.1; -. [P17509-1]
DR   PIR; A05266; A05266.
DR   PIR; S26400; S26400.
DR   RefSeq; NP_061825.2; NM_018952.4. [P17509-1]
DR   RefSeq; XP_005257340.1; XM_005257283.3. [P17509-1]
DR   RefSeq; XP_005257341.1; XM_005257284.3. [P17509-1]
DR   UniGene; Hs.98428; -.
DR   ProteinModelPortal; P17509; -.
DR   SMR; P17509; -.
DR   BioGrid; 109456; 31.
DR   ELM; P17509; -.
DR   IntAct; P17509; 9.
DR   MINT; MINT-1437085; -.
DR   STRING; 9606.ENSP00000225648; -.
DR   iPTMnet; P17509; -.
DR   PhosphoSitePlus; P17509; -.
DR   BioMuta; HOXB6; -.
DR   DMDM; 116242515; -.
DR   MaxQB; P17509; -.
DR   PaxDb; P17509; -.
DR   PeptideAtlas; P17509; -.
DR   PRIDE; P17509; -.
DR   DNASU; 3216; -.
DR   Ensembl; ENST00000225648; ENSP00000225648; ENSG00000108511. [P17509-1]
DR   Ensembl; ENST00000484302; ENSP00000420009; ENSG00000108511. [P17509-1]
DR   GeneID; 3216; -.
DR   KEGG; hsa:3216; -.
DR   UCSC; uc002ins.2; human. [P17509-1]
DR   CTD; 3216; -.
DR   DisGeNET; 3216; -.
DR   EuPathDB; HostDB:ENSG00000108511.9; -.
DR   GeneCards; HOXB6; -.
DR   HGNC; HGNC:5117; HOXB6.
DR   HPA; HPA042063; -.
DR   MIM; 142961; gene.
DR   neXtProt; NX_P17509; -.
DR   OpenTargets; ENSG00000108511; -.
DR   PharmGKB; PA29393; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P17509; -.
DR   KO; K09306; -.
DR   OMA; REKDPAC; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P17509; -.
DR   TreeFam; TF316310; -.
DR   SIGNOR; P17509; -.
DR   GeneWiki; HOXB6; -.
DR   GenomeRNAi; 3216; -.
DR   PRO; PR:P17509; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108511; -.
DR   CleanEx; HS_HOXB6; -.
DR   Genevisible; P17509; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    224       Homeobox protein Hox-B6.
FT                                /FTId=PRO_0000200135.
FT   DNA_BIND    146    205       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       127    132       Antp-type hexapeptide.
FT   COMPBIAS    216    220       Poly-Glu.
FT   MOD_RES     214    214       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VAR_SEQ     140    140       S -> E (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002388.
FT   VAR_SEQ     141    224       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002389.
FT   CONFLICT     24     25       QL -> HV (in Ref. 1; CAA41335 and 2;
FT                                CAB65909). {ECO:0000305}.
FT   CONFLICT     33     33       A -> R (in Ref. 1; CAA41335).
FT                                {ECO:0000305}.
FT   CONFLICT     60     60       P -> R (in Ref. 1; CAA41335).
FT                                {ECO:0000305}.
FT   CONFLICT     73     73       D -> A (in Ref. 1; CAA41335).
FT                                {ECO:0000305}.
FT   CONFLICT    149    150       GR -> A (in Ref. 7; AAA36004).
FT                                {ECO:0000305}.
SQ   SEQUENCE   224 AA;  25432 MW;  F60292D4D664099C CRC64;
     MSSYFVNSTF PVTLASGQES FLGQLPLYSS GYADPLRHYP APYGPGPGQD KGFATSSYYP
     PAGGGYGRAA PCDYGPAPAF YREKESACAL SGADEQPPFH PEPRKSDCAQ DKSVFGETEE
     QKCSTPVYPW MQRMNSCNSS SFGPSGRRGR QTYTRYQTLE LEKEFHYNRY LTRRRRIEIA
     HALCLTERQI KIWFQNRRMK WKKESKLLSA SQLSAEEEEE KQAE
//
ID   HXA10_HUMAN             Reviewed;         410 AA.
AC   P31260; O43370; O43605; Q15949; Q504T1;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 3.
DT   25-OCT-2017, entry version 178.
DE   RecName: Full=Homeobox protein Hox-A10;
DE   AltName: Full=Homeobox protein Hox-1.8;
DE   AltName: Full=Homeobox protein Hox-1H;
DE   AltName: Full=PL;
GN   Name=HOXA10; Synonyms=HOX1H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=1676505; DOI=10.1093/nar/19.12.3443;
RA   Lowney P., Corral J.C., Detmer K., Lebeau M.M., Deaven L.,
RA   Lawrence H.J., Largman C.;
RT   "A human Hox 1 homeobox gene exhibits myeloid-specific expression of
RT   alternative transcripts in human hematopoietic cells.";
RL   Nucleic Acids Res. 19:3443-3449(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Mi X., Winters J.L., Stevens D.B., Fleischman R.A.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 2-410 (ISOFORM 1).
RC   TISSUE=Muscle, and Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 318-400.
RX   PubMed=2573064; DOI=10.1073/pnas.86.21.8536;
RA   Shen W.-F., Largman C., Lowney P., Corral J.C., Detmer K.,
RA   Hauser C.A., Simonitch T.A., Hack F.M., Lawrence H.J.;
RT   "Lineage-restricted expression of homeobox-containing genes in human
RT   hematopoietic cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8536-8540(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 336-396.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 349-387.
RX   PubMed=7906121; DOI=10.1016/0006-2952(94)90447-2;
RA   Castronovo V., Kusaka M., Chariot A., Gielen J., Sobel M.;
RT   "Homeobox genes: potential candidates for the transcriptional control
RT   of the transformed and invasive phenotype.";
RL   Biochem. Pharmacol. 47:137-143(1994).
RN   [10]
RP   INTERACTION WITH SIRT2.
RX   PubMed=15213244; DOI=10.1093/jb/mvh084;
RA   Bae N.S., Swanson M.J., Vassilev A., Howard B.H.;
RT   "Human histone deacetylase SIRT2 interacts with the homeobox
RT   transcription factor HOXA10.";
RL   J. Biochem. 135:695-700(2004).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Binds to the DNA sequence 5'-AA[AT]TTTTATTAC-3'.
CC   -!- SUBUNIT: Interacts with SIRT2; the interaction is direct.
CC       {ECO:0000269|PubMed:15213244}.
CC   -!- INTERACTION:
CC       P17947:SPI1; NbExp=2; IntAct=EBI-2293516, EBI-2293548;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PL1;
CC         IsoId=P31260-1; Sequence=Displayed;
CC       Name=2; Synonyms=PL2;
CC         IsoId=P31260-2; Sequence=VSP_002384, VSP_002385;
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB96917.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH13971.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB86198.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58430; CAB86198.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AF040714; AAB96917.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AK312450; BAG35357.1; -; mRNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93885.1; -; Genomic_DNA.
DR   EMBL; BC013971; AAH13971.1; ALT_INIT; mRNA.
DR   EMBL; BC071843; AAH71843.1; -; mRNA.
DR   EMBL; BC094807; AAH94807.1; -; mRNA.
DR   EMBL; M30599; AAA36006.1; -; mRNA.
DR   EMBL; S69027; AAD14030.1; -; mRNA.
DR   EMBL; S69029; AAD14031.1; -; mRNA.
DR   CCDS; CCDS5410.2; -. [P31260-1]
DR   PIR; I65264; I65264.
DR   PIR; I65265; I65265.
DR   PIR; S26402; S26402.
DR   PIR; S28814; S28814.
DR   RefSeq; NP_061824.3; NM_018951.3. [P31260-1]
DR   UniGene; Hs.110637; -.
DR   UniGene; Hs.659350; -.
DR   ProteinModelPortal; P31260; -.
DR   SMR; P31260; -.
DR   BioGrid; 109446; 16.
DR   IntAct; P31260; 8.
DR   MINT; MINT-243009; -.
DR   STRING; 9606.ENSP00000283921; -.
DR   iPTMnet; P31260; -.
DR   PhosphoSitePlus; P31260; -.
DR   BioMuta; HOXA10; -.
DR   DMDM; 294862509; -.
DR   MaxQB; P31260; -.
DR   PaxDb; P31260; -.
DR   PeptideAtlas; P31260; -.
DR   PRIDE; P31260; -.
DR   DNASU; 3206; -.
DR   Ensembl; ENST00000283921; ENSP00000283921; ENSG00000253293. [P31260-1]
DR   Ensembl; ENST00000396344; ENSP00000379633; ENSG00000253293. [P31260-2]
DR   GeneID; 3206; -.
DR   KEGG; hsa:3206; -.
DR   UCSC; uc011jzm.3; human. [P31260-1]
DR   CTD; 3206; -.
DR   DisGeNET; 3206; -.
DR   EuPathDB; HostDB:ENSG00000253293.4; -.
DR   GeneCards; HOXA10; -.
DR   HGNC; HGNC:5100; HOXA10.
DR   HPA; CAB019384; -.
DR   MIM; 142957; gene.
DR   neXtProt; NX_P31260; -.
DR   OpenTargets; ENSG00000253293; -.
DR   PharmGKB; PA29377; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231182; -.
DR   HOVERGEN; HBG052934; -.
DR   InParanoid; P31260; -.
DR   KO; K17443; -.
DR   OMA; CRMEPPE; -.
DR   OrthoDB; EOG091G0DAN; -.
DR   PhylomeDB; P31260; -.
DR   TreeFam; TF317819; -.
DR   SIGNOR; P31260; -.
DR   GeneWiki; Homeobox_A10; -.
DR   GenomeRNAi; 3206; -.
DR   PRO; PR:P31260; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000253293; -.
DR   CleanEx; HS_HOXA10; -.
DR   ExpressionAtlas; P31260; baseline and differential.
DR   Genevisible; P31260; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0007338; P:single fertilization; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; TAS:ProtInc.
DR   GO; GO:0060065; P:uterus development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    410       Homeobox protein Hox-A10.
FT                                /FTId=PRO_0000200090.
FT   DNA_BIND    336    395       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     43     56       Poly-Gly.
FT   COMPBIAS     95    106       Poly-Gly.
FT   COMPBIAS    133    137       Poly-Pro.
FT   COMPBIAS    141    150       Poly-Pro.
FT   COMPBIAS    225    232       Poly-Gly.
FT   COMPBIAS    273    276       Poly-Pro.
FT   VAR_SEQ       1    316       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_002384.
FT   VAR_SEQ     317    319       DSL -> MCQ (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_002385.
FT   CONFLICT     20     20       C -> S (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       L -> W (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT     86     86       G -> R (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    153    154       QA -> HR (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    192    192       P -> R (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    216    216       L -> P (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       G -> A (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    231    231       G -> C (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    234    235       QQ -> HE (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       F -> V (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    248    248       R -> G (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    260    261       SA -> GS (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    292    292       A -> G (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    295    295       S -> R (in Ref. 1; CAB86198).
FT                                {ECO:0000305}.
FT   CONFLICT    349    349       L -> S (in Ref. 9; AAD14031).
FT                                {ECO:0000305}.
FT   CONFLICT    351    351       L -> F (in Ref. 9; AAD14031).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       L -> H (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    359    359       M -> R (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    364    364       E -> R (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    367    367       L -> I (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    370    374       SRSVH -> ANALC (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    377    377       D -> E (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       V -> S (in Ref. 9; AAD14030).
FT                                {ECO:0000305}.
FT   CONFLICT    387    387       R -> P (in Ref. 9; AAD14030/AAD14031).
FT                                {ECO:0000305}.
SQ   SEQUENCE   410 AA;  42414 MW;  E9544C35145FE7A4 CRC64;
     MSARKGYLLP SPNYPTTMSC SESPAANSFL VDSLISSGRG EAGGGGGGAG GGGGGGYYAH
     GGVYLPPAAD LPYGLQSCGL FPTLGGKRNE AASPGSGGGG GGLGPGAHGY GPSPIDLWLD
     APRSCRMEPP DGPPPPPQQQ PPPPPQPPQP APQATSCSFA QNIKEESSYC LYDSADKCPK
     VSATAAELAP FPRGPPPDGC ALGTSSGVPV PGYFRLSQAY GTAKGYGSGG GGAQQLGAGP
     FPAQPPGRGF DLPPALASGS ADAARKERAL DSPPPPTLAC GSGGGSQGDE EAHASSSAAE
     ELSPAPSESS KASPEKDSLG NSKGENAANW LTAKSGRKKR CPYTKHQTLE LEKEFLFNMY
     LTRERRLEIS RSVHLTDRQV KIWFQNRRMK LKKMNRENRI RELTANFNFS
//
ID   HXA5_HUMAN              Reviewed;         270 AA.
AC   P20719; A4D179; O43367; Q96CY6;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2004, sequence version 2.
DT   25-OCT-2017, entry version 164.
DE   RecName: Full=Homeobox protein Hox-A5;
DE   AltName: Full=Homeobox protein Hox-1C;
GN   Name=HOXA5; Synonyms=HOX1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2568583; DOI=10.1128/MCB.9.5.2273;
RA   Tournier-Lasserve E., Odenwald W.F., Garbern J., Trojanowski J.,
RA   Lazzarini R.A.;
RT   "Remarkable intron and exon sequence conservation in human and mouse
RT   homeobox Hox 1.3 genes.";
RL   Mol. Cell. Biol. 9:2273-2278(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 195-260.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Also binds to its own promoter. Binds specifically to the motif
CC       5'-CYYNATTA[TG]Y-3'.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed during embryogenesis and in adult
CC       kidney.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26679; AAA58663.1; -; Genomic_DNA.
DR   EMBL; BT009744; AAP88746.1; -; mRNA.
DR   EMBL; CR542256; CAG47052.1; -; mRNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236948; EAL24223.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93873.1; -; Genomic_DNA.
DR   EMBL; BC013682; AAH13682.1; -; mRNA.
DR   CCDS; CCDS5406.1; -.
DR   PIR; A24777; A24777.
DR   PIR; A32799; WJHU1C.
DR   RefSeq; NP_061975.2; NM_019102.3.
DR   UniGene; Hs.655218; -.
DR   ProteinModelPortal; P20719; -.
DR   SMR; P20719; -.
DR   BioGrid; 109442; 36.
DR   IntAct; P20719; 6.
DR   MINT; MINT-2801671; -.
DR   STRING; 9606.ENSP00000222726; -.
DR   iPTMnet; P20719; -.
DR   PhosphoSitePlus; P20719; -.
DR   BioMuta; HOXA5; -.
DR   DMDM; 52788238; -.
DR   MaxQB; P20719; -.
DR   PaxDb; P20719; -.
DR   PeptideAtlas; P20719; -.
DR   PRIDE; P20719; -.
DR   DNASU; 3202; -.
DR   Ensembl; ENST00000222726; ENSP00000222726; ENSG00000106004.
DR   GeneID; 3202; -.
DR   KEGG; hsa:3202; -.
DR   UCSC; uc003syn.2; human.
DR   CTD; 3202; -.
DR   DisGeNET; 3202; -.
DR   EuPathDB; HostDB:ENSG00000106004.4; -.
DR   GeneCards; HOXA5; -.
DR   H-InvDB; HIX0201165; -.
DR   HGNC; HGNC:5106; HOXA5.
DR   HPA; HPA029319; -.
DR   MIM; 142952; gene.
DR   neXtProt; NX_P20719; -.
DR   OpenTargets; ENSG00000106004; -.
DR   PharmGKB; PA29383; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231178; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P20719; -.
DR   KO; K09305; -.
DR   OMA; LKSMNMA; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P20719; -.
DR   TreeFam; TF316310; -.
DR   SignaLink; P20719; -.
DR   SIGNOR; P20719; -.
DR   GeneWiki; HOXA5; -.
DR   GenomeRNAi; 3202; -.
DR   PRO; PR:P20719; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106004; -.
DR   CleanEx; HS_HOXA5; -.
DR   Genevisible; P20719; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0060435; P:bronchiole development; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IEA:Ensembl.
DR   GO; GO:0060764; P:cell-cell signaling involved in mammary gland development; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl.
DR   GO; GO:0060574; P:intestinal epithelial cell maturation; IEA:Ensembl.
DR   GO; GO:0048286; P:lung alveolus development; IEA:Ensembl.
DR   GO; GO:0060480; P:lung goblet cell differentiation; IEA:Ensembl.
DR   GO; GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl.
DR   GO; GO:0060749; P:mammary gland alveolus development; IEA:Ensembl.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0060638; P:mesenchymal-epithelial cell signaling; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0045647; P:negative regulation of erythrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0045639; P:positive regulation of myeloid cell differentiation; IDA:UniProtKB.
DR   GO; GO:0010870; P:positive regulation of receptor biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0033599; P:regulation of mammary gland epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0003016; P:respiratory system process; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   GO; GO:0060535; P:trachea cartilage morphogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    270       Homeobox protein Hox-A5.
FT                                /FTId=PRO_0000200057.
FT   DNA_BIND    195    254       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       176    181       Antp-type hexapeptide.
FT   CONFLICT    114    114       S -> T (in Ref. 1; AAA58663).
FT                                {ECO:0000305}.
SQ   SEQUENCE   270 AA;  29345 MW;  2093BB73101AFCCC CRC64;
     MSSYFVNSFC GRYPNGPDYQ LHNYGDHSSV SEQFRDSASM HSGRYGYGYN GMDLSVGRSG
     SGHFGSGERA RSYAASASAA PAEPRYSQPA TSTHSPQPDP LPCSAVAPSP GSDSHHGGKN
     SLSNSSGASA DAGSTHISSR EGVGTASGAE EDAPASSEQA SAQSEPSPAP PAQPQIYPWM
     RKLHISHDNI GGPEGKRART AYTRYQTLEL EKEFHFNRYL TRRRRIEIAH ALCLSERQIK
     IWFQNRRMKW KKDNKLKSMS MAAAGGAFRP
//
ID   HXA9_HUMAN              Reviewed;         272 AA.
AC   P31269; O43369; O43429; Q99820;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 4.
DT   25-OCT-2017, entry version 178.
DE   RecName: Full=Homeobox protein Hox-A9;
DE   AltName: Full=Homeobox protein Hox-1G;
GN   Name=HOXA9; Synonyms=HOX1G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RA   Rozenfeld S., Sauvageau G., Largman C.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9880515; DOI=10.1074/jbc.274.3.1415;
RA   Patel C.V., Sharangpani R., Bandyopadhyay S., DiCorleto P.E.;
RT   "Endothelial cells express a novel, tumor necrosis factor-alpha-
RT   regulated variant of HOXA9.";
RL   J. Biol. Chem. 274:1415-1422(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 195-272, AND CHROMOSOMAL TRANSLOCATION
RP   WITH NUP98.
RX   PubMed=8563754; DOI=10.1038/ng0296-159;
RA   Borrow J., Shearman A.M., Stanton V.P., Becher R., Collins T.,
RA   Williams A.J., Dube I., Katz F., Kwong Y.L., Morris C., Ohyashiki K.,
RA   Toyama K., Rowley J., Housman D.E.;
RT   "The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses
RT   the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.";
RL   Nat. Genet. 12:159-167(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 206-271.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [8]
RP   CHROMOSOMAL TRANSLOCATION WITH MSI2.
RX   PubMed=12649177;
RA   Barbouti A., Hoeglund M., Johansson B., Lassen C., Nilsson P.-G.,
RA   Hagemeijer A., Mitelman F., Fioretos T.;
RT   "A novel gene, MSI2, encoding a putative RNA-binding protein is
RT   recurrently rearranged at disease progression of chronic myeloid
RT   leukemia and forms a fusion gene with HOXA9 as a result of the cryptic
RT   t(7;17)(p15;q23).";
RL   Cancer Res. 63:1202-1206(2003).
RN   [9]
RP   FUNCTION, INTERACTION WITH PRMT5, METHYLATION AT ARG-140, MUTAGENESIS
RP   OF ARG-140, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22269951; DOI=10.1128/MCB.05977-11;
RA   Bandyopadhyay S., Harris D.P., Adams G.N., Lause G.E., McHugh A.,
RA   Tillmaand E.G., Money A., Willard B., Fox P.L., Dicorleto P.E.;
RT   "HOXA9 methylation by PRMT5 is essential for endothelial cell
RT   expression of leukocyte adhesion molecules.";
RL   Mol. Cell. Biol. 32:1202-1213(2012).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Required for induction of E-selectin and VCAM-1, on the
CC       endothelial cells surface at sites of inflammation.
CC       {ECO:0000269|PubMed:22269951}.
CC   -!- SUBUNIT: Transiently interacts with PRMT5 in TNF-alpha stimulated
CC       endothelial cells. {ECO:0000269|PubMed:22269951}.
CC   -!- INTERACTION:
CC       O14744:PRMT5; NbExp=4; IntAct=EBI-742314, EBI-351098;
CC       Q15654:TRIP6; NbExp=4; IntAct=EBI-742314, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Methylated on Arg-140 by PRMT5; methylation is critical for
CC       E-selectin induction. {ECO:0000269|PubMed:22269951}.
CC   -!- DISEASE: Note=A chromosomal aberration involving HOXA9 is found in
CC       a form of acute myeloid leukemia. Translocation t(7;11)(p15;p15)
CC       with NUP98.
CC   -!- DISEASE: Note=A chromosomal aberration involving HOXA9 may
CC       contribute to disease progression in chronic myeloid leukemia.
CC       Translocation t(7;17)(p15;q23) with MSI2.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50364.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HOXA9ID61.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U82759; AAB40867.1; -; mRNA.
DR   EMBL; AF010258; AAD08713.1; -; Genomic_DNA.
DR   EMBL; BT006990; AAP35636.1; -; mRNA.
DR   EMBL; AC004080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006537; AAH06537.1; -; mRNA.
DR   EMBL; BC010023; AAH10023.1; -; mRNA.
DR   EMBL; U41813; AAC50364.1; ALT_INIT; mRNA.
DR   CCDS; CCDS5409.1; -.
DR   PIR; S14929; S14929.
DR   RefSeq; NP_689952.1; NM_152739.3.
DR   UniGene; Hs.659350; -.
DR   ProteinModelPortal; P31269; -.
DR   SMR; P31269; -.
DR   BioGrid; 109445; 16.
DR   CORUM; P31269; -.
DR   IntAct; P31269; 8.
DR   MINT; MINT-2802430; -.
DR   STRING; 9606.ENSP00000343619; -.
DR   iPTMnet; P31269; -.
DR   PhosphoSitePlus; P31269; -.
DR   BioMuta; HOXA9; -.
DR   DMDM; 6166219; -.
DR   EPD; P31269; -.
DR   MaxQB; P31269; -.
DR   PaxDb; P31269; -.
DR   PeptideAtlas; P31269; -.
DR   PRIDE; P31269; -.
DR   DNASU; 3205; -.
DR   Ensembl; ENST00000343483; ENSP00000343619; ENSG00000078399.
DR   GeneID; 3205; -.
DR   KEGG; hsa:3205; -.
DR   UCSC; uc003syt.4; human.
DR   CTD; 3205; -.
DR   DisGeNET; 3205; -.
DR   EuPathDB; HostDB:ENSG00000078399.15; -.
DR   GeneCards; HOXA9; -.
DR   HGNC; HGNC:5109; HOXA9.
DR   HPA; HPA061982; -.
DR   MIM; 142956; gene.
DR   neXtProt; NX_P31269; -.
DR   OpenTargets; ENSG00000078399; -.
DR   PharmGKB; PA29386; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231180; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P31269; -.
DR   KO; K21950; -.
DR   OMA; WSHVPAQ; -.
DR   OrthoDB; EOG091G0IP5; -.
DR   PhylomeDB; P31269; -.
DR   TreeFam; TF317819; -.
DR   SignaLink; P31269; -.
DR   SIGNOR; P31269; -.
DR   ChiTaRS; HOXA9; human.
DR   GeneWiki; HOXA9; -.
DR   GenomeRNAi; 3205; -.
DR   PRO; PR:P31269; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000078399; -.
DR   CleanEx; HS_HOXA9; -.
DR   ExpressionAtlas; P31269; baseline and differential.
DR   Genevisible; P31269; HS.
DR   GO; GO:0005634; C:nucleus; IDA:LIFEdb.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0042118; P:endothelial cell activation; IMP:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR006711; Hox9_activation_N.
DR   InterPro; IPR017112; HXA9/HXB9/HXC9.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF04617; Hox9_act; 1.
DR   PIRSF; PIRSF037109; Homeobox_Hox9; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Methylation; Nucleus; Proto-oncogene;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    272       Homeobox protein Hox-A9.
FT                                /FTId=PRO_0000200081.
FT   DNA_BIND    206    265       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   SITE        163    164       Breakpoint for translocation to form
FT                                MSI2/HOXA9 fusion protein.
FT   MOD_RES     140    140       Symmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:22269951}.
FT   MUTAGEN     140    140       R->A: Results in loss of methylation.
FT                                {ECO:0000269|PubMed:22269951}.
FT   CONFLICT     64     64       G -> V (in Ref. 1; AAB40867).
FT                                {ECO:0000305}.
FT   CONFLICT     67     67       W -> R (in Ref. 2; AAD08713).
FT                                {ECO:0000305}.
FT   CONFLICT     80     80       Missing (in Ref. 1; AAB40867).
FT                                {ECO:0000305}.
FT   CONFLICT    243    243       L -> F (in Ref. 1; AAB40867).
FT                                {ECO:0000305}.
SQ   SEQUENCE   272 AA;  30172 MW;  823A1A22BB07A881 CRC64;
     MATTGALGNY YVDSFLLGAD AADELSVGRY APGTLGQPPR QAATLAEHPD FSPCSFQSKA
     TVFGASWNPV HAAGANAVPA AVYHHHHHHP YVHPQAPVAA AAPDGRYMRS WLEPTPGALS
     FAGLPSSRPY GIKPEPLSAR RGDCPTLDTH TLSLTDYACG SPPVDREKQP SEGAFSENNA
     ENESGGDKPP IDPNNPAANW LHARSTRKKR CPYTKHQTLE LEKEFLFNMY LTRDRRYEVA
     RLLNLTERQV KIWFQNRRMK MKKINKDRAK DE
//
ID   HXB13_HUMAN             Reviewed;         284 AA.
AC   Q92826; B2R878; Q96QM4; Q99810;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   25-OCT-2017, entry version 164.
DE   RecName: Full=Homeobox protein Hox-B13;
GN   Name=HOXB13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8756292;
RA   Zeltser L.M., Desplan C., Heintz N.;
RT   "Hoxb-13: a new Hox gene in a distant region of the HOXB cluster
RT   maintains colinearity.";
RL   Development 122:2475-2484(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9665387; DOI=10.1046/j.1523-1747.1998.00238.x;
RA   Stelnicki E.J., Arbeit J., Cass D.L., Saner C., Harrison M.,
RA   Largman C.;
RT   "Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless
RT   fetal wounds.";
RL   J. Invest. Dermatol. 111:57-63(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   STRUCTURE BY NMR OF 216-273.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of human homeo box B13.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [8]
RP   VARIANT MET-41.
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [9]
RP   VARIANT PC GLU-84.
RX   PubMed=22714738; DOI=10.1158/1055-9965.EPI-12-0495;
RA   Breyer J.P., Avritt T.G., McReynolds K.M., Dupont W.D., Smith J.R.;
RT   "Confirmation of the HOXB13 G84E germline mutation in familial
RT   prostate cancer.";
RL   Cancer Epidemiol. Biomarkers Prev. 21:1348-1353(2012).
RN   [10]
RP   INVOLVEMENT IN PC, VARIANT PC GLU-84, AND VARIANTS ASP-88; PRO-144;
RP   CYS-216 AND GLY-229.
RX   PubMed=22236224; DOI=10.1056/NEJMoa1110000;
RA   Ewing C.M., Ray A.M., Lange E.M., Zuhlke K.A., Robbins C.M.,
RA   Tembe W.D., Wiley K.E., Isaacs S.D., Johng D., Wang Y., Bizon C.,
RA   Yan G., Gielzak M., Partin A.W., Shanmugam V., Izatt T., Sinari S.,
RA   Craig D.W., Zheng S.L., Walsh P.C., Montie J.E., Xu J., Carpten J.D.,
RA   Isaacs W.B., Cooney K.A.;
RT   "Germline mutations in HOXB13 and prostate-cancer risk.";
RL   N. Engl. J. Med. 366:141-149(2012).
RN   [11]
RP   INVOLVEMENT IN PC, AND VARIANT PC GLU-84.
RX   PubMed=23292082; DOI=10.1158/1055-9965.EPI-12-1000-T;
RA   Laitinen V.H., Wahlfors T., Saaristo L., Rantapero T., Pelttari L.M.,
RA   Kilpivaara O., Laasanen S.L., Kallioniemi A., Nevanlinna H.,
RA   Aaltonen L., Vessella R.L., Auvinen A., Visakorpi T., Tammela T.L.,
RA   Schleutker J.;
RT   "HOXB13 G84E mutation in Finland: population-based analysis of
RT   prostate, breast, and colorectal cancer risk.";
RL   Cancer Epidemiol. Biomarkers Prev. 22:452-460(2013).
RN   [12]
RP   INVOLVEMENT IN PC, AND VARIANT PC GLU-84.
RX   PubMed=23064873; DOI=10.1007/s00439-012-1229-4;
RG   International Consortium for Prostate Cancer Genetics;
RA   Xu J., Lange E.M., Lu L., Zheng S.L., Wang Z., Thibodeau S.N.,
RA   Cannon-Albright L.A., Teerlink C.C., Camp N.J., Johnson A.M.,
RA   Zuhlke K.A., Stanford J.L., Ostrander E.A., Wiley K.E., Isaacs S.D.,
RA   Walsh P.C., Maier C., Luedeke M., Vogel W., Schleutker J.,
RA   Wahlfors T., Tammela T., Schaid D., McDonnell S.K., DeRycke M.S.,
RA   Cancel-Tassin G., Cussenot O., Wiklund F., Gronberg H., Eeles R.,
RA   Easton D., Kote-Jarai Z., Whittemore A.S., Hsieh C.L., Giles G.G.,
RA   Hopper J.L., Severi G., Catalona W.J., Mandal D., Ledet E.,
RA   Foulkes W.D., Hamel N., Mahle L., Moller P., Powell I.,
RA   Bailey-Wilson J.E., Carpten J.D., Seminara D., Cooney K.A.,
RA   Isaacs W.B.;
RT   "HOXB13 is a susceptibility gene for prostate cancer: results from the
RT   international consortium for prostate cancer genetics (ICPCG).";
RL   Hum. Genet. 132:5-14(2013).
RN   [13]
RP   INVOLVEMENT IN PC, AND VARIANT PC GLU-84.
RX   PubMed=25629170; DOI=10.1371/journal.pgen.1004930;
RA   Hoffmann T.J., Sakoda L.C., Shen L., Jorgenson E., Habel L.A., Liu J.,
RA   Kvale M.N., Asgari M.M., Banda Y., Corley D., Kushi L.H.,
RA   Quesenberry C.P. Jr., Schaefer C., Van Den Eeden S.K., Risch N.,
RA   Witte J.S.;
RT   "Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a
RT   Large Population-Based Cohort.";
RL   PLoS Genet. 11:E1004930-E1004930(2015).
RN   [14]
RP   VARIANT PC GLU-84, AND VARIANT CYS-217.
RX   PubMed=27424772; DOI=10.1038/srep30026;
RA   Liu J., Prager-van der Smissen W.J., Schmidt M.K., Collee J.M.,
RA   Cornelissen S., Lamping R., Nieuwlaat A., Foekens J.A., Hooning M.J.,
RA   Verhoef S., van den Ouweland A.M., Hogervorst F.B., Martens J.W.,
RA   Hollestelle A.;
RT   "Recurrent HOXB13 mutations in the Dutch population do not associate
RT   with increased breast cancer risk.";
RL   Sci. Rep. 6:30026-30026(2016).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy
CC       originating in tissues of the prostate. Most prostate cancers are
CC       adenocarcinomas that develop in the acini of the prostatic ducts.
CC       Other rare histopathologic types of prostate cancer that occur in
CC       approximately 5% of patients include small cell carcinoma,
CC       mucinous carcinoma, prostatic ductal carcinoma, transitional cell
CC       carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid
CC       cystic carcinoma (basaloid), signet-ring cell carcinoma and
CC       neuroendocrine carcinoma. {ECO:0000269|PubMed:22236224,
CC       ECO:0000269|PubMed:22714738, ECO:0000269|PubMed:23064873,
CC       ECO:0000269|PubMed:23292082, ECO:0000269|PubMed:25629170,
CC       ECO:0000269|PubMed:27424772}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U57052; AAC50664.1; -; mRNA.
DR   EMBL; U81599; AAB39863.1; -; mRNA.
DR   EMBL; BT007410; AAP36078.1; -; mRNA.
DR   EMBL; AK313266; BAG36075.1; -; mRNA.
DR   EMBL; CH471109; EAW94714.1; -; Genomic_DNA.
DR   EMBL; BC007092; AAH07092.1; -; mRNA.
DR   EMBL; BC070233; AAH70233.1; -; mRNA.
DR   CCDS; CCDS11536.1; -.
DR   RefSeq; NP_006352.2; NM_006361.5.
DR   UniGene; Hs.66731; -.
DR   PDB; 2CRA; NMR; -; A=217-273.
DR   PDB; 5EDN; X-ray; 3.20 A; A/B/G/J=209-284.
DR   PDB; 5EEA; X-ray; 2.19 A; A/B/G/J=217-279.
DR   PDB; 5EF6; X-ray; 3.00 A; A/B/G/J=217-278.
DR   PDB; 5EG0; X-ray; 3.10 A; B=217-277.
DR   PDB; 5EGO; X-ray; 2.54 A; B=217-277.
DR   PDBsum; 2CRA; -.
DR   PDBsum; 5EDN; -.
DR   PDBsum; 5EEA; -.
DR   PDBsum; 5EF6; -.
DR   PDBsum; 5EG0; -.
DR   PDBsum; 5EGO; -.
DR   ProteinModelPortal; Q92826; -.
DR   SMR; Q92826; -.
DR   BioGrid; 115744; 15.
DR   IntAct; Q92826; 6.
DR   STRING; 9606.ENSP00000290295; -.
DR   iPTMnet; Q92826; -.
DR   PhosphoSitePlus; Q92826; -.
DR   BioMuta; HOXB13; -.
DR   DMDM; 50403792; -.
DR   MaxQB; Q92826; -.
DR   PaxDb; Q92826; -.
DR   PeptideAtlas; Q92826; -.
DR   PRIDE; Q92826; -.
DR   DNASU; 10481; -.
DR   Ensembl; ENST00000290295; ENSP00000290295; ENSG00000159184.
DR   GeneID; 10481; -.
DR   KEGG; hsa:10481; -.
DR   UCSC; uc002ioa.4; human.
DR   CTD; 10481; -.
DR   DisGeNET; 10481; -.
DR   EuPathDB; HostDB:ENSG00000159184.7; -.
DR   GeneCards; HOXB13; -.
DR   HGNC; HGNC:5112; HOXB13.
DR   HPA; CAB004438; -.
DR   HPA; HPA062852; -.
DR   HPA; HPA065019; -.
DR   MalaCards; HOXB13; -.
DR   MIM; 176807; phenotype.
DR   MIM; 604607; gene.
DR   neXtProt; NX_Q92826; -.
DR   OpenTargets; ENSG00000159184; -.
DR   Orphanet; 1331; Familial prostate cancer.
DR   PharmGKB; PA29388; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140879; -.
DR   HOGENOM; HOG000231176; -.
DR   HOVERGEN; HBG106958; -.
DR   InParanoid; Q92826; -.
DR   OMA; GCAFRRG; -.
DR   OrthoDB; EOG091G0E5Q; -.
DR   PhylomeDB; Q92826; -.
DR   TreeFam; TF330813; -.
DR   SIGNOR; Q92826; -.
DR   ChiTaRS; HOXB13; human.
DR   EvolutionaryTrace; Q92826; -.
DR   GeneWiki; HOXB13; -.
DR   GenomeRNAi; 10481; -.
DR   PRO; PR:Q92826; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000159184; -.
DR   CleanEx; HS_HOXB13; -.
DR   Genevisible; Q92826; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0060743; P:epithelial cell maturation involved in prostate gland development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl.
DR   GO; GO:0040008; P:regulation of growth; IEA:Ensembl.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR022067; HoxA13_N.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF12284; HoxA13_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    284       Homeobox protein Hox-B13.
FT                                /FTId=PRO_0000200160.
FT   DNA_BIND    216    275       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      41     41       T -> M (in dbSNP:rs199799743).
FT                                {ECO:0000269|PubMed:11857506}.
FT                                /FTId=VAR_031849.
FT   VARIANT      84     84       G -> E (in PC; rare variant associated
FT                                with disease susceptibility;
FT                                dbSNP:rs138213197).
FT                                {ECO:0000269|PubMed:22236224,
FT                                ECO:0000269|PubMed:22714738,
FT                                ECO:0000269|PubMed:23064873,
FT                                ECO:0000269|PubMed:23292082,
FT                                ECO:0000269|PubMed:25629170,
FT                                ECO:0000269|PubMed:27424772}.
FT                                /FTId=VAR_071866.
FT   VARIANT      88     88       Y -> D (found in prostate cancer samples;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:22236224}.
FT                                /FTId=VAR_071867.
FT   VARIANT     144    144       L -> P (found in prostate cancer samples;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:22236224}.
FT                                /FTId=VAR_071868.
FT   VARIANT     216    216       G -> C (found in prostate cancer samples;
FT                                unknown pathological significance;
FT                                dbSNP:rs375917549).
FT                                {ECO:0000269|PubMed:22236224}.
FT                                /FTId=VAR_071869.
FT   VARIANT     217    217       R -> C (in dbSNP:rs139475791).
FT                                {ECO:0000269|PubMed:27424772}.
FT                                /FTId=VAR_077246.
FT   VARIANT     229    229       R -> G (found in prostate cancer samples;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:22236224}.
FT                                /FTId=VAR_071870.
FT   CONFLICT    138    139       QP -> HA (in Ref. 1 and 2).
FT                                {ECO:0000305}.
FT   CONFLICT    211    211       C -> S (in Ref. 1; AAC50664).
FT                                {ECO:0000305}.
FT   HELIX       225    237       {ECO:0000244|PDB:5EEA}.
FT   HELIX       243    253       {ECO:0000244|PDB:5EEA}.
FT   HELIX       257    275       {ECO:0000244|PDB:5EEA}.
SQ   SEQUENCE   284 AA;  30676 MW;  3EE5898449C33CFE CRC64;
     MEPGNYATLD GAKDIEGLLG AGGGRNLVAH SPLTSHPAAP TLMPAVNYAP LDLPGSAEPP
     KQCHPCPGVP QGTSPAPVPY GYFGGGYYSC RVSRSSLKPC AQAATLAAYP AETPTAGEEY
     PSRPTEFAFY PGYPGTYQPM ASYLDVSVVQ TLGAPGEPRH DSLLPVDSYQ SWALAGGWNS
     QMCCQGEQNP PGPFWKAAFA DSSGQHPPDA CAFRRGRKKR IPYSKGQLRE LEREYAANKF
     ITKDKRRKIS AATSLSERQI TIWFQNRRVK EKKVLAKVKN SATP
//
ID   HXB1_HUMAN              Reviewed;         301 AA.
AC   P14653; Q4VB03;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 2.
DT   27-SEP-2017, entry version 179.
DE   RecName: Full=Homeobox protein Hox-B1;
DE   AltName: Full=Homeobox protein Hox-2I;
GN   Name=HOXB1; Synonyms=HOX2I;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-265.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 203-268, AND VARIANT GLY-265.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 170-266 IN COMPLEX WITH
RP   PBX1.
RX   PubMed=10052460; DOI=10.1016/S0092-8674(00)80662-5;
RA   Piper D.E., Batchelor A.H., Chang C.-P., Cleary M.L., Wolberger C.;
RT   "Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the
RT   hexapeptide and a fourth homeodomain helix in complex formation.";
RL   Cell 96:587-597(1999).
RN   [6]
RP   VARIANT HOXB1*B HIS-SER-ALA-27 INS.
RX   PubMed=10671062;
RA   Faiella A., Zortea M., Barbaria E., Albani F., Capra V., Cama A.,
RA   Boncinelli E.;
RT   "A genetic polymorphism in the human HOXB1 homeobox gene implying a
RT   9bp tandem repeat in the amino-terminal coding region.";
RL   Hum. Mutat. 12:363-363(1998).
RN   [7]
RP   VARIANT HOXB1*B HIS-SER-ALA-27 INS.
RX   PubMed=11091361;
RX   DOI=10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M;
RA   Ingram J.L., Stodgell C.J., Hyman S.L., Figlewicz D.A., Weitkamp L.R.,
RA   Rodier P.M.;
RT   "Discovery of allelic variants of HOXA1 and HOXB1: genetic
RT   susceptibility to autism spectrum disorders.";
RL   Teratology 62:393-405(2000).
RN   [8]
RP   VARIANT HCFP3 CYS-207, AND CHARACTERIZATION OF VARIANT HCFP3 CYS-207.
RX   PubMed=22770981; DOI=10.1016/j.ajhg.2012.05.018;
RA   Webb B.D., Shaaban S., Gaspar H., Cunha L.F., Schubert C.R., Hao K.,
RA   Robson C.D., Chan W.M., Andrews C., Mackinnon S., Oystreck D.T.,
RA   Hunter D.G., Iacovelli A.J., Ye X., Camminady A., Engle E.C.,
RA   Jabs E.W.;
RT   "HOXB1 founder mutation in humans recapitulates the phenotype of
RT   Hoxb1(-/-) mice.";
RL   Am. J. Hum. Genet. 91:171-179(2012).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC       Acts on the anterior body structures.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14653-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14653-2; Sequence=VSP_056813, VSP_056814;
CC         Note=No experimental confirmation available.;
CC   -!- POLYMORPHISM: The two common alleles; HOX1B*A and HOX1B*B have a
CC       frequency of 78.8% and 21.2% respectively.
CC   -!- DISEASE: Facial paresis, hereditary congenital, 3 (HCFP3)
CC       [MIM:614744]: A form of facial paresis, a disease characterized by
CC       isolated dysfunction of the facial nerve (CN VII). HCFP3 patients
CC       are affected by bilateral facial palsy, facial muscle weakness of
CC       muscles innervated by CN VII, hearing loss, and strabismus.
CC       {ECO:0000269|PubMed:22770981}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Labial subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16666; CAA34656.1; -; mRNA.
DR   EMBL; AC103702; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096191; AAH96191.1; -; mRNA.
DR   EMBL; BC099633; AAH99633.1; -; mRNA.
DR   CCDS; CCDS32675.1; -. [P14653-1]
DR   PIR; S07541; WJHU2I.
DR   RefSeq; NP_002135.2; NM_002144.3. [P14653-1]
DR   UniGene; Hs.99992; -.
DR   PDB; 1B72; X-ray; 2.35 A; A=170-264.
DR   PDBsum; 1B72; -.
DR   ProteinModelPortal; P14653; -.
DR   SMR; P14653; -.
DR   BioGrid; 109451; 5.
DR   DIP; DIP-6106N; -.
DR   ELM; P14653; -.
DR   IntAct; P14653; 1.
DR   STRING; 9606.ENSP00000355140; -.
DR   iPTMnet; P14653; -.
DR   PhosphoSitePlus; P14653; -.
DR   BioMuta; HOXB1; -.
DR   DMDM; 251757285; -.
DR   PaxDb; P14653; -.
DR   PRIDE; P14653; -.
DR   Ensembl; ENST00000239174; ENSP00000355140; ENSG00000120094. [P14653-1]
DR   Ensembl; ENST00000577092; ENSP00000459066; ENSG00000120094. [P14653-2]
DR   GeneID; 3211; -.
DR   KEGG; hsa:3211; -.
DR   UCSC; uc002ink.2; human. [P14653-1]
DR   CTD; 3211; -.
DR   DisGeNET; 3211; -.
DR   EuPathDB; HostDB:ENSG00000120094.6; -.
DR   GeneCards; HOXB1; -.
DR   HGNC; HGNC:5111; HOXB1.
DR   HPA; HPA044576; -.
DR   MalaCards; HOXB1; -.
DR   MIM; 142968; gene.
DR   MIM; 614744; phenotype.
DR   neXtProt; NX_P14653; -.
DR   OpenTargets; ENSG00000120094; -.
DR   Orphanet; 306530; Congenital hereditary facial paralysis with variable hearing loss.
DR   PharmGKB; PA29387; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000247020; -.
DR   HOVERGEN; HBG006089; -.
DR   InParanoid; P14653; -.
DR   KO; K09301; -.
DR   OMA; YAICNRG; -.
DR   OrthoDB; EOG091G0LR2; -.
DR   PhylomeDB; P14653; -.
DR   TreeFam; TF317730; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SIGNOR; P14653; -.
DR   EvolutionaryTrace; P14653; -.
DR   GeneWiki; HOXB1; -.
DR   GenomeRNAi; 3211; -.
DR   PRO; PR:P14653; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000120094; -.
DR   CleanEx; HS_HOXB1; -.
DR   Genevisible; P14653; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0021612; P:facial nerve structural organization; IEA:Ensembl.
DR   GO; GO:0021754; P:facial nucleus development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0007389; P:pattern specification process; TAS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0021570; P:rhombomere 4 development; IEA:Ensembl.
DR   GO; GO:0021571; P:rhombomere 5 development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    301       Homeobox protein Hox-B1.
FT                                /FTId=PRO_0000200107.
FT   DNA_BIND    203    262       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       179    184       Antp-type hexapeptide.
FT   VAR_SEQ     193    232       AKVSEPGLGSPSGLRTNFTTRQLTELEKEFHFNKYLSRAR
FT                                -> GRAQMWPPLLRGPKHLCFPCSDMSWVWAGFFSFSGSGR
FT                                HR (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056813.
FT   VAR_SEQ     233    301       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056814.
FT   VARIANT      27     27       A -> AHSA (in allele HOXB1*B).
FT                                {ECO:0000269|PubMed:10671062,
FT                                ECO:0000269|PubMed:11091361}.
FT                                /FTId=VAR_003817.
FT   VARIANT      71     71       T -> N (in dbSNP:rs35254561).
FT                                /FTId=VAR_055959.
FT   VARIANT     103    103       Q -> H (in dbSNP:rs12939811).
FT                                /FTId=VAR_055960.
FT   VARIANT     207    207       R -> C (in HCFP3; decreased
FT                                transactivation activity at low DNA
FT                                concentrations; increased transactivation
FT                                activity at high DNA concentrations
FT                                compared to wild-type;
FT                                dbSNP:rs387907239).
FT                                {ECO:0000269|PubMed:22770981}.
FT                                /FTId=VAR_068723.
FT   VARIANT     265    265       E -> G (in dbSNP:rs7226137).
FT                                {ECO:0000269|PubMed:2574852,
FT                                ECO:0000269|PubMed:2576652}.
FT                                /FTId=VAR_058129.
FT   HELIX       181    184       {ECO:0000244|PDB:1B72}.
FT   HELIX       212    222       {ECO:0000244|PDB:1B72}.
FT   HELIX       230    240       {ECO:0000244|PDB:1B72}.
FT   HELIX       244    262       {ECO:0000244|PDB:1B72}.
SQ   SEQUENCE   301 AA;  32193 MW;  6752A8C28AC55D11 CRC64;
     MDYNRMNSFL EYPLCNRGPS AYSAHSAPTS FPPSSAQAVD SYASEGRYGG GLSSPAFQQN
     SGYPAQQPPS TLGVPFPSSA PSGYAPAACS PSYGPSQYYP LGQSEGDGGY FHPSSYGAQL
     GGLSDGYGAG GAGPGPYPPQ HPPYGNEQTA SFAPAYADLL SEDKETPCPS EPNTPTARTF
     DWMKVKRNPP KTAKVSEPGL GSPSGLRTNF TTRQLTELEK EFHFNKYLSR ARRVEIAATL
     ELNETQVKIW FQNRRMKQKK REREEGRVPP APPGCPKEAA GDASDQSTCT SPEASPSSVT
     S
//
ID   HXB3_HUMAN              Reviewed;         431 AA.
AC   P14651; A8K567; B7Z5N8; B7Z5P8; B7ZAD0; D3DTV3; O95615; P17484;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=Homeobox protein Hox-B3;
DE   AltName: Full=Homeobox protein Hox-2.7;
DE   AltName: Full=Homeobox protein Hox-2G;
GN   Name=HOXB3; Synonyms=HOX2G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-82.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-82.
RA   Sauvageau G., Thorsteinsdottir U., Hough M.R., Hugo P., Lawrence H.J.,
RA   Largman C., Humphries R.K.;
RT   "Deregulated expression of HoxB3 in hematopoietic cells causes
RT   defective development of alpha beta T Lymphocytes and progressive
RT   myeloproliferation.";
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-82.
RA   Kidd K.K., Busygina V., DeMille M.M.C., Speed W.C., Ruggeri V.,
RA   Kidd J.R., Pakstis A.J.;
RT   "Overall linkage disequilibrium in 33 populations for highly
RT   informative multisite haplotypes spanning the HOXB gene cluster.";
RL   Am. J. Hum. Genet. 67:235-235(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-82.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 188-253.
RC   TISSUE=Placenta;
RX   PubMed=2570724; DOI=10.1111/j.1432-0436.1989.tb00598.x;
RA   Giampaolo A., Acampora D., Zappavigna V., Pannese M., D'Esposito M.,
RA   Care A., Faiella A., Stornaiuolo A., Russo G., Simeone A.,
RA   Boncinelli E., Peschle C.;
RT   "Differential expression of human HOX-2 genes along the anterior-
RT   posterior axis in embryonic central nervous system.";
RL   Differentiation 40:191-197(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 188-253.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P14651-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14651-2; Sequence=VSP_056434;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P14651-3; Sequence=VSP_056815;
CC         Note=No experimental confirmation available.;
CC   -!- DEVELOPMENTAL STAGE: Expressed in whole embryos and fetuses at 5-9
CC       weeks from conception.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16667; CAA34657.1; -; mRNA.
DR   EMBL; U59298; AAD10852.1; -; mRNA.
DR   EMBL; AF287967; AAG31555.1; -; Genomic_DNA.
DR   EMBL; AK291182; BAF83871.1; -; mRNA.
DR   EMBL; AK299226; BAH12974.1; -; mRNA.
DR   EMBL; AK299265; BAH12984.1; -; mRNA.
DR   EMBL; AK315102; BAG37563.1; -; mRNA.
DR   EMBL; AK316245; BAH14616.1; -; mRNA.
DR   EMBL; AC103702; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94739.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94740.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94741.1; -; Genomic_DNA.
DR   EMBL; X16175; CAA34297.1; -; Genomic_DNA.
DR   CCDS; CCDS11528.1; -. [P14651-1]
DR   CCDS; CCDS82153.1; -. [P14651-3]
DR   CCDS; CCDS82154.1; -. [P14651-2]
DR   PIR; S07543; WJHU2G.
DR   RefSeq; NP_001317251.1; NM_001330322.1. [P14651-2]
DR   RefSeq; NP_001317252.1; NM_001330323.1. [P14651-3]
DR   RefSeq; NP_002137.4; NM_002146.4. [P14651-1]
DR   RefSeq; XP_005257334.1; XM_005257277.3. [P14651-1]
DR   RefSeq; XP_006721917.1; XM_006721854.2. [P14651-1]
DR   RefSeq; XP_011523012.1; XM_011524710.1. [P14651-1]
DR   RefSeq; XP_011523021.1; XM_011524719.1. [P14651-1]
DR   RefSeq; XP_011523022.1; XM_011524720.2. [P14651-1]
DR   RefSeq; XP_011523028.1; XM_011524726.2. [P14651-2]
DR   UniGene; Hs.654560; -.
DR   UniGene; Hs.675434; -.
DR   UniGene; Hs.687723; -.
DR   ProteinModelPortal; P14651; -.
DR   SMR; P14651; -.
DR   BioGrid; 109453; 2.
DR   ELM; P14651; -.
DR   STRING; 9606.ENSP00000308252; -.
DR   iPTMnet; P14651; -.
DR   PhosphoSitePlus; P14651; -.
DR   BioMuta; HOXB3; -.
DR   DMDM; 215274007; -.
DR   PaxDb; P14651; -.
DR   PeptideAtlas; P14651; -.
DR   PRIDE; P14651; -.
DR   DNASU; 3213; -.
DR   Ensembl; ENST00000311626; ENSP00000308252; ENSG00000120093. [P14651-1]
DR   Ensembl; ENST00000460160; ENSP00000418035; ENSG00000120093. [P14651-3]
DR   Ensembl; ENST00000470495; ENSP00000417207; ENSG00000120093. [P14651-1]
DR   Ensembl; ENST00000472863; ENSP00000419676; ENSG00000120093. [P14651-2]
DR   Ensembl; ENST00000476342; ENSP00000418892; ENSG00000120093. [P14651-1]
DR   Ensembl; ENST00000489475; ENSP00000418729; ENSG00000120093. [P14651-2]
DR   Ensembl; ENST00000498678; ENSP00000420595; ENSG00000120093. [P14651-1]
DR   GeneID; 3213; -.
DR   KEGG; hsa:3213; -.
DR   UCSC; uc002inn.4; human. [P14651-1]
DR   CTD; 3213; -.
DR   DisGeNET; 3213; -.
DR   EuPathDB; HostDB:ENSG00000120093.11; -.
DR   GeneCards; HOXB3; -.
DR   HGNC; HGNC:5114; HOXB3.
DR   HPA; CAB009860; -.
DR   HPA; HPA064990; -.
DR   MIM; 142966; gene.
DR   neXtProt; NX_P14651; -.
DR   OpenTargets; ENSG00000120093; -.
DR   PharmGKB; PA29390; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000252944; -.
DR   HOVERGEN; HBG107984; -.
DR   InParanoid; P14651; -.
DR   KO; K09303; -.
DR   OMA; EYEPHVL; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P14651; -.
DR   TreeFam; TF315938; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SIGNOR; P14651; -.
DR   ChiTaRS; HOXB3; human.
DR   GeneWiki; HOXB3; -.
DR   GenomeRNAi; 3213; -.
DR   PRO; PR:P14651; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000120093; -.
DR   CleanEx; HS_HOXB3; -.
DR   ExpressionAtlas; P14651; baseline and differential.
DR   Genevisible; P14651; HS.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0060324; P:face development; IEA:Ensembl.
DR   GO; GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0021546; P:rhombomere development; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR025281; DUF4074.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF13293; DUF4074; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    431       Homeobox protein Hox-B3.
FT                                /FTId=PRO_0000200117.
FT   DNA_BIND    188    247       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       129    134       Antp-type hexapeptide.
FT   COMPBIAS    154    178       Gly-rich.
FT   VAR_SEQ       1    132       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056815.
FT   VAR_SEQ       1     73       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056434.
FT   VARIANT      82     82       P -> T (in dbSNP:rs2229304).
FT                                {ECO:0000269|PubMed:2574852,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.3,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_047729.
FT   CONFLICT    100    100       T -> A (in Ref. 4; BAH12984).
FT                                {ECO:0000305}.
FT   CONFLICT    199    200       QL -> HV (in Ref. 2; AAD10852).
FT                                {ECO:0000305}.
SQ   SEQUENCE   431 AA;  44340 MW;  56D39C0C9496E65A CRC64;
     MQKATYYDNA AAALFGGYSS YPGSNGFGFD VPPQPPFQAA THLEGDYQRS ACSLQSLGNA
     APHAKSKELN GSCMRPGLAP EPLSAPPGSP PPSAAPTSAT SNSSNGGGPS KSGPPKCGPG
     TNSTLTKQIF PWMKESRQTS KLKNNSPGTA EGCGGGGGGG GGGGSGGSGG GGGGGGGGDK
     SPPGSAASKR ARTAYTSAQL VELEKEFHFN RYLCRPRRVE MANLLNLSER QIKIWFQNRR
     MKYKKDQKAK GLASSSGGPS PAGSPPQPMQ STAGFMNALH SMTPSYESPS PPAFGKAHQN
     AYALPSNYQP PLKGCGAPQK YPPTPAPEYE PHVLQANGGA YGTPTMQGSP VYVGGGGYAD
     PLPPPAGPSL YGLNHLSHHP SGNLDYNGAP PMAPSQHHGP CEPHPTYTDL SSHHAPPPQG
     RIQEAPKLTH L
//
ID   HXB4_HUMAN              Reviewed;         251 AA.
AC   P17483; Q9NTA0;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   25-OCT-2017, entry version 170.
DE   RecName: Full=Homeobox protein Hox-B4;
DE   AltName: Full=Homeobox protein Hox-2.6;
DE   AltName: Full=Homeobox protein Hox-2F;
GN   Name=HOXB4; Synonyms=HOX2F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1981366; DOI=10.1111/j.1432-0436.1990.tb00458.x;
RA   Peverali F.A., D'Esposito M., Acampora D., Bunone G., Negri M.,
RA   Faiella A., Stornaiuolo A., Pannese M., Migliaccio E., Simeone A.,
RA   Valle G.D., Boncinelli E.;
RT   "Expression of HOX homeogenes in human neuroblastoma cell culture
RT   lines.";
RL   Differentiation 45:61-69(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kidd K.K., Busygina V., DeMille M.M.C., Speed W.C., Ruggeri V.,
RA   Kidd J.R., Pakstis A.J.;
RT   "Overall linkage disequilibrium in 33 populations for highly
RT   informative multisite haplotypes spanning the HOXB gene cluster.";
RL   Am. J. Hum. Genet. 67:235-235(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11085749; DOI=10.1084/jem.192.10.1479;
RA   Giannola D.M., Shlomchik W.D., Jegathesan M., Liebowitz D.,
RA   Abrams C.S., Kadesch T., Dancis A., Emerson S.G.;
RT   "Hematopoietic expression of HOXB4 is regulated in normal and leukemic
RT   stem cells through transcriptional activation of the HOXB4 promoter by
RT   upstream stimulating factor (USF)-1 and USF-2.";
RL   J. Exp. Med. 192:1479-1490(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-251.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 160-227.
RC   TISSUE=Placenta;
RX   PubMed=2570724; DOI=10.1111/j.1432-0436.1989.tb00598.x;
RA   Giampaolo A., Acampora D., Zappavigna V., Pannese M., D'Esposito M.,
RA   Care A., Faiella A., Stornaiuolo A., Russo G., Simeone A.,
RA   Boncinelli E., Peschle C.;
RT   "Differential expression of human HOX-2 genes along the anterior-
RT   posterior axis in embryonic central nervous system.";
RL   Differentiation 40:191-197(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 162-227.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed in whole embryos and fetuses at 5-9
CC       weeks from conception.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. Deformed
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16174; CAA34296.1; -; Genomic_DNA.
DR   EMBL; AF287967; AAG31554.1; -; Genomic_DNA.
DR   EMBL; AF307160; AAG45052.1; -; Genomic_DNA.
DR   EMBL; BC049204; AAH49204.1; -; mRNA.
DR   EMBL; AL137449; CAB70742.1; -; mRNA.
DR   CCDS; CCDS11529.1; -.
DR   PIR; B60492; B60492.
DR   PIR; T46446; T46446.
DR   RefSeq; NP_076920.1; NM_024015.4.
DR   UniGene; Hs.664706; -.
DR   ProteinModelPortal; P17483; -.
DR   SMR; P17483; -.
DR   BioGrid; 109454; 6.
DR   ELM; P17483; -.
DR   STRING; 9606.ENSP00000328928; -.
DR   iPTMnet; P17483; -.
DR   PhosphoSitePlus; P17483; -.
DR   BioMuta; HOXB4; -.
DR   DMDM; 547692; -.
DR   EPD; P17483; -.
DR   MaxQB; P17483; -.
DR   PaxDb; P17483; -.
DR   PeptideAtlas; P17483; -.
DR   PRIDE; P17483; -.
DR   Ensembl; ENST00000332503; ENSP00000328928; ENSG00000182742.
DR   GeneID; 3214; -.
DR   KEGG; hsa:3214; -.
DR   UCSC; uc002inp.4; human.
DR   CTD; 3214; -.
DR   DisGeNET; 3214; -.
DR   EuPathDB; HostDB:ENSG00000182742.5; -.
DR   GeneCards; HOXB4; -.
DR   HGNC; HGNC:5115; HOXB4.
DR   HPA; HPA057432; -.
DR   MIM; 142965; gene.
DR   neXtProt; NX_P17483; -.
DR   OpenTargets; ENSG00000182742; -.
DR   PharmGKB; PA29391; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140772; -.
DR   HOGENOM; HOG000231179; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P17483; -.
DR   KO; K09304; -.
DR   OMA; PSHSSCK; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P17483; -.
DR   TreeFam; TF352857; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   GeneWiki; HOXB4; -.
DR   GenomeRNAi; 3214; -.
DR   PRO; PR:P17483; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000182742; -.
DR   CleanEx; HS_HOXB4; -.
DR   Genevisible; P17483; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048539; P:bone marrow development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:2000738; P:positive regulation of stem cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0048103; P:somatic stem cell division; IEA:Ensembl.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017995; Homeobox_antennapedia.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00025; ANTENNAPEDIA.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    251       Homeobox protein Hox-B4.
FT                                /FTId=PRO_0000200122.
FT   DNA_BIND    162    221       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       141    146       Antp-type hexapeptide.
FT   COMPBIAS     15    139       Pro-rich (part of the transcriptional
FT                                activation domain).
FT   COMPBIAS     71     87       Poly-Pro.
FT   MOD_RES      90     90       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
SQ   SEQUENCE   251 AA;  27604 MW;  23EE1D0DDCCE2DB4 CRC64;
     MAMSSFLINS NYVDPKFPPC EEYSQSDYLP SDHSPGYYAG GQRRESSFQP EAGFGRRAAC
     TVQRYAACRD PGPPPPPPPP PPPPPPPGLS PRAPAPPPAG ALLPEPGQRC EAVSSSPPPP
     PCAQNPLHPS PSHSACKEPV VYPWMRKVHV STVNPNYAGG EPKRSRTAYT RQQVLELEKE
     FHYNRYLTRR RRVEIAHALC LSERQIKIWF QNRRMKWKKD HKLPNTKIRS GGAAGSAGGP
     PGRPNGGPRA L
//
ID   HXB8_HUMAN              Reviewed;         243 AA.
AC   P17481; Q9H1I2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Homeobox protein Hox-B8;
DE   AltName: Full=Homeobox protein Hox-2.4;
DE   AltName: Full=Homeobox protein Hox-2D;
GN   Name=HOXB8; Synonyms=HOX2D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T.,
RA   Sasaki K., Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 142-211.
RC   TISSUE=Placenta;
RX   PubMed=2570724; DOI=10.1111/j.1432-0436.1989.tb00598.x;
RA   Giampaolo A., Acampora D., Zappavigna V., Pannese M., D'Esposito M.,
RA   Care A., Faiella A., Stornaiuolo A., Russo G., Simeone A.,
RA   Boncinelli E., Peschle C.;
RT   "Differential expression of human HOX-2 genes along the anterior-
RT   posterior axis in embryonic central nervous system.";
RL   Differentiation 40:191-197(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 146-211.
RX   PubMed=2576652;
RA   Boncinelli E., Acampora D., Pannese M., D'Esposito M., Somma R.,
RA   Gaudino G., Stornaiuolo A., Cafiero M., Faiella A., Simeone A.;
RT   "Organization of human class I homeobox genes.";
RL   Genome 31:745-756(1989).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DEVELOPMENTAL STAGE: Expressed in whole embryos and fetuses at 5-9
CC       weeks from conception.
CC   -!- SIMILARITY: Belongs to the Antp homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY014294; AAG42143.1; -; Genomic_DNA.
DR   EMBL; AY014293; AAG42143.1; JOINED; Genomic_DNA.
DR   EMBL; X16173; CAA34295.1; -; Genomic_DNA.
DR   CCDS; CCDS11533.1; -.
DR   PIR; B37042; B37042.
DR   RefSeq; NP_076921.1; NM_024016.3.
DR   RefSeq; XP_016880053.1; XM_017024564.1.
DR   UniGene; Hs.514292; -.
DR   ProteinModelPortal; P17481; -.
DR   SMR; P17481; -.
DR   BioGrid; 109458; 3.
DR   ELM; P17481; -.
DR   STRING; 9606.ENSP00000239144; -.
DR   iPTMnet; P17481; -.
DR   PhosphoSitePlus; P17481; -.
DR   BioMuta; HOXB8; -.
DR   DMDM; 20141506; -.
DR   MaxQB; P17481; -.
DR   PaxDb; P17481; -.
DR   PeptideAtlas; P17481; -.
DR   PRIDE; P17481; -.
DR   DNASU; 3218; -.
DR   Ensembl; ENST00000239144; ENSP00000239144; ENSG00000120068.
DR   GeneID; 3218; -.
DR   KEGG; hsa:3218; -.
DR   UCSC; uc002inw.3; human.
DR   CTD; 3218; -.
DR   DisGeNET; 3218; -.
DR   EuPathDB; HostDB:ENSG00000120068.6; -.
DR   GeneCards; HOXB8; -.
DR   HGNC; HGNC:5119; HOXB8.
DR   HPA; HPA075905; -.
DR   MIM; 142963; gene.
DR   neXtProt; NX_P17481; -.
DR   OpenTargets; ENSG00000120068; -.
DR   PharmGKB; PA29395; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231181; -.
DR   HOVERGEN; HBG016849; -.
DR   InParanoid; P17481; -.
DR   KO; K09308; -.
DR   OMA; AGGTFQH; -.
DR   OrthoDB; EOG091G09XD; -.
DR   PhylomeDB; P17481; -.
DR   TreeFam; TF316310; -.
DR   SIGNOR; P17481; -.
DR   ChiTaRS; HOXB8; human.
DR   GeneWiki; HOXB8; -.
DR   GenomeRNAi; 3218; -.
DR   PRO; PR:P17481; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000120068; -.
DR   CleanEx; HS_HOXB8; -.
DR   ExpressionAtlas; P17481; baseline and differential.
DR   Genevisible; P17481; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0021516; P:dorsal spinal cord development; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0007625; P:grooming behavior; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0019233; P:sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001827; Homeobox_Antennapedia_CS.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00032; ANTENNAPEDIA; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    243       Homeobox protein Hox-B8.
FT                                /FTId=PRO_0000200148.
FT   DNA_BIND    146    205       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       134    139       Antp-type hexapeptide.
SQ   SEQUENCE   243 AA;  27574 MW;  36982182725F121F CRC64;
     MSSYFVNSLF SKYKTGESLR PNYYDCGFAQ DLGGRPTVVY GPSSGGSFQH PSQIQEFYHG
     PSSLSTAPYQ QNPCAVACHG DPGNFYGYDP LQRQSLFGAQ DPDLVQYADC KLAAASGLGE
     EAEGSEQSPS PTQLFPWMRP QAAAGRRRGR QTYSRYQTLE LEKEFLFNPY LTRKRRIEVS
     HALGLTERQV KIWFQNRRMK WKKENNKDKF PSSKCEQEEL EKQKLERAPE AADEGDAQKG
     DKK
//
ID   HXD11_HUMAN             Reviewed;         338 AA.
AC   P31277; A6NIS4; Q9NS02;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 3.
DT   25-OCT-2017, entry version 157.
DE   RecName: Full=Homeobox protein Hox-D11;
DE   AltName: Full=Homeobox protein Hox-4F;
GN   Name=HOXD11; Synonyms=HOX4F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Miwa N., Yoshiura K., Kantaputra P.K., Soeda E., Niikawa N.;
RT   "The role of HOXD11 and HOXD12 for the mesomelic dysplasia Kantaptra
RT   type.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 266-331.
RX   PubMed=2574852; DOI=10.1093/nar/17.24.10385;
RA   Acampora D., D'Esposito M., Faiella A., Pannese M., Migliaccio E.,
RA   Morelli F., Stornaiuolo A., Nigro V., Simeone A., Boncinelli E.;
RT   "The human HOX gene family.";
RL   Nucleic Acids Res. 17:10385-10402(1989).
RN   [4]
RP   VARIANT ASP-245.
RX   PubMed=17236141; DOI=10.1086/511387;
RA   Zhao X., Sun M., Zhao J., Leyva J.A., Zhu H., Yang W., Zeng X., Ao Y.,
RA   Liu Q., Liu G., Lo W.H.Y., Jabs E.W., Amzel L.M., Shan X., Zhang X.;
RT   "Mutations in HOXD13 underlie syndactyly type V and a novel
RT   brachydactyly-syndactyly syndrome.";
RL   Am. J. Hum. Genet. 80:361-371(2007).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of
CC       a developmental regulatory system that provides cells with
CC       specific positional identities on the anterior-posterior axis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF154915; AAF79045.1; -; Genomic_DNA.
DR   EMBL; AC009336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS2265.1; -.
DR   PIR; S14938; S14938.
DR   RefSeq; NP_067015.2; NM_021192.2.
DR   UniGene; Hs.421136; -.
DR   ProteinModelPortal; P31277; -.
DR   SMR; P31277; -.
DR   BioGrid; 109477; 1.
DR   STRING; 9606.ENSP00000249504; -.
DR   iPTMnet; P31277; -.
DR   PhosphoSitePlus; P31277; -.
DR   BioMuta; HOXD11; -.
DR   DMDM; 223590220; -.
DR   PaxDb; P31277; -.
DR   PeptideAtlas; P31277; -.
DR   PRIDE; P31277; -.
DR   DNASU; 3237; -.
DR   Ensembl; ENST00000249504; ENSP00000249504; ENSG00000128713.
DR   GeneID; 3237; -.
DR   KEGG; hsa:3237; -.
DR   UCSC; uc002uki.4; human.
DR   CTD; 3237; -.
DR   DisGeNET; 3237; -.
DR   EuPathDB; HostDB:ENSG00000128713.12; -.
DR   GeneCards; HOXD11; -.
DR   HGNC; HGNC:5134; HOXD11.
DR   HPA; HPA055155; -.
DR   MIM; 142986; gene.
DR   neXtProt; NX_P31277; -.
DR   OpenTargets; ENSG00000128713; -.
DR   PharmGKB; PA29408; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   eggNOG; ENOG4111FJP; LUCA.
DR   GeneTree; ENSGT00900000140792; -.
DR   HOGENOM; HOG000231898; -.
DR   HOVERGEN; HBG052048; -.
DR   InParanoid; P31277; -.
DR   KO; K09296; -.
DR   OMA; CAYYVSP; -.
DR   OrthoDB; EOG091G12E6; -.
DR   PhylomeDB; P31277; -.
DR   TreeFam; TF350668; -.
DR   SIGNOR; P31277; -.
DR   ChiTaRS; HOXD11; human.
DR   GeneWiki; HOXD11; -.
DR   GenomeRNAi; 3237; -.
DR   PRO; PR:P31277; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000128713; -.
DR   CleanEx; HS_HOXD11; -.
DR   Genevisible; P31277; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR021918; DUF3528.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF12045; DUF3528; 2.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    338       Homeobox protein Hox-D11.
FT                                /FTId=PRO_0000200231.
FT   DNA_BIND    266    325       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     90    102       Poly-Gly.
FT   COMPBIAS    108    120       Poly-Ala.
FT   VARIANT     245    245       G -> D (in dbSNP:rs376305712).
FT                                {ECO:0000269|PubMed:17236141}.
FT                                /FTId=VAR_031647.
FT   CONFLICT    196    205       PPPPAPPQPE -> RRHPRRHSPM (in Ref. 1;
FT                                AAF79045). {ECO:0000305}.
SQ   SEQUENCE   338 AA;  35197 MW;  2960C3C983EA9A6A CRC64;
     MNDFDECGQS AASMYLPGCA YYVAPSDFAS KPSFLSQPSS CQMTFPYSSN LAPHVQPVRE
     VAFRDYGLER AKWPYRGGGG GGSAGGGSSG GGPGGGGGGA GGYAPYYAAA AAAAAAAAAA
     EEAAMQRELL PPAGRRPDVL FKAPEPVCAA PGPPHGPAGA ASNFYSAVGR NGILPQGFDQ
     FYEAAPGPPF AGPQPPPPPA PPQPEGAADK GDPRTGAGGG GGSPCTKATP GSEPKGAAEG
     SGGDGEGPPG EAGAEKSSSA VAPQRSRKKR CPYTKYQIRE LEREFFFNVY INKEKRLQLS
     RMLNLTDRQV KIWFQNRRMK EKKLNRDRLQ YFTGNPLF
//
ID   IRX3_HUMAN              Reviewed;         501 AA.
AC   P78415; Q7Z4A4; Q7Z4A5; Q8IVC6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 3.
DT   27-SEP-2017, entry version 141.
DE   RecName: Full=Iroquois-class homeodomain protein IRX-3;
DE   AltName: Full=Homeodomain protein IRXB1;
DE   AltName: Full=Iroquois homeobox protein 3;
GN   Name=IRX3; Synonyms=IRXB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Hansen L., Wu Q., Tommerup N.;
RT   "Characterization of the human homeobox two-cluster Iroquois gene
RT   family.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-422.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 91-176.
RA   Lewis M.T., Strickland P.A., Ross S., Snyder C.J., Daniel C.W.;
RT   "IRX: a new family of human homeobox genes from the breast.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Transcription factor. Involved in SHH-dependent neural
CC       patterning. Together with NKX2-2 and NKX6-1 acts to restrict the
CC       generation of motor neurons to the appropriate region of the
CC       neural tube. Belongs to the class I proteins of neuronal
CC       progenitor factors, which are repressed by SHH signals. Involved
CC       in the transcriptional repression of MNX1 in non-motor neuron
CC       cells (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY335942; AAQ16548.1; -; Genomic_DNA.
DR   EMBL; AY335943; AAQ16549.1; -; mRNA.
DR   EMBL; BC023667; AAH23667.1; -; mRNA.
DR   EMBL; U90308; AAB50006.1; -; mRNA.
DR   CCDS; CCDS10750.1; -.
DR   RefSeq; NP_077312.2; NM_024336.2.
DR   UniGene; Hs.499205; -.
DR   ProteinModelPortal; P78415; -.
DR   SMR; P78415; -.
DR   DIP; DIP-62120N; -.
DR   IntAct; P78415; 1.
DR   STRING; 9606.ENSP00000331608; -.
DR   iPTMnet; P78415; -.
DR   PhosphoSitePlus; P78415; -.
DR   BioMuta; IRX3; -.
DR   DMDM; 47117874; -.
DR   EPD; P78415; -.
DR   MaxQB; P78415; -.
DR   PaxDb; P78415; -.
DR   PeptideAtlas; P78415; -.
DR   PRIDE; P78415; -.
DR   DNASU; 79191; -.
DR   Ensembl; ENST00000329734; ENSP00000331608; ENSG00000177508.
DR   GeneID; 79191; -.
DR   KEGG; hsa:79191; -.
DR   UCSC; uc002eht.2; human.
DR   CTD; 79191; -.
DR   DisGeNET; 79191; -.
DR   EuPathDB; HostDB:ENSG00000177508.11; -.
DR   GeneCards; IRX3; -.
DR   HGNC; HGNC:14360; IRX3.
DR   HPA; HPA062522; -.
DR   MIM; 612985; gene.
DR   neXtProt; NX_P78415; -.
DR   OpenTargets; ENSG00000177508; -.
DR   PharmGKB; PA29926; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000234546; -.
DR   HOVERGEN; HBG006180; -.
DR   InParanoid; P78415; -.
DR   OMA; QYIRPIY; -.
DR   OrthoDB; EOG091G0N9R; -.
DR   PhylomeDB; P78415; -.
DR   TreeFam; TF319371; -.
DR   ChiTaRS; IRX3; human.
DR   GeneWiki; IRX3; -.
DR   GenomeRNAi; 79191; -.
DR   PRO; PR:P78415; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000177508; -.
DR   CleanEx; HS_IRX3; -.
DR   ExpressionAtlas; P78415; baseline and differential.
DR   Genevisible; P78415; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR003893; Iroquois_homeo.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00548; IRO; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repressor;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    501       Iroquois-class homeodomain protein IRX-3.
FT                                /FTId=PRO_0000049155.
FT   DNA_BIND    125    188       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS     62     70       Poly-Ala.
FT   COMPBIAS    201    267       Asp/Glu-rich (acidic).
FT   COMPBIAS    229    232       Poly-Glu.
FT   COMPBIAS    304    433       Pro-rich.
FT   COMPBIAS    388    394       Poly-Ala.
FT   COMPBIAS    446    450       Poly-Ala.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P81067}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P81067}.
FT   VARIANT     422    422       L -> P (in dbSNP:rs1450355).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_061267.
FT   VARIANT     479    479       Q -> H (in dbSNP:rs1126960).
FT                                /FTId=VAR_055957.
FT   CONFLICT    222    222       G -> C (in Ref. 1; AAQ16549).
FT                                {ECO:0000305}.
SQ   SEQUENCE   501 AA;  52119 MW;  638D984ED0BEF6C9 CRC64;
     MSFPQLGYQY IRPLYPSERP GAAGGSGGSA GARGGLGAGA SELNASGSLS NVLSSVYGAP
     YAAAAAAAAA QGYGAFLPYA AELPIFPQLG AQYELKDSPG VQHPAAAAAF PHPHPAFYPY
     GQYQFGDPSR PKNATRESTS TLKAWLNEHR KNPYPTKGEK IMLAIITKMT LTQVSTWFAN
     ARRRLKKENK MTWAPRSRTD EEGNAYGSER EEEDEEEDEE DGKRELELEE EELGGEEEDT
     GGEGLADDDE DEEIDLENLD GAATEPELSL AGAARRDGDL GLGPISDSKN SDSEDSSEGL
     EDRPLPVLSL APAPPPVAVA SPSLPSPPVS LDPCAPAPAP ASALQKPKIW SLAETATSPD
     NPRRSPPGAG GSPPGAAVAP SALQLSPAAA AAAAHRLVSA PLGKFPAWTN RPFPGPPPGP
     RLHPLSLLGS APPHLLGLPG AAGHPAAAAA FARPAEPEGG TDRCSALEVE KKLLKTAFQP
     VPRRPQNHLD AALVLSALSS S
//
ID   IRX4_HUMAN              Reviewed;         519 AA.
AC   P78413; B2RMW5; D3DTC5; H1AFL0; H1AFL1; Q2NL64; Q9UHR2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   27-SEP-2017, entry version 139.
DE   RecName: Full=Iroquois-class homeodomain protein IRX-4;
DE   AltName: Full=Homeodomain protein IRXA3;
DE   AltName: Full=Iroquois homeobox protein 4;
GN   Name=IRX4; Synonyms=IRXA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10625552; DOI=10.1006/dbio.1999.9548;
RA   Bruneau B.G., Bao Z.-Z., Tanaka M., Schott J.-J., Izumo S.,
RA   Cepko C.L., Seidman J.G., Seidman C.E.;
RT   "Cardiac expression of the ventricle-specific homeobox gene Irx4 is
RT   modulated by Nkx2-5 and dHand.";
RL   Dev. Biol. 217:266-277(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hansen L., Wu Q., Tommerup N.;
RT   "Characterization of the human homeobox two-cluster Iroquois gene
RT   family.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING,
RP   AND INTERACTION WITH VDR.
RC   TISSUE=Prostate;
RX   PubMed=22323358; DOI=10.1093/hmg/dds025;
RA   Nguyen H.H., Takata R., Akamatsu S., Shigemizu D., Tsunoda T.,
RA   Furihata M., Takahashi A., Kubo M., Kamatani N., Ogawa O., Fujioka T.,
RA   Nakamura Y., Nakagawa H.;
RT   "IRX4 at 5p15 suppresses prostate cancer growth through the
RT   interaction with vitamin D receptor, conferring prostate cancer
RT   susceptibility.";
RL   Hum. Mol. Genet. 21:2076-2085(2012).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-119.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 80-191 (ISOFORM 1).
RA   Lewis M.T., Strickland P.A., Ross S., Snyder C.J., Daniel C.W.;
RT   "IRX: a new family of human homeobox genes from the breast.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Likely to be an important mediator of ventricular
CC       differentiation during cardiac development.
CC   -!- SUBUNIT: Interacts with the vitamin D receptor VDR but doesn't
CC       affect its transactivation activity.
CC       {ECO:0000269|PubMed:22323358}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78413-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78413-2; Sequence=VSP_054304;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in cardiac ventricles.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF124733; AAF23887.1; -; mRNA.
DR   EMBL; AY335941; AAQ16547.1; -; Genomic_DNA.
DR   EMBL; AB690778; BAL44219.1; -; mRNA.
DR   EMBL; AB690779; BAL44220.1; -; mRNA.
DR   EMBL; AB690780; BAL44221.1; -; mRNA.
DR   EMBL; AB690781; BAL44222.1; -; mRNA.
DR   EMBL; CH471102; EAX08138.1; -; Genomic_DNA.
DR   EMBL; CH471102; EAX08139.1; -; Genomic_DNA.
DR   EMBL; BC110912; AAI10913.1; -; mRNA.
DR   EMBL; BC136505; AAI36506.1; -; mRNA.
DR   EMBL; BC136506; AAI36507.1; -; mRNA.
DR   EMBL; U90306; AAB50004.1; -; mRNA.
DR   CCDS; CCDS3867.1; -. [P78413-1]
DR   CCDS; CCDS75225.1; -. [P78413-2]
DR   RefSeq; NP_001265561.1; NM_001278632.1. [P78413-1]
DR   RefSeq; NP_001265562.1; NM_001278633.1. [P78413-2]
DR   RefSeq; NP_001265563.1; NM_001278634.1. [P78413-1]
DR   RefSeq; NP_001265564.1; NM_001278635.1. [P78413-2]
DR   RefSeq; NP_057442.1; NM_016358.2. [P78413-1]
DR   UniGene; Hs.196927; -.
DR   ProteinModelPortal; P78413; -.
DR   SMR; P78413; -.
DR   BioGrid; 119125; 1.
DR   IntAct; P78413; 1.
DR   STRING; 9606.ENSP00000231357; -.
DR   iPTMnet; P78413; -.
DR   PhosphoSitePlus; P78413; -.
DR   BioMuta; IRX4; -.
DR   DMDM; 12644347; -.
DR   MaxQB; P78413; -.
DR   PaxDb; P78413; -.
DR   PeptideAtlas; P78413; -.
DR   PRIDE; P78413; -.
DR   Ensembl; ENST00000231357; ENSP00000231357; ENSG00000113430. [P78413-1]
DR   Ensembl; ENST00000505790; ENSP00000423161; ENSG00000113430. [P78413-1]
DR   Ensembl; ENST00000513692; ENSP00000424235; ENSG00000113430. [P78413-1]
DR   Ensembl; ENST00000613726; ENSP00000482393; ENSG00000113430. [P78413-2]
DR   Ensembl; ENST00000622814; ENSP00000481396; ENSG00000113430. [P78413-2]
DR   GeneID; 50805; -.
DR   KEGG; hsa:50805; -.
DR   UCSC; uc003jcz.2; human. [P78413-1]
DR   CTD; 50805; -.
DR   DisGeNET; 50805; -.
DR   EuPathDB; HostDB:ENSG00000113430.9; -.
DR   GeneCards; IRX4; -.
DR   HGNC; HGNC:6129; IRX4.
DR   HPA; HPA064094; -.
DR   MIM; 606199; gene.
DR   neXtProt; NX_P78413; -.
DR   OpenTargets; ENSG00000113430; -.
DR   PharmGKB; PA29927; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000234546; -.
DR   HOVERGEN; HBG006180; -.
DR   InParanoid; P78413; -.
DR   OMA; PYDRYGT; -.
DR   OrthoDB; EOG091G0N9R; -.
DR   PhylomeDB; P78413; -.
DR   GeneWiki; IRX4; -.
DR   GenomeRNAi; 50805; -.
DR   PRO; PR:P78413; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113430; -.
DR   CleanEx; HS_IRX4; -.
DR   ExpressionAtlas; P78413; baseline and differential.
DR   Genevisible; P78413; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0048561; P:establishment of animal organ orientation; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; TAS:ProtInc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR003893; Iroquois_homeo.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00548; IRO; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    519       Iroquois-class homeodomain protein IRX-4.
FT                                /FTId=PRO_0000049157.
FT   DNA_BIND    143    204       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS    223    228       Poly-Glu.
FT   COMPBIAS    375    382       Poly-Ala.
FT   VAR_SEQ     136    136       R -> RIKRLGGHPHKGIGLDLSGLGRSPGSL (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:22323358}.
FT                                /FTId=VSP_054304.
FT   VARIANT     119    119       A -> T (in dbSNP:rs2232376).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_049583.
FT   CONFLICT    181    181       I -> T (in Ref. 6; AAB50004).
FT                                {ECO:0000305}.
SQ   SEQUENCE   519 AA;  54445 MW;  B2FFB278BEFC5AD2 CRC64;
     MSYPQFGYPY SSAPQFLMAT NSLSTCCESG GRTLADSGPA ASAQAPVYCP VYESRLLATA
     RHELNSAAAL GVYGGPYGGS QGYGNYVTYG SEASAFYSLN SFDSKDGSGS AHGGLAPAAA
     AYYPYEPALG QYPYDRYGTM DSGTRRKNAT RETTSTLKAW LQEHRKNPYP TKGEKIMLAI
     ITKMTLTQVS TWFANARRRL KKENKMTWPP RNKCADEKRP YAEGEEEEGG EEEAREEPLK
     SSKNAEPVGK EEKELELSDL DDFDPLEAEP PACELKPPFH SLDGGLERVP AAPDGPVKEA
     SGALRMSLAA GGGAALDEDL ERARSCLRSA AAGPEPLPGA EGGPQVCEAK LGFVPAGASA
     GLEAKPRIWS LAHTATAAAA AATSLSQTEF PSCMLKRQGP AAPAAVSSAP ATSPSVALPH
     SGALDRHQDS PVTSLRNWVD GVFHDPILRH STLNQAWATA KGALLDPGPL GRSLGAGANV
     LTAPLARAFP PAVPQDAPAA GAARELLALP KAGGKPFCA
//
ID   IRX5_HUMAN              Reviewed;         483 AA.
AC   P78411; H0YMS7; P78416; Q7Z2E1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 3.
DT   27-SEP-2017, entry version 142.
DE   RecName: Full=Iroquois-class homeodomain protein IRX-5;
DE   AltName: Full=Homeodomain protein IRX-2A;
DE   AltName: Full=Homeodomain protein IRXB2;
DE   AltName: Full=Iroquois homeobox protein 5;
GN   Name=IRX5; Synonyms=IRX2A, IRXB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2).
RA   Hansen L., Wu Q., Tommerup N.;
RT   "Characterization of the human homeobox two-cluster Iroquois gene
RT   family.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE [MRNA]
RP   OF 84-256 (ISOFORM 1/3).
RX   PubMed=10370142; DOI=10.1007/s004410051316;
RA   Lewis M.T., Ross S., Strickland P.A., Snyder C.J., Daniel C.W.;
RT   "Regulated expression patterns of IRX-2, an Iroquois-class homeobox
RT   gene, in the human breast.";
RL   Cell Tissue Res. 296:549-554(1999).
RN   [3]
RP   DOWN-REGULATION BY 1,25-DIHYDROXYVITAMIN D3, AND POSSIBLE FUNCTION.
RX   PubMed=18519790; DOI=10.1158/1078-0432.CCR-07-4649;
RA   Myrthue A., Rademacher B.L.S., Pittsenbarger J., Kutyba-Brooks B.,
RA   Gantner M., Qian D.Z., Beer T.M.;
RT   "The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3
RT   in human prostate cancer and regulates apoptosis and the cell cycle in
RT   LNCaP prostate cancer cells.";
RL   Clin. Cancer Res. 14:3562-3570(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   FUNCTION, VARIANTS HMMS PRO-150 AND LYS-166, AND CHARACTERIZATION OF
RP   VARIANTS HMMS PRO-150 AND LYS-166.
RX   PubMed=22581230; DOI=10.1038/ng.2259;
RA   Bonnard C., Strobl A.C., Shboul M., Lee H., Merriman B., Nelson S.F.,
RA   Ababneh O.H., Uz E., Guran T., Kayserili H., Hamamy H., Reversade B.;
RT   "Mutations in IRX5 impair craniofacial development and germ cell
RT   migration via SDF1.";
RL   Nat. Genet. 44:709-713(2012).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-274 AND SER-464, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Establishes the cardiac repolarization gradient by its
CC       repressive actions on the KCND2 potassium-channel gene. Required
CC       for retinal cone bipolar cell differentiation. May regulate
CC       contrast adaptation in the retina and control specific aspects of
CC       visual function in circuits of the mammalian retina (By
CC       similarity). Could be involved in the regulation of both the cell
CC       cycle and apoptosis in prostate cancer cells. Involved in
CC       craniofacial and gonadal development. Modulates the migration of
CC       progenitor cell populations in branchial arches and gonads by
CC       repressing CXCL12. {ECO:0000250, ECO:0000269|PubMed:22581230}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P78411-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78411-2; Sequence=VSP_047364;
CC       Name=3;
CC         IsoId=P78411-3; Sequence=VSP_047363;
CC   -!- INDUCTION: Down-regulated by 1,25-dihydroxyvitamin D3 in prostate
CC       cancer samples from patients assigned to receive weekly high-dose
CC       1,25-dihydroxyvitamin D3 before radical prostatectomy. Also down-
CC       regulated by 1,25-dihydroxyvitamin D3 in the human androgen-
CC       sensitive prostate cancer cell line LNCaP and in the estrogen-
CC       sensitive breast cancer cell line MCF-7.
CC   -!- DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome
CC       characterized by severe hypertelorism, upslanting palpebral
CC       fissures, brachycephaly, abnormal ears, sloping shoulders, enamel
CC       hypoplasia, and osteopenia with repeated fractures. Additional
CC       features include myopia, mild to moderate sensorineural hearing
CC       loss, gonadal anomalies and borderline intelligence.
CC       {ECO:0000269|PubMed:22581230}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY335944; AAQ16550.1; -; Genomic_DNA.
DR   EMBL; AY335945; AAQ16551.1; -; mRNA.
DR   EMBL; U90304; AAB50002.1; -; mRNA.
DR   EMBL; U90309; AAB50007.1; -; mRNA.
DR   EMBL; AC106738; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS10751.1; -. [P78411-1]
DR   CCDS; CCDS58462.1; -. [P78411-2]
DR   RefSeq; NP_001239126.1; NM_001252197.1. [P78411-2]
DR   RefSeq; NP_005844.4; NM_005853.5. [P78411-1]
DR   UniGene; Hs.435730; -.
DR   ProteinModelPortal; P78411; -.
DR   SMR; P78411; -.
DR   STRING; 9606.ENSP00000378132; -.
DR   iPTMnet; P78411; -.
DR   PhosphoSitePlus; P78411; -.
DR   BioMuta; IRX5; -.
DR   DMDM; 143811406; -.
DR   MaxQB; P78411; -.
DR   PaxDb; P78411; -.
DR   PeptideAtlas; P78411; -.
DR   PRIDE; P78411; -.
DR   Ensembl; ENST00000320990; ENSP00000316250; ENSG00000176842. [P78411-2]
DR   Ensembl; ENST00000394636; ENSP00000378132; ENSG00000176842. [P78411-1]
DR   GeneID; 10265; -.
DR   KEGG; hsa:10265; -.
DR   UCSC; uc002ehv.4; human. [P78411-1]
DR   CTD; 10265; -.
DR   DisGeNET; 10265; -.
DR   EuPathDB; HostDB:ENSG00000176842.14; -.
DR   GeneCards; IRX5; -.
DR   H-InvDB; HIX0038585; -.
DR   HGNC; HGNC:14361; IRX5.
DR   HPA; HPA047130; -.
DR   MalaCards; IRX5; -.
DR   MIM; 606195; gene.
DR   MIM; 611174; phenotype.
DR   neXtProt; NX_P78411; -.
DR   OpenTargets; ENSG00000176842; -.
DR   Orphanet; 314555; Craniofacial dysplasia-osteopenia syndrome.
DR   PharmGKB; PA29928; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000234546; -.
DR   HOVERGEN; HBG006180; -.
DR   InParanoid; P78411; -.
DR   OMA; FGHLHSN; -.
DR   OrthoDB; EOG091G15AO; -.
DR   PhylomeDB; P78411; -.
DR   TreeFam; TF319371; -.
DR   GeneWiki; IRX5; -.
DR   GenomeRNAi; 10265; -.
DR   PRO; PR:P78411; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000176842; -.
DR   CleanEx; HS_IRX5; -.
DR   ExpressionAtlas; P78411; baseline and differential.
DR   Genevisible; P78411; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005499; F:vitamin D binding; IEA:UniProtKB-KW.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:UniProtKB.
DR   GO; GO:0008406; P:gonad development; IMP:UniProtKB.
DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.
DR   GO; GO:0002027; P:regulation of heart rate; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR003893; Iroquois_homeo.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00548; IRO; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   DNA-binding; Homeobox; Mental retardation; Nucleus; Phosphoprotein;
KW   Reference proteome; Sensory transduction; Transcription; Vision;
KW   Vitamin D.
FT   CHAIN         1    483       Iroquois-class homeodomain protein IRX-5.
FT                                /FTId=PRO_0000049160.
FT   DNA_BIND    113    175       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS     72     78       Poly-Ala.
FT   COMPBIAS    186    192       Poly-Glu.
FT   COMPBIAS    320    326       Poly-Pro.
FT   COMPBIAS    350    353       Poly-Gly.
FT   MOD_RES     274    274       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     464    464       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     83       MSYPQGYLYQPSASLALYSCPAYSTSVISGPRTDELGRSSS
FT                                GSAFSPYAGSTAFTAPSPGYNSHLQYGADPAAAAAAAFSSY
FT                                V -> MAVETTVHTHLSASPPQ (in isoform 3).
FT                                {ECO:0000303|PubMed:10370142}.
FT                                /FTId=VSP_047363.
FT   VAR_SEQ     219    219       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_047364.
FT   VARIANT     150    150       A -> P (in HMMS; hypomorphic mutation;
FT                                dbSNP:rs387907198).
FT                                {ECO:0000269|PubMed:22581230}.
FT                                /FTId=VAR_068483.
FT   VARIANT     166    166       N -> K (in HMMS; hypomorphic mutation;
FT                                dbSNP:rs786200931).
FT                                {ECO:0000269|PubMed:22581230}.
FT                                /FTId=VAR_068484.
FT   CONFLICT    211    211       G -> A (in Ref. 2; AAB50007).
FT                                {ECO:0000305}.
FT   CONFLICT    343    343       S -> L (in Ref. 2; AAB50002).
FT                                {ECO:0000305}.
SQ   SEQUENCE   483 AA;  50361 MW;  12E9397924EB5E6E CRC64;
     MSYPQGYLYQ PSASLALYSC PAYSTSVISG PRTDELGRSS SGSAFSPYAG STAFTAPSPG
     YNSHLQYGAD PAAAAAAAFS SYVGSPYDHT PGMAGSLGYH PYAAPLGSYP YGDPAYRKNA
     TRDATATLKA WLNEHRKNPY PTKGEKIMLA IITKMTLTQV STWFANARRR LKKENKMTWT
     PRNRSEDEEE EENIDLEKND EDEPQKPEDK GDPEGPEAGG AEQKAASGCE RLQGPPTPAG
     KETEGSLSDS DFKEPPSEGR LDALQGPPRT GGPSPAGPAA ARLAEDPAPH YPAGAPAPGP
     HPAAGEVPPG PGGPSVIHSP PPPPPPAVLA KPKLWSLAEI ATSSDKVKDG GGGNEGSPCP
     PCPGPIAGQA LGGSRASPAP APSRSPSAQC PFPGGTVLSR PLYYTAPFYP GYTNYGSFGH
     LHGHPGPGPG PTTGPGSHFN GLNQTVLNRA DALAKDPKML RSQSQLDLCK DSPYELKKGM
     SDI
//
ID   IRX2_HUMAN              Reviewed;         471 AA.
AC   Q9BZI1; Q68A19; Q7Z2I7;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   27-SEP-2017, entry version 119.
DE   RecName: Full=Iroquois-class homeodomain protein IRX-2;
DE   AltName: Full=Homeodomain protein IRXA2;
DE   AltName: Full=Iroquois homeobox protein 2;
GN   Name=IRX2; Synonyms=IRXA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Hansen L., Wu Q., Tommerup N.;
RT   "Characterization of the human homeobox two-cluster Iroquois gene
RT   family.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Sugiyama A., Inoue H., Oka M.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 101-181.
RX   PubMed=11435706;
RA   Ogura K., Matsumoto K., Kuroiwa A., Isobe T., Otoguro T., Jurecic V.,
RA   Baldini A., Matsuda Y., Ogura T.;
RT   "Cloning and chromosome mapping of human and chicken Iroquois (IRX)
RT   genes.";
RL   Cytogenet. Cell Genet. 92:320-325(2001).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY335939; AAQ16545.1; -; Genomic_DNA.
DR   EMBL; AY335940; AAQ16546.1; -; mRNA.
DR   EMBL; AB188492; BAD37140.1; -; mRNA.
DR   EMBL; BC065189; AAH65189.1; -; mRNA.
DR   EMBL; AF319967; AAK01202.1; -; Genomic_DNA.
DR   CCDS; CCDS3868.1; -.
DR   RefSeq; NP_001127694.1; NM_001134222.1.
DR   RefSeq; NP_150366.1; NM_033267.4.
DR   RefSeq; XP_011512281.1; XM_011513979.2.
DR   UniGene; Hs.282089; -.
DR   ProteinModelPortal; Q9BZI1; -.
DR   IntAct; Q9BZI1; 3.
DR   STRING; 9606.ENSP00000307006; -.
DR   iPTMnet; Q9BZI1; -.
DR   PhosphoSitePlus; Q9BZI1; -.
DR   BioMuta; IRX2; -.
DR   DMDM; 47117908; -.
DR   EPD; Q9BZI1; -.
DR   MaxQB; Q9BZI1; -.
DR   PaxDb; Q9BZI1; -.
DR   PeptideAtlas; Q9BZI1; -.
DR   PRIDE; Q9BZI1; -.
DR   Ensembl; ENST00000302057; ENSP00000307006; ENSG00000170561.
DR   Ensembl; ENST00000382611; ENSP00000372056; ENSG00000170561.
DR   GeneID; 153572; -.
DR   KEGG; hsa:153572; -.
DR   UCSC; uc003jda.4; human.
DR   CTD; 153572; -.
DR   DisGeNET; 153572; -.
DR   EuPathDB; HostDB:ENSG00000170561.12; -.
DR   GeneCards; IRX2; -.
DR   HGNC; HGNC:14359; IRX2.
DR   HPA; HPA050895; -.
DR   HPA; HPA054669; -.
DR   MalaCards; IRX2; -.
DR   MIM; 606198; gene.
DR   neXtProt; NX_Q9BZI1; -.
DR   OpenTargets; ENSG00000170561; -.
DR   PharmGKB; PA29924; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000234546; -.
DR   HOVERGEN; HBG006180; -.
DR   InParanoid; Q9BZI1; -.
DR   OMA; SYMGAPY; -.
DR   OrthoDB; EOG091G15AO; -.
DR   PhylomeDB; Q9BZI1; -.
DR   TreeFam; TF319371; -.
DR   GeneWiki; IRX2; -.
DR   GenomeRNAi; 153572; -.
DR   PRO; PR:Q9BZI1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170561; -.
DR   CleanEx; HS_IRX2; -.
DR   Genevisible; Q9BZI1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0072272; P:proximal/distal pattern formation involved in metanephric nephron development; IEA:Ensembl.
DR   GO; GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR003893; Iroquois_homeo.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00548; IRO; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    471       Iroquois-class homeodomain protein IRX-2.
FT                                /FTId=PRO_0000049153.
FT   DNA_BIND    112    175       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
SQ   SEQUENCE   471 AA;  49129 MW;  3B370608B5223C3C CRC64;
     MSYPQGYLYQ APGSLALYSC PAYGASALAA PRSEELARSA SGSAFSPYPG SAAFTAQAAT
     GFGSPLQYSA DAAAAAAGFP SYMGAPYDAH TTGMTGAISY HPYGSAAYPY QLNDPAYRKN
     ATRDATATLK AWLNEHRKNP YPTKGEKIML AIITKMTLTQ VSTWFANARR RLKKENKMTW
     APRNKSEDED EDEGDATRSK DESPDKAQEG TETSAEDEGI SLHVDSLTDH SCSAESDGEK
     LPCRAGDPLC ESGSECKDKY DDLEDDEDDD EEGERGLAPP KPVTSSPLTG LEAPLLSPPP
     EAAPRGGRKT PQGSRTSPGA PPPASKPKLW SLAEIATSDL KQPSLGPGCG PPGLPAAAAP
     ASTGAPPGGS PYPASPLLGR PLYYTSPFYG NYTNYGNLNA ALQGQGLLRY NSAAAAPGEA
     LHTAPKAASD AGKAGAHPLE SHYRSPGGGY EPKKDASEGC TVVGGGVQPY L
//
ID   ISL2_HUMAN              Reviewed;         359 AA.
AC   Q96A47; B3KM37;
DT   15-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   27-SEP-2017, entry version 139.
DE   RecName: Full=Insulin gene enhancer protein ISL-2;
DE            Short=Islet-2;
GN   Name=ISL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-279, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154 AND SER-157, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Transcriptional factor that defines subclasses of
CC       motoneurons that segregate into columns in the spinal cord and
CC       select distinct axon pathways. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with LHX4. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001022; BAG50849.1; -; mRNA.
DR   EMBL; CH471136; EAW99220.1; -; Genomic_DNA.
DR   EMBL; BC011967; AAH11967.1; -; mRNA.
DR   EMBL; BC012136; AAH12136.1; -; mRNA.
DR   CCDS; CCDS10290.1; -.
DR   RefSeq; NP_665804.1; NM_145805.2.
DR   UniGene; Hs.444677; -.
DR   ProteinModelPortal; Q96A47; -.
DR   SMR; Q96A47; -.
DR   BioGrid; 122318; 12.
DR   STRING; 9606.ENSP00000290759; -.
DR   iPTMnet; Q96A47; -.
DR   PhosphoSitePlus; Q96A47; -.
DR   BioMuta; ISL2; -.
DR   DMDM; 20978495; -.
DR   EPD; Q96A47; -.
DR   MaxQB; Q96A47; -.
DR   PaxDb; Q96A47; -.
DR   PeptideAtlas; Q96A47; -.
DR   PRIDE; Q96A47; -.
DR   DNASU; 64843; -.
DR   Ensembl; ENST00000290759; ENSP00000290759; ENSG00000159556.
DR   GeneID; 64843; -.
DR   KEGG; hsa:64843; -.
DR   UCSC; uc002bbw.2; human.
DR   CTD; 64843; -.
DR   EuPathDB; HostDB:ENSG00000159556.9; -.
DR   GeneCards; ISL2; -.
DR   HGNC; HGNC:18524; ISL2.
DR   HPA; HPA075192; -.
DR   MIM; 609481; gene.
DR   neXtProt; NX_Q96A47; -.
DR   OpenTargets; ENSG00000159556; -.
DR   PharmGKB; PA38566; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000236304; -.
DR   HOVERGEN; HBG004671; -.
DR   InParanoid; Q96A47; -.
DR   KO; K18492; -.
DR   OMA; RHDSAVQ; -.
DR   OrthoDB; EOG091G09L9; -.
DR   PhylomeDB; Q96A47; -.
DR   TreeFam; TF315442; -.
DR   SIGNOR; Q96A47; -.
DR   GenomeRNAi; 64843; -.
DR   PRO; PR:Q96A47; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000159556; -.
DR   CleanEx; HS_ISL2; -.
DR   ExpressionAtlas; Q96A47; baseline and differential.
DR   Genevisible; Q96A47; HS.
DR   GO; GO:0005634; C:nucleus; IC:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; TAS:BHF-UCL.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; TAS:BHF-UCL.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl.
DR   GO; GO:0021524; P:visceral motor neuron differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   LIM domain; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Zinc.
FT   CHAIN         1    359       Insulin gene enhancer protein ISL-2.
FT                                /FTId=PRO_0000075752.
FT   DOMAIN       25     86       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       87    149       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    191    250       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      272    301       LIM-binding domain (LID). {ECO:0000250}.
FT   MOD_RES     154    154       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     279    279       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
SQ   SEQUENCE   359 AA;  39768 MW;  2162FB3D430EE4BE CRC64;
     MVDIIFHYPF LGAMGDHSKK KPGTAMCVGC GSQIHDQFIL RVSPDLEWHA ACLKCAECSQ
     YLDETCTCFV RDGKTYCKRD YVRLFGIKCA KCQVGFSSSD LVMRARDSVY HIECFRCSVC
     SRQLLPGDEF SLREHELLCR ADHGLLLERA AAGSPRSPGP LPGARGLHLP DAGSGRQPAL
     RPHVHKQTEK TTRVRTVLNE KQLHTLRTCY AANPRPDALM KEQLVEMTGL SPRVIRVWFQ
     NKRCKDKKKS ILMKQLQQQQ HSDKTSLQGL TGTPLVAGSP IRHENAVQGS AVEVQTYQPP
     WKALSEFALQ SDLDQPAFQQ LVSFSESGSL GNSSGSDVTS LSSQLPDTPN SMVPSPVET
//
ID   IRX6_HUMAN              Reviewed;         446 AA.
AC   P78412; B2RN06; Q7Z2K0;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   27-SEP-2017, entry version 131.
DE   RecName: Full=Iroquois-class homeodomain protein IRX-6;
DE   AltName: Full=Homeodomain protein IRXB3;
DE   AltName: Full=Iroquois homeobox protein 6;
GN   Name=IRX6; Synonyms=IRX7, IRXB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Hansen L., Wu Q., Tommerup N.;
RT   "Characterization of the human homeobox two-cluster Iroquois gene
RT   family.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-195.
RA   Lewis M.T., Strickland P.A., Ross S., Snyder C.J., Daniel C.W.;
RT   "IRX: a new family of human homeobox genes from the breast.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY335937; AAQ16543.1; -; mRNA.
DR   EMBL; AY335946; AAQ16552.1; -; Genomic_DNA.
DR   EMBL; AK125053; BAC86033.1; -; mRNA.
DR   EMBL; CH471092; EAW82823.1; -; Genomic_DNA.
DR   EMBL; BC136573; AAI36574.1; -; mRNA.
DR   EMBL; BC136576; AAI36577.1; -; mRNA.
DR   EMBL; U90305; AAB50003.1; -; mRNA.
DR   CCDS; CCDS32449.1; -.
DR   RefSeq; NP_077311.2; NM_024335.2.
DR   RefSeq; XP_005256194.1; XM_005256137.2.
DR   UniGene; Hs.369907; -.
DR   ProteinModelPortal; P78412; -.
DR   SMR; P78412; -.
DR   IntAct; P78412; 6.
DR   STRING; 9606.ENSP00000290552; -.
DR   iPTMnet; P78412; -.
DR   PhosphoSitePlus; P78412; -.
DR   BioMuta; IRX6; -.
DR   DMDM; 116242594; -.
DR   MaxQB; P78412; -.
DR   PaxDb; P78412; -.
DR   PeptideAtlas; P78412; -.
DR   PRIDE; P78412; -.
DR   Ensembl; ENST00000290552; ENSP00000290552; ENSG00000159387.
DR   GeneID; 79190; -.
DR   KEGG; hsa:79190; -.
DR   UCSC; uc002ehy.4; human.
DR   CTD; 79190; -.
DR   EuPathDB; HostDB:ENSG00000159387.7; -.
DR   GeneCards; IRX6; -.
DR   HGNC; HGNC:14675; IRX6.
DR   HPA; HPA018332; -.
DR   MIM; 606196; gene.
DR   neXtProt; NX_P78412; -.
DR   OpenTargets; ENSG00000159387; -.
DR   PharmGKB; PA29929; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000234546; -.
DR   HOVERGEN; HBG006180; -.
DR   InParanoid; P78412; -.
DR   OMA; LCCAPYD; -.
DR   OrthoDB; EOG091G0N9R; -.
DR   PhylomeDB; P78412; -.
DR   TreeFam; TF319371; -.
DR   GeneWiki; IRX6; -.
DR   GenomeRNAi; 79190; -.
DR   PRO; PR:P78412; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000159387; -.
DR   CleanEx; HS_IRX6; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR003893; Iroquois_homeo.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00548; IRO; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    446       Iroquois-class homeodomain protein IRX-6.
FT                                /FTId=PRO_0000049162.
FT   DNA_BIND    144    207       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   CONFLICT    117    117       S -> G (in Ref. 5; AAB50003).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       Missing (in Ref. 1). {ECO:0000305}.
SQ   SEQUENCE   446 AA;  48240 MW;  4E542FEDD5D06912 CRC64;
     MSFPHFGHPY RGASQFLASA SSSTTCCEST QRSVSDVASG STPAPALCCA PYDSRLLGSA
     RPELGAALGI YGAPYAAAAA AQSYPGYLPY SPEPPSLYGA LNPQYEFKEA AGSFTSSLAQ
     PGAYYPYERT LGQYQYERYG AVELSGAGRR KNATRETTST LKAWLNEHRK NPYPTKGEKI
     MLAIITKMTL TQVSTWFANA RRRLKKENKM TWAPKNKGGE ERKAEGGEED SLGCLTADTK
     EVTASQEARG LRLSDLEDLE EEEEEEEEAE DEEVVATAGD RLTEFRKGAQ SLPGPCAAAR
     EGRLERRECG LAAPRFSFND PSGSEEADFL SAETGSPRLT MHYPCLEKPR IWSLAHTATA
     SAVEGAPPAR PRPRSPECRM IPGQPPASAR RLSVPRDSAC DESSCIPKAF GNPKFALQGL
     PLNCAPCPRR SEPVVQCQYP SGAEAG
//
ID   ISX_HUMAN               Reviewed;         245 AA.
AC   Q2M1V0; Q68DJ5;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   25-OCT-2017, entry version 104.
DE   RecName: Full=Intestine-specific homeobox;
DE   AltName: Full=RAX-like homeobox;
GN   Name=ISX; Synonyms=RAXLX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLY-28 AND
RP   SER-57.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor that regulates gene expression in
CC       intestine. May participate in vitamin A metabolism most likely by
CC       regulating BCO1 expression in the intestine (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P78424:POU6F2; NbExp=4; IntAct=EBI-6426064, EBI-12029004;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR749372; CAH18225.1; -; mRNA.
DR   EMBL; Z83853; CAI18752.1; -; Genomic_DNA.
DR   EMBL; AL024494; CAI18752.1; JOINED; Genomic_DNA.
DR   EMBL; AL024494; CAI19818.1; -; Genomic_DNA.
DR   EMBL; Z83853; CAI19818.1; JOINED; Genomic_DNA.
DR   EMBL; BC112212; AAI12213.1; -; mRNA.
DR   EMBL; BC113633; AAI13634.1; -; mRNA.
DR   CCDS; CCDS33640.1; -.
DR   RefSeq; NP_001290437.1; NM_001303508.1.
DR   UniGene; Hs.567637; -.
DR   ProteinModelPortal; Q2M1V0; -.
DR   SMR; Q2M1V0; -.
DR   BioGrid; 124838; 4.
DR   IntAct; Q2M1V0; 2.
DR   STRING; 9606.ENSP00000311492; -.
DR   PhosphoSitePlus; Q2M1V0; -.
DR   BioMuta; ISX; -.
DR   DMDM; 150387849; -.
DR   PaxDb; Q2M1V0; -.
DR   PeptideAtlas; Q2M1V0; -.
DR   PRIDE; Q2M1V0; -.
DR   DNASU; 91464; -.
DR   Ensembl; ENST00000308700; ENSP00000311492; ENSG00000175329.
DR   Ensembl; ENST00000404699; ENSP00000386037; ENSG00000175329.
DR   GeneID; 91464; -.
DR   KEGG; hsa:91464; -.
DR   UCSC; uc003anj.4; human.
DR   CTD; 91464; -.
DR   DisGeNET; 91464; -.
DR   EuPathDB; HostDB:ENSG00000175329.12; -.
DR   GeneCards; ISX; -.
DR   HGNC; HGNC:28084; ISX.
DR   HPA; HPA060328; -.
DR   MIM; 612019; gene.
DR   neXtProt; NX_Q2M1V0; -.
DR   OpenTargets; ENSG00000175329; -.
DR   PharmGKB; PA147357909; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000052524; -.
DR   HOVERGEN; HBG096596; -.
DR   InParanoid; Q2M1V0; -.
DR   OMA; CCEAPKK; -.
DR   OrthoDB; EOG091G0NQL; -.
DR   PhylomeDB; Q2M1V0; -.
DR   TreeFam; TF315976; -.
DR   GenomeRNAi; 91464; -.
DR   PRO; PR:Q2M1V0; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000175329; -.
DR   CleanEx; HS_ISX; -.
DR   Genevisible; Q2M1V0; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:1904479; P:negative regulation of intestinal absorption; IEA:Ensembl.
DR   GO; GO:1901738; P:regulation of vitamin A metabolic process; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    245       Intestine-specific homeobox.
FT                                /FTId=PRO_0000288602.
FT   DNA_BIND     82    141       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      28     28       S -> G (in dbSNP:rs361863).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032448.
FT   VARIANT      57     57       P -> S (in dbSNP:rs362090).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032449.
FT   VARIANT      83     83       R -> Q (in dbSNP:rs8140287).
FT                                /FTId=VAR_032450.
FT   VARIANT     158    158       A -> V (in dbSNP:rs7291048).
FT                                /FTId=VAR_032451.
SQ   SEQUENCE   245 AA;  27011 MW;  361FB0447DC6C02D CRC64;
     MCAEVGPALC RGMERNSLGC CEAPKKLSLS FSIEAILKRP ARRSDMDRPE GPGEEGPGEA
     AASGSGLEKP PKDQPQEGRK SKRRVRTTFT TEQLHELEKI FHFTHYPDVH IRSQLAARIN
     LPEARVQIWF QNQRAKWRKQ EKIGNLGAPQ QLSEASVALP TNLDVAGPTW TSTALRRLAP
     PTSCCPSAQD QLASAWFPAW ITLLPAHPWE TQPVPGLPIH QTCIPVLCIL PPPHPKWGSI
     CATST
//
ID   IRX1_HUMAN              Reviewed;         480 AA.
AC   P78414; Q7Z2F8; Q8N312;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 3.
DT   27-SEP-2017, entry version 135.
DE   RecName: Full=Iroquois-class homeodomain protein IRX-1;
DE   AltName: Full=Homeodomain protein IRXA1;
DE   AltName: Full=Iroquois homeobox protein 1;
GN   Name=IRX1; Synonyms=IRXA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RA   Hansen L., Wu Q., Tommerup N.;
RT   "Characterization of the human homeobox two-cluster Iroquois gene
RT   family.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 83-480.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 84-176.
RA   Lewis M.T., Strickland P.A., Ross S., Snyder C.J., Daniel C.W.;
RT   "IRX: a new family of human homeobox genes from the breast.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY335938; AAQ16544.1; -; mRNA.
DR   EMBL; AY335947; AAQ16553.1; -; Genomic_DNA.
DR   EMBL; BC029160; AAH29160.1; -; mRNA.
DR   EMBL; U90307; AAB50005.1; -; mRNA.
DR   CCDS; CCDS34132.1; -.
DR   RefSeq; NP_077313.3; NM_024337.3.
DR   UniGene; Hs.424156; -.
DR   ProteinModelPortal; P78414; -.
DR   SMR; P78414; -.
DR   BioGrid; 122604; 2.
DR   STRING; 9606.ENSP00000305244; -.
DR   iPTMnet; P78414; -.
DR   PhosphoSitePlus; P78414; -.
DR   BioMuta; IRX1; -.
DR   DMDM; 47117873; -.
DR   EPD; P78414; -.
DR   MaxQB; P78414; -.
DR   PaxDb; P78414; -.
DR   PeptideAtlas; P78414; -.
DR   PRIDE; P78414; -.
DR   DNASU; 79192; -.
DR   Ensembl; ENST00000302006; ENSP00000305244; ENSG00000170549.
DR   GeneID; 79192; -.
DR   KEGG; hsa:79192; -.
DR   UCSC; uc003jde.3; human.
DR   CTD; 79192; -.
DR   DisGeNET; 79192; -.
DR   EuPathDB; HostDB:ENSG00000170549.3; -.
DR   GeneCards; IRX1; -.
DR   HGNC; HGNC:14358; IRX1.
DR   HPA; HPA043160; -.
DR   MIM; 606197; gene.
DR   neXtProt; NX_P78414; -.
DR   OpenTargets; ENSG00000170549; -.
DR   PharmGKB; PA29924; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000234546; -.
DR   HOVERGEN; HBG006180; -.
DR   InParanoid; P78414; -.
DR   OMA; LYTCHIG; -.
DR   OrthoDB; EOG091G0BOB; -.
DR   PhylomeDB; P78414; -.
DR   TreeFam; TF319371; -.
DR   GeneWiki; IRX1; -.
DR   GenomeRNAi; 79192; -.
DR   PRO; PR:P78414; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170549; -.
DR   CleanEx; HS_IRX1; -.
DR   Genevisible; P78414; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0072272; P:proximal/distal pattern formation involved in metanephric nephron development; IEA:Ensembl.
DR   GO; GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR003893; Iroquois_homeo.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00548; IRO; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    480       Iroquois-class homeodomain protein IRX-1.
FT                                /FTId=PRO_0000049151.
FT   DNA_BIND    125    188       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS    334    337       Poly-Pro.
FT   COMPBIAS    407    415       Poly-Pro.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P81068}.
FT   CONFLICT    138    138       S -> N (in Ref. 2; AAB50005).
FT                                {ECO:0000305}.
SQ   SEQUENCE   480 AA;  49621 MW;  ABC3A7069593E0E1 CRC64;
     MSFPQLGYPQ YLSAAGPGAY GGERPGVLAA AAAAAAAASS GRPGAAELGG GAGAAAVTSV
     LGMYAAAGPY AGAPNYSAFL PYAADLSLFS QMGSQYELKD NPGVHPATFA AHTAPAYYPY
     GQFQYGDPGR PKNATRESTS TLKAWLNEHR KNPYPTKGEK IMLAIITKMT LTQVSTWFAN
     ARRRLKKENK VTWGARSKDQ EDGALFGSDT EGDPEKAEDD EEIDLESIDI DKIDEHDGDQ
     SNEDDEDKAE APHAPAAPSA LARDQGSPLA AADVLKPQDS PLGLAKEAPE PGSTRLLSPG
     AAAGGLQGAP HGKPKIWSLA ETATSPDGAP KASPPPPAGH PGAHGPSAGA PLQHPAFLPS
     HGLYTCHIGK FSNWTNSAFL AQGSLLNMRS FLGVGAPHAA PHGPHLPAPP PPQPPVAIAP
     GALNGDKASV RSSPTLPERD LVPRPDSPAQ QLKSPFQPVR DNSLAPQEGT PRILAALPSA
//
ID   LBX2_HUMAN              Reviewed;         198 AA.
AC   Q6XYB7; Q7Z5Y8;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 117.
DE   RecName: Full=Transcription factor LBX2;
DE   AltName: Full=Ladybird homeobox protein homolog 2;
GN   Name=LBX2; ORFNames=LP3727;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Huang C.Q., Wu S.L., Chen Z., Shan Y.X., Liu S., Xiao P.J.;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=11386758; DOI=10.1006/geno.2001.6539;
RA   Chen F., Collin G.B., Liu K.C., Beier D.R., Eccles M., Nishina P.M.,
RA   Moshang T., Epstein J.A.;
RT   "Characterization of the murine Lbx2 promoter, identification of the
RT   human homologue, and evaluation as a candidate for Alstrom syndrome.";
RL   Genomics 74:219-227(2001).
CC   -!- FUNCTION: Putative transcription factor. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P50750-2:CDK9; NbExp=4; IntAct=EBI-12029900, EBI-12029902;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6XYB7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6XYB7-2; Sequence=VSP_029522;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY305861; AAP74384.1; -; mRNA.
DR   EMBL; AY203953; AAP34476.1; -; mRNA.
DR   EMBL; CH471053; EAW99636.1; -; Genomic_DNA.
DR   EMBL; BC150517; AAI50518.1; -; mRNA.
DR   CCDS; CCDS33228.1; -. [Q6XYB7-2]
DR   CCDS; CCDS62938.1; -. [Q6XYB7-1]
DR   RefSeq; NP_001009812.1; NM_001009812.1. [Q6XYB7-2]
DR   RefSeq; NP_001269359.1; NM_001282430.1. [Q6XYB7-1]
DR   UniGene; Hs.516124; -.
DR   ProteinModelPortal; Q6XYB7; -.
DR   SMR; Q6XYB7; -.
DR   IntAct; Q6XYB7; 2.
DR   STRING; 9606.ENSP00000417116; -.
DR   iPTMnet; Q6XYB7; -.
DR   DMDM; 74749508; -.
DR   EPD; Q6XYB7; -.
DR   PaxDb; Q6XYB7; -.
DR   PeptideAtlas; Q6XYB7; -.
DR   PRIDE; Q6XYB7; -.
DR   DNASU; 85474; -.
DR   Ensembl; ENST00000377566; ENSP00000366789; ENSG00000179528. [Q6XYB7-1]
DR   Ensembl; ENST00000460508; ENSP00000417116; ENSG00000179528. [Q6XYB7-2]
DR   GeneID; 85474; -.
DR   KEGG; hsa:85474; -.
DR   UCSC; uc002slv.6; human. [Q6XYB7-1]
DR   CTD; 85474; -.
DR   EuPathDB; HostDB:ENSG00000179528.15; -.
DR   GeneCards; LBX2; -.
DR   HGNC; HGNC:15525; LBX2.
DR   HPA; HPA044257; -.
DR   MIM; 607164; gene.
DR   neXtProt; NX_Q6XYB7; -.
DR   OpenTargets; ENSG00000179528; -.
DR   PharmGKB; PA30305; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000007247; -.
DR   HOVERGEN; HBG006244; -.
DR   InParanoid; Q6XYB7; -.
DR   KO; K09353; -.
DR   OMA; DILAPRM; -.
DR   OrthoDB; EOG091G09CY; -.
DR   PhylomeDB; Q6XYB7; -.
DR   TreeFam; TF325047; -.
DR   GenomeRNAi; 85474; -.
DR   PRO; PR:Q6XYB7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000179528; -.
DR   CleanEx; HS_LBX2; -.
DR   ExpressionAtlas; Q6XYB7; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    198       Transcription factor LBX2.
FT                                /FTId=PRO_0000311328.
FT   DNA_BIND     85    144       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1     69       MNSGREPRTPRTLLSIADILAPRMVPRAPSAPQLPESGPGP
FT                                TSPLCALEELTSKTFRGLDARALQPSEG -> MGKRTSLEV
FT                                SLGELGGEKCRGGRRSFPPLAASRPARPGGWRWARRDLCKT
FT                                ASRAENNSQACRPQR (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_029522.
FT   VARIANT     158    158       S -> F (in dbSNP:rs17009998).
FT                                /FTId=VAR_037227.
SQ   SEQUENCE   198 AA;  21482 MW;  FF0796EB344F5C26 CRC64;
     MNSGREPRTP RTLLSIADIL APRMVPRAPS APQLPESGPG PTSPLCALEE LTSKTFRGLD
     ARALQPSEGR AGPDALGPGP FGRKRRKSRT AFTAQQVLEL ERRFVFQKYL APSERDGLAT
     RLGLANAQVV TWFQNRRAKL KRDVEEMRAD VASLRALSPE VLCSLALPEG APDPGLCLGP
     AGPDSRPHLS DEEIQVDD
//
ID   LBX1_HUMAN              Reviewed;         281 AA.
AC   P52954; B9EGA2; Q05BB2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 2.
DT   27-SEP-2017, entry version 137.
DE   RecName: Full=Transcription factor LBX1;
DE   AltName: Full=Ladybird homeobox protein homolog 1;
GN   Name=LBX1; Synonyms=LBX1H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8645601; DOI=10.1016/0925-4773(95)00450-5;
RA   Jagla K., Dolle P., Mattei M.-G., Jagla T., Schuhbaur B., Dretzen G.,
RA   Bellard F., Bellard M.;
RT   "Mouse Lbx1 and human LBX1 define a novel mammalian homeobox gene
RT   family related to the Drosophila lady bird genes.";
RL   Mech. Dev. 53:345-356(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor required for the development of
CC       GABAergic interneurons in the dorsal horn of the spinal cord and
CC       migration and further development of hypaxial muscle precursor
CC       cells for limb muscles, diaphragm and hypoglossal cord.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with SKOR1 which acts as a transcriptional
CC       corepressor. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X90828; CAA62342.1; -; mRNA.
DR   EMBL; AL135794; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49777.1; -; Genomic_DNA.
DR   EMBL; BC069156; AAH69156.1; -; mRNA.
DR   EMBL; BC136321; AAI36322.1; -; mRNA.
DR   CCDS; CCDS31270.1; -.
DR   RefSeq; NP_006553.2; NM_006562.4.
DR   UniGene; Hs.37128; -.
DR   ProteinModelPortal; P52954; -.
DR   SMR; P52954; -.
DR   BioGrid; 115903; 1.
DR   STRING; 9606.ENSP00000359212; -.
DR   iPTMnet; P52954; -.
DR   PhosphoSitePlus; P52954; -.
DR   BioMuta; LBX1; -.
DR   DMDM; 117949813; -.
DR   PaxDb; P52954; -.
DR   PeptideAtlas; P52954; -.
DR   PRIDE; P52954; -.
DR   Ensembl; ENST00000370193; ENSP00000359212; ENSG00000138136.
DR   GeneID; 10660; -.
DR   KEGG; hsa:10660; -.
DR   UCSC; uc001ksx.4; human.
DR   CTD; 10660; -.
DR   DisGeNET; 10660; -.
DR   EuPathDB; HostDB:ENSG00000138136.6; -.
DR   GeneCards; LBX1; -.
DR   HGNC; HGNC:16960; LBX1.
DR   HPA; HPA002016; -.
DR   HPA; HPA002086; -.
DR   MIM; 604255; gene.
DR   neXtProt; NX_P52954; -.
DR   OpenTargets; ENSG00000138136; -.
DR   PharmGKB; PA142671561; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000007247; -.
DR   HOVERGEN; HBG006244; -.
DR   InParanoid; P52954; -.
DR   KO; K09353; -.
DR   OMA; HTTSKEC; -.
DR   OrthoDB; EOG091G09CY; -.
DR   PhylomeDB; P52954; -.
DR   TreeFam; TF325047; -.
DR   SIGNOR; P52954; -.
DR   GeneWiki; LBX1; -.
DR   GenomeRNAi; 10660; -.
DR   PRO; PR:P52954; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000138136; -.
DR   CleanEx; HS_LBX1; -.
DR   Genevisible; P52954; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0001947; P:heart looping; IEA:Ensembl.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048664; P:neuron fate determination; IEA:Ensembl.
DR   GO; GO:0021920; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification; IEA:Ensembl.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Myogenesis; Neurogenesis; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    281       Transcription factor LBX1.
FT                                /FTId=PRO_0000049166.
FT   DNA_BIND    125    184       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    220    226       Poly-Gly.
FT   COMPBIAS    270    281       Asp/Glu-rich (highly acidic).
FT   CONFLICT     33     72       LTPFSIEDILNKPSVRRSYSLCGAAHLLAAADKHAQGGLP
FT                                -> YAVQHRGHPQQAVRAEKLLAAWGGAPAGRRGQARAGRL
FT                                A (in Ref. 1; CAA62342). {ECO:0000305}.
FT   CONFLICT     81     81       Q -> K (in Ref. 1; CAA62342).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       D -> E (in Ref. 1; CAA62342).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       A -> P (in Ref. 1; CAA62342).
FT                                {ECO:0000305}.
FT   CONFLICT    247    248       AG -> RC (in Ref. 1; CAA62342).
FT                                {ECO:0000305}.
SQ   SEQUENCE   281 AA;  30221 MW;  8467F2B515681CCA CRC64;
     MTSKEDGKAA PGEERRRSPL DHLPPPANSN KPLTPFSIED ILNKPSVRRS YSLCGAAHLL
     AAADKHAQGG LPLAGRALLS QTSPLCALEE LASKTFKGLE VSVLQAAEGR DGMTIFGQRQ
     TPKKRRKSRT AFTNHQIYEL EKRFLYQKYL SPADRDQIAQ QLGLTNAQVI TWFQNRRAKL
     KRDLEEMKAD VESAKKLGPS GQMDIVALAE LEQNSEATAG GGGGCGRAKS RPGSPVLPPG
     APKAPGAGAL QLSPASPLTD QPASSQDCSE DEEDEEIDVD D
//
ID   LMX1B_HUMAN             Reviewed;         402 AA.
AC   O60663; F8W7W6; O75463; Q5JU95; Q6ISC9;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2013, sequence version 3.
DT   27-SEP-2017, entry version 168.
DE   RecName: Full=LIM homeobox transcription factor 1-beta;
DE   AltName: Full=LIM/homeobox protein 1.2;
DE            Short=LMX-1.2;
DE   AltName: Full=LIM/homeobox protein LMX1B;
GN   Name=LMX1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT NPS
RP   PHE-118.
RX   PubMed=9618165; DOI=10.1093/hmg/7.7.1091;
RA   Vollrath D., Jaramillo-Babb V.L., Clough M.V., McIntosh I.,
RA   Scott K.M., Lichter P.R., Richards J.E.;
RT   "Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in
RT   nail-patella syndrome.";
RL   Hum. Mol. Genet. 7:1091-1098(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-402 (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-402 (ISOFORM 2), AND VARIANT NPS
RP   LYS-269.
RX   PubMed=9590287; DOI=10.1038/ng0598-47;
RA   Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W.,
RA   Johnson R.L., Lee B.;
RT   "Mutations in LMX1B cause abnormal skeletal patterning and renal
RT   dysplasia in nail patella syndrome.";
RL   Nat. Genet. 19:47-50(1998).
RN   [6]
RP   INTERACTION WITH DHX9.
RX   PubMed=23308148; DOI=10.1371/journal.pone.0053122;
RA   Hoekstra E.J., Mesman S., de Munnik W.A., Smidt M.P.;
RT   "LMX1B is part of a transcriptional complex with PSPC1 and PSF.";
RL   PLoS ONE 8:E53122-E53122(2013).
RN   [7]
RP   VARIANTS NPS TRP-165; GLN-223; PRO-236; PRO-241; PRO-249; VAL-253 AND
RP   LYS-269.
RX   PubMed=9837817; DOI=10.1086/302165;
RA   McIntosh I., Dreyer S.D., Clough M.V., Dunston J.A., Eyaid W.,
RA   Roig C.M., Montgomery T., Ala-Mello S., Kaitila I., Winterpacht A.,
RA   Zabel B., Frydman M., Cole W.G., Francomano C.A., Lee B.;
RT   "Mutation analysis of LMX1B gene in nail-patella syndrome patients.";
RL   Am. J. Hum. Genet. 63:1651-1658(1998).
RN   [8]
RP   VARIANTS NPS ARG-59; SER-59; GLN-77; TYR-77; ARG-80; GLY-83; TYR-83;
RP   ARG-86; GLY-106; TYR-118; SER-143; PHE-146; TYR-146 AND PRO-252.
RX   PubMed=10571942;
RX   DOI=10.1002/(SICI)1098-1004(199912)14:6<459::AID-HUMU3>3.0.CO;2-9;
RA   Clough M.V., Hamlington J.D., McIntosh I.;
RT   "Restricted distribution of loss-of-function mutations within the
RT   LMX1B genes of nail-patella syndrome patients.";
RL   Hum. Mutat. 14:459-465(1999).
RN   [9]
RP   VARIANTS NPS ASN-77; TRP-81; PHE-83; TRP-83; TRP-103; TYR-118;
RP   TYR-137; TYR-140; GLN-223; PRO-236; CYS-266 AND LYS-269.
RX   PubMed=11668639; DOI=10.1002/humu.1217.abs;
RA   Hamlington J.D., Jones C., McIntosh I.;
RT   "Twenty-two novel LMX1B mutations identified in nail patella syndrome
RT   (NPS) patients.";
RL   Hum. Mutat. 18:458-458(2001).
CC   -!- FUNCTION: Essential for the specification of dorsal limb fate at
CC       both the zeugopodal and autopodal levels.
CC   -!- SUBUNIT: Interacts with DHX9 (PubMed:23308148).
CC       {ECO:0000269|PubMed:23308148}.
CC   -!- INTERACTION:
CC       Q86U70:LDB1; NbExp=3; IntAct=EBI-10258690, EBI-677177;
CC       Q02962:PAX2; NbExp=3; IntAct=EBI-10258690, EBI-1805765;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=O60663-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=O60663-2; Sequence=VSP_003113;
CC       Name=3;
CC         IsoId=O60663-3; Sequence=VSP_046472, VSP_003113;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues. Highest levels in
CC       testis, thyroid, duodenum, skeletal muscle, and pancreatic islets.
CC   -!- DISEASE: Nail-patella syndrome (NPS) [MIM:161200]: Disease that
CC       cause abnormal skeletal patterning and renal dysplasia.
CC       {ECO:0000269|PubMed:10571942, ECO:0000269|PubMed:11668639,
CC       ECO:0000269|PubMed:9590287, ECO:0000269|PubMed:9618165,
CC       ECO:0000269|PubMed:9837817}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC27294.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC39738.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH69601.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI12121.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI13492.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAH70295.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAI40918.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=EAW87642.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF059575; AAC27294.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF059572; AAC27294.1; JOINED; Genomic_DNA.
DR   EMBL; AF059573; AAC27294.1; JOINED; Genomic_DNA.
DR   EMBL; AF059574; AAC27294.1; JOINED; Genomic_DNA.
DR   EMBL; AL161908; CAH70294.1; -; Genomic_DNA.
DR   EMBL; AL161731; CAH70294.1; JOINED; Genomic_DNA.
DR   EMBL; AL161908; CAH70295.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL161731; CAH70295.1; JOINED; Genomic_DNA.
DR   EMBL; AL161731; CAI40917.1; -; Genomic_DNA.
DR   EMBL; AL161908; CAI40917.1; JOINED; Genomic_DNA.
DR   EMBL; AL161731; CAI40918.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL161908; CAI40918.1; JOINED; Genomic_DNA.
DR   EMBL; CH471090; EAW87642.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC069601; AAH69601.1; ALT_INIT; mRNA.
DR   EMBL; BC112120; AAI12121.1; ALT_INIT; mRNA.
DR   EMBL; BC113491; AAI13492.1; ALT_INIT; mRNA.
DR   EMBL; AF057135; AAC39738.1; ALT_INIT; mRNA.
DR   CCDS; CCDS55342.1; -. [O60663-1]
DR   CCDS; CCDS55343.1; -. [O60663-3]
DR   CCDS; CCDS6866.2; -. [O60663-2]
DR   RefSeq; NP_001167618.1; NM_001174147.1. [O60663-1]
DR   RefSeq; NP_002307.2; NM_002316.3. [O60663-2]
DR   UniGene; Hs.129133; -.
DR   ProteinModelPortal; O60663; -.
DR   SMR; O60663; -.
DR   BioGrid; 110195; 18.
DR   IntAct; O60663; 5.
DR   STRING; 9606.ENSP00000347684; -.
DR   iPTMnet; O60663; -.
DR   PhosphoSitePlus; O60663; -.
DR   BioMuta; LMX1B; -.
DR   PaxDb; O60663; -.
DR   PeptideAtlas; O60663; -.
DR   PRIDE; O60663; -.
DR   DNASU; 4010; -.
DR   Ensembl; ENST00000355497; ENSP00000347684; ENSG00000136944. [O60663-3]
DR   Ensembl; ENST00000373474; ENSP00000362573; ENSG00000136944. [O60663-1]
DR   Ensembl; ENST00000526117; ENSP00000436930; ENSG00000136944. [O60663-2]
DR   GeneID; 4010; -.
DR   KEGG; hsa:4010; -.
DR   UCSC; uc004bqi.4; human. [O60663-1]
DR   CTD; 4010; -.
DR   DisGeNET; 4010; -.
DR   EuPathDB; HostDB:ENSG00000136944.17; -.
DR   GeneCards; LMX1B; -.
DR   GeneReviews; LMX1B; -.
DR   HGNC; HGNC:6654; LMX1B.
DR   HPA; HPA073716; -.
DR   MalaCards; LMX1B; -.
DR   MIM; 161200; phenotype.
DR   MIM; 602575; gene.
DR   neXtProt; NX_O60663; -.
DR   OpenTargets; ENSG00000136944; -.
DR   Orphanet; 2614; Nail-patella syndrome.
DR   PharmGKB; PA30417; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000231629; -.
DR   HOVERGEN; HBG052335; -.
DR   InParanoid; O60663; -.
DR   KO; K09371; -.
DR   OMA; NRMEGMM; -.
DR   OrthoDB; EOG091G09Z3; -.
DR   TreeFam; TF315442; -.
DR   SIGNOR; O60663; -.
DR   GeneWiki; LMX1B; -.
DR   GenomeRNAi; 4010; -.
DR   PRO; PR:O60663; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000136944; -.
DR   CleanEx; HS_LMX1B; -.
DR   ExpressionAtlas; O60663; baseline and differential.
DR   Genevisible; O60663; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0000983; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; ISS:BHF-UCL.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; NAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   LIM domain; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc.
FT   CHAIN         1    402       LIM homeobox transcription factor 1-beta.
FT                                /FTId=PRO_0000075828.
FT   DOMAIN       56    106       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      115    168       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    219    278       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    282    288       Poly-Gln.
FT   VAR_SEQ     293    293       L -> LGQGEPGPGQGL (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_046472.
FT   VAR_SEQ     345    351       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9590287}.
FT                                /FTId=VSP_003113.
FT   VARIANT      59     59       C -> R (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015201.
FT   VARIANT      59     59       C -> S (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015202.
FT   VARIANT      75     75       S -> F (in dbSNP:rs2235058).
FT                                /FTId=VAR_047755.
FT   VARIANT      77     77       H -> N (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015190.
FT   VARIANT      77     77       H -> Q (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015203.
FT   VARIANT      77     77       H -> Y (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015204.
FT   VARIANT      80     80       C -> R (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015205.
FT   VARIANT      81     81       L -> W (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015191.
FT   VARIANT      83     83       C -> F (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015192.
FT   VARIANT      83     83       C -> G (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015206.
FT   VARIANT      83     83       C -> W (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015193.
FT   VARIANT      83     83       C -> Y (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015207.
FT   VARIANT      86     86       C -> R (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015208.
FT   VARIANT     103    103       C -> W (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015194.
FT   VARIANT     106    106       D -> G (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015209.
FT   VARIANT     118    118       C -> F (in NPS; dbSNP:rs121909488).
FT                                {ECO:0000269|PubMed:9618165}.
FT                                /FTId=VAR_004198.
FT   VARIANT     118    118       C -> Y (in NPS).
FT                                {ECO:0000269|PubMed:10571942,
FT                                ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015195.
FT   VARIANT     137    137       H -> Y (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015196.
FT   VARIANT     140    140       C -> Y (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015197.
FT   VARIANT     143    143       C -> S (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015210.
FT   VARIANT     146    146       C -> F (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015211.
FT   VARIANT     146    146       C -> Y (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015212.
FT   VARIANT     165    165       C -> W (in NPS).
FT                                {ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004199.
FT   VARIANT     223    223       R -> Q (in NPS; dbSNP:rs28939692).
FT                                {ECO:0000269|PubMed:11668639,
FT                                ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004200.
FT   VARIANT     236    236       A -> P (in NPS).
FT                                {ECO:0000269|PubMed:11668639,
FT                                ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004201.
FT   VARIANT     241    241       S -> P (in NPS).
FT                                {ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004202.
FT   VARIANT     249    249       R -> P (in NPS).
FT                                {ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004203.
FT   VARIANT     252    252       L -> P (in NPS).
FT                                {ECO:0000269|PubMed:10571942}.
FT                                /FTId=VAR_015213.
FT   VARIANT     253    253       A -> V (in NPS).
FT                                {ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004204.
FT   VARIANT     266    266       W -> C (in NPS).
FT                                {ECO:0000269|PubMed:11668639}.
FT                                /FTId=VAR_015198.
FT   VARIANT     269    269       N -> K (in NPS; dbSNP:rs121909486).
FT                                {ECO:0000269|PubMed:11668639,
FT                                ECO:0000269|PubMed:9590287,
FT                                ECO:0000269|PubMed:9837817}.
FT                                /FTId=VAR_004205.
SQ   SEQUENCE   402 AA;  44917 MW;  E59FC36C39C7C9A3 CRC64;
     MDIATGPESL ERCFPRGQTD CAKMLDGIKM EEHALRPGPA TLGVLLGSDC PHPAVCEGCQ
     RPISDRFLMR VNESSWHEEC LQCAACQQAL TTSCYFRDRK LYCKQDYQQL FAAKCSGCME
     KIAPTEFVMR ALECVYHLGC FCCCVCERQL RKGDEFVLKE GQLLCKGDYE KEKDLLSSVS
     PDESDSVKSE DEDGDMKPAK GQGSQSKGSG DDGKDPRRPK RPRTILTTQQ RRAFKASFEV
     SSKPCRKVRE TLAAETGLSV RVVQVWFQNQ RAKMKKLARR HQQQQEQQNS QRLGQEVLSS
     RMEGMMASYT PLAPPQQQIV AMEQSPYGSS DPFQQGLTPP QMPGDHMNPY GNDSIFHDID
     SDTSLTSLSD CFLGSSDVGS LQARVGNPID RLYSMQSSYF AS
//
ID   LHX4_HUMAN              Reviewed;         390 AA.
AC   Q969G2; Q8NHE0; Q8NHM1; Q8TCJ1; Q8WWX2; Q969W2;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   25-OCT-2017, entry version 161.
DE   RecName: Full=LIM/homeobox protein Lhx4;
DE            Short=LIM homeobox protein 4;
GN   Name=LHX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH IGHG1.
RX   PubMed=12118377; DOI=10.1038/sj.onc.1205628;
RA   Kawamata N., Sakajiri S., Sugimoto K.J., Isobe Y., Kobayashi H.,
RA   Oshimi K.;
RT   "A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute
RT   lymphoblastic leukemia involves the LIM homeodomain protein gene,
RT   Lhx4.";
RL   Oncogene 21:4983-4991(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Liu Y., Zhou Y., Wang J., Yuan J., Qiang B., Fan M.;
RT   "Isolation and cloning of a novel cDNA encoding human LIM homeobox 4
RT   protein.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Machinis K., Pantel J., Duquesnoy P., Netchine I., Sobrier M.-L.,
RA   Dastot F., Amselem S.;
RT   "Human LIM homeobox protein 4 (LHX4) gene.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-390.
RC   TISSUE=Placenta;
RA   Muraki T., Nakamura K., Sakai T.;
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-390, NUCLEOTIDE SEQUENCE [GENOMIC
RP   DNA] OF 152-390, AND DISEASE.
RX   PubMed=11567216; DOI=10.1086/323764;
RA   Machinis K., Pantel J., Netchine I., Leger J., Camand O.J.A.,
RA   Sobrier M.-L., Dastot-Le Moal F., Duquesnoy P., Abitbol M.,
RA   Czernichow P., Amselem S.;
RT   "Syndromic short stature in patients with a germline mutation in the
RT   LIM homeobox LHX4.";
RL   Am. J. Hum. Genet. 69:961-968(2001).
RN   [8]
RP   VARIANT CPHD4 THR-389.
RX   PubMed=17527005; DOI=10.1507/endocrj.K06-200;
RA   Tajima T., Hattori T., Nakajima T., Okuhara K., Tsubaki J.,
RA   Fujieda K.;
RT   "A novel missense mutation (P366T) of the LHX4 gene causes severe
RT   combined pituitary hormone deficiency with pituitary hypoplasia,
RT   ectopic posterior lobe and a poorly developed sella turcica.";
RL   Endocr. J. 54:637-641(2007).
RN   [9]
RP   VARIANTS CPHD4 CYS-84; ARG-190 AND PRO-210, AND CHARACTERIZATION OF
RP   VARIANTS CPHD4 CYS-84; ARG-190 AND PRO-210.
RX   PubMed=18073311; DOI=10.1210/jc.2007-1525;
RA   Pfaeffle R.W., Hunter C.S., Savage J.J., Duran-Prado M., Mullen R.D.,
RA   Neeb Z.P., Eiholzer U., Hesse V., Haddad N.G., Stobbe H.M., Blum W.F.,
RA   Weigel J.F.W., Rhodes S.J.;
RT   "Three novel missense mutations within the LHX4 gene are associated
RT   with variable pituitary hormone deficiencies.";
RL   J. Clin. Endocrinol. Metab. 93:1062-1071(2008).
CC   -!- FUNCTION: May play a critical role in the development of
CC       respiratory control mechanisms and in the normal growth and
CC       maturation of the lung. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9Y6H1:CHCHD2; NbExp=3; IntAct=EBI-2865388, EBI-2321769;
CC       Q5QP82:DCAF10; NbExp=4; IntAct=EBI-2865388, EBI-723230;
CC       Q6P4F2:FDX2; NbExp=3; IntAct=EBI-2865388, EBI-10252800;
CC       Q17RB8:LONRF1; NbExp=3; IntAct=EBI-2865388, EBI-2341787;
CC       Q9Y5N6:ORC6; NbExp=5; IntAct=EBI-2865388, EBI-374840;
CC       P28069:POU1F1; NbExp=4; IntAct=EBI-2865388, EBI-8673859;
CC       O60880:SH2D1A; NbExp=7; IntAct=EBI-2865388, EBI-6983382;
CC       Q9BV90:SNRNP25; NbExp=5; IntAct=EBI-2865388, EBI-9675976;
CC       Q86UY0:TXNDC5; NbExp=3; IntAct=EBI-2865388, EBI-2825190;
CC       O75604:USP2; NbExp=3; IntAct=EBI-2865388, EBI-743272;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- DISEASE: Pituitary hormone deficiency, combined, 4 (CPHD4)
CC       [MIM:262700]: Combined pituitary hormone deficiency is defined as
CC       the impaired production of growth hormone and one or more of the
CC       other five anterior pituitary hormones. CPHD4 is characterized by
CC       complete or partial deficiencies of growth hormone, thyroid-
CC       stimulating hormone, luteinizing hormone, follicle stimulating
CC       hormone and adrenocorticotropic hormone. Clinical features include
CC       short stature, cerebellar defects, and small sella turcica.
CC       {ECO:0000269|PubMed:17527005, ECO:0000269|PubMed:18073311}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving LHX4 may be a
CC       cause of acute lymphoblastic leukemia. Translocation
CC       t(1;14)(q25;q32) with IGHG1. {ECO:0000269|PubMed:11567216}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB62817.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY053457; AAL07260.1; -; mRNA.
DR   EMBL; AF179849; AAK70923.1; -; mRNA.
DR   EMBL; AF405430; AAM91896.1; -; Genomic_DNA.
DR   EMBL; AF405425; AAM91896.1; JOINED; Genomic_DNA.
DR   EMBL; AF405426; AAM91896.1; JOINED; Genomic_DNA.
DR   EMBL; AF405427; AAM91896.1; JOINED; Genomic_DNA.
DR   EMBL; AF405428; AAM91896.1; JOINED; Genomic_DNA.
DR   EMBL; AF405429; AAM91896.1; JOINED; Genomic_DNA.
DR   EMBL; AL139141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011759; AAH11759.1; -; mRNA.
DR   EMBL; AB055703; BAB62817.1; ALT_INIT; mRNA.
DR   EMBL; AB037683; BAC01272.1; -; mRNA.
DR   EMBL; AF282899; AAK69169.1; -; mRNA.
DR   EMBL; AH011598; AAM19349.1; -; Genomic_DNA.
DR   CCDS; CCDS1338.1; -.
DR   RefSeq; NP_203129.1; NM_033343.3.
DR   UniGene; Hs.658487; -.
DR   PDB; 5HOD; X-ray; 2.68 A; A/D=156-216.
DR   PDBsum; 5HOD; -.
DR   ProteinModelPortal; Q969G2; -.
DR   SMR; Q969G2; -.
DR   BioGrid; 124635; 32.
DR   DIP; DIP-29454N; -.
DR   IntAct; Q969G2; 42.
DR   STRING; 9606.ENSP00000263726; -.
DR   iPTMnet; Q969G2; -.
DR   PhosphoSitePlus; Q969G2; -.
DR   BioMuta; LHX4; -.
DR   DMDM; 209572644; -.
DR   PaxDb; Q969G2; -.
DR   PeptideAtlas; Q969G2; -.
DR   PRIDE; Q969G2; -.
DR   DNASU; 89884; -.
DR   Ensembl; ENST00000263726; ENSP00000263726; ENSG00000121454.
DR   GeneID; 89884; -.
DR   KEGG; hsa:89884; -.
DR   UCSC; uc001goe.3; human.
DR   CTD; 89884; -.
DR   DisGeNET; 89884; -.
DR   EuPathDB; HostDB:ENSG00000121454.5; -.
DR   GeneCards; LHX4; -.
DR   HGNC; HGNC:21734; LHX4.
DR   HPA; HPA055705; -.
DR   MalaCards; LHX4; -.
DR   MIM; 262700; phenotype.
DR   MIM; 602146; gene.
DR   neXtProt; NX_Q969G2; -.
DR   OpenTargets; ENSG00000121454; -.
DR   Orphanet; 226307; Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
DR   Orphanet; 95496; Pituitary stalk interruption syndrome.
DR   Orphanet; 85442; Short stature - pituitary and cerebellar defects - small sella turcica.
DR   PharmGKB; PA134962876; -.
DR   eggNOG; KOG4577; Eukaryota.
DR   eggNOG; ENOG410XPDC; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000231629; -.
DR   HOVERGEN; HBG006263; -.
DR   InParanoid; Q969G2; -.
DR   KO; K09374; -.
DR   OMA; CSQHILD; -.
DR   OrthoDB; EOG091G0BSD; -.
DR   PhylomeDB; Q969G2; -.
DR   TreeFam; TF315442; -.
DR   GeneWiki; LHX4; -.
DR   GenomeRNAi; 89884; -.
DR   PRO; PR:Q969G2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000121454; -.
DR   CleanEx; HS_LHX4; -.
DR   ExpressionAtlas; Q969G2; baseline and differential.
DR   Genevisible; Q969G2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0021526; P:medial motor column neuron differentiation; IEA:Ensembl.
DR   GO; GO:0008045; P:motor neuron axon guidance; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosomal rearrangement; Complete proteome;
KW   Disease mutation; DNA-binding; Dwarfism; Homeobox; LIM domain;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Zinc.
FT   CHAIN         1    390       LIM/homeobox protein Lhx4.
FT                                /FTId=PRO_0000075787.
FT   DOMAIN       28     87       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       88    150       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    157    216       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES      70     70       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UBR4}.
FT   MOD_RES     234    234       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UBR4}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UBR4}.
FT   VARIANT      84     84       R -> C (in CPHD4; has impaired activity
FT                                on CGA, POU1F1 and TSHB promoters but
FT                                exhibits normal DNA binding to the CGA
FT                                pituitary glycoprotein basal element
FT                                (PGBE) and interaction with the POU1F1
FT                                protein; dbSNP:rs121912642).
FT                                {ECO:0000269|PubMed:18073311}.
FT                                /FTId=VAR_058715.
FT   VARIANT     190    190       L -> R (in CPHD4; the mutant protein is
FT                                inactive in DNA binding and pituitary
FT                                gene activation assays;
FT                                dbSNP:rs121912643).
FT                                {ECO:0000269|PubMed:18073311}.
FT                                /FTId=VAR_058716.
FT   VARIANT     210    210       A -> P (in CPHD4; the mutant protein is
FT                                inactive in DNA binding and pituitary
FT                                gene activation assays;
FT                                dbSNP:rs121912641).
FT                                {ECO:0000269|PubMed:18073311}.
FT                                /FTId=VAR_058717.
FT   VARIANT     328    328       N -> S (in dbSNP:rs7536561).
FT                                /FTId=VAR_046661.
FT   VARIANT     389    389       P -> T (in CPHD4; dbSNP:rs145433128).
FT                                {ECO:0000269|PubMed:17527005}.
FT                                /FTId=VAR_063241.
FT   CONFLICT    335    335       D -> G (in Ref. 1; AAL07260).
FT                                {ECO:0000305}.
FT   HELIX       165    176       {ECO:0000244|PDB:5HOD}.
FT   HELIX       184    194       {ECO:0000244|PDB:5HOD}.
FT   HELIX       198    214       {ECO:0000244|PDB:5HOD}.
SQ   SEQUENCE   390 AA;  43124 MW;  6499F38E78B79FD1 CRC64;
     MMQSATVPAE GAVKGLPEML GVPMQQIPQC AGCNQHILDK FILKVLDRHW HSSCLKCADC
     QMQLADRCFS RAGSVYCKED FFKRFGTKCT ACQQGIPPTQ VVRKAQDFVY HLHCFACIIC
     NRQLATGDEF YLMEDGRLVC KEDYETAKQN DDSEAGAKRP RTTITAKQLE TLKNAYKNSP
     KPARHVREQL SSETGLDMRV VQVWFQNRRA KEKRLKKDAG RHRWGQFYKS VKRSRGSSKQ
     EKESSAEDCG VSDSELSFRE DQILSELGHT NRIYGNVGDV TGGQLMNGSF SMDGTGQSYQ
     DLRDGSPYGI PQSPSSISSL PSHAPLLNGL DYTVDSNLGI IAHAGQGVSQ TLRAMAGGPT
     SDISTGSSVG YPDFPTSPGS WLDEMDHPPF
//
ID   LHX8_HUMAN              Reviewed;         356 AA.
AC   Q68G74; E9PGE3;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   25-OCT-2017, entry version 125.
DE   RecName: Full=LIM/homeobox protein Lhx8;
DE            Short=LIM homeobox protein 8;
GN   Name=LHX8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor involved in differentiation of
CC       certain neurons and mesenchymal cells. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P57682:KLF3; NbExp=3; IntAct=EBI-8474075, EBI-8472267;
CC       Q86U70:LDB1; NbExp=3; IntAct=EBI-8474075, EBI-677177;
CC       Q86U70-2:LDB1; NbExp=6; IntAct=EBI-8474075, EBI-11979761;
CC       Q86Y26:NUTM1; NbExp=3; IntAct=EBI-8474075, EBI-10178410;
CC       Q8IZE3:SCYL3; NbExp=3; IntAct=EBI-8474075, EBI-1380680;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q68G74-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q68G74-2; Sequence=VSP_047378;
CC         Note=Gene prediction based on EST data.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC099786; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC040321; AAH40321.1; -; mRNA.
DR   CCDS; CCDS30756.1; -. [Q68G74-1]
DR   CCDS; CCDS58008.1; -. [Q68G74-2]
DR   RefSeq; NP_001001933.1; NM_001001933.1. [Q68G74-1]
DR   RefSeq; NP_001243043.1; NM_001256114.1. [Q68G74-2]
DR   UniGene; Hs.403934; -.
DR   ProteinModelPortal; Q68G74; -.
DR   SMR; Q68G74; -.
DR   BioGrid; 136112; 8.
DR   IntAct; Q68G74; 17.
DR   MINT; MINT-8417689; -.
DR   STRING; 9606.ENSP00000294638; -.
DR   iPTMnet; Q68G74; -.
DR   PhosphoSitePlus; Q68G74; -.
DR   BioMuta; LHX8; -.
DR   DMDM; 296434566; -.
DR   PaxDb; Q68G74; -.
DR   PRIDE; Q68G74; -.
DR   DNASU; 431707; -.
DR   Ensembl; ENST00000294638; ENSP00000294638; ENSG00000162624. [Q68G74-1]
DR   Ensembl; ENST00000356261; ENSP00000348597; ENSG00000162624. [Q68G74-2]
DR   GeneID; 431707; -.
DR   KEGG; hsa:431707; -.
DR   UCSC; uc001dgo.3; human. [Q68G74-1]
DR   CTD; 431707; -.
DR   DisGeNET; 431707; -.
DR   EuPathDB; HostDB:ENSG00000162624.14; -.
DR   GeneCards; LHX8; -.
DR   HGNC; HGNC:28838; LHX8.
DR   HPA; HPA071806; -.
DR   MIM; 604425; gene.
DR   neXtProt; NX_Q68G74; -.
DR   OpenTargets; ENSG00000162624; -.
DR   PharmGKB; PA142671553; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000038965; -.
DR   HOVERGEN; HBG006261; -.
DR   InParanoid; Q68G74; -.
DR   KO; K09375; -.
DR   OMA; WKSDQMF; -.
DR   OrthoDB; EOG091G0EXT; -.
DR   PhylomeDB; Q68G74; -.
DR   TreeFam; TF315442; -.
DR   GenomeRNAi; 431707; -.
DR   PRO; PR:Q68G74; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162624; -.
DR   CleanEx; HS_LHX8; -.
DR   Genevisible; Q68G74; HS.
DR   GO; GO:0001674; C:female germ cell nucleus; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008585; P:female gonad development; IEA:Ensembl.
DR   GO; GO:0021884; P:forebrain neuron development; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   LIM domain; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc.
FT   CHAIN         1    356       LIM/homeobox protein Lhx8.
FT                                /FTId=PRO_0000295810.
FT   DOMAIN       73    133       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      134    196       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    225    284       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1     10       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_047378.
FT   CONFLICT    297    297       V -> A (in Ref. 2; AAH40321).
FT                                {ECO:0000305}.
SQ   SEQUENCE   356 AA;  39301 MW;  9BA025D3ECADCD56 CRC64;
     MQILSRCQGL MSEECGRTTA LAAGRTRKGA GEEGLVSPEG AGDEDSCSSS APLSPSSSPR
     SMASGSGCPP GKCVCNSCGL EIVDKYLLKV NDLCWHVRCL SCSVCRTSLG RHTSCYIKDK
     DIFCKLDYFR RYGTRCSRCG RHIHSTDWVR RAKGNVYHLA CFACFSCKRQ LSTGEEFALV
     EEKVLCRVHY DCMLDNLKRE VENGNGISVE GALLTEQDVN HPKPAKRART SFTADQLQVM
     QAQFAQDNNP DAQTLQKLAE RTGLSRRVIQ VWFQNCRARH KKHVSPNHSS STPVTAVPPS
     RLSPPMLEEM AYSAYVPQDG TMLTALHSYM DAHSPTTLGL QPLLPHSMTQ LPISHT
//
ID   LHX9_HUMAN              Reviewed;         397 AA.
AC   Q9NQ69; Q5VUE2; Q5VUE3; Q5VUE6; Q86UH2; Q9BYU6; Q9NQ70;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 3.
DT   27-SEP-2017, entry version 144.
DE   RecName: Full=LIM/homeobox protein Lhx9;
DE            Short=LIM homeobox protein 9;
GN   Name=LHX9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11397841; DOI=10.1210/jcem.86.6.7539;
RA   Ottolenghi C., Moreira-Filho C., Mendonca B.B., Barbieri M.,
RA   Fellous M., Berkovitz G.D., McElreavey K.;
RT   "Absence of mutations involving the LIM homeobox domain gene LHX9 in
RT   46,XY gonadal agenesis and dysgenesis.";
RL   J. Clin. Endocrinol. Metab. 86:2465-2469(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Shan Y.X., Pan J., Guo Z.K., Geng D.C., Huang C.Q., Yu L.;
RT   "Cloning and characterization of human novel LIM-homeobox 9 gene.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   STRUCTURE BY NMR OF 268-334.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of LIM/homeobox protein
RT   LHX9.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: Involved in gonadal development. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with LDB1 and LDB2. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q2TBE0:CWF19L2; NbExp=3; IntAct=EBI-10175218, EBI-5453285;
CC       P50053:KHK; NbExp=3; IntAct=EBI-10175218, EBI-1053974;
CC       P50053-2:KHK; NbExp=3; IntAct=EBI-10175218, EBI-12204387;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9NQ69-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQ69-2; Sequence=VSP_036428;
CC       Name=3;
CC         IsoId=Q9NQ69-3; Sequence=VSP_036428, VSP_036429;
CC       Name=4;
CC         IsoId=Q9NQ69-4; Sequence=VSP_036429;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ277915; CAB97493.1; -; mRNA.
DR   EMBL; AJ277916; CAB98128.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ277917; CAB98128.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277918; CAB98128.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277919; CAB98128.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277920; CAB98128.1; JOINED; Genomic_DNA.
DR   EMBL; AJ296272; CAC33174.1; -; mRNA.
DR   EMBL; AY273889; AAP32471.2; -; mRNA.
DR   EMBL; AL590115; CAH71760.1; -; Genomic_DNA.
DR   EMBL; AL590115; CAH71761.1; -; Genomic_DNA.
DR   EMBL; AL590115; CAH71763.1; -; Genomic_DNA.
DR   EMBL; AL590115; CAH71764.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91290.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91292.1; -; Genomic_DNA.
DR   EMBL; BC131622; AAI31623.1; -; mRNA.
DR   CCDS; CCDS1393.1; -. [Q9NQ69-1]
DR   CCDS; CCDS30962.1; -. [Q9NQ69-2]
DR   RefSeq; NP_001014434.1; NM_001014434.1. [Q9NQ69-2]
DR   RefSeq; NP_064589.2; NM_020204.2. [Q9NQ69-1]
DR   UniGene; Hs.442578; -.
DR   UniGene; Hs.706475; -.
DR   PDB; 2DMQ; NMR; -; A=268-334.
DR   PDBsum; 2DMQ; -.
DR   ProteinModelPortal; Q9NQ69; -.
DR   SMR; Q9NQ69; -.
DR   BioGrid; 121280; 8.
DR   IntAct; Q9NQ69; 5.
DR   STRING; 9606.ENSP00000356357; -.
DR   iPTMnet; Q9NQ69; -.
DR   PhosphoSitePlus; Q9NQ69; -.
DR   BioMuta; LHX9; -.
DR   DMDM; 224471883; -.
DR   PaxDb; Q9NQ69; -.
DR   PeptideAtlas; Q9NQ69; -.
DR   PRIDE; Q9NQ69; -.
DR   Ensembl; ENST00000367387; ENSP00000356357; ENSG00000143355. [Q9NQ69-1]
DR   Ensembl; ENST00000367390; ENSP00000356360; ENSG00000143355. [Q9NQ69-2]
DR   Ensembl; ENST00000367391; ENSP00000356361; ENSG00000143355. [Q9NQ69-3]
DR   GeneID; 56956; -.
DR   KEGG; hsa:56956; -.
DR   UCSC; uc001gui.2; human. [Q9NQ69-1]
DR   CTD; 56956; -.
DR   DisGeNET; 56956; -.
DR   EuPathDB; HostDB:ENSG00000143355.15; -.
DR   GeneCards; LHX9; -.
DR   HGNC; HGNC:14222; LHX9.
DR   HPA; HPA009695; -.
DR   MIM; 606066; gene.
DR   neXtProt; NX_Q9NQ69; -.
DR   OpenTargets; ENSG00000143355; -.
DR   PharmGKB; PA30368; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOVERGEN; HBG006262; -.
DR   InParanoid; Q9NQ69; -.
DR   KO; K09373; -.
DR   OMA; HGISGDH; -.
DR   OrthoDB; EOG091G13BH; -.
DR   PhylomeDB; Q9NQ69; -.
DR   TreeFam; TF315442; -.
DR   EvolutionaryTrace; Q9NQ69; -.
DR   GenomeRNAi; 56956; -.
DR   PRO; PR:Q9NQ69; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143355; -.
DR   CleanEx; HS_LHX9; -.
DR   ExpressionAtlas; Q9NQ69; baseline and differential.
DR   Genevisible; Q9NQ69; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0008585; P:female gonad development; IEA:Ensembl.
DR   GO; GO:0035262; P:gonad morphogenesis; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; LIM domain; Metal-binding; Nucleus; Reference proteome;
KW   Repeat; Zinc.
FT   CHAIN         1    397       LIM/homeobox protein Lhx9.
FT                                /FTId=PRO_0000075798.
FT   DOMAIN       69    130       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      131    193       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    267    326       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1     18       MEIVGCRAEDNSCPFRPP -> MLNGTTLEA (in
FT                                isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:11397841}.
FT                                /FTId=VSP_036428.
FT   VAR_SEQ     313    397       VWFQNARAKFRRNLLRQENGGVDKADGTSLPAPPSADSGAL
FT                                TPPGTATTLTDLTNPTITVVTSVTSNMDSHESGSPSQTTLT
FT                                NLF -> GEQILGHYSQTSRRLKIP (in isoform 3
FT                                and isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_036429.
FT   HELIX       276    288       {ECO:0000244|PDB:2DMQ}.
FT   HELIX       294    303       {ECO:0000244|PDB:2DMQ}.
FT   HELIX       308    327       {ECO:0000244|PDB:2DMQ}.
SQ   SEQUENCE   397 AA;  43976 MW;  FA8BBB550A5FCE03 CRC64;
     MEIVGCRAED NSCPFRPPAM LFHGISGGHI QGIMEEMERR SKTEARLAKG AQLNGRDAGM
     PPLSPEKPAL CAGCGGKISD RYYLLAVDKQ WHLRCLKCCE CKLALESELT CFAKDGSIYC
     KEDYYRRFSV QRCARCHLGI SASEMVMRAR DSVYHLSCFT CSTCNKTLTT GDHFGMKDSL
     VYCRAHFETL LQGEYPPQLS YTELAAKSGG LALPYFNGTG TVQKGRPRKR KSPALGVDIV
     NYNSGCNENE ADHLDRDQQP YPPSQKTKRM RTSFKHHQLR TMKSYFAINH NPDAKDLKQL
     AQKTGLTKRV LQVWFQNARA KFRRNLLRQE NGGVDKADGT SLPAPPSADS GALTPPGTAT
     TLTDLTNPTI TVVTSVTSNM DSHESGSPSQ TTLTNLF
//
ID   LHX2_HUMAN              Reviewed;         406 AA.
AC   P50458; O95860; Q52M57; Q8N1Z3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   27-SEP-2017, entry version 158.
DE   RecName: Full=LIM/homeobox protein Lhx2;
DE            Short=Homeobox protein LH-2;
DE            Short=LIM homeobox protein 2;
GN   Name=LHX2; Synonyms=LH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8649822;
RA   Wu H.-K., Heng H.H.Q., Siderovski D.P., Dong W.-F., Okuno Y.,
RA   Shi X.-M., Tsui L.-C., Minden M.D.;
RT   "Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed
RT   in chronic myelogenous leukaemia and located on 9q33-34.1.";
RL   Oncogene 12:1205-1212(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-406.
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 18-406.
RX   PubMed=10051612; DOI=10.1073/pnas.96.5.2165;
RA   Rincon-Limas D.E., Lu C.-H., Canal I., Calleja M.,
RA   Rodriguez-Esteban C., Izpisua-Belmonte J.-C., Botas J.;
RT   "Conservation of the expression and function of apterous orthologs in
RT   Drosophila and mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2165-2170(1999).
CC   -!- FUNCTION: Acts as a transcriptional activator. Stimulates the
CC       promoter of the alpha-glycoprotein gene. Transcriptional
CC       regulatory protein involved in the control of cell differentiation
CC       in developing lymphoid and neural cell types (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts (via LIM domains) with CITED2. Interacts with
CC       POU4F2. {ECO:0000250|UniProtKB:Q9Z0S2}.
CC   -!- INTERACTION:
CC       Q8N0U6:LINC00518; NbExp=4; IntAct=EBI-12179869, EBI-10264791;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DOMAIN: LIM domains are necessary for transcription activation.
CC       {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC04371.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U11701; AAB08752.1; -; mRNA.
DR   EMBL; BC093662; AAH93662.1; -; mRNA.
DR   EMBL; BC112185; AAI12186.1; -; mRNA.
DR   EMBL; AK094511; BAC04371.1; ALT_INIT; mRNA.
DR   EMBL; AF124735; AAD20013.1; -; mRNA.
DR   CCDS; CCDS6853.1; -.
DR   RefSeq; NP_004780.3; NM_004789.3.
DR   UniGene; Hs.696425; -.
DR   ProteinModelPortal; P50458; -.
DR   SMR; P50458; -.
DR   BioGrid; 114758; 5.
DR   IntAct; P50458; 24.
DR   MINT; MINT-112470; -.
DR   STRING; 9606.ENSP00000362717; -.
DR   iPTMnet; P50458; -.
DR   PhosphoSitePlus; P50458; -.
DR   BioMuta; LHX2; -.
DR   DMDM; 8247936; -.
DR   PaxDb; P50458; -.
DR   PeptideAtlas; P50458; -.
DR   PRIDE; P50458; -.
DR   DNASU; 9355; -.
DR   Ensembl; ENST00000373615; ENSP00000362717; ENSG00000106689.
DR   GeneID; 9355; -.
DR   KEGG; hsa:9355; -.
DR   UCSC; uc004boe.2; human.
DR   CTD; 9355; -.
DR   DisGeNET; 9355; -.
DR   EuPathDB; HostDB:ENSG00000106689.10; -.
DR   GeneCards; LHX2; -.
DR   HGNC; HGNC:6594; LHX2.
DR   HPA; HPA000838; -.
DR   MIM; 603759; gene.
DR   neXtProt; NX_P50458; -.
DR   OpenTargets; ENSG00000106689; -.
DR   PharmGKB; PA30365; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000034022; -.
DR   HOVERGEN; HBG006262; -.
DR   InParanoid; P50458; -.
DR   KO; K09373; -.
DR   PhylomeDB; P50458; -.
DR   TreeFam; TF315442; -.
DR   SIGNOR; P50458; -.
DR   ChiTaRS; LHX2; human.
DR   GeneWiki; LHX2; -.
DR   GenomeRNAi; 9355; -.
DR   PRO; PR:P50458; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106689; -.
DR   CleanEx; HS_LHX2; -.
DR   ExpressionAtlas; P50458; baseline and differential.
DR   Genevisible; P50458; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001076; F:transcription factor activity, RNA polymerase II transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
DR   GO; GO:0045199; P:maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0021978; P:telencephalon regionalization; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; LIM domain;
KW   Metal-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    406       LIM/homeobox protein Lhx2.
FT                                /FTId=PRO_0000075778.
FT   DOMAIN       53    105       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      115    168       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    266    325       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       307    323       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    187    196       Poly-Ala.
FT   CONFLICT     22     28       AKSEAPA -> QERGSR (in Ref. 1; AAB08752).
FT                                {ECO:0000305}.
FT   CONFLICT     54     54       A -> G (in Ref. 1; AAB08752).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       Y -> YSPSLHGPY (in Ref. 3).
FT                                {ECO:0000305}.
FT   CONFLICT    187    187       A -> Q (in Ref. 1). {ECO:0000305}.
FT   CONFLICT    190    192       AAA -> RAR (in Ref. 1). {ECO:0000305}.
FT   CONFLICT    196    196       Missing (in Ref. 1). {ECO:0000305}.
FT   CONFLICT    241    242       NA -> TR (in Ref. 1; AAB08752).
FT                                {ECO:0000305}.
FT   CONFLICT    391    406       GHEPHSPSQTTLTNLF -> AMSLTAPHKRLLPTFSNDSQP
FT                                PHPTISLKKKLSLV (in Ref. 1; AAB08752).
FT                                {ECO:0000305}.
SQ   SEQUENCE   406 AA;  44373 MW;  DF73AAC81867D30D CRC64;
     MLFHSLSGPE VHGVIDEMDR RAKSEAPAIS SAIDRGDTET TMPSISSDRA ALCAGCGGKI
     SDRYYLLAVD KQWHMRCLKC CECKLNLESE LTCFSKDGSI YCKEDYYRRF SVQRCARCHL
     GISASEMVMR ARDLVYHLNC FTCTTCNKML TTGDHFGMKD SLVYCRLHFE ALLQGEYPAH
     FNHADVAAAA AAAAAAKSAG LGAAGANPLG LPYYNGVGTV QKGRPRKRKS PGPGADLAAY
     NAALSCNEND AEHLDRDQPY PSSQKTKRMR TSFKHHQLRT MKSYFAINHN PDAKDLKQLA
     QKTGLTKRVL QVWFQNARAK FRRNLLRQEN TGVDKSTDAA LQTGTPSGPA SELSNASLSP
     SSTPTTLTDL TSPTLPTVTS VLTSVPGNLE GHEPHSPSQT TLTNLF
//
ID   LHX3_HUMAN              Reviewed;         397 AA.
AC   Q9UBR4; Q5TB39; Q5TB40; Q9NZB5; Q9P0I8; Q9P0I9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   27-SEP-2017, entry version 164.
DE   RecName: Full=LIM/homeobox protein Lhx3;
DE            Short=LIM homeobox protein 3;
GN   Name=LHX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=10598593; DOI=10.1210/mend.13.12.0395;
RA   Sloop K.W., Meier B.C., Bridwell J.L., Parker G.E., Schiller A.M.,
RA   Rhodes S.J.;
RT   "Differential activation of pituitary hormone genes by human Lhx3
RT   isoforms with distinct DNA binding properties.";
RL   Mol. Endocrinol. 13:2212-2225(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RA   Sobrier M.-L.;
RT   "Human LHX3: cloning, mapping, genomic structure.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   You X., Imperato-McGinley J., Zhu Y.-S.;
RT   "Molecular cloning and expression pattern of human Lhx3 gene.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PHOSPHORYLATION AT THR-63; SER-71; TYR-227; SER-234 AND SER-238.
RX   PubMed=15517599; DOI=10.1002/jcb.20287;
RA   Parker G.E., West B.E., Witzmann F.A., Rhodes S.J.;
RT   "Serine/threonine/tyrosine phosphorylation of the LHX3 LIM-homeodomain
RT   transcription factor.";
RL   J. Cell. Biochem. 94:67-80(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=21149718; DOI=10.1073/pnas.1009501108;
RA   Colvin S.C., Malik R.E., Showalter A.D., Sloop K.W., Rhodes S.J.;
RT   "Model of pediatric pituitary hormone deficiency separates the
RT   endocrine and neural functions of the LHX3 transcription factor in
RT   vivo.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:173-178(2011).
RN   [8]
RP   INTERACTION WITH POU1F1.
RX   PubMed=26612202; DOI=10.1093/hmg/ddv486;
RA   Sobrier M.L., Tsai Y.C., Perez C., Leheup B., Bouceba T.,
RA   Duquesnoy P., Copin B., Sizova D., Penzo A., Stanger B.Z., Cooke N.E.,
RA   Liebhaber S.A., Amselem S.;
RT   "Functional characterization of a human POU1F1 mutation associated
RT   with isolated growth hormone deficiency: a novel etiology for IGHD.";
RL   Hum. Mol. Genet. 25:472-483(2016).
RN   [9]
RP   VARIANT CPHD3 CYS-111.
RX   PubMed=10835633; DOI=10.1038/76041;
RA   Netchine I., Sobrier M.-L., Krude H., Schnabel D., Maghnie M.,
RA   Marcos E., Duriez B., Cacheux V., Moers A.V., Goossens M., Gruters A.,
RA   Amselem S.;
RT   "Mutations in LHX3 result in a new syndrome revealed by combined
RT   pituitary hormone deficiency.";
RL   Nat. Genet. 25:182-186(2000).
RN   [10]
RP   VARIANT CPHD3 VAL-210, AND CHARACTERIZATION OF VARIANT CPHD3 VAL-210.
RX   PubMed=17327381; DOI=10.1210/jc.2006-2177;
RA   Pfaeffle R.W., Savage J.J., Hunter C.S., Palme C., Ahlmann M.,
RA   Kumar P., Bellone J., Schoenau E., Korsch E., Braemswig J.H.,
RA   Stobbe H.M., Blum W.F., Rhodes S.J.;
RT   "Four novel mutations of the LHX3 gene cause combined pituitary
RT   hormone deficiencies with or without limited neck rotation.";
RL   J. Clin. Endocrinol. Metab. 92:1909-1919(2007).
CC   -!- FUNCTION: Acts as a transcriptional activator. Binds to and
CC       activates the promoter of the alpha-glycoprotein gene, and
CC       synergistically enhances transcription from the prolactin promoter
CC       in cooperation with POU1F1/Pit-1 (By similarity). Required for the
CC       establishment of the specialized cells of the pituitary gland and
CC       the nervous system. Involved in the development of interneurons
CC       and motor neurons in cooperation with LDB1 and ISL1. {ECO:0000250,
CC       ECO:0000269|PubMed:21149718}.
CC   -!- SUBUNIT: Interacts with POU1F1 (PubMed:26612202). At neuronal
CC       promoters, interacts with LDB1, in motor neurons LDB1 is displaced
CC       by ISL1 and a ternary complex is formed in which ISL1 contacts
CC       both LHX3 and LDB1 (By similarity). {ECO:0000250|UniProtKB:P50481,
CC       ECO:0000269|PubMed:26612202}.
CC   -!- INTERACTION:
CC       Q00444:HOXC5; NbExp=4; IntAct=EBI-12039345, EBI-11955357;
CC       Q2WGJ6:KLHL38; NbExp=4; IntAct=EBI-12039345, EBI-6426443;
CC       P54646:PRKAA2; NbExp=4; IntAct=EBI-12039345, EBI-1383852;
CC       P84022:SMAD3; NbExp=4; IntAct=EBI-12039345, EBI-347161;
CC       P25490:YY1; NbExp=4; IntAct=EBI-12039345, EBI-765538;
CC       Q8TAU3:ZNF417; NbExp=4; IntAct=EBI-12039345, EBI-740727;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=A;
CC         IsoId=Q9UBR4-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9UBR4-2; Sequence=VSP_003107;
CC   -!- DOMAIN: The LIM domain specifically interacts with the Pit-1 POU
CC       domain and is required for synergistic interactions with Pit-1,
CC       but not for basal transcriptional activation events.
CC       {ECO:0000250}.
CC   -!- DISEASE: Pituitary hormone deficiency, combined, 3 (CPHD3)
CC       [MIM:221750]: Combined pituitary hormone deficiency is defined as
CC       the impaired production of growth hormone and one or more of the
CC       other five anterior pituitary hormones. CPHD3 is characterized by
CC       a complete deficit in all but one (adrenocorticotropin) anterior
CC       pituitary hormone and a rigid cervical spine leading to limited
CC       head rotation. {ECO:0000269|PubMed:10835633,
CC       ECO:0000269|PubMed:17327381}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF156888; AAF36808.1; -; mRNA.
DR   EMBL; AF156889; AAF36809.1; -; mRNA.
DR   EMBL; AH008761; AAF17291.1; -; Genomic_DNA.
DR   EMBL; AF096169; AAF17292.1; -; mRNA.
DR   EMBL; AF214637; AAF26412.1; -; Genomic_DNA.
DR   EMBL; AF367089; AAL26314.1; -; Genomic_DNA.
DR   EMBL; AF367085; AAL26314.1; JOINED; Genomic_DNA.
DR   EMBL; AF367086; AAL26314.1; JOINED; Genomic_DNA.
DR   EMBL; AF367087; AAL26314.1; JOINED; Genomic_DNA.
DR   EMBL; AF367088; AAL26314.1; JOINED; Genomic_DNA.
DR   EMBL; AL138781; CAI16878.1; -; Genomic_DNA.
DR   EMBL; AL138781; CAI16879.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88205.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88206.1; -; Genomic_DNA.
DR   CCDS; CCDS6994.1; -. [Q9UBR4-1]
DR   CCDS; CCDS6995.1; -. [Q9UBR4-2]
DR   RefSeq; NP_055379.1; NM_014564.4. [Q9UBR4-2]
DR   RefSeq; NP_835258.1; NM_178138.5. [Q9UBR4-1]
DR   UniGene; Hs.148427; -.
DR   ProteinModelPortal; Q9UBR4; -.
DR   SMR; Q9UBR4; -.
DR   BioGrid; 113718; 7.
DR   IntAct; Q9UBR4; 69.
DR   STRING; 9606.ENSP00000360811; -.
DR   iPTMnet; Q9UBR4; -.
DR   PhosphoSitePlus; Q9UBR4; -.
DR   BioMuta; LHX3; -.
DR   DMDM; 12643415; -.
DR   PaxDb; Q9UBR4; -.
DR   PeptideAtlas; Q9UBR4; -.
DR   PRIDE; Q9UBR4; -.
DR   DNASU; 8022; -.
DR   Ensembl; ENST00000371746; ENSP00000360811; ENSG00000107187. [Q9UBR4-2]
DR   Ensembl; ENST00000371748; ENSP00000360813; ENSG00000107187. [Q9UBR4-1]
DR   GeneID; 8022; -.
DR   KEGG; hsa:8022; -.
DR   UCSC; uc004cgz.3; human. [Q9UBR4-1]
DR   CTD; 8022; -.
DR   DisGeNET; 8022; -.
DR   EuPathDB; HostDB:ENSG00000107187.15; -.
DR   GeneCards; LHX3; -.
DR   HGNC; HGNC:6595; LHX3.
DR   MalaCards; LHX3; -.
DR   MIM; 221750; phenotype.
DR   MIM; 600577; gene.
DR   neXtProt; NX_Q9UBR4; -.
DR   OpenTargets; ENSG00000107187; -.
DR   Orphanet; 226307; Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
DR   Orphanet; 231720; Non-acquired combined pituitary hormone deficiency with spine abnormalities.
DR   PharmGKB; PA30366; -.
DR   eggNOG; KOG4577; Eukaryota.
DR   eggNOG; ENOG410XPDC; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000231629; -.
DR   HOVERGEN; HBG006263; -.
DR   InParanoid; Q9UBR4; -.
DR   KO; K09374; -.
DR   OMA; SFPLEHG; -.
DR   PhylomeDB; Q9UBR4; -.
DR   TreeFam; TF315442; -.
DR   SignaLink; Q9UBR4; -.
DR   SIGNOR; Q9UBR4; -.
DR   ChiTaRS; LHX3; human.
DR   GeneWiki; LHX3; -.
DR   GenomeRNAi; 8022; -.
DR   PRO; PR:Q9UBR4; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000107187; -.
DR   CleanEx; HS_LHX3; -.
DR   ExpressionAtlas; Q9UBR4; baseline and differential.
DR   Genevisible; Q9UBR4; HS.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001076; F:transcription factor activity, RNA polymerase II transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0048839; P:inner ear development; IEP:UniProtKB.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0021526; P:medial motor column neuron differentiation; IEA:Ensembl.
DR   GO; GO:0008045; P:motor neuron axon guidance; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl.
DR   GO; GO:0021521; P:ventral spinal cord interneuron specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome; Disease mutation;
KW   DNA-binding; Dwarfism; Homeobox; LIM domain; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    397       LIM/homeobox protein Lhx3.
FT                                /FTId=PRO_0000075781.
FT   DOMAIN       31     81       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       90    144       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    157    216       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES      63     63       Phosphothreonine.
FT                                {ECO:0000269|PubMed:15517599}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000269|PubMed:15517599}.
FT   MOD_RES     227    227       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:15517599}.
FT   MOD_RES     234    234       Phosphoserine.
FT                                {ECO:0000269|PubMed:15517599}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000269|PubMed:15517599}.
FT   VAR_SEQ       1     25       MLLETGLERDRARPGAAAVCTLGGT -> MEARGELGPARE
FT                                SAGGDLLLALLARRADLR (in isoform B).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_003107.
FT   VARIANT     111    111       Y -> C (in CPHD3; dbSNP:rs104894117).
FT                                {ECO:0000269|PubMed:10835633}.
FT                                /FTId=VAR_010713.
FT   VARIANT     210    210       A -> V (in CPHD3; associated with
FT                                diminished DNA binding and pituitary gene
FT                                activation; dbSNP:rs137854503).
FT                                {ECO:0000269|PubMed:17327381}.
FT                                /FTId=VAR_063240.
FT   CONFLICT     34     34       C -> R (in Ref. 2; AAF17291).
FT                                {ECO:0000305}.
SQ   SEQUENCE   397 AA;  43358 MW;  FB4A2E48C015C249 CRC64;
     MLLETGLERD RARPGAAAVC TLGGTREIPL CAGCDQHILD RFILKALDRH WHSKCLKCSD
     CHTPLAERCF SRGESVYCKD DFFKRFGTKC AACQLGIPPT QVVRRAQDFV YHLHCFACVV
     CKRQLATGDE FYLMEDSRLV CKADYETAKQ REAEATAKRP RTTITAKQLE TLKSAYNTSP
     KPARHVREQL SSETGLDMRV VQVWFQNRRA KEKRLKKDAG RQRWGQYFRN MKRSRGGSKS
     DKDSVQEGQD SDAEVSFPDE PSLAEMGPAN GLYGSLGEPT QALGRPSGAL GNFSLEHGGL
     AGPEQYRELR PGSPYGVPPS PAAPQSLPGP QPLLSSLVYP DTSLGLVPSG APGGPPPMRV
     LAGNGPSSDL STGSSGGYPD FPASPASWLD EVDHAQF
//
ID   LHX5_HUMAN              Reviewed;         402 AA.
AC   Q9H2C1; Q32MA4;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-SEP-2017, entry version 133.
DE   RecName: Full=LIM/homeobox protein Lhx5;
DE            Short=LIM homeobox protein 5;
GN   Name=LHX5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11137295; DOI=10.1016/S0378-1119(00)00466-2;
RA   Zhao Y., Hermesz E., Yarolin M.C., Westphal H.;
RT   "Genomic structure, chromosomal localization and expression of the
RT   human LIM-homeobox gene LHX5.";
RL   Gene 260:95-101(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Plays an essential role in the regulation of neuronal
CC       differentiation and migration during development of the central
CC       nervous system.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in fetal brain and in various
CC       regions of the adult central nervous system including the spinal
CC       cord, the thalamus, and the cerebellum.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF291181; AAG36963.1; -; mRNA.
DR   EMBL; BC109230; AAI09231.1; -; mRNA.
DR   CCDS; CCDS9171.1; -.
DR   RefSeq; NP_071758.1; NM_022363.2.
DR   UniGene; Hs.302029; -.
DR   ProteinModelPortal; Q9H2C1; -.
DR   SMR; Q9H2C1; -.
DR   STRING; 9606.ENSP00000261731; -.
DR   iPTMnet; Q9H2C1; -.
DR   PhosphoSitePlus; Q9H2C1; -.
DR   BioMuta; LHX5; -.
DR   DMDM; 18202938; -.
DR   EPD; Q9H2C1; -.
DR   PaxDb; Q9H2C1; -.
DR   PeptideAtlas; Q9H2C1; -.
DR   PRIDE; Q9H2C1; -.
DR   Ensembl; ENST00000261731; ENSP00000261731; ENSG00000089116.
DR   GeneID; 64211; -.
DR   KEGG; hsa:64211; -.
DR   UCSC; uc001tvj.2; human.
DR   CTD; 64211; -.
DR   DisGeNET; 64211; -.
DR   EuPathDB; HostDB:ENSG00000089116.3; -.
DR   GeneCards; LHX5; -.
DR   HGNC; HGNC:14216; LHX5.
DR   HPA; HPA053908; -.
DR   MIM; 605992; gene.
DR   neXtProt; NX_Q9H2C1; -.
DR   OpenTargets; ENSG00000089116; -.
DR   PharmGKB; PA30367; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000231630; -.
DR   HOVERGEN; HBG006263; -.
DR   InParanoid; Q9H2C1; -.
DR   KO; K18493; -.
DR   OMA; NYDFFPH; -.
DR   OrthoDB; EOG091G0BSD; -.
DR   PhylomeDB; Q9H2C1; -.
DR   TreeFam; TF315442; -.
DR   GenomeRNAi; 64211; -.
DR   PRO; PR:Q9H2C1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000089116; -.
DR   CleanEx; HS_LHX5; -.
DR   Genevisible; Q9H2C1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl.
DR   GO; GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl.
DR   GO; GO:0021937; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; LIM domain; Metal-binding;
KW   Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    402       LIM/homeobox protein Lhx5.
FT                                /FTId=PRO_0000075789.
FT   DOMAIN        3     61       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       62    125       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    180    239       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   402 AA;  44406 MW;  E880138A1A3FCA2A CRC64;
     MMVHCAGCER PILDRFLLNV LDRAWHIKCV QCCECKTNLS EKCFSREGKL YCKNDFFRRF
     GTKCAGCAQG ISPSDLVRKA RSKVFHLNCF TCMVCNKQLS TGEELYVIDE NKFVCKDDYL
     SSSSLKEGSL NSVSSCTDRS LSPDLQDALQ DDPKETDNST SSDKETANNE NEEQNSGTKR
     RGPRTTIKAK QLETLKAAFA ATPKPTRHIR EQLAQETGLN MRVIQVWFQN RRSKERRMKQ
     LSALGARRHA FFRSPRRMRP LGGRLDESEM LGSTPYTYYG DYQGDYYAPG SNYDFFAHGP
     PSQAQSPADS SFLAASGPGS TPLGALEPPL AGPHAADNPR FTDMISHPDT PSPEPGLPGT
     LHPMPGEVFS GGPSPPFPMS GTSGYSGPLS HPNPELNEAA VW
//
ID   LHX6_HUMAN              Reviewed;         363 AA.
AC   Q9UPM6; A6PVQ1; A6PVQ2; A8K1B2; B7Z4D0; H0YN76; Q5T7S7; Q5T7S8;
AC   Q9NTK3; Q9UPM5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   27-SEP-2017, entry version 165.
DE   RecName: Full=LIM/homeobox protein Lhx6;
DE            Short=LIM homeobox protein 6;
DE   AltName: Full=LIM/homeobox protein Lhx6.1;
GN   Name=LHX6; Synonyms=LHX6.1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=10393337; DOI=10.1093/oxfordjournals.jbchem.a022420;
RA   Kimura N., Ueno M., Nakashima K., Taga T.;
RT   "A brain region-specific gene product Lhx6.1 interacts with Ldb1
RT   through tandem LIM-domains.";
RL   J. Biochem. 126:180-187(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 5 AND 6).
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Probable transcription factor required for the
CC       expression of a subset of genes involved in interneurons migration
CC       and development. Functions in the specification of cortical
CC       interneuron subtypes and in the migration of GABAergic interneuron
CC       precursors from the subpallium to the cerebral cortex (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with LDB1 (via the LIM zinc-binding domains).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q86U70:LDB1; NbExp=3; IntAct=EBI-10258746, EBI-677177;
CC       Q01974:ROR2; NbExp=4; IntAct=EBI-10258746, EBI-6422642;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Lhx6.1a;
CC         IsoId=Q9UPM6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Lhx6.1b;
CC         IsoId=Q9UPM6-2; Sequence=VSP_003109;
CC         Note=Ref.1 (BAA83423) sequence is in conflict in position:
CC         346:L->F. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q9UPM6-3; Sequence=VSP_037745;
CC       Name=4;
CC         IsoId=Q9UPM6-4; Sequence=VSP_037745, VSP_003109;
CC       Name=5;
CC         IsoId=Q9UPM6-5; Sequence=VSP_042073, VSP_003109;
CC       Name=6;
CC         IsoId=Q9UPM6-6; Sequence=VSP_046043;
CC         Note=No experimental confirmation available.;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI03937.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI03938.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB66505.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB031041; BAA83422.1; -; mRNA.
DR   EMBL; AB031042; BAA83423.1; -; mRNA.
DR   EMBL; AK126982; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK289827; BAF82516.1; -; mRNA.
DR   EMBL; AK297175; BAH12516.1; -; mRNA.
DR   EMBL; AK299709; BAH13108.1; -; mRNA.
DR   EMBL; AK313808; BAG36544.1; -; mRNA.
DR   EMBL; AL162424; CAO03566.1; -; Genomic_DNA.
DR   EMBL; AL162424; CAI14703.1; -; Genomic_DNA.
DR   EMBL; AL162424; CAI14704.1; -; Genomic_DNA.
DR   EMBL; AL162424; CAO03565.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87515.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87516.1; -; Genomic_DNA.
DR   EMBL; AL136570; CAB66505.1; ALT_INIT; mRNA.
DR   EMBL; BC103936; AAI03937.1; ALT_INIT; mRNA.
DR   EMBL; BC103937; AAI03938.1; ALT_INIT; mRNA.
DR   CCDS; CCDS56583.1; -. [Q9UPM6-1]
DR   CCDS; CCDS56584.1; -. [Q9UPM6-5]
DR   CCDS; CCDS59144.1; -. [Q9UPM6-6]
DR   CCDS; CCDS6837.2; -. [Q9UPM6-4]
DR   CCDS; CCDS6838.2; -. [Q9UPM6-3]
DR   PIR; T46907; T46907.
DR   RefSeq; NP_001229262.1; NM_001242333.1. [Q9UPM6-5]
DR   RefSeq; NP_001229263.1; NM_001242334.1. [Q9UPM6-1]
DR   RefSeq; NP_001229264.1; NM_001242335.1. [Q9UPM6-6]
DR   RefSeq; NP_001335119.1; NM_001348190.1. [Q9UPM6-2]
DR   RefSeq; NP_055183.2; NM_014368.4. [Q9UPM6-3]
DR   RefSeq; NP_954629.2; NM_199160.3. [Q9UPM6-4]
DR   UniGene; Hs.103137; -.
DR   ProteinModelPortal; Q9UPM6; -.
DR   SMR; Q9UPM6; -.
DR   BioGrid; 117692; 22.
DR   IntAct; Q9UPM6; 9.
DR   MINT; MINT-4718974; -.
DR   STRING; 9606.ENSP00000377854; -.
DR   iPTMnet; Q9UPM6; -.
DR   PhosphoSitePlus; Q9UPM6; -.
DR   BioMuta; LHX6; -.
DR   DMDM; 90185239; -.
DR   PaxDb; Q9UPM6; -.
DR   PeptideAtlas; Q9UPM6; -.
DR   PRIDE; Q9UPM6; -.
DR   DNASU; 26468; -.
DR   Ensembl; ENST00000340587; ENSP00000340137; ENSG00000106852. [Q9UPM6-4]
DR   Ensembl; ENST00000373754; ENSP00000362859; ENSG00000106852. [Q9UPM6-2]
DR   Ensembl; ENST00000373755; ENSP00000362860; ENSG00000106852. [Q9UPM6-1]
DR   Ensembl; ENST00000394319; ENSP00000377854; ENSG00000106852. [Q9UPM6-3]
DR   Ensembl; ENST00000541397; ENSP00000441464; ENSG00000106852. [Q9UPM6-5]
DR   Ensembl; ENST00000559895; ENSP00000475927; ENSG00000106852. [Q9UPM6-6]
DR   GeneID; 26468; -.
DR   KEGG; hsa:26468; -.
DR   UCSC; uc004blx.5; human. [Q9UPM6-1]
DR   CTD; 26468; -.
DR   DisGeNET; 26468; -.
DR   EuPathDB; HostDB:ENSG00000106852.15; -.
DR   GeneCards; LHX6; -.
DR   HGNC; HGNC:21735; LHX6.
DR   HPA; HPA047854; -.
DR   HPA; HPA058319; -.
DR   MIM; 608215; gene.
DR   neXtProt; NX_Q9UPM6; -.
DR   OpenTargets; ENSG00000106852; -.
DR   PharmGKB; PA134949308; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00760000118921; -.
DR   HOGENOM; HOG000038965; -.
DR   HOVERGEN; HBG006261; -.
DR   InParanoid; Q9UPM6; -.
DR   KO; K09375; -.
DR   OMA; GCKANTR; -.
DR   OrthoDB; EOG091G0EXT; -.
DR   PhylomeDB; Q9UPM6; -.
DR   TreeFam; TF315442; -.
DR   ChiTaRS; LHX6; human.
DR   GeneWiki; LHX6; -.
DR   GenomeRNAi; 26468; -.
DR   PRO; PR:Q9UPM6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106852; -.
DR   CleanEx; HS_LHX6; -.
DR   ExpressionAtlas; Q9UPM6; baseline and differential.
DR   Genevisible; Q9UPM6; HS.
DR   GO; GO:0005634; C:nucleus; IDA:LIFEdb.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0048469; P:cell maturation; ISS:UniProtKB.
DR   GO; GO:0021853; P:cerebral cortex GABAergic interneuron migration; ISS:UniProtKB.
DR   GO; GO:0021799; P:cerebral cortex radially oriented cell migration; ISS:UniProtKB.
DR   GO; GO:0021800; P:cerebral cortex tangential migration; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Differentiation; DNA-binding; Homeobox; LIM domain; Metal-binding;
KW   Neurogenesis; Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    363       LIM/homeobox protein Lhx6.
FT                                /FTId=PRO_0000075794.
FT   DOMAIN       70    122       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      131    184       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DNA_BIND    219    278       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       55    194       Required for interaction with LDB1.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1    187       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046043.
FT   VAR_SEQ       1      1       M -> MYWKHENAAPALPEGCRLPAEGGPATDQVM (in
FT                                isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037745.
FT   VAR_SEQ       1      1       M -> MRRGLCRRSAENPDAGPVM (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042073.
FT   VAR_SEQ     324    363       QVQCGQVHCRLPYTAPPVHLKADMDGPLSNRGEKVILFQY
FT                                -> HPFSVLTLPALPHLPVGAPQLPLSR (in isoform
FT                                2, isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:10393337,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_003109.
FT   CONFLICT     16     16       E -> K (in Ref. 1; BAA83422/BAA83423).
FT                                {ECO:0000305}.
SQ   SEQUENCE   363 AA;  40045 MW;  3633B5112D548532 CRC64;
     MAQPGSGCKA TTRCLEGTAP PAMAQSDAEA LAGALDKDEG QASPCTPSTP SVCSPPSAAS
     SVPSAGKNIC SSCGLEILDR YLLKVNNLIW HVRCLECSVC RTSLRQQNSC YIKNKEIFCK
     MDYFSRFGTK CARCGRQIYA SDWVRRARGN AYHLACFACF SCKRQLSTGE EFGLVEEKVL
     CRIHYDTMIE NLKRAAENGN GLTLEGAVPS EQDSQPKPAK RARTSFTAEQ LQVMQAQFAQ
     DNNPDAQTLQ KLADMTGLSR RVIQVWFQNC RARHKKHTPQ HPVPPSGAPP SRLPSALSDD
     IHYTPFSSPE RARMVTLHGY IESQVQCGQV HCRLPYTAPP VHLKADMDGP LSNRGEKVIL
     FQY
//
ID   MKX_HUMAN               Reviewed;         352 AA.
AC   Q8IYA7; B3KWM5;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   27-SEP-2017, entry version 126.
DE   RecName: Full=Homeobox protein Mohawk;
GN   Name=MKX; Synonyms=C10orf48, IRXL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May act as a morphogenetic regulator of cell adhesion.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TALE/IRO homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK125339; BAG54187.1; -; mRNA.
DR   EMBL; AC024606; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86052.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86053.1; -; Genomic_DNA.
DR   EMBL; BC036207; AAH36207.1; -; mRNA.
DR   CCDS; CCDS7156.1; -.
DR   RefSeq; NP_001229631.1; NM_001242702.1.
DR   RefSeq; NP_775847.2; NM_173576.2.
DR   RefSeq; XP_016871594.1; XM_017016105.1.
DR   RefSeq; XP_016871595.1; XM_017016106.1.
DR   UniGene; Hs.128193; -.
DR   ProteinModelPortal; Q8IYA7; -.
DR   SMR; Q8IYA7; -.
DR   BioGrid; 129453; 9.
DR   IntAct; Q8IYA7; 1.
DR   STRING; 9606.ENSP00000364946; -.
DR   iPTMnet; Q8IYA7; -.
DR   PhosphoSitePlus; Q8IYA7; -.
DR   BioMuta; MKX; -.
DR   DMDM; 296437371; -.
DR   PaxDb; Q8IYA7; -.
DR   PeptideAtlas; Q8IYA7; -.
DR   PRIDE; Q8IYA7; -.
DR   DNASU; 283078; -.
DR   Ensembl; ENST00000375790; ENSP00000364946; ENSG00000150051.
DR   Ensembl; ENST00000419761; ENSP00000400896; ENSG00000150051.
DR   GeneID; 283078; -.
DR   KEGG; hsa:283078; -.
DR   UCSC; uc001itx.5; human.
DR   CTD; 283078; -.
DR   EuPathDB; HostDB:ENSG00000150051.13; -.
DR   GeneCards; MKX; -.
DR   HGNC; HGNC:23729; MKX.
DR   HPA; HPA006927; -.
DR   neXtProt; NX_Q8IYA7; -.
DR   OpenTargets; ENSG00000150051; -.
DR   PharmGKB; PA134964449; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00750000117365; -.
DR   HOGENOM; HOG000290195; -.
DR   HOVERGEN; HBG057105; -.
DR   InParanoid; Q8IYA7; -.
DR   OMA; KCDSAAN; -.
DR   OrthoDB; EOG091G09ZM; -.
DR   PhylomeDB; Q8IYA7; -.
DR   TreeFam; TF319371; -.
DR   ChiTaRS; MKX; human.
DR   GeneWiki; MKX; -.
DR   GenomeRNAi; 283078; -.
DR   PRO; PR:Q8IYA7; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000150051; -.
DR   CleanEx; HS_MKX; -.
DR   ExpressionAtlas; Q8IYA7; baseline and differential.
DR   Genevisible; Q8IYA7; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007517; P:muscle organ development; ISS:HGNC.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    352       Homeobox protein Mohawk.
FT                                /FTId=PRO_0000268856.
FT   DNA_BIND     71    132       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   VARIANT      40     40       R -> H (in dbSNP:rs34439626).
FT                                /FTId=VAR_033875.
FT   CONFLICT     11     11       G -> S (in Ref. 4; AAH36207).
FT                                {ECO:0000305}.
SQ   SEQUENCE   352 AA;  39331 MW;  6450BDEF5BCCEDE9 CRC64;
     MNTIVFNKLS GAVLFEDGGA SERERGGRPY SGVLDSPHAR PEVGIPDGPP LKDNLGLRHR
     RTGARQNGGK VRHKRQALQD MARPLKQWLY KHRDNPYPTK TEKILLALGS QMTLVQVSNW
     FANARRRLKN TVRQPDLSWA LRIKLYNKYV QGNAERLSVS SDDSCSEDGE NPPRTHMNEG
     GYNTPVHHPV IKSENSVIKA GVRPESRASE DYVAPPKYKS SLLNRYLNDS LRHVMATNTT
     MMGKTRQRNH SGSFSSNEFE EELVSPSSSE TEGNFVYRTD TLENGSNKGE SAANRKGPSK
     DDTYWKEINA AMALTNLAQG KDKLQGTTSC IIQKSSHIAE VKTVKVPLVQ QF
//
ID   MEIS3_HUMAN             Reviewed;         375 AA.
AC   Q99687; A8K1N5; Q6NT73; Q8TC66; Q9NPW2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 3.
DT   27-SEP-2017, entry version 147.
DE   RecName: Full=Homeobox protein Meis3;
DE   AltName: Full=Meis1-related protein 2;
GN   Name=MEIS3; Synonyms=MRG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Salivary gland, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 168-375 (ISOFORMS 1/3).
RX   PubMed=9049632; DOI=10.1101/gr.7.2.142;
RA   Steelman S., Moskow J.J., Muzynski K., North C., Druck T.,
RA   Montgomery J.C., Huebner K., Daar I.O., Buchberg A.M.;
RT   "Identification of a conserved family of Meis1-related homeobox
RT   genes.";
RL   Genome Res. 7:142-156(1997).
CC   -!- FUNCTION: Transcriptional regulator which directly modulates PDPK1
CC       expression, thus promoting survival of pancreatic beta-cells. Also
CC       regulates expression of NDFIP1, BNIP3, and CCNG1.
CC       {ECO:0000250|UniProtKB:P97368}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P97368}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q99687-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99687-2; Sequence=VSP_012893;
CC       Name=3;
CC         IsoId=Q99687-3; Sequence=VSP_012892;
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK289950; BAF82639.1; -; mRNA.
DR   EMBL; AL359938; CAB95771.1; -; mRNA.
DR   EMBL; CR749687; CAH18472.1; -; mRNA.
DR   EMBL; CH471126; EAW57482.1; -; Genomic_DNA.
DR   EMBL; BC025404; AAH25404.1; -; mRNA.
DR   EMBL; BC069251; AAH69251.1; -; mRNA.
DR   EMBL; U68385; AAB19195.1; -; mRNA.
DR   CCDS; CCDS33064.1; -. [Q99687-2]
DR   CCDS; CCDS46132.1; -. [Q99687-3]
DR   CCDS; CCDS74406.1; -. [Q99687-1]
DR   RefSeq; NP_001009813.1; NM_001009813.2. [Q99687-3]
DR   RefSeq; NP_001287988.1; NM_001301059.1. [Q99687-1]
DR   RefSeq; NP_064545.1; NM_020160.2. [Q99687-2]
DR   UniGene; Hs.356135; -.
DR   UniGene; Hs.380923; -.
DR   ProteinModelPortal; Q99687; -.
DR   SMR; Q99687; -.
DR   BioGrid; 121245; 2.
DR   iPTMnet; Q99687; -.
DR   PhosphoSitePlus; Q99687; -.
DR   BioMuta; MEIS3; -.
DR   DMDM; 59803105; -.
DR   MaxQB; Q99687; -.
DR   PeptideAtlas; Q99687; -.
DR   PRIDE; Q99687; -.
DR   DNASU; 56917; -.
DR   Ensembl; ENST00000441740; ENSP00000388667; ENSG00000105419. [Q99687-3]
DR   Ensembl; ENST00000558555; ENSP00000454073; ENSG00000105419. [Q99687-1]
DR   Ensembl; ENST00000559524; ENSP00000452854; ENSG00000105419. [Q99687-2]
DR   Ensembl; ENST00000561293; ENSP00000453307; ENSG00000105419. [Q99687-2]
DR   GeneID; 56917; -.
DR   KEGG; hsa:56917; -.
DR   UCSC; uc002pgs.5; human. [Q99687-1]
DR   CTD; 56917; -.
DR   EuPathDB; HostDB:ENSG00000105419.17; -.
DR   GeneCards; MEIS3; -.
DR   HGNC; HGNC:29537; MEIS3.
DR   HPA; HPA046699; -.
DR   neXtProt; NX_Q99687; -.
DR   OpenTargets; ENSG00000105419; -.
DR   PharmGKB; PA30742; -.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000253923; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; Q99687; -.
DR   KO; K16671; -.
DR   OMA; PDSLKHH; -.
DR   PhylomeDB; Q99687; -.
DR   TreeFam; TF318093; -.
DR   ChiTaRS; MEIS3; human.
DR   GenomeRNAi; 56917; -.
DR   PRO; PR:Q99687; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105419; -.
DR   CleanEx; HS_MEIS3; -.
DR   ExpressionAtlas; Q99687; baseline and differential.
DR   Genevisible; Q99687; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    375       Homeobox protein Meis3.
FT                                /FTId=PRO_0000049110.
FT   DNA_BIND    262    324       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS    210    249       Ser/Thr-rich.
FT   COMPBIAS    252    259       Asp/Glu-rich (acidic).
FT   VAR_SEQ     150    166       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012892.
FT   VAR_SEQ     286    286       S -> SRRSEAPVLPDVCLGLGSPSPGPRWARPWGSDCGRP
FT                                GRQSDSCWWLQ (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012893.
FT   CONFLICT      1      4       MARR -> LASQ (in Ref. 2; CAB95771/
FT                                CAH18472). {ECO:0000305}.
FT   CONFLICT    168    169       KM -> RP (in Ref. 5). {ECO:0000305}.
FT   CONFLICT    202    202       M -> I (in Ref. 5). {ECO:0000305}.
FT   CONFLICT    238    238       D -> V (in Ref. 5). {ECO:0000305}.
FT   CONFLICT    260    260       R -> P (in Ref. 5). {ECO:0000305}.
FT   CONFLICT    351    351       Q -> E (in Ref. 5). {ECO:0000305}.
FT   CONFLICT    356    360       VRPPG -> FRAPA (in Ref. 5).
FT                                {ECO:0000305}.
FT   CONFLICT    364    370       MSLNLEG -> DEFGTRKE (in Ref. 5).
FT                                {ECO:0000305}.
SQ   SEQUENCE   375 AA;  41115 MW;  7C29818279800786 CRC64;
     MARRYDELPH YPGIVDGPAA LASFPETVPA VPGPYGPHRP PQPLPPGLDS DGLKREKDEI
     YGHPLFPLLA LVFEKCELAT CSPRDGAGAG LGTPPGGDVC SSDSFNEDIA AFAKQVRSER
     PLFSSNPELD NLMIQAIQVL RFHLLELEKV HDLCDNFCHR YITCLKGKMP IDLVIEDRDG
     GCREDFEDYP ASCPSLPDQN NMWIRDHEDS GSVHLGTPGP SSGGLASQSG DNSSDQGDGL
     DTSVASPSSG GEDEDLDQER RRNKKRGIFP KVATNIMRAW LFQHLSHPYP SEEQKKQLAQ
     DTGLTILQVN NWFINARRRI VQPMIDQSNR TGQGAAFSPE GQPIGGYTET QPHVAVRPPG
     SVGMSLNLEG EWHYL
//
ID   MNX1_HUMAN              Reviewed;         401 AA.
AC   P50219; F5H401; Q9Y648;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   27-SEP-2017, entry version 150.
DE   RecName: Full=Motor neuron and pancreas homeobox protein 1;
DE   AltName: Full=Homeobox protein HB9;
GN   Name=MNX1; Synonyms=HLXB9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7914194;
RA   Harrison K.A., Druey K.M., Deguchi Y., Tuscano J.M., Kehrl J.H.;
RT   "A novel human homeobox gene distantly related to proboscipedia is
RT   expressed in lymphoid and pancreatic tissues.";
RL   J. Biol. Chem. 269:19968-19975(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-353 (ISOFORM 1).
RX   PubMed=10329000; DOI=10.1006/geno.1999.5796;
RA   Heus H.C., Hing A., van Baren M.J., Joosse M., Breedveld G.J.,
RA   Wang J.C., Burgess A., Donnis-Keller H., Berglund C., Zguricas J.,
RA   Scherer S.W., Rommens J.M., Oostra B.A., Heutink P.;
RT   "A physical and transcriptional map of the preaxial polydactyly locus
RT   on chromosome 7q36.";
RL   Genomics 57:342-351(1999).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND SER-79, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   VARIANTS CURRAS SER-246 AND TRP-293.
RX   PubMed=10631160; DOI=10.1086/302723;
RA   Belloni E., Martucciello G., Verderio D., Ponti E., Seri M.,
RA   Jasonni V., Torre M., Ferrari M., Tsui L.-C., Scherer S.W.;
RT   "Involvement of the HLXB9 homeobox gene in Currarino syndrome.";
RL   Am. J. Hum. Genet. 66:312-319(2000).
RN   [8]
RP   VARIANTS CURRAS HIS-245; GLY-245; GLY-288; LEU-288; PRO-290; TRP-292
RP   AND GLN-293.
RX   PubMed=10749657; DOI=10.1086/302899;
RA   Hagan D.M., Ross A.J., Strachan T., Lynch S.A., Ruiz-Perez V.,
RA   Wang Y.M., Scambler P., Custard E., Reardon W., Hassan S., Nixon P.,
RA   Papapetrou C., Winter R.M., Edwards Y., Morrison K., Barrow M.,
RA   Cordier-Alex M.P., Correia P., Galvin-Parton P.A., Gaskill S.,
RA   Gaskin K.J., Garcia-Minaur S., Gereige R., Hayward R., Homfray T.,
RA   McKeown C., Murday V., Plauchu H., Shannon N., Spitz L., Lindsay S.;
RT   "Mutation analysis and embryonic expression of the HLXB9 Currarino
RT   syndrome gene.";
RL   Am. J. Hum. Genet. 66:1504-1515(2000).
RN   [9]
RP   ERRATUM.
RA   Hagan D.M., Ross A.J., Strachan T., Lynch S.A., Ruiz-Perez V.,
RA   Wang Y.M., Scambler P., Custard E., Reardon W., Hassan S., Nixon P.,
RA   Papapetrou C., Winter R.M., Edwards Y., Morrison K., Barrow M.,
RA   Cordier-Alex M.P., Correia P., Galvin-Parton P.A., Gaskill S.,
RA   Gaskin K.J., Garcia-Minaur S., Gereige R., Hayward R., Homfray T.,
RA   McKeown C., Murday V., Plauchu H., Shannon N., Spitz L., Lindsay S.;
RL   Am. J. Hum. Genet. 67:769-769(2000).
RN   [10]
RP   VARIANTS CURRAS TRP-243 AND GLY-288.
RX   PubMed=19853743; DOI=10.1016/j.jpedsurg.2009.03.039;
RA   Garcia-Barcelo M.M., Lui V.C., So M.T., Miao X., Leon T.Y., Yuan Z.W.,
RA   Ngan E.S., Ehsan T., Chung P.H., Khong P.L., Wong K.K., Tam P.K.;
RT   "MNX1 (HLXB9) mutations in Currarino patients.";
RL   J. Pediatr. Surg. 44:1892-1898(2009).
RN   [11]
RP   VARIANT CURRAS SER-289.
RX   PubMed=22820079; DOI=10.1016/j.gene.2012.06.096;
RA   Markljung E., Adamovic T., Cao J., Naji H., Kaiser S., Wester T.,
RA   Nordenskjold A.;
RT   "Novel mutations in the MNX1 gene in two families with Currarino
RT   syndrome and variable phenotype.";
RL   Gene 507:50-53(2012).
CC   -!- FUNCTION: Putative transcription factor involved in pancreas
CC       development and function.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50219-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50219-2; Sequence=VSP_046773, VSP_046774;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Expressed in lymphoid and pancreatic tissues.
CC   -!- DISEASE: Currarino syndrome (CURRAS) [MIM:176450]: The triad of a
CC       presacral tumor, sacral agenesis and anorectal malformation
CC       constitutes the Currarino syndrome which is caused by dorsal-
CC       ventral patterning defects during embryonic development. The
CC       syndrome occurs in the majority of patients as an autosomal
CC       dominant trait. {ECO:0000269|PubMed:10631160,
CC       ECO:0000269|PubMed:10749657, ECO:0000269|PubMed:19853743,
CC       ECO:0000269|PubMed:22820079}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HLXB9ID393.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07664; AAB60647.1; -; Genomic_DNA.
DR   EMBL; U07663; AAB60647.1; JOINED; Genomic_DNA.
DR   EMBL; AC006357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AH007909; AAD41467.1; -; Genomic_DNA.
DR   CCDS; CCDS34788.1; -. [P50219-1]
DR   CCDS; CCDS55187.1; -. [P50219-2]
DR   RefSeq; NP_001158727.1; NM_001165255.1. [P50219-2]
DR   RefSeq; NP_005506.3; NM_005515.3. [P50219-1]
DR   UniGene; Hs.37035; -.
DR   ProteinModelPortal; P50219; -.
DR   SMR; P50219; -.
DR   BioGrid; 109355; 1.
DR   STRING; 9606.ENSP00000252971; -.
DR   iPTMnet; P50219; -.
DR   PhosphoSitePlus; P50219; -.
DR   BioMuta; MNX1; -.
DR   DMDM; 259016336; -.
DR   MaxQB; P50219; -.
DR   PaxDb; P50219; -.
DR   PeptideAtlas; P50219; -.
DR   PRIDE; P50219; -.
DR   DNASU; 3110; -.
DR   Ensembl; ENST00000252971; ENSP00000252971; ENSG00000130675. [P50219-1]
DR   Ensembl; ENST00000543409; ENSP00000438552; ENSG00000130675. [P50219-2]
DR   GeneID; 3110; -.
DR   KEGG; hsa:3110; -.
DR   UCSC; uc003wnc.1; human. [P50219-1]
DR   CTD; 3110; -.
DR   DisGeNET; 3110; -.
DR   EuPathDB; HostDB:ENSG00000130675.14; -.
DR   GeneCards; MNX1; -.
DR   H-InvDB; HIX0033536; -.
DR   HGNC; HGNC:4979; MNX1.
DR   HPA; HPA071717; -.
DR   MalaCards; MNX1; -.
DR   MIM; 142994; gene.
DR   MIM; 176450; phenotype.
DR   neXtProt; NX_P50219; -.
DR   OpenTargets; ENSG00000130675; -.
DR   Orphanet; 1552; Currarino triad.
DR   PharmGKB; PA162396041; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000234345; -.
DR   HOVERGEN; HBG051910; -.
DR   InParanoid; P50219; -.
DR   KO; K08025; -.
DR   OrthoDB; EOG091G0PFO; -.
DR   PhylomeDB; P50219; -.
DR   TreeFam; TF351530; -.
DR   SIGNOR; P50219; -.
DR   GeneWiki; MNX1; -.
DR   GenomeRNAi; 3110; -.
DR   PRO; PR:P50219; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000130675; -.
DR   CleanEx; HS_MNX1; -.
DR   ExpressionAtlas; P50219; baseline and differential.
DR   Genevisible; P50219; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0031018; P:endocrine pancreas development; IBA:GO_Central.
DR   GO; GO:0006959; P:humoral immune response; TAS:ProtInc.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    401       Motor neuron and pancreas homeobox
FT                                protein 1.
FT                                /FTId=PRO_0000048905.
FT   DNA_BIND    241    300       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     35     38       Poly-Ala.
FT   COMPBIAS     40     49       Poly-Gly.
FT   COMPBIAS     98    112       Poly-Gly.
FT   COMPBIAS    121    134       Poly-Ala.
FT   COMPBIAS    168    176       Poly-Ala.
FT   COMPBIAS    315    324       Poly-Gly.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      79     79       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    212       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046773.
FT   VAR_SEQ     213    231       WLRASTAGMILPKMPDFNS -> MGGLSTVGACPGILGAQQ
FT                                A (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046774.
FT   VARIANT     243    243       R -> W (in CURRAS).
FT                                {ECO:0000269|PubMed:19853743}.
FT                                /FTId=VAR_068473.
FT   VARIANT     245    245       R -> G (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017874.
FT   VARIANT     245    245       R -> H (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017875.
FT   VARIANT     246    246       T -> S (in CURRAS; dbSNP:rs121912548).
FT                                {ECO:0000269|PubMed:10631160}.
FT                                /FTId=VAR_017876.
FT   VARIANT     288    288       W -> G (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657,
FT                                ECO:0000269|PubMed:19853743}.
FT                                /FTId=VAR_017877.
FT   VARIANT     288    288       W -> L (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017878.
FT   VARIANT     289    289       F -> S (in CURRAS).
FT                                {ECO:0000269|PubMed:22820079}.
FT                                /FTId=VAR_068474.
FT   VARIANT     290    290       Q -> P (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017879.
FT   VARIANT     292    292       R -> W (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017880.
FT   VARIANT     293    293       R -> Q (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017881.
FT   VARIANT     293    293       R -> W (in CURRAS).
FT                                {ECO:0000269|PubMed:10631160}.
FT                                /FTId=VAR_017882.
FT   CONFLICT     10     37       DALLAVDPPRAASAQSAPLALVTSLAAA -> EPCWRWTPH
FT                                EPPLAERALAKVTSPPVP (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       A -> AAA (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       A -> ARA (in Ref. 3; AAD41467).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       L -> F (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    340    340       G -> R (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    346    349       RRLR -> PPA (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
SQ   SEQUENCE   401 AA;  40569 MW;  67527C8F789DFFDB CRC64;
     MEKSKNFRID ALLAVDPPRA ASAQSAPLAL VTSLAAAASG TGGGGGGGGA SGGTSGSCSP
     ASSEPPAAPA DRLRAESPSP PRLLAAHCAL LPKPGFLGAG GGGGGTGGGH GGPHHHAHPG
     AAAAAAAAAA AAAAGGLALG LHPGGAQGGA GLPAQAALYG HPVYGYSAAA AAAALAGQHP
     ALSYSYPQVQ GAHPAHPADP IKLGAGTFQL DQWLRASTAG MILPKMPDFN SQAQSNLLGK
     CRRPRTAFTS QQLLELEHQF KLNKYLSRPK RFEVATSLML TETQVKIWFQ NRRMKWKRSK
     KAKEQAAQEA EKQKGGGGGA GKGGAEEPGA EELLGPPAPG DKGSGRRLRD LRDSDPEEDE
     DEDDEDHFPY SNGASVHAAS SDCSSEDDSP PPRPSHQPAP Q
//
ID   ME3L2_HUMAN             Reviewed;         358 AA.
AC   A8K0S8;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 1.
DT   27-SEP-2017, entry version 65.
DE   RecName: Full=Putative homeobox protein Meis3-like 2;
GN   Name=MEIS3P2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Although defined as a pseudogene by HGNC, it is clearly
CC       expressed. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK289643; BAF82332.1; -; mRNA.
DR   EMBL; AC087499; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   UniGene; Hs.462484; -.
DR   ProteinModelPortal; A8K0S8; -.
DR   SMR; A8K0S8; -.
DR   iPTMnet; A8K0S8; -.
DR   PhosphoSitePlus; A8K0S8; -.
DR   MaxQB; A8K0S8; -.
DR   PRIDE; A8K0S8; -.
DR   GeneCards; MEIS3P2; -.
DR   HGNC; HGNC:17638; MEIS3P2.
DR   HPA; HPA046699; -.
DR   neXtProt; NX_A8K0S8; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; A8K0S8; -.
DR   PRO; PR:A8K0S8; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    358       Putative homeobox protein Meis3-like 2.
FT                                /FTId=PRO_0000347056.
FT   DNA_BIND    245    307       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   358 AA;  39220 MW;  4A8D7C4EC758FFE8 CRC64;
     MARRYDELPH YPSIADGPAA LAGFPEAVPA APGPYGPHRP PQPLPPGLDS DGLKRDKDEI
     YGHPLFPLLA LVFEKCELAT CSPRDGAGAG LGTPRGGDVC SSDSFNEDNT AFAKQVRSER
     PFFSSNPELD NLMIQAIQVL RFHLLELEKG KMPIDLVIED RDGGCREDFE DYPASCLSLP
     DQNNIWIRDH EDSGSVHLGT PGPSSGGLAS QSGDNSSDQG VGLDTSVASP SSGGEDEDLD
     QEPRRNKKRG IFPKVATNIM RAWLFQHLWH PYPSEEQKKQ LVQDTGLTIL QVNNWFINAR
     RRMVQPMIDQ SNRIGQGAAF SPEGQPIGGY TETEPHVAFR PPASVGMSLN LEGEWHYL
//
ID   MIXL1_HUMAN             Reviewed;         232 AA.
AC   Q9H2W2; B7ZLF9;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-SEP-2017, entry version 147.
DE   RecName: Full=Homeobox protein MIXL1;
DE   AltName: Full=Homeodomain protein MIX;
DE            Short=hMix;
DE   AltName: Full=MIX1 homeobox-like protein 1;
DE   AltName: Full=Mix.1 homeobox-like protein;
GN   Name=MIXL1; Synonyms=MIXL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=12070013; DOI=10.1182/blood.V100.1.89;
RA   Guo W., Chan A.P., Liang H., Wieder E.D., Molldrem J.J., Etkin L.D.,
RA   Nagarajan L.;
RT   "A human Mix-like homeobox gene MIXL shows functional similarity to
RT   Xenopus Mix.1.";
RL   Blood 100:89-95(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11084649;
RX   DOI=10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O;
RA   Robb L., Hartley L., Begley C.G., Brodnicki T.C., Copeland N.G.,
RA   Gilbert D.J., Jenkins N.A., Elefanty A.G.;
RT   "Cloning, expression analysis, and chromosomal localization of murine
RT   and human homologues of a Xenopus mix gene.";
RL   Dev. Dyn. 219:497-504(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=16433620; DOI=10.1089/scd.2005.14.656;
RA   Mossman A.K., Sourris K., Ng E., Stanley E.G., Elefanty A.G.;
RT   "Mixl1 and oct4 proteins are transiently co-expressed in
RT   differentiating mouse and human embryonic stem cells.";
RL   Stem Cells Dev. 14:656-663(2005).
RN   [7]
RP   PHOSPHORYLATION AT TYR-20.
RX   PubMed=17224082; DOI=10.1186/1750-2187-1-6;
RA   Guo W., Nagarajan L.;
RT   "Amino terminal tyrosine phosphorylation of human MIXL1.";
RL   J. Mol. Signal. 1:6-6(2006).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17303500; DOI=10.1016/j.humpath.2006.09.020;
RA   Drakos E., Rassidakis G.Z., Leventaki V., Guo W., Medeiros L.J.,
RA   Nagarajan L.;
RT   "Differential expression of the human MIXL1 gene product in non-
RT   Hodgkin and Hodgkin lymphomas.";
RL   Hum. Pathol. 38:500-507(2007).
CC   -!- FUNCTION: Transcription factor that play a central role in proper
CC       axial mesendoderm morphogenesis and endoderm formation. Required
CC       for efficient differentiation of cells from the primitive streak
CC       stage to blood, by acting early in the recruitment and/or
CC       expansion of mesodermal progenitors to the hemangioblastic and
CC       hematopoietic lineages. Also involved in the morphogenesis of the
CC       heart and the gut during embryogenesis. Acts as a negative
CC       regulator of brachyury expression (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:12070013,
CC       ECO:0000269|PubMed:17303500}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2W2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2W2-2; Sequence=VSP_054305;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Restricted to progenitors and secondary lymph
CC       tissues. In normal hematopoiesis, it is restricted to immature
CC       B- and T-lymphoid cells. Present in differentiating embryonic stem
CC       cells (at protein level). {ECO:0000269|PubMed:12070013,
CC       ECO:0000269|PubMed:16433620, ECO:0000269|PubMed:17303500}.
CC   -!- PTM: Phosphorylated at multiple sites.
CC       {ECO:0000269|PubMed:17224082}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MIXL1ID47624ch1q42.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF211891; AAG35776.1; -; mRNA.
DR   EMBL; AF218357; AAK01479.1; -; Genomic_DNA.
DR   EMBL; AL592045; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471098; EAW69778.1; -; Genomic_DNA.
DR   EMBL; BC111974; AAI11975.1; -; mRNA.
DR   EMBL; BC113441; AAI13442.1; -; mRNA.
DR   EMBL; BC143784; AAI43785.1; -; mRNA.
DR   CCDS; CCDS1552.1; -. [Q9H2W2-1]
DR   CCDS; CCDS60432.1; -. [Q9H2W2-2]
DR   RefSeq; NP_001269331.1; NM_001282402.1. [Q9H2W2-2]
DR   RefSeq; NP_114150.1; NM_031944.2. [Q9H2W2-1]
DR   UniGene; Hs.282079; -.
DR   ProteinModelPortal; Q9H2W2; -.
DR   SMR; Q9H2W2; -.
DR   IntAct; Q9H2W2; 1.
DR   STRING; 9606.ENSP00000355775; -.
DR   iPTMnet; Q9H2W2; -.
DR   PhosphoSitePlus; Q9H2W2; -.
DR   DMDM; 74762734; -.
DR   EPD; Q9H2W2; -.
DR   PaxDb; Q9H2W2; -.
DR   PeptideAtlas; Q9H2W2; -.
DR   PRIDE; Q9H2W2; -.
DR   DNASU; 83881; -.
DR   Ensembl; ENST00000366810; ENSP00000355775; ENSG00000185155. [Q9H2W2-1]
DR   Ensembl; ENST00000542034; ENSP00000442439; ENSG00000185155. [Q9H2W2-2]
DR   GeneID; 83881; -.
DR   KEGG; hsa:83881; -.
DR   UCSC; uc010pvm.4; human. [Q9H2W2-1]
DR   CTD; 83881; -.
DR   DisGeNET; 83881; -.
DR   EuPathDB; HostDB:ENSG00000185155.11; -.
DR   GeneCards; MIXL1; -.
DR   HGNC; HGNC:13363; MIXL1.
DR   HPA; HPA005662; -.
DR   MIM; 609852; gene.
DR   neXtProt; NX_Q9H2W2; -.
DR   OpenTargets; ENSG00000185155; -.
DR   PharmGKB; PA134976348; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00860000133740; -.
DR   HOGENOM; HOG000113594; -.
DR   HOVERGEN; HBG106595; -.
DR   InParanoid; Q9H2W2; -.
DR   OMA; TMYPDIH; -.
DR   OrthoDB; EOG091G15I5; -.
DR   PhylomeDB; Q9H2W2; -.
DR   TreeFam; TF334098; -.
DR   GenomeRNAi; 83881; -.
DR   PRO; PR:Q9H2W2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185155; -.
DR   CleanEx; HS_MIXL1; -.
DR   ExpressionAtlas; Q9H2W2; baseline and differential.
DR   Genevisible; Q9H2W2; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISS:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000987; F:core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; ISS:BHF-UCL.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; ISS:BHF-UCL.
DR   GO; GO:0001190; F:transcriptional activator activity, RNA polymerase II transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl.
DR   GO; GO:0048565; P:digestive tract development; ISS:BHF-UCL.
DR   GO; GO:0007492; P:endoderm development; ISS:BHF-UCL.
DR   GO; GO:0035987; P:endodermal cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0007369; P:gastrulation; ISS:BHF-UCL.
DR   GO; GO:0007507; P:heart development; ISS:BHF-UCL.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISS:BHF-UCL.
DR   GO; GO:1901533; P:negative regulation of hematopoietic progenitor cell differentiation; ISS:BHF-UCL.
DR   GO; GO:2000382; P:positive regulation of mesoderm development; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Differentiation; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    232       Homeobox protein MIXL1.
FT                                /FTId=PRO_0000311333.
FT   DNA_BIND     86    145       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     31     76       Pro-rich.
FT   MOD_RES      20     20       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:17224082}.
FT   VAR_SEQ     130    130       I -> IQLLFSPLF (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054305.
SQ   SEQUENCE   232 AA;  24659 MW;  2E8A6A811799A8F0 CRC64;
     MATAESRALQ FAEGAAFPAY RAPHAGGALL PPPSPAAALL PAPPAGPGPA TFAGFLGRDP
     GPAPPPPASL GSPAPPKGAA APSASQRRKR TSFSAEQLQL LELVFRRTRY PDIHLRERLA
     ALTLLPESRI QVWFQNRRAK SRRQSGKSFQ PLARPEIILN HCAPGTETKC LKPQLPLEVD
     VNCLPEPNGV GGGISDSSSQ GQNFETCSPL SEDIGSKLDS WEEHIFSAFG NF
//
ID   MEIS1_HUMAN             Reviewed;         390 AA.
AC   O00470; A8MV50;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   27-SEP-2017, entry version 147.
DE   RecName: Full=Homeobox protein Meis1;
GN   Name=MEIS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9226379; DOI=10.1006/geno.1997.4766;
RA   Smith J.E. Jr., Bollekens J.A., Inghirami G., Takeshita K.;
RT   "Cloning and mapping of the MEIS1 gene, the human homolog of a murine
RT   leukemogenic gene.";
RL   Genomics 43:99-103(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH PBX1 AND PBX2.
RX   PubMed=12609849; DOI=10.1182/blood-2002-02-0380;
RA   Okada Y., Nagai R., Sato T., Matsuura E., Minami T., Morita I.,
RA   Doi T.;
RT   "Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific
RT   transcription of the platelet factor 4 gene.";
RL   Blood 101:4748-4756(2003).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANT HIS-272, AND POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO
RP   RESTLESS LEGS SYNDROME TYPE 7.
RX   PubMed=19620614; DOI=10.1212/WNL.0b013e3181ae7c79;
RA   Vilarino-Guell C., Chai H., Keeling B.H., Young J.E., Rajput A.,
RA   Lynch T., Aasly J.O., Uitti R.J., Wszolek Z.K., Farrer M.J.,
RA   Lin S.-C.;
RT   "MEIS1 p.R272H in familial restless legs syndrome.";
RL   Neurology 73:243-245(2009).
CC   -!- FUNCTION: Acts as a transcriptional regulator of PAX6. Acts as a
CC       transcriptional activator of PF4 in complex with PBX1 or PBX2.
CC       Required for hematopoiesis, megakaryocyte lineage development and
CC       vascular patterning. May function as a cofactor for HOXA7 and
CC       HOXA9 in the induction of myeloid leukemias.
CC       {ECO:0000269|PubMed:12609849}.
CC   -!- SUBUNIT: Interacts with the N-terminal region of PBX1 to form a
CC       heterodimer which binds DNA including a cAMP-responsive sequence
CC       in CYP17. Also forms heterodimers with PBX2. Forms heterotrimers
CC       with PBX1 or PBX2 and a number of HOX proteins including HOXA9,
CC       HOXD4 and HOXD9 where it acts as a non-DNA-binding partner. Also
CC       forms heterotrimers with PBX1 and HOX proteins including HOXD9 and
CC       HOXD10 where PBX1 is the non-DNA-binding partner.
CC       {ECO:0000269|PubMed:12609849}.
CC   -!- INTERACTION:
CC       P16220:CREB1; NbExp=9; IntAct=EBI-1210694, EBI-711855;
CC       P14921:ETS1; NbExp=2; IntAct=EBI-1210694, EBI-913209;
CC       P31314:TLX1; NbExp=4; IntAct=EBI-1210694, EBI-2820655;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00470-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00470-2; Sequence=VSP_034957, VSP_034958;
CC   -!- TISSUE SPECIFICITY: Expressed at low level in normal
CC       immunohepatopoietic tissues, including the fetal liver. Expressed
CC       in a subset of myeloid leukemia cell lines, with the highest
CC       expression seen in those with a megakaryocytic-erythroid
CC       phenotype. Also expressed at high levels in the cerebellum.
CC   -!- DISEASE: Restless legs syndrome 7 (RLS7) [MIM:612853]: A
CC       neurologic sleep/wake disorder characterized by uncomfortable and
CC       unpleasant sensations in the legs that appear at rest, usually at
CC       night, inducing an irresistible desire to move the legs. The
CC       disorder results in nocturnal insomnia and chronic sleep
CC       deprivation. The majority of patients also have periodic limb
CC       movements in sleep, which are characterized by involuntary, highly
CC       stereotypical, regularly occurring limb movements that occur
CC       during sleep. {ECO:0000305|PubMed:19620614}. Note=Disease
CC       susceptibility may be associated with variations affecting the
CC       gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MEIS1ID41331ch2p14.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U85707; AAC51642.1; -; mRNA.
DR   EMBL; CR612956; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC007392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092669; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093641; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC043503; AAH43503.1; -; mRNA.
DR   CCDS; CCDS46309.1; -. [O00470-1]
DR   RefSeq; NP_002389.1; NM_002398.2. [O00470-1]
DR   UniGene; Hs.526754; -.
DR   UniGene; Hs.603755; -.
DR   PDB; 4XRS; X-ray; 3.50 A; A/B=279-336.
DR   PDB; 5EGO; X-ray; 2.54 A; A=279-333.
DR   PDBsum; 4XRS; -.
DR   PDBsum; 5EGO; -.
DR   ProteinModelPortal; O00470; -.
DR   SMR; O00470; -.
DR   BioGrid; 110375; 27.
DR   IntAct; O00470; 12.
DR   STRING; 9606.ENSP00000272369; -.
DR   iPTMnet; O00470; -.
DR   PhosphoSitePlus; O00470; -.
DR   BioMuta; MEIS1; -.
DR   MaxQB; O00470; -.
DR   PaxDb; O00470; -.
DR   PeptideAtlas; O00470; -.
DR   PRIDE; O00470; -.
DR   Ensembl; ENST00000272369; ENSP00000272369; ENSG00000143995. [O00470-1]
DR   Ensembl; ENST00000398506; ENSP00000381518; ENSG00000143995. [O00470-2]
DR   GeneID; 4211; -.
DR   KEGG; hsa:4211; -.
DR   UCSC; uc002sdu.4; human. [O00470-1]
DR   CTD; 4211; -.
DR   DisGeNET; 4211; -.
DR   EuPathDB; HostDB:ENSG00000143995.19; -.
DR   GeneCards; MEIS1; -.
DR   HGNC; HGNC:7000; MEIS1.
DR   HPA; CAB011521; -.
DR   HPA; HPA056000; -.
DR   HPA; HPA058641; -.
DR   MIM; 601739; gene.
DR   MIM; 612853; phenotype.
DR   neXtProt; NX_O00470; -.
DR   OpenTargets; ENSG00000143995; -.
DR   PharmGKB; PA30740; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000253923; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; O00470; -.
DR   KO; K15613; -.
DR   OMA; VSQGAPY; -.
DR   OrthoDB; EOG091G0KDP; -.
DR   PhylomeDB; O00470; -.
DR   TreeFam; TF318093; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SignaLink; O00470; -.
DR   SIGNOR; O00470; -.
DR   ChiTaRS; MEIS1; human.
DR   GeneWiki; MEIS1; -.
DR   GenomeRNAi; 4211; -.
DR   PRO; PR:O00470; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143995; -.
DR   CleanEx; HS_MEIS1; -.
DR   ExpressionAtlas; O00470; baseline and differential.
DR   Genevisible; O00470; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription.
FT   CHAIN         1    390       Homeobox protein Meis1.
FT                                /FTId=PRO_0000049105.
FT   DNA_BIND    272    334       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   REGION      335    390       Required for transcriptional activation.
FT                                {ECO:0000250}.
FT   COMPBIAS    194    240       Ser/Thr-rich.
FT   COMPBIAS    242    269       Asp/Glu-rich (acidic).
FT   COMPBIAS    262    269       Poly-Asp.
FT   VAR_SEQ       1      4       MAQR -> MQ (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_034957.
FT   VAR_SEQ     373    390       PMSGMGMNMGMEGQWHYM -> LQSMPGEYVARGGPMGVSM
FT                                GQPSYTQPQMPPHPAQLRHGPPMHTYIPGHPHHPTVMMHGG
FT                                PPHPGMPMSASSPTVLNTGDPTMSGQVMDIHAQ (in
FT                                isoform 2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_034958.
FT   VARIANT     272    272       R -> H (found in a patient with
FT                                susceptibility to restless legs syndrome;
FT                                dbSNP:rs61752693).
FT                                {ECO:0000269|PubMed:19620614}.
FT                                /FTId=VAR_063166.
FT   HELIX       281    293       {ECO:0000244|PDB:5EGO}.
FT   TURN        294    296       {ECO:0000244|PDB:5EGO}.
FT   HELIX       302    312       {ECO:0000244|PDB:5EGO}.
FT   HELIX       316    329       {ECO:0000244|PDB:5EGO}.
FT   TURN        330    333       {ECO:0000244|PDB:5EGO}.
SQ   SEQUENCE   390 AA;  43016 MW;  3B6A0ACCF0C39121 CRC64;
     MAQRYDDLPH YGGMDGVGIP STMYGDPHAA RSMQPVHHLN HGPPLHSHQY PHTAHTNAMA
     PSMGSSVNDA LKRDKDAIYG HPLFPLLALI FEKCELATCT PREPGVAGGD VCSSESFNED
     IAVFAKQIRA EKPLFSSNPE LDNLMIQAIQ VLRFHLLELE KVHELCDNFC HRYISCLKGK
     MPIDLVIDDR EGGSKSDSED ITRSANLTDQ PSWNRDHDDT ASTRSGGTPG PSSGGHTSHS
     GDNSSEQGDG LDNSVASPST GDDDDPDKDK KRHKKRGIFP KVATNIMRAW LFQHLTHPYP
     SEEQKKQLAQ DTGLTILQVN NWFINARRRI VQPMIDQSNR AVSQGTPYNP DGQPMGGFVM
     DGQQHMGIRA PGPMSGMGMN MGMEGQWHYM
//
ID   MEOX1_HUMAN             Reviewed;         254 AA.
AC   P50221; A8K524; A8MWF9; Q15069;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   25-OCT-2017, entry version 153.
DE   RecName: Full=Homeobox protein MOX-1;
DE   AltName: Full=Mesenchyme homeobox 1;
GN   Name=MEOX1; Synonyms=MOX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Mammary gland;
RX   PubMed=7987315; DOI=10.1093/hmg/3.8.1359;
RA   Futreal P.A., Cochran C., Rosenthal J., Miki Y., Swenson J., Hobbs M.,
RA   Bennett L.M., Haugen-Strano A., Marks J., Barrett J.C.,
RA   Tavtigian S.V., Shattuck-Eidens D., Kamb A., Skolnick M.,
RA   Wiseman R.W.;
RT   "Isolation of a diverged homeobox gene, MOX1, from the BRCA1 region on
RT   17q21 by solution hybrid capture.";
RL   Hum. Mol. Genet. 3:1359-1364(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN KFS2, AND FUNCTION.
RX   PubMed=23290072; DOI=10.1016/j.ajhg.2012.11.016;
RA   Mohamed J.Y., Faqeih E., Alsiddiky A., Alshammari M.J., Ibrahim N.A.,
RA   Alkuraya F.S.;
RT   "Mutations in MEOX1, encoding mesenchyme homeobox 1, cause Klippel-
RT   Feil anomaly.";
RL   Am. J. Hum. Genet. 92:157-161(2013).
RN   [7]
RP   INVOLVEMENT IN KFS2, AND FUNCTION.
RX   PubMed=24073994; DOI=10.1186/1471-2156-14-95;
RA   Bayrakli F., Guclu B., Yakicier C., Balaban H., Kartal U., Erguner B.,
RA   Sagiroglu M.S., Yuksel S., Ozturk A.R., Kazanci B., Ozum U.,
RA   Kars H.Z.;
RT   "Mutation in MEOX1 gene causes a recessive Klippel-Feil syndrome
RT   subtype.";
RL   BMC Genet. 14:95-95(2013).
CC   -!- FUNCTION: Mesodermal transcription factor that plays a key role in
CC       somitogenesis and is specifically required for sclerotome
CC       development. Required for maintenance of the sclerotome polarity
CC       and formation of the cranio-cervical joints (PubMed:23290072,
CC       PubMed:24073994). Binds specifically to the promoter of target
CC       genes and regulates their expression. Activates expression of
CC       NKX3-2 in the sclerotome. Activates expression of CDKN1A and
CC       CDKN2A in endothelial cells, acting as a regulator of vascular
CC       cell proliferation. While it activates CDKN1A in a DNA-dependent
CC       manner, it activates CDKN2A in a DNA-independent manner. Required
CC       for hematopoietic stem cell (HSCs) induction via its role in
CC       somitogenesis: specification of HSCs occurs via the deployment of
CC       a specific endothelial precursor population, which arises within a
CC       sub-compartment of the somite named endotome.
CC       {ECO:0000250|UniProtKB:F1Q4R9, ECO:0000250|UniProtKB:P32442,
CC       ECO:0000269|PubMed:23290072, ECO:0000269|PubMed:24073994}.
CC   -!- INTERACTION:
CC       P09917:ALOX5; NbExp=3; IntAct=EBI-2864512, EBI-79934;
CC       Q9UKG1:APPL1; NbExp=3; IntAct=EBI-2864512, EBI-741243;
CC       Q12982:BNIP2; NbExp=4; IntAct=EBI-2864512, EBI-752094;
CC       Q68D86:CCDC102B; NbExp=4; IntAct=EBI-2864512, EBI-10171570;
CC       O76071:CIAO1; NbExp=3; IntAct=EBI-2864512, EBI-725145;
CC       Q96Q77:CIB3; NbExp=3; IntAct=EBI-2864512, EBI-10292696;
CC       P61024:CKS1B; NbExp=5; IntAct=EBI-2864512, EBI-456371;
CC       Q2TBE0:CWF19L2; NbExp=3; IntAct=EBI-2864512, EBI-5453285;
CC       O43602:DCX; NbExp=3; IntAct=EBI-2864512, EBI-8646694;
CC       O14893:GEMIN2; NbExp=4; IntAct=EBI-2864512, EBI-443648;
CC       P45984:MAPK9; NbExp=5; IntAct=EBI-2864512, EBI-713568;
CC       O15344:MID1; NbExp=6; IntAct=EBI-2864512, EBI-2340316;
CC       Q9UBU8:MORF4L1; NbExp=3; IntAct=EBI-2864512, EBI-399246;
CC       Q9UJ70:NAGK; NbExp=3; IntAct=EBI-2864512, EBI-372578;
CC       Q969S2:NEIL2; NbExp=5; IntAct=EBI-2864512, EBI-10281234;
CC       Q5JUK9:PAGE3; NbExp=3; IntAct=EBI-2864512, EBI-10244544;
CC       Q2TAL8:QRICH1; NbExp=3; IntAct=EBI-2864512, EBI-2798044;
CC       O00560:SDCBP; NbExp=4; IntAct=EBI-2864512, EBI-727004;
CC       Q99932-2:SPAG8; NbExp=4; IntAct=EBI-2864512, EBI-11959123;
CC       Q9BSW7:SYT17; NbExp=3; IntAct=EBI-2864512, EBI-745392;
CC       Q8N8B7:TCEANC; NbExp=3; IntAct=EBI-2864512, EBI-954696;
CC       P40222:TXLNA; NbExp=3; IntAct=EBI-2864512, EBI-359793;
CC       Q712K3:UBE2R2; NbExp=5; IntAct=EBI-2864512, EBI-2340879;
CC       Q14CS0:UBXN2B; NbExp=3; IntAct=EBI-2864512, EBI-1993619;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P32442}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P32442}. Note=Localizes
CC       predominantly in the nucleus. {ECO:0000250|UniProtKB:P32442}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P50221-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50221-2; Sequence=VSP_043340;
CC       Name=3;
CC         IsoId=P50221-3; Sequence=VSP_046700;
CC         Note=Gene prediction based on EST data.;
CC   -!- DISEASE: Klippel-Feil syndrome 2, autosomal recessive (KFS2)
CC       [MIM:214300]: A skeletal disorder characterized by congenital
CC       fusion of cervical vertebrae. It is due to a failure in the normal
CC       segmentation of vertebrae during the early weeks of fetal
CC       development. The clinical triad consists of short neck, low
CC       posterior hairline, and limited neck movement.
CC       {ECO:0000269|PubMed:23290072, ECO:0000269|PubMed:24073994}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10492; AAA19983.1; -; mRNA.
DR   EMBL; U10493; AAA19984.1; -; mRNA.
DR   EMBL; AK291139; BAF83828.1; -; mRNA.
DR   EMBL; AC004149; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068675; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471178; EAW51672.1; -; Genomic_DNA.
DR   EMBL; BC069474; AAH69474.1; -; mRNA.
DR   EMBL; BC069506; AAH69506.1; -; mRNA.
DR   CCDS; CCDS11466.1; -. [P50221-1]
DR   CCDS; CCDS11467.1; -. [P50221-2]
DR   CCDS; CCDS42343.1; -. [P50221-3]
DR   PIR; I38034; I38034.
DR   RefSeq; NP_001035091.1; NM_001040002.1. [P50221-3]
DR   RefSeq; NP_004518.1; NM_004527.3. [P50221-1]
DR   RefSeq; NP_054705.1; NM_013999.3. [P50221-2]
DR   UniGene; Hs.438; -.
DR   ProteinModelPortal; P50221; -.
DR   SMR; P50221; -.
DR   BioGrid; 110385; 32.
DR   IntAct; P50221; 91.
DR   MINT; MINT-202809; -.
DR   STRING; 9606.ENSP00000321684; -.
DR   iPTMnet; P50221; -.
DR   PhosphoSitePlus; P50221; -.
DR   BioMuta; MEOX1; -.
DR   DMDM; 1709078; -.
DR   PaxDb; P50221; -.
DR   PeptideAtlas; P50221; -.
DR   PRIDE; P50221; -.
DR   DNASU; 4222; -.
DR   Ensembl; ENST00000318579; ENSP00000321684; ENSG00000005102. [P50221-1]
DR   Ensembl; ENST00000329168; ENSP00000328678; ENSG00000005102. [P50221-2]
DR   Ensembl; ENST00000393661; ENSP00000377271; ENSG00000005102. [P50221-3]
DR   GeneID; 4222; -.
DR   KEGG; hsa:4222; -.
DR   UCSC; uc002idz.4; human. [P50221-1]
DR   CTD; 4222; -.
DR   DisGeNET; 4222; -.
DR   EuPathDB; HostDB:ENSG00000005102.12; -.
DR   GeneCards; MEOX1; -.
DR   HGNC; HGNC:7013; MEOX1.
DR   HPA; HPA045214; -.
DR   MalaCards; MEOX1; -.
DR   MIM; 214300; phenotype.
DR   MIM; 600147; gene.
DR   neXtProt; NX_P50221; -.
DR   OpenTargets; ENSG00000005102; -.
DR   Orphanet; 2345; Isolated Klippel-Feil syndrome.
DR   PharmGKB; PA30747; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000230987; -.
DR   HOVERGEN; HBG052456; -.
DR   InParanoid; P50221; -.
DR   KO; K09322; -.
DR   OMA; WHFPVSE; -.
DR   OrthoDB; EOG091G0PFO; -.
DR   PhylomeDB; P50221; -.
DR   TreeFam; TF351603; -.
DR   SIGNOR; P50221; -.
DR   GeneWiki; MEOX1; -.
DR   GenomeRNAi; 4222; -.
DR   PRO; PR:P50221; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000005102; -.
DR   CleanEx; HS_MEOX1; -.
DR   ExpressionAtlas; P50221; baseline and differential.
DR   Genevisible; P50221; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IBA:GO_Central.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0061056; P:sclerotome development; ISS:UniProtKB.
DR   GO; GO:0061053; P:somite development; ISS:UniProtKB.
DR   GO; GO:0001757; P:somite specification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome; Cytoplasm;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    254       Homeobox protein MOX-1.
FT                                /FTId=PRO_0000049195.
FT   DNA_BIND    171    230       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1    115       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_046700.
FT   VAR_SEQ     157    254       DNQENRGKPEGSSKARKERTAFTKEQLRELEAEFAHHNYLT
FT                                RLRRYEIAVNLDLSERQVKVWFQNRRMKWKRVKGGQPISPN
FT                                GQDPEDGDSTASPSSE -> GQSVVPEPKDEVEACEGRSAH
FT                                LPQWAGP (in isoform 2).
FT                                {ECO:0000303|PubMed:7987315}.
FT                                /FTId=VSP_043340.
FT   VARIANT      27     27       S -> L (in dbSNP:rs9898682).
FT                                /FTId=VAR_049584.
FT   CONFLICT     69     69       A -> G (in Ref. 2; BAF83828).
SQ   SEQUENCE   254 AA;  27997 MW;  A53724BF77C02166 CRC64;
     MDPAASSCMR SLQPPAPVWG CLRNPHSEGN GASGLPHYPP TPFSFHQKPD FLATATAAYP
     DFSASCLAAT PHSLPQEEHI FTEQHPAFPQ SPNWHFPVSD ARRRPNSGPA GGSKEMGTSS
     LGLVDTTGGP GDDYGVLGST ANETEKKSSR RRKESSDNQE NRGKPEGSSK ARKERTAFTK
     EQLRELEAEF AHHNYLTRLR RYEIAVNLDL SERQVKVWFQ NRRMKWKRVK GGQPISPNGQ
     DPEDGDSTAS PSSE
//
ID   MSX2_HUMAN              Reviewed;         267 AA.
AC   P35548; D3DQN1; Q53XM4; Q9UD60;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   25-OCT-2017, entry version 178.
DE   RecName: Full=Homeobox protein MSX-2;
DE   AltName: Full=Homeobox protein Hox-8;
GN   Name=MSX2; Synonyms=HOX8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-129.
RC   TISSUE=Osteoblast;
RX   PubMed=8101453; DOI=10.1016/0167-4781(93)90086-S;
RA   Hodgkinson J.E., Davidson C.L., Beresford J., Sharpe P.T.;
RT   "Expression of a human homeobox-containing gene is regulated by
RT   1,25(OH)2D3 in bone cells.";
RL   Biochim. Biophys. Acta 1174:11-16(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT CRS2 HIS-148, AND VARIANT
RP   THR-129.
RX   PubMed=8106171; DOI=10.1016/0092-8674(93)90379-5;
RA   Jabs E.W., Ma L., Li X., Mueller U., Sparkes R.S., Luo W.,
RA   Jackson C.E., Warman M.L., Mulliken J.B., Snead M., Haworth I.,
RA   Maxson R.E.;
RT   "A mutation in the homeodomain of the human MSX2 gene in a family
RT   affected with autosomal dominant craniosynostosis.";
RL   Cell 75:443-450(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT THR-129.
RX   PubMed=7897272;
RA   Iimura T.;
RT   "Molecular cloning and expression of homeobox-containing genes during
RT   hard tissue development.";
RL   Kokubyo Gakkai Zasshi 61:590-604(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Tooth;
RX   PubMed=9522127; DOI=10.3109/10425179709020891;
RA   Iimura T., Takeda K., Goseki M., Maruoka Y., Sasaki S., Oida S.;
RT   "Characterization of two length cDNA for human MSX-2 from dental pulp-
RT   derived cells.";
RL   DNA Seq. 8:87-92(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-129.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-129.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-129.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 96-267, AND VARIANT THR-129.
RC   TISSUE=Ovary tumor;
RX   PubMed=7687426; DOI=10.1006/bbrc.1993.1802;
RA   Suzuki M., Tanaka M., Iwase T., Naito Y., Sugimura H., Kino I.;
RT   "Over-expression of HOX-8, the human homologue of the mouse Hox-8
RT   homeobox gene, in human tumors.";
RL   Biochem. Biophys. Res. Commun. 194:187-193(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-188.
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
RN   [11]
RP   FUNCTION, INTERACTION WITH XRCC6 AND XRCC5, AND MUTAGENESIS OF
RP   THR-147.
RC   TISSUE=Osteoblast;
RX   PubMed=12145306; DOI=10.1074/jbc.M206482200;
RA   Willis D.M., Loewy A.P., Charlton-Kachigian N., Shao J.-S.,
RA   Ornitz D.M., Towler D.A.;
RT   "Regulation of osteocalcin gene expression by a novel Ku antigen
RT   transcription factor complex.";
RL   J. Biol. Chem. 277:37280-37291(2002).
RN   [12]
RP   INVOLVEMENT IN PFMCCD.
RX   PubMed=14571277; DOI=10.1038/sj.ejhg.5201062;
RA   Garcia-Minaur S., Mavrogiannis L.A., Rannan-Eliya S.V., Hendry M.A.,
RA   Liston W.A., Porteous M.E.M., Wilkie A.O.M.;
RT   "Parietal foramina with cleidocranial dysplasia is caused by mutation
RT   in MSX2.";
RL   Eur. J. Hum. Genet. 11:892-895(2003).
RN   [13]
RP   VARIANTS PFM1 PRO-154 AND HIS-172.
RX   PubMed=10767351; DOI=10.1093/hmg/9.8.1251;
RA   Wuyts W., Reardon W., Preis S., Homfray T., Rasore-Quartino A.,
RA   Christians H., Willems P.J., Van Hul W.;
RT   "Identification of mutations in the MSX2 homeobox gene in families
RT   affected with foramina parietalia permagna.";
RL   Hum. Mol. Genet. 9:1251-1255(2000).
RN   [14]
RP   VARIANTS PFM1 159-ARG-LYS-160 DEL AND HIS-172, AND VARIANT THR-129.
RX   PubMed=10742103; DOI=10.1038/74224;
RA   Wilkie A.O.M., Tang Z., Elanko N., Walsh S., Twigg S.R.F., Hurst J.A.,
RA   Wall S.A., Chrzanowska K.H., Maxson R.E. Jr.;
RT   "Functional haploinsufficiency of the human homeobox gene MSX2 causes
RT   defects in skull ossification.";
RL   Nat. Genet. 24:387-390(2000).
RN   [15]
RP   VARIANT CRS2 LEU-148.
RX   PubMed=23918290; DOI=10.1002/ajmg.a.36077;
RA   Janssen A., Hosen M.J., Jeannin P., Coucke P.J., De Paepe A.,
RA   Vanakker O.M.;
RT   "Second family with the Boston-type craniosynostosis syndrome: novel
RT   mutation and expansion of the clinical spectrum.";
RL   Am. J. Med. Genet. A 161A:2352-2357(2013).
RN   [16]
RP   VARIANT CRS2 LEU-148.
RX   PubMed=23949913; DOI=10.1002/ajmg.a.36126;
RA   Florisson J.M., Verkerk A.J., Huigh D., Hoogeboom A.J.,
RA   Swagemakers S., Kremer A., Heijsman D., Lequin M.H., Mathijssen I.M.,
RA   van der Spek P.J.;
RT   "Boston type craniosynostosis: report of a second mutation in MSX2.";
RL   Am. J. Med. Genet. A 161:2626-2633(2013).
CC   -!- FUNCTION: Acts as a transcriptional regulator in bone development.
CC       Represses the ALPL promoter activity and antogonizes the
CC       stimulatory effect of DLX5 on ALPL expression during osteoblast
CC       differentiation. Probable morphogenetic role. May play a role in
CC       limb-pattern formation. In osteoblasts, suppresses transcription
CC       driven by the osteocalcin FGF response element (OCFRE). Binds to
CC       the homeodomain-response element of the ALPL promoter.
CC       {ECO:0000269|PubMed:12145306}.
CC   -!- SUBUNIT: Interacts with MINT (By similarity). Interacts with XRCC6
CC       (Ku70) and XRCC5 (Ku80). {ECO:0000250,
CC       ECO:0000269|PubMed:12145306}.
CC   -!- INTERACTION:
CC       P78337:PITX1; NbExp=4; IntAct=EBI-6447480, EBI-748265;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Parietal foramina 1 (PFM1) [MIM:168500]: Autosomal
CC       dominant disease characterized by oval defects of the parietal
CC       bones caused by deficient ossification around the parietal notch,
CC       which is normally obliterated during the fifth fetal month.
CC       {ECO:0000269|PubMed:10742103, ECO:0000269|PubMed:10767351}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Parietal foramina with cleidocranial dysplasia (PFMCCD)
CC       [MIM:168550]: Combines skull defects in the form of enlarged
CC       parietal foramina and deficient ossification of the clavicles.
CC       {ECO:0000269|PubMed:14571277}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Craniosynostosis 2 (CRS2) [MIM:604757]: A primary
CC       abnormality of skull growth involving premature fusion of one or
CC       more cranial sutures. The growth velocity of the skull often
CC       cannot match that of the developing brain resulting in an abnormal
CC       head shape and, in some cases, increased intracranial pressure,
CC       which must be treated promptly to avoid permanent
CC       neurodevelopmental disability. CRS2 is characterized by either
CC       fronto-orbital recession, or frontal bossing, or
CC       turribrachycephaly, or cloverleaf skull. Associated features
CC       include severe headache, high incidence of visual problems (myopia
CC       or hyperopia), and short first metatarsals. Intelligence is
CC       normal. {ECO:0000269|PubMed:23918290, ECO:0000269|PubMed:23949913,
CC       ECO:0000269|PubMed:8106171}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Msh homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X69295; CAA49156.1; -; mRNA.
DR   EMBL; L22499; AAB42178.1; -; Genomic_DNA.
DR   EMBL; L22498; AAB42178.1; JOINED; Genomic_DNA.
DR   EMBL; S75308; AAD14169.1; -; Genomic_DNA.
DR   EMBL; S75361; AAB33867.1; -; mRNA.
DR   EMBL; D31771; BAA06549.1; -; mRNA.
DR   EMBL; D89377; BAA13949.1; -; mRNA.
DR   EMBL; BT009814; AAP88816.1; -; mRNA.
DR   EMBL; AC117531; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61381.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61382.1; -; Genomic_DNA.
DR   EMBL; BC015509; AAH15509.1; -; mRNA.
DR   EMBL; D14970; BAA03611.1; -; mRNA.
DR   CCDS; CCDS4392.1; -.
DR   PIR; A49068; A49068.
DR   RefSeq; NP_002440.2; NM_002449.4.
DR   UniGene; Hs.89404; -.
DR   ProteinModelPortal; P35548; -.
DR   SMR; P35548; -.
DR   BioGrid; 110594; 24.
DR   IntAct; P35548; 33.
DR   STRING; 9606.ENSP00000239243; -.
DR   iPTMnet; P35548; -.
DR   PhosphoSitePlus; P35548; -.
DR   BioMuta; MSX2; -.
DR   DMDM; 311033429; -.
DR   EPD; P35548; -.
DR   MaxQB; P35548; -.
DR   PaxDb; P35548; -.
DR   PeptideAtlas; P35548; -.
DR   PRIDE; P35548; -.
DR   DNASU; 4488; -.
DR   Ensembl; ENST00000239243; ENSP00000239243; ENSG00000120149.
DR   GeneID; 4488; -.
DR   KEGG; hsa:4488; -.
DR   UCSC; uc003mcy.4; human.
DR   CTD; 4488; -.
DR   DisGeNET; 4488; -.
DR   EuPathDB; HostDB:ENSG00000120149.8; -.
DR   GeneCards; MSX2; -.
DR   GeneReviews; MSX2; -.
DR   H-InvDB; HIX0005431; -.
DR   HGNC; HGNC:7392; MSX2.
DR   HPA; HPA005652; -.
DR   MalaCards; MSX2; -.
DR   MIM; 123101; gene.
DR   MIM; 168500; phenotype.
DR   MIM; 168550; phenotype.
DR   MIM; 604757; phenotype.
DR   neXtProt; NX_P35548; -.
DR   OpenTargets; ENSG00000120149; -.
DR   Orphanet; 1541; Craniosynostosis, Boston type.
DR   Orphanet; 60015; Parietal foramina.
DR   Orphanet; 251290; Parietal foramina with cleidocranial dysplasia.
DR   PharmGKB; PA31197; -.
DR   eggNOG; KOG0492; Eukaryota.
DR   eggNOG; ENOG410YT2J; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231922; -.
DR   HOVERGEN; HBG005205; -.
DR   InParanoid; P35548; -.
DR   KO; K09341; -.
DR   OMA; PLGYSMY; -.
DR   OrthoDB; EOG091G0P1V; -.
DR   PhylomeDB; P35548; -.
DR   TreeFam; TF350699; -.
DR   SIGNOR; P35548; -.
DR   ChiTaRS; MSX2; human.
DR   GeneWiki; Msh_homeobox_2; -.
DR   GenomeRNAi; 4488; -.
DR   PRO; PR:P35548; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000120149; -.
DR   CleanEx; HS_MSX2; -.
DR   ExpressionAtlas; P35548; baseline and differential.
DR   Genevisible; P35548; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003712; F:transcription cofactor activity; ISS:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0090427; P:activation of meiosis; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0061312; P:BMP signaling pathway involved in heart development; IEA:Ensembl.
DR   GO; GO:0060346; P:bone trabecula formation; IEA:Ensembl.
DR   GO; GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl.
DR   GO; GO:0002063; P:chondrocyte development; IEA:Ensembl.
DR   GO; GO:0060363; P:cranial suture morphogenesis; TAS:BHF-UCL.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035880; P:embryonic nail plate morphogenesis; IEA:Ensembl.
DR   GO; GO:0070166; P:enamel mineralization; IEA:Ensembl.
DR   GO; GO:0003416; P:endochondral bone growth; IEA:Ensembl.
DR   GO; GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IEA:Ensembl.
DR   GO; GO:0060364; P:frontal suture morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0032792; P:negative regulation of CREB transcription factor activity; IEA:Ensembl.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0045617; P:negative regulation of keratinocyte differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:2000678; P:negative regulation of transcription regulatory region DNA binding; ISS:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0002076; P:osteoblast development; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:2001055; P:positive regulation of mesenchymal cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0051795; P:positive regulation of timing of catagen; IEA:Ensembl.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0048863; P:stem cell differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0035313; P:wound healing, spreading of epidermal cells; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Craniosynostosis; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Osteogenesis;
KW   Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    267       Homeobox protein MSX-2.
FT                                /FTId=PRO_0000049099.
FT   DNA_BIND    142    201       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     129    129       M -> T (in dbSNP:rs4242182).
FT                                {ECO:0000269|PubMed:10742103,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7687426,
FT                                ECO:0000269|PubMed:7897272,
FT                                ECO:0000269|PubMed:8101453,
FT                                ECO:0000269|PubMed:8106171,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_010898.
FT   VARIANT     148    148       P -> H (in CRS2; gain of function;
FT                                dbSNP:rs104893895).
FT                                {ECO:0000269|PubMed:8106171}.
FT                                /FTId=VAR_003755.
FT   VARIANT     148    148       P -> L (in CRS2).
FT                                {ECO:0000269|PubMed:23918290,
FT                                ECO:0000269|PubMed:23949913}.
FT                                /FTId=VAR_071634.
FT   VARIANT     154    154       L -> P (in PFM1).
FT                                {ECO:0000269|PubMed:10767351}.
FT                                /FTId=VAR_010786.
FT   VARIANT     159    160       Missing (in PFM1; loss of function).
FT                                {ECO:0000269|PubMed:10742103}.
FT                                /FTId=VAR_010200.
FT   VARIANT     172    172       R -> H (in PFM1; loss of function;
FT                                dbSNP:rs104893896).
FT                                {ECO:0000269|PubMed:10742103,
FT                                ECO:0000269|PubMed:10767351}.
FT                                /FTId=VAR_010201.
FT   MUTAGEN     147    147       T->A: Does not bind DNA but still
FT                                suppresses OCFRE activation.
FT                                {ECO:0000269|PubMed:12145306}.
FT   CONFLICT     28     28       P -> L (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT     32     32       E -> A (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT     62     65       ASPL -> SPAV (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT     67     67       A -> P (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT     69     69       S -> G (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       T -> H (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT     85     85       G -> R (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       E -> G (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       R -> S (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       G -> A (in Ref. 1; CAA49156).
FT                                {ECO:0000305}.
SQ   SEQUENCE   267 AA;  28897 MW;  5B61B75F4A7C4AFD CRC64;
     MASPSKGNDL FSPDEEGPAV VAGPGPGPGG AEGAAEERRV KVSSLPFSVE ALMSDKKPPK
     EASPLPAESA SAGATLRPLL LSGHGAREAH SPGPLVKPFE TASVKSENSE DGAAWMQEPG
     RYSPPPRHMS PTTCTLRKHK TNRKPRTPFT TSQLLALERK FRQKQYLSIA ERAEFSSSLN
     LTETQVKIWF QNRRAKAKRL QEAELEKLKM AAKPMLPSSF SLPFPISSPL QAASIYGASY
     PFHRPVLPIP PVGLYATPVG YGMYHLS
//
ID   NANOG_HUMAN             Reviewed;         305 AA.
AC   Q9H9S0; D3DUU4; Q2TTG0; Q6JZS5;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   27-SEP-2017, entry version 144.
DE   RecName: Full=Homeobox protein NANOG;
DE   AltName: Full=Homeobox transcription factor Nanog;
DE            Short=hNanog;
GN   Name=NANOG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ASN-82, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Embryonic stem cell;
RX   PubMed=12787504; DOI=10.1016/S0092-8674(03)00393-3;
RA   Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K.,
RA   Maruyama M., Maeda M., Yamanaka S.;
RT   "The homeoprotein Nanog is required for maintenance of pluripotency in
RT   mouse epiblast and ES cells.";
RL   Cell 113:631-642(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Embryonic stem cell;
RX   PubMed=14990856; DOI=10.1634/stemcells.22-2-169;
RA   Clark A.T., Rodriguez R.T., Bodnar M.S., Abeyta M.J., Cedars M.I.,
RA   Turek P.J., Firpo M.T., Reijo Pera R.A.;
RT   "Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent
RT   cells and map to chromosome 12p13, a hotspot for teratocarcinoma.";
RL   Stem Cells 22:169-179(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, DNA-BINDING,
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Embryonic stem cell;
RX   PubMed=16391521; DOI=10.1038/emm.2005.73;
RA   Kim J.S., Kim J., Kim B.S., Chung H.Y., Lee Y.Y., Park C.-S.,
RA   Lee Y.S., Lee Y.H., Chung I.Y.;
RT   "Identification and functional characterization of an alternative
RT   splice variant within the fourth exon of human nanog.";
RL   Exp. Mol. Med. 37:601-607(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-82.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-82.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=12787505; DOI=10.1016/S0092-8674(03)00392-1;
RA   Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S.,
RA   Smith A.;
RT   "Functional expression cloning of Nanog, a pluripotency sustaining
RT   factor in embryonic stem cells.";
RL   Cell 113:643-655(2003).
RN   [7]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15108323; DOI=10.1002/dvdy.20034;
RA   Hart A.H., Hartley L., Ibrahim M., Robb L.;
RT   "Identification, cloning and expression analysis of the pluripotency
RT   promoting Nanog genes in mouse and human.";
RL   Dev. Dyn. 230:187-198(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=16000880; DOI=10.1038/emm.2005.33;
RA   Oh J.-H., Do H.-J., Yang H.-M., Moon S.-Y., Cha K.-Y., Chung H.-M.,
RA   Kim J.-H.;
RT   "Identification of a putative transactivation domain in human Nanog.";
RL   Exp. Mol. Med. 37:250-254(2005).
RN   [9]
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=15982323; DOI=10.1111/j.1365-2559.2005.02182.x;
RA   Hoei-Hansen C.E., Almstrup K., Nielsen J.E., Brask Sonne S., Graem N.,
RA   Skakkebaek N.E., Leffers H., Rajpert-De Meyts E.;
RT   "Stem cell pluripotency factor NANOG is expressed in human fetal
RT   gonocytes, testicular carcinoma in situ and germ cell tumours.";
RL   Histopathology 47:48-56(2005).
RN   [10]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15582778; DOI=10.1016/j.mod.2004.08.008;
RA   Hatano S.Y., Tada M., Kimura H., Yamaguchi S., Kono T., Nakano T.,
RA   Suemori H., Nakatsuji N., Tada T.;
RT   "Pluripotential competence of cells associated with Nanog activity.";
RL   Mech. Dev. 122:67-79(2005).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=15983365; DOI=10.1634/stemcells.2005-0080;
RA   Hyslop L.A., Stojkovic M., Armstrong L., Walter T., Stojkovic P.,
RA   Przyborski S., Herbert M., Murdoch A., Strachan T., Lako M.;
RT   "Downregulation of NANOG induces differentiation of human embryonic
RT   stem cells to extraembryonic lineages.";
RL   Stem Cells 23:1035-1043(2005).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH PCGF1.
RX   PubMed=26687479; DOI=10.1038/srep18388;
RA   Oliviero G., Munawar N., Watson A., Streubel G., Manning G.,
RA   Bardwell V., Bracken A.P., Cagney G.;
RT   "The variant Polycomb Repressor Complex 1 component PCGF1 interacts
RT   with a pluripotency sub-network that includes DPPA4, a regulator of
RT   embryogenesis.";
RL   Sci. Rep. 5:18388-18388(2015).
RN   [13]
RP   STRUCTURE BY NMR OF 75-157.
RG   Center for eukaryotic structural genomics (CESG);
RT   "Solution structure of human stem cell transcription factor NANOG.";
RL   Submitted (MAR-2010) to the PDB data bank.
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 94-162 IN COMPLEX WITH DNA,
RP   DNA-BINDING, MUTAGENESIS OF PHE-102; LEU-122; GLN-124; MET-125;
RP   TYR-136; LYS-137; LYS-140; THR-141; GLN-144; ASN-145; ARG-147; MET-148
RP   AND LYS-151, AND FUNCTION.
RX   PubMed=25825768; DOI=10.1073/pnas.1502855112;
RA   Hayashi Y., Caboni L., Das D., Yumoto F., Clayton T., Deller M.C.,
RA   Nguyen P., Farr C.L., Chiu H.J., Miller M.D., Elsliger M.A.,
RA   Deacon A.M., Godzik A., Lesley S.A., Tomoda K., Conklin B.R.,
RA   Wilson I.A., Yamanaka S., Fletterick R.J.;
RT   "Structure-based discovery of NANOG variant with enhanced properties
RT   to promote self-renewal and reprogramming of pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:4666-4671(2015).
RN   [15]
RP   VARIANT ASN-82.
RX   PubMed=15233988; DOI=10.1016/j.ygeno.2004.02.014;
RA   Booth H.A., Holland P.W.;
RT   "Eleven daughters of NANOG.";
RL   Genomics 84:229-238(2004).
CC   -!- FUNCTION: Transcription regulator involved in inner cell mass and
CC       embryonic stem (ES) cells proliferation and self-renewal. Imposes
CC       pluripotency on ES cells and prevents their differentiation
CC       towards extraembryonic endoderm and trophectoderm lineages. Blocks
CC       bone morphogenetic protein-induced mesoderm differentiation of ES
CC       cells by physically interacting with SMAD1 and interfering with
CC       the recruitment of coactivators to the active SMAD transcriptional
CC       complexes. Acts as a transcriptional activator or repressor. Binds
CC       optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-
CC       [CG][GA][CG]C[GC]ATTAN[GC]-3'. Binds to the POU5F1/OCT4 promoter
CC       (PubMed:25825768). Able to autorepress its expression in
CC       differentiating (ES) cells: binds to its own promoter following
CC       interaction with ZNF281/ZFP281, leading to recruitment of the NuRD
CC       complex and subsequent repression of expression. When
CC       overexpressed, promotes cells to enter into S phase and
CC       proliferation. {ECO:0000269|PubMed:15983365,
CC       ECO:0000269|PubMed:16000880, ECO:0000269|PubMed:16391521,
CC       ECO:0000269|PubMed:25825768}.
CC   -!- SUBUNIT: Interacts with SMAD1 and SALL4. Interacts with
CC       ZNF281/ZFP281 (By similarity). Interacts with PCGF1
CC       (PubMed:26687479). Interacts with ESRRB; reciprocally modulates
CC       their transcriptional activities (By similarity).
CC       {ECO:0000250|UniProtKB:Q80Z64, ECO:0000269|PubMed:26687479}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:15983365}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H9S0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Nanog-delta 48;
CC         IsoId=Q9H9S0-2; Sequence=VSP_021688;
CC   -!- TISSUE SPECIFICITY: Expressed in testicular carcinoma and derived
CC       germ cell tumors (at protein level). Expressed in fetal gonads,
CC       ovary and testis. Also expressed in ovary teratocarcinoma cell
CC       line and testicular embryonic carcinoma. Not expressed in many
CC       somatic organs and oocytes. {ECO:0000269|PubMed:12787504,
CC       ECO:0000269|PubMed:12787505, ECO:0000269|PubMed:14990856,
CC       ECO:0000269|PubMed:15982323, ECO:0000269|PubMed:16391521}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryonic stem (ES) and
CC       carcinoma (EC) cells. Expressed in inner cell mass (ICM) of the
CC       blastocyst and gonocytes between 14 and 19 weeks of gestation (at
CC       protein level). Not expressed in oocytes, unfertilized oocytes, 2-
CC       16 cell embryos and early morula (at protein level). Expressed in
CC       embryonic stem cells (ES). Expression decreases with ES
CC       differentiation. {ECO:0000269|PubMed:15108323,
CC       ECO:0000269|PubMed:15582778, ECO:0000269|PubMed:15982323,
CC       ECO:0000269|PubMed:15983365, ECO:0000269|PubMed:16391521}.
CC   -!- MISCELLANEOUS: Exists an other tandem duplicated non-processed
CC       pseudogene (NANOGP1) and 10 other NANOG-related nucleotide
CC       sequences located on different chromosomes, all of which are
CC       processed pseudogenes lacking introns (NANOGP2 to NANOGP11);
CC       except NANOGP8 which is a retrogene.
CC   -!- SIMILARITY: Belongs to the Nanog homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Nanog entry;
CC       URL="https://en.wikipedia.org/wiki/Nanog";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NANOGID46540ch12p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB093576; BAC76999.1; -; mRNA.
DR   EMBL; AY230262; AAP49529.1; -; mRNA.
DR   EMBL; AY578089; AAT81526.1; -; mRNA.
DR   EMBL; AK022643; BAB14151.1; -; mRNA.
DR   EMBL; CH471116; EAW88649.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88651.1; -; Genomic_DNA.
DR   CCDS; CCDS31736.1; -. [Q9H9S0-1]
DR   CCDS; CCDS73436.1; -. [Q9H9S0-2]
DR   RefSeq; NP_001284627.1; NM_001297698.1. [Q9H9S0-2]
DR   RefSeq; NP_079141.2; NM_024865.3. [Q9H9S0-1]
DR   UniGene; Hs.635882; -.
DR   PDB; 2KT0; NMR; -; A=75-157.
DR   PDB; 4RBO; X-ray; 3.30 A; A/D=94-162.
DR   PDBsum; 2KT0; -.
DR   PDBsum; 4RBO; -.
DR   ProteinModelPortal; Q9H9S0; -.
DR   SMR; Q9H9S0; -.
DR   BioGrid; 123000; 225.
DR   STRING; 9606.ENSP00000229307; -.
DR   ChEMBL; CHEMBL3580527; -.
DR   iPTMnet; Q9H9S0; -.
DR   PhosphoSitePlus; Q9H9S0; -.
DR   BioMuta; NANOG; -.
DR   DMDM; 118573073; -.
DR   PaxDb; Q9H9S0; -.
DR   PeptideAtlas; Q9H9S0; -.
DR   PRIDE; Q9H9S0; -.
DR   DNASU; 79923; -.
DR   Ensembl; ENST00000229307; ENSP00000229307; ENSG00000111704. [Q9H9S0-1]
DR   Ensembl; ENST00000526286; ENSP00000435288; ENSG00000111704. [Q9H9S0-2]
DR   GeneID; 79923; -.
DR   KEGG; hsa:79923; -.
DR   UCSC; uc009zfy.2; human. [Q9H9S0-1]
DR   CTD; 79923; -.
DR   DisGeNET; 79923; -.
DR   EuPathDB; HostDB:ENSG00000111704.10; -.
DR   GeneCards; NANOG; -.
DR   H-InvDB; HIX0010400; -.
DR   H-InvDB; HIX0038147; -.
DR   HGNC; HGNC:20857; NANOG.
DR   HPA; CAB019380; -.
DR   MIM; 607937; gene.
DR   neXtProt; NX_Q9H9S0; -.
DR   OpenTargets; ENSG00000111704; -.
DR   PharmGKB; PA134864904; -.
DR   eggNOG; KOG0491; Eukaryota.
DR   eggNOG; ENOG4111UAT; LUCA.
DR   GeneTree; ENSGT00670000098076; -.
DR   HOGENOM; HOG000236291; -.
DR   HOVERGEN; HBG058783; -.
DR   InParanoid; Q9H9S0; -.
DR   KO; K10164; -.
DR   OMA; SWNSQAW; -.
DR   OrthoDB; EOG091G0JYT; -.
DR   PhylomeDB; Q9H9S0; -.
DR   TreeFam; TF337402; -.
DR   Reactome; R-HSA-2892245; POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation.
DR   Reactome; R-HSA-2892247; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation.
DR   Reactome; R-HSA-452723; Transcriptional regulation of pluripotent stem cells.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   SignaLink; Q9H9S0; -.
DR   SIGNOR; Q9H9S0; -.
DR   EvolutionaryTrace; Q9H9S0; -.
DR   GeneWiki; Homeobox_protein_NANOG; -.
DR   GenomeRNAi; 79923; -.
DR   PRO; PR:Q9H9S0; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111704; -.
DR   CleanEx; HS_NANOG; -.
DR   ExpressionAtlas; Q9H9S0; baseline and differential.
DR   Genevisible; Q9H9S0; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:HGNC.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0030154; P:cell differentiation; IEP:HGNC.
DR   GO; GO:0008283; P:cell proliferation; IMP:HGNC.
DR   GO; GO:0001714; P:endodermal cell fate specification; IDA:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0045595; P:regulation of cell differentiation; IMP:HGNC.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IMP:UniProtKB.
DR   GO; GO:0019827; P:stem cell population maintenance; IEP:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    305       Homeobox protein NANOG.
FT                                /FTId=PRO_0000261418.
FT   REPEAT      196    200       1.
FT   REPEAT      201    205       2.
FT   REPEAT      206    210       3.
FT   REPEAT      216    220       4.
FT   REPEAT      221    225       5.
FT   REPEAT      226    230       6.
FT   REPEAT      231    235       7.
FT   REPEAT      236    240       8.
FT   DNA_BIND     95    154       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      122    151       Required for DNA-binding.
FT                                {ECO:0000269|PubMed:25825768}.
FT   REGION      196    240       8 X repeats starting with a Trp in each
FT                                unit.
FT   REGION      196    240       Sufficient for transactivation activity.
FT                                {ECO:0000250}.
FT   REGION      241    305       Sufficient for strong transactivation
FT                                activity. {ECO:0000250}.
FT   VAR_SEQ     168    183       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16391521}.
FT                                /FTId=VSP_021688.
FT   VARIANT      82     82       K -> N (in dbSNP:rs2889551).
FT                                {ECO:0000269|PubMed:12787504,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15233988,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_029384.
FT   MUTAGEN     102    102       F->A: No effect on POU5F1 promoter DNA-
FT                                binding. {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     122    122       L->A: Increased POU5F1 promoter DNA-
FT                                binding and protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     124    124       Q->A: Decreased POU5F1 promoter DNA-
FT                                binding and protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     125    125       M->A: Decreased POU5F1 promoter DNA-
FT                                binding and protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     136    136       Y->A: Decreased POU5F1 promoter DNA-
FT                                binding and protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     137    137       K->A: Inhibits POU5F1 promoter DNA-
FT                                binding. {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     140    140       K->A: Decreased POU5F1 promoter DNA-
FT                                binding and protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     141    141       T->A: Inhibits POU5F1 promoter DNA-
FT                                binding. {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     144    144       Q->A: No effect on POU5F1 promoter DNA-
FT                                binding. Decreased protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     145    145       N->A: Inhibits POU5F1 promoter DNA-
FT                                binding. {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     147    147       R->A: Inhibits POU5F1 promoter DNA-
FT                                binding. {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     148    148       M->A: No effect on POU5F1 promoter DNA-
FT                                binding. Increased protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   MUTAGEN     151    151       K->A: Decreased POU5F1 promoter DNA-
FT                                binding and protein stability.
FT                                {ECO:0000269|PubMed:25825768}.
FT   HELIX       104    116       {ECO:0000244|PDB:2KT0}.
FT   STRAND      117    119       {ECO:0000244|PDB:2KT0}.
FT   HELIX       122    131       {ECO:0000244|PDB:2KT0}.
FT   HELIX       136    148       {ECO:0000244|PDB:2KT0}.
FT   TURN        149    151       {ECO:0000244|PDB:2KT0}.
SQ   SEQUENCE   305 AA;  34620 MW;  AC3B2E067C591773 CRC64;
     MSVDPACPQS LPCFEASDCK ESSPMPVICG PEENYPSLQM SSAEMPHTET VSPLPSSMDL
     LIQDSPDSST SPKGKQPTSA EKSVAKKEDK VPVKKQKTRT VFSSTQLCVL NDRFQRQKYL
     SLQQMQELSN ILNLSYKQVK TWFQNQRMKS KRWQKNNWPK NSNGVTQKAS APTYPSLYSS
     YHQGCLVNPT GNLPMWSNQT WNNSTWSNQT QNIQSWSNHS WNTQTWCTQS WNNQAWNSPF
     YNCGEESLQS CMQFQPNSPA SDLEAALEAA GEGLNVIQQT TRYFSTPQTM DLFLNYSMNM
     QPEDV
//
ID   NANGN_HUMAN             Reviewed;         188 AA.
AC   Q7Z5D8;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   27-SEP-2017, entry version 108.
DE   RecName: Full=NANOG neighbor homeobox;
DE   AltName: Full=Homeobox protein C14;
GN   Name=NANOGNB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RA   Guo J.H., Yu L.;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 10-188.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY151139; AAP76323.1; -; mRNA.
DR   EMBL; BC036226; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS44826.1; -.
DR   RefSeq; NP_001138937.1; NM_001145465.1.
DR   UniGene; Hs.558004; -.
DR   ProteinModelPortal; Q7Z5D8; -.
DR   BioGrid; 131826; 1.
DR   STRING; 9606.ENSP00000371553; -.
DR   iPTMnet; Q7Z5D8; -.
DR   PhosphoSitePlus; Q7Z5D8; -.
DR   BioMuta; NANOGNB; -.
DR   DMDM; 74759191; -.
DR   PaxDb; Q7Z5D8; -.
DR   PeptideAtlas; Q7Z5D8; -.
DR   PRIDE; Q7Z5D8; -.
DR   Ensembl; ENST00000382119; ENSP00000371553; ENSG00000205857.
DR   GeneID; 360030; -.
DR   KEGG; hsa:360030; -.
DR   UCSC; uc009zfx.2; human.
DR   CTD; 360030; -.
DR   EuPathDB; HostDB:ENSG00000205857.1; -.
DR   GeneCards; NANOGNB; -.
DR   HGNC; HGNC:24958; NANOGNB.
DR   HPA; HPA060371; -.
DR   neXtProt; NX_Q7Z5D8; -.
DR   PharmGKB; PA165513123; -.
DR   eggNOG; ENOG410JG80; Eukaryota.
DR   eggNOG; ENOG4111BTG; LUCA.
DR   GeneTree; ENSGT00400000025247; -.
DR   InParanoid; Q7Z5D8; -.
DR   OMA; LMDTLWA; -.
DR   OrthoDB; EOG091G16VB; -.
DR   PhylomeDB; Q7Z5D8; -.
DR   TreeFam; TF350480; -.
DR   ChiTaRS; NANOGNB; human.
DR   GenomeRNAi; 360030; -.
DR   PRO; PR:Q7Z5D8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000205857; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    188       NANOG neighbor homeobox.
FT                                /FTId=PRO_0000341417.
FT   DNA_BIND    102    161       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   188 AA;  22750 MW;  8C907E0B232146F5 CRC64;
     MHRARWLTPV IPALWEAEAG RSRGQEIETI LANKKQSAMP WDQDPEQSTG NYSEDEQNGK
     QKWREEGEAG RKREREKEEK NEKELQDEQE NKRKRENEKQ KQYPEKRLVS KSLMHTLWAK
     FKLNRCPTIQ ESLSLSFEFD MTHKQISQWF CKTRKKYNKE MSKRKHKKKH MRWRSLCCQG
     WSRTPALK
//
ID   NANP8_HUMAN             Reviewed;         305 AA.
AC   Q6NSW7;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 109.
DE   RecName: Full=Putative homeobox protein NANOGP8;
GN   Name=NANOGP8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Urinary bladder carcinoma;
RX   PubMed=16623708; DOI=10.1111/j.1742-4658.2006.05186.x;
RA   Zhang J., Wang X., Li M., Han J., Chen B., Wang B., Dai J.;
RT   "NANOGP8 is a retrogene expressed in cancers.";
RL   FEBS J. 273:1723-1730(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   GENE FAMILY.
RX   PubMed=15233988; DOI=10.1016/j.ygeno.2004.02.014;
RA   Booth H.A., Holland P.W.;
RT   "Eleven daughters of NANOG.";
RL   Genomics 84:229-238(2004).
RN   [4]
RP   GENE FAMILY.
RX   PubMed=16469101; DOI=10.1186/1471-2148-6-12;
RA   Fairbanks D.J., Maughan P.J.;
RT   "Evolution of the NANOG pseudogene family in the human and chimpanzee
RT   genomes.";
RL   BMC Evol. Biol. 6:12-12(2006).
CC   -!- FUNCTION: May act as a transcription regulator (By similarity).
CC       When overexpressed, promotes entry of cells into S phase and cell
CC       proliferation. {ECO:0000250, ECO:0000269|PubMed:16623708}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:16623708}.
CC   -!- TISSUE SPECIFICITY: Expressed in osteosarcoma cancer cell line (at
CC       protein level), breast and urinary bladder tissues, and also
CC       osteosarcoma, hepatoma, and breast adenocarcinoma cancer cell
CC       lines. {ECO:0000269|PubMed:16623708}.
CC   -!- MISCELLANEOUS: Almost identical to NANOG. There is only one change
CC       in the inferred amino acid sequence from 'Gln-253' in NANOG to
CC       His-253 in NANOGP8.
CC   -!- SIMILARITY: Belongs to the Nanog homeobox family. {ECO:0000305}.
CC   -!- CAUTION: Could be the product of a pseudogene. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC069807; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC098275; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC099704; -; NOT_ANNOTATED_CDS; mRNA.
DR   ProteinModelPortal; Q6NSW7; -.
DR   SMR; Q6NSW7; -.
DR   IntAct; Q6NSW7; 1.
DR   DMDM; 74762336; -.
DR   EPD; Q6NSW7; -.
DR   PaxDb; Q6NSW7; -.
DR   PeptideAtlas; Q6NSW7; -.
DR   PRIDE; Q6NSW7; -.
DR   DisGeNET; 388112; -.
DR   GeneCards; NANOGP8; -.
DR   HGNC; HGNC:23106; NANOGP8.
DR   neXtProt; NX_Q6NSW7; -.
DR   eggNOG; KOG0491; Eukaryota.
DR   eggNOG; ENOG4111UAT; LUCA.
DR   HOVERGEN; HBG058783; -.
DR   InParanoid; Q6NSW7; -.
DR   PhylomeDB; Q6NSW7; -.
DR   PRO; PR:Q6NSW7; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:1902808; P:positive regulation of cell cycle G1/S phase transition; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   5: Uncertain;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation.
FT   CHAIN         1    305       Putative homeobox protein NANOGP8.
FT                                /FTId=PRO_0000261424.
FT   REPEAT      196    200       1.
FT   REPEAT      201    205       2.
FT   REPEAT      206    210       3.
FT   REPEAT      216    220       4.
FT   REPEAT      221    225       5.
FT   REPEAT      226    230       6.
FT   REPEAT      231    235       7.
FT   REPEAT      236    240       8.
FT   DNA_BIND     95    154       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      196    240       8 X repeats starting with a Trp in each
FT                                unit.
FT   REGION      196    240       Sufficient for transactivation activity.
FT                                {ECO:0000250}.
FT   REGION      241    305       Sufficient for strong transactivation
FT                                activity. {ECO:0000250}.
FT   COMPBIAS    196    236       Trp-rich.
SQ   SEQUENCE   305 AA;  34615 MW;  005F78401BA3E7CE CRC64;
     MSVDPACPQS LPCFEASDCK ESSPMPVICG PEENYPSLQM SSAEMPHTET VSPLPSSMDL
     LIQDSPDSST SPKGKQPTSA ENSVAKKEDK VPVKKQKTRT VFSSTQLCVL NDRFQRQKYL
     SLQQMQELSN ILNLSYKQVK TWFQNQRMKS KRWQKNNWPK NSNGVTQKAS APTYPSLYSS
     YHQGCLVNPT GNLPMWSNQT WNNSTWSNQT QNIQSWSNHS WNTQTWCTQS WNNQAWNSPF
     YNCGEESLQS CMHFQPNSPA SDLEAALEAA GEGLNVIQQT TRYFSTPQTM DLFLNYSMNM
     QPEDV
//
ID   NKX24_HUMAN             Reviewed;         354 AA.
AC   Q9H2Z4; Q5VZV8;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 3.
DT   25-OCT-2017, entry version 125.
DE   RecName: Full=Homeobox protein Nkx-2.4;
DE   AltName: Full=Homeobox protein NK-2 homolog D;
GN   Name=NKX2-4; Synonyms=NKX2D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-289.
RX   PubMed=10818213; DOI=10.1007/s003350010089;
RA   Wang C.-C., Brodnicki T., Copeland N.G., Jenkins N.A., Harvey R.P.;
RT   "Conserved linkage of NK-2 homeobox gene pairs Nkx2-2/2-4 and Nkx2-
RT   1/2-9 in mammals.";
RL   Mamm. Genome 11:466-468(2000).
CC   -!- FUNCTION: Probable transcription factor.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL158013; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10185.1; -; Genomic_DNA.
DR   EMBL; AF202037; AAG35617.1; -; Genomic_DNA.
DR   CCDS; CCDS42855.1; -.
DR   RefSeq; NP_149416.1; NM_033176.1.
DR   UniGene; Hs.456662; -.
DR   ProteinModelPortal; Q9H2Z4; -.
DR   SMR; Q9H2Z4; -.
DR   IntAct; Q9H2Z4; 1.
DR   iPTMnet; Q9H2Z4; -.
DR   PhosphoSitePlus; Q9H2Z4; -.
DR   BioMuta; NKX2-4; -.
DR   DMDM; 206729913; -.
DR   MaxQB; Q9H2Z4; -.
DR   PaxDb; Q9H2Z4; -.
DR   PeptideAtlas; Q9H2Z4; -.
DR   PRIDE; Q9H2Z4; -.
DR   Ensembl; ENST00000351817; ENSP00000345147; ENSG00000125816.
DR   GeneID; 644524; -.
DR   KEGG; hsa:644524; -.
DR   UCSC; uc010gcz.4; human.
DR   CTD; 644524; -.
DR   EuPathDB; HostDB:ENSG00000125816.4; -.
DR   GeneCards; NKX2-4; -.
DR   HGNC; HGNC:7837; NKX2-4.
DR   HPA; HPA074996; -.
DR   MIM; 607808; gene.
DR   neXtProt; NX_Q9H2Z4; -.
DR   OpenTargets; ENSG00000125816; -.
DR   PharmGKB; PA31644; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; Q9H2Z4; -.
DR   KO; K09344; -.
DR   OMA; YCNGGLG; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; Q9H2Z4; -.
DR   TreeFam; TF351204; -.
DR   GenomeRNAi; 644524; -.
DR   PRO; PR:Q9H2Z4; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000125816; -.
DR   CleanEx; HS_NKX2-4; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    354       Homeobox protein Nkx-2.4.
FT                                /FTId=PRO_0000048935.
FT   DNA_BIND    189    248       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     44     47       Poly-Ala.
FT   COMPBIAS     76     91       Poly-Ala.
FT   COMPBIAS    181    187       Poly-Ala.
FT   COMPBIAS    264    272       Poly-Pro.
FT   CONFLICT     97     97       P -> A (in Ref. 3; AAG35617).
FT                                {ECO:0000305}.
FT   CONFLICT    275    275       V -> A (in Ref. 3; AAG35617).
FT                                {ECO:0000305}.
SQ   SEQUENCE   354 AA;  36179 MW;  A2A8963F9A2C5356 CRC64;
     MSLSPKHTTP FSVSDILSPI EETYKKFSGA MDGAPPGLGA PLGAAAAYRA PPPGPSSQAA
     TVAGMQPSHA MAGHNAAAAA AAAAAAAAAA ATYHMPPGVS QFPHGAMGSY CNGGLGNMGE
     LPAYTDGMRG GAATGWYGAN PDPRYSSISR FMGPSAGVNV AGMGSLTGIA DAAKSLGPLH
     AAAAAAAPRR KRRVLFSQAQ VYELERRFKQ QKYLSAPERE HLASMIHLTP TQVKIWFQNH
     RYKMKRQAKD KAAQQLQQEG GLGPPPPPPP SPRRVAVPVL VKDGKPCQNG ASTPTPGQAG
     PQPPAPTPAP ELEELSPSPP ALHGPGGGLA ALDAAAGEYS GGVLGANLLY GRTW
//
ID   NKX26_HUMAN             Reviewed;         301 AA.
AC   A6NCS4;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 89.
DE   RecName: Full=Homeobox protein Nkx-2.6;
DE   AltName: Full=Homeobox protein NK-2 homolog F;
GN   Name=NKX2-6; Synonyms=NKX2F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 64-214.
RX   PubMed=15146197; DOI=10.1038/nbt971;
RA   Brandenberger R., Wei H., Zhang S., Lei S., Murage J., Fisk G.J.,
RA   Li Y., Xu C., Fang R., Guegler K., Rao M.S., Mandalam R.,
RA   Lebkowski J., Stanton L.W.;
RT   "Transcriptome characterization elucidates signaling networks that
RT   control human ES cell growth and differentiation.";
RL   Nat. Biotechnol. 22:707-716(2004).
RN   [3]
RP   VARIANT CTHM LEU-151, FUNCTION, CHARACTERIZATION OF VARIANT CTHM
RP   LEU-151, AND INVOLVEMENT IN CTHM.
RX   PubMed=15649947; DOI=10.1093/hmg/ddi055;
RA   Heathcote K., Braybrook C., Abushaban L., Guy M., Khetyar M.E.,
RA   Patton M.A., Carter N.D., Scambler P.J., Syrris P.;
RT   "Common arterial trunk associated with a homeodomain mutation of
RT   NKX2.6.";
RL   Hum. Mol. Genet. 14:585-593(2005).
RN   [4]
RP   VARIANT CTHM ALA-176.
RX   PubMed=25195019; DOI=10.1016/j.ejmg.2014.08.005;
RA   Zhao L., Ni S.H., Liu X.Y., Wei D., Yuan F., Xu L., Xin L., Li R.G.,
RA   Qu X.K., Xu Y.J., Fang W.Y., Yang Y.Q., Qiu X.B.;
RT   "Prevalence and spectrum of Nkx2.6 mutations in patients with
RT   congenital heart disease.";
RL   Eur. J. Med. Genet. 57:579-586(2014).
RN   [5]
RP   INVOLVEMENT IN CTHM.
RX   PubMed=24421281; DOI=10.1136/jmedgenet-2013-102100;
RA   Ta-Shma A., El-lahham N., Edvardson S., Stepensky P., Nir A.,
RA   Perles Z., Gavri S., Golender J., Yaakobi-Simhayoff N., Shaag A.,
RA   Rein A.J., Elpeleg O.;
RT   "Conotruncal malformations and absent thymus due to a deleterious
RT   NKX2-6 mutation.";
RL   J. Med. Genet. 51:268-270(2014).
RN   [6]
RP   VARIANT CTHM GLN-152.
RX   PubMed=25380965; DOI=10.1007/s00246-014-1060-x;
RA   Wang J., Mao J.H., Ding K.K., Xu W.J., Liu X.Y., Qiu X.B., Li R.G.,
RA   Qu X.K., Xu Y.J., Huang R.T., Xue S., Yang Y.Q.;
RT   "A novel NKX2.6 mutation associated with congenital ventricular septal
RT   defect.";
RL   Pediatr. Cardiol. 36:646-656(2015).
CC   -!- FUNCTION: Acts as a transcriptional activator (PubMed:15649947).
CC       In conjunction with NKX2-5, may play a role in both pharyngeal and
CC       cardiac embryonic development. {ECO:0000250|UniProtKB:P43688,
CC       ECO:0000269|PubMed:15649947}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A
CC       group of congenital heart defects involving the outflow tracts.
CC       Examples include truncus arteriosus communis, double-outlet right
CC       ventricle and transposition of great arteries. Truncus arteriosus
CC       communis is characterized by a single outflow tract instead of a
CC       separate aorta and pulmonary artery. In transposition of the great
CC       arteries, the aorta arises from the right ventricle and the
CC       pulmonary artery from the left ventricle. In double outlet of the
CC       right ventricle, both the pulmonary artery and aorta arise from
CC       the right ventricle. {ECO:0000269|PubMed:15649947,
CC       ECO:0000269|PubMed:24421281, ECO:0000269|PubMed:25195019,
CC       ECO:0000269|PubMed:25380965}. Note=The disease may be caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC012574; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CN272646; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001129743.2; NM_001136271.2.
DR   UniGene; Hs.532654; -.
DR   ProteinModelPortal; A6NCS4; -.
DR   SMR; A6NCS4; -.
DR   STRING; 9606.ENSP00000320089; -.
DR   iPTMnet; A6NCS4; -.
DR   PhosphoSitePlus; A6NCS4; -.
DR   BioMuta; NKX2-6; -.
DR   EPD; A6NCS4; -.
DR   PaxDb; A6NCS4; -.
DR   PRIDE; A6NCS4; -.
DR   Ensembl; ENST00000325017; ENSP00000320089; ENSG00000180053.
DR   GeneID; 137814; -.
DR   KEGG; hsa:137814; -.
DR   UCSC; uc011kzy.3; human.
DR   CTD; 137814; -.
DR   DisGeNET; 137814; -.
DR   EuPathDB; HostDB:ENSG00000180053.7; -.
DR   GeneCards; NKX2-6; -.
DR   HGNC; HGNC:32940; NKX2-6.
DR   MalaCards; NKX2-6; -.
DR   MIM; 217095; phenotype.
DR   MIM; 611770; gene.
DR   neXtProt; NX_A6NCS4; -.
DR   OpenTargets; ENSG00000180053; -.
DR   Orphanet; 3426; Double outlet right ventricle.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 99097; Single ventricular septal defect.
DR   Orphanet; 3303; Tetralogy of Fallot.
DR   Orphanet; 3384; Truncus arteriosus.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; A6NCS4; -.
DR   KO; K09346; -.
DR   OMA; SPENFQY; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; A6NCS4; -.
DR   TreeFam; TF351204; -.
DR   GenomeRNAi; 137814; -.
DR   PRO; PR:A6NCS4; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000180053; -.
DR   CleanEx; HS_NKX2-6; -.
DR   GO; GO:0005634; C:nucleus; IC:HGNC.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:HGNC.
DR   GO; GO:0055014; P:atrial cardiac muscle cell development; ISS:BHF-UCL.
DR   GO; GO:0030154; P:cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0048565; P:digestive tract development; ISS:BHF-UCL.
DR   GO; GO:0035050; P:embryonic heart tube development; IMP:HGNC.
DR   GO; GO:0021854; P:hypothalamus development; ISS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0060039; P:pericardium development; ISS:BHF-UCL.
DR   GO; GO:0060037; P:pharyngeal system development; ISS:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL.
DR   GO; GO:0043586; P:tongue development; ISS:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:HGNC.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; ISS:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    301       Homeobox protein Nkx-2.6.
FT                                /FTId=PRO_0000300262.
FT   DNA_BIND    132    191       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     59     63       Poly-Gly.
FT   VARIANT     151    151       F -> L (in CTHM; impairs transcriptional
FT                                activation; dbSNP:rs267606914).
FT                                {ECO:0000269|PubMed:15649947}.
FT                                /FTId=VAR_063278.
FT   VARIANT     152    152       K -> Q (in CTHM).
FT                                {ECO:0000269|PubMed:25380965}.
FT                                /FTId=VAR_073164.
FT   VARIANT     176    176       V -> A (in CTHM).
FT                                {ECO:0000269|PubMed:25195019}.
FT                                /FTId=VAR_073165.
FT   CONFLICT    199    199       A -> G (in Ref. 2; CN272646).
FT                                {ECO:0000305}.
SQ   SEQUENCE   301 AA;  32121 MW;  BA3FECFC7F1804EA CRC64;
     MLLSPVTSTP FSVKDILRLE RERSCPAASP HPRVRKSPEN FQYLRMDAEP RGSEVHNAGG
     GGGDRKLDGS EPPGGPCEAV LEMDAERMGE PQPGLNAASP LGGGTRVPER GVGNSGDSVR
     GGRSEQPKAR QRRKPRVLFS QAQVLALERR FKQQRYLSAP EREHLASALQ LTSTQVKIWF
     QNRRYKCKRQ RQDKSLELAG HPLTPRRVAV PVLVRDGKPC LGPGPGAPAF PSPYSAAVSP
     YSCYGGYSGA PYGAGYGTCY AGAPSGPAPH TPLASAGFGH GGQNATPQGH LAATLQGVRA
     W
//
ID   NKX62_HUMAN             Reviewed;         277 AA.
AC   Q9C056; Q5JSF3;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   25-OCT-2017, entry version 118.
DE   RecName: Full=Homeobox protein Nkx-6.2;
DE   AltName: Full=Homeobox protein NK-6 homolog B;
GN   Name=NKX6-2; Synonyms=GTX, NKX6B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT ALA-209, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11210186; DOI=10.1007/s003350010247;
RA   Lee S.-H., Davison J.A., Vidal S.M., Belouchi A.;
RT   "Cloning, expression and chromosomal location of NKX6B to 10q26, a
RT   region frequently deleted in brain tumors.";
RL   Mamm. Genome 12:157-162(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-209.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-209.
RC   TISSUE=Brain cortex;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highest expression in brain.
CC       {ECO:0000269|PubMed:11210186}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF184215; AAK13251.1; -; Genomic_DNA.
DR   EMBL; AL392043; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471211; EAW61308.1; -; Genomic_DNA.
DR   EMBL; BC101635; AAI01636.1; -; mRNA.
DR   EMBL; BC104823; AAI04824.1; -; mRNA.
DR   CCDS; CCDS7670.1; -.
DR   RefSeq; NP_796374.1; NM_177400.2.
DR   RefSeq; XP_016872278.1; XM_017016789.1.
DR   UniGene; Hs.134013; -.
DR   ProteinModelPortal; Q9C056; -.
DR   SMR; Q9C056; -.
DR   STRING; 9606.ENSP00000357581; -.
DR   iPTMnet; Q9C056; -.
DR   PhosphoSitePlus; Q9C056; -.
DR   BioMuta; NKX6-2; -.
DR   DMDM; 158564033; -.
DR   PaxDb; Q9C056; -.
DR   PeptideAtlas; Q9C056; -.
DR   PRIDE; Q9C056; -.
DR   Ensembl; ENST00000368592; ENSP00000357581; ENSG00000148826.
DR   GeneID; 84504; -.
DR   KEGG; hsa:84504; -.
DR   UCSC; uc001llr.3; human.
DR   CTD; 84504; -.
DR   DisGeNET; 84504; -.
DR   EuPathDB; HostDB:ENSG00000148826.8; -.
DR   GeneCards; NKX6-2; -.
DR   HGNC; HGNC:19321; NKX6-2.
DR   MIM; 605955; gene.
DR   neXtProt; NX_Q9C056; -.
DR   OpenTargets; ENSG00000148826; -.
DR   PharmGKB; PA134896334; -.
DR   eggNOG; KOG0847; Eukaryota.
DR   eggNOG; ENOG410XT1X; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000060127; -.
DR   HOVERGEN; HBG070987; -.
DR   InParanoid; Q9C056; -.
DR   KO; K09350; -.
DR   OMA; GRAPIFW; -.
DR   OrthoDB; EOG091G142D; -.
DR   PhylomeDB; Q9C056; -.
DR   TreeFam; TF327063; -.
DR   GeneWiki; NKX6-2; -.
DR   GenomeRNAi; 84504; -.
DR   PRO; PR:Q9C056; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148826; -.
DR   CleanEx; HS_NKX6-2; -.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0022010; P:central nervous system myelination; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0010454; P:negative regulation of cell fate commitment; IEA:Ensembl.
DR   GO; GO:0045686; P:negative regulation of glial cell differentiation; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0010455; P:positive regulation of cell fate commitment; IEA:Ensembl.
DR   GO; GO:0045687; P:positive regulation of glial cell differentiation; IEA:Ensembl.
DR   GO; GO:0021912; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification; IEA:Ensembl.
DR   GO; GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    277       Homeobox protein Nkx-6.2.
FT                                /FTId=PRO_0000300635.
FT   DNA_BIND    148    207       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     209    209       V -> A (in dbSNP:rs2804003).
FT                                {ECO:0000269|PubMed:11210186,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_034878.
SQ   SEQUENCE   277 AA;  29263 MW;  4B8EE650EC35D4A9 CRC64;
     MDTNRPGAFV LSSAPLAALH NMAEMKTSLF PYALQGPAGF KAPALGGLGA QLPLGTPHGI
     SDILGRPVGA AGGGLLGGLP RLNGLASSAG VYFGPAAAVA RGYPKPLAEL PGRPPIFWPG
     VVQGAPWRDP RLAGPAPAGG VLDKDGKKKH SRPTFSGQQI FALEKTFEQT KYLAGPERAR
     LAYSLGMTES QVKVWFQNRR TKWRKRHAVE MASAKKKQDS DAEKLKVGGS DAEDDDEYNR
     PLDPNSDDEK ITRLLKKHKP SNLALVSPCG GGAGDAL
//
ID   NKX22_HUMAN             Reviewed;         273 AA.
AC   O95096;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Homeobox protein Nkx-2.2;
DE   AltName: Full=Homeobox protein NK-2 homolog B;
GN   Name=NKX2-2; Synonyms=NKX2.2, NKX2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9703340; DOI=10.2337/diab.47.8.1356;
RA   Furuta H., Horikawa Y., Iwasaki N., Hara M., Sussel L., le Beau M.M.,
RA   Davis E.M., Ogata M., Iwamoto Y., German M.S., Bell G.I.;
RT   "Beta-cell transcription factors and diabetes: mutations in the coding
RT   region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not
RT   associated with maturity-onset diabetes of the young in Japanese.";
RL   Diabetes 47:1356-1358(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Acts as a transcriptional activator. Required for the
CC       maintenance of NEUROD1 expression in the horomone-producing
CC       endocrine cells of the pancreas. May be involved in specifying
CC       diencephalic neuromeric boundaries, and in controlling the
CC       expression of genes that play a role in axonal guidance.
CC       Associates with chromatin at the NEUROD1 promoter region. Binds to
CC       a subset of consensus elements within the NEUROD1 promoter (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with OLIG2. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- DOMAIN: The homeodomain is essential for interaction with OLIG2.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NKX22ID44177ch20p11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF019415; AAC83132.1; -; Genomic_DNA.
DR   EMBL; AF019414; AAC83132.1; JOINED; Genomic_DNA.
DR   EMBL; AL133325; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC075092; AAH75092.1; -; mRNA.
DR   EMBL; BC075093; AAH75093.1; -; mRNA.
DR   CCDS; CCDS13145.1; -.
DR   RefSeq; NP_002500.1; NM_002509.3.
DR   UniGene; Hs.516922; -.
DR   ProteinModelPortal; O95096; -.
DR   SMR; O95096; -.
DR   BioGrid; 110886; 2.
DR   IntAct; O95096; 1.
DR   STRING; 9606.ENSP00000366347; -.
DR   iPTMnet; O95096; -.
DR   PhosphoSitePlus; O95096; -.
DR   BioMuta; NKX2-2; -.
DR   PaxDb; O95096; -.
DR   PeptideAtlas; O95096; -.
DR   PRIDE; O95096; -.
DR   DNASU; 4821; -.
DR   Ensembl; ENST00000377142; ENSP00000366347; ENSG00000125820.
DR   GeneID; 4821; -.
DR   KEGG; hsa:4821; -.
DR   UCSC; uc002wsi.4; human.
DR   CTD; 4821; -.
DR   DisGeNET; 4821; -.
DR   EuPathDB; HostDB:ENSG00000125820.5; -.
DR   GeneCards; NKX2-2; -.
DR   HGNC; HGNC:7835; NKX2-2.
DR   HPA; HPA003468; -.
DR   MIM; 604612; gene.
DR   neXtProt; NX_O95096; -.
DR   OpenTargets; ENSG00000125820; -.
DR   PharmGKB; PA31642; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; O95096; -.
DR   KO; K08029; -.
DR   OMA; GKPCHTL; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; O95096; -.
DR   TreeFam; TF351204; -.
DR   Reactome; R-HSA-210745; Regulation of gene expression in beta cells.
DR   Reactome; R-HSA-210746; Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells.
DR   ChiTaRS; NKX2-2; human.
DR   GeneWiki; NKX2-2; -.
DR   GenomeRNAi; 4821; -.
DR   PRO; PR:O95096; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000125820; -.
DR   CleanEx; HS_NKX2-2; -.
DR   Genevisible; O95096; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0001159; F:core promoter proximal region DNA binding; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0048708; P:astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; TAS:ProtInc.
DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; TAS:Reactome.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048665; P:neuron fate specification; IEA:Ensembl.
DR   GO; GO:0014003; P:oligodendrocyte development; IEA:Ensembl.
DR   GO; GO:0021554; P:optic nerve development; IEA:Ensembl.
DR   GO; GO:0003326; P:pancreatic A cell fate commitment; IEA:Ensembl.
DR   GO; GO:0003329; P:pancreatic PP cell fate commitment; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021530; P:spinal cord oligodendrocyte cell fate specification; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0003323; P:type B pancreatic cell development; IEA:Ensembl.
DR   GO; GO:0003327; P:type B pancreatic cell fate commitment; IEA:Ensembl.
DR   GO; GO:0060580; P:ventral spinal cord interneuron fate determination; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Complete proteome; Developmental protein; DNA-binding;
KW   Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    273       Homeobox protein Nkx-2.2.
FT                                /FTId=PRO_0000048929.
FT   DNA_BIND    128    187       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
SQ   SEQUENCE   273 AA;  30133 MW;  91BDA220BAFA63D1 CRC64;
     MSLTNTKTGF SVKDILDLPD TNDEEGSVAE GPEEENEGPE PAKRAGPLGQ GALDAVQSLP
     LKNPFYDSSD NPYTRWLAST EGLQYSLHGL AAGAPPQDSS SKSPEPSADE SPDNDKETPG
     GGGDAGKKRK RRVLFSKAQT YELERRFRQQ RYLSAPEREH LASLIRLTPT QVKIWFQNHR
     YKMKRARAEK GMEVTPLPSP RRVAVPVLVR DGKPCHALKA QDLAAATFQA GIPFSAYSAQ
     SLQHMQYNAQ YSSASTPQYP TAHPLVQAQQ WTW
//
ID   NKX23_HUMAN             Reviewed;         364 AA.
AC   Q8TAU0; B4DUZ4; Q9NYS6;
DT   27-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-JAN-2003, sequence version 2.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Homeobox protein Nkx-2.3;
DE   AltName: Full=Homeobox protein NK-2 homolog C;
GN   Name=NKX2-3; Synonyms=NKX23, NKX2C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-211.
RA   Wang C.-C., Brodnicki T., Harvey R.P.;
RT   "Homeobox gene Nkx2-3 is critical for normal development of the gut,
RT   spleen and gut-associated lymphoid tissue.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Transcription factor. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH25788.1; Type=Miscellaneous discrepancy; Note=The lack of 97 nucleotides within coding exon 2 produces a frameshift and results in a truncated protein.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300856; BAG62506.1; -; mRNA.
DR   EMBL; AL353719; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025788; AAH25788.1; ALT_SEQ; mRNA.
DR   EMBL; AH009193; AAF44651.1; -; Genomic_DNA.
DR   CCDS; CCDS41558.1; -.
DR   RefSeq; NP_660328.2; NM_145285.2.
DR   UniGene; Hs.243272; -.
DR   ProteinModelPortal; Q8TAU0; -.
DR   SMR; Q8TAU0; -.
DR   BioGrid; 127740; 2.
DR   IntAct; Q8TAU0; 1.
DR   STRING; 9606.ENSP00000342828; -.
DR   PhosphoSitePlus; Q8TAU0; -.
DR   BioMuta; NKX2-3; -.
DR   DMDM; 27923815; -.
DR   PaxDb; Q8TAU0; -.
DR   PeptideAtlas; Q8TAU0; -.
DR   PRIDE; Q8TAU0; -.
DR   Ensembl; ENST00000344586; ENSP00000342828; ENSG00000119919.
DR   GeneID; 159296; -.
DR   KEGG; hsa:159296; -.
DR   UCSC; uc009xwj.4; human.
DR   CTD; 159296; -.
DR   DisGeNET; 159296; -.
DR   EuPathDB; HostDB:ENSG00000119919.10; -.
DR   GeneCards; NKX2-3; -.
DR   HGNC; HGNC:7836; NKX2-3.
DR   HPA; HPA047561; -.
DR   MIM; 606727; gene.
DR   neXtProt; NX_Q8TAU0; -.
DR   OpenTargets; ENSG00000119919; -.
DR   PharmGKB; PA31643; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; Q8TAU0; -.
DR   KO; K09343; -.
DR   OMA; YSYNSFP; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; Q8TAU0; -.
DR   TreeFam; TF351204; -.
DR   GeneWiki; NKX2-3; -.
DR   GenomeRNAi; 159296; -.
DR   PRO; PR:Q8TAU0; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000119919; -.
DR   CleanEx; HS_NKX2-3; -.
DR   ExpressionAtlas; Q8TAU0; baseline and differential.
DR   Genevisible; Q8TAU0; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0043367; P:CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl.
DR   GO; GO:0022612; P:gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0001776; P:leukocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; IEA:Ensembl.
DR   GO; GO:0048535; P:lymph node development; IEA:Ensembl.
DR   GO; GO:0030225; P:macrophage differentiation; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0048541; P:Peyer's patch development; IEA:Ensembl.
DR   GO; GO:0002317; P:plasma cell differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0048621; P:post-embryonic digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    364       Homeobox protein Nkx-2.3.
FT                                /FTId=PRO_0000048933.
FT   DNA_BIND    148    207       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    219    223       Poly-Pro.
FT   COMPBIAS    271    286       Poly-Ala.
FT   COMPBIAS    298    305       Poly-Gly.
SQ   SEQUENCE   364 AA;  38406 MW;  10A279CFA3C8A6DB CRC64;
     MMLPSPVTST PFSVKDILNL EQQHQHFHGA HLQADLEHHF HSAPCMLAAA EGTQFSDGGE
     EDEEDEGEKL SYLNSLAAAD GHGDSGLCPQ GYVHTVLRDS CSEPKEHEEE PEVVRDRSQK
     SCQLKKSLET AGDCKAAEES ERPKPRSRRK PRVLFSQAQV FELERRFKQQ RYLSAPEREH
     LASSLKLTST QVKIWFQNRR YKCKRQRQDK SLELGAHAPP PPPRRVAVPV LVRDGKPCVT
     PSAQAYGAPY SVGASAYSYN SFPAYGYGNS AAAAAAAAAA AAAAAAYSSS YGCAYPAGGG
     GGGGGTSAAT TAMQPACSAA GGGPFVNVSN LGGFGSGGSA QPLHQGTAAG AACAQGTLQG
     IRAW
//
ID   NKX28_HUMAN             Reviewed;         239 AA.
AC   O15522; Q8IUT7;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   25-OCT-2017, entry version 147.
DE   RecName: Full=Homeobox protein Nkx-2.8;
DE   AltName: Full=Homeobox protein NK-2 homolog H;
GN   Name=NKX2-8; Synonyms=NKX-2.8, NKX2G, NKX2H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=9446603; DOI=10.1074/jbc.273.5.2917;
RA   Apergis G.A., Crawford N., Ghosh D., Steppan C.M., Vorachek W.R.,
RA   Wen P., Locker J.;
RT   "A novel nk-2-related transcription factor associated with human fetal
RT   liver and hepatocellular carcinoma.";
RL   J. Biol. Chem. 273:2917-2925(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the NK-2 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000295; AAC71081.1; -; mRNA.
DR   EMBL; AF000297; AAC71082.1; -; Genomic_DNA.
DR   EMBL; AF000296; AAC71082.1; JOINED; Genomic_DNA.
DR   EMBL; AK313537; BAG36314.1; -; mRNA.
DR   EMBL; BC041090; AAH41090.1; -; mRNA.
DR   CCDS; CCDS9660.1; -.
DR   RefSeq; NP_055175.2; NM_014360.3.
DR   UniGene; Hs.234763; -.
DR   ProteinModelPortal; O15522; -.
DR   SMR; O15522; -.
DR   STRING; 9606.ENSP00000258829; -.
DR   BioMuta; NKX2-8; -.
DR   PaxDb; O15522; -.
DR   PeptideAtlas; O15522; -.
DR   PRIDE; O15522; -.
DR   Ensembl; ENST00000258829; ENSP00000258829; ENSG00000136327.
DR   GeneID; 26257; -.
DR   KEGG; hsa:26257; -.
DR   UCSC; uc001wtx.4; human.
DR   CTD; 26257; -.
DR   DisGeNET; 26257; -.
DR   EuPathDB; HostDB:ENSG00000136327.6; -.
DR   GeneCards; NKX2-8; -.
DR   H-InvDB; HIX0026629; -.
DR   HGNC; HGNC:16364; NKX2-8.
DR   HPA; HPA062879; -.
DR   MIM; 603245; gene.
DR   neXtProt; NX_O15522; -.
DR   OpenTargets; ENSG00000136327; -.
DR   PharmGKB; PA38402; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; O15522; -.
DR   KO; K09347; -.
DR   OMA; YKMKRGR; -.
DR   OrthoDB; EOG091G0LZ2; -.
DR   PhylomeDB; O15522; -.
DR   TreeFam; TF351204; -.
DR   GenomeRNAi; 26257; -.
DR   PRO; PR:O15522; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000136327; -.
DR   CleanEx; HS_NKX2-8; -.
DR   Genevisible; O15522; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; NAS:UniProtKB.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    239       Homeobox protein Nkx-2.8.
FT                                /FTId=PRO_0000048943.
FT   DNA_BIND     84    143       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    182    187       Poly-Gly.
FT   VARIANT      16     16       D -> A.
FT                                /FTId=VAR_003753.
FT   CONFLICT     16     16       D -> G (in Ref. 1; AAC71081/AAC71082).
FT                                {ECO:0000305}.
SQ   SEQUENCE   239 AA;  25866 MW;  E227378CCD6E9D27 CRC64;
     MATSGRLSFT VRSLLDLPEQ DAQHLPRREP EPRAPQPDPC AAWLDSERGH YPSSDESSLE
     TSPPDSSQRP SARPASPGSD AEKRKKRRVL FSKAQTLELE RRFRQQRYLS APEREQLASL
     LRLTPTQVKI WFQNHRYKLK RARAPGAAES PDLAASAELH AAPGLLRRVV VPVLVRDGQP
     CGGGGGGEVG TAAAQEKCGA PPAAACPLPG YPAFGPGSAL GLFPAYQHLA SPALVSWNW
//
ID   NKX32_HUMAN             Reviewed;         333 AA.
AC   P78367; Q2M2I7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   25-OCT-2017, entry version 138.
DE   RecName: Full=Homeobox protein Nkx-3.2;
DE   AltName: Full=Bagpipe homeobox protein homolog 1;
DE   AltName: Full=Homeobox protein NK-3 homolog B;
GN   Name=NKX3-2; Synonyms=BAPX1, NKX3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9426254; DOI=10.1016/S0378-1119(97)00520-9;
RA   Tribioli C., Lufkin T.;
RT   "Molecular cloning, chromosomal mapping and developmental expression
RT   of BAPX1, a novel human homeobox-containing gene homologous to
RT   Drosophila bagpipe.";
RL   Gene 203:225-233(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=9344671; DOI=10.1006/geno.1997.4926;
RA   Yoshiura K., Murray J.C.;
RT   "Sequence and chromosomal assignment of human BAPX1, a bagpipe-related
RT   gene, to 4p16.1: a candidate gene for skeletal dysplasia.";
RL   Genomics 45:425-428(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 206-265.
RX   PubMed=9256352; DOI=10.1016/S0925-4773(97)00067-1;
RA   Tribioli C., Frasch M., Lufkin T.;
RT   "Bapx1: an evolutionary conserved homologue of the Drosophila bagpipe
RT   homeobox gene is expressed in splanchnic mesoderm and the embryonic
RT   skeleton.";
RL   Mech. Dev. 65:145-162(1997).
RN   [5]
RP   INVOLVEMENT IN SMMD, AND TISSUE SPECIFICITY.
RX   PubMed=20004766; DOI=10.1016/j.ajhg.2009.11.005;
RA   Hellemans J., Simon M., Dheedene A., Alanay Y., Mihci E., Rifai L.,
RA   Sefiani A., van Bever Y., Meradji M., Superti-Furga A., Mortier G.;
RT   "Homozygous inactivating mutations in the NKX3-2 gene result in
RT   spondylo-megaepiphyseal-metaphyseal dysplasia.";
RL   Am. J. Hum. Genet. 85:916-922(2009).
CC   -!- FUNCTION: Transcriptional repressor that acts as a negative
CC       regulator of chondrocyte maturation. PLays a role in distal
CC       stomach development; required for proper antral-pyloric
CC       morphogenesis and development of antral-type epithelium. In
CC       concert with GSC, defines the structural components of the middle
CC       ear; required for tympanic ring and gonium development and in the
CC       regulation of the width of the malleus (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed at highest levels in cartilage, bone
CC       (osteosarcoma) and gut (small intestine and colon), whereas
CC       moderate expression is seen in trachea and brain. Expressed in
CC       visceral mesoderm and embryonic skeleton.
CC       {ECO:0000269|PubMed:20004766}.
CC   -!- DISEASE: Spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD)
CC       [MIM:613330]: A skeletal dysplasia characterized by
CC       disproportionate short stature with a short and stiff neck and
CC       trunk, relatively long limbs that may show flexion contractures of
CC       the distal joints, delayed and impaired ossification of the
CC       vertebral bodies, the presence of large epiphyseal ossification
CC       centers and wide growth plates in the long tubular bones, and
CC       numerous pseudoepiphyses of the short tubular bones in hands and
CC       feet. {ECO:0000269|PubMed:20004766}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NK-3 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF005260; AAC39536.1; -; Genomic_DNA.
DR   EMBL; AF009801; AAB82783.1; -; mRNA.
DR   EMBL; AF009802; AAB82784.1; -; Genomic_DNA.
DR   EMBL; BC111966; AAI11967.1; -; mRNA.
DR   EMBL; U89845; AAB49696.1; -; Genomic_DNA.
DR   CCDS; CCDS3410.1; -.
DR   RefSeq; NP_001180.1; NM_001189.3.
DR   UniGene; Hs.590927; -.
DR   ProteinModelPortal; P78367; -.
DR   SMR; P78367; -.
DR   BioGrid; 107055; 6.
DR   IntAct; P78367; 1.
DR   STRING; 9606.ENSP00000371875; -.
DR   iPTMnet; P78367; -.
DR   PhosphoSitePlus; P78367; -.
DR   BioMuta; NKX3-2; -.
DR   DMDM; 6016210; -.
DR   EPD; P78367; -.
DR   PaxDb; P78367; -.
DR   PeptideAtlas; P78367; -.
DR   PRIDE; P78367; -.
DR   DNASU; 579; -.
DR   Ensembl; ENST00000382438; ENSP00000371875; ENSG00000109705.
DR   GeneID; 579; -.
DR   KEGG; hsa:579; -.
DR   UCSC; uc003gmx.3; human.
DR   CTD; 579; -.
DR   DisGeNET; 579; -.
DR   EuPathDB; HostDB:ENSG00000109705.7; -.
DR   GeneCards; NKX3-2; -.
DR   HGNC; HGNC:951; NKX3-2.
DR   HPA; HPA027564; -.
DR   MalaCards; NKX3-2; -.
DR   MIM; 602183; gene.
DR   MIM; 613330; phenotype.
DR   neXtProt; NX_P78367; -.
DR   OpenTargets; ENSG00000109705; -.
DR   Orphanet; 228387; Spondylo-megaepiphyseal-metaphyseal dysplasia.
DR   PharmGKB; PA162397617; -.
DR   eggNOG; KOG0842; Eukaryota.
DR   eggNOG; ENOG410XR21; LUCA.
DR   GeneTree; ENSGT00900000140771; -.
DR   HOGENOM; HOG000231923; -.
DR   HOVERGEN; HBG006689; -.
DR   InParanoid; P78367; -.
DR   KO; K09995; -.
DR   OMA; ESPGGWD; -.
DR   OrthoDB; EOG091G0V1X; -.
DR   PhylomeDB; P78367; -.
DR   TreeFam; TF351204; -.
DR   GenomeRNAi; 579; -.
DR   PRO; PR:P78367; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109705; -.
DR   CleanEx; HS_NKX3-2; -.
DR   Genevisible; P78367; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0048645; P:animal organ formation; IEA:Ensembl.
DR   GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Dwarfism; Homeobox; Nucleus;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    333       Homeobox protein Nkx-3.2.
FT                                /FTId=PRO_0000048947.
FT   DNA_BIND    206    265       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    180    188       Poly-Gly.
FT   COMPBIAS    194    198       Poly-Glu.
FT   COMPBIAS    327    330       Poly-Ala.
SQ   SEQUENCE   333 AA;  34814 MW;  8C406E188D27780B CRC64;
     MAVRGANTLT SFSIQAILNK KEERGGLAAP EGRPAPGGTA ASVAAAPAVC CWRLFGERDA
     GALGGAEDSL LASPAGTRTA AGRTAESPEG WDSDSALSEE NESRRRCADA RGASGAGLAG
     GSLSLGQPVC ELAASKDLEE EAAGRSDSEM SASVSGDRSP RTEDDGVGPR GAHVSALCSG
     AGGGGGSGPA GVAEEEEEPA APKPRKKRSR AAFSHAQVFE LERRFNHQRY LSGPERADLA
     ASLKLTETQV KIWFQNRRYK TKRRQMAADL LASAPAAKKV AVKVLVRDDQ RQYLPGEVLR
     PPSLLPLQPS YYYPYYCLPG WALSTCAAAA GTQ
//
ID   NKX11_HUMAN             Reviewed;         411 AA.
AC   Q15270;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   25-OCT-2017, entry version 122.
DE   RecName: Full=NK1 transcription factor-related protein 1;
DE   AltName: Full=Homeobox protein 153;
DE            Short=HPX-153;
DE   AltName: Full=Homeobox protein SAX-2;
DE   AltName: Full=NKX-1.1;
GN   Name=NKX1-1; Synonyms=HPX153;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 267-305, AND TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Expressed in hemopoietic progenitor cells.
CC       {ECO:0000269|PubMed:7518789}.
CC   -!- SIMILARITY: Belongs to the NK-1 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC118281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X76978; CAA54282.1; -; mRNA.
DR   PIR; I38143; I38143.
DR   UniGene; Hs.526396; -.
DR   ProteinModelPortal; Q15270; -.
DR   SMR; Q15270; -.
DR   IntAct; Q15270; 1.
DR   PhosphoSitePlus; Q15270; -.
DR   DMDM; 189029591; -.
DR   PaxDb; Q15270; -.
DR   PeptideAtlas; Q15270; -.
DR   PRIDE; Q15270; -.
DR   Ensembl; ENST00000422806; ENSP00000407978; ENSG00000235608.
DR   UCSC; uc062ulo.1; human.
DR   DisGeNET; 54729; -.
DR   EuPathDB; HostDB:ENSG00000235608.1; -.
DR   GeneCards; NKX1-1; -.
DR   H-InvDB; HIX0031928; -.
DR   HGNC; HGNC:24975; NKX1-1.
DR   HPA; HPA029367; -.
DR   neXtProt; NX_Q15270; -.
DR   PharmGKB; PA145148380; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOGENOM; HOG000203703; -.
DR   InParanoid; Q15270; -.
DR   OMA; PATCAPC; -.
DR   OrthoDB; EOG091G0SCQ; -.
DR   TreeFam; TF316128; -.
DR   PRO; PR:Q15270; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000235608; -.
DR   CleanEx; HS_NKX1-1; -.
DR   Genevisible; Q15270; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:Ensembl.
DR   GO; GO:0050877; P:nervous system process; IEA:Ensembl.
DR   GO; GO:0043467; P:regulation of generation of precursor metabolites and energy; IEA:Ensembl.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    411       NK1 transcription factor-related protein
FT                                1.
FT                                /FTId=PRO_0000333009.
FT   DNA_BIND    259    318       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     59     62       Poly-Arg.
FT   COMPBIAS    105    238       Gly-rich.
FT   COMPBIAS    328    375       Gly-rich.
FT   CONFLICT    294    294       L -> V (in Ref. 2; CAA54282).
FT                                {ECO:0000305}.
SQ   SEQUENCE   411 AA;  40659 MW;  F99A130A98726769 CRC64;
     MDGRAELPAF PRAGAPPLAA SDTVPAAPEG AGAARPAAPL RPTSFSVLDI LDPNKFNSRR
     RRCVLLGPVA PAACAPCASA PCAPAPAASG RPPRAEELER RALAGAGGVG AAGAEPPNAG
     DPFKAGEAET NDTNGYSSGG GGHSPSADSG DEVPDDEDDD EDEAPETEAA RGAEEARGGG
     GGLGARGSGC QGAAETDASP GATVDEAAAP GPRENSPVAQ GPPGGAAAPG GAGTTPQGTA
     TAAKPKRKRT GSDSKSGKPR RARTAFTYEQ LVALENKFKA TRYLSVCERL NLALSLSLTE
     TQVKIWFQNR RTKWKKQNPG ADTSAPTGGG GGPGPGAGPG TGLPGGLSPL SPSPPMGAPL
     GMHGPAGYPA HGPGGLVCAA QLPFLSSPAV LSPFVLGSQT YGAPAFYAPH L
//
ID   NKX61_HUMAN             Reviewed;         367 AA.
AC   P78426;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 2.
DT   25-OCT-2017, entry version 147.
DE   RecName: Full=Homeobox protein Nkx-6.1;
DE   AltName: Full=Homeobox protein NK-6 homolog A;
GN   Name=NKX6-1; Synonyms=NKX6A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Pancreatic islet;
RX   PubMed=9119408; DOI=10.1006/geno.1996.4568;
RA   Inoue H., Rudnick A., German M.S., Veile R., Donis-Keller H.,
RA   Permutt M.A.;
RT   "Isolation, characterization, and chromosomal mapping of the human
RT   Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene.";
RL   Genomics 40:367-370(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-189, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Transcription factor which binds to specific A/T-rich
CC       DNA sequences in the promoter regions of a number of genes.
CC       Involved in transcriptional regulation in islet beta cells. Binds
CC       to the insulin promoter and is involved in regulation of the
CC       insulin gene. Together with NKX2-2 and IRX3 acts to restrict the
CC       generation of motor neurons to the appropriate region of the
CC       neural tube. Belongs to the class II proteins of neuronal
CC       progenitor factors, which are induced by SHH signals (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Pancreatic beta cells.
CC   -!- DOMAIN: The C-terminal domain contributes to sequence-specific
CC       DNA-binding. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66799; AAD11962.1; -; Genomic_DNA.
DR   EMBL; U66797; AAD11962.1; JOINED; Genomic_DNA.
DR   EMBL; U66798; AAD11962.1; JOINED; Genomic_DNA.
DR   EMBL; AC096766; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3607.1; -.
DR   RefSeq; NP_006159.2; NM_006168.2.
DR   UniGene; Hs.546270; -.
DR   ProteinModelPortal; P78426; -.
DR   SMR; P78426; -.
DR   BioGrid; 110889; 1.
DR   IntAct; P78426; 1.
DR   STRING; 9606.ENSP00000295886; -.
DR   iPTMnet; P78426; -.
DR   PhosphoSitePlus; P78426; -.
DR   BioMuta; NKX6-1; -.
DR   DMDM; 288558819; -.
DR   PaxDb; P78426; -.
DR   PeptideAtlas; P78426; -.
DR   PRIDE; P78426; -.
DR   DNASU; 4825; -.
DR   Ensembl; ENST00000295886; ENSP00000295886; ENSG00000163623.
DR   GeneID; 4825; -.
DR   KEGG; hsa:4825; -.
DR   UCSC; uc003hpa.2; human.
DR   CTD; 4825; -.
DR   DisGeNET; 4825; -.
DR   EuPathDB; HostDB:ENSG00000163623.9; -.
DR   GeneCards; NKX6-1; -.
DR   HGNC; HGNC:7839; NKX6-1.
DR   HPA; CAB070169; -.
DR   HPA; HPA036774; -.
DR   MIM; 602563; gene.
DR   neXtProt; NX_P78426; -.
DR   OpenTargets; ENSG00000163623; -.
DR   PharmGKB; PA31646; -.
DR   eggNOG; KOG0847; Eukaryota.
DR   eggNOG; ENOG410XT1X; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000060127; -.
DR   HOVERGEN; HBG070987; -.
DR   InParanoid; P78426; -.
DR   KO; K08030; -.
DR   OMA; VGAMEGP; -.
DR   OrthoDB; EOG091G142D; -.
DR   PhylomeDB; P78426; -.
DR   TreeFam; TF327063; -.
DR   Reactome; R-HSA-210745; Regulation of gene expression in beta cells.
DR   Reactome; R-HSA-210747; Regulation of gene expression in early pancreatic precursor cells.
DR   GeneWiki; NKX6-1; -.
DR   GenomeRNAi; 4825; -.
DR   PRO; PR:P78426; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000163623; -.
DR   CleanEx; HS_NKX6-1; -.
DR   ExpressionAtlas; P78426; baseline and differential.
DR   Genevisible; P78426; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl.
DR   GO; GO:0051594; P:detection of glucose; ISS:BHF-UCL.
DR   GO; GO:0045686; P:negative regulation of glial cell differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:InterPro.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0031016; P:pancreas development; ISS:BHF-UCL.
DR   GO; GO:0045687; P:positive regulation of glial cell differentiation; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:2000078; P:positive regulation of type B pancreatic cell development; ISS:BHF-UCL.
DR   GO; GO:0030516; P:regulation of axon extension; IEA:Ensembl.
DR   GO; GO:2001222; P:regulation of neuron migration; IEA:Ensembl.
DR   GO; GO:0021912; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification; IEA:Ensembl.
DR   GO; GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0072560; P:type B pancreatic cell maturation; ISS:BHF-UCL.
DR   GO; GO:0044342; P:type B pancreatic cell proliferation; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR033630; NKX-6.1.
DR   PANTHER; PTHR24340:SF31; PTHR24340:SF31; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Developmental protein; DNA-binding;
KW   Homeobox; Methylation; Nucleus; Reference proteome; Repressor;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    367       Homeobox protein Nkx-6.1.
FT                                /FTId=PRO_0000048951.
FT   DNA_BIND    236    295       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      102    268       Repressor domain. {ECO:0000250}.
FT   REGION      306    367       Involved in DNA-binding. {ECO:0000250}.
FT   COMPBIAS     49     61       Poly-Ser.
FT   COMPBIAS    119    135       Poly-Ser.
FT   COMPBIAS    136    150       Poly-Ala.
FT   COMPBIAS    168    173       Poly-Pro.
FT   COMPBIAS    351    355       Poly-Gly.
FT   MOD_RES     189    189       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CONFLICT    100    100       D -> N (in Ref. 1; AAD11962).
FT                                {ECO:0000305}.
SQ   SEQUENCE   367 AA;  37849 MW;  5C78F06C3CAE6486 CRC64;
     MLAVGAMEGT RQSAFLLSSP PLAALHSMAE MKTPLYPAAY PPLPAGPPSS SSSSSSSSSP
     SPPLGTHNPG GLKPPATGGL SSLGSPPQQL SAATPHGIND ILSRPSMPVA SGAALPSASP
     SGSSSSSSSS ASASSASAAA AAAAAAAAAA SSPAGLLAGL PRFSSLSPPP PPPGLYFSPS
     AAAVAAVGRY PKPLAELPGR TPIFWPGVMQ SPPWRDARLA CTPHQGSILL DKDGKRKHTR
     PTFSGQQIFA LEKTFEQTKY LAGPERARLA YSLGMTESQV KVWFQNRRTK WRKKHAAEMA
     TAKKKQDSET ERLKGASENE EEDDDYNKPL DPNSDDEKIT QLLKKHKSSS GGGGGLLLHA
     SEPESSS
//
ID   NKX63_HUMAN             Reviewed;         265 AA.
AC   A6NJ46; Q96LR0;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 91.
DE   RecName: Full=Homeobox protein Nkx-6.3;
GN   Name=NKX6-3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Putative transcription factor, which may be involved in
CC       patterning of central nervous system and pancreas. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A6NJ46-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A6NJ46-2; Sequence=VSP_029523;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK057898; BAB71610.1; -; mRNA.
DR   EMBL; AC113133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63251.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63252.1; -; Genomic_DNA.
DR   CCDS; CCDS6118.1; -. [A6NJ46-2]
DR   RefSeq; NP_689781.1; NM_152568.3. [A6NJ46-2]
DR   RefSeq; XP_016868632.1; XM_017013143.1. [A6NJ46-1]
DR   ProteinModelPortal; A6NJ46; -.
DR   SMR; A6NJ46; -.
DR   STRING; 9606.ENSP00000429553; -.
DR   iPTMnet; A6NJ46; -.
DR   PhosphoSitePlus; A6NJ46; -.
DR   PRIDE; A6NJ46; -.
DR   DNASU; 157848; -.
DR   Ensembl; ENST00000518699; ENSP00000428361; ENSG00000165066. [A6NJ46-1]
DR   Ensembl; ENST00000524115; ENSP00000429553; ENSG00000165066. [A6NJ46-2]
DR   GeneID; 157848; -.
DR   KEGG; hsa:157848; -.
DR   UCSC; uc003xoa.3; human. [A6NJ46-1]
DR   CTD; 157848; -.
DR   EuPathDB; HostDB:ENSG00000165066.12; -.
DR   GeneCards; NKX6-3; -.
DR   HGNC; HGNC:26328; NKX6-3.
DR   HPA; HPA042790; -.
DR   MIM; 610772; gene.
DR   neXtProt; NX_A6NJ46; -.
DR   OpenTargets; ENSG00000165066; -.
DR   PharmGKB; PA145148400; -.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000060127; -.
DR   HOVERGEN; HBG070987; -.
DR   InParanoid; A6NJ46; -.
DR   OMA; TRNCWAD; -.
DR   OrthoDB; EOG091G142D; -.
DR   PhylomeDB; A6NJ46; -.
DR   ChiTaRS; NKX6-3; human.
DR   GenomeRNAi; 157848; -.
DR   PRO; PR:A6NJ46; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000165066; -.
DR   CleanEx; HS_NKX6-3; -.
DR   Genevisible; A6NJ46; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    265       Homeobox protein Nkx-6.3.
FT                                /FTId=PRO_0000311330.
FT   DNA_BIND    139    198       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VAR_SEQ       1    184       MESNLQGTFLLNNTPLAQFPEMKAPVCQYSVQNSFYKLSPP
FT                                GLGPQLAAGTPHGITDILSRPVAAPNNSLLSGYPHVAGFGG
FT                                LSSQGVYYSPQVGNFSKAGNEYPTRTRNCWADTGQDWRGGR
FT                                QCSNTPDPLSDSIHKKKHTRPTFTGHQIFALEKTFEQTKYL
FT                                AGPERARLAYSLGMTESQVK -> MQQGQLAPGSRLCSGPW
FT                                GLPELQPAAPSSSAAQLPWGESWGEEADTPACLSASG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029523.
SQ   SEQUENCE   265 AA;  28948 MW;  D8CC4CF5B2201F1C CRC64;
     MESNLQGTFL LNNTPLAQFP EMKAPVCQYS VQNSFYKLSP PGLGPQLAAG TPHGITDILS
     RPVAAPNNSL LSGYPHVAGF GGLSSQGVYY SPQVGNFSKA GNEYPTRTRN CWADTGQDWR
     GGRQCSNTPD PLSDSIHKKK HTRPTFTGHQ IFALEKTFEQ TKYLAGPERA RLAYSLGMTE
     SQVKVWFQNR RTKWRKKSAL EPSSSTPRAP GGAGAGAGGD RAPSENEDDE YNKPLDPDSD
     DEKIRLLLRK HRAAFSVLSL GAHSV
//
ID   NOTO_HUMAN              Reviewed;         251 AA.
AC   A8MTQ0; B4DJ59; B7ZAU5;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 2.
DT   25-OCT-2017, entry version 86.
DE   RecName: Full=Homeobox protein notochord;
GN   Name=NOTO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Substantia nigra, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
CC   -!- FUNCTION: Transcription regulator acting downstream of both FOXA2
CC       and Brachyury (T) during notochord development. Required for node
CC       morphogenesis. Is essential for cilia formation in the posterior
CC       notochord (PNC) and for left-right patterning; acts upstream of
CC       FOXJ1 and RFX3 in this process and is required for the expression
CC       of various components important for axonemal assembly and
CC       function. Plays a role in regulating axial versus paraxial cell
CC       fate (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK295936; BAG58721.1; -; mRNA.
DR   EMBL; AK316410; BAH14781.1; -; mRNA.
DR   EMBL; AC010913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS46335.1; -.
DR   RefSeq; NP_001127934.1; NM_001134462.1.
DR   UniGene; Hs.694384; -.
DR   ProteinModelPortal; A8MTQ0; -.
DR   SMR; A8MTQ0; -.
DR   STRING; 9606.ENSP00000381486; -.
DR   iPTMnet; A8MTQ0; -.
DR   PhosphoSitePlus; A8MTQ0; -.
DR   BioMuta; NOTO; -.
DR   PaxDb; A8MTQ0; -.
DR   PRIDE; A8MTQ0; -.
DR   Ensembl; ENST00000398468; ENSP00000381486; ENSG00000214513.
DR   GeneID; 344022; -.
DR   KEGG; hsa:344022; -.
DR   UCSC; uc010yrd.3; human.
DR   CTD; 344022; -.
DR   EuPathDB; HostDB:ENSG00000214513.3; -.
DR   GeneCards; NOTO; -.
DR   HGNC; HGNC:31839; NOTO.
DR   HPA; HPA034660; -.
DR   neXtProt; NX_A8MTQ0; -.
DR   OpenTargets; ENSG00000214513; -.
DR   PharmGKB; PA134895171; -.
DR   eggNOG; KOG0843; Eukaryota.
DR   eggNOG; ENOG4111SRW; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000082431; -.
DR   HOVERGEN; HBG108196; -.
DR   InParanoid; A8MTQ0; -.
DR   OMA; YPVPGPR; -.
DR   OrthoDB; EOG091G0M18; -.
DR   PhylomeDB; A8MTQ0; -.
DR   TreeFam; TF326858; -.
DR   GenomeRNAi; 344022; -.
DR   PRO; PR:A8MTQ0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000214513; -.
DR   CleanEx; HS_NOTO; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; IEA:Ensembl.
DR   GO; GO:0044458; P:motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0030903; P:notochord development; IEA:Ensembl.
DR   GO; GO:1902017; P:regulation of cilium assembly; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    251       Homeobox protein notochord.
FT                                /FTId=PRO_0000343223.
FT   DNA_BIND    156    215       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      2     68       Pro-rich.
FT   VARIANT       5      5       R -> T (in dbSNP:rs1864492).
FT                                /FTId=VAR_059353.
FT   VARIANT     164    164       N -> K (in dbSNP:rs13418681).
FT                                /FTId=VAR_059354.
SQ   SEQUENCE   251 AA;  27003 MW;  56BBB3E0E6B5B092 CRC64;
     MPSPRPRGSP PPAPSGSRVR PPRSGRSPAP RSPTGPNTPR APGRFESPFS VEAILARPDP
     CAPAASQPSG SACVHPAFWT AASLCATGGL PWACPTSWLP AYLSVGFYPV PGPRVAPVCG
     LLGFGVTGLE LAHCSGLWAF PDWAPTEDLQ DTERQQKRVR TMFNLEQLEE LEKVFAKQHN
     LVGKKRAQLA ARLKLTENQV RVWFQNRRVK YQKQQKLRAA VTSAEAASLD EPSSSSIASI
     QSDDAESGVD G
//
ID   NKX12_HUMAN             Reviewed;         310 AA.
AC   Q9UD57;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 3.
DT   27-SEP-2017, entry version 116.
DE   RecName: Full=NK1 transcription factor-related protein 2;
DE   AltName: Full=Homeobox protein SAX-1;
DE   AltName: Full=NKX-1.1;
GN   Name=NKX1-2; Synonyms=C10orf121, NKX1.1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 171-209.
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
CC   -!- FUNCTION: May function in cell specification, particularly in the
CC       CNS. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the NK-1 homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL445237; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS59221.1; -.
DR   RefSeq; NP_001139812.1; NM_001146340.1.
DR   UniGene; Hs.712041; -.
DR   ProteinModelPortal; Q9UD57; -.
DR   SMR; Q9UD57; -.
DR   BioMuta; NKX1-2; -.
DR   DMDM; 338817978; -.
DR   EPD; Q9UD57; -.
DR   PeptideAtlas; Q9UD57; -.
DR   PRIDE; Q9UD57; -.
DR   Ensembl; ENST00000451024; ENSP00000451945; ENSG00000229544.
DR   GeneID; 390010; -.
DR   KEGG; hsa:390010; -.
DR   UCSC; uc010quf.3; human.
DR   CTD; 390010; -.
DR   EuPathDB; HostDB:ENSG00000229544.8; -.
DR   GeneCards; NKX1-2; -.
DR   H-InvDB; HIX0170557; -.
DR   HGNC; HGNC:31652; NKX1-2.
DR   HPA; HPA029367; -.
DR   neXtProt; NX_Q9UD57; -.
DR   OpenTargets; ENSG00000229544; -.
DR   PharmGKB; PA134977174; -.
DR   GeneTree; ENSGT00760000118940; -.
DR   HOVERGEN; HBG052632; -.
DR   InParanoid; Q9UD57; -.
DR   KO; K09309; -.
DR   OMA; GPSYLTP; -.
DR   OrthoDB; EOG091G0SCQ; -.
DR   TreeFam; TF316128; -.
DR   GenomeRNAi; 390010; -.
DR   PRO; PR:Q9UD57; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000229544; -.
DR   CleanEx; HS_NKX1-2; -.
DR   Genevisible; Q9UD57; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    310       NK1 transcription factor-related protein
FT                                2.
FT                                /FTId=PRO_0000325972.
FT   DNA_BIND    163    222       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     88     93       Poly-Glu.
FT   COMPBIAS    134    137       Poly-Gly.
FT   COMPBIAS    150    155       Poly-Arg.
FT   COMPBIAS    224    259       Gly-rich.
SQ   SEQUENCE   310 AA;  32381 MW;  FF2D02B4DCFC5689 CRC64;
     MLAWQDGGAK AAPSHHKISF SVLDILDPQK FTRAALPAVR PAPREARKSL AEVEAGKDAS
     SRDPVRQLET PDAAGPGAGQ ASPLEGSEAE EEEDAEDPRR PRLRERAARL LPGLARSPDA
     PAGALASGEP CEDGGGGPVR SPPGSPGSPR PRRRRLEPNC AKPRRARTAF TYEQLVALEN
     KFRATRYLSV CERLNLALSL SLTETQVKIW FQNRRTKWKK QNPGADGAAQ VGGGAPQPGA
     AGGGGGGGSG GSPGPPGTGA LHFQTFPSYS AANVLFPSAA SFPLTAAAPG SPFAPFLGPS
     YLTPFYAPRL
//
ID   ONEC2_HUMAN             Reviewed;         504 AA.
AC   O95948;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 2.
DT   27-SEP-2017, entry version 139.
DE   RecName: Full=One cut domain family member 2;
DE   AltName: Full=Hepatocyte nuclear factor 6-beta;
DE            Short=HNF-6-beta;
DE   AltName: Full=One cut homeobox 2;
DE   AltName: Full=Transcription factor ONECUT-2;
DE            Short=OC-2;
GN   Name=ONECUT2; Synonyms=HNF6B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9915796; DOI=10.1074/jbc.274.5.2665;
RA   Jacquemin P., Lannoy V., Rousseau G.G., Lemaigre F.P.;
RT   "OC-2, a novel mammalian member of the ONECUT class of homeodomain
RT   transcription factors whose function in liver partially overlaps with
RT   that of hepatocyte nuclear factor-6.";
RL   J. Biol. Chem. 274:2665-2671(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
CC   -!- FUNCTION: Transcriptional activator. Activates the transcription
CC       of a number of liver genes such as HNF3B.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-20 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB38253.1; Type=Frameshift; Positions=18; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hepatocyte nuclear factors
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Hepatocyte_nuclear_factors";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y18198; CAB38253.1; ALT_FRAME; mRNA.
DR   EMBL; AC090340; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS42440.1; -.
DR   RefSeq; NP_004843.2; NM_004852.2.
DR   UniGene; Hs.194725; -.
DR   ProteinModelPortal; O95948; -.
DR   SMR; O95948; -.
DR   BioGrid; 114865; 1.
DR   STRING; 9606.ENSP00000262095; -.
DR   iPTMnet; O95948; -.
DR   PhosphoSitePlus; O95948; -.
DR   BioMuta; ONECUT2; -.
DR   PaxDb; O95948; -.
DR   PeptideAtlas; O95948; -.
DR   PRIDE; O95948; -.
DR   TopDownProteomics; O95948; -.
DR   Ensembl; ENST00000491143; ENSP00000419185; ENSG00000119547.
DR   GeneID; 9480; -.
DR   KEGG; hsa:9480; -.
DR   UCSC; uc002lgo.4; human.
DR   CTD; 9480; -.
DR   DisGeNET; 9480; -.
DR   EuPathDB; HostDB:ENSG00000119547.5; -.
DR   GeneCards; ONECUT2; -.
DR   H-InvDB; HIX0039750; -.
DR   HGNC; HGNC:8139; ONECUT2.
DR   HPA; HPA057058; -.
DR   MIM; 604894; gene.
DR   neXtProt; NX_O95948; -.
DR   OpenTargets; ENSG00000119547; -.
DR   PharmGKB; PA31925; -.
DR   eggNOG; KOG2252; Eukaryota.
DR   eggNOG; ENOG410YWY4; LUCA.
DR   GeneTree; ENSGT00530000063019; -.
DR   HOGENOM; HOG000232114; -.
DR   HOVERGEN; HBG005981; -.
DR   InParanoid; O95948; -.
DR   OMA; NGMHHPG; -.
DR   OrthoDB; EOG091G0E7H; -.
DR   PhylomeDB; O95948; -.
DR   TreeFam; TF318206; -.
DR   GenomeRNAi; 9480; -.
DR   PRO; PR:O95948; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000119547; -.
DR   CleanEx; HS_ONECUT2; -.
DR   Genevisible; O95948; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0060271; P:cilium assembly; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0002064; P:epithelial cell development; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   Pfam; PF02376; CUT; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM01109; CUT; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS51042; CUT; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    504       One cut domain family member 2.
FT                                /FTId=PRO_0000202405.
FT   DNA_BIND    324    410       CUT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    426    485       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     37     56       Poly-Gly.
FT   COMPBIAS     81     85       Poly-Pro.
FT   COMPBIAS     94    101       Poly-Ala.
FT   COMPBIAS    168    184       Poly-His.
FT   COMPBIAS    317    322       Poly-Ser.
FT   CONFLICT     17     17       G -> R (in Ref. 1; CAB38253).
FT                                {ECO:0000305}.
FT   CONFLICT     35     36       PA -> AR (in Ref. 1; CAB38253).
FT                                {ECO:0000305}.
FT   CONFLICT     71     71       G -> R (in Ref. 1; CAB38253).
FT                                {ECO:0000305}.
FT   CONFLICT     74     75       AA -> PR (in Ref. 1; CAB38253).
FT                                {ECO:0000305}.
SQ   SEQUENCE   504 AA;  54303 MW;  09762F3C8BD6DD6B CRC64;
     MKAAYTAYRC LTKDLEGCAM NPELTMESLG TLHGPAGGGS GGGGGGGGGG GGGGPGHEQE
     LLASPSPHHA GRGAAGSLRG PPPPPTAHQE LGTAAAAAAA ASRSAMVTSM ASILDGGDYR
     PELSIPLHHA MSMSCDSSPP GMGMSNTYTT LTPLQPLPPI STVSDKFHHP HPHHHPHHHH
     HHHHQRLSGN VSGSFTLMRD ERGLPAMNNL YSPYKEMPGM SQSLSPLAAT PLGNGLGGLH
     NAQQSLPNYG PPGHDKMLSP NFDAHHTAML TRGEQHLSRG LGTPPAAMMS HLNGLHHPGH
     TQSHGPVLAP SRERPPSSSS GSQVATSGQL EEINTKEVAQ RITAELKRYS IPQAIFAQRV
     LCRSQGTLSD LLRNPKPWSK LKSGRETFRR MWKWLQEPEF QRMSALRLAA CKRKEQEPNK
     DRNNSQKKSR LVFTDLQRRT LFAIFKENKR PSKEMQITIS QQLGLELTTV SNFFMNARRR
     SLEKWQDDLS TGGSSSTSST CTKA
//
ID   ONEC3_HUMAN             Reviewed;         494 AA.
AC   O60422; A8MZM7;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   27-SEP-2017, entry version 121.
DE   RecName: Full=One cut domain family member 3;
DE   AltName: Full=One cut homeobox 3;
DE   AltName: Full=Transcription factor ONECUT-3;
DE            Short=OC-3;
GN   Name=ONECUT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=11944891; DOI=10.1006/bbrc.2002.6760;
RA   Vanhorenbeeck V., Jacquemin P., Lemaigre F.P., Rousseau G.G.;
RT   "OC-3, a novel mammalian member of the ONECUT class of transcription
RT   factors.";
RL   Biochem. Biophys. Res. Commun. 292:848-854(2002).
CC   -!- FUNCTION: Transcriptional activator. Binds the consensus DNA
CC       sequence 5'-DHWATTGAYTWWD-3' on a variety of gene promoters such
CC       as those of HNF3B and TTR (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00374}.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004755; AAC17602.1; -; Genomic_DNA.
DR   EMBL; AC005256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS45900.1; -.
DR   RefSeq; NP_001073957.1; NM_001080488.1.
DR   UniGene; Hs.654347; -.
DR   ProteinModelPortal; O60422; -.
DR   SMR; O60422; -.
DR   STRING; 9606.ENSP00000371786; -.
DR   iPTMnet; O60422; -.
DR   PhosphoSitePlus; O60422; -.
DR   BioMuta; ONECUT3; -.
DR   PaxDb; O60422; -.
DR   PeptideAtlas; O60422; -.
DR   PRIDE; O60422; -.
DR   Ensembl; ENST00000382349; ENSP00000371786; ENSG00000205922.
DR   GeneID; 390874; -.
DR   KEGG; hsa:390874; -.
DR   UCSC; uc010xgr.3; human.
DR   CTD; 390874; -.
DR   EuPathDB; HostDB:ENSG00000205922.4; -.
DR   GeneCards; ONECUT3; -.
DR   HGNC; HGNC:13399; ONECUT3.
DR   HPA; HPA059936; -.
DR   MIM; 611294; gene.
DR   neXtProt; NX_O60422; -.
DR   OpenTargets; ENSG00000205922; -.
DR   PharmGKB; PA31926; -.
DR   eggNOG; KOG2252; Eukaryota.
DR   eggNOG; ENOG410YWY4; LUCA.
DR   GeneTree; ENSGT00530000063019; -.
DR   HOGENOM; HOG000232114; -.
DR   HOVERGEN; HBG005981; -.
DR   InParanoid; O60422; -.
DR   OMA; AMTMSCD; -.
DR   OrthoDB; EOG091G0E7H; -.
DR   PhylomeDB; O60422; -.
DR   TreeFam; TF318206; -.
DR   Reactome; R-HSA-210744; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells.
DR   Reactome; R-HSA-210747; Regulation of gene expression in early pancreatic precursor cells.
DR   GenomeRNAi; 390874; -.
DR   PRO; PR:O60422; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000205922; -.
DR   CleanEx; HS_ONECUT3; -.
DR   Genevisible; O60422; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0048731; P:system development; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   Pfam; PF02376; CUT; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM01109; CUT; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS51042; CUT; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    494       One cut domain family member 3.
FT                                /FTId=PRO_0000271218.
FT   DNA_BIND    312    398       CUT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    414    473       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     37    315       Gly-rich.
FT   COMPBIAS    141    247       Pro-rich.
SQ   SEQUENCE   494 AA;  50037 MW;  FB97DF2CBA336B82 CRC64;
     MELSLESLGG LHSVAHAQAG ELLSPGHARS AAAQHRGLVA PGRPGLVAGM ASLLDGGGGG
     GGGGAGGAGG AGSAGGGADF RGELAGPLHP AMGMACEAPG LGGTYTTLTP LQHLPPLAAV
     ADKFHQHAAA AAVAGAHGGH PHAHPHPAAA PPPPPPPQRL AASVSGSFTL MRDERAALAS
     VGHLYGPYGK ELPAMGSPLS PLPNALPPAL HGAPQPPPPP PPPPLAAYGP PGHLAGDKLL
     PPAAFEPHAA LLGRAEDALA RGLPGGGGGT GSGGAGSGSA AGLLAPLGGL AAAGAHGPHG
     GGGGPGGSGG GPSAGAAAEE INTKEVAQRI TAELKRYSIP QAIFAQRILC RSQGTLSDLL
     RNPKPWSKLK SGRETFRRMW KWLQEPEFQR MSALRLAACK RKEQEQQKER ALQPKKQRLV
     FTDLQRRTLI AIFKENKRPS KEMQVTISQQ LGLELNTVSN FFMNARRRCM NRWAEEPSTA
     PGGPAGATAT FSKA
//
ID   OTX2_HUMAN              Reviewed;         289 AA.
AC   P32243; B2RAN5; Q6GTV3; Q9HAW3; Q9P2R1;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Homeobox protein OTX2;
DE   AltName: Full=Orthodenticle homolog 2;
GN   Name=OTX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=8101484;
RA   Simeone A., Acampora D., Mallamaci A., Stornaiuolo A., D'Apice M.R.,
RA   Nigro V., Boncinelli E.;
RT   "A vertebrate gene related to orthodenticle contains a homeodomain of
RT   the bicoid class and demarcates anterior neuroectoderm in the
RT   gastrulating mouse embryo.";
RL   EMBO J. 12:2735-2747(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Perrault I., Rozet J.-M., Gerber S., Munnich A., Kaplan J.;
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=10372988; DOI=10.1076/ceyr.18.4.283.5360;
RA   Fong S.L., Fong W.B.;
RT   "Elements regulating the transcription of human interstitial retinoid-
RT   binding protein (IRBP) gene in cultured retinoblastoma cells.";
RL   Curr. Eye Res. 18:283-291(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 171-283.
RA   Kitano T., Kobayakawa H., Saitou N.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   VARIANTS MCOPS5 GLY-89; THR-133 AND ALA-134, AND DEVELOPMENTAL STAGE.
RX   PubMed=15846561; DOI=10.1086/430721;
RA   Ragge N.K., Brown A.G., Poloschek C.M., Lorenz B., Henderson R.A.,
RA   Clarke M.P., Russell-Eggitt I., Fielder A., Gerrelli D.,
RA   Martinez-Barbera J.P., Ruddle P., Hurst J., Collin J.R., Salt A.,
RA   Cooper S.T., Thompson P.J., Sisodiya S.M., Williamson K.A.,
RA   Fitzpatrick D.R., van Heyningen V., Hanson I.M.;
RT   "Heterozygous mutations of OTX2 cause severe ocular malformations.";
RL   Am. J. Hum. Genet. 76:1008-1022(2005).
RN   [9]
RP   ERRATUM.
RA   Ragge N.K., Brown A.G., Poloschek C.M., Lorenz B., Henderson R.A.,
RA   Clarke M.P., Russell-Eggitt I., Fielder A., Gerrelli D.,
RA   Martinez-Barbera J.P., Ruddle P., Hurst J., Collin J.R., Salt A.,
RA   Cooper S.T., Thompson P.J., Sisodiya S.M., Williamson K.A.,
RA   Fitzpatrick D.R., van Heyningen V., Hanson I.M.;
RL   Am. J. Hum. Genet. 77:334-334(2005).
RN   [10]
RP   DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=19414065; DOI=10.1016/j.ijdevneu.2009.04.004;
RA   Larsen K.B., Lutterodt M., Rath M.F., Moeller M.;
RT   "Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early
RT   human fetal retina.";
RL   Int. J. Dev. Neurosci. 27:485-492(2009).
RN   [11]
RP   INVOLVEMENT IN RDEOP.
RX   PubMed=19956411;
RA   Henderson R.H., Williamson K.A., Kennedy J.S., Webster A.R.,
RA   Holder G.E., Robson A.G., FitzPatrick D.R., van Heyningen V.,
RA   Moore A.T.;
RT   "A rare de novo nonsense mutation in OTX2 causes early onset retinal
RT   dystrophy and pituitary dysfunction.";
RL   Mol. Vis. 15:2442-2447(2009).
RN   [12]
RP   INVOLVEMENT IN MCOPS5.
RX   PubMed=22577225; DOI=10.1136/jmedgenet-2012-100892;
RA   Chassaing N., Sorrentino S., Davis E.E., Martin-Coignard D.,
RA   Iacovelli A., Paznekas W., Webb B.D., Faye-Petersen O.,
RA   Encha-Razavi F., Lequeux L., Vigouroux A., Yesilyurt A.,
RA   Boyadjiev S.A., Kayserili H., Loget P., Carles D., Sergi C.,
RA   Puvabanditsin S., Chen C.P., Etchevers H.C., Katsanis N., Mercer C.L.,
RA   Calvas P., Jabs E.W.;
RT   "OTX2 mutations contribute to the otocephaly-dysgnathia complex.";
RL   J. Med. Genet. 49:373-379(2012).
RN   [13]
RP   INVOLVEMENT IN MCOPS5.
RX   PubMed=24167467; DOI=10.1159/000353727;
RA   Patat O., van Ravenswaaij-Arts C.M., Tantau J., Corsten-Janssen N.,
RA   van Tintelen J.P., Dijkhuizen T., Kaplan J., Chassaing N.;
RT   "Otocephaly-Dysgnathia Complex: Description of Four Cases and
RT   Confirmation of the Role of OTX2.";
RL   Mol. Syndromol. 4:302-305(2013).
RN   [14]
RP   INVOLVEMENT IN RDEOP, AND VARIANT RDEOP LYS-79.
RX   PubMed=25293953; DOI=10.1136/jmedgenet-2014-102620;
RG   FORGE Canada Consortium;
RA   Vincent A., Forster N., Maynes J.T., Paton T.A., Billingsley G.,
RA   Roslin N.M., Ali A., Sutherland J., Wright T., Westall C.A.,
RA   Paterson A.D., Marshall C.R., Heon E.;
RT   "OTX2 mutations cause autosomal dominant pattern dystrophy of the
RT   retinal pigment epithelium.";
RL   J. Med. Genet. 51:797-805(2014).
RN   [15]
RP   VARIANT CPHD6 SER-225, AND CHARACTERIZATION OF VARIANT CPHD6 SER-225.
RX   PubMed=18728160; DOI=10.1210/jc.2008-1189;
RA   Diaczok D., Romero C., Zunich J., Marshall I., Radovick S.;
RT   "A novel dominant negative mutation of OTX2 associated with combined
RT   pituitary hormone deficiency.";
RL   J. Clin. Endocrinol. Metab. 93:4351-4359(2008).
RN   [16]
RP   VARIANT MCOPS5 SER-90, AND CHARACTERIZATION OF VARIANT MCOPS5 SER-90.
RX   PubMed=20396904; DOI=10.1007/s00439-010-0820-9;
RA   Ashkenazi-Hoffnung L., Lebenthal Y., Wyatt A.W., Ragge N.K.,
RA   Dateki S., Fukami M., Ogata T., Phillip M., Gat-Yablonski G.;
RT   "A novel loss-of-function mutation in OTX2 in a patient with
RT   anophthalmia and isolated growth hormone deficiency.";
RL   Hum. Genet. 127:721-729(2010).
RN   [17]
RP   VARIANT CPHD6 ARG-134, AND FUNCTION.
RX   PubMed=22715480; DOI=10.1530/EJE-12-0333;
RA   Gorbenko Del Blanco D., Romero C.J., Diaczok D., de Graaff L.C.,
RA   Radovick S., Hokken-Koelega A.C.;
RT   "A novel OTX2 mutation in a patient with combined pituitary hormone
RT   deficiency, pituitary malformation, and an underdeveloped left optic
RT   nerve.";
RL   Eur. J. Endocrinol. 167:441-452(2012).
CC   -!- FUNCTION: Transcription factor probably involved in the
CC       development of the brain and the sense organs. Can bind to the
CC       bicoid/BCD target sequence (BTS): 5'-TCTAATCCC-3'.
CC       {ECO:0000269|PubMed:22715480}.
CC   -!- INTERACTION:
CC       P35680:HNF1B; NbExp=4; IntAct=EBI-9087860, EBI-2798841;
CC       P57682:KLF3; NbExp=4; IntAct=EBI-9087860, EBI-8472267;
CC       P62854:RPS26; NbExp=4; IntAct=EBI-9087860, EBI-353438;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19414065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P32243-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P32243-2; Sequence=VSP_021006;
CC   -!- DEVELOPMENTAL STAGE: At Carnegie stage (CS) 14, widely expressed
CC       throughout the telencephalon and mesencephalon, with a sharp
CC       cutoff at the midbrain-hindbrain boundary. At CS16, found in the
CC       lamina terminalis and the floor of the telencephalon. At CS16-
CC       CS19, in the developing eye, strongly expressed in the retinal
CC       pigment epithelium layer and more weakly in the neural retina, not
CC       expressed in the optic nerve itself (at protein level). Retinal
CC       expression peaks between CS19 and CS21 and decline in older
CC       fetuses. At CS22, detected in the choroid plexus, the dorsal
CC       thalamus, and the roof of the mesencephalon. In the developing
CC       nasal structures, expressed in the olfactory epithelium of the
CC       nasal pits at CS18. {ECO:0000269|PubMed:15846561,
CC       ECO:0000269|PubMed:19414065}.
CC   -!- DISEASE: Microphthalmia, syndromic, 5 (MCOPS5) [MIM:610125]:
CC       Patients manifest unilateral or bilateral microphthalmia/clinical
CC       anophthalmia and variable additional features including pituitary
CC       dysfunction, coloboma, microcornea, cataract, retinal dystrophy,
CC       hypoplasia or agenesis of the optic nerve, agenesis of the corpus
CC       callosum, developmental delay, joint laxity, hypotonia, and
CC       seizures. Microphthalmia is a disorder of eye formation, ranging
CC       from small size of a single eye to complete bilateral absence of
CC       ocular tissues (anophthalmia). In many cases,
CC       microphthalmia/anophthalmia occurs in association with syndromes
CC       that include non-ocular abnormalities.
CC       {ECO:0000269|PubMed:15846561, ECO:0000269|PubMed:20396904,
CC       ECO:0000269|PubMed:22577225, ECO:0000269|PubMed:24167467}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Pituitary hormone deficiency, combined, 6 (CPHD6)
CC       [MIM:613986]: Combined pituitary hormone deficiency is defined as
CC       the impaired production of growth hormone and one or more of the
CC       other five anterior pituitary hormones. CPHD6 patients manifest
CC       neonatal hypoglycemia, and deficiencies of growth hormone,
CC       thyroid-stimulating hormone, luteinizing hormone, follicle
CC       stimulating hormone and adrenocorticotropic hormone.
CC       {ECO:0000269|PubMed:18728160, ECO:0000269|PubMed:22715480}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Retinal dystrophy, early-onset, with or without pituitary
CC       dysfunction (RDEOP) [MIM:610125]: An autosomal dominant ocular
CC       disease characterized by pattern dystrophy of the retinal pigment
CC       epithelium, and photoreceptor degeneration. Mild developmental
CC       anomalies include optic nerve head dysplasia, microcornea, and
CC       Rathke's cleft cyst. Some patients manifest pituary dysfunction.
CC       {ECO:0000269|PubMed:19956411, ECO:0000269|PubMed:25293953}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/OTX2ID46429ch14q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF298117; AAG16243.1; -; Genomic_DNA.
DR   EMBL; AF093138; AAD31385.1; -; mRNA.
DR   EMBL; AK314271; BAG36932.1; -; mRNA.
DR   EMBL; CH471061; EAW80692.1; -; Genomic_DNA.
DR   EMBL; BC032579; AAH32579.1; -; mRNA.
DR   EMBL; AB037505; BAA90425.1; -; Genomic_DNA.
DR   CCDS; CCDS41960.1; -. [P32243-1]
DR   CCDS; CCDS9728.1; -. [P32243-2]
DR   RefSeq; NP_001257452.1; NM_001270523.1. [P32243-1]
DR   RefSeq; NP_001257453.1; NM_001270524.1. [P32243-1]
DR   RefSeq; NP_001257454.1; NM_001270525.1. [P32243-2]
DR   RefSeq; NP_068374.1; NM_021728.3. [P32243-2]
DR   RefSeq; NP_758840.1; NM_172337.2. [P32243-1]
DR   UniGene; Hs.288655; -.
DR   UniGene; Hs.741558; -.
DR   ProteinModelPortal; P32243; -.
DR   SMR; P32243; -.
DR   BioGrid; 111055; 10.
DR   IntAct; P32243; 41.
DR   MINT; MINT-2861458; -.
DR   STRING; 9606.ENSP00000343819; -.
DR   iPTMnet; P32243; -.
DR   PhosphoSitePlus; P32243; -.
DR   BioMuta; OTX2; -.
DR   EPD; P32243; -.
DR   PaxDb; P32243; -.
DR   PeptideAtlas; P32243; -.
DR   PRIDE; P32243; -.
DR   DNASU; 5015; -.
DR   Ensembl; ENST00000339475; ENSP00000343819; ENSG00000165588. [P32243-2]
DR   Ensembl; ENST00000408990; ENSP00000386185; ENSG00000165588. [P32243-1]
DR   Ensembl; ENST00000555006; ENSP00000452336; ENSG00000165588. [P32243-1]
DR   GeneID; 5015; -.
DR   KEGG; hsa:5015; -.
DR   UCSC; uc001xcp.5; human. [P32243-1]
DR   CTD; 5015; -.
DR   DisGeNET; 5015; -.
DR   EuPathDB; HostDB:ENSG00000165588.16; -.
DR   GeneCards; OTX2; -.
DR   GeneReviews; OTX2; -.
DR   HGNC; HGNC:8522; OTX2.
DR   HPA; HPA000633; -.
DR   MalaCards; OTX2; -.
DR   MIM; 600037; gene.
DR   MIM; 610125; phenotype.
DR   MIM; 613986; phenotype.
DR   neXtProt; NX_P32243; -.
DR   OpenTargets; ENSG00000165588; -.
DR   Orphanet; 990; Agnathia - holoprosencephaly - situs inversus.
DR   Orphanet; 95494; Combined pituitary hormone deficiencies, genetic forms.
DR   Orphanet; 2542; Isolated anophthalmia - microphthalmia.
DR   Orphanet; 3157; Septo-optic dysplasia.
DR   Orphanet; 178364; Syndromic microphthalmia type 5.
DR   PharmGKB; PA32849; -.
DR   eggNOG; KOG2251; Eukaryota.
DR   eggNOG; ENOG4111XIJ; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000082677; -.
DR   HOVERGEN; HBG004028; -.
DR   InParanoid; P32243; -.
DR   KO; K18490; -.
DR   OMA; STADCLD; -.
DR   PhylomeDB; P32243; -.
DR   TreeFam; TF351179; -.
DR   SIGNOR; P32243; -.
DR   GeneWiki; Orthodenticle_homeobox_2; -.
DR   GenomeRNAi; 5015; -.
DR   PRO; PR:P32243; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000165588; -.
DR   CleanEx; HS_OTX2; -.
DR   ExpressionAtlas; P32243; baseline and differential.
DR   Genevisible; P32243; HS.
DR   GO; GO:0030426; C:growth cone; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0008190; F:eukaryotic initiation factor 4E binding; TAS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IDA:UniProtKB.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0030900; P:forebrain development; TAS:UniProtKB.
DR   GO; GO:0030901; P:midbrain development; TAS:UniProtKB.
DR   GO; GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB.
DR   GO; GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0090009; P:primitive streak formation; ISS:UniProtKB.
DR   GO; GO:0006461; P:protein complex assembly; IDA:UniProtKB.
DR   GO; GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0008589; P:regulation of smoothened signaling pathway; TAS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003022; Otx2_TF.
DR   InterPro; IPR003025; Otx_TF.
DR   InterPro; IPR013851; Otx_TF_C.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03529; TF_Otx; 1.
DR   PRINTS; PR01257; OTX2HOMEOBOX.
DR   PRINTS; PR01255; OTXHOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Microphthalmia; Nucleus;
KW   Reference proteome.
FT   CHAIN         1    289       Homeobox protein OTX2.
FT                                /FTId=PRO_0000049210.
FT   DNA_BIND     38     97       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     95    101       Poly-Gln.
FT   VAR_SEQ      32     32       P -> PGPWASCPA (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8101484}.
FT                                /FTId=VSP_021006.
FT   VARIANT      79     79       E -> K (in RDEOP; dbSNP:rs786205224).
FT                                {ECO:0000269|PubMed:25293953}.
FT                                /FTId=VAR_073793.
FT   VARIANT      89     89       R -> G (in MCOPS5; dbSNP:rs104894464).
FT                                {ECO:0000269|PubMed:15846561}.
FT                                /FTId=VAR_029354.
FT   VARIANT      90     90       R -> S (in MCOPS5; does not affect the
FT                                expression or nuclear localization of the
FT                                protein but inhibits its DNA-binding
FT                                activity as well as its transactivation
FT                                capability; the protein is non-
FT                                functional).
FT                                {ECO:0000269|PubMed:20396904}.
FT                                /FTId=VAR_065952.
FT   VARIANT     133    133       P -> T (in MCOPS5; dbSNP:rs376333965).
FT                                {ECO:0000269|PubMed:15846561}.
FT                                /FTId=VAR_029355.
FT   VARIANT     134    134       P -> A (in MCOPS5; dbSNP:rs753783256).
FT                                {ECO:0000269|PubMed:15846561}.
FT                                /FTId=VAR_029356.
FT   VARIANT     134    134       P -> R (in CPHD6; unknown pathological
FT                                significance; loss of transcriptional
FT                                activity, when tested on bicoid binding
FT                                sites; decreases transactivation mediated
FT                                by the wild-type protein, when tested on
FT                                bicoid binding sites; no effect on DNA-
FT                                binding; dbSNP:rs199761861).
FT                                {ECO:0000269|PubMed:22715480}.
FT                                /FTId=VAR_078446.
FT   VARIANT     225    225       N -> S (in CPHD6; acts as a dominant
FT                                inhibitor of the HESX1 gene;
FT                                dbSNP:rs370761964).
FT                                {ECO:0000269|PubMed:18728160}.
FT                                /FTId=VAR_065953.
SQ   SEQUENCE   289 AA;  31636 MW;  66B86D5EAD6E2E7A CRC64;
     MMSYLKQPPY AVNGLSLTTS GMDLLHPSVG YPATPRKQRR ERTTFTRAQL DVLEALFAKT
     RYPDIFMREE VALKINLPES RVQVWFKNRR AKCRQQQQQQ QNGGQNKVRP AKKKTSPARE
     VSSESGTSGQ FTPPSSTSVP TIASSSAPVS IWSPASISPL SDPLSTSSSC MQRSYPMTYT
     QASGYSQGYA GSTSYFGGMD CGSYLTPMHH QLPGPGATLS PMGTNAVTSH LNQSPASLST
     QGYGASSLGF NSTTDCLDYK DQTASWKLNF NADCLDYKDQ TSSWKFQVL
//
ID   OTP_HUMAN               Reviewed;         325 AA.
AC   Q5XKR4;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   25-OCT-2017, entry version 123.
DE   RecName: Full=Homeobox protein orthopedia;
GN   Name=OTP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   IDENTIFICATION, DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=10458915; DOI=10.1006/geno.1999.5882;
RA   Lin X., State M.W., Vaccarino F.M., Greally J., Hass M., Leckman J.F.;
RT   "Identification, chromosomal assignment, and expression analysis of
RT   the human homeodomain-containing gene Orthopedia (OTP).";
RL   Genomics 60:96-104(1999).
CC   -!- FUNCTION: Probably involved in the differentiation of hypothalamic
CC       neuroendocrine cells.
CC   -!- INTERACTION:
CC       Q9UBL6-2:CPNE7; NbExp=4; IntAct=EBI-12865884, EBI-12012272;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138,
CC       ECO:0000269|PubMed:10458915}.
CC   -!- DEVELOPMENTAL STAGE: Present in fetal hypothalamus at 19 weeks of
CC       gestation (at protein level). {ECO:0000269|PubMed:10458915}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC001800; AAH01800.1; -; mRNA.
DR   CCDS; CCDS4039.1; -.
DR   RefSeq; NP_115485.1; NM_032109.2.
DR   UniGene; Hs.202247; -.
DR   ProteinModelPortal; Q5XKR4; -.
DR   SMR; Q5XKR4; -.
DR   IntAct; Q5XKR4; 7.
DR   STRING; 9606.ENSP00000302814; -.
DR   iPTMnet; Q5XKR4; -.
DR   PhosphoSitePlus; Q5XKR4; -.
DR   BioMuta; OTP; -.
DR   DMDM; 74762283; -.
DR   EPD; Q5XKR4; -.
DR   PaxDb; Q5XKR4; -.
DR   PeptideAtlas; Q5XKR4; -.
DR   PRIDE; Q5XKR4; -.
DR   DNASU; 23440; -.
DR   Ensembl; ENST00000306422; ENSP00000302814; ENSG00000171540.
DR   GeneID; 23440; -.
DR   KEGG; hsa:23440; -.
DR   UCSC; uc003kfg.4; human.
DR   CTD; 23440; -.
DR   DisGeNET; 23440; -.
DR   EuPathDB; HostDB:ENSG00000171540.7; -.
DR   GeneCards; OTP; -.
DR   HGNC; HGNC:8518; OTP.
DR   HPA; HPA039365; -.
DR   MIM; 604529; gene.
DR   neXtProt; NX_Q5XKR4; -.
DR   OpenTargets; ENSG00000171540; -.
DR   PharmGKB; PA32844; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000039976; -.
DR   HOVERGEN; HBG001617; -.
DR   InParanoid; Q5XKR4; -.
DR   OMA; WATAGMP; -.
DR   OrthoDB; EOG091G1416; -.
DR   PhylomeDB; Q5XKR4; -.
DR   TreeFam; TF351614; -.
DR   ChiTaRS; OTP; human.
DR   GenomeRNAi; 23440; -.
DR   PRO; PR:Q5XKR4; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000171540; -.
DR   CleanEx; HS_OTP; -.
DR   Genevisible; Q5XKR4; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl.
DR   GO; GO:0021985; P:neurohypophysis development; IEA:Ensembl.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Neurogenesis; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    325       Homeobox protein orthopedia.
FT                                /FTId=PRO_0000292432.
FT   DNA_BIND    104    163       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       306    319       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS    187    194       Poly-Ala.
FT   COMPBIAS    210    213       Poly-Ala.
SQ   SEQUENCE   325 AA;  34159 MW;  429E3A91E0A9BA5F CRC64;
     MLSHADLLDA RLGMKDAAEL LGHREAVKCR LGVGGSDPGG HPGDLAPNSD PVEGATLLPG
     EDITTVGSTP ASLAVSAKDP DKQPGPQGGP NPSQAGQQQG QQKQKRHRTR FTPAQLNELE
     RSFAKTHYPD IFMREELALR IGLTESRVQV WFQNRRAKWK KRKKTTNVFR APGTLLPTPG
     LPQFPSAAAA AAAAMGDSLC SFHANDTRWA AAAMPGVSQL PLPPALGRQQ AMAQSLSQCS
     LAAGPPPNSM GLSNSLAGSN GAGLQSHLYQ PAFPGMVPAS LPGPSNVSGS PQLCSSPDSS
     DVWRGTSIAS LRRKALEHTV SMSFT
//
ID   PBX4_HUMAN              Reviewed;         374 AA.
AC   Q9BYU1; A5D8Y0; B3KUK9;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   27-SEP-2017, entry version 144.
DE   RecName: Full=Pre-B-cell leukemia transcription factor 4;
DE   AltName: Full=Homeobox protein PBX4;
GN   Name=PBX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 45-374.
RX   PubMed=11335119; DOI=10.1016/S0925-4773(01)00349-5;
RA   Wagner K., Mincheva A., Korn B., Lichter P., Poepperl H.;
RT   "Pbx4, a new Pbx family member on mouse chromosome 8 is expressed
RT   during spermatogenesis.";
RL   Mech. Dev. 103:127-131(2001).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-283.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- INTERACTION:
CC       O94829:IPO13; NbExp=5; IntAct=EBI-10302990, EBI-747310;
CC       O14770-4:MEIS2; NbExp=6; IntAct=EBI-10302990, EBI-8025850;
CC       Q9NRD5:PICK1; NbExp=4; IntAct=EBI-10302990, EBI-79165;
CC       Q9UBB9:TFIP11; NbExp=5; IntAct=EBI-10302990, EBI-1105213;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the TALE/PBX homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BC033067; Type=Frameshift; Positions=137; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK097427; BAG53471.1; -; mRNA.
DR   EMBL; BC033067; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471106; EAW84835.1; -; Genomic_DNA.
DR   EMBL; BC141859; AAI41860.1; -; mRNA.
DR   EMBL; AJ300182; CAC28212.1; -; mRNA.
DR   CCDS; CCDS12406.1; -.
DR   RefSeq; NP_079521.1; NM_025245.2.
DR   UniGene; Hs.466257; -.
DR   ProteinModelPortal; Q9BYU1; -.
DR   SMR; Q9BYU1; -.
DR   BioGrid; 123272; 11.
DR   IntAct; Q9BYU1; 32.
DR   STRING; 9606.ENSP00000251203; -.
DR   iPTMnet; Q9BYU1; -.
DR   PhosphoSitePlus; Q9BYU1; -.
DR   BioMuta; PBX4; -.
DR   DMDM; 122065777; -.
DR   MaxQB; Q9BYU1; -.
DR   PaxDb; Q9BYU1; -.
DR   PeptideAtlas; Q9BYU1; -.
DR   PRIDE; Q9BYU1; -.
DR   Ensembl; ENST00000251203; ENSP00000251203; ENSG00000105717.
DR   GeneID; 80714; -.
DR   KEGG; hsa:80714; -.
DR   UCSC; uc002nmy.4; human.
DR   CTD; 80714; -.
DR   DisGeNET; 80714; -.
DR   EuPathDB; HostDB:ENSG00000105717.13; -.
DR   GeneCards; PBX4; -.
DR   HGNC; HGNC:13403; PBX4.
DR   HPA; HPA049859; -.
DR   HPA; HPA056469; -.
DR   MIM; 608127; gene.
DR   neXtProt; NX_Q9BYU1; -.
DR   OpenTargets; ENSG00000105717; -.
DR   PharmGKB; PA32973; -.
DR   eggNOG; KOG0774; Eukaryota.
DR   eggNOG; ENOG410XRVF; LUCA.
DR   GeneTree; ENSGT00390000016426; -.
DR   HOGENOM; HOG000266972; -.
DR   HOVERGEN; HBG000122; -.
DR   InParanoid; Q9BYU1; -.
DR   KO; K15611; -.
DR   OMA; GVPGNHA; -.
DR   OrthoDB; EOG091G10TD; -.
DR   PhylomeDB; Q9BYU1; -.
DR   TreeFam; TF314340; -.
DR   ChiTaRS; PBX4; human.
DR   GenomeRNAi; 80714; -.
DR   PRO; PR:Q9BYU1; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105717; -.
DR   CleanEx; HS_PBX4; -.
DR   ExpressionAtlas; Q9BYU1; baseline and differential.
DR   Genevisible; Q9BYU1; HS.
DR   GO; GO:0005634; C:nucleus; IC:BHF-UCL.
DR   GO; GO:0001741; C:XY body; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IC:BHF-UCL.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IC:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR005542; PBX.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03792; PBC; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    374       Pre-B-cell leukemia transcription factor
FT                                4.
FT                                /FTId=PRO_0000049241.
FT   DNA_BIND    210    272       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   VARIANT     169    169       V -> I (in dbSNP:rs8108180).
FT                                /FTId=VAR_059355.
FT   VARIANT     177    177       M -> V (in dbSNP:rs8108981).
FT                                /FTId=VAR_059356.
FT   VARIANT     283    283       T -> M (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs376647012).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036439.
FT   CONFLICT    368    368       I -> T (in Ref. 1; BAG53471).
FT                                {ECO:0000305}.
SQ   SEQUENCE   374 AA;  40854 MW;  B9CE8BE93D0B7ABC CRC64;
     MAAPPRPAPS PPAPRRLDTS DVLQQIMAIT DQSLDEAQAR KHALNCHRMK PALFSVLCEI
     KEKTVVSIRG IQDEDPPDAQ LLRLDNMLLA EGVCRPEKRG RGGAVARAGT ATPGGCPNDN
     SIEHSDYRAK LSQIRQIYHS ELEKYEQACR EFTTHVTNLL QEQSRMRPVS PKEIERMVGA
     IHGKFSAIQM QLKQSTCEAV MTLRSRLLDA RRKRRNFSKQ ATEVLNEYFY SHLNNPYPSE
     EAKEELARKG GLTISQVSNW FGNKRIRYKK NMGKFQEEAT IYTGKTAVDT TEVGVPGNHA
     SCLSTPSSGS SGPFPLPSAG DAFLTLRTLA SLQPPPGGGC LQSQAQGSWQ GATPQPATAS
     PAGDPGSINS STSN
//
ID   PBX1_HUMAN              Reviewed;         430 AA.
AC   P40424; B4DSC1; F5H4U9; Q5T488;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   25-OCT-2017, entry version 187.
DE   RecName: Full=Pre-B-cell leukemia transcription factor 1;
DE   AltName: Full=Homeobox protein PBX1;
DE   AltName: Full=Homeobox protein PRL;
GN   Name=PBX1; Synonyms=PRL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PBX1A).
RX   PubMed=1682799; DOI=10.1128/MCB.11.12.6149;
RA   Monica K., Galili N., Nourse J., Saltman D., Cleary M.L.;
RT   "PBX2 and PBX3, new homeobox genes with extensive homology to the
RT   human proto-oncogene PBX1.";
RL   Mol. Cell. Biol. 11:6149-6157(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM PBX1A).
RX   PubMed=11267683; DOI=10.1016/S0167-4781(01)00189-0;
RA   Thameem F., Wolford J.K., Bogardus C., Prochazka M.;
RT   "Analysis of PBX1 as a candidate gene for type 2 diabetes mellitus in
RT   Pima Indians.";
RL   Biochim. Biophys. Acta 1518:215-220(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   SER-31.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PBX1A).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 89-430, AND CHROMOSOMAL TRANSLOCATION
RP   WITH TCF3.
RX   PubMed=1967983; DOI=10.1016/0092-8674(90)90658-2;
RA   Kamps M.P., Murre C., Sun X.-H., Baltimore D.;
RT   "A new homeobox gene contributes the DNA binding domain of the t(1;19)
RT   translocation protein in pre-B ALL.";
RL   Cell 60:547-555(1990).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH TCF3.
RX   PubMed=1671560;
RA   Hunger S.P., Galili N., Carroll A.J., Crist W.M., Link M.P.,
RA   Cleary M.L.;
RT   "The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1
RT   coding sequences in acute lymphoblastic leukemias.";
RL   Blood 77:687-693(1991).
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=8327485; DOI=10.1073/pnas.90.13.6061;
RA   van Dijk M.A., Voorhoeve P.M., Murre C.;
RT   "Pbx1 is converted into a transcriptional activator upon acquiring the
RT   N-terminal region of E2A in pre-B-cell acute lymphoblastoid
RT   leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:6061-6065(1993).
RN   [9]
RP   CHARACTERIZATION.
RX   PubMed=7910944; DOI=10.1128/MCB.14.6.3938;
RA   Lu Q., Wright D.D., Kamps M.P.;
RT   "Fusion with E2A converts the Pbx1 homeodomain protein into a
RT   constitutive transcriptional activator in human leukemias carrying the
RT   t(1;19) translocation.";
RL   Mol. Cell. Biol. 14:3938-3948(1994).
RN   [10]
RP   INTERACTION WITH PBXIP1.
RX   PubMed=10825160; DOI=10.1074/jbc.M001323200;
RA   Abramovich C., Shen W.-F., Pineault N., Imren S., Montpetit B.,
RA   Largman C., Humphries R.K.;
RT   "Functional cloning and characterization of a novel nonhomeodomain
RT   protein that inhibits the binding of PBX1-HOX complexes to DNA.";
RL   J. Biol. Chem. 275:26172-26177(2000).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH MEIS1.
RX   PubMed=12609849; DOI=10.1182/blood-2002-02-0380;
RA   Okada Y., Nagai R., Sato T., Matsuura E., Minami T., Morita I.,
RA   Doi T.;
RT   "Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific
RT   transcription of the platelet factor 4 gene.";
RL   Blood 101:4748-4756(2003).
RN   [12]
RP   INTERACTION WITH MEIS2.
RX   PubMed=20553494; DOI=10.1111/j.1742-4658.2010.07668.x;
RA   Hyman-Walsh C., Bjerke G.A., Wotton D.;
RT   "An autoinhibitory effect of the homothorax domain of Meis2.";
RL   FEBS J. 277:2584-2597(2010).
RN   [13]
RP   INTERACTION WITH TLX1.
RX   PubMed=19559479; DOI=10.1016/j.leukres.2009.06.003;
RA   Milech N., Gottardo N.G., Ford J., D'Souza D., Greene W.K., Kees U.R.,
RA   Watt P.M.;
RT   "MEIS proteins as partners of the TLX1/HOX11 oncoprotein.";
RL   Leuk. Res. 34:358-363(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH SP1; SP3 AND KLF4.
RX   PubMed=21746878; DOI=10.1128/MCB.01456-10;
RA   Bjerke G.A., Hyman-Walsh C., Wotton D.;
RT   "Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.";
RL   Mol. Cell. Biol. 31:3723-3733(2011).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 233-319 IN COMPLEX WITH
RP   HOXB1.
RX   PubMed=10052460; DOI=10.1016/S0092-8674(00)80662-5;
RA   Piper D.E., Batchelor A.H., Chang C.-P., Cleary M.L., Wolberger C.;
RT   "Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the
RT   hexapeptide and a fourth homeodomain helix in complex formation.";
RL   Cell 96:587-597(1999).
CC   -!- FUNCTION: Binds the sequence 5'-ATCAATCAA-3'. Acts as a
CC       transcriptional activator of PF4 in complex with MEIS1. Converted
CC       into a potent transcriptional activator by the (1;19)
CC       translocation. May have a role in steroidogenesis and,
CC       subsequently, sexual development and differentiation. Isoform
CC       PBX1b as part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar
CC       cells is involved in the transcriptional activation of the ELA1
CC       enhancer; the complex binds to the enhancer B element and
CC       cooperates with the transcription factor 1 complex (PTF1) bound to
CC       the enhancer A element. Probably in complex with MEIS2, is
CC       involved in transcriptional regulation by KLF4. Acts as a
CC       transcriptional activator of NKX2-5 and a transcriptional
CC       repressor of CDKN2B. Together with NKX2-5, it is required for
CC       spleen development through a mechanism that involves CDKN2B
CC       repression (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:12609849, ECO:0000269|PubMed:21746878}.
CC   -!- SUBUNIT: Forms a heterodimer with MEIS1 which binds DNA including
CC       a cAMP-responsive sequence in CYP17. Also forms heterotrimers with
CC       MEIS1 and a number of HOX proteins including HOXA9, HOXD4, HOXD9
CC       and HOXD10. Interacts with PBXIP1 and TLX1. Isoform PBX1a
CC       interacts with MEIS2 isoform 4, SP1, SP3 and KLF4. Isoform PBX1b
CC       is part of a PDX1:PBX1b:MEIS2b complex; PBX1b recruits Meis2B to
CC       the complex. {ECO:0000269|PubMed:10052460,
CC       ECO:0000269|PubMed:10825160, ECO:0000269|PubMed:12609849,
CC       ECO:0000269|PubMed:19559479, ECO:0000269|PubMed:20553494,
CC       ECO:0000269|PubMed:21746878}.
CC   -!- INTERACTION:
CC       Q12948:FOXC1; NbExp=5; IntAct=EBI-301611, EBI-1175253;
CC       O14770-4:MEIS2; NbExp=8; IntAct=EBI-301611, EBI-8025850;
CC       P31314:TLX1; NbExp=2; IntAct=EBI-6390251, EBI-2820655;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=PBX1a;
CC         IsoId=P40424-1; Sequence=Displayed;
CC       Name=PBX1b;
CC         IsoId=P40424-2; Sequence=VSP_002271, VSP_002272;
CC       Name=3;
CC         IsoId=P40424-3; Sequence=VSP_044499;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues except in cells of
CC       the B and T lineage.
CC   -!- DISEASE: Note=A chromosomal aberration involving PBX1 is a cause
CC       of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation
CC       t(1;19)(q23;p13.3) with TCF3. TCF3-PBX1 transforms cells by
CC       constitutively activating transcription of genes regulated by PBX1
CC       or by other members of the PBX protein family.
CC       {ECO:0000269|PubMed:1671560, ECO:0000269|PubMed:1967983}.
CC   -!- SIMILARITY: Belongs to the TALE/PBX homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36764.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PBX1ID2.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86546; AAA60031.1; -; mRNA.
DR   EMBL; AF313404; AAG30941.1; -; Genomic_DNA.
DR   EMBL; AF313396; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313397; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313398; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313399; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313400; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313401; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313402; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AF313403; AAG30941.1; JOINED; Genomic_DNA.
DR   EMBL; AK299673; BAG61583.1; -; mRNA.
DR   EMBL; AL359255; CAI14854.1; -; Genomic_DNA.
DR   EMBL; AL357568; CAI14854.1; JOINED; Genomic_DNA.
DR   EMBL; AL390119; CAI14854.1; JOINED; Genomic_DNA.
DR   EMBL; AL390119; CAH73499.1; -; Genomic_DNA.
DR   EMBL; AL359255; CAH73499.1; JOINED; Genomic_DNA.
DR   EMBL; AL357568; CAH73499.1; JOINED; Genomic_DNA.
DR   EMBL; AL357568; CAI14908.1; -; Genomic_DNA.
DR   EMBL; AL390119; CAI14908.1; JOINED; Genomic_DNA.
DR   EMBL; AL359255; CAI14908.1; JOINED; Genomic_DNA.
DR   EMBL; AL391001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101578; AAI01579.1; -; mRNA.
DR   EMBL; M31522; AAA36764.1; ALT_INIT; mRNA.
DR   CCDS; CCDS1246.1; -. [P40424-1]
DR   CCDS; CCDS55653.1; -. [P40424-3]
DR   CCDS; CCDS55654.1; -. [P40424-2]
DR   PIR; B34734; B34734.
DR   RefSeq; NP_001191892.1; NM_001204963.1. [P40424-3]
DR   RefSeq; NP_002576.1; NM_002585.3. [P40424-1]
DR   RefSeq; XP_005245286.1; XM_005245229.3. [P40424-1]
DR   UniGene; Hs.557097; -.
DR   PDB; 1B72; X-ray; 2.35 A; B=233-319.
DR   PDB; 1PUF; X-ray; 1.90 A; B=233-305.
DR   PDBsum; 1B72; -.
DR   PDBsum; 1PUF; -.
DR   ProteinModelPortal; P40424; -.
DR   SMR; P40424; -.
DR   BioGrid; 111120; 48.
DR   IntAct; P40424; 19.
DR   MINT; MINT-1532549; -.
DR   STRING; 9606.ENSP00000405890; -.
DR   iPTMnet; P40424; -.
DR   PhosphoSitePlus; P40424; -.
DR   BioMuta; PBX1; -.
DR   DMDM; 730279; -.
DR   EPD; P40424; -.
DR   MaxQB; P40424; -.
DR   PaxDb; P40424; -.
DR   PeptideAtlas; P40424; -.
DR   PRIDE; P40424; -.
DR   DNASU; 5087; -.
DR   Ensembl; ENST00000367897; ENSP00000356872; ENSG00000185630. [P40424-2]
DR   Ensembl; ENST00000420696; ENSP00000405890; ENSG00000185630. [P40424-1]
DR   Ensembl; ENST00000627490; ENSP00000485692; ENSG00000185630. [P40424-3]
DR   GeneID; 5087; -.
DR   KEGG; hsa:5087; -.
DR   UCSC; uc001gct.4; human. [P40424-1]
DR   CTD; 5087; -.
DR   DisGeNET; 5087; -.
DR   EuPathDB; HostDB:ENSG00000185630.18; -.
DR   GeneCards; PBX1; -.
DR   HGNC; HGNC:8632; PBX1.
DR   HPA; CAB018768; -.
DR   HPA; HPA003505; -.
DR   HPA; HPA003881; -.
DR   MalaCards; PBX1; -.
DR   MIM; 176310; gene.
DR   neXtProt; NX_P40424; -.
DR   OpenTargets; ENSG00000185630; -.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA32970; -.
DR   eggNOG; KOG0774; Eukaryota.
DR   eggNOG; ENOG410XRVF; LUCA.
DR   GeneTree; ENSGT00390000016426; -.
DR   HOGENOM; HOG000266972; -.
DR   HOVERGEN; HBG000122; -.
DR   InParanoid; P40424; -.
DR   KO; K09355; -.
DR   OMA; TASQMYS; -.
DR   OrthoDB; EOG091G10TD; -.
DR   PhylomeDB; P40424; -.
DR   TreeFam; TF314340; -.
DR   Reactome; R-HSA-452723; Transcriptional regulation of pluripotent stem cells.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SignaLink; P40424; -.
DR   SIGNOR; P40424; -.
DR   ChiTaRS; PBX1; human.
DR   EvolutionaryTrace; P40424; -.
DR   GeneWiki; PBX1; -.
DR   GenomeRNAi; 5087; -.
DR   PRO; PR:P40424; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185630; -.
DR   CleanEx; HS_PBX1; -.
DR   CleanEx; HS_PRL; -.
DR   ExpressionAtlas; P40424; baseline and differential.
DR   Genevisible; P40424; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IDA:NTNU_SB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0030325; P:adrenal gland development; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   GO; GO:0007548; P:sex differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; TAS:Reactome.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0048538; P:thymus development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR005542; PBX.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03792; PBC; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Developmental protein;
KW   Differentiation; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Proto-oncogene; Reference proteome; Repressor; Sexual differentiation;
KW   Steroidogenesis; Transcription; Transcription regulation.
FT   CHAIN         1    430       Pre-B-cell leukemia transcription factor
FT                                1.
FT                                /FTId=PRO_0000049235.
FT   DNA_BIND    233    295       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   COMPBIAS    127    135       Poly-Ala.
FT   SITE         88     89       Breakpoint for translocation to form
FT                                TCF3-PBX1 oncogene.
FT   VAR_SEQ     334    347       SSSSFNMSNSGDLF -> GYPSPCYQPDRRIQ (in
FT                                isoform PBX1b). {ECO:0000305}.
FT                                /FTId=VSP_002271.
FT   VAR_SEQ     348    430       Missing (in isoform PBX1b).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002272.
FT   VAR_SEQ     401    430       ANGGWQDATTPSSVTSPTEGPGSVHSDTSN -> HLPRHPR
FT                                QAHYHFRLPTWHP (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044499.
FT   VARIANT      31     31       G -> S (in dbSNP:rs2275558).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_068904.
FT   CONFLICT    351    351       Q -> H (in Ref. 3; BAG61583).
FT                                {ECO:0000305}.
FT   HELIX       242    254       {ECO:0000244|PDB:1PUF}.
FT   TURN        255    257       {ECO:0000244|PDB:1PUF}.
FT   HELIX       263    273       {ECO:0000244|PDB:1PUF}.
FT   HELIX       277    293       {ECO:0000244|PDB:1PUF}.
FT   TURN        295    300       {ECO:0000244|PDB:1PUF}.
FT   HELIX       301    304       {ECO:0000244|PDB:1PUF}.
SQ   SEQUENCE   430 AA;  46626 MW;  AD3FFACBC5A9E715 CRC64;
     MDEQPRLMHS HAGVGMAGHP GLSQHLQDGA GGTEGEGGRK QDIGDILQQI MTITDQSLDE
     AQARKHALNC HRMKPALFNV LCEIKEKTVL SIRGAQEEEP TDPQLMRLDN MLLAEGVAGP
     EKGGGSAAAA AAAAASGGAG SDNSVEHSDY RAKLSQIRQI YHTELEKYEQ ACNEFTTHVM
     NLLREQSRTR PISPKEIERM VSIIHRKFSS IQMQLKQSTC EAVMILRSRF LDARRKRRNF
     NKQATEILNE YFYSHLSNPY PSEEAKEELA KKCGITVSQV SNWFGNKRIR YKKNIGKFQE
     EANIYAAKTA VTATNVSAHG SQANSPSTPN SAGSSSSFNM SNSGDLFMSV QSLNGDSYQG
     AQVGANVQSQ VDTLRHVISQ TGGYSDGLAA SQMYSPQGIS ANGGWQDATT PSSVTSPTEG
     PGSVHSDTSN
//
ID   PITX1_HUMAN             Reviewed;         314 AA.
AC   P78337; A8K3M0; D3DQB0; O14677; O60425; Q9BTI5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=Pituitary homeobox 1;
DE   AltName: Full=Hindlimb-expressed homeobox protein backfoot;
DE   AltName: Full=Homeobox protein PITX1;
DE   AltName: Full=Paired-like homeodomain transcription factor 1;
GN   Name=PITX1; Synonyms=BFT, PTX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9070926; DOI=10.1006/geno.1996.4558;
RA   Shang J., Li X., Ring H.Z., Clayton D.A., Francke U.;
RT   "Backfoot, a novel homeobox gene, maps to human chromosome 5 (BFT) and
RT   mouse chromosome 13 (Bft).";
RL   Genomics 40:108-113(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9337397; DOI=10.1007/s003359900589;
RA   Crawford M.J., Lanctot C., Tremblay J.J., Jenkins N.A., Gilbert D.J.,
RA   Copeland N.G., Beatty B., Drouin J.;
RT   "Human and murine PTX1/Ptx1 gene maps to the region for Treacher
RT   Collins syndrome.";
RL   Mamm. Genome 8:841-845(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-299.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-299.
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-299.
RC   TISSUE=Pancreas, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-48, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   INVOLVEMENT IN LBNBG.
RX   PubMed=23022097; DOI=10.1016/j.ajhg.2012.08.014;
RA   Spielmann M., Brancati F., Krawitz P.M., Robinson P.N., Ibrahim D.M.,
RA   Franke M., Hecht J., Lohan S., Dathe K., Nardone A.M., Ferrari P.,
RA   Landi A., Wittler L., Timmermann B., Chan D., Mennen U., Klopocki E.,
RA   Mundlos S.;
RT   "Homeotic arm-to-leg transformation associated with genomic
RT   rearrangements at the PITX1 locus.";
RL   Am. J. Hum. Genet. 91:629-635(2012).
RN   [9]
RP   INVOLVEMENT IN CCF.
RX   PubMed=22258522; DOI=10.1038/ejhg.2011.264;
RA   Klopocki E., Kahler C., Foulds N., Shah H., Joseph B., Vogel H.,
RA   Luttgen S., Bald R., Besoke R., Held K., Mundlos S., Kurth I.;
RT   "Deletions in PITX1 cause a spectrum of lower-limb malformations
RT   including mirror-image polydactyly.";
RL   Eur. J. Hum. Genet. 20:705-708(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   INTERACTION WITH POU1F1.
RX   PubMed=26612202; DOI=10.1093/hmg/ddv486;
RA   Sobrier M.L., Tsai Y.C., Perez C., Leheup B., Bouceba T.,
RA   Duquesnoy P., Copin B., Sizova D., Penzo A., Stanger B.Z., Cooke N.E.,
RA   Liebhaber S.A., Amselem S.;
RT   "Functional characterization of a human POU1F1 mutation associated
RT   with isolated growth hormone deficiency: a novel etiology for IGHD.";
RL   Hum. Mol. Genet. 25:472-483(2016).
RN   [12]
RP   VARIANT CCF LYS-130, AND CHARACTERIZATION OF VARIANT CCF LYS-130.
RX   PubMed=18950742; DOI=10.1016/j.ajhg.2008.10.004;
RA   Gurnett C.A., Alaee F., Kruse L.M., Desruisseau D.M., Hecht J.T.,
RA   Wise C.A., Bowcock A.M., Dobbs M.B.;
RT   "Asymmetric lower-limb malformations in individuals with homeobox
RT   PITX1 gene mutation.";
RL   Am. J. Hum. Genet. 83:616-622(2008).
CC   -!- FUNCTION: Sequence-specific transcription factor that binds gene
CC       promoters and activates their transcription. May play a role in
CC       the development of anterior structures, and in particular, the
CC       brain and facies and in specifying the identity or structure of
CC       hindlimb. {ECO:0000250|UniProtKB:P56673}.
CC   -!- SUBUNIT: Interacts with POU1F1 (PubMed:26612202).
CC       {ECO:0000269|PubMed:26612202}.
CC   -!- INTERACTION:
CC       Q08117-2:AES; NbExp=4; IntAct=EBI-748265, EBI-11741437;
CC       Q9NP55:BPIFA1; NbExp=4; IntAct=EBI-748265, EBI-953896;
CC       Q92997:DVL3; NbExp=3; IntAct=EBI-748265, EBI-739789;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-748265, EBI-618309;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-748265, EBI-724076;
CC       P35548:MSX2; NbExp=4; IntAct=EBI-748265, EBI-6447480;
CC       A7E2Y1-2:MYH7B; NbExp=4; IntAct=EBI-748265, EBI-12813813;
CC       Q93062:RBPMS; NbExp=4; IntAct=EBI-748265, EBI-740322;
CC       Q93062-3:RBPMS; NbExp=3; IntAct=EBI-748265, EBI-740343;
CC       O60806:TBX19; NbExp=4; IntAct=EBI-748265, EBI-12096770;
CC       Q12888:TP53BP1; NbExp=4; IntAct=EBI-748265, EBI-396540;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Clubfoot, congenital, with or without deficiency of long
CC       bones and/or mirror-image polydactyly (CCF) [MIM:119800]: A
CC       congenital limb deformity defined as fixation of the foot in
CC       cavus, adductus, varus, and equinus (i.e., inclined inwards,
CC       axially rotated outwards, and pointing downwards) with concomitant
CC       soft tissue abnormalities. Clubfoot may occur in isolation or as
CC       part of a syndrome. Some patients present tibial hemimelia,
CC       bilateral patellar hypoplasia, and preaxial mirror-image
CC       polydactyly. {ECO:0000269|PubMed:18950742,
CC       ECO:0000269|PubMed:22258522}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Liebenberg syndrome (LBNBG) [MIM:186550]: An upper limb-
CC       malformation syndrome characterized by the combination of
CC       dysplastic elbow joints and the fusion of wrist bones with
CC       consequent radial deviation. {ECO:0000269|PubMed:23022097}.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis. A chromosomal aberration involving the PITX1 locus
CC       results in LBNBG. Translocation t(5;18)(q31.1;q12.3).
CC       Additionally, two chromosome 5 deletions located 5'of PITX1 have
CC       been found in LBNBG patients. These structural variations cause
CC       altered expression of PITX1 in the forelimb via the activation of
CC       ectopic enhancers (PubMed:23022097).
CC       {ECO:0000269|PubMed:23022097}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U70370; AAC51126.1; -; mRNA.
DR   EMBL; AF009650; AAB65251.1; -; Genomic_DNA.
DR   EMBL; AF009648; AAB65251.1; JOINED; Genomic_DNA.
DR   EMBL; AF009649; AAB65251.1; JOINED; Genomic_DNA.
DR   EMBL; AK290635; BAF83324.1; -; mRNA.
DR   EMBL; AC004764; AAC17733.1; -; Genomic_DNA.
DR   EMBL; AC008406; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW62226.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62227.1; -; Genomic_DNA.
DR   EMBL; BC009412; AAH09412.1; -; mRNA.
DR   EMBL; BC003685; AAH03685.1; -; mRNA.
DR   CCDS; CCDS4182.1; -.
DR   RefSeq; NP_002644.4; NM_002653.4.
DR   UniGene; Hs.84136; -.
DR   ProteinModelPortal; P78337; -.
DR   SMR; P78337; -.
DR   BioGrid; 111324; 28.
DR   IntAct; P78337; 69.
DR   MINT; MINT-260914; -.
DR   STRING; 9606.ENSP00000265340; -.
DR   iPTMnet; P78337; -.
DR   PhosphoSitePlus; P78337; -.
DR   BioMuta; PITX1; -.
DR   DMDM; 108935922; -.
DR   PaxDb; P78337; -.
DR   PeptideAtlas; P78337; -.
DR   PRIDE; P78337; -.
DR   DNASU; 5307; -.
DR   Ensembl; ENST00000265340; ENSP00000265340; ENSG00000069011.
DR   Ensembl; ENST00000506438; ENSP00000427542; ENSG00000069011.
DR   GeneID; 5307; -.
DR   KEGG; hsa:5307; -.
DR   CTD; 5307; -.
DR   DisGeNET; 5307; -.
DR   EuPathDB; HostDB:ENSG00000069011.15; -.
DR   GeneCards; PITX1; -.
DR   H-InvDB; HIX0005190; -.
DR   HGNC; HGNC:9004; PITX1.
DR   HPA; HPA008743; -.
DR   MalaCards; PITX1; -.
DR   MIM; 119800; phenotype.
DR   MIM; 186550; phenotype.
DR   MIM; 602149; gene.
DR   neXtProt; NX_P78337; -.
DR   OpenTargets; ENSG00000069011; -.
DR   Orphanet; 1275; Brachydactyly - elbow wrist dysplasia.
DR   Orphanet; 293144; Familial clubfoot due to 5q31 microdeletion.
DR   Orphanet; 293150; Familial clubfoot due to PITX1 point mutation.
DR   PharmGKB; PA33338; -.
DR   eggNOG; KOG0486; Eukaryota.
DR   eggNOG; ENOG410ZZ6J; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000273886; -.
DR   HOVERGEN; HBG068770; -.
DR   InParanoid; P78337; -.
DR   KO; K09356; -.
DR   OMA; NNWTNKG; -.
DR   OrthoDB; EOG091G0H7U; -.
DR   PhylomeDB; P78337; -.
DR   TreeFam; TF351940; -.
DR   SIGNOR; P78337; -.
DR   ChiTaRS; PITX1; human.
DR   GeneWiki; PITX1; -.
DR   GenomeRNAi; 5307; -.
DR   PRO; PR:P78337; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000069011; -.
DR   CleanEx; HS_PITX1; -.
DR   ExpressionAtlas; P78337; baseline and differential.
DR   Genevisible; P78337; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001190; F:transcriptional activator activity, RNA polymerase II transcription factor binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0014707; P:branchiomeric skeletal muscle development; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0048625; P:myoblast fate commitment; IEA:Ensembl.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016233; Homeobox_Pitx/unc30.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   PIRSF; PIRSF000563; Homeobox_protein_Pitx/Unc30; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    314       Pituitary homeobox 1.
FT                                /FTId=PRO_0000049218.
FT   DNA_BIND     89    148       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      147    279       Interaction with PIT-1. {ECO:0000250}.
FT   MOTIF       280    293       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOTIF       286    290       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS     19     24       Poly-Pro.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      46     46       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VARIANT     130    130       E -> K (in CCF; reduces the ability to
FT                                transactivate a luciferase reporter gene;
FT                                suppresses wild-type activity in a dose-
FT                                dependent manner; dbSNP:rs121909109).
FT                                {ECO:0000269|PubMed:18950742}.
FT                                /FTId=VAR_058113.
FT   VARIANT     299    299       G -> A (in dbSNP:rs479632).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15372022,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_049586.
FT   CONFLICT     17     17       L -> F (in Ref. 1; AAC51126).
FT                                {ECO:0000305}.
SQ   SEQUENCE   314 AA;  34128 MW;  F0DFE45E14508A43 CRC64;
     MDAFKGGMSL ERLPEGLRPP PPPPHDMGPA FHLARPADPR EPLENSASES SDTELPEKER
     GGEPKGPEDS GAGGTGCGGA DDPAKKKKQR RQRTHFTSQQ LQELEATFQR NRYPDMSMRE
     EIAVWTNLTE PRVRVWFKNR RAKWRKRERN QQLDLCKGGY VPQFSGLVQP YEDVYAAGYS
     YNNWAAKSLA PAPLSTKSFT FFNSMSPLSS QSMFSAPSSI SSMTMPSSMG PGAVPGMPNS
     GLNNINNLTG SSLNSAMSPG ACPYGTPASP YSVYRDTCNS SLASLRLKSK QHSSFGYGGL
     QGPASGLNAC QYNS
//
ID   PKNX1_HUMAN             Reviewed;         436 AA.
AC   P55347; O00528; Q8IWT7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 3.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=Homeobox protein PKNOX1;
DE   AltName: Full=Homeobox protein PREP-1;
DE   AltName: Full=PBX/knotted homeobox 1;
GN   Name=PKNOX1; Synonyms=PREP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=9143494; DOI=10.1006/geno.1997.4632;
RA   Chen H., Rossier C., Nakamura Y., Lynn A., Chakravarti A.,
RA   Antonarakis S.E.;
RT   "Cloning of a novel homeobox-containing gene, PKNOX1, and mapping to
RT   human chromosome 21q22.3.";
RL   Genomics 41:193-200(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9479508; DOI=10.1006/geno.1997.5086;
RA   Berthelsen J., Viggiano L., Schulz H., Ferretti E., Consalez G.G.,
RA   Rocchi M., Blasi F.;
RT   "PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps
RT   on human chromosome 21q22.3 and murine chromosome 17B/C.";
RL   Genomics 47:323-324(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=15468914;
RA   Ni B., Li L.Y., Yin Z.C., Zou Y.H., Li H.;
RT   "Molecular cloning for an alternatively splicing cDNA of human PKNOX1
RT   gene and it's expression analysis.";
RL   Yi Chuan Xue Bao 31:19-25(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   STRUCTURE BY NMR OF 258-319.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of human homeobox protein
RT   PKNOX1.";
RL   Submitted (OCT-2005) to the PDB data bank.
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-265.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55347-1; Sequence=Displayed;
CC       Name=2; Synonyms=PKNOX1B;
CC         IsoId=P55347-2; Sequence=VSP_017260;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Isoform 2 is expressed in all
CC       examined tissues except in bone marrow.
CC       {ECO:0000269|PubMed:15468914, ECO:0000269|PubMed:9143494}.
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51243.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA95533.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U68727; AAC51243.1; ALT_INIT; mRNA.
DR   EMBL; Y13613; CAA73934.1; -; mRNA.
DR   EMBL; AY142115; AAN34940.1; -; mRNA.
DR   EMBL; AP001748; BAA95533.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS13692.1; -. [P55347-1]
DR   RefSeq; NP_004562.2; NM_004571.4. [P55347-1]
DR   UniGene; Hs.431043; -.
DR   PDB; 1X2N; NMR; -; A=260-319.
DR   PDBsum; 1X2N; -.
DR   ProteinModelPortal; P55347; -.
DR   SMR; P55347; -.
DR   BioGrid; 111333; 21.
DR   IntAct; P55347; 19.
DR   MINT; MINT-1532511; -.
DR   STRING; 9606.ENSP00000291547; -.
DR   iPTMnet; P55347; -.
DR   PhosphoSitePlus; P55347; -.
DR   DMDM; 115311619; -.
DR   SWISS-2DPAGE; P55347; -.
DR   EPD; P55347; -.
DR   PaxDb; P55347; -.
DR   PeptideAtlas; P55347; -.
DR   PRIDE; P55347; -.
DR   DNASU; 5316; -.
DR   Ensembl; ENST00000291547; ENSP00000291547; ENSG00000160199. [P55347-1]
DR   GeneID; 5316; -.
DR   KEGG; hsa:5316; -.
DR   CTD; 5316; -.
DR   DisGeNET; 5316; -.
DR   EuPathDB; HostDB:ENSG00000160199.14; -.
DR   GeneCards; PKNOX1; -.
DR   HGNC; HGNC:9022; PKNOX1.
DR   HPA; CAB004285; -.
DR   HPA; HPA057215; -.
DR   HPA; HPA065017; -.
DR   MIM; 602100; gene.
DR   neXtProt; NX_P55347; -.
DR   OpenTargets; ENSG00000160199; -.
DR   PharmGKB; PA33354; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000253922; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; P55347; -.
DR   OMA; MMAEQSE; -.
DR   OrthoDB; EOG091G09WJ; -.
DR   PhylomeDB; P55347; -.
DR   TreeFam; TF318093; -.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   SIGNOR; P55347; -.
DR   ChiTaRS; PKNOX1; human.
DR   EvolutionaryTrace; P55347; -.
DR   GeneWiki; PKNOX1; -.
DR   GenomeRNAi; 5316; -.
DR   PRO; PR:P55347; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000160199; -.
DR   CleanEx; HS_PKNOX1; -.
DR   ExpressionAtlas; P55347; baseline and differential.
DR   Genevisible; P55347; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0030218; P:erythrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    436       Homeobox protein PKNOX1.
FT                                /FTId=PRO_0000049248.
FT   DNA_BIND    259    321       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   MOD_RES      33     33       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70477}.
FT   MOD_RES      41     41       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     368    436       AVVTITTPVNMNVDSLQSLSSDGATLAVQQVMMAGQSEDES
FT                                VDSTEEDAGALAPAHISGLVLENSDSLQ -> TGGRPRPDM
FT                                VDHGVGIMNKRPGSGLLAVSHRARPRMTS (in isoform
FT                                2). {ECO:0000303|PubMed:15468914}.
FT                                /FTId=VSP_017260.
FT   VARIANT     126    126       R -> H (in dbSNP:rs9976017).
FT                                /FTId=VAR_049588.
FT   VARIANT     216    216       T -> A (in dbSNP:rs17115709).
FT                                /FTId=VAR_049589.
FT   VARIANT     265    265       V -> I (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs376883451).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036440.
FT   CONFLICT    153    153       K -> E (in Ref. 2; CAA73934).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       P -> A (in Ref. 1; AAC51243).
FT                                {ECO:0000305}.
FT   CONFLICT    430    430       E -> A (in Ref. 2; CAA73934).
FT                                {ECO:0000305}.
FT   HELIX       268    280       {ECO:0000244|PDB:1X2N}.
FT   TURN        281    283       {ECO:0000244|PDB:1X2N}.
FT   HELIX       289    299       {ECO:0000244|PDB:1X2N}.
FT   HELIX       303    319       {ECO:0000244|PDB:1X2N}.
SQ   SEQUENCE   436 AA;  47607 MW;  381E901F435AC5F2 CRC64;
     MMATQTLSID SYQDGQQMQV VTELKTEQDP NCSEPDAEGV SPPPVESQTP MDVDKQAIYR
     HPLFPLLALL FEKCEQSTQG SEGTTSASFD VDIENFVRKQ EKEGKPFFCE DPETDNLMVK
     AIQVLRIHLL ELEKVNELCK DFCSRYIACL KTKMNSETLL SGEPGSPYSP VQSQQIQSAI
     TGTISPQGIV VPASALQQGN VAMATVAGGT VYQPVTVVTP QGQVVTQTLS PGTIRIQNSQ
     LQLQLNQDLS ILHQDDGSSK NKRGVLPKHA TNVMRSWLFQ HIGHPYPTED EKKQIAAQTN
     LTLLQVNNWF INARRRILQP MLDSSCSETP KTKKKTAQNR PVQRFWPDSI ASGVAQPPPS
     ELTMSEGAVV TITTPVNMNV DSLQSLSSDG ATLAVQQVMM AGQSEDESVD STEEDAGALA
     PAHISGLVLE NSDSLQ
//
ID   PO2F1_HUMAN             Reviewed;         743 AA.
AC   P14859; B1AL91; B1AL93; B4E029; J3KP77; Q5TBT7; Q6PK46; Q8NEU9;
AC   Q9BPV1;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2003, sequence version 2.
DT   25-OCT-2017, entry version 209.
DE   RecName: Full=POU domain, class 2, transcription factor 1;
DE   AltName: Full=NF-A1;
DE   AltName: Full=Octamer-binding protein 1;
DE            Short=Oct-1;
DE   AltName: Full=Octamer-binding transcription factor 1;
DE            Short=OTF-1;
GN   Name=POU2F1; Synonyms=OCT1, OTF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=2905684; DOI=10.1101/gad.2.12a.1582;
RA   Sturm R.A., Das G., Herr W.;
RT   "The ubiquitous octamer-binding protein Oct-1 contains a POU domain
RT   with a homeo box subdomain.";
RL   Genes Dev. 2:1582-1599(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=B-cell lymphoma;
RX   PubMed=12663137; DOI=10.1016/S0165-2478(02)00179-7;
RA   Luchina N.N., Krivega I.V., Pankratova E.V.;
RT   "Human Oct-1L isoform has tissue-specific expression pattern similar
RT   to Oct-2.";
RL   Immunol. Lett. 85:237-241(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 93-653 (ISOFORM 4).
RC   TISSUE=Lung, Lymph, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION AT SER-385, MUTAGENESIS OF SER-385, AND FUNCTION IN
RP   DNA-BINDING ACTIVITY.
RX   PubMed=1684878; DOI=10.1126/science.1684878;
RA   Segil N., Roberts S.B., Heintz N.;
RT   "Mitotic phosphorylation of the Oct-1 homeodomain and regulation of
RT   Oct-1 DNA binding activity.";
RL   Science 254:1814-1816(1991).
RN   [8]
RP   INTERACTION WITH NR3C1; AR AND PGR.
RX   PubMed=10480874; DOI=10.1074/jbc.274.38.26713;
RA   Prefontaine G.G., Walther R., Giffin W., Lemieux M.E., Pope L.,
RA   Hache R.J.G.;
RT   "Selective binding of steroid hormone receptors to octamer
RT   transcription factors determines transcriptional synergism at the
RT   mouse mammary tumor virus promoter.";
RL   J. Biol. Chem. 274:26713-26719(1999).
RN   [9]
RP   INTERACTION WITH HCFC1.
RX   PubMed=10629049; DOI=10.1128/MCB.20.3.919-928.2000;
RA   Mahajan S.S., Wilson A.C.;
RT   "Mutations in host cell factor 1 separate its role in cell
RT   proliferation from recruitment of VP16 and LZIP.";
RL   Mol. Cell. Biol. 20:919-928(2000).
RN   [10]
RP   PHOSPHORYLATION.
RX   PubMed=14612514;
RA   Schild-Poulter C., Shih A., Yarymowich N.C., Hache R.J.G.;
RT   "Down-regulation of histone H2B by DNA-dependent protein kinase in
RT   response to DNA damage through modulation of octamer transcription
RT   factor 1.";
RL   Cancer Res. 63:7197-7205(2003).
RN   [11]
RP   REVIEW ON HERPES INFECTION.
RX   PubMed=12826401; DOI=10.1016/S0968-0004(03)00088-4;
RA   Wysocka J., Herr W.;
RT   "The herpes simplex virus VP16-induced complex: the makings of a
RT   regulatory switch.";
RL   Trends Biochem. Sci. 28:294-304(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-270; SER-283 AND
RP   SER-448, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-276 AND SER-448, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   STRUCTURE BY NMR OF 284-359.
RX   PubMed=8479524; DOI=10.1038/362852a0;
RA   Dekker N., Cox M., Boelens R., Verrijzer C.P., van der Vliet P.C.,
RA   Kaptein R.;
RT   "Solution structure of the POU-specific DNA-binding domain of Oct-1.";
RL   Nature 362:852-855(1993).
RN   [21]
RP   STRUCTURE BY NMR OF 284-354.
RX   PubMed=8462099; DOI=10.1016/0092-8674(93)90171-L;
RA   Assa-Munt N., Mortishire-Smith R.J., Aurora R., Herr W., Wright P.E.;
RT   "The solution structure of the Oct-1 POU-specific domain reveals a
RT   striking similarity to the bacteriophage lambda repressor DNA-binding
RT   domain.";
RL   Cell 73:193-205(1993).
RN   [22]
RP   STRUCTURE BY NMR OF 378-437.
RX   PubMed=7663141; DOI=10.1007/BF00417488;
RA   Cox M., van Tilborg P.J.A., de Laat W., Boelens R., van Leeuwen H.C.,
RA   van der Vliet P.C., Kaptein R.;
RT   "Solution structure of the Oct-1 POU homeodomain determined by NMR and
RT   restrained molecular dynamics.";
RL   J. Biomol. NMR 6:23-32(1995).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 284-439.
RX   PubMed=8156594; DOI=10.1016/0092-8674(94)90231-3;
RA   Klemm J.D., Rould M.A., Aurora R., Herr W., Pabo C.O.;
RT   "Crystal structure of the Oct-1 POU domain bound to an octamer site:
RT   DNA recognition with tethered DNA-binding modules.";
RL   Cell 77:21-32(1994).
RN   [24]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-88.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Transcription factor that binds to the octamer motif
CC       (5'-ATTTGCAT-3') and activates the promoters of the genes for some
CC       small nuclear RNAs (snRNA) and of genes such as those for histone
CC       H2B and immunoglobulins. Modulates transcription transactivation
CC       by NR3C1, AR and PGR (By similarity). In case of human herpes
CC       simplex virus (HSV) infection, POU2F1 forms a multiprotein-DNA
CC       complex with the viral transactivator protein VP16 and HCFC1
CC       thereby enabling the transcription of the viral immediate early
CC       genes. {ECO:0000250, ECO:0000269|PubMed:1684878}.
CC   -!- SUBUNIT: Interacts with NR3C1, AR, PGR and HCFC1. Associates with
CC       the herpes simplex virus VP16-induced complex; binding to HCFC1
CC       activates the viral transcriptional activator VP16 for association
CC       with POU2F1, to form a multiprotein-DNA complex responsible for
CC       activating transcription of the viral immediate early genes.
CC       {ECO:0000269|PubMed:10480874, ECO:0000269|PubMed:10629049}.
CC   -!- INTERACTION:
CC       Q9H4B4:PLK3; NbExp=3; IntAct=EBI-624770, EBI-751877;
CC       Q7Z3K3:POGZ; NbExp=3; IntAct=EBI-624770, EBI-1389308;
CC       P78424:POU6F2; NbExp=4; IntAct=EBI-11526590, EBI-12029004;
CC       P86480:PRR20D; NbExp=4; IntAct=EBI-11526590, EBI-12754095;
CC       P08047:SP1; NbExp=7; IntAct=EBI-624770, EBI-298336;
CC       Q02446:SP4; NbExp=5; IntAct=EBI-624770, EBI-10198587;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=P14859-1; Sequence=Displayed;
CC       Name=2; Synonyms=Oct-1L, lymphocyte-specific;
CC         IsoId=P14859-2; Sequence=VSP_002320;
CC       Name=3;
CC         IsoId=P14859-3; Sequence=VSP_013421;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=P14859-6; Sequence=VSP_043195;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P14859-4; Sequence=VSP_013422, VSP_013423;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P14859-5; Sequence=VSP_043195, VSP_043196;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Isoform 2 is lymphocyte-specific.
CC   -!- PTM: Phosphorylated by PRKDC. {ECO:0000269|PubMed:14612514,
CC       ECO:0000269|PubMed:1684878}.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13403; CAA31767.1; -; mRNA.
DR   EMBL; AY113189; AAM77920.1; -; mRNA.
DR   EMBL; AK303201; BAG64291.1; -; mRNA.
DR   EMBL; AL136984; CAI15167.1; -; Genomic_DNA.
DR   EMBL; AL136984; CAI15169.1; -; Genomic_DNA.
DR   EMBL; AL136984; CAI15170.1; -; Genomic_DNA.
DR   EMBL; AL136984; CAI15171.1; -; Genomic_DNA.
DR   EMBL; AL359962; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451050; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW90786.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90788.1; -; Genomic_DNA.
DR   EMBL; BC001664; AAH01664.1; -; mRNA.
DR   EMBL; BC003571; AAH03571.1; -; mRNA.
DR   EMBL; BC007388; AAH07388.1; -; mRNA.
DR   EMBL; BC052274; AAH52274.1; -; mRNA.
DR   CCDS; CCDS1259.2; -. [P14859-6]
DR   CCDS; CCDS55655.1; -. [P14859-5]
DR   CCDS; CCDS55656.1; -. [P14859-2]
DR   PIR; A47001; A47001.
DR   RefSeq; NP_001185712.1; NM_001198783.1. [P14859-2]
DR   RefSeq; NP_001185715.1; NM_001198786.1. [P14859-5]
DR   RefSeq; NP_002688.3; NM_002697.3. [P14859-6]
DR   RefSeq; XP_011507956.1; XM_011509654.2. [P14859-1]
DR   UniGene; Hs.283402; -.
DR   PDB; 1CQT; X-ray; 3.20 A; A/B=278-439.
DR   PDB; 1E3O; X-ray; 1.90 A; C=280-438.
DR   PDB; 1GT0; X-ray; 2.60 A; C=280-438.
DR   PDB; 1HF0; X-ray; 2.70 A; A/B=280-438.
DR   PDB; 1O4X; NMR; -; A=280-442.
DR   PDB; 1OCT; X-ray; 3.00 A; C=284-439.
DR   PDB; 1POG; NMR; -; A=378-437.
DR   PDB; 1POU; NMR; -; A=284-354.
DR   PDBsum; 1CQT; -.
DR   PDBsum; 1E3O; -.
DR   PDBsum; 1GT0; -.
DR   PDBsum; 1HF0; -.
DR   PDBsum; 1O4X; -.
DR   PDBsum; 1OCT; -.
DR   PDBsum; 1POG; -.
DR   PDBsum; 1POU; -.
DR   DisProt; DP00231; -.
DR   ProteinModelPortal; P14859; -.
DR   SMR; P14859; -.
DR   BioGrid; 111447; 63.
DR   CORUM; P14859; -.
DR   DIP; DIP-226N; -.
DR   IntAct; P14859; 22.
DR   MINT; MINT-149153; -.
DR   STRING; 9606.ENSP00000356840; -.
DR   BindingDB; P14859; -.
DR   ChEMBL; CHEMBL3509601; -.
DR   iPTMnet; P14859; -.
DR   PhosphoSitePlus; P14859; -.
DR   BioMuta; POU2F1; -.
DR   DMDM; 28202257; -.
DR   EPD; P14859; -.
DR   MaxQB; P14859; -.
DR   PaxDb; P14859; -.
DR   PeptideAtlas; P14859; -.
DR   PRIDE; P14859; -.
DR   DNASU; 5451; -.
DR   Ensembl; ENST00000367862; ENSP00000356836; ENSG00000143190. [P14859-2]
DR   Ensembl; ENST00000367866; ENSP00000356840; ENSG00000143190. [P14859-6]
DR   Ensembl; ENST00000429375; ENSP00000401217; ENSG00000143190. [P14859-5]
DR   Ensembl; ENST00000541643; ENSP00000441285; ENSG00000143190. [P14859-1]
DR   GeneID; 5451; -.
DR   KEGG; hsa:5451; -.
DR   UCSC; uc001gec.4; human. [P14859-1]
DR   CTD; 5451; -.
DR   DisGeNET; 5451; -.
DR   EuPathDB; HostDB:ENSG00000143190.21; -.
DR   GeneCards; POU2F1; -.
DR   H-InvDB; HIX0018279; -.
DR   HGNC; HGNC:9212; POU2F1.
DR   HPA; CAB002608; -.
DR   HPA; HPA058559; -.
DR   HPA; HPA064323; -.
DR   MIM; 164175; gene.
DR   neXtProt; NX_P14859; -.
DR   OpenTargets; ENSG00000143190; -.
DR   PharmGKB; PA33536; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000220842; -.
DR   HOVERGEN; HBG057016; -.
DR   InParanoid; P14859; -.
DR   KO; K09364; -.
DR   OMA; LGTSQVM; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; P14859; -.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   SignaLink; P14859; -.
DR   SIGNOR; P14859; -.
DR   ChiTaRS; POU2F1; human.
DR   EvolutionaryTrace; P14859; -.
DR   GeneWiki; POU2F1; -.
DR   GenomeRNAi; 5451; -.
DR   PRO; PR:P14859; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143190; -.
DR   CleanEx; HS_POU2F1; -.
DR   ExpressionAtlas; P14859; baseline and differential.
DR   Genevisible; P14859; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IMP:CAFA.
DR   GO; GO:0003677; F:DNA binding; IDA:CAFA.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IMP:CAFA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000983; F:transcription factor activity, RNA polymerase II core promoter sequence-specific; IMP:CAFA.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IC:CAFA.
DR   GO; GO:0042795; P:snRNA transcription from RNA polymerase II promoter; TAS:Reactome.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR000972; TF_octamer.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00029; OCTAMER.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    743       POU domain, class 2, transcription factor
FT                                1.
FT                                /FTId=PRO_0000100707.
FT   DOMAIN      280    354       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    379    438       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     270    270       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     276    276       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     385    385       Phosphoserine.
FT                                {ECO:0000269|PubMed:1684878}.
FT   MOD_RES     448    448       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     20       MNNPSETSKPSMESGDGNTG -> MKTRMKIFVMIHFHLMN
FT                                S (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_013421.
FT   VAR_SEQ       1      1       M -> MLDCSDYVLDSRM (in isoform 2).
FT                                {ECO:0000303|PubMed:12663137}.
FT                                /FTId=VSP_002320.
FT   VAR_SEQ       1      1       M -> MADGGAASQDESSAAAAAAADSRM (in isoform
FT                                5 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043195.
FT   VAR_SEQ     112    174       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043196.
FT   VAR_SEQ     641    653       ALASGGSLPITSL -> GLLHGLENFLTKN (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_013422.
FT   VAR_SEQ     654    743       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_013423.
FT   VARIANT      88     88       S -> F (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035816.
FT   MUTAGEN     385    385       S->A: Loss of inhibition of DNA binding.
FT                                {ECO:0000269|PubMed:1684878}.
FT   CONFLICT    225    225       L -> Q (in Ref. 1; CAA31767).
FT                                {ECO:0000305}.
FT   CONFLICT    546    546       T -> I (in Ref. 2; AAM77920).
FT                                {ECO:0000305}.
FT   HELIX       285    301       {ECO:0000244|PDB:1E3O}.
FT   HELIX       306    317       {ECO:0000244|PDB:1E3O}.
FT   HELIX       323    331       {ECO:0000244|PDB:1E3O}.
FT   HELIX       336    353       {ECO:0000244|PDB:1E3O}.
FT   HELIX       388    400       {ECO:0000244|PDB:1E3O}.
FT   HELIX       406    416       {ECO:0000244|PDB:1E3O}.
FT   HELIX       420    434       {ECO:0000244|PDB:1E3O}.
SQ   SEQUENCE   743 AA;  76472 MW;  FAB27FFC79CF2276 CRC64;
     MNNPSETSKP SMESGDGNTG TQTNGLDFQK QPVPVGGAIS TAQAQAFLGH LHQVQLAGTS
     LQAAAQSLNV QSKSNEESGD SQQPSQPSQQ PSVQAAIPQT QLMLAGGQIT GLTLTPAQQQ
     LLLQQAQAQA QLLAAAVQQH SASQQHSAAG ATISASAATP MTQIPLSQPI QIAQDLQQLQ
     QLQQQNLNLQ QFVLVHPTTN LQPAQFIISQ TPQGQQGLLQ AQNLLTQLPQ QSQANLLQSQ
     PSITLTSQPA TPTRTIAATP IQTLPQSQST PKRIDTPSLE EPSDLEELEQ FAKTFKQRRI
     KLGFTQGDVG LAMGKLYGND FSQTTISRFE ALNLSFKNMC KLKPLLEKWL NDAENLSSDS
     SLSSPSALNS PGIEGLSRRR KKRTSIETNI RVALEKSFLE NQKPTSEEIT MIADQLNMEK
     EVIRVWFCNR RQKEKRINPP SSGGTSSSPI KAIFPSPTSL VATTPSLVTS SAATTLTVSP
     VLPLTSAAVT NLSVTGTSDT TSNNTATVIS TAPPASSAVT SPSLSPSPSA SASTSEASSA
     SETSTTQTTS TPLSSPLGTS QVMVTASGLQ TAAAAALQGA AQLPANASLA AMAAAAGLNP
     SLMAPSQFAA GGALLSLNPG TLSGALSPAL MSNSTLATIQ ALASGGSLPI TSLDATGNLV
     FANAGGAPNI VTAPLFLNPQ NLSLLTSNPV SLVSAAAASA GNSAPVASLH ATSTSAESIQ
     NSLFTVASAS GAASTTTTAS KAQ
//
ID   PO6F2_HUMAN             Reviewed;         691 AA.
AC   P78424; A4D1W2; C4AMB9; P78425; Q75ME8; Q86UM6; Q9UDS7;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 3.
DT   25-OCT-2017, entry version 159.
DE   RecName: Full=POU domain, class 6, transcription factor 2;
DE   AltName: Full=Retina-derived POU domain factor 1;
DE            Short=RPF-1;
GN   Name=POU6F2; Synonyms=RPF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=8601806;
RA   Zhou H., Yoshioka T., Nathans J.;
RT   "Retina-derived POU-domain factor-1: a complex POU-domain gene
RT   implicated in the development of retinal ganglion and amacrine
RT   cells.";
RL   J. Neurosci. 16:2261-2274(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   VARIANT WT5 HIS-192.
RX   PubMed=11284034; DOI=10.1002/gcc.1116;
RA   Perotti D., Testi M.A., Mondini P., Pilotti S., Green E.D.,
RA   Pession A., Sozzi G., Pierotti M.A., Fossati-Bellani F., Radice P.;
RT   "Refinement within single yeast artificial chromosome clones of a
RT   minimal region commonly deleted on the short arm of chromosome 7 in
RT   Wilms tumours.";
RL   Genes Chromosomes Cancer 31:42-47(2001).
CC   -!- FUNCTION: Probable transcription factor likely to be involved in
CC       early steps in the differentiation of amacrine and ganglion cells.
CC       Recognizes and binds to the DNA sequence 5'-ATGCAAAT-3'. Isoform 1
CC       does not bind DNA.
CC   -!- INTERACTION:
CC       Q9NXR5-2:ANKRD10; NbExp=4; IntAct=EBI-12029004, EBI-12102070;
CC       Q9UI47-2:CTNNA3; NbExp=4; IntAct=EBI-12029004, EBI-11962928;
CC       Q9UH73:EBF1; NbExp=4; IntAct=EBI-12029004, EBI-765426;
CC       O00303:EIF3F; NbExp=4; IntAct=EBI-12029004, EBI-711990;
CC       Q14192:FHL2; NbExp=4; IntAct=EBI-12029004, EBI-701903;
CC       P34932:HSPA4; NbExp=4; IntAct=EBI-12029004, EBI-356933;
CC       Q2M1V0:ISX; NbExp=4; IntAct=EBI-12029004, EBI-6426064;
CC       O14841:OPLAH; NbExp=4; IntAct=EBI-12029004, EBI-3938544;
CC       P14859-6:POU2F1; NbExp=4; IntAct=EBI-12029004, EBI-11526590;
CC       Q9NVV9:THAP1; NbExp=4; IntAct=EBI-12029004, EBI-741515;
CC       Q86UV6-2:TRIM74; NbExp=4; IntAct=EBI-12029004, EBI-10259086;
CC       Q14119:VEZF1; NbExp=4; IntAct=EBI-12029004, EBI-11980193;
CC       Q9Y2B5:VPS9D1; NbExp=4; IntAct=EBI-12029004, EBI-9031083;
CC       A0A0C4DFM2:ZNF574; NbExp=4; IntAct=EBI-12029004, EBI-11993338;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78424-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2;
CC         IsoId=P78424-2; Sequence=VSP_002336;
CC   -!- TISSUE SPECIFICITY: Expressed only within the CNS, where its
CC       expression is restricted to the medical habenulla, to a dispersed
CC       population of neurons in the dorsal hypothalamus, and to subsets
CC       of ganglion and amacrine cells in the retina.
CC       {ECO:0000269|PubMed:8601806}.
CC   -!- DISEASE: Hereditary susceptibility to Wilms tumor 5 (WT5)
CC       [MIM:601583]: Pediatric malignancy of kidney and one of the most
CC       common solid cancers in childhood. {ECO:0000269|PubMed:11284034}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       6 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB49727.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAB49728.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAS07475.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=EAL23992.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/POU6F2ID42963ch7p14.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U91934; AAB49727.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U91935; AAB49728.1; ALT_INIT; mRNA.
DR   EMBL; AC005483; AAC83404.2; -; Genomic_DNA.
DR   EMBL; AC073345; AAS07475.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC092174; AAP21873.1; -; Genomic_DNA.
DR   EMBL; AC011292; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236951; EAL23992.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS34620.2; -. [P78424-1]
DR   CCDS; CCDS55103.1; -. [P78424-2]
DR   RefSeq; NP_001159490.1; NM_001166018.1. [P78424-2]
DR   RefSeq; NP_009183.3; NM_007252.3. [P78424-1]
DR   UniGene; Hs.137106; -.
DR   ProteinModelPortal; P78424; -.
DR   SMR; P78424; -.
DR   IntAct; P78424; 139.
DR   STRING; 9606.ENSP00000384004; -.
DR   iPTMnet; P78424; -.
DR   PhosphoSitePlus; P78424; -.
DR   BioMuta; POU6F2; -.
DR   DMDM; 327478564; -.
DR   PaxDb; P78424; -.
DR   PeptideAtlas; P78424; -.
DR   PRIDE; P78424; -.
DR   DNASU; 11281; -.
DR   Ensembl; ENST00000403058; ENSP00000384004; ENSG00000106536. [P78424-1]
DR   Ensembl; ENST00000518318; ENSP00000430514; ENSG00000106536. [P78424-2]
DR   GeneID; 11281; -.
DR   KEGG; hsa:11281; -.
DR   UCSC; uc003thb.3; human. [P78424-1]
DR   CTD; 11281; -.
DR   DisGeNET; 11281; -.
DR   EuPathDB; HostDB:ENSG00000106536.19; -.
DR   GeneCards; POU6F2; -.
DR   HGNC; HGNC:21694; POU6F2.
DR   HPA; HPA008699; -.
DR   MalaCards; POU6F2; -.
DR   MIM; 601583; phenotype.
DR   MIM; 609062; gene.
DR   neXtProt; NX_P78424; -.
DR   OpenTargets; ENSG00000106536; -.
DR   Orphanet; 654; Nephroblastoma.
DR   PharmGKB; PA134969420; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00900000141015; -.
DR   HOVERGEN; HBG008230; -.
DR   InParanoid; P78424; -.
DR   KO; K09368; -.
DR   OMA; GTPDQHQ; -.
DR   OrthoDB; EOG091G04YJ; -.
DR   PhylomeDB; P78424; -.
DR   TreeFam; TF350705; -.
DR   ChiTaRS; POU6F2; human.
DR   GenomeRNAi; 11281; -.
DR   PRO; PR:P78424; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106536; -.
DR   CleanEx; HS_POU6F2; -.
DR   ExpressionAtlas; P78424; baseline and differential.
DR   Genevisible; P78424; HS.
DR   GO; GO:0005634; C:nucleus; IC:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0007402; P:ganglion mother cell fate determination; TAS:ProtInc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR033056; POU6F2.
DR   InterPro; IPR000327; POU_dom.
DR   PANTHER; PTHR11636:SF68; PTHR11636:SF68; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 2.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    691       POU domain, class 6, transcription factor
FT                                2.
FT                                /FTId=PRO_0000100762.
FT   DOMAIN      476    586       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    607    666       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    167    446       Gln-rich.
FT   COMPBIAS    197    293       Pro-rich.
FT   COMPBIAS    435    461       Ser-rich.
FT   VAR_SEQ     524    559       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8601806}.
FT                                /FTId=VSP_002336.
FT   VARIANT     192    192       Q -> H (in WT5).
FT                                {ECO:0000269|PubMed:11284034}.
FT                                /FTId=VAR_022419.
FT   VARIANT     199    199       P -> L (in dbSNP:rs2074936).
FT                                /FTId=VAR_028410.
FT   VARIANT     500    500       L -> M (in dbSNP:rs4992268).
FT                                /FTId=VAR_028411.
FT   VARIANT     639    639       E -> K (in dbSNP:rs7804851).
FT                                /FTId=VAR_028412.
FT   CONFLICT    196    196       Q -> QQ (in Ref. 1; AAB49727/AAB49728).
FT                                {ECO:0000305}.
FT   CONFLICT    258    258       Q -> H (in Ref. 1; AAB49727/AAB49728).
FT                                {ECO:0000305}.
SQ   SEQUENCE   691 AA;  73265 MW;  3460C858ECBB5535 CRC64;
     MSALLQDPMI AGQVSKPLLS VRSEMNAELR GEDKAATSDS ELNEPLLAPV ESNDSEDTPS
     KLFGARGNPA LSDPGTPDQH QASQTHPPFP VGPQPLLTAQ QLASAVAGVM PGGPPALNQP
     ILIPFNMAGQ LGGQQGLVLT LPTANLTNIQ GLVAAAAAGG IMTLPLQNLQ ATSSLNSQLQ
     QLQLQLQQQQ QQQQQQPPPS TNQHPQPAPQ APSQSQQQPL QPTPPQQPPP ASQQPPAPTS
     QLQQAPQPQQ HQPHSHSQNQ NQPSPTQQSS SPPQKPSQSP GHGLPSPLTP PNPLQLVNNP
     LASQAAAAAA AMSSIASSQA FGNALSSLQG VTGQLVTNAQ GQIIGTIPLM PNPGPSSQAA
     SGTQGLQVQP ITPQLLTNAQ GQIIATVIGN QILPVINTQG ITLSPIKPGQ QLHQPSQTSV
     GQAASQGNLL HLAHSQASMS QSPVRQASSS SSSSSSSSAL SVGQLVSNPQ TAAGEVDGVN
     LEEIREFAKA FKIRRLSLGL TQTQVGQALS ATEGPAYSQS AICRHTILRS HFFLPQEAQE
     NTIASSLTAK LNPGLLYPAR FEKLDITPKS AQKIKPVLER WMAEAEARHR AGMQNLTEFI
     GSEPSKKRKR RTSFTPQALE ILNAHFEKNT HPSGQEMTEI AEKLNYDREV VRVWFCNKRQ
     ALKNTIKRLK QHEPATAVPL EPLTDSLEEN S
//
ID   PHX2A_HUMAN             Reviewed;         284 AA.
AC   O14813; A8K3N0; Q8IVZ2;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   25-OCT-2017, entry version 166.
DE   RecName: Full=Paired mesoderm homeobox protein 2A;
DE   AltName: Full=ARIX1 homeodomain protein;
DE   AltName: Full=Aristaless homeobox protein homolog;
DE   AltName: Full=Paired-like homeobox 2A;
GN   Name=PHOX2A; Synonyms=ARIX, PMX2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8661014; DOI=10.1006/geno.1996.0230;
RA   Johnson K.R., Smith L., Johnson D.K., Rhodes J., Rinchik E.M.,
RA   Thayer M., Lewis E.J.;
RT   "Mapping of the ARIX homeodomain gene to mouse chromosome 7 and human
RT   chromosome 11q13.";
RL   Genomics 33:527-531(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT CFEOM2 VAL-72.
RX   PubMed=11600883; DOI=10.1038/ng744;
RA   Nakano M., Yamada K., Fain J., Sener E.C., Selleck C.J., Awad A.H.,
RA   Zwaan J., Mullaney P.B., Bosley T.M., Engle E.C.;
RT   "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of
RT   the extraocular muscles type 2.";
RL   Nat. Genet. 29:315-320(2001).
RN   [6]
RP   VARIANT GLN-256.
RX   PubMed=14566559; DOI=10.1007/s00439-003-1036-z;
RA   Sasaki A., Kanai M., Kijima K., Akaba K., Hashimoto M., Hasegawa H.,
RA   Otaki S., Koizumi T., Kusuda S., Ogawa Y., Tuchiya K., Yamamoto W.,
RA   Nakamura T., Hayasaka K.;
RT   "Molecular analysis of congenital central hypoventilation syndrome.";
RL   Hum. Genet. 114:22-26(2003).
CC   -!- FUNCTION: May be involved in regulating the specificity of
CC       expression of the catecholamine biosynthetic genes. Acts as a
CC       transcription activator/factor. Could maintain the noradrenergic
CC       phenotype.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- DISEASE: Fibrosis of extraocular muscles, congenital, 2 (CFEOM2)
CC       [MIM:602078]: A congenital ocular motility disorder marked by
CC       restrictive ophthalmoplegia affecting extraocular muscles
CC       innervated by the oculomotor and/or trochlear nerves. It is
CC       clinically characterized by anchoring of the eyes in downward
CC       gaze, ptosis, and backward tilt of the head. Congenital fibrosis
CC       of extraocular muscles type 2 may result from the defective
CC       development of the oculomotor (nIII), trochlear (nIV) and abducens
CC       (nVI) cranial nerve nuclei. {ECO:0000269|PubMed:11600883}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF022724; AAB82744.1; -; Genomic_DNA.
DR   EMBL; AF022722; AAB82744.1; JOINED; Genomic_DNA.
DR   EMBL; AF022723; AAB82744.1; JOINED; Genomic_DNA.
DR   EMBL; AK290645; BAF83334.1; -; mRNA.
DR   EMBL; CH471076; EAW74856.1; -; Genomic_DNA.
DR   EMBL; BC041564; AAH41564.1; -; mRNA.
DR   CCDS; CCDS8214.1; -.
DR   RefSeq; NP_005160.2; NM_005169.3.
DR   UniGene; Hs.731115; -.
DR   ProteinModelPortal; O14813; -.
DR   SMR; O14813; -.
DR   BioGrid; 106894; 6.
DR   STRING; 9606.ENSP00000298231; -.
DR   iPTMnet; O14813; -.
DR   PhosphoSitePlus; O14813; -.
DR   BioMuta; PHOX2A; -.
DR   EPD; O14813; -.
DR   PaxDb; O14813; -.
DR   PeptideAtlas; O14813; -.
DR   PRIDE; O14813; -.
DR   DNASU; 401; -.
DR   Ensembl; ENST00000298231; ENSP00000298231; ENSG00000165462.
DR   GeneID; 401; -.
DR   KEGG; hsa:401; -.
DR   UCSC; uc001osh.4; human.
DR   CTD; 401; -.
DR   DisGeNET; 401; -.
DR   EuPathDB; HostDB:ENSG00000165462.5; -.
DR   GeneCards; PHOX2A; -.
DR   GeneReviews; PHOX2A; -.
DR   HGNC; HGNC:691; PHOX2A.
DR   HPA; HPA065621; -.
DR   MalaCards; PHOX2A; -.
DR   MIM; 602078; phenotype.
DR   MIM; 602753; gene.
DR   neXtProt; NX_O14813; -.
DR   OpenTargets; ENSG00000165462; -.
DR   Orphanet; 45358; Congenital fibrosis of extraocular muscles.
DR   PharmGKB; PA28093; -.
DR   eggNOG; KOG0484; Eukaryota.
DR   eggNOG; ENOG4111QRU; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000013060; -.
DR   HOVERGEN; HBG053590; -.
DR   InParanoid; O14813; -.
DR   KO; K09330; -.
DR   OMA; VPYKFFS; -.
DR   OrthoDB; EOG091G0YX9; -.
DR   PhylomeDB; O14813; -.
DR   TreeFam; TF351612; -.
DR   SignaLink; O14813; -.
DR   SIGNOR; O14813; -.
DR   GeneWiki; PHOX2A; -.
DR   GenomeRNAi; 401; -.
DR   PRO; PR:O14813; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000165462; -.
DR   CleanEx; HS_PHOX2A; -.
DR   ExpressionAtlas; O14813; baseline and differential.
DR   Genevisible; O14813; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; IC:BHF-UCL.
DR   GO; GO:0021703; P:locus ceruleus development; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0003357; P:noradrenergic neuron differentiation; NAS:BHF-UCL.
DR   GO; GO:0021623; P:oculomotor nerve formation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; IEA:Ensembl.
DR   GO; GO:0021523; P:somatic motor neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048485; P:sympathetic nervous system development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0021642; P:trochlear nerve formation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    284       Paired mesoderm homeobox protein 2A.
FT                                /FTId=PRO_0000049259.
FT   DNA_BIND     90    149       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    193    198       Poly-Pro.
FT   COMPBIAS    237    246       Poly-Gly.
FT   VARIANT      72     72       A -> V (in CFEOM2; dbSNP:rs104894269).
FT                                {ECO:0000269|PubMed:11600883}.
FT                                /FTId=VAR_019014.
FT   VARIANT     256    256       P -> Q (may be involved in congenital
FT                                central hypoventilation syndrome).
FT                                {ECO:0000269|PubMed:14566559}.
FT                                /FTId=VAR_019016.
FT   CONFLICT     76     76       K -> N (in Ref. 1; AAB82744).
FT                                {ECO:0000305}.
SQ   SEQUENCE   284 AA;  29653 MW;  F123D5695FB45A99 CRC64;
     MDYSYLNSYD SCVAAMEASA YGDFGACSQP GGFQYSPLRP AFPAAGPPCP ALGSSNCALG
     ALRDHQPAPY SAVPYKFFPE PSGLHEKRKQ RRIRTTFTSA QLKELERVFA ETHYPDIYTR
     EELALKIDLT EARVQVWFQN RRAKFRKQER AASAKGAAGA AGAKKGEARC SSEDDDSKES
     TCSPTPDSTA SLPPPPAPGL ASPRLSPSPL PVALGSGPGP GPGPQPLKGA LWAGVAGGGG
     GGPGAGAAEL LKAWQPAESG PGPFSGVLSS FHRKPGPALK TNLF
//
ID   PITX3_HUMAN             Reviewed;         302 AA.
AC   O75364; Q5VZL2;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   25-OCT-2017, entry version 158.
DE   RecName: Full=Pituitary homeobox 3;
DE   AltName: Full=Homeobox protein PITX3;
DE   AltName: Full=Paired-like homeodomain transcription factor 3;
GN   Name=PITX3; Synonyms=PTX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT CTRCT11 ASN-13, AND INVOLVEMENT IN
RP   ASGD1.
RC   TISSUE=Craniofacial;
RX   PubMed=9620774; DOI=10.1038/527;
RA   Semina E.V., Ferrell R.E., Mintz-Hittner H.A., Bitoun P.,
RA   Alward W.L.M., Reiter R.S., Funkhauser C., Daack-Hirsch S.,
RA   Murray J.C.;
RT   "A novel homeobox gene PITX3 is mutated in families with autosomal-
RT   dominant cataracts and ASMD.";
RL   Nat. Genet. 19:167-170(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INVOLVEMENT IN CTRCT11.
RX   PubMed=15286169; DOI=10.1136/jmg.2004.020289;
RA   Berry V., Yang Z., Addison P.K., Francis P.J., Ionides A., Karan G.,
RA   Jiang L., Lin W., Hu J., Yang R., Moore A., Zhang K.,
RA   Bhattacharya S.S.;
RT   "Recurrent 17 bp duplication in PITX3 is primarily associated with
RT   posterior polar cataract (CPP4).";
RL   J. Med. Genet. 41:E109-E109(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Transcriptional regulator which is important for the
CC       differentiation and maintenance of meso-diencephalic dopaminergic
CC       (mdDA) neurons during development. In addition to its importance
CC       during development, it also has roles in the long-term survival
CC       and maintenance of the mdDA neurons. Activates NR4A2/NURR1-
CC       mediated transcription of genes such as SLC6A3, SLC18A2, TH and
CC       DRD2 which are essential for development of mdDA neurons. Acts by
CC       decreasing the interaction of NR4A2/NURR1 with the corepressor
CC       NCOR2/SMRT which acts through histone deacetylases (HDACs) to keep
CC       promoters of NR4A2/NURR1 target genes in a repressed deacetylated
CC       state. Essential for the normal lens development and
CC       differentiation. Plays a critical role in the maintenance of
CC       mitotic activity of lens epithelial cells, fiber cell
CC       differentiation and in the control of the temporal and spatial
CC       activation of fiber cell-specific crystallins. Positively
CC       regulates FOXE3 expression and negatively regulates PROX1 in the
CC       anterior lens epithelium, preventing activation of CDKN1B/P27Kip1
CC       and CDKN1C/P57Kip2 and thus maintains lens epithelial cells in
CC       cell cycle (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with SFPQ. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in developing eye lens.
CC   -!- DISEASE: Anterior segment dysgenesis 1 (ASGD1) [MIM:107250]: A
CC       form of anterior segment dysgenesis, a group of defects affecting
CC       anterior structures of the eye including cornea, iris, lens,
CC       trabecular meshwork, and Schlemm canal. Anterior segment
CC       dysgeneses result from abnormal migration or differentiation of
CC       the neural crest derived mesenchymal cells that give rise to
CC       components of the anterior chamber during eye development.
CC       Different anterior segment anomalies may exist alone or in
CC       combination, including iris hypoplasia, enlarged or reduced
CC       corneal diameter, corneal vascularization and opacity, posterior
CC       embryotoxon, corectopia, polycoria, abnormal iridocorneal angle,
CC       ectopia lentis, and anterior synechiae between the iris and
CC       posterior corneal surface. Clinical conditions falling within the
CC       phenotypic spectrum of anterior segment dysgeneses include
CC       aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters
CC       anomaly, and iridogoniodysgenesis. {ECO:0000269|PubMed:9620774}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Cataract 11, multiple types (CTRCT11) [MIM:610623]: An
CC       opacification of the crystalline lens of the eye that frequently
CC       results in visual impairment or blindness. Opacities vary in
CC       morphology, are often confined to a portion of the lens, and may
CC       be static or progressive. CTRCT11 includes posterior polar
CC       cataract, among others. Posterior polar cataract is a subcapsular
CC       opacity, usually disk-shaped, located at the back of the lens.
CC       Some CTRCT11 patients can present a severe phenotype including
CC       microphthalmia and neurological dysfunction.
CC       {ECO:0000269|PubMed:15286169, ECO:0000269|PubMed:9620774}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF041339; AAC24502.1; -; mRNA.
DR   EMBL; AL160011; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011642; AAH11642.1; -; mRNA.
DR   CCDS; CCDS7532.1; -.
DR   RefSeq; NP_005020.1; NM_005029.3.
DR   UniGene; Hs.137568; -.
DR   ProteinModelPortal; O75364; -.
DR   SMR; O75364; -.
DR   BioGrid; 111326; 4.
DR   STRING; 9606.ENSP00000359019; -.
DR   iPTMnet; O75364; -.
DR   PhosphoSitePlus; O75364; -.
DR   BioMuta; PITX3; -.
DR   MaxQB; O75364; -.
DR   PaxDb; O75364; -.
DR   PeptideAtlas; O75364; -.
DR   PRIDE; O75364; -.
DR   DNASU; 5309; -.
DR   Ensembl; ENST00000370002; ENSP00000359019; ENSG00000107859.
DR   Ensembl; ENST00000539804; ENSP00000439383; ENSG00000107859.
DR   GeneID; 5309; -.
DR   KEGG; hsa:5309; -.
DR   UCSC; uc001kuu.2; human.
DR   CTD; 5309; -.
DR   DisGeNET; 5309; -.
DR   EuPathDB; HostDB:ENSG00000107859.9; -.
DR   GeneCards; PITX3; -.
DR   GeneReviews; PITX3; -.
DR   HGNC; HGNC:9006; PITX3.
DR   MalaCards; PITX3; -.
DR   MIM; 107250; phenotype.
DR   MIM; 602669; gene.
DR   MIM; 610623; phenotype.
DR   neXtProt; NX_O75364; -.
DR   OpenTargets; ENSG00000107859; -.
DR   Orphanet; 162; Cataract-glaucoma.
DR   Orphanet; 88632; Familial ocular anterior segment mesenchymal dysgenesis.
DR   Orphanet; 98993; Posterior polar cataract.
DR   PharmGKB; PA33340; -.
DR   eggNOG; KOG0486; Eukaryota.
DR   eggNOG; ENOG410ZZ6J; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000273886; -.
DR   HOVERGEN; HBG068770; -.
DR   InParanoid; O75364; -.
DR   KO; K09357; -.
DR   OMA; LCKGGFA; -.
DR   OrthoDB; EOG091G0H7U; -.
DR   PhylomeDB; O75364; -.
DR   TreeFam; TF351940; -.
DR   SIGNOR; O75364; -.
DR   GeneWiki; PITX3; -.
DR   GenomeRNAi; 5309; -.
DR   PRO; PR:O75364; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107859; -.
DR   CleanEx; HS_PITX3; -.
DR   CleanEx; HS_PTX3; -.
DR   Genevisible; O75364; HS.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:1990792; P:cellular response to glial cell derived neurotrophic factor; IEA:Ensembl.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0002088; P:lens development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; ISS:UniProtKB.
DR   GO; GO:0014014; P:negative regulation of gliogenesis; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:1904935; P:positive regulation of cell proliferation in midbrain; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:1904313; P:response to methamphetamine hydrochloride; IEA:Ensembl.
DR   GO; GO:0043278; P:response to morphine; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016233; Homeobox_Pitx/unc30.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   PIRSF; PIRSF000563; Homeobox_protein_Pitx/Unc30; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Activator; Cataract; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    302       Pituitary homeobox 3.
FT                                /FTId=PRO_0000049229.
FT   DNA_BIND     62    121       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       262    275       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOTIF       268    272       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    240    250       Poly-Ala.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P81062}.
FT   MOD_RES      57     57       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P81062}.
FT   VARIANT      13     13       S -> N (in CTRCT11; dbSNP:rs104894175).
FT                                {ECO:0000269|PubMed:9620774}.
FT                                /FTId=VAR_003767.
SQ   SEQUENCE   302 AA;  31832 MW;  1E5259206ABC2E87 CRC64;
     MEFGLLSEAE ARSPALSLSD AGTPHPQLPE HGCKGQEHSD SEKASASLPG GSPEDGSLKK
     KQRRQRTHFT SQQLQELEAT FQRNRYPDMS TREEIAVWTN LTEARVRVWF KNRRAKWRKR
     ERSQQAELCK GSFAAPLGGL VPPYEEVYPG YSYGNWPPKA LAPPLAAKTF PFAFNSVNVG
     PLASQPVFSP PSSIAASMVP SAAAAPGTVP GPGALQGLGG GPPGLAPAAV SSGAVSCPYA
     SAAAAAAAAA SSPYVYRDPC NSSLASLRLK AKQHASFSYP AVHGPPPAAN LSPCQYAVER
     PV
//
ID   PHX2B_HUMAN             Reviewed;         314 AA.
AC   Q99453; Q6PJD9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   25-OCT-2017, entry version 163.
DE   RecName: Full=Paired mesoderm homeobox protein 2B;
DE   AltName: Full=Neuroblastoma Phox;
DE            Short=NBPhox;
DE   AltName: Full=PHOX2B homeodomain protein;
DE   AltName: Full=Paired-like homeobox 2B;
GN   Name=PHOX2B; Synonyms=PMX2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Neuroblastoma;
RX   PubMed=9039501; DOI=10.1093/dnares/3.5.311;
RA   Yokoyama M., Nishi Y., Yoshii J., Okubo K., Matsubara K.;
RT   "Identification and cloning of neuroblastoma-specific and nerve
RT   tissue-specific genes through compiled expression profiles.";
RL   DNA Res. 3:311-320(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11034547; DOI=10.1089/104454900439773;
RA   Adachi M., Browne D., Lewis E.J.;
RT   "Paired-like homeodomain proteins Phox2a/Arix and Phox2b/NBPhox have
RT   similar genetic organization and independently regulate dopamine beta-
RT   hydroxylase gene transcription.";
RL   DNA Cell Biol. 19:539-554(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10395798; DOI=10.1006/geno.1999.5845;
RA   Yokoyama M., Watanabe H., Nakamura M.;
RT   "Genomic structure and functional characterization of NBPhox (PMX2B),
RT   a homeodomain protein specific to catecholaminergic cells that is
RT   involved in second messenger-mediated transcriptional activation.";
RL   Genomics 59:40-50(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT CCHS ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-241 INS, AND
RP   VARIANTS 254-ALA--ALA-258 DEL AND 255-ALA--ALA-259 DEL.
RX   PubMed=14566559; DOI=10.1007/s00439-003-1036-z;
RA   Sasaki A., Kanai M., Kijima K., Akaba K., Hashimoto M., Hasegawa H.,
RA   Otaki S., Koizumi T., Kusuda S., Ogawa Y., Tuchiya K., Yamamoto W.,
RA   Nakamura T., Hayasaka K.;
RT   "Molecular analysis of congenital central hypoventilation syndrome.";
RL   Hum. Genet. 114:22-26(2003).
RN   [6]
RP   INVOLVEMENT IN CCHS, AND TRIPLET REPEAT EXPANSION.
RX   PubMed=12640453; DOI=10.1038/ng1130;
RA   Amiel J., Laudier B., Attie-Bitach T., Trang H., de Pontual L.,
RA   Gener B., Trochet D., Etchevers H., Ray P., Simonneau M., Vekemans M.,
RA   Munnich A., Gaultier C., Lyonnet S.;
RT   "Polyalanine expansion and frameshift mutations of the paired-like
RT   homeobox gene PHOX2B in congenital central hypoventilation syndrome.";
RL   Nat. Genet. 33:459-461(2003).
RN   [7]
RP   VARIANTS LEU-100 AND GLY-141, AND POSSIBLE INVOLVEMENT IN NBLST2.
RX   PubMed=15024693; DOI=10.1086/383253;
RA   Trochet D., Bourdeaut F., Janoueix-Lerosey I., Deville A.,
RA   de Pontual L., Schleiermacher G., Coze C., Philip N., Frebourg T.,
RA   Munnich A., Lyonnet S., Delattre O., Amiel J.;
RT   "Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in
RT   neuroblastoma.";
RL   Am. J. Hum. Genet. 74:761-764(2004).
RN   [8]
RP   VARIANTS CCHS GLN-141 AND ARG-143, AND TRIPLET REPEAT EXPANSION.
RX   PubMed=15657873; DOI=10.1086/428366;
RA   Trochet D., O'Brien L.M., Gozal D., Trang H., Nordenskjoeld A.,
RA   Laudier B., Svensson P.-J., Uhrig S., Cole T., Niemann S., Munnich A.,
RA   Gaultier C., Lyonnet S., Amiel J.;
RT   "PHOX2B genotype allows for prediction of tumor risk in congenital
RT   central hypoventilation syndrome.";
RL   Am. J. Hum. Genet. 76:421-426(2005).
RN   [9]
RP   ERRATUM.
RA   Trochet D., O'Brien L.M., Gozal D., Trang H., Nordenskjoeld A.,
RA   Laudier B., Svensson P.-J., Uhrig S., Cole T., Niemann S., Munnich A.,
RA   Gaultier C., Lyonnet S., Amiel J.;
RL   Am. J. Hum. Genet. 76:715-715(2002).
RN   [10]
RP   VARIANT ASP-197, AND NEUROBLASTOMA SUSCEPTIBILITY.
RX   PubMed=16691592; DOI=10.1002/ajmg.a.31278;
RA   McConville C., Reid S., Baskcomb L., Douglas J., Rahman N.;
RT   "PHOX2B analysis in non-syndromic neuroblastoma cases shows novel
RT   mutations and genotype-phenotype associations.";
RL   Am. J. Med. Genet. A 140:1297-1301(2006).
CC   -!- FUNCTION: Involved in the development of several major
CC       noradrenergic neuron populations, including the locus coeruleus.
CC       Transcription factor which could determine a neurotransmitter
CC       phenotype in vertebrates. Enhances second-messenger-mediated
CC       activation of the dopamine beta-hydrolase and c-fos promoters, and
CC       of several enhancers including cAMP-response element and serum-
CC       response element.
CC   -!- SUBUNIT: Interacts with TRIM11. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Expressed in neuroblastoma, brain and adrenal
CC       gland.
CC   -!- DISEASE: Congenital central hypoventilation syndrome (CCHS)
CC       [MIM:209880]: Rare disorder characterized by abnormal control of
CC       respiration in the absence of neuromuscular or lung disease, or an
CC       identifiable brain stem lesion. A deficiency in autonomic control
CC       of respiration results in inadequate or negligible ventilatory and
CC       arousal responses to hypercapnia and hypoxemia.
CC       {ECO:0000269|PubMed:12640453, ECO:0000269|PubMed:14566559,
CC       ECO:0000269|PubMed:15657873}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Neuroblastoma 2 (NBLST2) [MIM:613013]: A common neoplasm
CC       of early childhood arising from embryonic cells that form the
CC       primitive neural crest and give rise to the adrenal medulla and
CC       the sympathetic nervous system. {ECO:0000305|PubMed:15024693}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D82344; BAA11555.1; -; mRNA.
DR   EMBL; AF117979; AAD26698.1; -; Genomic_DNA.
DR   EMBL; AB015671; BAA82670.1; -; Genomic_DNA.
DR   EMBL; BC017199; AAH17199.1; -; mRNA.
DR   CCDS; CCDS3463.1; -.
DR   PIR; JC5273; JC5273.
DR   RefSeq; NP_003915.2; NM_003924.3.
DR   UniGene; Hs.87202; -.
DR   ProteinModelPortal; Q99453; -.
DR   SMR; Q99453; -.
DR   BioGrid; 114443; 1.
DR   STRING; 9606.ENSP00000226382; -.
DR   iPTMnet; Q99453; -.
DR   PhosphoSitePlus; Q99453; -.
DR   BioMuta; PHOX2B; -.
DR   DMDM; 116242712; -.
DR   MaxQB; Q99453; -.
DR   PaxDb; Q99453; -.
DR   PeptideAtlas; Q99453; -.
DR   PRIDE; Q99453; -.
DR   Ensembl; ENST00000226382; ENSP00000226382; ENSG00000109132.
DR   GeneID; 8929; -.
DR   KEGG; hsa:8929; -.
DR   UCSC; uc003gwf.4; human.
DR   CTD; 8929; -.
DR   DisGeNET; 8929; -.
DR   EuPathDB; HostDB:ENSG00000109132.6; -.
DR   GeneCards; PHOX2B; -.
DR   GeneReviews; PHOX2B; -.
DR   H-InvDB; HIX0120072; -.
DR   HGNC; HGNC:9143; PHOX2B.
DR   HPA; HPA074325; -.
DR   MalaCards; PHOX2B; -.
DR   MIM; 209880; phenotype.
DR   MIM; 603851; gene.
DR   MIM; 613013; phenotype.
DR   neXtProt; NX_Q99453; -.
DR   OpenTargets; ENSG00000109132; -.
DR   Orphanet; 99803; Haddad syndrome.
DR   Orphanet; 635; Neuroblastoma.
DR   Orphanet; 661; Ondine syndrome.
DR   PharmGKB; PA33467; -.
DR   eggNOG; KOG0484; Eukaryota.
DR   eggNOG; ENOG4111YNP; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000013060; -.
DR   HOVERGEN; HBG094678; -.
DR   InParanoid; Q99453; -.
DR   KO; K09330; -.
DR   OMA; QGWASAP; -.
DR   OrthoDB; EOG091G0YX9; -.
DR   PhylomeDB; Q99453; -.
DR   TreeFam; TF351612; -.
DR   SignaLink; Q99453; -.
DR   SIGNOR; Q99453; -.
DR   GeneWiki; PHOX2B; -.
DR   GenomeRNAi; 8929; -.
DR   PRO; PR:Q99453; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109132; -.
DR   CleanEx; HS_PHOX2B; -.
DR   Genevisible; Q99453; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0048483; P:autonomic nervous system development; IMP:BHF-UCL.
DR   GO; GO:0003360; P:brainstem development; IEP:BHF-UCL.
DR   GO; GO:0021533; P:cell differentiation in hindbrain; ISS:BHF-UCL.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISS:BHF-UCL.
DR   GO; GO:0048894; P:efferent axon development in a lateral line nerve; ISS:BHF-UCL.
DR   GO; GO:0048484; P:enteric nervous system development; IEP:BHF-UCL.
DR   GO; GO:0010001; P:glial cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0021934; P:hindbrain tangential cell migration; ISS:BHF-UCL.
DR   GO; GO:0048839; P:inner ear development; ISS:BHF-UCL.
DR   GO; GO:0021723; P:medullary reticular formation development; ISS:BHF-UCL.
DR   GO; GO:0071157; P:negative regulation of cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:1901166; P:neural crest cell migration involved in autonomic nervous system development; ISS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; ISS:BHF-UCL.
DR   GO; GO:0003358; P:noradrenergic neuron development; ISS:UniProtKB.
DR   GO; GO:0003357; P:noradrenergic neuron differentiation; ISS:BHF-UCL.
DR   GO; GO:0048486; P:parasympathetic nervous system development; ISS:BHF-UCL.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0010468; P:regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; ISS:BHF-UCL.
DR   GO; GO:0060541; P:respiratory system development; ISS:BHF-UCL.
DR   GO; GO:0061452; P:retrotrapezoid nucleus neuron differentiation; ISS:BHF-UCL.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0061549; P:sympathetic ganglion development; ISS:UniProtKB.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:BHF-UCL.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation; Triplet repeat expansion.
FT   CHAIN         1    314       Paired mesoderm homeobox protein 2B.
FT                                /FTId=PRO_0000049262.
FT   DNA_BIND     98    157       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    159    167       Poly-Ala.
FT   COMPBIAS    212    217       Poly-Gly.
FT   COMPBIAS    241    260       Poly-Ala.
FT   VARIANT     100    100       R -> L (confers susceptibility to
FT                                neuroblastoma; found as germline mutation
FT                                in a neuroblastoma family;
FT                                dbSNP:rs104893855).
FT                                {ECO:0000269|PubMed:15024693}.
FT                                /FTId=VAR_026969.
FT   VARIANT     141    141       R -> G (in dbSNP:rs28939716).
FT                                {ECO:0000269|PubMed:15024693}.
FT                                /FTId=VAR_026970.
FT   VARIANT     141    141       R -> Q (in CCHS).
FT                                {ECO:0000269|PubMed:15657873}.
FT                                /FTId=VAR_046900.
FT   VARIANT     143    143       Q -> R (in CCHS).
FT                                {ECO:0000269|PubMed:15657873}.
FT                                /FTId=VAR_046901.
FT   VARIANT     197    197       G -> D (confers susceptibility to
FT                                neuroblastoma; dbSNP:rs104893856).
FT                                {ECO:0000269|PubMed:16691592}.
FT                                /FTId=VAR_046902.
FT   VARIANT     241    241       A -> AAAAAAAAAAA (in CCHS).
FT                                {ECO:0000269|PubMed:14566559}.
FT                                /FTId=VAR_018257.
FT   VARIANT     254    258       Missing. {ECO:0000269|PubMed:14566559}.
FT                                /FTId=VAR_018258.
FT   VARIANT     255    259       Missing. {ECO:0000269|PubMed:14566559}.
FT                                /FTId=VAR_018259.
FT   CONFLICT    292    292       A -> G (in Ref. 1; BAA11555, 2; AAD26698
FT                                and 3; BAA82670). {ECO:0000305}.
SQ   SEQUENCE   314 AA;  31621 MW;  40737F71948B595A CRC64;
     MYKMEYSYLN SSAYESCMAG MDTSSLASAY ADFSSCSQAS GFQYNPIRTT FGATSGCPSL
     TPGSCSLGTL RDHQSSPYAA VPYKLFTDHG GLNEKRKQRR IRTTFTSAQL KELERVFAET
     HYPDIYTREE LALKIDLTEA RVQVWFQNRR AKFRKQERAA AAAAAAAKNG SSGKKSDSSR
     DDESKEAKST DPDSTGGPGP NPNPTPSCGA NGGGGGGPSP AGAPGAAGPG GPGGEPGKGG
     AAAAAAAAAA AAAAAAAAAA GGLAAAGGPG QGWAPGPGPI TSIPDSLGGP FASVLSSLQR
     PNGAKAALVK SSMF
//
ID   PO2F3_HUMAN             Reviewed;         436 AA.
AC   Q9UKI9; A8K7H8; B4DY07; F5GWW6; Q3MIY3; Q9UKR7; Q9Y504;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=POU domain, class 2, transcription factor 3;
DE   AltName: Full=Octamer-binding protein 11;
DE            Short=Oct-11;
DE   AltName: Full=Octamer-binding transcription factor 11;
DE            Short=OTF-11;
DE   AltName: Full=Transcription factor PLA-1;
DE   AltName: Full=Transcription factor Skn-1;
GN   Name=POU2F3; Synonyms=OTF11, PLA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-152.
RX   PubMed=10473598; DOI=10.1074/jbc.274.37.26399;
RA   Hildesheim J., Foster R.A., Chamberlin M.E., Vogel J.C.;
RT   "Characterization of the regulatory domains of the human skn-1a/Epoc-
RT   1/Oct-11 POU transcription factor.";
RL   J. Biol. Chem. 274:26399-26406(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-152.
RA   Fischer D.F., Hemelaar J., Backendorf C.;
RT   "Characterisation of the human transcription factor Oct-11:
RT   involvement in the regulation of the SPRR2A gene.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Jimenez-Mateo O., Castrillo J.-L.;
RT   "PLA-1, a novel human POU transcription factor, regulates the
RT   placental lactogen-3 gene expression.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS ARG-152 AND LYS-390.
RC   TISSUE=Small intestine, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor that binds to the octamer motif
CC       (5'-ATTTGCAT-3'). Regulated the expression of a number of genes
CC       such as SPRR2A or placental lactogen.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Skn-1a;
CC         IsoId=Q9UKI9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKI9-2; Sequence=VSP_043900;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=Skn-1n;
CC         IsoId=Q9UKI9-3; Sequence=VSP_043901;
CC         Note=Specifically expressed in keratinocytes, induced by high
CC         calcium concentration.;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in epidermis and
CC       cultured keratinocytes.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF162278; AAF00199.1; -; mRNA.
DR   EMBL; AF133895; AAD55245.1; -; mRNA.
DR   EMBL; AJ012214; CAB45383.1; -; mRNA.
DR   EMBL; AK291993; BAF84682.1; -; mRNA.
DR   EMBL; AK302212; BAG63569.1; -; mRNA.
DR   EMBL; AP000679; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001150; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101649; AAI01650.1; -; mRNA.
DR   CCDS; CCDS58190.1; -. [Q9UKI9-2]
DR   CCDS; CCDS8431.1; -. [Q9UKI9-1]
DR   RefSeq; NP_001231611.1; NM_001244682.1. [Q9UKI9-2]
DR   RefSeq; NP_055167.2; NM_014352.3. [Q9UKI9-1]
DR   RefSeq; XP_011541041.1; XM_011542739.2. [Q9UKI9-3]
DR   RefSeq; XP_011541042.1; XM_011542740.2. [Q9UKI9-3]
DR   UniGene; Hs.227115; -.
DR   ProteinModelPortal; Q9UKI9; -.
DR   SMR; Q9UKI9; -.
DR   BioGrid; 117361; 2.
DR   IntAct; Q9UKI9; 1.
DR   STRING; 9606.ENSP00000260264; -.
DR   iPTMnet; Q9UKI9; -.
DR   PhosphoSitePlus; Q9UKI9; -.
DR   BioMuta; POU2F3; -.
DR   DMDM; 311033416; -.
DR   PaxDb; Q9UKI9; -.
DR   PeptideAtlas; Q9UKI9; -.
DR   PRIDE; Q9UKI9; -.
DR   DNASU; 25833; -.
DR   Ensembl; ENST00000260264; ENSP00000260264; ENSG00000137709. [Q9UKI9-2]
DR   Ensembl; ENST00000543440; ENSP00000441687; ENSG00000137709. [Q9UKI9-1]
DR   GeneID; 25833; -.
DR   KEGG; hsa:25833; -.
DR   UCSC; uc001pxc.4; human. [Q9UKI9-1]
DR   CTD; 25833; -.
DR   DisGeNET; 25833; -.
DR   EuPathDB; HostDB:ENSG00000137709.9; -.
DR   GeneCards; POU2F3; -.
DR   H-InvDB; HIX0010200; -.
DR   HGNC; HGNC:19864; POU2F3.
DR   HPA; HPA019652; -.
DR   MIM; 607394; gene.
DR   neXtProt; NX_Q9UKI9; -.
DR   OpenTargets; ENSG00000137709; -.
DR   PharmGKB; PA134963258; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000220842; -.
DR   HOVERGEN; HBG052783; -.
DR   InParanoid; Q9UKI9; -.
DR   KO; K09364; -.
DR   OMA; KPPVYNS; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; Q9UKI9; -.
DR   TreeFam; TF316413; -.
DR   GeneWiki; POU2F3; -.
DR   GenomeRNAi; 25833; -.
DR   PRO; PR:Q9UKI9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000137709; -.
DR   CleanEx; HS_POU2F3; -.
DR   ExpressionAtlas; Q9UKI9; baseline and differential.
DR   Genevisible; Q9UKI9; HS.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00093; HTH_XRE; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR000972; TF_octamer.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00029; OCTAMER.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    436       POU domain, class 2, transcription factor
FT                                3.
FT                                /FTId=PRO_0000100717.
FT   DOMAIN      183    257       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    281    340       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    354    425       Ser-rich.
FT   VAR_SEQ       1      9       MVNLESMHT -> MESPRTAKGGR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043900.
FT   VAR_SEQ       1      9       MVNLESMHT -> MNDAK (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_043901.
FT   VARIANT     152    152       H -> R (in dbSNP:rs7110845).
FT                                {ECO:0000269|PubMed:10473598,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_031618.
FT   VARIANT     390    390       R -> K (in dbSNP:rs2282537).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_055906.
FT   CONFLICT      6      6       S -> P (in Ref. 3; CAB45383).
FT                                {ECO:0000305}.
FT   CONFLICT     37     37       N -> K (in Ref. 2; AAD55245).
FT                                {ECO:0000305}.
FT   CONFLICT    351    351       V -> D (in Ref. 1; AAF00199).
FT                                {ECO:0000305}.
SQ   SEQUENCE   436 AA;  47432 MW;  CFF7F0153F0B7589 CRC64;
     MVNLESMHTD IKMSGDVADS TDARSTLSQV EPGNDRNGLD FNRQIKTEDL SDSLQQTLSH
     RPCHLSQGPA MMSGNQMSGL NASPCQDMAS LHPLQQLVLV PGHLQSVSQF LLSQTQPGQQ
     GLQPNLLPFP QQQSGLLLPQ TGPGLASQAF GHPGLPGSSL EPHLEASQHL PVPKHLPSSG
     GADEPSDLEE LEKFAKTFKQ RRIKLGFTQG DVGLAMGKLY GNDFSQTTIS RFEALNLSFK
     NMCKLKPLLE KWLNDAESSP SDPSVSTPSS YPSLSEVFGR KRKKRTSIET NIRLTLEKRF
     QDNPKPSSEE ISMIAEQLSM EKEVVRVWFC NRRQKEKRIN CPVATPIKPP VYNSRLVSPS
     GSLGPLSVPP VHSTMPGTVT SSCSPGNNSR PSSPGSGLHA SSPTASQNNS KAAVNSASSF
     NSSGSWYRWN HSTYLH
//
ID   PO3F4_HUMAN             Reviewed;         361 AA.
AC   P49335; B2RC71; Q5H9G9; Q99410;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   27-SEP-2017, entry version 167.
DE   RecName: Full=POU domain, class 3, transcription factor 4;
DE   AltName: Full=Brain-specific homeobox/POU domain protein 4;
DE            Short=Brain-4;
DE            Short=Brn-4;
DE   AltName: Full=Octamer-binding protein 9;
DE            Short=Oct-9;
DE   AltName: Full=Octamer-binding transcription factor 9;
DE            Short=OTF-9;
GN   Name=POU3F4; Synonyms=BRN4, OTF9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-237; DFNX2 TRP-317 AND
RP   GLU-334.
RC   TISSUE=Brain;
RX   PubMed=7839145; DOI=10.1126/science.7839145;
RA   de Kok Y.J.M., van der Maarel S.M., Bitner-Glindzicz M., Huber I.,
RA   Monaco A.P., Malcolm S., Pembrey M.E., Ropers H.-H., Cremers F.P.M.;
RT   "Association between X-linked mixed deafness and mutations in the POU
RT   domain gene POU3F4.";
RL   Science 267:685-688(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-237.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   VARIANT DFNX2 VAL-312.
RX   PubMed=7581392; DOI=10.1093/hmg/4.8.1467;
RA   Bitner-Glindzicz M., Turnpenny P., Hoeglund P., Keaearieainen H.,
RA   Sankila E.-M., van der Maarel S.M., de Kok Y.J.M., Ropers H.-H.,
RA   Cremers F.P.M., Pembrey M., Malcolm S.;
RT   "Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-
RT   linked deafness, DFN3.";
RL   Hum. Mol. Genet. 4:1467-1469(1995).
RN   [6]
RP   VARIANTS DFNX2 GLY-323 AND SER-330.
RX   PubMed=9298820;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:3<207::AID-HUMU5>3.3.CO;2-X;
RA   de Kok Y.J.M., Cremers C.W.R.J., Ropers H.-H., Cremers F.P.M.;
RT   "The molecular basis of X-linked deafness type 3 (DFN3) in two
RT   sporadic cases: identification of a somatic mosaicism for a POU3F4
RT   missense mutation.";
RL   Hum. Mutat. 10:207-211(1997).
RN   [7]
RP   VARIANT DFNX2 201-PHE-LYS-202 DEL.
RX   PubMed=9778298; DOI=10.1097/00005537-199810000-00022;
RA   Hagiwara H., Tamagawa Y., Kitamura K., Kodera K.;
RT   "A new mutation in the POU3F4 gene in a Japanese family with X-linked
RT   mixed deafness (DFN3).";
RL   Laryngoscope 108:1544-1547(1998).
CC   -!- FUNCTION: Probable transcription factor which exert its primary
CC       action widely during early neural development and in a very
CC       limited set of neurons in the mature brain.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Brain specific.
CC   -!- DISEASE: Deafness, X-linked, 2 (DFNX2) [MIM:304400]: A form of
CC       deafness characterized by both conductive hearing loss resulting
CC       from stapes (perilymphatic gusher) fixation, and progressive
CC       sensorineural deafness. {ECO:0000269|PubMed:7581392,
CC       ECO:0000269|PubMed:7839145, ECO:0000269|PubMed:9298820,
CC       ECO:0000269|PubMed:9778298}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       3 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Hereditary hearing loss homepage; Note=Gene
CC       page;
CC       URL="http://hereditaryhearingloss.org/main.aspx?c=.HHH&n=86162";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X82324; CAA57767.1; -; mRNA.
DR   EMBL; AK314967; BAG37468.1; -; mRNA.
DR   EMBL; Z82170; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471104; EAW98577.1; -; Genomic_DNA.
DR   CCDS; CCDS14450.1; -.
DR   PIR; A55557; A55557.
DR   RefSeq; NP_000298.3; NM_000307.4.
DR   UniGene; Hs.2229; -.
DR   ProteinModelPortal; P49335; -.
DR   SMR; P49335; -.
DR   STRING; 9606.ENSP00000362296; -.
DR   iPTMnet; P49335; -.
DR   PhosphoSitePlus; P49335; -.
DR   DMDM; 77416874; -.
DR   MaxQB; P49335; -.
DR   PaxDb; P49335; -.
DR   PeptideAtlas; P49335; -.
DR   PRIDE; P49335; -.
DR   DNASU; 5456; -.
DR   Ensembl; ENST00000373200; ENSP00000362296; ENSG00000196767.
DR   GeneID; 5456; -.
DR   KEGG; hsa:5456; -.
DR   UCSC; uc004eeg.3; human.
DR   CTD; 5456; -.
DR   DisGeNET; 5456; -.
DR   EuPathDB; HostDB:ENSG00000196767.6; -.
DR   GeneCards; POU3F4; -.
DR   GeneReviews; POU3F4; -.
DR   H-InvDB; HIX0028415; -.
DR   HGNC; HGNC:9217; POU3F4.
DR   HPA; HPA031984; -.
DR   MalaCards; POU3F4; -.
DR   MIM; 300039; gene.
DR   MIM; 304400; phenotype.
DR   neXtProt; NX_P49335; -.
DR   Orphanet; 163988; Developmental delay - deafness, Hildebrand type.
DR   Orphanet; 383; X-linked mixed deafness with perilymphatic gusher.
DR   PharmGKB; PA33541; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   HOGENOM; HOG000116303; -.
DR   HOVERGEN; HBG053120; -.
DR   InParanoid; P49335; -.
DR   KO; K09365; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; P49335; -.
DR   TreeFam; TF316413; -.
DR   SIGNOR; P49335; -.
DR   GeneWiki; POU3F4; -.
DR   GenomeRNAi; 5456; -.
DR   PRO; PR:P49335; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000196767; -.
DR   CleanEx; HS_POU3F4; -.
DR   Genevisible; P49335; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003680; F:AT DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB.
DR   GO; GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl.
DR   GO; GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:InterPro.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR016362; TF_POU_3.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PIRSF; PIRSF002629; Transcription_factor_POU; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Deafness; Disease mutation; DNA-binding; Homeobox;
KW   Non-syndromic deafness; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    361       POU domain, class 3, transcription factor
FT                                4.
FT                                /FTId=PRO_0000100732.
FT   DOMAIN      186    260       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    278    337       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     265    265       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P20265}.
FT   VARIANT     201    202       Missing (in DFNX2).
FT                                {ECO:0000269|PubMed:9778298}.
FT                                /FTId=VAR_015261.
FT   VARIANT     237    237       G -> A (in dbSNP:rs5921979).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:7839145}.
FT                                /FTId=VAR_067431.
FT   VARIANT     312    312       A -> V (in DFNX2).
FT                                {ECO:0000269|PubMed:7581392}.
FT                                /FTId=VAR_003782.
FT   VARIANT     317    317       L -> W (in DFNX2).
FT                                {ECO:0000269|PubMed:7839145}.
FT                                /FTId=VAR_003783.
FT   VARIANT     323    323       R -> G (in DFNX2; somatic mosaicism in
FT                                50% of the peripheral blood lymphocytes).
FT                                {ECO:0000269|PubMed:9298820}.
FT                                /FTId=VAR_003784.
FT   VARIANT     330    330       R -> S (in DFNX2).
FT                                {ECO:0000269|PubMed:9298820}.
FT                                /FTId=VAR_003785.
FT   VARIANT     334    334       K -> E (in DFNX2).
FT                                {ECO:0000269|PubMed:7839145}.
FT                                /FTId=VAR_003786.
SQ   SEQUENCE   361 AA;  39427 MW;  DE30602CFAC4683A CRC64;
     MATAASNPYS ILSSTSLVHA DSAGMQQGSP FRNPQKLLQS DYLQGVPSNG HPLGHHWVTS
     LSDGGPWSST LATSPLDQQD VKPGREDLQL GAIIHHRSPH VAHHSPHTNH PNAWGASPAP
     NPSITSSGQP LNVYSQPGFT VSGMLEHGGL TPPPAAASAQ SLHPVLREPP DHGELGSHHC
     QDHSDEETPT SDELEQFAKQ FKQRRIKLGF TQADVGLALG TLYGNVFSQT TICRFEGLQL
     SFKNMCKLKP LLNKWLEEAD SSTGSPTSID KIAAQGRKRK KRTSIEVSVK GVLETHFLKC
     PKPAAQEISS LADSLQLEKE VVRVWFCNRR QKEKRMTPPG DQQPHEVYSH TVKTDTSCHD
     L
//
ID   PO4F3_HUMAN             Reviewed;         338 AA.
AC   Q15319; O60557; Q2M3F8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 157.
DE   RecName: Full=POU domain, class 4, transcription factor 3;
DE   AltName: Full=Brain-specific homeobox/POU domain protein 3C;
DE            Short=Brain-3C;
DE            Short=Brn-3C;
GN   Name=POU4F3; Synonyms=BRN3C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=7623109;
RA   Xiang M., Zhou L.-J., Macke J.P., Yoshioka T., Hendry S.H., Eddy R.L.,
RA   Shows T.B., Nathans J.;
RT   "The Brn-3 family of POU-domain factors: primary structure, binding
RT   specificity, and expression in subsets of retinal ganglion cells and
RT   somatosensory neurons.";
RL   J. Neurosci. 15:4762-4785(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND INVOLVEMENT
RP   IN DFNA15.
RX   PubMed=9506947; DOI=10.1126/science.279.5358.1950;
RA   Vahava O., Morell R., Lynch E.D., Weiss S., Kagan M.E., Ahituv N.,
RA   Morrow J.E., Lee M.K., Skvorak A.B., Morton C.C., Blumenfeld A.,
RA   Frydman M., Friedman T.B., King M.-C., Avraham K.B.;
RT   "Mutation in transcription factor POU4F3 associated with inherited
RT   progressive hearing loss in humans.";
RL   Science 279:1950-1954(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANTS DFNA15 PRO-223 AND PHE-289, AND CHARACTERIZATION OF VARIANTS
RP   DFNA15 PRO-223 AND PHE-289.
RX   PubMed=18228599; DOI=10.1002/humu.20693;
RA   Collin R.W.J., Chellappa R., Pauw R.-J., Vriend G., Oostrik J.,
RA   van Drunen W., Huygen P.L., Admiraal R., Hoefsloot L.H.,
RA   Cremers F.P.M., Xiang M., Cremers C.W.R.J., Kremer H.;
RT   "Missense mutations in POU4F3 cause autosomal dominant hearing
RT   impairment DFNA15 and affect subcellular localization and DNA
RT   binding.";
RL   Hum. Mutat. 29:545-554(2008).
CC   -!- FUNCTION: Acts as a transcriptional activator. Acts by binding to
CC       sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in
CC       the regulatory regions of its target genes. Involved in the
CC       auditory system development, required for terminal differentiation
CC       of hair cells in the inner ear. {ECO:0000250|UniProtKB:Q63955}.
CC   -!- SUBUNIT: Interacts with ISL1. {ECO:0000250|UniProtKB:Q63955}.
CC   -!- INTERACTION:
CC       Q08379:GOLGA2; NbExp=4; IntAct=EBI-12033574, EBI-618309;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Brain. Seems to be specific to the retina.
CC       {ECO:0000269|PubMed:7623109, ECO:0000269|PubMed:9506947}.
CC   -!- DISEASE: Deafness, autosomal dominant, 15 (DFNA15) [MIM:602459]: A
CC       form of non-syndromic hearing loss with variable phenotype in
CC       terms of age at onset, levels of progression, and shape of
CC       audiograms. {ECO:0000269|PubMed:18228599,
CC       ECO:0000269|PubMed:9506947}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       4 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Hereditary hearing loss homepage; Note=Gene
CC       page;
CC       URL="http://hereditaryhearingloss.org/main.aspx?c=.HHH&n=86162";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10061; AAA57160.1; -; Genomic_DNA.
DR   EMBL; U10060; AAA57160.1; JOINED; Genomic_DNA.
DR   EMBL; AF044575; AAC06203.1; -; Genomic_DNA.
DR   EMBL; BC104923; AAI04924.1; -; mRNA.
DR   EMBL; BC112207; AAI12208.1; -; mRNA.
DR   CCDS; CCDS4281.1; -.
DR   RefSeq; NP_002691.1; NM_002700.2.
DR   UniGene; Hs.553499; -.
DR   ProteinModelPortal; Q15319; -.
DR   SMR; Q15319; -.
DR   BioGrid; 111455; 2.
DR   IntAct; Q15319; 4.
DR   STRING; 9606.ENSP00000230732; -.
DR   iPTMnet; Q15319; -.
DR   PhosphoSitePlus; Q15319; -.
DR   BioMuta; POU4F3; -.
DR   DMDM; 2495302; -.
DR   PaxDb; Q15319; -.
DR   PeptideAtlas; Q15319; -.
DR   PRIDE; Q15319; -.
DR   DNASU; 5459; -.
DR   Ensembl; ENST00000230732; ENSP00000230732; ENSG00000091010.
DR   GeneID; 5459; -.
DR   KEGG; hsa:5459; -.
DR   UCSC; uc003loa.2; human.
DR   CTD; 5459; -.
DR   DisGeNET; 5459; -.
DR   EuPathDB; HostDB:ENSG00000091010.4; -.
DR   GeneCards; POU4F3; -.
DR   GeneReviews; POU4F3; -.
DR   HGNC; HGNC:9220; POU4F3.
DR   HPA; HPA038215; -.
DR   MalaCards; POU4F3; -.
DR   MIM; 602459; phenotype.
DR   MIM; 602460; gene.
DR   neXtProt; NX_Q15319; -.
DR   OpenTargets; ENSG00000091010; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA33544; -.
DR   eggNOG; KOG1168; Eukaryota.
DR   eggNOG; ENOG410XPNX; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116305; -.
DR   HOVERGEN; HBG031829; -.
DR   InParanoid; Q15319; -.
DR   KO; K09366; -.
DR   OMA; DVTYHTM; -.
DR   OrthoDB; EOG091G0WBK; -.
DR   PhylomeDB; Q15319; -.
DR   TreeFam; TF316413; -.
DR   GeneWiki; POU4F3; -.
DR   GenomeRNAi; 5459; -.
DR   PRO; PR:Q15319; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000091010; -.
DR   CleanEx; HS_POU4F3; -.
DR   Genevisible; Q15319; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; TAS:ProtInc.
DR   GO; GO:0021562; P:vestibulocochlear nerve development; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00093; HTH_XRE; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR032961; POU4F3.
DR   InterPro; IPR000327; POU_dom.
DR   PANTHER; PTHR11636:SF43; PTHR11636:SF43; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Deafness; Differentiation;
KW   Disease mutation; DNA-binding; Homeobox; Non-syndromic deafness;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    338       POU domain, class 4, transcription factor
FT                                3.
FT                                /FTId=PRO_0000100742.
FT   DOMAIN      179    256       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    274    333       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF        56     65       POU-IV box.
FT   VARIANT     223    223       L -> P (in DFNA15; whereas wild-type
FT                                protein is located in the nucleus part of
FT                                the mutant protein is also present in the
FT                                cytoplasm; mutant protein shows greatly
FT                                reduced capability for binding to DNA as
FT                                well as transcriptionally activating
FT                                reporter gene expression;
FT                                dbSNP:rs121909057).
FT                                {ECO:0000269|PubMed:18228599}.
FT                                /FTId=VAR_045682.
FT   VARIANT     289    289       L -> F (in DFNA15; whereas wild-type
FT                                protein is located in the nucleus part of
FT                                the mutant protein is also present in the
FT                                cytoplasm; mutant protein shows greatly
FT                                reduced capability for binding to DNA as
FT                                well as transcriptionally activating
FT                                reporter gene expression;
FT                                dbSNP:rs121909056).
FT                                {ECO:0000269|PubMed:18228599}.
FT                                /FTId=VAR_045683.
FT   CONFLICT     67     67       S -> F (in Ref. 2; AAC06203).
FT                                {ECO:0000305}.
SQ   SEQUENCE   338 AA;  37052 MW;  E2D2EEB25B299A5C CRC64;
     MMAMNSKQPF GMHPVLQEPK FSSLHSGSEA MRRVCLPAPQ LQGNIFGSFD ESLLARAEAL
     AAVDIVSHGK NHPFKPDATY HTMSSVPCTS TSSTVPISHP AALTSHPHHA VHQGLEGDLL
     EHISPTLSVS GLGAPEHSVM PAQIHPHHLG AMGHLHQAMG MSHPHTVAPH SAMPACLSDV
     ESDPRELEAF AERFKQRRIK LGVTQADVGA ALANLKIPGV GSLSQSTICR FESLTLSHNN
     MIALKPVLQA WLEEAEAAYR EKNSKPELFN GSERKRKRTS IAAPEKRSLE AYFAIQPRPS
     SEKIAAIAEK LDLKKNVVRV WFCNQRQKQK RMKYSAVH
//
ID   PROP1_HUMAN             Reviewed;         226 AA.
AC   O75360;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   27-SEP-2017, entry version 151.
DE   RecName: Full=Homeobox protein prophet of Pit-1;
DE            Short=PROP-1;
DE   AltName: Full=Pituitary-specific homeodomain factor;
GN   Name=PROP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANTS SER-20 AND CPHD
RP   CYS-73.
RX   PubMed=9824293; DOI=10.1016/S0014-5793(98)01234-4;
RA   Duquesnoy P., Roy A., Dastot F., Ghali I., Teinturier C., Netchine I.,
RA   Cacheux V., Hafez M., Salah N., Chaussain J.-L., Goossens M.,
RA   Bougneres P., Amselem S.;
RT   "Human Prop-1: cloning, mapping, genomic structure. Mutations in
RT   familial combined pituitary hormone deficiency.";
RL   FEBS Lett. 437:216-220(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-20; CPHD2 ILE-117
RP   AND CYS-120.
RX   PubMed=9462743; DOI=10.1038/ng0298-147;
RA   Wu W., Cogan J.D., Pfaeffle R.W., Dasen J.S., Frisch H.,
RA   O'Connell S.M., Flynn S.E., Brown M.R., Mullis P.E., Parks J.S.,
RA   Phillips J.A. III, Rosenfeld M.G.;
RT   "Mutations in PROP1 cause familial combined pituitary hormone
RT   deficiency.";
RL   Nat. Genet. 18:147-149(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-20.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT CPHD2 CYS-120.
RX   PubMed=9768691; DOI=10.1210/jcem.83.10.5172;
RA   Fluck C., Deladoey J., Rutishauser K., Eble A., Marti U., Wu W.,
RA   Mullis P.E.;
RT   "Phenotypic variability in familial combined pituitary hormone
RT   deficiency caused by a PROP1 gene mutation resulting in the
RT   substitution of Arg-->Cys at codon 120 (R120C).";
RL   J. Clin. Endocrinol. Metab. 83:3727-3734(1998).
RN   [6]
RP   VARIANT CPHD2 SER-88, AND CHARACTERIZATION OF VARIANT CPHD2 SER-88.
RX   PubMed=10946881; DOI=10.1210/jcem.85.8.6744;
RA   Osorio M.G., Kopp P., Marui S., Latronico A.C., Mendonca B.B.,
RA   Arnhold I.J.;
RT   "Combined pituitary hormone deficiency caused by a novel mutation of a
RT   highly conserved residue (F88S) in the homeodomain of PROP-1.";
RL   J. Clin. Endocrinol. Metab. 85:2779-2785(2000).
RN   [7]
RP   VARIANTS CPHD2 CYS-73 AND HIS-73.
RX   PubMed=11549703; DOI=10.1210/jcem.86.9.7811;
RA   Vallette-Kasic S., Barlier A., Teinturier C., Diaz A., Manavela M.,
RA   Berthezene F., Bouchard P., Chaussain J.-L., Brauner R.,
RA   Pellegrini-Bouiller I., Jaquet P., Enjalbert A., Brue T.;
RT   "PROP1 gene screening in patients with multiple pituitary hormone
RT   deficiency reveals two sites of hypermutability and a high incidence
RT   of corticotroph deficiency.";
RL   J. Clin. Endocrinol. Metab. 86:4529-4535(2001).
RN   [8]
RP   VARIANT CPHD2 GLN-99.
RX   PubMed=12519826; DOI=10.1210/jc.2001-011872;
RA   Vieira T.C., Dias da Silva M.R., Cerutti J.M., Brunner E., Borges M.,
RA   Arnaldi L.T., Kopp P., Abucham J.;
RT   "Familial combined pituitary hormone deficiency due to a novel
RT   mutation R99Q in the hot spot region of Prophet of Pit-1 presenting as
RT   constitutional growth delay.";
RL   J. Clin. Endocrinol. Metab. 88:38-44(2003).
RN   [9]
RP   VARIANT CPHD2 CYS-73, AND CHARACTERIZATION OF VARIANT CPHD2 CYS-73.
RX   PubMed=15531542; DOI=10.1210/jc.2003-032124;
RA   Reynaud R., Chadli-Chaieb M., Vallette-Kasic S., Barlier A.,
RA   Sarles J., Pellegrini-Bouiller I., Enjalbert A., Chaieb L., Brue T.;
RT   "A familial form of congenital hypopituitarism due to a PROP1 mutation
RT   in a large kindred: phenotypic and in vitro functional studies.";
RL   J. Clin. Endocrinol. Metab. 89:5779-5786(2004).
RN   [10]
RP   VARIANT CPHD2 TRP-125.
RX   PubMed=19128366; DOI=10.1111/j.1365-2265.2008.03326.x;
RA   Kelberman D., Turton J.P., Woods K.S., Mehta A., Al-Khawari M.,
RA   Greening J., Swift P.G., Otonkoski T., Rhodes S.J., Dattani M.T.;
RT   "Molecular analysis of novel PROP1 mutations associated with combined
RT   pituitary hormone deficiency (CPHD).";
RL   Clin. Endocrinol. (Oxf.) 70:96-103(2009).
CC   -!- FUNCTION: Possibly involved in the ontogenesis of pituitary
CC       gonadotropes, as well as somatotropes, lactotropes and caudomedial
CC       thyrotropes.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=4; IntAct=EBI-9027467, EBI-717810;
CC       P35070:BTC; NbExp=4; IntAct=EBI-9027467, EBI-6590057;
CC       P35219:CA8; NbExp=4; IntAct=EBI-9027467, EBI-718700;
CC       Q5MAI5-2:CDKL4; NbExp=4; IntAct=EBI-9027467, EBI-12116542;
CC       P05813:CRYBA1; NbExp=4; IntAct=EBI-9027467, EBI-7043337;
CC       Q8TB03:CXorf38; NbExp=4; IntAct=EBI-9027467, EBI-12024320;
CC       O95967:EFEMP2; NbExp=4; IntAct=EBI-9027467, EBI-743414;
CC       Q7L775:EPM2AIP1; NbExp=4; IntAct=EBI-9027467, EBI-6255981;
CC       Q8NCA5-2:FAM98A; NbExp=4; IntAct=EBI-9027467, EBI-10970131;
CC       O75603:GCM2; NbExp=4; IntAct=EBI-9027467, EBI-10188645;
CC       P52790:HK3; NbExp=4; IntAct=EBI-9027467, EBI-2965780;
CC       P49639:HOXA1; NbExp=4; IntAct=EBI-9027467, EBI-740785;
CC       Q6P597-3:KLC3; NbExp=4; IntAct=EBI-9027467, EBI-12076930;
CC       Q969R5:L3MBTL2; NbExp=4; IntAct=EBI-9027467, EBI-739909;
CC       Q9Y316:MEMO1; NbExp=4; IntAct=EBI-9027467, EBI-1104564;
CC       Q8N6F8:METTL27; NbExp=4; IntAct=EBI-9027467, EBI-8487781;
CC       P82932:MRPS6; NbExp=4; IntAct=EBI-9027467, EBI-716172;
CC       Q96CV9:OPTN; NbExp=4; IntAct=EBI-9027467, EBI-748974;
CC       P43351:RAD52; NbExp=4; IntAct=EBI-9027467, EBI-706448;
CC       P78317:RNF4; NbExp=4; IntAct=EBI-9027467, EBI-2340927;
CC       Q53HV7-2:SMUG1; NbExp=4; IntAct=EBI-9027467, EBI-12275818;
CC       Q96M29:TEKT5; NbExp=4; IntAct=EBI-9027467, EBI-10239812;
CC       Q9NWC5:TMEM45A; NbExp=4; IntAct=EBI-9027467, EBI-10823938;
CC       Q9Y2X8:UBE2D4; NbExp=4; IntAct=EBI-9027467, EBI-745527;
CC       A5D8V6:VPS37C; NbExp=4; IntAct=EBI-9027467, EBI-2559305;
CC       Q6P2D0:ZFP1; NbExp=4; IntAct=EBI-9027467, EBI-2555749;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Expressed specifically in embryonic pituitary.
CC   -!- DISEASE: Pituitary hormone deficiency, combined, 2 (CPHD2)
CC       [MIM:262600]: Combined pituitary hormone deficiency is defined as
CC       the impaired production of growth hormone and one or more of the
CC       other five anterior pituitary hormones. CPHD2 is characterized by
CC       pleiotropic deficiencies of growth hormone, thyroid-stimulating
CC       hormone, follicle-stimulating hormone, luteinizing hormone,
CC       prolactin and adrenocorticotropic hormone.
CC       {ECO:0000269|PubMed:10946881, ECO:0000269|PubMed:11549703,
CC       ECO:0000269|PubMed:12519826, ECO:0000269|PubMed:15531542,
CC       ECO:0000269|PubMed:19128366, ECO:0000269|PubMed:9462743,
CC       ECO:0000269|PubMed:9768691}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF076214; AAC77453.1; -; Genomic_DNA.
DR   EMBL; AF076215; AAC77454.1; -; mRNA.
DR   EMBL; AF041141; AAC27900.1; -; Genomic_DNA.
DR   EMBL; AF041139; AAC27900.1; JOINED; Genomic_DNA.
DR   EMBL; AF041140; AAC27900.1; JOINED; Genomic_DNA.
DR   EMBL; AC136940; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069076; AAH69076.1; -; mRNA.
DR   CCDS; CCDS4430.1; -.
DR   RefSeq; NP_006252.3; NM_006261.4.
DR   UniGene; Hs.158301; -.
DR   ProteinModelPortal; O75360; -.
DR   SMR; O75360; -.
DR   BioGrid; 111610; 2.
DR   IntAct; O75360; 356.
DR   STRING; 9606.ENSP00000311290; -.
DR   iPTMnet; O75360; -.
DR   PhosphoSitePlus; O75360; -.
DR   BioMuta; PROP1; -.
DR   EPD; O75360; -.
DR   PaxDb; O75360; -.
DR   PRIDE; O75360; -.
DR   Ensembl; ENST00000308304; ENSP00000311290; ENSG00000175325.
DR   GeneID; 5626; -.
DR   KEGG; hsa:5626; -.
DR   UCSC; uc003mif.1; human.
DR   CTD; 5626; -.
DR   DisGeNET; 5626; -.
DR   EuPathDB; HostDB:ENSG00000175325.2; -.
DR   GeneCards; PROP1; -.
DR   GeneReviews; PROP1; -.
DR   HGNC; HGNC:9455; PROP1.
DR   MalaCards; PROP1; -.
DR   MIM; 262600; phenotype.
DR   MIM; 601538; gene.
DR   neXtProt; NX_O75360; -.
DR   OpenTargets; ENSG00000175325; -.
DR   Orphanet; 95494; Combined pituitary hormone deficiencies, genetic forms.
DR   Orphanet; 226307; Hypothyroidism due to deficient transcription factors involved in pituitary development or function.
DR   Orphanet; 90695; Panhypopituitarism.
DR   PharmGKB; PA33808; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00860000133740; -.
DR   HOGENOM; HOG000115706; -.
DR   HOVERGEN; HBG053691; -.
DR   InParanoid; O75360; -.
DR   KO; K09327; -.
DR   OMA; TCFPHPY; -.
DR   OrthoDB; EOG091G0R1U; -.
DR   PhylomeDB; O75360; -.
DR   TreeFam; TF315976; -.
DR   GeneWiki; PROP1; -.
DR   GenomeRNAi; 5626; -.
DR   PRO; PR:O75360; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000175325; -.
DR   CleanEx; HS_PROP1; -.
DR   Genevisible; O75360; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0008013; F:beta-catenin binding; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001206; F:transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0048850; P:hypophysis morphogenesis; IEA:Ensembl.
DR   GO; GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0060126; P:somatotropin secreting cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; DNA-binding; Dwarfism; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    226       Homeobox protein prophet of Pit-1.
FT                                /FTId=PRO_0000049271.
FT   DNA_BIND     69    128       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      20     20       N -> S (in dbSNP:rs7445271).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9462743,
FT                                ECO:0000269|PubMed:9824293}.
FT                                /FTId=VAR_054972.
FT   VARIANT      73     73       R -> C (in CPHD2; familial; no detectable
FT                                DNA binding observed with the mutant
FT                                protein in electromobility shift assays;
FT                                whereas in vitro translated PROP1 and the
FT                                mutant proteins were similar in their
FT                                expression and electrophoretic
FT                                properties; dbSNP:rs121917843).
FT                                {ECO:0000269|PubMed:11549703,
FT                                ECO:0000269|PubMed:15531542,
FT                                ECO:0000269|PubMed:9824293}.
FT                                /FTId=VAR_003768.
FT   VARIANT      73     73       R -> H (in CPHD2; familial;
FT                                dbSNP:rs121917842).
FT                                {ECO:0000269|PubMed:11549703}.
FT                                /FTId=VAR_012746.
FT   VARIANT      88     88       F -> S (in CPHD2; impairs binding of the
FT                                mutated protein to DNA target sequences;
FT                                dbSNP:rs121917841).
FT                                {ECO:0000269|PubMed:10946881}.
FT                                /FTId=VAR_063235.
FT   VARIANT      99     99       R -> Q (in CPHD2; displays a significant
FT                                decrease in DNA binding on a paired-box
FT                                response element (PRDQ9) and trans-
FT                                activation of a luciferase reporter gene;
FT                                dbSNP:rs137853100).
FT                                {ECO:0000269|PubMed:12519826}.
FT                                /FTId=VAR_063236.
FT   VARIANT     117    117       F -> I (in CPHD2; familial;
FT                                dbSNP:rs121917840).
FT                                {ECO:0000269|PubMed:9462743}.
FT                                /FTId=VAR_003769.
FT   VARIANT     120    120       R -> C (in CPHD2; familial;
FT                                dbSNP:rs121917839).
FT                                {ECO:0000269|PubMed:9462743,
FT                                ECO:0000269|PubMed:9768691}.
FT                                /FTId=VAR_003770.
FT   VARIANT     125    125       R -> W (in CPHD2; dbSNP:rs146918863).
FT                                {ECO:0000269|PubMed:19128366}.
FT                                /FTId=VAR_054973.
FT   VARIANT     142    142       A -> T (in dbSNP:rs1800197).
FT                                /FTId=VAR_014531.
SQ   SEQUENCE   226 AA;  24984 MW;  CE6D59B3D295A86D CRC64;
     MEAERRRQAE KPKKGRVGSN LLPERHPATG TPTTTVDSSA PPCRRLPGAG GGRSRFSPQG
     GQRGRPHSRR RHRTTFSPVQ LEQLESAFGR NQYPDIWARE SLARDTGLSE ARIQVWFQNR
     RAKQRKQERS LLQPLAHLSP AAFSSFLPES TACPYSYAAP PPPVTCFPHP YSHALPSQPS
     TGGAFALSHQ SEDWYPTLHP APAGHLPCPP PPPMLPLSLE PSKSWN
//
ID   PRRX2_HUMAN             Reviewed;         253 AA.
AC   Q99811; Q5SZB5; Q9UIB3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   25-OCT-2017, entry version 159.
DE   RecName: Full=Paired mesoderm homeobox protein 2;
DE   AltName: Full=Paired-related homeobox protein 2;
DE            Short=PRX-2;
GN   Name=PRRX2; Synonyms=PMX2, PRX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11063257; DOI=10.1007/s003350010193;
RA   Norris R.A., Scott K.K., Moore C.S., Stetten G., Brown C.R.,
RA   Jabs E.W., Wulfsberg E.A., Yu J., Kern M.J.;
RT   "Human PRRX1 and PRRX2 genes: cloning, expression, genomic
RT   localization, and exclusion as disease genes for Nager syndrome.";
RL   Mamm. Genome 11:1000-1005(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 90-253, FUNCTION, TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   TISSUE=Fetal fibroblast;
RX   PubMed=9665387; DOI=10.1046/j.1523-1747.1998.00238.x;
RA   Stelnicki E.J., Arbeit J., Cass D.L., Saner C., Harrison M.,
RA   Largman C.;
RT   "Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless
RT   fetal wounds.";
RL   J. Invest. Dermatol. 111:57-63(1998).
CC   -!- FUNCTION: May play a role in the scarless healing of cutaneous
CC       wounds during the first two trimesters of development.
CC       {ECO:0000269|PubMed:9665387}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.
CC   -!- TISSUE SPECIFICITY: In fetal skin, highest expression found in
CC       cells of mesodermal origin within the dermal papilla of the
CC       developing hair shaft. Not detected in epidermis or dermis. In
CC       adult skin, weakly expressed within the basal layers of the
CC       epidermis. Not expressed in dermis. {ECO:0000269|PubMed:9665387}.
CC   -!- DEVELOPMENTAL STAGE: Higher expression in fetus than in adult.
CC       {ECO:0000269|PubMed:9665387}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PRRX2ID42897ch9q34.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF061970; AAF17708.1; -; mRNA.
DR   EMBL; AL590369; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW87901.1; -; Genomic_DNA.
DR   EMBL; BC014645; AAH14645.1; -; mRNA.
DR   EMBL; U81600; AAB39864.1; -; mRNA.
DR   CCDS; CCDS6926.1; -.
DR   RefSeq; NP_057391.1; NM_016307.3.
DR   UniGene; Hs.660115; -.
DR   ProteinModelPortal; Q99811; -.
DR   SMR; Q99811; -.
DR   STRING; 9606.ENSP00000361547; -.
DR   iPTMnet; Q99811; -.
DR   PhosphoSitePlus; Q99811; -.
DR   BioMuta; PRRX2; -.
DR   DMDM; 12644475; -.
DR   EPD; Q99811; -.
DR   PaxDb; Q99811; -.
DR   PeptideAtlas; Q99811; -.
DR   PRIDE; Q99811; -.
DR   Ensembl; ENST00000372469; ENSP00000361547; ENSG00000167157.
DR   GeneID; 51450; -.
DR   KEGG; hsa:51450; -.
DR   UCSC; uc004byh.4; human.
DR   CTD; 51450; -.
DR   DisGeNET; 51450; -.
DR   EuPathDB; HostDB:ENSG00000167157.10; -.
DR   GeneCards; PRRX2; -.
DR   HGNC; HGNC:21338; PRRX2.
DR   HPA; HPA006607; -.
DR   HPA; HPA026808; -.
DR   MIM; 604675; gene.
DR   neXtProt; NX_Q99811; -.
DR   OpenTargets; ENSG00000167157; -.
DR   PharmGKB; PA134871679; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG021349; -.
DR   InParanoid; Q99811; -.
DR   KO; K09329; -.
DR   OMA; SPEYLSW; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; Q99811; -.
DR   TreeFam; TF351612; -.
DR   ChiTaRS; PRRX2; human.
DR   GeneWiki; PRRX2; -.
DR   GenomeRNAi; 51450; -.
DR   PRO; PR:Q99811; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000167157; -.
DR   CleanEx; HS_PRRX2; -.
DR   ExpressionAtlas; Q99811; baseline and differential.
DR   Genevisible; Q99811; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    253       Paired mesoderm homeobox protein 2.
FT                                /FTId=PRO_0000049255.
FT   DNA_BIND    104    163       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       230    243       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   CONFLICT     90     90       P -> S (in Ref. 5; AAB39864).
FT                                {ECO:0000305}.
FT   CONFLICT     96     98       SAA -> RPP (in Ref. 5; AAB39864).
FT                                {ECO:0000305}.
SQ   SEQUENCE   253 AA;  27079 MW;  C7A861D46DC46DD3 CRC64;
     MDSAAAAFAL DKPALGPGPP PPPPALGPGD CAQARKNFSV SHLLDLEEVA AAGRLAARPG
     ARAEAREGAA REPSGGSSGS EAAPQDGECP SPGRGSAAKR KKKQRRNRTT FNSSQLQALE
     RVFERTHYPD AFVREELARR VNLSEARVQV WFQNRRAKFR RNERAMLASR SASLLKSYSQ
     EAAIEQPVAP RPTALSPDYL SWTASSPYST VPPYSPGSSG PATPGVNMAN SIASLRLKAK
     EFSLHHSQVP TVN
//
ID   PKNX2_HUMAN             Reviewed;         472 AA.
AC   Q96KN3; B7Z5I5; F5GZ15; Q63HL6; Q86XD1;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 2.
DT   27-SEP-2017, entry version 131.
DE   RecName: Full=Homeobox protein PKNOX2;
DE   AltName: Full=Homeobox protein PREP-2;
DE   AltName: Full=PBX/knotted homeobox 2;
GN   Name=PKNOX2; Synonyms=PREP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Small intestine;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-447 DEL.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-472 (ISOFORM 1), AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11549286; DOI=10.1006/bbrc.2001.5578;
RA   Imoto I., Sonoda I., Yuki Y., Inazawa J.;
RT   "Identification and characterization of human PKNOX2, a novel
RT   homeobox-containing gene.";
RL   Biochem. Biophys. Res. Commun. 287:270-276(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 13-472 (ISOFORM 1).
RX   PubMed=11972344; DOI=10.1093/nar/30.9.2043;
RA   Fognani C., Kilstrup-Nielsen C., Berthelsen J., Ferretti E.,
RA   Zappavigna V., Blasi F.;
RT   "Characterization of PREP2, a paralog of PREP1, which defines a novel
RT   sub-family of the MEINOX TALE homeodomain transcription factors.";
RL   Nucleic Acids Res. 30:2043-2051(2002).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:11549286}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96KN3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96KN3-2; Sequence=VSP_054306;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the TALE/MEIS homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB83665.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298999; BAH12921.1; -; mRNA.
DR   EMBL; BX648615; CAH56146.1; -; mRNA.
DR   EMBL; AP000708; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001007; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003061; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003069; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC045626; AAH45626.3; -; mRNA.
DR   EMBL; AB065001; BAB83665.1; ALT_INIT; mRNA.
DR   EMBL; AJ417081; CAD01142.1; -; mRNA.
DR   CCDS; CCDS41730.1; -. [Q96KN3-1]
DR   PIR; JC7766; JC7766.
DR   RefSeq; NP_071345.2; NM_022062.2. [Q96KN3-1]
DR   RefSeq; XP_005271699.1; XM_005271642.2. [Q96KN3-1]
DR   RefSeq; XP_011541246.1; XM_011542944.2. [Q96KN3-1]
DR   RefSeq; XP_011541247.1; XM_011542945.2. [Q96KN3-1]
DR   RefSeq; XP_016873599.1; XM_017018110.1. [Q96KN3-1]
DR   UniGene; Hs.278564; -.
DR   ProteinModelPortal; Q96KN3; -.
DR   SMR; Q96KN3; -.
DR   BioGrid; 121969; 6.
DR   IntAct; Q96KN3; 30.
DR   STRING; 9606.ENSP00000298282; -.
DR   iPTMnet; Q96KN3; -.
DR   PhosphoSitePlus; Q96KN3; -.
DR   BioMuta; PKNOX2; -.
DR   DMDM; 115311621; -.
DR   EPD; Q96KN3; -.
DR   MaxQB; Q96KN3; -.
DR   PaxDb; Q96KN3; -.
DR   PeptideAtlas; Q96KN3; -.
DR   PRIDE; Q96KN3; -.
DR   DNASU; 63876; -.
DR   Ensembl; ENST00000298282; ENSP00000298282; ENSG00000165495. [Q96KN3-1]
DR   GeneID; 63876; -.
DR   KEGG; hsa:63876; -.
DR   UCSC; uc001qbu.4; human. [Q96KN3-1]
DR   CTD; 63876; -.
DR   DisGeNET; 63876; -.
DR   EuPathDB; HostDB:ENSG00000165495.15; -.
DR   GeneCards; PKNOX2; -.
DR   H-InvDB; HIX0171308; -.
DR   HGNC; HGNC:16714; PKNOX2.
DR   HPA; CAB034342; -.
DR   HPA; HPA028867; -.
DR   HPA; HPA055368; -.
DR   HPA; HPA066962; -.
DR   MIM; 613066; gene.
DR   neXtProt; NX_Q96KN3; -.
DR   OpenTargets; ENSG00000165495; -.
DR   PharmGKB; PA33355; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000253922; -.
DR   HOVERGEN; HBG055193; -.
DR   InParanoid; Q96KN3; -.
DR   OMA; TMMATQS; -.
DR   OrthoDB; EOG091G09WJ; -.
DR   PhylomeDB; Q96KN3; -.
DR   TreeFam; TF318093; -.
DR   ChiTaRS; PKNOX2; human.
DR   GenomeRNAi; 63876; -.
DR   PRO; PR:Q96KN3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000165495; -.
DR   CleanEx; HS_PKNOX2; -.
DR   ExpressionAtlas; Q96KN3; baseline and differential.
DR   Genevisible; Q96KN3; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0003785; F:actin monomer binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   InterPro; IPR032453; PKNOX/Meis_N.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   Pfam; PF16493; Meis_PKNOX_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    472       Homeobox protein PKNOX2.
FT                                /FTId=PRO_0000049250.
FT   DNA_BIND    291    350       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     20     23       Poly-Pro.
FT   COMPBIAS    426    454       Asp/Glu-rich (acidic).
FT   VAR_SEQ       1     75       MMQHASPAPALTMMATQNVPPPPYQDSPQMTATAQPPSKAQ
FT                                AVHISAPSAAASTPVPSAPIDPQAQLEADKRAVY -> MSR
FT                                PHPTRTAH (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054306.
FT   VARIANT     110    110       E -> K (in dbSNP:rs34936365).
FT                                /FTId=VAR_049590.
FT   VARIANT     447    447       Missing. {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027500.
FT   CONFLICT    427    427       D -> G (in Ref. 1; BAH12921).
FT                                {ECO:0000305}.
SQ   SEQUENCE   472 AA;  52028 MW;  C83EBE0DA3F286E8 CRC64;
     MMQHASPAPA LTMMATQNVP PPPYQDSPQM TATAQPPSKA QAVHISAPSA AASTPVPSAP
     IDPQAQLEAD KRAVYRHPLF PLLTLLFEKC EQATQGSECI TSASFDVDIE NFVHQQEQEH
     KPFFSDDPEL DNLMVKAIQV LRIHLLELEK VNELCKDFCN RYITCLKTKM HSDNLLRNDL
     GGPYSPNQPS INLHSQDLLQ NSPNSMSGVS NNPQGIVVPA SALQQGNIAM TTVNSQVVSG
     GALYQPVTMV TSQGQVVTQA IPQGAIQIQN TQVNLDLTSL LDNEDKKSKN KRGVLPKHAT
     NIMRSWLFQH LMHPYPTEDE KRQIAAQTNL TLLQVNNWFI NARRRILQPM LDASNPDPAP
     KAKKIKSQHR PTQRFWPNSI AAGVLQQQGG APGTNPDGSI NLDNLQSLSS DSATMAMQQA
     MMAAHDDSLD GTEEEDEDEM EEEEEEELEE EVDELQTTNV SDLGLEHSDS LE
//
ID   PO5F2_HUMAN             Reviewed;         328 AA.
AC   Q8N7G0; Q15169; Q6MZL7; Q8N748;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   25-OCT-2017, entry version 114.
DE   RecName: Full=POU domain, class 5, transcription factor 2;
DE   AltName: Full=Sperm 1 POU domain transcription factor;
DE            Short=SPRM-1;
GN   Name=POU5F2; Synonyms=SPRM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 148-328.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 168-254, AND TISSUE SPECIFICITY.
RC   TISSUE=Skeletal muscle;
RX   PubMed=7908264; DOI=10.1111/j.1432-1033.1994.tb18676.x;
RA   Wey E., Lyons G.E., Schaefer B.W.;
RT   "A human POU domain gene, mPOU, is expressed in developing brain and
RT   specific adult tissues.";
RL   Eur. J. Biochem. 220:753-762(1994).
CC   -!- FUNCTION: Transcription factor that binds preferentially to the
CC       octamer motif (5'-ATGTTAAT-3'). May exert a regulatory function in
CC       meiotic events that are required for terminal differentiation of
CC       male germ cell (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00530}.
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal and cardiac muscles,
CC       brain, heart and lung. Little or no detectable expression found in
CC       pancreas, kidney, liver or placenta. {ECO:0000269|PubMed:7908264}.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       5 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK098546; BAC05328.1; -; mRNA.
DR   EMBL; BC029532; AAH29532.2; -; mRNA.
DR   EMBL; BX641019; CAE46012.1; -; mRNA.
DR   EMBL; Z21965; CAA79976.1; -; mRNA.
DR   CCDS; CCDS59489.1; -.
DR   RefSeq; NP_694948.1; NM_153216.1.
DR   UniGene; Hs.678995; -.
DR   ProteinModelPortal; Q8N7G0; -.
DR   SMR; Q8N7G0; -.
DR   IntAct; Q8N7G0; 2.
DR   STRING; 9606.ENSP00000464890; -.
DR   iPTMnet; Q8N7G0; -.
DR   PhosphoSitePlus; Q8N7G0; -.
DR   BioMuta; POU5F2; -.
DR   DMDM; 28201897; -.
DR   EPD; Q8N7G0; -.
DR   PaxDb; Q8N7G0; -.
DR   PeptideAtlas; Q8N7G0; -.
DR   PRIDE; Q8N7G0; -.
DR   DNASU; 134187; -.
DR   Ensembl; ENST00000606183; ENSP00000489796; ENSG00000248483.
DR   GeneID; 134187; -.
DR   KEGG; hsa:134187; -.
DR   UCSC; uc003kkl.2; human.
DR   CTD; 134187; -.
DR   EuPathDB; HostDB:ENSG00000248483.5; -.
DR   GeneCards; POU5F2; -.
DR   HGNC; HGNC:26367; POU5F2.
DR   neXtProt; NX_Q8N7G0; -.
DR   OpenTargets; ENSG00000248483; -.
DR   PharmGKB; PA162399970; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOVERGEN; HBG057998; -.
DR   InParanoid; Q8N7G0; -.
DR   OMA; CKMEMIL; -.
DR   OrthoDB; EOG091G0ICI; -.
DR   PhylomeDB; Q8N7G0; -.
DR   GenomeRNAi; 134187; -.
DR   PRO; PR:Q8N7G0; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000248483; -.
DR   CleanEx; HS_POU5F2; -.
DR   Genevisible; Q8N7G0; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR015585; POU_dom_5.
DR   PANTHER; PTHR11636:SF14; PTHR11636:SF14; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    328       POU domain, class 5, transcription factor
FT                                2.
FT                                /FTId=PRO_0000100756.
FT   DOMAIN      118    192       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    210    269       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CONFLICT      2      2       A -> D (in Ref. 2; AAH29532).
FT                                {ECO:0000305}.
FT   CONFLICT    229    229       F -> L (in Ref. 3; CAE46012).
FT                                {ECO:0000305}.
SQ   SEQUENCE   328 AA;  36051 MW;  DD90D7153E69A3ED CRC64;
     MAGHRPSNHF CPLPGSGGGG PRGPMPLRVD TLTWLSTQAA PGRVMVWPAV RPGICPGPDV
     WRIPLGPLPH EFRGWIAPCR PRLGASEAGD WLRRPSEGAL PGPYIALRSI PKLPPPEDIS
     GILKELQQLA KELRQKRLSL GYSQADVGIA VGALFGKVLS QTTICRFEAQ QLSVANMWKL
     RPLLKKWLKE VEAENLLGLC KMEMILQQSG KWRRASRERR IGNSLEKFFQ RCPKPTPQQI
     SHIAGCLQLQ KDVVRVWFYN RSKMGSRPTN DASPREIVGT AGPPCPGAPV CFHLGLGLPV
     DIPHYTRLYS AGVAHSSAPA TTLGLLRF
//
ID   PO2F2_HUMAN             Reviewed;         479 AA.
AC   P09086; Q16648; Q7M4M8; Q9BRS4;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   27-SEP-2017, entry version 193.
DE   RecName: Full=POU domain, class 2, transcription factor 2;
DE   AltName: Full=Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2;
DE   AltName: Full=Octamer-binding protein 2;
DE            Short=Oct-2;
DE   AltName: Full=Octamer-binding transcription factor 2;
DE            Short=OTF-2;
GN   Name=POU2F2; Synonyms=OCT2, OTF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [MRNA]
RP   OF 450-479 (ISOFORM 1).
RX   PubMed=3265124; DOI=10.1101/gad.2.12a.1570;
RA   Clerc R.G., Corcoran L.M., Lebowitz J.H., Baltimore D., Sharp P.A.;
RT   "The B-cell-specific Oct-2 protein contains POU box- and homeo box-
RT   type domains.";
RL   Genes Dev. 2:1570-1581(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=B-cell lymphoma;
RX   PubMed=2904654; DOI=10.1038/336551a0;
RA   Scheidereit C., Cromlish J.A., Gerster T., Kawakami K.,
RA   Balmaceda C.-G., Currie R.A., Roder R.G.;
RT   "A human lymphoid-specific transcription factor that activates
RT   immunoglobulin genes is a homoeobox protein.";
RL   Nature 336:551-557(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-479 (ISOFORM 1).
RC   TISSUE=B-cell;
RX   PubMed=2904653; DOI=10.1038/336544a0;
RA   Mueller M.M., Ruppert S., Schaffner W., Matthias P.;
RT   "A cloned octamer transcription factor stimulates transcription from
RT   lymphoid-specific promoters in non-B cells.";
RL   Nature 336:544-551(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 99-161, AND FUNCTION.
RX   PubMed=2328728;
RA   Muller-Immergluck M.M., Schaffner W., Matthias P.;
RT   "Transcription factor Oct-2A contains functionally redundant
RT   activating domains and works selectively from a promoter but not from
RT   a remote enhancer position in non-lymphoid (HeLa) cells.";
RL   EMBO J. 9:1625-1634(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 168-377.
RX   PubMed=7888080; DOI=10.1515/bchm3.1994.375.10.675;
RA   Matsuo K., Clay O., Kuenzler P., Georgiev O., Urbanek P.,
RA   Schaffner W.;
RT   "Short introns interrupting the Oct-2 POU domain may prevent
RT   recombination between POU family genes without interfering with
RT   potential POU domain 'shuffling' in evolution.";
RL   Biol. Chem. Hoppe-Seyler 375:675-683(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 240-387, AND FUNCTION.
RX   PubMed=2901913; DOI=10.1016/0092-8674(88)90016-5;
RA   Ko H.-S., Fast P., McBride W., Staudt L.M.;
RT   "A human protein specific for the immunoglobulin octamer DNA motif
RT   contains a functional homeobox domain.";
RL   Cell 55:135-144(1988).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 468-479 (ISOFORM 5), AND FUNCTION.
RX   PubMed=1739980; DOI=10.1016/0092-8674(92)90150-B;
RA   Tanaka M., Lai J.-S., Herr W.;
RT   "Promoter-selective activation domains in Oct-1 and Oct-2 direct
RT   differential activation of an snRNA and mRNA promoter.";
RL   Cell 68:755-767(1992).
RN   [10]
RP   IDENTIFICATION (ISOFORM 5), AND TISSUE SPECIFICITY.
RX   PubMed=3072196;
RA   Schreiber E., Matthias P., Mueller M.M., Schaffner W.;
RT   "Identification of a novel lymphoid specific octamer binding protein
RT   (OTF-2B) by proteolytic clipping bandshift assay (PCBA).";
RL   EMBO J. 7:4221-4229(1988).
RN   [11]
RP   INTERACTION WITH NR3C1; AR AND PGR.
RX   PubMed=10480874; DOI=10.1074/jbc.274.38.26713;
RA   Prefontaine G.G., Walther R., Giffin W., Lemieux M.E., Pope L.,
RA   Hache R.J.G.;
RT   "Selective binding of steroid hormone receptors to octamer
RT   transcription factors determines transcriptional synergism at the
RT   mouse mammary tumor virus promoter.";
RL   J. Biol. Chem. 274:26713-26719(1999).
RN   [12]
RP   STRUCTURE BY NMR OF 297-359.
RX   PubMed=7914745; DOI=10.1021/bi00199a005;
RA   Sivaraja M., Botfield M.C., Mueller M., Jancso A., Weiss M.A.;
RT   "Solution structure of a POU-specific homeodomain: 3D-NMR studies of
RT   human B-cell transcription factor Oct-2.";
RL   Biochemistry 33:9845-9855(1994).
CC   -!- FUNCTION: Transcription factor that specifically binds to the
CC       octamer motif (5'-ATTTGCAT-3'). Regulates transcription in a
CC       number of tissues in addition to activating immunoglobulin gene
CC       expression. Modulates transcription transactivation by NR3C1, AR
CC       and PGR. Isoform 5 activates the U2 small nuclear RNA (snRNA)
CC       promoter. {ECO:0000269|PubMed:1739980, ECO:0000269|PubMed:2328728,
CC       ECO:0000269|PubMed:2901913, ECO:0000269|PubMed:2904654}.
CC   -!- SUBUNIT: Interacts with NR3C1, AR and PGR.
CC       {ECO:0000269|PubMed:10480874}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P09086-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09086-2; Sequence=VSP_002325;
CC       Name=3;
CC         IsoId=P09086-3; Sequence=VSP_002324;
CC       Name=4;
CC         IsoId=P09086-4; Sequence=VSP_002324, VSP_007848, VSP_007849;
CC       Name=5; Synonyms=Oct-2B;
CC         IsoId=P09086-5; Sequence=VSP_032187;
CC         Note=Incomplete sequence.;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is B-cell specific. Isoform 5 is
CC       expressed in B-cells and the immunoglobulin-expressing T-cell line
CC       MOLT-4, but not in the T-cell line BW5147.
CC       {ECO:0000269|PubMed:2904654, ECO:0000269|PubMed:3072196}.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       2 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA32039.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M36653; AAA36389.1; -; mRNA.
DR   EMBL; X53468; CAA37562.1; -; mRNA.
DR   EMBL; X53469; CAA37565.1; -; mRNA.
DR   EMBL; M36542; AAA36732.1; -; mRNA.
DR   EMBL; X13810; CAA32040.1; -; mRNA.
DR   EMBL; BT007438; AAP36106.1; -; mRNA.
DR   EMBL; BC006101; AAH06101.1; -; mRNA.
DR   EMBL; M36718; AAA59978.1; -; mRNA.
DR   EMBL; X13809; CAA32039.1; ALT_INIT; mRNA.
DR   EMBL; X81030; CAA56933.1; -; Genomic_DNA.
DR   CCDS; CCDS33035.1; -. [P09086-3]
DR   CCDS; CCDS56094.1; -. [P09086-2]
DR   CCDS; CCDS56095.1; -. [P09086-1]
DR   CCDS; CCDS58665.1; -. [P09086-4]
DR   PIR; A31753; A31753.
DR   PIR; A42098; A42098.
DR   RefSeq; NP_001193954.1; NM_001207025.2. [P09086-1]
DR   RefSeq; NP_001193955.1; NM_001207026.1. [P09086-2]
DR   RefSeq; NP_001234923.1; NM_001247994.1. [P09086-4]
DR   RefSeq; NP_002689.1; NM_002698.4. [P09086-3]
DR   UniGene; Hs.147381; -.
DR   PDB; 1HDP; NMR; -; A=297-359.
DR   PDBsum; 1HDP; -.
DR   ProteinModelPortal; P09086; -.
DR   SMR; P09086; -.
DR   BioGrid; 111448; 19.
DR   CORUM; P09086; -.
DR   DIP; DIP-51N; -.
DR   IntAct; P09086; 6.
DR   MINT; MINT-194986; -.
DR   STRING; 9606.ENSP00000431603; -.
DR   BindingDB; P09086; -.
DR   ChEMBL; CHEMBL3509582; -.
DR   DrugBank; DB08930; Dolutegravir.
DR   iPTMnet; P09086; -.
DR   PhosphoSitePlus; P09086; -.
DR   BioMuta; POU2F2; -.
DR   DMDM; 123402; -.
DR   MaxQB; P09086; -.
DR   PaxDb; P09086; -.
DR   PeptideAtlas; P09086; -.
DR   PRIDE; P09086; -.
DR   DNASU; 5452; -.
DR   Ensembl; ENST00000389341; ENSP00000373992; ENSG00000028277. [P09086-3]
DR   Ensembl; ENST00000526816; ENSP00000431603; ENSG00000028277. [P09086-1]
DR   Ensembl; ENST00000529067; ENSP00000437224; ENSG00000028277. [P09086-4]
DR   Ensembl; ENST00000529952; ENSP00000436988; ENSG00000028277. [P09086-2]
DR   GeneID; 5452; -.
DR   KEGG; hsa:5452; -.
DR   UCSC; uc002osn.4; human. [P09086-1]
DR   CTD; 5452; -.
DR   DisGeNET; 5452; -.
DR   EuPathDB; HostDB:ENSG00000028277.20; -.
DR   GeneCards; POU2F2; -.
DR   HGNC; HGNC:9213; POU2F2.
DR   HPA; CAB002513; -.
DR   HPA; HPA040368; -.
DR   HPA; HPA062096; -.
DR   HPA; HPA064404; -.
DR   MIM; 164176; gene.
DR   neXtProt; NX_P09086; -.
DR   OpenTargets; ENSG00000028277; -.
DR   PharmGKB; PA33537; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000220842; -.
DR   HOVERGEN; HBG052783; -.
DR   InParanoid; P09086; -.
DR   KO; K09364; -.
DR   PhylomeDB; P09086; -.
DR   TreeFam; TF316413; -.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   SIGNOR; P09086; -.
DR   ChiTaRS; POU2F2; human.
DR   EvolutionaryTrace; P09086; -.
DR   GenomeRNAi; 5452; -.
DR   PRO; PR:P09086; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000028277; -.
DR   CleanEx; HS_POU2F2; -.
DR   ExpressionAtlas; P09086; baseline and differential.
DR   Genevisible; P09086; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0006959; P:humoral immune response; TAS:ProtInc.
DR   GO; GO:0002380; P:immunoglobulin secretion involved in immune response; IEA:Ensembl.
DR   GO; GO:0002335; P:mature B cell differentiation; IEA:Ensembl.
DR   GO; GO:0042795; P:snRNA transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR000972; TF_octamer.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00029; OCTAMER.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Cytoplasm; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    479       POU domain, class 2, transcription factor
FT                                2.
FT                                /FTId=PRO_0000100714.
FT   DOMAIN      195    269       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    297    356       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION      389    410       Leucine-zipper.
FT   COMPBIAS    417    424       Gly-rich.
FT   VAR_SEQ     168    183       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2904654,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_002324.
FT   VAR_SEQ     400    416       VTTLSSAVGTLHPSRTA -> AQTPALKAATRLSACQA
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_007848.
FT   VAR_SEQ     417    479       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_007849.
FT   VAR_SEQ     468    479       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:3265124}.
FT                                /FTId=VSP_002325.
FT   VAR_SEQ     468    479       PGLWWNPAPYQP -> STMVGLSSGLSPALMSNNPLATIQA
FT                                LASGGTLPLTSLDGSGNLVLGAAGAAPGSPSLVTSPLFLNH
FT                                TGLPLLSAPPGVGLVSAAAAAVAASISSKSPGLSSSSSSSS
FT                                SSSSSTCSDVAAQTPGGPGGPEAGSKAE (in isoform
FT                                5). {ECO:0000303|PubMed:1739980}.
FT                                /FTId=VSP_032187.
FT   MUTAGEN     340    342       VIR->FNP: Suppresses DNA-binding ability.
FT   HELIX       307    318       {ECO:0000244|PDB:1HDP}.
FT   HELIX       324    331       {ECO:0000244|PDB:1HDP}.
FT   TURN        332    335       {ECO:0000244|PDB:1HDP}.
FT   HELIX       338    350       {ECO:0000244|PDB:1HDP}.
FT   TURN        356    358       {ECO:0000244|PDB:1HDP}.
SQ   SEQUENCE   479 AA;  51209 MW;  8DA661DC07644D43 CRC64;
     MVHSSMGAPE IRMSKPLEAE KQGLDSPSEH TDTERNGPDT NHQNPQNKTS PFSVSPTGPS
     TKIKAEDPSG DSAPAAPLPP QPAQPHLPQA QLMLTGSQLA GDIQQLLQLQ QLVLVPGHHL
     QPPAQFLLPQ AQQSQPGLLP TPNLFQLPQQ TQGALLTSQP RAGLPTQAVT RPTLPDPHLS
     HPQPPKCLEP PSHPEEPSDL EELEQFARTF KQRRIKLGFT QGDVGLAMGK LYGNDFSQTT
     ISRFEALNLS FKNMCKLKPL LEKWLNDAET MSVDSSLPSP NQLSSPSLGF DGLPGRRRKK
     RTSIETNVRF ALEKSFLANQ KPTSEEILLI AEQLHMEKEV IRVWFCNRRQ KEKRINPCSA
     APMLPSPGKP ASYSPHMVTP QGGAGTLPLS QASSSLSTTV TTLSSAVGTL HPSRTAGGGG
     GGGGAAPPLN SIPSVTPPPP ATTNSTNPSP QGSHSAIGLS GLNPSTGPGL WWNPAPYQP
//
ID   PO3F2_HUMAN             Reviewed;         443 AA.
AC   P20265; Q14960; Q86V54; Q9UJL0;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 4.
DT   27-SEP-2017, entry version 183.
DE   RecName: Full=POU domain, class 3, transcription factor 2;
DE   AltName: Full=Brain-specific homeobox/POU domain protein 2;
DE            Short=Brain-2;
DE            Short=Brn-2;
DE   AltName: Full=Nervous system-specific octamer-binding transcription factor N-Oct-3;
DE   AltName: Full=Octamer-binding protein 7;
DE            Short=Oct-7;
DE   AltName: Full=Octamer-binding transcription factor 7;
DE            Short=OTF-7;
GN   Name=POU3F2; Synonyms=BRN2, OCT7, OTF7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8441633; DOI=10.1093/nar/21.2.253;
RA   Schreiber E., Tobler A., Malipiero U., Schaffner W., Fontana A.;
RT   "cDNA cloning of human N-Oct3, a nervous-system specific POU domain
RT   transcription factor binding to the octamer DNA motif.";
RL   Nucleic Acids Res. 21:253-258(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=7651733;
RA   Angus J., Thomson F., Murphy K., Baker E., Sutherland G.R.,
RA   Parsons P.G., Sturm R.A.;
RT   "The brn-2 gene regulates the melanocytic phenotype and tumorigenic
RT   potential of human melanoma cells.";
RL   Oncogene 11:691-700(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 280-404.
RC   TISSUE=Brain;
RX   PubMed=2739723; DOI=10.1038/340035a0;
RA   He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W.,
RA   Rosenfeld M.G.;
RT   "Expression of a large family of POU-domain regulatory genes in
RT   mammalian brain development.";
RL   Nature 340:35-42(1989).
RN   [6]
RP   INTERACTION WITH PQBP1.
RC   TISSUE=Brain;
RX   PubMed=10332029; DOI=10.1093/hmg/8.6.977;
RA   Waragai M., Lammers C.-H., Takeuchi S., Imafuku I., Udagawa Y.,
RA   Kanazawa I., Kawabata M., Mouradian M.M., Okazawa H.;
RT   "PQBP-1, a novel polyglutamine tract binding protein, inhibits
RT   transcription activation by Brn-2 and affects cell survival.";
RL   Hum. Mol. Genet. 8:977-987(1999).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Transcription factor that plays a key role in neuronal
CC       differentiation (By similarity). Binds preferentially to the
CC       recognition sequence which consists of two distinct half-sites,
CC       ('GCAT') and ('TAAT'), separated by a non-conserved spacer region
CC       of 0, 2, or 3 nucleotides (By similarity). The combination of
CC       three transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, is
CC       sufficient to reprogram fibroblasts and other somatic cells into
CC       induced neuronal (iN) cells in vitro. Acts downstream of ASCL1,
CC       accessing chromatin that has been opened by ASCL1, and promotes
CC       transcription of neuronal genes (By similarity).
CC       {ECO:0000250|UniProtKB:P31360, ECO:0000250|UniProtKB:P56222}.
CC   -!- SUBUNIT: Interacts with PQBP1 (PubMed:10332029). Interaction with
CC       ISL1 (By similarity). {ECO:0000250|UniProtKB:P31360,
CC       ECO:0000269|PubMed:10332029}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1167176, EBI-1167176;
CC       Q09472:EP300; NbExp=3; IntAct=EBI-1167176, EBI-447295;
CC       P23760:PAX3; NbExp=2; IntAct=EBI-1167176, EBI-1167564;
CC       P56693:SOX10; NbExp=3; IntAct=EBI-1167176, EBI-1167533;
CC       P20226:TBP; NbExp=2; IntAct=EBI-1167176, EBI-355371;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=3;
CC       Name=N-OCT 3;
CC         IsoId=P20265-1; Sequence=Displayed;
CC       Name=N-OCT 5A;
CC         IsoId=P20265-2; Sequence=VSP_018749;
CC       Name=N-OCT 5B;
CC         IsoId=P20265-3; Sequence=VSP_018750;
CC   -!- TISSUE SPECIFICITY: Expressed specifically in the neuroectodermal
CC       cell lineage.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11933; CAA77990.1; -; mRNA.
DR   EMBL; L37868; AAB59611.1; -; Genomic_DNA.
DR   EMBL; AL022395; CAB37982.1; -; Genomic_DNA.
DR   EMBL; BC051699; AAH51699.2; -; mRNA.
DR   CCDS; CCDS5040.1; -. [P20265-1]
DR   PIR; S29334; S29334.
DR   RefSeq; NP_005595.2; NM_005604.3. [P20265-1]
DR   UniGene; Hs.182505; -.
DR   ProteinModelPortal; P20265; -.
DR   SMR; P20265; -.
DR   BioGrid; 111450; 8.
DR   IntAct; P20265; 6.
DR   MINT; MINT-2801637; -.
DR   STRING; 9606.ENSP00000329170; -.
DR   BindingDB; P20265; -.
DR   ChEMBL; CHEMBL4189; -.
DR   iPTMnet; P20265; -.
DR   PhosphoSitePlus; P20265; -.
DR   BioMuta; POU3F2; -.
DR   DMDM; 78100757; -.
DR   MaxQB; P20265; -.
DR   PaxDb; P20265; -.
DR   PeptideAtlas; P20265; -.
DR   PRIDE; P20265; -.
DR   Ensembl; ENST00000328345; ENSP00000329170; ENSG00000184486. [P20265-1]
DR   GeneID; 5454; -.
DR   KEGG; hsa:5454; -.
DR   UCSC; uc003ppe.4; human. [P20265-1]
DR   CTD; 5454; -.
DR   DisGeNET; 5454; -.
DR   EuPathDB; HostDB:ENSG00000184486.8; -.
DR   GeneCards; POU3F2; -.
DR   HGNC; HGNC:9215; POU3F2.
DR   HPA; HPA047081; -.
DR   HPA; HPA056261; -.
DR   MIM; 600494; gene.
DR   neXtProt; NX_P20265; -.
DR   OpenTargets; ENSG00000184486; -.
DR   PharmGKB; PA33539; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116303; -.
DR   HOVERGEN; HBG053120; -.
DR   InParanoid; P20265; -.
DR   KO; K09365; -.
DR   OMA; SFTVNGM; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; P20265; -.
DR   TreeFam; TF316413; -.
DR   SignaLink; P20265; -.
DR   SIGNOR; P20265; -.
DR   ChiTaRS; POU3F2; human.
DR   GeneWiki; POU3F2; -.
DR   GenomeRNAi; 5454; -.
DR   PRO; PR:P20265; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000184486; -.
DR   CleanEx; HS_POU3F2; -.
DR   Genevisible; P20265; HS.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0014002; P:astrocyte development; IEA:Ensembl.
DR   GO; GO:0071310; P:cellular response to organic substance; IEA:Ensembl.
DR   GO; GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl.
DR   GO; GO:0008544; P:epidermis development; IEA:Ensembl.
DR   GO; GO:0021869; P:forebrain ventricular zone progenitor cell division; IEA:Ensembl.
DR   GO; GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0021985; P:neurohypophysis development; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0048663; P:neuron fate commitment; ISS:UniProtKB.
DR   GO; GO:0048665; P:neuron fate specification; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:MGI.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0050770; P:regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR016362; TF_POU_3.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PIRSF; PIRSF002629; Transcription_factor_POU; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative initiation; Complete proteome; Differentiation;
KW   DNA-binding; Homeobox; Neurogenesis; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    443       POU domain, class 3, transcription factor
FT                                2.
FT                                /FTId=PRO_0000013495.
FT   DOMAIN      262    336       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    354    413       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     68     90       Poly-Gly.
FT   COMPBIAS    125    149       Poly-Gln.
FT   MOD_RES     341    341       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VAR_SEQ       1    199       Missing (in isoform N-OCT 5B).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018750.
FT   VAR_SEQ       1    180       Missing (in isoform N-OCT 5A).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018749.
FT   CONFLICT     26     26       G -> A (in Ref. 1; CAA77990).
FT                                {ECO:0000305}.
FT   CONFLICT    170    170       S -> T (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    207    207       P -> S (in Ref. 4; AAH51699).
FT                                {ECO:0000305}.
SQ   SEQUENCE   443 AA;  46893 MW;  D470360894D788C6 CRC64;
     MATAASNHYS LLTSSASIVH AEPPGGMQQG AGGYREAQSL VQGDYGALQS NGHPLSHAHQ
     WITALSHGGG GGGGGGGGGG GGGGGGGGDG SPWSTSPLGQ PDIKPSVVVQ QGGRGDELHG
     PGALQQQHQQ QQQQQQQQQQ QQQQQQQQQR PPHLVHHAAN HHPGPGAWRS AAAAAHLPPS
     MGASNGGLLY SQPSFTVNGM LGAGGQPAGL HHHGLRDAHD EPHHADHHPH PHSHPHQQPP
     PPPPPQGPPG HPGAHHDPHS DEDTPTSDDL EQFAKQFKQR RIKLGFTQAD VGLALGTLYG
     NVFSQTTICR FEALQLSFKN MCKLKPLLNK WLEEADSSSG SPTSIDKIAA QGRKRKKRTS
     IEVSVKGALE SHFLKCPKPS AQEITSLADS LQLEKEVVRV WFCNRRQKEK RMTPPGGTLP
     GAEDVYGGSR DTPPHHGVQT PVQ
//
ID   PO4F1_HUMAN             Reviewed;         419 AA.
AC   Q01851; Q14986; Q15318; Q5T227;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 4.
DT   25-OCT-2017, entry version 167.
DE   RecName: Full=POU domain, class 4, transcription factor 1 {ECO:0000312|HGNC:HGNC:9218};
DE   AltName: Full=Brain-specific homeobox/POU domain protein 3A;
DE            Short=Brain-3A;
DE            Short=Brn-3A;
DE   AltName: Full=Homeobox/POU domain protein RDC-1;
DE   AltName: Full=Oct-T1;
GN   Name=POU4F1 {ECO:0000312|HGNC:HGNC:9218};
GN   Synonyms=BRN3A, RDC1 {ECO:0000303|PubMed:1357630};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND DEVELOPMENTAL STAGE.
RC   TISSUE=Placenta;
RX   PubMed=1357630; DOI=10.1093/nar/20.18.4919;
RA   Collum R.G., Fisher P.E., Datta M., Mellis S., Thiele C., Huebner K.,
RA   Croce C.M., Israel M.A., Theil T., Moroy T., DePinho R.A., Alt F.W.;
RT   "A novel POU homeodomain gene specifically expressed in cells of the
RT   developing mammalian nervous system.";
RL   Nucleic Acids Res. 20:4919-4925(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8234287; DOI=10.1073/pnas.90.21.10260;
RA   Bhargava A.K., Li Z., Weissman S.M.;
RT   "Differential expression of four members of the POU family of proteins
RT   in activated and phorbol 12-myristate 13-acetate-treated Jurkat T
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10260-10264(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=7623109;
RA   Xiang M., Zhou L.-J., Macke J.P., Yoshioka T., Hendry S.H., Eddy R.L.,
RA   Shows T.B., Nathans J.;
RT   "The Brn-3 family of POU-domain factors: primary structure, binding
RT   specificity, and expression in subsets of retinal ganglion cells and
RT   somatosensory neurons.";
RL   J. Neurosci. 15:4762-4785(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-163
RP   DEL.
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-163
RP   DEL.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12934100; DOI=10.1038/sj.onc.1206635;
RA   Calissano M., Latchman D.S.;
RT   "Functional interaction between the small GTP-binding protein Rin and
RT   the N-terminal of Brn-3a transcription factor.";
RL   Oncogene 22:5408-5414(2003).
CC   -!- FUNCTION: Multifunctional transcription factor with different
CC       regions mediating its different effects. Acts by binding (via its
CC       C-terminal domain) to sequences related to the consensus octamer
CC       motif 5'-ATGCAAAT-3' in the regulatory regions of its target
CC       genes. Regulates the expression of specific genes involved in
CC       differentiation and survival within a subset of neuronal lineages.
CC       It has been shown that activation of some of these genes requires
CC       its N-terminal domain, maybe through a neuronal-specific cofactor.
CC       Ativates BCL2 expression and protects neuronal cells from
CC       apoptosis (via the N-terminal domain). Induces neuronal process
CC       outgrowth and the coordinate expression of genes encoding synaptic
CC       proteins. Exerts its major developmental effects in somatosensory
CC       neurons and in brainstem nuclei involved in motor control.
CC       Stimulates the binding affinity of the nuclear estrogene receptor
CC       ESR1 to DNA estrogen response element (ERE), and hence modulates
CC       ESR1-induced transcriptional activity. May positively regulate
CC       POU4F2 and POU4F3. Regulates dorsal root ganglion sensory neuron
CC       specification and axonal projection into the spinal cord. Plays a
CC       role in TNFSF11-mediated terminal osteoclast differentiation.
CC       Negatively regulates its own expression interacting directly with
CC       a highly conserved autoregulatory domain surrounding the
CC       transcription initiation site. {ECO:0000250|UniProtKB:P17208}.
CC   -!- FUNCTION: Isoform 2: Able to act as transcription factor, cannot
CC       regulate the expression of the same subset of genes than isoform
CC       1. Does not have antiapoptotic effect on neuronal cells.
CC       {ECO:0000250|UniProtKB:P17208}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with RIT2; the interaction
CC       controls POU4F1 transactivation activity on some neuronal target
CC       genes. Isoform 1 interacts with POU4F2; this interaction inhibits
CC       both POU4F1 DNA-binding and transcriptional activities. Isoform 1
CC       interacts (C-terminus) with ESR1 (via DNA-binding domain); this
CC       interaction decreases the estrogen receptor ESR1 transcriptional
CC       activity in a DNA- and ligand 17-beta-estradiol-independent
CC       manner. {ECO:0000250|UniProtKB:P17208}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12934100}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P17208}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Brn-3A-Long {ECO:0000305};
CC         IsoId=Q01851-1; Sequence=Displayed;
CC       Name=2; Synonyms=Brn-3A-Short {ECO:0000305};
CC         IsoId=Q01851-2; Sequence=VSP_058636;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain and the retina. Present
CC       in the developing brain, spinal cord and eye.
CC       {ECO:0000269|PubMed:1357630, ECO:0000269|PubMed:7623109}.
CC   -!- DEVELOPMENTAL STAGE: Expression peaks early in embryogenesis (day
CC       13.5) and is undetectable 14 days after birth.
CC       {ECO:0000269|PubMed:1357630}.
CC   -!- DOMAIN: The C-terminal domain is able to act as both DNA-binding
CC       domain and a transcriptional activator. The N-terminal domain is
CC       also required for transactivation acitvitty on some target genes
CC       acting as a discrete activation domain. Neurite outgrowth and
CC       expression of genes required for synapse formation are primarily
CC       dependent on the C-terminal domain, however the N-terminal domain
CC       is required for maximal induction. {ECO:0000250|UniProtKB:P17208}.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       4 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA45907.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/POU4F1ID44173ch13q31.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20433; AAA65605.1; -; mRNA.
DR   EMBL; U10063; AAA57161.1; -; Genomic_DNA.
DR   EMBL; U10062; AAA57161.1; JOINED; Genomic_DNA.
DR   EMBL; AL445209; CAI15184.1; -; Genomic_DNA.
DR   EMBL; CH471093; EAW80585.1; -; Genomic_DNA.
DR   EMBL; X64624; CAA45907.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS31996.1; -. [Q01851-1]
DR   PIR; I59234; I59234.
DR   PIR; S78452; S78452.
DR   RefSeq; NP_006228.3; NM_006237.3. [Q01851-1]
DR   UniGene; Hs.654522; -.
DR   ProteinModelPortal; Q01851; -.
DR   SMR; Q01851; -.
DR   BioGrid; 111453; 3.
DR   STRING; 9606.ENSP00000366413; -.
DR   iPTMnet; Q01851; -.
DR   PhosphoSitePlus; Q01851; -.
DR   BioMuta; POU4F1; -.
DR   DMDM; 334302933; -.
DR   PaxDb; Q01851; -.
DR   PeptideAtlas; Q01851; -.
DR   PRIDE; Q01851; -.
DR   DNASU; 5457; -.
DR   Ensembl; ENST00000377208; ENSP00000366413; ENSG00000152192. [Q01851-1]
DR   GeneID; 5457; -.
DR   KEGG; hsa:5457; -.
DR   UCSC; uc001vkv.4; human. [Q01851-1]
DR   CTD; 5457; -.
DR   DisGeNET; 5457; -.
DR   EuPathDB; HostDB:ENSG00000152192.7; -.
DR   GeneCards; POU4F1; -.
DR   HGNC; HGNC:9218; POU4F1.
DR   HPA; HPA068024; -.
DR   MIM; 601632; gene.
DR   neXtProt; NX_Q01851; -.
DR   OpenTargets; ENSG00000152192; -.
DR   PharmGKB; PA33542; -.
DR   eggNOG; KOG1168; Eukaryota.
DR   eggNOG; ENOG410XPNX; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116305; -.
DR   HOVERGEN; HBG031829; -.
DR   InParanoid; Q01851; -.
DR   KO; K09366; -.
DR   OMA; KYTTLHS; -.
DR   OrthoDB; EOG091G0WBK; -.
DR   PhylomeDB; Q01851; -.
DR   TreeFam; TF316413; -.
DR   Reactome; R-HSA-6804759; Regulation of TP53 Activity through Association with Co-factors.
DR   SIGNOR; Q01851; -.
DR   GeneWiki; POU4F1; -.
DR   GenomeRNAi; 5457; -.
DR   PRO; PR:Q01851; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000152192; -.
DR   CleanEx; HS_POU4F1; -.
DR   Genevisible; Q01851; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0051020; F:GTPase binding; IEA:Ensembl.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; ISS:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007409; P:axonogenesis; TAS:BHF-UCL.
DR   GO; GO:0021535; P:cell migration in hindbrain; IEA:Ensembl.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB.
DR   GO; GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021986; P:habenula development; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; TAS:BHF-UCL.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; ISS:UniProtKB.
DR   GO; GO:2001208; P:negative regulation of transcription elongation from RNA polymerase I promoter; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0048665; P:neuron fate specification; ISS:BHF-UCL.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; ISS:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; ISS:UniProtKB.
DR   GO; GO:0051355; P:proprioception involved in equilibrioception; IEA:Ensembl.
DR   GO; GO:0050767; P:regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0048880; P:sensory system development; ISS:BHF-UCL.
DR   GO; GO:0001967; P:suckling behavior; IEA:Ensembl.
DR   GO; GO:0007416; P:synapse assembly; TAS:ProtInc.
DR   GO; GO:0021559; P:trigeminal nerve development; ISS:BHF-UCL.
DR   GO; GO:0003223; P:ventricular compact myocardium morphogenesis; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00093; HTH_XRE; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR015584; POU4-TF1.
DR   InterPro; IPR000327; POU_dom.
DR   PANTHER; PTHR11636:SF42; PTHR11636:SF42; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Developmental protein; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    419       POU domain, class 4, transcription factor
FT                                1.
FT                                /FTId=PRO_0000100736.
FT   DOMAIN      261    338       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    356    415       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF        57     66       POU-IV box.
FT   COMPBIAS    100    108       Poly-His.
FT   COMPBIAS    130    186       Gly-rich.
FT   COMPBIAS    204    257       Ala-rich.
FT   VAR_SEQ       1     84       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_058636.
FT   VARIANT     163    163       Missing.
FT                                /FTId=VAR_046449.
FT   CONFLICT     91     92       TS -> H (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT     99     99       A -> R (in Ref. 3; AAA57161).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       A -> AGAG (in Ref. 3; AAA57161).
FT                                {ECO:0000305}.
FT   CONFLICT    146    147       GP -> AA (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT    152    153       GP -> PR (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT    159    159       P -> PG (in Ref. 2; AAA65605, 3; AAA57161
FT                                and 1; CAA45907). {ECO:0000305}.
FT   CONFLICT    170    171       GP -> AA (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT    185    185       G -> A (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT    236    236       A -> S (in Ref. 2; AAA65605).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       Missing (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT    252    252       A -> R (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
FT   CONFLICT    272    274       AER -> GS (in Ref. 1; CAA45907).
FT                                {ECO:0000305}.
SQ   SEQUENCE   419 AA;  42697 MW;  6EDC2A2082F95F23 CRC64;
     MMSMNSKQPH FAMHPTLPEH KYPSLHSSSE AIRRACLPTP PLQSNLFASL DETLLARAEA
     LAAVDIAVSQ GKSHPFKPDA TYHTMNSVPC TSTSTVPLAH HHHHHHHHQA LEPGDLLDHI
     SSPSLALMAG AGGAGAAAGG GGAHDGPGGG GGPGGGGGPG GGPGGGGGGG PGGGGGGPGG
     GLLGGSAHPH PHMHSLGHLS HPAAAAAMNM PSGLPHPGLV AAAAHHGAAA AAAAAAAGQV
     AAASAAAAVV GAAGLASICD SDTDPRELEA FAERFKQRRI KLGVTQADVG SALANLKIPG
     VGSLSQSTIC RFESLTLSHN NMIALKPILQ AWLEEAEGAQ REKMNKPELF NGGEKKRKRT
     SIAAPEKRSL EAYFAVQPRP SSEKIAAIAE KLDLKKNVVR VWFCNQRQKQ KRMKFSATY
//
ID   PO3F1_HUMAN             Reviewed;         451 AA.
AC   Q03052; Q5TAG2;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 3.
DT   27-SEP-2017, entry version 161.
DE   RecName: Full=POU domain, class 3, transcription factor 1;
DE   AltName: Full=Octamer-binding protein 6;
DE            Short=Oct-6;
DE   AltName: Full=Octamer-binding transcription factor 6;
DE            Short=OTF-6;
DE   AltName: Full=POU domain transcription factor SCIP;
GN   Name=POU3F1; Synonyms=OCT6, OTF6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7909356; DOI=10.1128/MCB.14.5.3263;
RA   Faus I., Hsu H.J., Fuchs E.;
RT   "Oct-6: a regulator of keratinocyte gene expression in stratified
RT   squamous epithelia.";
RL   Mol. Cell. Biol. 14:3263-3275(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 53-451.
RX   PubMed=8451175; DOI=10.1093/nar/21.4.1043;
RA   Tobler A., Schreiber E., Fontana A.;
RT   "The human Oct-6 POU transcription factor lacks the first 50 amino
RT   acids of its murine counterpart.";
RL   Nucleic Acids Res. 21:1043-1043(1993).
CC   -!- FUNCTION: Transcription factor that binds to the octamer motif
CC       (5'-ATTTGCAT-3'). Thought to be involved in early embryogenesis
CC       and neurogenesis.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in embryonal stem cells and in the
CC       developing brain.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L26494; AAA59965.1; -; mRNA.
DR   EMBL; AL139158; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07298.1; -; Genomic_DNA.
DR   EMBL; Z18284; CAA79158.1; -; mRNA.
DR   CCDS; CCDS30679.1; -.
DR   PIR; A56018; A56018.
DR   RefSeq; NP_002690.3; NM_002699.3.
DR   UniGene; Hs.1837; -.
DR   ProteinModelPortal; Q03052; -.
DR   SMR; Q03052; -.
DR   BioGrid; 111449; 1.
DR   DIP; DIP-277N; -.
DR   STRING; 9606.ENSP00000362103; -.
DR   BioMuta; POU3F1; -.
DR   DMDM; 218512119; -.
DR   EPD; Q03052; -.
DR   MaxQB; Q03052; -.
DR   PaxDb; Q03052; -.
DR   PeptideAtlas; Q03052; -.
DR   PRIDE; Q03052; -.
DR   DNASU; 5453; -.
DR   Ensembl; ENST00000373012; ENSP00000362103; ENSG00000185668.
DR   GeneID; 5453; -.
DR   KEGG; hsa:5453; -.
DR   UCSC; uc001ccp.2; human.
DR   CTD; 5453; -.
DR   DisGeNET; 5453; -.
DR   EuPathDB; HostDB:ENSG00000185668.6; -.
DR   GeneCards; POU3F1; -.
DR   H-InvDB; HIX0028895; -.
DR   HGNC; HGNC:9214; POU3F1.
DR   HPA; HPA055980; -.
DR   HPA; HPA073824; -.
DR   MIM; 602479; gene.
DR   neXtProt; NX_Q03052; -.
DR   OpenTargets; ENSG00000185668; -.
DR   PharmGKB; PA33538; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116303; -.
DR   HOVERGEN; HBG053120; -.
DR   InParanoid; Q03052; -.
DR   KO; K09365; -.
DR   OMA; MEDVYSQ; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; Q03052; -.
DR   TreeFam; TF316413; -.
DR   SignaLink; Q03052; -.
DR   SIGNOR; Q03052; -.
DR   GeneWiki; POU3F1; -.
DR   GenomeRNAi; 5453; -.
DR   PRO; PR:Q03052; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185668; -.
DR   CleanEx; HS_POU3F1; -.
DR   Genevisible; Q03052; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0008366; P:axon ensheathment; TAS:ProtInc.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; IEA:Ensembl.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR016362; TF_POU_3.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PIRSF; PIRSF002629; Transcription_factor_POU; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    451       POU domain, class 3, transcription factor
FT                                1.
FT                                /FTId=PRO_0000100720.
FT   DOMAIN      247    321       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    339    398       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     27     45       Ala-rich.
FT   COMPBIAS     59    242       Gly-rich.
FT   COMPBIAS    225    228       Poly-Ala.
FT   COMPBIAS    418    423       Poly-Gly.
FT   COMPBIAS    430    435       Poly-Pro.
FT   COMPBIAS    439    444       Poly-His.
FT   CONFLICT     27     28       Missing (in Ref. 1; AAA59965).
FT                                {ECO:0000305}.
FT   CONFLICT     87     88       GP -> A (in Ref. 1; AAA59965 and 4;
FT                                CAA79158). {ECO:0000305}.
SQ   SEQUENCE   451 AA;  45496 MW;  563217BD6A3D00CD CRC64;
     MATTAQYLPR GPGGGAGGTG PLMHPDAAAA AAAAAAAERL HAGAAYREVQ KLMHHEWLGA
     GAGHPVGLAH PQWLPTGGGG GGDWAGGPHL EHGKAGGGGT GRADDGGGGG GFHARLVHQG
     AAHAGAAWAQ GSTAHHLGPA MSPSPGASGG HQPQPLGLYA QAAYPGGGGG GLAGMLAAGG
     GGAGPGLHHA LHEDGHEAQL EPSPPPHLGA HGHAHGHAHA GGLHAAAAHL HPGAGGGGSS
     VGEHSDEDAP SSDDLEQFAK QFKQRRIKLG FTQADVGLAL GTLYGNVFSQ TTICRFEALQ
     LSFKNMCKLK PLLNKWLEET DSSSGSPTNL DKIAAQGRKR KKRTSIEVGV KGALESHFLK
     CPKPSAHEIT GLADSLQLEK EVVRVWFCNR RQKEKRMTPA AGAGHPPMDD VYAPGELGPG
     GGGASPPSAP PPPPPAALHH HHHHTLPGSV Q
//
ID   PO3F3_HUMAN             Reviewed;         500 AA.
AC   P20264; P78379; Q4ZG25;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   25-OCT-2017, entry version 162.
DE   RecName: Full=POU domain, class 3, transcription factor 3;
DE   AltName: Full=Brain-specific homeobox/POU domain protein 1;
DE            Short=Brain-1;
DE            Short=Brn-1;
DE   AltName: Full=Octamer-binding protein 8;
DE            Short=Oct-8;
DE   AltName: Full=Octamer-binding transcription factor 8;
DE            Short=OTF-8;
GN   Name=POU3F3; Synonyms=BRN1, OTF8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8703082; DOI=10.1007/BF02338824;
RA   Sumiyama K., Washio-Watanabe K., Saitou N., Hayakawa T., Ueda S.;
RT   "Class III POU genes: generation of homopolymeric amino acid repeats
RT   under GC pressure in mammals.";
RL   J. Mol. Evol. 43:170-178(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 332-456.
RC   TISSUE=Brain;
RX   PubMed=2739723; DOI=10.1038/340035a0;
RA   He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W.,
RA   Rosenfeld M.G.;
RT   "Expression of a large family of POU-domain regulatory genes in
RT   mammalian brain development.";
RL   Nature 340:35-42(1989).
CC   -!- FUNCTION: Transcription factor that acts synergistically with
CC       SOX11 and SOX4. Plays a role in neuronal development. Is
CC       implicated in an enhancer activity at the embryonic met-
CC       mesencephalic junction; the enhancer element contains the octamer
CC       motif (5'-ATTTGCAT-3') (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB001835; BAA19459.1; -; Genomic_DNA.
DR   EMBL; AC018730; AAX88973.1; -; Genomic_DNA.
DR   CCDS; CCDS33265.1; -.
DR   RefSeq; NP_006227.1; NM_006236.2.
DR   UniGene; Hs.248158; -.
DR   ProteinModelPortal; P20264; -.
DR   SMR; P20264; -.
DR   BioGrid; 111451; 1.
DR   IntAct; P20264; 2.
DR   MINT; MINT-1410140; -.
DR   STRING; 9606.ENSP00000355001; -.
DR   BindingDB; P20264; -.
DR   ChEMBL; CHEMBL5243; -.
DR   iPTMnet; P20264; -.
DR   PhosphoSitePlus; P20264; -.
DR   BioMuta; POU3F3; -.
DR   DMDM; 2506534; -.
DR   MaxQB; P20264; -.
DR   PaxDb; P20264; -.
DR   PeptideAtlas; P20264; -.
DR   PRIDE; P20264; -.
DR   DNASU; 5455; -.
DR   Ensembl; ENST00000361360; ENSP00000355001; ENSG00000198914.
DR   GeneID; 5455; -.
DR   KEGG; hsa:5455; -.
DR   UCSC; uc010ywg.3; human.
DR   CTD; 5455; -.
DR   DisGeNET; 5455; -.
DR   EuPathDB; HostDB:ENSG00000198914.2; -.
DR   GeneCards; POU3F3; -.
DR   HGNC; HGNC:9216; POU3F3.
DR   HPA; HPA052792; -.
DR   HPA; HPA056039; -.
DR   HPA; HPA067151; -.
DR   MIM; 602480; gene.
DR   neXtProt; NX_P20264; -.
DR   OpenTargets; ENSG00000198914; -.
DR   PharmGKB; PA33540; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00760000118935; -.
DR   HOGENOM; HOG000116303; -.
DR   HOVERGEN; HBG053120; -.
DR   InParanoid; P20264; -.
DR   KO; K09365; -.
DR   OMA; GMTGSPQ; -.
DR   OrthoDB; EOG091G0U0S; -.
DR   PhylomeDB; P20264; -.
DR   TreeFam; TF316413; -.
DR   SIGNOR; P20264; -.
DR   GenomeRNAi; 5455; -.
DR   PRO; PR:P20264; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000198914; -.
DR   CleanEx; HS_POU3F3; -.
DR   Genevisible; P20264; HS.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl.
DR   GO; GO:0048878; P:chemical homeostasis; IEA:Ensembl.
DR   GO; GO:0007588; P:excretion; IEA:Ensembl.
DR   GO; GO:0021869; P:forebrain ventricular zone progenitor cell division; IEA:Ensembl.
DR   GO; GO:0072218; P:metanephric ascending thin limb development; ISS:UniProtKB.
DR   GO; GO:0072240; P:metanephric DCT cell differentiation; ISS:UniProtKB.
DR   GO; GO:0072236; P:metanephric loop of Henle development; ISS:UniProtKB.
DR   GO; GO:0072227; P:metanephric macula densa development; ISS:UniProtKB.
DR   GO; GO:0072233; P:metanephric thick ascending limb development; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   InterPro; IPR016362; TF_POU_3.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PIRSF; PIRSF002629; Transcription_factor_POU; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Neurogenesis; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    500       POU domain, class 3, transcription factor
FT                                3.
FT                                /FTId=PRO_0000100727.
FT   DOMAIN      314    388       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    406    465       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     28    304       Gly-rich.
FT   COMPBIAS     81    204       Ala-rich.
FT   COMPBIAS    133    184       Pro-rich.
FT   COMPBIAS    270    294       His-rich.
FT   CONFLICT    433    433       A -> S (in Ref. 3). {ECO:0000305}.
SQ   SEQUENCE   500 AA;  50327 MW;  E536EFFFA5212319 CRC64;
     MATAASNPYL PGNSLLAAGS IVHSDAAGAG GGGGGGGGGG GGGAGGGGGG MQPGSAAVTS
     GAYRGDPSSV KMVQSDFMQG AMAASNGGHM LSHAHQWVTA LPHAAAAAAA AAAAAVEASS
     PWSGSAVGMA GSPQQPPQPP PPPPQGPDVK GGAGRDDLHA GTALHHRGPP HLGPPPPPPH
     QGHPGGWGAA AAAAAAAAAA AAAAHLPSMA GGQQPPPQSL LYSQPGGFTV NGMLSAPPGP
     GGGGGGAGGG AQSLVHPGLV RGDTPELAEH HHHHHHHAHP HPPHPHHAQG PPHHGGGGGG
     AGPGLNSHDP HSDEDTPTSD DLEQFAKQFK QRRIKLGFTQ ADVGLALGTL YGNVFSQTTI
     CRFEALQLSF KNMCKLKPLL NKWLEEADSS TGSPTSIDKI AAQGRKRKKR TSIEVSVKGA
     LESHFLKCPK PSAQEITNLA DSLQLEKEVV RVWFCNRRQK EKRMTPPGIQ QQTPDDVYSQ
     VGTVSADTPP PHHGLQTSVQ
//
ID   PO6F1_HUMAN             Reviewed;         301 AA.
AC   Q14863; Q15944; Q6DK47; Q7Z7P6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 157.
DE   RecName: Full=POU domain, class 6, transcription factor 1;
DE   AltName: Full=Brain-specific homeobox/POU domain protein 5;
DE            Short=Brain-5;
DE            Short=Brn-5;
DE   AltName: Full=mPOU homeobox protein;
GN   Name=POU6F1; Synonyms=BRN5, MPOU, TCFB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=7908264; DOI=10.1111/j.1432-1033.1994.tb18676.x;
RA   Wey E., Lyons G.E., Schaefer B.W.;
RT   "A human POU domain gene, mPOU, is expressed in developing brain and
RT   specific adult tissues.";
RL   Eur. J. Biochem. 220:753-762(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8102789; DOI=10.1128/MCB.13.9.5450;
RA   Messier H., Brickner H., Gaikwad J., Fotedar A.;
RT   "A novel POU domain protein which binds to the T-cell receptor beta
RT   enhancer.";
RL   Mol. Cell. Biol. 13:5450-5460(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor that binds preferentially to a
CC       variant of the octamer motif (5'-ATGATAAT-3'). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: In the embryo, expressed exclusively in the
CC       developing brain, whereas in the adult its expression is
CC       restricted to brain, heart, skeletal muscle and lung. In the
CC       brain, the highest expression levels are found in specific cell
CC       layers of the cortex, the olfactory bulb, the hippocampus and the
CC       cerebellum.
CC   -!- SIMILARITY: Belongs to the POU transcription factor family. Class-
CC       6 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z21966; CAA79977.1; -; mRNA.
DR   EMBL; Z21967; CAA79978.1; -; mRNA.
DR   EMBL; L14482; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471111; EAW58180.1; -; Genomic_DNA.
DR   EMBL; BC051326; AAH51326.2; -; mRNA.
DR   EMBL; BC074765; AAH74765.3; -; mRNA.
DR   PIR; A54687; A54687.
DR   RefSeq; NP_001317351.1; NM_001330422.1.
DR   RefSeq; NP_002693.3; NM_002702.3.
DR   RefSeq; XP_016875013.1; XM_017019524.1.
DR   RefSeq; XP_016875014.1; XM_017019525.1.
DR   RefSeq; XP_016875015.1; XM_017019526.1.
DR   RefSeq; XP_016875016.1; XM_017019527.1.
DR   RefSeq; XP_016875017.1; XM_017019528.1.
DR   RefSeq; XP_016875018.1; XM_017019529.1.
DR   RefSeq; XP_016875019.1; XM_017019530.1.
DR   UniGene; Hs.555886; -.
DR   PDB; 3D1N; X-ray; 2.51 A; I/J/K/L/M/N/O/P=142-292.
DR   PDBsum; 3D1N; -.
DR   ProteinModelPortal; Q14863; -.
DR   SMR; Q14863; -.
DR   iPTMnet; Q14863; -.
DR   PhosphoSitePlus; Q14863; -.
DR   BioMuta; POU6F1; -.
DR   DMDM; 2495306; -.
DR   PaxDb; Q14863; -.
DR   PeptideAtlas; Q14863; -.
DR   PRIDE; Q14863; -.
DR   DNASU; 5463; -.
DR   Ensembl; ENST00000389243; ENSP00000373895; ENSG00000184271.
DR   GeneID; 5463; -.
DR   KEGG; hsa:5463; -.
DR   UCSC; uc001rxy.4; human.
DR   CTD; 5463; -.
DR   DisGeNET; 5463; -.
DR   EuPathDB; HostDB:ENSG00000184271.15; -.
DR   GeneCards; POU6F1; -.
DR   HGNC; HGNC:9224; POU6F1.
DR   HPA; HPA047021; -.
DR   HPA; HPA050411; -.
DR   neXtProt; NX_Q14863; -.
DR   OpenTargets; ENSG00000184271; -.
DR   PharmGKB; PA33548; -.
DR   eggNOG; KOG3802; Eukaryota.
DR   eggNOG; ENOG410XQ7X; LUCA.
DR   GeneTree; ENSGT00900000141015; -.
DR   HOGENOM; HOG000115597; -.
DR   HOVERGEN; HBG008230; -.
DR   InParanoid; Q14863; -.
DR   KO; K09368; -.
DR   OrthoDB; EOG091G04YJ; -.
DR   PhylomeDB; Q14863; -.
DR   TreeFam; TF350705; -.
DR   SignaLink; Q14863; -.
DR   ChiTaRS; POU6F1; human.
DR   GenomeRNAi; 5463; -.
DR   PRO; PR:Q14863; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000184271; -.
DR   CleanEx; HS_POU6F1; -.
DR   ExpressionAtlas; Q14863; baseline and differential.
DR   Genevisible; Q14863; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0007420; P:brain development; TAS:ProtInc.
DR   GO; GO:0007507; P:heart development; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR013847; POU.
DR   InterPro; IPR000327; POU_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00157; Pou; 1.
DR   PRINTS; PR00028; POUDOMAIN.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00352; POU; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00035; POU_1; 1.
DR   PROSITE; PS00465; POU_2; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    301       POU domain, class 6, transcription factor
FT                                1.
FT                                /FTId=PRO_0000100759.
FT   DOMAIN      139    213       POU-specific. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00530}.
FT   DNA_BIND    234    293       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      1    139       Gln/Pro-rich.
FT   CONFLICT    210    210       N -> M (in Ref. 1; CAA79978).
FT                                {ECO:0000305}.
FT   HELIX       144    159       {ECO:0000244|PDB:3D1N}.
FT   TURN        160    162       {ECO:0000244|PDB:3D1N}.
FT   HELIX       165    172       {ECO:0000244|PDB:3D1N}.
FT   STRAND      175    177       {ECO:0000244|PDB:3D1N}.
FT   HELIX       182    189       {ECO:0000244|PDB:3D1N}.
FT   HELIX       195    218       {ECO:0000244|PDB:3D1N}.
FT   HELIX       223    227       {ECO:0000244|PDB:3D1N}.
FT   HELIX       243    255       {ECO:0000244|PDB:3D1N}.
FT   HELIX       261    271       {ECO:0000244|PDB:3D1N}.
FT   HELIX       275    289       {ECO:0000244|PDB:3D1N}.
SQ   SEQUENCE   301 AA;  32645 MW;  9C552BA84ABAB17A CRC64;
     MPGISSQILT NAQGQVIGTL PWVVNSASVA APAPAQSLQV QAVTPQLLLN AQGQVIATLA
     SSPLPPPVAV RKPSTPESPA KSEVQPIQPT PTVPQPAVVI ASPAPAAKPS ASAPIPITCS
     ETPTVSQLVS KPHTPSLDED GINLEEIREF AKNFKIRRLS LGLTQTQVGQ ALTATEGPAY
     SQSAICRFEK LDITPKSAQK LKPVLEKWLN EAELRNQEGQ QNLMEFVGGE PSKKRKRRTS
     FTPQAIEALN AYFEKNPLPT GQEITEIAKE LNYDREVVRV WFCNRRQTLK NTSKLNVFQI
     P
//
ID   PRRX1_HUMAN             Reviewed;         245 AA.
AC   P54821; B5BUM7; O60807;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   25-OCT-2017, entry version 156.
DE   RecName: Full=Paired mesoderm homeobox protein 1;
DE   AltName: Full=Homeobox protein PHOX1;
DE   AltName: Full=Paired-related homeobox protein 1;
DE            Short=PRX-1;
GN   Name=PRRX1; Synonyms=PMX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-197 (ISOFORM 2).
RX   PubMed=1509260; DOI=10.1126/science.257.5073.1089;
RA   Grueneberg D.A., Natesan S., Alexandre C., Gilman M.Z.;
RT   "Human and Drosophila homeodomain proteins that enhance the DNA-
RT   binding activity of serum response factor.";
RL   Science 257:1089-1095(1992).
RN   [5]
RP   VARIANT AGOTC SER-113.
RX   PubMed=21294718; DOI=10.1111/j.1399-0004.2010.01531.x;
RA   Sergi C., Kamnasaran D.;
RT   "PRRX1 is mutated in a fetus with agnathia-otocephaly.";
RL   Clin. Genet. 79:293-295(2011).
CC   -!- FUNCTION: Acts as a transcriptional regulator of muscle creatine
CC       kinase (MCK) and so has a role in the establishment of diverse
CC       mesodermal muscle types. The protein binds to an A/T-rich element
CC       in the muscle creatine enhancer (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PMX1-B;
CC         IsoId=P54821-1; Sequence=Displayed;
CC       Name=2; Synonyms=PMX1-A;
CC         IsoId=P54821-2; Sequence=VSP_002278;
CC   -!- DISEASE: Agnathia-otocephaly complex (AGOTC) [MIM:202650]: A rare
CC       condition characterized by mandibular hypoplasia or agnathia,
CC       ventromedial auricular malposition (melotia) and/or auricular
CC       fusion (synotia), and microstomia with oroglossal hypoplasia or
CC       aglossia. Holoprosencephaly is the most commonly identified
CC       association, but skeletal, genitourinary, and cardiovascular
CC       anomalies, and situs inversus have been reported. The disorder is
CC       almost always lethal. {ECO:0000269|PubMed:21294718}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB451463; BAG70277.1; -; mRNA.
DR   EMBL; Z97200; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074993; AAH74993.1; -; mRNA.
DR   EMBL; M95929; AAA60085.1; -; mRNA.
DR   CCDS; CCDS1290.1; -. [P54821-1]
DR   CCDS; CCDS1291.1; -. [P54821-2]
DR   RefSeq; NP_008833.1; NM_006902.4. [P54821-2]
DR   RefSeq; NP_073207.1; NM_022716.3. [P54821-1]
DR   UniGene; Hs.283416; -.
DR   ProteinModelPortal; P54821; -.
DR   SMR; P54821; -.
DR   BioGrid; 111405; 1.
DR   IntAct; P54821; 2.
DR   STRING; 9606.ENSP00000239461; -.
DR   iPTMnet; P54821; -.
DR   PhosphoSitePlus; P54821; -.
DR   BioMuta; PRRX1; -.
DR   DMDM; 6174916; -.
DR   PaxDb; P54821; -.
DR   PeptideAtlas; P54821; -.
DR   PRIDE; P54821; -.
DR   DNASU; 5396; -.
DR   Ensembl; ENST00000239461; ENSP00000239461; ENSG00000116132. [P54821-1]
DR   Ensembl; ENST00000367760; ENSP00000356734; ENSG00000116132. [P54821-2]
DR   GeneID; 5396; -.
DR   KEGG; hsa:5396; -.
DR   UCSC; uc001ghe.4; human. [P54821-1]
DR   CTD; 5396; -.
DR   DisGeNET; 5396; -.
DR   EuPathDB; HostDB:ENSG00000116132.11; -.
DR   GeneCards; PRRX1; -.
DR   HGNC; HGNC:9142; PRRX1.
DR   HPA; HPA051084; -.
DR   MalaCards; PRRX1; -.
DR   MIM; 167420; gene.
DR   MIM; 202650; phenotype.
DR   neXtProt; NX_P54821; -.
DR   OpenTargets; ENSG00000116132; -.
DR   Orphanet; 990; Agnathia - holoprosencephaly - situs inversus.
DR   PharmGKB; PA33466; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG021349; -.
DR   InParanoid; P54821; -.
DR   KO; K09329; -.
DR   OMA; MATYPPT; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; P54821; -.
DR   TreeFam; TF351612; -.
DR   SIGNOR; P54821; -.
DR   ChiTaRS; PRRX1; human.
DR   GeneWiki; PRRX1; -.
DR   GenomeRNAi; 5396; -.
DR   PRO; PR:P54821; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116132; -.
DR   CleanEx; HS_PRRX1; -.
DR   ExpressionAtlas; P54821; baseline and differential.
DR   Genevisible; P54821; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0048844; P:artery morphogenesis; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0048664; P:neuron fate determination; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0070570; P:regulation of neuron projection regeneration; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN         1    245       Paired mesoderm homeobox protein 1.
FT                                /FTId=PRO_0000049251.
FT   DNA_BIND     94    153       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       222    235       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63014}.
FT   MOD_RES     160    160       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63013}.
FT   MOD_RES     197    197       Phosphoserine. {ECO:0000255}.
FT   VAR_SEQ     200    245       SAMATYSATCANNSPAQGINMANSIANLRLKAKEYSLQRNQ
FT                                VPTVN -> RSSSLPRCCLHEGLHNGF (in isoform
FT                                2). {ECO:0000303|PubMed:1509260}.
FT                                /FTId=VSP_002278.
FT   VARIANT     113    113       F -> S (in AGOTC; dbSNP:rs387906667).
FT                                {ECO:0000269|PubMed:21294718}.
FT                                /FTId=VAR_066414.
SQ   SEQUENCE   245 AA;  27296 MW;  7CA4B7FD9492FC19 CRC64;
     MTSSYGHVLE RQPALGGRLD SPGNLDTLQA KKNFSVSHLL DLEEAGDMVA AQADENVGEA
     GRSLLESPGL TSGSDTPQQD NDQLNSEEKK KRKQRRNRTT FNSSQLQALE RVFERTHYPD
     AFVREDLARR VNLTEARVQV WFQNRRAKFR RNERAMLANK NASLLKSYSG DVTAVEQPIV
     PRPAPRPTDY LSWGTASPYS AMATYSATCA NNSPAQGINM ANSIANLRLK AKEYSLQRNQ
     VPTVN
//
ID   RAX2_HUMAN              Reviewed;         184 AA.
AC   Q96IS3;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 137.
DE   RecName: Full=Retina and anterior neural fold homeobox protein 2;
DE   AltName: Full=Q50-type retinal homeobox protein;
DE   AltName: Full=Retina and anterior neural fold homeobox-like protein 1;
GN   Name=RAX2; Synonyms=QRX, RAXL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CRX, VARIANT
RP   ARMD6 GLN-87, VARIANTS CORD11 GLY-PRO-140 INS AND ARG-137,
RP   CHARACTERIZATION OF VARIANT ARMD6 GLN-87, AND CHARACTERIZATION OF
RP   VARIANTS CORD11 GLY-PRO-140 INS AND ARG-137.
RX   PubMed=15028672; DOI=10.1093/hmg/ddh117;
RA   Wang Q.-L., Chen S., Esumi N., Swain P.K., Haines H.S., Peng G.,
RA   Melia B.M., McIntosh I., Heckenlively J.R., Jacobson S.G., Stone E.M.,
RA   Swaroop A., Zack D.J.;
RT   "QRX, a novel homeobox gene, modulates photoreceptor gene
RT   expression.";
RL   Hum. Mol. Genet. 13:1025-1040(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May be involved in modulating the expression of
CC       photoreceptor specific genes. Binds to the Ret-1 and Bat-1 element
CC       within the rhodopsin promoter. {ECO:0000269|PubMed:15028672}.
CC   -!- SUBUNIT: Interacts with CRX. {ECO:0000269|PubMed:15028672}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- DOMAIN: The Homeobox transactivates the Ret-1 element in the
CC       presence of CRX and NRL.
CC   -!- DISEASE: Macular degeneration, age-related, 6 (ARMD6)
CC       [MIM:613757]: A form of age-related macular degeneration, a
CC       multifactorial eye disease and the most common cause of
CC       irreversible vision loss in the developed world. In most patients,
CC       the disease is manifest as ophthalmoscopically visible yellowish
CC       accumulations of protein and lipid that lie beneath the retinal
CC       pigment epithelium and within an elastin-containing structure
CC       known as Bruch membrane. {ECO:0000269|PubMed:15028672}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Cone-rod dystrophy 11 (CORD11) [MIM:610381]: An inherited
CC       retinal dystrophy characterized by retinal pigment deposits
CC       visible on fundus examination, predominantly in the macular
CC       region, and initial loss of cone photoreceptors followed by rod
CC       degeneration. This leads to decreased visual acuity and
CC       sensitivity in the central visual field, followed by loss of
CC       peripheral vision. Severe loss of vision occurs earlier than in
CC       retinitis pigmentosa, due to cone photoreceptors degenerating at a
CC       higher rate than rod photoreceptors.
CC       {ECO:0000269|PubMed:15028672}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY211277; AAP41547.1; -; mRNA.
DR   EMBL; AC005777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007284; AAH07284.1; -; mRNA.
DR   EMBL; BC018709; AAH18709.1; -; mRNA.
DR   EMBL; BC032512; AAH32512.1; -; mRNA.
DR   CCDS; CCDS12112.1; -.
DR   RefSeq; NP_001306003.1; NM_001319074.1.
DR   RefSeq; NP_116142.1; NM_032753.3.
DR   UniGene; Hs.532691; -.
DR   ProteinModelPortal; Q96IS3; -.
DR   SMR; Q96IS3; -.
DR   IntAct; Q96IS3; 1.
DR   STRING; 9606.ENSP00000450687; -.
DR   BioMuta; RAX2; -.
DR   DMDM; 74760880; -.
DR   EPD; Q96IS3; -.
DR   PaxDb; Q96IS3; -.
DR   PeptideAtlas; Q96IS3; -.
DR   PRIDE; Q96IS3; -.
DR   Ensembl; ENST00000555633; ENSP00000450456; ENSG00000173976.
DR   Ensembl; ENST00000555978; ENSP00000450687; ENSG00000173976.
DR   GeneID; 84839; -.
DR   KEGG; hsa:84839; -.
DR   UCSC; uc002lyr.4; human.
DR   CTD; 84839; -.
DR   DisGeNET; 84839; -.
DR   EuPathDB; HostDB:ENSG00000173976.15; -.
DR   GeneCards; RAX2; -.
DR   HGNC; HGNC:18286; RAX2.
DR   HPA; HPA052533; -.
DR   MalaCards; RAX2; -.
DR   MIM; 610362; gene.
DR   MIM; 610381; phenotype.
DR   MIM; 613757; phenotype.
DR   neXtProt; NX_Q96IS3; -.
DR   OpenTargets; ENSG00000173976; -.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   PharmGKB; PA162400734; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG021349; -.
DR   InParanoid; Q96IS3; -.
DR   KO; K09333; -.
DR   OMA; SMVDDSC; -.
DR   OrthoDB; EOG091G0SKL; -.
DR   PhylomeDB; Q96IS3; -.
DR   GenomeRNAi; 84839; -.
DR   PRO; PR:Q96IS3; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000173976; -.
DR   CleanEx; HS_RAX2; -.
DR   Genevisible; Q96IS3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036934; Homeobox_RAX2.
DR   PANTHER; PTHR24329:SF81; PTHR24329:SF81; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Age-related macular degeneration; Complete proteome;
KW   Cone-rod dystrophy; Disease mutation; DNA-binding; Homeobox; Nucleus;
KW   Reference proteome; Sensory transduction; Transcription;
KW   Transcription regulation; Vision.
FT   CHAIN         1    184       Retina and anterior neural fold homeobox
FT                                protein 2.
FT                                /FTId=PRO_0000285048.
FT   DNA_BIND     27     86       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     98    140       Pro-rich.
FT   VARIANT      87     87       R -> Q (in ARMD6; increased
FT                                transactivation and DNA-binding activity;
FT                                dbSNP:rs121908280).
FT                                {ECO:0000269|PubMed:15028672}.
FT                                /FTId=VAR_031907.
FT   VARIANT     137    137       G -> R (in CORD11; decreased interaction
FT                                with Crx and transactivation activity;
FT                                dbSNP:rs121908281).
FT                                {ECO:0000269|PubMed:15028672}.
FT                                /FTId=VAR_031908.
FT   VARIANT     140    140       P -> PGP (in CORD11; decreased
FT                                interaction with Crx and increased
FT                                transactivation activity).
FT                                /FTId=VAR_031909.
SQ   SEQUENCE   184 AA;  20086 MW;  DE2FC85C4A4DE063 CRC64;
     MFLSPGEGPA TEGGGLGPGE EAPKKKHRRN RTTFTTYQLH QLERAFEASH YPDVYSREEL
     AAKVHLPEVR VQVWFQNRRA KWRRQERLES GSGAVAAPRL PEAPALPFAR PPAMSLPLEP
     WLGPGPPAVP GLPRLLGPGP GLQASFGPHA FAPTFADGFA LEEASLRLLA KEHAQALDRA
     WPPA
//
ID   RHXF2_HUMAN             Reviewed;         288 AA.
AC   Q9BQY4; Q9BR00;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   25-OCT-2017, entry version 139.
DE   RecName: Full=Rhox homeobox family member 2;
DE   AltName: Full=Paired-like homeobox protein PEPP-2;
DE   AltName: Full=Testis homeobox gene 1;
GN   Name=RHOXF2 {ECO:0000312|HGNC:HGNC:30011}; Synonyms=PEPP2, THG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RA   Yin Y., Jin Y., Levine A.J.;
RT   "Molecular cloning and characterization of a novel testis homeobox
RT   gene, THG1, as a potential testicular tumor suppressor gene.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12490318; DOI=10.1016/S0378-1119(02)01087-9;
RA   Wayne C.M., MacLean J.A. II, Cornwall G., Wilkinson M.F.;
RT   "Two novel human X-linked homeobox genes, hPEPP1 and hPEPP2,
RT   selectively expressed in the testis.";
RL   Gene 301:1-11(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6]
RP   VARIANTS ARG-68; PHE-176; ARG-227 AND GLY-235, CHARACTERIZATION OF
RP   VARIANTS ARG-68 AND ARG-227, FUNCTION, CAUTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=28171660; DOI=10.1093/hmg/ddw313;
RA   Borgmann J., Tuettelmann F., Dworniczak B., Roepke A., Song H.W.,
RA   Kliesch S., Wilkinson M.F., Laurentino S., Gromoll J.;
RT   "The human RHOX gene cluster: target genes and functional analysis of
RT   gene variants in infertile men.";
RL   Hum. Mol. Genet. 25:4898-4910(2016).
CC   -!- FUNCTION: Transcription factor maybe involved in reproductive
CC       processes. Modulates expression of target genes encoding proteins
CC       involved in processes relevant to spermatogenesis.
CC       {ECO:0000269|PubMed:28171660}.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=3; IntAct=EBI-372094, EBI-717810;
CC       Q9BUX1:CHAC1; NbExp=2; IntAct=EBI-372094, EBI-751127;
CC       P05813:CRYBA1; NbExp=3; IntAct=EBI-372094, EBI-7043337;
CC       O75553:DAB1; NbExp=3; IntAct=EBI-372094, EBI-7875264;
CC       Q15038:DAZAP2; NbExp=8; IntAct=EBI-372094, EBI-724310;
CC       O95967:EFEMP2; NbExp=2; IntAct=EBI-372094, EBI-743414;
CC       Q6ICL0:Em:AC006547.7; NbExp=4; IntAct=EBI-372094, EBI-12810603;
CC       Q96A09:FAM46B; NbExp=3; IntAct=EBI-372094, EBI-752030;
CC       Q5VWP2:FAM46C; NbExp=3; IntAct=EBI-372094, EBI-741787;
CC       Q8WVV9:HNRNPLL; NbExp=3; IntAct=EBI-372094, EBI-535849;
CC       Q3LI72:KRTAP19-5; NbExp=3; IntAct=EBI-372094, EBI-1048945;
CC       Q3SYF9:KRTAP19-7; NbExp=3; IntAct=EBI-372094, EBI-10241353;
CC       Q14847:LASP1; NbExp=3; IntAct=EBI-372094, EBI-742828;
CC       Q9Y5V3:MAGED1; NbExp=5; IntAct=EBI-372094, EBI-716006;
CC       O60568:PLOD3; NbExp=2; IntAct=EBI-372094, EBI-741582;
CC       Q93062:RBPMS; NbExp=6; IntAct=EBI-372094, EBI-740322;
CC       P63165:SUMO1; NbExp=3; IntAct=EBI-372094, EBI-80140;
CC       O75069-4:TMCC2; NbExp=3; IntAct=EBI-372094, EBI-10177480;
CC       Q15645:TRIP13; NbExp=7; IntAct=EBI-372094, EBI-358993;
CC       Q8IWF7:UBE2DNL; NbExp=3; IntAct=EBI-372094, EBI-2340154;
CC       Q08AM6:VAC14; NbExp=5; IntAct=EBI-372094, EBI-2107455;
CC       A0A0C4DGF1:ZBTB32; NbExp=5; IntAct=EBI-372094, EBI-10188476;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Testis. Not detected in epididymis nor
CC       placenta. In testis, mainly expressed in germ cells, but also
CC       detected in somatic cells such as Sertoli cells, Leydig cells and
CC       peritubular cells (PubMed:28171660). {ECO:0000269|PubMed:12490318,
CC       ECO:0000269|PubMed:28171660}.
CC   -!- DEVELOPMENTAL STAGE: Predominantly expressed in early stage germ
CC       cells, type-B spermatogonia and early spermatocytes.
CC       {ECO:0000269|PubMed:28171660}.
CC   -!- SIMILARITY: Belongs to the paired-like homeobox family. PEPP
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: RHOF2 and RHOF2B are arranged in a head-to-head
CC       orientation and share high sequence similarity (>99%). They cannot
CC       easily be distinguished and are usually analyzed as a single gene.
CC       {ECO:0000305|PubMed:28171660}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF317219; AAL02160.1; -; mRNA.
DR   EMBL; AL590526; CAC36519.1; -; mRNA.
DR   EMBL; AK058125; BAB71675.1; -; mRNA.
DR   EMBL; BC021719; AAH21719.1; -; mRNA.
DR   CCDS; CCDS14594.1; -.
DR   RefSeq; NP_115887.1; NM_032498.2.
DR   UniGene; Hs.567620; -.
DR   ProteinModelPortal; Q9BQY4; -.
DR   SMR; Q9BQY4; -.
DR   BioGrid; 124119; 60.
DR   IntAct; Q9BQY4; 79.
DR   MINT; MINT-1435872; -.
DR   STRING; 9606.ENSP00000360441; -.
DR   iPTMnet; Q9BQY4; -.
DR   PhosphoSitePlus; Q9BQY4; -.
DR   BioMuta; RHOXF2; -.
DR   DMDM; 37537987; -.
DR   EPD; Q9BQY4; -.
DR   MaxQB; Q9BQY4; -.
DR   PaxDb; Q9BQY4; -.
DR   PeptideAtlas; Q9BQY4; -.
DR   PRIDE; Q9BQY4; -.
DR   DNASU; 84528; -.
DR   Ensembl; ENST00000371388; ENSP00000360441; ENSG00000131721.
DR   GeneID; 84528; -.
DR   KEGG; hsa:84528; -.
DR   UCSC; uc004esl.4; human.
DR   CTD; 84528; -.
DR   DisGeNET; 84528; -.
DR   EuPathDB; HostDB:ENSG00000131721.5; -.
DR   GeneCards; RHOXF2; -.
DR   H-InvDB; HIX0056374; -.
DR   HGNC; HGNC:30011; RHOXF2.
DR   HPA; CAB020794; -.
DR   HPA; HPA003314; -.
DR   MIM; 300447; gene.
DR   neXtProt; NX_Q9BQY4; -.
DR   OpenTargets; ENSG00000131721; -.
DR   PharmGKB; PA162401288; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00820000127081; -.
DR   HOGENOM; HOG000154119; -.
DR   HOVERGEN; HBG094802; -.
DR   InParanoid; Q9BQY4; -.
DR   OMA; MRDGYFW; -.
DR   OrthoDB; EOG091G0JEY; -.
DR   PhylomeDB; Q9BQY4; -.
DR   TreeFam; TF339348; -.
DR   GenomeRNAi; 84528; -.
DR   PRO; PR:Q9BQY4; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000131721; -.
DR   CleanEx; HS_RHOXF2; -.
DR   Genevisible; Q9BQY4; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    288       Rhox homeobox family member 2.
FT                                /FTId=PRO_0000049246.
FT   DNA_BIND    134    193       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       186    195       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   COMPBIAS    245    286       Pro-rich.
FT   VARIANT      68     68       G -> R (found in infertile men; unknown
FT                                pathological significance; decreased
FT                                induction of target genes expression;
FT                                dbSNP:rs148604152).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078297.
FT   VARIANT     176    176       L -> F (found in infertile men; unknown
FT                                pathological significance;
FT                                dbSNP:rs199871532).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078298.
FT   VARIANT     227    227       G -> R (found in infertile men; unknown
FT                                pathological significance; decreased
FT                                induction of target genes expression).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078299.
FT   VARIANT     235    235       D -> G (found in infertile men; unknown
FT                                pathological significance;
FT                                dbSNP:rs6646602).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078300.
SQ   SEQUENCE   288 AA;  31692 MW;  2B0E007064515808 CRC64;
     MEPPDQCSQY MTSLLSPAVD DEKELQDMNA MVLSLTEEVK EEEEDAQPEP EQGTAAGEKL
     KSAGAQGGEE KDGGGEEKDG GGAGVPGHLW EGDLEGTSGS DGNVEDSDQS EKEPGQQYSR
     PQGAVGGLEP GNAQQPNVHA FTPLQLQELE RIFQREQFPS EFLRRRLARS MNVTELAVQI
     WFENRRAKWR RHQRALMARN MLPFMAVGQP VMVTAAEAIT APLFISGMRD DYFWDHSHSS
     SLCFPMPPFP PPSLPLPLML LPPMPPAGQA EFGPFPFVIV PSFTFPNV
//
ID   RHF2B_HUMAN             Reviewed;         288 AA.
AC   P0C7M4;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   27-SEP-2017, entry version 73.
DE   RecName: Full=Rhox homeobox family member 2B;
GN   Name=RHOXF2B {ECO:0000312|HGNC:HGNC:33519};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Howell G.R., Huckle E., Ross M.T.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   VARIANTS ARG-68; PHE-176; ARG-227 AND GLY-235, CHARACTERIZATION OF
RP   VARIANTS ARG-68 AND ARG-227, FUNCTION, CAUTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=28171660; DOI=10.1093/hmg/ddw313;
RA   Borgmann J., Tuettelmann F., Dworniczak B., Roepke A., Song H.W.,
RA   Kliesch S., Wilkinson M.F., Laurentino S., Gromoll J.;
RT   "The human RHOX gene cluster: target genes and functional analysis of
RT   gene variants in infertile men.";
RL   Hum. Mol. Genet. 25:4898-4910(2016).
CC   -!- FUNCTION: Transcription factor maybe involved in reproductive
CC       processes. Modulates expression of target genes encoding proteins
CC       involved in processes relevant to spermatogenesis.
CC       {ECO:0000269|PubMed:28171660}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis, mainly expressed in germ
CC       cells, but also detected in somatic cells such as Sertoli cells,
CC       Leydig cells and peritubular cells. {ECO:0000269|PubMed:28171660}.
CC   -!- DEVELOPMENTAL STAGE: Predominantly expressed in early stage germ
CC       cells, type-B spermatogonia and early spermatocytes.
CC       {ECO:0000269|PubMed:28171660}.
CC   -!- SIMILARITY: Belongs to the paired-like homeobox family. PEPP
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: RHOF2 and RHOF2B are arranged in a head-to-head
CC       orientation and share high sequence similarity (>99%). They cannot
CC       easily be distinguished and are usually analyzed as a single gene.
CC       {ECO:0000305|PubMed:28171660}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL590524; CAC36517.1; -; mRNA.
DR   EMBL; AC005023; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS43985.1; -.
DR   RefSeq; NP_001093155.1; NM_001099685.1.
DR   UniGene; Hs.196956; -.
DR   UniGene; Hs.567620; -.
DR   ProteinModelPortal; P0C7M4; -.
DR   SMR; P0C7M4; -.
DR   STRING; 9606.ENSP00000360455; -.
DR   BioMuta; RHOXF2B; -.
DR   DMDM; 190360188; -.
DR   EPD; P0C7M4; -.
DR   MaxQB; P0C7M4; -.
DR   PaxDb; P0C7M4; -.
DR   PeptideAtlas; P0C7M4; -.
DR   PRIDE; P0C7M4; -.
DR   Ensembl; ENST00000371402; ENSP00000360455; ENSG00000203989.
DR   GeneID; 727940; -.
DR   KEGG; hsa:727940; -.
DR   UCSC; uc004esj.5; human.
DR   CTD; 727940; -.
DR   EuPathDB; HostDB:ENSG00000203989.4; -.
DR   GeneCards; RHOXF2B; -.
DR   HGNC; HGNC:33519; RHOXF2B.
DR   HPA; HPA003314; -.
DR   neXtProt; NX_P0C7M4; -.
DR   OpenTargets; ENSG00000203989; -.
DR   PharmGKB; PA162401289; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00820000127081; -.
DR   HOGENOM; HOG000154119; -.
DR   HOVERGEN; HBG094802; -.
DR   InParanoid; P0C7M4; -.
DR   OMA; QELECIF; -.
DR   OrthoDB; EOG091G0JEY; -.
DR   PhylomeDB; P0C7M4; -.
DR   TreeFam; TF339348; -.
DR   GenomeRNAi; 727940; -.
DR   PRO; PR:P0C7M4; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000203989; -.
DR   CleanEx; HS_RHOXF2B; -.
DR   Genevisible; P0C7M4; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    288       Rhox homeobox family member 2B.
FT                                /FTId=PRO_0000339371.
FT   DNA_BIND    134    193       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       186    195       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   COMPBIAS    245    286       Pro-rich.
FT   VARIANT      68     68       G -> R (found in infertile men; unknown
FT                                pathological significance; decreased
FT                                induction of target genes expression;
FT                                dbSNP:rs781837897).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078301.
FT   VARIANT     176    176       L -> F (found in infertile men; unknown
FT                                pathological significance;
FT                                dbSNP:rs201815129).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078302.
FT   VARIANT     227    227       G -> R (found in infertile men; unknown
FT                                pathological significance; decreased
FT                                induction of target genes expression).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078303.
FT   VARIANT     235    235       D -> G (found in infertile men; unknown
FT                                pathological significance;
FT                                dbSNP:rs782251394).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_078304.
SQ   SEQUENCE   288 AA;  31637 MW;  50B571B13DB712B9 CRC64;
     MEPPDQCSQY MTSLLSPAVD DEKELQDMNA MVLSLTEEVK EEEEDAQPEP EQGTAAGEKL
     KSAGAQGGEE KDGGGEEKDG GGAGVPGHLW EGNLEGTSGS DGNVEDSDQS EKEPGQQYSR
     PQGAVGGLEP GNAQQPNVHA FTPLQLQELE CIFQREQFPS EFLRRRLARS MNVTELAVQI
     WFENRRAKWR RHQRALMARN MLPFMAVGQP VMVTAAEAIT APLFISGMRD DYFWDHSHSS
     SLCFPMPPFP PPSLPLPLML LPPMPPAGQA EFGPFPFVIV PSFTFPNV
//
ID   RHXF1_HUMAN             Reviewed;         184 AA.
AC   Q8NHV9; O95030; Q3SYE0;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   27-SEP-2017, entry version 125.
DE   RecName: Full=Rhox homeobox family member 1 {ECO:0000305};
DE   AltName: Full=Ovary-, testis- and epididymis-expressed gene protein;
DE   AltName: Full=Paired-like homeobox protein PEPP-1;
GN   Name=RHOXF1 {ECO:0000312|HGNC:HGNC:29993}; Synonyms=OTEX, PEPP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   THE NUCLEAR LOCALIZATION SIGNAL.
RC   TISSUE=Ovary, and Testis;
RX   PubMed=11980563; DOI=10.1042/BJ20020399;
RA   Geserick C., Weiss B., Schleuning W.-D., Haendler B.;
RT   "OTEX, an androgen-regulated human member of the paired-like class of
RT   homeobox genes.";
RL   Biochem. J. 366:367-375(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12490318; DOI=10.1016/S0378-1119(02)01087-9;
RA   Wayne C.M., MacLean J.A. II, Cornwall G., Wilkinson M.F.;
RT   "Two novel human X-linked homeobox genes, hPEPP1 and hPEPP2,
RT   selectively expressed in the testis.";
RL   Gene 301:1-11(2002).
RN   [5]
RP   VARIANT HIS-177.
RX   PubMed=26506222; DOI=10.1002/ana.24550;
RA   Park H.J., Hong Y.B., Choi Y.C., Lee J., Kim E.J., Lee J.S., Mo W.M.,
RA   Ki S.M., Kim H.I., Kim H.J., Hyun Y.S., Hong H.D., Nam K., Jung S.C.,
RA   Kim S.B., Kim S.H., Kim D.H., Oh K.W., Kim S.H., Yoo J.H., Lee J.E.,
RA   Chung K.W., Choi B.O.;
RT   "ADSSL1 mutation relevant to autosomal recessive adolescent onset
RT   distal myopathy.";
RL   Ann. Neurol. 79:231-243(2016).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, VARIANT HIS-172, AND CHARACTERIZATION OF
RP   VARIANT HIS-172.
RX   PubMed=28171660; DOI=10.1093/hmg/ddw313;
RA   Borgmann J., Tuettelmann F., Dworniczak B., Roepke A., Song H.W.,
RA   Kliesch S., Wilkinson M.F., Laurentino S., Gromoll J.;
RT   "The human RHOX gene cluster: target genes and functional analysis of
RT   gene variants in infertile men.";
RL   Hum. Mol. Genet. 25:4898-4910(2016).
CC   -!- FUNCTION: Transcription factor maybe involved in reproductive
CC       processes. Modulates expression of target genes encoding proteins
CC       involved in processes relevant to spermatogenesis.
CC       {ECO:0000269|PubMed:28171660}.
CC   -!- SUBUNIT: Does not interact with itself.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:11980563}.
CC   -!- TISSUE SPECIFICITY: Ovary, testis and epididymis. Also detected in
CC       the prostate and the mammary gland. Expressed in many tumor cell
CC       lines derived from acute lymphocytic leukemia, prostate,
CC       endometrial adenocarcinoma, melanoma, bladder carcinoma, colon
CC       carcinoma, erythroleukemia and breast carcinoma. Not expressed in
CC       placenta. In testis, mainly expressed in germ cells, but also
CC       detected in somatic cells such as Sertoli cells, Leydig cells and
CC       peritubular cells (PubMed:28171660). {ECO:0000269|PubMed:12490318,
CC       ECO:0000269|PubMed:28171660}.
CC   -!- DEVELOPMENTAL STAGE: Predominantly expressed in late stage germ
CC       cells, pachytene spermatocytes and round spermatides.
CC       {ECO:0000269|PubMed:28171660}.
CC   -!- INDUCTION: By androgen.
CC   -!- DOMAIN: Mutagenesis of amino acids 147 to 164 and 155 to 164 lead
CC       to a major cytoplasmic localization, with only minor localization
CC       in the nucleus.
CC   -!- SIMILARITY: Belongs to the paired-like homeobox family. PEPP
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC78617.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY099086; AAM22794.1; -; mRNA.
DR   EMBL; AC005023; AAC78617.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC069324; AAH69324.1; -; mRNA.
DR   EMBL; BC069529; AAH69529.1; -; mRNA.
DR   EMBL; BC103857; AAI03858.1; -; mRNA.
DR   EMBL; BC103858; AAI03859.1; -; mRNA.
DR   CCDS; CCDS14593.1; -.
DR   RefSeq; NP_644811.1; NM_139282.2.
DR   UniGene; Hs.644617; -.
DR   ProteinModelPortal; Q8NHV9; -.
DR   SMR; Q8NHV9; -.
DR   BioGrid; 127708; 2.
DR   IntAct; Q8NHV9; 1.
DR   STRING; 9606.ENSP00000217999; -.
DR   DMDM; 37537960; -.
DR   PaxDb; Q8NHV9; -.
DR   PeptideAtlas; Q8NHV9; -.
DR   PRIDE; Q8NHV9; -.
DR   DNASU; 158800; -.
DR   Ensembl; ENST00000217999; ENSP00000217999; ENSG00000101883.
DR   GeneID; 158800; -.
DR   KEGG; hsa:158800; -.
DR   UCSC; uc004esk.2; human.
DR   CTD; 158800; -.
DR   EuPathDB; HostDB:ENSG00000101883.4; -.
DR   GeneCards; RHOXF1; -.
DR   HGNC; HGNC:29993; RHOXF1.
DR   HPA; HPA056506; -.
DR   MIM; 300446; gene.
DR   neXtProt; NX_Q8NHV9; -.
DR   OpenTargets; ENSG00000101883; -.
DR   PharmGKB; PA162401287; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00820000127081; -.
DR   HOGENOM; HOG000154120; -.
DR   InParanoid; Q8NHV9; -.
DR   OMA; GNMNPEG; -.
DR   OrthoDB; EOG091G0ZM6; -.
DR   PhylomeDB; Q8NHV9; -.
DR   TreeFam; TF339348; -.
DR   GeneWiki; RHOXF1; -.
DR   GenomeRNAi; 158800; -.
DR   PRO; PR:Q8NHV9; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101883; -.
DR   CleanEx; HS_RHOXF1; -.
DR   Genevisible; Q8NHV9; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; NAS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0007276; P:gamete generation; NAS:UniProtKB.
DR   GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0019953; P:sexual reproduction; IEP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    184       Rhox homeobox family member 1.
FT                                /FTId=PRO_0000049245.
FT   DNA_BIND    103    162       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       155    164       Nuclear localization signal.
FT   VARIANT     172    172       R -> H (found in infertile men; unknown
FT                                pathological significance; no effect on
FT                                induction of target genes expression;
FT                                dbSNP:rs2301977).
FT                                {ECO:0000269|PubMed:28171660}.
FT                                /FTId=VAR_049587.
FT   VARIANT     177    177       D -> H (in dbSNP:rs138060880).
FT                                {ECO:0000269|PubMed:26506222}.
FT                                /FTId=VAR_077002.
SQ   SEQUENCE   184 AA;  20542 MW;  90C67C7ACA2B292B CRC64;
     MARSLVHDTV FYCLSVYQVK ISPTPQLGAA SSAEGHVGQG APGLMGNMNP EGGVNHENGM
     NRDGGMIPEG GGGNQEPRQQ PQPPPEEPAQ AAMEGPQPEN MQPRTRRTKF TLLQVEELES
     VFRHTQYPDV PTRRELAENL GVTEDKVRVW FKNKRARCRR HQRELMLANE LRADPDDCVY
     IVVD
//
ID   RX_HUMAN                Reviewed;         346 AA.
AC   Q9Y2V3; Q86V11;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=Retinal homeobox protein Rx;
DE   AltName: Full=Retina and anterior neural fold homeobox protein;
GN   Name=RAX; Synonyms=RX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=10625658; DOI=10.1074/jbc.275.2.1152;
RA   Kimura A., Singh D., Wawrousek E.F., Kikuchi M., Nakamura M.,
RA   Shinohara T.;
RT   "Both PCE-1/RX and OTX/CRX interactions are necessary for
RT   photoreceptor-specific gene expression.";
RL   J. Biol. Chem. 275:1152-1160(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Retinoblastoma;
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M.,
RA   Toyama S., Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT MCOP3 GLN-192, VARIANT GLU-44, CHARACTERIZATION OF VARIANT
RP   GLU-44, AND CHARACTERIZATION OF VARIANT MCOP3 GLN-192.
RX   PubMed=14662654; DOI=10.1093/hmg/ddh025;
RA   Voronina V.A., Kozhemyakina E.A., O'Kernick C.M., Kahn N.D.,
RA   Wenger S.L., Linberg J.V., Schneider A.S., Mathers P.H.;
RT   "Mutations in the human RAX homeobox gene in a patient with
RT   anophthalmia and sclerocornea.";
RL   Hum. Mol. Genet. 13:315-322(2004).
RN   [6]
RP   VARIANTS MCOP3 HIS-160; GLN-187 AND GLN-188.
RX   PubMed=24033328; DOI=10.1111/cge.12275;
RA   Chassaing N., Causse A., Vigouroux A., Delahaye A., Alessandri J.L.,
RA   Boespflug-Tanguy O., Boute-Benejean O., Dollfus H., Duban-Bedu B.,
RA   Gilbert-Dussardier B., Giuliano F., Gonzales M., Holder-Espinasse M.,
RA   Isidor B., Jacquemont M.L., Lacombe D., Martin-Coignard D.,
RA   Mathieu-Dramard M., Odent S., Picone O., Pinson L., Quelin C.,
RA   Sigaudy S., Toutain A., Thauvin-Robinet C., Kaplan J., Calvas P.;
RT   "Molecular findings and clinical data in a cohort of 150 patients with
RT   anophthalmia/microphthalmia.";
RL   Clin. Genet. 86:326-334(2014).
CC   -!- FUNCTION: Plays a critical role in eye formation by regulating the
CC       initial specification of retinal cells and/or their subsequent
CC       proliferation. Binds to the photoreceptor conserved element-I
CC       (PCE-1/Ret 1) in the photoreceptor cell-specific arrestin
CC       promoter.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y2V3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2V3-2; Sequence=VSP_053558, VSP_053559;
CC   -!- TISSUE SPECIFICITY: Expressed in the developing eye and weakly
CC       expressed in the adult retina.
CC   -!- DISEASE: Microphthalmia, isolated, 3 (MCOP3) [MIM:611038]: A
CC       disorder of eye formation, ranging from small size of a single eye
CC       to complete bilateral absence of ocular tissues. Ocular
CC       abnormalities like opacities of the cornea and lens, scaring of
CC       the retina and choroid, and other abnormalities may also be
CC       present. {ECO:0000269|PubMed:14662654,
CC       ECO:0000269|PubMed:24033328}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF115392; AAD23438.1; -; mRNA.
DR   EMBL; AB593018; BAJ83973.1; -; mRNA.
DR   EMBL; AC067859; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC051901; AAH51901.1; -; mRNA.
DR   CCDS; CCDS11972.1; -. [Q9Y2V3-1]
DR   RefSeq; NP_038463.2; NM_013435.2. [Q9Y2V3-1]
DR   UniGene; Hs.278957; -.
DR   ProteinModelPortal; Q9Y2V3; -.
DR   SMR; Q9Y2V3; -.
DR   BioGrid; 119034; 1.
DR   STRING; 9606.ENSP00000334813; -.
DR   iPTMnet; Q9Y2V3; -.
DR   PhosphoSitePlus; Q9Y2V3; -.
DR   BioMuta; RAX; -.
DR   DMDM; 296452886; -.
DR   PaxDb; Q9Y2V3; -.
DR   PeptideAtlas; Q9Y2V3; -.
DR   PRIDE; Q9Y2V3; -.
DR   DNASU; 30062; -.
DR   Ensembl; ENST00000256852; ENSP00000256852; ENSG00000134438. [Q9Y2V3-2]
DR   Ensembl; ENST00000334889; ENSP00000334813; ENSG00000134438. [Q9Y2V3-1]
DR   GeneID; 30062; -.
DR   KEGG; hsa:30062; -.
DR   UCSC; uc002lhx.3; human. [Q9Y2V3-1]
DR   CTD; 30062; -.
DR   DisGeNET; 30062; -.
DR   EuPathDB; HostDB:ENSG00000134438.9; -.
DR   GeneCards; RAX; -.
DR   GeneReviews; RAX; -.
DR   H-InvDB; HIX0202674; -.
DR   HGNC; HGNC:18662; RAX.
DR   MalaCards; RAX; -.
DR   MIM; 601881; gene.
DR   MIM; 611038; phenotype.
DR   neXtProt; NX_Q9Y2V3; -.
DR   OpenTargets; ENSG00000134438; -.
DR   Orphanet; 2542; Isolated anophthalmia - microphthalmia.
DR   PharmGKB; PA38626; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000147164; -.
DR   HOVERGEN; HBG021349; -.
DR   InParanoid; Q9Y2V3; -.
DR   KO; K09332; -.
DR   OMA; YPCGPGF; -.
DR   OrthoDB; EOG091G0NQL; -.
DR   PhylomeDB; Q9Y2V3; -.
DR   TreeFam; TF315976; -.
DR   ChiTaRS; RAX; human.
DR   GenomeRNAi; 30062; -.
DR   PRO; PR:Q9Y2V3; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000134438; -.
DR   CleanEx; HS_RAX; -.
DR   ExpressionAtlas; Q9Y2V3; baseline and differential.
DR   Genevisible; Q9Y2V3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0021854; P:hypothalamus development; IEA:Ensembl.
DR   GO; GO:0060173; P:limb development; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Microphthalmia; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    346       Retinal homeobox protein Rx.
FT                                /FTId=PRO_0000049276.
FT   DNA_BIND    136    195       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF        33     40       Octapeptide motif.
FT   MOTIF       323    336       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOTIF       329    333       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    276    282       Poly-Pro.
FT   VAR_SEQ      97    104       APRPYCPK -> GVVPEPTG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:21697133}.
FT                                /FTId=VSP_053558.
FT   VAR_SEQ     105    346       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:21697133}.
FT                                /FTId=VSP_053559.
FT   VARIANT      44     44       D -> E (in dbSNP:rs2271733).
FT                                {ECO:0000269|PubMed:14662654}.
FT                                /FTId=VAR_020150.
FT   VARIANT     160    160       Y -> H (in MCOP3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24033328}.
FT                                /FTId=VAR_075630.
FT   VARIANT     187    187       R -> Q (in MCOP3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24033328}.
FT                                /FTId=VAR_075631.
FT   VARIANT     188    188       R -> Q (in MCOP3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24033328}.
FT                                /FTId=VAR_075632.
FT   VARIANT     192    192       R -> Q (in MCOP3; does not affect nuclear
FT                                localization; reduces DNA binding
FT                                activity; dbSNP:rs121909127).
FT                                {ECO:0000269|PubMed:14662654}.
FT                                /FTId=VAR_034905.
FT   CONFLICT    107    107       G -> W (in Ref. 1; AAD23438).
FT                                {ECO:0000305}.
SQ   SEQUENCE   346 AA;  36676 MW;  FEDA196F6A326F31 CRC64;
     MHLPGCAPAM ADGSFSLAGH LLRSPGGSTS RLHSIEAILG FTKDDGILGT FPAERGARGA
     KERDRRLGAR PACPKAPEEG SEPSPPPAPA PAPEYEAPRP YCPKEPGEAR PSPGLPVGPA
     TGEAKLSEEE QPKKKHRRNR TTFTTYQLHE LERAFEKSHY PDVYSREELA GKVNLPEVRV
     QVWFQNRRAK WRRQEKLEVS SMKLQDSPLL SFSRSPPSAT LSPLGAGPGS GGGPAGGALP
     LESWLGPPLP GGGATALQSL PGFGPPAQSL PASYTPPPPP PPFLNSPPLG PGLQPLAPPP
     PSYPCGPGFG DKFPLDEADP RNSSIAALRL KAKEHIQAIG KPWQAL
//
ID   SATB2_HUMAN             Reviewed;         733 AA.
AC   Q9UPW6; A8K5Z8; Q3ZB87; Q4V763;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   25-OCT-2017, entry version 161.
DE   RecName: Full=DNA-binding protein SATB2;
DE   AltName: Full=Special AT-rich sequence-binding protein 2;
GN   Name=SATB2; Synonyms=KIAA1034;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH PIAS1, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF LYS-233 AND LYS-350, AND SUMOYLATION.
RX   PubMed=14701874; DOI=10.1101/gad.1153003;
RA   Dobreva G., Dambacher J., Grosschedl R.;
RT   "SUMO modification of a novel MAR-binding protein, SATB2, modulates
RT   immunoglobulin mu gene expression.";
RL   Genes Dev. 17:3048-3061(2003).
RN   [7]
RP   INVOLVEMENT IN CPI, AND CHROMOSOMAL TRANSLOCATIONS.
RX   PubMed=12915443; DOI=10.1093/hmg/ddg248;
RA   FitzPatrick D.R., Carr I.M., McLaren L., Leek J.P., Wightman P.,
RA   Williamson K., Gautier P., McGill N., Hayward C., Firth H.,
RA   Markham A.F., Fantes J.A., Bonthron D.T.;
RT   "Identification of SATB2 as the cleft palate gene on 2q32-q33.";
RL   Hum. Mol. Genet. 12:2491-2501(2003).
RN   [8]
RP   INVOLVEMENT IN CPI.
RX   PubMed=17377962; DOI=10.1002/humu.20515;
RA   Leoyklang P., Suphapeetiporn K., Siriwan P., Desudchit T.,
RA   Chaowanapanja P., Gahl W.A., Shotelersuk V.;
RT   "Heterozygous nonsense mutation SATB2 associated with cleft palate,
RT   osteoporosis, and cognitive defects.";
RL   Hum. Mutat. 28:732-738(2007).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=19170718; DOI=10.1111/j.1399-0004.2008.01145.x;
RA   Tegay D.H., Chan K.K., Leung L., Wang C., Burkett S., Stone G.,
RA   Stanyon R., Toriello H.V., Hatchwell E.;
RT   "Toriello-Carey syndrome in a patient with a de novo balanced
RT   translocation [46,XY,t(2;14)(q33;q22)] interrupting SATB2.";
RL   Clin. Genet. 75:259-264(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-39; SER-454;
RP   THR-467 AND SER-594, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-350, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-350, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-350, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-24; LYS-30; LYS-161;
RP   LYS-350; LYS-475 AND LYS-724, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [15]
RP   STRUCTURE BY NMR OF 615-674.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeodomain of KIAA1034 protein.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [16]
RP   STRUCTURE BY NMR OF 350-437.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the first CUT domain of KIAA1034 protein.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [17]
RP   STRUCTURE BY NMR OF 473-560.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second CUT domain of human SATB2.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Binds to DNA, at nuclear matrix- or scaffold-associated
CC       regions. Thought to recognize the sugar-phosphate structure of
CC       double-stranded DNA. Transcription factor controlling nuclear gene
CC       expression, by binding to matrix attachment regions (MARs) of DNA
CC       and inducing a local chromatin-loop remodeling. Acts as a docking
CC       site for several chromatin remodeling enzymes and also by
CC       recruiting corepressors (HDACs) or coactivators (HATs) directly to
CC       promoters and enhancers. Required for the initiation of the upper-
CC       layer neurons (UL1) specific genetic program and for the
CC       inactivation of deep-layer neurons (DL) and UL2 specific genes,
CC       probably by modulating BCL11B expression. Repressor of Ctip2 and
CC       regulatory determinant of corticocortical connections in the
CC       developing cerebral cortex. May play an important role in palate
CC       formation. Acts as a molecular node in a transcriptional network
CC       regulating skeletal development and osteoblast differentiation.
CC       {ECO:0000269|PubMed:14701874}.
CC   -!- SUBUNIT: Interacts with ATF4 and RUNX2; resulting in enhanced DNA
CC       binding and transactivation by these transcription factors (By
CC       similarity). Interacts with PIAS1. {ECO:0000250,
CC       ECO:0000269|PubMed:14701874}.
CC   -!- INTERACTION:
CC       Q8TBN0:RAB3IL1; NbExp=3; IntAct=EBI-8298169, EBI-743796;
CC       Q9H3D4-2:TP63; NbExp=5; IntAct=EBI-8298169, EBI-6481107;
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00374,
CC       ECO:0000269|PubMed:14701874}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UPW6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPW6-2; Sequence=VSP_054416;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High expression in adult brain, moderate
CC       expression in fetal brain, and weak expression in adult liver,
CC       kidney, and spinal cord and in select brain regions, including
CC       amygdala, corpus callosum, caudate nucleus, and hippocampus.
CC       {ECO:0000269|PubMed:14701874}.
CC   -!- PTM: Sumoylated by PIAS1. Sumoylation promotes nuclear
CC       localization, but represses transcription factor activity.
CC       {ECO:0000269|PubMed:14701874}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving SATB2 are found in
CC       isolated cleft palate. Translocation t(2;7); translocation
CC       t(2;11). {ECO:0000269|PubMed:12915443}.
CC   -!- DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital
CC       fissure of the soft and/or hard palate, due to faulty fusion.
CC       Isolated cleft palate is not associated with cleft lips. Some
CC       patients may manifest other craniofacial dysmorphic features,
CC       mental retardation, and osteoporosis.
CC       {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}.
CC       Note=The disease may be caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving SATB2 is found in
CC       a patient with classical features of Toriello-Carey syndrome.
CC       Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.
CC   -!- SIMILARITY: Belongs to the CUT homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA82986.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028957; BAA82986.1; ALT_INIT; mRNA.
DR   EMBL; AK291463; BAF84152.1; -; mRNA.
DR   EMBL; AC016746; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC017096; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70180.1; -; Genomic_DNA.
DR   EMBL; BC098136; AAH98136.1; -; mRNA.
DR   EMBL; BC099723; AAH99723.1; -; mRNA.
DR   EMBL; BC103492; AAI03493.1; -; mRNA.
DR   EMBL; BC103500; AAI03501.1; -; mRNA.
DR   CCDS; CCDS2327.1; -. [Q9UPW6-1]
DR   RefSeq; NP_001165980.1; NM_001172509.1. [Q9UPW6-1]
DR   RefSeq; NP_001165988.1; NM_001172517.1. [Q9UPW6-1]
DR   RefSeq; NP_056080.1; NM_015265.3. [Q9UPW6-1]
DR   RefSeq; XP_006712435.1; XM_006712372.2. [Q9UPW6-1]
DR   RefSeq; XP_011509142.1; XM_011510840.2. [Q9UPW6-1]
DR   UniGene; Hs.516617; -.
DR   PDB; 1WI3; NMR; -; A=615-672.
DR   PDB; 1WIZ; NMR; -; A=350-437.
DR   PDB; 2CSF; NMR; -; A=473-560.
DR   PDBsum; 1WI3; -.
DR   PDBsum; 1WIZ; -.
DR   PDBsum; 2CSF; -.
DR   ProteinModelPortal; Q9UPW6; -.
DR   SMR; Q9UPW6; -.
DR   BioGrid; 116905; 53.
DR   DIP; DIP-60551N; -.
DR   ELM; Q9UPW6; -.
DR   IntAct; Q9UPW6; 29.
DR   MINT; MINT-2822679; -.
DR   STRING; 9606.ENSP00000260926; -.
DR   iPTMnet; Q9UPW6; -.
DR   PhosphoSitePlus; Q9UPW6; -.
DR   BioMuta; SATB2; -.
DR   DMDM; 13634020; -.
DR   EPD; Q9UPW6; -.
DR   PaxDb; Q9UPW6; -.
DR   PeptideAtlas; Q9UPW6; -.
DR   PRIDE; Q9UPW6; -.
DR   DNASU; 23314; -.
DR   Ensembl; ENST00000260926; ENSP00000260926; ENSG00000119042. [Q9UPW6-1]
DR   Ensembl; ENST00000417098; ENSP00000401112; ENSG00000119042. [Q9UPW6-1]
DR   Ensembl; ENST00000428695; ENSP00000388581; ENSG00000119042. [Q9UPW6-2]
DR   Ensembl; ENST00000457245; ENSP00000405420; ENSG00000119042. [Q9UPW6-1]
DR   Ensembl; ENST00000614512; ENSP00000483287; ENSG00000119042. [Q9UPW6-2]
DR   GeneID; 23314; -.
DR   KEGG; hsa:23314; -.
DR   UCSC; uc002uuy.2; human. [Q9UPW6-1]
DR   CTD; 23314; -.
DR   DisGeNET; 23314; -.
DR   EuPathDB; HostDB:ENSG00000119042.16; -.
DR   GeneCards; SATB2; -.
DR   HGNC; HGNC:21637; SATB2.
DR   HPA; CAB023669; -.
DR   HPA; CAB062562; -.
DR   HPA; CAB067751; -.
DR   HPA; CAB068229; -.
DR   HPA; CAB068230; -.
DR   HPA; CAB068231; -.
DR   HPA; HPA001042; -.
DR   HPA; HPA029543; -.
DR   MalaCards; SATB2; -.
DR   MIM; 119540; phenotype.
DR   MIM; 608148; gene.
DR   neXtProt; NX_Q9UPW6; -.
DR   OpenTargets; ENSG00000119042; -.
DR   Orphanet; 251019; 2q32q33 microdeletion syndrome.
DR   Orphanet; 251028; 2q33.1 microdeletion syndrome.
DR   Orphanet; 199306; Cleft lip/palate.
DR   PharmGKB; PA128394624; -.
DR   eggNOG; ENOG410ISJ9; Eukaryota.
DR   eggNOG; ENOG41113K2; LUCA.
DR   GeneTree; ENSGT00390000008096; -.
DR   HOGENOM; HOG000004805; -.
DR   HOVERGEN; HBG054240; -.
DR   InParanoid; Q9UPW6; -.
DR   OMA; CVVEQSD; -.
DR   OrthoDB; EOG091G02HV; -.
DR   PhylomeDB; Q9UPW6; -.
DR   TreeFam; TF332714; -.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   ChiTaRS; SATB2; human.
DR   EvolutionaryTrace; Q9UPW6; -.
DR   GeneWiki; SATB2; -.
DR   GenomeRNAi; 23314; -.
DR   PRO; PR:Q9UPW6; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000119042; -.
DR   CleanEx; HS_SATB2; -.
DR   ExpressionAtlas; Q9UPW6; baseline and differential.
DR   Genevisible; Q9UPW6; HS.
DR   GO; GO:0000118; C:histone deacetylase complex; IEA:Ensembl.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0071310; P:cellular response to organic substance; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0021902; P:commitment of neuronal cell to specific neuron type in forebrain; IEA:Ensembl.
DR   GO; GO:0016569; P:covalent chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0002076; P:osteoblast development; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR003350; CUT_dom.
DR   InterPro; IPR032355; CUTL.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom.
DR   InterPro; IPR032392; ULD.
DR   Pfam; PF02376; CUT; 2.
DR   Pfam; PF16557; CUTL; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16534; ULD; 1.
DR   SMART; SM01109; CUT; 2.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF47413; SSF47413; 2.
DR   PROSITE; PS51042; CUT; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator;
KW   Chromosomal rearrangement; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Isopeptide bond;
KW   Mental retardation; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    733       DNA-binding protein SATB2.
FT                                /FTId=PRO_0000202400.
FT   DNA_BIND    350    437       CUT 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    473    560       CUT 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00374}.
FT   DNA_BIND    615    674       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      39     39       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     454    454       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     467    467       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     594    594       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     24     24       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     30     30       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    161    161       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    233    233       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000305}.
FT   CROSSLNK    350    350       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000305}.
FT   CROSSLNK    350    350       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    475    475       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    724    724       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     116    233       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054416.
FT   VARIANT     263    263       S -> P (in dbSNP:rs12619995).
FT                                /FTId=VAR_059320.
FT   MUTAGEN     233    233       K->R: Reduced sumoylation, impaired
FT                                nuclear localization, but enhanced
FT                                transcription factor activity.
FT                                {ECO:0000269|PubMed:14701874}.
FT   MUTAGEN     350    350       K->R: Reduced sumoylation, impaired
FT                                nuclear localization, but enhanced
FT                                transcription factor activity.
FT                                {ECO:0000269|PubMed:14701874}.
FT   HELIX       364    375       {ECO:0000244|PDB:1WIZ}.
FT   HELIX       379    387       {ECO:0000244|PDB:1WIZ}.
FT   HELIX       391    399       {ECO:0000244|PDB:1WIZ}.
FT   TURN        404    406       {ECO:0000244|PDB:1WIZ}.
FT   HELIX       409    421       {ECO:0000244|PDB:1WIZ}.
FT   HELIX       426    437       {ECO:0000244|PDB:1WIZ}.
FT   HELIX       486    498       {ECO:0000244|PDB:2CSF}.
FT   HELIX       502    508       {ECO:0000244|PDB:2CSF}.
FT   HELIX       514    523       {ECO:0000244|PDB:2CSF}.
FT   HELIX       532    545       {ECO:0000244|PDB:2CSF}.
FT   HELIX       549    559       {ECO:0000244|PDB:2CSF}.
FT   HELIX       624    636       {ECO:0000244|PDB:1WI3}.
FT   HELIX       642    651       {ECO:0000244|PDB:1WI3}.
FT   HELIX       656    669       {ECO:0000244|PDB:1WI3}.
SQ   SEQUENCE   733 AA;  82555 MW;  1FE1FCBD34F11E9E CRC64;
     MERRSESPCL RDSPDRRSGS PDVKGPPPVK VARLEQNGSP MGARGRPNGA VAKAVGGLMI
     PVFCVVEQLD GSLEYDNREE HAEFVLVRKD VLFSQLVETA LLALGYSHSS AAQAQGIIKL
     GRWNPLPLSY VTDAPDATVA DMLQDVYHVV TLKIQLQSCS KLEDLPAEQW NHATVRNALK
     ELLKEMNQST LAKECPLSQS MISSIVNSTY YANVSATKCQ EFGRWYKKYK KIKVERVERE
     NLSDYCVLGQ RPMHLPNMNQ LASLGKTNEQ SPHSQIHHST PIRNQVPALQ PIMSPGLLSP
     QLSPQLVRQQ IAMAHLINQQ IAVSRLLAHQ HPQAINQQFL NHPPIPRAVK PEPTNSSVEV
     SPDIYQQVRD ELKRASVSQA VFARVAFNRT QGLLSEILRK EEDPRTASQS LLVNLRAMQN
     FLNLPEVERD RIYQDERERS MNPNVSMVSS ASSSPSSSRT PQAKTSTPTT DLPIKVDGAN
     INITAAIYDE IQQEMKRAKV SQALFAKVAA NKSQGWLCEL LRWKENPSPE NRTLWENLCT
     IRRFLNLPQH ERDVIYEEES RHHHSERMQH VVQLPPEPVQ VLHRQQSQPA KESSPPREEA
     PPPPPPTEDS CAKKPRSRTK ISLEALGILQ SFIHDVGLYP DQEAIHTLSA QLDLPKHTII
     KFFQNQRYHV KHHGKLKEHL GSAVDVAEYK DEELLTESEE NDSEEGSEEM YKVEAEEENA
     DKSKAAPAEI DQR
//
ID   SEBOX_HUMAN             Reviewed;         216 AA.
AC   Q9HB31;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   27-SEP-2017, entry version 126.
DE   RecName: Full=Homeobox protein SEBOX;
DE   AltName: Full=Homeobox OG-9;
DE   AltName: Full=Skin-, embryo-, brain- and oocyte-specific homeobox;
GN   Name=SEBOX; Synonyms=OG9X;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-207.
RX   PubMed=10922053; DOI=10.1073/pnas.97.16.8904;
RA   Cinquanta M., Rovescalli A.C., Kozak C.A., Nirenberg M.;
RT   "Mouse Sebox homeobox gene expression in skin, brain, oocytes, and
RT   two-cell embryos.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8904-8909(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-207.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable transcription factor involved in the control of
CC       specification of mesoderm and endoderm. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG14458.1; Type=Frameshift; Positions=9; Evidence={ECO:0000305};
CC       Sequence=EAW51081.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF284337; AAG14458.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AC002094; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471159; EAW51081.1; ALT_SEQ; Genomic_DNA.
DR   ProteinModelPortal; Q9HB31; -.
DR   SMR; Q9HB31; -.
DR   STRING; 9606.ENSP00000416240; -.
DR   BioMuta; SEBOX; -.
DR   DMDM; 322510071; -.
DR   PaxDb; Q9HB31; -.
DR   PRIDE; Q9HB31; -.
DR   Ensembl; ENST00000438614; ENSP00000395142; ENSG00000274529.
DR   UCSC; uc010wai.1; human.
DR   EuPathDB; HostDB:ENSG00000274529.4; -.
DR   GeneCards; SEBOX; -.
DR   HGNC; HGNC:32942; SEBOX.
DR   HPA; HPA045689; -.
DR   MIM; 610975; gene.
DR   neXtProt; NX_Q9HB31; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG098434; -.
DR   InParanoid; Q9HB31; -.
DR   OrthoDB; EOG091G183Z; -.
DR   TreeFam; TF315976; -.
DR   PRO; PR:Q9HB31; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000274529; -.
DR   Genevisible; Q9HB31; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    216       Homeobox protein SEBOX.
FT                                /FTId=PRO_0000311336.
FT   DNA_BIND     45    104       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     207    207       L -> S (in dbSNP:rs9910163).
FT                                {ECO:0000269|PubMed:10922053,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_037228.
SQ   SEQUENCE   216 AA;  22879 MW;  97FD1BC8BF8F716C CRC64;
     MGGSGVGTAW HGPLARPSGT LPFASSMPSP VDASSADGGS GLGSHRRKRT TFSKGQLLEL
     ERAFAAWPYP NISTHEHLAW VTCLPEAKVQ VWFQKRWAKI IKNRKSGILS PGSECPQSSC
     SLPDTLQQPW DPQMPGQPPP SSGTPQRTSV CRHSSCPAPG LSPRQGWEGA KAVAPWGSAG
     ASEVHPSLER ATPQTSLGSL SDLIYALAIV VNVDHS
//
ID   SIX5_HUMAN              Reviewed;         739 AA.
AC   Q8N196;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 3.
DT   27-SEP-2017, entry version 137.
DE   RecName: Full=Homeobox protein SIX5;
DE   AltName: Full=DM locus-associated homeodomain protein;
DE   AltName: Full=Sine oculis homeobox homolog 5;
GN   Name=SIX5; Synonyms=DMAHP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8595416; DOI=10.1093/hmg/4.10.1919;
RA   Boucher C.A., King S.K., Carey N., Krahe R., Winchester C.L.,
RA   Rahman S., Creavin T., Meghji P., Bailey M.E., Chartier F.L.,
RA   Brown S.D., Sicilliano M.J., Johnson K.J.;
RT   "A novel homeodomain-encoding gene is associated with a large CpG
RT   island interrupted by the myotonic dystrophy unstable (CTG)n repeat.";
RL   Hum. Mol. Genet. 4:1919-1925(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 185-739.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=9949207; DOI=10.1093/hmg/8.3.481;
RA   Winchester C.L., Ferrier R.K., Sermoni A., Clark B.J., Johnson K.J.;
RT   "Characterization of the expression of DMPK and SIX5 in the human eye
RT   and implications for pathogenesis in myotonic dystrophy.";
RL   Hum. Mol. Genet. 8:481-492(1999).
RN   [6]
RP   DNA-BINDING.
RX   PubMed=10756185; DOI=10.1093/nar/28.9.1871;
RA   Harris S.E., Winchester C.L., Johnson K.J.;
RT   "Functional analysis of the homeodomain protein SIX5.";
RL   Nucleic Acids Res. 28:1871-1878(2000).
RN   [7]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=12500905; DOI=10.1023/A:1020990825644;
RA   Fougerousse F., Durand M., Lopez S., Suel L., Demignon J.,
RA   Thornton C., Ozaki H., Kawakami K., Barbet P., Beckmann J.S.,
RA   Maire P.;
RT   "Six and Eya expression during human somitogenesis and MyoD gene
RT   family activation.";
RL   J. Muscle Res. Cell Motil. 23:255-264(2002).
RN   [8]
RP   VARIANTS BOR2 THR-158; THR-296; ARG-365 AND MET-552, AND
RP   CHARACTERIZATION OF VARIANTS BOR2 THR-158 AND MET-552.
RX   PubMed=17357085; DOI=10.1086/513322;
RA   Hoskins B.E., Cramer C.H., Silvius D., Zou D., Raymond R.M.,
RA   Orten D.J., Kimberling W.J., Smith R.J.H., Weil D., Petit C.,
RA   Otto E.A., Xu P.-X., Hildebrandt F.;
RT   "Transcription factor SIX5 is mutated in patients with branchio-oto-
RT   renal syndrome.";
RL   Am. J. Hum. Genet. 80:800-804(2007).
CC   -!- FUNCTION: Transcription factor that is thought to be involved in
CC       regulation of organogenesis. May be involved in determination and
CC       maintenance of retina formation. Binds a 5'-GGTGTCAG-3' motif
CC       present in the ARE regulatory element of ATP1A1. Binds a 5'-
CC       TCA[AG][AG]TTNC-3' motif present in the MEF3 element in the
CC       myogenin promoter, and in the IGFBP5 promoter (By similarity).
CC       Thought to be regulated by association with Dach and Eya proteins,
CC       and seems to be coactivated by EYA1, EYA2 and EYA3 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Probably binds DNA dimer. Interacts with EYA3, and
CC       probably EYA1 and EYA2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P54253:ATXN1; NbExp=4; IntAct=EBI-946167, EBI-930964;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12500905}.
CC       Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108,
CC       ECO:0000269|PubMed:12500905}.
CC   -!- TISSUE SPECIFICITY: Expressed in adult but not in fetal eyes.
CC       Found in corneal epithelium and endothelium, lens epithelium,
CC       ciliary body epithelia, cellular layers of the retina and the
CC       sclera. {ECO:0000269|PubMed:9949207}.
CC   -!- DEVELOPMENTAL STAGE: At the begin of fourth week of development
CC       detected in cytoplasm of somite cells, and at the end of fourth
CC       week is accumulated in the nucleus. Between the sixth and eighth
CC       week of development detected in the nucleus of limb bud cells.
CC       {ECO:0000269|PubMed:12500905}.
CC   -!- DISEASE: Branchiootorenal syndrome 2 (BOR2) [MIM:610896]: A
CC       syndrome characterized by branchial cleft fistulas or cysts,
CC       sensorineural and/or conductive hearing loss, pre-auricular pits,
CC       structural defects of the outer, middle or inner ear, and renal
CC       malformations. {ECO:0000269|PubMed:17357085}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH33204.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=AK074826; Type=Erroneous termination; Positions=721; Note=Translated as Glu.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X84813; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC074212; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033204; AAH33204.1; ALT_SEQ; mRNA.
DR   EMBL; BU859227; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK074826; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS12673.1; -.
DR   RefSeq; NP_787071.2; NM_175875.4.
DR   UniGene; Hs.43314; -.
DR   ProteinModelPortal; Q8N196; -.
DR   SMR; Q8N196; -.
DR   BioGrid; 127096; 6.
DR   IntAct; Q8N196; 7.
DR   MINT; MINT-2855964; -.
DR   STRING; 9606.ENSP00000316842; -.
DR   iPTMnet; Q8N196; -.
DR   PhosphoSitePlus; Q8N196; -.
DR   BioMuta; SIX5; -.
DR   DMDM; 150421671; -.
DR   EPD; Q8N196; -.
DR   MaxQB; Q8N196; -.
DR   PaxDb; Q8N196; -.
DR   PeptideAtlas; Q8N196; -.
DR   PRIDE; Q8N196; -.
DR   DNASU; 147912; -.
DR   Ensembl; ENST00000317578; ENSP00000316842; ENSG00000177045.
DR   GeneID; 147912; -.
DR   KEGG; hsa:147912; -.
DR   UCSC; uc002pdb.4; human.
DR   CTD; 147912; -.
DR   DisGeNET; 147912; -.
DR   EuPathDB; HostDB:ENSG00000177045.7; -.
DR   GeneCards; SIX5; -.
DR   GeneReviews; SIX5; -.
DR   H-InvDB; HIX0202857; -.
DR   HGNC; HGNC:10891; SIX5.
DR   HPA; HPA042068; -.
DR   MalaCards; SIX5; -.
DR   MIM; 600963; gene.
DR   MIM; 610896; phenotype.
DR   neXtProt; NX_Q8N196; -.
DR   OpenTargets; ENSG00000177045; -.
DR   Orphanet; 107; BOR syndrome.
DR   PharmGKB; PA35791; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000154329; -.
DR   HOVERGEN; HBG050139; -.
DR   InParanoid; Q8N196; -.
DR   KO; K19474; -.
DR   OMA; NGGPVII; -.
DR   OrthoDB; EOG091G06MV; -.
DR   PhylomeDB; Q8N196; -.
DR   TreeFam; TF315545; -.
DR   GeneWiki; SIX5; -.
DR   GenomeRNAi; 147912; -.
DR   PRO; PR:Q8N196; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000177045; -.
DR   CleanEx; HS_SIX5; -.
DR   ExpressionAtlas; Q8N196; baseline and differential.
DR   Genevisible; Q8N196; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0002088; P:lens development in camera-type eye; IEA:Ensembl.
DR   GO; GO:1902723; P:negative regulation of skeletal muscle satellite cell proliferation; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; Cytoplasm; Deafness;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    739       Homeobox protein SIX5.
FT                                /FTId=PRO_0000049305.
FT   DNA_BIND    201    260       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT     158    158       A -> T (in BOR2; affects Eya1 binding and
FT                                the ability to activate gene
FT                                transcription; dbSNP:rs80356461).
FT                                {ECO:0000269|PubMed:17357085}.
FT                                /FTId=VAR_032941.
FT   VARIANT     296    296       A -> T (in BOR2; dbSNP:rs80356462).
FT                                {ECO:0000269|PubMed:17357085}.
FT                                /FTId=VAR_032942.
FT   VARIANT     365    365       G -> R (in BOR2; dbSNP:rs80356463).
FT                                {ECO:0000269|PubMed:17357085}.
FT                                /FTId=VAR_032943.
FT   VARIANT     552    552       T -> M (in BOR2; affects Eya1 binding and
FT                                the ability to activate gene
FT                                transcription; dbSNP:rs80356464).
FT                                {ECO:0000269|PubMed:17357085}.
FT                                /FTId=VAR_032944.
FT   VARIANT     556    556       L -> V (in dbSNP:rs2014377).
FT                                /FTId=VAR_032945.
FT   VARIANT     635    635       P -> S (in dbSNP:rs2014576).
FT                                /FTId=VAR_032946.
FT   VARIANT     693    693       V -> M (in dbSNP:rs2341097).
FT                                /FTId=VAR_032947.
SQ   SEQUENCE   739 AA;  74562 MW;  D8A2E8DBBBA263A2 CRC64;
     MATLPAEPSA GPAAGGEAVA AAAATEEEEE EARQLLQTLQ AAEGEAAAAA GAGAGAAAAG
     AEGPGSPGVP GSPPEAASEP PTGLRFSPEQ VACVCEALLQ AGHAGRLSRF LGALPPAERL
     RGSDPVLRAR ALVAFQRGEY AELYRLLESR PFPAAHHAFL QDLYLRARYH EAERARGRAL
     GAVDKYRLRK KFPLPKTIWD GEETVYCFKE RSRAALKACY RGNRYPTPDE KRRLATLTGL
     SLTQVSNWFK NRRQRDRTGA GGGAPCKSES DGNPTTEDES SRSPEDLERG AAPVSAEAAA
     QGSIFLAGTG PPAPCPASSS ILVNGSFLAA SGSPAVLLNG GPVIINGLAL GEASSLGPLL
     LTGGGGAPPP QPSPQGASET KTSLVLDPQT GEVRLEEAQS EAPETKGAQV AAPGPALGEE
     VLGPLAQVVP GPPTAATFPL PPGPVPAVAA PQVVPLSPPP GYPTGLSPTS PLLNLPQVVP
     TSQVVTLPQA VGPLQLLAAG PGSPVKVAAA AGPANVHLIN SGVGVTALQL PSATAPGNFL
     LANPVSGSPI VTGVALQQGK IILTATFPTS MLVSQVLPPA PGLALPLKPE TAISVPEGGL
     PVAPSPALPE AHALGTLSAQ QPPPAAATTS STSLPFSPDS PGLLPNFPAP PPEGLMLSPA
     AVPVWSAGLE LSAGTEGLLE AEKGLGTQAP HTVLRLPDPD PEGLLLGATA GGEVDEGLEA
     EAKVLTQLQS VPVEEPLEL
//
ID   SIX4_HUMAN              Reviewed;         781 AA.
AC   Q9UIU6; Q4QQH5; Q4V764;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   27-SEP-2017, entry version 136.
DE   RecName: Full=Homeobox protein SIX4;
DE   AltName: Full=Sine oculis homeobox homolog 4;
GN   Name=SIX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-605.
RX   PubMed=10640827;
RA   Ozaki H., Yamada K., Kobayashi M., Asakawa S., Minoshima S.,
RA   Shimizu N., Kajitani M., Kawakami K.;
RT   "Structure and chromosome mapping of the human SIX4 and murine Six4
RT   genes.";
RL   Cytogenet. Cell Genet. 87:108-112(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 22-781, AND VARIANT PRO-605.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14966291; DOI=10.1128/MCB.24.5.2132-2143.2004;
RA   Himeda C.L., Ranish J.A., Angello J.C., Maire P., Aebersold R.,
RA   Hauschka S.D.;
RT   "Quantitative proteomic identification of six4 as the trex-binding
RT   factor in the muscle creatine kinase enhancer.";
RL   Mol. Cell. Biol. 24:2132-2143(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-23; ASP-446 AND GLU-780.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Transcriptional regulator which can act as both a
CC       transcriptional repressor and activator by binding a DNA sequence
CC       on these target genes and is involved in processes like cell
CC       differentiation, cell migration and cell survival. Transactivates
CC       gene expression by binding a 5'-[CAT]A[CT][CT][CTG]GA[GAT]-3'
CC       motif present in the Trex site and a 5'-TCA[AG][AG]TTNC-3' motif
CC       present in the MEF3 site of the muscle-specific genes enhancer.
CC       Acts cooperatively with EYA proteins to transactivate their target
CC       genes through interaction and nuclear translocation of EYA
CC       protein. Acts synergistically with SIX1 to regulate target genes
CC       involved in formation of various organs, including muscle, kidney,
CC       gonad, ganglia, olfactory epithelium and cranial skeleton. Plays a
CC       role in several important steps of muscle development. Controls
CC       the genesis of hypaxial myogenic progenitors in the dermomyotome
CC       by transactivating PAX3 and the delamination and migration of the
CC       hypaxial precursors from the ventral lip to the limb buds through
CC       the transactivation of PAX3, MET and LBX1. Controls myoblast
CC       determination by transactivating MYF5, MYOD1 and MYF6. Controls
CC       somitic differentiation in myocyte through MYOG transactivation.
CC       Plays a role in synaptogenesis and sarcomere organization by
CC       participating in myofiber specialization during embryogenesis by
CC       activating fast muscle program in the primary myotome resulting in
CC       an up-regulation of fast muscle genes, including ATP2A1, MYL1 and
CC       TNNT3. Simultaneously, is also able to activate inhibitors of slow
CC       muscle genes, such as SOX6, HRASLS, and HDAC4, thereby restricting
CC       the activation of the slow muscle genes. During muscle
CC       regeneration, negatively regulates differentiation of muscle
CC       satellite cells through down-regulation of MYOG expression. During
CC       kidney development regulates the early stages of metanephros
CC       development and ureteric bud formation through regulation of GDNF,
CC       SALL1, PAX8 and PAX2 expression. Plays a role in gonad development
CC       by regulating both testis determination and size determination. In
CC       gonadal sex determination, transactivates ZFPM2 by binding a MEF3
CC       consensus sequence, resulting in SRY up-regulation. In gonadal
CC       size determination, transactivates NR5A1 by binding a MEF3
CC       consensus sequence resulting in gonadal precursor cell formation
CC       regulation. During olfactory development mediates the
CC       specification and patterning of olfactory placode through
CC       fibroblast growth factor and BMP4 signaling pathways and also
CC       regulates epithelial cell proliferation during placode formation.
CC       Promotes survival of sensory neurons during early trigeminal
CC       gangliogenesis. In the developing dorsal root ganglia, up-
CC       regulates SLC12A2 transcription. Regulates early
CC       thymus/parathyroid organogenesis through regulation of GCM2 and
CC       FOXN1 expression. Forms gustatory papillae during development of
CC       the tongue. Also plays a role during embryonic cranial skeleton
CC       morphogenesis. {ECO:0000250|UniProtKB:Q61321}.
CC   -!- SUBUNIT: Interacts with EYA3; acts cooperatively with EYA3 to
CC       transactivate target genes through interaction and nuclear
CC       translocation of EYA3 protein. {ECO:0000250|UniProtKB:Q61321}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q61321}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q61321}.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86223.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=EAW80786.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB024687; BAA86223.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL132777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80786.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC098135; AAH98135.1; -; mRNA.
DR   EMBL; BC098282; AAH98282.1; -; mRNA.
DR   EMBL; BC099722; AAH99722.1; -; mRNA.
DR   EMBL; BC101934; AAI01935.1; -; mRNA.
DR   CCDS; CCDS9749.2; -.
DR   RefSeq; NP_059116.3; NM_017420.4.
DR   UniGene; Hs.690393; -.
DR   UniGene; Hs.97849; -.
DR   ProteinModelPortal; Q9UIU6; -.
DR   SMR; Q9UIU6; -.
DR   BioGrid; 119730; 7.
DR   IntAct; Q9UIU6; 2.
DR   MINT; MINT-7949397; -.
DR   STRING; 9606.ENSP00000216513; -.
DR   iPTMnet; Q9UIU6; -.
DR   PhosphoSitePlus; Q9UIU6; -.
DR   BioMuta; SIX4; -.
DR   DMDM; 254763333; -.
DR   EPD; Q9UIU6; -.
DR   MaxQB; Q9UIU6; -.
DR   PaxDb; Q9UIU6; -.
DR   PeptideAtlas; Q9UIU6; -.
DR   PRIDE; Q9UIU6; -.
DR   DNASU; 51804; -.
DR   Ensembl; ENST00000216513; ENSP00000216513; ENSG00000100625.
DR   GeneID; 51804; -.
DR   KEGG; hsa:51804; -.
DR   UCSC; uc001xfc.4; human.
DR   CTD; 51804; -.
DR   EuPathDB; HostDB:ENSG00000100625.8; -.
DR   GeneCards; SIX4; -.
DR   H-InvDB; HIX0037650; -.
DR   HGNC; HGNC:10890; SIX4.
DR   HPA; HPA031794; -.
DR   MIM; 606342; gene.
DR   neXtProt; NX_Q9UIU6; -.
DR   OpenTargets; ENSG00000100625; -.
DR   PharmGKB; PA35790; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000261651; -.
DR   HOVERGEN; HBG017802; -.
DR   InParanoid; Q9UIU6; -.
DR   KO; K15615; -.
DR   OMA; PVYMQQI; -.
DR   OrthoDB; EOG091G083I; -.
DR   PhylomeDB; Q9UIU6; -.
DR   TreeFam; TF315545; -.
DR   SignaLink; Q9UIU6; -.
DR   SIGNOR; Q9UIU6; -.
DR   GeneWiki; SIX4; -.
DR   GenomeRNAi; 51804; -.
DR   PRO; PR:Q9UIU6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100625; -.
DR   CleanEx; HS_SIX4; -.
DR   ExpressionAtlas; Q9UIU6; baseline and differential.
DR   Genevisible; Q9UIU6; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0061197; P:fungiform papilla morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048699; P:generation of neurons; ISS:UniProtKB.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; ISS:UniProtKB.
DR   GO; GO:0030238; P:male sex determination; ISS:UniProtKB.
DR   GO; GO:0046661; P:male sex differentiation; ISS:UniProtKB.
DR   GO; GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB.
DR   GO; GO:0051451; P:myoblast migration; IEA:Ensembl.
DR   GO; GO:0061055; P:myotome development; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:1902725; P:negative regulation of satellite cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0030910; P:olfactory placode formation; ISS:UniProtKB.
DR   GO; GO:0060037; P:pharyngeal system development; ISS:UniProtKB.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0072107; P:positive regulation of ureteric bud formation; ISS:UniProtKB.
DR   GO; GO:0034504; P:protein localization to nucleus; ISS:UniProtKB.
DR   GO; GO:0072095; P:regulation of branch elongation involved in ureteric bud branching; ISS:UniProtKB.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IEA:Ensembl.
DR   GO; GO:0008582; P:regulation of synaptic growth at neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0045214; P:sarcomere organization; ISS:UniProtKB.
DR   GO; GO:0098528; P:skeletal muscle fiber differentiation; ISS:UniProtKB.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISS:UniProtKB.
DR   GO; GO:0048538; P:thymus development; IEA:Ensembl.
DR   GO; GO:0043586; P:tongue development; ISS:UniProtKB.
DR   GO; GO:0061551; P:trigeminal ganglion development; ISS:UniProtKB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Cytoplasm; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    781       Homeobox protein SIX4.
FT                                /FTId=PRO_0000049303.
FT   DNA_BIND    223    282       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     36    102       Ala-rich.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     640    640       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VARIANT      23     23       E -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036441.
FT   VARIANT     446    446       G -> D (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs750515774).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036442.
FT   VARIANT     605    605       H -> P (in dbSNP:rs3742636).
FT                                {ECO:0000269|PubMed:10640827,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_058281.
FT   VARIANT     780    780       D -> E (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036443.
SQ   SEQUENCE   781 AA;  82933 MW;  0054080AFF7BFF7E CRC64;
     MSSSSPTGQI ASAADIKQEN GMESASEGQE AHREVAGGAA VGLSPPAPAP FPLEPGDAAT
     AAARVSGEEG AVAAAAAGAA ADQVQLHSEL LGRHHHAAAA AAQTPLAFSP DHVACVCEAL
     QQGGNLDRLA RFLWSLPQSD LLRGNESLLK ARALVAFHQG IYPELYSILE SHSFESANHP
     LLQQLWYKAR YTEAERARGR PLGAVDKYRL RRKFPLPRTI WDGEETVYCF KEKSRNALKE
     LYKQNRYPSP AEKRHLAKIT GLSLTQVSNW FKNRRQRDRN PSETQSKSES DGNPSTEDES
     SKGHEDLSPH PLSSSSDGIT NLSLSSHMEP VYMQQIGNAK ISLSSSGVLL NGSLVPASTS
     PVFLNGNSFI QGPSGVILNG LNVGNTQAVA LNPPKMSSNI VSNGISMTDI LGSTSQDVKE
     FKVLQSSANS ATTTSYSPSV PVSFPGLIPS TEVKREGIQT VASQDGGSVV TFTTPVQINQ
     YGIVQIPNSG ANSQFLNGSI GFSPLQLPPV SVAASQGNIS VSSSTSDGST FTSESTTVQQ
     GKVFLSSLAP SAVVYTVPNT GQTIGSVKQE GLERSLVFSQ LMPVNQNAQV NANLSSENIS
     GSGLHPLASS LVNVSPTHNF SLSPSTLLNP TELNRDIADS QPMSAPVASK STVTSVSNTN
     YATLQNCSLI TGQDLLSVPM TQAALGEIVP TAEDQVGHPS PAVHQDFVQE HRLVLQSVAN
     MKENFLSNSE SKATSSLMML DSKSKYVLDG MVDTVCEDLE TDKKELAKLQ TVQLDEDMQD
     L
//
ID   SHOX2_HUMAN             Reviewed;         331 AA.
AC   O60902; O60465; O60467; O60903;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 4.
DT   25-OCT-2017, entry version 163.
DE   RecName: Full=Short stature homeobox protein 2;
DE   AltName: Full=Homeobox protein Og12X;
DE   AltName: Full=Paired-related homeobox protein SHOT;
GN   Name=SHOX2; Synonyms=OG12X, SHOT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Fibroblast;
RX   PubMed=9482898; DOI=10.1073/pnas.95.5.2406;
RA   Blaschke R.J., Monaghan A.P., Schiller S., Schechinger B., Rao E.,
RA   Padilla-Nash H., Ried T., Rappold G.A.;
RT   "SHOT, a SHOX-related homeobox gene, is implicated in craniofacial,
RT   brain, heart, and limb development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:2406-2411(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 116-331 (ISOFORM 2).
RC   TISSUE=Craniofacial;
RX   PubMed=9466998; DOI=10.1093/hmg/7.3.415;
RA   Semina E.V., Reiter R.S., Murray J.C.;
RT   "A new human homeobox gene OG12X is a member of the most conserved
RT   homeobox gene family and is expressed during heart development in
RT   mouse.";
RL   Hum. Mol. Genet. 7:415-422(1998).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
CC   -!- FUNCTION: May be a growth regulator and have a role in specifying
CC       neural systems involved in processing somatosensory information,
CC       as well as in face and body structure formation.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=SHOX2A, SHOTA;
CC         IsoId=O60902-1; Sequence=Displayed;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=2; Synonyms=SHOX2B, SHOTB, OG12XB;
CC         IsoId=O60902-2; Sequence=VSP_002288;
CC       Name=3;
CC         IsoId=O60902-3; Sequence=VSP_024427;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, liver,
CC       lung, bone marrow fibroblast, pancreas and placenta.
CC   -!- DEVELOPMENTAL STAGE: Expressed during cranofacial development as
CC       well as in heart.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC39662.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA05341.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA05342.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ002367; CAA05341.1; ALT_INIT; mRNA.
DR   EMBL; AJ002368; CAA05342.1; ALT_INIT; mRNA.
DR   EMBL; BC008829; AAH08829.1; -; mRNA.
DR   EMBL; AF022654; AAC39662.1; ALT_INIT; mRNA.
DR   EMBL; AF023203; AAC39663.1; -; mRNA.
DR   CCDS; CCDS33884.2; -. [O60902-3]
DR   CCDS; CCDS43164.1; -. [O60902-1]
DR   CCDS; CCDS54664.1; -. [O60902-2]
DR   RefSeq; NP_001157150.1; NM_001163678.1. [O60902-2]
DR   RefSeq; NP_003021.3; NM_003030.4. [O60902-3]
DR   RefSeq; NP_006875.2; NM_006884.3. [O60902-1]
DR   RefSeq; XP_006713791.1; XM_006713728.3.
DR   RefSeq; XP_016862544.1; XM_017007055.1.
DR   UniGene; Hs.55967; -.
DR   ProteinModelPortal; O60902; -.
DR   SMR; O60902; -.
DR   BioGrid; 112370; 5.
DR   IntAct; O60902; 2.
DR   STRING; 9606.ENSP00000419362; -.
DR   iPTMnet; O60902; -.
DR   PhosphoSitePlus; O60902; -.
DR   BioMuta; SHOX2; -.
DR   PaxDb; O60902; -.
DR   PeptideAtlas; O60902; -.
DR   PRIDE; O60902; -.
DR   DNASU; 6474; -.
DR   Ensembl; ENST00000389589; ENSP00000374240; ENSG00000168779. [O60902-3]
DR   Ensembl; ENST00000441443; ENSP00000397099; ENSG00000168779. [O60902-1]
DR   Ensembl; ENST00000483851; ENSP00000419362; ENSG00000168779. [O60902-2]
DR   GeneID; 6474; -.
DR   KEGG; hsa:6474; -.
DR   UCSC; uc003fbr.4; human. [O60902-1]
DR   CTD; 6474; -.
DR   DisGeNET; 6474; -.
DR   EuPathDB; HostDB:ENSG00000168779.19; -.
DR   GeneCards; SHOX2; -.
DR   HGNC; HGNC:10854; SHOX2.
DR   MIM; 602504; gene.
DR   neXtProt; NX_O60902; -.
DR   OpenTargets; ENSG00000168779; -.
DR   PharmGKB; PA35756; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG007233; -.
DR   InParanoid; O60902; -.
DR   KO; K09331; -.
DR   OMA; CTEAGRD; -.
DR   OrthoDB; EOG091G0ICT; -.
DR   PhylomeDB; O60902; -.
DR   TreeFam; TF350757; -.
DR   GeneWiki; SHOX2; -.
DR   GenomeRNAi; 6474; -.
DR   PRO; PR:O60902; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000168779; -.
DR   CleanEx; HS_SHOX2; -.
DR   ExpressionAtlas; O60902; baseline and differential.
DR   Genevisible; O60902; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003209; P:cardiac atrium morphogenesis; IEA:Ensembl.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0002063; P:chondrocyte development; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; TAS:ProtInc.
DR   GO; GO:0003170; P:heart valve development; IEA:Ensembl.
DR   GO; GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0048743; P:positive regulation of skeletal muscle fiber development; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:2000172; P:regulation of branching morphogenesis of a nerve; IEA:Ensembl.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    331       Short stature homeobox protein 2.
FT                                /FTId=PRO_0000049292.
FT   DNA_BIND    140    199       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       313    326       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS     60     86       Poly-Gly.
FT   VAR_SEQ     115    115       E -> EGRRKPTKAEVQATLLLPGEAFRFL (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_024427.
FT   VAR_SEQ     235    246       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9466998,
FT                                ECO:0000303|PubMed:9482898}.
FT                                /FTId=VSP_002288.
FT   CONFLICT    125    125       E -> D (in Ref. 1; CAA05341).
FT                                {ECO:0000305}.
FT   CONFLICT    244    244       S -> P (in Ref. 1; CAA05341).
FT                                {ECO:0000305}.
FT   CONFLICT    312    312       N -> D (in Ref. 1; CAA05341/CAA05342).
FT                                {ECO:0000305}.
FT   CONFLICT    325    325       H -> L (in Ref. 3; AAC39663).
FT                                {ECO:0000305}.
SQ   SEQUENCE   331 AA;  34953 MW;  06402B3955682252 CRC64;
     MEELTAFVSK SFDQKVKEKK EAITYREVLE SGPLRGAKEP TGCTEAGRDD RSSPAVRAAG
     GGGGGGGGGG GGGGGGGVGG GGAGGGAGGG RSPVRELDMG AAERSREPGS PRLTEVSPEL
     KDRKEDAKGM EDEGQTKIKQ RRSRTNFTLE QLNELERLFD ETHYPDAFMR EELSQRLGLS
     EARVQVWFQN RRAKCRKQEN QLHKGVLIGA ASQFEACRVA PYVNVGALRM PFQQDSHCNV
     TPLSFQVQAQ LQLDSAVAHA HHHLHPHLAA HAPYMMFPAP PFGLPLATLA ADSASAASVV
     AAAAAAKTTS KNSSIADLRL KAKKHAAALG L
//
ID   SIX6_HUMAN              Reviewed;         246 AA.
AC   O95475; Q6NT42; Q9P1X8;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 2.
DT   25-OCT-2017, entry version 149.
DE   RecName: Full=Homeobox protein SIX6;
DE   AltName: Full=Homeodomain protein OPTX2;
DE   AltName: Full=Optic homeobox 2;
DE   AltName: Full=Sine oculis homeobox homolog 6;
GN   Name=SIX6; Synonyms=OPTX2, SIX9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-141.
RC   TISSUE=Eye;
RA   Leppert G.S., Yang J.-M., Toy J., Sundin O.H.;
RT   "OPTX2, a novel gene expressed in the eye, belongs to a cluster of
RT   sine oculis-related homeobox genes.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASN-141.
RX   PubMed=10381575; DOI=10.1016/S0925-4773(99)00017-9;
RA   Lopez-Rios J., Gallardo E., Rodriguez de Cordoba S., Bovolenta P.;
RT   "Six9 (Optx2), a new member of the Six gene family of transcription
RT   factors, is expressed at early stages of vertebrate ocular and
RT   pituitary development.";
RL   Mech. Dev. 83:155-159(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-141.
RX   PubMed=10512683; DOI=10.1006/geno.1999.5916;
RA   Gallardo M.E., Lopez-Rios J., Fernaud-Espinosa I., Granadino B.,
RA   Sanz R., Ramos C., Ayuso C., Seller M.J., Brunner H.G., Bovolenta P.,
RA   Rodriguez de Cordoba S.;
RT   "Genomic cloning and characterization of the human homeobox gene SIX6
RT   reveals a cluster of SIX genes in chromosome 14 and associates SIX6
RT   hemizygosity with bilateral anophthalmia and pituitary anomalies.";
RL   Genomics 61:82-91(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-141.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-165.
RX   PubMed=15014171; DOI=10.1093/molbev/msh100;
RA   Kitano T., Liu Y.-H., Ueda S., Saitou N.;
RT   "Human-specific amino acid changes found in 103 protein-coding
RT   genes.";
RL   Mol. Biol. Evol. 21:936-944(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-212; SER-221; SER-225;
RP   SER-227 AND SER-228, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   INVOLVEMENT IN ODRMD.
RX   PubMed=23167593; DOI=10.1111/cge.12046;
RA   Aldahmesh M.A., Khan A.O., Hijazi H., Alkuraya F.S.;
RT   "Homozygous truncation of SIX6 causes complex microphthalmia in
RT   humans.";
RL   Clin. Genet. 84:198-199(2013).
RN   [8]
RP   VARIANTS ASN-141 AND ALA-165.
RX   PubMed=15266624; DOI=10.1002/ajmg.a.30126;
RA   Gallardo M.E., Rodriguez De Cordoba S., Schneider A.S., Dwyer M.A.,
RA   Ayuso C., Bovolenta P.;
RT   "Analysis of the developmental SIX6 homeobox gene in patients with
RT   anophthalmia/microphthalmia.";
RL   Am. J. Med. Genet. A 129:92-94(2004).
CC   -!- FUNCTION: May be involved in eye development.
CC   -!- SUBUNIT: Interacts with TLE4 and AES. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Expressed in the developing and adult retina.
CC       Also expressed in the hypothalamic and the pituitary regions.
CC   -!- DISEASE: Optic disk anomalies with retinal and/or macular
CC       dystrophy (ODRMD) [MIM:212550]: An ocular disorder characterized
CC       by optic nerve dysplasia, optic disk anomalies, chorioretinal
CC       dystrophy and macular atrophy. Some patients have microphthalmia.
CC       {ECO:0000269|PubMed:23167593}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF031648; AAF04402.1; -; Genomic_DNA.
DR   EMBL; AJ011785; CAA09773.1; -; mRNA.
DR   EMBL; AF141651; AAD49844.1; -; Genomic_DNA.
DR   EMBL; BC069413; AAH69413.2; -; mRNA.
DR   EMBL; AB041399; BAA94484.1; -; Genomic_DNA.
DR   CCDS; CCDS9747.1; -.
DR   RefSeq; NP_031400.2; NM_007374.2.
DR   UniGene; Hs.194756; -.
DR   ProteinModelPortal; O95475; -.
DR   SMR; O95475; -.
DR   BioGrid; 111034; 3.
DR   STRING; 9606.ENSP00000328596; -.
DR   iPTMnet; O95475; -.
DR   PhosphoSitePlus; O95475; -.
DR   BioMuta; SIX6; -.
DR   EPD; O95475; -.
DR   MaxQB; O95475; -.
DR   PaxDb; O95475; -.
DR   PeptideAtlas; O95475; -.
DR   PRIDE; O95475; -.
DR   DNASU; 4990; -.
DR   Ensembl; ENST00000327720; ENSP00000328596; ENSG00000184302.
DR   GeneID; 4990; -.
DR   KEGG; hsa:4990; -.
DR   UCSC; uc001xfa.5; human.
DR   CTD; 4990; -.
DR   DisGeNET; 4990; -.
DR   EuPathDB; HostDB:ENSG00000184302.6; -.
DR   GeneCards; SIX6; -.
DR   GeneReviews; SIX6; -.
DR   HGNC; HGNC:10892; SIX6.
DR   HPA; HPA001403; -.
DR   MalaCards; SIX6; -.
DR   MIM; 212550; phenotype.
DR   MIM; 606326; gene.
DR   neXtProt; NX_O95475; -.
DR   OpenTargets; ENSG00000184302; -.
DR   Orphanet; 264200; 14q22q23 microdeletion syndrome.
DR   Orphanet; 2543; Microphthalmia - cataract.
DR   PharmGKB; PA35792; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000261680; -.
DR   HOVERGEN; HBG003609; -.
DR   InParanoid; O95475; -.
DR   KO; K19473; -.
DR   OMA; RPAGICC; -.
DR   OrthoDB; EOG091G083I; -.
DR   PhylomeDB; O95475; -.
DR   TreeFam; TF315545; -.
DR   SIGNOR; O95475; -.
DR   GenomeRNAi; 4990; -.
DR   PRO; PR:O95475; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000184302; -.
DR   CleanEx; HS_SIX6; -.
DR   Genevisible; O95475; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0001205; F:transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0001654; P:eye development; IEA:InterPro.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   InterPro; IPR032947; SIX6.
DR   PANTHER; PTHR10390:SF12; PTHR10390:SF12; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Cataract; Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Microphthalmia; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    246       Homeobox protein SIX6.
FT                                /FTId=PRO_0000049307.
FT   DNA_BIND    128    187       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     212    212       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     221    221       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     225    225       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     228    228       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VARIANT     141    141       H -> N (in dbSNP:rs33912345).
FT                                {ECO:0000269|PubMed:10381575,
FT                                ECO:0000269|PubMed:10512683,
FT                                ECO:0000269|PubMed:15266624,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_031631.
FT   VARIANT     165    165       T -> A (found in a patient with bilateral
FT                                asymmetric microphthalmia, cataract and
FT                                nystagmus; unknown pathological
FT                                significance; dbSNP:rs104894480).
FT                                {ECO:0000269|PubMed:15266624}.
FT                                /FTId=VAR_026241.
SQ   SEQUENCE   246 AA;  27687 MW;  5378438C9DE8C597 CRC64;
     MFQLPILNFS PQQVAGVCET LEESGDVERL GRFLWSLPVA PAACEALNKN ESVLRARAIV
     AFHGGNYREL YHILENHKFT KESHAKLQAL WLEAHYQEAE KLRGRPLGPV DKYRVRKKFP
     LPRTIWDGEQ KTHCFKERTR HLLREWYLQD PYPNPSKKRE LAQATGLTPT QVGNWFKNRR
     QRDRAAAAKN RLQQQVLSQG SGRALRAEGD GTPEVLGVAT SPAASLSSKA ATSAISITSS
     DSECDI
//
ID   SHOX_HUMAN              Reviewed;         292 AA.
AC   O15266; O00412; O00413; O15267;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   25-OCT-2017, entry version 174.
DE   RecName: Full=Short stature homeobox protein;
DE   AltName: Full=Pseudoautosomal homeobox-containing osteogenic protein;
DE   AltName: Full=Short stature homeobox-containing protein;
GN   Name=SHOX; Synonyms=PHOG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS SHOXA AND SHOXB),
RP   AND INVOLVEMENT IN ISS.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9140395; DOI=10.1038/ng0597-54;
RA   Rao E., Weiss B., Fukami M., Rump A., Niesler B., Mertz A., Muroya K.,
RA   Binder G., Kirsch S., Winkelmann M., Nordsiek G., Heinrich U.,
RA   Breuning M.H., Ranke M.B., Rosenthal A., Ogata T., Rappold G.A.;
RT   "Pseudoautosomal deletions encompassing a novel homeobox gene cause
RT   growth failure in idiopathic short stature and Turner syndrome.";
RL   Nat. Genet. 16:54-63(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHOXA).
RX   PubMed=9259282; DOI=10.1093/hmg/6.8.1341;
RA   Ellison J.W., Wardak Z., Young M.F., Gehron Robey P., Laig-Webster M.,
RA   Chiong W.;
RT   "PHOG, a candidate gene for involvement in the short stature of Turner
RT   syndrome.";
RL   Hum. Mol. Genet. 6:1341-1347(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   VARIANTS LWD VAL-132 AND LEU-153.
RX   PubMed=11030412; DOI=10.1007/s004390000352;
RA   Grigelioniene G., Ekloef O., Ivarsson S.A., Westphal O., Neumeyer L.,
RA   Kedra D., Dumanski J., Hagenaes L.;
RT   "Mutations in short stature homeobox containing gene (SHOX) in
RT   dyschondrosteosis but not in hypochondroplasia.";
RL   Hum. Genet. 107:145-149(2000).
RN   [5]
RP   DISEASE.
RX   PubMed=11891678; DOI=10.1002/ajmg.10228;
RA   Cormier-Daire V., Huber C., Munnich A.;
RT   "Allelic and nonallelic heterogeneity in dyschondrosteosis (Leri-Weill
RT   syndrome).";
RL   Am. J. Med. Genet. 106:272-274(2001).
RN   [6]
RP   VARIANT LWD CYS-173.
RX   PubMed=11403039; DOI=10.1136/jmg.38.5.323;
RA   Huber C., Cusin V., Le Merrer M., Mathieu M., Sulmont V., Dagoneau N.,
RA   Munnich A., Cormier-Daire V.;
RT   "SHOX point mutations in dyschondrosteosis.";
RL   J. Med. Genet. 38:323-323(2001).
RN   [7]
RP   VARIANT LMD TRP-168.
RX   PubMed=11889214; DOI=10.1210/jcem.87.3.8348;
RA   Ogata T., Muroya K., Sasaki G., Nishimura G., Kitoh H., Hattori T.;
RT   "SHOX nullizygosity and haploinsufficiency in a Japanese family:
RT   implication for the development of Turner skeletal features.";
RL   J. Clin. Endocrinol. Metab. 87:1390-1394(2002).
CC   -!- FUNCTION: Controls fundamental aspects of growth and development.
CC   -!- INTERACTION:
CC       P35711:SOX5; NbExp=2; IntAct=EBI-3505698, EBI-3505701;
CC       P35712:SOX6; NbExp=3; IntAct=EBI-3505698, EBI-3505706;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=SHOXA;
CC         IsoId=O15266-1; Sequence=Displayed;
CC       Name=SHOXB;
CC         IsoId=O15266-2; Sequence=VSP_002287;
CC   -!- TISSUE SPECIFICITY: SHOXA is expressed in skeletal muscle,
CC       placenta, pancreas, heart and bone marrow fibroblast and SHOXB is
CC       highly expressed in bone marrow fibroblast followed by kidney and
CC       skeletal muscle. SHOXB is not expressed in brain, kidney, liver
CC       and lung. Highly expressed in osteogenic cells.
CC   -!- INDUCTION: By retinoic acid and phorbol-12-myristate 13-acetate
CC       (PMA).
CC   -!- DISEASE: Leri-Weill dyschondrosteosis (LWD) [MIM:127300]:
CC       Dominantly inherited skeletal dysplasia characterized by moderate
CC       short stature predominantly because of short mesomelic limb
CC       segments. It is often associated with the Madelung deformity of
CC       the wrist, comprising bowing of the radius and dorsal dislocation
CC       of the distal ulna. {ECO:0000269|PubMed:11030412,
CC       ECO:0000269|PubMed:11403039}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Langer mesomelic dysplasia (LMD) [MIM:249700]: Autosomal
CC       recessive rare skeletal dysplasia characterized by severe short
CC       stature owing to shortening and maldevelopment of the mesomelic
CC       and rhizomelic segments of the limbs. Associated malformations are
CC       rarely reported and intellect is normal in all affected subjects
CC       reported to date. {ECO:0000269|PubMed:11889214}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Short stature, idiopathic, X-linked (ISS) [MIM:300582]: A
CC       condition defined by a standing height more than 2 standard
CC       deviations below the mean (or below the 2.5 percentile) for sex
CC       and chronological age, compared with a well-nourished, genetically
CC       relevant population, in the absence of specific causative
CC       disorders. {ECO:0000269|PubMed:9140395}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The gene coding for this protein is located in the
CC       pseudoautosomal region 1 (PAR1) of X and Y chromosomes.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y11536; CAA72299.1; -; mRNA.
DR   EMBL; Y11535; CAA72298.1; -; mRNA.
DR   EMBL; U82668; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U89331; AAC18820.1; -; mRNA.
DR   EMBL; BX004827; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS14106.1; -. [O15266-2]
DR   CCDS; CCDS14107.1; -. [O15266-1]
DR   RefSeq; NP_000442.1; NM_000451.3. [O15266-1]
DR   RefSeq; NP_006874.1; NM_006883.2. [O15266-2]
DR   UniGene; Hs.105932; -.
DR   ProteinModelPortal; O15266; -.
DR   SMR; O15266; -.
DR   IntAct; O15266; 7.
DR   STRING; 9606.ENSP00000370990; -.
DR   iPTMnet; O15266; -.
DR   PhosphoSitePlus; O15266; -.
DR   BioMuta; SHOX; -.
DR   PaxDb; O15266; -.
DR   PeptideAtlas; O15266; -.
DR   PRIDE; O15266; -.
DR   DNASU; 6473; -.
DR   Ensembl; ENST00000334060; ENSP00000335505; ENSG00000185960. [O15266-2]
DR   Ensembl; ENST00000381575; ENSP00000370987; ENSG00000185960. [O15266-2]
DR   Ensembl; ENST00000381578; ENSP00000370990; ENSG00000185960. [O15266-1]
DR   Ensembl; ENST00000554971; ENSP00000452016; ENSG00000185960. [O15266-1]
DR   GeneID; 6473; -.
DR   KEGG; hsa:6473; -.
DR   UCSC; uc004cph.1; human. [O15266-1]
DR   CTD; 6473; -.
DR   DisGeNET; 6473; -.
DR   EuPathDB; HostDB:ENSG00000185960.13; -.
DR   GeneCards; SHOX; -.
DR   GeneReviews; SHOX; -.
DR   HGNC; HGNC:10853; SHOX.
DR   HPA; HPA035141; -.
DR   HPA; HPA060931; -.
DR   MalaCards; SHOX; -.
DR   MIM; 127300; phenotype.
DR   MIM; 249700; phenotype.
DR   MIM; 300582; phenotype.
DR   MIM; 312865; gene.
DR   MIM; 400020; gene.
DR   neXtProt; NX_O15266; -.
DR   OpenTargets; ENSG00000185960; -.
DR   Orphanet; 2632; Langer mesomelic dysplasia.
DR   Orphanet; 240; Leri-Weill dyschondrosteosis.
DR   Orphanet; 314795; SHOX-related short stature.
DR   PharmGKB; PA134978644; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG007233; -.
DR   InParanoid; O15266; -.
DR   KO; K09331; -.
DR   OMA; FKDHVES; -.
DR   OrthoDB; EOG091G0ICT; -.
DR   PhylomeDB; O15266; -.
DR   TreeFam; TF350757; -.
DR   SIGNOR; O15266; -.
DR   ChiTaRS; SHOX; human.
DR   GeneWiki; Short_stature_homeobox_gene; -.
DR   GenomeRNAi; 6473; -.
DR   PRO; PR:O15266; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000185960; -.
DR   CleanEx; HS_SHOX; -.
DR   ExpressionAtlas; O15266; baseline and differential.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:NTNU_SB.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; Disease mutation; DNA-binding; Dwarfism;
KW   Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    292       Short stature homeobox protein.
FT                                /FTId=PRO_0000049291.
FT   DNA_BIND    117    176       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       242    249       SH3-binding. {ECO:0000255}.
FT   MOTIF       274    287       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS     19     28       Poly-Gly.
FT   COMPBIAS    242    245       Poly-Pro.
FT   COMPBIAS    264    267       Poly-Ala.
FT   VAR_SEQ     212    292       VQAQLQLEGVAHAHPHLHPHLAAHAPYLMFPPPPFGLPIAS
FT                                LAESASAAAVVAAAAKSNSKNSSIADLRLKARKHAEALGL
FT                                -> MEFCSCRPGWSIMA (in isoform SHOXB).
FT                                {ECO:0000303|PubMed:9140395}.
FT                                /FTId=VSP_002287.
FT   VARIANT     132    132       L -> V (in LWD; dbSNP:rs137852554).
FT                                {ECO:0000269|PubMed:11030412}.
FT                                /FTId=VAR_019414.
FT   VARIANT     153    153       R -> L (in LWD; dbSNP:rs137852555).
FT                                {ECO:0000269|PubMed:11030412}.
FT                                /FTId=VAR_019415.
FT   VARIANT     168    168       R -> W (in LMD; dbSNP:rs137852557).
FT                                {ECO:0000269|PubMed:11889214}.
FT                                /FTId=VAR_019416.
FT   VARIANT     173    173       R -> C (in LWD; dbSNP:rs137852556).
FT                                {ECO:0000269|PubMed:11403039}.
FT                                /FTId=VAR_012346.
SQ   SEQUENCE   292 AA;  32236 MW;  0F2A61A3051CB360 CRC64;
     MEELTAFVSK SFDQKSKDGN GGGGGGGGKK DSITYREVLE SGLARSRELG TSDSSLQDIT
     EGGGHCPVHL FKDHVDNDKE KLKEFGTARV AEGIYECKEK REDVKSEDED GQTKLKQRRS
     RTNFTLEQLN ELERLFDETH YPDAFMREEL SQRLGLSEAR VQVWFQNRRA KCRKQENQMH
     KGVILGTANH LDACRVAPYV NMGALRMPFQ QVQAQLQLEG VAHAHPHLHP HLAAHAPYLM
     FPPPPFGLPI ASLAESASAA AVVAAAAKSN SKNSSIADLR LKARKHAEAL GL
//
ID   SIX2_HUMAN              Reviewed;         291 AA.
AC   Q9NPC8; Q9BXH7;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-SEP-2017, entry version 134.
DE   RecName: Full=Homeobox protein SIX2;
DE   AltName: Full=Sine oculis homeobox homolog 2;
GN   Name=SIX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10677303; DOI=10.1086/302779;
RA   Celli J., Van Beusekom E., Hennekam R.C.M., Gallardo M.E.,
RA   Smeets D.F.C.M., Rodriguez de Cordoba S., Innis J.W., Frydman M.,
RA   Konig R., Kingston H., Tolmie J., Lutgarde L.C.P., van Bokhoven H.,
RA   Brunner H.G.;
RT   "Familial syndromic esophageal atresia maps to 2p23-p24.";
RL   Am. J. Hum. Genet. 66:436-444(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=10773454; DOI=10.1016/S0378-1119(00)00105-0;
RA   Boucher C.A., Winchester C.L., Hamilton G.M., Winter A.D.,
RA   Johnson K.J., Bailey M.E.S.;
RT   "Structure, mapping and expression of the human gene encoding the
RT   homeodomain protein, SIX2.";
RL   Gene 247:145-151(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Salivary gland;
RA   Hedrich K., Hehr A.J., Hansmann I., Hehr U.;
RT   "Molecular characterization of the human SIX2 gene: alternative
RT   polyadenylation and localization within the HPE2 critical region
RT   2p21.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20515681; DOI=10.1016/j.ydbio.2010.05.509;
RA   He G., Tavella S., Hanley K.P., Self M., Oliver G., Grifone R.,
RA   Hanley N., Ward C., Bobola N.;
RT   "Inactivation of Six2 in mouse identifies a novel genetic mechanism
RT   controlling development and growth of the cranial base.";
RL   Dev. Biol. 344:720-730(2010).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=22703800; DOI=10.1016/j.jpedsurg.2012.03.034;
RA   Murphy A.J., Pierce J., de Caestecker C., Taylor C., Anderson J.R.,
RA   Perantoni A.O., de Caestecker M.P., Lovvorn H.N. III;
RT   "SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain
RT   active in primitive elements of Wilms' tumor.";
RL   J. Pediatr. Surg. 47:1239-1249(2012).
RN   [7]
RP   FUNCTION IN CELL MIGRATION AND CELL PROLIFERATION.
RX   PubMed=22995329; DOI=10.1016/j.humpath.2012.05.021;
RA   Senanayake U., Koller K., Pichler M., Leuschner I., Strohmaier H.,
RA   Hadler U., Das S., Hoefler G., Guertl B.;
RT   "The pluripotent renal stem cell regulator SIX2 is activated in renal
RT   neoplasms and influences cellular proliferation and migration.";
RL   Hum. Pathol. 44:336-345(2013).
RN   [8]
RP   VARIANTS PHE-43; LEU-241 AND ASN-276.
RX   PubMed=18305125; DOI=10.1681/ASN.2006111282;
RA   Weber S., Taylor J.C., Winyard P., Baker K.F., Sullivan-Brown J.,
RA   Schild R., Knueppel T., Zurowska A.M., Caldas-Alfonso A., Litwin M.,
RA   Emre S., Ghiggeri G.M., Bakkaloglu A., Mehls O., Antignac C.,
RA   Schaefer F., Burdine R.D.;
RT   "SIX2 and BMP4 mutations associate with anomalous kidney
RT   development.";
RL   J. Am. Soc. Nephrol. 19:891-903(2008).
CC   -!- FUNCTION: Transcription factor that plays an important role in the
CC       development of several organs, including kidney, skull and
CC       stomach. During kidney development, maintains cap mesenchyme
CC       multipotent nephron progenitor cells in an undifferentiated state
CC       by opposing the inductive signals emanating from the ureteric bud
CC       and cooperates with WNT9B to promote renewing progenitor cells
CC       proliferation. Acts through its interaction with TCF7L2 and OSR1
CC       in a canonical Wnt signaling independent manner preventing
CC       transcription of differentiation genes in cap mesenchyme such as
CC       WNT4. Also acts independently of OSR1 to activate expression of
CC       many cap mesenchyme genes, including itself, GDNF and OSR1. During
CC       craniofacial development plays a role in growth and elongation of
CC       the cranial base through regulation of chondrocyte
CC       differentiation. During stomach organogenesis, controls pyloric
CC       sphincter formation and mucosal growth through regulation of a
CC       gene network including NKX2-5, BMPR1B, BMP4, SOX9 and GREM1.
CC       During branchial arch development, acts to mediate HOXA2 control
CC       over the insulin-like growth factor pathway. Also may be involved
CC       in limb tendon and ligament development (By similarity). Plays a
CC       role in cell proliferation and migration.
CC       {ECO:0000250|UniProtKB:Q62232, ECO:0000269|PubMed:22995329}.
CC   -!- SUBUNIT: Interacts with TCF7L2; in a canonical Wnt signaling
CC       independent manner; prevents transcription of differentiation
CC       genes in cap mesenchyme. Interacts with OSR1; form a strong
CC       repressor complex with TCF7L2, TLE2 and TLE3 to prevent the
CC       activation of Wnt/beta-catenin target genes in the cap mesenchyme.
CC       Interacts with HOXA11, EYA1 and EYA3.
CC       {ECO:0000250|UniProtKB:Q62232}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q62232}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in skeletal muscle.
CC       Expressed in Wilms' tumor and in the cap mesenchyme of fetal
CC       kidney (at protein level). {ECO:0000269|PubMed:22703800}.
CC   -!- DEVELOPMENTAL STAGE: Found at 48 dpc in the anterior cranial base
CC       with detection concentrated in the sphenoid precursor. Expression
CC       is also detected in the pituitary gland.
CC       {ECO:0000269|PubMed:20515681}.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF136939; AAF69031.1; -; Genomic_DNA.
DR   EMBL; AF136940; AAF69032.1; -; mRNA.
DR   EMBL; AF332196; AAK16581.1; -; mRNA.
DR   EMBL; AF332197; AAK16582.1; -; mRNA.
DR   EMBL; AF332198; AAK16583.1; -; Genomic_DNA.
DR   EMBL; AF323498; AAK06773.1; -; Genomic_DNA.
DR   EMBL; BT020100; AAV38903.1; -; mRNA.
DR   CCDS; CCDS1822.1; -.
DR   RefSeq; NP_058628.3; NM_016932.4.
DR   UniGene; Hs.101937; -.
DR   ProteinModelPortal; Q9NPC8; -.
DR   SMR; Q9NPC8; -.
DR   BioGrid; 115959; 21.
DR   STRING; 9606.ENSP00000304502; -.
DR   iPTMnet; Q9NPC8; -.
DR   PhosphoSitePlus; Q9NPC8; -.
DR   BioMuta; SIX2; -.
DR   DMDM; 12230598; -.
DR   EPD; Q9NPC8; -.
DR   MaxQB; Q9NPC8; -.
DR   PaxDb; Q9NPC8; -.
DR   PeptideAtlas; Q9NPC8; -.
DR   PRIDE; Q9NPC8; -.
DR   DNASU; 10736; -.
DR   Ensembl; ENST00000303077; ENSP00000304502; ENSG00000170577.
DR   GeneID; 10736; -.
DR   KEGG; hsa:10736; -.
DR   UCSC; uc002ruo.4; human.
DR   CTD; 10736; -.
DR   DisGeNET; 10736; -.
DR   EuPathDB; HostDB:ENSG00000170577.7; -.
DR   GeneCards; SIX2; -.
DR   HGNC; HGNC:10888; SIX2.
DR   HPA; HPA052782; -.
DR   HPA; HPA056958; -.
DR   MalaCards; SIX2; -.
DR   MIM; 604994; gene.
DR   neXtProt; NX_Q9NPC8; -.
DR   OpenTargets; ENSG00000170577; -.
DR   PharmGKB; PA35788; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000261680; -.
DR   HOVERGEN; HBG003609; -.
DR   InParanoid; Q9NPC8; -.
DR   KO; K19472; -.
DR   OMA; HSLHHET; -.
DR   OrthoDB; EOG091G083I; -.
DR   PhylomeDB; Q9NPC8; -.
DR   TreeFam; TF315545; -.
DR   ChiTaRS; SIX2; human.
DR   GeneWiki; SIX2; -.
DR   GenomeRNAi; 10736; -.
DR   PRO; PR:Q9NPC8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170577; -.
DR   CleanEx; HS_SIX2; -.
DR   Genevisible; Q9NPC8; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0072137; P:condensed mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IMP:UniProtKB.
DR   GO; GO:0072161; P:mesenchymal cell differentiation involved in kidney development; ISS:UniProtKB.
DR   GO; GO:0072038; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:0097168; P:mesenchymal stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007501; P:mesodermal cell fate specification; ISS:UniProtKB.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0072006; P:nephron development; ISS:UniProtKB.
DR   GO; GO:0072028; P:nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0090189; P:regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    291       Homeobox protein SIX2.
FT                                /FTId=PRO_0000049297.
FT   DNA_BIND    124    183       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      43     43       L -> F (in a renal hypodysplasia patient;
FT                                dbSNP:rs142188105).
FT                                {ECO:0000269|PubMed:18305125}.
FT                                /FTId=VAR_071207.
FT   VARIANT     241    241       P -> L (in a renal hypodysplasia patient;
FT                                dbSNP:rs147806994).
FT                                {ECO:0000269|PubMed:18305125}.
FT                                /FTId=VAR_071208.
FT   VARIANT     276    276       D -> N (in a renal hypodysplasia patient;
FT                                dbSNP:rs201675842).
FT                                {ECO:0000269|PubMed:18305125}.
FT                                /FTId=VAR_071209.
SQ   SEQUENCE   291 AA;  32286 MW;  8388C3C331575BDD CRC64;
     MSMLPTFGFT QEQVACVCEV LQQGGNIERL GRFLWSLPAC EHLHKNESVL KAKAVVAFHR
     GNFRELYKIL ESHQFSPHNH AKLQQLWLKA HYIEAEKLRG RPLGAVGKYR VRRKFPLPRS
     IWDGEETSYC FKEKSRSVLR EWYAHNPYPS PREKRELAEA TGLTTTQVSN WFKNRRQRDR
     AAEAKERENN ENSNSNSHNP LNGSGKSVLG SSEDEKTPSG TPDHSSSSPA LLLSPPPPGL
     PSLHSLGHPP GPSAVPVPVP GGGGADPLQH HHGLQDSILN PMSANLVDLG S
//
ID   TF2LX_HUMAN             Reviewed;         241 AA.
AC   Q8IUE1; Q5JRM9; Q8TD48;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   27-SEP-2017, entry version 123.
DE   RecName: Full=Homeobox protein TGIF2LX;
DE   AltName: Full=TGF-beta-induced transcription factor 2-like protein;
DE   AltName: Full=TGFB-induced factor 2-like protein, X-linked;
DE   AltName: Full=TGIF-like on the X;
GN   Name=TGIF2LX; Synonyms=TGIFLX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Testis;
RX   PubMed=12226713; DOI=10.1007/s00335-002-3010-9;
RA   Blanco-Arias P., Sargent C.A., Affara N.A.;
RT   "The human-specific Yp11.2/Xq21.3 homology block encodes a potentially
RT   functional testis-specific TGIF-like retroposon.";
RL   Mamm. Genome 13:463-468(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-197.
RX   PubMed=12815422; DOI=10.1038/nature01722;
RA   Skaletsky H., Kuroda-Kawaguchi T., Minx P.J., Cordum H.S.,
RA   Hillier L.W., Brown L.G., Repping S., Pyntikova T., Ali J., Bieri T.,
RA   Chinwalla A., Delehaunty A., Delehaunty K., Du H., Fewell G.,
RA   Fulton L., Fulton R., Graves T.A., Hou S.-F., Latrielle P.,
RA   Leonard S., Mardis E., Maupin R., McPherson J., Miner T., Nash W.,
RA   Nguyen C., Ozersky P., Pepin K., Rock S., Rohlfing T., Scott K.,
RA   Schultz B., Strong C., Tin-Wollam A., Yang S.-P., Waterston R.H.,
RA   Wilson R.K., Rozen S., Page D.C.;
RT   "The male-specific region of the human Y chromosome is a mosaic of
RT   discrete sequence classes.";
RL   Nature 423:825-837(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-197.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   STRUCTURE BY NMR OF 51-120.
RG   RIKEN structural genomics initiative (RSGI);
RT   "The solution structure of the homeobox domain of human homeobox
RT   protein TGIF2LX.";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: May have a transcription role in testis.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in adult testis.
CC   -!- SIMILARITY: Belongs to the TALE/TGIF homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ427749; CAD20750.1; -; Genomic_DNA.
DR   EMBL; AF497480; AAM18073.1; -; mRNA.
DR   EMBL; AL590041; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC117398; AAI17399.1; -; mRNA.
DR   EMBL; BC117400; AAI17401.1; -; mRNA.
DR   CCDS; CCDS14459.1; -.
DR   RefSeq; NP_620410.3; NM_138960.3.
DR   UniGene; Hs.592220; -.
DR   PDB; 2DMN; NMR; -; A=51-120.
DR   PDBsum; 2DMN; -.
DR   ProteinModelPortal; Q8IUE1; -.
DR   SMR; Q8IUE1; -.
DR   BioGrid; 124690; 2.
DR   STRING; 9606.ENSP00000355119; -.
DR   iPTMnet; Q8IUE1; -.
DR   PhosphoSitePlus; Q8IUE1; -.
DR   BioMuta; TGIF2LX; -.
DR   DMDM; 44888510; -.
DR   EPD; Q8IUE1; -.
DR   MaxQB; Q8IUE1; -.
DR   PaxDb; Q8IUE1; -.
DR   PeptideAtlas; Q8IUE1; -.
DR   PRIDE; Q8IUE1; -.
DR   DNASU; 90316; -.
DR   Ensembl; ENST00000283891; ENSP00000355119; ENSG00000153779.
DR   Ensembl; ENST00000561129; ENSP00000453704; ENSG00000153779.
DR   GeneID; 90316; -.
DR   KEGG; hsa:90316; -.
DR   UCSC; uc004efe.4; human.
DR   CTD; 90316; -.
DR   DisGeNET; 90316; -.
DR   EuPathDB; HostDB:ENSG00000153779.9; -.
DR   GeneCards; TGIF2LX; -.
DR   H-InvDB; HIX0016906; -.
DR   HGNC; HGNC:18570; TGIF2LX.
DR   HPA; HPA034543; -.
DR   MIM; 300411; gene.
DR   neXtProt; NX_Q8IUE1; -.
DR   OpenTargets; ENSG00000153779; -.
DR   PharmGKB; PA38582; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000232039; -.
DR   HOVERGEN; HBG001143; -.
DR   InParanoid; Q8IUE1; -.
DR   KO; K19554; -.
DR   OMA; WPLPKGQ; -.
DR   OrthoDB; EOG091G0HJ6; -.
DR   PhylomeDB; Q8IUE1; -.
DR   TreeFam; TF318093; -.
DR   EvolutionaryTrace; Q8IUE1; -.
DR   GenomeRNAi; 90316; -.
DR   PRO; PR:Q8IUE1; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000153779; -.
DR   CleanEx; HS_TGIF2LX; -.
DR   Genevisible; Q8IUE1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    241       Homeobox protein TGIF2LX.
FT                                /FTId=PRO_0000049324.
FT   DNA_BIND     48    111       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   VARIANT     197    197       V -> I (in dbSNP:rs2290380).
FT                                {ECO:0000269|PubMed:12815422,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_017867.
FT   HELIX        59     71       {ECO:0000244|PDB:2DMN}.
FT   TURN         72     75       {ECO:0000244|PDB:2DMN}.
FT   HELIX        80     90       {ECO:0000244|PDB:2DMN}.
FT   HELIX        94    107       {ECO:0000244|PDB:2DMN}.
FT   HELIX       109    112       {ECO:0000244|PDB:2DMN}.
SQ   SEQUENCE   241 AA;  26675 MW;  A3E393E0BAD0B3BA CRC64;
     MEAAADGPAE TQSPVEKDSP AKTQSPAQDT SIMSRNNADT GRVLALPEHK KKRKGNLPAE
     SVKILRDWMY KHRFKAYPSE EEKQMLSEKT NLSLLQISNW FINARRRILP DMLQQRRNDP
     IIGHKTGKDA HATHLQSTEA SVPAKSGPSG PDNVQSLPLW PLPKGQMSRE KQPDPESAPS
     QKLTGIAQPK KKVKVSVTSP SSPELVSPEE HADFSSFLLL VDAAVQRAAE LELEKKQEPN
     P
//
ID   TGIF2_HUMAN             Reviewed;         237 AA.
AC   Q9GZN2; B2R9U3; E1P5T9; H0YNI0;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-SEP-2017, entry version 150.
DE   RecName: Full=Homeobox protein TGIF2;
DE   AltName: Full=5'-TG-3'-interacting factor 2;
DE   AltName: Full=TGF-beta-induced transcription factor 2;
DE            Short=TGFB-induced factor 2;
GN   Name=TGIF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=11006116; DOI=10.1006/bbrc.2000.3449;
RA   Imoto I., Pimkhaokham A., Watanabe T., Saito-Ohara F., Soeda E.,
RA   Inazawa J.;
RT   "Amplification and overexpression of TGIF2, a novel homeobox gene of
RT   the TALE superclass, in ovarian cancer cell lines.";
RL   Biochem. Biophys. Res. Commun. 276:264-270(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, PHOSPHORYLATION AT THR-182 AND THR-186, INTERACTION WITH
RP   HDAC1 AND SMAD3, AND MUTAGENESIS OF THR-182 AND THR-186.
RX   PubMed=11427533; DOI=10.1074/jbc.M103377200;
RA   Melhuish T.A., Gallo C.M., Wotton D.;
RT   "TGIF2 interacts with histone deacetylase 1 and represses
RT   transcription.";
RL   J. Biol. Chem. 276:32109-32114(2001).
CC   -!- FUNCTION: Transcriptional repressor, which probably repress
CC       transcription by binding directly the 5'-CTGTCAA-3' DNA sequence
CC       or by interacting with TGF-beta activated SMAD proteins. Probably
CC       represses transcription via the recruitment of histone deacetylase
CC       proteins. {ECO:0000269|PubMed:11427533}.
CC   -!- SUBUNIT: Interacts with the transcriptional modulator SMAD3 and
CC       the histone deacetylase HDAC1. {ECO:0000269|PubMed:11427533}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Excluded from nucleoli.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9GZN2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9GZN2-2; Sequence=VSP_047346, VSP_047347;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in heart,
CC       kidney and testis. Weakly expressed in brain and prostate.
CC   -!- PTM: The C-terminal part is phosphorylated in response to EGF
CC       signaling by the Ras/MAPK pathway. {ECO:0000269|PubMed:11427533}.
CC   -!- MISCELLANEOUS: TGIF2 is amplified and overexpressed in several
CC       ovarian cancer cell lines.
CC   -!- SIMILARITY: Belongs to the TALE/TGIF homeobox family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BX377269; Type=Frameshift; Positions=87, 118; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB042646; BAB16424.1; -; mRNA.
DR   EMBL; BX377269; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK074802; BAC11216.1; -; mRNA.
DR   EMBL; AK313919; BAG36640.1; -; mRNA.
DR   EMBL; AL050318; CAB75368.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76127.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76128.1; -; Genomic_DNA.
DR   EMBL; BC006549; AAH06549.1; -; mRNA.
DR   EMBL; BC012816; AAH12816.1; -; mRNA.
DR   CCDS; CCDS13278.1; -. [Q9GZN2-1]
DR   PIR; JC7392; JC7392.
DR   RefSeq; NP_001186442.1; NM_001199513.1. [Q9GZN2-1]
DR   RefSeq; NP_001186443.1; NM_001199514.1. [Q9GZN2-1]
DR   RefSeq; NP_001186444.1; NM_001199515.1. [Q9GZN2-1]
DR   RefSeq; NP_068581.1; NM_021809.6. [Q9GZN2-1]
DR   UniGene; Hs.632264; -.
DR   ProteinModelPortal; Q9GZN2; -.
DR   SMR; Q9GZN2; -.
DR   BioGrid; 121908; 17.
DR   BioGrid; 1529332; 1.
DR   STRING; 9606.ENSP00000362979; -.
DR   iPTMnet; Q9GZN2; -.
DR   PhosphoSitePlus; Q9GZN2; -.
DR   BioMuta; TGIF2; -.
DR   DMDM; 27805750; -.
DR   EPD; Q9GZN2; -.
DR   MaxQB; Q9GZN2; -.
DR   PaxDb; Q9GZN2; -.
DR   PeptideAtlas; Q9GZN2; -.
DR   PRIDE; Q9GZN2; -.
DR   DNASU; 60436; -.
DR   Ensembl; ENST00000373872; ENSP00000362979; ENSG00000118707. [Q9GZN2-1]
DR   Ensembl; ENST00000373874; ENSP00000362981; ENSG00000118707. [Q9GZN2-1]
DR   Ensembl; ENST00000560025; ENSP00000453773; ENSG00000118707. [Q9GZN2-1]
DR   Ensembl; ENST00000611732; ENSP00000481787; ENSG00000118707. [Q9GZN2-1]
DR   GeneID; 60436; -.
DR   KEGG; hsa:60436; -.
DR   UCSC; uc002xfn.4; human. [Q9GZN2-1]
DR   CTD; 60436; -.
DR   DisGeNET; 60436; -.
DR   EuPathDB; HostDB:ENSG00000118707.9; -.
DR   GeneCards; TGIF2; -.
DR   HGNC; HGNC:15764; TGIF2.
DR   HPA; HPA053786; -.
DR   MIM; 607294; gene.
DR   neXtProt; NX_Q9GZN2; -.
DR   OpenTargets; ENSG00000118707; -.
DR   PharmGKB; PA38035; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00390000004786; -.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000232039; -.
DR   HOVERGEN; HBG001143; -.
DR   InParanoid; Q9GZN2; -.
DR   KO; K19553; -.
DR   OMA; TKFTISR; -.
DR   OrthoDB; EOG091G0N1F; -.
DR   PhylomeDB; Q9GZN2; -.
DR   TreeFam; TF314558; -.
DR   TreeFam; TF318093; -.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   ChiTaRS; TGIF2; human.
DR   GeneWiki; TGIF2; -.
DR   GenomeRNAi; 60436; -.
DR   PRO; PR:Q9GZN2; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000118707; -.
DR   CleanEx; HS_TGIF2; -.
DR   ExpressionAtlas; Q9GZN2; baseline and differential.
DR   Genevisible; Q9GZN2; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0038092; P:nodal signaling pathway; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0010470; P:regulation of gastrulation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    237       Homeobox protein TGIF2.
FT                                /FTId=PRO_0000049321.
FT   DNA_BIND     16     79       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   REGION      103    237       Repressive function.
FT   MOD_RES     182    182       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11427533}.
FT   MOD_RES     186    186       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11427533}.
FT   VAR_SEQ      65    155       ICNWFINARRRLLPDMLRKDGKDPNQFTISRRGGKASDVAL
FT                                PRGSSPSVLAVSVPAPTNVLSLSVCSMPLHSGQGEKPAAPF
FT                                PRGELESPK -> DEFLDVIYWFRQIIAVVLGVIWGVLPLR
FT                                GFLGIAGFCLINAGVLYLYFSNYLQIDEEEYGGTWELTKEG
FT                                FMTSFALFMVIWIIFYTAIHYD (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047346.
FT   VAR_SEQ     156    237       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047347.
FT   MUTAGEN     182    182       T->V: Decrease of phosphorylation. Strong
FT                                decrease of phosphorylation; when
FT                                associated with V-186.
FT                                {ECO:0000269|PubMed:11427533}.
FT   MUTAGEN     186    186       T->V: Decrease of phosphorylation. Strong
FT                                decrease of phosphorylation; when
FT                                associated with V-182.
FT                                {ECO:0000269|PubMed:11427533}.
SQ   SEQUENCE   237 AA;  25878 MW;  E78101CF7EF12555 CRC64;
     MSDSDLGEDE GLLSLAGKRK RRGNLPKESV KILRDWLYLH RYNAYPSEQE KLSLSGQTNL
     SVLQICNWFI NARRRLLPDM LRKDGKDPNQ FTISRRGGKA SDVALPRGSS PSVLAVSVPA
     PTNVLSLSVC SMPLHSGQGE KPAAPFPRGE LESPKPLVTP GSTLTLLTRA EAGSPTGGLF
     NTPPPTPPEQ DKEDFSSFQL LVEVALQRAA EMELQKQQDP SLPLLHTPIP LVSENPQ
//
ID   TGIF1_HUMAN             Reviewed;         401 AA.
AC   Q15583; A6NE42; A6NLU7; F8VZB6; Q6ICR0; Q8N5X9; Q9NRS0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   25-OCT-2017, entry version 186.
DE   RecName: Full=Homeobox protein TGIF1;
DE   AltName: Full=5'-TG-3'-interacting factor 1;
GN   Name=TGIF1; Synonyms=TGIF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=8537382; DOI=10.1074/jbc.270.52.31178;
RA   Bertolino E., Reimund B., Wildt-Perinic D., Clerc R.G.;
RT   "A novel homeobox protein which recognizes a TGT core and functionally
RT   interferes with a retinoid-responsive motif.";
RL   J. Biol. Chem. 270:31178-31188(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT SER-292.
RC   TISSUE=Brain;
RX   PubMed=10764806; DOI=10.1074/jbc.M908382199;
RA   Yang Y., Hwang C.K., D'Souza U.M., Lee S.-H., Junn E., Mouradian M.M.;
RT   "Three-amino acid extension loop homeodomain proteins Meis2 and TGIF
RT   differentially regulate transcription.";
RL   J. Biol. Chem. 275:20734-20741(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   SER-292.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-137 (ISOFORM 4).
RC   TISSUE=Brain, Placenta, and Rhabdomyosarcoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   STRUCTURE BY NMR OF 171-248.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution NMR structure of homeobox domain (171-248) of human homeobox
RT   protein TGIF1, northeast structural genomics consortium target
RT   hr4411b.";
RL   Submitted (OCT-2011) to the PDB data bank.
RN   [9]
RP   VARIANTS HPE4 CYS-157; ARG-192; ALA-280 AND PHE-291.
RX   PubMed=10835638; DOI=10.1038/76074;
RA   Gripp K.W., Wotton D., Edwards M.C., Roessler E., Ades L.,
RA   Meinecke P., Richieri-Costa A., Zackai E.H., Massague J., Muenke M.,
RA   Elledge S.J.;
RT   "Mutations in TGIF cause holoprosencephaly and link NODAL signalling
RT   to human neural axis determination.";
RL   Nat. Genet. 25:205-208(2000).
RN   [10]
RP   VARIANT HPE4 LEU-236.
RX   PubMed=15221788; DOI=10.1002/humu.20056;
RA   Dubourg C., Lazaro L., Pasquier L., Bendavid C., Blayau M.,
RA   Le Duff F., Durou M.-R., Odent S., David V.;
RT   "Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients
RT   with features of holoprosencephaly spectrum: mutation review and
RT   genotype-phenotype correlations.";
RL   Hum. Mutat. 24:43-51(2004).
CC   -!- FUNCTION: Binds to a retinoid X receptor (RXR) responsive element
CC       from the cellular retinol-binding protein II promoter (CRBPII-
CC       RXRE). Inhibits the 9-cis-retinoic acid-dependent RXR alpha
CC       transcription activation of the retinoic acid responsive element.
CC       Active transcriptional corepressor of SMAD2. Links the nodal
CC       signaling pathway to the bifurcation of the forebrain and the
CC       establishment of ventral midline structures. May participate in
CC       the transmission of nuclear signals during development and in the
CC       adult, as illustrated by the down-modulation of the RXR alpha
CC       activities.
CC   -!- SUBUNIT: Interacts with CTBP, SMAD2, SMAD3 and HDAC1.
CC   -!- INTERACTION:
CC       O15169:AXIN1; NbExp=4; IntAct=EBI-714215, EBI-710484;
CC       O35625:Axin1 (xeno); NbExp=2; IntAct=EBI-714215, EBI-2365912;
CC       Q9Y2T1:AXIN2; NbExp=5; IntAct=EBI-714215, EBI-4400025;
CC       O88566:Axin2 (xeno); NbExp=3; IntAct=EBI-714215, EBI-7690990;
CC       Q13363-2:CTBP1; NbExp=3; IntAct=EBI-12691451, EBI-10171858;
CC       P56545:CTBP2; NbExp=5; IntAct=EBI-714215, EBI-741533;
CC       O00214:LGALS8; NbExp=10; IntAct=EBI-714215, EBI-740058;
CC       Q99750:MDFI; NbExp=4; IntAct=EBI-714215, EBI-724076;
CC       P29590:PML; NbExp=3; IntAct=EBI-714215, EBI-295890;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q15583-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15583-2; Sequence=VSP_013020, VSP_013021;
CC       Name=3;
CC         IsoId=Q15583-3; Sequence=VSP_043108, VSP_043109;
CC       Name=4;
CC         IsoId=Q15583-4; Sequence=VSP_046848;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Holoprosencephaly 4 (HPE4) [MIM:142946]: A structural
CC       anomaly of the brain, in which the developing forebrain fails to
CC       correctly separate into right and left hemispheres.
CC       Holoprosencephaly is genetically heterogeneous and associated with
CC       several distinct facies and phenotypic variability.
CC       {ECO:0000269|PubMed:10835638, ECO:0000269|PubMed:15221788}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the TALE/TGIF homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X89750; CAA61897.1; -; mRNA.
DR   EMBL; AF179900; AAF81643.1; -; mRNA.
DR   EMBL; CR450333; CAG29329.1; -; mRNA.
DR   EMBL; AK291112; BAF83801.1; -; mRNA.
DR   EMBL; AP001025; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471113; EAX01672.1; -; Genomic_DNA.
DR   EMBL; BC000814; AAH00814.1; -; mRNA.
DR   EMBL; BC031268; AAH31268.1; -; mRNA.
DR   EMBL; BE296707; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS11832.1; -. [Q15583-3]
DR   CCDS; CCDS11833.1; -. [Q15583-2]
DR   CCDS; CCDS11834.1; -. [Q15583-1]
DR   CCDS; CCDS11835.1; -. [Q15583-4]
DR   RefSeq; NP_001265611.1; NM_001278682.1.
DR   RefSeq; NP_001265613.1; NM_001278684.1. [Q15583-2]
DR   RefSeq; NP_001265615.1; NM_001278686.1. [Q15583-4]
DR   RefSeq; NP_003235.1; NM_003244.3. [Q15583-2]
DR   RefSeq; NP_733796.2; NM_170695.3. [Q15583-1]
DR   RefSeq; NP_775299.1; NM_173207.2. [Q15583-3]
DR   RefSeq; NP_775300.1; NM_173208.2. [Q15583-2]
DR   RefSeq; NP_775301.1; NM_173209.2. [Q15583-4]
DR   RefSeq; NP_775302.1; NM_173210.2. [Q15583-4]
DR   RefSeq; NP_775303.1; NM_173211.1. [Q15583-4]
DR   RefSeq; NP_777480.1; NM_174886.2. [Q15583-4]
DR   RefSeq; XP_011524037.1; XM_011525735.2. [Q15583-4]
DR   RefSeq; XP_016881447.1; XM_017025958.1. [Q15583-2]
DR   RefSeq; XP_016881448.1; XM_017025959.1. [Q15583-4]
DR   UniGene; Hs.373550; -.
DR   PDB; 2LK2; NMR; -; A=171-248.
DR   PDBsum; 2LK2; -.
DR   ProteinModelPortal; Q15583; -.
DR   SMR; Q15583; -.
DR   BioGrid; 112908; 22.
DR   CORUM; Q15583; -.
DR   ELM; Q15583; -.
DR   IntAct; Q15583; 14.
DR   MINT; MINT-145985; -.
DR   STRING; 9606.ENSP00000327959; -.
DR   iPTMnet; Q15583; -.
DR   PhosphoSitePlus; Q15583; -.
DR   BioMuta; TGIF1; -.
DR   DMDM; 215274200; -.
DR   MaxQB; Q15583; -.
DR   PaxDb; Q15583; -.
DR   PeptideAtlas; Q15583; -.
DR   PRIDE; Q15583; -.
DR   Ensembl; ENST00000330513; ENSP00000327959; ENSG00000177426. [Q15583-1]
DR   Ensembl; ENST00000343820; ENSP00000339631; ENSG00000177426. [Q15583-2]
DR   Ensembl; ENST00000345133; ENSP00000343969; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000400167; ENSP00000383031; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000401449; ENSP00000385206; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000405385; ENSP00000384970; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000407501; ENSP00000384133; ENSG00000177426. [Q15583-2]
DR   Ensembl; ENST00000472042; ENSP00000449501; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000548489; ENSP00000447747; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000551541; ENSP00000450025; ENSG00000177426. [Q15583-4]
DR   Ensembl; ENST00000618001; ENSP00000483499; ENSG00000177426. [Q15583-3]
DR   GeneID; 7050; -.
DR   KEGG; hsa:7050; -.
DR   UCSC; uc002klu.5; human. [Q15583-1]
DR   CTD; 7050; -.
DR   DisGeNET; 7050; -.
DR   EuPathDB; HostDB:ENSG00000177426.20; -.
DR   GeneCards; TGIF1; -.
DR   GeneReviews; TGIF1; -.
DR   H-InvDB; HIX0174209; -.
DR   HGNC; HGNC:11776; TGIF1.
DR   HPA; HPA062160; -.
DR   MalaCards; TGIF1; -.
DR   MIM; 142946; phenotype.
DR   MIM; 602630; gene.
DR   neXtProt; NX_Q15583; -.
DR   OpenTargets; ENSG00000177426; -.
DR   Orphanet; 93925; Alobar holoprosencephaly.
DR   Orphanet; 93924; Lobar holoprosencephaly.
DR   Orphanet; 280200; Microform holoprosencephaly.
DR   Orphanet; 93926; Midline interhemispheric variant of holoprosencephaly.
DR   Orphanet; 220386; Semilobar holoprosencephaly.
DR   Orphanet; 280195; Septopreoptic holoprosencephaly.
DR   PharmGKB; PA36489; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000232039; -.
DR   HOVERGEN; HBG001143; -.
DR   InParanoid; Q15583; -.
DR   KO; K19383; -.
DR   OMA; IAANNFT; -.
DR   OrthoDB; EOG091G0GOO; -.
DR   PhylomeDB; Q15583; -.
DR   TreeFam; TF318093; -.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   SignaLink; Q15583; -.
DR   SIGNOR; Q15583; -.
DR   EvolutionaryTrace; Q15583; -.
DR   GeneWiki; Homeobox_protein_TGIF1; -.
DR   GenomeRNAi; 7050; -.
DR   PRO; PR:Q15583; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000177426; -.
DR   CleanEx; HS_TGIF1; -.
DR   ExpressionAtlas; Q15583; baseline and differential.
DR   Genevisible; Q15583; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0070410; F:co-SMAD binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:ProtInc.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Disease mutation; DNA-binding; Holoprosencephaly; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    401       Homeobox protein TGIF1.
FT                                /FTId=PRO_0000049318.
FT   DNA_BIND    164    226       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
FT   MOTIF       153    157       CTBP-binding motif.
FT   COMPBIAS    165    168       Poly-Arg.
FT   VAR_SEQ       1    149       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046848.
FT   VAR_SEQ       1    129       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10764806,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8537382,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_013020.
FT   VAR_SEQ       1    115       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043108.
FT   VAR_SEQ     116    134       PSQGAQGPAPRRRLLETMK -> MTCSGKSCALARSSLTSS
FT                                Q (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043109.
FT   VAR_SEQ     130    133       LETM -> MKGK (in isoform 2).
FT                                {ECO:0000303|PubMed:10764806,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8537382,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_013021.
FT   VARIANT     157    157       S -> C (in HPE4; dbSNP:rs121909066).
FT                                {ECO:0000269|PubMed:10835638}.
FT                                /FTId=VAR_009961.
FT   VARIANT     192    192       P -> R (in HPE4; dbSNP:rs121909067).
FT                                {ECO:0000269|PubMed:10835638}.
FT                                /FTId=VAR_009962.
FT   VARIANT     236    236       Q -> L (in HPE4; dbSNP:rs28939693).
FT                                {ECO:0000269|PubMed:15221788}.
FT                                /FTId=VAR_023803.
FT   VARIANT     280    280       T -> A (in HPE4; dbSNP:rs121909068).
FT                                {ECO:0000269|PubMed:10835638}.
FT                                /FTId=VAR_009963.
FT   VARIANT     289    289       P -> S (in dbSNP:rs11571512).
FT                                /FTId=VAR_047363.
FT   VARIANT     291    291       S -> F (in HPE4; dbSNP:rs121909069).
FT                                {ECO:0000269|PubMed:10835638}.
FT                                /FTId=VAR_009964.
FT   VARIANT     292    292       P -> L (in dbSNP:rs2229333).
FT                                /FTId=VAR_020151.
FT   VARIANT     292    292       P -> S (in dbSNP:rs4468717).
FT                                {ECO:0000269|PubMed:10764806,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_061268.
FT   CONFLICT     96     96       P -> Q (in Ref. 7; AAH31268).
FT                                {ECO:0000305}.
FT   HELIX       173    185       {ECO:0000244|PDB:2LK2}.
FT   HELIX       188    190       {ECO:0000244|PDB:2LK2}.
FT   HELIX       194    203       {ECO:0000244|PDB:2LK2}.
FT   STRAND      204    206       {ECO:0000244|PDB:2LK2}.
FT   HELIX       208    230       {ECO:0000244|PDB:2LK2}.
SQ   SEQUENCE   401 AA;  43013 MW;  4D9C76AFB37A29F0 CRC64;
     MVLAQSRVSA GVGSPHCSGS GGGGSDSFPW PASHPGNPQC SFSTAFLASP RLSRGTLAYL
     PPAPWSSLAT PSALLGSSCA PPPPPARCPQ PRALSPELGT KAGPRRPHRW ELPRSPSQGA
     QGPAPRRRLL ETMKGIVAAS GSETEDEDSM DIPLDLSSSA GSGKRRRRGN LPKESVQILR
     DWLYEHRYNA YPSEQEKALL SQQTHLSTLQ VCNWFINARR RLLPDMLRKD GKDPNQFTIS
     RRGAKISETS SVESVMGIKN FMPALEETPF HSCTAGPNPT LGRPLSPKPS SPGSVLARPS
     VICHTTVTAL KDVPFSLCQS VGVGQNTDIQ QIAAKNFTDT SLMYPEDTCK SGPSTNTQSG
     LFNTPPPTPP DLNQDFSGFQ LLVDVALKRA AEMELQAKLT A
//
ID   TF2LY_HUMAN             Reviewed;         185 AA.
AC   Q8IUE0; A2VCU1;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   27-SEP-2017, entry version 124.
DE   RecName: Full=Homeobox protein TGIF2LY;
DE   AltName: Full=TGF-beta-induced transcription factor 2-like protein;
DE   AltName: Full=TGFB-induced factor 2-like protein, Y-linked;
DE   AltName: Full=TGIF-like on the Y;
GN   Name=TGIF2LY; Synonyms=TGIFLY;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Testis;
RX   PubMed=12226713; DOI=10.1007/s00335-002-3010-9;
RA   Blanco-Arias P., Sargent C.A., Affara N.A.;
RT   "The human-specific Yp11.2/Xq21.3 homology block encodes a potentially
RT   functional testis-specific TGIF-like retroposon.";
RL   Mamm. Genome 13:463-468(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=12815422; DOI=10.1038/nature01722;
RA   Skaletsky H., Kuroda-Kawaguchi T., Minx P.J., Cordum H.S.,
RA   Hillier L.W., Brown L.G., Repping S., Pyntikova T., Ali J., Bieri T.,
RA   Chinwalla A., Delehaunty A., Delehaunty K., Du H., Fewell G.,
RA   Fulton L., Fulton R., Graves T.A., Hou S.-F., Latrielle P.,
RA   Leonard S., Mardis E., Maupin R., McPherson J., Miner T., Nash W.,
RA   Nguyen C., Ozersky P., Pepin K., Rock S., Rohlfing T., Scott K.,
RA   Schultz B., Strong C., Tin-Wollam A., Yang S.-P., Waterston R.H.,
RA   Wilson R.K., Rozen S., Page D.C.;
RT   "The male-specific region of the human Y chromosome is a mosaic of
RT   discrete sequence classes.";
RL   Nature 423:825-837(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May have a transcription role in testis. May act as a
CC       competitor/regulator of TGIF2LX.
CC   -!- INTERACTION:
CC       Q9NS73-5:MBIP; NbExp=3; IntAct=EBI-8063723, EBI-10182361;
CC       Q15742:NAB2; NbExp=5; IntAct=EBI-8063723, EBI-8641936;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in adult testis.
CC   -!- SIMILARITY: Belongs to the TALE/TGIF homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ427750; CAD20751.1; -; Genomic_DNA.
DR   EMBL; AF332223; AAK13475.1; -; mRNA.
DR   EMBL; AK292609; BAF85298.1; -; mRNA.
DR   EMBL; BC128604; AAI28605.1; -; mRNA.
DR   CCDS; CCDS14775.1; -.
DR   RefSeq; NP_631960.1; NM_139214.2.
DR   UniGene; Hs.112148; -.
DR   ProteinModelPortal; Q8IUE0; -.
DR   SMR; Q8IUE0; -.
DR   BioGrid; 124750; 29.
DR   IntAct; Q8IUE0; 3.
DR   MINT; MINT-7899478; -.
DR   STRING; 9606.ENSP00000318502; -.
DR   iPTMnet; Q8IUE0; -.
DR   PhosphoSitePlus; Q8IUE0; -.
DR   BioMuta; TGIF2LY; -.
DR   DMDM; 44888509; -.
DR   EPD; Q8IUE0; -.
DR   MaxQB; Q8IUE0; -.
DR   PaxDb; Q8IUE0; -.
DR   PeptideAtlas; Q8IUE0; -.
DR   PRIDE; Q8IUE0; -.
DR   Ensembl; ENST00000321217; ENSP00000318502; ENSG00000176679.
DR   Ensembl; ENST00000559055; ENSP00000453750; ENSG00000176679.
DR   GeneID; 90655; -.
DR   KEGG; hsa:90655; -.
DR   UCSC; uc004fqk.4; human.
DR   CTD; 90655; -.
DR   EuPathDB; HostDB:ENSG00000176679.8; -.
DR   GeneCards; TGIF2LY; -.
DR   HGNC; HGNC:18569; TGIF2LY.
DR   MIM; 400025; gene.
DR   neXtProt; NX_Q8IUE0; -.
DR   PharmGKB; PA38581; -.
DR   eggNOG; KOG0773; Eukaryota.
DR   eggNOG; ENOG410XPMQ; LUCA.
DR   GeneTree; ENSGT00550000074260; -.
DR   HOGENOM; HOG000237310; -.
DR   HOVERGEN; HBG001143; -.
DR   InParanoid; Q8IUE0; -.
DR   KO; K19554; -.
DR   OrthoDB; EOG091G0HJ6; -.
DR   PhylomeDB; Q8IUE0; -.
DR   TreeFam; TF318093; -.
DR   GenomeRNAi; 90655; -.
DR   PRO; PR:Q8IUE0; -.
DR   Proteomes; UP000005640; Chromosome Y.
DR   Bgee; ENSG00000176679; -.
DR   CleanEx; HS_TGIF2LY; -.
DR   Genevisible; Q8IUE0; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR008422; Homeobox_KN_domain.
DR   Pfam; PF05920; Homeobox_KN; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Homeobox; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    185       Homeobox protein TGIF2LY.
FT                                /FTId=PRO_0000049332.
FT   DNA_BIND     48    111       Homeobox; TALE-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00108}.
SQ   SEQUENCE   185 AA;  20814 MW;  F02975B3EA9866F4 CRC64;
     MEAAADGPAE TQSPVEKDSP AKTQSPAQDT SIMSRNNADT GRVLALPEHK KKRKGNLPAE
     SVKILRDWMY KHRFKAYPSE EEKQMLSEKT NLSLLRISNW FINARRRILP DMLQQRRNDP
     IIGHKTGKDA HATHLQSTEA SVPAKSGPVV QTMYKACPCG PCQRARCQER SNQIRSRPLA
     RSSPE
//
ID   TLX1_HUMAN              Reviewed;         330 AA.
AC   P31314; A1L4G3; O75699; Q5VXP2; Q9HCA0; Q9UD59;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   25-OCT-2017, entry version 161.
DE   RecName: Full=T-cell leukemia homeobox protein 1;
DE   AltName: Full=Homeobox protein Hox-11;
DE   AltName: Full=Proto-oncogene TCL-3;
DE   AltName: Full=T-cell leukemia/lymphoma protein 3;
GN   Name=TLX1; Synonyms=HOX11, TCL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH TCRD.
RC   TISSUE=T-cell;
RX   PubMed=1717256;
RA   Lu M., Gong Z., Shen W., Ho A.D.;
RT   "The tcl-3 proto-oncogene altered by chromosomal translocation in T-
RT   cell leukemia codes for a homeobox protein.";
RL   EMBO J. 10:2905-2910(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH TCRD.
RC   TISSUE=T-cell;
RX   PubMed=1681546; DOI=10.1073/pnas.88.20.8900;
RA   Kennedy M.A., Gonzalez-Sarmiento R., Kees U.R., Lampert F., Dear T.N.,
RA   Boehm T., Rabbitts T.H.;
RT   "HOX11, a homeobox-containing T-cell oncogene on human chromosome
RT   10q24.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:8900-8904(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH TCRD.
RX   PubMed=1676542; DOI=10.1126/science.1676542;
RA   Hatano M., Roberts C.W., Minden M., Crist W.M., Korsmeyer S.J.;
RT   "Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell
RT   leukemia.";
RL   Science 253:79-82(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1352396;
RA   Lu M., Zhang N., Ho A.D.;
RT   "Genomic organization of the putative human homeobox proto-oncogene
RT   HOX-11 (TCL-3) and its endogenous expression in T cells.";
RL   Oncogene 7:1325-1330(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10393251; DOI=10.1016/S0378-1119(99)00157-2;
RA   Watt P.M., Ranford P.R., Kees U.R.;
RT   "Sequence of 10q24 locus surrounding the HOX11 oncogene reveals a new
RT   gene HUG1 expressed in a T-ALL cell line.";
RL   Gene 234:169-176(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-64.
RX   PubMed=9778044; DOI=10.1038/sj.onc.1202078;
RA   Brake R.L., Kees U.R., Watt P.M.;
RT   "Multiple negative elements contribute to repression of the HOX11
RT   proto-oncogene.";
RL   Oncogene 17:1787-1795(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 209-247 (ISOFORM 1/2).
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
RN   [11]
RP   IDENTIFICATION.
RX   PubMed=17303350; DOI=10.1016/j.gene.2006.12.034;
RA   Greene W.K., Sontani Y., Sharp M.A., Dunn D.S., Kees U.R.,
RA   Bellgard M.I.;
RT   "A promoter with bidirectional activity is located between TLX1/HOX11
RT   and a divergently transcribed novel human gene.";
RL   Gene 391:223-232(2007).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-236, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   INTERACTION WITH MEIS1; MEIS2; PBX1; PBX2 AND PBX3.
RX   PubMed=19559479; DOI=10.1016/j.leukres.2009.06.003;
RA   Milech N., Gottardo N.G., Ford J., D'Souza D., Greene W.K., Kees U.R.,
RA   Watt P.M.;
RT   "MEIS proteins as partners of the TLX1/HOX11 oncoprotein.";
RL   Leuk. Res. 34:358-363(2010).
CC   -!- FUNCTION: Controls the genesis of the spleen. Binds to the DNA
CC       sequence 5'-GGCGGTAAGTGG-3'.
CC   -!- SUBUNIT: Interacts with MEIS1, MEIS2, PBX1, PBX2 and PBX3.
CC       {ECO:0000269|PubMed:19559479}.
CC   -!- INTERACTION:
CC       P27577:Ets1 (xeno); NbExp=2; IntAct=EBI-2820655, EBI-4289053;
CC       O00470:MEIS1; NbExp=4; IntAct=EBI-2820655, EBI-1210694;
CC       O14770-2:MEIS2; NbExp=4; IntAct=EBI-2820655, EBI-6390216;
CC       P40424-2:PBX1; NbExp=2; IntAct=EBI-2820655, EBI-6390251;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31314-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31314-2; Sequence=VSP_043068;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Note=A chromosomal aberration involving TLX1 may be a
CC       cause of a form of T-cell acute lymphoblastic leukemia (T-ALL).
CC       Translocation t(10;14)(q24;q11) with TCRD.
CC       {ECO:0000269|PubMed:1676542, ECO:0000269|PubMed:1681546,
CC       ECO:0000269|PubMed:1717256}.
CC   -!- MISCELLANEOUS: TLX1 is oriented in a head-to-head manner with TDI.
CC       Both genes share the same promoter with robust bidirectional
CC       activity.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M62626; AAA36719.1; -; mRNA.
DR   EMBL; M75952; AAA58662.1; -; mRNA.
DR   EMBL; S38742; AAB19293.1; -; mRNA.
DR   EMBL; AJ009794; CAA08834.1; -; Genomic_DNA.
DR   EMBL; AL357395; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49778.1; -; Genomic_DNA.
DR   EMBL; BC130530; AAI30531.1; -; mRNA.
DR   EMBL; AF067443; AAG10096.1; -; Genomic_DNA.
DR   CCDS; CCDS55725.1; -. [P31314-2]
DR   CCDS; CCDS7510.1; -. [P31314-1]
DR   PIR; A40855; A40855.
DR   RefSeq; NP_001182446.1; NM_001195517.1. [P31314-2]
DR   RefSeq; NP_005512.1; NM_005521.3. [P31314-1]
DR   UniGene; Hs.89583; -.
DR   ProteinModelPortal; P31314; -.
DR   SMR; P31314; -.
DR   BioGrid; 109435; 4.
DR   DIP; DIP-155N; -.
DR   ELM; P31314; -.
DR   IntAct; P31314; 9.
DR   STRING; 9606.ENSP00000359215; -.
DR   iPTMnet; P31314; -.
DR   PhosphoSitePlus; P31314; -.
DR   BioMuta; TLX1; -.
DR   DMDM; 399982; -.
DR   PaxDb; P31314; -.
DR   PRIDE; P31314; -.
DR   Ensembl; ENST00000370196; ENSP00000359215; ENSG00000107807. [P31314-1]
DR   Ensembl; ENST00000467928; ENSP00000434914; ENSG00000107807. [P31314-2]
DR   GeneID; 3195; -.
DR   KEGG; hsa:3195; -.
DR   UCSC; uc001ksw.4; human. [P31314-1]
DR   CTD; 3195; -.
DR   DisGeNET; 3195; -.
DR   EuPathDB; HostDB:ENSG00000107807.12; -.
DR   GeneCards; TLX1; -.
DR   HGNC; HGNC:5056; TLX1.
DR   MalaCards; TLX1; -.
DR   MIM; 186770; gene+phenotype.
DR   neXtProt; NX_P31314; -.
DR   OpenTargets; ENSG00000107807; -.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA35095; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000116280; -.
DR   HOVERGEN; HBG036206; -.
DR   InParanoid; P31314; -.
DR   KO; K09340; -.
DR   OMA; GEYGLGC; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; P31314; -.
DR   TreeFam; TF325347; -.
DR   SignaLink; P31314; -.
DR   SIGNOR; P31314; -.
DR   GeneWiki; TLX1; -.
DR   GenomeRNAi; 3195; -.
DR   PRO; PR:P31314; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107807; -.
DR   CleanEx; HS_TLX1; -.
DR   ExpressionAtlas; P31314; baseline and differential.
DR   Genevisible; P31314; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Proto-oncogene; Reference proteome.
FT   CHAIN         1    330       T-cell leukemia homeobox protein 1.
FT                                /FTId=PRO_0000049333.
FT   DNA_BIND    201    260       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     236    236       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     258    330       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043068.
FT   CONFLICT     71     71       A -> T (in Ref. 5; CAA08834).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       L -> R (in Ref. 3; AAB19293).
FT                                {ECO:0000305}.
SQ   SEQUENCE   330 AA;  34365 MW;  09A518FB5271F7ED CRC64;
     MEHLGPHHLH PGHAEPISFG IDQILNSPDQ GGCMGPASRL QDGEYGLGCL VGGAYTYGGG
     GSAAATGAGG AGAYGTGGPG GPGGPAGGGG ACSMGPLTGS YNVNMALAGG PGPGGGGGSS
     GGAGALSAAG VIRVPAHRPL AGAVAHPQPL ATGLPTVPSV PAMPGVNNLT GLTFPWMESN
     RRYTKDRFTG HPYQNRTPPK KKKPRTSFTR LQICELEKRF HRQKYLASAE RAALAKALKM
     TDAQVKTWFQ NRRTKWRRQT AEEREAERQQ ANRILLQLQQ EAFQKSLAQP LPADPLCVHN
     SSLFALQNLQ PWSDDSTKIT SVTSVASACE
//
ID   TLX3_HUMAN              Reviewed;         291 AA.
AC   O43711; Q96AD3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=T-cell leukemia homeobox protein 3;
DE   AltName: Full=Homeobox protein Hox-11L2;
GN   Name=TLX3; Synonyms=HOX11L2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Delgado P., Rodriguez R., Gonzalez-Sarmiento R.;
RT   "Genomic characterization of the human and mouse HOX11L2 genes.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       P27577:Ets1 (xeno); NbExp=2; IntAct=EBI-3939165, EBI-4289053;
CC       Q2TAY7:SMU1; NbExp=4; IntAct=EBI-3939165, EBI-298027;
CC       Q96M29:TEKT5; NbExp=4; IntAct=EBI-3939165, EBI-10239812;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TLX3ID398.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ223798; CAA11550.1; -; Genomic_DNA.
DR   EMBL; AJ223799; CAA11550.1; JOINED; Genomic_DNA.
DR   EMBL; AJ223800; CAA11550.1; JOINED; Genomic_DNA.
DR   EMBL; BC017291; AAH17291.1; -; mRNA.
DR   CCDS; CCDS34288.1; -.
DR   RefSeq; NP_066305.2; NM_021025.3.
DR   UniGene; Hs.249125; -.
DR   ProteinModelPortal; O43711; -.
DR   SMR; O43711; -.
DR   BioGrid; 119030; 15.
DR   ELM; O43711; -.
DR   IntAct; O43711; 65.
DR   STRING; 9606.ENSP00000296921; -.
DR   iPTMnet; O43711; -.
DR   PhosphoSitePlus; O43711; -.
DR   BioMuta; TLX3; -.
DR   PaxDb; O43711; -.
DR   PRIDE; O43711; -.
DR   DNASU; 30012; -.
DR   Ensembl; ENST00000296921; ENSP00000296921; ENSG00000164438.
DR   GeneID; 30012; -.
DR   KEGG; hsa:30012; -.
DR   UCSC; uc003mbf.3; human.
DR   CTD; 30012; -.
DR   DisGeNET; 30012; -.
DR   EuPathDB; HostDB:ENSG00000164438.5; -.
DR   GeneCards; TLX3; -.
DR   HGNC; HGNC:13532; TLX3.
DR   HPA; HPA074512; -.
DR   MalaCards; TLX3; -.
DR   MIM; 604640; gene.
DR   neXtProt; NX_O43711; -.
DR   OpenTargets; ENSG00000164438; -.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA37797; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000116280; -.
DR   HOVERGEN; HBG036206; -.
DR   InParanoid; O43711; -.
DR   KO; K15607; -.
DR   OMA; YNPACSM; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; O43711; -.
DR   TreeFam; TF325347; -.
DR   SignaLink; O43711; -.
DR   GeneWiki; TLX3; -.
DR   GenomeRNAi; 30012; -.
DR   PRO; PR:O43711; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164438; -.
DR   CleanEx; HS_TLX3; -.
DR   Genevisible; O43711; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048665; P:neuron fate specification; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Reference proteome.
FT   CHAIN         1    291       T-cell leukemia homeobox protein 3.
FT                                /FTId=PRO_0000049338.
FT   DNA_BIND    166    225       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   CONFLICT     66     66       L -> P (in Ref. 1; CAA11550).
FT                                {ECO:0000305}.
FT   CONFLICT    122    122       G -> R (in Ref. 1; CAA11550).
FT                                {ECO:0000305}.
FT   CONFLICT    232    233       ER -> DG (in Ref. 1; CAA11550).
FT                                {ECO:0000305}.
SQ   SEQUENCE   291 AA;  31867 MW;  B5E3B910393EB4F3 CRC64;
     MEAPASAQTP HPHEPISFGI DQILNSPDQD SAPAPRGPDG ASYLGGPPGG RPGATYPSLP
     ASFAGLGAPF EDAGSYSVNL SLAPAGVIRV PAHRPLPGAV PPPLPSALPA MPSVPTVSSL
     GGLNFPWMES SRRFVKDRFT AAAALTPFTV TRRIGHPYQN RTPPKRKKPR TSFSRVQICE
     LEKRFHRQKY LASAERAALA KSLKMTDAQV KTWFQNRRTK WRRQTAEERE AERQQASRLM
     LQLQHDAFQK SLNDSIQPDP LCLHNSSLFA LQNLQPWEED SSKVPAVTSL V
//
ID   TLX2_HUMAN              Reviewed;         284 AA.
AC   O43763; Q9UD56; Q9UQ48;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2002, sequence version 2.
DT   25-OCT-2017, entry version 148.
DE   RecName: Full=T-cell leukemia homeobox protein 2;
DE   AltName: Full=Homeobox protein Hox-11L1;
DE   AltName: Full=Neural crest homeobox protein;
GN   Name=TLX2; Synonyms=HOX11L1, NCX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10446220; DOI=10.1074/jbc.274.34.24401;
RA   Iitsuka Y., Shimizu H., Kang M.M., Sasagawa K., Sekiya S.,
RA   Tokuhisa T., Hatano M.;
RT   "An enhancer element for expression of the Ncx (Enx, Hox11L1) gene in
RT   neural crest-derived cells.";
RL   J. Biol. Chem. 274:24401-24407(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Delgado P., Rodriguez R.E., Gonzalez-Sarmiento R.;
RT   "Genomic characterization and chromosomal location of the human
RT   homeobox gene HOX11L1.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 165-203.
RC   TISSUE=Bone marrow;
RX   PubMed=7518789; DOI=10.1016/0378-1119(94)90380-8;
RA   Moretti P., Simmons P., Thomas P., Haylock D., Rathjen P., Vadas M.,
RA   D'Andrea R.;
RT   "Identification of homeobox genes expressed in human haemopoietic
RT   progenitor cells.";
RL   Gene 144:213-219(1994).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 162-216, AND DNA-BINDING.
RX   PubMed=20389279; DOI=10.1038/emboj.2010.53;
RA   Miyazono K., Zhi Y., Takamura Y., Nagata K., Saigo K., Kojima T.,
RA   Tanokura M.;
RT   "Cooperative DNA-binding and sequence-recognition mechanism of
RT   aristaless and clawless.";
RL   EMBO J. 29:1613-1623(2010).
CC   -!- FUNCTION: Transcription activator that binds DNA elements with the
CC       consensus sequence 5'-CGGTAATTGG-3'. Binds DNA via its homeobox.
CC       Required for normal cell death of enteric neurons in the
CC       gastrointestinal tract. Required for normal development of the
CC       enteric nervous system, and for proper development of normal
CC       motility of the gastrointestinal tract (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB008501; BAA83463.1; -; mRNA.
DR   EMBL; AJ002607; CAA05636.1; -; Genomic_DNA.
DR   EMBL; AJ002608; CAA05636.1; JOINED; Genomic_DNA.
DR   EMBL; AJ002609; CAA05636.1; JOINED; Genomic_DNA.
DR   EMBL; AC005041; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006356; AAH06356.1; -; mRNA.
DR   CCDS; CCDS1947.1; -.
DR   RefSeq; NP_057254.1; NM_016170.4.
DR   UniGene; Hs.168586; -.
DR   PDB; 3A03; X-ray; 1.54 A; A=162-216.
DR   PDBsum; 3A03; -.
DR   ProteinModelPortal; O43763; -.
DR   SMR; O43763; -.
DR   BioGrid; 109436; 9.
DR   ELM; O43763; -.
DR   IntAct; O43763; 2.
DR   STRING; 9606.ENSP00000233638; -.
DR   iPTMnet; O43763; -.
DR   PhosphoSitePlus; O43763; -.
DR   BioMuta; TLX2; -.
DR   PaxDb; O43763; -.
DR   PRIDE; O43763; -.
DR   DNASU; 3196; -.
DR   Ensembl; ENST00000233638; ENSP00000233638; ENSG00000115297.
DR   GeneID; 3196; -.
DR   KEGG; hsa:3196; -.
DR   UCSC; uc002smb.3; human.
DR   CTD; 3196; -.
DR   DisGeNET; 3196; -.
DR   EuPathDB; HostDB:ENSG00000115297.10; -.
DR   GeneCards; TLX2; -.
DR   HGNC; HGNC:5057; TLX2.
DR   HPA; HPA040969; -.
DR   HPA; HPA062254; -.
DR   MIM; 604240; gene.
DR   neXtProt; NX_O43763; -.
DR   OpenTargets; ENSG00000115297; -.
DR   PharmGKB; PA35096; -.
DR   eggNOG; KOG0488; Eukaryota.
DR   eggNOG; ENOG411188D; LUCA.
DR   GeneTree; ENSGT00900000140795; -.
DR   HOGENOM; HOG000116280; -.
DR   HOVERGEN; HBG036206; -.
DR   InParanoid; O43763; -.
DR   KO; K15606; -.
DR   OMA; QHHEPIS; -.
DR   OrthoDB; EOG091G0RNV; -.
DR   PhylomeDB; O43763; -.
DR   TreeFam; TF325347; -.
DR   SignaLink; O43763; -.
DR   EvolutionaryTrace; O43763; -.
DR   GeneWiki; TLX2; -.
DR   GenomeRNAi; 3196; -.
DR   PRO; PR:O43763; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115297; -.
DR   CleanEx; HS_TLX2; -.
DR   ExpressionAtlas; O43763; baseline and differential.
DR   Genevisible; O43763; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0048484; P:enteric nervous system development; IEA:Ensembl.
DR   GO; GO:0001707; P:mesoderm formation; IEA:Ensembl.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    284       T-cell leukemia homeobox protein 2.
FT                                /FTId=PRO_0000049336.
FT   DNA_BIND    157    216       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     27    115       Gly-rich.
FT   CONFLICT     16     16       P -> A (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   CONFLICT     30     32       TPG -> PR (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   CONFLICT     37     48       LGRGGQGHGENG -> WVAGQVIGEWA (in Ref. 2;
FT                                CAA05636). {ECO:0000305}.
FT   CONFLICT    100    102       Missing (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   CONFLICT    131    136       RLTAAL -> PAV (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   CONFLICT    196    196       M -> T (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    219    219       Missing (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       R -> T (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       V -> A (in Ref. 2; CAA05636).
FT                                {ECO:0000305}.
FT   HELIX       166    178       {ECO:0000244|PDB:3A03}.
FT   HELIX       184    194       {ECO:0000244|PDB:3A03}.
FT   HELIX       198    215       {ECO:0000244|PDB:3A03}.
SQ   SEQUENCE   284 AA;  30251 MW;  794B07A9E7817939 CRC64;
     MEPGMLGPHN LPHHEPISFG IDQILSGPET PGGGLGLGRG GQGHGENGAF SGGYHGASGY
     GPAGSLAPLP GSSGVGPGGV IRVPAHRPLP VPPPAGGAPA VPGPSGLGGA GGLAGLTFPW
     MDSGRRFAKD RLTAALSPFS GTRRIGHPYQ NRTPPKRKKP RTSFSRSQVL ELERRFLRQK
     YLASAERAAL AKALRMTDAQ VKTWFQNRRT KWRRQTAEER EAERHRAGRL LLHLQQDALP
     RPLRPPLPPD PLCLHNSSLF ALQNLQPWAE DNKVASVSGL ASVV
//
ID   UNC4_HUMAN              Reviewed;         531 AA.
AC   A6NJT0; A4D221;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 97.
DE   RecName: Full=Homeobox protein unc-4 homolog;
DE   AltName: Full=Homeobox protein Uncx4.1;
GN   Name=UNCX; Synonyms=UNCX4.1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
CC   -!- FUNCTION: Transcription factor involved in somitogenesis and
CC       neurogenesis. Required for the maintenance and differentiation of
CC       particular elements of the axial skeleton. May act upstream of
CC       PAX9. Plays a role in controlling the development of connections
CC       of hypothalamic neurons to pituitary elements, allowing central
CC       neurons to reach the peripheral blood circulation and to deliver
CC       hormones for control of peripheral functions (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Unc-4
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073094; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236953; EAL23940.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS34583.1; -.
DR   RefSeq; NP_001073930.1; NM_001080461.1.
DR   UniGene; Hs.232272; -.
DR   ProteinModelPortal; A6NJT0; -.
DR   SMR; A6NJT0; -.
DR   STRING; 9606.ENSP00000314480; -.
DR   iPTMnet; A6NJT0; -.
DR   PhosphoSitePlus; A6NJT0; -.
DR   BioMuta; UNCX; -.
DR   EPD; A6NJT0; -.
DR   MaxQB; A6NJT0; -.
DR   PaxDb; A6NJT0; -.
DR   PRIDE; A6NJT0; -.
DR   Ensembl; ENST00000316333; ENSP00000314480; ENSG00000164853.
DR   GeneID; 340260; -.
DR   KEGG; hsa:340260; -.
DR   UCSC; uc011jvw.3; human.
DR   CTD; 340260; -.
DR   EuPathDB; HostDB:ENSG00000164853.8; -.
DR   GeneCards; UNCX; -.
DR   HGNC; HGNC:33194; UNCX.
DR   HPA; HPA063294; -.
DR   neXtProt; NX_A6NJT0; -.
DR   OpenTargets; ENSG00000164853; -.
DR   PharmGKB; PA162408642; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140776; -.
DR   HOGENOM; HOG000154780; -.
DR   HOVERGEN; HBG096185; -.
DR   InParanoid; A6NJT0; -.
DR   KO; K09328; -.
DR   OMA; SCDQTPH; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; A6NJT0; -.
DR   TreeFam; TF315554; -.
DR   GenomeRNAi; 340260; -.
DR   PRO; PR:A6NJT0; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164853; -.
DR   CleanEx; HS_UNCX; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0001502; P:cartilage condensation; IEA:Ensembl.
DR   GO; GO:0035726; P:common myeloid progenitor cell proliferation; IEA:Ensembl.
DR   GO; GO:0021516; P:dorsal spinal cord development; IEA:Ensembl.
DR   GO; GO:0021889; P:olfactory bulb interneuron differentiation; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0045595; P:regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; Neurogenesis; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    531       Homeobox protein unc-4 homolog.
FT                                /FTId=PRO_0000334624.
FT   DNA_BIND    105    164       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    244    523       Ala/Pro-rich.
SQ   SEQUENCE   531 AA;  53690 MW;  F538F74E77D7F32E CRC64;
     MMDGRLLEHP HAQFGGSLGG VVGFPYPLGH HHVYELAGHQ LQSAAAAASV PFSIDGLLGG
     SCAAAASVVN PTPLLPAACG VGGDGQPFKL SDSGDPDKES PGCKRRRTRT NFTGWQLEEL
     EKAFNESHYP DVFMREALAL RLDLVESRVQ VWFQNRRAKW RKKENTKKGP GRPAHNSHPT
     TCSGEPMDPE EIARKELEKM EKKKRKHEKK LLKSQGRHLH SPGGLSLHSA PSSDSDSGGG
     GLSPEPPEPP PPAAKGPGAH ASGAAGTAPA PPGEPPAPGT CDPAFYPSQR SGAGPQPRPG
     RPADKDAASC GPGAAVAAVE RGAAGLPKAS PFSVESLLSD SPPRRKAASN AAAAAAAGLD
     FAPGLPCAPR TLIGKGHFLL YPITQPLGFL VPQAALKGGA GLEPAPKDAP PAPAVPPAPP
     AQASFGAFSG PGGAPDSAFA RRSPDAVASP GAPAPAPAPF RDLASAAATE GGGGDCADAG
     TAGPAPPPPA PSPRPGPRPP SPAEEPATCG VPEPGAAAGP SPPEGEELDM D
//
ID   VAX1_HUMAN              Reviewed;         334 AA.
AC   Q5SQQ9; B1AVW5; Q6ZSX0;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   25-OCT-2017, entry version 113.
DE   RecName: Full=Ventral anterior homeobox 1;
GN   Name=VAX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1).
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT MCOPS11 SER-152, AND CHARACTERIZATION OF VARIANT MCOPS11
RP   SER-152.
RX   PubMed=22095910; DOI=10.1002/humu.21658;
RA   Slavotinek A.M., Chao R., Vacik T., Yahyavi M., Abouzeid H.,
RA   Bardakjian T., Schneider A., Shaw G., Sherr E.H., Lemke G.,
RA   Youssef M., Schorderet D.F.;
RT   "VAX1 mutation associated with microphthalmia, corpus callosum
RT   agenesis, and orofacial clefting: The first description of a VAX1
RT   phenotype in humans.";
RL   Hum. Mutat. 33:364-368(2012).
CC   -!- FUNCTION: Transcription factor that may function in dorsoventral
CC       specification of the forebrain. Required for axon guidance and
CC       major tract formation in the developing forebrain. May contribute
CC       to the differentiation of the neuroretina, pigmented epithelium
CC       and optic stalk (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5SQQ9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5SQQ9-2; Sequence=VSP_019396;
CC   -!- DISEASE: Microphthalmia, syndromic, 11 (MCOPS11) [MIM:614402]: A
CC       rare clinical entity including as main characteristics
CC       microphthalmia and small optic nerves, cleft lip and palate,
CC       absence of corpus callosum, hippocampal malformations, and absence
CC       of the pineal gland. Microphthalmia is a disorder of eye
CC       formation, ranging from small size of a single eye to complete
CC       bilateral absence of ocular tissues (anophthalmia). In many cases,
CC       microphthalmia/anophthalmia occurs in association with syndromes
CC       that include non-ocular abnormalities.
CC       {ECO:0000269|PubMed:22095910}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the EMX homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK127095; BAC86826.1; -; mRNA.
DR   EMBL; CH471066; EAW49433.1; -; Genomic_DNA.
DR   EMBL; BC101694; AAI01695.1; -; mRNA.
DR   EMBL; BC101696; AAI01697.1; -; mRNA.
DR   EMBL; AL731557; CAI14824.1; -; Genomic_DNA.
DR   EMBL; AL731557; CAI14825.1; -; Genomic_DNA.
DR   CCDS; CCDS44483.1; -. [Q5SQQ9-1]
DR   CCDS; CCDS7597.1; -. [Q5SQQ9-2]
DR   RefSeq; NP_001106175.1; NM_001112704.1. [Q5SQQ9-1]
DR   RefSeq; NP_954582.1; NM_199131.2. [Q5SQQ9-2]
DR   UniGene; Hs.441536; -.
DR   ProteinModelPortal; Q5SQQ9; -.
DR   SMR; Q5SQQ9; -.
DR   IntAct; Q5SQQ9; 4.
DR   STRING; 9606.ENSP00000358207; -.
DR   iPTMnet; Q5SQQ9; -.
DR   PhosphoSitePlus; Q5SQQ9; -.
DR   BioMuta; VAX1; -.
DR   DMDM; 74743553; -.
DR   EPD; Q5SQQ9; -.
DR   PaxDb; Q5SQQ9; -.
DR   PeptideAtlas; Q5SQQ9; -.
DR   PRIDE; Q5SQQ9; -.
DR   DNASU; 11023; -.
DR   Ensembl; ENST00000277905; ENSP00000277905; ENSG00000148704. [Q5SQQ9-2]
DR   Ensembl; ENST00000369206; ENSP00000358207; ENSG00000148704. [Q5SQQ9-1]
DR   GeneID; 11023; -.
DR   KEGG; hsa:11023; -.
DR   UCSC; uc001ldb.1; human. [Q5SQQ9-1]
DR   CTD; 11023; -.
DR   DisGeNET; 11023; -.
DR   EuPathDB; HostDB:ENSG00000148704.12; -.
DR   GeneCards; VAX1; -.
DR   GeneReviews; VAX1; -.
DR   HGNC; HGNC:12660; VAX1.
DR   HPA; HPA028946; -.
DR   MalaCards; VAX1; -.
DR   MIM; 604294; gene.
DR   MIM; 614402; phenotype.
DR   neXtProt; NX_Q5SQQ9; -.
DR   OpenTargets; ENSG00000148704; -.
DR   PharmGKB; PA37283; -.
DR   eggNOG; KOG0843; Eukaryota.
DR   eggNOG; ENOG4111SRW; LUCA.
DR   GeneTree; ENSGT00900000140915; -.
DR   HOGENOM; HOG000049217; -.
DR   HOVERGEN; HBG007558; -.
DR   InParanoid; Q5SQQ9; -.
DR   KO; K09318; -.
DR   OMA; ASEDCNK; -.
DR   OrthoDB; EOG091G0XAA; -.
DR   PhylomeDB; Q5SQQ9; -.
DR   TreeFam; TF319504; -.
DR   GeneWiki; VAX1; -.
DR   GenomeRNAi; 11023; -.
DR   PRO; PR:Q5SQQ9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148704; -.
DR   CleanEx; HS_VAX1; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0001162; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR033020; Vax1.
DR   PANTHER; PTHR24339:SF32; PTHR24339:SF32; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Microphthalmia; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    334       Ventral anterior homeobox 1.
FT                                /FTId=PRO_0000240522.
FT   DNA_BIND    100    159       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS    216    268       Ala-rich.
FT   VAR_SEQ     144    334       VKVWFQNRRTKQKKDQGKDSELRSVVSETAATCSVLRLLEQ
FT                                GRLLSPPGLPALLPPCATGALGSALRGPSLPALGAGAAAGS
FT                                AAAAAAAAPGPAGAASPHPPAVGGAPGPGPAGPGGLHAGAP
FT                                AAGHSLFSLPVPSLLGSVASRLSSAPLTMAGSLAGNLQELS
FT                                ARYLSSSAFEPYSRTNNKEGAEKKALD -> ANSEENNERF
FT                                KRGIKKQKKKRKKEPANDESRRGDSGGRGWQPL (in
FT                                isoform 2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019396.
FT   VARIANT     152    152       R -> S (in MCOPS11; loss of function
FT                                mutation; dbSNP:rs387907252).
FT                                {ECO:0000269|PubMed:22095910}.
FT                                /FTId=VAR_067307.
SQ   SEQUENCE   334 AA;  34713 MW;  927FCADCFE937C12 CRC64;
     MFGKPDKMDV RCHSDAEAAR VSKNAHKESR ESKGAEGNLP AAFLKEPQGA FSASGAAEDC
     NKSKSNSAAD PDYCRRILVR DAKGSIREII LPKGLDLDRP KRTRTSFTAE QLYRLEMEFQ
     RCQYVVGRER TELARQLNLS ETQVKVWFQN RRTKQKKDQG KDSELRSVVS ETAATCSVLR
     LLEQGRLLSP PGLPALLPPC ATGALGSALR GPSLPALGAG AAAGSAAAAA AAAPGPAGAA
     SPHPPAVGGA PGPGPAGPGG LHAGAPAAGH SLFSLPVPSL LGSVASRLSS APLTMAGSLA
     GNLQELSARY LSSSAFEPYS RTNNKEGAEK KALD
//
ID   VENTX_HUMAN             Reviewed;         258 AA.
AC   O95231; Q32MZ3;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   27-SEP-2017, entry version 143.
DE   RecName: Full=Homeobox protein VENTX;
DE   AltName: Full=VENT homeobox homolog;
DE   AltName: Full=VENT-like homeobox protein 2;
GN   Name=VENTX; Synonyms=HPX42B, VENTX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   PubMed=11549314; DOI=10.1006/geno.2001.6574;
RA   Moretti P.A.B., Davidson A.J., Baker E., Lilley B., Zon L.I.,
RA   D'Andrea R.J.;
RT   "Molecular cloning of a human Vent-like homeobox gene.";
RL   Genomics 76:21-29(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-42.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May be involved in ventralization.
CC   -!- INTERACTION:
CC       Q8NFV4-4:ABHD11; NbExp=4; IntAct=EBI-10191303, EBI-12318443;
CC       Q6P1W5:C1orf94; NbExp=3; IntAct=EBI-10191303, EBI-946029;
CC       P78358:CTAG1B; NbExp=4; IntAct=EBI-10191303, EBI-1188472;
CC       O75553:DAB1; NbExp=3; IntAct=EBI-10191303, EBI-7875264;
CC       Q9NVL1-2:FAM86C1; NbExp=4; IntAct=EBI-10191303, EBI-12845222;
CC       P59991:KRTAP12-2; NbExp=5; IntAct=EBI-10191303, EBI-10176379;
CC       P60329:KRTAP12-4; NbExp=3; IntAct=EBI-10191303, EBI-10176396;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-10191303, EBI-740322;
CC       Q96SF7:TBX15; NbExp=3; IntAct=EBI-10191303, EBI-10191361;
CC       Q9Y458:TBX22; NbExp=5; IntAct=EBI-10191303, EBI-6427217;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in bone marrow of patients
CC       recovering from chemotherapy. Also expressed in an erythroleukemia
CC       cell line. {ECO:0000269|PubMed:11549314}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF068006; AAC82375.1; -; mRNA.
DR   EMBL; AF288039; AAK83043.1; -; Genomic_DNA.
DR   EMBL; AL445199; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC108915; AAI08916.1; -; mRNA.
DR   EMBL; BC108916; AAI08917.1; -; mRNA.
DR   CCDS; CCDS7675.1; -.
DR   RefSeq; NP_055283.1; NM_014468.3.
DR   UniGene; Hs.125231; -.
DR   ProteinModelPortal; O95231; -.
DR   SMR; O95231; -.
DR   BioGrid; 118111; 15.
DR   IntAct; O95231; 79.
DR   STRING; 9606.ENSP00000357556; -.
DR   iPTMnet; O95231; -.
DR   PhosphoSitePlus; O95231; -.
DR   BioMuta; VENTX; -.
DR   EPD; O95231; -.
DR   PaxDb; O95231; -.
DR   PRIDE; O95231; -.
DR   DNASU; 27287; -.
DR   Ensembl; ENST00000325980; ENSP00000357556; ENSG00000151650.
DR   GeneID; 27287; -.
DR   KEGG; hsa:27287; -.
DR   UCSC; uc010quy.3; human.
DR   CTD; 27287; -.
DR   DisGeNET; 27287; -.
DR   EuPathDB; HostDB:ENSG00000151650.7; -.
DR   GeneCards; VENTX; -.
DR   H-InvDB; HIX0036778; -.
DR   HGNC; HGNC:13639; VENTX.
DR   HPA; HPA050955; -.
DR   MIM; 607158; gene.
DR   neXtProt; NX_O95231; -.
DR   OpenTargets; ENSG00000151650; -.
DR   PharmGKB; PA37803; -.
DR   eggNOG; ENOG410J3ER; Eukaryota.
DR   eggNOG; ENOG411280P; LUCA.
DR   GeneTree; ENSGT00890000139333; -.
DR   HOGENOM; HOG000154815; -.
DR   InParanoid; O95231; -.
DR   OMA; WLSQSSC; -.
DR   OrthoDB; EOG091G0HNO; -.
DR   PhylomeDB; O95231; -.
DR   TreeFam; TF351607; -.
DR   GenomeRNAi; 27287; -.
DR   PRO; PR:O95231; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000151650; -.
DR   CleanEx; HS_VENTX; -.
DR   Genevisible; O95231; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding; IC:NTNU_SB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    258       Homeobox protein VENTX.
FT                                /FTId=PRO_0000305938.
FT   DNA_BIND     91    150       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      42     42       L -> P (in dbSNP:rs2240892).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_035243.
FT   VARIANT      79     79       M -> V (in dbSNP:rs2240891).
FT                                /FTId=VAR_035244.
FT   VARIANT     101    101       E -> K (in dbSNP:rs2270192).
FT                                /FTId=VAR_049591.
FT   VARIANT     191    191       G -> R (in dbSNP:rs9418952).
FT                                /FTId=VAR_049592.
FT   VARIANT     247    247       G -> D (in dbSNP:rs9418953).
FT                                /FTId=VAR_061269.
SQ   SEQUENCE   258 AA;  27552 MW;  6F611169122D8244 CRC64;
     MRLSSSPPRG PQQLSSFGSV DWLSQSSCSG PTHTPRPADF SLGSLPGPGQ TSGAREPPQA
     VSIKEAAGSS NLPAPERTMA GLSKEPNTLR APRVRTAFTM EQVRTLEGVF QHHQYLSPLE
     RKRLAREMQL SEVQIKTWFQ NRRMKHKRQM QDPQLHSPFS GSLHAPPAFY STSSGLANGL
     QLLCPWAPLS GPQALMLPPG SFWGLCQVAQ EALASAGASC CGQPLASHPP TPGRPSLGPA
     LSTGPRGLCA MPQTGDAF
//
ID   VSX1_HUMAN              Reviewed;         365 AA.
AC   Q9NZR4; B9EGJ4; D1MF28; Q0GM60; Q0GM61; Q0GM62; Q0GM63; Q0GM64;
AC   Q0GM65; Q5TF40; Q5TF41; Q9HCU3; Q9NU27;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 2.
DT   25-OCT-2017, entry version 149.
DE   RecName: Full=Visual system homeobox 1;
DE   AltName: Full=Homeodomain protein RINX;
DE   AltName: Full=Retinal inner nuclear layer homeobox protein;
DE   AltName: Full=Transcription factor VSX1;
GN   Name=VSX1; Synonyms=RINX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Craniofacial;
RX   PubMed=10673340; DOI=10.1006/geno.1999.6093;
RA   Semina E.V., Mintz-Hittner H.A., Murray J.C.;
RT   "Isolation and characterization of a novel human paired-like
RT   homeodomain-containing transcription factor gene, VSX1, expressed in
RT   ocular tissues.";
RL   Genomics 63:289-293(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=10903837; DOI=10.1006/geno.2000.6248;
RA   Hayashi T., Huang J., Deeb S.S.;
RT   "RINX(VSX1), a novel homeobox gene expressed in the inner nuclear
RT   layer of the adult retina.";
RL   Genomics 67:128-139(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 5; 6; 7 AND 8), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=18253095;
RA   Hosseini S.M., Herd S., Vincent A.L., Heon E.;
RT   "Genetic analysis of chromosome 20-related posterior polymorphous
RT   corneal dystrophy: genetic heterogeneity and exclusion of three
RT   candidate genes.";
RL   Mol. Vis. 14:71-80(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 168-186 (ISOFORMS 1/2/3/5/6/7/8),
RP   AND VARIANT KTCN1 HIS-175.
RX   PubMed=19956409;
RA   Paliwal P., Singh A., Tandon R., Titiyal J.S., Sharma A.;
RT   "A novel VSX1 mutation identified in an individual with keratoconus in
RT   India.";
RL   Mol. Vis. 15:2475-2479(2009).
RN   [7]
RP   TISSUE SPECIFICITY, VARIANTS KTCN1 MET-159; ASP-160; TRP-166; ARG-244
RP   AND ARG-247, AND VARIANT GLU-144.
RX   PubMed=11978762; DOI=10.1093/hmg/11.9.1029;
RA   Heon E., Greenberg A., Kopp K.K., Rootman D., Vincent A.L.,
RA   Billingsley G., Priston M., Dorval K.M., Chow R.L., McInnes R.R.,
RA   Heathcote G., Westall C., Sutphin J.E., Semina E., Bremner R.,
RA   Stone E.M.;
RT   "VSX1: a gene for posterior polymorphous dystrophy and keratoconus.";
RL   Hum. Mol. Genet. 11:1029-1036(2002).
RN   [8]
RP   VARIANT CAASDS SER-256, AND VARIANT SER-131.
RX   PubMed=15051220; DOI=10.1016/j.ophtha.2003.07.006;
RA   Mintz-Hittner H.A., Semina E.V., Frishman L.J., Prager T.C.,
RA   Murray J.C.;
RT   "VSX1 (RINX) mutation with craniofacial anomalies, empty sella,
RT   corneal endothelial changes, and abnormal retinal and auditory bipolar
RT   cells.";
RL   Ophthalmology 111:828-836(2004).
RN   [9]
RP   VARIANTS KTCN1 PRO-17; ASP-160 AND ARG-247, AND VARIANT GLU-144.
RX   PubMed=15623752; DOI=10.1167/iovs.04-0533;
RA   Bisceglia L., Ciaschetti M., De Bonis P., Campo P.A., Pizzicoli C.,
RA   Scala C., Grifa M., Ciavarella P., Delle Noci N., Vaira F.,
RA   Macaluso C., Zelante L.;
RT   "VSX1 mutational analysis in a series of Italian patients affected by
RT   keratoconus: detection of a novel mutation.";
RL   Invest. Ophthalmol. Vis. Sci. 46:39-45(2005).
RN   [10]
RP   VARIANT KTCN1 MET-159, AND VARIANT ARG-244.
RX   PubMed=18216574; DOI=10.1097/ICO.0b013e31815a50e7;
RA   Tang Y.G., Picornell Y., Su X., Li X., Yang H., Rabinowitz Y.S.;
RT   "Three VSX1 gene mutations, L159M, R166W, and H244R, are not
RT   associated with keratoconus.";
RL   Cornea 27:189-192(2008).
RN   [11]
RP   VARIANT GLU-144, AND VARIANT KTCN1 ASP-160.
RX   PubMed=19763142; DOI=10.1038/eye.2009.217;
RA   Dash D.P., George S., O'Prey D., Burns D., Nabili S., Donnelly U.,
RA   Hughes A.E., Silvestri G., Jackson J., Frazer D., Heon E.,
RA   Willoughby C.E.;
RT   "Mutational screening of VSX1 in keratoconus patients from the
RT   European population.";
RL   Eye 24:1085-1092(2010).
RN   [12]
RP   VARIANTS KTCN1 PRO-17; ASP-160; ARG-239 AND ARG-247, AND VARIANT
RP   GLU-144.
RX   PubMed=21976959;
RA   De Bonis P., Laborante A., Pizzicoli C., Stallone R., Barbano R.,
RA   Longo C., Mazzilli E., Zelante L., Bisceglia L.;
RT   "Mutational screening of VSX1, SPARC, SOD1, LOX, and TIMP3 in
RT   keratoconus.";
RL   Mol. Vis. 17:2482-2494(2011).
CC   -!- FUNCTION: Binds to the 37-bp core of the locus control region
CC       (LCR) of the red/green visual pigment gene cluster. May regulate
CC       the activity of the LCR and the cone opsin genes at earlier stages
CC       of development.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=L1;
CC         IsoId=Q9NZR4-1; Sequence=Displayed;
CC         Note=Major form.;
CC       Name=2; Synonyms=S1, L3;
CC         IsoId=Q9NZR4-2; Sequence=VSP_002302, VSP_002303;
CC         Note=Major form.;
CC       Name=3; Synonyms=S2;
CC         IsoId=Q9NZR4-3; Sequence=VSP_002299, VSP_002302, VSP_002303;
CC         Note=Minor form.;
CC       Name=4; Synonyms=S3;
CC         IsoId=Q9NZR4-4; Sequence=VSP_002300, VSP_002301;
CC         Note=Minor form.;
CC       Name=5;
CC         IsoId=Q9NZR4-5; Sequence=VSP_039144, VSP_039146;
CC       Name=6;
CC         IsoId=Q9NZR4-6; Sequence=VSP_039140, VSP_039142;
CC       Name=7;
CC         IsoId=Q9NZR4-7; Sequence=VSP_039141, VSP_039143;
CC       Name=8;
CC         IsoId=Q9NZR4-8; Sequence=VSP_039145, VSP_039147;
CC   -!- TISSUE SPECIFICITY: In the adult eye, expressed in lens, iris,
CC       ciliary body, choroid, optical nerve head and, most strongly, in
CC       retina, but not expressed in sclera and cornea. According to
CC       PubMed:11978762, expressed in adult retina but not in lens and
CC       cornea. Within adult retina, found exclusively in the inner
CC       nuclear layer. Isoform 1, isoform 2, isoform 3 and isoform 4
CC       expressed in adult retina, but not in brain, heart, kidney, liver,
CC       lung, pancreas, placenta and skeletal muscle. Not expressed in
CC       thymus and spleen. Expressed in embryonic craniofacial tissue.
CC       Expressed in fetal (week 14) retina. Strongly expressed in
CC       neonatal retina (day 0), weakly in neonatal lens (day 0), choroid
CC       (day 0) and cornea (day 0, 4; month 9).
CC       {ECO:0000269|PubMed:10673340, ECO:0000269|PubMed:10903837,
CC       ECO:0000269|PubMed:11978762, ECO:0000269|PubMed:18253095}.
CC   -!- DISEASE: Keratoconus 1 (KTCN1) [MIM:148300]: Frequent corneal
CC       dystrophy with an incidence that varies from 50 to 230 per
CC       100'000. The cornea assumes a conical shape as a result of a
CC       progressive non-inflammatory thinning of the corneal stroma.
CC       Keratoconus is most often an isolated sporadic condition with
CC       cases of autosomal dominant and autosomal recessive transmission.
CC       {ECO:0000269|PubMed:11978762, ECO:0000269|PubMed:15623752,
CC       ECO:0000269|PubMed:18216574, ECO:0000269|PubMed:19763142,
CC       ECO:0000269|PubMed:19956409, ECO:0000269|PubMed:21976959}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Craniofacial anomalies and anterior segment dysgenesis
CC       syndrome (CAASDS) [MIM:614195]: A disorder with extremely variable
CC       expressivity. Clinical features include wide interpupillary
CC       distance, abnormal corneal endothelium, unusual pinnae, partially
CC       to completely empty sella turcica, posterior fossa cyst, anterior
CC       encephalocele, and/or hydrocephalus.
CC       {ECO:0000269|PubMed:15051220}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF176797; AAF37425.2; -; mRNA.
DR   EMBL; AF251033; AAF99656.1; -; mRNA.
DR   EMBL; AF251034; AAF99657.1; -; mRNA.
DR   EMBL; DQ854807; ABI23973.1; -; mRNA.
DR   EMBL; DQ854808; ABI23974.1; -; mRNA.
DR   EMBL; DQ854809; ABI23975.1; -; mRNA.
DR   EMBL; DQ854810; ABI23976.1; -; mRNA.
DR   EMBL; DQ854811; ABI23977.1; -; mRNA.
DR   EMBL; DQ854812; ABI23978.1; -; mRNA.
DR   EMBL; AL080312; CAI18918.1; -; Genomic_DNA.
DR   EMBL; AL080312; CAX15203.1; -; Genomic_DNA.
DR   EMBL; AL080312; CAX15204.1; -; Genomic_DNA.
DR   EMBL; AL080312; CAX15205.1; -; Genomic_DNA.
DR   EMBL; BC126228; AAI26229.1; -; mRNA.
DR   EMBL; BC136497; AAI36498.1; -; mRNA.
DR   EMBL; GU138372; ACZ01961.1; -; Genomic_DNA.
DR   CCDS; CCDS13168.1; -. [Q9NZR4-1]
DR   CCDS; CCDS13169.1; -. [Q9NZR4-2]
DR   CCDS; CCDS58766.1; -. [Q9NZR4-7]
DR   CCDS; CCDS58767.1; -. [Q9NZR4-8]
DR   RefSeq; NP_001243200.1; NM_001256271.1. [Q9NZR4-7]
DR   RefSeq; NP_001243201.1; NM_001256272.1. [Q9NZR4-8]
DR   RefSeq; NP_055403.2; NM_014588.5. [Q9NZR4-1]
DR   RefSeq; NP_955457.1; NM_199425.2. [Q9NZR4-2]
DR   RefSeq; XP_016883326.1; XM_017027837.1. [Q9NZR4-5]
DR   RefSeq; XP_016883327.1; XM_017027838.1. [Q9NZR4-6]
DR   UniGene; Hs.274264; -.
DR   ProteinModelPortal; Q9NZR4; -.
DR   SMR; Q9NZR4; -.
DR   BioGrid; 119037; 11.
DR   STRING; 9606.ENSP00000365899; -.
DR   iPTMnet; Q9NZR4; -.
DR   PhosphoSitePlus; Q9NZR4; -.
DR   BioMuta; VSX1; -.
DR   DMDM; 25009572; -.
DR   PaxDb; Q9NZR4; -.
DR   PeptideAtlas; Q9NZR4; -.
DR   PRIDE; Q9NZR4; -.
DR   Ensembl; ENST00000376707; ENSP00000365897; ENSG00000100987. [Q9NZR4-2]
DR   Ensembl; ENST00000376709; ENSP00000365899; ENSG00000100987. [Q9NZR4-1]
DR   Ensembl; ENST00000409285; ENSP00000386612; ENSG00000100987. [Q9NZR4-5]
DR   Ensembl; ENST00000409958; ENSP00000387069; ENSG00000100987. [Q9NZR4-6]
DR   Ensembl; ENST00000429762; ENSP00000401690; ENSG00000100987. [Q9NZR4-8]
DR   Ensembl; ENST00000444511; ENSP00000387720; ENSG00000100987. [Q9NZR4-7]
DR   GeneID; 30813; -.
DR   KEGG; hsa:30813; -.
DR   UCSC; uc002wuf.5; human. [Q9NZR4-1]
DR   CTD; 30813; -.
DR   DisGeNET; 30813; -.
DR   EuPathDB; HostDB:ENSG00000100987.14; -.
DR   GeneCards; VSX1; -.
DR   HGNC; HGNC:12723; VSX1.
DR   MalaCards; VSX1; -.
DR   MIM; 148300; phenotype.
DR   MIM; 605020; gene.
DR   MIM; 614195; phenotype.
DR   neXtProt; NX_Q9NZR4; -.
DR   OpenTargets; ENSG00000100987; -.
DR   Orphanet; 2335; Isolated keratoconus.
DR   Orphanet; 98973; Posterior polymorphous corneal dystrophy.
DR   PharmGKB; PA37334; -.
DR   eggNOG; ENOG410IRDQ; Eukaryota.
DR   eggNOG; ENOG4111PWF; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOVERGEN; HBG036251; -.
DR   InParanoid; Q9NZR4; -.
DR   KO; K09335; -.
DR   OMA; TVFTSHQ; -.
DR   OrthoDB; EOG091G14DA; -.
DR   PhylomeDB; Q9NZR4; -.
DR   TreeFam; TF350743; -.
DR   GeneWiki; VSX1; -.
DR   GenomeRNAi; 30813; -.
DR   PRO; PR:Q9NZR4; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000100987; -.
DR   CleanEx; HS_VSX1; -.
DR   Genevisible; Q9NZR4; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IBA:GO_Central.
DR   GO; GO:0048666; P:neuron development; IBA:GO_Central.
DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR023339; CVC.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS51496; CVC; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Corneal dystrophy;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Sensory transduction;
KW   Transcription; Transcription regulation; Vision.
FT   CHAIN         1    365       Visual system homeobox 1.
FT                                /FTId=PRO_0000049355.
FT   DOMAIN      224    277       CVC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00829}.
FT   DNA_BIND    164    223       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF        31     38       Octapeptide motif.
FT   MOTIF       161    166       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS     44    127       Pro-rich.
FT   COMPBIAS     76     89       Gly/Leu-rich.
FT   COMPBIAS    142    152       Asp/Glu-rich (acidic).
FT   VAR_SEQ     141    141       S -> SGNQARAFRSCPCPLGSEPRRGHRPSPHRTPGPSGP
FT                                DLGGEPRARPRRGRGIRGAAPPAPCCILNPCLSSGVLFPQR
FT                                CETATTWFRVEPFDETLGSSTTISRGPFFPPAPGASLRLWQ
FT                                LRGSGRPGPVVVTSSTEQ (in isoform 3).
FT                                {ECO:0000303|PubMed:10903837}.
FT                                /FTId=VSP_002299.
FT   VAR_SEQ     142    143       DE -> AM (in isoform 4).
FT                                {ECO:0000303|PubMed:10903837}.
FT                                /FTId=VSP_002300.
FT   VAR_SEQ     144    365       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10903837}.
FT                                /FTId=VSP_002301.
FT   VAR_SEQ     210    236       VWFQNRRAKWRKREKRWGGSSVMAEYG -> CKLLLLEAPV
FT                                HWTLQETHRLPRPRGGA (in isoform 7).
FT                                {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039141.
FT   VAR_SEQ     210    218       VWFQNRRAK -> RVRHWAAEK (in isoform 6).
FT                                {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039140.
FT   VAR_SEQ     211    239       WFQNRRAKWRKREKRWGGSSVMAEYGLYG -> SGVPFLRS
FT                                KDTTENVSFPHSVSQSAVPSL (in isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:10903837,
FT                                ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_002302.
FT   VAR_SEQ     219    365       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039142.
FT   VAR_SEQ     237    365       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039143.
FT   VAR_SEQ     240    365       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10903837,
FT                                ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_002303.
FT   VAR_SEQ     270    301       GMHKKSMGMIRKPGSEDKLAGLWGSDHFKEGS -> VQTSA
FT                                PGGSRSLDFAGDTQAPQTPWWCLMTFS (in isoform
FT                                8). {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039145.
FT   VAR_SEQ     270    280       GMHKKSMGMIR -> EGETLGCREMK (in isoform
FT                                5). {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039144.
FT   VAR_SEQ     281    365       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039146.
FT   VAR_SEQ     302    365       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:18253095}.
FT                                /FTId=VSP_039147.
FT   VARIANT      17     17       L -> P (in KTCN1; dbSNP:rs74315436).
FT                                {ECO:0000269|PubMed:15623752,
FT                                ECO:0000269|PubMed:21976959}.
FT                                /FTId=VAR_066670.
FT   VARIANT     131    131       R -> S (in dbSNP:rs6050307).
FT                                {ECO:0000269|PubMed:15051220}.
FT                                /FTId=VAR_066671.
FT   VARIANT     144    144       D -> E (in dbSNP:rs140122268).
FT                                {ECO:0000269|PubMed:11978762,
FT                                ECO:0000269|PubMed:15623752,
FT                                ECO:0000269|PubMed:19763142,
FT                                ECO:0000269|PubMed:21976959}.
FT                                /FTId=VAR_014243.
FT   VARIANT     159    159       L -> M (in KTCN1; unknown pathological
FT                                significance; dbSNP:rs74315434).
FT                                {ECO:0000269|PubMed:11978762,
FT                                ECO:0000269|PubMed:18216574}.
FT                                /FTId=VAR_014244.
FT   VARIANT     160    160       G -> D (in KTCN1; unknown pathological
FT                                significance; dbSNP:rs74315433).
FT                                {ECO:0000269|PubMed:11978762,
FT                                ECO:0000269|PubMed:15623752,
FT                                ECO:0000269|PubMed:19763142,
FT                                ECO:0000269|PubMed:21976959}.
FT                                /FTId=VAR_014245.
FT   VARIANT     166    166       R -> W (in KTCN1; sporadic;
FT                                dbSNP:rs74315432).
FT                                {ECO:0000269|PubMed:11978762}.
FT                                /FTId=VAR_014246.
FT   VARIANT     175    175       Q -> H (in KTCN1; dbSNP:rs771561481).
FT                                {ECO:0000269|PubMed:19956409}.
FT                                /FTId=VAR_063100.
FT   VARIANT     239    239       G -> R (in KTCN1; unknown pathological
FT                                significance; dbSNP:rs749663315).
FT                                {ECO:0000269|PubMed:21976959}.
FT                                /FTId=VAR_076692.
FT   VARIANT     244    244       H -> R (in KTCN1; unknown pathological
FT                                significance; dbSNP:rs148957473).
FT                                {ECO:0000269|PubMed:11978762,
FT                                ECO:0000269|PubMed:18216574}.
FT                                /FTId=VAR_014247.
FT   VARIANT     247    247       P -> R (in KTCN1; unknown pathological
FT                                significance; also in a patient with
FT                                retinal dysfunction; dbSNP:rs576300014).
FT                                {ECO:0000269|PubMed:11978762,
FT                                ECO:0000269|PubMed:15623752,
FT                                ECO:0000269|PubMed:21976959}.
FT                                /FTId=VAR_014248.
FT   VARIANT     256    256       A -> S (in CAASDS; dbSNP:rs74315435).
FT                                {ECO:0000269|PubMed:15051220}.
FT                                /FTId=VAR_066672.
SQ   SEQUENCE   365 AA;  38431 MW;  C58BE94767D66FCB CRC64;
     MTGRDSLSDG RTSSRALVPG GSPRGSRPRG FAITDLLGLE AELPAPAGPG QGSGCEGPAV
     APCPGPGLDG SSLARGALPL GLGLLCGFGT QPPAAARAPC LLLADVPFLP PRGPEPAAPL
     APSRPPPALG RQKRSDSVST SDEDSQSEDR NDLKASPTLG KRKKRRHRTV FTAHQLEELE
     KAFSEAHYPD VYAREMLAVK TELPEDRIQV WFQNRRAKWR KREKRWGGSS VMAEYGLYGA
     MVRHCIPLPD SVLNSAEGGL LGSCAPWLLG MHKKSMGMIR KPGSEDKLAG LWGSDHFKEG
     SSQSESGSQR GSDKVSPENG LEDVAIDLSS SARQETKKVH PGAGAQGGSN STALEGPQPG
     KVGAT
//
ID   VSX2_HUMAN              Reviewed;         361 AA.
AC   P58304; A1A4X6;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2001, sequence version 1.
DT   25-OCT-2017, entry version 154.
DE   RecName: Full=Visual system homeobox 2;
DE   AltName: Full=Ceh-10 homeodomain-containing homolog;
DE   AltName: Full=Homeobox protein CHX10;
GN   Name=VSX2; Synonyms=CHX10, HOX10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MCOPCTI GLN-200 AND
RP   PRO-200.
RX   PubMed=10932181; DOI=10.1038/78071;
RA   Percin E.F., Ploder L.A., Yu J.J., Arici K., Horsford D.J.,
RA   Rutherford A., Bapat B., Cox D.W., Duncan A.M.V., Kalnins V.I.,
RA   Kocak-Altintas A., Sowden J.C., Traboulsi E., Sarfarazi M.,
RA   McInnes R.R.;
RT   "Human microphthalmia associated with mutations in the retinal
RT   homeobox gene CHX10.";
RL   Nat. Genet. 25:397-401(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Shan Y.X., Yu L.;
RT   "Cloning and characterization of human CHX10 (Ceh-10 homeodomain
RT   containing homolog) gene.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN MCOPCB3, AND VARIANT MCOP2 TRP-227.
RX   PubMed=15257456; DOI=10.1007/s00439-004-1154-2;
RA   Bar-Yosef U., Abuelaish I., Harel T., Hendler N., Ofir R., Birk O.S.;
RT   "CHX10 mutations cause non-syndromic microphthalmia/ anophthalmia in
RT   Arab and Jewish kindreds.";
RL   Hum. Genet. 115:302-309(2004).
RN   [7]
RP   VARIANT MCOP2 ALA-223.
RX   PubMed=21976963;
RA   Reis L.M., Khan A., Kariminejad A., Ebadi F., Tyler R.C., Semina E.V.;
RT   "VSX2 mutations in autosomal recessive microphthalmia.";
RL   Mol. Vis. 17:2527-2532(2011).
RN   [8]
RP   VARIANT MCOPCB3 ARG-223.
RX   PubMed=24033328; DOI=10.1111/cge.12275;
RA   Chassaing N., Causse A., Vigouroux A., Delahaye A., Alessandri J.L.,
RA   Boespflug-Tanguy O., Boute-Benejean O., Dollfus H., Duban-Bedu B.,
RA   Gilbert-Dussardier B., Giuliano F., Gonzales M., Holder-Espinasse M.,
RA   Isidor B., Jacquemont M.L., Lacombe D., Martin-Coignard D.,
RA   Mathieu-Dramard M., Odent S., Picone O., Pinson L., Quelin C.,
RA   Sigaudy S., Toutain A., Thauvin-Robinet C., Kaplan J., Calvas P.;
RT   "Molecular findings and clinical data in a cohort of 150 patients with
RT   anophthalmia/microphthalmia.";
RL   Clin. Genet. 86:326-334(2014).
CC   -!- FUNCTION: Plays a significant role in the specification and
CC       morphogenesis of the sensory retina. May also participate in the
CC       development of the cells of the inner nuclear layer, particularly
CC       bipolar cells (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in retinal neuroblasts
CC       during eye development and in the inner nuclear layer of the adult
CC       retina. Within this layer, expression is stronger in the outer
CC       margin where bipolar cells predominate.
CC   -!- DISEASE: Microphthalmia, isolated, 2 (MCOP2) [MIM:610093]: A
CC       disorder of eye formation, ranging from small size of a single eye
CC       to complete bilateral absence of ocular tissues. Ocular
CC       abnormalities like opacities of the cornea and lens, scaring of
CC       the retina and choroid, and other abnormalities may also be
CC       present. {ECO:0000269|PubMed:15257456,
CC       ECO:0000269|PubMed:21976963}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Microphthalmia with cataracts and iris abnormalities
CC       (MCOPCTI) [MIM:610092]: A disorder of eye formation, ranging from
CC       small size of a single eye to complete bilateral absence of ocular
CC       tissues. Ocular abnormalities like opacities of the cornea and
CC       lens, scaring of the retina and choroid, cataract and other
CC       abnormalities like cataract may also be present.
CC       {ECO:0000269|PubMed:10932181}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Microphthalmia, isolated, with coloboma, 3 (MCOPCB3)
CC       [MIM:610092]: A disorder of eye formation, ranging from small size
CC       of a single eye to complete bilateral absence of ocular tissues.
CC       Ocular abnormalities like opacities of the cornea and lens,
CC       scaring of the retina and choroid, and other abnormalities may
CC       also be present. Ocular colobomas are a set of malformations
CC       resulting from abnormal morphogenesis of the optic cup and stalk,
CC       and the fusion of the fetal fissure (optic fissure).
CC       {ECO:0000269|PubMed:15257456, ECO:0000269|PubMed:24033328}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY336059; AAQ01593.1; -; mRNA.
DR   EMBL; AC005519; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81164.1; -; Genomic_DNA.
DR   EMBL; BC128153; AAI28154.1; -; mRNA.
DR   CCDS; CCDS9827.1; -.
DR   RefSeq; NP_878314.1; NM_182894.2.
DR   UniGene; Hs.449771; -.
DR   ProteinModelPortal; P58304; -.
DR   SMR; P58304; -.
DR   BioGrid; 130813; 14.
DR   IntAct; P58304; 2.
DR   STRING; 9606.ENSP00000261980; -.
DR   iPTMnet; P58304; -.
DR   PhosphoSitePlus; P58304; -.
DR   BioMuta; VSX2; -.
DR   DMDM; 17374365; -.
DR   EPD; P58304; -.
DR   PaxDb; P58304; -.
DR   PeptideAtlas; P58304; -.
DR   PRIDE; P58304; -.
DR   Ensembl; ENST00000261980; ENSP00000261980; ENSG00000119614.
DR   GeneID; 338917; -.
DR   KEGG; hsa:338917; -.
DR   UCSC; uc001xpq.3; human.
DR   CTD; 338917; -.
DR   DisGeNET; 338917; -.
DR   EuPathDB; HostDB:ENSG00000119614.2; -.
DR   GeneCards; VSX2; -.
DR   GeneReviews; VSX2; -.
DR   HGNC; HGNC:1975; VSX2.
DR   HPA; HPA003436; -.
DR   MalaCards; VSX2; -.
DR   MIM; 142993; gene.
DR   MIM; 610092; phenotype.
DR   MIM; 610093; phenotype.
DR   neXtProt; NX_P58304; -.
DR   OpenTargets; ENSG00000119614; -.
DR   Orphanet; 98938; Colobomatous microphthalmia.
DR   Orphanet; 2542; Isolated anophthalmia - microphthalmia.
DR   Orphanet; 2543; Microphthalmia - cataract.
DR   PharmGKB; PA26511; -.
DR   eggNOG; KOG0494; Eukaryota.
DR   eggNOG; ENOG410ZN24; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000115909; -.
DR   HOVERGEN; HBG036251; -.
DR   InParanoid; P58304; -.
DR   KO; K09336; -.
DR   OMA; DKMEQEE; -.
DR   OrthoDB; EOG091G14DA; -.
DR   PhylomeDB; P58304; -.
DR   TreeFam; TF350743; -.
DR   SignaLink; P58304; -.
DR   GeneWiki; VSX2; -.
DR   GenomeRNAi; 338917; -.
DR   PRO; PR:P58304; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000119614; -.
DR   CleanEx; HS_VSX2; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR023339; CVC.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS51496; CVC; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Cataract; Complete proteome; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Microphthalmia; Nucleus; Polymorphism;
KW   Reference proteome; Sensory transduction; Transcription;
KW   Transcription regulation; Vision.
FT   CHAIN         1    361       Visual system homeobox 2.
FT                                /FTId=PRO_0000049362.
FT   DOMAIN      208    261       CVC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00829}.
FT   DNA_BIND    148    207       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       304    317       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS     12    114       Pro-rich.
FT   COMPBIAS    117    138       Ser/Thr-rich.
FT   COMPBIAS    335    346       Asp/Glu-rich (acidic).
FT   VARIANT     100    100       P -> Q (in dbSNP:rs35214083).
FT                                /FTId=VAR_049593.
FT   VARIANT     200    200       R -> P (in MCOPCTI; loss of DNA binding
FT                                capacity; dbSNP:rs121912543).
FT                                {ECO:0000269|PubMed:10932181}.
FT                                /FTId=VAR_011618.
FT   VARIANT     200    200       R -> Q (in MCOPCTI; loss of DNA binding
FT                                capacity; dbSNP:rs121912543).
FT                                {ECO:0000269|PubMed:10932181}.
FT                                /FTId=VAR_011619.
FT   VARIANT     223    223       G -> A (in MCOP2).
FT                                {ECO:0000269|PubMed:21976963}.
FT                                /FTId=VAR_067269.
FT   VARIANT     223    223       G -> R (in MCOPCB3; the patient also has
FT                                cataracts; dbSNP:rs755799430).
FT                                {ECO:0000269|PubMed:24033328}.
FT                                /FTId=VAR_075633.
FT   VARIANT     227    227       R -> W (in MCOP2; dbSNP:rs121912545).
FT                                {ECO:0000269|PubMed:15257456}.
FT                                /FTId=VAR_029357.
SQ   SEQUENCE   361 AA;  39411 MW;  19EF3E8E783375F8 CRC64;
     MTGKAGEALS KPKSETVAKS TSGGAPARCT GFGIQEILGL NKEPPSSHPR AALDGLAPGH
     LLAARSVLSP AGVGGMGLLG PGGLPGFYTQ PTFLEVLSDP QSVHLQPLGR ASGPLDTSQT
     ASSDSEDVSS SDRKMSKSAL NQTKKRKKRR HRTIFTSYQL EELEKAFNEA HYPDVYAREM
     LAMKTELPED RIQVWFQNRR AKWRKREKCW GRSSVMAEYG LYGAMVRHSI PLPESILKSA
     KDGIMDSCAP WLLGMHKKSL EAAAESGRKP EGERQALPKL DKMEQDERGP DAQAAISQEE
     LRENSIAVLR AKAQEHSTKV LGTVSGPDSL ARSTEKPEEE EAMDEDRPAE RLSPPQLEDM
     A
//
ID   VAX2_HUMAN              Reviewed;         290 AA.
AC   Q9UIW0; Q53Y33;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Ventral anterior homeobox 2;
GN   Name=VAX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], POSSIBLE FUNCTION IN EYE DEVELOPMENT, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=10485894; DOI=10.1073/pnas.96.19.10729;
RA   Barbieri A.M., Lupo G., Bulfone A., Andreazzoli M., Mariani M.,
RA   Fougerousse F., Consalez G.G., Borsani G., Beckmann J.S.,
RA   Barsacchi G., Ballabio A., Banfi S.;
RT   "A homeobox gene, vax2, controls the patterning of the eye
RT   dorsoventral axis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:10729-10734(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS GLY-24 AND ARG-254.
RX   PubMed=22095910; DOI=10.1002/humu.21658;
RA   Slavotinek A.M., Chao R., Vacik T., Yahyavi M., Abouzeid H.,
RA   Bardakjian T., Schneider A., Shaw G., Sherr E.H., Lemke G.,
RA   Youssef M., Schorderet D.F.;
RT   "VAX1 mutation associated with microphthalmia, corpus callosum
RT   agenesis, and orofacial clefting: The first description of a VAX1
RT   phenotype in humans.";
RL   Hum. Mutat. 33:364-368(2012).
CC   -!- FUNCTION: Transcription factor that may function in dorsoventral
CC       specification of the forebrain. Regulates the expression of Wnt
CC       signaling antagonists including the expression of a truncated
CC       TCF7L2 isoform that cannot bind CTNNB1 and acts therefore as a
CC       potent dominant-negative Wnt antagonist. Plays a crucial role in
CC       eye development and, in particular, in the specification of the
CC       ventral optic vesicle (By similarity). May be a regulator of axial
CC       polarization in the retina. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the ventral part of the optic
CC       vesicles at 7 week dpc. {ECO:0000269|PubMed:10485894}.
CC   -!- SIMILARITY: Belongs to the EMX homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17791; CAB56166.1; -; mRNA.
DR   EMBL; BT007035; AAP35683.1; -; mRNA.
DR   EMBL; CH471053; EAW99792.1; -; Genomic_DNA.
DR   EMBL; BC006336; AAH06336.1; -; mRNA.
DR   CCDS; CCDS1911.1; -.
DR   RefSeq; NP_036608.1; NM_012476.2.
DR   UniGene; Hs.249170; -.
DR   ProteinModelPortal; Q9UIW0; -.
DR   SMR; Q9UIW0; -.
DR   BioGrid; 117338; 3.
DR   IntAct; Q9UIW0; 3.
DR   STRING; 9606.ENSP00000234392; -.
DR   iPTMnet; Q9UIW0; -.
DR   PhosphoSitePlus; Q9UIW0; -.
DR   BioMuta; VAX2; -.
DR   DMDM; 20532295; -.
DR   PaxDb; Q9UIW0; -.
DR   PeptideAtlas; Q9UIW0; -.
DR   PRIDE; Q9UIW0; -.
DR   DNASU; 25806; -.
DR   Ensembl; ENST00000234392; ENSP00000234392; ENSG00000116035.
DR   GeneID; 25806; -.
DR   KEGG; hsa:25806; -.
DR   UCSC; uc002shh.4; human.
DR   CTD; 25806; -.
DR   DisGeNET; 25806; -.
DR   EuPathDB; HostDB:ENSG00000116035.2; -.
DR   GeneCards; VAX2; -.
DR   HGNC; HGNC:12661; VAX2.
DR   HPA; HPA009708; -.
DR   MIM; 604295; gene.
DR   neXtProt; NX_Q9UIW0; -.
DR   OpenTargets; ENSG00000116035; -.
DR   PharmGKB; PA37284; -.
DR   eggNOG; KOG0843; Eukaryota.
DR   eggNOG; ENOG4111SRW; LUCA.
DR   GeneTree; ENSGT00900000140915; -.
DR   HOGENOM; HOG000049217; -.
DR   HOVERGEN; HBG007558; -.
DR   InParanoid; Q9UIW0; -.
DR   KO; K09318; -.
DR   OMA; LCFSTAP; -.
DR   OrthoDB; EOG091G0XAA; -.
DR   PhylomeDB; Q9UIW0; -.
DR   TreeFam; TF319504; -.
DR   GenomeRNAi; 25806; -.
DR   PRO; PR:Q9UIW0; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000116035; -.
DR   CleanEx; HS_VAX2; -.
DR   ExpressionAtlas; Q9UIW0; baseline and differential.
DR   Genevisible; Q9UIW0; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0001162; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl.
DR   GO; GO:0007398; P:ectoderm development; TAS:ProtInc.
DR   GO; GO:0048048; P:embryonic eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; ISS:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR033021; Vax2.
DR   PANTHER; PTHR24339:SF34; PTHR24339:SF34; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Wnt signaling pathway.
FT   CHAIN         1    290       Ventral anterior homeobox 2.
FT                                /FTId=PRO_0000049351.
FT   DNA_BIND    102    161       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS      1     71       Gly-rich.
FT   VARIANT      24     24       R -> G (in dbSNP:rs2234496).
FT                                {ECO:0000269|PubMed:22095910}.
FT                                /FTId=VAR_067308.
FT   VARIANT     254    254       P -> R (in dbSNP:rs2234500).
FT                                {ECO:0000269|PubMed:22095910}.
FT                                /FTId=VAR_020152.
SQ   SEQUENCE   290 AA;  30874 MW;  917164EE66E66051 CRC64;
     MGDGGAERDR GPARRAESGG GGGRCGDRSG AGDLRADGGG HSPTEVAGTS ASSPAGSRES
     GADSDGQPGP GEADHCRRIL VRDAKGTIRE IVLPKGLDLD RPKRTRTSFT AEQLYRLEME
     FQRCQYVVGR ERTELARQLN LSETQVKVWF QNRRTKQKKD QSRDLEKRAS SSASEAFATS
     NILRLLEQGR LLSVPRAPSL LALTPSLPGL PASHRGTSLG DPRNSSPRLN PLSSASASPP
     LPPPLPAVCF SSAPLLDLPA GYELGSSAFE PYSWLERKVG SASSCKKANT
//
ID   ZHX2_HUMAN              Reviewed;         837 AA.
AC   Q9Y6X8;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   25-OCT-2017, entry version 152.
DE   RecName: Full=Zinc fingers and homeoboxes protein 2;
DE   AltName: Full=Alpha-fetoprotein regulator 1;
DE            Short=AFP regulator 1;
DE   AltName: Full=Regulator of AFP;
DE   AltName: Full=Zinc finger and homeodomain protein 2;
GN   Name=ZHX2; Synonyms=AFR1, KIAA0854, RAF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, HOMODIMERIZATION,
RP   HETERODIMERIZATION WITH ZHX1 AND ZHX3, INTERACTION WITH NFYA,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis {ECO:0000312|EMBL:BAC76615.1};
RX   PubMed=12741956; DOI=10.1042/BJ20030171;
RA   Kawata H., Yamada K., Shou Z., Mizutani T., Yazawa T., Yoshino M.,
RA   Sekiguchi T., Kajitani T., Miyamoto K.;
RT   "Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX
RT   family, functions as a transcriptional repressor.";
RL   Biochem. J. 373:747-757(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Suyama M., Kikuno R., Nagase T., Ishikawa K.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph {ECO:0000312|EMBL:AAH42145.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=17056598; DOI=10.1074/jbc.M606664200;
RA   Liu G., Clement L.C., Kanwar Y.S., Avila-Casado C., Chugh S.S.;
RT   "ZHX proteins regulate podocyte gene expression during the development
RT   of nephrotic syndrome.";
RL   J. Biol. Chem. 281:39681-39692(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND THR-207, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-64 AND LYS-455, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [10]
RP   STRUCTURE BY NMR OF 524-601.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the third homeobox domain of zinc fingers and
RT   homeoboxes protein 2.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 444-501.
RX   PubMed=20509910; DOI=10.1186/1472-6807-10-13;
RA   Bird L.E., Ren J., Nettleship J.E., Folkers G.E., Owens R.J.,
RA   Stammers D.K.;
RT   "Novel structural features in two ZHX homeodomains derived from a
RT   systematic study of single and multiple domains.";
RL   BMC Struct. Biol. 10:13-13(2010).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Represses the
CC       promoter activity of the CDC25C gene stimulated by NFYA.
CC       {ECO:0000269|PubMed:12741956}.
CC   -!- SUBUNIT: Forms a homodimer (via homeobox domain). Forms a
CC       heterodimer with ZHX1 (via HD1 domain). Forms a heterodimer with
CC       ZHX3. Heterodimerization with ZHX1 is not necessary for repressor
CC       activity. Interacts (via homeobox domain) with NFYA (via N-
CC       terminus). {ECO:0000269|PubMed:12741956}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-948566, EBI-948566;
CC       Q9UKY1:ZHX1; NbExp=2; IntAct=EBI-948566, EBI-347767;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:12741956,
CC       ECO:0000269|PubMed:17056598}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in
CC       podocytes. {ECO:0000269|PubMed:12741956,
CC       ECO:0000269|PubMed:17056598}.
CC   -!- SIMILARITY: Belongs to the ZHX family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74877.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB083653; BAC76615.1; -; mRNA.
DR   EMBL; AB020661; BAA74877.2; ALT_INIT; mRNA.
DR   EMBL; BC042145; AAH42145.1; -; mRNA.
DR   CCDS; CCDS6336.1; -.
DR   RefSeq; NP_055758.1; NM_014943.3.
DR   RefSeq; XP_005250893.1; XM_005250836.4.
DR   RefSeq; XP_005250894.1; XM_005250837.4.
DR   RefSeq; XP_011515233.1; XM_011516931.2.
DR   RefSeq; XP_011515234.1; XM_011516932.2.
DR   UniGene; Hs.377090; -.
DR   UniGene; Hs.658443; -.
DR   PDB; 2DMP; NMR; -; A=524-599.
DR   PDB; 3NAU; X-ray; 2.70 A; A/B=444-501.
DR   PDBsum; 2DMP; -.
DR   PDBsum; 3NAU; -.
DR   ProteinModelPortal; Q9Y6X8; -.
DR   SMR; Q9Y6X8; -.
DR   BioGrid; 116549; 14.
DR   IntAct; Q9Y6X8; 31.
DR   MINT; MINT-2869930; -.
DR   STRING; 9606.ENSP00000314709; -.
DR   iPTMnet; Q9Y6X8; -.
DR   PhosphoSitePlus; Q9Y6X8; -.
DR   BioMuta; ZHX2; -.
DR   DMDM; 44888553; -.
DR   EPD; Q9Y6X8; -.
DR   MaxQB; Q9Y6X8; -.
DR   PaxDb; Q9Y6X8; -.
DR   PeptideAtlas; Q9Y6X8; -.
DR   PRIDE; Q9Y6X8; -.
DR   DNASU; 22882; -.
DR   Ensembl; ENST00000314393; ENSP00000314709; ENSG00000178764.
DR   GeneID; 22882; -.
DR   KEGG; hsa:22882; -.
DR   UCSC; uc003ypk.2; human.
DR   CTD; 22882; -.
DR   DisGeNET; 22882; -.
DR   EuPathDB; HostDB:ENSG00000178764.7; -.
DR   GeneCards; ZHX2; -.
DR   HGNC; HGNC:18513; ZHX2.
DR   HPA; HPA006769; -.
DR   HPA; HPA006996; -.
DR   MIM; 609185; gene.
DR   neXtProt; NX_Q9Y6X8; -.
DR   OpenTargets; ENSG00000178764; -.
DR   PharmGKB; PA128394591; -.
DR   eggNOG; ENOG410IHET; Eukaryota.
DR   eggNOG; ENOG410Z8A2; LUCA.
DR   GeneTree; ENSGT00530000063149; -.
DR   HOGENOM; HOG000013231; -.
DR   HOVERGEN; HBG007920; -.
DR   InParanoid; Q9Y6X8; -.
DR   OMA; KFPYPTQ; -.
DR   OrthoDB; EOG091G02WT; -.
DR   PhylomeDB; Q9Y6X8; -.
DR   TreeFam; TF333363; -.
DR   ChiTaRS; ZHX2; human.
DR   EvolutionaryTrace; Q9Y6X8; -.
DR   GeneWiki; ZHX2; -.
DR   GenomeRNAi; 22882; -.
DR   PRO; PR:Q9Y6X8; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000178764; -.
DR   CleanEx; HS_ZHX2; -.
DR   ExpressionAtlas; Q9Y6X8; baseline and differential.
DR   Genevisible; Q9Y6X8; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 4.
DR   Gene3D; 4.10.1050.10; -; 1.
DR   InterPro; IPR026939; At2g23090-like.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 3.
DR   SMART; SM00389; HOX; 4.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   SUPFAM; SSF46689; SSF46689; 4.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; DNA-binding; Homeobox;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    837       Zinc fingers and homeoboxes protein 2.
FT                                /FTId=PRO_0000049391.
FT   ZN_FING      78    101       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042, ECO:0000305}.
FT   ZN_FING     110    133       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042, ECO:0000305}.
FT   DNA_BIND    263    324       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    439    501       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    530    591       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    628    690       Homeobox 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   REGION      195    358       Required for homodimerization.
FT   REGION      263    497       Required for interaction with NFYA.
FT                                {ECO:0000269|PubMed:12741956}.
FT   REGION      263    446       Required for repressor activity.
FT   REGION      317    446       Required for nuclear localization.
FT   MOD_RES      37     37       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     207    207       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     825    825       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C0C0}.
FT   MOD_RES     827    827       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C0C0}.
FT   CROSSLNK     64     64       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    455    455       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     357    357       V -> M (in dbSNP:rs9649951).
FT                                /FTId=VAR_049594.
FT   VARIANT     649    649       R -> K (in dbSNP:rs35319449).
FT                                /FTId=VAR_049595.
FT   VARIANT     779    779       G -> S (in dbSNP:rs3802264).
FT                                /FTId=VAR_049596.
FT   HELIX       448    459       {ECO:0000244|PDB:3NAU}.
FT   HELIX       460    462       {ECO:0000244|PDB:3NAU}.
FT   HELIX       466    476       {ECO:0000244|PDB:3NAU}.
FT   HELIX       480    500       {ECO:0000244|PDB:3NAU}.
FT   HELIX       538    550       {ECO:0000244|PDB:2DMP}.
FT   HELIX       556    566       {ECO:0000244|PDB:2DMP}.
FT   HELIX       570    585       {ECO:0000244|PDB:2DMP}.
SQ   SEQUENCE   837 AA;  92307 MW;  BE377ADF76D987D2 CRC64;
     MASKRKSTTP CMVRTSQVVE QDVPEEVDRA KEKGIGTPQP DVAKDSWAAE LENSSKENEV
     IEVKSMGESQ SKKLQGGYEC KYCPYSTQNL NEFTEHVDMQ HPNVILNPLY VCAECNFTTK
     KYDSLSDHNS KFHPGEANFK LKLIKRNNQT VLEQSIETTN HVVSITTSGP GTGDSDSGIS
     VSKTPIMKPG KPKADAKKVP KKPEEITPEN HVEGTARLVT DTAEILSRLG GVELLQDTLG
     HVMPSVQLPP NINLVPKVPV PLNTTKYNSA LDTNATMINS FNKFPYPTQA ELSWLTAASK
     HPEEHIRIWF ATQRLKHGIS WSPEEVEEAR KKMFNGTIQS VPPTITVLPA QLAPTKVTQP
     ILQTALPCQI LGQTSLVLTQ VTSGSTTVSC SPITLAVAGV TNHGQKRPLV TPQAAPEPKR
     PHIAQVPEPP PKVANPPLTP ASDRKKTKEQ IAHLKASFLQ SQFPDDAEVY RLIEVTGLAR
     SEIKKWFSDH RYRCQRGIVH ITSESLAKDQ LAIAASRHGR TYHAYPDFAP QKFKEKTQGQ
     VKILEDSFLK SSFPTQAELD RLRVETKLSR REIDSWFSER RKLRDSMEQA VLDSMGSGKK
     GQDVGAPNGA LSRLDQLSGA QLTSSLPSPS PAIAKSQEQV HLLRSTFART QWPTPQEYDQ
     LAAKTGLVRT EIVRWFKENR CLLKTGTVKW MEQYQHQPMA DDHGYDAVAR KATKPMAESP
     KNGGDVVPQY YKDPKKLCEE DLEKLVTRVK VGSEPAKDCL PAKPSEATSD RSEGSSRDGQ
     GSDENEESSV VDYVEVTVGE EDAISDRSDS WSQAAAEGVS ELAESDSDCV PAEAGQA
//
ID   ZHX1_HUMAN              Reviewed;         873 AA.
AC   Q9UKY1; Q8IWD8;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Zinc fingers and homeoboxes protein 1;
GN   Name=ZHX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAF35183.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INTERACTION WITH NFYA.
RC   TISSUE=Liver {ECO:0000269|PubMed:10441475};
RX   PubMed=10441475; DOI=10.1006/bbrc.1999.1087;
RA   Yamada K., Printz R.L., Osawa H., Granner D.K.;
RT   "Human ZHX1: cloning, chromosomal location, and interaction with
RT   transcription factor NF-Y.";
RL   Biochem. Biophys. Res. Commun. 261:614-621(1999).
RN   [2] {ECO:0000312|EMBL:AAF35183.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Mueller R., Ziegler B.L.;
RT   "Identification and cloning of the human ZHX1 gene.";
RL   Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis {ECO:0000312|EMBL:AAH40481.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   INTERACTION WITH NFYA.
RX   PubMed=10571058; DOI=10.1016/S0014-5793(99)01311-3;
RA   Yamada K., Osawa H., Granner D.K.;
RT   "Identification of proteins that interact with NF-YA.";
RL   FEBS Lett. 460:41-45(1999).
RN   [5] {ECO:0000305}
RP   FUNCTION, HOMODIMERIZATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12237128; DOI=10.1016/S0006-291X(02)02203-9;
RA   Yamada K., Kawata H., Matsuura K., Shou Z., Hirano S., Mizutani T.,
RA   Yazawa T., Yoshino M., Sekiguchi T., Kajitani T., Miyamoto K.;
RT   "Functional analysis and the molecular dissection of zinc-fingers and
RT   homeoboxes 1 (ZHX1).";
RL   Biochem. Biophys. Res. Commun. 297:368-374(2002).
RN   [6] {ECO:0000305}
RP   HETERODIMERIZATION WITH ZHX3, AND INTERACTION WITH ATF7IP.
RX   PubMed=12659632; DOI=10.1042/BJ20021866;
RA   Yamada K., Kawata H., Shou Z., Hirano S., Mizutani T., Yazawa T.,
RA   Sekiguchi T., Yoshino M., Kajitani T., Miyamoto K.;
RT   "Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins:
RT   molecular cloning and characterization of a member of the ZHX family,
RT   ZHX3.";
RL   Biochem. J. 373:167-178(2003).
RN   [7] {ECO:0000305}
RP   HETERODIMERIZATION WITH ZHX2.
RX   PubMed=12741956; DOI=10.1042/BJ20030171;
RA   Kawata H., Yamada K., Shou Z., Mizutani T., Yazawa T., Yoshino M.,
RA   Sekiguchi T., Kajitani T., Miyamoto K.;
RT   "Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX
RT   family, functions as a transcriptional repressor.";
RL   Biochem. J. 373:747-757(2003).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=17056598; DOI=10.1074/jbc.M606664200;
RA   Liu G., Clement L.C., Kanwar Y.S., Avila-Casado C., Chugh S.S.;
RT   "ZHX proteins regulate podocyte gene expression during the development
RT   of nephrotic syndrome.";
RL   J. Biol. Chem. 281:39681-39692(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   INTERACTION WITH DNMT3B.
RX   PubMed=17303076; DOI=10.1016/j.bbrc.2007.01.187;
RA   Kim S.H., Park J., Choi M.C., Kim H.P., Park J.H., Jung Y., Lee J.H.,
RA   Oh D.Y., Im S.A., Bang Y.J., Kim T.Y.;
RT   "Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase
RT   (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression.";
RL   Biochem. Biophys. Res. Commun. 355:318-323(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-47 AND SER-48,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-48 AND SER-648,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202 AND SER-774, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-36 AND SER-48, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-454, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-159; LYS-441; LYS-454;
RP   LYS-485 AND LYS-629, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [18] {ECO:0000312|EMBL:AAF35183.1}
RP   STRUCTURE BY NMR OF 60-153.
RG   Structural proteomics in Europe (SPINE);
RT   "Solution structure of the zinc-finger region of human zinc-fingers
RT   and homeoboxes 1 (ZHX1).";
RL   Submitted (APR-2006) to the PDB data bank.
RN   [19] {ECO:0000312|EMBL:AAF35183.1}
RP   STRUCTURE BY NMR OF 565-640.
RG   RIKEN structural genomics initiative (RSGI);
RT   "The solution structure of the third homeobox domain of human zinc
RT   fingers and homeoboxes protein.";
RL   Submitted (FEB-2007) to the PDB data bank.
RN   [20]
RP   STRUCTURE BY NMR OF 60-153.
RX   PubMed=19348505; DOI=10.1021/bi9001997;
RA   Wienk H., Lammers I., Hotze A., Wu J., Wechselberger R.W., Owens R.,
RA   Stammers D.K., Stuart D., Kaptein R., Folkers G.E.;
RT   "The tandem zinc-finger region of human ZHX adopts a novel C2H2 zinc
RT   finger structure with a C-terminal extension.";
RL   Biochemistry 48:4431-4439(2009).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 655-731.
RX   PubMed=20509910; DOI=10.1186/1472-6807-10-13;
RA   Bird L.E., Ren J., Nettleship J.E., Folkers G.E., Owens R.J.,
RA   Stammers D.K.;
RT   "Novel structural features in two ZHX homeodomains derived from a
RT   systematic study of single and multiple domains.";
RL   BMC Struct. Biol. 10:13-13(2010).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Increases DNMT3B-
CC       mediated repressive transcriptional activity when DNMT3B is
CC       tethered to DNA. May link molecule between DNMT3B and other co-
CC       repressor proteins. {ECO:0000269|PubMed:12237128}.
CC   -!- SUBUNIT: Forms homodimers. Heterodimer (via HD1 domain) with ZHX2
CC       (via HD1 domain). Also forms a heterodimer with ZHX3 which is a
CC       prerequisite for repressor activity. Interacts with ATF7IP and
CC       NFYA. Interacts (via homeobox domains) with DNMT3B (via PWWP
CC       domain). {ECO:0000269|PubMed:10441475,
CC       ECO:0000269|PubMed:10571058, ECO:0000269|PubMed:12659632,
CC       ECO:0000269|PubMed:17303076}.
CC   -!- INTERACTION:
CC       P54253:ATXN1; NbExp=5; IntAct=EBI-347767, EBI-930964;
CC       Q9UBC3-1:DNMT3B; NbExp=6; IntAct=EBI-347767, EBI-6083193;
CC       Q9Y6X8:ZHX2; NbExp=2; IntAct=EBI-347767, EBI-948566;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:12237128,
CC       ECO:0000269|PubMed:17056598}. Note=Colocalized in the nucleus with
CC       DNMT3B.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UKY1-1; Sequence=Displayed;
CC       Name=2; Synonyms=ZHX1-C8orf76;
CC         IsoId=Q96EF9-1; Sequence=External;
CC         Note=Based on a readthrough transcript which may produce a
CC         ZHX1-C8orf76 fusion protein. No experimental confirmation
CC         available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in
CC       podocytes. {ECO:0000269|PubMed:10441475,
CC       ECO:0000269|PubMed:17056598}.
CC   -!- SIMILARITY: Belongs to the ZHX family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF106862; AAD50624.1; -; mRNA.
DR   EMBL; AF195766; AAF35183.1; -; mRNA.
DR   EMBL; BC040481; AAH40481.1; -; mRNA.
DR   CCDS; CCDS6342.1; -. [Q9UKY1-1]
DR   PIR; JC7079; JC7079.
DR   RefSeq; NP_001017926.1; NM_001017926.2. [Q9UKY1-1]
DR   RefSeq; NP_009153.3; NM_007222.4. [Q9UKY1-1]
DR   UniGene; Hs.521800; -.
DR   PDB; 2ECB; NMR; -; A=565-640.
DR   PDB; 2GHF; NMR; -; A=60-153.
DR   PDB; 2LY9; NMR; -; A=462-532.
DR   PDB; 3NAR; X-ray; 2.60 A; A/B=655-731.
DR   PDBsum; 2ECB; -.
DR   PDBsum; 2GHF; -.
DR   PDBsum; 2LY9; -.
DR   PDBsum; 3NAR; -.
DR   ProteinModelPortal; Q9UKY1; -.
DR   SMR; Q9UKY1; -.
DR   BioGrid; 116406; 58.
DR   IntAct; Q9UKY1; 58.
DR   MINT; MINT-1424551; -.
DR   STRING; 9606.ENSP00000297857; -.
DR   iPTMnet; Q9UKY1; -.
DR   PhosphoSitePlus; Q9UKY1; -.
DR   BioMuta; ZHX1; -.
DR   DMDM; 44888551; -.
DR   EPD; Q9UKY1; -.
DR   MaxQB; Q9UKY1; -.
DR   PaxDb; Q9UKY1; -.
DR   PeptideAtlas; Q9UKY1; -.
DR   PRIDE; Q9UKY1; -.
DR   Ensembl; ENST00000297857; ENSP00000297857; ENSG00000165156. [Q9UKY1-1]
DR   Ensembl; ENST00000395571; ENSP00000378938; ENSG00000165156. [Q9UKY1-1]
DR   Ensembl; ENST00000522655; ENSP00000428821; ENSG00000165156. [Q9UKY1-1]
DR   GeneID; 11244; -.
DR   KEGG; hsa:11244; -.
DR   UCSC; uc003yqe.4; human. [Q9UKY1-1]
DR   CTD; 11244; -.
DR   DisGeNET; 11244; -.
DR   EuPathDB; HostDB:ENSG00000165156.14; -.
DR   GeneCards; ZHX1; -.
DR   HGNC; HGNC:12871; ZHX1.
DR   HPA; HPA055357; -.
DR   HPA; HPA060251; -.
DR   MIM; 604764; gene.
DR   neXtProt; NX_Q9UKY1; -.
DR   OpenTargets; ENSG00000165156; -.
DR   PharmGKB; PA37460; -.
DR   eggNOG; ENOG410IHET; Eukaryota.
DR   eggNOG; ENOG410Z8A2; LUCA.
DR   GeneTree; ENSGT00530000063149; -.
DR   HOGENOM; HOG000013231; -.
DR   HOVERGEN; HBG007920; -.
DR   InParanoid; Q9UKY1; -.
DR   OMA; KIWFSAQ; -.
DR   OrthoDB; EOG091G02WT; -.
DR   PhylomeDB; Q9UKY1; -.
DR   TreeFam; TF333363; -.
DR   EvolutionaryTrace; Q9UKY1; -.
DR   GeneWiki; ZHX1; -.
DR   GenomeRNAi; 11244; -.
DR   PRO; PR:Q9UKY1; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000165156; -.
DR   CleanEx; HS_ZHX1; -.
DR   ExpressionAtlas; Q9UKY1; baseline and differential.
DR   Genevisible; Q9UKY1; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 5.
DR   Gene3D; 4.10.1050.10; -; 1.
DR   InterPro; IPR026939; At2g23090-like.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR024578; Homez_homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 4.
DR   Pfam; PF11569; Homez; 1.
DR   SMART; SM00389; HOX; 5.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   SUPFAM; SSF46689; SSF46689; 5.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Differentiation; DNA-binding; Homeobox; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    873       Zinc fingers and homeoboxes protein 1.
FT                                /FTId=PRO_0000049388.
FT   ZN_FING      70     93       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042, ECO:0000305}.
FT   ZN_FING     102    125       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042, ECO:0000305}.
FT   DNA_BIND    284    346       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    464    526       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    569    630       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    660    722       Homeobox 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   DNA_BIND    777    832       Homeobox 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108, ECO:0000305}.
FT   REGION      272    564       Required for interaction with NFYA.
FT   REGION      272    432       Required for dimerization.
FT   REGION      734    768       Required for nuclear localization.
FT   REGION      831    873       Required for repressor activity.
FT   MOD_RES      36     36       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      45     45       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     202    202       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     774    774       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    159    159       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    441    441       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    454    454       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    485    485       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    629    629       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CONFLICT    263    263       V -> M (in Ref. 3; AAH40481).
FT                                {ECO:0000305}.
FT   CONFLICT    792    792       H -> R (in Ref. 3; AAH40481).
FT                                {ECO:0000305}.
FT   TURN         60     62       {ECO:0000244|PDB:2GHF}.
FT   STRAND       68     71       {ECO:0000244|PDB:2GHF}.
FT   STRAND       78     80       {ECO:0000244|PDB:2GHF}.
FT   HELIX        82     92       {ECO:0000244|PDB:2GHF}.
FT   STRAND      102    104       {ECO:0000244|PDB:2GHF}.
FT   TURN        105    108       {ECO:0000244|PDB:2GHF}.
FT   STRAND      109    113       {ECO:0000244|PDB:2GHF}.
FT   HELIX       115    118       {ECO:0000244|PDB:2GHF}.
FT   HELIX       120    123       {ECO:0000244|PDB:2GHF}.
FT   STRAND      131    135       {ECO:0000244|PDB:2GHF}.
FT   STRAND      144    150       {ECO:0000244|PDB:2GHF}.
FT   HELIX       473    485       {ECO:0000244|PDB:2LY9}.
FT   HELIX       491    501       {ECO:0000244|PDB:2LY9}.
FT   HELIX       505    518       {ECO:0000244|PDB:2LY9}.
FT   TURN        519    523       {ECO:0000244|PDB:2LY9}.
FT   HELIX       577    589       {ECO:0000244|PDB:2ECB}.
FT   HELIX       595    604       {ECO:0000244|PDB:2ECB}.
FT   HELIX       609    624       {ECO:0000244|PDB:2ECB}.
FT   STRAND      664    667       {ECO:0000244|PDB:3NAR}.
FT   HELIX       669    681       {ECO:0000244|PDB:3NAR}.
FT   HELIX       687    697       {ECO:0000244|PDB:3NAR}.
FT   HELIX       701    715       {ECO:0000244|PDB:3NAR}.
FT   TURN        716    718       {ECO:0000244|PDB:3NAR}.
FT   HELIX       721    730       {ECO:0000244|PDB:3NAR}.
SQ   SEQUENCE   873 AA;  98098 MW;  66CF1CEC5EF824E5 CRC64;
     MASRRKSTTP CMVLASEQDP DLELISDLDE GPPVLTPVEN TRAESISSDE EVHESVDSDN
     QQNKKVEGGY ECKYCTFQTP DLNMFTFHVD SEHPNVVLNS SYVCVECNFL TKRYDALSEH
     NLKYHPGEEN FKLTMVKRNN QTIFEQTIND LTFDGSFVKE ENAEQAESTE VSSSGISISK
     TPIMKMMKNK VENKRIAVHH NSVEDVPEEK ENEIKPDREE IVENPSSSAS ESNTSTSIVN
     RIHPSTASTV VTPAAVLPGL AQVITAVSAQ QNSNLIPKVL IPVNSIPTYN AALDNNPLLL
     NTYNKFPYPT MSEITVLSAQ AKYTEEQIKI WFSAQRLKHG VSWTPEEVEE ARRKQFNGTV
     HTVPQTITVI PTHISTGSNG LPSILQTCQI VGQPGLVLTQ VAGTNTLPVT APIALTVAGV
     PSQNNIQKSQ VPAAQPTAET KPATAAVPTS QSVKHETALV NPDSFGIRAK KTKEQLAELK
     VSYLKNQFPH DSEIIRLMKI TGLTKGEIKK WFSDTRYNQR NSKSNQCLHL NNDSSTTIII
     DSSDETTESP TVGTAQPKQS WNPFPDFTPQ KFKEKTAEQL RVLQASFLNS SVLTDEELNR
     LRAQTKLTRR EIDAWFTEKK KSKALKEEKM EIDESNAGSS KEEAGETSPA DESGAPKSGS
     TGKICKKTPE QLHMLKSAFV RTQWPSPEEY DKLAKESGLA RTDIVSWFGD TRYAWKNGNL
     KWYYYYQSAN SSSMNGLSSL RKRGRGRPKG RGRGRPRGRP RGSKRINNWD RGPSLIKFKT
     GTAILKDYYL KHKFLNEQDL DELVNKSHMG YEQVREWFAE RQRRSELGIE LFEENEEEDE
     VIDDQEEDEE ETDDSDTWEP PRHVKRKLSK SDD
//
ID   ZHX3_HUMAN              Reviewed;         956 AA.
AC   Q9H4I2; E1P5W5; F5H820; O43145; Q6NUJ7;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 3.
DT   25-OCT-2017, entry version 154.
DE   RecName: Full=Zinc fingers and homeoboxes protein 3;
DE   AltName: Full=Triple homeobox protein 1;
DE   AltName: Full=Zinc finger and homeodomain protein 3;
GN   Name=ZHX3; Synonyms=KIAA0395, TIX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, HOMODIMERIZATION,
RP   HETERODIMERIZATION WITH ZFX1, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INTERACTION WITH NFYA.
RC   TISSUE=Testis;
RX   PubMed=12659632; DOI=10.1042/BJ20021866;
RA   Yamada K., Kawata H., Shou Z., Hirano S., Mizutani T., Yazawa T.,
RA   Sekiguchi T., Yoshino M., Kajitani T., Miyamoto K.;
RT   "Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins:
RT   molecular cloning and characterization of a member of the ZHX family,
RT   ZHX3.";
RL   Biochem. J. 373:167-178(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-680, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-946, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   FUNCTION, INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21174497; DOI=10.1089/scd.2010.0279;
RA   Suehiro F., Nishimura M., Kawamoto T., Kanawa M., Yoshizawa Y.,
RA   Murata H., Kato Y.;
RT   "Impact of zinc fingers and homeoboxes 3 on the regulation of
RT   mesenchymal stem cell osteogenic differentiation.";
RL   Stem Cells Dev. 20:1539-1547(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-599; SER-604; SER-680
RP   AND SER-723, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927 AND SER-946, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   STRUCTURE BY NMR OF 494-675.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of zinc fingers and
RT   homeoboxes protein 3 (triple homeobox 1 protein).";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [16]
RP   STRUCTURE BY NMR OF 494-556.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second homeobox domain of human zinc
RT   fingers and homeoboxes protein 3.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Acts as a transcriptional repressor. Involved in the
CC       early stages of mesenchymal stem cell (MSC) osteogenic
CC       differentiation. Is a regulator of podocyte gene expression during
CC       primary glomerula disease. Binds to promoter DNA.
CC       {ECO:0000269|PubMed:12659632, ECO:0000269|PubMed:21174497}.
CC   -!- SUBUNIT: Homodimer (via homeobox domain). Also forms heterodimers
CC       with ZHX1 and ZHX2. Heterodimerization with ZHX1 is a prerequisite
CC       for repressor activity. Interacts with NFYA.
CC       {ECO:0000269|PubMed:12659632}.
CC   -!- INTERACTION:
CC       Q9UBE8:NLK; NbExp=4; IntAct=EBI-948582, EBI-366978;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000269|PubMed:12659632}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H4I2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H4I2-2; Sequence=VSP_054307;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. High expression in kidney.
CC       Expressed during osteogenic differentiation.
CC       {ECO:0000269|PubMed:12659632, ECO:0000269|PubMed:21174497}.
CC   -!- INDUCTION: Up-regulated during osteogenic differentiation of
CC       mesenchymal stem cells. {ECO:0000269|PubMed:21174497}.
CC   -!- SIMILARITY: Belongs to the ZHX family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA23691.3; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB081948; BAC65211.1; -; mRNA.
DR   EMBL; AB007855; BAA23691.3; ALT_INIT; mRNA.
DR   EMBL; AL022394; CAA18538.1; -; Genomic_DNA.
DR   EMBL; AL031257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75987.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75988.1; -; Genomic_DNA.
DR   EMBL; BC068569; AAH68569.1; -; mRNA.
DR   CCDS; CCDS13315.1; -. [Q9H4I2-1]
DR   RefSeq; NP_055850.1; NM_015035.3. [Q9H4I2-1]
DR   RefSeq; XP_005260398.1; XM_005260341.3. [Q9H4I2-2]
DR   RefSeq; XP_011527022.1; XM_011528720.1. [Q9H4I2-1]
DR   RefSeq; XP_016883226.1; XM_017027737.1. [Q9H4I2-1]
DR   RefSeq; XP_016883227.1; XM_017027738.1. [Q9H4I2-1]
DR   UniGene; Hs.380133; -.
DR   PDB; 2DA5; NMR; -; A=613-674.
DR   PDB; 2DN0; NMR; -; A=494-556.
DR   PDBsum; 2DA5; -.
DR   PDBsum; 2DN0; -.
DR   ProteinModelPortal; Q9H4I2; -.
DR   SMR; Q9H4I2; -.
DR   BioGrid; 116688; 10.
DR   IntAct; Q9H4I2; 5.
DR   MINT; MINT-2870187; -.
DR   STRING; 9606.ENSP00000362360; -.
DR   iPTMnet; Q9H4I2; -.
DR   PhosphoSitePlus; Q9H4I2; -.
DR   BioMuta; ZHX3; -.
DR   DMDM; 44889075; -.
DR   EPD; Q9H4I2; -.
DR   MaxQB; Q9H4I2; -.
DR   PaxDb; Q9H4I2; -.
DR   PeptideAtlas; Q9H4I2; -.
DR   PRIDE; Q9H4I2; -.
DR   Ensembl; ENST00000309060; ENSP00000312222; ENSG00000174306. [Q9H4I2-1]
DR   Ensembl; ENST00000432768; ENSP00000415498; ENSG00000174306. [Q9H4I2-1]
DR   Ensembl; ENST00000544979; ENSP00000443783; ENSG00000174306. [Q9H4I2-2]
DR   Ensembl; ENST00000559234; ENSP00000452965; ENSG00000174306. [Q9H4I2-1]
DR   Ensembl; ENST00000560361; ENSP00000454006; ENSG00000174306. [Q9H4I2-1]
DR   GeneID; 23051; -.
DR   KEGG; hsa:23051; -.
DR   UCSC; uc002xjr.2; human. [Q9H4I2-1]
DR   CTD; 23051; -.
DR   EuPathDB; HostDB:ENSG00000174306.21; -.
DR   GeneCards; ZHX3; -.
DR   H-InvDB; HIX0015822; -.
DR   HGNC; HGNC:15935; ZHX3.
DR   HPA; HPA046498; -.
DR   MIM; 609598; gene.
DR   neXtProt; NX_Q9H4I2; -.
DR   OpenTargets; ENSG00000174306; -.
DR   PharmGKB; PA38056; -.
DR   eggNOG; ENOG410IHET; Eukaryota.
DR   eggNOG; ENOG410Z8A2; LUCA.
DR   GeneTree; ENSGT00530000063149; -.
DR   HOGENOM; HOG000013231; -.
DR   HOVERGEN; HBG007920; -.
DR   InParanoid; Q9H4I2; -.
DR   OrthoDB; EOG091G02WT; -.
DR   PhylomeDB; Q9H4I2; -.
DR   TreeFam; TF333363; -.
DR   ChiTaRS; ZHX3; human.
DR   EvolutionaryTrace; Q9H4I2; -.
DR   GeneWiki; ZHX3; -.
DR   GenomeRNAi; 23051; -.
DR   PRO; PR:Q9H4I2; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000174306; -.
DR   CleanEx; HS_ZHX3; -.
DR   ExpressionAtlas; Q9H4I2; baseline and differential.
DR   Genevisible; Q9H4I2; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 4.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR024578; Homez_homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 3.
DR   Pfam; PF11569; Homez; 1.
DR   SMART; SM00389; HOX; 4.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   SUPFAM; SSF46689; SSF46689; 5.
DR   SUPFAM; SSF57667; SSF57667; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Differentiation; DNA-binding; Homeobox; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    956       Zinc fingers and homeoboxes protein 3.
FT                                /FTId=PRO_0000049395.
FT   ZN_FING      77    100       C2H2-type 1.
FT   ZN_FING     109    132       C2H2-type 2.
FT   DNA_BIND    304    363       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    494    553       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    612    671       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    764    823       Homeobox 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND    835    894       Homeobox 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION        1    107       Required for nuclear localization.
FT   REGION      242    488       Required for homodimerization and
FT                                interaction with NFYA.
FT                                {ECO:0000269|PubMed:12659632}.
FT   REGION      303    502       Required for repressor activity.
FT   REGION      497    555       Required for nuclear localization.
FT   MOD_RES     599    599       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     604    604       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     680    680       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     708    708       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C0Q2}.
FT   MOD_RES     723    723       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     927    927       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     946    946       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     879    956       VKQWFAEKMGEETRAVADTGSEDQGPGTGELTAVHKGMGDT
FT                                YSEVSENSESWEPRVPEASSEPFDTSSPQAGRQLETD ->
FT                                KQTEFDLINVKDWPVWETACHVEEPNPTLCCHMPFPCPAAG
FT                                HLGELPESSQTAQSLPLPSACPPPSKQQARWGSHQFFLPQC
FT                                RTFPLPSNG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054307.
FT   VARIANT     310    310       N -> S (in dbSNP:rs17265513).
FT                                /FTId=VAR_049597.
FT   CONFLICT    642    642       L -> M (in Ref. 7; AAH68569).
FT                                {ECO:0000305}.
FT   CONFLICT    907    907       G -> T (in Ref. 2; BAA23691).
FT                                {ECO:0000305}.
FT   HELIX       503    515       {ECO:0000244|PDB:2DN0}.
FT   STRAND      516    518       {ECO:0000244|PDB:2DN0}.
FT   HELIX       522    531       {ECO:0000244|PDB:2DN0}.
FT   HELIX       535    548       {ECO:0000244|PDB:2DN0}.
FT   STRAND      549    551       {ECO:0000244|PDB:2DN0}.
FT   STRAND      554    556       {ECO:0000244|PDB:2DN0}.
FT   HELIX       621    633       {ECO:0000244|PDB:2DA5}.
FT   HELIX       639    649       {ECO:0000244|PDB:2DA5}.
FT   HELIX       653    663       {ECO:0000244|PDB:2DA5}.
FT   HELIX       666    669       {ECO:0000244|PDB:2DA5}.
SQ   SEQUENCE   956 AA;  104658 MW;  B3DB35CFC1781A3A CRC64;
     MASKRKSTTP CMIPVKTVVL QDASMEAQPA ETLPEGPQQD LPPEASAASS EAAQNPSSTD
     GSTLANGHRS TLDGYLYSCK YCDFRSHDMT QFVGHMNSEH TDFNKDPTFV CSGCSFLAKT
     PEGLSLHNAT CHSGEASFVW NVAKPDNHVV VEQSIPESTS TPDLAGEPSA EGADGQAEII
     ITKTPIMKIM KGKAEAKKIH TLKENVPSQP VGEALPKLST GEMEVREGDH SFINGAVPVS
     QASASSAKNP HAANGPLIGT VPVLPAGIAQ FLSLQQQPPV HAQHHVHQPL PTAKALPKVM
     IPLSSIPTYN AAMDSNSFLK NSFHKFPYPT KAELCYLTVV TKYPEEQLKI WFTAQRLKQG
     ISWSPEEIED ARKKMFNTVI QSVPQPTITV LNTPLVASAG NVQHLIQAAL PGHVVGQPEG
     TGGGLLVTQP LMANGLQATS SPLPLTVTSV PKQPGVAPIN TVCSNTTSAV KVVNAAQSLL
     TACPSITSQA FLDASIYKNK KSHEQLSALK GSFCRNQFPG QSEVEHLTKV TGLSTREVRK
     WFSDRRYHCR NLKGSRAMIP GDHSSIIIDS VPEVSFSPSS KVPEVTCIPT TATLATHPSA
     KRQSWHQTPD FTPTKYKERA PEQLRALESS FAQNPLPLDE ELDRLRSETK MTRREIDSWF
     SERRKKVNAE ETKKAEENAS QEEEEAAEDE GGEEDLASEL RVSGENGSLE MPSSHILAER
     KVSPIKINLK NLRVTEANGR NEIPGLGACD PEDDESNKLA EQLPGKVSCK KTAQQRHLLR
     QLFVQTQWPS NQDYDSIMAQ TGLPRPEVVR WFGDSRYALK NGQLKWYEDY KRGNFPPGLL
     VIAPGNRELL QDYYMTHKML YEEDLQNLCD KTQMSSQQVK QWFAEKMGEE TRAVADTGSE
     DQGPGTGELT AVHKGMGDTY SEVSENSESW EPRVPEASSE PFDTSSPQAG RQLETD
//
ID   ZFHX2_HUMAN             Reviewed;        2572 AA.
AC   Q9C0A1; Q9UPU6;
DT   12-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 3.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Zinc finger homeobox protein 2;
DE   AltName: Full=Zinc finger homeodomain protein 2;
DE            Short=ZFH-2;
GN   Name=ZFHX2; Synonyms=KIAA1056, KIAA1762, ZNF409;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1113-2572 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9C0A1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9C0A1-2; Sequence=VSP_039496, VSP_039497;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA83008.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028979; BAA83008.2; ALT_INIT; mRNA.
DR   EMBL; AB051549; BAB21853.1; -; mRNA.
DR   EMBL; AL132855; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL135999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS55907.1; -. [Q9C0A1-1]
DR   RefSeq; NP_207646.2; NM_033400.2. [Q9C0A1-1]
DR   RefSeq; XP_011535547.1; XM_011537245.2. [Q9C0A1-1]
DR   RefSeq; XP_011535548.1; XM_011537246.2. [Q9C0A1-1]
DR   RefSeq; XP_011535549.1; XM_011537247.2. [Q9C0A1-1]
DR   RefSeq; XP_016877203.1; XM_017021714.1. [Q9C0A1-1]
DR   UniGene; Hs.508937; -.
DR   ProteinModelPortal; Q9C0A1; -.
DR   BioGrid; 124533; 1.
DR   iPTMnet; Q9C0A1; -.
DR   PhosphoSitePlus; Q9C0A1; -.
DR   BioMuta; ZFHX2; -.
DR   DMDM; 300669698; -.
DR   EPD; Q9C0A1; -.
DR   PaxDb; Q9C0A1; -.
DR   PeptideAtlas; Q9C0A1; -.
DR   PRIDE; Q9C0A1; -.
DR   Ensembl; ENST00000419474; ENSP00000413418; ENSG00000136367. [Q9C0A1-1]
DR   GeneID; 85446; -.
DR   KEGG; hsa:85446; -.
DR   UCSC; uc010tno.2; human. [Q9C0A1-1]
DR   CTD; 85446; -.
DR   EuPathDB; HostDB:ENSG00000136367.13; -.
DR   GeneCards; ZFHX2; -.
DR   H-InvDB; HIX0011544; -.
DR   H-InvDB; HIX0172362; -.
DR   HGNC; HGNC:20152; ZFHX2.
DR   HPA; HPA000720; -.
DR   HPA; HPA005146; -.
DR   neXtProt; NX_Q9C0A1; -.
DR   OpenTargets; ENSG00000136367; -.
DR   eggNOG; KOG1146; Eukaryota.
DR   eggNOG; ENOG410XVMY; LUCA.
DR   GeneTree; ENSGT00530000063717; -.
DR   HOGENOM; HOG000128272; -.
DR   HOVERGEN; HBG063719; -.
DR   InParanoid; Q9C0A1; -.
DR   KO; K09379; -.
DR   OMA; HNVVPEC; -.
DR   OrthoDB; EOG091G0611; -.
DR   PhylomeDB; Q9C0A1; -.
DR   TreeFam; TF323288; -.
DR   GenomeRNAi; 85446; -.
DR   PRO; PR:Q9C0A1; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000136367; -.
DR   CleanEx; HS_ZFHX2; -.
DR   ExpressionAtlas; Q9C0A1; baseline and differential.
DR   Genevisible; Q9C0A1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030534; P:adult behavior; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 3.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR027028; ZFHX2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24208:SF119; PTHR24208:SF119; 1.
DR   Pfam; PF00046; Homeobox; 3.
DR   SMART; SM00389; HOX; 3.
DR   SMART; SM00355; ZnF_C2H2; 15.
DR   SMART; SM00451; ZnF_U1; 7.
DR   SUPFAM; SSF46689; SSF46689; 3.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 9.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 5.
PE   2: Evidence at transcript level;
KW   Activator; Alternative splicing; Complete proteome; DNA-binding;
KW   Homeobox; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1   2572       Zinc finger homeobox protein 2.
FT                                /FTId=PRO_0000047243.
FT   ZN_FING     821    845       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     870    894       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1009   1032       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1191   1217       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1248   1272       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1480   1503       C2H2-type 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   1595   1654       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    1670   1696       C2H2-type 10; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    1769   1791       C2H2-type 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   1857   1916       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND   2065   2124       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    2451   2472       C2H2-type 12; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    2495   2519       C2H2-type 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   COMPBIAS    605    710       Pro-rich.
FT   COMPBIAS   1061   1144       Pro-rich.
FT   COMPBIAS   1321   1471       Pro-rich.
FT   COMPBIAS   1699   1759       Glu-rich.
FT   COMPBIAS   1921   2018       Pro-rich.
FT   COMPBIAS   2193   2424       Pro-rich.
FT   VAR_SEQ     854    862       FLLDMEGAE -> RTETGLLIK (in isoform 2).
FT                                {ECO:0000303|PubMed:11214970}.
FT                                /FTId=VSP_039496.
FT   VAR_SEQ     863   2572       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11214970}.
FT                                /FTId=VSP_039497.
FT   CONFLICT    473    473       R -> Q (in Ref. 1; BAA83008).
FT                                {ECO:0000305}.
FT   CONFLICT    550    550       P -> T (in Ref. 1; BAA83008).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2572 AA;  274176 MW;  239C8050F65B25C2 CRC64;
     MATLNSASTT GTTPSPGHNA PSLPSDTFSS STPSDPVTKD PPAASSTSEN MRSSEPGGQL
     LESGCGLVPP KEIGEPQEGP DCGHFPPNDP GVEKDKEQEE EEEGLPPMDL SNHLFFTAGG
     EAYLVAKLSL PGGSELLLPK GFPWGEAGIK EEPSLPFLAY PPPSHLTALH IQHGFDPIQG
     FSSSDQILSH DTSAPSPAAC EERHGAFWSY QLAPNPPGDP KDGPMGNSGG NHVAVFWLCL
     LCRLGFSKPQ AFMDHTQSHG VKLTPAQYQG LSGSPAVLQE GDEGCKALIS FLEPKLPARP
     SSDIPLDNSS TVNMEANVAQ TEDGPPEAEV QALILLDEEV MALSPPSPPT ATWDPSPTQA
     KESPVAAGEA GPDWFPEGQE EDGGLCPPLN QSSPTSKEGG TLPAPVGSPE DPSDPPQPYR
     LADDYTPAPA AFQGLSLSSH MSLLHSRNSC KTLKCPKCNW HYKYQQTLDV HMREKHPESN
     SHCSYCSAGG AHPRLARGES YNCGYKPYRC DVCNYSTTTK GNLSIHMQSD KHLANLQGFQ
     AGPGGQGSPP EASLPPSAGD KEPKTKSSWQ CKVCSYETNI SRNLRIHMTS EKHMQNVLML
     HQGLPLGLPP GLMGPGPPPP PGATPTSPPE LFQYFGPQAL GQPQTPLAGP GLRPDKPLEA
     QLLLNGFHHV GAPARKFPTS APGSLSPDAH LPPSQLLGSS SDSLPTSPPP DDSLSLKVFR
     CLVCQAFSTD SLELLLYHCS IGRSLPEAEW KEVAGDTHRC KLCCYGTQLK ANFQLHLKTD
     KHAQKYQLAA HLREGGGAMG TPSPASLGDG APYGSVSPLH LRCNICDFES NSKEKMQLHA
     RGAAHEENSQ IYKFLLDMEG AEAGAELGLY HCLLCAWETP SRLAVLQHLR TPAHRDAQAQ
     RRLQLLQNGP TTEEGLAALQ SILSFSHGQL RTPGKAPVTP LAEPPTPEKD AQNKTEQLAS
     EETENKTGPS RDSANQTTVY CCPYCSFLSP ESSQVRAHTL SQHAVQPKYR CPLCQEQLVG
     RPALHFHLSH LHNVVPECVE KLLLVATTVE MTFTTKVLSA PTLSPLDNGQ EPPTHGPEPT
     PSRDQAAEGP NLTPEASPDP LPEPPLASVE VPDKPSGSPG QPPSPAPSPV PEPDAQAEDV
     APPPTMAEEE EGTTGELRSA EPAPADSRHP LTYRKTTNFA LDKFLDPARP YKCTVCKESF
     TQKNILLVHY NSVSHLHKMK KAAIDPSAPA RGEAGAPPTT TAATDKPFKC TVCRVSYNQS
     STLEIHMRSV LHQTRSRGTK TDSKIEGPER SQEEPKEGET EGEVGTEKKG PDTSGFISGL
     PFLSPPPPPL DLHRFPAPLF TPPVLPPFPL VPESLLKLQQ QQLLLPFYLH DLKVGPKLTL
     AGPAPVLSLP AATPPPPPQP PKAELAEREW ERPPMAKEGN EAGPSSPPDP LPNEAARTAA
     KALLENFGFE LVIQYNEGKQ AVPPPPTPPP PEALGGGDKL ACGACGKLFS NMLILKTHEE
     HVHRRFLPFE ALSRYAAQFR KSYDSLYPPL AEPPKPPDGS LDSPVPHLGP PFLVPEPEAG
     GTRAPEERSR AGGHWPIEEE ESSRGNLPPL VPAGRRFSRT KFTEFQTQAL QSFFETSAYP
     KDGEVERLAS LLGLASRVVV VWFQNARQKA RKNACEGGSM PTGGGTGGAS GCRRCHATFS
     CVFELVRHLK KCYDDQTLEE EEEEAERGEE EEEVEEEEVE EEQGLEPPAG PEGPLPEPPD
     GEELSQAEAT KAGGKEPEEK ATPSPSPAHT CDQCAISFSS QDLLTSHRRL HFLPSLQPSA
     PPQLLDLPLL VFGERNPLVA ATSPMPGPPL KRKHEDGSLS PTGSEAGGGG EGEPPRDKRL
     RTTILPEQLE ILYRWYMQDS NPTRKMLDCI SEEVGLKKRV VQVWFQNTRA RERKGQFRST
     PGGVPSPAVK PPATATPASL PKFNLLLGKV DDGTGREAPK REAPAFPYPT ATLASGPQPF
     LPPGKEATTP TPEPPLPLLP PPPPSEEEGP EEPPKASPES EACSLSAGDL SDSSASSLAE
     PESPGAGGTS GGPGGGTGVP DGMGQRRYRT QMSSLQLKIM KACYEAYRTP TMQECEVLGE
     EIGLPKRVIQ VWFQNARAKE KKAKLQGTAA GSTGGSSEGL LAAQRTDCPY CDVKYDFYVS
     CRGHLFSRQH LAKLKEAVRA QLKSESKCYD LAPAPEAPPA LKAPPATTPA SMPLGAAPTL
     PRLAPVLLSG PALAQPPLGN LAPFNSGPAA SSGLLGLATS VLPTTTVVQT AGPGRPLPQR
     PMPDQTNTST AGTTDPVPGP PTEPLGDKVS SERKPVAGPT SSSNDALKNL KALKTTVPAL
     LGGQFLPFPL PPAGGTAPPA VFGPQLQGAY FQQLYGMKKG LFPMNPMIPQ TLIGLLPNAL
     LQPPPQPPEP TATAPPKPPE LPAPGEGEAG EVDELLTGST GISTVDVTHR YLCRQCKMAF
     DGEAPATAHQ RSFCFFGRGS GGSMPPPLRV PICTYHCLAC EVLLSGREAL ASHLRSSAHR
     RKAAPPQGGP PISITNAATA ASAAVAFAKE EARLPHTDSN PKTTTTSTLL AL
//
ID   ZFHX4_HUMAN             Reviewed;        3567 AA.
AC   Q86UP3; G3V138; Q18PS0; Q6ZN20;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   25-OCT-2017, entry version 143.
DE   RecName: Full=Zinc finger homeobox protein 4;
DE   AltName: Full=Zinc finger homeodomain protein 4;
DE            Short=ZFH-4;
GN   Name=ZFHX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RX   PubMed=16946494; DOI=10.1248/bpb.29.1830;
RA   Hemmi K., Ma D., Miura Y., Kawaguchi M., Sasahara M.,
RA   Hashimoto-Tamaoki T., Tamaoki T., Sakata N., Tsuchiya K.;
RT   "A homeodomain-zinc finger protein, ZFHX4, is expressed in neuronal
RT   differentiation manner and suppressed in muscle differentiation
RT   manner.";
RL   Biol. Pharm. Bull. 29:1830-1835(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Shan Y.X., Huang C.Q., Dang Y.J., Yu L.;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Mesangial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   CHROMOSOMAL REARRANGEMENT.
RX   PubMed=11935336; DOI=10.1007/s00439-002-0679-5;
RA   McMullan T.W., Crolla J.A., Gregory S.G., Carter N.P., Cooper R.A.,
RA   Howell G.R., Robinson D.O.;
RT   "A candidate gene for congenital bilateral isolated ptosis identified
RT   by molecular analysis of a de novo balanced translocation.";
RL   Hum. Genet. 110:244-250(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2663, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-3154, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1149; LYS-1299; LYS-1324;
RP   LYS-1546; LYS-1790 AND LYS-3154, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May play a role in neural and muscle differentiation (By
CC       similarity). May be involved in transcriptional regulation.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q86UP3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UP3-2; Sequence=VSP_023298, VSP_023301, VSP_023302,
CC                                  VSP_023303, VSP_023304;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q86UP3-3; Sequence=VSP_023299, VSP_023300;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q86UP3-4; Sequence=VSP_023304;
CC       Name=5;
CC         IsoId=Q86UP3-5; Sequence=VSP_023298, VSP_023301, VSP_023302,
CC                                  VSP_023304;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, skeletal muscle and liver.
CC       Very low expression in stomach.
CC   -!- DISEASE: Note=A chromosomal aberration involving ZFHX4 is found in
CC       one patient with ptosis. Translocation t(1;8)(p34.3;q21.12).
CC       {ECO:0000269|PubMed:11935336}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK131408; Type=Frameshift; Positions=338; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB083343; BAE96598.1; -; mRNA.
DR   EMBL; AY260762; AAP20225.1; -; mRNA.
DR   EMBL; AK131408; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC011716; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023200; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087110; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW87051.1; -; Genomic_DNA.
DR   CCDS; CCDS47878.2; -. [Q86UP3-5]
DR   RefSeq; NP_078997.4; NM_024721.4. [Q86UP3-5]
DR   RefSeq; XP_011515894.1; XM_011517592.2. [Q86UP3-5]
DR   RefSeq; XP_011515895.1; XM_011517593.2. [Q86UP3-5]
DR   RefSeq; XP_011515896.1; XM_011517594.2. [Q86UP3-5]
DR   RefSeq; XP_011515897.1; XM_011517595.2. [Q86UP3-5]
DR   UniGene; Hs.458973; -.
DR   ProteinModelPortal; Q86UP3; -.
DR   SMR; Q86UP3; -.
DR   BioGrid; 122877; 11.
DR   IntAct; Q86UP3; 4.
DR   STRING; 9606.ENSP00000430497; -.
DR   iPTMnet; Q86UP3; -.
DR   PhosphoSitePlus; Q86UP3; -.
DR   BioMuta; ZFHX4; -.
DR   DMDM; 74762449; -.
DR   EPD; Q86UP3; -.
DR   MaxQB; Q86UP3; -.
DR   PaxDb; Q86UP3; -.
DR   PeptideAtlas; Q86UP3; -.
DR   PRIDE; Q86UP3; -.
DR   Ensembl; ENST00000521891; ENSP00000430497; ENSG00000091656. [Q86UP3-5]
DR   GeneID; 79776; -.
DR   KEGG; hsa:79776; -.
DR   UCSC; uc003yau.3; human. [Q86UP3-1]
DR   CTD; 79776; -.
DR   DisGeNET; 79776; -.
DR   EuPathDB; HostDB:ENSG00000091656.15; -.
DR   GeneCards; ZFHX4; -.
DR   HGNC; HGNC:30939; ZFHX4.
DR   HPA; HPA023837; -.
DR   MalaCards; ZFHX4; -.
DR   MIM; 606940; gene.
DR   neXtProt; NX_Q86UP3; -.
DR   OpenTargets; ENSG00000091656; -.
DR   PharmGKB; PA134986366; -.
DR   eggNOG; KOG1146; Eukaryota.
DR   eggNOG; ENOG410XYHC; LUCA.
DR   GeneTree; ENSGT00530000063717; -.
DR   HOGENOM; HOG000155777; -.
DR   HOVERGEN; HBG050606; -.
DR   InParanoid; Q86UP3; -.
DR   KO; K09380; -.
DR   OMA; RAATMCN; -.
DR   OrthoDB; EOG091G0611; -.
DR   PhylomeDB; Q86UP3; -.
DR   TreeFam; TF323288; -.
DR   ChiTaRS; ZFHX4; human.
DR   GenomeRNAi; 79776; -.
DR   PRO; PR:Q86UP3; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000091656; -.
DR   CleanEx; HS_ZFHX4; -.
DR   ExpressionAtlas; Q86UP3; baseline and differential.
DR   Genevisible; Q86UP3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 4.
DR   Gene3D; 3.30.40.10; -; 2.
DR   Gene3D; 4.10.1050.10; -; 2.
DR   InterPro; IPR026939; At2g23090-like.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00046; Homeobox; 4.
DR   SMART; SM00389; HOX; 4.
DR   SMART; SM00355; ZnF_C2H2; 23.
DR   SMART; SM00451; ZnF_U1; 7.
DR   SUPFAM; SSF46689; SSF46689; 4.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS00027; HOMEOBOX_1; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 13.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; DNA-binding; Homeobox;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   3567       Zinc finger homeobox protein 4.
FT                                /FTId=PRO_0000278465.
FT   ZN_FING     613    636       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     644    667       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     699    723       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     767    789       C2H2-type 4; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     917    941       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     973    995       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1021   1045       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1172   1195       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1201   1224       C2H2-type 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1352   1374       C2H2-type 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1380   1403       C2H2-type 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1496   1522       C2H2-type 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1548   1572       C2H2-type 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1901   1924       C2H2-type 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   2084   2143       Homeobox 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   DNA_BIND   2181   2240       Homeobox 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    2267   2291       C2H2-type 15; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    2448   2470       C2H2-type 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   2560   2619       Homeobox 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    2630   2653       C2H2-type 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   DNA_BIND   2884   2943       Homeobox 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   ZN_FING    2962   2986       C2H2-type 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    3354   3378       C2H2-type 19; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    3398   3422       C2H2-type 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   COILED     3265   3294       {ECO:0000255}.
FT   COMPBIAS    523    526       Poly-Ser.
FT   COMPBIAS   1644   1793       Gln-rich.
FT   COMPBIAS   1949   2048       Pro-rich.
FT   COMPBIAS   2345   2429       Pro-rich.
FT   COMPBIAS   3050   3124       Pro-rich.
FT   COMPBIAS   3454   3533       Ser-rich.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES    2663   2663       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK   1149   1149       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1299   1299       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1324   1324       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1546   1546       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1790   1790       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   3154   3154       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     863    863       L -> LVNNELPPEIRLASGQLMGDDLSLLTA (in
FT                                isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:16946494}.
FT                                /FTId=VSP_023298.
FT   VAR_SEQ    1006   1049       HLQKQEGAVNPESCYYYCAVCDYTTKVKLNLVQHVRSVKHQ
FT                                QTE -> VSSDIHFRWHRVEKGINSFRAWSTSLQLKEKKRE
FT                                KTSKGRGHSF (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023299.
FT   VAR_SEQ    1050   3567       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023300.
FT   VAR_SEQ    1100   1100       H -> QLRSTSEEQS (in isoform 2 and isoform
FT                                5). {ECO:0000303|PubMed:16946494}.
FT                                /FTId=VSP_023301.
FT   VAR_SEQ    1135   1135       S -> SGIITPEKELK (in isoform 2 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:16946494}.
FT                                /FTId=VSP_023302.
FT   VAR_SEQ    2000   2016       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16946494}.
FT                                /FTId=VSP_023303.
FT   VAR_SEQ    3082   3083       IS -> TLTPPG (in isoform 2, isoform 4 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:16946494}.
FT                                /FTId=VSP_023304.
FT   VARIANT    2036   2036       I -> V (in dbSNP:rs16919452).
FT                                /FTId=VAR_057375.
FT   VARIANT    3033   3033       V -> G (in dbSNP:rs16939380).
FT                                /FTId=VAR_057376.
FT   CONFLICT     32     32       P -> L (in Ref. 3; AK131408).
FT                                {ECO:0000305}.
FT   CONFLICT    406    406       V -> A (in Ref. 3; AK131408).
FT                                {ECO:0000305}.
FT   CONFLICT    937    937       K -> E (in Ref. 3; AK131408).
FT                                {ECO:0000305}.
SQ   SEQUENCE   3567 AA;  393730 MW;  99DE9E581F477EFB CRC64;
     METCDSPPIS RQENGQSTSK LCGTTQLDNE VPEKVAGMEP DRENSSTDDN LKTDERKSEA
     LLGFSVENAA ATQVTSAKEI PCNECATSFP SLQKYMEHHC PNARLPVLKD DNESEISELE
     DSDVENLTGE IVYQPDGSAY IIEDSKESGQ NAQTGANSKL FSTAMFLDSL ASAGEKSDQS
     ASAPMSFYPQ IINTFHIASS LGKPFTADQA FPNTSALAGV GPVLHSFRVY DLRHKREKDY
     LTSDGSAKNS CVSKDVPNNV DLSKFDGCVS DGKRKPVLMC FLCKLSFGYI RSFVTHAVHD
     HRMTLNDEEQ KLLSNKCVSA IIQGIGKDKE PLISFLEPKK STSVYPHFST TNLIGPDPTF
     RGLWSAFHVE NGDSLPAGFA FLKGSASTSS SAEQPLGITQ MPKAEVNLGG LSSLVVNTPI
     TSVSLSHSSS ESSKMSESKD QENNCERPKE SNVLHPNGEC PVKSEPTEPG DEDEEDAYSN
     ELDDEEVLGE LTDSIGNKDF PLLNQSISPL SSSVLKFIEK GTSSSSATVS DDTEKKKQTA
     AVRASGSVAS NYGISGKDFA DASASKDSAT AAHPSEIARG DEDSSATPHQ HGFTPSTPGT
     PGPGGDGSPG SGIECPKCDT VLGSSRSLGG HMTMMHSRNS CKTLKCPKCN WHYKYQQTLE
     AHMKEKHPEP GGSCVYCKTG QPHPRLARGE SYTCGYKPFR CEVCNYSTTT KGNLSIHMQS
     DKHLNNVQNL QNGNGEQVFG HSAPAPNTSL SGCGTPSPSK PKQKPTWRCE VCDYETNVAR
     NLRIHMTSEK HMHNMMLLQQ NMKQIQHNLH LGLAPAEAEL YQYYLAQNIG LTGMKLENPA
     DPQLMINPFQ LDPATAAALA PGLGELSPYI SDPALKLFQC AVCNKFTSDS LEALSVHVSS
     ERSLPEEEWR AVIGDIYQCK LCNYNTQLKA NFQLHCKTDK HMQKYQLVAH IKEGGKSNEW
     RLKCIAIGNP VHLKCNACDY YTNSVDKLRL HTTNHRHEAA LKLYKHLQKQ EGAVNPESCY
     YYCAVCDYTT KVKLNLVQHV RSVKHQQTEG LRKLQLHQQG LAPEEDNLSE IFFVKDCPPN
     ELETASLGAR TCDDDLTEQH EEAEGAIKPT AVAEDDEKDT SERDNSEGKN SNKDSVSVAG
     GTQPLLLAKE EDVATKRSKP TEDNKFCHEQ FYQCPYCNYN SRDQSRIQMH VLSQHSVQPV
     ICCPLCQDVL SNKMHLQLHL THLHSVSPDC VEKLLMTVPV PDVMMPNSML LPAAASEKSE
     RDTPAAVTAE GSGKYSGESP MDDKSMAGLE DSKANVEVKN EEQKPTKEPL EVSEWNKNSS
     KDVKIPDTLQ DQLNEQQKRQ PLSVSDRHVY KYRCNHCSLA FKTMQKLQIH SQYHAIRAAT
     MCNLCQRSFR TFQALKKHLE AGHPELSEAE LQQLYASLPV NGELWAESET MSQDDHGLEQ
     EMEREYEVDH EGKASPVGSD SSSIPDDMGS EPKRTLPFRK GPNFTMEKFL DPSRPYKCTV
     CKESFTQKNI LLVHYNSVSH LHKLKKVLQE ASSPVPQETN SNTDNKPYKC SICNVAYSQS
     STLEIHMRSV LHQTKARAAK LEPSGHVAGG HSIAANVNSP GQGMLDSMSL AAVNSKDTHL
     DAKELNKKQT PDLISAQPAH HPPQSPAQIQ MQLQHELQQQ AAFFQPQFLN PAFLPHFPMT
     PEALLQFQQP QFLFPFYIPG TEFSLGPDLG LPGSATFGMP GMTGMAGSLL EDLKQQIQTQ
     HHVGQTQLQI LQQQAQQYQA TQPQLQPQKQ QQQPPPPQQQ QQQQASKLLK QEQSNIVSAD
     CQIMKDVPSY KEAEDISEKP EKPKQEFISE GEGLKEGKDT KKQKSLEPSI PPPRIASGAR
     GNAAKALLEN FGFELVIQYN ENRQKVQKKG KSGEGENTDK LECGTCGKLF SNVLILKSHQ
     EHVHGQFFPY AALEKFARQY REAYDKLYPI SPSSPETPPP PPPPPPLPPA PPQPSSMGPV
     KIPNTVSTPL QAPPPTPPPP PPPPPPPPPP PPPPPPSAPP QVQLPVSLDL PLFPSIMMQP
     VQHPALPPQL ALQLPQMDAL SADLTQLCQQ QLGLDPNFLR HSQFKRPRTR ITDDQLKILR
     AYFDINNSPS EEQIQEMAEK SGLSQKVIKH WFRNTLFKER QRNKDSPYNF SNPPITVLED
     IRIDPQPTSL EHYKSDASFS KRSSRTRFTD YQLRVLQDFF DTNAYPKDDE IEQLSTVLNL
     PTRVIVVWFQ NARQKARKSY ENQAETKDNE KRELTNERYI RTSNMQYQCK KCNVVFPRIF
     DLITHQKKQC YKDEDDDAQD ESQTEDSMDA TDQVVYKHCT VSGQTDAAKN AAAPAASSGS
     GTSTPLIPSP KPEPEKTSPK PEYPAEKPKQ SDPSPPSQGT KPALPLASTS SDPPQASTAQ
     PQPQPQPPKQ PQLIGRPPSA SQTPVPSSPL QISMTSLQNS LPPQLLQYQC DQCTVAFPTL
     ELWQEHQHMH FLAAQNQFLH SPFLERPMDM PYMIFDPNNP LMTGQLLGSS LTQMPPQASS
     SHTTAPTTVA ASLKRKLDDK EDNNCSEKEG GNSGEDQHRD KRLRTTITPE QLEILYEKYL
     LDSNPTRKML DHIAREVGLK KRVVQVWFQN TRARERKGQF RAVGPAQSHK RCPFCRALFK
     AKSALESHIR SRHWNEGKQA GYSLPPSPLI STEDGGESPQ KYIYFDYPSL PLTKIDLSSE
     NELASTVSTP VSKTAELSPK NLLSPSSFKA ECSEDVENLN APPAEAGYDQ NKTDFDETSS
     INTAISDATT GDEGNTEMES TTGSSGDVKP ALSPKEPKTL DTLPKPATTP TTEVCDDKFL
     FSLTSPSIHF NDKDGDHDQS FYITDDPDDN ADRSETSSIA DPSSPNPFGS SNPFKSKSND
     RPGHKRFRTQ MSNLQLKVLK ACFSDYRTPT MQECEMLGNE IGLPKRVVQV WFQNARAKEK
     KFKINIGKPF MINQGGTEGT KPECTLCGVK YSARLSIRDH IFSKQHISKV RETVGSQLDR
     EKDYLAPTTV RQLMAQQELD RIKKASDVLG LTVQQPGMMD SSSLHGISLP TAYPGLPGLP
     PVLLPGMNGP SSLPGFPQNS NISAGMLGFP TSATSSPALS LSSAPTKPLL QTPPPPPPPP
     PPPPSSSLSG QQTEQQNKES EKKQTKPNKV KKIKEEELEA TKPEKHPKKE EKISSALSVL
     GKVVGETHVD PIQLQALQNA IAGDPASFIG GQFLPYFIPG FASYFTPQLP GTVQGGYFPP
     VCGMESLFPY GPTMPQTLAG LSPGALLQQY QQYQQNLQES LQKQQKQQQE QQQKPVQAKT
     SKVESDQPQN SNDASETKED KSTATESTKE EPQLESKSAD FSDTYVVPFV KYEFICRKCQ
     MMFTDEDAAV NHQKSFCYFG QPLIDPQETV LRVPVSKYQC LACDVAISGN EALSQHLQSS
     LHKEKTIKQA MRNAKEHVRL LPHSVCSPNP NTTSTSQSAA SSNNTYPHLS CFSMKSWPNI
     LFQASARRAA SPPSSPPSLS LPSTVTSSLC STSGVQTSLP TESCSDESDS ELSQKLEDLD
     NSLEVKAKPA SGLDGNFNSI RMDMFSV
//
